PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Canzoneri, E; Magosso, E; Serino, A				Canzoneri, Elisa; Magosso, Elisa; Serino, Andrea			Dynamic Sounds Capture the Boundaries of Peripersonal Space Representation in Humans	PLOS ONE			English	Article							VENTRAL INTRAPARIETAL AREA; SOMATOSENSORY MULTISENSORY INTERACTIONS; ENDOGENOUS SPATIAL ATTENTION; VISUAL RECEPTIVE-FIELDS; COMPLEX MOVEMENTS; PARIETAL CORTEX; REAR SPACE; AUDIOTACTILE INTERACTIONS; POSTERIOR PARIETAL; CROSSMODAL LINKS	Background: We physically interact with external stimuli when they occur within a limited space immediately surrounding the body, i.e., Peripersonal Space (PPS). In the primate brain, specific fronto-parietal areas are responsible for the multisensory representation of PPS, by integrating tactile, visual and auditory information occurring on and near the body. Dynamic stimuli are particularly relevant for PPS representation, as they might refer to potential harms approaching the body. However, behavioural tasks for studying PPS representation with moving stimuli are lacking. Here we propose a new dynamic audio-tactile interaction task in order to assess the extension of PPS in a more functionally and ecologically valid condition. Methodology/Principal Findings: Participants vocally responded to a tactile stimulus administered at the hand at different delays from the onset of task-irrelevant dynamic sounds which gave the impression of a sound source either approaching or receding from the subject's hand. Results showed that a moving auditory stimulus speeded up the processing of a tactile stimulus at the hand as long as it was perceived at a limited distance from the hand, that is within the boundaries of PPS representation. The audio-tactile interaction effect was stronger when sounds were approaching compared to when sounds were receding. Conclusion/Significance: This study provides a new method to dynamically assess PPS representation: The function describing the relationship between tactile processing and the position of sounds in space can be used to estimate the location of PPS boundaries, along a spatial continuum between far and near space, in a valuable and ecologically significant way.	[Canzoneri, Elisa; Serino, Andrea] ALMA MATER STUDIORUM Univ Bologna, Dipartimento Psicol, Bologna, Italy; [Canzoneri, Elisa; Serino, Andrea] Ctr Studi Ric & Neurosci Cognit, Cesena, Italy; [Magosso, Elisa] ALMA MATER STUDIORUM Univ Bologna, Dipartimento Elettron Informat & Sistemist, Bologna, Italy	University of Bologna; University of Bologna	Serino, A (corresponding author), ALMA MATER STUDIORUM Univ Bologna, Dipartimento Psicol, Bologna, Italy.	andrea.serino@unibo.it		Magosso, Elisa/0000-0002-4673-2974	Volkswagen Stiftung grant [85 639]	Volkswagen Stiftung grant(Volkswagen)	This work was supported by a Volkswagen Stiftung grant (the_unboundbody_project, ref. 85 639; www.unboundbody.eu) to AS. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspell JE, 2010, EUR J NEUROSCI, V31, P1868, DOI 10.1111/j.1460-9568.2010.07210.x; Avillac M, 2005, NAT NEUROSCI, V8, P941, DOI 10.1038/nn1480; Bassolino M, 2010, NEUROPSYCHOLOGIA, V48, P803, DOI 10.1016/j.neuropsychologia.2009.11.009; Bremmer F, 2002, EUR J NEUROSCI, V16, P1554, DOI 10.1046/j.1460-9568.2002.02207.x; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; Brozzoli C, 2011, J NEUROSCI, V31, P9023, DOI 10.1523/JNEUROSCI.1172-11.2011; Bruns P, 2010, EXP PSYCHOL, V57, P267, DOI 10.1027/1618-3169/a000032; Cappe C, 2009, NEUROPSYCHOLOGIA, V47, P1045, DOI 10.1016/j.neuropsychologia.2008.11.003; Cappe C, 2012, J NEUROSCI, V32, P1171, DOI 10.1523/JNEUROSCI.5517-11.2012; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; Cooke DF, 2003, P NATL ACAD SCI USA, V100, P6163, DOI 10.1073/pnas.1031751100; diPellegrino G, 1997, NATURE, V388, P730, DOI 10.1038/41921; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; Farne A, 2002, J COGNITIVE NEUROSCI, V14, P1030, DOI 10.1162/089892902320474481; Farne A, 2000, NEUROREPORT, V11, P1645, DOI 10.1097/00001756-200006050-00010; Fogassi L, 1996, J NEUROPHYSIOL, V76, P141, DOI 10.1152/jn.1996.76.1.141; Gentile G, 2011, J NEUROPHYSIOL, V105, P910, DOI 10.1152/jn.00840.2010; Ghazanfar AA, 2002, P NATL ACAD SCI USA, V99, P15755, DOI 10.1073/pnas.242469699; Gillmeister H, 2007, BRAIN RES, V1160, P58, DOI 10.1016/j.brainres.2007.03.041; Graziano MSA, 1999, NATURE, V397, P428, DOI 10.1038/17115; GRAZIANO MSA, 1993, EXP BRAIN RES, V97, P96; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; Graziano MSA, 2006, NEUROPSYCHOLOGIA, V44, P845, DOI 10.1016/j.neuropsychologia.2005.09.009; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; Hall DA, 2003, CURR BIOL, V13, pR91, DOI 10.1016/S0960-9822(03)00034-4; Holmes NP, 2007, CORTEX, V43, P469, DOI 10.1016/S0010-9452(08)70471-4; Jacobs S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00089; Kitagawa N, 2005, EXP BRAIN RES, V166, P528, DOI 10.1007/s00221-005-2393-8; Ladavas E, 1998, BRAIN, V121, P2317, DOI 10.1093/brain/121.12.2317; Ladavas E, 1998, J COGNITIVE NEUROSCI, V10, P581, DOI 10.1162/089892998562988; Ladavas E, 2008, COGN NEUROPSYCHOL, V25, P1099, DOI 10.1080/02643290802359113; Leo F, 2011, EXP BRAIN RES, V213, P193, DOI 10.1007/s00221-011-2742-8; Lloyd DM, 2003, PERCEPT PSYCHOPHYS, V65, P901, DOI 10.3758/BF03194823; Longo MR, BEHAV BRAIN IN PRESS; Macaluso E, 2010, NEUROPSYCHOLOGIA, V48, P782, DOI 10.1016/j.neuropsychologia.2009.10.010; Maier JX, 2004, NEURON, V43, P177, DOI 10.1016/j.neuron.2004.06.027; Makin TR, 2007, J NEUROSCI, V27, P731, DOI 10.1523/JNEUROSCI.3653-06.2007; Makin TR, 2009, J NEUROSCI, V29, P11841, DOI 10.1523/JNEUROSCI.2955-09.2009; MIDDLEBROOKS JC, 1991, ANNU REV PSYCHOL, V42, P135, DOI 10.1146/annurev.ps.42.020191.001031; Murray MM, 2005, CEREB CORTEX, V15, P963, DOI 10.1093/cercor/bhh197; Neuhoff JG, 1998, NATURE, V395, P123, DOI 10.1038/25862; Occelli V, 2011, NEUROSCI BIOBEHAV R, V35, P589, DOI 10.1016/j.neubiorev.2010.07.004; Occelli V, 2010, EXP BRAIN RES, V203, P517, DOI 10.1007/s00221-010-2255-x; Rizzolatti G, 1997, SCIENCE, V277, P190, DOI 10.1126/science.277.5323.190; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P147, DOI 10.1016/0166-4328(81)90053-X; Ro T, 2009, EXP BRAIN RES, V195, P135, DOI 10.1007/s00221-009-1759-8; Romei V, 2009, CURR BIOL, V19, P1799, DOI 10.1016/j.cub.2009.09.027; Sambo CF, 2009, J COGNITIVE NEUROSCI, V21, P1550, DOI 10.1162/jocn.2009.21109; Schiff W, 1965, PSYCHOL MONOGR, V79, P11; Schlack A, 2005, J NEUROSCI, V25, P4616, DOI 10.1523/JNEUROSCI.0455-05.2005; Seifritz E, 2002, CURR BIOL, V12, P2147, DOI 10.1016/S0960-9822(02)01356-8; Serino A, 2007, PSYCHOL SCI, V18, P642, DOI 10.1111/j.1467-9280.2007.01952.x; Serino A, 2011, J COGNITIVE NEUROSCI, V23, P2956, DOI 10.1162/jocn_a_00006; Serino A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006582; Soto-Faraco S, 2009, BEHAV BRAIN RES, V196, P145, DOI 10.1016/j.bbr.2008.09.018; Spence C, 1996, J EXP PSYCHOL HUMAN, V22, P1005, DOI 10.1037/0096-1523.22.4.1005; Spence C, 2000, J EXP PSYCHOL HUMAN, V26, P1298, DOI 10.1037//0096-1523.26.4.1298; Spence C, 2004, COGN AFFECT BEHAV NE, V4, P148, DOI 10.3758/CABN.4.2.148; Stein BE., 1993, MERGING SENSES; Stepniewska I, 2005, P NATL ACAD SCI USA, V102, P4878, DOI 10.1073/pnas.0501048102; Tajadura-Jimenez A, 2009, NEUROPSYCHOLOGIA, V47, P195, DOI 10.1016/j.neuropsychologia.2008.07.025; Yau JM, 2009, CURR BIOL, V19, P561, DOI 10.1016/j.cub.2009.02.013; Zampini M, 2005, ACTA PSYCHOL, V118, P277, DOI 10.1016/j.actpsy.2004.10.017; Zampini M, 2007, NEUROPSYCHOLOGIA, V45, P1869, DOI 10.1016/j.neuropsychologia.2006.12.004	65	144	144	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e44306	10.1371/journal.pone.0044306	http://dx.doi.org/10.1371/journal.pone.0044306			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022PZ	23028516	gold, Green Published, Green Submitted			2022-12-27	WOS:000309973900008
J	Liu, YY; Slotine, JJ; Barabasi, AL				Liu, Yang-Yu; Slotine, Jean-Jacques; Barabasi, Albert-Laszlo			Control Centrality and Hierarchical Structure in Complex Networks	PLOS ONE			English	Article							CONTROLLABILITY; DYNAMICS; SYSTEMS	We introduce the concept of control centrality to quantify the ability of a single node to control a directed weighted network. We calculate the distribution of control centrality for several real networks and find that it is mainly determined by the network's degree distribution. We show that in a directed network without loops the control centrality of a node is uniquely determined by its layer index or topological position in the underlying hierarchical structure of the network. Inspired by the deep relation between control centrality and hierarchical structure in a general directed network, we design an efficient attack strategy against the controllability of malicious networks.	[Liu, Yang-Yu; Barabasi, Albert-Laszlo] Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA; [Liu, Yang-Yu; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Liu, Yang-Yu; Barabasi, Albert-Laszlo] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; [Slotine, Jean-Jacques] MIT, Nonlinear Syst Lab, Cambridge, MA 02139 USA; [Slotine, Jean-Jacques] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Slotine, Jean-Jacques] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Barabasi, Albert-Laszlo] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA	Northeastern University; Northeastern University; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard Medical School	Barabasi, AL (corresponding author), Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA.	alb@neu.edu	Barabasi, Albert-Laszlo/S-6474-2017; Liu, Yang-Yu/G-8885-2011	Liu, Yang-Yu/0000-0003-2728-4907; Barabasi, Albert/0000-0002-4028-3522	Network Science Collaborative Technology Alliance; United States Army Research Laboratory [W911NF-09-2-0053]; Defense Advanced Research Projects Agency [11645021]; Defense Threat Reduction Agency [WMD BRBAA07-J-2-0035]; Lockheed Martin	Network Science Collaborative Technology Alliance; United States Army Research Laboratory; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Lockheed Martin	This work was supported by the Network Science Collaborative Technology Alliance sponsored by the United States Army Research Laboratory under Agreement Number W911NF-09-2-0053; the Defense Advanced Research Projects Agency under Agreement Number 11645021; the Defense Threat Reduction Agency award WMD BRBAA07-J-2-0035; and the generous support of Lockheed Martin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic L. A., 2005, P WWW 2005 WORKSH WE; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; [Anonymous], [No title captured], DOI DOI 10.1103/PhysRevE.69.066133; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Blackhall L., 2010, IFAC P VOLUMES, P245; Bollobas B., 2001, RANDOM GRAPHS; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Bonacich P, 2001, SOC NETWORKS, V23, P191, DOI 10.1016/S0378-8733(01)00038-7; Brin S., 1998, 7 INT WORLD WID WEB; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Cowan N. J., 2011, ARXIV11062573V3; Cross R., 2004, HIDDEN POWER SOCIAL; Dion JM, 2003, AUTOMATICA, V39, P1125, DOI 10.1016/S0005-1098(03)00104-3; Dolev S, 2010, J ACM, V57, DOI 10.1145/1734213.1734219; Eckmann JP, 2004, P NATL ACAD SCI USA, V101, P14333, DOI 10.1073/pnas.0405728101; Egerstedt M, 2011, NATURE, V473, P158, DOI 10.1038/473158a; ERDOS P, 1960, B INT STATIST INST, V38, P343; FELD SL, 1991, AM J SOCIOL, V96, P1464, DOI 10.1086/229693; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Harary F, 1994, GRAPH THEORY; HOSOE S, 1980, IEEE T AUTOMAT CONTR, V25, P1192, DOI 10.1109/TAC.1980.1102506; Kalman R. E., 1963, SIAM J CONTROL     A, V1, P152, DOI [DOI 10.1137/0301010, 10.1137/0301010]; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; LIN CT, 1974, IEEE T AUTOMAT CONTR, VAC19, P201, DOI 10.1109/TAC.1974.1100557; Liu YY, 2011, NATURE, V478, pE4, DOI 10.1038/nature10544; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Lombardi A, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.056110; Luenberger D. G., 1979, INTRO DYNAMIC SYSTEM; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mednick SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009775; Mesbahi M, 2010, GRAPH THEORETIC METHODS IN MULTIAGENT NETWORKS, P1; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Motter AE, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.016116; Nepusz T, 2012, NAT PHYS, V8, P568, DOI [10.1038/nphys2327, 10.1038/NPHYS2327]; Newman MEJ, 2003, SOC NETWORKS, V25, P83, DOI 10.1016/S0378-8733(02)00039-4; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; NORLEN K, 2002, P INT TEL SOC 14 BIE; POLJAK S, 1990, IEEE T AUTOMAT CONTR, V35, P367, DOI 10.1109/9.50361; Rahman A, 2009, SIAM J CONTROL OPTIM, V48, P162, DOI 10.1137/060674909; SHIELDS RW, 1976, IEEE T AUTOMAT CONTR, V21, P203, DOI 10.1109/TAC.1976.1101198; Slotine J.J.E., 1991, APPL NONLINEAR CONTR; Su RQ, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.065201; Tanner HG, 2004, IEEE DECIS CONTR P, P2467, DOI 10.1109/CDC.2004.1428782; Wang BB, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/04/P04011; Wang XF, 2002, PHYSICA A, V310, P521, DOI 10.1016/S0378-4371(02)00772-0; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yan Koon-Kiu, 2010, Proc Natl Acad Sci U S A, V107, P9186, DOI 10.1073/pnas.0914771107; Yang R, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.066109; Yu WW, 2009, AUTOMATICA, V45, P429, DOI 10.1016/j.automatica.2008.07.016; [No title captured]; [No title captured]	53	162	167	4	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e44459	10.1371/journal.pone.0044459	http://dx.doi.org/10.1371/journal.pone.0044459			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23028542	gold, Green Published, Green Submitted			2022-12-27	WOS:000309517500006
J	Harvey, AJ; Mao, SH; Lalancette, C; Krawetz, SA; Brenner, CA				Harvey, Alexandra J.; Mao, Shihong; Lalancette, Claudia; Krawetz, Stephen A.; Brenner, Carol A.			Transcriptional Differences between Rhesus Embryonic Stem Cells Generated from In Vitro and In Vivo Derived Embryos	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; PREIMPLANTATION BOVINE EMBRYOS; LARGE OFFSPRING SYNDROME; GENE-EXPRESSION; SELF-RENEWAL; OXYGEN-TENSION; MONKEY OOCYTES; MOUSE EMBRYOS; ES CELLS; MOLECULAR SIGNATURE	Numerous studies have focused on the transcriptional signatures that underlie the maintenance of embryonic stem cell (ESC) pluripotency. However, it remains unclear whether ESC retain transcriptional aberrations seen in in vitro cultured embryos. Here we report the first global transcriptional profile comparison between ESC generated from either in vitro cultured or in vivo derived primate embryos by microarray analysis. Genes involved in pluripotency, oxygen regulation and the cell cycle were downregulated in rhesus ESC generated from in vitro cultured embryos (in vitro ESC). Significantly, several gene differences are similarly downregulated in preimplantation embryos cultured in vitro, which have been associated with long term developmental consequences and disease predisposition. This data indicates that prior to derivation, embryo quality may influence the molecular signature of ESC lines, and may differentially impact the physiology of cells prior to or following differentiation.	[Harvey, Alexandra J.; Brenner, Carol A.] Wayne State Univ, Dept Physiol, Detroit, MI USA; [Mao, Shihong; Lalancette, Claudia; Krawetz, Stephen A.] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI USA; [Lalancette, Claudia] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Krawetz, Stephen A.; Brenner, Carol A.] Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI USA; [Krawetz, Stephen A.] Wayne State Univ, Inst Comp Sci, Detroit, MI USA	Wayne State University; Wayne State University; McGill University; Wayne State University; Wayne State University	Harvey, AJ (corresponding author), Univ Melbourne, Dept Zool, Melbourne, Vic, Australia.	ajharvey@unimelb.edu.au	krawetz, stephen/GQQ-3308-2022; Lalancette, Claudia/K-2502-2013	HARVEY, ALEXANDRA/0000-0001-6696-0950	National Institutes of Health [HD045966, RR015395, RR021881, HD046553]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD046553, R01HD045966] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR021881, R24RR015395] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by the National Institutes of Health grants HD045966, RR015395, RR021881 and HD046553. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaci HE, 2010, AM J PHYSIOL-CELL PH, V298, pC1527, DOI 10.1152/ajpcell.00484.2009; Abe H, 1999, ANAT EMBRYOL, V199, P519, DOI 10.1007/s004290050249; Akopian V, 2010, IN VITRO CELL DEV-AN, V46, P247, DOI 10.1007/s11626-010-9297-z; Allegrucci C, 2007, HUM REPROD UPDATE, V13, P103, DOI 10.1093/humupd/dml041; Allegrucci C, 2007, HUM MOL GENET, V16, P1253, DOI 10.1093/hmg/ddm074; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776; Bertolini M, 2002, THERIOGENOLOGY, V58, P973, DOI 10.1016/S0093-691X(02)00935-4; Bertolini M, 2002, MOL REPROD DEV, V63, P318, DOI 10.1002/mrd.90015; Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; Bhattacharya B, 2009, CURR STEM CELL RES T, V4, P98, DOI 10.2174/157488809788167409; Brink TC, 2008, CELLS TISSUES ORGANS, V188, P9, DOI 10.1159/000112843; Byrne JA, 2006, BIOL REPROD, V75, P908, DOI 10.1095/biolreprod.106.053868; Cai JL, 2006, STEM CELLS, V24, P516, DOI 10.1634/stemcells.2005-0143; Chen HF, 2007, HUM REPROD, V22, P567, DOI 10.1093/humrep/del412; Chen HF, 2010, TISSUE ENG PT A, V16, P2901, DOI 10.1089/ten.tea.2009.0722; Corcoran D, 2006, REPRODUCTION, V131, P651, DOI 10.1530/rep.1.01015; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Fernandez-Gonzalez R, 2004, P NATL ACAD SCI USA, V101, P5880, DOI 10.1073/pnas.0308560101; Fernandez-Gonzalez R, 2009, REPRODUCTION, V137, P271, DOI 10.1530/REP-08-0265; FISCHER B, 1992, EUR J OBSTET GYN R B, V43, P39, DOI 10.1016/0028-2243(92)90241-P; Fluckiger AC, 2006, STEM CELLS, V24, P547, DOI 10.1634/stemcells.2005-0194; Forristal CE, 2010, REPRODUCTION, V139, P85, DOI 10.1530/REP-09-0300; Forsyth NR, 2008, REGEN MED, V3, P817, DOI 10.2217/17460751.3.6.817; Forsyth NR, 2006, CLONING STEM CELLS, V8, P16, DOI 10.1089/clo.2006.8.16; Frost JM, 2010, EPIGENETICS, P6; Fujimoto A, 2006, STEM CELLS, V24, P595, DOI 10.1634/stemcells.2005-0301; Grandela C, 2008, STEM CELL RES, V1, P116, DOI 10.1016/j.scr.2007.10.003; Gutierrez-Adan A, 2004, MOL REPROD DEV, V68, P441, DOI 10.1002/mrd.20113; Harvey AJ, 2004, BIOL REPROD, V71, P1108, DOI 10.1095/biolreprod.104.028639; HO YG, 1995, MOL REPROD DEV, V41, P232, DOI 10.1002/mrd.1080410214; Horii T, 2010, CELL REPROGRAM, V12, P551, DOI 10.1089/cell.2009.0104; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Huntriss John, 2008, Hum Fertil (Camb), V11, P85, DOI 10.1080/14647270802116250; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Kim CG, 2006, MOL CELLS, V21, P343; Kim KP, 2007, GENOME RES, V17, P1731, DOI 10.1101/gr.6609207; Kind KL, 2005, MOL REPROD DEV, V70, P37, DOI 10.1002/mrd.20183; Lawrence LT, 2008, SEMIN REPROD MED, V26, P143, DOI 10.1055/s-2008-1042953; Lazzari G, 2002, BIOL REPROD, V67, P767, DOI 10.1095/biolreprod.102.004481; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Li XP, 2006, CLONING STEM CELLS, V8, P214, DOI 10.1089/clo.2006.8.214; Lonergan P, 2003, BIOL REPROD, V69, P1424, DOI 10.1095/biolreprod.103.018168; MASTROIANNI L, 1965, J REPROD FERTIL, V9, P99; Mitalipov S, 2007, STEM CELLS, V25, P581, DOI 10.1634/stemcells.2006-0120; Mitalipov S, 2006, STEM CELLS, V24, P2177, DOI 10.1634/stemcells.2006-0125; Mtango NR, 2008, REPROD FERT DEVELOP, V20, P846, DOI 10.1071/RD08078; Mtango NR, 2008, BIOL REPROD, V78, P254, DOI 10.1095/biolreprod.107.064931; Mtango NR, 2011, GENE EXPR PATTERNS, V11, P285, DOI 10.1016/j.gep.2011.02.001; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Nowak-Imialek M, 2008, MOL REPROD DEV, V75, P731, DOI 10.1002/mrd.20816; Pannetier M, 2007, TRENDS BIOTECHNOL, V25, P556, DOI 10.1016/j.tibtech.2007.09.003; Park SB, 2009, GROWTH FACTORS, V27, P425, DOI 10.3109/08977190903289875; Pera RAR, 2009, DIFFERENTIATION, V78, P18, DOI 10.1016/j.diff.2009.03.004; Player A, 2006, STEM CELLS DEV, V15, P315, DOI 10.1089/scd.2006.15.315; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Rao RR, 2004, BIOTECHNOL BIOENG, V88, P273, DOI 10.1002/bit.20245; Rinaudo PF, 2006, FERTIL STERIL, V86, P1252, DOI 10.1016/j.fertnstert.2006.05.017; Rizos D, 2002, MOL REPROD DEV, V62, P320, DOI 10.1002/mrd.10138; Rugg-Gunn PJ, 2007, HUM MOL GENET, V16, pR243, DOI 10.1093/hmg/ddm245; Rugg-Gunn PJ, 2005, NAT GENET, V37, P585, DOI 10.1038/ng1556; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; Sinclair KD, 2000, HUM REPROD, V15, P68, DOI 10.1093/humrep/15.suppl_5.68; Sinclair KD, 2007, THERIOGENOLOGY, V67, P43, DOI 10.1016/j.theriogenology.2006.09.017; Skottman H, 2005, STEM CELLS, V23, P1343, DOI 10.1634/stemcells.2004-0341; Skottman H, 2006, STEM CELLS; Skottman H, 2006, REPRODUCTION, V132, P691, DOI 10.1530/rep.1.01079; Tavakoli T, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-44; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Turan N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001033; Vassena R, 2005, MOL REPROD DEV, V72, P430, DOI 10.1002/mrd.20375; Wale PL, 2010, REPROD BIOMED ONLINE, V21, P402, DOI 10.1016/j.rbmo.2010.04.028; Watkins AJ, 2008, SEMIN REPROD MED, V26, P175, DOI 10.1055/s-2008-1042956; Watkins AJ, 2007, P NATL ACAD SCI USA, V104, P5449, DOI 10.1073/pnas.0610317104; Wei CL, 2005, STEM CELLS, V23, P166, DOI 10.1634/stemcells.2004-0162; Westfall SD, 2008, STEM CELLS DEV, V17, P869, DOI 10.1089/scd.2007.0240; Wrenzycki C, 2001, HUM REPROD, V16, P893, DOI 10.1093/humrep/16.5.893; Wrenzycki C, 2004, ANIM REPROD SCI, V82-3, P593, DOI 10.1016/j.anireprosci.2004.05.009; Wrenzycki C, 2005, REPROD FERT DEVELOP, V17, P23, DOI 10.1071/RD04109; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yaseen MA, 2001, REPRODUCTION, V122, P601, DOI 10.1530/rep.0.1220601; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769; Zeng XM, 2004, STEM CELLS, V22, P292, DOI 10.1634/stemcells.22-3-292; Zheng P, 2007, MOL HUM REPROD, V13, P361, DOI 10.1093/molehr/gam014; Zhong W, 2006, MOL REPROD DEV, V73, P540, DOI 10.1002/mrd.20417	87	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e43239	10.1371/journal.pone.0043239	http://dx.doi.org/10.1371/journal.pone.0043239			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028448	gold, Green Published, Green Submitted			2022-12-27	WOS:000311313900005
J	Barbadoro, P; Chiatti, C; D'Errico, MM; Di Stanislao, F; Prospero, E				Barbadoro, Pamela; Chiatti, Carlos; D'Errico, Marcello Mario; Di Stanislao, Francesco; Prospero, Emilia			Caesarean Delivery in South Italy: Women without Choice. A Cross Sectional Survey	PLOS ONE			English	Article							REQUEST	Background: In spite of the World Health Organization's recommendations to maintain caesarean delivery (CD) between 5% and 15% of total births, the rates of CD continue to rise in countries with routine access to medical services. As in Italy CD rate reached 38% in 2008, the highest at EU level, we evaluated socioeconomic and clinical correlates of "elective" and "non programmed" CD in the Country. We performed a stratified analysis in order to verify whether the effect of such correlates differed among women with an "a priori" preference for natural and caesarean delivery respectively. Methods and Findings: We analyzed cross-sectional data from the Italian National Statistics Institute (ISTAT) survey on health condition. Socio-demographic variables, information on maternal care services use and health conditions during pregnancy, as well as maternal preferences on delivery, were available for a representative sample of 2,474 primiparous women. After an initial bivariate analysis, we used logistic regressions to evaluate factors associated to the study outcomes. Overall CD accounted for 35.5% of the total births in our sample (CI 33.6-37.4%); moreover, 30.7% (CI 28.6-32.6%) of women preferring natural delivery actually delivered with a CD. Elective CD rate is higher among women over 35 years (22.9%, CI 18.8-27.4%), and those living in the South (26.2%, CI 23.0-29.6%). The multivariate analysis showed that, even adjusting for several confounders, women in the South, receiving care in the private sector had higher chances of CD, also in case of preference for natural delivery. Conclusion: Policy interventions are required to reduce the rate of undesired CD, e. g. increasing women knowledge regarding delivery in order to favour aware choices. An effective strategy to reduce CD rate should address the Southern Regions, as women here appear to have a very limited control over the delivery, in spite of a widespread preference for natural delivery.	[Barbadoro, Pamela; Chiatti, Carlos; D'Errico, Marcello Mario; Di Stanislao, Francesco; Prospero, Emilia] Univ Politecn Marche, Dept Biomed Sci, Ancona, Italy	Marche Polytechnic University	Prospero, E (corresponding author), Univ Politecn Marche, Dept Biomed Sci, Ancona, Italy.	e.prospero@univpm.it	barbadoro, pamela/AAC-5041-2022; Chiatti, Carlos/J-4115-2012	Chiatti, Carlos/0000-0003-4810-9630; Prospero, Emilia/0000-0002-2387-8639; BARBADORO, Pamela/0000-0003-1495-0165; D'ERRICO, Marcello Mario/0000-0002-6648-877X				[Anonymous], 1997, BIRTH-ISS PERINAT C, V24, P121; Bagatta G, 2006, SISTEMA INDAGINI SOC; Caranci N, 2008, MONITOR, V22, P28; Carbonne B, 2009, INT J GYNECOL OBSTET, V107, P183, DOI 10.1016/j.ijgo.2009.07.030; Cardano M, 2004, SOC SCI MED, V58, P1563, DOI 10.1016/S0277-9536(03)00354-X; Chalmers B, 2001, BIRTH-ISS PERINAT C, V28, P202, DOI 10.1046/j.1523-536x.2001.00202.x; Commissione per la garanzia dell'informazione statistica [Italian Government-Commission on evaluation of quality of statistical information], 2001, COMPL QUAL INF STAT; Declercq E, 2011, BIRTH-ISS PERINAT C, V38, P99, DOI 10.1111/j.1523-536X.2010.00459.x; EURO-PERISTAT Project with SCPE EUROCAT EURO-NEOSTAT, 2008, EUR PER HLTH REP; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Gamble J, 2007, BIRTH-ISS PERINAT C, V34, P331, DOI 10.1111/j.1523-536X.2007.00193.x; Istituto Superiore di Sanita [Italian Institute of Health], 2012, SIST NAZ LIN GUID TA; MacDorman MF, 2008, CLIN PERINATOL, V35, P293, DOI 10.1016/j.clp.2008.03.007; MADOW WG, 1949, ANN MATH STAT, V20, P333, DOI 10.1214/aoms/1177729988; Mancuso A, 2008, J OBSTET GYNAECOL, V28, P382, DOI 10.1080/01443610802091545; Mazzoni A, 2011, BJOG-INT J OBSTET GY, V118, P391, DOI 10.1111/j.1471-0528.2010.02793.x; NICE, 2011, CLIN GUID CAES SECT; Patel RR, 2005, INT J EPIDEMIOL, V34, P353, DOI 10.1093/ije/dyh401; Say R, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000261; Turner M, 2011, BMJ, V23	20	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e43906	10.1371/journal.pone.0043906	http://dx.doi.org/10.1371/journal.pone.0043906			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	019MC	23028476	Green Published, gold, Green Submitted			2022-12-27	WOS:000309742800008
J	Kapusi, E; Kempe, K; Rubtsova, M; Kumlehn, J; Gils, M				Kapusi, Eszter; Kempe, Katja; Rubtsova, Myroslava; Kumlehn, Jochen; Gils, Mario			phiC31 Integrase-Mediated Site-Specific Recombination in Barley	PLOS ONE			English	Article							TRANSGENIC WHEAT; PHAGE PHI-C31-INTEGRASE; GENE INTEGRATION; LOX SITES; CRE; DNA; TRANSFORMATION; EXPRESSION; SYSTEM; ARABIDOPSIS	The Streptomyces phage phiC31 integrase was tested for its feasibility in excising transgenes from the barley genome through site-specific recombination. We produced transgenic barley plants expressing an active phiC31 integrase and crossed them with transgenic barley plants carrying a target locus for recombination. The target sequence involves a reporter gene encoding green fluorescent protein (GFP), which is flanked by the attB and attP recognition sites for the phiC31 integrase. This sequence disruptively separates a gusA coding sequence from an upstream rice actin promoter. We succeeded in producing site-specific recombination events in the hybrid progeny of 11 independent barley plants carrying the above target sequence after crossing with plants carrying a phiC31 expression cassette. Some of the hybrids displayed fully executed recombination. Excision of the GFP gene fostered activation of the gusA gene, as visualized in tissue of hybrid plants by histochemical staining. The recombinant loci were detected in progeny of selfed F-1, even in individuals lacking the phiC31 transgene, which provides evidence of stability and generative transmission of the recombination events. In several plants that displayed incomplete recombination, extrachromosomal excision circles were identified. Besides the technical advance achieved in this study, the generated phiC31 integrase-expressing barley plants provide foundational stock material for use in future approaches to barley genetic improvement, such as the production of marker-free transgenic plants or switching transgene activity.	[Kapusi, Eszter; Kempe, Katja; Rubtsova, Myroslava; Kumlehn, Jochen; Gils, Mario] Leibniz Inst Plant Genet & Crop Plant Res IPK, Gatersleben, Germany	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Kapusi, E (corresponding author), Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, Vienna, Austria.	gils@ipk-gatersleben.de	Kumlehn, Jochen/AAF-8241-2020	Kumlehn, Jochen/0000-0001-7080-7983; Rubtsova, Myroslava/0000-0002-5950-5914	Bundesministerium fur Bildung und Forschung (BMBF, GABI-FUTURE) [0315043A]; GABI- FUTURE grant [0315043*B*]	Bundesministerium fur Bildung und Forschung (BMBF, GABI-FUTURE)(Federal Ministry of Education & Research (BMBF)); GABI- FUTURE grant	Financed with funding from the Bundesministerium fur Bildung und Forschung (BMBF, GABI-FUTURE grant 0315043A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Nordsaat received its own funding for a separate part of the project (GABI- FUTURE grant 0315043*B*) which is not part of the research described in the submitted manuscript. The involvement of Nordsaat as a project partner does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ahmad K, 1996, GENETICS, V144, P657; ALBERT H, 1995, PLANT J, V7, P649, DOI 10.1046/j.1365-313X.1995.7040649.x; Allen BG, 2005, NAT METHODS, V2, P975, DOI 10.1038/NMETH814; Allen BG, 2006, NAT PROTOC, V1, P1248, DOI 10.1038/nprot.2006.183; Andreas S, 2002, NUCLEIC ACIDS RES, V30, P2299, DOI 10.1093/nar/30.11.2299; Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; BAUBONIS W, 1993, NUCLEIC ACIDS RES, V21, P2025, DOI 10.1093/nar/21.9.2025; Chalberg TW, 2006, J MOL BIOL, V357, P28, DOI 10.1016/j.jmb.2005.11.098; Chawla R, 2006, PLANT BIOTECHNOL J, V4, P209, DOI 10.1111/j.1467-7652.2005.00173.x; Coppoolse ER, 2005, PLANT MOL BIOL, V58, P687, DOI 10.1007/s11103-005-7705-7; Coppoolse ER, 2003, PLANT MOL BIOL, V51, P263, DOI 10.1023/A:1021174726070; De Buck S, 2007, PLANT PHYSIOL, V145, P1171, DOI 10.1104/pp.107.104067; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Druka A., 2011, BARLEY PRODUCTION IM, P1; Dunwell Jim M., 2009, V478, P333, DOI 10.1007/978-1-59745-379-0_20; Gils M, 2008, PLANT BIOTECHNOL J, V6, P226, DOI 10.1111/j.1467-7652.2007.00318.x; Gleba Y, 2004, CURR OPIN PLANT BIOL, V7, P182, DOI 10.1016/j.pbi.2004.01.003; Goedeke S, 2007, TRANSGENIC PLANT J, V1, P104; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Gronlund JT, 2007, PLANT MOL BIOL, V63, P545, DOI 10.1007/s11103-006-9108-9; Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082; Hensel Goetz, 2009, Int J Plant Genomics, V2009, P835608, DOI 10.1155/2009/835608; Hoa TTC, 2002, THEOR APPL GENET, V104, P518, DOI 10.1007/s001220100748; Hohn B, 2001, CURR OPIN BIOTECH, V12, P139, DOI 10.1016/S0958-1669(00)00188-9; Hu Q, 2008, PLANT BIOTECHNOL J, V6, P176, DOI 10.1111/j.1467-7652.2007.00310.x; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Karow M, 2011, EXPERT OPIN BIOL TH, V11, P1287, DOI 10.1517/14712598.2011.601293; Kempe K, 2010, PLANT MOL BIOL, V72, P673, DOI 10.1007/s11103-010-9606-7; Keravala A, 2006, MOL GENET GENOMICS, V276, P135, DOI 10.1007/s00438-006-0129-5; Kittiwongwattana C, 2007, PLANT MOL BIOL, V64, P137, DOI 10.1007/s11103-007-9140-4; Kopertekh L, 2012, TRANSGENIC PLANTS AD; LAZO GR, 1991, BIO-TECHNOL, V9, P963, DOI 10.1038/nbt1091-963; Leonhard WN, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-18; Luo H, 2000, PLANT J, V23, P423, DOI 10.1046/j.1365-313x.2000.00782.x; Lutz KA, 2004, PLANT J, V37, P906, DOI 10.1111/j.1365-313X.2004.02015.x; Lyznik LA, 2003, PLANT CELL REP, V21, P925, DOI 10.1007/s00299-003-0616-7; Lyznik LA, 2007, TRANSGENIC PLANT J, V1, P1; MAESER S, 1991, MOL GEN GENET, V230, P170, DOI 10.1007/BF00290665; Mengiste T, 1999, EMBO J, V18, P4505, DOI 10.1093/emboj/18.16.4505; Mlynarova L, 2003, TRANSGENIC RES, V12, P45, DOI 10.1023/A:1022112221427; Moon HS, 2011, PLANT MOL BIOL, V75, P621, DOI 10.1007/s11103-011-9756-2; Ow DW, 2007, CURR OPIN BIOTECH, V18, P115, DOI 10.1016/j.copbio.2007.02.004; Ow DW, 2011, J INTEGR PLANT BIOL, V53, P512, DOI 10.1111/j.1744-7909.2011.01061.x; Ow DW, 2005, IN VITRO CELL DEV-PL, V41, P213, DOI 10.1079/IVP2004610; OW DW, 1995, CRIT REV PLANT SCI, V14, P239, DOI 10.1080/713608117; Ow DW, 2002, PLANT MOL BIOL, V48, P183, DOI 10.1023/A:1013718106742; Que QD, 1998, PLANT J, V13, P401, DOI 10.1046/j.1365-313X.1998.00038.x; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Rubtsova M, 2008, PLANT CELL REP, V27, P1821, DOI 10.1007/s00299-008-0604-z; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Smith MCA, 2004, NUCLEIC ACIDS RES, V32, P2607, DOI 10.1093/nar/gkh538; Southern E M, 1992, Biotechnology, V24, P122; Sreenivasulu N., 2008, INT J PLANT GENOMICS, DOI DOI 10.1155/2008/486258; Srivastava V, 2004, PLANT BIOTECHNOL J, V2, P169, DOI 10.1111/j.1467-7652.2003.00061.x; Srivastava V, 2003, PLANT MOL BIOL, V52, P661, DOI 10.1023/A:1024839617490; Srivastava V, 1999, P NATL ACAD SCI USA, V96, P11117, DOI 10.1073/pnas.96.20.11117; Srivastava V, 2001, PLANT MOL BIOL, V46, P561, DOI 10.1023/A:1010646100261; Thomas WTB, 2011, BARLEY PRODUCTION IM, P122; Thomason LC, 2001, MOL GENET GENOMICS, V265, P1031, DOI 10.1007/s004380100498; Thomson JG, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-9; Thomson JG, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-17; Thorpe HM, 2000, MOL MICROBIOL, V38, P232, DOI 10.1046/j.1365-2958.2000.02142.x; Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505; Thyagarajan B, 2000, GENE, V244, P47, DOI 10.1016/S0378-1119(00)00008-1; Tungsuchat T, 2006, PLANT MOL BIOL, V61, P711, DOI 10.1007/s11103-006-0044-5; Tungsuchat-Huang T, 2012, PLANT J, V70, P717, DOI 10.1111/j.1365-313X.2012.04918.x; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; von Wettstein D, 2007, ANNU REV PLANT BIOL, V58, P1, DOI 10.1146/annurev.arplant.58.032806.104003; Wang YJ, 2011, PLANT CELL REP, V30, P267, DOI 10.1007/s00299-010-0938-1; Yang MZ, 2009, PLANT MOL BIOL, V70, P669, DOI 10.1007/s11103-009-9499-5; Yau YY, 2011, METHODS MOL BIOL, V701, P147, DOI 10.1007/978-1-61737-957-4_8	71	23	25	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45353	10.1371/journal.pone.0045353	http://dx.doi.org/10.1371/journal.pone.0045353			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024817	gold, Green Submitted, Green Published			2022-12-27	WOS:000308860100075
J	Shi, BS; Ren, GX; Hu, YW; Wang, S; Zhang, ZQ; Yuan, ZH				Shi, Bisheng; Ren, Guangxu; Hu, Yunwen; Wang, Sen; Zhang, Zhanqing; Yuan, Zhenghong			HBsAg Inhibits IFN-alpha Production in Plasmacytoid Dendritic Cells through TNF-alpha and IL-10 Induction in Monocytes	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; VIRUS INFECTION; T-CELLS; I INTERFERON; PROTEIN; ACTIVATION; ANTIGEN; BLOOD	Type I Interferon (IFN) is one of the first lines of defense against viral infection. Plasmacytoid dendritic cells (pDCs) are professional IFN-alpha-producing cells that play an important role in the antiviral immune response. Previous studies have reported that IFN-alpha production is impaired in chronic hepatitis B (CHB) patients. However, the mechanisms underlying the impairment in IFN-alpha production are not fully understood. Here, we report that plasma-derived hepatitis B surface antigen (HBsAg) and HBsAg expressed in CHO cells can significantly inhibit toll like receptor (TLR) 9-mediated Interferon-alpha (IFN-alpha) production in peripheral blood mononuclear cells (PBMCs) from healthy donors. Further analysis indicated that monocytes participate in the inhibitory effect of HBsAg on pDCs through the secretion of TNF-alpha and IL-10. Furthermore, TLR9 expression on pDCs was down-regulated by TNF-alpha, IL-10 and HBsAg treatment. This down-regulation may partially explain the inhibition of IFN-alpha production in pDCs. In conclusion, we determined that HBsAg inhibited the production of IFN-alpha by pDCs through the induction of monocytes that secreted TNF-alpha and IL-10 and through the down-regulation of TLR9 expression on pDCs. These data may aid in the development of effective antiviral treatments and lead to the immune control of the viral infections.	[Shi, Bisheng; Ren, Guangxu; Hu, Yunwen; Wang, Sen; Zhang, Zhanqing; Yuan, Zhenghong] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China; [Ren, Guangxu; Yuan, Zhenghong] Fudan Univ, Mol Virol Lab, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Shi, BS (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China.	zhyuan@shaphc.org		Ren, Guangxu/0000-0003-2378-260X; zhang, zhanqing/0000-0001-7709-9027	National Program on Key Basic Research Project [2012CB519005]; Shanghai Clinical New Frontier Project [SHDC12010106]; National Natural Science Foundation of China [81101242]; Shanghai Science and Technology Commission [09ZR1426500]	National Program on Key Basic Research Project(National Basic Research Program of China); Shanghai Clinical New Frontier Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Program on Key Basic Research Project (2012CB519005), Shanghai Clinical New Frontier Project (SHDC12010106), National Natural Science Foundation of China (81101242) and grants from Shanghai Science and Technology Commission (09ZR1426500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aborsangaya KB, 2007, HEPATOLOGY, V45, P623, DOI 10.1002/hep.21511; Brooks DG, 2010, P NATL ACAD SCI USA, V107, P3018, DOI 10.1073/pnas.0914500107; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Chisari FV, 2010, PATHOL BIOL, V58, P258, DOI 10.1016/j.patbio.2009.11.001; Clemens MJ, 1997, J INTERF CYTOK RES, V17, P503, DOI 10.1089/jir.1997.17.503; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; den Brouw MLO, 2008, J VIRAL HEPATITIS, V15, P675, DOI 10.1111/j.1365-2893.2008.00993.x; den Brouw MLO, 2009, IMMUNOLOGY, V126, P280, DOI 10.1111/j.1365-2567.2008.02896.x; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Dolganiuc A, 2006, J IMMUNOL, V177, P6758, DOI 10.4049/jimmunol.177.10.6758; Duan XZ, 2004, J CLIN IMMUNOL, V24, P637, DOI 10.1007/s10875-004-6249-y; Duramad O, 2003, BLOOD, V102, P4487, DOI 10.1182/blood-2003-07-2465; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Hyodo N, 2004, CLIN EXP IMMUNOL, V135, P462, DOI 10.1111/j.1365-2249.2003.02376.x; Kajaste-Rudnitski A, 2006, J BIOL CHEM, V281, P4624, DOI 10.1074/jbc.M508649200; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; Patient R, 2007, J VIROL, V81, P3842, DOI 10.1128/JVI.02741-06; Schroeder JT, 2008, J ALLERGY CLIN IMMUN, V121, P486, DOI 10.1016/j.jaci.2007.09.049; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Untergasser A, 2006, HEPATOLOGY, V43, P539, DOI 10.1002/hep.21048; van der Molen RG, 2004, HEPATOLOGY, V40, P738, DOI 10.1002/hep.20366; Vanlandschoot P, 2002, J GEN VIROL, V83, P2279, DOI 10.1099/0022-1317-83-9-2279; Vincent IE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026315; Woltman AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015324; Xie Q, 2009, MICROBES INFECT, V11, P515, DOI 10.1016/j.micinf.2009.02.008; Xu Y, 2009, MOL IMMUNOL, V46, P2640, DOI 10.1016/j.molimm.2009.04.031; Yang PL, 2010, P NATL ACAD SCI USA, V107, P798, DOI 10.1073/pnas.0913498107	30	69	75	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44900	10.1371/journal.pone.0044900	http://dx.doi.org/10.1371/journal.pone.0044900			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024774	Green Published, Green Submitted, gold			2022-12-27	WOS:000308860100032
J	Wyse, MM; Lei, J; Nestor-Kalinoski, AL; Eisenmann, KM				Wyse, Meghan M.; Lei, Jun; Nestor-Kalinoski, Andrea L.; Eisenmann, Kathryn M.			Dia-Interacting Protein (DIP) Imposes Migratory Plasticity in mDia2-Dependent Tumor Cells in Three-Dimensional Matrices	PLOS ONE			English	Article							BREAST-CANCER METASTASIS; ARP2/3 COMPLEX; CHEMOKINE RECEPTORS; ACTIN; FORMIN; INVASION; ACTIVATION; MOTILITY; SRC; PROMOTES	Tumor cells rely upon membrane pliancy to escape primary lesions and invade secondary metastatic sites. This process relies upon localized assembly and disassembly cycles of F-actin that support and underlie the plasma membrane. Dynamic actin generates both spear-like and bleb structures respectively characterizing mesenchymal and amoeboid motility programs utilized by metastatic cells in three-dimensional matrices. The molecular mechanism and physiological trigger(s) driving membrane plasticity are poorly understood. mDia formins are F-actin assembly factors directing membrane pliancy in motile cells. mDia2 is functionally coupled with its binding partner DIP, regulating cortical actin and inducing membrane blebbing in amoeboid cells. Here we show that mDia2 and DIP co-tether to nascent blebs and this linkage is required for bleb formation. DIP controls mesenchymal/amoeboid cell interconvertability, while CXCL12 induces assembly of mDia2: DIP complexes to bleb cortices in 3D matrices. These results demonstrate how DIP-directed mDia2-dependent F-actin dynamics regulate morphological plasticity in motile cancer cells.	[Wyse, Meghan M.; Lei, Jun; Eisenmann, Kathryn M.] Univ Toledo, Dept Biochem, Toledo, OH 43606 USA; [Nestor-Kalinoski, Andrea L.] Univ Toledo, Dept Surg, Toledo, OH 43606 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Wyse, MM (corresponding author), Univ Toledo, Dept Biochem, Hlth Sci Campus, Toledo, OH 43606 USA.	kathryn.eisenmann@utoledo.edu		Eisenmann, Kathryn/0000-0002-5337-5928	University of Toledo Foundation; Department of Defense Breast Cancer Concept Award [BC062565]; National Cancer Institute [R01CA151632]; NATIONAL CANCER INSTITUTE [R01CA151632] Funding Source: NIH RePORTER	University of Toledo Foundation; Department of Defense Breast Cancer Concept Award(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the University of Toledo Foundation (KME, ALNK), the Department of Defense Breast Cancer Concept Award (KME, BC062565), and the National Cancer Institute (KME, ALNK, R01CA151632). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2006, ANN ONCOL, V17, P945, DOI 10.1093/annonc/mdl053; Aspenstrom P, 2010, BBA-MOL CELL RES, V1803, P174, DOI 10.1016/j.bbamcr.2009.06.002; Asrar S, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-39; Baarlink C, 2010, CELL, V142, DOI 10.1016/j.cell.2010.06.030; Basu R, 2011, CURR BIOL, V21, P905, DOI 10.1016/j.cub.2011.04.047; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Charras GT, 2008, J MICROSC-OXFORD, V231, P466, DOI 10.1111/j.1365-2818.2008.02059.x; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Cunningham CC, 1997, J CELL BIOL, V136, P845, DOI 10.1083/jcb.136.4.845; Deakin NO, 2011, MOL BIOL CELL, V22, P327, DOI 10.1091/mbc.E10-09-0790; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Demou ZN, 2005, CANCER RES, V65, P5674, DOI 10.1158/0008-5472.CAN-04-1682; DeWard AD, 2010, BBA-MOL CELL RES, V1803, P226, DOI 10.1016/j.bbamcr.2009.11.006; Di Vizio D, 2009, CANCER RES, V69, P5601, DOI 10.1158/0008-5472.CAN-08-3860; Eisenmann KM, 2007, J BIOL CHEM, V282, P25152, DOI 10.1074/jbc.M703243200; Eisenmann KM, 2007, CURR BIOL, V17, P579, DOI 10.1016/j.cub.2007.03.024; Flanagan LA, 2001, J CELL BIOL, V155, P511, DOI 10.1083/jcb.200105148; Fukumi-Tominaga T, 2009, GENES CELLS, V14, P1197, DOI 10.1111/j.1365-2443.2009.01345.x; Fukuoka M, 2001, J CELL BIOL, V152, P471, DOI 10.1083/jcb.152.3.471; Gozgit JM, 2006, MOL CANCER RES, V4, P905, DOI 10.1158/1541-7786.MCR-06-0147; Gupton SL, 2007, J CELL SCI, V120, P3475, DOI 10.1242/jcs.006049; Hager MH, 2012, EMBO MOL MED; Han YY, 2009, J BIOL CHEM, V284, P33409, DOI 10.1074/jbc.M109.060699; Hannemann S, 2008, J BIOL CHEM, V283, P27891, DOI 10.1074/jbc.M801800200; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Hinton CV, 2010, CLIN EXP METASTAS, V27, P97, DOI 10.1007/s10585-008-9210-2; Holland JD, 2006, CANCER RES, V66, P4117, DOI 10.1158/0008-5472.CAN-05-1631; Hooper S, 2006, METHOD ENZYMOL, V406, P625, DOI 10.1016/S0076-6879(06)06049-6; KAGEYAMA T, 1977, DEV GROWTH DIFFER, V19, P103; Kim DJ, 2006, J BIOL CHEM, V281, P617, DOI 10.1074/jbc.M504450200; Kim SM, 2009, J NEUROCHEM, V109, P1106, DOI 10.1111/j.1471-4159.2009.06039.x; Kitzing TM, 2010, ONCOGENE, V29, P2441, DOI 10.1038/onc.2009.515; Kitzing TM, 2007, GENE DEV, V21, P1478, DOI 10.1101/gad.424807; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Lai SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003439; Lapteva N, 2005, CANCER GENE THER, V12, P84, DOI 10.1038/sj.cgt.7700770; Lee S, 2006, EMBO J, V25, P4983, DOI 10.1038/sj.emboj.7601349; Liang ZX, 2005, CANCER RES, V65, P967; Lizarraga F, 2009, CANCER RES, V69, P2792, DOI 10.1158/0008-5472.CAN-08-3709; Lorentzen A, 2011, J CELL SCI, V124, P1256, DOI 10.1242/jcs.074849; Meng WX, 2004, EMBO J, V23, P760, DOI 10.1038/sj.emboj.7600095; Mizoguchi T, 2008, DEVELOPMENT, V135, P2521, DOI 10.1242/dev.020107; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Peng J, 2003, CURR BIOL, V13, P534, DOI 10.1016/S0960-9822(03)00170-2; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Rizvi SA, 2009, CHEM BIOL, V16, P1158, DOI 10.1016/j.chembiol.2009.10.006; Ronty M, 2007, EXP CELL RES, V313, P2575, DOI 10.1016/j.yexcr.2007.04.030; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Sakata D, 2007, J EXP MED, V204, P2031, DOI 10.1084/jem.20062647; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Satoh S, 2001, J BIOL CHEM, V276, P39290, DOI 10.1074/jbc.M107026200; Shi YQ, 2009, BIOCHEM CELL BIOL, V87, P207, DOI 10.1139/O08-130; Shi YQ, 2009, J IMMUNOL, V182, P3837, DOI 10.4049/jimmunol.0803838; Tanizaki H, 2010, BLOOD, V116, P5875, DOI 10.1182/blood-2010-01-264150; Teodorof C, 2009, EXP CELL RES, V315, P2410, DOI 10.1016/j.yexcr.2009.05.010; Tournaviti S, 2007, J CELL SCI, V120, P3820, DOI 10.1242/jcs.011130; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Zhu XL, 2011, J PATHOL, V224, P377, DOI 10.1002/path.2871	64	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45085	10.1371/journal.pone.0045085	http://dx.doi.org/10.1371/journal.pone.0045085			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024796	gold, Green Published, Green Submitted			2022-12-27	WOS:000308860100054
J	Sciacqua, A; Maio, R; Miceli, S; Pascale, A; Carullo, G; Grillo, N; Arturi, F; Sesti, G; Perticone, F				Sciacqua, Angela; Maio, Raffaele; Miceli, Sofia; Pascale, Alessandra; Carullo, Giuseppe; Grillo, Nadia; Arturi, Franco; Sesti, Giorgio; Perticone, Francesco			Association between One- Hour Post-Load Plasma Glucose Levels and Vascular Stiffness in Essential Hypertension	PLOS ONE			English	Article							ARTERIAL STIFFNESS; ENDOTHELIAL DYSFUNCTION; INSULIN SENSITIVITY; STROKE; RISK; DISTENSIBILITY; THICKNESS; TOLERANCE; INCREASES; WOMEN	Objectives: Pulse wave velocity (PWV) is a surrogate end-point for cardiovascular morbidity and mortality. A plasma glucose value >= 155 mg/dl for the 1-hour post-load plasma glucose during an oral glucose tolerance test (OGTT) is able to identify subjects with normal glucose tolerance (NGT) at high-risk for type-2 diabetes (T2D) and for subclinical organ damage. Thus, we addressed the question if 1-hour post-load plasma glucose levels, affects PWV and its central hemodynamic correlates, as augmentation pressure (AP) and augmentation index (AI). Methods: We enrolled 584 newly diagnosed hypertensives. All patients underwent OGTT and measurements of PWV, AP and AI. Insulin sensitivity was assessed by Matsuda-index. Results: Among participants, 424 were NGT and 160 had impaired glucose tolerance (IGT). Of 424 NGT, 278 had 1-h post-load plasma glucose <155 mg/dl (NGT < 155) and 146 had 1-h post-load plasma glucose >= 155 mg/dl (NGT > 155). NGT >= 155 had a worse insulin sensitivity and higher hs-CRP than NGT < 155, similar to IGT subjects. In addition, NGT >= 155 in comparison with NGT, 155 had higher central systolic blood pressure (134 +/- 12 vs 131 +/- 10 mmHg), as well as PWV (8.4 +/- 3.7 vs 6.7 +/- 1.7 m/s), AP (12.5 +/- 7.1 vs 9.8 +/- 5.7 mmHg) and AI (29.4 +/- 11.9 vs 25.1 +/- 12.4%), and similar to IGT. At multiple regression analysis, 1-h post-load plasma glucose resulted the major determinant of all indices of vascular stiffness. Conclusion: Hypertensive NGT >= 155 subjects, compared with NGT< 155, have higher PWV and its hemodynamic correlates that increase their cardiovascular risk profile.	[Sciacqua, Angela; Maio, Raffaele; Miceli, Sofia; Pascale, Alessandra; Carullo, Giuseppe; Grillo, Nadia; Arturi, Franco; Sesti, Giorgio; Perticone, Francesco] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy	Magna Graecia University of Catanzaro	Sciacqua, A (corresponding author), Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy.	perticone@unicz.it	Sesti, Giorgio/B-1509-2012; Perticone, Francesco/I-4260-2017; Maio, Raffaele/A-2846-2015	Maio, Raffaele/0000-0002-7290-9470; ARTURI, Franco/0000-0002-1660-1228; Sesti, Giorgio/0000-0002-1618-7688				Abdul-Ghani MA, 2008, DIABETES CARE, V31, P1650, DOI 10.2337/dc08-0225; Arcaro G, 2002, CIRCULATION, V105, P576, DOI 10.1161/hc0502.103333; Avolio AP, 2009, HYPERTENSION, V54, P375, DOI 10.1161/HYPERTENSIONAHA.109.134379; Bardini G, 2010, DIABETES CARE, V33, P411, DOI 10.2337/dc09-1342; Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397, DOI 10.1001/archinte.161.3.397; Chen CH, 1996, HYPERTENSION, V27, P168, DOI 10.1161/01.HYP.27.2.168; Giltay EJ, 1999, DIABETOLOGIA, V42, P214, DOI 10.1007/s001250051141; Hansen TW, 2006, CIRCULATION, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342; Henry RMA, 2003, CIRCULATION, V107, P2089, DOI 10.1161/01.CIR.0000065222.34933.FC; Ilercil A, 2001, AM HEART J, V141, P992, DOI 10.1067/mhj.2001.115302; KANNEL WB, 1974, AM J CARDIOL, V34, P29, DOI 10.1016/0002-9149(74)90089-7; Kimoto E, 2003, DIABETES, V52, P448, DOI 10.2337/diabetes.52.2.448; Laurent S, 2003, STROKE, V34, P1203, DOI 10.1161/01.STR.0000065428.03209.64; Lee IK, 2002, INT J CLIN PRACT, P59; Matsuda M, 1999, DIABETES CARE; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; Mitchell GF, 2004, HYPERTENSION, V43, P1239, DOI 10.1161/01.HYP.0000128420.01881.aa; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Perticone F, 2001, EUR J CLIN INVEST, V31, P1013, DOI 10.1046/j.1365-2362.2001.00909.x; Safar ME, 2004, HYPERTENSION, V43, P163, DOI 10.1161/01.HYP.0000114571.75762.b0; Sciacqua A, 2011, DIABETES CARE, V34, P2291, DOI 10.2337/dc11-0879; Sciacqua A, 2011, DIABETES CARE, V34, P1406, DOI 10.2337/dc11-0155; Scuteri A, 2004, J AM COLL CARDIOL, V43, P1388, DOI 10.1016/j.jacc.2003.10.061; Sengstock DM, 2005, J CLIN ENDOCR METAB, V90, P2823, DOI 10.1210/jc.2004-1686; Stacey RB, 2010, HYPERTENSION, V55, P26, DOI 10.1161/HYPERTENSIONAHA.109.134031; Succurro E, 2009, ATHEROSCLER IN PRESS; Succurro E, 2010, CLIN J AM SOC NEPHRO, V5, P1922, DOI 10.2215/CJN.03240410; van Dijk RAJM, 2003, EUR J CLIN INVEST, V33, P307, DOI 10.1046/j.1365-2362.2003.01137.x; Wautier J L, 1998, Vasc Med, V3, P131, DOI 10.1191/135886398672565440; Wilkinson IB, 2002, CIRCULATION, V105, P213, DOI 10.1161/hc0202.101970	30	52	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44470	10.1371/journal.pone.0044470	http://dx.doi.org/10.1371/journal.pone.0044470			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028545	gold, Green Submitted, Green Published			2022-12-27	WOS:000308788700021
J	Hart, JA; Detwiler, KM; Gilbert, CC; Burrell, AS; Fuller, JL; Emetshu, M; Hart, TB; Vosper, A; Sargis, EJ; Tosi, AJ				Hart, John A.; Detwiler, Kate M.; Gilbert, Christopher C.; Burrell, Andrew S.; Fuller, James L.; Emetshu, Maurice; Hart, Terese B.; Vosper, Ashley; Sargis, Eric J.; Tosi, Anthony J.			Lesula: A New Species of Cercopithecus Monkey Endemic to the Democratic Republic of Congo and Implications for Conservation of Congo's Central Basin	PLOS ONE			English	Article							BIEGA-NATIONAL-PARK; Y-CHROMOSOME; EVOLUTIONARY HISTORY; DIVERSITY; PRIMATES; FOREST; INFERENCE; MRBAYES; WINDOW; ZAIRE	In June 2007, a previously undescribed monkey known locally as "lesula" was found in the forests of the middle Lomami Basin in central Democratic Republic of Congo (DRC). We describe this new species as Cercopithecus lomamiensis sp. nov., and provide data on its distribution, morphology, genetics, ecology and behavior. C. lomamiensis is restricted to the lowland rain forests of central DRC between the middle Lomami and the upper Tshuapa Rivers. Morphological and molecular data confirm that C. lomamiensis is distinct from its nearest congener, C. hamlyni, from which it is separated geographically by both the Congo (Lualaba) and the Lomami Rivers. C. lomamiensis, like C. hamlyni, is semi-terrestrial with a diet containing terrestrial herbaceous vegetation. The discovery of C. lomamiensis highlights the biogeographic significance and importance for conservation of central Congo's interfluvial TL2 region, defined from the upper Tshuapa River through the Lomami Basin to the Congo (Lualaba) River. The TL2 region has been found to contain a high diversity of anthropoid primates including three forms, in addition to C. lomamiensis, that are endemic to the area. We recommend the common name, lesula, for this new species, as it is the vernacular name used over most of its known range.	[Hart, John A.; Emetshu, Maurice; Hart, Terese B.] Lukuru Wildlife Res Fdn, Kinshasa, Gombe, DEM REP CONGO; [Hart, John A.; Hart, Terese B.; Sargis, Eric J.] Yale Peabody Museum Nat Hist, Div Vertebrate Zool, New Haven, CT USA; [Detwiler, Kate M.] Florida Atlantic Univ, Dept Anthropol, Boca Raton, FL 33431 USA; [Gilbert, Christopher C.] CUNY Hunter Coll, Dept Anthropol, New York, NY USA; [Gilbert, Christopher C.; Fuller, James L.] New York Consortium Evolutionary Primatol, New York, NY USA; [Burrell, Andrew S.; Tosi, Anthony J.] NYU, Dept Anthropol, Ctr Study Human Origins, New York, NY 10003 USA; [Fuller, James L.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY USA; [Vosper, Ashley] Wildlife Conservat Soc Congo, Wildlife Conservat Soc Zanaga Project, Brazzaville, Rep Congo; [Sargis, Eric J.] Yale Univ, Dept Anthropol, New Haven, CT 06520 USA	Yale University; State University System of Florida; Florida Atlantic University; City University of New York (CUNY) System; Hunter College (CUNY); New York University; Columbia University; Yale University	Hart, JA (corresponding author), Lukuru Wildlife Res Fdn, Kinshasa, Gombe, DEM REP CONGO.	kdetwile@fau.edu		Gilbert, Christopher/0000-0001-8768-3171	Arcus Foundation; United States Fish and Wildlife Service; Abraham Foundation; Margot Marsh Biodiversity Foundation; Yale Institute for Biospheric Studies	Arcus Foundation; United States Fish and Wildlife Service(US Fish & Wildlife Service); Abraham Foundation; Margot Marsh Biodiversity Foundation; Yale Institute for Biospheric Studies	The research was supported by Arcus Foundation (http://www.arcusfoundation.org/), United States Fish and Wildlife Service (http://www.fws.gov/grants/), a grant from Edith McBean, Abraham Foundation (http://abrahamfoundation.org/cms/), Margot Marsh Biodiversity Foundation Grant, and a Gaylord Donnelley Environmental Postdoctoral Fellowship from the Yale Institute for Biospheric Studies (http://www.yale.edu/yibs/programs_donnelley.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, TRACER V1 6; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Butynski Thomas M., 2002, P3; Chapman Colin A., 2002, P325; COLYN M, 1987, FOLIA PRIMATOL, V49, P203, DOI 10.1159/000156324; COLYN M, 1991, ANN SCI ZOOLOGIQUES, V264, P1; COLYN M M, 1987, Revue de Zoologie Africaine, V101, P183; Dowsett RJ, 1990, ENQUETE FAUNISTIQUE, P111; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fleagle JG, 2010, AM J PHYS ANTHROPOL, V142, P565, DOI 10.1002/ajpa.21272; GAUTIER J-P, 1971, Biologia Gabonica, V7, P229; Groves C, 2004, INT J PRIMATOL, V25, P1105, DOI 10.1023/B:IJOP.0000043354.36778.55; Groves C.P., 2001, PRIMATE TAXONOMY; Grubb P, 2003, INT J PRIMATOL, V24, P1301, DOI 10.1023/B:IJOP.0000005994.86792.b9; Hall JS, 2003, AFR PRIMATES, V6, P35; Hamilton A.C., 1988, P13; HANKE M, 1994, BIOTECHNIQUES, V17, P858; Harcourt AH, 2012, INT J PRIMATOL, V33, P168, DOI 10.1007/s10764-011-9558-z; Hart JA, 2012, MAMMALS AFRICA, V2; Hart TB, 2009, ANNEX 7 BUSHMEAT CRI; Hart TB, 2009, DOCUMENTATION ESTABL; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Inogwabini BI, 2000, AFR J ECOL, V38, P269, DOI 10.1046/j.1365-2028.2000.00223.x; IUCN Standards and Petitions Subcommittee, 2010, GUID US IUCN RED LIS; Kaessmann H, 1999, SCIENCE, V286, P1159, DOI 10.1126/science.286.5442.1159; KINGDON J S, 1980, Transactions of the Zoological Society of London, V35, P425; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Maruhashi T, 1989, INTERSPECIES RELATIO, P53; Nagaraja R, 1997, GENOME RES, V7, P210, DOI 10.1101/gr.7.3.210; O'Higgins P, 1998, J ANAT, V193, P251, DOI 10.1046/j.1469-7580.1998.19320251.x; Oates J.F., 1988, P79; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Raaum RL, 2006, DVLR MSI V 0 4 9; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Slice DE, 2005, DEV PRIMATOL-PROG PR, P1, DOI 10.1007/0-387-27614-9_1; Smithe F, 1975, NATURALISTS COLOR 1; Struhsaker TT, 2010, RED COLOBUS MONKEYS: VARIATION IN DEMOGRAPHY, BEHAVIOR, AND ECOLOGY OF ENDANGERED SPECIES, P1, DOI 10.1093/acprof:oso/9780198529583.001.0001; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Sys C, 1960, NOTICE EXPLICATIVE C; THOMAS SC, 1991, BIOTROPICA, V23, P68, DOI 10.2307/2388690; Ting N, 2008, J HUM EVOL, V55, P312, DOI 10.1016/j.jhevol.2008.02.011; Tosi AJ, 2000, MOL PHYLOGENET EVOL, V17, P133, DOI 10.1006/mpev.2000.0834; Tosi AJ, 2005, MOL PHYLOGENET EVOL, V36, P58, DOI 10.1016/j.ympev.2005.01.009; Tosi AJ, 2003, MOL PHYLOGENET EVOL, V27, P510, DOI 10.1016/S1055-7903(03)00024-1; Tosi AJ, 2008, ZOOL J LINN SOC-LOND, V154, P408, DOI 10.1111/j.1096-3642.2008.00419.x; Vogel T, 1998, CYTOGENET CELL GENET, V80, P209, DOI 10.1159/000014982; Yamagiwa J, 1989, INTERSPECIES RELATIO, P5; Young A, 1980, CAMBRIDGE GEOGRAPHIC; Zwickl DJ., 2006, GENETIC ALGORITHM AP	50	38	41	1	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44271	10.1371/journal.pone.0044271	http://dx.doi.org/10.1371/journal.pone.0044271			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984482	gold, Green Submitted, Green Published			2022-12-27	WOS:000308738500041
J	Kohn, G; Delvaux, D; Lakaye, B; Servais, AC; Scholer, G; Fillet, M; Elias, B; Derochette, JM; Crommen, J; Wins, P; Bettendorff, L				Kohn, Gregory; Delvaux, David; Lakaye, Bernard; Servais, Anne-Catherine; Scholer, Georges; Fillet, Marianne; Elias, Benjamin; Derochette, Jean-Michel; Crommen, Jacques; Wins, Pierre; Bettendorff, Lucien			High Inorganic Triphosphatase Activities in Bacteria and Mammalian Cells: Identification of the Enzymes Involved	PLOS ONE			English	Article							TUNNEL METALLOENZYME SUPERFAMILY; ESCHERICHIA-COLI; THIAMINE TRIPHOSPHATASE; ADENYLYL-CYCLASE; RNA TRIPHOSPHATASE; CATALYTIC-MECHANISM; TRYPANOSOMA-BRUCEI; POLYPHOSPHATE; PYROPHOSPHATASE; TRIPOLYPHOSPHATE	Background: We recently characterized a specific inorganic triphosphatase (PPPase) from Nitrosomonas europaea. This enzyme belongs to the CYTH superfamily of proteins. Many bacterial members of this family are annotated as predicted adenylate cyclases, because one of the founding members is CyaB adenylate cyclase from A. hydrophila. The aim of the present study is to determine whether other members of the CYTH protein family also have a PPPase activity, if there are PPPase activities in animal tissues and what enzymes are responsible for these activities. Methodology/Principal Findings: Recombinant enzymes were expressed and purified as GST- or His-tagged fusion proteins and the enzyme activities were determined by measuring the release of inorganic phosphate. We show that the hitherto uncharacterized E. coli CYTH protein ygiF is a specific PPPase, but it contributes only marginally to the total PPPase activity in this organism, where the main enzyme responsible for hydrolysis of inorganic triphosphate (PPPi) is inorganic pyrophosphatase. We further show that CyaB hydrolyzes PPPi but this activity is low compared to its adenylate cyclase activity. Finally we demonstrate a high PPPase activity in mammalian and quail tissue, particularly in the brain. We show that this activity is mainly due to Prune, an exopolyphosphatase overexpressed in metastatic tumors where it promotes cell motility. Conclusions and General Significance: We show for the first time that PPPase activities are widespread in bacteria and animals. We identified the enzymes responsible for these activities but we were unable to detect significant amounts of PPPi in E. coli or brain extracts using ion chromatography and capillary electrophoresis. The role of these enzymes may be to hydrolyze PPPi, which could be cytotoxic because of its high affinity for Ca2+, thereby interfering with Ca2+ signaling.	[Kohn, Gregory; Delvaux, David; Lakaye, Bernard; Wins, Pierre; Bettendorff, Lucien] Univ Liege, GIGA Neurosci, Liege, Belgium; [Servais, Anne-Catherine; Fillet, Marianne; Crommen, Jacques] Univ Liege, Dept Pharmaceut Sci, Lab Analyt Pharmaceut Chem, CIRM, Liege, Belgium; [Scholer, Georges; Elias, Benjamin] Catholic Univ Louvain, Inst Condensed Matter & Nanosci, B-1348 Louvain, Belgium; [Derochette, Jean-Michel] Prayon SA, Engis, Belgium	University of Liege; University of Liege; Universite Catholique Louvain	Kohn, G (corresponding author), Univ Liege, GIGA Neurosci, Liege, Belgium.	L.Bettendorff@ulg.ac.be		Fillet, Marianne/0000-0002-1453-6282; Elias, Benjamin/0000-0001-5037-3313	Fonds de la Recherche Fondamendale collective [2.4558.04, 2.4508.10]	Fonds de la Recherche Fondamendale collective	LB is a Research Director and BL is a Research Associate at the Funds for Scientific Research - FNRS (Belgium). DD is a Research Fellows of the Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture (F.R.I.A.). This work was supported by grants of the "Fonds de la Recherche Fondamendale collective" (Grants and 2.4558.04 and 2.4508.10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA M, 1993, J BIOL CHEM, V268, P633; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P17, DOI 10.1016/S0968-0004(97)01162-6; Ault-Riche D, 1998, J BACTERIOL, V180, P1841; Avaeva S, 1996, FEBS LETT, V399, P99, DOI 10.1016/S0014-5793(96)01296-3; Baltscheffsky M, 1998, BBA-BIOENERGETICS, V1364, P301, DOI 10.1016/S0005-2728(98)00062-0; Bettendorff L, 2003, ANAL BIOCHEM, V322, P190, DOI 10.1016/j.ab.2003.08.013; Carotenuto P, 2006, J BIOENERG BIOMEMBR, V38, P233, DOI 10.1007/s10863-006-9044-z; CHANG DM, 1983, J AM OIL CHEM SOC, V60, P618, DOI 10.1007/BF02679800; Cui H, 2000, J CHROMATOGR A, V884, P89, DOI 10.1016/S0021-9673(00)00055-8; Delvaux D, 2011, J BIOL CHEM, V286, P34023, DOI 10.1074/jbc.M111.233585; Gallagher DT, 2011, J MOL BIOL, V405, P787, DOI 10.1016/j.jmb.2010.11.026; Gong CL, 2006, RNA, V12, P1468, DOI 10.1261/rna.119806; Gong CL, 2003, J BIOL CHEM, V278, P50843, DOI 10.1074/jbc.M309188200; Himeno S, 2007, J SEP SCI, V30, P1077, DOI 10.1002/jssc.200600501; Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-33; Jain Ruchi, 2008, J Biol Chem, V283, P31047, DOI 10.1074/jbc.M805392200; JOSSE J, 1966, J BIOL CHEM, V241, P1938; Keppetipola N, 2007, J BIOL CHEM, V282, P11941, DOI 10.1074/jbc.M611328200; KORNBERG SR, 1958, J BIOL CHEM, V233, P159; KUKKOKALSKE E, 1989, J BACTERIOL, V171, P4498, DOI 10.1128/JB.171.8.4498-4500.1989; KUMBLE KD, 1995, J BIOL CHEM, V270, P5818, DOI 10.1074/jbc.270.11.5818; Kuroda A, 1997, J BIOL CHEM, V272, P21240, DOI 10.1074/jbc.272.34.21240; Lakaye B, 2002, J BIOL CHEM, V277, P13771, DOI 10.1074/jbc.M111241200; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lima CD, 1999, CELL, V99, P533, DOI 10.1016/S0092-8674(00)81541-X; Linster CL, 2011, J BIOL CHEM, V286, P42992, DOI 10.1074/jbc.M111.281527; Makarchikov AF, 2003, CELL MOL LIFE SCI, V60, P1477, DOI 10.1007/s00018-003-3098-4; Marbaix AY, 2011, J BIOL CHEM, V286, P41246, DOI 10.1074/jbc.C111.310847; Moreno B, 2000, J BIOL CHEM, V275, P28356, DOI 10.1074/jbc.M003893200; Pavlov E, 2010, J BIOL CHEM, V285, P9420, DOI 10.1074/jbc.M109.013011; Simonovic AD, 2004, ANAL BIOCHEM, V334, P312, DOI 10.1016/j.ab.2004.07.010; Sismeiro O, 1998, J BACTERIOL, V180, P3339, DOI 10.1128/JB.180.13.3339-3344.1998; Song JK, 2008, J BIOL CHEM, V283, P10939, DOI 10.1074/jbc.M709675200; Tammenkoski M, 2008, BIOCHEMISTRY-US, V47, P9707, DOI 10.1021/bi8010847; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Terkeltaub RA, 2001, AM J PHYSIOL-CELL PH, V281, pC1, DOI 10.1152/ajpcell.2001.281.1.C1; Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756; TSUTSUI K, 1986, J BIOL CHEM, V261, P2645; VANHEESWIJK WC, 1993, MOL MICROBIOL, V9, P443; Zyryanov AB, 2002, BIOCHEM J, V367, P901, DOI 10.1042/BJ20020880	40	16	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43879	10.1371/journal.pone.0043879	http://dx.doi.org/10.1371/journal.pone.0043879			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984449	Green Published, Green Submitted, gold			2022-12-27	WOS:000308738500026
J	Kotipatruni, RR; Nalla, AK; Asuthkar, S; Gondi, CS; Dinh, DH; Rao, JS				Kotipatruni, Ramaprasada Rao; Nalla, Arun Kumar; Asuthkar, Swapna; Gondi, Christopher S.; Dinh, Dzung H.; Rao, Jasti S.			Apoptosis Induced by Knockdown of uPAR and MMP-9 is Mediated by Inactivation of EGFR/STAT3 Signaling in Medulloblastoma	PLOS ONE			English	Article							NF-KAPPA-B; GROWTH-FACTOR RECEPTOR; DOWN-REGULATION; MATRIX METALLOPROTEINASES; MITOCHONDRIAL APOPTOSIS; RNA INTERFERENCE; GENE-EXPRESSION; CELL-DEATH; FACTOR EGF; IN-VIVO	Background: Medulloblastoma is a highly invasive cancer of central nervous system diagnosed mainly in children. Matrix metalloproteinase-9 (MMP-9) and urokinase plasminogen activator receptor (uPAR) are over expressed in several cancers and well established for their roles in tumor progression. The present study is aimed to determine the consequences of targeting these molecules on medulloblastoma progression. Methodology/Principal Findings: Radiation is one of the foremost methods applied for treating cancer and considerable evidence showed that radiation elevated uPAR and MMP-9 expression in medulloblastoma cell. Therefore efforts are made to target these molecules in non-irradiated and irradiated medulloblastoma cells. Our results showed that siRNA-mediated knockdown of uPAR and MMP-9, either alone or in combination with radiation modulated a series of events leading to apoptosis. Down regulation of uPAR and MMP-9 inhibited the expression of anti-apoptotic molecules like Bcl-2, Bcl-xL, survivin, XIAP and cIAPI; activated BID cleavage, enhanced the expression of Bak and translocated cyctochrome C to cytosol. Capsase-3 and -9 activities were also increased in uPAR-and MMP-9-downregulated cells. The apoptosis induced by targeting MMP-9 and uPAR was initiated by inhibiting epidermal growth factor receptor (EGFR) mediated activation of STAT3 and NF-kappa B related signaling molecules. Silencing uPAR and MMP-9 inhibited DNA binding activity of STAT3 and also reduced the recruitment of STAT3 protein at the promoter region of Bcl-2 and survivin genes. Our results suggest that inhibiting uPAR and MMP-9 reduced the expression of anti-apoptotic molecules by inactivating the transcriptional activity of STAT3. In addition, treating pre-established medulloblastoma with siRNAs against uPAR and MMP-9 both alone or in combination with radiation suppressed uPAR, MMP-9, EGFR, STAT3 expression and induced Bak activation leading to apoptosis. Conclusion/Significance: Taken together, our results illustrated that RNAi mediated targeting of uPAR and MMP-9 might have therapeutic potential against medulloblastoma.	[Kotipatruni, Ramaprasada Rao; Nalla, Arun Kumar; Asuthkar, Swapna; Gondi, Christopher S.; Rao, Jasti S.] Univ Illinois, Coll Med Peoria, Dept Canc Biol & Pharmacol, Peoria, IL USA; [Dinh, Dzung H.; Rao, Jasti S.] Univ Illinois, Coll Med Peoria, Dept Neurosurg, Peoria, IL USA	University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria	Kotipatruni, RR (corresponding author), Univ Illinois, Coll Med Peoria, Dept Canc Biol & Pharmacol, Peoria, IL USA.	jsrao@uic.edu	K, R/F-5701-2011	K, R/0000-0001-9853-2686; Gondi, Christopher/0000-0002-3036-9920	National Institutes of Health [CA138409]; NATIONAL CANCER INSTITUTE [R01CA138409] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by award number CA138409 (to J.S.R.) from the National Institutes of Health. Contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhardwaj A, 2007, BLOOD, V109, P2293, DOI 10.1182/blood-2006-02-003988; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Cattaneo E, 1998, ANTICANCER RES, V18, P2381; Chen FX, 2010, J MOL NEUROSCI, V40, P353, DOI 10.1007/s12031-009-9323-3; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Crawford JR, 2007, LANCET NEUROL, V6, P1073, DOI 10.1016/S1474-4422(07)70289-2; David M, 1996, J BIOL CHEM, V271, P9185, DOI 10.1074/jbc.271.16.9185; Dolled-Filhart M, 2003, CLIN CANCER RES, V9, P594; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fan YJ, 2008, ADV EXP MED BIOL, V615, P223, DOI 10.1007/978-1-4020-6554-5_11; Finucane DM, 1999, J BIOL CHEM, V274, P2225, DOI 10.1074/jbc.274.4.2225; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Ganji PCN, 2011, MOL CANCER RES, V9, P51, DOI 10.1158/1541-7786.MCR-10-0399; GERSCHENSON LE, 1992, FASEB J, V6, P2450, DOI 10.1096/fasebj.6.7.1563596; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; Gondi CS, 2008, INT J ONCOL, V33, P783, DOI 10.3892/ijo_00000065; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Guerrero J, 2004, EXP CELL RES, V292, P201, DOI 10.1016/j.yexcr.2003.08.011; Hemmati PG, 2006, ONCOGENE, V25, P6582, DOI 10.1038/sj.onc.1209668; Henson ES, 2006, CELL SIGNAL, V18, P2089, DOI 10.1016/j.cellsig.2006.05.015; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kargiotis O, 2008, INT J ONCOL, V33, P937, DOI 10.3892/ijo_00000081; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kim KW, 2006, MOL CANCER THER, V5, P2659, DOI 10.1158/1535-7163.MCT-06-0261; Kumar A, 2002, EUR J CANCER, V38, P505, DOI 10.1016/S0959-8049(01)00392-6; Kunigal S, 2009, INT J ONCOL, V34, P1209, DOI 10.3892/ijo_00000249; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Liu D, 2002, CANCER CELL, V1, P445, DOI 10.1016/S1535-6108(02)00072-7; Lo HW, 2008, CLIN CANCER RES, V14, P6042, DOI 10.1158/1078-0432.CCR-07-4923; McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a; Motamed K, 2002, J CELL BIOCHEM, V84, P759, DOI 10.1002/jcb.10095; MURPHY G, 1992, AM J RESP CELL MOL, V7, P120, DOI 10.1165/ajrcmb/7.2.120; Nalla AK, 2010, CANCER GENE THER, V17, P599, DOI 10.1038/cgt.2010.16; Nalla AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013006; Orlowski RZ, 2002, TRENDS MOL MED, V8, P385, DOI 10.1016/S1471-4914(02)02375-4; Pulukuri SM, 2005, J BIOL CHEM, V280, P36529, DOI 10.1074/jbc.M503111200; Rao JS, 2007, CANCER RES, V67, P4956, DOI 10.1158/0008-5472.CAN-07-0380; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Rood BR, 2004, SEMIN ONCOL, V31, P666, DOI 10.1053/j.seminoncol.2004.07.009; Rossi A, 2008, CLIN CANCER RES, V14, P971, DOI 10.1158/1078-0432.CCR-07-2072; Schaefer LK, 2002, ONCOGENE, V21, P2058, DOI 10.1038/sj.onc.1205263; Siddiquee KAZ, 2008, CELL RES, V18, P254, DOI 10.1038/cr.2008.18; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Squarize CH, 2006, NEOPLASIA, V8, P733, DOI 10.1593/neo.06274; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu XT, 2007, J CANCER RES CLIN, V133, P145, DOI 10.1007/s00432-006-0139-z	49	25	28	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44798	10.1371/journal.pone.0044798	http://dx.doi.org/10.1371/journal.pone.0044798			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984561	Green Published, gold			2022-12-27	WOS:000308738500086
J	Mechiche, H; Grassin-Delyle, S; Robinet, A; Nazeyrollas, P; Devillier, P				Mechiche, Hakima; Grassin-Delyle, Stanislas; Robinet, Arnaud; Nazeyrollas, Pierre; Devillier, Philippe			Prostanoid Receptors Involved in Regulation of the Beating Rate of Neonatal Rat Cardiomyocytes	PLOS ONE			English	Article							IN-VIVO; CALCIUM MOBILIZATION; INTERNATIONAL UNION; SIGNALING PATHWAYS; PROSTAGLANDINS; SUBTYPES; HEART; CLASSIFICATION; ARRHYTHMIAS; MYOCYTES	Although prostanoids are known to be involved in regulation of the spontaneous beating rate of cultured neonatal rat cardiomyocytes, the various subtypes of prostanoid receptors have not been investigated in detail. In our experiments, prostaglandin (PG)(F2 alpha) and prostanoid FP receptor agonists (fluprostenol, latanoprost and cloprostenol) produced a decrease in the beating rate. Two prostanoid IP receptor agonists (iloprost and beraprost) induced first a marked drop in the beating rate and then definitive abrogation of beating. In contrast, the prostanoid DP receptor agonists (PGD(2) and BW245C) and TP receptor agonists (U-46619) produced increases in the beating rate. Sulprostone (a prostanoid EP1 and EP3 receptor agonist) induced marked increases in the beating rate, which were suppressed by SC-19220 (a selective prostanoid EP1 antagonist). Butaprost (a selective prostanoid EP2 receptor agonist), misoprostol (a prostanoid EP2 and EP3 receptor agonist), 11-deoxy-PGE(1) (a prostanoid EP2, EP3 and EP4 receptor agonist) did not alter the beating rate. Our results strongly suggest that prostanoid EP1 receptors are involved in positive regulation of the beating rate. Prostanoid EP1 receptor expression was confirmed by western blotting with a selective antibody. Hence, neonatal rat cardiomyocytes express both prostanoid IP and FP receptors (which negatively regulate the spontaneous beating rate) and prostanoid TP, DP1 and EP1 receptors (which positively regulate the spontaneous beating rate).	[Mechiche, Hakima; Robinet, Arnaud; Nazeyrollas, Pierre; Devillier, Philippe] Univ Reims, Lab Cardiovasc Pharmacol, Reims, France; [Mechiche, Hakima; Grassin-Delyle, Stanislas; Devillier, Philippe] Univ Versailles St Quentin Yvelines, Hop Foch, UPRES EA 220, Suresnes, France	Universite de Reims Champagne-Ardenne; Hospital Foch; UDICE-French Research Universities; Universite Paris Saclay	Mechiche, H (corresponding author), Univ Reims, Lab Cardiovasc Pharmacol, Reims, France.	p.devillier@hopital-foch.org	Grassin-Delyle, Stanislas/AAC-5921-2021	Grassin-Delyle, Stanislas/0000-0001-5747-4432	French Society of Pharmacology	French Society of Pharmacology	HM received a grant from the French Society of Pharmacology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitz M, 2000, BBA-MOL CELL BIOL L, V1483, P285, DOI 10.1016/S1388-1981(99)00164-X; Adams JW, 1996, J BIOL CHEM, V271, P1179, DOI 10.1074/jbc.271.2.1179; Aicindor D, 2004, ANESTHESIOLOGY, V100, P547, DOI 10.1097/00000542-200403000-00013; ALSINAWI LAH, 1985, PROSTAGLANDINS, V29, P99; Arad M, 1996, MOL CELL BIOCHEM, V161, P249; ATHIAS P, 1979, PATHOL BIOL, V27, P13; Birincioglu M, 1997, PHARMACOL RES, V36, P299, DOI 10.1006/phrs.1997.0232; Boie Y, 1997, EUR J PHARMACOL, V340, P227, DOI 10.1016/S0014-2999(97)01383-6; Bolli R, 2002, CARDIOVASC RES, V55, P506, DOI 10.1016/S0008-6363(02)00414-5; COLEMAN RA, 1994, PHARMACOL REV, V46, P205; Cracowski JL, 2001, J VASC RES, V38, P93, DOI 10.1159/000051036; Griffin BW, 1998, J PHARMACOL EXP THER, V286, P411; Griffin BW, 1997, J PHARMACOL EXP THER, V281, P845; Ishizuka T, 2003, EUR J PHARMACOL, V468, P27, DOI 10.1016/S0014-2999(03)01626-1; Jenkins CM, 2009, CARDIOVASC RES, V82, P240, DOI 10.1093/cvr/cvn346; JOHNSTON SL, 1992, BRIT J CLIN PHARMACO, V34, P402, DOI 10.1111/j.1365-2125.1992.tb05649.x; Jones RL, 2009, BRIT J PHARMACOL, V158, P104, DOI 10.1111/j.1476-5381.2009.00317.x; Jovanovic N, 2006, PROSTAG OTH LIPID M, V80, P110, DOI 10.1016/j.prostaglandins.2006.05.014; KARMAZYN M, 1983, CAN J PHYSIOL PHARM, V61, P1207, DOI 10.1139/y83-180; KENNEDY I, 1982, PROSTAGLANDINS, V24, P667, DOI 10.1016/0090-6980(82)90036-3; Kiriyama M, 1997, BRIT J PHARMACOL, V122, P217, DOI 10.1038/sj.bjp.0701367; Kunapuli P, 1998, J BIOL CHEM, V273, P22442, DOI 10.1074/jbc.273.35.22442; Li YY, 1997, PROSTAGLANDINS, V54, P511, DOI 10.1016/S0090-6980(97)00122-6; LYDFORD SJ, 1994, BRIT J PHARMACOL, V112, P133, DOI 10.1111/j.1476-5381.1994.tb13042.x; Mattera R, 2001, CIRCULATION, V103, P2395; Meja KK, 1997, BRIT J PHARMACOL, V122, P149, DOI 10.1038/sj.bjp.0701360; Miyatake S, 2007, J CARDIOVASC PHARM, V50, P548, DOI 10.1097/FJC.0b013e318145ae2e; Morrison K, 2010, J PHARMACOL EXP THER, V335, P249, DOI 10.1124/jpet.110.169748; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; Ocklind A, 1997, PROSTAG LEUKOTR ESS, V57, P527, DOI 10.1016/S0952-3278(97)90555-X; ORCHARD MA, 1983, BRIT J CLIN PHARMACO, V15, P509, DOI 10.1111/j.1365-2125.1983.tb02083.x; OUDOT F, 1995, AM J PHYSIOL-HEART C, V268, pH308, DOI 10.1152/ajpheart.1995.268.1.H308; Shichijo M, 2003, J PHARMACOL EXP THER, V307, P518, DOI 10.1124/jpet.103.055442; Shinmura K, 2005, AM J PHYSIOL-HEART C, V288, pH2093, DOI 10.1152/ajpheart.01003.2004; Takayama K, 2005, NAT MED, V11, P562, DOI 10.1038/nm1231; TOSAKI A, 1990, EUR J PHARMACOL, V191, P69, DOI 10.1016/0014-2999(90)94097-H; Walch L, 1999, BRIT J PHARMACOL, V126, P859, DOI 10.1038/sj.bjp.0702393; Woodward DF, 2011, PHARMACOL REV, V63, P471, DOI 10.1124/pr.110.003517; WOODWARD DF, 1995, J PHARMACOL EXP THER, V273, P285	39	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45273	10.1371/journal.pone.0045273	http://dx.doi.org/10.1371/journal.pone.0045273			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984630	gold, Green Submitted, Green Published			2022-12-27	WOS:000308738500128
J	Aydiner, A; Lusebrink, J; Schildgen, V; Winterfeld, I; Knuver, O; Schwarz, K; Messler, S; Schildgen, O; Mattner, F				Aydiner, Aylin; Luesebrink, Jessica; Schildgen, Verena; Winterfeld, Ingo; Knuever, Oliver; Schwarz, Katja; Messler, Sabine; Schildgen, Oliver; Mattner, Frauke			Comparison of Two Commercial PCR Methods for Methicillin-Resistant Staphylococcus aureus (MRSA) Screening in a Tertiary Care Hospital	PLOS ONE			English	Article							ASSAY; CHROMOSOME; INFECTIONS; STRAINS; CULTURE; MECA; IDENTIFICATION; COLONIZATION; METAANALYSIS; PREVALENCE	Nose/throat-swabs from 1049 patients were screened for MRSA using CHROMagar MRSA, LightCycler Advanced MRSA, and Detect-Ready MRSA. Results were compared to the CHROMagar MRSA results, which was set as reference system. MRSA was detected in 3.05% of the patients with CHROMagar MRSA. LightCycler MRSA Advanced showed a higher clinical sensitivity (84.38%) than Detect-Ready MRSA (57.69%). The negative predictive values were high for both tests (>98%). The specificity and the positive predictive value were higher for the Detect-Ready MRSA test than for the LightCycler MRSA test (99.59% and 78.95% versus 98.52% and 64.29%). For routine screening LightCycler MRSA Advanced proved to be more efficient in our clinical setting as the clinical sensitivity was much higher than the sensitivity of Detect-Ready MRSA. CHROMagar MRSA detected more MRSA positive samples than both PCR methods, leading to the conclusion that the combination of PCR with cultural screening is still the most reliable way for the detection of MRSA. LightCycler MRSA Advanced was faster and needed less hands-on time. The advantage of Detect-Ready MRSA was the additional identification of methicillin-sensitive S. aureus (here in 34.63% of the samples), an information which can be possibly used for reducing the risk of postoperative infections in surgical patients in future.	[Aydiner, Aylin; Luesebrink, Jessica; Schildgen, Verena; Knuever, Oliver; Schildgen, Oliver] Kliniken Stadt Koln gGmbH, Inst Pathol, Cologne, Germany; [Winterfeld, Ingo; Schwarz, Katja; Messler, Sabine; Mattner, Frauke] Kliniken Stadt Koln gGmbH, Inst Hyg, Cologne, Germany	University of Cologne	Schildgen, O (corresponding author), Kliniken Stadt Koln gGmbH, Inst Pathol, Cologne, Germany.	schildgeno@kliniken-koeln.de; mattnerf@kliniken-koeln.de	Schildgen, Oliver/D-5327-2014	Schildgen, Oliver/0000-0003-4297-9627	Roche Diagnostics, Germany	Roche Diagnostics, Germany	Oliver Schildgen reports to having received a travel grant by Roche Diagnostics, Germany. No other competing interests apply to this manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Arcenas RC, 2012, J MOL DIAGN, V14, P367, DOI 10.1016/j.jmoldx.2012.01.015; Bartels MD, 2009, J CLIN MICROBIOL, V47, P1524, DOI 10.1128/JCM.02153-08; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; Boyce JM, 2008, J CLIN MICROBIOL, V46, P350, DOI 10.1128/JCM.02130-07; Boye K, 2007, CLIN MICROBIOL INFEC, V13, P725, DOI 10.1111/j.1469-0691.2007.01720.x; Coia JE, 2006, J HOSP INFECT, V63, pS1, DOI 10.1016/j.jhin.2006.01.001; Corkill JE, 2004, J ANTIMICROB CHEMOTH, V54, P229, DOI 10.1093/jac/dkh284; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Cosgrove SE, 2005, INFECT CONT HOSP EP, V26, P166, DOI 10.1086/502522; Cuny C, 2005, CLIN MICROBIOL INFEC, V11, P834, DOI 10.1111/j.1469-0691.2005.01236.x; de San N, 2007, J CLIN MICROBIOL, V45, P1098, DOI 10.1128/JCM.02208-06; Deplano A, 2000, J ANTIMICROB CHEMOTH, V46, P617, DOI 10.1093/jac/46.4.617; Fodrie TY, 2009, ANAL QUANT CYTOL, V31, P410; Francois P, 2007, J CLIN MICROBIOL, V45, P2011, DOI 10.1128/JCM.00232-07; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Hamdan-Partida A, 2010, J CLIN MICROBIOL, V48, P1701, DOI 10.1128/JCM.01929-09; Hiramatsu K, 2002, INT J MED MICROBIOL, V292, P67, DOI 10.1078/1438-4221-00192; Hsueh PR, 2004, ANTIMICROB AGENTS CH, V48, P1361, DOI 10.1128/AAC.48.4.1361-1364.2004; Huletsky A, 2004, J CLIN MICROBIOL, V42, P1875, DOI 10.1128/JCM.42.5.1875-1884.2004; KISS, 2010, KISS KRANK INF SURV; Klevens RM, 2006, CLIN INFECT DIS, V42, P389, DOI 10.1086/499367; Kresken M, 1999, INFECTION, V27, pS2, DOI 10.1007/BF02561661; Kresken M, 2003, RESISTENZSITUATION B; Lauderdale TLY, 2010, EUR J CLIN MICROBIOL, V29, P1553, DOI 10.1007/s10096-010-1042-8; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Luteijn JM, 2011, CLIN MICROBIOL INFEC, V17, P146, DOI 10.1111/j.1469-0691.2010.03202.x; Malhotra-Kumar S, 2010, J CLIN MICROBIOL, V48, P1040, DOI 10.1128/JCM.01745-09; Peterson LR, 2010, J CLIN MICROBIOL, V48, P1661, DOI 10.1128/JCM.00003-10; Ringberg H, 2006, SCAND J INFECT DIS, V38, P888, DOI 10.1080/00365540600740546; Robert Koch-Institut, 2008, EPIDEMIOL B, P363; Robotham JV, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5694; Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P3765, DOI 10.1128/AAC.00187-11; STEWART GT, 1963, BRIT MED J, P308; Styers David, 2006, Ann Clin Microbiol Antimicrob, V5, P2; Tiemersma EW, 2004, EMERG INFECT DIS, V10, P1627, DOI 10.3201/eid1009.040069; Wertheim HFL, 2004, J HOSP INFECT, V56, P321, DOI 10.1016/j.jhin.2004.01.026	36	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e43935	10.1371/journal.pone.0043935	http://dx.doi.org/10.1371/journal.pone.0043935			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028480	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388400016
J	Yan, HF; Zhang, CY; Wang, FY; Hu, CM; Ge, XJ; Hao, G				Yan, Hai-Fei; Zhang, Cai-Yun; Wang, Feng-Ying; Hu, Chi-Ming; Ge, Xue-Jun; Hao, Gang			Population Expanding with the Phalanx Model and Lineages Split by Environmental Heterogeneity: A Case Study of Primula obconica in Subtropical China	PLOS ONE			English	Article							QINGHAI-TIBETAN PLATEAU; TEMPERATE PLANTS; COMPARATIVE PHYLOGEOGRAPHY; HISTORICAL DEMOGRAPHY; HENGDUAN MOUNTAINS; EAST-ASIA; DNA; CHLOROPLAST; PLEISTOCENE; MITOCHONDRIAL	Background: Current and historical events have both affected the current distribution patterns and intraspecific divergence of plants. While numerous studies have focused on the Qinghai-Tibetan Plateau (QTP), the impacts of such events on the flora of subtropical China remain poorly understood. Subtropical China is famous for its highly complex topography and the limited impact from glaciation during the Pleistocene; this may have resulted in a different genetic legacy for species in this region compared to fully glaciated areas. Methodology/Principal Findings: We used plastid and nuclear DNA sequence data and distribution modeling to analyze the divergence patterns and demographic history of Primula obconica Hance, a widespread herbaceous montane species in subtropical China. The phylogenetic analysis revealed two major lineages (lineage A and lineage B), representing a west-east split into the Yunnan and Eastern groups, and the Sichuan and Central groups, respectively. The Eastern and Central groups comprised relatively new derived haplotypes. Nested Clade Analysis and Bayesian Skyline Plot analyses both indicated that P. obconica mainly experienced a gradual expansion of populations. In addition, the simulated distribution of P. obconica during the Last Glacial Maximum was slightly larger than its present-day distribution. Conclusion/Significance: Our results are the first to identify a west-east migration of P. obconica. The gradual expansion pattern and a larger potential distribution range in cold periods detected for P. obconica indicate that the population expansion of this species is consistent with the phalanx model. In addition, the current patterns of genetic differentiation have persisted as a result of the extensive environmental heterogeneity that exists in subtropical China.	[Hao, Gang] S China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China; [Wang, Feng-Ying] Chinese Acad Sci, Shanghai Chenshan Bot Garden, Shanghai Chenshan Plant Sci Res Ctr, Shanghai, Peoples R China; [Zhang, Cai-Yun] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Yan, Hai-Fei; Zhang, Cai-Yun; Hu, Chi-Ming; Ge, Xue-Jun] Chinese Acad Sci, S China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS	Hao, G (corresponding author), S China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China.	haogang@scau.edu.cn	Ge, Xue-Jun/AAP-5967-2020	Ge, Xue-Jun/0000-0002-5008-9475	National Natural Science Foundation of China [31170205, 30900160]; Special Research Program of Shanghai Chenshan Botanical Garden [G102401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Research Program of Shanghai Chenshan Botanical Garden	This study was financially supported by the National Natural Science Foundation of China (Grant Nos. 31170205 and 30900160) and a Special Research Program of Shanghai Chenshan Botanical Garden (G102401). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Axelrod D., 1996, FLORISTIC CHARACTERI, P43; Chiang TY, 2006, TAXON, V55, P31, DOI 10.2307/25065526; Chiang YC, 2004, MOL PHYLOGENET EVOL, V31, P929, DOI 10.1016/j.ympev.2003.09.017; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Comes HP, 1998, TRENDS PLANT SCI, V3, P432, DOI 10.1016/S1360-1385(98)01327-2; *COMM CHIN AC SCI, 1985, PHYS GEOGR CHIN PAND; CRANDALL KA, 1993, GENETICS, V134, P959; Cui ZJ, 2005, QUATERARY GLACIATION; DeChaine EG, 2004, EVOLUTION, V58, P113, DOI 10.1111/j.0014-3820.2004.tb01578.x; DOWRICK V. PAMELA J., 1956, HEREDITY, V10, P219; Doyle J. J., 1987, PHYTOCHEM B, P11; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flanders J, 2011, J BIOGEOGR, V38, P439, DOI 10.1111/j.1365-2699.2010.02411.x; Fu YX, 1997, GENETICS, V147, P915; Gao LM, 2007, MOL ECOL, V16, P4684, DOI 10.1111/j.1365-294X.2007.03537.x; Gong W, 2008, MOL PHYLOGENET EVOL, V48, P1094, DOI 10.1016/j.ympev.2008.05.003; Guggisberg A, 2006, NEW PHYTOL, V171, P617, DOI 10.1111/j.1469-8137.2006.01722.x; HARPENDING HC, 1994, HUM BIOL, V66, P591; Harrison SP, 2001, NATURE, V413, P129, DOI 10.1038/35093166; Hasumi H., 2004, 1 U TOK CTR CLIM SYS; [何国生 He Guosheng], 2002, [植物分类学报, Acta Phytotaxonomica Sinica], V40, P551; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hu CM, 1996, PRIMULACEAE; Hu CM, 1994, J TROPICAL SUBTROPIC, V2, P1; Hu CM, 1990, PRIMULACEAE; KELSO S, 1992, ARCTIC ALPINE RES, V24, P82, DOI 10.2307/1551324; Li BY., 1989, J MOUNTAIN RES, V7, P13; Li SH, 2009, MOL ECOL, V18, P622, DOI 10.1111/j.1365-294X.2008.04028.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mast AR, 2006, NEW PHYTOL, V171, P605, DOI [10.1111/j.1469-8137.2006.01700.x, 10.1111/j.1469-8137.2006.01833.x]; Oxelman B, 1997, PLANT SYST EVOL, V206, P393, DOI 10.1007/BF00987959; Pauls SU, 2006, MOL ECOL, V15, P2153, DOI 10.1111/j.1365-294X.2006.02916.x; Petit RJ, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P23, DOI 10.1007/1-4020-4904-8_2; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pons O, 1996, GENETICS, V144, P1237; Porter J.E., 1994, QUATERNARY SCI, V1, P24; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 2000, MOL ECOL, V9, P487, DOI 10.1046/j.1365-294x.2000.00887.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Posada D, 2006, MOL ECOL NOTES, V6, P590, DOI 10.1111/j.1471-8286.2006.01368.x; Qian H, 2000, NATURE, V407, P180, DOI 10.1038/35025052; Qian H, 2002, AM J BOT, V89, P1818, DOI 10.3732/ajb.89.11.1818; Qiu YX, 2009, MOL PHYLOGENET EVOL, V51, P281, DOI 10.1016/j.ympev.2009.01.016; Qu Y, 2010, MOL ECOL, V19, P338, DOI 10.1111/j.1365-294X.2009.04445.x; Qu YH, 2005, MOL ECOL, V14, P1767, DOI 10.1111/j.1365-294X.2005.02528.x; Rambaut A, 2005, TRACER V1 5; Richards J, 2003, PRIMULA; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SARKAR A K, 1988, Feddes Repertorium, V99, P113; Schneider S, 1999, GENETICS, V152, P1079; Shepard DB, 2009, MOL ECOL, V18, P2243, DOI 10.1111/j.1365-294X.2009.04164.x; Shepard DB, 2008, MOL ECOL, V17, P5315, DOI 10.1111/j.1365-294X.2008.03998.x; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Song G, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-143; Sun XJ, 2000, ACTA BOT SIN, V42, P1201; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TAJIMA F, 1989, GENETICS, V123, P585; TEMPLETON AR, 1993, GENETICS, V134, P659; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Geert A, 2008, CONSERV GENET, V9, P845, DOI 10.1007/s10592-007-9409-9; Wang FY, 2008, J SYST EVOL, V46, P13, DOI 10.3724/SP.J.1002.2008.07049; Wang JF, 2011, J SYST EVOL, V49, P108, DOI 10.1111/j.1759-6831.2011.00117.x; Wang J, 2009, J BIOGEOGR, V36, P2156, DOI 10.1111/j.1365-2699.2009.02165.x; Wang L., 2011, PLOS ONE, V6; Wang SJ, 2004, LAND DEGRAD DEV, V15, P115, DOI 10.1002/ldr.592; Wang W.-T., 1992, ACTA PHYTOTAXONOMICA, V30, P97; WANG WT, 1992, ACTA PHYTOTAXON SIN, V30, P1, DOI DOI 10.4324/9780429500190-1; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wu ZY, 1980, CHINAS VEGETATION; Wu ZY, 2011, FLORISICS SEED PLANT; Yan HF, 2010, J SYST EVOL, V48, P123, DOI 10.1111/j.1759-6831.2010.00068.x; Yang FS, 2008, MOL ECOL, V17, P5135, DOI 10.1111/j.1365-294X.2008.03976.x; YING JS, 2001, BIODIVERSITY SCI, V9, P393, DOI DOI 10.17520/BI0DS.2001058; Ying T.-S., 1993, ENDEMIC GENERA SEED; Yu G, 2000, J BIOGEOGR, V27, P635, DOI 10.1046/j.1365-2699.2000.00431.x; Yuan QJ, 2008, MOL ECOL, V17, P1054, DOI 10.1111/j.1365-294X.2007.03628.x; Zhang DC, 2009, NORD J BOT, V27, P405, DOI 10.1111/j.1756-1051.2008.00235.x; Zhang Q, 2005, MOL ECOL, V14, P3513, DOI 10.1111/j.1365-294X.2005.02677.x; Zhang Q, 2003, PLANT CELL PHYSIOL, V44, P941, DOI 10.1093/pcp/pcg121; Zhang R., 1997, PHYS GEOGRAPHY HENGD; Zheng BX, 2005, QUATERARY GLACIATION	94	32	42	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e41315	10.1371/journal.pone.0041315	http://dx.doi.org/10.1371/journal.pone.0041315			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028425	Green Submitted, gold, Green Published			2022-12-27	WOS:000309388400002
J	Kong, DJ; Ahmad, A; Bao, B; Li, YW; Banerjee, S; Sarkar, FH				Kong, Dejuan; Ahmad, Aamir; Bao, Bin; Li, Yiwei; Banerjee, Sanjeev; Sarkar, Fazlul H.			Histone Deacetylase Inhibitors Induce Epithelial-to-Mesenchymal Transition in Prostate Cancer Cells	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; PLURIPOTENT STEM-CELLS; ANDROGEN-DEPRIVATION; METASTASIS; GROWTH; INVASION; ANGIOGENESIS; CARCINOMA; EMT; 3,3'-DIINDOLYLMETHANE	Clinical experience of histone deacetylase inhibitors (HDACIs) in patients with solid tumors has been disappointing; however, the molecular mechanism of treatment failure is not known. Therefore, we sought to investigate the molecular mechanism of treatment failure of HDACIs in the present study. We found that HDACIs Trichostatin A (TSA) and Suberoylanilide hydroxamic acid (SAHA) could induce epithelial-to-mesenchymal transition (EMT) phenotype in prostate cancer (PCa) cells, which was associated with changes in cellular morphology consistent with increased expression of transcription factors ZEB1, ZEB2 and Slug, and mesenchymal markers such as vimentin, N-cadherin and Fibronectin. CHIP assay showed acetylation of histone 3 on proximal promoters of selected genes, which was in part responsible for increased expression of EMT markers. Moreover, TSA treatment led to further increase in the expression of Sox2 and Nanog in PCa cells with EMT phenotype, which was associated with cancer stem-like cell (CSLC) characteristics consistent with increased cell motility. Our results suggest that HDACIs alone would lead to tumor aggressiveness, and thus strategies for reverting EMT-phenotype to mesenchymal-to-epithelial transition (MET) phenotype or the reversal of CSLC characteristics prior to the use of HDACIs would be beneficial to realize the value of HDACIs for the treatment of solid tumors especially PCa.	[Kong, Dejuan; Ahmad, Aamir; Bao, Bin; Li, Yiwei; Banerjee, Sanjeev; Sarkar, Fazlul H.] Wayne State Univ, Sch Med, Dept Pathol, Karmanos Canc Inst, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University	Kong, DJ (corresponding author), Wayne State Univ, Sch Med, Dept Pathol, Karmanos Canc Inst, Detroit, MI 48201 USA.	fsarkar@med.wayne.edu	Ahmad, Aamir/E-8747-2010	Ahmad, Aamir/0000-0003-1784-5723	National Cancer Institute, National Institutes of Health [5R01CA108535-06, 5R01CA083695-09]; NATIONAL CANCER INSTITUTE [R01CA083695, R01CA108535] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by a grant from the National Cancer Institute, National Institutes of Health (5R01CA108535-06 and 5R01CA083695-09) awarded to FHS (http://projectreporter.nih.gov/reporter_searchresults.cfm?&new = 1&icde = 4342569&loc = 2&CFID = 28929570&CFTOKEN = 80568291). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albino D, 2012, CANCER RES, V72, P2889, DOI 10.1158/0008-5472.CAN-12-0212; Armstrong AJ, 2011, MOL CANCER RES, V9, P997, DOI 10.1158/1541-7786.MCR-10-0490; Barriere G, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-114; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bertino EM, 2011, EXPERT OPIN INV DRUG, V20, P1151, DOI 10.1517/13543784.2011.594437; Bruzzese F, 2011, J CELL PHYSIOL, V226, P2378, DOI 10.1002/jcp.22574; Chin SP, 2011, CLIN EPIGENETICS, V2, P151, DOI 10.1007/s13148-011-0041-7; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Gu GY, 2007, CANCER RES, V67, P4807, DOI 10.1158/0008-5472.CAN-06-4608; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Jennbacken K, 2010, ENDOCR-RELAT CANCER, V17, P469, DOI 10.1677/ERC-10-0015; Kanwal R, 2012, CLIN GENET, V81, P303, DOI 10.1111/j.1399-0004.2011.01809.x; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; Kong DJ, 2008, STEM CELLS, V26, P1425, DOI 10.1634/stemcells.2007-1076; Kong D, 2008, CANCER RES, V68, P1927, DOI 10.1158/0008-5472.CAN-07-3241; Kong DJ, 2007, CANCER RES, V67, P3310, DOI 10.1158/0008-5472.CAN-06-4277; Kong Dejuan, 2011, Cancers (Basel), V3, P716, DOI 10.3390/cancers30100716; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Ksiazkiewicz M, 2012, PATHOBIOLOGY, V79, P195, DOI 10.1159/000337106; Lei WW, 2010, INT J BIOCHEM CELL B, V42, P1489, DOI 10.1016/j.biocel.2010.05.006; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Mulholland DJ, 2012, CANCER RES, V72, P1878, DOI 10.1158/0008-5472.CAN-11-3132; Nalls D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024099; Olsen EA, 2007, J CLIN ONCOL, V25, P3109, DOI 10.1200/JCO.2006.10.2434; Pasha Z, 2012, STEM CELLS DEV; Piekarz RL, 2011, BLOOD, V117, P5827, DOI 10.1182/blood-2010-10-312603; Piekarz RL, 2009, J CLIN ONCOL, V27, P5410, DOI 10.1200/JCO.2008.21.6150; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Robey RW, 2011, MOL PHARMACEUT, V8, P2021, DOI 10.1021/mp200329f; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Srivastava RK, 2010, MOL CANCER THER, V9, P3254, DOI 10.1158/1535-7163.MCT-10-0582; Sun YT, 2012, CANCER RES, V72, P527, DOI 10.1158/0008-5472.CAN-11-3004; Tanaka H, 2010, NAT MED, V16, P1414, DOI 10.1038/nm.2236; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Uchida H, 2012, J BIOL CHEM, V287, P4441, DOI 10.1074/jbc.M111.286138; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Wang ZW, 2010, DRUG RESIST UPDATE, V13, P109, DOI 10.1016/j.drup.2010.07.001; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Whittaker SJ, 2010, J CLIN ONCOL, V28, P4485, DOI 10.1200/JCO.2010.28.9066; Wu YZ, 2007, GENES CELLS, V12, P905, DOI 10.1111/j.1365-2443.2007.01104.x; Yoshikawa M, 2007, J AM SOC NEPHROL, V18, P58, DOI 10.1681/ASN.2005111187; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang XP, 2009, MOL CANCER THER, V8, P499, DOI 10.1158/1535-7163.MCT-08-0544	50	31	35	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45045	10.1371/journal.pone.0045045	http://dx.doi.org/10.1371/journal.pone.0045045			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024790	Green Submitted, Green Published, gold			2022-12-27	WOS:000308860100048
J	Lopez-Arenas, E; Mackay-Sim, A; Bacigalupo, J; Sulz, L				Lopez-Arenas, Estefania; Mackay-Sim, Alan; Bacigalupo, Juan; Sulz, Lorena			Leukaemia Inhibitory Factor Stimulates Proliferation of Olfactory Neuronal Progenitors via Inducible Nitric Oxide Synthase	PLOS ONE			English	Article							GLOBOSE BASAL-CELLS; NEURAL STEM-CELLS; MOUSE SUBVENTRICULAR ZONE; MESSENGER-RNA EXPRESSION; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; IN-VITRO; DENTATE GYRUS; INDUCED NEUROGENESIS; FUNCTIONAL DEFICITS	Neurogenesis continues in the adult brain and in the adult olfactory epithelium. The cytokine, leukaemia inhibitory factor and nitric oxide are both known to stimulate neuronal progenitor cell proliferation in the olfactory epithelium after injury. Our aim here was to determine whether these observations are independent, specifically, whether leukaemia inhibitory factor triggers neural precursor proliferation via the inducible nitric oxide synthase pathway. We evaluated the effects of leukaemia inhibitory factor on inducible form of nitric oxide synthase (iNOS) expression, and cell proliferation in olfactory epithelial cell cultures and olfactory neurosphere-derived cells. Leukaemia inhibitory factor induced expression of iNOS and increased cell proliferation. An iNOS inhibitor and an anti-leukaemia inhibitory factor receptor blocking antibody inhibited leukaemia inhibitory factor-induced cell proliferation, an effect that was reversed by a NO donor. Altogether, the results strongly suggest that leukaemia inhibitory factor induces iNOS expression, increasing nitric oxide levels, to stimulate proliferation of olfactory neural precursor cells. This finding sheds light on neuronal regeneration occurring after injury of the olfactory epithelium.	[Lopez-Arenas, Estefania; Bacigalupo, Juan] Univ Chile, Fac Sci, Dept Biol, Santiago, Chile; [Lopez-Arenas, Estefania; Bacigalupo, Juan] Univ Chile, Millennium Inst Cell Dynam & Biotechnol, Santiago, Chile; [Mackay-Sim, Alan] Griffith Univ, Natl Ctr Adult Stem Cell Res, Eskitis Inst Cell & Mol Therapies, Brisbane, Qld 4111, Australia; [Sulz, Lorena] Univ Santiago Chile, Lab Embryol, Sch Med, Fac Med Sci, Usach Santiago, Chile	Universidad de Chile; Universidad de Chile; Griffith University	Lopez-Arenas, E (corresponding author), Univ Chile, Fac Sci, Dept Biol, Santiago, Chile.	bacigalu@uchile.cl; lorena.sulz@usach.cl	Mackay-Sim, Alan/C-3431-2008	Mackay-Sim, Alan/0000-0003-4446-5371	DICYT (Direccion de Investigacion en Ciencia y Tecnologia) [021091SE]; MIDEPLAN (Ministerio de Planificacion y Desarrollo) [ICM-P05-001-F]; DICYT [021091SE]; MIDEPLAN [ICM-P05-001-F]; Fondecyt [1100682]; Australian Department of Health and Ageing	DICYT (Direccion de Investigacion en Ciencia y Tecnologia); MIDEPLAN (Ministerio de Planificacion y Desarrollo); DICYT; MIDEPLAN; Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Australian Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	Funded by national grants DICYT (Direccion de Investigacion en Ciencia y Tecnologia) 021091SE and MIDEPLAN (Ministerio de Planificacion y Desarrollo) ICM-P05-001-F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Jimena Sierralta (Laboratory of Cellular and Molecular Neurobiology, Faculty of Medicine, University of Chile) and Dr. Luis Michea (Laboratory of Integrative Physiology Faculty of Medicine, University of Chile) for their assistance in the qPCRs experiments and to Dr. Maria Rosa Bono (Laboratory of Immunology, Faculty of Science, Universidad de Chile) for her assistance in the flow cytometer protocols. Funded by DICYT 021091SE to LS, MIDEPLAN ICM-P05-001-F and Fondecyt 1100682 to JB and Australian Department of Health and Ageing to AMS.	BANNER LR, 1994, P NATL ACAD SCI USA, V91, P7109, DOI 10.1073/pnas.91.15.7109; Bauer S, 2003, J NEUROSCI, V23, P1792; Bauer S, 2009, ANN NY ACAD SCI, V1153, P48, DOI 10.1111/j.1749-6632.2009.03986.x; CAGGIANO M, 1994, NEURON, V13, P339, DOI 10.1016/0896-6273(94)90351-4; CALOF AL, 1989, NEURON, V3, P115, DOI 10.1016/0896-6273(89)90120-7; Chen JL, 2004, BRAIN RES, V1005, P21, DOI 10.1016/j.brainres.2003.11.080; Chen XY, 2004, J COMP NEUROL, V469, P457, DOI 10.1002/cne.11031; Corsani L, 2008, EXP NEUROL, V211, P433, DOI 10.1016/j.expneurol.2008.02.008; Dell'Albani P, 2001, J NEUROSCI RES, V65, P417, DOI 10.1002/jnr.1169; Farlik M, 2010, IMMUNITY, V33, P25, DOI 10.1016/j.immuni.2010.07.001; GEARING DP, 1987, EMBO J, V6, P3995, DOI 10.1002/j.1460-2075.1987.tb02742.x; Getchell TV, 2002, J NEUROSCI RES, V67, P246, DOI 10.1002/jnr.10090; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; Guo Z, 2007, FASEB J, V21, P535, DOI 10.1096/fj.06-6739com; Hambartsoumian E, 2001, AM J REPROD IMMUNOL, V45, P78, DOI 10.1111/j.8755-8920.2001.450203.x; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; HUARD JMT, 1995, DEV DYNAM, V203, P17, DOI 10.1002/aja.1002030103; Keynes RG, 2004, CURR MOL MED, V4, P179, DOI 10.2174/1566524043479176; Kim EJ, 2005, NEUROREPORT, V16, P25, DOI 10.1097/00001756-200501190-00007; Kim SJ, 2000, BIOCHEM BIOPH RES CO, V278, P712, DOI 10.1006/bbrc.2000.3862; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; Leung CT, 2006, HORIZONTAL BASEL CEL, P115; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Lu DY, 2003, J NEUROSURG, V99, P351, DOI 10.3171/jns.2003.99.2.0351; Mackay-Sim A, 2000, PROG NEUROBIOL, V62, P527, DOI 10.1016/S0301-0082(00)00009-5; MACKAYSIM A, 1991, J NEUROSCI, V11, P979; Matarredona ER, 2004, BRAIN RES, V995, P274, DOI 10.1016/j.brainres.2003.10.010; Minami M, 2002, MOL BRAIN RES, V107, P39, DOI 10.1016/S0169-328X(02)00443-6; Moon C, 2002, P NATL ACAD SCI USA, V99, P9015, DOI 10.1073/pnas.132131699; Moran CS, 1997, J VASC RES, V34, P378, DOI 10.1159/000159246; Moreno-Lopez B, 2004, J NEUROSCI, V24, P85, DOI 10.1523/JNEUROSCI.1574-03.2004; Moreno-Lopez B, 2000, BRAIN RES, V869, P244, DOI 10.1016/S0006-8993(00)02474-4; Moro MA, 2004, CELL CALCIUM, V36, P265, DOI 10.1016/j.ceca.2004.02.011; MOULTON DG, 1974, ANN NY ACAD SCI, V237, P52, DOI 10.1111/j.1749-6632.1974.tb49843.x; Murphy M, 1997, PROG NEUROBIOL, V52, P355, DOI 10.1016/S0301-0082(97)00020-8; Murrell W, 2005, DEV DYNAM, V233, P496, DOI 10.1002/dvdy.20360; Nan B, 2001, J COMP NEUROL, V435, P60, DOI 10.1002/cne.1193; Newman MP, 2000, NEUROSCIENCE, V99, P343, DOI 10.1016/S0306-4522(00)00194-9; Packer MA, 2003, P NATL ACAD SCI USA, V100, P9566, DOI 10.1073/pnas.1633579100; Park C, 2001, NEUROSCI LETT, V309, P9, DOI 10.1016/S0304-3940(01)02003-1; Peunova N, 2001, J NEUROSCI, V21, P8809, DOI 10.1523/JNEUROSCI.21-22-08809.2001; Pitman M, 2004, MOL CELL NEUROSCI, V27, P255, DOI 10.1016/j.mcn.2004.07.004; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Rolfe BE, 2003, CARDIOVASC RES, V58, P222, DOI 10.1016/S0008-6363(02)00832-5; ROSKAMS AJ, 1994, NEURON, V13, P289; Satoh M, 1997, NEUROSCI LETT, V225, P165, DOI 10.1016/S0304-3940(97)00216-4; Shimazaki T, 2001, J NEUROSCI, V21, P7642, DOI 10.1523/JNEUROSCI.21-19-07642.2001; Sulz L, 2009, NITRIC OXIDE-BIOL CH, V20, P238, DOI 10.1016/j.niox.2009.01.004; Sugiyama T, 2003, J ENDOTOXIN RES, V9, P108, DOI 10.1179/096805103125001496; Sun YJ, 2005, J CEREBR BLOOD F MET, V25, P485, DOI 10.1038/sj.jcbfm.9600049; Suzuki S, 2000, J CEREBR BLOOD F MET, V20, P661, DOI 10.1097/00004647-200004000-00003; Wetzig A, 2011, CELL TRANSP IN PRESS; Yu ZY, 2004, J AM SOC NEPHROL, V15, P585, DOI 10.1097/01.ASN.0000114556.19556.F9; Zhang RL, 2001, ANN NEUROL, V50, P602, DOI 10.1002/ana.1249; Zhu DY, 2003, J NEUROSCI, V23, P223	56	10	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45018	10.1371/journal.pone.0045018	http://dx.doi.org/10.1371/journal.pone.0045018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024784	Green Published, Green Submitted, gold			2022-12-27	WOS:000308860100042
J	Poudel, A; Elsasser, TH; Rahman, KS; Chowdhury, EU; Kaltenboeck, B				Poudel, Anil; Elsasser, Theodore H.; Rahman, Kh. Shamsur; Chowdhury, Erfan U.; Kaltenboeck, Bernhard			Asymptomatic Endemic Chlamydia pecorum Infections Reduce Growth Rates in Calves by up to 48 Percent	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ACUTE-PHASE PROTEINS; CHLAMYDOPHILA-ABORTUS; BINDING-PROTEINS; HIGH PREVALENCE; FACTOR-I; PSITTACI; CATTLE; FEED; IMMUNOGLOBULINS	Intracellular Chlamydia (C.) bacteria cause in cattle some acute but rare diseases such as abortion, sporadic bovine encephalomyelitis, kerato-conjunctivitis, pneumonia, enteritis and polyarthritis. More frequent, essentially ubiquitous worldwide, are low-level, asymptomatic chlamydial infections in cattle. We investigated the impact of these naturally acquired infections in a cohort of 51 female Holstein and Jersey calves from birth to 15 weeks of age. In biweekly sampling, we measured blood/plasma markers of health and infection and analyzed their association with clinical appearance and growth in dependence of chlamydial infection intensity as determined by mucosal chlamydial burden or contemporaneous anti-chlamydial plasma IgM. Chlamydia 23S rRNA gene PCR and ompA genotyping identified only C. pecorum (strains 1710S, Maeda, and novel strain Smith3v8) in conjunctival and vaginal swabs. All calves acquired the infection but remained clinically asymptomatic. High chlamydial infection associated with reduction of body weight gains by up to 48% and increased conjunctival reddening (P<10(-4)). Simultaneously decreased plasma albumin and increased globulin (P<10(-4)) suggested liver injury by inflammatory mediators as mechanisms for the growth inhibition. This was confirmed by the reduction of plasma insulin like growth factor-1 at high chlamydial infection intensity (P<10(-4)). High anti-C. pecorum IgM associated eight weeks later with 66% increased growth (P = 0.027), indicating a potential for immune protection from C. pecorum-mediated growth depression. The worldwide prevalence of chlamydiae in livestock and their high susceptibility to common feed-additive antibiotics suggests the possibility that suppression of chlamydial infections may be a major contributor to the growth promoting effect of feed-additive antibiotics.	[Poudel, Anil; Rahman, Kh. Shamsur; Chowdhury, Erfan U.; Kaltenboeck, Bernhard] Auburn Univ, Coll Vet Med, Dept Pathobiol, Auburn, AL 36849 USA; [Elsasser, Theodore H.] ARS, Bovine Funct Genom Lab, USDA, Beltsville, MD USA	Auburn University System; Auburn University; United States Department of Agriculture (USDA)	Poudel, A (corresponding author), Auburn Univ, Coll Vet Med, Dept Pathobiol, Auburn, AL 36849 USA.	kaltebe@auburn.edu	Rahman, Kh Shamsur/M-2419-2019	Rahman, Kh Shamsur/0000-0001-7243-8501	United States Department of Agriculture Hatch Grant of the Alabama Agricultural Experiment Station [ALA051-1-10012]	United States Department of Agriculture Hatch Grant of the Alabama Agricultural Experiment Station	This study was supported by United States Department of Agriculture Hatch Grant ALA051-1-10012 of the Alabama Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin AS, 2003, VET J, V166, P86, DOI 10.1016/S1090-0233(02)00251-4; Biesenkamp-Uhe C, 2007, INFECT IMMUN, V75, P870, DOI 10.1128/IAI.00691-06; Brun-Hansen HC, 2006, VET CLIN PATH, V35, P182, DOI 10.1111/j.1939-165X.2006.tb00111.x; Butaye P, 2003, CLIN MICROBIOL REV, V16, P175, DOI 10.1128/CMR.16.2.175-188.2003; Collett-Solberg PF, 2000, ENDOCRINE, V12, P121, DOI 10.1385/ENDO:12:2:121; Cray C, 2009, COMPARATIVE MED, V59, P517; DeGraves FJ, 2004, INFECT IMMUN, V72, P2538, DOI 10.1128/IAI.72.5.2538-2545.2004; DeGraves FJ, 2003, J CLIN MICROBIOL, V41, P1726, DOI 10.1128/JCM.41.4.1726-1729.2003; DeGraves FJ, 2003, BIOTECHNIQUES, V34, P106, DOI 10.2144/03341rr01; Dibner JJ, 2005, POULTRY SCI, V84, P634, DOI 10.1093/ps/84.4.634; Elsasser T. H., 2008, J ANIM SCI, V86, pE105, DOI [10.2527/jas.2007-0634, DOI 10.2527/JAS.2007-0634]; ELSASSER TH, 1988, J ENDOCRINOL, V116, P191, DOI 10.1677/joe.0.1160191; FEIGHNER SD, 1987, APPL ENVIRON MICROB, V53, P331, DOI 10.1128/AEM.53.2.331-336.1987; FLECK A, 1989, P NUTR SOC, V48, P347, DOI 10.1079/PNS19890050; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; GALLO GF, 1995, CAN VET J, V36, P223; Godin AC, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-39; Horn M, 2011, BERGEYS MANUAL SYSTE, V4, P843; HUSBAND AJ, 1972, AUST J EXP BIOL MED, V50, P491, DOI 10.1038/icb.1972.41; Jaeger J, 2007, VET RES, V38, P711, DOI 10.1051/vetres:2007027; Jee JB, 2004, J CLIN MICROBIOL, V42, P5664, DOI 10.1128/JCM.42.12.5664-5672.2004; Kaltenbock B, 1997, J CLIN MICROBIOL, V35, P1835; Kaltenboeck B, 2005, VET RES COMMUN, V29, P1, DOI 10.1007/s11259-005-0832-4; KALTENBOECK B, 1993, J BACTERIOL, V175, P487, DOI 10.1128/JB.175.2.487-502.1993; Kaltenboeck B, 2009, VET MICROBIOL, V135, P175, DOI 10.1016/j.vetmic.2008.09.036; Kaltenboeck B, 1997, J CLIN MICROBIOL, V35, P2293, DOI 10.1128/JCM.35.9.2293-2298.1997; Kauffold J, 2007, ANIM REPROD SCI, V102, P111, DOI 10.1016/j.anireprosci.2006.10.013; Kemmerling K, 2009, J DAIRY SCI, V92, P4347, DOI 10.3168/jds.2009-2051; Khan MA, 2011, J DAIRY SCI, V94, P1071, DOI 10.3168/jds.2010-3733; Knowles TG, 2000, VET REC, V147, P593, DOI 10.1136/vr.147.21.593; Kuo CC, 2011, BERGEYS MANUAL SYSTE, V4, P846; Lang CH, 2002, CURR OPIN CLIN NUTR, V5, P271, DOI 10.1097/00075197-200205000-00006; Li D, 2005, J MICROBIOL METH, V61, P17, DOI 10.1016/j.mimet.2004.10.020; Livingstone M, 2006, VET J, V172, P3, DOI 10.1016/j.tvjl.2005.05.001; McNUTT S. H., 1940, CORNELL VET, V30, P437; Mohamad KY, 2010, VET RES, V41, DOI 10.1051/vetres/2009075; Mohamad KY, 2008, INFECT GENET EVOL, V8, P764, DOI 10.1016/j.meegid.2008.06.009; Mohri M, 2007, RES VET SCI, V83, P30, DOI 10.1016/j.rvsc.2006.10.017; Otter P, 2003, VET REC, V152, P787; PEREZMARTINEZ JA, 1986, AM J VET RES, V47, P1501; Petit T, 2008, VET MICROBIOL, V127, P325, DOI 10.1016/j.vetmic.2007.08.022; PORTER P, 1972, IMMUNOLOGY, V23, P225; Reggiardo C, 1989, J Vet Diagn Invest, V1, P305; Reinhold P, 2008, VET J, V175, P202, DOI 10.1016/j.tvjl.2007.01.004; Reinhold P, 2011, VET J, V189, P257, DOI 10.1016/j.tvjl.2010.09.003; RONSHOLT L, 1981, ACTA VET SCAND, V22, P9; Sachse K, 2009, VET MICROBIOL, V135, P2, DOI 10.1016/j.vetmic.2008.09.040; Sandoz KM, 2010, FUTURE MICROBIOL, V5, P1427, DOI [10.2217/fmb.10.96, 10.2217/FMB.10.96]; SHEWEN PE, 1980, CAN VET J, V21, P2; SHUSTER DE, 1995, P SOC EXP BIOL MED, V210, P140; Silbergeld EK, 2008, ANNU REV PUBL HEALTH, V29, P151, DOI 10.1146/annurev.publhealth.29.020907.090904; Smieja M, 2001, J CLIN MICROBIOL, V39, P1796, DOI 10.1128/JCM.39.5.1796-1801.2001; SMITH WD, 1976, CLIN EXP IMMUNOL, V23, P544; STORZ J., 1960, JOUR AMER VET MED ASSOC, V137, P509; STORZ J, 1966, AM J VET RES, V27, P633; STORZ J, 1971, ANN NY ACAD SCI, V176, P162, DOI 10.1111/j.1749-6632.1971.tb35002.x; Wang CM, 2009, J INFECT DIS, V200, P279, DOI 10.1086/599796; Wang FI, 2001, J VET MED SCI, V63, P1215, DOI 10.1292/jvms.63.1215; Wehrend A, 2005, THERIOGENOLOGY, V63, P923, DOI 10.1016/j.theriogenology.2004.05.009; WILSON MR, 1968, RES VET SCI, V9, P467; WITTENBRINK MM, 1988, J VET MED B, V35, P237, DOI 10.1111/j.1439-0450.1988.tb00493.x	61	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44961	10.1371/journal.pone.0044961	http://dx.doi.org/10.1371/journal.pone.0044961			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024776	Green Published, Green Submitted, gold			2022-12-27	WOS:000308860100034
J	Li, YF; Qian, H; Wang, Y; Cucinotta, FA				Li, Yongfeng; Qian, Hong; Wang, Ya; Cucinotta, Francis A.			A Stochastic Model of DNA Fragments Rejoining	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; INDUCE CHROMOSOME BREAKAGE; GAMMA-H2AX FOCI; DSB-REPAIR; END; KU; RADIATION; DAMAGE; KINETICS; COMPLEX	When cells are exposed to ionizing radiation, DNA damages in the form of single strand breaks (SSBs), double strand breaks (DSBs), base damage or their combinations are frequent events. It is known that the complexity and severity of DNA damage depends on the quality of radiation, and the microscopic dose deposited in small segments of DNA, which is often related to the linear transfer energy (LET) of the radiation. Experimental studies have suggested that under the same dose, high LET radiation induces more small DNA fragments than low-LET radiation, which affects Ku efficiently binding with DNA end and might be a main reason for high-LET radiation induced RBE [1] since DNA DSB is a major cause for radiationinduced cell death. In this work, we proposed a mathematical model of DNA fragments rejoining according to nonhomologous end joining (NHEJ) mechanism. By conducting Gillespie's stochastic simulation, we found several factors that impact the efficiency of DNA fragments rejoining. Our results demonstrated that aberrant DNA damage repair can result predominantly from the occurrence of a spatial distribution of DSBs leading to short DNA fragments. Because of the low efficiency that short DNA fragments recruit repair protein and release the protein residue after fragments rejoining, Kudependent NHEJ is significantly interfered with short fragments. Overall, our work suggests that inhibiting the Kudependent NHEJ may significantly contribute to the increased efficiency for cell death and mutation observed for high LET radiation.	[Li, Yongfeng] Univ Space Res Assoc, Div Space Life Sci, Houston, TX USA; [Qian, Hong] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA; [Wang, Ya] Emory Univ, Dept Radiat Oncol, Atlanta, GA 30322 USA; [Cucinotta, Francis A.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA	Universities Space Research Association (USRA); University of Washington; University of Washington Seattle; Emory University; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Li, YF (corresponding author), Univ Space Res Assoc, Div Space Life Sci, Houston, TX USA.	francis.a.cucinotta@nasa.gov	Cucinotta, Francis/AAZ-5941-2020		NASA Space Radiation Program	NASA Space Radiation Program(National Aeronautics & Space Administration (NASA))	This work was supported by the NASA Space Radiation Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arosio D, 2004, J BIOL CHEM, V279, P42826, DOI 10.1074/jbc.M406529200; Asaithamby A, 2011, NUCLEIC ACIDS RES, V39, P5474, DOI 10.1093/nar/gkr149; Asaithamby A, 2011, P NATL ACAD SCI USA, V108, P8293, DOI 10.1073/pnas.1016045108; *BEIR 7, 2006, HLTH RISKS EXP LOW L; BEIR VI, 1999, HLTH EFF EXP RAND BE; Cucinotta FA, 2000, INT J RADIAT BIOL, V76, P1463, DOI 10.1080/09553000050176225; Cucinotta FA, 2008, RADIAT RES, V169, P214, DOI 10.1667/RR1035.1; Cucinotta FA, 2006, LANCET ONCOL, V7, P431, DOI 10.1016/S1470-2045(06)70695-7; de Almodovar JMR, 2002, RADIOTHER ONCOL, V62, P327, DOI 10.1016/S0167-8140(01)00490-X; Durante M, 2008, NAT REV CANCER, V8, P465, DOI 10.1038/nrc2391; Friedland W, 2010, RADIAT RES, V173, P677, DOI 10.1667/RR1965.1; Fung H, 2011, J BIOL CHEM, V286, P4968, DOI 10.1074/jbc.M110.146498; Georgakilas AG, 2004, NUCLEIC ACIDS RES, V32, P5609, DOI 10.1093/nar/gkh871; George KA, 2009, RADIAT RES, V171, P752, DOI 10.1667/RR1680.1; Gillespie DT, 2007, ANNU REV PHYS CHEM, V58, P35, DOI 10.1146/annurev.physchem.58.032806.104637; GOODHEAD DT, 1994, INT J RADIAT BIOL, V65, P7, DOI 10.1080/09553009414550021; Gulston M, 2002, NUCLEIC ACIDS RES, V30, P3464, DOI 10.1093/nar/gkf467; Langerak P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002271; Leatherbarrow EL, 2006, INT J RADIAT BIOL, V82, P111, DOI 10.1080/09553000600599783; Li YF, 2011, J THEOR BIOL, V283, P122, DOI 10.1016/j.jtbi.2011.05.015; Lobrich M, 1996, INT J RADIAT BIOL, V70, P493, DOI 10.1080/095530096144680; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Mansour WY, 2010, NUCLEIC ACIDS RES, V38, P6065, DOI 10.1093/nar/gkq387; Mari PO, 2006, P NATL ACAD SCI USA, V103, P18597, DOI 10.1073/pnas.0609061103; MIMORI T, 1986, J BIOL CHEM, V261, P2274; Nikjoo H, 2001, RADIAT RES, V156, P577, DOI 10.1667/0033-7587(2001)156[0577:CAFDTS]2.0.CO;2; Pinto M, 2004, RADIAT RES, V162, P453, DOI 10.1667/RR3241; Ponomarev AL, 2006, INT J RADIAT BIOL, V82, P293, DOI 10.1080/09553000600637716; Postow L, 2011, FEBS LETT, V585, P2876, DOI 10.1016/j.febslet.2011.05.046; PRIDAL I, 1984, J THEOR BIOL, V111, P81, DOI 10.1016/S0022-5193(84)80197-6; Richard M, 2012, J THEOR BIOL, V292, P39, DOI 10.1016/j.jtbi.2011.08.024; Rydberg B, 1998, J MOL BIOL, V284, P71, DOI 10.1006/jmbi.1998.2150; Schulz-Ertner D, 2007, J CLIN ONCOL, V25; Schwartz JL, 1996, BRIT J CANCER, V74, P37, DOI 10.1038/bjc.1996.312; Smith J, 2001, NUCLEIC ACIDS RES, V29, P4783, DOI 10.1093/nar/29.23.4783; THOMPSON B, 1987, MATH BIOSCI, V84, P139, DOI 10.1016/0025-5564(87)90088-5; TSENG SJ, 1990, MATH BIOSCI, V100, P21, DOI 10.1016/0025-5564(90)90045-Z; Wang HY, 2008, DNA REPAIR, V7, P725, DOI 10.1016/j.dnarep.2008.01.010; Wang HY, 2010, NUCLEIC ACIDS RES, V38, P3245, DOI 10.1093/nar/gkq069; Wang HY, 2009, INT J RADIAT ONCOL, V74, P1236, DOI 10.1016/j.ijrobp.2008.12.089; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; Yoo S, 1999, NUCLEIC ACIDS RES, V27, P4679, DOI 10.1093/nar/27.24.4679; Yoo S, 1999, J BIOL CHEM, V274, P20034, DOI 10.1074/jbc.274.28.20034	44	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44293	10.1371/journal.pone.0044293	http://dx.doi.org/10.1371/journal.pone.0044293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028515	gold, Green Published, Green Submitted			2022-12-27	WOS:000308788700018
J	Patrawalla, P; Kazeros, A; Rogers, L; Shao, YZ; Liu, ML; Fernandez-Beros, ME; Shang, SL; Reibman, J				Patrawalla, Paru; Kazeros, Angeliki; Rogers, Linda; Shao, Yongzhao; Liu, Mengling; Fernandez-Beros, Maria-Elena; Shang, Shulian; Reibman, Joan			Application of the Asthma Phenotype Algorithm from the Severe Asthma Research Program to an Urban Population	PLOS ONE			English	Article							CLUSTER-ANALYSIS; SENSITIZATION; ASSOCIATION	Rationale: Identification and characterization of asthma phenotypes are challenging due to disease complexity and heterogeneity. The Severe Asthma Research Program (SARP) used unsupervised cluster analysis to define 5 phenotypically distinct asthma clusters that they replicated using 3 variables in a simplified algorithm. We evaluated whether this simplified SARP algorithm could be used in a separate and diverse urban asthma population to recreate these 5 phenotypic clusters. Methods: The SARP simplified algorithm was applied to adults with asthma recruited to the New York University/Bellevue Asthma Registry (NYUBAR) to classify patients into five groups. The clinical phenotypes were summarized and compared. Results: Asthma subjects in NYUBAR (n = 471) were predominantly women (70%) and Hispanic (57%), which were demographically different from the SARP population. The clinical phenotypes of the five groups generated by the simplified SARP algorithm were distinct across groups and distributed similarly to those described for the SARP population. Groups 1 and 2 (6 and 63%, respectively) had predominantly childhood onset atopic asthma. Groups 4 and 5 (20%) were older, with the longest duration of asthma, increased symptoms and exacerbations. Group 4 subjects were the most atopic and had the highest peripheral eosinophils. Group 3 (10%) had the least atopy, but included older obese women with adult-onset asthma, and increased exacerbations. Conclusions: Application of the simplified SARP algorithm to the NYUBAR yielded groups that were phenotypically distinct and useful to characterize disease heterogeneity. Differences across NYUBAR groups support phenotypic variation and support the use of the simplified SARP algorithm for classification of asthma phenotypes in future prospective studies to investigate treatment and outcome differences between these distinct groups.	[Patrawalla, Paru; Kazeros, Angeliki; Rogers, Linda; Fernandez-Beros, Maria-Elena; Reibman, Joan] NYU, Sch Med, Dept Med, Div Pulm & Crit Care Med, New York, NY 10003 USA	New York University	Patrawalla, P (corresponding author), NYU, Sch Med, Dept Med, Div Pulm & Crit Care Med, New York, NY 10003 USA.	joan.reibman@nyumc.org	Shang, Shulian/A-2173-2013	Reibman, Joan/0000-0001-7878-1511; Liu, Mengling/0000-0001-9758-8522	Colton Family Foundation; National Institutes of Health [T32 ES007267, M01RR00096]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007267] Funding Source: NIH RePORTER	Colton Family Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Colton Family Foundation, and the National Institutes of Health (Grants T32 ES007267, M01RR00096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Cassino C, 2000, AM J RESP CRIT CARE, V162, P1423, DOI 10.1164/ajrccm.162.4.9912140; Centers for Disease Control and Prevention Asthma Prevalence Health care use and Mortality, 2003, HLTH CAR US MORT US; Enright PL, 1999, CHEST, V116, P603, DOI 10.1378/chest.116.3.603; Global Initiative for Asthma, 2002, GLOB IN ASTHM PUBL; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Holguin F, 2011, J ALLERGY CLIN IMMUN, V127, P1486, DOI 10.1016/j.jaci.2011.03.036; Kaminska M, 2009, J ALLERGY CLIN IMMUN, V124, P45, DOI 10.1016/j.jaci.2009.03.049; Kauffmann F, 1997, AM J RESP CRIT CARE, V156, pS123, DOI 10.1164/ajrccm.156.4.12tac9; Liu ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025099; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; National Heart Lung and Blood Institute, 2007, NIH PUBL; National Heart Lung and Blood Institute., 2009, MORB MORT CHART BOOK; Pleis John R, 2009, Vital Health Stat 10, P1; Ravault C, 2001, INT J TUBERC LUNG D, V5, P191; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Reibman J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004060; Rogers L, 2002, CHEST, V122, P1580, DOI 10.1378/chest.122.5.1580; Tunnicliffe WS, 1999, EUR RESPIR J, V13, P654, DOI 10.1183/09031936.99.13365499; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8; Wisnivesky JP, 2007, J ALLERGY CLIN IMMUN, V120, P113, DOI 10.1016/j.jaci.2007.03.044	22	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44540	10.1371/journal.pone.0044540	http://dx.doi.org/10.1371/journal.pone.0044540			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028556	Green Published, gold, Green Submitted			2022-12-27	WOS:000308788700023
J	Garcia-Quiroz, J; Garcia-Becerra, R; Barrera, D; Santos, N; Avila, E; Ordaz-Rosado, D; Rivas-Suarez, M; Halhali, A; Rodriguez, P; Gamboa-Dominguez, A; Medina-Franco, H; Camacho, J; Larrea, F; Diaz, L				Garcia-Quiroz, Janice; Garcia-Becerra, Rocio; Barrera, David; Santos, Nancy; Avila, Euclides; Ordaz-Rosado, David; Rivas-Suarez, Mariana; Halhali, Ali; Rodriguez, Pamela; Gamboa-Dominguez, Armando; Medina-Franco, Heriberto; Camacho, Javier; Larrea, Fernando; Diaz, Lorenza			Astemizole Synergizes Calcitriol Antiproliferative Activity by Inhibiting CYP24A1 and Upregulating VDR: A Novel Approach for Breast Cancer Therapy	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; GO POTASSIUM CHANNELS; HIGH-DOSE CALCITRIOL; PHASE-I TRIAL; CELL-CYCLE; 1,25-DIHYDROXYVITAMIN-D3 RECEPTOR; K+ CHANNELS; EXPRESSION; CYP3A4; KI-67	Background: Calcitriol antiproliferative effects include inhibition of the oncogenic ether-a-go-go-1 potassium channel (Eag1) expression, which is necessary for cell cycle progression and tumorigenesis. Astemizole, a new promising antineoplastic drug, targets Eag1 by blocking ion currents. Herein, we characterized the interaction between calcitriol and astemizole as well as their conjoint antiproliferative action in SUM-229PE, T-47D and primary tumor-derived breast cancer cells. Methodology/Principal Findings: Molecular markers were studied by immunocytochemistry, Western blot and real time PCR. Inhibitory concentrations were determined by dose-response curves and metabolic activity assays. At clinically achievable drug concentrations, synergistic antiproliferative interaction was observed between calcitriol and astemizole, as calculated by combination index analysis (CI <1). Astemizole significantly enhanced calcitriol's growth-inhibitory effects (311 folds, P<0.01). Mean IC20 values were 1.82 +/- 2.41 nM and 1.62 +/- 0.75 mu M; for calcitriol (in estrogen receptor negative cells) and astemizole, respectively. Real time PCR showed that both drugs alone downregulated, while simultaneous treatment further reduced Ki-67 and Eag1 gene expression (P<0.05). Astemizole inhibited basal and calcitriol-induced CYP24A1 and CYP3A4 mRNA expression (cytochromes involved in calcitriol and astemizole degradation) in breast and hepatoma cancer cells, respectively, while upregulated vitamin D receptor (VDR) expression. Conclusions/Significance: Astemizole synergized calcitriol antiproliferative effects by downregulating CYP24A1, upregulating VDR and targeting Eag1. This study provides insight into the molecular mechanisms involved in astemizole-calcitriol combined antineoplastic effect, offering scientific support to test both compounds in combination in further preclinical and clinical studies of neoplasms expressing VDR and Eag1. VDR-negative tumors might also be sensitized to calcitriol antineoplastic effects by the use of astemizole. Herein we suggest a novel combined adjuvant therapy for the management of VDR/Eag1-expressing breast cancer tumors. Since astemizole improves calcitriol bioavailability and activity, decreased calcitriol dosing is advised for conjoint administration.	[Garcia-Quiroz, Janice; Garcia-Becerra, Rocio; Barrera, David; Santos, Nancy; Avila, Euclides; Ordaz-Rosado, David; Rivas-Suarez, Mariana; Halhali, Ali; Rodriguez, Pamela; Larrea, Fernando; Diaz, Lorenza] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Reprod Biol, Mexico City, DF, Mexico; [Garcia-Quiroz, Janice; Santos, Nancy; Camacho, Javier] IPN, Ctr Invest & Estudios Avanzados, Dept Farmacol, Mexico City 07738, DF, Mexico; [Medina-Franco, Heriberto] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Cirugia, Mexico City, DF, Mexico; [Gamboa-Dominguez, Armando] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Patol, Mexico City, DF, Mexico	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Garcia-Quiroz, J (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Reprod Biol, Mexico City, DF, Mexico.	lorenzadiaz@gmail.com	Larrea, Fernando/AAC-1900-2021; , Javier/AAS-1379-2021; García-Becerra, Rocío/A-2171-2019; Díaz, Lorenza/AAJ-9052-2021; Ordaz, David/AAF-9757-2021	García-Becerra, Rocío/0000-0002-2482-3963; Díaz, Lorenza/0000-0002-5947-4222; Ordaz, David/0000-0003-2044-4584; GARCIA-QUIROZ, JANICE/0000-0002-3311-2258; Avila, Euclides/0000-0003-3063-5093; Barrera, David/0000-0003-2692-8213	Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico [153862, 129315]; CONACyT	Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico (grants number 153862 and 129315). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge with thanks to Hoffmann-La Roche Ltd and Liomont for calcitriol and astemizole donation, respectively. JGQ is a Ph.D. student from Centro de Investigacion y Estudios Avanzados, Instituto Politecnico Nacional, Mexico, under a fellowship from CONACyT.	Avila E, 2010, ANTICANCER RES, V30, P2667; Beer TM, 2003, UROL ONCOL-SEMIN ORI, V21, P399, DOI 10.1016/S1078-1439(03)00170-4; Beer TM, 2004, MOL CANCER THER, V3, P373; Beer TM, 2001, CANCER-AM CANCER SOC, V91, P2431, DOI 10.1002/1097-0142(20010615)91:12<2431::AID-CNCR1278>3.0.CO;2-3; Beer TM, 2001, SEMIN ONCOL, V28, P49, DOI 10.1053/sonc.2001.26901; BERGER U, 1991, CANCER RES, V51, P239; Bortner CD, 1997, J BIOL CHEM, V272, P32436, DOI 10.1074/jbc.272.51.32436; Camacho J, 2006, CANCER LETT, V233, P1, DOI 10.1016/j.canlet.2005.02.016; Chen Y, PLOS ONE, V6; Chou TC, CANC RES, V70, P440; COSTA EM, 1987, ENDOCRINOLOGY, V120, P1173, DOI 10.1210/endo-120-3-1173; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Diaz L, 2011, CYTOKINE, V55, P188, DOI 10.1016/j.cyto.2011.04.013; Drocourt L, 2002, J BIOL CHEM, V277, P25125, DOI 10.1074/jbc.M201323200; DUMANOIR S, 1991, CYTOMETRY, V12, P455; Fakih MG, 2007, CLIN CANCER RES, V13, P1216, DOI 10.1158/1078-0432.CCR-06-1165; Farias LMB, 2004, CANCER RES, V64, P6996, DOI 10.1158/0008-5472.CAN-04-1204; Fischer MJE, 1997, EUR J PHARMACOL, V322, P97, DOI 10.1016/S0014-2999(96)00981-8; Friedrich M, 2003, RECENT RES CANCER, V164, P239; Garcia-Becerra R, 2010, EXP CELL RES, V316, P433, DOI 10.1016/j.yexcr.2009.11.008; Garcia-Ferreiro RE, 2004, J GEN PHYSIOL, V124, P301, DOI 10.1085/jgp.200409041; Garcia-Quiroz J, 2011, ANTI-CANCER AGENT ME, V11, P307, DOI 10.2174/187152011795347513; Guyton KZ, 2003, NUTR REV, V61, P227, DOI 10.1301/nr.2003.jul.227-238; Hansen CM, 2001, FRONT BIOSCI-LANDMRK, V6, pD820, DOI 10.2741/Hansen; Hemmerlein B, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-41; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kill IR, 1996, J CELL SCI, V109, P1253; Li Z, 1998, CANCER RES, V58, P5271; Lopes N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-483; Muindi JR, 2010, ENDOCRINOLOGY, V151, P4301, DOI 10.1210/en.2009-1156; Muindi JR, 2002, CLIN PHARMACOL THER, V72, P648, DOI 10.1067/mcp.2002.129305; Ouadid-Ahidouch H, 2004, AM J PHYSIOL-CELL PH, V287, pC125, DOI 10.1152/ajpcell.00488.2003; Ouadid-Ahidouch H, 2001, RECEPTOR CHANNEL, V7, P345; Ouadid-Ahidouch H, 2008, J MEMBRANE BIOL, V221, P1, DOI 10.1007/s00232-007-9080-6; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Pardo LA, 2008, EXPERT OPIN THER TAR, V12, P837, DOI 10.1517/14728222.12.7.837 ; Peehl DM, 2001, UROLOGY, V58, P123, DOI 10.1016/S0090-4295(01)01254-7; Pramanik R, 2004, CELL IMMUNOL, V232, P137, DOI 10.1016/j.cellimm.2005.03.004; Sanderson JT, 2006, TOXICOL SCI, V94, P3, DOI 10.1093/toxsci/kfl051; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schulz M, 2003, PHARMAZIE, V58, P447; Slominski AT, 2011, AM J PHYSIOL-CELL PH, V300, pC526, DOI 10.1152/ajpcell.00203.2010; Theodoropoulos C, 2003, CLIN ENDOCRINOL, V58, P489, DOI 10.1046/j.1365-2265.2003.01743.x; Thompson PD, 2002, BIOCHEM BIOPH RES CO, V299, P730, DOI 10.1016/S0006-291X(02)02742-0; Thummel KE, 2001, MOL PHARMACOL, V60, P1399, DOI 10.1124/mol.60.6.1399; Trump DL, 2010, CANCER J, V16, P1, DOI 10.1097/PPO.0b013e3181c51ee6; Urruticoechea A, 2005, J CLIN ONCOL, V23, P7212, DOI 10.1200/JCO.2005.07.501; Wang QM, 1996, CANCER RES, V56, P264; Weber C, 2006, J BIOL CHEM, V281, P13030, DOI 10.1074/jbc.M600883200; Welsh J, 2007, ACTA PHARMACOL SIN, V28, P1373, DOI 10.1111/j.1745-7254.2007.00700.x; WIESE RJ, 1992, J BIOL CHEM, V267, P20082; Xu Y, 2006, MOL PHARMACOL, V69, P56, DOI 10.1124/mol.105.017392; Yin Y, 2009, CLIN CANCER RES, V15, P190, DOI 10.1158/1078-0432.CCR-08-0910; YU XP, 1991, P NATL ACAD SCI USA, V88, P8347, DOI 10.1073/pnas.88.19.8347; Zinser GA, 2004, J STEROID BIOCHEM, V89-90, P433, DOI 10.1016/j.jsbmb.2004.03.012; Zinser GM, 2004, CARCINOGENESIS, V25, P2361, DOI 10.1093/carcin/bgh271	56	51	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45063	10.1371/journal.pone.0045063	http://dx.doi.org/10.1371/journal.pone.0045063			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984610	Green Published, gold, Green Submitted			2022-12-27	WOS:000308738500111
J	Maffioli, C; Grandgirard, D; Leib, SL; Engler, O				Maffioli, Carola; Grandgirard, Denis; Leib, Stephen L.; Engler, Olivier			SiRNA Inhibits Replication of Langat Virus, a Member of the Tick-Borne Encephalitis Virus Complex in Organotypic Rat Brain Slices	PLOS ONE			English	Article							SMALL INTERFERING RNA; INFECTION; CULTURES; PATHOGENESIS; MICE; NEUROINVASIVENESS; THERAPEUTICS; DELIVERY; NEURONS; MODELS	Tick-borne encephalitis virus is the causative agent of tick-borne encephalitis, a potentially fatal neurological infection. Tick-borne encephalitis virus belongs to the family of flaviviruses and is transmitted by infected ticks. Despite the availability of vaccines, approximately 2000-3000 cases of tick-borne encephalitis occur annually in Europe for which no curative therapy is available. The antiviral effects of RNA mediated interference by small interfering RNA ( siRNA) was evaluated in cell culture and organotypic hippocampal cultures. Langat virus, a flavivirus highly related to Tick-borne encephalitis virus exhibits low pathogenicity for humans but retains neurovirulence for rodents. Langat virus was used for the establishment of an in vitro model of tick-borne encephalitis. We analyzed the efficacy of 19 siRNA sequences targeting different regions of the Langat genome to inhibit virus replication in the two in vitro systems. The most efficient suppression of virus replication was achieved by siRNA sequences targeting structural genes and the 39 untranslated region. When siRNA was administered to HeLa cells before the infection with Langat virus, a 96.5% reduction of viral RNA and more than 98% reduction of infectious virus particles was observed on day 6 post infection, while treatment after infection decreased the viral replication by more than 98%. In organotypic hippocampal cultures the replication of Langat virus was reduced by 99.7% by siRNA sequence D3. Organotypic hippocampal cultures represent a suitable in vitro model to investigate neuronal infection mechanisms and treatment strategies in a preserved three-dimensional tissue architecture. Our results demonstrate that siRNA is an efficient approach to limit Langat virus replication in vitro.	[Maffioli, Carola; Grandgirard, Denis; Leib, Stephen L.] Univ Bern, Neuroinfect Lab, Inst Infect Dis, Bern, Switzerland; [Leib, Stephen L.; Engler, Olivier] Fed Off Civil Protect, Div Biol, Spiez Lab, Spiez, Switzerland	University of Bern	Maffioli, C (corresponding author), Univ Bern, Neuroinfect Lab, Inst Infect Dis, Bern, Switzerland.	stephen.leib@ifik.unibe.ch	Leib, Stephen/M-3786-2019; Leib, Stephen L/A-7866-2011; Grandgirard, Denis/AAB-8786-2020; Kummer, Juerg/B-3322-2011	Leib, Stephen/0000-0002-1106-6123; Leib, Stephen L/0000-0002-1106-6123; Grandgirard, Denis/0000-0002-4151-5196; 	Swiss Federal Office for Civil Protection [353001545]; Swiss National Science Foundation [138094]	Swiss Federal Office for Civil Protection; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the Swiss Federal Office for Civil Protection (Research Contract No 353001545). Additional support was received by the Swiss National Science Foundation (grant No. 138094). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achazi K, 2012, ANTIVIR RES, V93, P94, DOI 10.1016/j.antiviral.2011.10.023; Agrawal N, 2003, MICROBIOL MOL BIOL R, V67, P657, DOI 10.1128/MMBR.67.4.657-685.2003; Anesti AM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn371; Anthony KG, 2009, ANTIVIR RES, V82, P166, DOI 10.1016/j.antiviral.2008.12.007; Chambers TJ, 2003, ADV VIRUS RES, V60, P273, DOI 10.1016/S0065-3527(03)60008-4; Charrel RN, 2004, CLIN MICROBIOL INFEC, V10, P1040, DOI 10.1111/j.1469-0691.2004.01022.x; Cho S, 2007, CURR NEUROPHARMACOL, V5, P19, DOI 10.2174/157015907780077105; Davidson BL, 2011, NAT REV GENET, V12, P329, DOI 10.1038/nrg2968; DeVincenzo J, 2008, ANTIVIR RES, V77, P225, DOI 10.1016/j.antiviral.2007.11.009; Dorrbecker B, 2010, TRAVEL MED INFECT DI, V8, P213, DOI 10.1016/j.tmaid.2010.05.010; Gadkari DA, 2005, INDIAN J MED RES, V121, P147; Gantier MP, 2007, CYTOKINE GROWTH F R, V18, P363, DOI 10.1016/j.cytogfr.2007.06.016; Gelpi E, 2005, J NEUROPATH EXP NEUR, V64, P506, DOI 10.1093/jnen/64.6.506; Gianinazzi C, 2005, PARASITOLOGY, V131, P797, DOI 10.1017/S0031182005008619; Gianinazzi C, 2004, J NEUROPATH EXP NEUR, V63, P610, DOI 10.1093/jnen/63.6.610; Gritsun TS, 2003, ANTIVIR RES, V57, P129, DOI 10.1016/S0166-3542(02)00206-1; Haasnoot J, 2007, NAT BIOTECHNOL, V25, P1435, DOI 10.1038/nbt1369; Haglund M, 2003, VACCINE, V21, pS11, DOI 10.1016/S0264-410X(02)00811-3; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hayasaka D, 2009, VIROLOGY, V390, P139, DOI 10.1016/j.virol.2009.04.026; Higuchi Y, 2010, BIODRUGS, V24, P195, DOI 10.2165/11534450-000000000-00000; Holbrook MR, 2005, J INFECT DIS, V191, P100, DOI 10.1086/426397; Holzmann H, 2009, EMERG INFECT DIS, V15, P1671, DOI 10.3201/eid1510.090743; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; ILLAVIA SJ, 1970, LANCET, V2, P284; Kaiser R, 1999, BRAIN, V122, P2067, DOI 10.1093/brain/122.11.2067; Kawasaki Hideya, 2003, Congenital Anomalies, V43, P105, DOI 10.1111/j.1741-4520.2003.tb01034.x; Kedmi R, 2010, BIOMATERIALS, V31, P6867, DOI 10.1016/j.biomaterials.2010.05.027; Kim SS, 2009, TRENDS MOL MED, V15, P491, DOI 10.1016/j.molmed.2009.09.001; Kumar P, 2006, PLOS MED, V3, P505, DOI 10.1371/journal.pmed.0030096; Kumar S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008615; Leung RKM, 2005, PHARMACOL THERAPEUT, V107, P222, DOI 10.1016/j.pharmthera.2005.03.004; Ma Z, 2005, BIOCHEM BIOPH RES CO, V330, P755, DOI 10.1016/j.bbrc.2005.03.041; Mandl CW, 2005, VIRUS RES, V111, P161, DOI 10.1016/j.virusres.2005.04.007; Mansfield KL, 2009, J GEN VIROL, V90, P1781, DOI 10.1099/vir.0.011437-0; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Moshkin MP, 2009, BIOESSAYS, V31, P620, DOI 10.1002/bies.200800196; Murakami M, 2005, MICROBIOL IMMUNOL, V49, P1047, DOI 10.1111/j.1348-0421.2005.tb03701.x; Nguyen T, 2008, CURR OPIN MOL THER, V10, P158; Pletnev AG, 2001, VIROLOGY, V282, P288, DOI 10.1006/viro.2001.0846; PRICE WH, 1970, B WORLD HEALTH ORGAN, V42, P89; Raineteau O, 2004, MOL CELL NEUROSCI, V26, P241, DOI 10.1016/j.mcn.2004.01.003; Rumyantsev AA, 2006, J VIROL, V80, P1427, DOI 10.1128/JVI.80.3.1427-1439.2006; Ruzek D, 2010, TRAVEL MED INFECT DI, V8, P223, DOI 10.1016/j.tmaid.2010.06.004; SEAMER J, 1967, BRIT J EXP PATHOL, V48, P403; Sledz Carol A, 2003, Discov Med, V3, P30; Stein DA, 2011, J VIROL, V85, P10154, DOI 10.1128/JVI.05298-11; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Stram Y, 2006, VIRUS GENES, V32, P299, DOI 10.1007/s11262-005-6914-0; Subramanya S, 2010, J VIROL, V84, P2490, DOI 10.1128/JVI.02105-08; Suss J, 2011, TICKS TICK-BORNE DIS, V2, P2, DOI 10.1016/j.ttbdis.2010.10.007; SUSS J, 2008, EURO SURVEILL, V13; Tiemann K, 2009, EMBO MOL MED, V1, P142, DOI 10.1002/emmm.200900023; von Eije KJ, 2008, J VIROL, V82, P2895, DOI 10.1128/JVI.02035-07; WALKER DH, 1979, BRIT J EXP PATHOL, V60, P604; Wu XW, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-270; Ye CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017889	58	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44703	10.1371/journal.pone.0044703	http://dx.doi.org/10.1371/journal.pone.0044703			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984545	gold, Green Published, Green Submitted			2022-12-27	WOS:000308738500076
J	Otsuji, TG; Kurose, Y; Suemori, H; Tada, M; Nakatsuji, N				Otsuji, Tomomi G.; Kurose, Yuko; Suemori, Hirofumi; Tada, Masako; Nakatsuji, Norio			Dynamic Link between Histone H3 Acetylation and an Increase in the Functional Characteristics of Human ESC/iPSC-Derived Cardiomyocytes	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; MYOSIN HEAVY-CHAIN; DEVELOPMENTAL-CHANGES; GENE-EXPRESSION; MOUSE HEART; DIFFERENTIATION; HYPERTROPHY; GENERATION; CONTRIBUTE; CHROMATIN	Cardiomyocytes (CMs) derived from human embryonic stem cells (hESCs) or human induced pluripotent stem cells (hiPSCs) are functionally heterogeneous, display insufficient biological efficacy and generally possess the electrophysiological properties seen in fetal CMs. However, a homogenous population of hESC/hiPSC-CMs, with properties similar to those of adult human ventricular cells, is required for use in drug cardiotoxicity screening. Unfortunately, despite the requirement for the functional characteristics of post-mitotic beating cell aggregates to mimic the behavior of mature cardiomyocytes in vitro, few technological improvements have been made in this field to date. Previously, we showed that culturing hESC-CMs under low-adhesion conditions with cyclic replating confers continuous contractility on the cells, leading to a functional increase in cardiac gene expression and electrophysiological properties over time. The current study reveals that culturing hESC/hiPSC-CMs under non-adhesive culture conditions enhances the electrophysiological properties of the CMs through an increase in the acetylation of histone H3 lysine residues, as confirmed by western blot analyses. Histone H3 acetylation was induced chemically by treating primitive hESC/hiPSC-CMs with Trichostatin A (TSA), a histone deacetylase (HDAC) inhibitor, resulting in an immediate increase in global cardiac gene expression. In functional analyses using multi-electrode array (MEA) recordings, TSA-treated hESC/hiPSC-CM colonies showed appropriate responses to particular concentrations of known potassium ion channel inhibitors. Thus, the combination of a cell-autonomous functional increase in response to non-adhesive culture and short-term TSA treatment of hESC/hiPSC-CM colonies cultured on MEA electrodes will help to make cardiac toxicity tests more accurate and reproducible via genome-wide chromatin activation.	[Otsuji, Tomomi G.; Kurose, Yuko; Tada, Masako] Stem Cell & Drug Discovery Inst, Kyoto, Japan; [Otsuji, Tomomi G.; Suemori, Hirofumi; Nakatsuji, Norio] Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, Kyoto, Japan; [Otsuji, Tomomi G.; Nakatsuji, Norio] Kyoto Univ, Inst Integrated Cell Mat Sci, Sakyo Ku, Kyoto, Japan; [Tada, Masako] Tottori Univ, Chromosome Engn Res Ctr, Yonago, Tottori, Japan	Kyoto University; Kyoto University; Tottori University	Otsuji, TG (corresponding author), Stem Cell & Drug Discovery Inst, Kyoto, Japan.	matada@med.tottori-u.ac.jp			New Energy and Industrial Technology Development Organization [06990420-0]	New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This research was supported by a grant from the New Energy and Industrial Technology Development Organization (06990420-0). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Antos CL, 2003, J BIOL CHEM, V278, P28930, DOI 10.1074/jbc.M303113200; Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Braam SR, 2010, STEM CELL RES, V4, P107, DOI 10.1016/j.scr.2009.11.004; Cao DJ, 2011, P NATL ACAD SCI USA, V108, P4123, DOI 10.1073/pnas.1015081108; Chavan AV, 2010, MINI-REV MED CHEM, V10, P1263; Dambrot C, 2011, BIOCHEM J, V434, P25, DOI 10.1042/BJ20101707; Hang CT, 2010, NATURE, V466, P62, DOI 10.1038/nature09130; Harrell MD, 2007, PHYSIOL GENOMICS, V28, P273, DOI 10.1152/physiolgenomics.00163.2006; Hattori F, 2010, NAT METHODS, V7, P61, DOI [10.1038/NMETH.1403, 10.1038/nmeth.1403]; Hosseinkhani M, 2007, BIOCHEM BIOPH RES CO, V356, P386, DOI 10.1016/j.bbrc.2007.02.151; Hoyer K, 2007, J MOL CELL CARDIOL, V42, P214, DOI 10.1016/j.yjmcc.2006.08.116; JECK CD, 1992, CIRC RES, V71, P1390, DOI 10.1161/01.RES.71.6.1390; Jonsson MKB, 2010, STEM CELL RES, V4, P189, DOI 10.1016/j.scr.2010.02.001; Kawamura T, 2005, J BIOL CHEM, V280, P19682, DOI 10.1074/jbc.M412428200; Kim YB, 2005, J BIOL CHEM, V280, P28357, DOI 10.1074/jbc.M412608200; Kong YL, 2006, CIRCULATION, V113, P2579, DOI 10.1161/CIRCULATIONAHA.106.625467; Lowes BD, 1997, J CLIN INVEST, V100, P2315, DOI 10.1172/JCI119770; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; MUMMERY CL, 1991, DIFFERENTIATION, V46, P51, DOI 10.1111/j.1432-0436.1991.tb00865.x; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Narolska NA, 2005, J MUSCLE RES CELL M, V26, P39, DOI 10.1007/s10974-005-9005-x; Obreztchikova MN, 2003, CARDIOVASC RES, V59, P339, DOI 10.1016/S0008-6363(03)00360-2; Otsuji TG, 2010, STEM CELL RES, V4, P201, DOI 10.1016/j.scr.2010.01.002; Passier R, 2005, STEM CELLS, V23, P772, DOI 10.1634/stemcells.2004-0184; Rajala K, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/383709; Redfern WS, 2003, CARDIOVASC RES, V58, P32, DOI 10.1016/S0008-6363(02)00846-5; Reiser PJ, 2001, AM J PHYSIOL-HEART C, V280, pH1814, DOI 10.1152/ajpheart.2001.280.4.H1814; Salameh A, 2010, CIRC RES, V106, P1592, DOI 10.1161/CIRCRESAHA.109.214429; Sartiani L, 2007, STEM CELLS, V25, P1136, DOI 10.1634/stemcells.2006-0466; Snir M, 2003, AM J PHYSIOL-HEART C, V285, pH2355, DOI 10.1152/ajpheart.00020.2003; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vidarsson H, 2010, STEM CELL REV REP, V6, P108, DOI 10.1007/s12015-010-9113-x; Yamauchi K, 2010, GENES CELLS, V15, P1216, DOI 10.1111/j.1365-2443.2010.01455.x; Yanagi K, 2007, STEM CELLS, V25, P2712, DOI 10.1634/stemcells.2006-0388; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237	40	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45010	10.1371/journal.pone.0045010	http://dx.doi.org/10.1371/journal.pone.0045010			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984602	Green Published, Green Submitted, gold			2022-12-27	WOS:000308738500107
J	Quintana-Hayashi, MP; Thakur, S				Quintana-Hayashi, Macarena P.; Thakur, Siddhartha			Phylogenetic Analysis Reveals Common Antimicrobial Resistant Campylobacter coli Population in Antimicrobial-Free (ABF) and Commercial Swine Systems	PLOS ONE			English	Article							GROWTH PROMOTERS; JEJUNI; PREVALENCE; STRAINS; PIGS; MECHANISMS; DIVERSITY; SLAUGHTER; PATTERNS; POULTRY	The objective of this study was to compare the population biology of antimicrobial resistant (AR) Campylobacter coli isolated from swine reared in the conventional and antimicrobial-free (ABF) swine production systems at farm, slaughter and environment. A total of 200 C. coli isolates selected from fecal, environmental, and carcass samples of ABF (n = 100) and conventional (n = 100) swine production systems were typed by multilocus sequence typing (MLST). Sequence data from seven housekeeping genes was analyzed for the identification of allelic profiles, sequence types (STs) and clonal complex determination. Phylogenetic trees were generated to establish the relationships between the genotyped isolates. A total of 51 STs were detected including two novel alleles (glnA 424 and glyA 464) and 14 novel STs reported for the first time. The majority of the C. coli isolates belonged to ST-854 (ABF: 31, conventional: 17), and were grouped in clonal complex ST-828 (ABF: 68%, conventional: 66%). The mean genetic diversity (H) for the ABF (0.3963+/-0.0806) and conventional (0.4655+/-0.0714) systems were similar. The index of association (I-A(s)) for the ABF (I-A(s) = 0.1513) and conventional (I-A(s) = 0.0991) C. coli populations were close to linkage equilibrium, indicative of a freely recombining population. Identical STs were detected between the pigs and their environment both at farm and slaughter. A minimum spanning tree revealed the close clustering of C. coli STs that originated from swine and carcass with those from the environment. In conclusion, our study reveals a genotypic diverse C. coli population that shares a common ancestry in the conventional and ABF swine production systems. This could potentially explain the high prevalence of antimicrobial resistant C. coli in the ABF system in the absence of antimicrobial selection pressure.	[Quintana-Hayashi, Macarena P.; Thakur, Siddhartha] N Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Quintana-Hayashi, MP (corresponding author), N Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA.	sthakur@ncsu.edu		Thakur, Siddhartha/0000-0003-3787-9939	USDA-National Research Initiative grant; USDA-National Integrated Food Safety Initiative grant; College of Veterinary Medicine at NC State University grant	USDA-National Research Initiative grant; USDA-National Integrated Food Safety Initiative grant; College of Veterinary Medicine at NC State University grant	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was funded by the USDA-National Research Initiative grant, USDA-National Integrated Food Safety Initiative grant and the College of Veterinary Medicine at NC State University grant.	Castanon JIR, 2007, POULTRY SCI, V86, P2466, DOI 10.3382/ps.2007-00249; Chatre P, 2010, J FOOD PROTECT, V73, P825, DOI 10.4315/0362-028X-73.5.825; Colles FM, 2010, INT J FOOD MICROBIOL, V137, P259, DOI 10.1016/j.ijfoodmicro.2009.12.021; de Boer P, 2002, MOL MICROBIOL, V44, P351, DOI 10.1046/j.1365-2958.2002.02930.x; Dibner JJ, 2005, POULTRY SCI, V84, P634, DOI 10.1093/ps/84.4.634; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Dingle KE, 2002, EMERG INFECT DIS, V8, P949; Dingle KE, 2005, J CLIN MICROBIOL, V43, P340, DOI 10.1128/JCM.43.1.340-347.2005; Engberg J, 2001, EMERG INFECT DIS, V7, P24, DOI 10.3201/eid0701.010104; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Gripp E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-584; Grove-White DH, 2010, EPIDEMIOL INFECT, V138, P549, DOI 10.1017/S0950268809991051; Gu WM, 2009, APPL ENVIRON MICROB, V75, P474, DOI 10.1128/AEM.02012-08; Gurtler M, 2005, EPIDEMIOL INFECT, V133, P1081, DOI 10.1017/S0950268805004164; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Hermans D, 2012, VECTOR-BORNE ZOONOT, V12, P89, DOI 10.1089/vbz.2011.0676; Hume ME, 2002, CURR MICROBIOL, V45, P128, DOI 10.1007/s00284-001-0096-3; Johnsen G, 2006, POULTRY SCI, V85, P2278, DOI 10.1093/ps/85.12.2278; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Levesque S, 2012, APPL ENVIRON MICROB, V78, P2470, DOI 10.1128/AEM.06527-11; Litrup E, 2007, J APPL MICROBIOL, V103, P210, DOI 10.1111/j.1365-2672.2006.03214.x; Luangtongkum T, 2009, FUTURE MICROBIOL, V4, P189, DOI 10.2217/17460913.4.2.189; McEwen SA, 2002, CLIN INFECT DIS, V34, pS93, DOI 10.1086/340246; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Miller WG, 2006, MICROBIOL-SGM, V152, P245, DOI 10.1099/mic.0.28348-0; Quintana-Hayashi MP, 2012, APPL ENVIRON MICROB, V78, P2698, DOI 10.1128/AEM.07723-11; Rollo SN, 2010, JAVMA-J AM VET MED A, V236, P201, DOI 10.2460/javma.236.2.201; Sheppard SK, 2009, CLIN INFECT DIS, V48, P1072, DOI 10.1086/597402; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Tadesse DA, 2011, FOODBORNE PATHOG DIS, V8, P367, DOI 10.1089/fpd.2010.0665; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thakur S, 2005, J CLIN MICROBIOL, V43, P5705, DOI 10.1128/JCM.43.11.5705-5714.2005; Thakur S, 2010, ZOONOSES PUBLIC HLTH, V57, P100, DOI 10.1111/j.1863-2378.2010.01363.x; Thakur S, 2009, J APPL MICROBIOL, V106, P1722, DOI 10.1111/j.1365-2672.2008.04142.x; Thakur S, 2006, APPL ENVIRON MICROB, V72, P5666, DOI 10.1128/AEM.00658-06	36	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44662	10.1371/journal.pone.0044662	http://dx.doi.org/10.1371/journal.pone.0044662			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984540	gold, Green Submitted, Green Published			2022-12-27	WOS:000308738500073
J	Guimera, R; Llorente, A; Moro, E; Sales-Pardo, M				Guimera, Roger; Llorente, Alejandro; Moro, Esteban; Sales-Pardo, Marta			Predicting Human Preferences Using the Block Structure of Complex Social Networks	PLOS ONE			English	Article							BLOCKMODELS; OBESITY	With ever-increasing available data, predicting individuals' preferences and helping them locate the most relevant information has become a pressing need. Understanding and predicting preferences is also important from a fundamental point of view, as part of what has been called a "new" computational social science. Here, we propose a novel approach based on stochastic block models, which have been developed by sociologists as plausible models of complex networks of social interactions. Our model is in the spirit of predicting individuals' preferences based on the preferences of others but, rather than fitting a particular model, we rely on a Bayesian approach that samples over the ensemble of all possible models. We show that our approach is considerably more accurate than leading recommender algorithms, with major relative improvements between 38% and 99% over industry-level algorithms. Besides, our approach sheds light on decision-making processes by identifying groups of individuals that have consistently similar preferences, and enabling the analysis of the characteristics of those groups.	[Guimera, Roger] Inst Catalana Recerca & Estudis Avancats, Barcelona, Catalonia, Spain; [Guimera, Roger; Sales-Pardo, Marta] Univ Rovira & Virgili, Dept Engn Qum, Tarragona, Catalonia, Spain; [Llorente, Alejandro; Moro, Esteban] Univ Autonoma Madrid, Inst Ingn Conocimiento, Madrid, Spain; [Moro, Esteban] Univ Carlos III Madrid, Dept Matemat, Madrid, Spain; [Moro, Esteban] Univ Carlos III Madrid, Grp Interdisciplinar Sistemas Complejos, Madrid, Spain; [Moro, Esteban] Univ Carlos III Madrid, Univ Complutense Madrid, Autonomous Univ Madrid, CSIC,Inst Ciencias Matemat, Madrid, Spain	ICREA; Universitat Rovira i Virgili; Autonomous University of Madrid; Universidad Carlos III de Madrid; Universidad Carlos III de Madrid; Autonomous University of Madrid; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Matematicas (ICMAT); Universidad Carlos III de Madrid	Guimera, R (corresponding author), Inst Catalana Recerca & Estudis Avancats, Barcelona, Catalonia, Spain.	roger.guimera@urv.cat	Sales-Pardo, Marta/C-1725-2008; Guimera, Roger/C-1727-2008; Sales-Pardo, Marta/O-9797-2019; Guimera, Roger/M-9808-2019; Moro, Esteban/AAB-1159-2019	Sales-Pardo, Marta/0000-0002-8140-6525; Guimera, Roger/0000-0002-3597-4310; Sales-Pardo, Marta/0000-0002-8140-6525; Guimera, Roger/0000-0002-3597-4310; Moro, Esteban/0000-0003-2894-1024	James S. McDonnell Foundation Research Award; European Union [PIRG-GA-2010-277166, PIRG-GA-2010-268342]; Spanish Ministerio de Economia y Competitividad [FIS2010-18639, FIS2006-01485, FIS2010-22047-C05-04]; ICREA Funding Source: Custom	James S. McDonnell Foundation Research Award; European Union(European Commission); Spanish Ministerio de Economia y Competitividad(Spanish Government); ICREA(ICREA)	This work was supported by a James S. McDonnell Foundation Research Award (RG and MSP), grants PIRG-GA-2010-277166 (RG) and PIRG-GA-2010-268342 (MSP) from the European Union, and grants FIS2010-18639 (RG and MSP), FIS2006-01485 (MOSAICO) (EM) and FIS2010-22047-C05-04 (EM) from the Spanish Ministerio de Economia y Competitividad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adomavicius G, 2005, IEEE T KNOWL DATA EN, V17, P734, DOI 10.1109/TKDE.2005.99; [Anonymous], 2010, ECONOMIST       1230; BREIGER RL, 1975, J MATH PSYCHOL, V12, P328, DOI 10.1016/0022-2496(75)90028-0; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Decelle A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.065701; Ekstrand MD, 2011, P 5 ACM C REC SYST, P133; Fowler JH, 2008, J HEALTH ECON, V27, P1400, DOI 10.1016/j.jhealeco.2008.07.001; Gardner W, 2003, SIGNAL PROCESS, V6, P113; Guimera R, 2009, P NATL ACAD SCI USA, V106, P22073, DOI 10.1073/pnas.0908366106; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; HOLLAND PW, 1983, SOC NETWORKS, V5, P109, DOI 10.1016/0378-8733(83)90021-7; Jaynes E.T., 2003, PROBABILITY THEORY L; Koren Y, 2009, COMPUTER, V42, P30, DOI 10.1109/MC.2009.263; Lakemeyer G., 2003, EXPLORING ARTIFICIAL, P239; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Iribarren JL, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.038702; Malmgren RD, 2009, SCIENCE, V325, P1696, DOI 10.1126/science.1174562; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Newman MEJ, 2012, NAT PHYS, V8, P25, DOI 10.1038/nphys2162; Nowicki K, 2001, J AM STAT ASSOC, V96, P1077, DOI 10.1198/016214501753208735; Paterek A., 2007, P KDD CUP WORKSH, V2007, P5, DOI DOI 10.1145/1557019.1557072; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Sarwar B., 2001, P 10 INT C WORLD WID, P285, DOI [DOI 10.1145/371920.372071, 10.1145/371920.372071]; Sindhwani Vikas, 2010, ENCY MACHINE LEARNIN; Su X., 2009, ADV ARTIF INTELL, V2009, P19, DOI [10.1155/2009/421425, DOI 10.1155/2009/421425]; Towe BC., 2009, MS T09 P, DOI DOI 10.1145/1557019.1557088; Vespignani A, 2009, SCIENCE, V325, P425, DOI 10.1126/science.1171990; Watts DJ, 2007, NATURE, V445, P489, DOI 10.1038/445489a; WHITE HC, 1976, AM J SOCIOL, V81, P730, DOI 10.1086/226141	33	32	32	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44620	10.1371/journal.pone.0044620	http://dx.doi.org/10.1371/journal.pone.0044620			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	003VE	22984533	Green Submitted, gold, Green Published			2022-12-27	WOS:000308638700072
J	Wang, CS; Shi, JH; Sun, B; Liu, DS; Li, P; Gong, YL; He, Y; Liu, SJ; Xu, GW; Li, JY; Luo, AL; Li, EY				Wang, Changsong; Shi, Jinghui; Sun, Bo; Liu, Desheng; Li, Peng; Gong, Yulei; He, Ying; Liu, Shujuan; Xu, Guowang; Li, Jianyi; Luo, Ailin; Li, Enyou			Breath Pentane as a Potential Biomarker for Survival in Hepatic Ischemia and Reperfusion Injury-A Pilot Study	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; MEDIATED LIPID-PEROXIDATION; OXIDATIVE STRESS; DIPHENYL DISELENIDE; HYDROGEN-PEROXIDE; PROPOFOL; LIVER; RAT; CELL; EXPRESSION	Background: Exhaled pentane, which is produced as a consequence of reactive oxygen species-mediated lipid peroxidation, is a marker of oxidative stress. Propofol is widely used as a hypnotic agent in intensive care units and the operating room. Moreover, this agent has been reported to inhibit lipid peroxidation by directly scavenging reactive oxygen species. In this study, using a porcine liver ischemia-reperfusion injury model, we have evaluated the hypothesis that high concentrations of breath pentane are related to adverse outcome and that propofol could reduce breath pentane and improve liver injury and outcome in swine in this situation. Methodology/Principal Findings: Twenty male swine were assigned to two groups: propofol (n = 10) and chloral hydrate groups (n = 10). Hepatic ischemia was induced by occluding the portal inflow vessels. Ischemia lasted for 30 min, followed by reperfusion for 360 min. Exhaled and blood pentane concentrations in the chloral hydrate group markedly increased 1 min after reperfusion and then decreased to baseline. Breath and blood pentane concentrations in the propofol group increased 1 min after reperfusion but were significantly lower than in the chloral hydrate group. A negative correlation was found between breath pentane levels and survival in the chloral hydrate group. The median overall survival was 251 min after reperfusion (range 150-360 min) in the chloral hydrate group. All of the swine were alive in the propofol group. Conclusions: Monitoring of exhaled pentane may be useful for evaluating the severity of hepatic ischemia-reperfusion injury and aid in predicting the outcome; propofol may improve the outcome in this situation.	[Wang, Changsong; Sun, Bo; Liu, Desheng; Li, Peng; Gong, Yulei; He, Ying; Liu, Shujuan; Li, Enyou] Harbin Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Harbin, Peoples R China; [Shi, Jinghui; Luo, Ailin] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Anesthesiol, Wuhan 430074, Peoples R China; [Xu, Guowang] Chinese Acad Sci, Dalian Inst Chem Phys, CAS Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China; [Li, Jianyi] Third High Sch Harbin, Harbin, Peoples R China	Harbin Medical University; Huazhong University of Science & Technology; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS	Wang, CS (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Harbin, Peoples R China.	enyouli@yahoo.cn	Xu, Guowang/L-6910-2014	Xu, Guowang/0000-0003-4298-3554; wang, changsong/0000-0002-0079-5259	National Natural Science Foundation of China [30571783, 30972839]; Ministry of Education of China [20092307110005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	Financial support by grants from the National Natural Science Foundation of China (No. 30571783 and 30972839) and Doctoral Fund of Ministry of Education of China (No. 20092307110005) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaviva R, 2004, ANESTHESIOLOGY, V101, P1363; Andreoni KA, 1999, FREE RADICAL BIO MED, V26, P439, DOI 10.1016/S0891-5849(98)00220-2; Brown RH, 2009, J BREATH RES, V3, DOI 10.1088/1752-7155/3/1/016002; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6; CASINI AF, 1985, AM J PATHOL, V118, P225; Cavalca V, 2008, ANESTHESIOLOGY, V108, P988, DOI 10.1097/ALN.0b013e318173efb4; Chao CM, 2002, CHINESE J PHYSIOL, V45, P123; Clark D., 1996, GUIDE CARE USE LAB A; Collard CD, 2001, ANESTHESIOLOGY, V94, P1133, DOI 10.1097/00000542-200106000-00030; Crohns M, 2009, FREE RADICAL RES, V43, P965, DOI 10.1080/10715760903159162; De la Cruz JP, 1998, ANESTH ANALG, V87, P1141, DOI 10.1097/00000539-199811000-00031; DUMELIN EE, 1977, LIPIDS, V12, P894, DOI 10.1007/BF02533308; Giakoustidis D, 2001, FREE RADICAL RES, V35, P103, DOI 10.1080/10715760100300641; Goodyear-Bruch C, 2002, AM J CRIT CARE, V11, P543, DOI 10.4037/ajcc2002.11.6.543; Hassan W, 2009, ENVIRON TOXICOL PHAR, V28, P152, DOI 10.1016/j.etap.2009.02.004; Hassan W, 2009, CHEM-BIOL INTERACT, V180, P47, DOI 10.1016/j.cbi.2008.12.013; Hassan W, 2009, BRAIN RES, V1258, P71, DOI 10.1016/j.brainres.2008.12.046; He Jing, 2008, Nan Fang Yi Ke Da Xue Xue Bao, V28, P1064; Ikeda H, 1998, GUT, V42, P530, DOI 10.1136/gut.42.4.530; Jaeschke H, 2011, J GASTROEN HEPATOL, V26, P173, DOI 10.1111/j.1440-1746.2010.06592.x; Kamada N, 2008, CAN J ANAESTH, V55, P595, DOI 10.1007/BF03021433; Kanakura H, 2007, J ANESTH, V21, P354, DOI 10.1007/s00540-007-0533-y; Kanoria S, 2004, TRANSPL P, V36, P2586, DOI 10.1016/j.transproceed.2004.10.031; Kato R, 2002, CAN J ANAESTH, V49, P777, DOI 10.1007/BF03017409; KAZUI M, 1992, FREE RADICAL BIO MED, V13, P509, DOI 10.1016/0891-5849(92)90145-7; KAZUI M, 1994, J VASC SURG, V19, P473, DOI 10.1016/S0741-5214(94)70074-5; Lee SM, 2000, SHOCK, V13, P279, DOI 10.1097/00024382-200004000-00005; Li P, 2009, EUR J ANAESTH, V26, P513, DOI 10.1097/EJA.0b013e328326f7b7; Luo T, 2005, ANESTH ANALG, V100, P1653, DOI 10.1213/01.ANE.0000150945.95254.D8; MATHEWS WR, 1994, FREE RADICAL BIO MED, V16, P763, DOI 10.1016/0891-5849(94)90191-0; Navapurkar VU, 1998, ANESTH ANALG, V87, P1152, DOI 10.1097/00000539-199811000-00033; Nycyk JA, 1998, ARCH DIS CHILD-FETAL, V79, pF67, DOI 10.1136/fn.79.1.F67; PITKANEN OM, 1990, J PEDIATR-US, V116, P760, DOI 10.1016/S0022-3476(05)82668-X; RISBY TH, 1994, SURGERY, V115, P94; Risby TH, 1999, FREE RADICAL BIO MED, V27, P1182, DOI 10.1016/S0891-5849(99)00212-9; Runzer TD, 2002, ANESTH ANALG, V94, P89, DOI 10.1097/00000539-200201000-00017; SCHOENIGER LO, 1994, GASTROENTEROLOGY, V106, P177, DOI 10.1016/S0016-5085(94)95209-4; Scholpp J, 2002, CLIN CHEM LAB MED, V40, P587, DOI 10.1515/CCLM.2002.101; Schubert JK, 2004, EXPERT REV MOL DIAGN, V4, P619, DOI 10.1586/14737159.4.5.619; Spinhirne JP, 2003, BIOSYST ENG, V84, P239, DOI 10.1016/S1537-5110(02)00240-4; Taniguchi T, 2000, CRIT CARE MED, V28, P1101, DOI 10.1097/00003246-200004000-00032; Tsai KL, 1997, J PHYSIOL-LONDON, V502, P161, DOI 10.1111/j.1469-7793.1997.161bl.x; Wang H, 2008, ANESTH ANALG, V107, P534, DOI 10.1213/ane.0b013e3181770be9; Yuzawa H, 2005, HEPATO-GASTROENTEROL, V52, P839; Zhu SM, 2009, ANESTH ANALG, V109, P1493, DOI 10.1213/ANE.0b013e3181b893f3	45	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44940	10.1371/journal.pone.0044940	http://dx.doi.org/10.1371/journal.pone.0044940			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984587	Green Published, Green Submitted, gold			2022-12-27	WOS:000308638700100
J	Kou, G; Zhao, YY; Peng, Y; Shi, Y				Kou, Gang; Zhao, Yiyi; Peng, Yi; Shi, Yong			Multi-Level Opinion Dynamics under Bounded Confidence	PLOS ONE			English	Article							MODEL; DISSEMINATION; CULTURE	Opinion dynamics focuses on the opinion evolution in a social community. Recently, some models of continuous opinion dynamics under bounded confidence were proposed by Deffuant and Krause, et al. In the literature, agents were generally assumed to have a homogeneous confidence level. This paper proposes an extended model for a group of agents with heterogeneous confidence levels. First, a social differentiation theory is introduced and a social group is divided into opinion subgroups with distinct confidence levels. Second, a multi-level heterogeneous opinion formation model is formulated under the framework of bounded confidence. Finally, computer simulations are conducted to study the collective opinion evolution, focusing on three key factors: the fractions of heterogeneous agents, the initial opinions, and the group size. The simulation results demonstrate that the number of final opinions depends on the fraction of close-minded agents when the group size and the initial opinions are fixed; the final opinions converge more easily when the initial opinions are closer; and the number of final opinions can be approximately modeled by a linear increasing function of the group size and the increasing rate is the fraction of close-minded agents.	[Kou, Gang; Zhao, Yiyi; Peng, Yi] Univ Elect Sci & Technol China, Sch Management & Econ, Chengdu 610054, Peoples R China; [Shi, Yong] Chinese Acad Sci, Res Ctr Fictitious Econ & Data Sci, Beijing, Peoples R China; [Shi, Yong] Univ Nebraska, Coll Informat Sci & Technol, Omaha, NE 68182 USA	University of Electronic Science & Technology of China; Chinese Academy of Sciences; University of Nebraska System	Kou, G (corresponding author), Univ Elect Sci & Technol China, Sch Management & Econ, Chengdu 610054, Peoples R China.	Kougang@yahoo.com	Kou, Gang/G-3869-2010	Kou, Gang/0000-0002-9220-8647; Zhao, Yiyi/0000-0002-8766-1383	National Natural Science Foundation of China [70901015, 1222108, 70901011, 71173028, 70921061]; Program for New Century Excellent Talents in University [NCET-10-0293]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This research has been partially supported by grants from the National Natural Science Foundation of China (#70901015 and #71222108 for GK, #70901011 and #71173028 for YP, and #70921061 for YS), and Program for New Century Excellent Talents in University (NCET-10-0293). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar M, 2010, JASSS-J ARTIF SOC S, V13, DOI 10.18564/jasss.1665; ALBA RD, 1973, J MATH SOCIOL, V3, P113, DOI 10.1080/0022250X.1973.9989826; Axelrod R, 1997, J CONFLICT RESOLUT, V41, P203, DOI 10.1177/0022002797041002001; Barth V, 2006, P WORKSH POT COMPL S; Deffuant G, 2000, APPLICATIONS OF SIMULATION TO SOCIAL SCIENCES, P87, DOI 10.1142/S0219525900000078; Fortunato S, 2005, INT J MOD PHYS C, V16, P1535, DOI 10.1142/S0129183105008126; Frank KA, 1998, AM J SOCIOL, V104, P642, DOI 10.1086/210083; Freeman LC, 2004, DEV SOCIAL NETWORK A; Galam S, 2002, EUR PHYS J B, V25, P403, DOI 10.1140/epjb/e20020045; Hegselmann R, 2002, JASSS-J ARTIF SOC S, V5; Helbing D., 1991, QUANTITATIVE SOCIODY; HOLLEY RA, 1975, ANN PROBAB, V3, P643, DOI 10.1214/aop/1176996306; Krause U, 2000, COMMUNICATIONS IN DIFFERENCE EQUATIONS, P227; Lanchier N, 2012, ANN APPL PROBAB, V22, P860, DOI 10.1214/11-AAP790; Lorenz J, 2007, INT J MOD PHYS C, V18, P1819, DOI 10.1142/S0129183107011789; Lorenz J, 2006, JASSS-J ARTIF SOC S, V9; Lorenz J, 2010, COMPLEXITY, V15, P43, DOI 10.1002/cplx.20295; Mirtabatabaei A, 2011, ARXIV11032829V2; Oh H, 2006, ACAD MANAGE REV, V31, P569, DOI 10.2307/20159229; Peng Y, 2011, OMEGA-INT J MANAGE S, V39, P677, DOI 10.1016/j.omega.2011.01.009; Peng Y, 2011, INT J INF TECH DECIS, V10, P187, DOI 10.1142/S0219622011004282; Peng Y, 2008, INT J INF TECH DECIS, V7, P639, DOI 10.1142/S0219622008003204; Sznajd-Weron K, 2000, INT J MOD PHYS C, V11, P1157, DOI 10.1142/S0129183100000936; TICHY N, 1973, ADMIN SCI QUART, V18, P194, DOI 10.2307/2392063; Valente TW, 1999, ANN AM ACAD POLIT SS, V566, P55, DOI 10.1177/0002716299566001005; Weidlich W., 2002, SOCIODYNAMICS SYSTEM	26	55	57	5	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e43507	10.1371/journal.pone.0043507	http://dx.doi.org/10.1371/journal.pone.0043507			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014PP	23028458	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400009
J	Koul, S; Khandrika, L; Meacham, RB; Koul, HK				Koul, Sweaty; Khandrika, Lakshmipathi; Meacham, Randall B.; Koul, Hari K.			Genome Wide Analysis of Differentially Expressed Genes in HK-2 Cells, a Line of Human Kidney Epithelial Cells in Response to Oxalate	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CALCIUM-OXALATE; LLC-PK1 CELLS; DNA-SYNTHESIS; CRYSTAL RETENTION; MICROARRAY DATA; TRANSPORT; PATHWAYS; EXPOSURE; PROLIFERATION	Nephrolithiasis is a multi-factorial disease which, in the majority of cases, involves the renal deposition of calcium oxalate. Oxalate is a metabolic end product excreted primarily by the kidney. Previous studies have shown that elevated levels of oxalate are detrimental to the renal epithelial cells; however, oxalate renal epithelial cell interactions are not completely understood. In this study, we utilized an unbiased approach of gene expression profiling using Affymetrix HG_U133_plus2 gene chips to understand the global gene expression changes in human renal epithelial cells [HK-2] after exposure to oxalate. We analyzed the expression of 47,000 transcripts and variants, including 38,500 well characterized human genes, in the HK2 cells after 4 hours and 24 hours of oxalate exposure. Gene expression was compared among replicates as per the Affymetrix statistical program. Gene expression among various groups was compared using various analytical tools, and differentially expressed genes were classified according to the Gene Ontology Functional Category. The results from this study show that oxalate exposure induces significant expression changes in many genes. We show for the first time that oxalate exposure induces as well as shuts off genes differentially. We found 750 up-regulated and 2276 down-regulated genes which have not been reported before. Our results also show that renal cells exposed to oxalate results in the regulation of genes that are associated with specific molecular function, biological processes, and other cellular components. In addition we have identified a set of 20 genes that is differentially regulated by oxalate irrespective of duration of exposure and may be useful in monitoring oxalate nephrotoxicity. Taken together our studies profile global gene expression changes and provide a unique insight into oxalate renal cell interactions and oxalate nephrotoxicity.	[Koul, Sweaty; Khandrika, Lakshmipathi; Meacham, Randall B.; Koul, Hari K.] Univ Colorado, Signal Transduct & Mol Urol Lab, Sch Med, Div Urol,Dept Surg,Program Urosci, Aurora, CO USA; [Koul, Hari K.] Univ Colorado, Ctr Comprehens Canc, Sch Med, Aurora, CO USA; [Koul, Hari K.] Denver Vet Affairs Med Ctr, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver	Koul, HK (corresponding author), Univ Colorado, Signal Transduct & Mol Urol Lab, Sch Med, Div Urol,Dept Surg,Program Urosci, Aurora, CO USA.	hari.koul@uchsc.edu		Khandrika, Lakshmipathi/0000-0003-4438-9073	National Institutes of Health (NIH) [NIH-DK-RO1-54084]; Department of Surgery Academic Enrichment Funds; VA Merit Award [01BX001258]; NIH/National Cancer Institute [R01CA161880]; NATIONAL CANCER INSTITUTE [R01CA161880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054084] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Surgery Academic Enrichment Funds; VA Merit Award(US Department of Veterans Affairs); NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by a research grant to Hari K. Koul from the National Institutes of Health (NIH) (NIH-DK-RO1-54084) and Department of Surgery Academic Enrichment Funds (HKK). HKK is also supported in part by VA Merit Award-01BX001258 and NIH/National Cancer Institute R01CA161880 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhandari A, 2002, J UROLOGY, V168, P253, DOI 10.1016/S0022-5347(05)64903-8; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Chaturvedi LS, 2002, J BIOL CHEM, V277, P13321, DOI 10.1074/jbc.M108203200; Habibzadegah-Tari P, 2005, UROL RES, V33, P440, DOI 10.1007/s00240-005-0505-3; HACKETT RL, 1988, SCANNING MICROSCOPY, V2, P241; Han HJ, 2004, AM J PHYSIOL-CELL PH, V287, pC1058, DOI 10.1152/ajpcell.00063.2004; Hoppe B, 2009, KIDNEY INT, V75, P1264, DOI 10.1038/ki.2009.32; Huang MY, 2005, KIDNEY INT, V68, P497, DOI 10.1111/j.1523-1755.2005.00427.x; Iida S, 1999, J UROLOGY, V162, P1480, DOI 10.1016/S0022-5347(05)68344-9; Jeong BC, 2005, UROL RES, V33, P87, DOI 10.1007/s00240-004-0451-5; KNIGHT TF, 1979, KIDNEY INT, V16, P572, DOI 10.1038/ki.1979.167; KOUL H, 1994, AM J PHYSIOL, V266, pF266, DOI 10.1152/ajprenal.1994.266.2.F266; KOUL H, 1994, BIOCHEM BIOPH RES CO, V205, P1632, DOI 10.1006/bbrc.1994.2854; Koul H, 1996, ITAL J MINER ELECT M, V10, P67; Koul HK, 2008, AIP CONF PROC, V1049, P120, DOI 10.1063/1.2998006; Koul HK, 2002, J BIOL CHEM, V277, P36845, DOI 10.1074/jbc.M200832200; Koul HK, 1999, J AM SOC NEPHROL, V10, pS417; Koul S, 2006, J UROLOGY, V175, P499, DOI 10.1016/S0022-5347(18)33751-0; Koul S, 2003, ANN NY ACAD SCI, V1010, P292, DOI 10.1196/annals.1299.050; Koul S, 2002, KIDNEY INT, V61, P525, DOI 10.1046/j.1523-1755.2002.00163.x; Koul S, 2008, UROL RES, V36, P1, DOI 10.1007/s00240-007-0130-4; Kuo SM, 1996, J BIOL CHEM, V271, P15491, DOI 10.1074/jbc.271.26.15491; Lieske JC, 1997, KIDNEY INT, V51, P679, DOI 10.1038/ki.1997.98; LIESKE JC, 1992, J UROLOGY, V148, P1517, DOI 10.1016/S0022-5347(17)36954-9; McShane LM, 2002, BIOINFORMATICS, V18, P1462, DOI 10.1093/bioinformatics/18.11.1462; Ono K, 1987, ASAIO Trans, V33, P245; RADI MJ, 1989, ARCH PATHOL LAB MED, V113, P1367; Robertson WG, 1979, OXALATE HUMAN BIOCH, P173; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; TRUONG LD, 1992, MODERN PATHOL, V5, P146; Verkoelen CF, 1998, AM J PHYSIOL-RENAL, V274, pF958, DOI 10.1152/ajprenal.1998.274.5.F958; WHARTON R, 1990, CLIN NEPHROL, V34, P116; Wiessner JH, 2001, KIDNEY INT, V59, P637, DOI 10.1046/j.1523-1755.2001.059002637.x	34	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e43886	10.1371/journal.pone.0043886	http://dx.doi.org/10.1371/journal.pone.0043886			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028475	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400013
J	Gobin, YP; Dunkel, IJ; Marr, BP; Francis, JH; Brodie, SE; Abramson, DH				Gobin, Y. Pierre; Dunkel, Ira J.; Marr, Brian P.; Francis, Jasmine H.; Brodie, Scott E.; Abramson, David H.			Combined, Sequential Intravenous and Intra-Arterial Chemotherapy (Bridge Chemotherapy) for Young Infants with Retinoblastoma	PLOS ONE			English	Article							OPHTHALMIC ARTERY CHEMOTHERAPY; INTRAOCULAR RETINOBLASTOMA; BILATERAL RETINOBLASTOMA; LIFE; CARBOPLATIN; MELPHALAN; THERAPY; TUMORS; AGE	Background: Intra-arterial (IA) chemotherapy has more risks of procedural complications in neonates and young infants. For these reasons, we have developed a strategy of bridge intravenous single agent chemotherapy to postpone IA chemotherapy in these children Procedure: Neonates and young infants with retinoblastoma who required chemotherapy were treated with systemic carboplatin chemotherapy (18.7 mg/kg IV every 3-4 weeks) until they reached the age of 3 months and a weight of 6 Kg. If necessary, IA chemotherapy was subsequently performed at 4 weeks intervals. Efficacy was judged by tumor regression on ophthalmological examination. Retinal toxicity was judged by electroretinography. Results: Eleven children (19 eyes) were treated. All patients are alive and no patient has developed metastatic disease or second malignancies (mean follow-up 27 months, range 9-46 months). Intravenous carboplatin (median 2 cycles, range 15) combined with cryotherapy and laser was given to all children. This was effective for five eyes, which did not require IA chemotherapy. IA chemotherapy was administered to 14 eyes (median 3.5 cycles per eye, range 1 to 6). No radiation therapy was required. The Kaplan Meier estimate of ocular radiation-free survival was 94.7% at one year (95% confidence interval 68.1-99.2%). One eye was enucleated due to tumor progression. ERG showed no deterioration of retinal function. Conclusion: Bridge IV-IA chemotherapy was feasible and safe, and is a promising strategy to treat retinoblastoma in neonates and young infants.	[Gobin, Y. Pierre] New York Presbyterian Hosp, Weill Cornell Med Coll, Serv Intervent Neuroradiol, Dept Neurol Neurosurg, New York, NY 10032 USA; [Gobin, Y. Pierre] New York Presbyterian Hosp, Weill Cornell Med Coll, Serv Intervent Neuroradiol, Dept Radiol, New York, NY USA; [Dunkel, Ira J.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; [Marr, Brian P.; Francis, Jasmine H.; Abramson, David H.] Mem Sloan Kettering Canc Ctr, Ophthalm Oncol Serv, New York, NY 10021 USA; [Marr, Brian P.; Francis, Jasmine H.; Abramson, David H.] Weill Cornell Med Coll, Dept Ophthalmol, New York, NY USA; [Brodie, Scott E.] Mt Sinai Sch Med, Dept Ophthalmol, New York, NY USA	Cornell University; NewYork-Presbyterian Hospital; Cornell University; NewYork-Presbyterian Hospital; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Icahn School of Medicine at Mount Sinai	Gobin, YP (corresponding author), New York Presbyterian Hosp, Weill Cornell Med Coll, Serv Intervent Neuroradiol, Dept Neurol Neurosurg, New York, NY 10032 USA.	yvg2001@med.cornell.edu		Dunkel, Ira/0000-0001-8091-6067; Brodie, Scott/0000-0002-3303-4552; Francis, Jasmine/0000-0002-7637-3108				Abramson DH, 2008, OPHTHALMOLOGY, V115, P1398, DOI 10.1016/j.ophtha.2007.12.014; Abramson DH, 2010, OPHTHALMOLOGY, V117, P1623, DOI 10.1016/j.ophtha.2009.12.030; Abramson DH, 2010, ARCH OPHTHALMOL-CHIC, V128, P370, DOI 10.1001/archophthalmol.2010.7; Abramson DH, 1998, OPHTHALMOLOGY, V105, P573, DOI 10.1016/S0161-6420(98)94006-4; Abramson DH, 2004, ARCH OPHTHALMOL-CHIC, V122, P1316, DOI 10.1001/archopht.122.9.1316; ABRAMSON DH, 1992, OPHTHALMIC PAED GEN, V13, P191, DOI 10.3109/13816819209105167; Abramson DH, 2002, ARCH OPHTHALMOL-CHIC, V120, P738; ABRAMSON DH, 1983, ARCH OPHTHALMOL-CHIC, V101, P1362; Antoneli CBG, 2006, J PEDIAT HEMATOL ONC, V28, P342, DOI 10.1097/00043426-200606000-00004; Brodie SE, 2009, DOC OPHTHALMOL, V119, P13, DOI 10.1007/s10633-008-9164-3; Cohen VML, 2009, BRIT J OPHTHALMOL, V93, P887, DOI 10.1136/bjo.2008.142679; Dunkel IJ, 2007, PEDIATR BLOOD CANCER, V49, P643, DOI 10.1002/pbc.21163; Gobin YP, 2011, ARCH OPHTHALMOL-CHIC, V129, P732, DOI 10.1001/archophthalmol.2011.5; Gombos DS, 2007, OPHTHALMOLOGY, V114, P1378, DOI 10.1016/j.ophtha.2007.03.074; Gombos DS, 2002, BRIT J OPHTHALMOL, V86, P80, DOI 10.1136/bjo.86.1.80; Graeber CP, 2011, OPEN OPHTHALMOL J, V5, P1, DOI 10.2174/1874364101105010001; Lambert MP, 2008, PEDIATR BLOOD CANCER, V50, P223, DOI 10.1002/pbc.21155; Marees T, 2009, EUR J CANCER, V45, P3245, DOI 10.1016/j.ejca.2009.05.011; Marr B, 2010, MIDDLE EAST AFR J OP, V17, P207, DOI 10.4103/0974-9233.65492; Muen WJ, 2012, OPHTHALMOLOGY, V119, P611, DOI 10.1016/j.ophtha.2011.08.045; Munier FL, 2011, RETINA-J RET VIT DIS, V31, P566, DOI 10.1097/IAE.0b013e318203c101; Peterson EC, 2011, J NEUROSURG, V114, P1603, DOI 10.3171/2011.1.JNS10466; Rizzuti AE, 2008, ARCH OPHTHALMOL-CHIC, V126, P862, DOI 10.1001/archopht.126.6.862; Shields CL, 2011, ARCH OPHTHALMOL-CHIC, V129, P1399, DOI 10.1001/archophthalmol.2011.150; Venturi C, 2013, ACTA OPHTHALMOL, V91, P335, DOI 10.1111/j.1755-3768.2011.02296.x; Yamane Takashi, 2004, Int J Clin Oncol, V9, P69, DOI 10.1007/s10147-004-0392-6	26	44	48	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44322	10.1371/journal.pone.0044322	http://dx.doi.org/10.1371/journal.pone.0044322			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028521	gold, Green Published, Green Submitted			2022-12-27	WOS:000311313900018
J	Zhu, X; Srivastava, DS; Smith, JNM; Martin, K				Zhu, Xiang; Srivastava, Diane S.; Smith, James N. M.; Martin, Kathy			Habitat Selection and Reproductive Success of Lewis's Woodpecker (Melanerpes lewis) at Its Northern Limit	PLOS ONE			English	Article							NEST-SITE SELECTION; LOGISTIC-REGRESSION; CAVITY AVAILABILITY; ACORN WOODPECKER; ECOLOGICAL TRAPS; SOUTH-DAKOTA; BLACK-HILLS; SURVIVAL; BIRDS; FORESTS	Lewis's Woodpecker (Melanerpes lewis) has experienced population declines in both Canada and the United States and in 2010 was assigned a national listing of threatened in Canada. We conducted a two-year study (2004-2005) of this species at its northern range limit, the South Okanagan Valley in British Columbia, Canada. Our main objective was to determine whether the habitat features that influenced nest-site selection also predicted nest success, or whether other factors (e. g. cavity dimensions, clutch initiation date or time of season) were more important. Nest tree decay class, density of suitable cavities and total basal area of large trees were the best predictors of nest-site selection, but these factors were unrelated to nesting success. Estimates of demographic parameters (mean 6 SE) included daily nest survival rate (0.988 +/- 0.003, years combined), nest success (0.52 +/- 0.08), clutch size (5.00 +/- 0.14 eggs), female fledglings per successful nest (1.31 +/- 0.11), and annual productivity (0.68 +/- 0.12 female fledglings per nest per year). Although higher nest survival was associated with both early and late initiated clutches, early-initiated clutches allowed birds to gain the highest annual productivity as early clutches were larger. Nests in deep cavities with small entrances experienced lower predation risk especially during the peak period of nest predation. We concluded that nest-site selection can be predicted by a number of easily measured habitat variables, whereas nest success depended on complicated ecological interactions among nest predators, breeding behaviors, and cavity features. Thus, habitat-based conservation strategies should also consider ecological factors that may not be well predicted by habitat.	[Zhu, Xiang; Srivastava, Diane S.; Smith, James N. M.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Martin, Kathy] Univ British Columbia, Ctr Appl Conservat Biol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Srivastava, DS (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.	srivast@zoology.ubc.ca			Natural Sciences and Engineering Research Council of Canada; Endangered Species Recovery Fund of the World Wildlife Fund (Canada); Southern Interior Bluebird Trail Society	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Endangered Species Recovery Fund of the World Wildlife Fund (Canada); Southern Interior Bluebird Trail Society	Funding was provided by the Natural Sciences and Engineering Research Council of Canada, the Endangered Species Recovery Fund of the World Wildlife Fund (Canada) to J.N.M. Smith and by the Southern Interior Bluebird Trail Society to X. Zhu. The authors thank the Nature Conservancy Canada, the Nature Trust of British Columbia and British Columbia Parks for allowing us to conduct field research on their lands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken KEH, 2004, CAN J FOREST RES, V34, P2099, DOI [10.1139/x04-086, 10.1139/X04-086]; Block WM, 1987, W BIRDS, P209; Bock C.E., 1970, ZOOLOGY, V92, P1; Bonnot TW, 2008, CONDOR, V110, P450, DOI 10.1525/cond.2008.8460; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Campbell RW, 1990, BIRDS BRIT COLUMBIA, V2, P1; CAMPBELL RW, 1990, BIRDS BRIT COLUMBIA, V0002; Cannings R. A., 1987, BIRDS OKANAGAN VALLE; Chase MK, 2002, CONDOR, V104, P103, DOI 10.1650/0010-5422(2002)104[0103:NSSANS]2.0.CO;2; Clark RG, 1999, ECOLOGY, V80, P272, DOI 10.1890/0012-9658(1999)080[0272:AHSPFP]2.0.CO;2; Cockle K, 2011, BIOTROPICA, V43, P228, DOI 10.1111/j.1744-7429.2010.00661.x; Cooper JM, 1998, STATUS LEWISS WOODPE; COSEWIC, 2010, WILDL SPEC ASS DET V; Davis SK, 2005, CONDOR, V107, P605, DOI 10.1650/0010-5422(2005)107[0605:NSPATI]2.0.CO;2; Dinsmore SJ, 2002, ECOLOGY, V83, P3476, DOI 10.1890/0012-9658(2002)083[3476:ATFMAN]2.0.CO;2; FOLLMANN DA, 1989, J AM STAT ASSOC, V84, P295, DOI 10.2307/2289877; Gentry DJ, 2007, CONDOR, V109, P122, DOI 10.1650/0010-5422(2007)109[122:OBASHF]2.0.CO;2; Grant TA, 2005, AUK, V122, P661, DOI 10.1642/0004-8038(2005)122[0661:TVIPNS]2.0.CO;2; Hazler KR, 2004, AUK, V121, P707, DOI 10.1642/0004-8038(2004)121[0707:MLRAPA]2.0.CO;2; Hoekstra JM, 2002, ECOL APPL, V12, P701, DOI 10.1890/1051-0761(2002)012[0701:ACRFCH]2.0.CO;2; Holt RF, 1997, AUK, V114, P443; Hooge PN, 1999, AUK, V116, P45, DOI 10.2307/4089452; *IUCN, 2004, RED LIST THREAT SPEC; Janos Mark, 1991, C.F.O. Journal, V25, P43; Koenig WD, 2001, BEHAV ECOL SOCIOBIOL, V49, P357, DOI 10.1007/s002650000316; Kozma JM, 2010, CONDOR, V112, P87, DOI 10.1525/cond.2010.090153; Kristan WB, 2003, OIKOS, V103, P457; LEONARD ML, 1987, AUK, V104, P491, DOI 10.2307/4087548; LI PJ, 1991, AUK, V108, P405; Linder KA, 1998, J FIELD ORNITHOL, V69, P109; Mahon CL, 2006, J WILDLIFE MANAGE, V70, P1257, DOI 10.2193/0022-541X(2006)70[1257:NSOCIM]2.0.CO;2; Mahon CL, 2008, FOREST ECOL MANAG, V256, P2145, DOI 10.1016/j.foreco.2008.08.005; Manolis JC, 2000, AUK, V117, P615, DOI 10.1642/0004-8038(2000)117[0615:UNFISS]2.0.CO;2; Martin K, 2004, CONDOR, V106, P5, DOI 10.1650/7482; Martin TE, 1998, ECOLOGY, V79, P656, DOI 10.1890/0012-9658(1998)079[0656:AMPOCS]2.0.CO;2; MARTIN TE, 1993, AM NAT, V141, P897, DOI 10.1086/285515; Misenhelter MD, 2000, ECOLOGY, V81, P2892, DOI 10.2307/177349; Mood A., 1973, INTRO THEORY STAT; Newlon KR, 2011, CONDOR, V113, P183, DOI 10.1525/cond.2011.100056; NEWTON I, 1994, BIOL CONSERV, V70, P265, DOI 10.1016/0006-3207(94)90172-4; Nguyen LP, 2003, WILSON BULL, V115, P285, DOI 10.1676/03-044; NILSSON SG, 1984, ORNIS SCAND, V15, P167, DOI 10.2307/3675958; Nordby JC, 2009, BIOL INVASIONS, V11, P565, DOI 10.1007/s10530-008-9271-9; Nur N, 2004, CONDOR, V106, P457, DOI 10.1650/7336; Petit LJ, 1996, ECOL MONOGR, V66, P367, DOI 10.2307/2963523; Pribil S, 1998, CAN J ZOOL, V76, P2227, DOI 10.1139/cjz-76-12-2227; Rangel-Salazar JL, 2008, AUK, V125, P358, DOI 10.1525/auk.2008.06233; RAPHAEL MG, 1984, WILDLIFE MONOGR, P1; Remes V, 2003, CONSERV BIOL, V17, P1127, DOI 10.1046/j.1523-1739.2003.01611.x; RENDELL WB, 1989, CONDOR, V91, P875, DOI 10.2307/1368072; Robertson BA, 2006, ECOLOGY, V87, P1075, DOI 10.1890/0012-9658(2006)87[1075:AFFUET]2.0.CO;2; Rotella J. J., 2004, Animal Biodiversity and Conservation, V27, P187; Russell RE, 2007, J WILDLIFE MANAGE, V71, P2600, DOI 10.2193/2007-034; Saab VA, 2004, CONDOR, V106, P20, DOI 10.1650/7485; Saab VA, 2001, CONDOR, V103, P491, DOI 10.1650/0010-5422(2001)103[0491:RSOLSW]2.0.CO;2; Saab VA, 2007, CONDOR, V109, P97, DOI 10.1650/0010-5422(2007)109[97:NDOCBI]2.0.CO;2; Saab VA, 2009, FOREST ECOL MANAG, V257, P151, DOI 10.1016/j.foreco.2008.08.028; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Sousa PJ, 1982, FWSOBS82103214 SERV; StataCorp, 2007, STAT STAT SOFTW REL; Thomas J.W., 1979, WILDLIFE HABITATS MA, P512; Tobalske B. W., 1997, BIRDS N AM; Tobalske Bret W., 1997, Birds of North America, V284, P1; Vierling KT, 1997, WILSON BULL, V109, P121; Wiebe KL, 2003, OIKOS, V100, P291, DOI 10.1034/j.1600-0706.2003.12046.x; Wildlife Tree Committee of British Columbia, 2001, WILDL DANG TREE ASS; Wilson S, 2007, CONDOR, V109, P377, DOI 10.1650/0010-5422(2007)109[377:NSPIWP]2.0.CO;2; Zhu X, 2006, HABITAT SELECTION RE	68	14	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44346	10.1371/journal.pone.0044346	http://dx.doi.org/10.1371/journal.pone.0044346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028525	Green Submitted, gold, Green Published			2022-12-27	WOS:000311313900020
J	Jang, KY; Noh, SJ; Lehwald, N; Tao, GZ; Bellovin, DI; Park, HS; Moon, WS; Felsher, DW; Sylvester, KG				Jang, Kyu Yun; Noh, Sang Jae; Lehwald, Nadja; Tao, Guo-Zhong; Bellovin, David I.; Park, Ho Sung; Moon, Woo Sung; Felsher, Dean W.; Sylvester, Karl G.			SIRT1 and c-Myc Promote Liver Tumor Cell Survival and Predict Poor Survival of Human Hepatocellular Carcinomas	PLOS ONE			English	Article							BETA-CATENIN; CANCER-CELLS; PROGNOSTIC-SIGNIFICANCE; TISSUE MICROARRAY; FEEDBACK LOOP; EXPRESSION; GROWTH; DEACETYLASE; APOPTOSIS; PROTEIN	The increased expression of SIRT1 has recently been identified in numerous human tumors and a possible correlation with c-Myc oncogene has been proposed. However, it remains unclear whether SIRT1 functions as an oncogene or tumor suppressor. We sought to elucidate the role of SIRT1 in liver cancer under the influence of c-Myc and to determine the prognostic significance of SIRT1 and c-Myc expression in human hepatocellular carcinoma. The effect of either overexpression or knock down of SIRT1 on cell proliferation and survival was evaluated in both mouse and human liver cancer cells. Nicotinamide, an inhibitor of SIRT1, was also evaluated for its effects on liver tumorigenesis. The prognostic significance of the immunohistochemical detection of SIRT1 and c-Myc was evaluated in 154 hepatocellular carcinoma patients. SIRT1 and c-Myc regulate each other via a positive feedback loop and act synergistically to promote hepatocellular proliferation in both mice and human liver tumor cells. Tumor growth was significantly inhibited by nicotinamide in vivo and in vitro. In human hepatocellular carcinoma, SIRT1 expression positively correlated with c-Myc, Ki67 and p53 expression, as well as high a-fetoprotein level. Moreover, the expression of SIRT1, c-Myc and p53 were independent prognostic indicators of hepatocellular carcinoma. In conclusion, this study demonstrates that SIRT1 expression supports liver tumorigenesis and is closely correlated with oncogenic c-MYC expression. In addition, both SIRT1 and c-Myc may be useful prognostic indicators of hepatocellular carcinoma and SIRT1 targeted therapy may be beneficial in the treatment of hepatocellular carcinoma.	[Jang, Kyu Yun; Noh, Sang Jae; Park, Ho Sung; Moon, Woo Sung] Chonbuk Natl Univ, Dept Pathol, Sch Med, Jeonju, South Korea; [Jang, Kyu Yun; Noh, Sang Jae; Park, Ho Sung; Moon, Woo Sung] Res Inst Clin Med, Jeonju, South Korea; [Jang, Kyu Yun; Lehwald, Nadja; Tao, Guo-Zhong; Sylvester, Karl G.] Stanford Univ, Sch Med, Dept Surg, Div Pediat Surg, Stanford, CA 94305 USA; [Lehwald, Nadja] Univ Dusseldorf, Sch Med, Dept Gen Visceral & Pediat Surg, D-40225 Dusseldorf, Germany; [Bellovin, David I.; Felsher, Dean W.] Stanford Univ, Sch Med, Div Oncol, Dept Med, Stanford, CA 94305 USA; [Bellovin, David I.; Felsher, Dean W.] Stanford Univ, Sch Med, Canc Biol Program, Stanford, CA 94305 USA	Jeonbuk National University; Stanford University; Heinrich Heine University Dusseldorf; Stanford University; Stanford University	Jang, KY (corresponding author), Chonbuk Natl Univ, Dept Pathol, Sch Med, Jeonju, South Korea.	sylvester@stanford.edu	NOH, SANG JAE/R-4395-2019	NOH, SANG JAE/0000-0002-7005-056X; Sylvester, Karl G./0000-0002-8559-0155	Chonbuk National University; National Research Foundation of Korea; Korean Government [2011-0028223]; American Pediatric Surgical Association; Oak Foundation; Packard Foundation; National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases (Digestive Disease Center at Stanford) [DK56339]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056339] Funding Source: NIH RePORTER	Chonbuk National University; National Research Foundation of Korea(National Research Foundation of Korea); Korean Government(Korean Government); American Pediatric Surgical Association; Oak Foundation; Packard Foundation(The David & Lucile Packard Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases (Digestive Disease Center at Stanford); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by research funds of Chonbuk National University in 2009, the National Research Foundation of Korea grant funded by the Korean Government (2011-0028223) and grants from the American Pediatric Surgical Association, Oak Foundation, Packard Foundation, and the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (pilot grant DK56339: Digestive Disease Center at Stanford). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouElella A, 1996, MODERN PATHOL, V9, P95; ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; Beer S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002493; Bosman FT, 2010, WHO CALSSIFICATION T; Bourguignon LYW, 2009, J BIOL CHEM, V284, P2657, DOI 10.1074/jbc.M806708200; Boyle P, 2008, WORLD CANC REPORT 20; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cha EJ, 2009, CLIN CANCER RES, V15, P4453, DOI 10.1158/1078-0432.CCR-08-3329; Chen H. T., 2011, ANN SURG ONCOL; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Choi HN, 2011, ONCOL REP, V26, P503, DOI 10.3892/or.2011.1301; Chu F, 2005, CANCER RES, V65, P10183, DOI 10.1158/0008-5472.CAN-05-2002; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Dang CV, 1999, MOL CELL BIOL, V19, P1; Edge S, 2010, AJCC CANC STAGING HD; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Hida Y, 2007, ARCH DERMATOL RES, V299, P103, DOI 10.1007/s00403-006-0725-6; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Hu M, 2007, GASTROENTEROLOGY, V133, P1579, DOI 10.1053/j.gastro.2007.08.036; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jang KY, 2008, AM J SURG PATHOL, V32, P1523, DOI 10.1097/PAS.0b013e31816b6478; Jang KY, 2009, PATHOLOGY, V41, P366, DOI 10.1080/00313020902884451; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kim KM, 2011, INT J CANC; Lee H, 2011, HUM PATHOL, V42, P204, DOI 10.1016/j.humpath.2010.05.023; Lehwald N, 2011, GASTROENTEROLOGY, V141, P707, DOI 10.1053/j.gastro.2011.04.051; Liang XJ, 2008, MOL CANCER RES, V6, P1499, DOI 10.1158/1541-7786.MCR-07-2130; Mao BB, 2011, INT J BIOCHEM CELL B, V43, P1573, DOI 10.1016/j.biocel.2011.07.006; Menssen A, 2012, P NATL ACAD SCI USA, V109, pE187, DOI 10.1073/pnas.1105304109; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Sun YN, 2007, LUNG CANCER, V58, P21, DOI 10.1016/j.lungcan.2007.05.013; Wang RH, 2008, MOL CELL, V32, P11, DOI 10.1016/j.molcel.2008.09.011; Wang Y, 2002, CANCER-AM CANCER SOC, V95, P2346, DOI 10.1002/cncr.10963; Wong S, 2007, BIOCHEM J, V407, P451, DOI 10.1042/BJ20070151; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yoo YG, 2008, ONCOGENE, V27, P3405, DOI 10.1038/sj.onc.1211000; Yuan J, 2009, J CELL BIOL, V185, P203, DOI 10.1083/jcb.200809167; Zucnan-Rossi J, 2007, PHARMACOGENOMICS, V8, P997, DOI 10.2217/14622416.8.8.997	44	82	90	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45119	10.1371/journal.pone.0045119	http://dx.doi.org/10.1371/journal.pone.0045119			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024800	gold, Green Submitted, Green Published			2022-12-27	WOS:000308860100058
J	Yeo, RWY; Yang, KY; Li, GD; Lim, SK				Yeo, Ronne Wee Yeh; Yang, Kaiyuan; Li, GuoDong; Lim, Sai Kiang			High Glucose Predisposes Gene Expression and ERK Phosphorylation to Apoptosis and Impaired Glucose-Stimulated Insulin Secretion via the Cytoskeleton	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; GAP-JUNCTION; INTERCELLULAR COMMUNICATION; CONNEXIN-43 EXPRESSION; ACTIN CYTOSKELETON; FILAMENTOUS ACTIN; ELEVATED GLUCOSE; CHRONIC EXPOSURE; PROTEIN-KINASE; MAP KINASE	Chronic high glucose (HG) inflicts glucotoxicity on vulnerable cell types such as pancreatic beta cells and contributes to insulin resistance and impaired insulin secretion in diabetic patients. To identify HG-induced cellular aberrations that are candidate mediators of glucotoxicity in pancreatic b cells, we analyzed gene expression in ERoSHK6, a mouse insulin-secreting cell line after chronic HG exposure (six-day exposure to 33.3 mM glucose). Chronic HG exposure which reduced glucose-stimulated insulin secretion (GSIS) increased transcript levels of 185 genes that clustered primarily in 5 processes namely cellular growth and proliferation; cell death; cellular assembly and organization; cell morphology; and cell-to-cell signaling and interaction. The former two were validated by increased apoptosis of ERoSHK6 cells after chronic HG exposure and reaffirmed the vulnerability of b cells to glucotoxicity. The three remaining processes were partially substantiated by changes in cellular morphology and structure, and instigated an investigation of the cytoskeleton and cell-cell adhesion. These studies revealed a depolymerized actin cytoskeleton that lacked actin stress fibers anchored at vinculin-containing focal adhesion sites as well as loss of E-cadherin-mediated cell-cell adherence after exposure to chronic HG, and were concomitant with constitutive ERK1/2 phosphorylation that was refractory to serum and glucose deprivation. Although inhibition of ERK phosphorylation by PD98059 promoted actin polymerization, it increased apoptosis and GSIS impairment. These findings suggest that ERK phosphorylation is a proximate regulator of cellular processes targeted by chronic HG-induced gene expression and that dynamic actin polymerization and depolymerization is important in b cell survival and function. Therefore, chronic HG alters gene expression and signal transduction to predispose the cytoskeleton towards apoptosis and GSIS impairment.	[Yeo, Ronne Wee Yeh; Lim, Sai Kiang] ASTAR, Inst Med Biol, Singapore, Singapore; [Yeo, Ronne Wee Yeh] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Yang, Kaiyuan] Raffles Inst, Singapore, Singapore; [Li, GuoDong] Singapore Gen Hosp, Dept Clin Res, Singapore 0316, Singapore; [Lim, Sai Kiang] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117595, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); National University of Singapore; Singapore General Hospital; National University of Singapore	Yeo, RWY (corresponding author), ASTAR, Inst Med Biol, Singapore, Singapore.	saikiang.lim@imb.a-star.edu.sg	Yang, Kaiyuan/T-7575-2017; Lim, Sai Kiang/AEN-0252-2022	Yang, Kaiyuan/0000-0003-0591-2079; Lim, Sai Kiang/0000-0002-5752-3297	Agency for Science, Technology and Research - Biomedical Research Council (A*STAR BMRC); National Medical Research Council of Singapore [NMRC1218/2009, NMRC/EDG/0056/2009]	Agency for Science, Technology and Research - Biomedical Research Council (A*STAR BMRC)(Agency for Science Technology & Research (A*STAR)); National Medical Research Council of Singapore(National Medical Research Council, Singapore)	This work was funded by the Agency for Science, Technology and Research - Biomedical Research Council (A*STAR BMRC) and partially supported by grants from the National Medical Research Council of Singapore (NMRC1218/2009; NMRC/EDG/0056/2009 to G.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejandro EU, 2010, ENDOCRINOLOGY, V151, P502, DOI 10.1210/en.2009-0678; Andreozzi F, 2004, ENDOCRINOLOGY, V145, P2845, DOI 10.1210/en.2003-0939; Briaud I, 2003, DIABETES, V52, P974, DOI 10.2337/diabetes.52.4.974; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; BRUNZELL JD, 1976, J CLIN ENDOCR METAB, V42, P222, DOI 10.1210/jcem-42-2-222; Buchanan Thomas A., 2003, Clinical Therapeutics, V25, pB32, DOI 10.1016/S0149-2918(03)80241-2; BURGOYNE RD, 1990, ANNU REV PHYSIOL, V52, P647; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; CARVER TD, 1995, PEDIATR RES, V38, P754, DOI 10.1203/00006450-199511000-00020; Charollais A, 2000, J CLIN INVEST, V106, P235, DOI 10.1172/JCI9398; Chen JG, 2007, AM J PHYSIOL-ENDOC M, V292, pE1906, DOI 10.1152/ajpendo.00356.2006; Chen TS, 2010, ENDOCRINOLOGY, V151, P3600, DOI 10.1210/en.2009-1418; Costes S, 2006, DIABETES, V55, P2220, DOI 10.2337/db05-1618; Dahl U, 1996, DEVELOPMENT, V122, P2895; DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013; Deng SP, 2004, DIABETES, V53, P624, DOI 10.2337/diabetes.53.3.624; EDDLESTONE GT, 1984, J MEMBRANE BIOL, V77, P1, DOI 10.1007/BF01871095; Eliasson L, 2008, J PHYSIOL-LONDON, V586, P3313, DOI 10.1113/jphysiol.2008.155317; Federici M, 2001, DIABETES, V50, P1290, DOI 10.2337/diabetes.50.6.1290; Fei HQ, 2008, MOL CELL BIOCHEM, V315, P75, DOI 10.1007/s11010-008-9791-8; Finegood DT, 2001, DIABETES, V50, P1021, DOI 10.2337/diabetes.50.5.1021; FRODIN M, 1995, J BIOL CHEM, V270, P7882, DOI 10.1074/jbc.270.14.7882; Gandhi GK, 2010, ASN NEURO, V2, DOI 10.1042/AN20090048; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Haffner SM, 1996, DIABETOLOGIA, V39, P1201, DOI 10.1007/BF02658507; Hauge-Evans AC, 1999, DIABETES, V48, P1402, DOI 10.2337/diabetes.48.7.1402; Hayden MR, 2008, EXP BIOL MED, V233, P1109, DOI 10.3181/0709-RM-251; Hayden MR, 2007, ANTIOXID REDOX SIGN, V9, P891, DOI 10.1089/ars.2007.1610; Hayden Melvin R, 2008, J Cardiometab Syndr, V3, P234, DOI 10.1111/j.1559-4572.2008.00024.x; Holman RR, 1998, DIABETES RES CLIN PR, V40, pS21; HOWELL S L, 1986, Diabetes Metabolism Reviews, V2, P107; HOWELL SL, 1979, BIOCHEM J, V178, P367, DOI 10.1042/bj1780367; INOGUCHI T, 1995, BIOCHEM BIOPH RES CO, V208, P492, DOI 10.1006/bbrc.1995.1365; Jacobo SMP, 2009, J PHARMACOL EXP THER, V331, P724, DOI 10.1124/jpet.109.158519; Jaques F, 2008, ENDOCRINOLOGY, V149, P2494, DOI 10.1210/en.2007-0974; Jewell JL, 2008, J BIOL CHEM, V283, P10716, DOI 10.1074/jbc.M709876200; Jewell JL, 2010, AM J PHYSIOL-REG I, V298, pR517, DOI 10.1152/ajpregu.00597.2009; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P4047, DOI 10.1210/jc.86.9.4047; Khaldi MZ, 2004, AM J PHYSIOL-ENDOC M, V287, pE207, DOI 10.1152/ajpendo.00426.2003; KOFFER A, 1990, J CELL BIOL, V111, P919, DOI 10.1083/jcb.111.3.919; Kowluru A, 2010, DIABETES, V59, P967, DOI 10.2337/db09-1334; Kowluru A, 2010, ENDOCR REV, V31, P52, DOI 10.1210/er.2009-0022; Kuroki T, 1998, DIABETES, V47, P931, DOI 10.2337/diabetes.47.6.931; Leahy JL, 2004, DIABETES MELLITUS FU, pxviii; Li AF, 2003, INVEST OPHTH VIS SCI, V44, P5376, DOI 10.1167/iovs.03-0360; Li GD, 2009, STEM CELL RES, V2, P41, DOI 10.1016/j.scr.2008.07.006; Li JS, 2004, AM J PHYSIOL-ENDOC M, V286, pE818, DOI 10.1152/ajpendo.00307.2003; Longuet C, 2005, ENDOCRINOLOGY, V146, P643, DOI 10.1210/en.2004-0841; Lorenzo C, 2003, DIABETES CARE, V26, P3153, DOI 10.2337/diacare.26.11.3153; Maedler K, 2004, DIABETES, V53, P1706, DOI 10.2337/diabetes.53.7.1706; Malacombe M, 2006, BBA-MOL CELL RES, V1763, P1175, DOI 10.1016/j.bbamcr.2006.09.004; MALAISSE WJ, 1971, DIABETES, V20, P257, DOI 10.2337/diab.20.5.257; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Marchetti P, 2008, REGUL PEPTIDES, V146, P4, DOI 10.1016/j.regpep.2007.08.017; Maris M, 2010, J PROTEOME RES, V9, P6274, DOI 10.1021/pr100557w; McKenzie MD, 2010, DIABETES, V59, P644, DOI 10.2337/db09-1151; Michon L, 2005, BBA-BIOMEMBRANES, V1719, P82, DOI 10.1016/j.bbamem.2005.11.003; Moreno AP, 2005, AM J PHYSIOL-ENDOC M, V288, pE948, DOI 10.1152/ajpendo.00216.2004; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nyblom HK, 2006, PROTEOMICS, V6, P5193, DOI 10.1002/pmic.200600137; Oku H, 2001, INVEST OPHTH VIS SCI, V42, P1915; OLSON LK, 1993, J CLIN INVEST, V92, P514, DOI 10.1172/JCI116596; ORCI L, 1972, SCIENCE, V175, P1128, DOI 10.1126/science.175.4026.1128; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Papoutsopoulou S, 2006, NAT IMMUNOL, V7, P606, DOI 10.1038/ni1334; Patane G, 2002, DIABETES, V51, P2749, DOI 10.2337/diabetes.51.9.2749; Pieczenik SR, 2007, EXP MOL PATHOL, V83, P84, DOI 10.1016/j.yexmp.2006.09.008; Pratley Richard E, 2002, Curr Diab Rep, V2, P242, DOI 10.1007/s11892-002-0090-6; Ritzel RA, 2007, DIABETES, V56, P65, DOI 10.2337/db06-0734; Rondas D, 2011, DIABETES, V60, P1146, DOI 10.2337/db10-0946; Rose SD, 2001, J BIOL CHEM, V276, P36757, DOI 10.1074/jbc.M006518200; ROSSETTI L, 1987, J CLIN INVEST, V80, P1037, DOI 10.1172/JCI113157; Sato T, 2002, DIABETES, V51, P1565, DOI 10.2337/diabetes.51.5.1565; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Skyler J.S., 2004, CLIN DIABETES, V22, P162, DOI [10.2337/diaclin.22.4.162, DOI 10.2337/DIACLIN.22.4.162]; SNABES MC, 1982, BIOCHEM BIOPH RES CO, V104, P207, DOI 10.1016/0006-291X(82)91960-X; Stalmans P, 1997, INVEST OPHTH VIS SCI, V38, P1598; Stolar M, 2010, AM J MED, V123, pS3, DOI 10.1016/j.amjmed.2009.12.004; SWANSTONFLATT SK, 1980, FEBS LETT, V117, P299, DOI 10.1016/0014-5793(80)80966-5; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Tomas A, 2006, J CELL SCI, V119, P2156, DOI 10.1242/jcs.02942; Tsuboi T, 2003, BIOCHEM SOC T, V31, P833, DOI 10.1042/BST0310833; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wajchenberg BL, 2007, ENDOCR REV, V28, P187, DOI 10.1210/er.2006-0038; WANG JL, 1990, BIOCHEM BIOPH RES CO, V171, P424, DOI 10.1016/0006-291X(90)91410-T; Wang ZX, 2010, J BIOL CHEM, V285, P6186, DOI 10.1074/jbc.M109.072421; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Wijesekara N, 2010, J BIOL CHEM, V285, P33623, DOI 10.1074/jbc.M109.085084; Wilson JR, 2001, FEBS LETT, V492, P101, DOI 10.1016/S0014-5793(01)02241-4	92	8	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44988	10.1371/journal.pone.0044988	http://dx.doi.org/10.1371/journal.pone.0044988			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024780	gold, Green Published, Green Submitted			2022-12-27	WOS:000308860100038
J	Bogie, JFJ; Timmermans, S; Van, AHT; Irrthum, A; Smeets, HJM; Gustafsson, JA; Steffensen, KR; Mulder, M; Stinissen, P; Hellings, N; Hendriks, JJA				Bogie, Jeroen F. J.; Timmermans, Silke; Van Anh Huynh-Thu; Irrthum, Alexandre; Smeets, Hubert J. M.; Gustafsson, Jan-Ake; Steffensen, Knut R.; Mulder, Monique; Stinissen, Piet; Hellings, Niels; Hendriks, Jerome J. A.			Myelin-Derived Lipids Modulate Macrophage Activity by Liver X Receptor Activation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; TUMOR-NECROSIS-FACTOR; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; INTERACTING PROTEIN KINASE-2; MULTIPLE-SCLEROSIS LESIONS; HIGH-DENSITY-LIPOPROTEINS; CHOLESTEROL EFFLUX; CELLULAR CHOLESTEROL; NUCLEAR RECEPTORS	Multiple sclerosis is a chronic, inflammatory, demyelinating disease of the central nervous system in which macrophages and microglia play a central role. Foamy macrophages and microglia, containing degenerated myelin, are abundantly found in active multiple sclerosis lesions. Recent studies have described an altered macrophage phenotype after myelin internalization. However, it is unclear by which mechanisms myelin affects the phenotype of macrophages and how this phenotype can influence lesion progression. Here we demonstrate, by using genome wide gene expression analysis, that myelin-phagocytosing macrophages have an enhanced expression of genes involved in migration, phagocytosis and inflammation. Interestingly, myelin internalization also induced the expression of genes involved in liver-X-receptor signaling and cholesterol efflux. In vitro validation shows that myelin-phagocytosing macrophages indeed have an increased capacity to dispose intracellular cholesterol. In addition, myelin suppresses the secretion of the pro-inflammatory mediator IL-6 by macrophages, which was mediated by activation of liver-X-receptor beta. Our data show that myelin modulates the phenotype of macrophages by nuclear receptor activation, which may subsequently affect lesion progression in demyelinating diseases such as multiple sclerosis.	[Bogie, Jeroen F. J.; Timmermans, Silke; Stinissen, Piet; Hellings, Niels; Hendriks, Jerome J. A.] Hasselt Univ Transnat Univ Limburg, Biomed Res Inst, Sch Life Sci, Diepenbeek, Belgium; [Van Anh Huynh-Thu] Univ Liege, GIGA Res Bioinformat & Modeling, Liege, Belgium; [Irrthum, Alexandre] Univ Liege, Dept Elect Engn & Comp Sci, Liege, Belgium; [Smeets, Hubert J. M.] Maastricht UMC, Sch Cardiovasc Res, Dept Genet Celbiol, Maastricht, Netherlands; [Smeets, Hubert J. M.] Maastricht UMC, Sch Oncol & Dev Biol, Dept Genet Celbiol, Maastricht, Netherlands; [Gustafsson, Jan-Ake; Steffensen, Knut R.] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Mulder, Monique] Rotterdam Univ, Dept Internal Med, Div Pharmacol Vasc & Metab Dis, Rotterdam, Netherlands	Hasselt University; University of Liege; University of Liege; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Karolinska Institutet; Erasmus University Rotterdam	Bogie, JFJ (corresponding author), Hasselt Univ Transnat Univ Limburg, Biomed Res Inst, Sch Life Sci, Diepenbeek, Belgium.	Jerome.hendriks@uhasselt.be	HELLINGS, Niels/AAS-5033-2020; Hendriks, Jerome J/C-7698-2013	Hendriks, Jerome J/0000-0002-7717-8582; Stinissen, Piet/0000-0002-4830-4084; Steffensen, Knut/0000-0001-6093-2801; Hellings, Niels/0000-0003-2308-406X	Agentschap voor Innovatie van Wetenschap en Technology (IWT); Fonds Wetenschappelijk Onderzoek (FWO); transnational University Limburg; Limburg Sterk Merk and Alma-in-Silico [EMR INT4.-1.3.-2008-03/003]; Interuniversity Attraction Poles Programme [IAP P6/25 BIOMAGNET]; European Network of Excellence PASCAL2; Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (F.R.I.A.)	Agentschap voor Innovatie van Wetenschap en Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Fonds Wetenschappelijk Onderzoek (FWO)(FWO); transnational University Limburg; Limburg Sterk Merk and Alma-in-Silico; Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office); European Network of Excellence PASCAL2; Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (F.R.I.A.)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by Agentschap voor Innovatie van Wetenschap en Technology (IWT), Fonds Wetenschappelijk Onderzoek (FWO), transnational University Limburg, Limburg Sterk Merk and Alma-in-Silico (EMR INT4.-1.3.-2008-03/003). This work was partially funded by the Interuniversity Attraction Poles Programme (IAP P6/25 BIOMAGNET), initiated by the Belgian State, Science Policy Office, by the French Community of Belgium (ARC Biomod), and by the European Network of Excellence PASCAL2. VAHT is recipient of a Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (F.R.I.A.) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alberti S, 2001, J CLIN INVEST, V107, P565, DOI 10.1172/JCI9794; Alfaro C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017922; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Barnett MH, 2006, MULT SCLER, V12, P121, DOI 10.1191/135248506ms1304rr; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; Bogie JFJ, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-85; Boven LA, 2006, BRAIN, V129, P517, DOI 10.1093/brain/awh707; BROSNAN CF, 1981, J IMMUNOL, V126, P614; CANNELLA B, 1995, ANN NEUROL, V37, P424, DOI 10.1002/ana.410370404; Castano T, 2009, CHEMMEDCHEM, V4, P866, DOI 10.1002/cmdc.200900043; Castrillo A, 2003, J BIOL CHEM, V278, P10443, DOI 10.1074/jbc.M213071200; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Cui GL, 2011, J CLIN INVEST, V121, P658, DOI 10.1172/JCI42974; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; de Vos AF, 2002, J IMMUNOL, V169, P5415, DOI 10.4049/jimmunol.169.10.5415; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Espinosa JM, 2001, MOL CELL, V8, P57, DOI 10.1016/S1097-2765(01)00283-0; Essayan DM, 1999, BIOCHEM PHARMACOL, V57, P965, DOI 10.1016/S0006-2952(98)00331-1; Flavin MP, 1997, NEUROSCIENCE, V80, P437, DOI 10.1016/S0306-4522(97)00078-X; Fox R, 2007, EMBO J, V26, P505, DOI 10.1038/sj.emboj.7601522; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Giorelli M, 2007, EXP NEUROL, V204, P759, DOI 10.1016/j.expneurol.2007.01.013; Gitik M, 2010, FASEB J, V24, P2211, DOI 10.1096/fj.09-146118; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Gredler V, 2010, CLIN IMMUNOL, V134, P296, DOI 10.1016/j.clim.2009.11.003; Guo RF, 2004, SHOCK, V21, P1, DOI 10.1097/01.shk.0000105502.75189.5e; Hellings N, 2002, IMMUNOL RES, V25, P27, DOI 10.1385/IR:25:1:27; Hendriks JJA, 2008, J NEUROIMMUNOL, V204, P52, DOI 10.1016/j.jneuroim.2008.07.015; Hendriks JJA, 2005, BRAIN RES REV, V48, P185, DOI 10.1016/j.brainresrev.2004.12.008; Hindinger C, 2006, J NEUROSCI RES, V84, P1225, DOI 10.1002/jnr.21038; HOFMAN FM, 1989, J EXP MED, V170, P607, DOI 10.1084/jem.170.2.607; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Hong C, 2008, CURR OPIN GENET DEV, V18, P461, DOI 10.1016/j.gde.2008.07.016; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUITINGA I, 1990, J EXP MED, V172, P1025, DOI 10.1084/jem.172.4.1025; HUITINGA I, 1995, CLIN EXP IMMUNOL, V100, P344; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iynedjian P, 2009, CELL MOL LIFE SCI, V66, P27, DOI 10.1007/s00018-008-8322-9; Jeyakumar M, 2002, NEUROPATH APPL NEURO, V28, P343, DOI 10.1046/j.1365-2990.2002.00422.x; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Jou I, 2006, AM J PATHOL, V168, P1619, DOI 10.2353/ajpath.2006.050924; Kadl A, 2010, CIRC RES, V107, P737, DOI 10.1161/CIRCRESAHA.109.215715; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; Kotter MR, 2005, NEUROBIOL DIS, V18, P166, DOI 10.1016/j.nbd.2004.09.019; Lai Y, 2011, INT J BIOL SCI, V7, P782, DOI 10.7150/ijbs.7.782; Liu Y, 2006, J NEUROSCI, V26, P12904, DOI 10.1523/JNEUROSCI.2531-06.2006; Matsumoto T, 1997, J LEUKOCYTE BIOL, V62, P581, DOI 10.1002/jlb.62.5.581; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Miller Elzbieta, 2009, Pol Merkur Lekarski, V27, P499; Mosley K, 1996, NEUROCHEM RES, V21, P481, DOI 10.1007/BF02527713; Nelissen K, 2010, J NEUROSCI METH, V187, P78, DOI 10.1016/j.jneumeth.2009.12.018; NORTON WT, 1973, J NEUROCHEM, V21, P759, DOI 10.1111/j.1471-4159.1973.tb07520.x; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Ogden CA, 2005, AUTOIMMUNITY, V38, P259, DOI 10.1080/08916930500124452; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Oram JF, 1996, J LIPID RES, V37, P2473; Papenfuss Tracey L, 2007, ScientificWorldJournal, V7, P112; Park EJ, 2007, SHOCK, V28, P112, DOI 10.1097/SHK.0b013e3180310fec; Paterniti I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015937; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; PIANI D, 1991, NEUROSCI LETT, V133, P159, DOI 10.1016/0304-3940(91)90559-C; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Repa JJ, 2002, NAT MED, V8, P1243, DOI 10.1038/nm1102-1243; Robinson S, 1999, DEV BIOL, V216, P359, DOI 10.1006/dbio.1999.9466; SELMAJ K, 1991, J CLIN INVEST, V87, P949, DOI 10.1172/JCI115102; Smith JD, 2004, J LIPID RES, V45, P635, DOI 10.1194/jlr.M300336-JLR200; Smythies LE, 2006, J LEUKOCYTE BIOL, V80, P492, DOI 10.1189/jlb.1005566; Sordi V, 2006, TRANSPLANTATION, V82, P826, DOI 10.1097/01.tp.0000235433.03554.4f; Sun X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009380; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Tall AR, 2008, J INTERN MED, V263, P256, DOI 10.1111/j.1365-2796.2007.01898.x; Valledor AF, 2005, IMMUNOBIOLOGY, V210, P127, DOI 10.1016/j.imbio.2005.05.007; van Rossum D, 2008, GLIA, V56, P271, DOI 10.1002/glia.20611; van Zwam M, 2010, J NEUROIMMUNOL, V225, P112, DOI 10.1016/j.jneuroim.2010.04.021; van Zwam M, 2009, J MOL MED, V87, P273, DOI 10.1007/s00109-008-0421-4; vanderLaan LJW, 1996, J NEUROIMMUNOL, V70, P145, DOI 10.1016/S0165-5728(96)00110-5; Vanderlocht J, 2007, CRIT REV IMMUNOL, V27, P1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vaughan AM, 2005, J BIOL CHEM, V280, P30150, DOI 10.1074/jbc.M505368200; Vega FM, 2011, J CELL BIOL, V193, P655, DOI 10.1083/jcb.201011038; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Weinstein SL, 2000, J LEUKOCYTE BIOL, V67, P405, DOI 10.1002/jlb.67.3.405; WILLIAMS K, 1994, J NEUROSCI RES, V38, P433, DOI 10.1002/jnr.490380409; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Xu JH, 2009, J LEUKOCYTE BIOL, V86, P401, DOI 10.1189/jlb.1008600; Zhang YH, 2006, AM J PHYSIOL-RENAL, V290, pF1065, DOI 10.1152/ajprenal.00131.2005; Zhang Z, 2011, J NEUROIMMUNOL, V237, P73, DOI 10.1016/j.jneuroim.2011.06.006	92	44	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44998	10.1371/journal.pone.0044998	http://dx.doi.org/10.1371/journal.pone.0044998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984598	gold, Green Published			2022-12-27	WOS:000308738500104
J	Cardozo, BL; Crawford, CG; Eriksson, C; Zhu, J; Sabin, M; Ager, A; Foy, D; Snider, L; Scholte, W; Kaiser, R; Olff, M; Rijnen, B; Simon, W				Cardozo, Barbara Lopes; Crawford, Carol Gotway; Eriksson, Cynthia; Zhu, Julia; Sabin, Miriam; Ager, Alastair; Foy, David; Snider, Leslie; Scholte, Willem; Kaiser, Reinhard; Olff, Miranda; Rijnen, Bas; Simon, Winnifred			Psychological Distress, Depression, Anxiety, and Burnout among International Humanitarian Aid Workers: A Longitudinal Study	PLOS ONE			English	Article							HOPKINS SYMPTOM CHECKLIST-25; MENTAL-HEALTH; SUPPORT	Background: International humanitarian aid workers providing care in emergencies are subjected to numerous chronic and traumatic stressors. Objectives: To examine consequences of such experiences on aid workers' mental health and how the impact is influenced by moderating variables. Methodology: We conducted a longitudinal study in a sample of international non-governmental organizations. Study outcomes included anxiety, depression, burnout, and life and job satisfaction. We performed bivariate regression analyses at three time points. We fitted generalized estimating equation multivariable regression models for the longitudinal analyses. Results: Study participants from 19 NGOs were assessed at three time points: 212 participated at pre-deployment; 169 (80%) post-deployment; and 154 (73%) within 3-6 months after deployment. Prior to deployment, 12 (3.8%) participants reported anxiety symptoms, compared to 20 (11.8%) at post-deployment (p = 0.0027); 22 (10.4%) reported depression symptoms, compared to 33 (19.5%) at post-deployment (p = 0.0117) and 31 (20.1%) at follow-up (p = .00083). History of mental illness (adjusted odds ratio [AOR] 4.2; 95% confidence interval [CI] 1.45-12.50) contributed to an increased risk for anxiety. The experience of extraordinary stress was a contributor to increased risk for burnout depersonalization (AOR 1.5; 95% CI 1.17-1.83). Higher levels of chronic stress exposure during deployment were contributors to an increased risk for depression (AOR 1.1; 95% CI 1.02-1.20) comparing post-versus pre-deployment, and increased risk for burnout emotional exhaustion (AOR 1.1; 95% CI 1.04-1.19). Social support was associated with lower levels of depression (AOR 0.9; 95% CI 0.84-0.95), psychological distress (AOR = 0.9; [CI] 0.85-0.97), burnout lack of personal accomplishment (AOR 0.95; 95% CI 0.91-0.98), and greater life satisfaction (p = 0.0213). Conclusions: When recruiting and preparing aid workers for deployment, organizations should consider history of mental illness and take steps to decrease chronic stressors, and strengthen social support networks.	[Cardozo, Barbara Lopes; Sabin, Miriam; Kaiser, Reinhard] Ctr Dis Control & Prevent CDC, Ctr Global Hlth, Int Emergency & Refugee Hlth Branch, Atlanta, GA USA; [Crawford, Carol Gotway; Zhu, Julia] Ctr Dis Control & Prevent CDC, Off Surveillance Epidemiol & Lab Serv, Atlanta, GA USA; [Scholte, Willem; Olff, Miranda] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Foy, David] Pepperdine Univ, Malibu, CA 90265 USA; [Eriksson, Cynthia] Fuller Theol Seminary, Pasadena, CA 91101 USA; [Snider, Leslie] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA; [Ager, Alastair; Rijnen, Bas; Simon, Winnifred] Antares Fdn, Amsterdam, Netherlands	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of Amsterdam; Academic Medical Center Amsterdam; Pepperdine University; Tulane University	Cardozo, BL (corresponding author), Ctr Dis Control & Prevent CDC, Ctr Global Hlth, Int Emergency & Refugee Hlth Branch, Atlanta, GA USA.	bhc8@cdc.gov	Scholte, Willem/AAJ-1088-2020; Olff, Miranda/S-6235-2019	Olff, Miranda/0000-0003-1016-9515; Sabin, Miriam/0000-0002-7758-8338; Ager, Alastair/0000-0002-9474-3563	Antares Foundation	Antares Foundation	This study was funded by the Antares Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ager A., 1999, APPL PSYCHOL, P226; AMIRKHAN JH, 1994, J PERS ASSESS, V62, P242, DOI 10.1207/s15327752jpa6202_6; Bliese PD, 1996, J APPL SOC PSYCHOL, V26, P1171, DOI 10.1111/j.1559-1816.1996.tb02291.x; Brayfield AH, 1951, J APPL PSYCHOL, V35, P307, DOI 10.1037/h0055617; Cardozo BL, 2005, DISASTERS, V29, P152, DOI 10.1111/j.0361-3666.2005.00278.x; Centers for Disease Control and Prevention, 2010, BEH RISK FACT SURV S; Coyne JC, 2000, J CONSULT CLIN PSYCH, V68, P864, DOI 10.1037/0022-006X.68.5.864; CUTRONA CE, 1989, J PERS SOC PSYCHOL, V57, P723, DOI 10.1037/0022-3514.57.4.723; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diggle PJ, 2002, ANAL LONGITUDINAL DA; Ehrenreich JH, 2001, COPING DISASTERS GUI; Eriksson C. B., 2003, STRESS TRAUMA HDB ST, P68; Eriksson CB, 2001, J TRAUMA STRESS, V14, P205, DOI 10.1023/A:1007804119319; Eriksson CB, 2012, TRAUMATOLOGY; Goldberg R, 1996, ACAD EMERG MED, V3, P1156, DOI 10.1111/j.1553-2712.1996.tb03379.x; HACKMAN JR, 1976, ORGAN BEHAV HUM PERF, V16, P250, DOI 10.1016/0030-5073(76)90016-7; Holtz TH, 2002, J TRAUMA STRESS, V15, P389, DOI 10.1023/A:1020133308188; Knutson J, 1988, HDB PEDIAT PSYCHOL; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C., 1996, MASLACH BURNOUT INVE; McCall M, 1999, BRIT MED J, V318, P113, DOI 10.1136/bmj.318.7176.113; MOLLICA RF, 1987, AM J PSYCHIAT, V144, P497; Ostell A., 2006, CBT OCCUPATIONAL STR, P59; Purvanova RK, 2010, J VOCAT BEHAV, V77, P168, DOI 10.1016/j.jvb.2010.04.006; Resnick H., 1996, MEASUREMENT STRESS T; Salama P., 2001, SHARING FRONT LINE B, P242; Sandanger I, 1999, SOC PSYCH PSYCH EPID, V34, P53, DOI 10.1007/s001270050112; Sheik M, 2000, BRIT MED J, V321, P166, DOI 10.1136/bmj.321.7254.166; STRAUS MA, 1979, J MARRIAGE FAM, V41, P75, DOI 10.2307/351733; Thormar SB, 2010, J NERV MENT DIS, V198, P529, DOI 10.1097/NMD.0b013e3181ea1fa9; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	32	109	109	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44948	10.1371/journal.pone.0044948	http://dx.doi.org/10.1371/journal.pone.0044948			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005GJ	22984592	Green Published, Green Submitted, gold			2022-12-27	WOS:000308738500099
J	Jahangir, E; Irazola, V; Rubinstein, A				Jahangir, Eiman; Irazola, Vilma; Rubinstein, Adolfo			Need, Enabling, Predisposing, and Behavioral Determinants of Access to Preventative Care in Argentina: Analysis of the National Survey of Risk Factors	PLOS ONE			English	Article							HEALTH-SERVICES UTILIZATION; MEDICAL-CARE; RECOMMENDATIONS; INEQUALITIES; PREDICTORS; REDUCTION; MORBIDITY; STATEMENT; EDUCATION; DISEASE	Introduction: Health care utilization is an important step to disease management, providing opportunities for prevention and treatment. Anderson's Health Behavior Model has defined utilization by need, predisposing, and enabling determinants. We hypothesize that need, predisposing, and enabling, highlighting behavioral factors are associated with utilization in Argentina. Methods: We performed a logistic regression analysis of the 2005 and 2009 Argentinean Survey of Risk Factors, a cohort of 41,392 and 34,732 individuals, to explore the association between need, enabling, predisposing, and behavioral factors to blood pressure measurement in the last year. Results: In the 2005 cohort, blood pressure measurement was associated with perception of health, insurance coverage, basic needs met, and income. Additionally, female sex, civil state, household type, older age groups, education, and alcohol use were associated with utilization. The 2009 cohort showed similar associations with only minor differences between the models. Conclusions: We explored the association between utilization of clinical preventive services with need, enabling, predisposing, and behavioral factors. While predisposing and need determinants are associated with utilization, enabling factors such as insurance coverage provides an area for public intervention. These are important findings where policies should be focused to improve utilization of preventive services in Argentina.	[Jahangir, Eiman; Irazola, Vilma; Rubinstein, Adolfo] Inst Clin Effectiveness & Hlth Policy, Buenos Aires, DF, Argentina; [Jahangir, Eiman] Vanderbilt Univ, Med Ctr, Dept Cardiovasc Med, Nashville, TN USA	Vanderbilt University	Jahangir, E (corresponding author), Inst Clin Effectiveness & Hlth Policy, Buenos Aires, DF, Argentina.	eiman.jahangir@vanderbilt.edu	Jahangir, Eiman/P-1053-2015	Jahangir, Eiman/0000-0001-6944-5321	National Institutes of Health (NIH) Office of the Director, Fogarty International Center [R24 TW007988]; American Relief and Recovery Act; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007411] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Office of the Director, Fogarty International Center; American Relief and Recovery Act; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Eiman Jahangir is currently a Fogarty International Clinical Research Fellow and is supported by the National Institutes of Health (NIH) Office of the Director, Fogarty International Center, Office of AIDS Research, National Cancer Center, National Eye Institute, National Heart, Blood, and Lung Institute, National Institute of Dental & Craniofacial Research, National Institute On Drug Abuse, National Institute of Mental Health, National Institute of Allergy and Infectious Diseases Health, and NIH Office of Women's Health and Research through the International Clinical Research Scholars and Fellows Program at Vanderbilt University (R24 TW007988) and the American Relief and Recovery Act. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of family physicians, 2005, SUMM REC CLIN PREV S; ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; [Anonymous], STEPWISE APPR CHRON; Augustovski FA, 2009, VALUE HEALTH, V12, P587, DOI 10.1111/j.1524-4733.2008.00468.x; Ariza-Montoya John F, 2008, Rev. salud pública, V10, P58; Artinian NT, 2010, CIRCULATION, V122, P406, DOI 10.1161/CIR.0b013e3181e8edf1; Augustovski FA, 2008, J CLIN EPIDEMIOL, V61, P1279, DOI 10.1016/j.jclinepi.2008.05.004; Brenes-Camacho G, 2009, J AGING HEALTH, V21, P730, DOI 10.1177/0898264309338299; Calonge N, 2007, ANN INTERN MED, V147, P783, DOI 10.7326/0003-4819-147-11-200712040-00009; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; deBoer AGEM, 1997, HEALTH POLICY, V42, P101, DOI 10.1016/S0168-8510(97)00062-6; Roux AVD, 2007, J URBAN HEALTH, V84, P319, DOI 10.1007/s11524-007-9159-5; DUTTON D, 1986, SOC SCI MED, V23, P721, DOI 10.1016/0277-9536(86)90121-8; Elo I T, 1992, Health Transit Rev, V2, P49; EVASHWICK C, 1984, HEALTH SERV RES, V19, P357; EVE SB, 1988, J GERONTOL, V43, pM31, DOI 10.1093/geronj/43.2.M31; Ferrante D, 2011, REV ARGENT SALUD PUB, V2, P34; GARFIELD SR, 1976, NEW ENGL J MED, V294, P426, DOI 10.1056/NEJM197602192940806; Garratt AN, 2002, BMJ-BRIT MED J, V324, P1417, DOI 10.1136/bmj.324.7351.1417; Ham OK, 2007, PUBLIC HEALTH NURS, V24, P518, DOI 10.1111/j.1525-1446.2007.00664.x; KEMPEN GIJM, 1991, SOC SCI MED, V33, P1081, DOI 10.1016/0277-9536(91)90013-3; LAVECCHIA C, 1987, J EPIDEMIOL COMMUN H, V41, P161, DOI 10.1136/jech.41.2.161; LEVKOFF SE, 1987, MED CARE, V25, P1148, DOI 10.1097/00005650-198712000-00004; Lopez-Cevallos DF, 2010, HEALTH POLICY PLANN, V25, P209, DOI 10.1093/heapol/czp052; Malta DC, 2011, CAD SAUDE PUBLICA, V27, P57, DOI 10.1590/S0102-311X2011000100006; MAPELLI V, 1993, SOC SCI MED, V36, P999, DOI 10.1016/0277-9536(93)90117-M; Ministerio de Salud de la Nacion, 2005, SEG ENC NAC FACT RIE; Murimi MW, 2010, J RURAL HEALTH, V26, P273, DOI 10.1111/j.1748-0361.2010.00289.x; Nogueira MC, 2009, CAD SAUDE PUBLICA, V25, P2321, DOI 10.1590/S0102-311X2009001100003; PADGETT DK, 1992, SOC SCI MED, V35, P1189, DOI 10.1016/0277-9536(92)90231-E; Pagan JA, 2007, HEALTH ECON, V16, P1359, DOI 10.1002/hec.1226; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Pickering TG, 2005, CIRCULATION, V111, P697, DOI 10.1161/01.CIR.0000154900.76284.F6; Louvison MCP, 2008, REV SAUDE PUBL, V42, P733, DOI 10.1590/S0034-89102008000400021; Reyes-Ortiz Carlos A, 2007, Cancer Control, V14, P388; Rubinstein A, 2009, INT J TECHNOL ASSESS, V25, P260, DOI 10.1017/S0266462309090734; Salinas JJ, 2010, J RURAL HEALTH, V26, P333, DOI 10.1111/j.1748-0361.2010.00297.x; Silva H, 2010, AM J THER, V17, P159, DOI 10.1097/MJT.0b013e3181a84ec5; Vyas A, 2011, J COMMUNITY HLTH; Ware JE, 2004, USE PSYCHOL TESTING, V3, P693; WOLINSKY FD, 1978, J HEALTH SOC BEHAV, V19, P384, DOI 10.2307/2136586; Wright J, 1998, BRIT MED J, V316, P1310, DOI 10.1136/bmj.316.7140.1310; ZOOK CJ, 1980, NEW ENGL J MED, V302, P996, DOI 10.1056/NEJM198005013021804	44	45	45	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45053	10.1371/journal.pone.0045053	http://dx.doi.org/10.1371/journal.pone.0045053			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005GJ	22984608	Green Published, Green Submitted, gold			2022-12-27	WOS:000308738500110
J	Kim, SJ; Park, JH; Lee, MJ; Park, YG; Ahn, MJ; Bang, OY				Kim, Suk Jae; Park, Jae Hyun; Lee, Mi-Ji; Park, Yun Gyoung; Ahn, Myung-Ju; Bang, Oh Young			Clues to Occult Cancer in Patients with Ischemic Stroke	PLOS ONE			English	Article							ACUTE PULMONARY-EMBOLISM; DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; CARCINOMA; PROGNOSIS; PATTERNS	Background: We hypothesized that hidden malignancy could be detected in patients with cryptogenic stroke without active cancer when they showed the distinctive characteristics of cancer-related stroke. Methods and Findings: Among 2,562 consecutive patients with acute ischemic stroke, patients with cryptogenic stroke were analyzed and categorized into two groups according to the presence of active cancer: cryptogenic stroke with active cancer (cancer-related stroke, CA-stroke) group and without active cancer (CR-stroke) group. Patients with active lung cancer without stroke were also recruited for comparison purposes (CA-control). Clinical factors, lesion patterns on diffusion-weighted MRI (DWI), and laboratory findings were analyzed among groups. A total of 348 patients with cryptogenic stroke were enrolled in this study. Among them, 71 (20.4%) patients had active cancer at the time of stroke. The D-dimer levels were significantly higher in patients with CA-stroke than those with CR-stroke or CA-control (both p < 0.001). Regarding lesion patterns, patients with CA-stroke mostly had multiple lesions in multiple vascular territories, while more than 80% of patients with CR-stroke had single/multiple lesions in a single vascular territory (P < 0.001). D-dimer levels (OR 1.11 per 1 mu g/mL increase; 95% CI 1.06-1.15; P < 0.001) and DWI lesion patterns (OR 7.13; 95% CI 3.42-14.87; P < 0.001) were independently associated with CA-stroke. Workup for hidden malignancy was performed during hospitalization in 10 patients who showed elevated D-dimer levels and multiple infarcts involving multiple vascular territories but had no known cancer, and it revealed hidden malignancies in all the patients. Conclusion: Patients with CA-stroke have distinctive D-dimer levels and lesion patterns. These characteristics can serve as clues to occult cancer in patients with cryptogenic stroke.	[Kim, Suk Jae; Park, Jae Hyun; Lee, Mi-Ji; Bang, Oh Young] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea; [Park, Yun Gyoung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med, Seoul, South Korea; [Ahn, Myung-Ju] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Hematooncol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, SJ (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea.	nmboy@unitel.co.kr		Lee, Mi Ji/0000-0003-1364-1969	Ministry of Health Welfare [A110208]	Ministry of Health Welfare	This study was supported by the Korean Healthcare Technology Research & Development Project, Ministry of Health & Welfare (A110208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ay H, 2005, ANN NEUROL, V58, P688, DOI 10.1002/ana.20617; Baird AE, 2000, NEUROLOGY, V54, P674, DOI 10.1212/WNL.54.3.674; Bang OY, 2011, J CLIN NEUROL, V7, P53, DOI 10.3988/jcn.2011.7.2.53; Blom JW, 2004, J THROMB HAEMOST, V2, P1760, DOI 10.1111/j.1538-7836.2004.00928.x; Bura A, 2004, J THROMB HAEMOST, V2, P441, DOI 10.1111/j.1538-7933.2004.00619.x; Fujimoto S, 2011, CEREBROVASC DIS, V32, P148, DOI 10.1159/000328652; GORE JM, 1982, ANN INTERN MED, V96, P556, DOI 10.7326/0003-4819-96-5-556; GRAUS F, 1985, MEDICINE, V64, P16, DOI 10.1097/00005792-198501000-00002; GREENBERG E, 1964, AM J MED, V36, P106, DOI 10.1016/0002-9343(64)90153-6; Grisold W, 2009, ACTA NEUROL SCAND, V119, P1, DOI 10.1111/j.1600-0404.2008.01059.x; Guercini F, 2008, J THROMB HAEMOST, V6, P549, DOI 10.1111/j.1538-7836.2008.02903.x; Hong CT, 2009, CEREBROVASC DIS, V28, P411, DOI 10.1159/000235629; Kang DW, 2003, ARCH NEUROL-CHICAGO, V60, P1730, DOI 10.1001/archneur.60.12.1730; Kim SG, 2010, STROKE, V41, P798, DOI 10.1161/STROKEAHA.109.571356; Kono T, 2012, GERIATR GERONTOL INT, V12, P468, DOI 10.1111/j.1447-0594.2011.00796.x; Kwon HM, 2007, J NEUROL SCI, V258, P80, DOI 10.1016/j.jns.2007.02.035; Lee AYY, 2003, NEW ENGL J MED, V349, P146, DOI 10.1056/NEJMoa025313; Lee AYY, 2003, CIRCULATION, V107, pI17, DOI 10.1161/01.CIR.0000078466.72504.AC; Monreal M, 2004, J THROMB HAEMOST, V2, P876, DOI 10.1111/j.1538-7836.2004.00721.x; MONREAL M, 1993, CHEST, V103, P816, DOI 10.1378/chest.103.3.816; PRANDONI P, 1992, NEW ENGL J MED, V327, P1128, DOI 10.1056/NEJM199210153271604; Seok JM, 2010, ANN NEUROL, V68, P213, DOI 10.1002/ana.22050; Sorensen HT, 2000, NEW ENGL J MED, V343, P1846, DOI 10.1056/NEJM200012213432504; Tesselaar MET, 2007, J THROMB HAEMOST, V5, P520, DOI 10.1111/j.1538-7836.2007.02369.x; Zwicker JI, 2009, CLIN CANCER RES, V15, P6830, DOI 10.1158/1078-0432.CCR-09-0371	25	75	85	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44959	10.1371/journal.pone.0044959	http://dx.doi.org/10.1371/journal.pone.0044959			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984594	gold, Green Published, Green Submitted			2022-12-27	WOS:000308738500100
J	Sariyer, IK; Merabova, N; Patel, PK; Knezevic, T; Rosati, A; Turco, MC; Khalili, K				Sariyer, Ilker Kudret; Merabova, Nana; Patel, Prem Kumer; Knezevic, Tijana; Rosati, Alessandra; Turco, Maria C.; Khalili, Kamel			Bag3-Induced Autophagy Is Associated with Degradation of JCV Oncoprotein, T-Ag	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; HEAT-SHOCK-PROTEIN; BAG3 PROTEIN; FUNCTIONAL INTERACTION; NATALIZUMAB; ANTIGEN; CANCER; SIMIAN-VIRUS-40; POLYOMAVIRUSES; ACTIVATION	JC virus, JCV, is a human neurotropic polyomavirus whose replication in glial cells causes the fatal demyelinating disease progressive multifocal leukoencephalopathy (PML). In addition, JCV possesses oncogenic activity and expression of its transforming protein, large T-antigen (T-Ag), in several experimental animals induces tumors of neural origin. Further, the presence of JCV DNA and T-Ag have been repeatedly observed in several human malignant tissues including primitive neuroectodermal tumors and glioblastomas. Earlier studies have demonstrated that Bag3, a member of the Bcl-2-associated athanogene (Bag) family of proteins, which is implicated in autophagy and apoptosis, is downregulated upon JCV infection of glial cells and that JCV T-Ag is responsible for suppressing the activity of the BAG3 promoter. Here, we investigated the possible impact of Bag3 on T-Ag expression in JCV-infected human primary glial cells as well as in cells derived from T-Ag-induced medulloblastoma in transgenic animals. Results from these studies revealed that overexpression of Bag3 drastically decreases the level of T-Ag expression by inducing the autophagic degradation of the viral protein. Interestingly, this event leads to the inhibition of JCV infection of glial cells, suggesting that the reduced levels of T-antigen seen upon the overexpression of Bag3 has a biological impact on the viral lytic cycle. Results from protein-protein interaction studies showed that T-Ag and Bag3 physically interact with each other through the zinc-finger of T-Ag and the proline rich domains of Bag3, and this interaction is important for the autophagic degradation of T-Ag. Our observations open a new avenue of research for better understanding of virus-host interaction by investigating the interplay between T-Ag and Bag3, and their impact on the development of JCV-associated diseases.	[Sariyer, Ilker Kudret; Merabova, Nana; Patel, Prem Kumer; Knezevic, Tijana; Khalili, Kamel] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA; [Sariyer, Ilker Kudret; Merabova, Nana; Patel, Prem Kumer; Knezevic, Tijana; Khalili, Kamel] Temple Univ, Sch Med, Ctr Neurovirol, Philadelphia, PA 19122 USA; [Rosati, Alessandra; Turco, Maria C.] Univ Salerno, Dept Pharmaceut & Biomed Sci FARMABIOMED, Fisciano, Italy	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Salerno	Sariyer, IK (corresponding author), Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA.	kamel.khalili@temple.edu	Sariyer, Ilker/AAE-7677-2020; TURCO, Maria Caterina/AAC-5282-2022	TURCO, Maria Caterina/0000-0002-7835-359X; Merabova, Nana/0000-0003-4832-1551; Rosati, Alessandra/0000-0001-6675-0857	National Institutes of Health [R01 MH086358 BAG3]; JCV in brain; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH092177, R01MH086358] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JCV in brain; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grant Number R01 MH086358 BAG3 mediates interplay of HIV-1 and JCV in brain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akan I, 2006, VIROLOGY, V349, P66, DOI 10.1016/j.virol.2006.01.025; Arndt V, 2010, CURR BIOL, V20, P143, DOI 10.1016/j.cub.2009.11.022; Basile A, 2009, J GEN VIROL, V90, P1629, DOI 10.1099/vir.0.008722-0; Beere HM, 2005, J CLIN INVEST, V115, P2633, DOI 10.1172/JCI26471; Behl C, 2011, AUTOPHAGY, V7, P795, DOI 10.4161/auto.7.7.15844; BERGER JR, 1995, J NEUROVIROL, V1, P5, DOI 10.3109/13550289509111006; Bonelli P, 2004, LEUKEMIA, V18, P358, DOI 10.1038/sj.leu.2403219; Carra S, 2008, AUTOPHAGY, V4, P237, DOI 10.4161/auto.5407; Carra S, 2008, J BIOL CHEM, V283, P1437, DOI 10.1074/jbc.M706304200; Carra S, 2009, J BIOL CHEM, V284, P5523, DOI 10.1074/jbc.M807440200; Carson KR, 2009, LANCET ONCOL, V10, P816, DOI 10.1016/S1470-2045(09)70161-5; Chang CF, 1996, J VIROL, V70, P4150, DOI 10.1128/JVI.70.6.4150-4156.1996; Doong H, 2000, ONCOGENE, V19, P4385, DOI 10.1038/sj.onc.1203797; Festa M, 2011, AM J PATHOL, V178, P2504, DOI 10.1016/j.ajpath.2011.02.002; Franceschelli S, 2008, J CELL PHYSIOL, V215, P575, DOI 10.1002/jcp.21397; Gentilella A, 2008, ONCOGENE, V27, P5011, DOI 10.1038/onc.2008.142; Gentilella A, 2011, J BIOL CHEM, V286, P9205, DOI 10.1074/jbc.M110.175836; Kelley WL, 1997, P NATL ACAD SCI USA, V94, P3679, DOI 10.1073/pnas.94.8.3679; Khalili K, 2008, J CELL PHYSIOL, V215, P309, DOI 10.1002/jcp.21326; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; Krynska B, 2000, VIROLOGY, V274, P65, DOI 10.1006/viro.2000.0450; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; Lee JH, 1999, ONCOGENE, V18, P6183, DOI 10.1038/sj.onc.1203043; MILLER JR, 1982, NEW ENGL J MED, V307, P1436, DOI 10.1056/NEJM198212023072307; Moens U, 2008, J DTSCH DERMATOL GES, V6, P704, DOI 10.1111/j.1610-0387.2008.06810.x; Rosati A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.24; Rosati A, 2007, INT J BIOCHEM CELL B, V39, P1337, DOI 10.1016/j.biocel.2007.03.007; Rosati A, 2009, J CELL PHYSIOL, V218, P264, DOI 10.1002/jcp.21604; Safak M, 1999, J VIROL, V73, P10146, DOI 10.1128/JVI.73.12.10146-10157.1999; Safak M., 2005, The neurology of AIDS, P461; Sandborn WJ, 2005, NEW ENGL J MED, V353, P1912, DOI 10.1056/NEJMoa043335; Sariyer IK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014630; SAWAI ET, 1989, J VIROL, V63, P3961, DOI 10.1128/JVI.63.9.3961-3973.1989; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; Weber T, 2008, NEUROL CLIN, V26, P833, DOI 10.1016/j.ncl.2008.03.007; White MK, 2006, ONCOGENE, V25, P5286, DOI 10.1038/sj.onc.1209618; White MK, 2005, EUR J CANCER, V41, P2537, DOI 10.1016/j.ejca.2005.08.019	37	32	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45000	10.1371/journal.pone.0045000	http://dx.doi.org/10.1371/journal.pone.0045000			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984599	gold, Green Published, Green Submitted			2022-12-27	WOS:000308738500105
J	Elze, T; Tanner, TG				Elze, Tobias; Tanner, Thomas G.			Temporal Properties of Liquid Crystal Displays: Implications for Vision Science Experiments	PLOS ONE			English	Article							COLOR MEASUREMENT METHODS; RESPONSE-TIME EVALUATION; MOTION-BLUR; LCD; RESOLUTION; FLICKER	Liquid crystal displays (LCD) are currently replacing the previously dominant cathode ray tubes (CRT) in most vision science applications. While the properties of the CRT technology are widely known among vision scientists, the photometric and temporal properties of LCDs are unfamiliar to many practitioners. We provide the essential theory, present measurements to assess the temporal properties of different LCD panel types, and identify the main determinants of the photometric output. Our measurements demonstrate that the specifications of the manufacturers are insufficient for proper display selection and control for most purposes. Furthermore, we show how several novel display technologies developed to improve fast transitions or the appearance of moving objects may be accompanied by side-effects in some areas of vision research. Finally, we unveil a number of surprising technical deficiencies. The use of LCDs may cause problems in several areas in vision science. Aside from the well-known issue of motion blur, the main problems are the lack of reliable and precise onsets and offsets of displayed stimuli, several undesirable and uncontrolled components of the photometric output, and input lags which make LCDs problematic for real-time applications. As a result, LCDs require extensive individual measurements prior to applications in vision science.	[Elze, Tobias] Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02114 USA; [Elze, Tobias] Max Planck Inst Math Sci, Leipzig, Germany; [Tanner, Thomas G.] Max Planck Inst Biol Cybernet, Tubingen, Germany	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Max Planck Society; Max Planck Society	Elze, T (corresponding author), Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02114 USA.	tobias.elze@schepens.harvard.edu		Elze, Tobias/0000-0002-2032-0496	Max Planck Society; National Institutes of Health [R01 EY018664]; NATIONAL EYE INSTITUTE [R01EY018664] Funding Source: NIH RePORTER	Max Planck Society(Max Planck Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	TE and TGT have been supported by Max Planck Society. TE has been supported by National Institutes of Health grant R01 EY018664. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach M, 1997, SPATIAL VISION, V10, P403, DOI 10.1163/156856897X00311; Badano A, 2003, ADV DIGITAL RADIOGRA, P91; Becker ME, 2008, SID INT SYMP DIG TEC, V39, P24, DOI 10.1889/1.3069637; Becker ME, 2008, J SOC INF DISPLAY, V16, P989, DOI 10.1889/JSID16.10.989; Brainard D.H., 2002, ENCY IMAGING SCI TEC, P172, DOI DOI 10.1002/0471443395.IMG011; Brown J.L., 1965, VISION VISUAL PERCEP, P251; Cowan WB, 1995, HDB OPTICS, V1, P2721; Cristaldi DJ, 2009, LIQUID CRYSTAL DISPL, P769; den Boer W., 2005, ACTIVE MATRIX LIQUID; ELZE T, 2009, J VIS, V9, P58; Elze T, 2010, J NEUROSCI METH, V191, P171, DOI 10.1016/j.jneumeth.2010.06.018; Elze T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012792; Elze T, 2009, MED PHYS, V36, P4984, DOI 10.1118/1.3238154; Feng XF, 2008, J SOC INF DISPLAY, V16, P981, DOI 10.1889/JSID16.10.981; Gallistel CR, 2009, PSYCHOL REV, V116, P439, DOI 10.1037/a0015251; HARRIS FJ, 1978, P IEEE, V66, P51, DOI 10.1109/PROC.1978.10837; Kihara K, 2010, BEHAV RES METHODS, V42, P1105, DOI 10.3758/BRM.42.4.1105; Kurita T., 1998, P IDW 98, V'98 3D3-4, P823; LaFontaine D, 2006, ELECTRON WORLD, V112, P15; Lagroix HEP, 2012, ATTEN PERCEPT PSYCHO, V74, P1033, DOI 10.3758/s13414-012-0281-4; Lee B-W., 2001, SOC INF DISP INT S, V32, P1260, DOI [10.1889/1.1831790, DOI 10.1889/1.1831790]; Lee JH, 2008, SID INT S, V35, p[1344, 21]; Lee SW, 2006, J SOC INF DISPLAY, V14, P387, DOI 10.1889/1.2196515; Liang HY, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2205152; Liang HY, 2007, MED PHYS, V34, P639, DOI 10.1118/1.2428403; Robson T, 1998, VISION RES PRACTICAL, P81; Saha A, 2006, J SOC INF DISPLAY, V14, P979, DOI 10.1889/1.2393035; Saha A, 2010, MED PHYS, V37, P74, DOI 10.1118/1.3265879; Schanda J, 2007, COLORIMETRY: UNDERSTANDING THE CIE SYSTEM, P25, DOI 10.1002/9780470175637.ch3; Sheather SJ, 2004, STAT SCI, V19, P588, DOI 10.1214/088342304000000297; Someya J, 2007, J SOC INF DISPLAY, V15, P79, DOI 10.1889/1.2451570; SPERLING G, 1971, BEHAV RES METH INSTR, V3, P151, DOI 10.3758/BF03209940; SPERLING G, 1971, BEHAV RES METH INSTR, V3, P148, DOI 10.3758/BF03209939; SRINIVASAN M, 1985, J COMP PHYSIOL A, V157, P579, DOI 10.1007/BF01351352; Suzuki S, 2002, P SOC PHOTO-OPT INS, V4657, P85, DOI 10.1117/12.463794; Theis D, 2003, OPTICS ENCY, P327; van Heesch FH, 2008, J SOC INF DISPLAY, V16, P1009, DOI 10.1889/JSID16.10.1009; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105; Wang P, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00085; Watson A. B., 2010, SOC INFORM DISPLAY D, V41, P184; Watson A. B., 2006, SID S, V37, P1312; Watson AB, 2010, J SOC INF DISPLAY, V18, P179, DOI 10.1889/JSID18.2.179; Wiens S, 2004, PSYCHOL SCI, V15, P282, DOI 10.1111/j.0956-7976.2004.00667.x; Woods RL, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3292015; X Li, 2006, SID S, V37, P6, DOI DOI 10.1016/j.watres.2006.06.037; Yamamoto T, 2000, SID S, V31, P456	46	36	38	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44048	10.1371/journal.pone.0044048	http://dx.doi.org/10.1371/journal.pone.0044048			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984458	Green Published, Green Submitted, gold			2022-12-27	WOS:000308638700039
J	Maayan, I; Beenstock, J; Marbach, I; Tabachnick, S; Livnah, O; Engelberg, D				Maayan, Inbal; Beenstock, Jonah; Marbach, Irit; Tabachnick, Shira; Livnah, Oded; Engelberg, David			Osmostress Induces Autophosphorylation of Hog1 via a C-Terminal Regulatory Region That Is Conserved in p38 alpha	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; YEAST SACCHAROMYCES-CEREVISIAE; SIGNAL-TRANSDUCTION PATHWAY; MAP KINASE; IN-VITRO; TYROSINE KINASES; DOCKING SITES; PHOSPHORYLATION; VARIANTS; MUTANTS	Many protein kinases require phosphorylation at their activation loop for induction of catalysis. Mitogen-activated protein kinases (MAPKs) are activated by a unique mode of phosphorylation, on neighboring Tyrosine and Threonine residues. Whereas many kinases obtain their activation via autophosphorylation, MAPKs are usually phosphorylated by specific, dedicated, MAPK kinases (MAP2Ks). Here we show however, that the yeast MAPK Hog1, known to be activated by the MAP2K Pbs2, is activated in pbs2 Delta cells via an autophosphorylation activity that is induced by osmotic pressure. We mapped a novel domain at the Hog1 C-terminal region that inhibits this activity. Removal of this domain provides a Hog1 protein that is partially independent of MAP2K, namely, partially rescues osmostress sensitivity of pbs2 Delta cells. We further mapped a short domain (7 amino acid residues long) that is critical for induction of autophosphorylation. Its removal abolishes autophosphorylation, but maintains Pbs2-mediated phosphorylation. This 7 amino acids stretch is conserved in the human p38 alpha. Similar to the case of Hog1, it's removal from p38 alpha abolishes p38 alpha's autophosphorylation capability, but maintains, although reduces, its activation by MKK6. This study joins a few recent reports to suggest that, like many protein kinases, MAPKs are also regulated via induced autoactivation.	[Maayan, Inbal; Beenstock, Jonah; Marbach, Irit; Tabachnick, Shira; Livnah, Oded; Engelberg, David] Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Maayan, I (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	engelber@cc.huji.ac.il		Tabachnick Cherny, Shira/0000-0003-1595-4619	Israel Science Foundation [180/09]; U.S.-Israel Binational [2009116]; Singapore National Research Foundation under its HUJ-NUS partnership program in the Campus for Research Excellence And Technology Enterprise (CREATE)	Israel Science Foundation(Israel Science Foundation); U.S.-Israel Binational; Singapore National Research Foundation under its HUJ-NUS partnership program in the Campus for Research Excellence And Technology Enterprise (CREATE)	The study was supported by the Israel Science Foundation (http://www.isf.org.il/english/) grant 180/09 (Research Center); the U.S.-Israel Binational (http://www.bsf.org.il/BSFPublic/Default.aspx) grant 2009116 and by the Singapore National Research Foundation under its HUJ-NUS partnership program in the Campus for Research Excellence And Technology Enterprise (CREATE). The funders had no role in study design, data collection and analysis, decision to publish or preparation of manuscript.	AHN NG, 1991, J BIOL CHEM, V266, P4220; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; Askari N, 2007, J BIOL CHEM, V282, P91, DOI 10.1074/jbc.M608012200; Askari N, 2009, BIOCHEMISTRY-US, V48, P2497, DOI 10.1021/bi900024v; Avitzour M, 2007, FEBS J, V274, P963, DOI 10.1111/j.1742-4658.2007.05644.x; Belham C, 1999, CURR BIOL, V9, pR93, DOI 10.1016/S0960-9822(99)80058-X; Bell M, 2003, J BIOL CHEM, V278, P14603, DOI 10.1074/jbc.C300006200; Bell M, 2001, J BIOL CHEM, V276, P25351, DOI 10.1074/jbc.M101818200; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Clotet J, 2007, METHOD ENZYMOL, V428, P63, DOI 10.1016/S0076-6879(07)28004-8; de Nadal E, 2002, EMBO REP, V3, P735, DOI 10.1093/embo-reports/kvf158; Diskin R, 2004, J BIOL CHEM, V279, P47040, DOI 10.1074/jbc.M404595200; Diskin R, 2007, J MOL BIOL, V365, P66, DOI 10.1016/j.jmb.2006.08.043; Friedmann Y, 2006, MOL PHARMACOL, V70, P1395, DOI 10.1124/mol.106.022962; GALCHEVAGARGOVA Z, 1994, SCIENCE, V265, P806, DOI 10.1126/science.8047888; GARTNER A, 1992, GENE DEV, V6, P1280, DOI 10.1101/gad.6.7.1280; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Hohmann S, 2007, METHOD ENZYMOL, V428, P29, DOI 10.1016/S0076-6879(07)28002-4; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Knebel A, 1996, EMBO J, V15, P5314, DOI 10.1002/j.1460-2075.1996.tb00916.x; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Levin-Salomon V, 2009, BIOCHEM J, V417, P331, DOI 10.1042/BJ20081335; Levin-Salomon V, 2008, J BIOL CHEM, V283, P34500, DOI 10.1074/jbc.M806443200; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Lochhead PA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.254pe4; Maayan I, 2009, FEBS LETT, V583, P2015, DOI 10.1016/j.febslet.2009.05.014; Macia J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000056; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; Murakami Y, 2008, MOL CELL BIOL, V28, P2481, DOI 10.1128/MCB.01817-07; Nitta RT, 2008, J BIOL CHEM, V283, P34935, DOI 10.1074/jbc.M804970200; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; Saito H, 2004, J BIOCHEM, V136, P267, DOI 10.1093/jb/mvh135; Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177; Sclafani RA, 1996, CURR OPIN CELL BIOL, V8, P788, DOI 10.1016/S0955-0674(96)80079-2; SEGER R, 1991, P NATL ACAD SCI USA, V88, P6142, DOI 10.1073/pnas.88.14.6142; Westfall PJ, 2008, P NATL ACAD SCI USA, V105, P12212, DOI 10.1073/pnas.0805797105; Wilson C, 1997, J MOL EVOL, V44, P683; Yaakov G, 2003, MOL CELL BIOL, V23, P4826, DOI 10.1128/MCB.23.14.4826-4840.2003; Yao Z, 2000, FEBS LETT, V468, P37, DOI 10.1016/S0014-5793(00)01191-1; Zhang YY, 2008, J BIOL CHEM, V283, P26591, DOI 10.1074/jbc.M801703200; Zhou B, 2002, J BIOL CHEM, V277, P13889, DOI 10.1074/jbc.M200377200	49	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44749	10.1371/journal.pone.0044749	http://dx.doi.org/10.1371/journal.pone.0044749			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984552	Green Published, Green Submitted, gold			2022-12-27	WOS:000308638700081
J	Xu, L; He, X; Zhang, DM; Feng, FS; Wang, Z; Guan, LL; Wu, JH; Zhou, R; Zheng, BJ; Yuen, KY; Li, MF; Cao, KY				Xu, Lin; He, Xia; Zhang, Ding-mei; Feng, Fa-shen; Wang, Zhu; Guan, Lin-lin; Wu, Jue-heng; Zhou, Rong; Zheng, Bo-jian; Yuen, Kwok-yung; Li, Meng-feng; Cao, Kai-yuan			Surveillance and Genome Analysis of Human Bocavirus in Patients with Respiratory Infection in Guangzhou, China	PLOS ONE			English	Article							REAL-TIME PCR; ACUTE GASTROENTERITIS; TRACT INFECTION; YOUNG-CHILDREN; HOSPITALIZED CHILDREN; HONG-KONG; SAMPLES; PREVALENCE; PARVOVIRUS; PNEUMONIA	Human bocavirus (HBoV) is a novel parvovirus associated with respiratory tract diseases and gastrointestinal illness in adult and pediatric patients throughout the world. To investigate the epidemiological and genetic variation of HBoV in Guangzhou, South China, we screened 3460 throat swab samples from 1686 children and 1774 adults with acute respiratory infection symptoms for HBoV between March 2010 and February 2011, and analyzed the complete genome sequence of 2 HBoV strains. Specimens were screened for HBoV by real-time PCR and other 6 common respiratory viruses by RT-PCR or PCR. HBoV was detected in 58 (1.68%) out of 3460 samples, mostly from pediatric patients (52/58) and inpatient children (47/58). Six adult patients were detected as HBoV positive and 5 were emergency cases. Of these HBoV positive cases, 19 (32.76%) had co-pathogens including influenza virus (n = 5), RSV (n = 5), parainfluenza (n = 4), adenovirus (n = 1), coronavirus (n = 7). The complete genome sequences of 2 HBoVs strains (Genbank no. JN794565 and JN794566) were analyzed. Phylogenetic analysis showed that the 2 HBoV strains were HBoV1, and were most genetically close to ST2 (GenBank accession number DQ0000496). Recombination analysis confirmed that HBoV strain GZ9081 was an intra-genotype recombinant strain among HBoV1 variants.	[Xu, Lin; He, Xia; Zhang, Ding-mei; Feng, Fa-shen; Wang, Zhu; Guan, Lin-lin; Wu, Jue-heng; Li, Meng-feng; Cao, Kai-yuan] Sun Yat Sen Univ, Dept Microbiol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Xu, Lin; He, Xia; Zhang, Ding-mei; Feng, Fa-shen; Wang, Zhu; Guan, Lin-lin; Wu, Jue-heng; Li, Meng-feng; Cao, Kai-yuan] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China; [Xu, Lin; He, Xia; Zhang, Ding-mei; Feng, Fa-shen; Wang, Zhu; Guan, Lin-lin; Wu, Jue-heng; Zheng, Bo-jian; Yuen, Kwok-yung; Li, Meng-feng; Cao, Kai-yuan] Sun Yat Sen Univ, Univ Hong Kong, Joint Lab Infect Dis Surveillance, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Rong] Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Zheng, Bo-jian; Yuen, Kwok-yung] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; University of Hong Kong; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; University of Hong Kong	Xu, L (corresponding author), Sun Yat Sen Univ, Dept Microbiol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China.	caoky@mail.sysu.edu.cn	Zhang, Dingmei/ABC-7476-2020; meng, li/GVT-2063-2022	He, Xia/0000-0003-4319-4995; Yuen, Kwok-yung/0000-0002-2083-1552	National Major Projects of Major Infectious Disease Control and Prevention, the Ministry of Science and Technology of the People's Republic of China [2009ZX10004-213, 2012ZX10004213-001]	National Major Projects of Major Infectious Disease Control and Prevention, the Ministry of Science and Technology of the People's Republic of China	This research was supported by National Major Projects of Major Infectious Disease Control and Prevention, the Ministry of Science and Technology of the People's Republic of China (grant numbers 2009ZX10004-213 and 2012ZX10004213-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Arden KE, 2006, J MED VIROL, V78, P1232, DOI 10.1002/jmv.20689; Arnold JC, 2006, CLIN INFECT DIS, V43, P283, DOI 10.1086/505399; Cheng WX, 2008, CLIN INFECT DIS, V47, P161, DOI 10.1086/589244; Chieochansin T, 2008, JPN J INFECT DIS, V61, P479; Chung JY, 2006, EMERG INFECT DIS, V12, P1254, DOI 10.3201/eid1708.060261; Coiras MT, 2003, J MED VIROL, V69, P132, DOI 10.1002/jmv.10255; Foulongne V, 2006, EMERG INFECT DIS, V12, P1251, DOI 10.3201/eid1708.060213.; Fry AM, 2007, J INFECT DIS, V195, P1038, DOI 10.1086/512163; Fu XL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-182; Kapoor A, 2010, J INFECT DIS, V201, P1633, DOI 10.1086/652416; Kesebir D, 2006, J INFECT DIS, V194, P1276, DOI 10.1086/508213; Kim JS, 2011, KOREAN J LAB MED, V31, P179, DOI 10.3343/kjlm.2011.31.3.179; Kleines M, 2007, J CLIN MICROBIOL, V45, P1032, DOI 10.1128/JCM.01884-06; Lau SKP, 2007, J INFECT DIS, V196, P986, DOI 10.1086/521310; Lin JH, 2009, J CLIN VIROL, V44, P219, DOI 10.1016/j.jcv.2008.12.018; Longtin J, 2008, EMERG INFECT DIS, V14, P217, DOI 10.3201/eid1402.070851; Lu XY, 2006, J CLIN MICROBIOL, V44, P3231, DOI 10.1128/JCM.00889-06; Maggi F, 2007, J CLIN VIROL, V38, P321, DOI 10.1016/j.jcv.2007.01.008; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Neske F, 2007, J CLIN MICROBIOL, V45, P2116, DOI 10.1128/JCM.00027-07; Ngan TKP, 2011, J MED VIROL, V83, P286, DOI 10.1002/jmv.21876; Peiris JSM, 2003, EMERG INFECT DIS, V9, P628; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Santos N, 2010, J CLIN VIROL, V48, P127, DOI 10.1016/j.jcv.2010.03.014; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; Yu JM, 2008, J CLIN VIROL, V42, P280, DOI 10.1016/j.jcv.2008.03.032; Zheng LS, 2010, J MED VIROL, V82, P282, DOI 10.1002/jmv.21689	30	17	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44876	10.1371/journal.pone.0044876	http://dx.doi.org/10.1371/journal.pone.0044876			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984581	Green Published, gold			2022-12-27	WOS:000308638700096
J	Brommer, JE; Lehikoinen, A; Valkama, J				Brommer, Jon E.; Lehikoinen, Aleksi; Valkama, Jari			The Breeding Ranges of Central European and Arctic Bird Species Move Poleward	PLOS ONE			English	Article							BOREAL PROTECTED AREAS; CLIMATE-CHANGE; NORTHERN BIRDS; SHIFTS; VARIABILITY; BOUNDARIES; RESPONSES	Background: Climatic warming predicts that species move their entire distribution poleward. Poleward movement of the 'cold' side of the distribution of species is empirically supported, but evidence of poleward movement at the 'warm' distributional side is relatively scarce. Methodology/Principal Finding: Finland has, as the first country in the world, completed three national atlas surveys of breeding birds, which we here use to calculate the sizes and weighted mean latitudes of the national range of 114 southern and 34 northern bird species during three periods (1974-1979; 1986-1989; 2006-2010), each denoting species presence in approximately 3 800 10610 km(2) squares. We find strong evidence that southern species (breeding predominantly in central Europe) showed a latitudinal shift of 1.1-1.3 km/year poleward during all three pairwise comparisons between these atlases (covering 11, 20.5 and 31.5 years respectively). We find evidence of a latitudinal shift of 0.7-0.8 km/year poleward of northern boreal and Arctic species, but this shift was not found in all study periods and may have been influenced by increased effort put into the more recent surveys. Species showed no significant correlation in changes in range size and weighted mean latitude between the first (11 year) and second (20.5 year) period covered by consecutive atlases, suggesting weak phylogenetic signal and little scope of species characteristics in explaining latitudinal avian range changes. Conclusions: Extinction-driven avian range changes (at the 'warm' side) of a species' distribution occur at approximately half the rate of colonisation-driven range changes (at the 'cold' side), and its quantification therefore requires long-term monitoring data, possibly explaining why evidence for such changes is currently rare. A clear latitudinal shift in an assemblage of species may still harbour considerable temporal inconsistency in latitudinal movement on the species level. Understanding this inconsistency is important for predictive modelling of species composition in a changing world.	[Brommer, Jon E.] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Brommer, Jon E.] Novia Univ Appl Sci, ARONIA Coastal Zone Res Team, Ekenas, Finland; [Brommer, Jon E.] Abo Akad Univ, Ekenas, Finland; [Lehikoinen, Aleksi; Valkama, Jari] Univ Helsinki, Finnish Museum Nat Hist, Helsinki, Finland	University of Helsinki; Novia University of Applied Sciences; Abo Akademi University; University of Helsinki	Brommer, JE (corresponding author), Univ Helsinki, Dept Biosci, Helsinki, Finland.	jon.brommer@helsinki.fi	Lehikoinen, Aleksi/O-5444-2016; Brommer, Jon E/C-3613-2008	Brommer, Jon E/0000-0002-2435-2612; Valkama, Jari/0000-0002-0393-7320; Lehikoinen, Aleksi/0000-0002-1989-277X	Academy of Finland	Academy of Finland(Academy of Finland)	This work was supported by Academy of Finland (JEB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brommer JE, 2004, ANN ZOOL FENN, V41, P391; Brommer JE, 2010, CLIMATE CHANGE BIRDS; Brommer JE, 2008, ORNIS FENNICA, V85, P109; Buntgen U, 2011, SCIENCE, V331, P578, DOI 10.1126/science.1197175; Cormont A, 2011, CLIM RES, V49, P59, DOI 10.3354/cr01007; Davis AJ, 1998, J ANIM ECOL, V67, P600, DOI 10.1046/j.1365-2656.1998.00223.x; Gaston KJ, 2009, P R SOC B, V276, P1395, DOI 10.1098/rspb.2008.1480; Grinnell J, 1917, AM NAT, V51, P115, DOI 10.1086/279591; Holm S., 1979, SCAND J STAT, V6, P56; Hyytia K, 1983, SUOMEN LINTUATLAS; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Kellomaki S, 2005, FINNISH ENV I MIMEOG, V334, P1; MacArthur R.H., 1972, pvii; Metsantutkimuslaitos, 2010, METS VUOS 2010; Parmesan C, 2005, OIKOS, V108, P58, DOI 10.1111/j.0030-1299.2005.13150.x; ROOT T, 1988, J BIOGEOGR, V15, P489, DOI 10.2307/2845278; Setchell WA, 1920, SCIENCE, V52, P187, DOI 10.1126/science.52.1339.187; Shoo LP, 2006, AUSTRAL ECOL, V31, P22, DOI 10.1111/j.1442-9993.2006.01539.x; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; Thomas CD, 2006, TRENDS ECOL EVOL, V21, P415, DOI 10.1016/j.tree.2006.05.012; Thomas CD, 2010, DIVERS DISTRIB, V16, P488, DOI 10.1111/j.1472-4642.2010.00642.x; Tietavainen H, 2009, ACTA GEOSCI SIN, V30, P2247; Travis JMJ, 2003, P ROY SOC B-BIOL SCI, V270, P467, DOI 10.1098/rspb.2002.2246; Vaisanen R., 1998, MUUTTUVA PESIMALINNU; Valkama J., 2011, 3 FINNISH BREEDING B; Virkkala R, 2011, BOREAL ENVIRON RES, V16, P2; Virkkala R, 2011, BIOL LETTERS, V7, P395, DOI 10.1098/rsbl.2010.1052; Zuckerberg B, 2009, GLOBAL CHANGE BIOL, V15, P1866, DOI 10.1111/j.1365-2486.2009.01878.x	28	64	72	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e43648	10.1371/journal.pone.0043648	http://dx.doi.org/10.1371/journal.pone.0043648			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028465	gold, Green Submitted, Green Published			2022-12-27	WOS:000309388900004
J	Gross, S; Catez, F; Masumoto, H; Lomonte, P				Gross, Sylvain; Catez, Frederic; Masumoto, Hiroshi; Lomonte, Patrick			Centromere Architecture Breakdown Induced by the Viral E3 Ubiquitin Ligase ICP0 Protein of Herpes Simplex Virus Type 1	PLOS ONE			English	Article							ALPHA-SATELLITE DNA; PROTEASOME-DEPENDENT DEGRADATION; CENP-A NUCLEOSOMES; OUTER KINETOCHORE; BINDING PROTEIN; HISTONE H3; CELL-FATE; CHROMATIN; COMPLEX; DOMAIN	The viral E3 ubiquitin ligase ICP0 protein has the unique property to temporarily localize at interphase and mitotic centromeres early after infection of cells by the herpes simplex virus type 1 (HSV-1). As a consequence ICP0 induces the proteasomal degradation of several centromeric proteins (CENPs), namely CENP-A, the centromeric histone H3 variant, CENP-B and CENP-C. Following ICP0-induced centromere modification cells trigger a specific response to centromeres called interphase Centromere Damage Response (iCDR). The biological significance of the iCDR is unknown; so is the degree of centromere structural damage induced by ICP0. Interphase centromeres are complex structures made of proximal and distal protein layers closely associated to CENP-A-containing centromeric chromatin. Using several cell lines constitutively expressing GFP-tagged CENPs, we investigated the extent of the centromere destabilization induced by ICP0. We show that ICP0 provokes the disappearance from centromeres, and the proteasomal degradation of several CENPs from the NAC (CENP-A nucleosome associated) and CAD (CENP-A Distal) complexes. We then investigated the nucleosomal occupancy of the centromeric chromatin in ICP0-expressing cells by micrococcal nuclease (MNase) digestion analysis. ICP0 expression either following infection or in cell lines constitutively expressing ICP0 provokes significant modifications of the centromeric chromatin structure resulting in higher MNase accessibility. Finally, using human artificial chromosomes (HACs), we established that ICP0-induced iCDR could also target exogenous centromeres. These results demonstrate that, in addition to the protein complexes, ICP0 also destabilizes the centromeric chromatin resulting in the complete breakdown of the centromere architecture, which consequently induces iCDR.	[Gross, Sylvain; Catez, Frederic; Lomonte, Patrick] CNRS, Ctr Genet & Physiol Mol & Cellulaire, UMR5534, Virus & Centromere Team, Villeurbanne, France; [Gross, Sylvain; Catez, Frederic; Lomonte, Patrick] Univ Lyon 1, F-69365 Lyon, France; [Gross, Sylvain; Lomonte, Patrick] Labex DEVweCAN, Lab Excellence, Lyon, France; [Masumoto, Hiroshi] Kazusa DNA Res Inst, Lab Cell Engn, Chiba, Japan	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Kazusa DNA Research Institute	Lomonte, P (corresponding author), CNRS, Ctr Genet & Physiol Mol & Cellulaire, UMR5534, Virus & Centromere Team, Villeurbanne, France.	patrick.lomonte@univ-lyon1.fr	CATEZ, Frédéric/GQP-7328-2022; CATEZ, Frédéric/AAM-4854-2020	CATEZ, Frédéric/0000-0001-8255-9091; LOMONTE, PATRICK/0000-0001-9248-648X	Association pour la Recherche contre le Cancer [ARC-7979, ARC-4910]; ANR [ANR-05-MIIM-008-01]; FINOVI Foundation; LabEX DEVweCAN [ANR-10-LABX-61]; Ligue Nationale Contre le Cancer (LNCC); French Ministry for Education and Research; Fondation pour la Recherche Medicale (FRM)	Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); ANR(French National Research Agency (ANR)); FINOVI Foundation; LabEX DEVweCAN; Ligue Nationale Contre le Cancer (LNCC)(Ligue nationale contre le cancer); French Ministry for Education and Research; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This work was funded by the Association pour la Recherche contre le Cancer (grants ARC-7979 and ARC-4910), ANR (grant ANR-05-MIIM-008-01, CENTROLAT), FINOVI Foundation, the LabEX DEVweCAN (ANR-10-LABX-61), and the Ligue Nationale Contre le Cancer (LNCC). SG was supported by the French Ministry for Education and Research and the Fondation pour la Recherche Medicale (FRM). FC and PL are CNRS researchers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 2009, J CELL BIOL, V186, P173, DOI 10.1083/jcb.200903100; Amor DJ, 2004, TRENDS CELL BIOL, V14, P359, DOI 10.1016/j.tcb.2004.05.009; Bergmann JH, 2011, EMBO J, V30, P328, DOI 10.1038/emboj.2010.329; Black BE, 2007, P NATL ACAD SCI USA, V104, P5008, DOI 10.1073/pnas.0700390104; Black BE, 2007, MOL CELL, V25, P309, DOI 10.1016/j.molcel.2006.12.018; Bloom DC, 2010, BBA-GENE REGUL MECH, V1799, P246, DOI 10.1016/j.bbagrm.2009.12.001; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Boutell C, 2005, J VIROL, V79, P12342, DOI 10.1128/JVI.79.19.12342-12354.2005; Boutell C, 2003, J BIOL CHEM, V278, P36596, DOI 10.1074/jbc.M300776200; Boutell C, 2003, J VIROL, V77, P8686, DOI 10.1128/JVI.77.16.8686-8694.2003; Boutell C, 2002, J VIROL, V76, P841, DOI 10.1128/JVI.76.2.841-850.2002; Boutell C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002245; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Brown KE, 2001, NAT CELL BIOL, V3, P602, DOI 10.1038/35078577; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Canning M, 2004, J BIOL CHEM, V279, P38160, DOI 10.1074/jbc.M402885200; Carroll CW, 2010, J CELL BIOL, V189, P1143, DOI 10.1083/jcb.201001013; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Catez F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002852; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Chelbi-Alix MK, 1999, ONCOGENE, V18, P935, DOI 10.1038/sj.onc.1202366; Conn KL, 2008, J VIROL, V82, P8629, DOI 10.1128/JVI.00616-08; Conn KL, 2011, J VIROL, V85, P13234, DOI 10.1128/JVI.06038-11; Du YQ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000835; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; EVERETT RD, 1993, VIROLOGY, V197, P751, DOI 10.1006/viro.1993.1651; EVERETT RD, 1994, EMBO J, V13, P5062, DOI 10.1002/j.1460-2075.1994.tb06835.x; Everett RD, 1999, EMBO J, V18, P1526, DOI 10.1093/emboj/18.6.1526; Everett RD, 1998, J VIROL, V72, P6581, DOI 10.1128/JVI.72.8.6581-6591.1998; Fisher AG, 2002, CURR OPIN GENET DEV, V12, P193, DOI 10.1016/S0959-437X(02)00286-1; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Francastel C, 2000, NAT REV MOL CELL BIO, V1, P137, DOI 10.1038/35040083; Francastel C, 1999, CELL, V99, P259, DOI 10.1016/S0092-8674(00)81657-8; Francastel C, 2001, P NATL ACAD SCI USA, V98, P12120, DOI 10.1073/pnas.211444898; Gascoigne KE, 2011, CELL, V145, P410, DOI 10.1016/j.cell.2011.03.031; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; Gilbert N, 2003, EMBO J, V22, P5540, DOI 10.1093/emboj/cdg520; Goshima G, 2003, J CELL BIOL, V160, P25, DOI 10.1083/jcb.200210005; Guasconi V, 2010, EPIGENETICS-US, V5, P704, DOI 10.4161/epi.5.8.13025; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; Hagglund R, 2004, J VIROL, V78, P2169, DOI 10.1128/JVI.78.5.2169-2178.2004; Halford WP, 2001, J VIROL, V75, P3240, DOI 10.1128/JVI.75.7.3240-3249.2001; Hellwig D, 2011, J CELL SCI, V124, P3871, DOI 10.1242/jcs.088625; Hellwig D, 2008, J BIOPHOTONICS, V1, P245, DOI 10.1002/jbio.200810014; Hori T, 2008, MOL BIOL CELL, V19, P843, DOI 10.1091/mbc.E07-06-0556; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; IKENO M, 1994, HUM MOL GENET, V3, P1245, DOI 10.1093/hmg/3.8.1245; Kummer M, 2007, J VIROL, V81, P6326, DOI 10.1128/JVI.02327-06; Lam AL, 2006, P NATL ACAD SCI USA, V103, P4186, DOI 10.1073/pnas.0507947103; Lee C, 1997, HUM GENET, V100, P291, DOI 10.1007/s004390050508; Lilley CE, 2010, EMBO J, V29, P943, DOI 10.1038/emboj.2009.400; Lomonte P, 1999, J VIROL, V73, P9456, DOI 10.1128/JVI.73.11.9456-9467.1999; Lomonte P, 2001, J BIOL CHEM, V276, P5829, DOI 10.1074/jbc.M008547200; Lomonte P, 2007, FEBS LETT, V581, P658, DOI 10.1016/j.febslet.2007.01.027; Masumoto H, 2004, CHROMOSOME RES, V12, P543, DOI 10.1023/B:CHRO.0000036593.72788.99; MASUMOTO H, 1989, J CELL BIOL, V109, P1963, DOI 10.1083/jcb.109.5.1963; McAinsh AD, 2011, SEMIN CELL DEV BIOL, V22, P946, DOI 10.1016/j.semcdb.2011.09.016; McClelland SE, 2007, EMBO J, V26, P5033, DOI 10.1038/sj.emboj.7601927; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Monier K, 2000, NAT CELL BIOL, V2, P661, DOI 10.1038/35023615; Morency E, 2005, ARCH VIROL, V150, P2387, DOI 10.1007/s00705-005-0546-5; Morency E, 2007, J CELL BIOL, V177, P757, DOI 10.1083/jcb.200612107; Nakano M, 2008, DEV CELL, V14, P507, DOI 10.1016/j.devcel.2008.02.001; Nishihashi A, 2002, DEV CELL, V2, P463, DOI 10.1016/S1534-5807(02)00144-2; Ohzeki J, 2002, J CELL BIOL, V159, P765, DOI 10.1083/jcb.200207112; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Okada T, 2007, CELL, V131, P1287, DOI 10.1016/j.cell.2007.10.045; PALMER DK, 1987, J CELL BIOL, V104, P805, DOI 10.1083/jcb.104.4.805; Parkinson J, 2000, J VIROL, V74, P10006, DOI 10.1128/JVI.74.21.10006-10017.2000; Parkinson J, 1999, J VIROL, V73, P650, DOI 10.1128/JVI.73.1.650-657.1999; Perpelescu M, 2011, CHROMOSOMA, V120, P425, DOI 10.1007/s00412-011-0330-0; Pluta AF, 1998, J CELL SCI, V111, P2029; Politi V, 2002, J CELL SCI, V115, P2317; Preston CM, 2000, J GEN VIROL, V81, P1; Przewloka MR, 2011, CURR BIOL, V21, P399, DOI 10.1016/j.cub.2011.02.005; Schang LM, 2000, J VIROL, V74, P2107, DOI 10.1128/JVI.74.5.2107-2120.2000; Schubeler D, 2000, GENE DEV, V14, P940; Schueler MG, 2006, ANNU REV GENOM HUM G, V7, P301, DOI 10.1146/annurev.genom.7.080505.115613; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Sekulic N, 2009, NAT CELL BIOL, V11, P793, DOI 10.1038/ncb0709-793; Solovei I, 2002, EXP CELL RES, V276, P10, DOI 10.1006/excr.2002.5513; STOW ND, 1986, J GEN VIROL, V67, P2571, DOI 10.1099/0022-1317-67-12-2571; Sugata N, 2000, HUM MOL GENET, V9, P2919, DOI 10.1093/hmg/9.19.2919; SUGIMOTO K, 1994, J BIOCHEM-TOKYO, V116, P877, DOI 10.1093/oxfordjournals.jbchem.a124610; SULLIVAN KF, 1994, J CELL BIOL, V127, P581, DOI 10.1083/jcb.127.3.581; Tanaka Y, 2005, J BIOL CHEM, V280, P41609, DOI 10.1074/jbc.M509666200; Terranova R, 2005, EXP CELL RES, V310, P344, DOI 10.1016/j.yexcr.2005.07.031; Thompson RL, 2006, J VIROL, V80, P10919, DOI 10.1128/JVI.01253-06; Thompson RL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000352; Trazzi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005832; Wagner EK, 1997, CLIN MICROBIOL REV, V10, P419, DOI 10.1128/CMR.10.3.419; Yoda K, 1998, GENES CELLS, V3, P533, DOI 10.1046/j.1365-2443.1998.00210.x; YODA K, 1992, J CELL BIOL, V119, P1413, DOI 10.1083/jcb.119.6.1413	94	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e44227	10.1371/journal.pone.0044227	http://dx.doi.org/10.1371/journal.pone.0044227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028505	gold, Green Submitted, Green Published			2022-12-27	WOS:000309388900006
J	Astrup, E; Lekva, T; Davi, G; Otterdal, K; Santilli, F; Oie, E; Halvorsen, B; Damas, JK; Raoult, D; Vitale, G; Olano, JP; Ueland, T; Aukrust, P				Astrup, Elisabeth; Lekva, Tove; Davi, Giovanni; Otterdal, Kari; Santilli, Francesca; Oie, Erik; Halvorsen, Bente; Damas, Jan Kristian; Raoult, Didier; Vitale, Giustina; Olano, Juan P.; Ueland, Thor; Aukrust, Pal			A Complex Interaction between Rickettsia conorii and Dickkopf-1-Potential Role in Immune Evasion Mechanisms in Endothelial Cells	PLOS ONE			English	Article							MEDITERRANEAN SPOTTED-FEVER; TICK BITE FEVER; ACTIVATION; EXPRESSION; MODULATORS; PLATELETS; APOPTOSIS; RESPONSES; ADHESION; PATHWAY	The pathophysiological hallmark of spotted fever group rickettsioses comprises vascular inflammation. Based on the emerging importance of the wingless (Wnt) pathways in inflammation and vascular biology, we hypothesized that Dickkopf-1 (DKK-1), as a major modulator of Wnt signaling, could be involved in the pathogenesis in rickettsial infections. Our major findings were: (i) While baseline concentration of DKK-1 in patients with R. conorii infection (n = 32) were not different from levels in controls (n = 24), DKK-1 rose significantly from presentation to first follow-up sample (median 7 days after baseline). (ii) In vitro experiments in human umbilical vein endothelial cells (HUVECs) showed that while heat-inactivated R. conorii enhanced the release of interleukin-6 (IL-6) and IL-8, it down-regulated the release of endothelial-derived DKK-1 in a time-and dose-dependent manner. (iii) Silencing of DKK-1 attenuated the release of IL-6, IL-8 and growth-related oncogene (GRO)alpha in R. conorii-exposed HUVECs, suggesting inflammatory effects of DKK-1. (iv) Silencing of DKK-1 attenuated the expression of tissue factor and enhanced the expression of thrombomodulin in R. conorii-exposed HUVECs suggesting pro-thrombotic effects of DKK-1. The capacity of R. conorii to down-regulate endothelial-derived DKK-1 and the ability of silencing DKK-1 to attenuate R. conorii-induced inflammation in endothelial cells could potentially reflect a novel mechanism by which R. conorii escapes the immune response at the site of infection.	[Astrup, Elisabeth] Akershus Univ Hosp, Inst Clin Med, Lorenskog, Norway; [Astrup, Elisabeth; Lekva, Tove; Otterdal, Kari; Oie, Erik; Halvorsen, Bente; Ueland, Thor; Aukrust, Pal] Univ Oslo, Rikshosp, Oslo Univ Hosp, Internal Med Res Inst, N-0027 Oslo, Norway; [Lekva, Tove] Univ Oslo, Rikshosp, Oslo Univ Hosp, Sect Specialized Endocrinol, N-0027 Oslo, Norway; [Aukrust, Pal] Univ Oslo, Rikshosp, Oslo Univ Hosp, Sect Clin Immunol & Infect Dis, N-0027 Oslo, Norway; [Astrup, Elisabeth; Ueland, Thor; Aukrust, Pal] Univ Oslo, Fac Med, Oslo, Norway; [Damas, Jan Kristian] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Damas, Jan Kristian] St Olavs Hosp, Dept Infect Dis, Trondheim, Norway; [Davi, Giovanni; Santilli, Francesca] Univ G dAnnunzio, Ctr Excellence Aging, Palermo, Italy; [Vitale, Giustina] Sch Med, Dept Med, Palermo, Italy; [Raoult, Didier] Univ Aix Marseille 2, Fac Med, Unite Rickettsies, Marseille, France; [Olano, Juan P.] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA	University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); G d'Annunzio University of Chieti-Pescara; University of Palermo; UDICE-French Research Universities; Aix-Marseille Universite; University of Texas System; University of Texas Medical Branch Galveston	Astrup, E (corresponding author), Akershus Univ Hosp, Inst Clin Med, Lorenskog, Norway.	Elisabeth.Astrup.Strand@rr-research.no	Santilli, Francesca/ABC-6243-2021; St Olav Hospital, Medisinsk Klinikk -/AAD-6414-2022; RAOULT, Didier/A-8434-2008; Davi, Giovanni/K-7659-2016	Santilli, Francesca/0000-0002-4593-905X; RAOULT, Didier/0000-0002-0633-5974; Davi, Giovanni/0000-0002-3044-0870; Lekva, Tove/0000-0002-7962-4726	Norwegian Research Council; University of Oslo; Helse Sor-Ost	Norwegian Research Council(Research Council of NorwayEuropean Commission); University of Oslo; Helse Sor-Ost	Sources of financial support are Norwegian Research Council, www.forskningsradet.no University of Oslo,uio.no, Helse Sor-Ost, www.helse-sorost.no. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Damas JK, 2006, J IMMUNOL, V177, P2699, DOI 10.4049/jimmunol.177.4.2699; Damas JK, 2009, J INFECTION, V58, P68, DOI 10.1016/j.jinf.2008.11.008; DAVI G, 1995, THROMB HAEMOSTASIS, V74, P631; Dehner M, 2008, J BIOL CHEM, V283, P19201, DOI 10.1074/jbc.M710366200; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Goodwin AM, 2006, DEV DYNAM, V235, P3110, DOI 10.1002/dvdy.20939; Heiland GR, 2010, ANN RHEUM DIS, V69, P2152, DOI 10.1136/ard.2010.132852; Hornef MW, 2002, NAT IMMUNOL, V3, P1033, DOI 10.1038/ni1102-1033; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kessler M, 2012, AM J PATHOL, V180, P186, DOI 10.1016/j.ajpath.2011.09.015; Ko JY, 2010, BONE, V46, P584, DOI 10.1016/j.bone.2009.10.030; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Lee DK, 2006, BIOCHEM BIOPH RES CO, V347, P109, DOI 10.1016/j.bbrc.2006.06.082; Liu XY, 2011, AM J PHYSIOL-GASTR L, V301, pG992, DOI 10.1152/ajpgi.00080.2011; Masckauchan T. Nestor H., 2005, Angiogenesis, V8, P43, DOI 10.1007/s10456-005-5612-9; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Otterdal K, 2006, BLOOD, V108, P928, DOI 10.1182/blood-2005-09-010629; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; RAOULT D, 1987, J INFECT DIS, V155, P1059, DOI 10.1093/infdis/155.5.1059; Schaale K, 2011, EUR J CELL BIOL, V90, P553, DOI 10.1016/j.ejcb.2010.11.004; Smadja DM, 2010, ARTERIOSCL THROM VAS, V30, P2544, DOI 10.1161/ATVBAHA.110.213751; Ueland T, 2009, ARTERIOSCL THROM VAS, V29, P1228, DOI 10.1161/ATVBAHA.109.189761; Vitale G, 2001, J INFECTION, V42, P33, DOI 10.1053/jinf.2000.0758; Walker DH, 2008, NAT REV MICROBIOL, V6, P375, DOI 10.1038/nrmicro1866; Walker DH, 2003, ANN NY ACAD SCI, V990, P1, DOI 10.1111/j.1749-6632.2003.tb07331.x; Weng LH, 2010, ARTHRITIS RHEUM-US, V62, P1393, DOI 10.1002/art.27357; Zerlin M, 2008, ANGIOGENESIS, V11, P63, DOI 10.1007/s10456-008-9095-3	28	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e43638	10.1371/journal.pone.0043638	http://dx.doi.org/10.1371/journal.pone.0043638			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028464	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900008
J	Recio-Spinoso, A				Recio-Spinoso, Alberto			Enhancement and Distortion in the Temporal Representation of Sounds in the Ventral Cochlear Nucleus of Chinchillas and Cats	PLOS ONE			English	Article							AUDITORY-NERVE FIBERS; SPHERICAL BUSHY CELLS; DISCHARGE PATTERNS; NEURAL SYNCHRONIZATION; LATERAL LEMNISCUS; RESPONSE PATTERNS; TONAL STIMULI; NEURONS; TONES; MECHANISMS	A subset of neurons in the cochlear nucleus (CN) of the auditory brainstem has the ability to enhance the auditory nerve's temporal representation of stimulating sounds. These neurons reside in the ventral region of the CN (VCN) and are usually known as highly synchronized, or high-sync, neurons. Most published reports about the existence and properties of high-sync neurons are based on recordings performed on a VCN output tract-not the VCN itself-of cats. In other species, comprehensive studies detailing the properties of high-sync neurons, or even acknowledging their existence, are missing. Examination of the responses of a population of VCN neurons in chinchillas revealed that a subset of those neurons have temporal properties similar to high-sync neurons in the cat. Phase locking and entrainment-the ability of a neuron to fire action potentials at a certain stimulus phase and at almost every stimulus period, respectively-have similar maximum values in cats and chinchillas. Ranges of characteristic frequencies for high-sync neurons in chinchillas and cats extend up to 600 and 1000 Hz, respectively. Enhancement of temporal processing relative to auditory nerve fibers (ANFs), which has been shown previously in cats using tonal and white-noise stimuli, is also demonstrated here in the responses of VCN neurons to synthetic and spoken vowel sounds. Along with the large amount of phase locking displayed by some VCN neurons there occurs a deterioration in the spectral representation of the stimuli (tones or vowels). High-sync neurons exhibit a greater distortion in their responses to tones or vowels than do other types of VCN neurons and auditory nerve fibers. Standard deviations of first-spike latency measured in responses of high-sync neurons are lower than similar values measured in ANFs' responses. This might indicate a role of high-sync neurons in other tasks beyond sound localization.	Univ Castilla La Mancha, IDINE, Lab Auditory Neuroengn, Albacete, Spain	Universidad de Castilla-La Mancha	Recio-Spinoso, A (corresponding author), Univ Castilla La Mancha, IDINE, Lab Auditory Neuroengn, Albacete, Spain.	alberto.recio@uclm.es	Recio-Spinoso, Alberto/F-7744-2013	Recio-Spinoso, Alberto/0000-0003-1909-832X	National Institute on Deafness and Other Communication Disorders [NS-17590]; Regional Operational Programme European Social Fund within the Spain Instituto de Recursos Humanos para la Ciencia y la Tecnologia program of the Fundacion Parque Cientifico y Tecnologico de Albacete; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017590] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Regional Operational Programme European Social Fund within the Spain Instituto de Recursos Humanos para la Ciencia y la Tecnologia program of the Fundacion Parque Cientifico y Tecnologico de Albacete; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Work was supported by National Institute on Deafness and Other Communication Disorders grant NS-17590 (http://www.nidcd.nih.gov) and by the Regional Operational Programme European Social Fund 2007/2013 within the frame of the Spain Instituto de Recursos Humanos para la Ciencia y la Tecnologia program of the Fundacion Parque Cientifico y Tecnologico de Albacete (http://www.pcyta.com). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLACKBURN CC, 1990, J NEUROPHYSIOL, V63, P1191, DOI 10.1152/jn.1990.63.5.1191; BLACKBURN CC, 1989, J NEUROPHYSIOL, V62, P1303, DOI 10.1152/jn.1989.62.6.1303; BOURK TR, 1976, THESIS MIT CAMBRIDGE; CARNEY LH, 1990, J NEUROPHYSIOL, V64, P437, DOI 10.1152/jn.1990.64.2.437; COVEY E, 1991, J NEUROSCI, V11, P3456; Dehmel S, 2010, HEARING RES, V268, P234, DOI 10.1016/j.heares.2010.06.005; Frisina RD, 2001, HEARING RES, V158, P1, DOI 10.1016/S0378-5955(01)00296-9; Gai Y, 2008, J NEUROPHYSIOL, V99, P1077, DOI 10.1152/jn.00708.2007; Galambos R, 1943, J NEUROPHYSIOL, V6, P39, DOI 10.1152/jn.1943.6.1.39; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; JOHNSON DH, 1980, J ACOUST SOC AM, V68, P1115, DOI 10.1121/1.384982; Joris PX, 2008, NEUROSCIENCE, V154, P65, DOI 10.1016/j.neuroscience.2008.03.002; Joris PX, 2006, HEARING RES, V216, P19, DOI 10.1016/j.heares.2006.03.010; JORIS PX, 1994, J NEUROPHYSIOL, V71, P1037, DOI 10.1152/jn.1994.71.3.1037; JORIS PX, 1994, J NEUROPHYSIOL, V71, P1022, DOI 10.1152/jn.1994.71.3.1022; Kiang NYS, 1965, DISCHARGE PATTERNS S; KNOX CK, 1970, KYBERNETIK, V7, P167, DOI 10.1007/BF00289403; Kopp-Scheinpflug C, 2002, J NEUROSCI, V22, P11004; Kuenzel T, 2011, J NEUROSCI, V31, P4260, DOI 10.1523/JNEUROSCI.5433-10.2011; LAVINE RA, 1971, J NEUROPHYSIOL, V34, P467, DOI 10.1152/jn.1971.34.3.467; Louage DHG, 2005, J NEUROSCI, V25, P1560, DOI 10.1523/JNEUROSCI.4742-04.2005; Mardia KV, 2000, DIRECTIONAL STAT; Moore BCJ, 2008, JARO-J ASSOC RES OTO, V9, P399, DOI 10.1007/s10162-008-0143-x; MOREST DK, 1990, J COMP NEUROL, V300, P230, DOI 10.1002/cne.903000207; Oertel D, 2002, SPR HDB AUD, V15, P207; OSEN KK, 1969, J COMP NEUROL, V136, P453, DOI 10.1002/cne.901360407; Paolini AG, 2001, HEARING RES, V159, P101, DOI 10.1016/S0378-5955(01)00327-6; Recio A, 2000, HEARING RES, V146, P167, DOI 10.1016/S0378-5955(00)00111-8; Rhode WS, 2008, NEUROSCIENCE, V154, P87, DOI 10.1016/j.neuroscience.2008.03.013; Rhode WS, 1999, J NEUROPHYSIOL, V82, P1019, DOI 10.1152/jn.1999.82.2.1019; RHODE WS, 1986, J NEUROPHYSIOL, V56, P261, DOI 10.1152/jn.1986.56.2.261; RHODE WS, 1986, J NEUROPHYSIOL, V56, P287, DOI 10.1152/jn.1986.56.2.287; RHODE WS, 1985, HEARING RES, V18, P159, DOI 10.1016/0378-5955(85)90008-5; Rhode WS, 1998, HEARING RES, V117, P39, DOI 10.1016/S0378-5955(98)00002-1; ROSE JE, 1967, J NEUROPHYSIOL, V30, P769, DOI 10.1152/jn.1967.30.4.769; Shofner WP, 1999, J NEUROPHYSIOL, V81, P2662, DOI 10.1152/jn.1999.81.6.2662; SIEBERT WM, 1970, PR INST ELECTR ELECT, V58, P723, DOI 10.1109/PROC.1970.7727; SINEX DG, 1983, J ACOUST SOC AM, V73, P602, DOI 10.1121/1.389007; Smith PH, 2005, J COMP NEUROL, V482, P349, DOI 10.1002/cne.20407; Stein R.B, 1970, NEUROSCIENCES, P597; Stein RB, 2005, NAT REV NEUROSCI, V6, P389, DOI 10.1038/nrn1668; Temchin AN, 2005, J NEUROPHYSIOL, V93, P3635, DOI 10.1152/jn.00885.2004; Temchin AN, 2010, JARO-J ASSOC RES OTO, V11, P297, DOI 10.1007/s10162-009-0197-4; THOMAS IB, 1969, J ACOUST SOC AM, V46, P468, DOI 10.1121/1.1911712; WINTER IM, 1990, HEARING RES, V44, P161, DOI 10.1016/0378-5955(90)90078-4; Yin TCT, 2002, SPR HDB AUD, V15, P99; YOUNG ED, 1979, J ACOUST SOC AM, V66, P1381, DOI 10.1121/1.383532	47	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44286	10.1371/journal.pone.0044286	http://dx.doi.org/10.1371/journal.pone.0044286			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028514	Green Submitted, Green Published, gold			2022-12-27	WOS:000311313900017
J	Bragg, JN; Wu, JJ; Gordon, SP; Guttman, ME; Thilmony, R; Lazo, GR; Gu, YQ; Vogel, JP				Bragg, Jennifer N.; Wu, Jiajie; Gordon, Sean P.; Guttman, Mara E.; Thilmony, Roger; Lazo, Gerard R.; Gu, Yong Q.; Vogel, John P.			Generation and Characterization of the Western Regional Research Center Brachypodium T-DNA Insertional Mutant Collection	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; GENETIC-LINKAGE MAP; TAGGING LINES; FUNCTIONAL GENOMICS; MODEL SYSTEM; DISTACHYON; MUTAGENESIS; EXPRESSION; DATABASE; VECTOR	The model grass Brachypodium distachyon (Brachypodium) is an excellent system for studying the basic biology underlying traits relevant to the use of grasses as food, forage and energy crops. To add to the growing collection of Brachypodium resources available to plant scientists, we further optimized our Agrobacterium tumefaciens-mediated high-efficiency transformation method and generated 8,491 Brachypodium T-DNA lines. We used inverse PCR to sequence the DNA flanking the insertion sites in the mutants. Using these flanking sequence tags (FSTs) we were able to assign 7,389 FSTs from 4,402 T-DNA mutants to 5,285 specific insertion sites (ISs) in the Brachypodium genome. More than 29% of the assigned ISs are supported by multiple FSTs. T-DNA insertions span the entire genome with an average of 19.3 insertions/Mb. The distribution of T-DNA insertions is non-uniform with a larger number of insertions at the distal ends compared to the centromeric regions of the chromosomes. Insertions are correlated with genic regions, but are biased toward UTRs and non-coding regions within 1 kb of genes over exons and intron regions. More than 1,300 unique genes have been tagged in this population. Information about the Western Regional Research Center Brachypodium insertional mutant population is available on a searchable website (http://brachypodium.pw.usda.gov) designed to provide researchers with a means to order T-DNA lines with mutations in genes of interest.	[Bragg, Jennifer N.; Wu, Jiajie; Gordon, Sean P.; Guttman, Mara E.; Thilmony, Roger; Lazo, Gerard R.; Gu, Yong Q.; Vogel, John P.] USDA ARS, Western Reg Res Ctr, Albany, CA 94710 USA; [Bragg, Jennifer N.; Wu, Jiajie] Univ Calif Davis, Davis, CA 95616 USA	United States Department of Agriculture (USDA); University of California System; University of California Davis	Vogel, JP (corresponding author), USDA ARS, Western Reg Res Ctr, 800 Buchanan St, Albany, CA 94710 USA.	john.vogel@ars.usda.gov	Lazo, Gerard/A-8900-2009	Lazo, Gerard/0000-0002-9160-2052; Vogel, John/0000-0003-1786-2689	Office of Science (BER), US Department of Energy, Interagency Agreement [DE-AI02-07ER64452]; USDA CRIS project [5325-21000-013-00]	Office of Science (BER), US Department of Energy, Interagency Agreement(United States Department of Energy (DOE)); USDA CRIS project	This work was supported by the Office of Science (BER), US Department of Energy, Interagency Agreement No. DE-AI02-07ER64452 and by USDA CRIS project 5325-21000-013-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; An SY, 2003, PLANT PHYSIOL, V133, P2040, DOI 10.1104/pp.103.030478; BABLAK P, 1995, PLANT CELL TISS ORG, V42, P97, DOI 10.1007/BF00037687; Barrero JM, 2012, NEW PHYTOL, V193, P376, DOI 10.1111/j.1469-8137.2011.03938.x; Berkman PJ, 2012, THEOR APPL GENET, V124, P423, DOI 10.1007/s00122-011-1717-2; Bevan MW, 2010, CURR OPIN BIOTECH, V21, P211, DOI 10.1016/j.copbio.2010.03.006; Bouteille M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032319; Bragg J, 2010, HDB BIOENERGY CROP P; Brkljacic J, 2011, PLANT PHYSIOL, V157, P3, DOI 10.1104/pp.111.179531; Brown AN, 2011, G3-GENES GENOM GENET, V1, P437, DOI 10.1534/g3.111.000703; Cao SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021805; Carpita NC, 1996, ANNU REV PLANT PHYS, V47, P445, DOI 10.1146/annurev.arplant.47.1.445; Catalan P, 2012, ANN BOT; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; Christensen U, 2010, PHYTOCHEMISTRY, V71, P62, DOI 10.1016/j.phytochem.2009.09.019; Christiansen P, 2005, PLANT CELL REP, V23, P751, DOI 10.1007/s00299-004-0889-5; Draper J, 2001, PLANT PHYSIOL, V127, P1539, DOI 10.1104/pp.010196; Faricelli ME, 2010, FUNCT INTEGR GENOMIC, V10, P293, DOI 10.1007/s10142-009-0146-7; Filiz E, 2009, GENOME, V52, P876, DOI [10.1139/G09-062, 10.1139/g09-062]; Garvin DF, 2008, CROP SCI, V48, pS69, DOI 10.2135/cropsci2007.06.0332tpg; Garvin DF, 2010, GENOME, V53, P1, DOI [10.1139/G09-079, 10.1139/g09-079]; Gu YQ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-496; Guillon F, 2012, J EXP BOT, V63, P739, DOI 10.1093/jxb/err298; Guillon F, 2011, J EXP BOT, V62, P1001, DOI 10.1093/jxb/erq332; Hasterok R, 2006, GENETICS, V173, P349, DOI 10.1534/genetics.105.049726; Higgins JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010065; Huo NX, 2008, FUNCT INTEGR GENOMIC, V8, P135, DOI 10.1007/s10142-007-0062-7; Huo NX, 2011, THEOR APPL GENET, V123, P455, DOI 10.1007/s00122-011-1598-4; Huo NX, 2006, GENOME, V49, P1099, DOI 10.1139/G06-087; Jeon JS, 2000, PLANT J, V22, P561, DOI 10.1046/j.1365-313x.2000.00767.x; Jeong DH, 2006, PLANT J, V45, P123, DOI 10.1111/j.1365-313X.2005.02610.x; Jeong DH, 2002, PLANT PHYSIOL, V130, P1636, DOI 10.1104/pp.014357; Krysan PJ, 1999, PLANT CELL, V11, P2283, DOI 10.1105/tpc.11.12.2283; Kumar CS, 2005, PLANT J, V44, P879, DOI 10.1111/j.1365-313X.2005.02570.x; LAZO GR, 1991, BIO-TECHNOL, V9, P963, DOI 10.1038/nbt1091-963; Liu LZ, 2012, THEOR APPL GENET, V124, P1573, DOI 10.1007/s00122-012-1811-0; Massa AN, 2011, MOL BIOL EVOL, V28, P2537, DOI 10.1093/molbev/msr080; Mochida K, 2011, DNA RES, V18, P321, DOI 10.1093/dnares/dsr019; Mori M, 2007, PLANT MOL BIOL, V63, P847, DOI 10.1007/s11103-006-9130-y; Mur LAJ, 2011, NEW PHYTOL, V191, P334, DOI 10.1111/j.1469-8137.2011.03748.x; Peraldi A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-100; Podevin N, 2006, TRANSGENIC RES, V15, P557, DOI 10.1007/s11248-006-9003-9; Rosewarne GM, 2012, THEOR APPL GENET, V124, P1283, DOI 10.1007/s00122-012-1786-x; Ryu CH, 2004, PLANT MOL BIOL, V54, P489, DOI 10.1023/B:PLAN.0000038257.93381.05; Sonah H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021298; Thole V, 2007, PLANT PHYSIOL, V145, P1211, DOI 10.1104/pp.107.108563; Thole V, 2010, PLANT BIOTECHNOL J, V8, P734, DOI 10.1111/j.1467-7652.2010.00518.x; Trijatmiko KR, 2005, COMP ANAL DROUGHT RE; US-DOE, 2006, BREAK BIOL BARR CELL; Vain P, 2008, PLANT BIOTECHNOL J, V6, P236, DOI 10.1111/j.1467-7652.2007.00308.x; Vogel J, 2008, CURR OPIN PLANT BIOL, V11, P301, DOI 10.1016/j.pbi.2008.03.002; Vogel J, 2008, PLANT CELL REP, V27, P471, DOI 10.1007/s00299-007-0472-y; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Vogel JP, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-88; Vogel JP, 2006, PLANT CELL TISS ORG, V84, P199, DOI 10.1007/s11240-005-9023-9; Wan SY, 2009, PLANT MOL BIOL, V69, P69, DOI 10.1007/s11103-008-9406-5; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Wiebe K, 2010, THEOR APPL GENET, V121, P1047, DOI 10.1007/s00122-010-1370-1; Yordem BK, 2011, ANN BOT-LONDON, V108, P821, DOI 10.1093/aob/mcr200; Yu SM, 2007, PLANT MOL BIOL, V65, P417, DOI 10.1007/s11103-007-9232-1; Zhang J, 2007, PLANT J, V49, P947, DOI 10.1111/j.1365-313X.2006.03001.x	61	82	83	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e41916	10.1371/journal.pone.0041916	http://dx.doi.org/10.1371/journal.pone.0041916			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028431	gold, Green Submitted, Green Published			2022-12-27	WOS:000309742800002
J	Chen, SM; Lu, C; Gu, HB; Mehta, A; Li, JW; Romano, PB; Horn, D; Hooper, DC; Bazemore-Walker, CR; Block, T				Chen, Songming; Lu, Chen; Gu, Hongbo; Mehta, Anand; Li, Jianwei; Romano, Patrick B.; Horn, David; Hooper, D. Craig; Bazemore-Walker, Carthene R.; Block, Timothy			Aleuria Aurantia Lectin (AAL)-Reactive Immunoglobulin G Rapidly Appears in Sera of Animals following Antigen Exposure	PLOS ONE			English	Article							IGG GLYCOSYLATION; RHEUMATOID-ARTHRITIS; MONOCLONAL-ANTIBODY; IMPACT; SPECIFICITIES; GLYCANS	We have discovered an Aleuria Aurantia Lectin (AAL)-reactive immunoglobulin G (IgG) that naturally occurs in the circulation of rabbits and mice, following immune responses induced by various foreign antigens. AAL can specifically bind to fucose moieties on glycoproteins. However, most serum IgGs are poorly bound by AAL unless they are denatured or treated with glycosidase. In this study, using an immunogen-independent AAL-antibody microarray assay that we developed, we detected AAL-reactive IgG in the sera of all animals that had been immunized 1-2 weeks previously with various immunogens with and without adjuvants and developed immunogen-specific responses. All of these animals subsequently developed immunogen-specific immune responses. The kinetics of the production of AAL-reactive IgG in mice and rabbits were distinct from those of the immunogen-specific IgGs elicited in the same animals: they rose and fell within one to two weeks, and peaked between four to seven days after exposure, while immunogen-specific IgGs continued to rise during the same period. Mass spectrometric profiling of the Fc glycoforms of purified AAL-reactive IgGs indicates that these are mainly comprised of IgGs with core-fucosylated and either mono- or non-galactosylated Fc N-glycan structures. Our results suggest that AAL-reactive IgG could be a previously unrecognized IgG subset that is selectively produced at the onset of a humoral response.	[Chen, Songming; Lu, Chen; Horn, David; Block, Timothy] Inst Hepatitis & Virus Res, Doylestown, PA USA; [Gu, Hongbo; Bazemore-Walker, Carthene R.] Brown Univ, Dept Chem, Providence, RI 02912 USA; [Mehta, Anand; Romano, Patrick B.; Block, Timothy] Drexel Univ, Coll Med, Doylestown, PA USA; [Li, Jianwei; Hooper, D. Craig] Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA 19107 USA; [Li, Jianwei; Hooper, D. Craig] Thomas Jefferson Univ, Dept Neurol Surg, Philadelphia, PA 19107 USA	Brown University; Drexel University; Jefferson University; Jefferson University	Chen, SM (corresponding author), Inst Hepatitis & Virus Res, Doylestown, PA USA.	songming.chen@ihvr.org; Timothy.Block@DrexelMed.edu	Bazemore-Walker, Carthene/I-1879-2013	Hooper, Douglas/0000-0002-8578-5104; Bazemore-Walker, Carthene/0000-0001-5157-4440	Department of Defense [HDTRA1-07-RDINO-BAA]; NATIONAL CANCER INSTITUTE [U01CA168856, R01CA120206] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Department of Defense (HDTRA1-07-RDINO-BAA) to TB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 2007, CELLUAR MOL IMMUNOLO; Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Anthony RM, 2010, CURRENT OPINION ORGA; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Prados MB, 2011, IMMUNOL LETT, V137, P28, DOI 10.1016/j.imlet.2011.01.017; Bergsma D, 2010, MOL CELL PROTEOMICS, V9, P446, DOI 10.1074/mcp.M900418-MCP200; Chen Lu JLW, 2011, J VISUALIZE IN PRESS; Chen SM, 2007, NAT METHODS, V4, P437, DOI 10.1038/NMETH1035; Chen Songming, 2009, V520, P39, DOI 10.1007/978-1-60327-811-9_4; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Guo NX, 2005, CLIN BIOCHEM, V38, P149, DOI 10.1016/j.clinbiochem.2004.10.002; Houde D, 2010, MOL CELL PROTEOMICS, V9, P1716, DOI 10.1074/mcp.M900540-MCP200; Huhn C, 2009, PROTEOMICS, V9, P882, DOI 10.1002/pmic.200800715; Jefferis R, 1998, IMMUNOL REV, V163, P59, DOI 10.1111/j.1600-065X.1998.tb01188.x; Jung JH, 2010, ANGEW CHEM INT EDIT, V49, P5708, DOI 10.1002/anie.201001428; Kim WD, 2010, APPL MICROBIOL BIOT, V85, P535, DOI 10.1007/s00253-009-2152-z; Lastra GC, 1998, AUTOIMMUNITY, V28, P25, DOI 10.3109/08916939808993842; Lee BE, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-277; Lin S, 2010, LANCET, V375, P178, DOI 10.1016/S0140-6736(09)61791-8; Lu C, 2012, JOVE-J VIS EXP, DOI 10.3791/3791; MALHOTRA R, 1995, NAT MED, V1, P237, DOI 10.1038/nm0395-237; MATSUDA H, 1990, MOL IMMUNOL, V27, P571, DOI 10.1016/0161-5890(90)90076-C; Mehta AS, 2008, J VIROL, V82, P1259, DOI 10.1128/JVI.01600-07; Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880; Nandakumar KS, 2007, EUR J IMMUNOL, V37, P2973, DOI 10.1002/eji.200737581; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; Patel Dipa, 2010, Human Antibodies, V19, P89, DOI 10.3233/HAB-2010-0232; Peipp M, 2008, BLOOD, V112, P2390, DOI 10.1182/blood-2008-03-144600; Perdivara I, 2011, J PROTEOME RES, V10, P2969, DOI 10.1021/pr200397h; Poritz MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026047; Porter A, 2010, GLYCOBIOLOGY, V20, P369, DOI 10.1093/glycob/cwp187; Qian J, 2007, ANAL BIOCHEM, V364, P8, DOI 10.1016/j.ab.2007.01.023; Renaudineau Y, 1998, REV RHUM, V65, P429; Romano PR, 2011, BIOCHEM BIOPH RES CO, V414, P84, DOI 10.1016/j.bbrc.2011.09.027; Scherer HU, 2009, PROTEOM CLIN APPL, V3, P106, DOI 10.1002/prca.200800098; Selman MHJ, 2011, J PROTEOME RES, V10, P143, DOI 10.1021/pr1004373; Shao CX, 2009, PROTEOM CLIN APPL, V3, P923, DOI 10.1002/prca.200800245; Siberil S, 2006, CLIN IMMUNOL, V118, P170, DOI 10.1016/j.clim.2005.10.008; Tran TNN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016735; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wang J, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.010017-1, 10.1074/mcp.M110.004655, 10.1074/mcp.M111.010017]; Wuhrer M, 2007, PROTEOMICS, V7, P4070, DOI 10.1002/pmic.200700289; Wuhrer M, 2009, J PROTEOME RES, V8, P450, DOI 10.1021/pr800651j	43	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44422	10.1371/journal.pone.0044422	http://dx.doi.org/10.1371/journal.pone.0044422			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024749	Green Published, Green Submitted, gold			2022-12-27	WOS:000308860100007
J	Li, DD; Sun, T; Wu, XQ; Chen, SP; Deng, R; Jiang, S; Feng, GK; Pan, JX; Zhang, XS; Zeng, YX; Zhu, XF				Li, Dan-Dan; Sun, Ting; Wu, Xiao-Qi; Chen, Shu-Peng; Deng, Rong; Jiang, Shan; Feng, Gong-Kan; Pan, Jing-Xuan; Zhang, Xiao-Shi; Zeng, Yi-Xin; Zhu, Xiao-Feng			The Inhibition of Autophagy Sensitises Colon Cancer Cells with Wild-Type p53 but Not Mutant p53 to Topotecan Treatment	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; DEATH; MECHANISM; APOPTOSIS; SESTRIN2; DISEASE; STRESS; PHOSPHORYLATION; UPSTREAM; PATHWAYS	Background: Topotecan produces DNA damage that induces autophagy in cancer cells. In this study, sensitising topotecan to colon cancer cells with different P53 status via modulation of autophagy was examined. Methodology/Principal Findings: The DNA damage induced by topotecan treatment resulted in cytoprotective autophagy in colon cancer cells with wild-type p53. However, in cells with mutant p53 or p53 knockout, treatment with topotecan induced autophagy-associated cell death. In wild-type p53 colon cancer cells, topotecan treatment activated p53, upregulated the expression of sestrin 2, induced the phosphorylation of the AMPKa subunit at Thr172, and inhibited the mTORC1 pathway. Furthermore, the inhibition of autophagy enhanced the anti-tumour effect of topotecan treatment in wild-type p53 colon cancer cells but alleviated the anti-tumour effect of topotecan treatment in p53 knockout cells in vivo. Conclusions/Significance: These results imply that the wild-type p53-dependent induction of cytoprotective autophagy is one of the cellular responses that determines the cellular sensitivity to the DNA-damaging drug topotecan. Therefore, our study provides a potential therapeutic strategy that utilises a combination of DNA-damaging agents and autophagy inhibitors for the treatment of colon cancer with wild-type p53.	[Li, Dan-Dan; Sun, Ting; Wu, Xiao-Qi; Chen, Shu-Peng; Deng, Rong; Jiang, Shan; Feng, Gong-Kan; Zhang, Xiao-Shi; Zeng, Yi-Xin; Zhu, Xiao-Feng] Sun Yat Sen Univ, State Key Lab Oncol S China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Pan, Jing-Xuan] Sun Yat Sen Univ, Dept Pathophysiol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Li, DD (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol S China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	zhuxfeng@mail.sysu.edu.cn			National Natural Science Foundation of China [30873085, 30972882, 81101670]; Major Science and Technology Project of the National Basic Research Program (973 Program) of China [2011CB504300]; Natural Science Foundation of Guangdong in China [S2011020002759]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Science and Technology Project of the National Basic Research Program (973 Program) of China(National Basic Research Program of China); Natural Science Foundation of Guangdong in China	This work was supported by grants from the National Natural Science Foundation of China (30873085, 30972882, 81101670) (http://www.nsfc.gov.cn/Portal0/default106.htm), the Major Science and Technology Project of the National Basic Research Program (973 Program) of China (2011CB504300) and the Natural Science Foundation of Guangdong in China (S2011020002759). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bareford MD, 2011, CANCER RES, V71, P4955, DOI 10.1158/0008-5472.CAN-11-0898; Bialik S, 2008, ADV EXP MED BIOL, V615, P177, DOI 10.1007/978-1-4020-6554-5_9; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Crighton D, 2007, AUTOPHAGY, V3, P72, DOI 10.4161/auto.3438; D'Amelio M, 2009, CELL CYCLE, V8, P1467; Facompre M, 2002, MOL PHARMACOL, V62, P1215, DOI 10.1124/mol.62.5.1215; Florey O, 2011, NAT CELL BIOL; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Grander D, 2010, FUTURE MED CHEM, V2, P285, DOI [10.4155/fmc.09.155, 10.4155/FMC.09.155]; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Herrero-Martin G, 2009, EMBO J, V28, P677, DOI 10.1038/emboj.2009.8; Hoyer-Hansen M, 2007, AUTOPHAGY, V3, P381, DOI 10.4161/auto.4240; Jiang H, 2007, J NATL CANCER I, V99, P1410, DOI 10.1093/jnci/djm102; Kim HS, 2008, J BIOL CHEM, V283, P3731, DOI 10.1074/jbc.M704432200; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li DD, 2009, ONCOGENE, V28, P886, DOI 10.1038/onc.2008.441; Li DD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012176; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Liu B, 2010, ACTA PHARMACOL SIN, V31, P1154, DOI 10.1038/aps.2010.118; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maiuri MC, 2009, CELL CYCLE, V8, P1571, DOI 10.4161/cc.8.10.8498; Marino ML, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.67; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mizushima N, 2005, CELL DEATH DIFFER, V12, P1535, DOI 10.1038/sj.cdd.4401728; Mujumdar N, 2010, AUTOPHAGY, V6, P997, DOI 10.4161/auto.6.7.13334; Murray-Zmijewski F, 2008, NAT REV MOL CELL BIO, V9, P702, DOI 10.1038/nrm2451; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Sanchez AM, 2011, J CELL BIOCH; Scherz-Shouval R, P NATL ACAD SCI US, V107, P18511; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Szigeti A, 2010, J BIOL CHEM, V285, P2140, DOI 10.1074/jbc.M109.015222; Tang Y, 2012, MOL PHARM; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Todde V, 2009, BBA-MOL BASIS DIS, V1792, P3, DOI 10.1016/j.bbadis.2008.10.016; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; White EJ, 2011, AM J CANCER RES, V1, P362; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Wu JX, 2006, BIOCHEM BIOPH RES CO, V339, P437, DOI 10.1016/j.bbrc.2005.10.211; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Zhou WJ, 2009, MOL CANCER THER, V8, P3203, DOI 10.1158/1535-7163.MCT-09-0244	50	52	52	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45058	10.1371/journal.pone.0045058	http://dx.doi.org/10.1371/journal.pone.0045058			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024792	gold, Green Published, Green Submitted			2022-12-27	WOS:000308860100050
J	Moore, SM; Monaghan, A; Griffith, KS; Apangu, T; Mead, PS; Eisen, RJ				Moore, Sean M.; Monaghan, Andrew; Griffith, Kevin S.; Apangu, Titus; Mead, Paul S.; Eisen, Rebecca J.			Improvement of Disease Prediction and Modeling through the Use of Meteorological Ensembles: Human Plague in Uganda	PLOS ONE			English	Article							WEST NILE REGION; GLOBAL PRECIPITATION; USAMBARA MOUNTAINS; CLIMATE-CHANGE; RAINFALL; PATTERNS; OUTBREAKS; DYNAMICS; RODENTS; EPIDEMIOLOGY	Climate and weather influence the occurrence, distribution, and incidence of infectious diseases, particularly those caused by vector-borne or zoonotic pathogens. Thus, models based on meteorological data have helped predict when and where human cases are most likely to occur. Such knowledge aids in targeting limited prevention and control resources and may ultimately reduce the burden of diseases. Paradoxically, localities where such models could yield the greatest benefits, such as tropical regions where morbidity and mortality caused by vector-borne diseases is greatest, often lack high-quality in situ local meteorological data. Satellite- and model-based gridded climate datasets can be used to approximate local meteorological conditions in data-sparse regions, however their accuracy varies. Here we investigate how the selection of a particular dataset can influence the outcomes of disease forecasting models. Our model system focuses on plague (Yersinia pestis infection) in the West Nile region of Uganda. The majority of recent human cases have been reported from East Africa and Madagascar, where meteorological observations are sparse and topography yields complex weather patterns. Using an ensemble of meteorological datasets and model-averaging techniques we find that the number of suspected cases in the West Nile region was negatively associated with dry season rainfall (December-February) and positively with rainfall prior to the plague season. We demonstrate that ensembles of available meteorological datasets can be used to quantify climatic uncertainty and minimize its impacts on infectious disease models. These methods are particularly valuable in regions with sparse observational networks and high morbidity and mortality from vector-borne diseases.	[Moore, Sean M.; Monaghan, Andrew] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Moore, Sean M.; Griffith, Kevin S.; Mead, Paul S.; Eisen, Rebecca J.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA; [Apangu, Titus] Uganda Virus Res Inst, Arua, Uganda	National Center Atmospheric Research (NCAR) - USA; Centers for Disease Control & Prevention - USA	Moore, SM (corresponding author), Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA.	smoore@ucar.edu		Monaghan, Andrew/0000-0002-8170-2359	Centers for Disease Control and Prevention; United States Agency for International Development through an Interagency Agreement; National Science Foundation; National Center for Atmospheric Research (NCAR); U.S. National Science Foundation; Div Atmospheric & Geospace Sciences [0964768] Funding Source: National Science Foundation	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); United States Agency for International Development through an Interagency Agreement(United States Agency for International Development (USAID)); National Science Foundation(National Science Foundation (NSF)); National Center for Atmospheric Research (NCAR)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); U.S. National Science Foundation(National Science Foundation (NSF)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was funded by the Centers for Disease Control and Prevention (www.cdc.gov) and the United States Agency for International Development (www.usaid.gov) through an Interagency Agreement with the National Science Foundation (www.nsf.gov). National Center for Atmospheric Research (NCAR) is funded by the U.S. National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatre G, 2009, AM J TROP MED HYG, V81, P718, DOI 10.4269/ajtmh.2009.09-0104; [Anonymous], 1999, WALKERS MAMMALS WORL; Anyamba A, 2009, P NATL ACAD SCI USA, V106, P955, DOI 10.1073/pnas.0806490106; Ari TB, 2010, AM J TROP MED HYG, V83, P624, DOI 10.4269/ajtmh.2010.09-0775; Asadullah A, 2008, HYDROLOG SCI J, V53, P1137, DOI 10.1623/hysj.53.6.1137; Ben Ari T, 2008, BIOL LETTERS, V4, P737, DOI 10.1098/rsbl.2008.0363; Brown HE, 2010, AM J TROP MED HYG, V82, P95, DOI 10.4269/ajtmh.2010.09-0247; CAVANAUGH D C, 1972, Journal of Wildlife Diseases, V8, P85; Chanteau S, 2000, MICROBES INFECT, V2, P25, DOI 10.1016/S1286-4579(00)00289-6; CROOK LD, 1992, ARCH INTERN MED, V152, P1253, DOI 10.1001/archinte.152.6.1253; Davis D. H. S., 1953, Bulletin of the World Health Organization, V9, P665; DAVIS DHS, 1968, T ROY SOC TROP MED H, V62, P838, DOI 10.1016/0035-9203(68)90013-8; Davis S, 2008, NATURE, V454, P634, DOI 10.1038/nature07053; Davis S, 2004, SCIENCE, V304, P736, DOI 10.1126/science.1095854; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Dennis D. T., 2003, INFECT DIS, V2, P1641; Dinku T, 2007, INT J REMOTE SENS, V28, P1503, DOI 10.1080/01431160600954688; Duplantier JM, 2005, VET RES, V36, P437, DOI 10.1051/vetres:2005007; Eisen L, 2011, ANNU REV ENTOMOL, V56, P41, DOI 10.1146/annurev-ento-120709-144847; Eisen RJ, 2010, AM J TROP MED HYG, V82, P904, DOI 10.4269/ajtmh.2010.09-0737; Eisen RJ, 2009, VET RES, V40, DOI 10.1051/vetres:2008039; Enscore RE, 2002, AM J TROP MED HYG, V66, P186, DOI 10.4269/ajtmh.2002.66.186; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Gage KL, 2008, AM J PREV MED, V35, P436, DOI 10.1016/j.amepre.2008.08.030; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; Gneiting T, 2005, SCIENCE, V310, P248, DOI 10.1126/science.1115255; Gratz N., 1999, PLAGUE MANUAL EPIDEM, V6, P63; Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012; Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326; HEISCH RB, 1953, T ROY SOC TROP MED H, V47, P503, DOI 10.1016/S0035-9203(53)80004-0; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holt AC, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-38; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Huffman GJ, 2001, J HYDROMETEOROL, V2, P36, DOI 10.1175/1525-7541(2001)002<0036:GPAODD>2.0.CO;2; Hughes DA, 2006, J HYDROL, V327, P399, DOI 10.1016/j.jhydrol.2005.11.041; Johansson MA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000168; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Joyce RJ, 2004, J HYDROMETEOROL, V5, P487, DOI 10.1175/1525-7541(2004)005<0487:CAMTPG>2.0.CO;2; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI 10.1175/Bams-83-11-1631; Kausrud KL, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-112; KILONZO BS, 1992, ACTA TROP, V50, P323, DOI 10.1016/0001-706X(92)90067-8; Krishnamurti TN, 2000, J CLIMATE, V13, P4196, DOI 10.1175/1520-0442(2000)013<4196:MEFFWA>2.0.CO;2; Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397; Love TB, 2004, 20 YEAR DAILY AFRICA; MacMillan K, 2012, AM J TROP MED HYG, V86, P514, DOI 10.4269/ajtmh.2012.11-0569; MacMillan K, 2011, AM J TROP MED HYG, V84, P435, DOI 10.4269/ajtmh.2011.10-0571; Migliani R, 2006, TROP MED INT HEALTH, V11, P1228, DOI 10.1111/j.1365-3156.2006.01677.x; Monaghan AJ, 2012, J APPL METEOROL CLIM, V51, P1201, DOI 10.1175/JAMC-D-11-0195.1; Msangi A.S., 1975, University Sci J Dar-es-Salaam, V1, P8; Murphy JM, 2004, NATURE, V430, P768, DOI 10.1038/nature02771; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Myneni RB, 1996, GEOPHYS RES LETT, V23, P729, DOI 10.1029/96GL00266; Neerinckx S, 2010, T ROY SOC TROP MED H, V104, P97, DOI 10.1016/j.trstmh.2009.07.028; Nicholson SE, 1997, INT J CLIMATOL, V17, P345, DOI 10.1002/(SICI)1097-0088(19970330)17:4<345::AID-JOC127>3.0.CO;2-3; NJUNWA KJ, 1989, MED VET ENTOMOL, V3, P17, DOI 10.1111/j.1365-2915.1989.tb00469.x; OLSON WP, 1969, AM J TROP MED HYG, V18, P621, DOI 10.4269/ajtmh.1969.18.621; Orochi-Orach, 2002, PLAGUE OUTBREAKS GEN; Parmenter RR, 1999, AM J TROP MED HYG, V61, P814, DOI 10.4269/ajtmh.1999.61.814; Pascual M, 2008, P ROY SOC B-BIOL SCI, V275, P123, DOI 10.1098/rspb.2007.1068; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Pham HV, 2009, INT J EPIDEMIOL, V38, P1634, DOI 10.1093/ije/dyp244; Randall DA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P589; Reichler T, 2008, B AM METEOROL SOC, V89, P303, DOI 10.1175/BAMS-89-3-303; ROPELEWSKI CF, 1987, MON WEATHER REV, V115, P1606, DOI 10.1175/1520-0493(1987)115<1606:GARSPP>2.0.CO;2; Sachs J.D., 2001, TROPICAL UNDERDEVELO; Salkeld DJ, 2010, P NATL ACAD SCI USA, V107, P14247, DOI 10.1073/pnas.1002826107; Samia NI, 2011, P NATL ACAD SCI USA, V108, P14527, DOI 10.1073/pnas.1015946108; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Stapp P, 2004, FRONT ECOL ENVIRON, V2, P235, DOI 10.2307/3868263; Stenseth NC, 2006, P NATL ACAD SCI USA, V103, P13110, DOI 10.1073/pnas.0602447103; VELIMIROVIC B, 1969, Z TROPENMED PARASIT, V20, P373; WHO (World Health Organization), 2005, WKLY EPIDEMIOL REC, V80, P433; Winters AM, 2009, AM J TROP MED HYG, V80, P1014, DOI 10.4269/ajtmh.2009.80.1014; World Health Organization, 2010, Weekly Epidemiological Record, V85, P37; Xu L, 2011, P NATL ACAD SCI USA, V108, P10214, DOI 10.1073/pnas.1019486108	75	37	38	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44431	10.1371/journal.pone.0044431	http://dx.doi.org/10.1371/journal.pone.0044431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024750	Green Submitted, gold, Green Published			2022-12-27	WOS:000308860100008
J	Ben-Lulu, S; Pollak, Y; Mogilner, J; Bejar, J; Coran, AG; Sukhotnik, I				Ben-Lulu, Shani; Pollak, Yulia; Mogilner, Jorge; Bejar, Jacob; Coran, Arnold G.; Sukhotnik, Igor			Dietary Transforming Growth Factor-Beta 2 (TGF-beta 2) Supplementation Reduces Methotrexate-Induced Intestinal Mucosal Injury in a Rat	PLOS ONE			English	Article							APOPTOSIS; CELLS; PROLIFERATION; CHEMOTHERAPY; EXPRESSION; MUCOSITIS	Background/Aims: Dietary supplementation with transforming growth factor-beta (TGF-beta) has been proven to minimize intestinal damage and facilitate regeneration after mucosal injury. In the present study, we evaluated the effects of oral TGF-beta 2 supplementation on intestinal structural changes, enterocyte proliferation and apoptosis following methotrexate (MTX)-induced intestinal damage in a rat and in a cell culture model. Methods: Caco-2 cells were treated with MTX and were incubated with increasing concentrations of TGF-beta 2. Cell apoptosis was assessed using FACS analysis by annexin staining and cell viability was monitored using Trypan Blue assay. Male rats were divided into four experimental groups: Control rats, CONTR-TGF-beta rats were treated with diet enriched with TGF-beta 2, MTX rats were treated with a single dose of methotrexate, and MTX-TGF-beta rats were treated with diet enriched with TGF-b beta 2. Intestinal mucosal damage, mucosal structural changes, enterocyte proliferation and enterocyte apoptosis were determined at sacrifice. Real Time PCR and Western blot were used to determine bax and bcl-2 mRNA, p-ERK, beta-catenin, IL-1B and bax protein expression. Results: Treatment of MTX-pretreated Caco-2 cells with TGF-B2 resulted in increased cell viability and decreased cell apoptosis. Treatment of MTX-rats with TGF-beta 2 resulted in a significant increase in bowel and mucosal weight, DNA and protein content, villus-height (ileum), crypt-depth (jejunum), decreased intestinal-injury score, decreased level of apoptosis and increased cell proliferation in jejunum and ileum compared to the untreated MTX group. MTX-TGF-beta 2 rats demonstrated a lower bax mRNA and protein levels as well as increased bcl-2 mRNA levels in jejunum and ileum compared to MTX group. Treatment with TGF-beta 2 also led to increased pERK, IL-1B and beta-catenin protein levels in intestinal mucosa. Conclusions: Treatment with TGF-beta 2 prevents mucosal-injury, enhances p-ERK and beta-catenin induced enterocyte proliferation, inhibits enterocyte apoptosis and improves intestinal recovery following MTX-induced intestinal-mucositis in rats.	[Ben-Lulu, Shani; Pollak, Yulia; Sukhotnik, Igor] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Lab Intestinal Adaptat & Recovery, IL-31096 Haifa, Israel; [Mogilner, Jorge; Sukhotnik, Igor] Bnai Zion Med Ctr, Dept Pediat Surg, Haifa, Israel; [Bejar, Jacob] Bnai Zion Med Ctr, Dept Pathol, Haifa, Israel; [Coran, Arnold G.] Univ Michigan, CS Mott Childrens Hosp, Pediat Surg Sect, Ann Arbor, MI 48109 USA; [Coran, Arnold G.] Univ Michigan, Sch Med, Ann Arbor, MI USA	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Bnai Zion Medical Center; Bnai Zion Medical Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ben-Lulu, S (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Lab Intestinal Adaptat & Recovery, POB 9649, IL-31096 Haifa, Israel.	igor-dr@internet-zahav.net			Israeli Ministry of Health [3/6164]	Israeli Ministry of Health	This work was supported by a research grant from Israeli Ministry of Health No 3/6164 from 01/06/10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALISON MR, 1994, CELL BIOL INT, V18, P1, DOI 10.1006/cbir.1994.1001; Biasi F, 2006, FREE RADICAL BIO MED, V41, P443, DOI 10.1016/j.freeradbiomed.2006.04.005; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Dignass AU, 2001, EUR J GASTROEN HEPAT, V13, P763, DOI 10.1097/00042737-200107000-00002; Dufour C, 2008, AM J PHYSIOL-ENDOC M, V294, pE794, DOI 10.1152/ajpendo.00791.2007; Elvers M, 2005, MECH DEVELOP, V122, P587, DOI 10.1016/j.mod.2004.10.012; Genestier L, 1998, J CLIN INVEST, V102, P322, DOI 10.1172/JCI2676; GOLDMAN ID, 1985, PHARMACOL THERAPEUT, V28, P77, DOI 10.1016/0163-7258(85)90083-X; GORDON JI, 1994, CURR OPIN CELL BIOL, V6, P795, DOI 10.1016/0955-0674(94)90047-7; Harsha WTF, 2006, J PEDIATR GASTR NUTR, V42, P53, DOI 10.1097/01.mpg.0000189136.06151.7a; Huang X, 2011, J DENT RES, V90, P981, DOI 10.1177/0022034511408613; Keefe DMK, 2004, SUPPORT CARE CANCER, V12, P6, DOI 10.1007/s00520-003-0550-9; Keefe DMK, 2000, GUT, V47, P632, DOI 10.1136/gut.47.5.632; Kim YJ, 2009, EXPERT OPIN DRUG SAF, V8, P451, DOI 10.1517/14740330903066734; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; Kol TC, 1998, ONCOGENE, V16, P3445; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Mei J, 2005, BRIT J NUTR, V93, P37, DOI 10.1079/BJN20041302; Naidu MUR, 2004, NEOPLASIA, V6, P423, DOI 10.1593/neo.04169; Nakayama GR, 1997, J IMMUNOL METHODS, V204, P205, DOI 10.1016/S0022-1759(97)00043-4; PARK PO, 1990, SURGERY, V107, P574; Pritchard DM, 1998, CANCER RES, V58, P5453; Sancho P, 2004, WASTE MANAGE, V24, P919, DOI 10.1016/j.wasman.2004.04.003; Savion S, 2009, TOXICOL IN VITRO, V23, P1062, DOI 10.1016/j.tiv.2009.06.004; Singla DK, 2011, AM J PHYSIOL-HEART C, V300, pH1442, DOI 10.1152/ajpheart.00917.2010; Sonis ST, 2004, CANCER-AM CANCER SOC, V100, P1995, DOI 10.1002/cncr.20162; Sonis ST, 2004, NAT REV CANCER, V4, P277, DOI 10.1038/nrc1318; Sonis Stephen T., 1993, P2381; van de Wetering M, 2002, CELL, V109, pS13, DOI 10.1016/S0092-8674(02)00709-2; Verburg M, 2000, AM J PHYSIOL-GASTR L, V279, pG1037, DOI 10.1152/ajpgi.2000.279.5.G1037; Vizio B, 2005, BIOFACTORS, V24, P237, DOI 10.1002/biof.5520240128; Walia B, 2003, FASEB J, V17, P2130, DOI 10.1096/fj.02-1211fje; Winesett MP, 1996, CARCINOGENESIS, V17, P989, DOI 10.1093/carcin/17.5.989; Zanetti D., 2003, Molecular Aspects of Medicine, V24, P273, DOI 10.1016/S0098-2997(03)00022-0; Zhang MF, 1999, PEDIATR RES, V46, P657, DOI 10.1203/00006450-199912000-00017	35	27	27	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45221	10.1371/journal.pone.0045221	http://dx.doi.org/10.1371/journal.pone.0045221			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984629	Green Published, Green Submitted, gold			2022-12-27	WOS:000308738500127
J	Blajecka, K; Marinov, M; Leitner, L; Uth, K; Posern, G; Arcaro, A				Blajecka, Karolina; Marinov, Marin; Leitner, Laura; Uth, Kristin; Posern, Guido; Arcaro, Alexandre			Phosphoinositide 3-Kinase C2 beta Regulates RhoA and the Actin Cytoskeleton through an Interaction with Dbl	PLOS ONE			English	Article							CELL-MIGRATION; DOWN-REGULATION; ALPHA-ISOFORM; C2 DOMAIN; ACTIVATION; GTPASES; GROWTH; FAMILY; RAS; TRANSCRIPTION	The regulation of cell morphology is a dynamic process under the control of multiple protein complexes acting in a coordinated manner. Phosphoinositide 3-kinases (PI3K) and their lipid products are widely involved in cytoskeletal regulation by interacting with proteins regulating RhoGTPases. Class II PI3K isoforms have been implicated in the regulation of the actin cytoskeleton, although their exact role and mechanism of action remain to be established. In this report, we have identified Dbl, a Rho family guanine nucleotide exchange factor (RhoGEF) as an interaction partner of PI3KC2 beta. Dbl was co-immunoprecipitated with PI3KC2 beta in NIH3T3 cells and cancer cell lines. Over-expression of Class II phosphoinositide 3-kinase PI3KC2 beta in NIH3T3 fibroblasts led to increased stress fibres formation and cell spreading. Accordingly, we found high basal RhoA activity and increased serum response factor (SRF) activation downstream of RhoA upon serum stimulation. In contrast, the dominant-negative form of PI3KC2 beta strongly reduced cell spreading and stress fibres formation, as well as SRF response. Platelet-derived growth factor (PDGF) stimulation of wild-type PI3KC2 beta over-expressing NIH3T3 cells strongly increased Rac and c-Jun N-terminal kinase (JNK) activation, but failed to show similar effect in the cells with the dominant-negative enzyme. Interestingly, epidermal growth factor (EGF) and PDGF stimulation led to increased extracellular signal-regulated kinase (Erk) and Akt pathway activation in cells with elevated wild-type PI3KC2 beta expression. Furthermore, increased expression of PI3KC2 beta protected NIH3T3 from detachment-dependent death (anoikis) in a RhoA-dependent manner. Taken together, these findings suggest that PI3KC2 beta modulates the cell morphology and survival through a specific interaction with Dbl and the activation of RhoA.	[Blajecka, Karolina; Uth, Kristin; Arcaro, Alexandre] Univ Bern, Dept Clin Res, Bern, Switzerland; [Marinov, Marin] Univ Childrens Hosp Zurich, Dept Oncol, Zurich, Switzerland; [Leitner, Laura; Posern, Guido] Max Planck Inst Biochem, Dept Mol Biol, AG Regulat Gene Express, D-82152 Martinsried, Germany	University of Bern; University Children's Hospital Zurich; Max Planck Society	Blajecka, K (corresponding author), Univ Bern, Dept Clin Res, Bern, Switzerland.	alexandre.arcaro@dkf.unibe.ch	Arcaro, Alexandre/G-1711-2010	Arcaro, Alexandre/0000-0001-9107-2947	Swiss National Science Foundation [3100A0-105321, 31003A-120294]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by the Swiss National Science Foundation (grants 3100A0-105321 and 31003A-120294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcaro A, 2002, EMBO J, V21, P5097, DOI 10.1093/emboj/cdf512; Arcaro A, 2000, MOL CELL BIOL, V20, P3817, DOI 10.1128/MCB.20.11.3817-3830.2000; Arcaro A, 1998, J BIOL CHEM, V273, P33082, DOI 10.1074/jbc.273.49.33082; Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Bi F, 2001, MOL CELL BIOL, V21, P1463, DOI 10.1128/MCB.21.5.1463-1474.2001; Broome MA, 1996, J BIOL CHEM, V271, P16798, DOI 10.1074/jbc.271.28.16798; Brown RA, 1999, J BIOL CHEM, V274, P14529, DOI 10.1074/jbc.274.21.14529; Buchsbaum RJ, 2007, J CELL SCI, V120, P1149, DOI 10.1242/jcs.03428; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Cain RJ, 2009, BIOL CELL, V101, P13, DOI 10.1042/BC20080079; Coleman ML, 2002, CELL DEATH DIFFER, V9, P493, DOI 10.1038/sj.cdd.4400987; Das M, 2007, MOL CELL BIOL, V27, P7906, DOI 10.1128/MCB.01369-07; DiNitto Jonathan P, 2003, Sci STKE, V2003, pre16, DOI 10.1126/stke.2132003re16; Domin J, 2005, J CELL PHYSIOL, V205, P452, DOI 10.1002/jcp.20478; Domin J, 1997, BIOCHEM J, V326, P139, DOI 10.1042/bj3260139; Engelman JA, 1998, AM J HUM GENET, V63, P1578, DOI 10.1086/302172; Engelman JA, 1997, J BIOL CHEM, V272, P16374, DOI 10.1074/jbc.272.26.16374; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; EVA A, 1985, NATURE, V316, P273, DOI 10.1038/316273a0; EVA A, 1987, ONCOGENE, V1, P355; Falasca M, 2007, J BIOL CHEM, V282, P28226, DOI 10.1074/jbc.M704357200; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Gaidarov I, 2005, J BIOL CHEM, V280, P40766, DOI 10.1074/jbc.M507731200; Gaidarov I, 2001, MOL CELL, V7, P443, DOI 10.1016/S1097-2765(01)00191-5; Galbiati F, 1998, EMBO J, V17, P6633, DOI 10.1093/emboj/17.22.6633; Galisteo ML, 2006, P NATL ACAD SCI USA, V103, P9796, DOI 10.1073/pnas.0603714103; GRAZIANI G, 1989, ONCOGENE, V4, P823; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Innocenti M, 2003, J CELL BIOL, V160, P17, DOI 10.1083/jcb.200206079; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jiang K, 2004, MOL CELL BIOL, V24, P5565, DOI 10.1128/MCB.24.12.5565-5576.2004; Kamynina E, 2007, MOL CELL BIOL, V27, P1809, DOI 10.1128/MCB.01051-06; Kato J, 2000, BIOCHEM BIOPH RES CO, V268, P141, DOI 10.1006/bbrc.2000.2106; Kato-Stankiewicz J, 2001, BIOCHEM BIOPH RES CO, V284, P470, DOI 10.1006/bbrc.2001.5004; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Katso RM, 2006, MOL BIOL CELL, V17, P3729, DOI 10.1091/mbc.E05-11-1083; Kauppinen KP, 2005, J BIOL CHEM, V280, P21638, DOI 10.1074/jbc.M413984200; Liu Z, 2011, J INT MED RES, V39, P1319, DOI 10.1177/147323001103900419; Maffucci T, 2005, J CELL BIOL, V169, P789, DOI 10.1083/jcb.200408005; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; MOOLENAAR WH, 1995, J BIOL CHEM, V270, P12949, DOI 10.1074/jbc.270.22.12949; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; PERONA R, 1993, ONCOGENE, V8, P1285; Posern G, 2002, MOL BIOL CELL, V13, P4167, DOI 10.1091/mbc.02-05-0068; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; QIU RG, 1995, P NATL ACAD SCI USA, V92, P11781, DOI 10.1073/pnas.92.25.11781; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; RON D, 1988, EMBO J, V7, P2465, DOI 10.1002/j.1460-2075.1988.tb03093.x; RON D, 1989, ONCOGENE, V4, P1067; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Russo C, 2001, J BIOL CHEM, V276, P19524, DOI 10.1074/jbc.M009742200; Sasaki T, 2002, J BIOCHEM, V131, P495, DOI 10.1093/oxfordjournals.jbchem.a003126; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Scita G, 2000, EMBO J, V19, P2393, DOI 10.1093/emboj/19.11.2393; Seok YM, 2010, HYPERTENSION, V56, P934, DOI 10.1161/HYPERTENSIONAHA.110.160853; van den Heuvel APJ, 2005, BIOCHEM J, V385, P795, DOI 10.1042/BJ20041449; Velichkova M, 2010, J CELL BIOL, V190, P407, DOI 10.1083/jcb.200911020; Wheeler M, 2001, MOL CELL BIOL, V21, P6660, DOI 10.1128/MCB.21.19.6660-6667.2001; Whitehead IP, 1997, BBA-REV CANCER, V1332, pF1, DOI 10.1016/S0304-419X(96)00040-6; Wymann MP, 2003, BIOCHEM SOC T, V31, P275, DOI 10.1042/bst0310275; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9	63	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44945	10.1371/journal.pone.0044945	http://dx.doi.org/10.1371/journal.pone.0044945			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984590	Green Published, Green Submitted, gold			2022-12-27	WOS:000308738500097
J	Hirsch, G; Lavoie-Lamoureux, A; Beauchamp, G; Lavoie, JP				Hirsch, Gaelle; Lavoie-Lamoureux, Anouk; Beauchamp, Guy; Lavoie, Jean-Pierre			Neutrophils Are Not Less Sensitive Than Other Blood Leukocytes to the Genomic Effects of Glucocorticoids	PLOS ONE			English	Article							RECURRENT AIRWAY-OBSTRUCTION; SEVERE ASTHMA; GLUTAMINE-SYNTHETASE; RECEPTOR ANTAGONIST; EQUINE NEUTROPHILS; CELL-DEATH; L-SELECTIN; DEXAMETHASONE; EXPRESSION; HORSES	Background: Neutrophils are generally considered less responsive to glucocorticoids compared to other inflammatory cells. The reported increase in human neutrophil survival mediated by these drugs partly supports this assertion. However, it was recently shown that dexamethasone exerts potent anti-inflammatory effects in equine peripheral blood neutrophils. Few comparative studies of glucocorticoid effects in neutrophils and other leukocytes have been reported and a relative insensitivity of neutrophils to these drugs could not be ruled out. Objective: We assessed glucocorticoid-responsiveness in equine and human peripheral blood neutrophils and neutrophil-depleted leukocytes. Methods: Blood neutrophils and neutrophil-depleted leukocytes were isolated from 6 healthy horses and 4 human healthy subjects. Cells were incubated for 5 h with or without LPS (100 ng/mL) alone or combined with hydrocortisone, prednisolone or dexamethasone (10(-8) M and 10(-6) M). IL-1 beta, TNF-alpha, IL-8, glutamine synthetase and GR-alpha mRNA expression was quantified by qPCR. Equine neutrophils were also incubated for 20 h with or without the three glucocorticoids and cell survival was assessed by flow cytometry and light microscopy on cytospin preparations. Results: We found that glucocorticoids down-regulated LPS-induced pro-inflammatory mRNA expression in both cell populations and species. These drugs also significantly increased glutamine synthetase gene expression in both equine cell populations. The magnitude of glucocorticoid response between cell populations was generally similar in both species. We also showed that dexamethasone had a comparable inhibitory effect on pro-inflammatory gene expression in both human and equine neutrophils. As reported in other species, glucocorticoids significantly increase the survival in equine neutrophils. Conclusions: Glucocorticoids exert genomic effects of similar magnitude on neutrophils and on other blood leukocytes. We speculate that the poor response to glucocorticoids observed in some chronic neutrophilic diseases such as severe asthma or COPD is not explained by a relative lack of inhibition of these drugs on pro-inflammatory cytokines expression in neutrophils.	[Hirsch, Gaelle; Lavoie-Lamoureux, Anouk; Beauchamp, Guy; Lavoie, Jean-Pierre] Univ Montreal, Fac Vet Med, Dept Clin Sci, St Hyacinthe, PQ J2S 7C6, Canada	Universite de Montreal	Hirsch, G (corresponding author), Univ Montreal, Fac Vet Med, Dept Clin Sci, St Hyacinthe, PQ J2S 7C6, Canada.	jean-pierre.lavoie@umontreal.ca			Natural Sciences and Engineering Research Council of Canada [MOP-94848]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding was provided by the Natural Sciences and Engineering Research Council of Canada (grant # MOP-94848). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mokdad M, 1998, INFLAMMATION, V22, P145, DOI 10.1023/A:1022383922039; Barnes PJ, 2007, J ALLERGY CLIN IMMUN, V119, P1055, DOI 10.1016/j.jaci.2007.01.015; Barnes PJ, 2011, BRIT J PHARMACOL, V163, P29, DOI 10.1111/j.1476-5381.2010.01199.x; Barnes PJ, 2010, J STEROID BIOCHEM, V120, P76, DOI 10.1016/j.jsbmb.2010.02.018; Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; BERCZI I, 1966, CAN J MICROBIOL, V12, P1070, DOI 10.1139/m66-143; BURROWS GE, 1981, CAN J COMP MED, V45, P207; BURTON JL, 1995, J LEUKOCYTE BIOL, V57, P317, DOI 10.1002/jlb.57.2.317; Buttgereit F, 1999, BIOCHEM PHARMACOL, V58, P363, DOI 10.1016/S0006-2952(99)00090-8; CASSATELLA MA, 1995, IMMUNOL TODAY, V16, P21, DOI 10.1016/0167-5699(95)80066-2; Cassatella MA, 1999, ADV IMMUNOL, V73, P369, DOI 10.1016/S0065-2776(08)60791-9; Chandrasekhar S, 1999, AM J PHYSIOL-LUNG C, V276, pL319, DOI 10.1152/ajplung.1999.276.2.L319; Cohen, 2007, ORPHANET J RARE DIS; COLOTTA F, 1992, BLOOD, V80, P2012; COX G, 1995, J IMMUNOL, V154, P4719; Czock D, 2005, CLIN PHARMACOKINET, V44, P61, DOI 10.2165/00003088-200544010-00003; Dandona P, 1999, CLIN PHARMACOL THER, V66, P58, DOI 10.1016/S0009-9236(99)70054-8; Fialkow L, 2006, CRIT CARE, V10, DOI 10.1186/cc5090; Filep JG, 2009, J CELL BIOCHEM, V108, P1039, DOI 10.1002/jcb.22351; Gaunitz F, 2002, BIOCHEM BIOPH RES CO, V296, P1026, DOI 10.1016/S0006-291X(02)02044-2; Grady JA, 2010, AM J VET RES, V71, P831, DOI 10.2460/ajvr.71.7.831; Grossmann C, 2004, EUR J ENDOCRINOL, V151, P397, DOI 10.1530/eje.0.1510397; HASLETT C, 1985, AM J PATHOL, V119, P101; Joubert P, 2001, EQUINE VET J, V33, P730, DOI 10.2746/042516401776249246; Langereis JD, 2011, EUR RESPIR J, V37, P406, DOI 10.1183/09031936.00170409; Lavoie JP, 2006, J VET INTERN MED, V20, P175, DOI 10.1892/0891-6640(2006)20[175:LOCEOA]2.0.CO;2; Lavoie JP, 2002, AM J VET RES, V63, P579, DOI 10.2460/ajvr.2002.63.579; Lavoie-Lamoureux A, 2012, VET IMMUNOL IMMUNOP, V146, P35, DOI 10.1016/j.vetimm.2012.01.020; Lavoie-Lamoureux A, 2010, AM J PHYSIOL-LUNG C, V299, pL472, DOI 10.1152/ajplung.00135.2009; Leclere M, 2010, EQUINE VET J, V42, P316, DOI 10.1111/j.2042-3306.2009.00022.x; Leclere M, 2011, RESPIROLOGY, V16, P1027, DOI 10.1111/j.1440-1843.2011.02033.x; Lecoq L, 2009, VET IMMUNOL IMMUNOP, V128, P126, DOI 10.1016/j.vetimm.2008.10.303; Meagher LC, 1996, J IMMUNOL, V156, P4422; Nicolaides NC, 2010, STEROIDS, V75, P1, DOI 10.1016/j.steroids.2009.09.002; Nupponen I, 2002, ACTA PAEDIATR, V91, P1200, DOI 10.1080/080352502320777432; Ordonez CL, 2000, AM J RESP CRIT CARE, V161, P1185, DOI 10.1164/ajrccm.161.4.9812061; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Pujols L, 2007, CURR ALLERGY ASTHM R, V7, P93, DOI 10.1007/s11882-007-0005-3; Sabroe I, 2002, J IMMUNOL, V168, P4701, DOI 10.4049/jimmunol.168.9.4701; Saffar AS, 2008, J ALLERGY CLIN IMMUN, V121, P492, DOI 10.1016/j.jaci.2007.10.003; Saffar AS, 2011, CURR DRUG TARGETS, V12, P556; Schleimer Robert P, 2004, Proc Am Thorac Soc, V1, P222, DOI 10.1513/pats.200402-018MS; SCHLEIMER RP, 1990, AM REV RESPIR DIS, V141, pS59; SCHLEIMER RP, 1989, J PHARMACOL EXP THER, V250, P598; Strandberg K, 2010, PULM PHARMACOL THER, V23, P316, DOI 10.1016/j.pupt.2010.03.004; Strickland I, 2001, J EXP MED, V193, P585, DOI 10.1084/jem.193.5.585; Vazquez-Tello A, 2010, CLIN EXP ALLERGY, V40, P1312, DOI 10.1111/j.1365-2222.2010.03544.x; WAKAJTYSRODE E, 1988, INT J IMMUNOPHARMACO, V10, P925, DOI 10.1016/0192-0561(88)90038-0; Weber PSD, 2004, J LEUKOCYTE BIOL, V75, P815, DOI 10.1189/jlb.1003505; Wenzel SE, 1999, AM J RESP CRIT CARE, V160, P1001, DOI 10.1164/ajrccm.160.3.9812110; Wenzel SE, 1997, AM J RESP CRIT CARE, V156, P737, DOI 10.1164/ajrccm.156.3.9610046; WERTHEIM WA, 1993, J IMMUNOL, V151, P2166; Wang XQ, 2008, RESPIROLOGY, V13, P772, DOI 10.1111/j.1440-1843.2008.01344.x; Xu J, 2007, J PHARMACOKINET PHAR, V34, P355, DOI 10.1007/s10928-007-9050-8; Yang IA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002991.pub2	55	40	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44606	10.1371/journal.pone.0044606	http://dx.doi.org/10.1371/journal.pone.0044606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984532	Green Published, Green Submitted, gold			2022-12-27	WOS:000308738500069
J	Kaur, R; Gonzales, WL; Llambi, LD; Soriano, PJ; Callaway, RM; Rout, ME; Gallaher, TJ; Inderjit				Kaur, Rajwant; Gonzales, Wilfredo L.; Daniel Llambi, Luis; Soriano, Pascual J.; Callaway, Ragan M.; Rout, Marnie E.; Gallaher, Timothy J.; Inderjit			Community Impacts of Prosopis juliflora Invasion: Biogeographic and Congeneric Comparisons	PLOS ONE			English	Article							EXOTIC PLANT INVASIONS; SEEDLING GROWTH; SOIL PROPERTIES; WEAPONS; VEGETATION; MONOGRAPH; GRASSLAND; MECHANISM; SAVANNA; FOLIAGE	We coordinated biogeographical comparisons of the impacts of an exotic invasive tree in its native and non-native ranges with a congeneric comparison in the non-native range. Prosopis juliflora is taxonomically complicated and with P. pallida forms the P. juliflora complex. Thus we sampled P. juliflora in its native Venezuela, and also located two field sites in Peru, the native range of Prosopis pallida. Canopies of Prosopis juliflora, a native of the New World but an invader in many other regions, had facilitative effects on the diversity of other species in its native Venezuela, and P. pallida had both negative and positive effects depending on the year, (overall neutral effects) in its native Peru. However, in India and Hawaii, USA, where P. juliflora is an aggressive invader, canopy effects were consistently and strongly negative on species richness. Prosopis cineraria, a native to India, had much weaker effects on species richness in India than P. juliflora. We carried out multiple congeneric comparisons between P. juliflora and P. cineraria, and found that soil from the rhizosphere of P. juliflora had higher extractable phosphorus, soluble salts and total phenolics than P. cineraria rhizosphere soils. Experimentally applied P. juliflora litter caused far greater mortality of native Indian species than litter from P. cineraria. Prosopis juliflora leaf leachate had neutral to negative effects on root growth of three common crop species of north-west India whereas P. cineraria leaf leachate had positive effects. Prosopis juliflora leaf leachate also had higher concentrations of total phenolics and L-tryptophan than P. cineraria, suggesting a potential allelopathic mechanism for the congeneric differences. Our results also suggest the possibility of regional evolutionary trajectories among competitors and that recent mixing of species from different trajectories has the potential to disrupt evolved interactions among native species.	[Kaur, Rajwant; Inderjit] Univ Delhi, CEMDE, Dept Environm Studies, Delhi 110007, India; [Gonzales, Wilfredo L.] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, LID, Lab Ecol Evolut, Lima, Peru; [Daniel Llambi, Luis; Soriano, Pascual J.] Univ Los Andes, Inst Ciencias Ambientales & Ecol, Merida, Venezuela; [Callaway, Ragan M.; Rout, Marnie E.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Gallaher, Timothy J.] Univ Hawaii Manoa, Dept Bot, Honolulu, HI 96822 USA	University of Delhi; Universidad Peruana Cayetano Heredia; University of Los Andes Venezuela; University of Montana System; University of Montana; University of Hawaii System; University of Hawaii Manoa	Kaur, R (corresponding author), Univ Delhi, CEMDE, Dept Environm Studies, Delhi 110007, India.	inderjitdu@gmail.com		GONZALES, WILFREDO/0000-0002-8885-5972; Gallaher, Timothy/0000-0002-5781-6874	University of Delhi; National Science Foundation [DEB 0614406]; Rocky Mountain Research Station, United States Department of Agriculture Forest Service; Programa de Ciencia y Tecnologia (FINCyT) [011-FINCyT-PIBAP-2007]	University of Delhi(University of Delhi); National Science Foundation(National Science Foundation (NSF)); Rocky Mountain Research Station, United States Department of Agriculture Forest Service; Programa de Ciencia y Tecnologia (FINCyT)	The research was funded by the University of Delhi. RMC gratefully acknowledges funding from the National Science Foundation, DEB 0614406, and the Rocky Mountain Research Station, United States Department of Agriculture Forest Service. WGL gratefully acknowledges funding from the Programa de Ciencia y Tecnologia (FINCyT), Contrato No011-FINCyT-PIBAP-2007. The funders had no role in study, design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R. K., 1976, Indian Forester, V102, P863; Aggarwal R. K., 1993, Indian Forester, V119, P321; Al-Humaid AI, 1998, J ARID ENVIRON, V38, P237, DOI 10.1006/jare.1997.0312; Allen SE, 1989, CHEM ANAL ECOLOGICAL; Allison SD, 2004, OECOLOGIA, V141, P612, DOI 10.1007/s00442-004-1679-z; ARCHER S, 1988, ECOL MONOGR, V58, P111, DOI 10.2307/1942463; Atlas RM., 2004, HDB MICROBIOLOGICAL; Brooker RW, 2009, AM NAT, V174, P919, DOI 10.1086/648058; BURKART A, 1976, J ARNOLD ARBORETUM, V57, P219; Burkart A, 1976, J ARNOLD ARBORAT, P450; Callaway RM, 2008, ECOLOGY, V89, P1043, DOI 10.1890/07-0370.1; Callaway RM, 2006, TRENDS ECOL EVOL, V21, P369, DOI 10.1016/j.tree.2006.04.008; Callaway RM, 2012, BIOL INVASIONS, V14, P1143, DOI 10.1007/s10530-011-0145-1; Callaway RM, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P341; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.1890/1540-9295(2004)002[0436:NWISAT]2.0.CO;2; Carrillo-Garcia A, 2000, PLANT SOIL, V218, P207, DOI 10.1023/A:1014953028163; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; El-Keblawy A, 2007, PLANT ECOL, V190, P23, DOI 10.1007/s11258-006-9188-2; FRANCOPIZANA J, 1995, J VEG SCI, V6, P73, DOI 10.2307/3236258; FrancoPizana JG, 1996, J VEG SCI, V7, P257, DOI 10.2307/3236326; GOEL U, 1989, J CHEM ECOL, V15, P591, DOI 10.1007/BF01014703; IBM SPSS, 2010, IBM SPSS STAT 19 BRI; Inderjit, 2011, TRENDS ECOL EVOL, V26, P655, DOI 10.1016/j.tree.2011.08.003; Inderjit, 2011, ECOLOGY, V92, P316, DOI 10.1890/10-0400.1; Inderjit, 2010, TRENDS ECOL EVOL, V25, P512, DOI 10.1016/j.tree.2010.06.006; Jha P, 2010, PLANT SOIL, V326, P481, DOI 10.1007/s11104-009-0027-9; Kaushik N, 2003, J ARID ENVIRON, V55, P433, DOI 10.1016/S0140-1963(02)00289-6; Larrea-Alcazar DM, 2008, PLANT ECOL, V196, P153, DOI 10.1007/s11258-007-9344-3; Lortie CJ, 2004, OIKOS, V107, P433, DOI 10.1111/j.0030-1299.2004.13250.x; MacDougall AS, 2005, ECOLOGY, V86, P42, DOI 10.1890/04-0669; Nakano H, 2003, PLANT GROWTH REGUL, V40, P49, DOI 10.1023/A:1023049026335; NOOR M, 1995, J ARID ENVIRON, V31, P83, DOI 10.1006/jare.1995.0051; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Palacios RA, 2012, PLANT SYST EVOL, V298, P165, DOI 10.1007/s00606-011-0535-y; Pandit MK, 2011, J ECOL, V99, P1108, DOI 10.1111/j.1365-2745.2011.01838.x; Pasiecznik NM, 2001, PROSOPIS JULIFLORA P; Piper C.S., 1966, SOIL PLANT ANAL; Pollock JL, 2008, BIOL INVASIONS, V10, P875, DOI 10.1007/s10530-008-9239-9; REASONER DJ, 1979, APPL ENVIRON MICROB, V38, P229, DOI 10.1128/AEM.38.2.229-236.1979; Rossi BE, 2003, J VEG SCI, V14, P543, DOI 10.1658/1100-9233(2003)014[0543:EOPFOS]2.0.CO;2; Rothstein DE, 2004, ECOSYSTEMS, V7, P805, DOI 10.1007/s10021-004-0009-y; Rout ME, 2009, SCIENCE, V324, P734, DOI 10.1126/science.1173651; Schade JD, 2003, J VEG SCI, V14, P743, DOI 10.1658/1100-9233(2003)014[0743:TIOPCO]2.0.CO;2; Schaffner U, 2011, ECOLOGY, V92, P829, DOI 10.1890/10-1230.1; Simberloff D, 2012, ECOLOGY, V93, P598, DOI 10.1890/11-1232.1; SPSS Inc, 2008, SPSS VERS 16 0 2; SWAIN T., 1959, Journal of the Science of Food and Agriculture, V10, P63, DOI 10.1002/jsfa.2740100110; te Beest M, 2012, ANN BOT-LONDON, V109, P19, DOI 10.1093/aob/mcr277; Thorpe AS, 2009, J ECOL, V97, P641, DOI 10.1111/j.1365-2745.2009.01520.x; TIEDEMANN AR, 1986, SOIL SCI SOC AM J, V50, P472, DOI 10.2136/sssaj1986.03615995005000020044x; TIEDEMANN AR, 1977, J RANGE MANAGE, V30, P361, DOI 10.2307/3897722; TIEDEMANN AR, 1973, SOIL SCI SOC AM J, V37, P107, DOI 10.2136/sssaj1973.03615995003700010033x; Treier UA, 2009, ECOLOGY, V90, P1366, DOI 10.1890/08-0420.1; Trenchard LJ, 2008, BOT J LINN SOC, V156, P425, DOI 10.1111/j.1095-8339.2007.00712.x; VIRGINIA RA, 1983, SOIL SCI SOC AM J, V47, P138, DOI 10.2136/sssaj1983.03615995004700010028x; Wardle DA, 2011, SCIENCE, V332, P1273, DOI 10.1126/science.1197479; Zou CB, 2005, OECOLOGIA, V145, P32, DOI 10.1007/s00442-005-0110-8	58	76	81	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44966	10.1371/journal.pone.0044966	http://dx.doi.org/10.1371/journal.pone.0044966			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984595	Green Published, gold			2022-12-27	WOS:000308738500101
J	Li, XY; Kong, XN; Chen, X; Zhang, N; Jiang, LY; Ma, TT; Yang, QF				Li, Xiaoyan; Kong, Xiangnan; Chen, Xi; Zhang, Ning; Jiang, Liyu; Ma, Tingting; Yang, Qifeng			LAPTM4B Allele*2 Is Associated with Breast Cancer Susceptibility and Prognosis	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; GENETIC SUSCEPTIBILITY; OVEREXPRESSION; POLYMORPHISM; PROGRESSION; MARKER; RESISTANCE; EXPRESSION; PROTEIN; TUMORS	Background: Lysosome-associated protein transmembrane 4 beta (LAPTM4B) has two alleles named LAPTM4B*1 and LAPTM4B*2. Allele *1 contains only one copy of a 19-bp sequence at the 5'UTR in the first exon, whereas this sequence of allele*2 is duplicated and arrayed as a tandem repeat. Previous studies revealed that LAPTM4B polymorphisms contribute to the risk of certain types of cancers. This study aimed to investigate the polymorphism of LAPTM4B in breast cancer by analysis the correlation of LAPTM4B genotype with breast cancer susceptibility, clinicopathologic features and prognosis. Methods: Genotyping of the LAPTM4B polymorphism was determined by PCR method. The expression levels of LAPTM4B in breast cancer tissues and breast cancer cell lines were determined by quantitative reverse-transcription PCR (qRT-PCR) analysis. The correlation of LAPTM4B genotype with clinicopathologic parameters and prognosis were assessed statistically. Results: The results of qRT-PCR analysis indicated that LAPTM4B*2 was associated with the higher level of LAPTM4B expression compared with the LAPTM4B*1 in both breast cancer cell lines and breast cancer tissues. We found that LAPTM4B*2 was associated with an increased risk for breast cancer. LAPTM4B*2 was significantly associated with higher histopathologic grade, lymph node metastasis and poor prognosis. Conclusion: LAPTM4B*2 is a risk factor associated with breast cancer susceptibility and poor prognosis. LAPTM4B*2 may be a potential predicative marker for the susceptibility, progression and metastasis of breast cancer.	[Li, Xiaoyan; Kong, Xiangnan; Chen, Xi; Zhang, Ning; Jiang, Liyu; Ma, Tingting; Yang, Qifeng] Shandong Univ, Qilu Hosp, Dept Breast Surg, Jinan 250100, Shandong, Peoples R China; [Yang, Qifeng] Shandong Univ, Sch Med, Minist Educ, Key Lab Expt Teratol, Jinan 250100, Shandong, Peoples R China; [Yang, Qifeng] Shandong Univ, Sch Med, Inst Mol Med & Genet, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Li, XY (corresponding author), Shandong Univ, Qilu Hosp, Dept Breast Surg, Jinan 250100, Shandong, Peoples R China.	qifengy@gmail.com	Zhang, Ning/GNP-1966-2022; Zhang, Ning/GOJ-8058-2022; yang, qiang/GYJ-0971-2022	Zhang, Ning/0000-0002-6430-4236; Yang, Qifeng/0000-0003-0576-8513	National Natural Science Foundation of China [81072150, 81172529]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81072150; No. 81172529). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng XJ, 2008, ANN ONCOL, V19, P527, DOI 10.1093/annonc/mdm469; Fan MR, 2012, CANCER EPIDEMIOL, V36, P364, DOI 10.1016/j.canep.2011.12.004; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Kasper G, 2005, CANCER LETT, V224, P93, DOI 10.1016/j.canlet.2004.10.004; Li L, 2010, ONCOGENE, V29, P5785, DOI 10.1038/onc.2010.303; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Liu Xinrong, 2003, Beijing Da Xue Xue Bao Yi Xue Ban, V35, P340; Liu XR, 2009, CANCER SCI, V100, P2335, DOI 10.1111/j.1349-7006.2009.01346.x; Liu Y, 2007, ANN ONCOL, V18, P311, DOI 10.1093/annonc/mdl394; Mavaddat N, 2010, MOL ONCOL, V4, P174, DOI 10.1016/j.molonc.2010.04.011; Meng FL, 2010, INT J GYNECOL CANCER, V20, P745, DOI 10.1111/IGC.0b013e3181e02f90; Meng FL, 2011, CANCER-AM CANCER SOC, V117, P2652, DOI 10.1002/cncr.25833; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; RonnovJessen L, 1996, PHYSIOL REV, V76, P69, DOI 10.1152/physrev.1996.76.1.69; Shao GZ, 2003, ONCOGENE, V22, P5060, DOI 10.1038/sj.onc.1206832; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Su P, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-38; Xu Y, 2012, JPN J CLIN ONCOL, V42, P413, DOI 10.1093/jjco/hys026; Yang H, 2011, SURG TODAY, V41, P810, DOI 10.1007/s00595-010-4338-5; Yang H, 2010, J SURG ONCOL, V101, P363, DOI 10.1002/jso.21489; Yin MZ, 2012, INT J GYNECOL CANCER, V22, P54, DOI 10.1097/IGC.0b013e318234f9ac; Yin MZ, 2011, INT J CANCER, V129, P629, DOI 10.1002/ijc.25689; Yu JC, 2009, CARCINOGENESIS, V30, P1562, DOI 10.1093/carcin/bgp173; Zhai GJ, 2012, MED ONCOL, V29, P2744, DOI 10.1007/s12032-011-0139-y; Zhang N, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-48; Zhou L, 2008, CANCER LETT, V264, P209, DOI 10.1016/j.canlet.2008.01.025; Zhou L, 2007, EUR J CANCER, V43, P809, DOI 10.1016/j.ejca.2006.10.025; Zinzani PL, 2011, ANN ONCOL, V22, P186	28	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44916	10.1371/journal.pone.0044916	http://dx.doi.org/10.1371/journal.pone.0044916			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984585	gold, Green Published, Green Submitted			2022-12-27	WOS:000308738500094
J	Defour, A; Dessalle, K; Perez, AC; Poyot, T; Castells, J; Gallot, YS; Durand, C; Euthine, V; Gu, YS; Bechet, D; Peinnequin, A; Lefai, E; Freyssenet, D				Defour, Aurelia; Dessalle, Kevin; Perez, Andrea Castro; Poyot, Thomas; Castells, Josiane; Gallot, Yann Simon; Durand, Christine; Euthine, Vanessa; Gu, Yansong; Bechet, Daniel; Peinnequin, Andre; Lefai, Etienne; Freyssenet, Damien			Sirtuin 1 Regulates SREBP-1c Expression in a LXR-Dependent Manner in Skeletal Muscle	PLOS ONE			English	Article							TIME QUANTITATIVE PCR; LIVER-X-RECEPTORS; TRANSCRIPTION FACTORS; GENE-EXPRESSION; LIPID-METABOLISM; RELATIVE QUANTIFICATION; INSULIN; HOMEOSTASIS; GLUCOSE; ELECTROTRANSFER	Sirtuin 1 (SIRT1), a NAD(+)-dependent protein deacetylase, has emerged as a main determinant of whole body homeostasis in mammals by regulating a large spectrum of transcriptional regulators in metabolically relevant tissue such as liver, adipose tissue and skeletal muscle. Sterol regulatory element binding protein (SREBP)-1c is a transcription factor that controls the expression of genes related to fatty acid and triglyceride synthesis in tissues with high lipid synthesis rates such as adipose tissue and liver. Previous studies indicate that SIRT1 can regulate the expression and function of SREBP-1c in liver. In the present study, we determined whether SIRT1 regulates SREBP-1c expression in skeletal muscle. SREBP-1c mRNA and protein levels were decreased in the gastrocnemius muscle of mice harboring deletion of the catalytic domain of SIRT1 (SIRT1(Delta ex4/Delta ex4) mice). By contrast, adenoviral expression of SIRT1 in human myotubes increased SREBP-1c mRNA and protein levels. Importantly, SREBP-1c promoter transactivation, which was significantly increased in response to SIRT1 overexpression by gene electrotransfer in skeletalmuscle, was completely abolished when liver X receptor (LXR) response elements were deleted. Finally, our in vivo data fromSIRT1(Delta ex4/Delta ex4) mice and in vitro data from human myotubes overexpressing SIRT1 show that SIRT1 regulates LXR acetylation in skeletal muscle cells. This suggests a possible mechanism by which the regulation of SREBP-1c gene expression by SIRT1 may require the deacetylation of LXR transcription factors.	[Defour, Aurelia; Perez, Andrea Castro; Castells, Josiane; Gallot, Yann Simon; Freyssenet, Damien] Univ Lyon, Lab Physiol Exercice, St Etienne, France; [Dessalle, Kevin; Durand, Christine; Euthine, Vanessa; Lefai, Etienne] Univ Lyon, INRA 1235, INSERM, U1060,Lab CarMeN, Oullins, France; [Poyot, Thomas; Peinnequin, Andre] Ctr Rech, Inst Rech Biomed Armees, Serv Sante Armees, La Tronche, France; [Gu, Yansong] Obenomics Inc, Bellevue, WA USA; [Bechet, Daniel] INRA UMR 1019, Unite Nutr Humaine, St Genes Champanelle, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE	Defour, A (corresponding author), Univ Lyon, Lab Physiol Exercice, St Etienne, France.	damien.freyssenet@univ-st-etienne.fr	Gallot, Yann Simon/GNO-9167-2022; Gallot, Yann Simon/GQI-2372-2022; Gallot, Yann Simon/ABC-1826-2021; Lefai, Etienne/L-7961-2019; Bechet, Daniel/AAU-2874-2020; Lefai, Etienne/E-9615-2019	Gallot, Yann Simon/0000-0003-4447-1448; Gallot, Yann Simon/0000-0003-4447-1448; Gallot, Yann Simon/0000-0003-4447-1448; Lefai, Etienne/0000-0002-3042-7801; Bechet, Daniel/0000-0002-3812-8099; Lefai, Etienne/0000-0002-3042-7801; defour, aurelia/0000-0002-9114-0054	Caisse d'Epargne Rhone-Alpes	Caisse d'Epargne Rhone-Alpes(Region Auvergne-Rhone-Alpes)	AD was financially supported by a grant from the Caisse d'Epargne Rhone-Alpes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Canto C, 2012, PHARMACOL REV, V64, P166, DOI 10.1124/pr.110.003905; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cozzone D, 2006, DIABETOLOGIA, V49, P990, DOI 10.1007/s00125-006-0140-8; Dif N, 2006, BIOCHEM J, V400, P179, DOI 10.1042/BJ20060499; Ducluzeau PH, 2001, DIABETES, V50, P1134, DOI 10.2337/diabetes.50.5.1134; Durieux AC, 2005, BBA-GEN SUBJECTS, V1725, P403, DOI 10.1016/j.bbagen.2005.06.016; Durieux AC, 2002, BIOCHEM BIOPH RES CO, V296, P443, DOI 10.1016/S0006-291X(02)00901-4; Durieux AC, 2004, J GENE MED, V6, P809, DOI 10.1002/jgm.534; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Erion DM, 2009, P NATL ACAD SCI USA, V106, P11288, DOI 10.1073/pnas.0812931106; Frojdo S, 2011, MOL CELL ENDOCRINOL, V335, P166, DOI 10.1016/j.mce.2011.01.008; Giandomenico V, 2003, MOL CELL BIOL, V23, P2587, DOI 10.1128/MCB.23.7.2587-2599.2003; Gosmain Y, 2005, J LIPID RES, V46, P697, DOI 10.1194/jlr.M400261-JLR200; Gosmain Y, 2004, DIABETES, V53, P321, DOI 10.2337/diabetes.53.2.321; Guillet-Deniau I, 2002, DIABETES, V51, P1722, DOI 10.2337/diabetes.51.6.1722; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Lecomte V, 2010, MOL CELL BIOL, V30, P1182, DOI 10.1128/MCB.00690-09; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Muscat GEO, 2002, J BIOL CHEM, V277, P40722, DOI 10.1074/jbc.M206681200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Qiang L, 2011, CELL METAB, V14, P758, DOI 10.1016/j.cmet.2011.10.007; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rome S, 2008, PHYSIOL GENOMICS, V34, P327, DOI 10.1152/physiolgenomics.90211.2008; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Walker AK, 2010, GENE DEV, V24, P1403, DOI 10.1101/gad.1901210; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001; Yu JJ, 2010, PHARMACOL RES, V62, P35, DOI 10.1016/j.phrs.2009.12.006; Yu JJ, 2009, ANN NY ACAD SCI, V1173, pE10, DOI 10.1111/j.1749-6632.2009.04952.x	46	21	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43490	10.1371/journal.pone.0043490	http://dx.doi.org/10.1371/journal.pone.0043490			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984430	Green Published, Green Submitted, gold			2022-12-27	WOS:000308638700023
J	Halvorsen, K; Wong, WP				Halvorsen, Ken; Wong, Wesley P.			Binary DNA Nanostructures for Data Encryption	PLOS ONE			English	Article							NUCLEIC-ACIDS; COMPUTATION; OLIGONUCLEOTIDES; SHAPES	We present a simple and secure system for encrypting and decrypting information using DNA self-assembly. Binary data is encoded in the geometry of DNA nanostructures with two distinct conformations. Removing or leaving out a single component reduces these structures to an encrypted solution of ssDNA, whereas adding back this missing "decryption key" causes the spontaneous formation of the message through self-assembly, enabling rapid read out via gel electrophoresis. Applications include authentication, secure messaging, and barcoding.	[Halvorsen, Ken; Wong, Wesley P.] Harvard Univ, Sch Med, Immune Dis Inst, Program Cellular & Mol Med, Boston, MA 02114 USA; [Halvorsen, Ken; Wong, Wesley P.] Childrens Hosp, Boston, MA 02115 USA; [Halvorsen, Ken; Wong, Wesley P.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Halvorsen, K (corresponding author), Harvard Univ, Sch Med, Immune Dis Inst, Program Cellular & Mol Med, Boston, MA 02114 USA.	wong@idi.harvard.edu		Wong, Wesley/0000-0001-7398-546X	IDI startup funds	IDI startup funds	This work was supported by IDI startup funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URL of IDI: http://www.idi.harvard.edu/.	ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; Braich RS, 2002, SCIENCE, V296, P499, DOI 10.1126/science.1069528; Clelland CT, 1999, NATURE, V399, P533, DOI 10.1038/21092; Cui GZ, 2008, 2008 THIRD INTERNATIONAL CONFERENCE ON BIO-INSPIRED COMPUTING: THEORIES AND APPLICATIONS, P37, DOI 10.1109/BICTA.2008.4656701; Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Farand J, 2009, ANAL CHEM, V81, P3723, DOI 10.1021/ac802452p; Franca LTC, 2002, Q REV BIOPHYS, V35, P169, DOI 10.1017/S0033583502003797; Gehani A., 2004, ASPECTS MOL COMPUTIN, P34; Guarnieri F, 1996, SCIENCE, V273, P220, DOI 10.1126/science.273.5272.220; Halvorsen K, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494005; Hashiyada M, 2004, TOHOKU J EXP MED, V204, P109, DOI 10.1620/tjem.204.109; Kawai J, 2003, GENOME RES, V13, P1488, DOI 10.1101/gr.914203; Lee I, 2004, NUCLEIC ACIDS RES, V32, P681, DOI 10.1093/nar/gkh196; Leier A, 2000, BIOSYSTEMS, V57, P13, DOI 10.1016/S0303-2647(00)00083-6; LIPTON RJ, 1995, SCIENCE, V268, P542, DOI 10.1126/science.7725098; Oberacher H, 2004, J AM SOC MASS SPECTR, V15, P32, DOI 10.1016/j.jasms.2003.09.005; Oberacher H, 2009, BIOPOLYMERS, V91, P401, DOI 10.1002/bip.21156; Ouyang Q, 1997, SCIENCE, V278, P446, DOI 10.1126/science.278.5337.446; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; Quek SY, 2009, NAT NANOTECHNOL, V4, P230, DOI [10.1038/NNANO.2009.10, 10.1038/nnano.2009.10]; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Roweis S, 1998, J COMPUT BIOL, V5, P615, DOI 10.1089/cmb.1998.5.615; Schafer C, 2007, J AM CHEM SOC, V129, P1488, DOI 10.1021/ja067734h; Seeman NC, 2007, MOL BIOTECHNOL, V37, P246, DOI 10.1007/s12033-007-0059-4; Tanaka K, 2005, BIOSYSTEMS, V81, P25, DOI 10.1016/j.biosystems.2005.01.004; Yan H, 2003, P NATL ACAD SCI USA, V100, P8103, DOI 10.1073/pnas.1032954100; Yin P, 2008, SCIENCE, V321, P824, DOI 10.1126/science.1157312	29	30	33	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44212	10.1371/journal.pone.0044212	http://dx.doi.org/10.1371/journal.pone.0044212			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984477	Green Published, gold			2022-12-27	WOS:000308638700049
J	Siegel, D; Kepa, JK; Ross, D				Siegel, David; Kepa, Jadwiga K.; Ross, David			NAD(P)H: Quinone Oxidoreductase 1 (NQO1) Localizes to the Mitotic Spindle in Human Cells	PLOS ONE			English	Article							20S PROTEASOMAL DEGRADATION; NAD(P)H-QUINONE OXIDOREDUCTASE-1; IN-VITRO; ANTITUMOR QUINONES; DT-DIAPHORASE; P53; EXPRESSION; STABILITY; GENE; PROTEINS	NAD(P)H: quinone oxidoreductase 1 (NQO1) is an FAD containing quinone reductase that catalyzes the 2-electron reduction of a broad range of quinones. The 2-electron reduction of quinones to hydroquinones by NQO1 is believed to be a detoxification process since this reaction bypasses the formation of the highly reactive semiquinone. NQO1 is expressed at high levels in normal epithelium, endothelium and adipocytes as well as in many human solid tumors. In addition to its function as a quinone reductase NQO1 has been shown to reduce superoxide and regulate the 20 S proteasomal degradation of proteins including p53. Biochemical studies have indicated that NQO1 is primarily located in the cytosol, however, lower levels of NQO1 have also been found in the nucleus. In these studies we demonstrate using immunocytochemistry and confocal imaging that NQO1 was found associated with mitotic spindles in cells undergoing division. The association of NQO1 with the mitotic spindles was observed in many different human cell lines including nontransformed cells (astrocytes, HUVEC) immortalized cell lines (HBMEC, 16HBE) and cancer (pancreatic adenocarcinoma, BXPC3). Confocal analysis of double-labeling experiments demonstrated co-localization of NQO1 with alpha-tubulin in mitotic spindles. In studies with BxPc-3 human pancreatic cancer cells the association of NQO1 with mitotic spindles appeared to be unchanged in the presence of NQO1 inhibitors ES936 or dicoumarol suggesting that NQO1 can associate with the mitotic spindle and still retain catalytic activity. Analysis of archival human squamous lung carcinoma tissue immunostained for NQO1 demonstrated positive staining for NQO1 in the spindles of mitotic cells. The purpose of this study is to demonstrate for the first time the association of the quinone reductase NQO1 with the mitotic spindle in human cells.	[Siegel, David; Kepa, Jadwiga K.; Ross, David] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Siegel, D (corresponding author), Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Anschutz Med Campus, Aurora, CO 80045 USA.	david.siegel@ucdenver.edu		Ross, David/0000-0002-8307-5942	National Institutes of Health [R01ES108943]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES018943] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grant R01ES108943. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ade N, 2009, TOXICOL SCI, V107, P451, DOI 10.1093/toxsci/kfn243; AIZAWA H, 1990, J BIOL CHEM, V265, P13849; Asher G, 2005, MOL CELL, V17, P645, DOI 10.1016/j.molcel.2005.01.020; Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Asher G, 2001, P NATL ACAD SCI USA, V98, P1188, DOI 10.1073/pnas.021558898; Beall HD, 1998, J MED CHEM, V41, P4755, DOI 10.1021/jm980328r; Bui CB, 2011, BIOCHEM BIOPH RES CO, V412, P347, DOI 10.1016/j.bbrc.2011.07.101; Cao JN, 2010, CANCER RES, V70, P6004, DOI 10.1158/0008-5472.CAN-09-4490; Chan TS, 2002, FREE RADICAL RES, V36, P421, DOI 10.1080/10715760290021270; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; DURKACZ BW, 1980, NATURE, V283, P593, DOI 10.1038/283593a0; Khutornenko AA, 2010, P NATL ACAD SCI USA, V107, P12828, DOI 10.1073/pnas.0910885107; Lafarga M, 2002, GLIA, V38, P313, DOI 10.1002/glia.10075; LIND C, 1990, METHOD ENZYMOL, V186, P287; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Morris VB, 2000, EXP CELL RES, V256, P122, DOI 10.1006/excr.2000.4800; Nioi P, 2004, MUTAT RES-FUND MOL M, V555, P149, DOI 10.1016/j.mrfmmm.2004.05.023; Patrick BA, 2011, ONCOGENE, V30, P1098, DOI 10.1038/onc.2010.491; Pfeiffer E, 1996, CHEM-BIOL INTERACT, V102, P37, DOI 10.1016/0009-2797(96)03730-1; Rokah OH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011401; SCHLAGER JJ, 1990, INT J CANCER, V45, P403, DOI 10.1002/ijc.2910450304; Schweitzer KM, 1997, LAB INVEST, V76, P25; Sharp SY, 2000, MOL PHARMACOL, V58, P1146, DOI 10.1124/mol.58.5.1146; Siegel D, 1998, CLIN CANCER RES, V4, P2065; Siegel D, 1999, PHARMACOGENETICS, V9, P113, DOI 10.1097/00008571-199902000-00015; Siegel D, 2001, MOL PHARMACOL, V59, P263, DOI 10.1124/mol.59.2.263; Siegel D, 1997, MOL PHARMACOL, V52, P300, DOI 10.1124/mol.52.2.300; Siegel D, 2004, MOL PHARMACOL, V65, P1238, DOI 10.1124/mol.65.5.1238; Siegel D, 2012, BIOCHEM PHARMACOL, V83, P1033, DOI 10.1016/j.bcp.2011.12.017; Siegel D, 2011, J PHARMACOL EXP THER, V336, P874, DOI 10.1124/jpet.110.176438; Sieger D, 2000, FREE RADICAL BIO MED, V29, P246, DOI 10.1016/S0891-5849(00)00310-5; Sollner S, 2009, FEBS J, V276, P4313, DOI 10.1111/j.1742-4658.2009.07143.x; Tsvetkov P, 2011, J BIOL CHEM, V286, P8839, DOI 10.1074/jbc.M110.193276; Wignall SM, 2004, CHEM BIOL, V11, P135, DOI 10.1016/j.chembiol.2003.12.019; Winski SL, 2002, CANCER RES, V62, P1420; Winski SL, 2001, BIOCHEM PHARMACOL, V61, P1509, DOI 10.1016/S0006-2952(01)00631-1; Wu N, 2006, J MOL BIOL, V364, P955, DOI 10.1016/j.jmb.2006.09.075	37	29	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44861	10.1371/journal.pone.0044861	http://dx.doi.org/10.1371/journal.pone.0044861			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984577	Green Submitted, Green Published, gold			2022-12-27	WOS:000308638700093
J	Zheng, JS; Huang, T; Yang, J; Fu, YQ; Li, D				Zheng, Ju-Sheng; Huang, Tao; Yang, Jing; Fu, Yuan-Qing; Li, Duo			Marine N-3 Polyunsaturated Fatty Acids Are Inversely Associated with Risk of Type 2 Diabetes in Asians: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							INSULIN SENSITIVITY; DIETARY-FAT; FISH INTAKE; TREND ESTIMATION; GLYCEMIC CONTROL; BLOOD-PRESSURE; PLASMA; OMEGA-3-FATTY-ACIDS; ERYTHROCYTE; CONSUMPTION	Background: Prospective cohort studies in relation to the associations between n-3 polyunsaturated fatty acids (PUFA) and risk of type 2 diabetes (T2D) were inconsistent. Differences in tissue n-3 PUFA compositions in subjects with and without T2D were also inconsistent in both cohort and case-control studies. We conducted a systematic review and meta-analysis of prospective cohort studies to examine the associations of fish and n-3 PUFA intake with T2D risk. The differences in tissue n-3 PUFA compositions in subjects with and without T2D were investigated based on cohort and case-control studies. Methods and Findings: PubMed, Embase, Cochrane library, China National Knowledge Infrastructure (CNKI) and Chinese VIP database up to January 2012 was used to identify relevant studies, and reference lists from retrieved studies were reviewed. Two authors independently extracted the data. Random-effects models were used to pool the summary relative risk (RR). Twenty-four studies including 24,509 T2D patients and 545,275 participants were identified. For cohort studies, the summary RR of T2D for the highest vs lowest categories of total fish, marine n-3 PUFA and alpha-linolenic acid intake was 1.07 (95% CI: 0.91, 1.25), 1.07 (95% CI: 0.95, 1.20) and 0.93 (95% CI: 0.81, 1.07), respectively. Subgroup analyses indicated that summary RR (highest vs lowest category) of T2D for fish and marine n-3 PUFA intake was 0.89 (95% CI: 0.81, 0.98) and 0.87 (95% CI: 0.79, 0.96) for Asian populations, and 1.20 (95% CI: 1.01, 1.44) and 1.16 (95% CI: 1.04, 1.28) for Western populations. Asian subjects with T2D had significantly lower tissue compositions of C22:6n-3 (SMD: -1.43; 95% CI: -1.75, -1.12) and total n-3 PUFA (SMD: -1.41; 95% CI: -2.23, -0.59) compared with those without T2D. Conclusion: This systematic review and meta-analysis provides evidence that marine n-3 PUFA have beneficial effects on the prevention of T2D in Asian populations.	[Zheng, Ju-Sheng; Huang, Tao; Yang, Jing; Fu, Yuan-Qing; Li, Duo] Zhejiang Univ, Dept Food Sci & Nutr, Hangzhou 310003, Zhejiang, Peoples R China; [Zheng, Ju-Sheng; Huang, Tao; Yang, Jing; Fu, Yuan-Qing; Li, Duo] APCNS Ctr Nutr & Food Safety, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Zheng, JS (corresponding author), Zhejiang Univ, Dept Food Sci & Nutr, Hangzhou 310003, Zhejiang, Peoples R China.	duoli@zju.edu.cn	; Zheng, Ju-Sheng/J-3970-2015; Li, Duo/N-3682-2013	Fu, Yuanqing/0000-0002-3955-9376; Zheng, Ju-Sheng/0000-0001-6560-4890; Li, Duo/0000-0001-5227-5565	National Natural Science Foundation of China (NSFC) [30972464]; National Basic Research Program of China (973 Program) [2011CB504002]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	The project was funded by the National Natural Science Foundation of China (NSFC, No. 30972464) and the National Basic Research Program of China (973 Program: 2011CB504002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinkuolie AO, 2011, BELG FOOD CONS SURV; Bakan E, 2006, ACTA DIABETOL, V43, P109, DOI 10.1007/s00592-007-0224-4; BOHOV P, 1993, ANN NY ACAD SCI, V683, P367; BORKMAN M, 1993, NEW ENGL J MED, V328, P238, DOI 10.1056/NEJM199301283280404; Brostow DP, 2011, AM J CLIN NUTR, V94, P520, DOI 10.3945/ajcn.110.009357; Chen R, 2012, PLOS GENET, V8, P100, DOI 10.1371/journal.pgen.1002621; Deckelbaum RJ, 2006, AM J CLIN NUTR, V83, p1520S, DOI 10.1093/ajcn/83.6.1520S; Dedoussis George V Z, 2007, Rev Diabet Stud, V4, P13, DOI 10.1900/RDS.2007.4.13; Djousse L, 2011, AM J CLIN NUTR, V94, P527, DOI 10.3945/ajcn.111.013334; Djousse L, 2011, AM J CLIN NUTR, V93, P143, DOI 10.3945/ajcn.110.005603; Egert S, 2008, ANN NUTR METAB, V53, P182, DOI 10.1159/000172980; FAAS FH, 1988, METABOLISM, V37, P711, DOI 10.1016/0026-0495(88)90002-9; Feskens EJM, 2011, AM J CLIN NUTR, V94, P369, DOI 10.3945/ajcn.111.020172; FESKENS EJM, 1995, DIABETES CARE, V18, P1104, DOI 10.2337/diacare.18.8.1104; FESKENS EJM, 1991, DIABETES CARE, V14, P935, DOI 10.2337/diacare.14.11.935; Friedberg CE, 1998, DIABETES CARE, V21, P494, DOI 10.2337/diacare.21.4.494; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hodge AM, 2007, AM J CLIN NUTR, V86, P189, DOI 10.1093/ajcn/86.1.189; Huang T, 2010, MOL NUTR FOOD RES, V54, P1628, DOI 10.1002/mnfr.201000025; Huang T, 2010, MOL NUTR FOOD RES, V54, pS112, DOI 10.1002/mnfr.200900189; Kaushik M, 2009, AM J CLIN NUTR, V90, P613, DOI 10.3945/ajcn.2008.27424; Klimentidis YC, 2011, HUM GENET, V129, P407, DOI 10.1007/s00439-010-0935-z; Krachler B, 2008, NUTR METAB CARDIOVAS, V18, P503, DOI 10.1016/j.numecd.2007.04.005; Kroger J, 2011, AM J CLIN NUTR, V93, P127, DOI 10.3945/ajcn.110.005447; Lai CQ, 2012, PROG MOL BIOL TRANSL, V108, P461, DOI 10.1016/B978-0-12-398397-8.00018-6; Lee YC, 2011, J DATA MINING GENOMI, V2; Leonardini A, 2009, PPAR RES, V2009, DOI 10.1155/2009/818945; [楼大钧 Lou Dajun], 2010, [中国糖尿病杂志, Chinese Journal of Diabetes], V18, P464; [茅小燕 MAO Xiaoyan], 2007, [中国全科医学, Chinese General Practice], V10, P1508; Meyer KA, 2001, DIABETES CARE, V24, P1528, DOI 10.2337/diacare.24.9.1528; Montonen J, 2005, AM J EPIDEMIOL, V161, P219, DOI 10.1093/aje/kwi039; Mostad IL, 2006, AM J CLIN NUTR, V84, P540, DOI 10.1093/ajcn/84.3.540; Nanri A, 2011, AM J CLIN NUTR, V94, P884, DOI 10.3945/ajcn.111.012252; Nkondjock A, 2003, DIABETES METAB, V29, P635, DOI 10.1016/S1262-3636(07)70080-0; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Patel PS, 2009, DIABETES CARE, V32, P1857, DOI 10.2337/dc09-0116; Pelikanova T, 2001, METABOLISM, V50, P1472, DOI 10.1053/meta.2001.27195; Rodriguez Y, 2004, ANN NUTR METAB, V48, P335, DOI 10.1159/000081201; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; STORLIEN LH, 1987, SCIENCE, V237, P885, DOI 10.1126/science.3303333; STORLIEN LH, 1991, DIABETES, V40, P280, DOI 10.2337/diabetes.40.2.280; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; TOFT I, 1995, ANN INTERN MED, V123, P911, DOI 10.7326/0003-4819-123-12-199512150-00003; van Dam RM, 2002, DIABETES CARE, V25, P417, DOI 10.2337/diacare.25.3.417; van Dam RM, 2002, ANN INTERN MED, V136, P201, DOI 10.7326/0003-4819-136-3-200202050-00008; van Woudenbergh GJ, 2009, DIABETES CARE, V32, P2021, DOI 10.2337/dc09-1042; VESSBY B, 1994, DIABETES, V43, P1353, DOI 10.2337/diabetes.43.11.1353; Villegas R, 2011, AM J CLIN NUTR, V94, P543, DOI 10.3945/ajcn.111.013193; Wang L, 2003, AM J CLIN NUTR, V78, P91; Woodman RJ, 2002, AM J CLIN NUTR, V76, P1007, DOI 10.1093/ajcn/76.5.1007; Zhang B, 2011, J CHINA TRADITIONAL, V3, P353; Zheng JS, 2012, PUBLIC HEALTH NUTR, V15, P725, DOI 10.1017/S1368980011002254	54	91	97	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44525	10.1371/journal.pone.0044525	http://dx.doi.org/10.1371/journal.pone.0044525			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984522	Green Submitted, Green Published, gold			2022-12-27	WOS:000308638700068
J	Mellerup, E; Andreassen, O; Bennike, B; Dam, H; Durovic, S; Hansen, T; Melle, I; Moller, GL; Mors, O; Koefoed, P				Mellerup, Erling; Andreassen, Ole; Bennike, Bente; Dam, Henrik; Durovic, Srdjan; Hansen, Thomas; Melle, Ingrid; Moller, Gert Lykke; Mors, Ole; Koefoed, Pernille			Connection between Genetic and Clinical Data in Bipolar Disorder	PLOS ONE			English	Article								Complex diseases may be associated with combinations of changes in DNA, where the single change has little impact alone. In a previous study of patients with bipolar disorder and controls combinations of SNP genotypes were analyzed, and four large clusters of combinations were found to be significantly associated with bipolar disorder. It has now been found that these clusters may be connected to clinical data.	[Mellerup, Erling; Bennike, Bente; Koefoed, Pernille] Univ Copenhagen, Dept Neurosci & Pharmacol, Lab Neuropsychiat, Copenhagen, Denmark; [Dam, Henrik; Koefoed, Pernille] Rigshosp, Copenhagen Univ Hosp, Dept O, Psychiat Ctr Copenhagen, DK-2100 Copenhagen, Denmark; [Andreassen, Ole; Melle, Ingrid] Univ Oslo, Dept Psychiat, Oslo Univ Hosp, Oslo, Norway; [Andreassen, Ole; Durovic, Srdjan; Melle, Ingrid] Univ Oslo, Inst Psychiat, Oslo, Norway; [Durovic, Srdjan] Univ Oslo, Dept Med Genet, Oslo Univ Hosp, Oslo, Norway; [Hansen, Thomas] Copenhagen Univ Hosp, Mental Hlth Ctr Sct Hans, Dept Biol Psychiat, Roskilde, Denmark; [Mors, Ole] Aarhus Univ Hosp, Ctr Psychiat Res, Risskov, Denmark; [Moller, Gert Lykke] Tech Univ Denmark, ScionDTU, Genokey ApS, Agern Alle, Hoersholm, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Oslo; University of Oslo; University of Oslo; University of Copenhagen; Aarhus University; Technical University of Denmark	Mellerup, E (corresponding author), Univ Copenhagen, Dept Neurosci & Pharmacol, Lab Neuropsychiat, Copenhagen, Denmark.	mellerup@sund.ku.dk	Hansen, Thomas/GWZ-2858-2022; Hansen, Thomas Folkmann/O-5965-2014; Andreassen, Ole A./AAY-7531-2020; Melle, Ingrid S/B-4858-2011	Hansen, Thomas Folkmann/0000-0001-6703-7762; Melle, Ingrid S/0000-0002-9783-548X; Djurovic, Srdjan/0000-0002-8140-8061; Mors, Ole/0000-0002-5660-0393; Andreassen, Ole A./0000-0002-4461-3568				Abo R, 2011, BIOINFORMATICS, V27, P134, DOI 10.1093/bioinformatics/btq616; Askland K, 2009, HUM GENET, V125, P63, DOI 10.1007/s00439-008-0600-y; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; El-Mallakh RS, 2001, HARVARD REV PSYCHIAT, V9, P23, DOI 10.1080/10673220127873; Koefoed P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023812; Mellerup E, 2004, MED HYPOTHESES, V63, P464, DOI 10.1016/j.mehy.2004.03.007; Mellerup E, 2012, MED HYPOTHESES, V78, P732, DOI 10.1016/j.mehy.2012.02.019; WILLIAMS JBW, 1992, ARCH GEN PSYCHIAT, V49, P630	8	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e44623	10.1371/journal.pone.0044623	http://dx.doi.org/10.1371/journal.pone.0044623			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028568	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388900010
J	Yan, F; Liu, HH; Hao, JJ; Liu, ZR				Yan, Fang; Liu, Haihong; Hao, Junjun; Liu, Zengrong			Dynamical Behaviors of Rb-E2F Pathway Including Negative Feedback Loops Involving miR449	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; CELL-PROLIFERATION; MICRORNAS; NETWORK; DIFFERENTIATION; MODEL; E2F1; TARGETS; SWITCH; LIFE	MiRNAs, which are a family of small non-coding RNAs, regulate a broad array of physiological and developmental processes. However, their regulatory roles have remained largely mysterious. E2F is a positive regulator of cell cycle progression and also a potent inducer of apoptosis. Positive feedback loops in the regulation of Rb-E2F pathway are predicted and shown experimentally. Recently, it has been discovered that E2F induce a cluster of miRNAs called miR449. In turn, E2F is inhibited by miR449 through regulating different transcripts, thus forming negative feedback loops in the interaction network. Here, based on the integration of experimental evidence and quantitative data, we studied Rb-E2F pathway coupling the positive feedback loops and negative feedback loops mediated by miR449. Therefore, a mathematical model is constructed based in part on the model proposed in Yao-Lee et al. (2008) and nonlinear dynamical behaviors including the stability and bifurcations of the model are discussed. A comparison is given to reveal the implication of the fundamental differences of Rb-E2F pathway between regulation and deregulation of miR449. Coherent with the experiments it predicts that miR449 plays a critical role in regulating the cell cycle progression and provides a twofold safety mechanism to avoid excessive E2F-induced proliferation by cell cycle arrest and apoptosis. Moreover, numerical simulation and bifurcation analysis shows that the mechanisms of the negative regulation of miR449 to three different transcripts are quite distinctive which needs to be verified experimentally. This study may help us to analyze the whole cell cycle process mediated by other miRNAs more easily. A better knowledge of the dynamical behaviors of miRNAs mediated networks is also of interest for bio-engineering and artificial control.	[Yan, Fang; Liu, Zengrong] Shanghai Univ, Dept Math, Shanghai, Peoples R China; [Yan, Fang; Hao, Junjun; Liu, Zengrong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Liu, Haihong] Yunnan Normal Univ, Dept Math, Kunming, Peoples R China	Shanghai University; Shanghai University; Yunnan Normal University	Liu, ZR (corresponding author), Shanghai Univ, Dept Math, Shanghai, Peoples R China.	zrongliu@126.com		Yan, Fang/0000-0001-6624-9720	National Natural Science Foundation of China (NSFC) [10832006, 11172158]; Yunnan NSFC [2011FZ086]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Yunnan NSFC	This work was supported by the National Natural Science Foundation of China (NSFC) (Grant No. 10832006 and 11172158) and Yunnan NSFC (Grant No. 2011FZ086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Barberis M, 2007, PLOS COMPUT BIOL, V3, P649, DOI 10.1371/journal.pcbi.0030064; Barik D, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.55; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bell LA, 2004, CELL DEATH DIFFER, V11, P137, DOI 10.1038/sj.cdd.4401324; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Capuano M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029094; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cohen SM, 2006, GENE DEV, V20, P2769, DOI 10.1101/gad.1484606; Csikasz-Nagy A, 2006, BIOPHYS J, V90, P4361, DOI 10.1529/biophysj.106.081240; Cui J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001469; Feng M, 2010, CELL CYCLE, V9, P213, DOI 10.4161/cc.9.2.10502; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; Johnston RJ, 2005, P NATL ACAD SCI USA, V102, P12449, DOI 10.1073/pnas.0505530102; Kashiwagi A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000049; Kheir TB, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-29; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lin K, 2010, MOL DIVERS, V14, P719, DOI 10.1007/s11030-009-9216-y; Liu DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017029; Lize M, 2010, CELL DEATH DIFFER, V17, P452, DOI 10.1038/cdd.2009.188; Marcet B, 2011, NAT CELL BIOL, V13, P693, DOI 10.1038/ncb2241; Mehra S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002724; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Muller H, 2000, BBA-REV CANCER, V1470, pM1, DOI 10.1016/S0304-419X(99)00030-X; Obeyesekere MN, 1999, B MATH BIOL, V61, P917, DOI 10.1006/bulm.1999.0118; Petri A, 2009, CANCER RES, V69, P393, DOI 10.1158/0008-5472.CAN-08-2749; Pfeuty B, 2008, CELL CYCLE, V7, P3246, DOI 10.4161/cc.7.20.6853; Polager S, 2008, TRENDS CELL BIOL, V18, P528, DOI 10.1016/j.tcb.2008.08.003; Qiao L, 2007, PLOS COMPUT BIOL, V3, P1819, DOI 10.1371/journal.pcbi.0030184; Sears RC, 2002, J BIOL CHEM, V277, P11617, DOI 10.1074/jbc.R100063200; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sluijter JPG, 2010, ARTERIOSCL THROM VAS, V30, P859, DOI 10.1161/ATVBAHA.109.197434; Stiefel KM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003947; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Wee KB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004407; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Yang XJ, 2009, GENE DEV, V23, P2388, DOI 10.1101/gad.1819009; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zhang XP, 2010, J BIOL CHEM, V285, P31571, DOI 10.1074/jbc.M110.134650	48	24	25	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e43908	10.1371/journal.pone.0043908	http://dx.doi.org/10.1371/journal.pone.0043908			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028477	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900011
J	Lim, TS; Goh, JKH; Mortellaro, A; Lim, CT; Hammerling, GJ; Ricciardi-Castagnoli, P				Lim, Tong Seng; Goh, James Kang Hao; Mortellaro, Alessandra; Lim, Chwee Teck; Haemmerling, Guenter J.; Ricciardi-Castagnoli, Paola			CD80 and CD86 Differentially Regulate Mechanical Interactions of T-Cells with Antigen-Presenting Dendritic Cells and B-Cells	PLOS ONE			English	Article							SUPRAMOLECULAR ACTIVATION CLUSTERS; ATOMIC-FORCE MICROSCOPY; KINASE-C-THETA; IMMUNOLOGICAL SYNAPSE; MOLECULAR-CLONING; LYMPH-NODES; LIPID RAFTS; CD28; RECEPTOR; CTLA-4	Functional T-cell responses are initiated by physical interactions between T-cells and antigen-presenting cells (APCs), including dendritic cells (DCs) and B-cells. T-cells are activated more effectively by DCs than by B-cells, but little is known about the key molecular mechanisms that underpin the particular potency of DC in triggering T-cell responses. To better understand the influence of physical intercellular interactions on APC efficacy in activating T-cells, we used single cell force spectroscopy to characterize and compare the mechanical forces of interactions between DC:T-cells and B:T-cells. Following antigen stimulation, intercellular interactions of DC:T-cell conjugates were stronger than B:T-cell interactions. DCs induced higher levels of T-cell calcium mobilization and production of IL-2 and IFN gamma than were elicited by B-cells, thus suggesting that tight intercellular contacts are important in providing mechanically stable environment to initiate T-cell activation. Blocking antibodies targeting surface co-stimulatory molecules CD80 or CD86 weakened intercellular interactions and dampen T-cell activation, highlighting the amplificatory roles of CD80/86 in regulating APC:T-cell interactions and T-cell functional activation. The variable strength of mechanical forces between DC:T-cells and B:T-cell interactions were not solely dependent on differential APC expression of CD80/86, since DCs were superior to B-cells in promoting strong interactions with T-cells even when CD80 and CD86 were inhibited. These data provide mechanical insights into the effects of costimulatory molecules in regulating APC:T-cell interactions.	[Lim, Tong Seng; Goh, James Kang Hao; Mortellaro, Alessandra; Ricciardi-Castagnoli, Paola] ASTAR, Singapore Immunol Network, Singapore, Singapore; [Lim, Chwee Teck] Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore; [Lim, Chwee Teck] Natl Univ Singapore, Dept Bioengn, Singapore 117548, Singapore; [Lim, Chwee Teck] Natl Univ Singapore, Dept Mech Engn, Singapore 117548, Singapore; [Haemmerling, Guenter J.] German Canc Res Ctr, Div Mol Immunol, Heidelberg, Germany	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore; National University of Singapore; National University of Singapore; Helmholtz Association; German Cancer Research Center (DKFZ)	Lim, TS (corresponding author), ASTAR, Singapore Immunol Network, Singapore, Singapore.	lim_tong_seng@immunol.a-star.edu.sg; paola_castagnoli@immunol.a-star.edu.sg	Lim, chwee Teck/B-3307-2011; Mortellaro, Alessandra/AAN-4678-2020	Lim, chwee Teck/0000-0003-4019-9782; Mortellaro, Alessandra/0000-0003-1744-2430	Biomedical Research Council (BMRC); Joint Council Office Grant (JCO) from the Agency for Science, Technology and Research (A*STAR) [10/03/FG/05/03]	Biomedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); Joint Council Office Grant (JCO) from the Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR))	Biomedical Research Council (BMRC) and Joint Council Office Grant (JCO Grant No: 10/03/FG/05/03) from the Agency for Science, Technology and Research (A*STAR) are acknowledged for funding this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Andres PG, 2004, J IMMUNOL, V172, P5880, DOI 10.4049/jimmunol.172.10.5880; ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P8573, DOI 10.1073/pnas.84.23.8573; Benoit M, 2000, NAT CELL BIOL, V2, P313, DOI 10.1038/35014000; Bhatia S, J IMMUNOL, V184, P1821; Boehm T, 2003, EMBO J, V22, P1014, DOI 10.1093/emboj/cdg101; Borriello F, 1997, IMMUNITY, V6, P303, DOI 10.1016/S1074-7613(00)80333-7; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; Brossard C, 2005, EUR J IMMUNOL, V35, P1741, DOI 10.1002/eji.200425857; BRUNET JF, 1987, NATURE, V328, P267, DOI 10.1038/328267a0; Clarke SRM, 2000, IMMUNOL CELL BIOL, V78, P110, DOI 10.1046/j.1440-1711.2000.00889.x; Delon J, 1998, EUR J IMMUNOL, V28, P716, DOI 10.1002/(SICI)1521-4141(199802)28:02<716::AID-IMMU716>3.0.CO;2-E; Delon J, 1998, J EXP MED, V188, P1473, DOI 10.1084/jem.188.8.1473; Dustin ML, 2007, CURR OPIN CELL BIOL, V19, P529, DOI 10.1016/j.ceb.2007.08.003; Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; Friedl P, 2005, NAT REV IMMUNOL, V5, P532, DOI 10.1038/nri1647; GROSS JA, 1990, J IMMUNOL, V144, P3201; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Gunzer M, 2004, BLOOD, V104, P2801, DOI 10.1182/blood-2004-03-1193; HATHCOCK KS, 1994, J EXP MED, V180, P631, DOI 10.1084/jem.180.2.631; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; Hosseini BH, 2009, P NATL ACAD SCI USA, V106, P17852, DOI 10.1073/pnas.0905384106; Huang JY, 2002, P NATL ACAD SCI USA, V99, P9369, DOI 10.1073/pnas.142298399; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Kaga S, 1998, J IMMUNOL, V160, P24; KAPPLER J, 1982, P NATL ACAD SCI-BIOL, V79, P3604, DOI 10.1073/pnas.79.11.3604; Khoshnan A, 2000, J IMMUNOL, V165, P6933, DOI 10.4049/jimmunol.165.12.6933; Kovacs B, 2005, J IMMUNOL, V175, P7848, DOI 10.4049/jimmunol.175.12.7848; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Lim TS, 2011, J IMMUNOL, V187, P258, DOI 10.4049/jimmunol.1100267; Lim TS, J IMMUNOL, V187, P258; LINSLEY PS, 1994, IMMUNITY, V1, P793, DOI 10.1016/S1074-7613(94)80021-9; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; Masten BJ, 1999, J IMMUNOL, V162, P1310; McAdam AJ, 1998, IMMUNOL REV, V165, P231; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Pentcheva-Hoang T, 2004, IMMUNITY, V21, P401, DOI 10.1016/j.immuni.2004.06.017; Potter TA, 2001, P NATL ACAD SCI USA, V98, P12624, DOI 10.1073/pnas.221458898; Puech PH, 2005, J CELL SCI, V118, P4199, DOI 10.1242/jcs.02547; Reichardt P, 2007, IMMUNOL REV, V218, P165, DOI 10.1111/j.1600-065X.2007.00526.x; Sadra A, 2004, P NATL ACAD SCI USA, V101, P11422, DOI 10.1073/pnas.0403792101; Salazar-Fontana LI, 2003, J IMMUNOL, V171, P2225, DOI 10.4049/jimmunol.171.5.2225; Sanchez-Lockhart M, 2008, J IMMUNOL, V181, P7639, DOI 10.4049/jimmunol.181.11.7639; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Tavano R, 2004, J IMMUNOL, V173, P5392, DOI 10.4049/jimmunol.173.9.5392; Tavano R, 2006, NAT CELL BIOL, V8, P1270, DOI 10.1038/ncb1492; Tomas EM, 2002, IMMUNOL LETT, V83, P143, DOI 10.1016/S0165-2478(02)00075-5; Tseng SY, 2005, J IMMUNOL, V175, P7829, DOI 10.4049/jimmunol.175.12.7829; Tskvitaria-Fuller I, 2003, J IMMUNOL, V171, P2287, DOI 10.4049/jimmunol.171.5.2287; Wetzel SA, 2002, J IMMUNOL, V169, P6092, DOI 10.4049/jimmunol.169.11.6092; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Wojcikiewicz EP, 2006, BIOMACROMOLECULES, V7, P3188, DOI 10.1021/bm060559c; Yokosuka T, 2009, IMMUNOL REV, V229, P27, DOI 10.1111/j.1600-065X.2009.00779.x	61	78	83	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45185	10.1371/journal.pone.0045185	http://dx.doi.org/10.1371/journal.pone.0045185			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024807	Green Published, gold, Green Submitted			2022-12-27	WOS:000308860100065
J	Shafat, I; Agbaria, A; Boaz, M; Schwartz, D; Baruch, R; Nakash, R; Ilan, N; Vlodavsky, I; Weinstein, T				Shafat, Itay; Agbaria, Amir; Boaz, Mona; Schwartz, Doron; Baruch, Ronny; Nakash, Richard; Ilan, Neta; Vlodavsky, Israel; Weinstein, Talia			Elevated Urine Heparanase Levels Are Associated with Proteinuria and Decreased Renal Allograft Function	PLOS ONE			English	Article							OVERT DIABETIC-NEPHROPATHY; TISSUE FACTOR; MAMMALIAN HEPARANASE; INCREASED EXPRESSION; GLOMERULAR-DISEASES; REDUCES PROTEINURIA; NEPHROTIC SYNDROME; BASEMENT-MEMBRANE; HEYMANN NEPHRITIS; SULFATE	Heparanase is an endo-beta-glucuronidase that cleaves heparan sulfate side chains, leading to structural modifications that loosen the extracellular matrix barrier and associated with tumor metastasis, inflammation and angiogenesis. In addition, the highly sulfated heparan sulfate proteoglycans are important constituents of the glomerular basement membrane and its permselective properties. Recent studies suggest a role for heparanase in several experimental and human glomerular diseases associated with proteinuria such as diabetes, minimal change disease, and membranous nephropathy. Here, we quantified blood and urine heparanase levels in renal transplant recipients and patients with chronic kidney disease (CKD), and assessed whether alterations in heparanase levels correlate with proteinuria and renal function. We report that in transplanted patients, urinary heparanase was markedly elevated, inversely associated with estimated glomerular filtration rate (eGFR), suggesting a relationship between heparanase and graft function. In CKD patients, urinary heparanase was markedly elevated and associated with proteinuria, but not with eGFR. In addition, urinary heparanase correlated significantly with plasma heparanase in transplanted patients. Such a systemic spread of heparanase may lead to damage of cells and tissues alongside the kidney. The newly described association between heparanase, proteinuria and decreased renal function is expected to pave the way for new therapeutic options aimed at attenuating chronic renal allograft nephropathy, leading to improved graft survival and patient outcome.	[Shafat, Itay; Ilan, Neta; Vlodavsky, Israel] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc & Vasc Biol Res Ctr, IL-31096 Haifa, Israel; [Agbaria, Amir; Schwartz, Doron; Baruch, Ronny; Weinstein, Talia] Tel Aviv Med Ctr & Sch Med, Dept Nephrol, Tel Aviv, Israel; [Boaz, Mona] E Wolfson Med Ctr, Epidemiol Unit, Holon, Israel; [Nakash, Richard] Tel Aviv Univ, Sackler Sch Med, Tel Aviv Med Ctr, Transplant Clin, IL-69978 Tel Aviv, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Shafat, I (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc & Vasc Biol Res Ctr, POB 9649, IL-31096 Haifa, Israel.	vlodavsk@cc.huji.ac.il; tweinste@post.tau.ac.il	Boaz, Mona/O-6940-2014	Boaz, Mona/0000-0002-3920-7549	Israel Science Foundation [549/06]; Israel Ministry of Health, National Cancer Institute, National Institutes of Health [RO1-CA106456]; Israel Cancer Research Fund (ICRF); Juvenile Diabetes Research Foundation [JDRF 1-2006-695, 38-2009-635]; NATIONAL CANCER INSTITUTE [R01CA106456] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); Israel Ministry of Health, National Cancer Institute, National Institutes of Health; Israel Cancer Research Fund (ICRF); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Israel Science Foundation (549/06); Israel Ministry of Health, National Cancer Institute, National Institutes of Health (RO1-CA106456); the Israel Cancer Research Fund (ICRF); and the Juvenile Diabetes Research Foundation (JDRF 1-2006-695 and 38-2009-635). IV is a Research Professor of the ICRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer H, 2007, AM J TRANSPLANT, V7, P2748, DOI 10.1111/j.1600-6143.2007.02006.x; Amer H, 2009, J AM SOC NEPHROL, V20, P2490, DOI 10.1681/ASN.2008091005; Baker AB, 2009, CIRC RES, V104, P380, DOI 10.1161/CIRCRESAHA.108.180695; Barash U, 2010, FEBS J, V277, P3890, DOI 10.1111/j.1742-4658.2010.07799.x; Granqvist ABR, 2006, AM J PHYSIOL-RENAL, V291, pF722, DOI 10.1152/ajprenal.00433.2005; Holt RCL, 2005, KIDNEY INT, V67, P122, DOI 10.1111/j.1523-1755.2005.00062.x; Kanwar YS, 2007, AM J PATHOL, V171, P9, DOI 10.2353/ajpath.2007.070356; KANWAR YS, 1980, J CELL BIOL, V86, P688, DOI 10.1083/jcb.86.2.688; Katz A, 2002, ISRAEL MED ASSOC J, V4, P996; Kramer A, 2006, J AM SOC NEPHROL, V17, P2513, DOI 10.1681/ASN.2006020184; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levidiotis V, 2005, NEPHROLOGY, V10, P167, DOI 10.1111/j.1440-1797.2005.00388.x; Levidiotis V, 2004, J AM SOC NEPHROL, V15, P2882, DOI 10.1097/01.ASN.0000142426.55612.6D; Levidiotis V, 2004, J AM SOC NEPHROL, V15, P68, DOI 10.1097/01.ASN.0000103229.25389.40; Levidiotis V, 2001, KIDNEY INT, V60, P1287, DOI 10.1046/j.1523-1755.2001.00934.x; Levy-Adam F, 2010, SEMIN CANCER BIOL, V20, P153, DOI 10.1016/j.semcancer.2010.06.005; Lewis KD, 2008, INVEST NEW DRUG, V26, P89, DOI 10.1007/s10637-007-9080-5; Massy ZA, 1996, KIDNEY INT, V49, P518, DOI 10.1038/ki.1996.74; Maxhimer JB, 2005, DIABETES, V54, P2172, DOI 10.2337/diabetes.54.7.2172; Myler HA, 2006, J BIOCHEM, V139, P339, DOI 10.1093/jb/mvj061; Nadir Y, 2006, J THROMB HAEMOST, V4, P2443, DOI 10.1111/j.1538-7836.2006.02212.x; Nadir Y, 2008, THROMB HAEMOSTASIS, V99, P133, DOI 10.1055/s-0037-1608919; Nadir Y, 2010, HAEMATOL-HEMATOL J, V95, P1927, DOI 10.3324/haematol.2010.023713; Najafian B, 2008, CURR OPIN NEPHROL HY, V17, P149, DOI 10.1097/MNH.0b013e3282f4e514; Raats CJI, 1999, J AM SOC NEPHROL, V10, P1689; Raats CJI, 2000, KIDNEY INT, V57, P385, DOI 10.1046/j.1523-1755.2000.00858.x; Rops ALWMM, 2004, KIDNEY INT, V65, P768, DOI 10.1111/j.1523-1755.2004.00451.x; Shafat I, 2006, BIOCHEM BIOPH RES CO, V341, P958, DOI 10.1016/j.bbrc.2006.01.048; Shafat I, 2007, NEOPLASIA, V9, P909, DOI 10.1593/neo.07673; Shafat I, 2006, J BIOL CHEM, V281, P23804, DOI 10.1074/jbc.M602762200; Shafat I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017312; Szymczak M, 2010, ARCH IMMUNOL THER EX, V58, P45, DOI 10.1007/s00005-009-0061-6; van den Hoven MJ, 2007, KIDNEY INT, V72, P543, DOI 10.1038/sj.ki.5002337; van den Hoven MJ, 2006, KIDNEY INT, V70, P2100, DOI 10.1038/sj.ki.5001985; VANDENBORN J, 1992, KIDNEY INT, V41, P115, DOI 10.1038/ki.1992.15; VANDENBORN J, 1993, KIDNEY INT, V43, P454, DOI 10.1038/ki.1993.67; VLODAVSKY I, 1992, INVAS METAST, V12, P112; Vlodavsky I, 2008, NEOPLASIA, V10, P125, DOI 10.1593/neo.07875; Vlodavsky I, 2007, CURR PHARM DESIGN, V13, P2057; Vreys V, 2007, J CELL MOL MED, V11, P427, DOI 10.1111/j.1582-4934.2007.00039.x; Wang F, 2010, CARDIOVASC RES, V87, P127, DOI 10.1093/cvr/cvq051; Wijnhoven TJM, 2008, DIABETOLOGIA, V51, P372, DOI 10.1007/s00125-007-0879-6; Wijnhoven TJM, 2007, CURR OPIN MOL THER, V9, P364; Yilmaz MI, 2011, NEPHROL DIA IN PRESS	45	27	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44076	10.1371/journal.pone.0044076	http://dx.doi.org/10.1371/journal.pone.0044076			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028487	Green Submitted, Green Published, gold			2022-12-27	WOS:000308788700014
J	Guasch, L; Ojeda, MJ; Gonzalez-Abuin, N; Sala, E; Cereto-Massague, A; Mulero, M; Valls, C; Pinent, M; Ardevol, A; Garcia-Vallve, S; Pujadas, G				Guasch, Laura; Jose Ojeda, Maria; Gonzalez-Abuin, Noemi; Sala, Esther; Cereto-Massague, Adria; Mulero, Miquel; Valls, Cristina; Pinent, Montserrat; Ardevol, Anna; Garcia-Vallve, Santiago; Pujadas, Gerard			Identification of Novel Human Dipeptidyl Peptidase-IV Inhibitors of Natural Origin (Part I): Virtual Screening and Activity Assays	PLOS ONE			English	Article							MEDICINAL CHEMISTRY; DPP-4 INHIBITOR; DRUG DISCOVERY; HIGHLY POTENT; DATABASE; POLYPEPTIDE; DESIGN; SYSTEM; MODEL	Background: There has been great interest in determining whether natural products show biological activity toward protein targets of pharmacological relevance. One target of particular interest is DPP-IV whose most important substrates are incretins that, among other beneficial effects, stimulates insulin biosynthesis and secretion. Incretins have very short half-lives because of their rapid degradation by DPP-IV and, therefore, inhibiting this enzyme improves glucose homeostasis. As a result, DPP-IV inhibitors are of considerable interest to the pharmaceutical industry. The main goals of this study were (a) to develop a virtual screening process to identify potential DPP-IV inhibitors of natural origin; (b) to evaluate the reliability of our virtual-screening protocol by experimentally testing the in vitro activity of selected natural-product hits; and (c) to use the most active hit for predicting derivatives with higher binding affinities for the DPP-IV binding site. Methodology/Principal Findings: We predicted that 446 out of the 89,165 molecules present in the natural products subset of the ZINC database would inhibit DPP-IV with good ADMET properties. Notably, when these 446 molecules were merged with 2,342 known DPP-IV inhibitors and the resulting set was classified into 50 clusters according to chemical similarity, there were 12 clusters that contained only natural products for which no DPP-IV inhibitory activity has been previously reported. Nine molecules from 7 of these 12 clusters were then selected for in vitro activity testing and 7 out of the 9 molecules were shown to inhibit DPP-IV (where the remaining two molecules could not be solubilized, preventing the evaluation of their DPP-IV inhibitory activity). Then, the hit with the highest activity was used as a lead compound in the prediction of more potent derivatives. Conclusions/Significance: We have demonstrated that our virtual-screening protocol was successful in identifying novel lead compounds for developing more potent DPP-IV inhibitors.	[Guasch, Laura; Jose Ojeda, Maria; Gonzalez-Abuin, Noemi; Sala, Esther; Cereto-Massague, Adria; Mulero, Miquel; Valls, Cristina; Pinent, Montserrat; Ardevol, Anna; Garcia-Vallve, Santiago; Pujadas, Gerard] Univ Rovira & Virgili, Dept Bioquim & Biotecnol, Grp Recerca Nutrigen, Tarragona, Catalonia, Spain; [Garcia-Vallve, Santiago; Pujadas, Gerard] Avinguda Univ, TECNIO, Ctr Tecnol Nutr & Salut, Catalonia, Spain	Universitat Rovira i Virgili	Guasch, L (corresponding author), Univ Rovira & Virgili, Dept Bioquim & Biotecnol, Grp Recerca Nutrigen, Campus Sescelades, Tarragona, Catalonia, Spain.	gerard.pujadas@urv.cat	Pinent, Montserrat/C-7109-2011; Ardévol, Anna/AAO-6194-2021; Valls-Bautista, Cristina/K-8769-2014; Cereto-Massagué, Adrià/I-1643-2015; MJosé, Ojeda/ABB-5745-2020; Pujadas, Gerard/B-1457-2010; Massagué, Adrià Cereto i/AAC-2630-2021; PUJADAS, GERARD/W-9348-2019; Mulero, Miquel/L-4672-2014; Garcia-Vallve, Santi/A-4226-2008; Pinent, Montserrat/ABE-6178-2021; Sala, Esther/AAB-4997-2022	Pinent, Montserrat/0000-0003-3550-5378; Ardévol, Anna/0000-0003-0156-7538; Valls-Bautista, Cristina/0000-0001-5583-5695; Cereto-Massagué, Adrià/0000-0002-9319-6377; Pujadas, Gerard/0000-0003-2598-8089; PUJADAS, GERARD/0000-0003-2598-8089; Mulero, Miquel/0000-0003-2545-2065; Garcia-Vallve, Santi/0000-0002-0348-7497; Pinent, Montserrat/0000-0003-3550-5378; Guasch, Laura/0000-0003-4990-7765; Sala, Esther/0000-0002-5149-1992; Gonzalez-Abuin, Noemi/0000-0001-5484-1604; Ojeda Montes, Maria Jose/0000-0002-9290-1935	Ministerio de Educacion y Ciencia of the Spanish Government [AGL2011-25831/ALI, AGL2011-23879/ALI]; ACC1O [TECCT11-1-0012]	Ministerio de Educacion y Ciencia of the Spanish Government(Spanish Government); ACC1O	This research was supported by grants from the Ministerio de Educacion y Ciencia of the Spanish Government (AGL2011-25831/ALI and AGL2011-23879/ALI) and the ACC1O(TECCT11-1-0012) program (Generalitat de Catalunya). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aertgeerts K, 2004, PROTEIN SCI, V13, P412, DOI 10.1110/ps.03460604; Akiyama T, 2001, J ANTIBIOT, V54, P744, DOI 10.7164/antibiotics.54.744; Al-masri IM, 2009, J ENZYM INHIB MED CH, V24, P1061, DOI 10.1080/14756360802610761; Andrews KM, 2011, BIOORG MED CHEM LETT, V21, P1810, DOI 10.1016/j.bmcl.2011.01.055; Backes BJ, 2007, BIOORG MED CHEM LETT, V17, P2005, DOI 10.1016/j.bmcl.2007.01.026; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biftu T, 2007, BIOORG MED CHEM LETT, V17, P3384, DOI 10.1016/j.bmcl.2007.03.095; Brubaker PL, 2004, ENDOCRINOLOGY, V145, P2653, DOI 10.1210/en.2004-0015; Demuth HU, 2005, BBA-PROTEINS PROTEOM, V1751, P33, DOI 10.1016/j.bbapap.2005.05.010; Dixon SL, 2006, J COMPUT AID MOL DES, V20, P647, DOI 10.1007/s10822-006-9087-6; Duan JX, 2010, J MOL GRAPH MODEL, V29, P157, DOI 10.1016/j.jmgm.2010.05.008; Eckhardt M, 2007, J MED CHEM, V50, P6450, DOI 10.1021/jm701280z; Edmondson SD, 2008, BIOORG MED CHEM LETT, V18, P2409, DOI 10.1016/j.bmcl.2008.02.050; Edmondson SD, 2006, J MED CHEM, V49, P3614, DOI 10.1021/jm060015t; Edmondson SD, 2009, BIOORG MED CHEM LETT, V19, P4097, DOI 10.1016/j.bmcl.2009.06.011; Green Brian D, 2006, Diab Vasc Dis Res, V3, P159, DOI 10.3132/dvdr.2006.024; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Havale SH, 2009, BIOORGAN MED CHEM, V17, P1783, DOI 10.1016/j.bmc.2009.01.061; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Kaelin DE, 2007, BIOORG MED CHEM LETT, V17, P5806, DOI 10.1016/j.bmcl.2007.08.049; Kim D, 2005, J MED CHEM, V48, P141, DOI 10.1021/jm0493156; Kleywegt GJ, 2004, ACTA CRYSTALLOGR D, V60, P2240, DOI 10.1107/S0907444904013253; Kuhn B, 2007, CURR TOP MED CHEM, V7, P609, DOI 10.2174/156802607780091064; Lagorce D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-396; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999; Meier JJ, 2002, REGUL PEPTIDES, V107, P1, DOI 10.1016/S0167-0115(02)00039-3; Mendieta L, 2011, EXPERT OPIN THER PAT, V21, P1693, DOI 10.1517/13543776.2011.627325; MENTLEIN R, 1993, EUR J BIOCHEM, V214, P829, DOI 10.1111/j.1432-1033.1993.tb17986.x; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Nordhoff S, 2009, BIOORG MED CHEM LETT, V19, P4201, DOI 10.1016/j.bmcl.2009.05.109; Pascual I, 2007, ENZYME MICROB TECH, V40, P414, DOI 10.1016/j.enzmictec.2006.07.012; Qiao L, 2006, BIOORG MED CHEM LETT, V16, P123, DOI 10.1016/j.bmcl.2005.09.037; Rush TS, 2005, J MED CHEM, V48, P1489, DOI 10.1021/jm040163o; Salam NK, 2009, J CHEM INF MODEL, V49, P2356, DOI 10.1021/ci900212v; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wallace MB, 2008, BIOORG MED CHEM LETT, V18, P2362, DOI 10.1016/j.bmcl.2008.02.071; Ward RA, 2005, J MED CHEM, V48, P6991, DOI 10.1021/jm0505866; Yazbeck R, 2009, TRENDS PHARMACOL SCI, V30, P600, DOI 10.1016/j.tips.2009.08.003; Zettl H, 2010, CHEMMEDCHEM, V5, P179, DOI 10.1002/cmdc.200900448; Zhang SD, 2011, MEDCHEMCOMM, V2, P471, DOI 10.1039/c0md00245c; Zsoldos Z, 2007, J MOL GRAPH MODEL, V26, P198, DOI 10.1016/j.jmgm.2006.06.002	42	31	32	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44971	10.1371/journal.pone.0044971	http://dx.doi.org/10.1371/journal.pone.0044971			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984596	Green Submitted, gold, Green Published			2022-12-27	WOS:000308738500102
J	Ren, J; Yan, XM; Ai, HS; Zhang, ZY; Huang, X; Ouyang, J; Yang, M; Yang, HG; Han, PF; Zeng, WH; Chen, YJ; Guo, YM; Xiao, SJ; Ding, NS; Huang, LS				Ren, Jun; Yan, Xueming; Ai, Huashui; Zhang, Zhiyan; Huang, Xiang; Ouyang, Jing; Yang, Ming; Yang, Huaigu; Han, Pengfei; Zeng, Weihong; Chen, Yijie; Guo, Yuanmei; Xiao, Shijun; Ding, Nengshui; Huang, Lusheng			Susceptibility towards Enterotoxigenic Escherichia coli F4ac Diarrhea Is Governed by the MUC13 Gene in Pigs	PLOS ONE			English	Article							K88AC FIMBRIAL ADHESIN; ASSOCIATION ANALYSIS; RECEPTOR LOCUS; ETEC F4AB/AC; BAC LIBRARY; MUCIN; GENOME; EXPRESSION; RESOURCE; SWINE	Enterotoxigenic Escherichia coli (ETEC) F4ac is a major determinant of diarrhea and mortality in neonatal and young pigs. Susceptibility to ETEC F4ac is governed by the intestinal receptor specific for the bacterium and is inherited as a monogenic dominant trait. To identify the receptor gene (F4acR), we first mapped the locus to a 7.8-cM region on pig chromosome 13 using a genome scan with 194 microsatellite markers. A further scan with high density markers on chromosome 13 refined the locus to a 5.7-cM interval. Recombination breakpoint analysis defined the locus within a 2.3-Mb region. Further genome-wide mapping using 39,720 informative SNPs revealed that the most significant markers were proximal to the MUC13 gene in the 2.3-Mb region. Association studies in a collection of diverse outbred populations strongly supported that MUC13 is the most likely responsible gene. We characterized the porcine MUC13 gene that encodes two transcripts: MUC13A and MUC13B. Both transcripts have the characteristic PTS regions of mucins that are enriched in distinct tandem repeats. MUC13B is predicated to be heavily O-glycosylated, forming the binding site of the bacterium; while MUC13A does not have the O-glycosylation binding site. Concordantly, 127 independent pigs homozygous for MUC13A across diverse breeds are all resistant to ETEC F4ac, and all 718 susceptible animals from the broad breed panel carry at least one MUC13B allele. Altogether, we conclude that susceptibility towards ETEC F4ac is governed by the MUC13 gene in pigs. The finding has an immediate translation into breeding practice, as it allows us to establish an efficient and accurate diagnostic test for selecting against susceptible animals. Moreover, the finding improves our understanding of mucins that play crucial roles in defense against enteric pathogens. It revealed, for the first time, the direct interaction between MUC13 and enteric bacteria, which is poorly understood in mammals.	[Ren, Jun; Yan, Xueming; Ai, Huashui; Zhang, Zhiyan; Huang, Xiang; Ouyang, Jing; Yang, Ming; Yang, Huaigu; Han, Pengfei; Zeng, Weihong; Chen, Yijie; Guo, Yuanmei; Xiao, Shijun; Ding, Nengshui; Huang, Lusheng] Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China; [Ren, Jun; Yan, Xueming; Ai, Huashui; Zhang, Zhiyan; Huang, Xiang; Ouyang, Jing; Yang, Ming; Yang, Huaigu; Han, Pengfei; Zeng, Weihong; Chen, Yijie; Guo, Yuanmei; Xiao, Shijun; Ding, Nengshui; Huang, Lusheng] Jiangxi Agr Univ, Minist Agr China, Nanchang, Peoples R China; [Yan, Xueming] Jiangxi Sci & Technol Normal Univ, Coll Life Sci, Nanchang, Peoples R China	Jiangxi Agricultural University; Jiangxi Agricultural University; Ministry of Agriculture & Rural Affairs; Jiangxi Science & Technology Normal University	Ren, J (corresponding author), Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China.	renjunjxau@hotmail.com; Lushenghuang@hotmail.com	Chen, Yijie/AAE-8964-2019; Ren, Jun/H-9793-2019		National 863 Program of China [2011AA100304-4]; National Swine Industry and Technology System of China [nycytx-009]; National Natural Science Foundation of China [30960248]	National 863 Program of China(National High Technology Research and Development Program of China); National Swine Industry and Technology System of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National 863 Program of China (2011AA100304-4), National Swine Industry and Technology System of China (nycytx-009), and National Natural Science Foundation of China (30960248). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bayati HK, 1999, MAMM GENOME, V10, P569, DOI 10.1007/s003359901046; Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Baker DR, 1997, VET MICROBIOL, V54, P123, DOI 10.1016/S0378-1135(96)01277-1; Browning BL, 2007, GENET EPIDEMIOL, V31, P365, DOI 10.1002/gepi.20216; Dekker J, 2002, TRENDS BIOCHEM SCI, V27, P126, DOI 10.1016/S0968-0004(01)02052-7; Druet T, 2010, GENETICS, V184, P789, DOI 10.1534/genetics.109.108431; ERICKSON AK, 1994, INFECT IMMUN, V62, P5404, DOI 10.1128/IAI.62.12.5404-5410.1994; Fahrenkrug SC, 2001, MAMM GENOME, V12, P472, DOI 10.1007/s003350020015; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Francis DH, 1998, INFECT IMMUN, V66, P4050; GIBBONS RA, 1977, THEOR APPL GENET, V51, P65, DOI 10.1007/BF00299479; Grange PA, 1998, INFECT IMMUN, V66, P1613, DOI 10.1128/IAI.66.4.1613-1621.1998; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; GUINEE PAM, 1979, INFECT IMMUN, V23, P700; Guo Y, 2009, ANIM GENET, V40, P47, DOI 10.1111/j.1365-2052.2008.01802.x; Gupta R, 1999, GLYCOBIOLOGY, V9, P1009, DOI 10.1093/glycob/9.10.1009; Hoorens PR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-140; Jacobsen M, 2010, ANIM GENET, V41, P21, DOI 10.1111/j.1365-2052.2009.01952.x; Jacobsen Mette, 2011, BMC Res Notes, V4, P225, DOI 10.1186/1756-0500-4-225; Ji HY, 2011, MOL BIOL REP, V38, P1593, DOI 10.1007/s11033-010-0268-y; Joller D, 2009, ANIM GENET, V40, P749, DOI 10.1111/j.1365-2052.2009.01881.x; Jorgensen C.B., 2004, International application published under the patent cooperation treaty (PCT), Patent No. [PCT/DK2003/000807, 2003000807]; Jorgensen CB, 2003, CYTOGENET GENOME RES, V102, P157, DOI 10.1159/000075742; Jorgensen CB, 2004, International application published under the patent cooperation treaty (PCT), Patent No. [WO2004/048606-A2, 2004048606]; Liu W, 2006, PROG NAT SCI-MATER, V16, P889; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036949, 10.1371/journal.pone.0032127, 10.1371/journal.pone.0040003, 10.1186/1746-1596-7-49]; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Maher DM, 2011, MOL CANCER RES, V9, P531, DOI 10.1158/1541-7786.MCR-10-0443; Moncada DM, 2003, TRENDS PARASITOL, V19, P305, DOI 10.1016/S1471-4922(03)00122-3; Moon HW, 1999, J VET DIAGN INVEST, V11, P557, DOI 10.1177/104063879901100617; Peng QL, 2007, ANIM GENET, V38, P397, DOI 10.1111/j.1365-2052.2007.01608.x; Python P, 2005, J ANIM BREED GENET, V122, P5, DOI 10.1111/j.1439-0388.2005.00490.x; Python P, 2002, ANIM GENET, V33, P441, DOI 10.1046/j.1365-2052.2002.00915.x; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Rampoldi A, 2011, MAMM GENOME, V22, P122, DOI 10.1007/s00335-010-9305-3; Rogel-Gaillard C, 1999, CYTOGENET CELL GENET, V85, P205, DOI 10.1159/000015294; Schroyen M, 2012, ANIM GENET, V43, P324, DOI 10.1111/j.1365-2052.2011.02241.x; Sheng YH, 2011, GUT, V60, P1661, DOI 10.1136/gut.2011.239194; Sobel E, 2001, HUM HERED, V52, P121, DOI 10.1159/000053366; Sobel E, 1996, AM J HUM GENET, V58, P1323; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Wang Y, 2007, J ANIM BREED GENET, V124, P225, DOI 10.1111/j.1439-0388.2007.00664.x; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Yan XM, 2009, J MED MICROBIOL, V58, P1112, DOI 10.1099/jmm.0.009803-0; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zhang B, 2008, ANIM GENET, V39, P258, DOI 10.1111/j.1365-2052.2008.01721.x	48	40	54	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44573	10.1371/journal.pone.0044573	http://dx.doi.org/10.1371/journal.pone.0044573			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984528	Green Published, Green Submitted, gold			2022-12-27	WOS:000308738500066
J	Stella, SL; Vila, A; Hung, AY; Rome, ME; Huynh, U; Sheng, M; Kreienkamp, HJ; Brecha, NC				Stella, Salvatore L., Jr.; Vila, Alejandro; Hung, Albert Y.; Rome, Michael E.; Huynh, Uyenchi; Sheng, Morgan; Kreienkamp, Hans-Juergen; Brecha, Nicholas C.			Association of Shank 1A Scaffolding Protein with Cone Photoreceptor Terminals in the Mammalian Retina	PLOS ONE			English	Article							90/POSTSYNAPTIC DENSITY-95-ASSOCIATED PROTEIN; POSTSYNAPTIC DENSITY PROTEINS; SYNAPSE-ASSOCIATED PROTEIN; SENSITIVE CALCIUM-CHANNEL; DENDRITIC SPINES; MOUSE RETINA; RAT RETINA; IMMUNOCYTOCHEMICAL LOCALIZATION; GLUTAMATE RECEPTORS; EXCITATORY SYNAPSES	Photoreceptor terminals contain post-synaptic density (PSD) proteins e. g., PSD-95/PSD-93, but their role at photoreceptor synapses is not known. PSDs are generally restricted to post-synaptic boutons in central neurons and form scaffolding with multiple proteins that have structural and functional roles in neuronal signaling. The Shank family of proteins (Shank 1-3) functions as putative anchoring proteins for PSDs and is involved in the organization of cytoskeletal/signaling complexes in neurons. Specifically, Shank 1 is restricted to neurons and interacts with both receptors and signaling molecules at central neurons to regulate plasticity. However, it is not known whether Shank 1 is expressed at photoreceptor terminals. In this study we have investigated Shank 1A localization in the outer retina at photoreceptor terminals. We find that Shank 1A is expressed presynaptically in cone pedicles, but not rod spherules, and it is absent from mice in which the Shank 1 gene is deleted. Shank 1A co-localizes with PSD-95, peanut agglutinin, a marker of cone terminals, and glycogen phosphorylase, a cone specific marker. These findings provide convincing evidence for Shank 1A expression in both the inner and outer plexiform layers, and indicate a potential role for PSD-95/Shank 1 complexes at cone synapses in the outer retina.	[Stella, Salvatore L., Jr.] Univ Missouri, Sch Med, Dept Ophthalmol, Kansas City, MO 64108 USA; [Stella, Salvatore L., Jr.] Univ Missouri, Sch Med, Dept Basic Med Sci, Kansas City, MO 64108 USA; [Brecha, Nicholas C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Stella, Salvatore L., Jr.; Vila, Alejandro; Rome, Michael E.; Huynh, Uyenchi; Brecha, Nicholas C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Brecha, Nicholas C.] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Brecha, Nicholas C.] VAGLAHS, CURE Digest Dis Res Ctr, Los Angeles, CA USA; [Brecha, Nicholas C.] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; [Kreienkamp, Hans-Juergen] Univ Klinikum Hamburg Eppendorf, Inst Humangenet, Hamburg, Germany; [Hung, Albert Y.; Sheng, Morgan] MIT, Picower Inst Learning & Memory, Inst Phys & Chem Res RIKEN, Neurosci Res Ctr,Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Hung, Albert Y.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of Hamburg; University Medical Center Hamburg-Eppendorf; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Harvard University; Massachusetts General Hospital	Stella, SL (corresponding author), Univ Missouri, Sch Med, Dept Ophthalmol, Kansas City, MO 64108 USA.	stellas@umkc.edu		Stella Jr., Salvatore/0000-0003-1971-2537	National Institutes of Health [EY 04067, DK 41301, NS41411]; Department of Veterans Affairs; Fight for Sight [GA05039]; Deutsche Forschungsgemeinschaft [Kr 1321/3-1, Kr 1321/4-1]; NATIONAL EYE INSTITUTE [R01EY004067, R56EY004067, R01EY015573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS041411] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Fight for Sight; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institutes of Health, grants EY 04067 (NCB) and DK 41301 (NCB). A Senior Career Scientist Award from the Department of Veterans Affairs to NCB. A Fight for Sight Grant-in-Aid (GA05039) to SLS, Jr., and the Deutsche Forschungsgemeinschaft (Kr 1321/3-1 and Kr 1321/4-1) to HJK. AYH was a recipient of National Institutes of Health K08 Award NS41411. MS is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball SL, 2003, VISUAL NEUROSCI, V20, P267, DOI 10.1017/S0952523803203059; Barnes S, 2002, ADV EXP MED BIOL, V514, P465; Blackmon SM, 2000, BRAIN RES, V885, P53, DOI 10.1016/S0006-8993(00)02928-0; BLANKS JC, 1984, INVEST OPHTH VIS SCI, V25, P546; Boeckers TM, 1999, BIOCHEM BIOPH RES CO, V264, P247, DOI 10.1006/bbrc.1999.1489; Boeckers TM, 1999, J NEUROSCI, V19, P6506; Brandstatter JH, 2004, J COMP NEUROL, V475, P551, DOI 10.1002/cne.20194; Calin-Jageman I, 2007, J NEUROSCI, V27, P1374, DOI 10.1523/JNEUROSCI.5191-06.2007; Chetkovich DM, 2002, J NEUROSCI, V22, P6415; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; El-Hussein AE, 2000, SCIENCE, V290, P1364; FARISS RN, 1990, EXP EYE RES, V51, P473, DOI 10.1016/0014-4835(90)90160-V; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gessert S, 2011, DEV DYNAM, V240, P1528, DOI 10.1002/dvdy.22613; Haverkamp S, 2005, J NEUROSCI, V25, P5438, DOI 10.1523/JNEUROSCI.1117-05.2005; Heidelberger R, 2005, PROG RETIN EYE RES, V24, P682, DOI 10.1016/j.preteyeres.2005.04.002; Hirano AA, 2005, J COMP NEUROL, V488, P70, DOI 10.1002/cne.20577; Hirao K, 2000, GENES CELLS, V5, P203, DOI 10.1046/j.1365-2443.2000.00318.x; Hung AY, 2008, J NEUROSCI, V28, P1697, DOI 10.1523/JNEUROSCI.3032-07.2008; IWASAKI M, 1992, J COMP NEUROL, V319, P277, DOI 10.1002/cne.903190207; Johnson J, 2003, J NEUROSCI, V23, P518, DOI 10.1523/JNEUROSCI.23-02-00518.2003; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kim JH, 2009, EXP MOL MED, V41, P236, DOI 10.3858/emm.2009.41.4.026; Koulen P, 1998, J NEUROSCI, V18, P10136; Lim S, 1999, J BIOL CHEM, V274, P29510, DOI 10.1074/jbc.274.41.29510; Mehta S, 2001, J BIOL CHEM, V276, P16092, DOI 10.1074/jbc.M100643200; Morgans CW, 2005, VISUAL NEUROSCI, V22, P561, DOI 10.1017/S0952523805225038; Morgans CW, 2001, MOL VIS, V7, P202; Morgans CW, 2001, INVEST OPHTH VIS SCI, V42, P2414; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Pfeiffer-Guglielmi B, 2003, J NEUROCHEM, V85, P73, DOI 10.1046/j.1471-4159.2003.01644.x; Pham E, 2010, FEBS J, V277, P3051, DOI 10.1111/j.1742-4658.2010.07719.x; Quitsch A, 2005, J NEUROSCI, V25, P479, DOI 10.1523/JNEUROSCI.2699-04.2005; ROSTAS JAP, 1991, MOL NEUROBIOL, V5, P203, DOI 10.1007/BF02935546; Sala C, 2005, J NEUROSCI, V25, P4587, DOI 10.1523/JNEUROSCI.4822-04.2005; Sala C, 2003, J NEUROSCI, V23, P6327; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Schluter OM, 2006, NEURON, V51, P99, DOI 10.1016/j.neuron.2006.05.016; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Schmitz Y, 1997, NEUROSCIENCE, V78, P1209, DOI 10.1016/S0306-4522(96)00678-1; Schutt J, 2009, J BIOL CHEM, V284, P25479, DOI 10.1074/jbc.M109.042663; Sharma K, 2006, MOL CELL NEUROSCI, V31, P702, DOI 10.1016/j.mcn.2006.01.010; Sheng M, 2000, J CELL SCI, V113, P1851; Sheng M, 2001, J CELL SCI, V114, P1251; Sherry DM, 2003, J COMP NEUROL, V465, P480, DOI 10.1002/cne.10838; Stella SL, 2007, J NEUROSCI RES, V85, P1126, DOI 10.1002/jnr.21210; Stella SL, 2002, J NEUROPHYSIOL, V87, P351, DOI 10.1152/jn.00010.2001; Taylor WR, 1998, VISUAL NEUROSCI, V15, P541; Thomas U, 1997, MECH DEVELOP, V62, P161, DOI 10.1016/S0925-4773(97)00658-8; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Wassle H, 2006, J COMP NEUROL, V496, P544, DOI 10.1002/cne.20942; Wilkinson MF, 1996, J GEN PHYSIOL, V107, P621, DOI 10.1085/jgp.107.5.621; Wyneken U, 2004, BRAIN RES REV, V47, P54, DOI 10.1016/j.brainresrev.2004.06.005; Yao I, 1999, J BIOL CHEM, V274, P27463, DOI 10.1074/jbc.274.39.27463; Yao I, 2002, J NEUROSCI, V22, P5354; ZHANG DR, 1991, VISUAL NEUROSCI, V6, P429, DOI 10.1017/S0952523800001292; Zhang H, 2005, J NEUROSCI, V25, P1037, DOI 10.1523/JNEUROSCI.4554-04.2005; Zhang H, 2006, EUR J NEUROSCI, V23, P2297, DOI 10.1111/j.1460-9568.2006.04734.x; Zitzer H, 1999, J BIOL CHEM, V274, P32997, DOI 10.1074/jbc.274.46.32997	66	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43463	10.1371/journal.pone.0043463	http://dx.doi.org/10.1371/journal.pone.0043463			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984429	gold, Green Submitted, Green Published			2022-12-27	WOS:000308738500015
J	Lavin, KM; Straub, AM; Uhranowsky, KA; Smoliga, JM; Zavorsky, GS				Lavin, Kaleen M.; Straub, Allison M.; Uhranowsky, Kathleen A.; Smoliga, James M.; Zavorsky, Gerald S.			Alveolar-Membrane Diffusing Capacity Limits Performance in Boston Marathon Qualifiers	PLOS ONE			English	Article							INDUCED ARTERIAL HYPOXEMIA; CHRONIC HEART-FAILURE; NITRIC-OXIDE; CARBON-MONOXIDE; EXERCISE PERFORMANCE; PULMONARY DIFFUSION; AEROBIC CAPACITY; REFERENCE VALUES; LUNG DIFFUSION; SEA-LEVEL	Purpose: (1) to examine the relation between pulmonary diffusing capacity and marathon finishing time, and (2), to evaluate the accuracy of pulmonary diffusing capacity for nitric oxide (DLNO) in predicting marathon finishing time relative to that of pulmonary diffusing capacity for carbon monoxide (DLCO). Methods: 28 runners [18 males, age = 37 (SD 9) years, body mass = 70 (13) kg, height = 173 (9) cm, percent body fat = 17 (7) %] completed a test battery consisting of measurement of DLNO and DLCO at rest, and a graded exercise test to determine running economy and aerobic capacity prior to the 2011 Steamtown Marathon (Scranton, PA). One to three weeks later, all runners completed the marathon (range: 2: 22: 38 to 4: 48: 55). Linear regressions determined the relation between finishing time and a variety of anthropometric characteristics, resting lung function variables, and exercise parameters. Results: In runners meeting Boston Marathon qualification standards, 74% of the variance in marathon finishing time was accounted for by differences in DLNO relative to body surface area (BSA) (SEE = 11.8 min, p<0.01); however, the relation between DLNO or DLCO to finishing time was non-significant in the non-qualifiers (p = 0.14 to 0.46). Whereas both DLCO and DLNO were predictive of finishing time for all finishers, DLNO showed a stronger relation (r(2) = 0.30, SEE = 33.4 min, p<0.01) compared to DLCO when considering BSA. Conclusion: DLNO is a performance-limiting factor in only Boston qualifiers. This suggests that alveolar-capillary membrane conductance is a limitation to performance in faster marathoners. Additionally, DLNO/BSA predicts marathon finishing time and aerobic capacity more accurately than DLCO.	[Lavin, Kaleen M.; Straub, Allison M.; Uhranowsky, Kathleen A.; Zavorsky, Gerald S.] Marywood Univ, Human Physiol Lab, Scranton, PA 18509 USA; [Zavorsky, Gerald S.] Commonwealth Med Coll, Scranton, PA USA; [Smoliga, James M.] High Point Univ, Dept Phys Therapy, High Point, NC USA	Geisinger Commonwealth School of Medicine	Lavin, KM (corresponding author), Marywood Univ, Human Physiol Lab, Scranton, PA 18509 USA.	zavorsky@marywood.edu	Zavorsky, Gerald S./AAI-1422-2021; Zavorsky, Gerald S./I-7753-2013	Zavorsky, Gerald S./0000-0002-4473-1601; Zavorsky, Gerald S./0000-0002-4473-1601; Smoliga, James/0000-0002-1895-5687; Lavin, Kaleen/0000-0003-1426-8174				Aguilaniu B, 2008, EUR RESPIR J, V31, P1091, DOI 10.1183/09031936.00063207; Amann M, 2012, EXP PHYSIOL, V97, P311, DOI 10.1113/expphysiol.2011.058800; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Billat VL, 2001, MED SCI SPORT EXER, V33, P2089, DOI 10.1097/00005768-200112000-00018; BORLAND CDR, 1989, EUR RESPIR J, V2, P56; Ceridon ML, 2010, J APPL PHYSIOL, V109, P643, DOI 10.1152/japplphysiol.01411.2009; Coyle EF, 2007, SPORTS MED, V37, P306, DOI 10.2165/00007256-200737040-00009; de Bisschop C, 2012, J APPL PHYSIOL, V112, P20, DOI 10.1152/japplphysiol.00670.2011; DEMPSEY JA, 1984, J PHYSIOL-LONDON, V355, P161, DOI 10.1113/jphysiol.1984.sp015412; DEMPSEY JA, 1985, AM J CARDIOL, V55, pD59, DOI 10.1016/0002-9149(85)91056-2; Dennis SC, 1999, EUR J APPL PHYSIOL, V79, P280, DOI 10.1007/s004210050507; Florence SL, 1997, EUR J APPL PHYSIOL O, V75, P274, DOI 10.1007/s004210050160; Guazzi M, 2002, EUR HEART J, V23, P467, DOI 10.1053/euhj.2001.2803; Hagan R D, 1987, Br J Sports Med, V21, P3; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; HANSON P, 1982, J APPL PHYSIOL, V52, P615, DOI 10.1152/jappl.1982.52.3.615; Harms CA, 2000, MED SCI SPORT EXER, V32, P1101, DOI 10.1097/00005768-200006000-00010; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; Joyner MJ, 2011, J APPL PHYSIOL, V110, P275, DOI 10.1152/japplphysiol.00563.2010; KOSKOLOU MD, 1994, EUR J APPL PHYSIOL, V68, P80, DOI 10.1007/BF00599246; La Torre A, 2011, J STRENGTH COND RES, V25, P3242, DOI 10.1519/JSC.0b013e31821bf2bd; Loftin M, 2007, J STRENGTH COND RES, V21, P1188; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; MANIER G, 1991, RESP PHYSIOL, V83, P143, DOI 10.1016/0034-5687(91)90024-D; MARON MB, 1976, J APPL PHYSIOL, V40, P836, DOI 10.1152/jappl.1976.40.5.836; MAUGHAN RJ, 1983, EUR J APPL PHYSIOL O, V52, P80, DOI 10.1007/BF00429030; MILES DS, 1983, RESP PHYSIOL, V52, P349, DOI 10.1016/0034-5687(83)90090-7; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Millet GY, 2011, SCAND J MED SCI SPOR, V21, P54, DOI 10.1111/j.1600-0838.2009.01001.x; POWERS SK, 1988, EUR J APPL PHYSIOL O, V58, P298, DOI 10.1007/BF00417266; PURI S, 1995, CIRCULATION, V91, P2769, DOI 10.1161/01.CIR.91.11.2769; Rapoport BI, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000960; Romer LM, 2006, AM J PHYSIOL-REG I, V290, pR365, DOI 10.1152/ajpregu.00332.2005; ROUGHTON FJW, 1957, J APPL PHYSIOL, V11, P290, DOI 10.1152/jappl.1957.11.2.290; SJODIN B, 1985, SPORTS MED, V2, P83; Stellingwerff T, 2011, J APPL PHYSIOL, V110, P278, DOI 10.1152/japplphysiol.01259.2010; Tamhane RM, 2001, CHEST, V120, P1850, DOI 10.1378/chest.120.6.1850; Wagner PD, 2005, EXERC SPORT SCI REV, V33, P3; Wilkinson L, 1999, AM PSYCHOL, V54, P594, DOI 10.1037/0003-066X.54.8.594; Zavorsky GS, 2010, ACTA PHYSIOL, V198, P499, DOI 10.1111/j.1748-1716.2009.02059.x; Zavorsky GS, 2008, NITRIC OXIDE-BIOL CH, V18, P70, DOI 10.1016/j.niox.2007.10.002; Zavorsky GS, 2005, NITRIC OXIDE-BIOL CH, V12, P31, DOI 10.1016/j.niox.2004.11.002	42	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44513	10.1371/journal.pone.0044513	http://dx.doi.org/10.1371/journal.pone.0044513			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984520	Green Published, gold, Green Submitted			2022-12-27	WOS:000308638700067
J	Velyvis, A; Ruschak, AM; Kay, LE				Velyvis, Algirdas; Ruschak, Amy M.; Kay, Lewis E.			An Economical Method for Production of H-2, (CH3)-C-13-Threonine for Solution NMR Studies of Large Protein Complexes: Application to the 670 kDa Proteasome	PLOS ONE			English	Article							MOLECULAR-WEIGHT PROTEINS; ESCHERICHIA-COLI; 2-KETO-4-HYDROXYGLUTARATE ALDOLASE; THREONINE DEHYDROGENASE; LABELING STRATEGIES; 20S PROTEASOME; SPECTROSCOPY; C-13; RELAXATION; TROSY	NMR studies of very high molecular weight protein complexes have been greatly facilitated through the development of labeling strategies whereby (CH3)-C-13 methyl groups are introduced into highly deuterated proteins. Robust and cost-effective labeling methods are well established for all methyl containing amino acids with the exception of Thr. Here we describe an inexpensive biosynthetic strategy for the production of L-[alpha-H-2; beta-H-2; gamma-C-13]-Thr that can then be directly added during protein expression to produce highly deuterated proteins with Thr methyl group probes of structure and dynamics. These reporters are particularly valuable, because unlike other methyl containing amino acids, Thr residues are localized predominantly to the surfaces of proteins, have unique hydrogen bonding capabilities, have a higher propensity to be found at protein nucleic acid interfaces and can play important roles in signaling pathways through phosphorylation. The utility of the labeling methodology is demonstrated with an application to the 670 kDa proteasome core particle, where high quality Thr C-13,H-1 correlation spectra are obtained that could not be generated from samples prepared with commercially available U-[C-13,H-1]-Thr.	[Velyvis, Algirdas; Ruschak, Amy M.; Kay, Lewis E.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Velyvis, Algirdas; Ruschak, Amy M.; Kay, Lewis E.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Velyvis, Algirdas; Ruschak, Amy M.; Kay, Lewis E.] Univ Toronto, Dept Chem, Toronto, ON M5S 1A1, Canada; [Kay, Lewis E.] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Velyvis, A (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	algirdas.velyvis@utoronto.ca; kay@pound.med.utoronto.ca			Canadian Institutes of Health Research (CIHR); CIHR; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Salary support for A.M.R. was obtained in the form of a Canadian Institutes of Health Research (CIHR) post-doctoral fellowship. This work was supported by grants from the CIHR and the Natural Sciences and Engineering Research Council of Canada (L.E.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amero C, 2009, J AM CHEM SOC, V131, P3448, DOI 10.1021/ja809880p; Ayala I, 2009, J BIOMOL NMR, V43, P111, DOI 10.1007/s10858-008-9294-7; Baldwin AJ, 2011, J MOL BIOL, V413, P310, DOI 10.1016/j.jmb.2011.07.017; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Clapes P, 2010, CURR OPIN CHEM BIOL, V14, P154, DOI 10.1016/j.cbpa.2009.11.029; CLORE GM, 1991, SCIENCE, V252, P1390, DOI 10.1126/science.2047852; Fesko K, 2008, J MOL CATAL B-ENZYM, V52-53, P19, DOI 10.1016/j.molcatb.2007.10.010; Fiaux J, 2002, NATURE, V418, P207, DOI 10.1038/nature00860; Fischer M, 2007, CHEMBIOCHEM, V8, P610, DOI 10.1002/cbic.200600551; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Freeman AK, 2011, SEMIN CELL DEV BIOL, V22, P681, DOI 10.1016/j.semcdb.2011.08.009; Gans P, 2010, ANGEW CHEM INT EDIT, V49, P1958, DOI 10.1002/anie.200905660; Gardino AK, 2011, SEMIN CELL DEV BIOL, V22, P688, DOI 10.1016/j.semcdb.2011.09.008; Gardner KH, 1997, J AM CHEM SOC, V119, P7599, DOI 10.1021/ja9706514; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; Gerstein M, 1997, J MOL BIOL, V274, P562, DOI 10.1006/jmbi.1997.1412; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Goto NK, 2000, CURR OPIN STRUC BIOL, V10, P585, DOI 10.1016/S0959-440X(00)00135-4; Goto NK, 1999, J BIOMOL NMR, V13, P369, DOI 10.1023/A:1008393201236; GRZESIEK S, 1993, J AM CHEM SOC, V115, P4369, DOI 10.1021/ja00063a068; Haines DC, 2001, BIOCHEMISTRY-US, V40, P13456, DOI 10.1021/bi011197q; Hamel DJ, 2005, J AM CHEM SOC, V127, P9676, DOI 10.1021/ja052517m; Huo XW, 1996, BIOCHEMISTRY-US, V35, P16180, DOI 10.1021/bi962203z; Isaacson RL, 2007, J AM CHEM SOC, V129, P15428, DOI 10.1021/ja0761784; Kainosho M, 2006, NATURE, V440, P52, DOI 10.1038/nature04525; Karagoz GE, 2011, P NATL ACAD SCI USA, V108, P580, DOI 10.1073/pnas.1011867108; Kato H, 2011, P NATL ACAD SCI USA, V108, P12283, DOI 10.1073/pnas.1105848108; Kim D, 2009, BIOTECHNOL LETT, V31, P1427, DOI 10.1007/s10529-009-0016-3; Kreishman-Deitrick M, 2005, BIOCHEMISTRY-US, V44, P15247, DOI 10.1021/bi051065n; Kupce E, 1996, J MAGN RESON SER B, V110, P309, DOI 10.1006/jmrb.1996.0048; LABER B, 1994, BIOCHEMISTRY-US, V33, P3413, DOI 10.1021/bi00177a035; LANE RS, 1971, BIOCHEMISTRY-US, V10, P1353; Laver WG, 1959, J CHEM SOC, P1483; LeMaster DM, 1996, J AM CHEM SOC, V118, P9255, DOI 10.1021/ja960877r; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; MARCUS JP, 1993, J BACTERIOL, V175, P6505, DOI 10.1128/jb.175.20.6505-6511.1993; MARCUS JP, 1993, BIOCHEM BIOPH RES CO, V190, P1066, DOI 10.1006/bbrc.1993.1157; MARCUS JP, 1993, BIOCHIM BIOPHYS ACTA, V1164, P299, DOI 10.1016/0167-4838(93)90262-P; McCourt JA, 2006, AMINO ACIDS, V31, P173, DOI 10.1007/s00726-005-0297-3; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Ollerenshaw JE, 2005, J BIOMOL NMR, V33, P25, DOI 10.1007/s10858-005-2614-2; Ollerenshaw JE, 2003, MAGN RESON CHEM, V41, P843, DOI 10.1002/mrc.1256; Ost TWB, 2000, FEBS LETT, V486, P173, DOI 10.1016/S0014-5793(00)02267-5; PATIL RV, 1992, J BACTERIOL, V174, P102, DOI 10.1128/jb.174.1.102-107.1992; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Religa TL, 2011, J AM CHEM SOC, V133, P9063, DOI 10.1021/ja202259a; Religa TL, 2010, J BIOMOL NMR, V47, P163, DOI 10.1007/s10858-010-9419-7; Religa TL, 2010, SCIENCE, V328, P98, DOI 10.1126/science.1184991; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Ruschak AM, 2010, J BIOMOL NMR, V48, P129, DOI 10.1007/s10858-010-9449-1; Ruschak AM, 2010, NATURE, V467, P868, DOI 10.1038/nature09444; SANTORO J, 1992, J MAGN RESON, V97, P202, DOI 10.1016/0022-2364(92)90250-B; SEEMULLER E, 1995, SCIENCE, V268, P579, DOI 10.1126/science.7725107; Sinha K, 2011, BIOCHEMISTRY-US, V50, P10189, DOI 10.1021/bi201496d; Sprangers R, 2007, NATURE, V445, P618, DOI 10.1038/nature05512; Steinreiber J, 2007, TETRAHEDRON, V63, P918, DOI 10.1016/j.tet.2006.11.035; Stoffregen MC, 2012, STRUCTURE, V20, P573, DOI 10.1016/j.str.2012.02.012; Takeda M, 2011, J AM CHEM SOC, V133, P17420, DOI 10.1021/ja206799v; Tugarinov V, 2004, ANNU REV BIOCHEM, V73, P107, DOI 10.1146/annurev.biochem.73.011303.074004; Tugarinov V, 2004, J BIOMOL NMR, V28, P165, DOI 10.1023/B:JNMR.0000013824.93994.1f; Tugarinov V, 2003, J AM CHEM SOC, V125, P10420, DOI 10.1021/ja030153x; Velyvis A, 2007, P NATL ACAD SCI USA, V104, P8815, DOI 10.1073/pnas.0703347104; VUISTER GW, 1992, J MAGN RESON, V98, P428, DOI 10.1016/0022-2364(92)90144-V; Zhang KC, 2010, P NATL ACAD SCI USA, V107, P6234, DOI 10.1073/pnas.0912903107	65	68	68	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43725	10.1371/journal.pone.0043725	http://dx.doi.org/10.1371/journal.pone.0043725			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984438	Green Submitted, gold, Green Published			2022-12-27	WOS:000308638700027
J	Grachev, P; Li, XF; Lin, YS; Hu, MH; Elsamani, L; Paterson, SJ; Millar, RP; Lightman, SL; O'Byrne, KT				Grachev, Pasha; Li, Xiao Feng; Lin, Yuan Shao; Hu, Ming Han; Elsamani, Leena; Paterson, Stewart J.; Millar, Robert P.; Lightman, Stafford L.; O'Byrne, Kevin T.			GPR54-Dependent Stimulation of Luteinizing Hormone Secretion by Neurokinin B in Prepubertal Rats	PLOS ONE			English	Article							GNRH PULSE-GENERATOR; STRESS-INDUCED SUPPRESSION; MONKEY MACACA-MULATTA; ARCUATE NUCLEUS; GONADOTROPIN-SECRETION; FEMALE RAT; HYPOGONADOTROPIC HYPOGONADISM; MORPHOLOGIC EVIDENCE; KISSPEPTIN NEURONS; SEXUAL-MATURATION	Kisspeptin, neurokinin B (NKB) and dynorphin A (Dyn) are coexpressed within KNDy neurons that project from the hypothalamic arcuate nucleus (ARC) to GnRH neurons and numerous other hypothalamic targets. Each of the KNDy neuropeptides has been implicated in regulating pulsatile GnRH/LH secretion. In isolation, kisspeptin is generally known to stimulate, and Dyn to inhibit LH secretion. However, the NKB analog, senktide, has variously been reported to inhibit, stimulate or have no effect on LH secretion. In prepubertal mice, rats and monkeys, senktide stimulates LH secretion. Furthermore, in the monkey this effect is dependent on kisspeptin signaling through its receptor, GPR54. The present study tested the hypotheses that the stimulatory effects of NKB on LH secretion in intact rats are mediated by kisspeptin/GPR54 signaling and are independent of a Dyn tone. To test this, ovarian-intact prepubertal rats were subjected to frequent automated blood sampling before and after intracerebroventricular injections of KNDy neuropeptide analogs. Senktide robustly induced single LH pulses, while neither the GPR54 antagonist, Kp-234, nor the Dyn agonist and antagonist (U50488 and nor-BNI, respectively) had an effect on basal LH levels. However, Kp-234 potently blocked the senktide-induced LH pulses. Modulation of the Dyn tone by U50488 or nor-BNI did not affect the senktide-induced LH pulses. These data demonstrate that the stimulatory effect of NKB on LH secretion in intact female rats is dependent upon kisspeptin/GPR54 signaling, but not on Dyn signaling.	[Grachev, Pasha; Li, Xiao Feng; Lin, Yuan Shao; Hu, Ming Han; Elsamani, Leena; O'Byrne, Kevin T.] Kings Coll London, Sch Med, Div Womens Hlth, London WC2R 2LS, England; [Paterson, Stewart J.] Kings Coll London, Sch Biomed Sci, Dept Pharmacol & Therapeut, London WC2R 2LS, England; [Millar, Robert P.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Millar, Robert P.] Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0002 Pretoria, South Africa; [Millar, Robert P.] Univ Cape Town, Res Grp Receptor Biol, MRC, Div Med Biochem,Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Lightman, Stafford L.] Univ Bristol, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol, Avon, England	University of London; King's College London; University of London; King's College London; University of Edinburgh; University of Pretoria; University of Cape Town; University of Bristol	O'Byrne, KT (corresponding author), Kings Coll London, Sch Med, Div Womens Hlth, London WC2R 2LS, England.	kevin.o'byrne@kcl.ac.uk	Grachev, Pasha/I-4460-2019; Grachev, Pasha/A-1193-2012; Hu, Minghan/L-3085-2019	Grachev, Pasha/0000-0002-6611-6423; Grachev, Pasha/0000-0002-6611-6423; Millar, Robert P/0000-0003-3606-2708; Lightman, Stafford/0000-0002-8546-9646	Biotechnology and Biological Sciences Research Council (BBSRC) UK; Medical Research Council (MRC) UK; BBSRC [BB/J002232/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J002232/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC) UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) UK. PG is a recipient of a Medical Research Council (MRC) UK PhD Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARB CR, 1988, BIOL REPROD, V39, P603, DOI 10.1095/biolreprod39.3.603; BHANOT R, 1983, ENDOCRINOLOGY, V113, P596, DOI 10.1210/endo-113-2-596; Bowe JE, 2005, J PHYSIOL-LONDON, V566, P921, DOI 10.1113/jphysiol.2005.085662; Burke MC, 2006, J COMP NEUROL, V498, P712, DOI 10.1002/cne.21086; Cates PS, 1999, J NEUROENDOCRINOL, V11, P677; Chan YM, 2009, J NEUROENDOCRINOL, V21, P1015, DOI 10.1111/j.1365-2826.2009.01926.x; Chan YM, 2011, J CLIN ENDOCR METAB, V96, pE1771, DOI 10.1210/jc.2011-0518; Ciofi P, 2007, NEUROSCIENCE, V146, P630, DOI 10.1016/j.neuroscience.2007.02.028; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; EBLING FJP, 1989, ENDOCRINOLOGY, V125, P369, DOI 10.1210/endo-125-1-369; Francou B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025614; Garcia-Galiano D, 2012, ENDOCRINOLOGY, V153, P316, DOI 10.1210/en.2011-1260; Goodman RL, 2007, ENDOCRINOLOGY, V148, P5752, DOI 10.1210/en.2007-0961; Grachev P, 2012, ENDOCRINOLOGY, DOI [10.1210/en.2012-1574, DOI 10.1210/EN.20121574]; KALRA SP, 1983, ENDOCR REV, V4, P311, DOI 10.1210/edrv-4-4-311; Kauffman AS, 2009, AM J PHYSIOL-ENDOC M, V297, pE1212, DOI 10.1152/ajpendo.00461.2009; KIMURA F, 1982, NEUROENDOCRINOLOGY, V35, P128, DOI 10.1159/000123367; KINOSHITA F, 1982, LIFE SCI, V30, P1915, DOI 10.1016/0024-3205(82)90472-6; Kinsey-Jones JS, 2012, ENDOCRINOLOGY, V153, P307, DOI 10.1210/en.2011-1641; KNOBIL E, 1990, AM J OBSTET GYNECOL, V163, P1721, DOI 10.1016/0002-9378(90)91435-F; Krajewski SJ, 2010, NEUROSCIENCE, V166, P680, DOI 10.1016/j.neuroscience.2009.12.053; Krajewski SJ, 2005, J COMP NEUROL, V489, P372, DOI 10.1002/cne.20626; Li XF, 2003, J NEUROENDOCRINOL, V15, P468, DOI 10.1046/j.1365-2826.2003.01014.x; Li XF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008334; MAURAS N, 1987, J ANDROL, V8, P203; Mayer C, 2011, NAT NEUROSCI, V14, P704, DOI 10.1038/nn.2818; MEDHAMURTHY R, 1990, ENDOCRINOLOGY, V126, P1036, DOI 10.1210/endo-126-2-1036; MONROE SE, 1968, ENDOCRINOLOGY, V83, P1004, DOI 10.1210/endo-83-5-1004; Navarro VM, 2011, ENDOCRINOLOGY, V152, P4265, DOI 10.1210/en.2011-1143; Navarro VM, 2012, J NEUROSCI, V32, P2388, DOI 10.1523/JNEUROSCI.4288-11.2012; Navarro VM, 2011, AM J PHYSIOL-ENDOC M, V300, pE202, DOI 10.1152/ajpendo.00517.2010; Navarro Victor M, 2011, Front Biosci (Schol Ed), V3, P267, DOI 10.2741/s150; Navarro VM, 2009, J NEUROSCI, V29, P11859, DOI 10.1523/JNEUROSCI.1569-09.2009; Navarro VM, 2004, J PHYSIOL-LONDON, V561, P379, DOI 10.1113/jphysiol.2004.072298; Neal-Perry G, 2009, ENDOCRINOLOGY, V150, P3699, DOI 10.1210/en.2008-1667; OHKURA S, 1991, J NEUROENDOCRINOL, V3, P503, DOI 10.1111/j.1365-2826.1991.tb00310.x; Ojeda Sergio R., 1994, P363; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Pineda R, 2010, ENDOCRINOLOGY, V151, P722, DOI 10.1210/en.2009-0803; Ramaswamy S, 2011, NEUROENDOCRINOLOGY, V94, P237, DOI 10.1159/000329045; Rance NE, 2010, BRAIN RES, V1364, P116, DOI 10.1016/j.brainres.2010.08.059; RECABARREN SE, 1989, J VET MED A, V36, P467, DOI 10.1111/j.1439-0442.1989.tb00754.x; SAUDER SE, 1984, PEDIATR RES, V18, P322, DOI 10.1203/00006450-198404000-00004; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Takase K, 2009, J NEUROENDOCRINOL, V21, P527, DOI 10.1111/j.1365-2826.2009.01868.x; Takumi K, 2011, J MOL NEUROSCI, V43, P138, DOI 10.1007/s12031-010-9430-1; Topaloglu AK, 2009, NAT GENET, V41, P354, DOI 10.1038/ng.306; True C, 2011, J NEUROENDOCRINOL, V23, P52, DOI 10.1111/j.1365-2826.2010.02076.x; ULLOAAGUIRRE A, 1988, CLIN ENDOCRINOL, V29, P17, DOI 10.1111/j.1365-2265.1988.tb00245.x; VANCAUTER E, 1988, AM J PHYSIOL, V254, pE786, DOI 10.1152/ajpendo.1988.254.6.E786; Wakabayashi Y, 2010, J NEUROSCI, V30, P3124, DOI 10.1523/JNEUROSCI.5848-09.2010; YOUNGLAI EV, 1988, CAN J PHYSIOL PHARM, V66, P38, DOI 10.1139/y88-007	52	49	53	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e44344	10.1371/journal.pone.0044344	http://dx.doi.org/10.1371/journal.pone.0044344			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028524	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900009
J	Jansen, BD; Jenks, JA				Jansen, Brian D.; Jenks, Jonathan A.			Birth Timing for Mountain Lions (Puma concolor); Testing the Prey Availability Hypothesis	PLOS ONE			English	Article							SURVIVAL; COUGARS; CONSERVATION; POPULATION; DISPERSAL; PATTERNS	We investigated potential advantages in birth timing for mountain lion (Puma concolor) cubs. We examined cub body mass, survival, and age of natal dispersal in relation to specific timing of birth. We also investigated the role of maternal age relative to timing of births. We captured mountain lion cubs while in the natal den to determine birth date, which allowed for precise estimates of the population birth pulse and age of natal dispersal. A birth pulse occurred during June-August. Body mass of cubs was related to litter size and timing of birth; heaviest cubs occurred in litters of 2, and those born after 1 July. Cubs born within pulse months exhibited similar survival to those born out of the pulse. We found that cubs born April-June dispersed at younger ages than those born after 1 July. There was less variation in birth timing for 1st litters of females than older females. We hypothesize that cubs born after the peak in births of neonate prey are advantaged by the abundance of vulnerable prey and those cubs and mothers realize an evolutionary advantage.	[Jansen, Brian D.; Jenks, Jonathan A.] S Dakota State Univ, Dept Nat Resource Management, Brookings, SD 57007 USA	South Dakota State University	Jansen, BD (corresponding author), S Dakota State Univ, Dept Nat Resource Management, Brookings, SD 57007 USA.	bighorns101@yahoo.com	Jenks, Jonathan A/B-7321-2009		Federal Aid in Fish and Wildlife Restoration [7587]	Federal Aid in Fish and Wildlife Restoration	This study was funded by Federal Aid in Fish and Wildlife Restoration administered through South Dakota Game, Fish and Parks (Study Number 7587). The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript. The authors acknowledge that members of the funding agency participated in capture of study animals.	Barber-Meyer SM, 2008, WILDLIFE MONOGR, P1, DOI 10.2193/2008-004; Bauer JW, 2005, SW NATURALIST, V50, P446, DOI [10.1894/0038-4909(2005)050[0466:SBIP]2.0.CO;2, DOI 10.1894/0038-4909(2005)050C[0466:SBIP]2.0.CO;2]; BEIER P, 1995, J WILDLIFE MANAGE, V59, P228, DOI 10.2307/3808935; Berger J, 2001, SCIENCE, V291, P1036, DOI 10.1126/science.1056466; Bleich VC, 1996, GREAT BASIN NAT, V56, P276; Currier M.J.P, 1983, MAMMALIAN SPECIES, V200, P1, DOI [10.2307/3503951, DOI 10.2307/3503951]; Fisher DO, 2002, EVOLUTION, V56, P167; Froiland S. G., 1990, NATURAL HIST BLACK H; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Halls L.K., 1978, P43; Hemker T.P., 1986, P327; HEMKER TP, 1984, J WILDLIFE MANAGE, V48, P1275, DOI 10.2307/3801788; Hornocker M.G., 1970, WILDLIFE MONOGR, V21, P3; Jansen B.D., 2005, THESIS U ARIZONA TUC; Johnson JR, 1999, PLANTS BLACK HILLS B; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kreeger T.J., 1996, HDB WILDLIFE CHEM IM; Laundre JW, 2007, J MAMMAL, V88, P1300, DOI 10.1644/06-MAMM-A-296R.1; Lent P.C., 1974, IUCN Publs (New Series), VNo. 24, P14; LINDZEY F. G., 2000, GUIDE ESTIMATING MOU; Logan KA, 1999, WILDLIFE SOC B, V27, P201; Logan KA, 2001, DESERT PUMA EVOLUTIO, P1; POLLOCK KH, 1989, J WILDLIFE MANAGE, V53, P7, DOI 10.2307/3801296; Robbins C. T, 2001, WILDLIFE FEEDING NUT; ROBINETTE W. LESLIE, 1961, JOUR MAMMAL, V42, P204, DOI 10.2307/1376830; ROSS PI, 1992, J WILDLIFE MANAGE, V56, P417, DOI 10.2307/3808853; RUTBERG AT, 1987, AM NAT, V130, P692, DOI 10.1086/284739; Samuel M. D., 1996, RES MANAGEMENT TECHN, P370; Schmitz LE, 2006, THESIS S DAKOTA STAT; Schmitz LE, 2010, 201005 S DAK GAM FIS, P1; Sweanor LL, 2000, CONSERV BIOL, V14, P798, DOI 10.1046/j.1523-1739.2000.99079.x; Thompson D. J., 2009, THESIS S DAKOTA STAT; Wallace MC, 1996, BIOL DEER, P69; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Whittaker DG, 1999, WILDLIFE SOC B, V27, P256; [No title captured]	36	19	19	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e44625	10.1371/journal.pone.0044625	http://dx.doi.org/10.1371/journal.pone.0044625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028569	Green Published, gold, Green Submitted			2022-12-27	WOS:000309554700014
J	Watson, CT; Disanto, G; Sandve, GK; Breden, F; Giovannoni, G; Ramagopalan, SV				Watson, Corey T.; Disanto, Giulio; Sandve, Geir Kjetil; Breden, Felix; Giovannoni, Gavin; Ramagopalan, Sreeram V.			Age-Associated Hyper-Methylated Regions in the Human Brain Overlap with Bivalent Chromatin Domains	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; LARGE GENE LISTS; DNA METHYLATION; EPIGENETIC DIFFERENCES; ALZHEIMERS-DISEASE; MONOZYGOTIC TWINS; HYPERMETHYLATION; PLURIPOTENT; SIGNATURES	Recent associations between age-related differentially methylated sites and bivalently marked chromatin domains have implicated a role for these genomic regions in aging and age-related diseases. However, the overlap between such epigenetic modifications has so far only been identified with respect to age-associated hyper-methylated sites in blood. In this study, we observed that age-associated differentially methylated sites characterized in the human brain were also highly enriched in bivalent domains. Analysis of hyper-vs. hypo-methylated sites partitioned by age (fetal, child, and adult) revealed that enrichment was significant for hyper-methylated sites identified in children and adults (child, fold difference = 2.28, P = 0.0016; adult, fold difference = 4.73, P = 4.00 x 10(-5)); this trend was markedly more pronounced in adults when only the top 100 most significantly hypo-and hyper-methylated sites were considered (adult, fold difference = 10.7, P = 2.00 x 10(-5)). Interestingly, we found that bivalently marked genes overlapped by age-associated hyper-methylation in the adult brain had strong involvement in biological functions related to developmental processes, including neuronal differentiation. Our findings provide evidence that the accumulation of methylation in bivalent gene regions with age is likely to be a common process that occurs across tissue types. Furthermore, particularly with respect to the aging brain, this accumulation might be targeted to loci with important roles in cell differentiation and development, and the closing off of these developmental pathways. Further study of these genes is warranted to assess their potential impact upon the development of age-related neurological disorders.	[Giovannoni, Gavin; Ramagopalan, Sreeram V.] Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England; [Watson, Corey T.; Breden, Felix] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Disanto, Giulio] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Disanto, Giulio] Univ Oxford, Dept Clin Neurol, John Radcliffe Hosp, Oxford, England; [Sandve, Geir Kjetil] Univ Oslo, Dept Informat, N-0316 Oslo, Norway; [Ramagopalan, Sreeram V.] Univ Oxford, Dept Physiol Anat & Genet, MRC, Funct Genom Unit, Oxford, England	University of London; Queen Mary University London; Simon Fraser University; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oslo; University of Oxford	Ramagopalan, SV (corresponding author), Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England.	s.ramagopalan@qmul.ac.uk		Watson, Corey/0000-0001-7248-8787; Sandve, Geir Kjetil/0000-0002-4959-1409; McKeating, Jane/0000-0002-7229-5886; Breden, Felix/0000-0001-9762-6314	FISM-Fondazione Italiana Sclerosi Multipla [2010/B/5]; EMBIO at the University of Oslo; Natural Sciences and Engineering Research Council of Canada; Multiple Sclerosis Society of Canada Scientific Research Foundation; Multiple Sclerosis Society of Northern Ireland; Medical Research Council [G0801976]; Wellcome Trust [075491/Z/04]; Multiple Sclerosis Society of Great Britain; Bayer Schering Pharma; Biogen Idec; Merck Serono; Novartis; UCB; Merz Pharmaceuticals, LLC; Teva Pharmaceutical Industries Ltd.-sanofiaventis; GW Pharma; Ironwood; MRC [G0801976] Funding Source: UKRI	FISM-Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); EMBIO at the University of Oslo; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Multiple Sclerosis Society of Canada Scientific Research Foundation; Multiple Sclerosis Society of Northern Ireland; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Multiple Sclerosis Society of Great Britain; Bayer Schering Pharma(Bayer AG); Biogen Idec(Biogen); Merck Serono(Merck & Company); Novartis(Novartis); UCB(UCB Pharma SA); Merz Pharmaceuticals, LLC; Teva Pharmaceutical Industries Ltd.-sanofiaventis(Sanofi-Aventis); GW Pharma; Ironwood; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Dr. Disanto is funded by research fellowship FISM-Fondazione Italiana Sclerosi Multipla-Cod.: 2010/B/5. Dr. Kjetil is supported by EMBIO at the University of Oslo. Dr. Breden is supported by the Natural Sciences and Engineering Research Council of Canada. Dr. Ramagopalan receives research support from the Multiple Sclerosis Society of Canada Scientific Research Foundation and the Multiple Sclerosis Society of Great Britain and Northern Ireland. This work was supported by the Medical Research Council (G0801976), the Wellcome Trust (075491/Z/04), and by a research fellowship FISM Fondazione Italiana Sclerosi Multipla-Cod.: 2010/B/5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests. Dr. Giovannoni serves on scientific advisory boards for Merck Serono and Biogen Idec and Vertex Pharmaceuticals; has served on the editorial board of Multiple Sclerosis; has received speaker honoraria from Bayer Schering Pharma, Merck Serono, Biogen Idec, Pfizer Inc, Teva Pharmaceutical Industries Ltd.-sanofiaventis, Vertex Pharmaceuticals, Genzyme Corporation, Ironwood, and Novartis; has served as a consultant for Bayer Schering Pharma, Biogen Idec, GlaxoSmithKline, Merck Serono, Protein Discovery Laboratories, Teva Pharmaceutical Industries Ltd.-sanofiaventis, UCB, Vertex Pharmaceuticals, GW Pharma, Novartis, and FivePrime; serves on the speakers bureau for Merck Serono; and has received research support from Bayer Schering Pharma, Biogen Idec, Merck Serono, Novartis, UCB, Merz Pharmaceuticals, LLC, Teva Pharmaceutical Industries Ltd.-sanofiaventis, GW Pharma, and Ironwood. There are no patents, products in development, or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Alisch RS, 2012, GENOME RES, V22, P623, DOI 10.1101/gr.125187.111; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; Enciu AM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-75; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Hernandez DG, 2011, HUM MOL GENET, V20, P1164, DOI 10.1093/hmg/ddq561; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Koch CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016679; Maegawa S, 2010, GENOME RES, V20, P332, DOI 10.1101/gr.096826.109; Mastroeni D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006617; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020; Ohm JE, 2007, CELL CYCLE, V6, P1040, DOI 10.4161/cc.6.9.4210; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Sandve GK, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r121; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	21	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e43840	10.1371/journal.pone.0043840	http://dx.doi.org/10.1371/journal.pone.0043840			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028473	Green Published, gold			2022-12-27	WOS:000309554700004
J	Yan, YB; Qi, W; Wu, ZX; Qiu, TX; Teo, EC; Lei, W				Yan, Ya-Bo; Qi, Wei; Wu, Zi-Xiang; Qiu, Tian-Xia; Teo, Ee-Chon; Lei, Wei			Finite Element Study of the Mechanical Response in Spinal Cord during the Thoracolumbar Burst Fracture	PLOS ONE			English	Article							QUANTITATIVE 3-DIMENSIONAL ANATOMY; CANAL STENOSIS; NEUROLOGICAL DEFICIT; LUMBAR VERTEBRAE; WHITE-MATTER; GRAY-MATTER; PIA MATER; INJURY; MODEL	Background: The mechanical response of the spinal cord during burst fracture was seldom quantitatively addressed and only few studies look into the internal strain of the white and grey matters within the spinal cord during thoracolumbar burst fracture (TLBF). The aim of the study is to investigate the mechanical response of the spinal cord during TLBF and correlate the percent canal compromise (PCC) with the strain in the spinal cord. Methodology/Principal Findings: A three-dimensional (3D) finite element (FE) model of human T12-L1 spinal cord with visco-elastic property was generated based on the transverse sections images of spinal cord, and the model was validated against published literatures under static uniaxial tension and compression. With the validated model, a TLBF simulation was performed to compute the mechanical strain in the spinal cord with the PCC. Linear regressions between PCC and strain in the spinal cord show that at the initial stage, with the PCC at 20%, and 45%, the corresponding mechanical strains in ventral grey, dorsal grey, ventral white, dorsal white matters were 0.06, 0.04, 0.12, 0.06, and increased to 0.14, 0.12, 0.23, and 0.13, respectively. At the recoiled stage, when the PCC was decreased from 45% to 20%, the corresponding strains were reduced to 0.03, 0.02, 0.04 and 0.03. The strain was correlated well with PCC. Conclusions/Significance: The simulation shows that the strain in the spinal cord correlated well with the PCC, and the mechanical strains in the ventral regions are higher than those in the dorsal regions of spinal cord tissue during burst fracture, suggesting that the ventral regions of the spinal cord may susceptible to injury than the dorsal regions.	[Yan, Ya-Bo; Qi, Wei; Wu, Zi-Xiang; Lei, Wei] Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed, Xian 710032, Peoples R China; [Yan, Ya-Bo; Qiu, Tian-Xia; Teo, Ee-Chon] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore; [Qi, Wei] PLA, Hosp 520, Dept Surg, Mianyang, Peoples R China	Air Force Military Medical University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Lei, W (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed, Xian 710032, Peoples R China.	leiwei@fmmu.edu.cn	Teo, Ee Chon/F-7308-2010	Lei, Wei/0000-0002-7346-6915				Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bilston LE, 1996, ANN BIOMED ENG, V24, P67, DOI 10.1007/BF02770996; Boerger TO, 2000, J BONE JOINT SURG BR, V82B, P629, DOI 10.1302/0301-620X.82B5.11321; Christ AF, 2010, J BIOMECH, V43, P2986, DOI 10.1016/j.jbiomech.2010.07.002; Clarke EC, 2009, J BIOMECH, V42, P1397, DOI 10.1016/j.jbiomech.2009.04.008; Coats B, 2006, J BIOMECH, V39, P2521, DOI 10.1016/j.jbiomech.2005.07.020; Dai LY, 2008, EUR J RADIOL, V67, P526, DOI 10.1016/j.ejrad.2007.08.020; Drake R. L., 2010, GRAYS ANATOMY STUDEN; FONTIJNE WPJ, 1992, J BONE JOINT SURG BR, V74, P683, DOI 10.1302/0301-620X.74B5.1527112; Greaves CY, 2008, ANN BIOMED ENG, V36, P396, DOI 10.1007/s10439-008-9440-0; HASHIMOTO T, 1988, SPINE, V13, P1268, DOI 10.1097/00007632-198811000-00011; HUNG TK, 1982, SURG NEUROL, V17, P213, DOI 10.1016/0090-3019(82)90284-1; HUNG TK, 1979, SURG NEUROL, V11, P470; Ichihara K, 2001, J NEUROTRAUM, V18, P361, DOI 10.1089/08977150151071053; Ko HY, 2004, SPINAL CORD, V42, P35, DOI 10.1038/sj.sc.3101538; LEMAY DR, 1988, STROKE, V19, P1411, DOI 10.1161/01.STR.19.11.1411; Li XF, 2009, SPINE, V34, P1140, DOI 10.1097/BRS.0b013e31819e2af1; LIMB D, 1995, J BONE JOINT SURG BR, V77, P774, DOI 10.1302/0301-620X.77B5.7559709; Meves R, 2006, SPINE, V31, P2137, DOI 10.1097/01.brs.0000231730.34754.9e; Mikles MR, 2004, J AM ACAD ORTHOP SUR, V12, P424, DOI 10.5435/00124635-200411000-00007; Mohanty S P, 2008, J Orthop Surg (Hong Kong), V16, P20; Ozawa H, 2004, J NEUROSURG-SPINE, V1, P122, DOI 10.3171/spi.2004.1.1.0122; PANJABI MM, 1994, SPINE, V19, P578, DOI 10.1097/00007632-199403000-00014; PANJABI MM, 1992, SPINE, V17, P299, DOI 10.1097/00007632-199203000-00010; Qiu TX, 2006, MED ENG PHYS, V28, P656, DOI 10.1016/j.medengphy.2005.10.011; RASMUSSEN PA, 1994, J NEUROTRAUM, V11, P711, DOI 10.1089/neu.1994.11.711; Schoenen J., 2004, HUMAN NERVOUS SYSTEM; Shirado O, 1993, Nihon Seikeigeka Gakkai Zasshi, V67, P644; SHUMAN WP, 1985, AM J ROENTGENOL, V145, P337, DOI 10.2214/ajr.145.2.337; Sparrey CJ, 2009, J NEUROTRAUM, V26, P585, DOI 10.1089/neu.2008.0654; Tan SH, 2002, EUR SPINE J, V11, P152, DOI 10.1007/s00586-001-0365-7; TENCER AF, 1985, SPINE, V10, P741, DOI 10.1097/00007632-198510000-00009; Wilcox RK, 2004, EUR SPINE J, V13, P481, DOI 10.1007/s00586-003-0625-9; Wilcox RK, 2003, J BONE JOINT SURG AM, V85A, P2184, DOI 10.2106/00004623-200311000-00020; Wilcox Ruth K, 2003, J Orthop Sci, V8, P432, DOI 10.1007/s10776-003-0644-9; Wood K, 2003, J BONE JOINT SURG AM, V85A, P773, DOI 10.2106/00004623-200305000-00001; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhao X, 2010, MED HYPOTHESES, V75, P550, DOI 10.1016/j.mehy.2010.07.026	38	12	17	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e41397	10.1371/journal.pone.0041397	http://dx.doi.org/10.1371/journal.pone.0041397			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028426	gold, Green Published			2022-12-27	WOS:000309554700002
J	Bernhardt, SA; Simmons, MP; Olson, KE; Beaty, BJ; Blair, CD; Black, WC				Bernhardt, Scott A.; Simmons, Mark P.; Olson, Ken E.; Beaty, Barry J.; Blair, Carol D.; Black, William C.			Rapid Intraspecific Evolution of miRNA and siRNA Genes in the Mosquito Aedes aegypti	PLOS ONE			English	Article							YELLOW-FEVER VIRUS; RNA INTERFERENCE RESPONSE; INDUCED SILENCING COMPLEX; ANTIVIRAL IMMUNITY; VECTOR COMPETENCE; ORAL INFECTION; DROSOPHILA-MELANOGASTER; MAXIMUM-LIKELIHOOD; NODAMURA VIRUS; DNA-SEQUENCES	RNA silencing, or RNA interference (RNAi) in metazoans mediates development, reduces viral infection and limits transposon mobility. RNA silencing involves 21-30 nucleotide RNAs classified into microRNA (miRNA), exogenous and endogenous small interfering RNAs (siRNA), and Piwi-interacting RNA (piRNA). Knock-out, silencing and mutagenesis of genes in the exogenous siRNA (exo-siRNA) regulatory network demonstrate the importance of this RNAi pathway in antiviral immunity in Drosophila and mosquitoes. In Drosophila, genes encoding components for processing exo-siRNAs are among the fastest evolving 3% of all genes, suggesting that infection with pathogenic RNA viruses may drive diversifying selection in their host. In contrast, paralogous miRNA pathway genes do not evolve more rapidly than the genome average. Silencing of exo-siRNA pathway genes in mosquitoes orally infected with arboviruses leads to increased viral replication, but little is known about the comparative patterns of molecular evolution among the exo-siRNA and miRNA pathways genes in mosquitoes. We generated nearly complete sequences of all exons of major miRNA and siRNA pathway genes dicer-1 and dicer-2, argonaute-1 and argonaute-2, and r3d1 and r2d2 in 104 Aedes aegypti mosquitoes collected from six distinct geographic populations and analyzed their genetic diversity. The ratio of replacement to silent amino acid substitutions was 1.4 fold higher in dicer-2 than in dicer-1, 27.4 fold higher in argonaute-2 than in argonaute-1 and similar in r2d2 and r3d1. Positive selection was supported in 32% of non-synonymous sites in dicer-1, in 47% of sites in dicer-2, in 30% of sites in argonaute-1, in all sites in argonaute-2, in 22% of sites in r3d1 and in 55% of sites in r2d2. Unlike Drosophila, in Ae. aegypti, both exo-siRNA and miRNA pathway genes appear to be undergoing rapid, positive, diversifying selection. Furthermore, refractoriness of mosquitoes to infection with dengue virus was significantly positively correlated for nucleotide diversity indices in dicer-2.	[Bernhardt, Scott A.; Olson, Ken E.; Beaty, Barry J.; Blair, Carol D.; Black, William C.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Simmons, Mark P.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Black, WC (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	wcb4@lamar.colostate.edu	Simmons, Mark Pitkin/F-7157-2013	Simmons, Mark Pitkin/0000-0003-3896-4633	UNICEF/UNDP/WorldBank/WHO Special Programme for Research and Training in Tropical Disease (TDR) [A50363]; NIH/NIAID [N01-AI 25489, R01 AI034014, AI083368]; FTP Training Grant from the Centers for Disease Control and Prevention [CCT 822307]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034014, R01AI083368, N01AI025489] Funding Source: NIH RePORTER	UNICEF/UNDP/WorldBank/WHO Special Programme for Research and Training in Tropical Disease (TDR); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FTP Training Grant from the Centers for Disease Control and Prevention; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work received financial support from the UNICEF/UNDP/WorldBank/WHO Special Programme for Research and Training in Tropical Disease (TDR): A50363. This work was also supported by NIH/NIAID contract N01-AI 25489 and R01 AI034014 to CDB and AI083368 to WCB4. SAB was supported by the FTP Training Grant CCT 822307 from the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliyari R, 2008, CELL HOST MICROBE, V4, P387, DOI 10.1016/j.chom.2008.09.001; Attarzadeh-Yazdi G, 2009, J VIROL, V83, P5735, DOI 10.1128/JVI.02440-08; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Black W. C. IV, 1997, The molecular biology of insect disease vectors: a methods manual., P361; Blair CD, 2011, FUTURE MICROBIOL, V6, P265, DOI [10.2217/FMB.11.11, 10.2217/fmb.11.11]; Blakqori G, 2007, J VIROL, V81, P4991, DOI 10.1128/JVI.01933-06; Bolling BG, 2012, VIROLOGY, V427, P90, DOI 10.1016/j.virol.2012.02.016; Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856; Brackney DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000502; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Chow VTK, 1998, AM J TROP MED HYG, V58, P578, DOI 10.4269/ajtmh.1998.58.578; Chung YK, 2002, TROP MED INT HEALTH, V7, P322, DOI 10.1046/j.1365-3156.2002.00873.x; Cirimotich CM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-49; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Hartig JV, 2009, EMBO J, V28, P2932, DOI 10.1038/emboj.2009.220; Hoshino K, 2007, VIROLOGY, V359, P405, DOI 10.1016/j.virol.2006.09.039; Hoshino K, 2009, VIROLOGY, V391, P119, DOI 10.1016/j.virol.2009.06.025; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101; Lambrechts L, 2009, P R SOC B, V276, P1369, DOI 10.1098/rspb.2008.1709; Li F, 2006, ANNU REV MICROBIOL, V60, P503, DOI 10.1146/annurev.micro.60.080805.142205; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Lim DH, 2008, BIOCHEM BIOPH RES CO, V371, P525, DOI 10.1016/j.bbrc.2008.04.118; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; LORENZ L, 1984, AM J TROP MED HYG, V33, P690, DOI 10.4269/ajtmh.1984.33.690; Lozano-Fuentes S., 2009, PLoS Neglected Tropical Diseases, V3, pe468; MADDISON DR, 2001, MACCLADE ANAL PHYLOG, P13102; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Mattingly P. F., 1957, Annals of Tropical Medicine and Parasitology, V51, P392; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470; Myles KM, 2008, P NATL ACAD SCI USA, V105, P19938, DOI 10.1073/pnas.0803408105; Nei M., 1987, MOL EVOLUTIONARY GEN; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Obbard DJ, 2011, MOL BIOL EVOL, V28, P1043, DOI 10.1093/molbev/msq280; Obbard DJ, 2009, PHILOS T R SOC B, V364, P99, DOI 10.1098/rstb.2008.0168; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Rand TA, 2004, P NATL ACAD SCI USA, V101, P14385, DOI 10.1073/pnas.0405913101; Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299; SCHERER WF, 1967, AM J EPIDEMIOL, V86, P271, DOI 10.1093/oxfordjournals.aje.a120737; Schuetz S, 2006, VIROLOGY, V344, P151, DOI 10.1016/j.virol.2005.09.034; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; Scott JC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000848; Siu RWC, 2011, J VIROL, V85, P2907, DOI 10.1128/JVI.02052-10; Stamatakis A., 2008, RAXML 7 0 4 MANUAL; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; TABACHNICK WJ, 1985, AM J TROP MED HYG, V34, P1219, DOI 10.4269/ajtmh.1985.34.1219; TAJIMA F, 1983, GENETICS, V105, P437; TESH RB, 1980, J GEN VIROL, V48, P177, DOI 10.1099/0022-1317-48-1-177; Urdaneta Ludmel, 2005, Infection Genetics and Evolution, V5, P177, DOI 10.1016/j.meegid.2004.09.004; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Venter PA, 2008, CELL MOL LIFE SCI, V65, P2675, DOI 10.1007/s00018-008-8037-y; WALLIS GP, 1985, AM J TROP MED HYG, V34, P1225, DOI 10.4269/ajtmh.1985.34.1225; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x; Zamore PD, 2007, NATURE, V446, P864, DOI 10.1038/446864a	75	39	39	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44198	10.1371/journal.pone.0044198	http://dx.doi.org/10.1371/journal.pone.0044198			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028502	gold, Green Published, Green Submitted			2022-12-27	WOS:000309392800004
J	White, LJ; Newton, PN; Maude, RJ; Pan-ngum, W; Fried, JR; Mayxay, M; Maude, RR; Day, NPJ				White, Lisa J.; Newton, Paul N.; Maude, Richard J.; Pan-ngum, Wirichada; Fried, Jessica R.; Mayxay, Mayfong; Maude, Rapeephan R.; Day, Nicholas P. J.			Defining Disease Heterogeneity to Guide the Empirical Treatment of Febrile Illness in Resource Poor Settings	PLOS ONE			English	Article							FEVER; VIENTIANE; MALARIA	Background: Malaria incidence is in decline in many parts of SE Asia leading to a decreasing proportion of febrile illness that is attributable to malaria. However in the absence of rapid, affordable and accurate diagnostic tests, the non-malaria causes of these illnesses cannot be reliably identified. Studies on the aetiology of febrile illness have indicated that the causes are likely to vary by geographical location within countries (i.e. be spatially heterogeneous) and that national empirical treatment policies based on the aetiology measured in a single location could lead to inappropriate treatment. Methods: Using data from Vientiane as a reference for the incidence of major febrile illnesses in the Lao People's Democratic Republic (Laos) and estimated incidences, plausible incidence in other Lao provinces were generated using a mathematical model for a range of national and local scale variations. For a range of treatment protocols, the mean number of appropriate treatments was predicted and the potential impact of a spatially explicit national empirical treatment protocol assessed. Findings: The model predicted a negative correlation between number of appropriate treatments and the level of spatial heterogeneity. A spatially explicit national treatment protocol was predicted to increase the number of appropriate treatments by 50% for intermediate levels of spatial heterogeneity. Conclusions: The results suggest that given even only moderate spatial variation, a spatially explicit treatment algorithm will result in a significant improvement in the outcome of undifferentiated fevers in Laos and other similar resource poor settings.	[White, Lisa J.; Newton, Paul N.; Maude, Richard J.; Fried, Jessica R.; Mayxay, Mayfong; Day, Nicholas P. J.] Univ Oxford, Nuffield Dept Clin Med, Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford, England; [White, Lisa J.; Maude, Richard J.; Pan-ngum, Wirichada; Fried, Jessica R.; Maude, Rapeephan R.; Day, Nicholas P. J.] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Newton, Paul N.; Mayxay, Mayfong] Mahosot Hosp, Wellcome Trust Mahosot Hosp, Oxford Trop Med Res Collaborat, Microbiol Lab, Viangchan, Laos; [Mayxay, Mayfong] Univ Hlth Sci, Fac Postgrad Studies, Viangchan, Laos	University of Oxford; Mahidol University	White, LJ (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford, England.	lisa@tropmedres.ac	Maude, Richard James/AAV-3567-2020; Maude, Rapeephan/AHB-3558-2022; White, Lisa/AAC-9396-2020	Maude, Richard James/0000-0002-5355-0562; White, Lisa/0000-0002-6523-185X; pan-ngum, wirichada/0000-0002-9839-5359; Newton, Paul/0000-0002-4608-6431; Maude, Rapeephan/0000-0002-3383-3629	Wellcome Trust of Great Britain (Major Overseas Programme-Thailand Unit Core Grant); Li Ka Shing Foundation - University of Oxford Global Health Programme	Wellcome Trust of Great Britain (Major Overseas Programme-Thailand Unit Core Grant)(Wellcome Trust); Li Ka Shing Foundation - University of Oxford Global Health Programme	This research was a part of the Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme, supported by the Wellcome Trust of Great Britain (Major Overseas Programme-Thailand Unit Core Grant) and was funded by the Li Ka Shing Foundation - University of Oxford Global Health Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acestor N, 2012, PLOS ONE IN PRESS; Anglaret X, 2002, AIDS, V16, P909, DOI 10.1097/00002030-200204120-00011; Clark TW, 2010, J INFECTION, V60, P91, DOI 10.1016/j.jinf.2009.11.009; Jorgensen P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-59; Joshi R, 2008, AM J TROP MED HYG, V78, P393, DOI 10.4269/ajtmh.2008.78.393; Laurichesse H, 1998, EUR RESPIR J, V11, P73, DOI 10.1183/09031936.98.11010073; Machado BM, 2009, J PEDIAT-BRAZIL, V85, P426, DOI [10.2223/JPED.1928, 10.1590/S0021-75572009000500010]; Mayxay M, 2012, CAUSES NONMALA UNPUB; Mayxay M, 2010, AM J TROP MED HYG, V83, P1221, DOI 10.4269/ajtmh.2010.10-0276; Phetsouvanh R, 2006, AM J TROP MED HYG, V75, P978; Phongmany S, 2006, EMERG INFECT DIS, V12, P256; Societe de Pathologie Infectieuse de Langue Francaise, 1991, MED MAL INFECT S, V21, P1; Stoesser N, 2012, J ANTIMICROB CHEMOTH, V67, P240, DOI 10.1093/jac/dkr434; Zurovac D, 2008, AM J TROP MED HYG, V78, P884, DOI 10.4269/ajtmh.2008.78.884	14	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44545	10.1371/journal.pone.0044545	http://dx.doi.org/10.1371/journal.pone.0044545			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028559	Green Published, gold, Green Submitted			2022-12-27	WOS:000309392800011
J	Xu, GYG; Slebodnick, C; Etzkorn, FA				Xu, Guoyan G.; Slebodnick, Carla; Etzkorn, Felicia A.			Cyclohexyl Ketone Inhibitors of Pin1 Dock in a Trans-Diaxial Cyclohexane Conformation	PLOS ONE			English	Article							ALZHEIMERS GAMMA-SECRETASE; CIS/TRANS ISOMERASE PIN1; SUBSTRATE RECOGNITION; PROLINE ISOMERIZATION; PROLYL; CYCLOPHILIN; MECHANISM; CATALYSIS; INACTIVATION; CALCINEURIN	Cyclohexyl ketone substrate analogue inhibitors (Ac-pSer-Psi[C = OCH]-Pip-tryptamine) of Pin1, the cell cycle regulatory peptidyl-prolyl isomerase (PPIase), were designed and synthesized as potential electrophilic acceptors for the Pin1 active site Cys113 nucleophile to test a proposed nucleophilic addition-isomerization mechanism. Because they were weak inhibitors, models of all three stereoisomers were docked into the active site of Pin1. Each isomer consistently minimized to a trans-diaxial cyclohexane conformation. From this, we hypothesize that Pin1 stretches substrates into a trans-pyrrolidine conformation to lower the barrier to isomerization. Our reduced amide inhibitor of Pin1 adopted a similar trans-pyrrolidine conformation in the crystal structure. The molecular model of 1, which mimics the L-Ser-L-Pro stereochemistry, in the Pin1 active site showed a distance of 4.4 angstrom, and an angle of 31 degrees between Cys113-S and the ketone carbon. The computational models suggest that the mechanism of Pin1 PPIase is not likely to proceed through nucleophilic addition.	[Xu, Guoyan G.; Slebodnick, Carla; Etzkorn, Felicia A.] Virginia Tech, Dept Chem, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Etzkorn, FA (corresponding author), Virginia Tech, Dept Chem, Blacksburg, VA 24061 USA.	fetzkorn@vt.edu		Etzkorn, Felicia A./0000-0001-5850-3661; Slebodnick, Carla/0000-0003-4188-7595	National Institutes of Health (NIH) [R01 CA110940, S10 RR16658]; NATIONAL CANCER INSTITUTE [R01CA110940] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016658] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank National Institutes of Health (NIH) (http://www.nih.gov/) grant R01 CA110940, and NIH grant S10 RR16658 for the LC-MSMS, and Oxford Instruments for the use of the diffractometer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton D. H. R., 1997, ORG SYNTH, V74, P101; Braukmuller S, 2006, EUR J ORG CHEM, V2006, P2110, DOI 10.1002/ejoc.200500961; Chatterjee S, 1997, J MED CHEM, V40, P3820, DOI 10.1021/jm970197e; Dai Y, 2000, BIOCHEMISTRY-US, V39, P6498, DOI 10.1021/bi0002378; Daum S, 2006, ANGEW CHEM INT EDIT, V45, P7454, DOI 10.1002/anie.200601569; DEBONT HBA, 1989, INT J PEPT PROT RES, V33, P115; DELANO WL, 2006, MACPYMOL; ETZKORN FA, 1993, CURR OPIN STRUC BIOL, V3, P929, DOI 10.1016/0959-440X(93)90158-H; FISCHER S, 1993, BIOCHEMISTRY-US, V32, P13830, DOI 10.1021/bi00213a011; Frisch MJ, 2009, GAUSSIAN; HARRISON RK, 1990, J AM CHEM SOC, V112, P7063, DOI 10.1021/ja00175a052; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P1684, DOI 10.1021/bi00459a003; Hennig L, 1998, BIOCHEMISTRY-US, V37, P5953, DOI 10.1021/bi973162p; Hur S, 2002, J AM CHEM SOC, V124, P7303, DOI 10.1021/ja020222s; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Moore CL, 2000, J MED CHEM, V43, P3434, DOI 10.1021/jm000100f; Namanja AT, 2007, STRUCTURE, V15, P313, DOI 10.1016/j.str.2007.01.014; *OXF DIFFR, 2004, CRYSALIS V1 171; PARK ST, 1992, J BIOL CHEM, V267, P3316; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; ROSEN MK, 1990, SCIENCE, V248, P863, DOI 10.1126/science.1693013; Ryo A, 2003, J CELL SCI, V116, P773, DOI 10.1242/jcs.00276; Schroeder OE, 2006, J PHYS CHEM A, V110, P6522, DOI 10.1021/jp060642u; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; *TRIP INT, 2008, SYBYL; Uchida T, 2003, CHEM BIOL, V10, P15, DOI 10.1016/S1074-5521(02)00310-1; Wang XDJ, 2004, J AM CHEM SOC, V126, P15533, DOI 10.1021/ja046396m; Wang XDJ, 2003, J ORG CHEM, V68, P2343, DOI 10.1021/jo026663b; Wiederrecht Greg, 1994, Perspectives in Drug Discovery and Design, V2, P57, DOI 10.1007/BF02171737; Wildemann D, 2006, J MED CHEM, V49, P2147, DOI 10.1021/jm060036n; WILLIAMS DR, 1989, J AM CHEM SOC, V111, P1923, DOI 10.1021/ja00187a081; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P4720, DOI 10.1021/bi982562p; Xie J, 2005, CARBOHYD RES, V340, P481, DOI 10.1016/j.carres.2004.12.001; Xu GYG, 2011, BIOCHEMISTRY-US, V50, P9545, DOI 10.1021/bi201055c; Xu GYG, 2010, ORG LETT, V12, P696, DOI 10.1021/ol9027013; Xu GYG, 2009, DRUG NEWS PERSPECT, V22, P399, DOI [10.1358/dnp.2009.22.7.1414594, 10.1358/dnp.2009.22.7.1381751]; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yeh ES, 2007, NAT REV CANCER, V7, P381, DOI 10.1038/nrc2107; Zhang MM, 2012, ACS CHEM BIOL, V7, P1462, DOI 10.1021/cb3000887; Zhang Y, 2007, ACS CHEM BIOL, V2, P320, DOI 10.1021/cb7000044; Zhang YX, 2002, BIOCHEMISTRY-US, V41, P11868, DOI 10.1021/bi0262395; Zhao S, 2007, BIOORG MED CHEM LETT, V17, P6615, DOI 10.1016/j.bmcl.2007.09.073; ZYDOWSKY LD, 1992, PROTEIN SCI, V1, P1092, DOI 10.1002/pro.5560010903	44	9	10	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44226	10.1371/journal.pone.0044226	http://dx.doi.org/10.1371/journal.pone.0044226			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028504	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400022
J	Su, LY; Zhao, YY; Yan, TS; Li, FL				Su, Liyun; Zhao, Yanyong; Yan, Tianshun; Li, Fenglan			Local Polynomial Estimation of Heteroscedasticity in a Multivariate Linear Regression Model and Its Applications in Economics	PLOS ONE			English	Article							OLS REGRESSION; HETEROSKEDASTICITY; INFERENCE	Multivariate local polynomial fitting is applied to the multivariate linear heteroscedastic regression model. Firstly, the local polynomial fitting is applied to estimate heteroscedastic function, then the coefficients of regression model are obtained by using generalized least squares method. One noteworthy feature of our approach is that we avoid the testing for heteroscedasticity by improving the traditional two-stage method. Due to non-parametric technique of local polynomial estimation, it is unnecessary to know the form of heteroscedastic function. Therefore, we can improve the estimation precision, when the heteroscedastic function is unknown. Furthermore, we verify that the regression coefficients is asymptotic normal based on numerical simulations and normal Q-Q plots of residuals. Finally, the simulation results and the local polynomial estimation of real data indicate that our approach is surely effective in finite-sample situations.	[Su, Liyun; Zhao, Yanyong; Yan, Tianshun] Chongqing Univ Technol, Sch Math & Stat, Chongqing, Peoples R China	Chongqing University of Technology	Su, LY (corresponding author), Chongqing Univ Technol, Sch Math & Stat, Chongqing, Peoples R China.	cloudhopping@163.com		su, liyun/0000-0001-7150-2161	Chongqing CSTC foundations of China [CSTC2010BB2310, CSTC2011jjA40033]; Chongqing CMEC foundations of China [KJ080614, KJ100810, KJ100818]	Chongqing CSTC foundations of China; Chongqing CMEC foundations of China	This work was supported by Chongqing CSTC foundations of China (CSTC2010BB2310, CSTC2011jjA40033), Chongqing CMEC foundations of China (KJ080614, KJ100810, KJ100818). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AM, 2002, J CHROMATOGR B, V774, P215, DOI 10.1016/S1570-0232(02)00244-1; [Anonymous], 1977, J ECONOMETRICS, DOI DOI 10.1016/0304-4076(77)90006-9; Cai L, 2008, J EDUC BEHAV STAT, V33, P21, DOI 10.3102/1076998607302628; Chen P, 2007, J MATH IMAGING VIS, V28, P191, DOI 10.1007/s10851-007-0003-z; Cribari-Neto F, 2004, COMPUT STAT DATA AN, V45, P215, DOI 10.1016/S0167-9473(02)00366-3; Cribari-Neto F, 2007, COMMUN STAT-THEOR M, V36, P1877, DOI 10.1080/03610920601126589; Fan JQ, 1999, ANN STAT, V27, P1491, DOI 10.1214/aos/1017939139; FAN JQ, 1993, ANN STAT, V21, P196, DOI 10.1214/aos/1176349022; FAN JQ, 1995, J R STAT SOC B, V57, P371; Fan JQ, 1996, LOCAL POLYNOMIAL MOD, P263; Fan JQ, 2003, NONLINEAR TIME SERIE, P313; Farsiu S, 2004, IEEE T IMAGE PROCESS, V13, P1327, DOI 10.1109/TIP.2004.834669; Galtchouk L, 2009, J KOREAN STAT SOC, V38, P305, DOI 10.1016/j.jkss.2008.12.001; Galtchouk L, 2009, J NONPARAMETR STAT, V21, P1, DOI 10.1080/10485250802504096; Godfrey LG, 2006, COMPUT STAT DATA AN, V50, P2715, DOI 10.1016/j.csda.2005.04.004; Greene WH, 1993, ECONOMETRIC ANAL, P362; Hardle W, 2004, NONPARAMETRIC SEMIPA, P85; Hayes AF, 2007, BEHAV RES METHODS, V39, P709, DOI 10.3758/BF03192961; Lima VMC, 2010, COMMUN STAT-SIMUL C, V39, P194, DOI 10.1080/03610910903402572; Liu H, 2009, DISCRETE DYN NAT SOC, V2009, DOI 10.1155/2009/743685; Ma JH, 2008, DISCRETE DYN NAT SOC, V2008, DOI 10.1155/2008/526734; RUPPERT D, 1994, ANN STAT, V22, P1346, DOI 10.1214/aos/1176325632; RUTEMILLER HC, 1968, J AM STAT ASSOC, V63, P552, DOI 10.2307/2284026; Su LY, 2012, CHINESE PHYS B, V21, DOI 10.1088/1674-1056/21/2/020508; Su LY, 2010, COMPUT MATH APPL, V59, P737, DOI 10.1016/j.camwa.2009.10.019; Su LY, 2012, DISCRETE DYN NAT SOC, V2012, DOI 10.1155/2012/696927; Su LY, 2011, DISCRETE DYN NAT SOC, V2011, DOI 10.1155/2011/930958; Su LY, 2010, MATH PROBL ENG, V2010, DOI 10.1155/2010/605241; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934	30	1	1	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e43719	10.1371/journal.pone.0043719	http://dx.doi.org/10.1371/journal.pone.0043719			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	019MC	23028468	Green Published, gold, Green Submitted			2022-12-27	WOS:000309742800006
J	Wang, YJ; Tang, X; Yu, B; Gu, Y; Yuan, Y; Yao, DB; Ding, F; Gu, XS				Wang, Yongjun; Tang, Xin; Yu, Bin; Gu, Yun; Yuan, Ying; Yao, Dengbing; Ding, Fei; Gu, Xiaosong			Gene Network Revealed Involvements of Birc2, Birc3 and Tnfrsf1a in Anti-Apoptosis of Injured Peripheral Nerves	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; SCHWANN-CELL DEATH; FACTOR-ALPHA; TNF-ALPHA; INFLAMMATORY MEDIATORS; IN-VITRO; ACTIVATION; MECHANISMS; EXPRESSION; DEGENERATION	Crush injury or axotomy of peripheral nerves results in the rapid production of the inflammatory cytokines, which were confirmed in various models, to some extent, to be noxious to the myelin sheath or Schwann cells (SCs). TNF-alpha is one of the primary initiators of the inflammatory cascade and exerts pleiotropic functions in the physiological conditions by binding to its receptors, type I (TNFRI) and type II (TNFRII). The pathway molecules TNFRI, Birc2 and Birc3 play key roles during the activation of the signaling. Injured peripheral nerves, preventing them from TNF-alpha-mediated destruction and proceeding to successful regeneration, might initiate an anti-apoptotic mechanism. To identity the exact functions of TNFRI, Birc2 and Birc3, as well as its involved pathways in the cellular events, we inferred a dynamic gene regulatory network from short time-series measurements of the proximal nerve segment cDNA microarray following rat sciatic nerve transection. TNFRI family member Tnfrsf1a, Birc2 and Birc3 were mined out integrating as master regulators to mediate inflammatory responses. Experiments revealed that Tnfrsf1a, Birc2 and Birc3 proteins colocalized with S100 in the rat peripheral nerve tissues, and the expression levels increased with the time extension. Knockdown of the proteins induced the apoptotic formation of primary cultured SCs by upregulation of caspase 3 and caspase 6. Our systematic analysis indicated that Tnfrsf1a, Birc2 and Birc3 of SCs, not originally regarded as XIAP, were mainly responsible for the inflammation-mediated anti-apoptosis of peripheral nerves. Birc2 and Birc3 might be the most potential targets for anti-apoptotic protection mediated by inflammatory cytokines.	[Wang, Yongjun; Tang, Xin; Yu, Bin; Gu, Yun; Yuan, Ying; Yao, Dengbing; Ding, Fei; Gu, Xiaosong] Nantong Univ, Key Lab Neuroregenerat, Nantong, Peoples R China	Nantong University	Gu, XS (corresponding author), Nantong Univ, Key Lab Neuroregenerat, Nantong, Peoples R China.	neurongu@public.nt.js.cn			National Natural Science Foundation of China [81130080, 81171180, 81000678]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Provincial Natural Science Foundation [BK2008010]; Jiangsu Education Department [08KJA310002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Provincial Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Jiangsu Education Department	This study was supported by the National Natural Science Foundation of China (Grant No. 81130080, No. 81171180 and No. 81000678), the Priority Academic Program Development of Jiangsu Higher Education Institutions, the Jiangsu Provincial Natural Science Foundation (Grant No. BK2008010), and the Basic Research Program of Jiangsu Education Department (Grant No. 08KJA310002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Blakemore WF, 2008, CURR TOP MICROBIOL, V318, P193; Bonetti B, 2000, J NEUROPATH EXP NEUR, V59, P74, DOI 10.1093/jnen/59.1.74; Boyle K, 2005, NEUROBIOL DIS, V20, P412, DOI 10.1016/j.nbd.2005.03.022; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Busch H, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.36; Caminero A, 2011, J NEUROIMMUNOL, V234, P1, DOI 10.1016/j.jneuroim.2011.03.004; Clarke R, 2008, NAT REV CANCER, V8, P37, DOI 10.1038/nrc2294; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Deretzi G, 1999, IMMUNOLOGY, V97, P582; deTorres C, 1997, NEUROSCI LETT, V230, P1, DOI 10.1016/S0304-3940(97)00445-X; Dhadialla PS, 2009, P NATL ACAD SCI USA, V106, P12494, DOI 10.1073/pnas.0902237106; Dupuy D, 2007, NAT BIOTECHNOL, V25, P663, DOI 10.1038/nbt1305; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Grinspan JB, 1996, J NEUROSCI, V16, P6107; Gupta S, 2005, INT J BIOCHEM CELL B, V37, P1034, DOI 10.1016/j.biocel.2004.08.013; Hanada T, 2002, CYTOKINE GROWTH F R, V13, P413, DOI 10.1016/S1359-6101(02)00026-6; HARTUNG HP, 1992, J NEUROIMMUNOL, V40, P197, DOI 10.1016/0165-5728(92)90134-7; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jensen LE, 2003, CELL SIGNAL, V15, P793, DOI 10.1016/S0898-6568(03)00039-1; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Martini R, 2008, GLIA, V56, P1566, DOI 10.1002/glia.20766; Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Nave KA, 2007, NAT CLIN PRACT NEURO, V3, P453, DOI 10.1038/ncpneuro0583; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; OPPENHEIM JJ, 2001, CYTOKINE REFERENCE, P3; Park SH, 2011, NAT IMMUNOL, V12, P607, DOI 10.1038/ni.2043; Parkinson DB, 2001, J NEUROSCI, V21, P8572, DOI 10.1523/JNEUROSCI.21-21-08572.2001; Petratos S, 2003, J NEUROPATH EXP NEUR, V62, P398, DOI 10.1093/jnen/62.4.398; Popko B, 2010, NAT NEUROSCI, V13, P275, DOI 10.1038/nn0310-275; Qin YW, 2008, NEUROCHEM RES, V33, P1077, DOI 10.1007/s11064-007-9552-1; REDFORD EJ, 1995, BRAIN, V118, P869, DOI 10.1093/brain/118.4.869; Camara-Lemarroy CR, 2010, NEUROIMMUNOMODULAT, V17, P314, DOI 10.1159/000292020; Schlitt T, 2003, GENOME RES, V13, P2568, DOI 10.1101/gr.1111403; Shamash S, 2002, J NEUROSCI, V22, P3052, DOI 10.1523/JNEUROSCI.22-08-03052.2002; Stuebgen JP, 2008, MUSCLE NERVE, V37, P281, DOI 10.1002/mus.20924; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Syroid DE, 2000, J NEUROSCI, V20, P5741, DOI 10.1523/JNEUROSCI.20-15-05741.2000; Tao T, 2009, J NEUROCHEM, V111, P647, DOI 10.1111/j.1471-4159.2009.06346.x; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200	43	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e43436	10.1371/journal.pone.0043436	http://dx.doi.org/10.1371/journal.pone.0043436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028454	Green Submitted, gold, Green Published			2022-12-27	WOS:000309742800004
J	Bagnall, RD; Tsoutsman, T; Shephard, RE; Ritchie, W; Semsarian, C				Bagnall, Richard D.; Tsoutsman, Tatiana; Shephard, Rhian E.; Ritchie, William; Semsarian, Christopher			Global MicroRNA Profiling of the Mouse Ventricles during Development of Severe Hypertrophic Cardiomyopathy and Heart Failure	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; EXPRESSION; MUTATIONS; COMPOUND; DISEASE; GENES; IDENTIFICATION; PROLIFERATION; CARDIOGENESIS; DYSREGULATION	MicroRNAs (miRNAs) regulate post-transcriptional gene expression during development and disease. We have determined the miRNA expression levels of early- and end-stage hypertrophic cardiomyopathy (HCM) in a severe, transgenic mouse model of the disease. Five miRNAs were differentially expressed at an early stage of HCM development. Time-course analysis revealed that decreased expression of miR-1 and miR-133a commences at a pre-disease stage, and precedes upregulation of target genes causal of cardiac hypertrophy and extracellular matrix remodelling, suggesting a role for miR-1 and miR-133a in early disease development. At end-stage HCM, 16 miRNA are dysregulated to form an expression profile resembling that of other forms of cardiac hypertrophy, suggesting common responses. Analysis of the mRNA transcriptome revealed that miRNAs potentially target 15.7% upregulated and 4.8% downregulated mRNAs at end-stage HCM, and regulate mRNAs associated with cardiac hypertrophy and electrophysiology, calcium signalling, fibrosis, and the TGF-beta signalling pathway. Collectively, these results define the miRNA expression signatures during development and progression of severe HCM and highlight critical miRNA regulated gene networks that are involved in disease pathogenesis.	[Bagnall, Richard D.; Tsoutsman, Tatiana; Shephard, Rhian E.; Semsarian, Christopher] Centenary Inst, Agnes Ginges Ctr Mol Cardiol, Sydney, NSW, Australia; [Bagnall, Richard D.; Tsoutsman, Tatiana; Shephard, Rhian E.; Semsarian, Christopher] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Ritchie, William] Royal Prince Alfred Hosp, Centenary Inst, Dept Bioinformat, Sydney, NSW, Australia; [Semsarian, Christopher] Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW, Australia	University of Sydney; Centenary Institute; University of Sydney; University of Sydney; Centenary Institute; University of Sydney	Bagnall, RD (corresponding author), Centenary Inst, Agnes Ginges Ctr Mol Cardiol, Sydney, NSW, Australia.	c.semsarian@centenary.org.au			Rotary Australia PhD scholarship; National Health and Medical Research Council (NHMRC) of Australia fellowship [517756]; NHMRC Practitioner fellowship [571084]; NHMRC [635576]	Rotary Australia PhD scholarship; National Health and Medical Research Council (NHMRC) of Australia fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Practitioner fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	RS is the recipient of a Rotary Australia PhD scholarship (www.rotaryaustralia.org.au). WR is a recipient of a National Health and Medical Research Council (NHMRC) of Australia fellowship (No. 517756; www.nhmrc.gov.au). CS is the recipient of an NHMRC Practitioner fellowship (No. 571084). This work was supported by a research project grant from NHMRC (No. 635576). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Carrillo ED, 2011, J CARDIOVASC PHARM, V58, P470, DOI 10.1097/FJC.0b013e31822a789b; Catalucci D, 2009, CIRC-CARDIOVASC GENE, V2, P402, DOI 10.1161/CIRCGENETICS.109.857425; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Ikeda S, 2009, MOL CELL BIOL, V29, P2193, DOI 10.1128/MCB.01222-08; Ingles J, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.033886; Jazdzewski K, 2011, J CLIN ENDOCR METAB, V96, pE546, DOI 10.1210/jc.2010-1594; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee JH, 2011, CIRC RES, V109, P1332, DOI 10.1161/CIRCRESAHA.111.249433; Li Q, 2010, J CELL SCI, V123, P2444, DOI 10.1242/jcs.067165; Lind Joanne M, 2006, Expert Rev Cardiovasc Ther, V4, P927, DOI 10.1586/14779072.4.6.927; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Maron BJ, 2012, HEART RHYTHM, V9, P57, DOI 10.1016/j.hrthm.2011.08.009; Matkovich SJ, 2011, CIRC RES, V108, P18, DOI 10.1161/CIRCRESAHA.110.233528; Matkovich SJ, 2010, CIRC RES, V106, P1459, DOI 10.1161/CIRCRESAHA.110.217513; Morita H, 2008, NEW ENGL J MED, V358, P1899, DOI 10.1056/NEJMoa075463; Sarkar J, 2010, AM J PHYSIOL-LUNG C, V299, pL861, DOI 10.1152/ajplung.00201.2010; Sarkar S, 2004, J BIOL CHEM, V279, P20422, DOI 10.1074/jbc.M308488200; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Schellings MWM, 2009, J CELL COMMUN SIGNAL, V3, P201, DOI 10.1007/s12079-009-0070-6; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Shephard R, 2009, J CARDIOVASC TRANSL, V2, P471, DOI 10.1007/s12265-009-9120-y; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Song HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035552; Sucharov C, 2008, J MOL CELL CARDIOL, V45, P185, DOI 10.1016/j.yjmcc.2008.04.014; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; Tsoutsman T, 2008, CLIN EXP PHARMACOL P, V35, P1349, DOI 10.1111/j.1440-1681.2008.05037.x; Tsoutsman T, 2008, CIRCULATION, V117, P1820, DOI 10.1161/CIRCULATIONAHA.107.755777; Van Driest SL, 2004, J AM COLL CARDIOL, V44, P1903, DOI 10.1016/j.jacc.2004.07.045; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017167; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	41	61	68	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44744	10.1371/journal.pone.0044744	http://dx.doi.org/10.1371/journal.pone.0044744			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024758	gold, Green Published, Green Submitted			2022-12-27	WOS:000308860100016
J	Aldini, R; Budriesi, R; Roda, G; Micucci, M; Ioan, P; D'Errico-Grigioni, A; Sartini, A; Guidetti, E; Marocchi, M; Cevenini, M; Rosini, F; Montagnani, M; Chiarini, A; Mazzella, G				Aldini, Rita; Budriesi, Roberta; Roda, Giulia; Micucci, Matteo; Ioan, Pierfranco; D'Errico-Grigioni, Antonia; Sartini, Alessandro; Guidetti, Elena; Marocchi, Margherita; Cevenini, Monica; Rosini, Francesca; Montagnani, Marco; Chiarini, Alberto; Mazzella, Giuseppe			Curcuma longa Extract Exerts a Myorelaxant Effect on the Ileum and Colon in a Mouse Experimental Colitis Model, Independent of the Anti-Inflammatory Effect	PLOS ONE			English	Article							NF-KAPPA-B; TRINITROBENZENE SULFONIC-ACID; INFLAMMATORY-BOWEL-DISEASE; ENTERIC NERVOUS-SYSTEM; DEXTRAN SULFATE SODIUM; ULCERATIVE-COLITIS; SMOOTH-MUSCLE; INTESTINAL INFLAMMATION; MAINTENANCE THERAPY; CELLS	Background: Curcuma has long been used as an anti-inflammatory agent in inflammatory bowel disease. Since gastrointestinal motility is impaired in inflammatory states, the aim of this work was to evaluate if Curcuma Longa had any effect on intestinal mortality Methods: The biological activity of Curcuma extract was evaluated against Carbachol induced contraction in isolated mice intestine. Acute and chronic colitis were induced in Balb/c mice by Dextran Sulphate Sodium administration (5% and 2.5% respectively) and either Curcuma extract (200 mg/kg/day) or placebo was thereafter administered for 7 and 21 days respectively. Spontaneous contractions and the response to Carbachol and Atropine of ileum and colon were studied after colitis induction and Curcuma administration. Results: Curcuma extract reduced the spontaneous contractions in the ileum and colon; the maximal response to Carbachol was inhibited in a non-competitive and reversible manner. Similar results were obtained in ileum and colon from Curcuma fed mice. DSS administration decreased the motility, mainly in the colon and Curcuma almost restored both the spontaneous contractions and the response to Carbachol after 14 days assumption, compared to standard diet, but a prolonged assumption of Curcuma decreased the spontaneous and Carbachol-induced contractions. Conclusions: Curcuma extract has a direct and indirect myorelaxant effect on mouse ileum and colon, independent of the anti-inflammatory effect. The indirect effect is reversible and non-competitive with the cholinergic agent. These results suggest the use of curcuma extract as a spasmolytic agent.	[Aldini, Rita; Roda, Giulia; Sartini, Alessandro; Guidetti, Elena; Marocchi, Margherita; Cevenini, Monica; Montagnani, Marco; Mazzella, Giuseppe] Univ Bologna, Dipartimento Med Clin, Osped Policlin S Orsola, Bologna, Italy; [Aldini, Rita] Univ Bologna, Dipartimento Sci Metalli Elettrochim & Tecn Chim, Bologna, Italy; [Budriesi, Roberta; Micucci, Matteo; Ioan, Pierfranco; Chiarini, Alberto] Univ Bologna, Dipartimento Sci Farmaceut, I-40126 Bologna, Italy; [D'Errico-Grigioni, Antonia; Rosini, Francesca] Univ Bologna, Dipartimento Med Interna Invecchiamento & Malatt, Osped Policlin S Orsola, Bologna, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Aldini, R (corresponding author), Univ Bologna, Dipartimento Med Clin, Osped Policlin S Orsola, Bologna, Italy.	rita.aldini@unibo.it; roberta.budriesi@unibo.it	Roda, Giulia/E-5521-2011; Sartini, Alessandro/AAN-3396-2020; Micucci, Matteo/AAM-6126-2020; mazzella, giuseppe/A-1865-2016	Sartini, Alessandro/0000-0003-1573-6451; MICUCCI, MATTEO/0000-0003-3525-1531; D'ERRICO, ANTONIETTA/0000-0003-2747-3732; Mazzella, Giuseppe/0000-0001-8656-8112; MONTAGNANI, MARCO/0000-0003-0103-0327	Fondazione del Monte di Bologna e Ravenna; Alisal [Mazz100136- 2010]; MINISTERO DELLE POLITICHE AGRICOLE, ALIMENTARI E FORESTALI [D.M. 11008/7303/10]	Fondazione del Monte di Bologna e Ravenna(Fondazione del Monte di Bologna e Ravenna); Alisal; MINISTERO DELLE POLITICHE AGRICOLE, ALIMENTARI E FORESTALI	This work was supported by grants from Fondazione del Monte di Bologna e Ravenna and from Alisal (Mazz100136- 2010). ALISAL is a project supported by the MINISTERO DELLE POLITICHE AGRICOLE, ALIMENTARI E FORESTALI, with D.M. 11008/7303/10, dated 17/05/2010. The title of the project is: Miglioramento delle proprieta igienico-sanitarie, salutistiche e funzionali di commodity per l'alimentazione dell'uomo e/o degli animali (Improvement of sanitary properties, healthy and functional food commodities for human and/or animals). Prof. Mazzella was supported with materials, reagents, animals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED T, 2008, PHARM BIOCH BEHAV, V91, P554; Akiho Hirotada, 2011, World J Gastrointest Pathophysiol, V2, P72; AMMON HPT, 1991, PLANTA MED, V57, P1, DOI 10.1055/s-2006-960004; [Anonymous], VERS 3 0 GRAPHPAD SO; ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48, DOI 10.1111/j.1476-5381.1959.tb00928.x; Aube AC, 1999, NEUROGASTROENT MOTIL, V11, P55; Bharti AC, 2003, BLOOD, V101, P1053, DOI 10.1182/blood-2002-05-1320; Blandizzi C, 2003, BRIT J PHARMACOL, V139, P309, DOI 10.1038/sj.bjp.0705249; Camacho-Barquero L, 2007, INT IMMUNOPHARMACOL, V7, P333, DOI 10.1016/j.intimp.2006.11.006; Claramunt RM, 2009, BIOORGAN MED CHEM, V17, P1290, DOI 10.1016/j.bmc.2008.12.029; Deguchi Y, 2007, DIGEST DIS SCI, V52, P2993, DOI 10.1007/s10620-006-9138-9; Fitzpatrick LR, 2000, DIGEST DIS SCI, V45, P2327, DOI 10.1023/A:1005630723111; Furness JB, 2008, NEUROGASTROENT MOTIL, V20, P32, DOI 10.1111/j.1365-2982.2008.01094.x; Grundy D, 2005, CURR OPIN GASTROEN, V21, P176, DOI 10.1097/01.mog.0000153315.28327.6e; Han SS, 2002, J BIOCHEM MOL BIOL, V35, P337; Hanai H, 2006, CLIN GASTROENTEROL H, V4, P1502, DOI 10.1016/j.cgh.2006.08.008; HUANG TS, 1991, P NATL ACAD SCI USA, V88, P5292, DOI 10.1073/pnas.88.12.5292; Ihara E, 2009, MOL PHARMACOL, V75, P1031, DOI 10.1124/mol.108.049858; Itthipanichpong C, 2006, J MED ASS THAI S2, V86, pS2999; JACOBSON K, 1995, GASTROENTEROLOGY, V109, P718, DOI 10.1016/0016-5085(95)90378-X; JAIN SK, 1994, CIBA F SYMP, V185, P153; Jian YT, 2005, WORLD J GASTROENTERO, V11, P1747, DOI 10.3748/wjg.v11.i12.1747; Kim GY, 2005, J IMMUNOL, V174, P8116, DOI 10.4049/jimmunol.174.12.8116; Kinoshita K, 2003, AM J PHYSIOL-GASTR L, V285, pG483, DOI 10.1152/ajpgi.00038.2003; Kohno N, 2006, J MED INVESTIG, V53, P277, DOI 10.2152/jmi.53.277; Kondo T, 2011, EUR J PHARMACOL, V670, P236, DOI 10.1016/j.ejphar.2011.08.034; Kumar Anil, 2010, Indian J Physiol Pharmacol, V54, P284; Larmonier CB, 2011, INFLAMM BOWEL DIS, V17, P503, DOI 10.1002/ibd.21391; Lim Allen W, 2011, Therap Adv Gastroenterol, V4, P145, DOI 10.1177/1756283X10382816; Linden D, 2003, BRIT J PHARMACOL, V139, P185, DOI 10.1038/sj.bjp.0705250; Linden DR, 2004, J PHYSIOL-LONDON, V557, P191, DOI 10.1113/jphysiol.2004.062174; Lomax AE, 2005, NEUROGASTROENT MOTIL, V17, P4, DOI 10.1111/j.1365-2982.2004.00607.x; Mattar Mark C, 2011, Gastrointest Cancer Res, V4, P53; Mizuta Y, 2000, GASTROENTEROLOGY, V118, P714, DOI 10.1016/S0016-5085(00)70141-7; Motagally MA, 2009, AM J PHYSIOL-GASTR L, V296, pG1077, DOI 10.1152/ajpgi.00006.2009; Motulsky H, 2003, PRACTICAL GUIDE CURV; Myers BS, 1997, AM J PHYSIOL-GASTR L, V273, pG928, DOI 10.1152/ajpgi.1997.273.4.G928; Negi PS, 1999, J AGR FOOD CHEM, V47, P4297, DOI 10.1021/jf990308d; Papadakis KA, 2000, INFLAMM BOWEL DIS, V6, P303, DOI 10.1002/ibd.3780060408; Pazdrak K, 2004, GASTROENTEROLOGY, V127, P1096, DOI 10.1053/j.gastro.2004.07.008; Qureshi S, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01406.x; Qureshi S, 2010, NEUROGASTROENT MOTIL, V22, pe64; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; REDDY SN, 1991, GASTROENTEROLOGY, V101, P1289, DOI 10.1016/0016-5085(91)90079-Z; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Salh B, 2003, AM J PHYSIOL-GASTR L, V285, pG235, DOI 10.1152/ajpgi.00449.2002; Sato K, 2006, BRIT J PHARMACOL, V148, P200, DOI 10.1038/sj.bjp.0706717; Shimouchi A, 2009, DIGEST DIS SCI, V54, P1725, DOI 10.1007/s10620-008-0550-1; Singh AK, 1996, CANCER LETT, V107, P109, DOI 10.1016/0304-3835(96)04357-1; Singh G, 2010, FOOD CHEM TOXICOL, V48, P1026, DOI 10.1016/j.fct.2010.01.015; SINGH S, 1995, J BIOL CHEM, V270, P24995, DOI 10.1074/jbc.270.42.24995; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Sugimoto K, 2002, GASTROENTEROLOGY, V123, P1912, DOI 10.1053/gast.2002.37050; TAKEMASA KENJIRO, 1957, JOUR PHYSIOL SOC JAPAN, V19, P1217; Tallarida RJ, 1987, MANUAL PHARM CALCULA; Tomita R, 1998, J GASTROENTEROL, V33, P48, DOI 10.1007/PL00009965; Triantafillidis JK, 2011, DRUG DES DEV THER, V5, P185, DOI 10.2147/DDDT.S11290; Ukil A, 2003, BRIT J PHARMACOL, V139, P209, DOI 10.1038/sj.bjp.0705241; Vasina V, 2006, AUTON NEUROSCI-BASIC, V126, P264, DOI 10.1016/j.autneu.2006.02.025; Vrees MD, 2002, ARCH SURG-CHICAGO, V137, P439, DOI 10.1001/archsurg.137.4.439; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xu YX, 1997, EXP HEMATOL, V25, P413; Xu YX, 1998, HEMATOPATHOL MOL HEM, V11, P49	64	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44650	10.1371/journal.pone.0044650	http://dx.doi.org/10.1371/journal.pone.0044650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984538	gold, Green Published, Green Submitted			2022-12-27	WOS:000308738500071
J	Hoxha, E; Lambers, E; Wasserstrom, JA; Mackie, A; Ramirez, V; Abramova, T; Verma, SK; Krishnamurthy, P; Kishore, R				Hoxha, Eneda; Lambers, Erin; Wasserstrom, John A.; Mackie, Alexander; Ramirez, Veronica; Abramova, Tatiana; Verma, Suresh K.; Krishnamurthy, Prasanna; Kishore, Raj			Elucidation of a Novel Pathway through Which HDAC1 Controls Cardiomyocyte Differentiation through Expression of SOX-17 and BMP2	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HISTONE DEACETYLASE 1; DEVELOPMENTAL REGULATORS; PLURIPOTENT; OCT4; POLYCOMB; THERAPY; NETWORK; REPAIR; HEART	Embryonic Stem Cells not only hold a lot of potential for use in regenerative medicine, but also provide an elegant and efficient way to study specific developmental processes and pathways in mammals when whole animal gene knock out experiments fail. We have investigated a pathway through which HDAC1 affects cardiovascular and more specifically cardiomyocyte differentiation in ES cells by controlling expression of SOX17 and BMP2 during early differentiation. This data explains current discrepancies in the role of HDAC1 in cardiovascular differentiation and sheds light into a new pathway through which ES cells determine cardiovascular cell fate.	[Hoxha, Eneda; Lambers, Erin; Wasserstrom, John A.; Mackie, Alexander; Ramirez, Veronica; Abramova, Tatiana; Verma, Suresh K.; Krishnamurthy, Prasanna; Kishore, Raj] Northwestern Univ, Feinberg Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Hoxha, E (corresponding author), Northwestern Univ, Feinberg Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA.	r-kishore@northwestern.edu	Verma, Suresh/AAU-9979-2020	Verma, Suresh Kumar/0000-0002-0739-1302; KRISHNAMURTHY, PRASANNA/0000-0002-4842-6364	National Institute of Health [HL091983, HL105597, HL095874, HL053354, HL108795]; American Heart Association's pre-doctoral fellowship grant [11PRE7360065]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105597, R01HL053354, R37HL053354, R01HL095874, R01HL091983, P01HL108795] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association's pre-doctoral fellowship grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Work described in this manuscript was supported in part by National Institute of Health grants HL091983, HL105597, HL095874, HL053354 and HL108795 to RK and American Heart Association's pre-doctoral fellowship grant 11PRE7360065 to EH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-David U, 2012, CELL STEM CELL, V10, P10, DOI 10.1016/j.stem.2011.12.007; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Campbell PA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000553; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Hinkel R, 2011, EXPERT OPIN BIOL TH, V11, P723, DOI 10.1517/14712598.2011.570749; Joggerst SJ, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001124; Karantzali E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r65; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lagger S, 2010, EMBO J, V29, P3992, DOI 10.1038/emboj.2010.264; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Liu Y, 2007, P NATL ACAD SCI USA, V104, P3859, DOI 10.1073/pnas.0609100104; Ma PP, 2008, DEV BIOL, V319, P110, DOI 10.1016/j.ydbio.2008.04.011; Marmorstein R, 2001, NAT REV MOL CELL BIO, V2, P422, DOI 10.1038/35073047; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Narazaki G, 2008, CIRCULATION, V118, P498, DOI 10.1161/CIRCULATIONAHA.108.769562; Rajasingh J, 2008, CIRC RES, V102, pE107, DOI 10.1161/CIRCRESAHA.108.176115; Ren XF, 2006, MED HYPOTHESES, V67, P1469, DOI 10.1016/j.mehy.2006.06.021; Rolletschek A, 2009, BIOL CHEM, V390, P845, DOI 10.1515/BC.2009.103; Stefanovic S, 2009, J CELL BIOL, V186, P665, DOI 10.1083/jcb.200901040; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wasserstrom JA, 2009, CIRC-HEART FAIL, V2, P223, DOI 10.1161/CIRCHEARTFAILURE.108.811539	27	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45046	10.1371/journal.pone.0045046	http://dx.doi.org/10.1371/journal.pone.0045046			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984607	Green Published, Green Submitted, gold			2022-12-27	WOS:000308738500109
J	Kulhankova, K; Rouse, T; Nasr, ME; Field, EH				Kulhankova, Katarina; Rouse, Todd; Nasr, Mohamed E.; Field, Elizabeth H.			Dendritic Cells Control CD4(+)CD25(+) Treg Cell Suppressor Function In Vitro through Juxtacrine Delivery of IL-2	PLOS ONE			English	Article							REGULATORY T-CELLS; RECEPTOR-ALPHA-CHAIN; AUTOIMMUNE-DISEASE; SELF-TOLERANCE; CUTTING EDGE; INTERLEUKIN-2; ACTIVATION; EXPRESSION; EXPANSION; ANTIGEN	CD4(+)CD25(+)Foxp3(+) regulatory T cells (Tregs) restrict inflammatory responses to self and nonself. Aberrant Treg activity is pathologic: Insufficient Treg activity is implicated in autoimmunity, allergy, and graft-versus-host-disease; overabundant activity is implicated in chronic infection and cancer. Tregs require IL-2 for their expansion and acquisition/execution of suppressor function; however, because Tregs cannot produce IL-2, they depend on IL-2 from an exogenous source. Until now, that IL-2 source had not been established. We asked whether dendritic cells (DCs) could supply IL-2 to Tregs and, if so, what was required for that delivery. We used flow cytometry, IL-2 ELISPOT, RT-qPCR, and IL-2 promoter-driven reporter assays to measure intracytoplasmic IL-2, secreted protein, IL-2 message and IL-2 promoter activity in bone marrow-derived (BMDC) and splenic DCs. We examined conjugate formation between Tregs, conventional CD4(+) cells, and IL-2-expressing DCs. We measured Treg levels of CD25, Foxp3, and suppressor function after co-culture with IL-2 sufficient and IL-2(-/-) DCs. We generated IL-2-mCherry-expressing DCs and used epifluorescence microscopy and flow cytometry to track IL-2 transfer to Tregs and test requirements for transfer. Between 0.7 to 2.4% of DCs constitutively produced IL-2 and diverted IL-2 secretion to Tregs by preferentially forming conjugates with them. Uptake of DC IL-2 by Tregs required cell-cell contact and CD25. Tregs increased levels of CD25 and Foxp3 from baseline and showed greater suppressor function when co-cultured with IL-2-sufficient DCs, but not when co-cultured with IL-2(-/-) DCs. Exogenous IL-2, added in excess of 500 U/ml to co-cultures with IL-2(-/-) DCs, restored Treg suppressor function. These data support a model of juxtacrine delivery of IL-2 from DCs to Tregs and suggest that a subset of DCs modulates Treg function through controlled, spatial delivery of IL-2. Knowledge of how DCs regulate Tregs should be integrated into the design of interventions intended to alter Treg function.	[Kulhankova, Katarina; Field, Elizabeth H.] Univ Iowa, Dept Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Rouse, Todd; Nasr, Mohamed E.; Field, Elizabeth H.] Dept Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Kulhankova, K (corresponding author), Univ Iowa, Dept Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	elizabeth-field@uiowa.edu		Field, Elizabeth/0000-0003-4043-7461	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; VA Merit Review Grant; VA MREP Grant; NIH [R21 DE19609-01, NIH T32 AI007260-22]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE019609] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); VA Merit Review Grant(US Department of Veterans Affairs); VA MREP Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This material is based upon work supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development with VA Merit Review Grant (EHF) and VA MREP Grant (MEN), and also NIH R21 DE19609-01(EHF), NIH T32 AI007260-22 (KK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida ARM, 2002, J IMMUNOL, V169, P4850, DOI 10.4049/jimmunol.169.9.4850; Barron L, 2010, J IMMUNOL, V185, P6426, DOI 10.4049/jimmunol.0903940; Battaglia M, 2011, SEMIN IMMUNOL, V23, P182, DOI 10.1016/j.smim.2011.07.007; Bayer AL, 2005, J EXP MED, V201, P769, DOI 10.1084/jem.20041179; Berntsen A, 2010, J IMMUNOTHER, V33, P425, DOI 10.1097/CJI.0b013e3181cd870f; Beyer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030422; Brinster C, 2005, J IMMUNOL, V175, P7332, DOI 10.4049/jimmunol.175.11.7332; Bruno L, 2008, CELL CYCLE, V7, P2296, DOI 10.4161/cc.6444; Brusko T, 2008, EUR J IMMUNOL, V38, P931, DOI 10.1002/eji.200738108; Brusko TM, 2008, IMMUNOL REV, V223, P371, DOI 10.1111/j.1600-065X.2008.00637.x; Chen YL, 2001, J IMMUNOASS IMMUNOCH, V22, P353, DOI 10.1081/IAS-100107400; Cheng GY, 2011, IMMUNOL REV, V241, P63, DOI 10.1111/j.1600-065X.2011.01004.x; Curiel TJ, 2008, CURR OPIN IMMUNOL, V20, P241, DOI 10.1016/j.coi.2008.04.008; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; Edinger M, 2011, CURR OPIN IMMUNOL, V23, P679, DOI 10.1016/j.coi.2011.06.006; Ekerfelt C, 2002, J IMMUNOL METHODS, V260, P55, DOI 10.1016/S0022-1759(01)00520-8; Fehervari Z, 2006, TRENDS IMMUNOL, V27, P109, DOI 10.1016/j.it.2006.01.005; Fehervari Z, 2004, INT IMMUNOL, V16, P1769, DOI 10.1093/intimm/dxh178; Feng G, 2008, TRANSPLANTATION, V86, P578, DOI 10.1097/TP.0b013e3181806a60; Furtado GC, 2002, J EXP MED, V196, P851, DOI 10.1084/jem.20020190; Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Granucci F, 2003, J IMMUNOL, V170, P5075, DOI 10.4049/jimmunol.170.10.5075; Guiducci C, 2005, EUR J IMMUNOL, V35, P557, DOI 10.1002/eji.200425810; HEMAR A, 1995, J CELL BIOL, V129, P55, DOI 10.1083/jcb.129.1.55; Kalantari T, 2011, IMMUNOL RES, V51, P153, DOI 10.1007/s12026-011-8255-5; Kim HP, 2002, EMBO J, V21, P3051, DOI 10.1093/emboj/cdf321; Koenen HJPM, 2003, J IMMUNOL, V171, P6431, DOI 10.4049/jimmunol.171.12.6431; Liu CP, 1996, J EXP MED, V184, P1619, DOI 10.1084/jem.184.5.1619; Malek TR, 2003, J LEUKOCYTE BIOL, V74, P961, DOI 10.1189/jlb.0603272; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Marguti I, 2009, IMMUNOLOGY, V127, P50, DOI 10.1111/j.1365-2567.2008.02927.x; Murawski MR, 2006, ANN NY ACAD SCI, V1079, P198, DOI 10.1196/annals.1375.031; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Muthuswamy R, 2008, CANCER RES, V68, P5972, DOI 10.1158/0008-5472.CAN-07-6818; Ohkura N, 2010, SEMIN IMMUNOPATHOL, V32, P95, DOI 10.1007/s00281-010-0200-5; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Papiernik M, 1998, INT IMMUNOL, V10, P371, DOI 10.1093/intimm/10.4.371; Piccirillo CA, 2004, TRENDS IMMUNOL, V25, P374, DOI 10.1016/j.it.2004.04.009; Putnam AL, 2009, DIABETES, V58, P652, DOI 10.2337/db08-1168; Rigby SM, 2003, BLOOD, V101, P2024, DOI 10.1182/blood-2002-05-1513; Riley JL, 2009, IMMUNITY, V30, P656, DOI 10.1016/j.immuni.2009.04.006; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Ruter J, 2009, FRONT BIOSCI-LANDMRK, V14, P1761, DOI 10.2741/3338; SADLACK B, 1995, EUR J IMMUNOL, V25, P3053, DOI 10.1002/eji.1830251111; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sauma D, 2004, SCAND J IMMUNOL, V59, P183, DOI 10.1111/j.0300-9475.2004.01380.x; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Sgouroudis E, 2011, AUTOIMMUNITY, V44, P406, DOI 10.3109/08916934.2010.536795; Smith KA, 2006, MED IMMUNOL, V5, P3; Sojka DK, 2005, J IMMUNOL, V175, P7274, DOI 10.4049/jimmunol.175.11.7274; Soper DM, 2007, EUR J IMMUNOL, V37, P1817, DOI 10.1002/eji.200737101; Stauber DJ, 2006, P NATL ACAD SCI USA, V103, P2788, DOI 10.1073/pnas.0511161103; Suffner J, 2010, J IMMUNOL, V184, P1810, DOI 10.4049/jimmunol.0902420; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Tang QZ, 2012, J MOL CELL BIOL, V4, P11, DOI 10.1093/jmcb/mjr047; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Thornton AM, 2004, J IMMUNOL, V172, P6519, DOI 10.4049/jimmunol.172.11.6519; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Wei S, 2007, CANCER RES, V67, P7487, DOI 10.1158/0008-5472.CAN-07-0565; Welters MJP, 2008, EXPERT OPIN BIOL TH, V8, P1365, DOI 10.1517/14712598.8.9.1365 ; Welters MJP, 2010, P NATL ACAD SCI USA, V107, P11895, DOI 10.1073/pnas.1006500107; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Wolf M, 2001, EUR J IMMUNOL, V31, P1637, DOI 10.1002/1521-4141(200106)31:6<1637::AID-IMMU1637>3.0.CO;2-T; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Wuest TY, 2008, J LEUKOCYTE BIOL, V84, P973, DOI 10.1189/jlb.1107778; Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1084/jem.20030422; Yu AX, 2006, J IMMUNOL, V177, P5115, DOI 10.4049/jimmunol.177.8.5115; Yu AX, 2001, J BIOL CHEM, V276, P381, DOI 10.1074/jbc.M007991200; Yui MA, 2001, J IMMUNOL, V166, P1730, DOI 10.4049/jimmunol.166.3.1730; Yui MA, 2004, J IMMUNOL, V172, P4691, DOI 10.4049/jimmunol.172.8.4691; Zanoni I, 2005, J IMMUNOL, V175, P286, DOI 10.4049/jimmunol.175.1.286; zur Wiesch JS, 2011, J VIROL, V85, P1287, DOI 10.1128/JVI.01758-10	78	15	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43609	10.1371/journal.pone.0043609	http://dx.doi.org/10.1371/journal.pone.0043609			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984435	Green Submitted, gold, Green Published			2022-12-27	WOS:000308738500018
J	Wu, YN; Zhang, YA; Xie, GX; Zhao, AH; Pan, XL; Chen, TL; Hu, YX; Liu, YM; Cheng, Y; Chi, Y; Yao, L; Jia, W				Wu, Yani; Zhang, Yinan; Xie, Guoxiang; Zhao, Aihua; Pan, Xiaolan; Chen, Tianlu; Hu, Yixue; Liu, Yumin; Cheng, Yu; Chi, Yi; Yao, Lei; Jia, Wei			The Metabolic Responses to Aerial Diffusion of Essential Oils	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; GENERALIZED ANXIETY DISORDER; IDENTIFYING DIFFERENCES; PSYCHIATRIC-DISORDERS; INOSITOL TREATMENT; OXIDATIVE STRESS; GUT MICROBIOTA; PANIC DISORDER; ANIMAL-MODELS; DOUBLE-BLIND	Anxiety disorders are the most prevalent psychiatric disorders and affect a great number of people worldwide. Essential oils, take effects through inhalation or topical application, are believed to enhance physical, emotional, and spiritual well-being. Although clinical studies suggest that the use of essential oils may have therapeutic potential, evidence for the efficacy of essential oils in treating medical conditions remains poor, with a particular lack of studies employing rigorous analytical methods that capture its identifiable impact on human biology. Here, we report a comprehensive gas chromatography time-of-flight mass spectrometry (GC-TOFMS) based metabonomics study that reveals the aromas-induced metabolic changes and the anxiolytic effect of aromas in elevated plus maze (EPM) induced anxiety model rats. The significant alteration of metabolites in the EPM group was attenuated by aromas treatment, concurrent with the behavioral improvement with significantly increased open arms time and open arms entries. Brain tissue and urinary metabonomic analysis identified a number of altered metabolites in response to aromas intervention. These metabolic changes included the increased carbohydrates and lowered levels of neurotransmitters (tryptophan, serine, glycine, aspartate, tyrosine, cysteine, phenylalanine, hypotaurine, histidine, and asparagine), amino acids, and fatty acids in the brain. Elevated aspartate, carbohydrates (sucrose, maltose, fructose, and glucose), nucleosides and organic acids such as lactate and pyruvate were also observed in the urine. The EPM induced metabolic differences observed in urine or brain tissue was significantly reduced after 10 days of aroma inhalation, as noted with the loss of statistical significance on many of the metabolites in the aroma-EPM group. This study demonstrates, for the first time, that the metabonomics approach can capture the subtle metabolic changes resulting from exposure to essential oils and provide the basis for pinpointing affected pathways in anxiety-related behavior, which will lead to an improved mechanistic understanding of anxiolytic effect of essential oils.	[Wu, Yani; Zhao, Aihua; Cheng, Yu; Chi, Yi] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China; [Wu, Yani; Pan, Xiaolan; Hu, Yixue; Yao, Lei] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China; [Zhang, Yinan; Chen, Tianlu] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Xom Res Ctr Metab Dis, Shanghai 200030, Peoples R China; [Xie, Guoxiang; Jia, Wei] Univ N Carolina Greensboro, Ctr Translat Biomed Res, Kannapolis, NC USA; [Liu, Yumin] Shanghai Jiao Tong Univ, Ctr Instrumental Anal, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of North Carolina; University of North Carolina Greensboro; Shanghai Jiao Tong University	Wu, YN (corresponding author), Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China.	g_xie@uncg.edu; w_jia@uncg.edu	Jia, Wei/AAN-5102-2020; Xie, Guoxiang/F-3022-2016	Jia, Wei/0000-0002-3739-8994; Xie, Guoxiang/0000-0002-0951-4150				Aoshima H, 1999, BIOSCI BIOTECH BIOCH, V63, P743, DOI 10.1271/bbb.63.743; Bagetta G, 2010, FITOTERAPIA, V81, P453, DOI 10.1016/j.fitote.2010.01.013; BELIVEAU GP, 1987, J NUTR, V117, P36, DOI 10.1093/jn/117.1.36; BENJAMIN J, 1995, AM J PSYCHIAT, V152, P1084; Beyoglu D, 2012, BIOCHEM PHARMACOL, V83, P1331, DOI 10.1016/j.bcp.2011.12.031; Bouayed J, 2009, OXID MED CELL LONGEV, V2, P63, DOI 10.4161/oxim.2.2.7944; Bradley BF, 2007, PHYSIOL BEHAV, V92, P931, DOI 10.1016/j.physbeh.2007.06.023; Bradley BF, 2007, J ETHNOPHARMACOL, V111, P517, DOI 10.1016/j.jep.2006.12.021; BUCHBAUER G, 1993, J PHARM SCI-US, V82, P660, DOI 10.1002/jps.2600820623; Cheng Y, 2012, J PROTEOME RES, V11, P1354, DOI 10.1021/pr201001a; Chepulis LM, 2009, PHYSIOL BEHAV, V97, P359, DOI 10.1016/j.physbeh.2009.03.001; Davis P., 2005, IEE Seminar on Security of Distributed Control Systems, P1, DOI 10.1049/ic:20050251; de Almeida RN, 2004, PHARMACOL BIOCHEM BE, V77, P361, DOI 10.1016/j.pbb.2003.11.004; Edris AE, 2007, PHYTOTHER RES, V21, P308, DOI 10.1002/ptr.2072; Einat H, 2001, J AFFECT DISORDERS, V62, P113, DOI 10.1016/S0165-0327(00)00355-4; Ersan S, 2006, PROG NEURO-PSYCHOPH, V30, P1039, DOI 10.1016/j.pnpbp.2006.03.034; Gormanns P, 2011, J PSYCHIATR RES, V45, P973, DOI 10.1016/j.jpsychires.2010.12.010; Haug TT, 2002, SCAND J GASTROENTERO, V37, P294, DOI 10.1080/003655202317284192; Jonsson P, 2004, ANAL CHEM, V76, P1738, DOI 10.1021/ac0352427; Jonsson P, 2005, ANAL CHEM, V77, P5635, DOI 10.1021/ac050601e; Kasper S, 2010, INT CLIN PSYCHOPHARM, V25, P277, DOI 10.1097/YIC.0b013e32833b3242; Komiya M, 2006, BEHAV BRAIN RES, V172, P240, DOI 10.1016/j.bbr.2006.05.006; Kuloglu M, 2002, NEUROPSYCHOBIOLOGY, V46, P186, DOI 10.1159/000067810; LAPIN IP, 1993, PHARMACOL BIOCHEM BE, V44, P241, DOI 10.1016/0091-3057(93)90305-D; Lee MS, 2012, MATURITAS, V71, P257, DOI 10.1016/j.maturitas.2011.12.018; Lehrner J, 2005, PHYSIOL BEHAV, V86, P92, DOI 10.1016/j.physbeh.2005.06.031; Lis-Balchin M, 1997, J ROY SOC HEALTH, V117, P324, DOI 10.1177/146642409711700511; LOWRY OH, 1964, J BIOL CHEM, V239, P18; National Cancer Institute USNIoH, 2010, AR ESS OILS PDQS; Ng F, 2008, INT J NEUROPSYCHOPH, V11, P851, DOI 10.1017/S1461145707008401; Nutt DJ, 2001, J CLIN PSYCHIAT, V62, P22; Oroszi G, 2005, ALCOHOL CLIN EXP RES, V29, P303, DOI 10.1097/01.ALC.0000156128.28257.2E; Pan L, 2010, J PHARMACEUT BIOMED, V52, P589, DOI 10.1016/j.jpba.2010.01.046; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Pike N, 2011, METHODS ECOL EVOL, V2, P278, DOI 10.1111/j.2041-210X.2010.00061.x; Quide Y, 2012, NEUROSCI BIOBEHAV R, V36, P626, DOI 10.1016/j.neubiorev.2011.09.004; Setzer WN, 2009, NAT PROD COMMUN, V4, P1305; SMIRNOVA A V, 1957, Farmakol Toksikol, V20, P62; Stein MB, 2004, J CLIN PSYCHIAT, V65, P3; Tannock GW, 2005, GASTROENTEROL CLIN N, V34, P361, DOI 10.1016/j.gtc.2005.05.006; THURSTON JH, 1989, METAB BRAIN DIS, V4, P177, DOI 10.1007/BF01000294; Tsang HWH, 2010, REV NEUROSCIENCE, V21, P141; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Umezu T, 2010, PHARMACOL BIOCHEM BE, V94, P497, DOI 10.1016/j.pbb.2009.11.001; van der Watt G, 2008, CONTEMP NURSE, V30, P69, DOI 10.5172/conu.673.30.1.69; Wildwood C, 1996, ENCY AROMATHERAPY, P1; Yap IKS, 2008, J PROTEOME RES, V7, P3718, DOI 10.1021/pr700864x; Zheng XJ, 2011, J PROTEOME RES, V10, P5512, DOI 10.1021/pr2007945	48	11	12	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44830	10.1371/journal.pone.0044830	http://dx.doi.org/10.1371/journal.pone.0044830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984571	gold, Green Published, Green Submitted			2022-12-27	WOS:000308738500090
J	Chaikind, B; Kilambi, KP; Gray, JJ; Ostermeier, M				Chaikind, Brian; Kilambi, Krishna Praneeth; Gray, Jeffrey J.; Ostermeier, Marc			Targeted DNA Methylation Using an Artificially Bisected M. HhaI Fused to Zinc Fingers	PLOS ONE			English	Article							PROTEIN-FRAGMENT COMPLEMENTATION; GENE-EXPRESSION; PROMOTER; SITE; METHYLTRANSFERASE; SEQUENCES; ANGSTROM	Little is known about the effects of single DNA methylation events on gene transcription. The ability to direct the methylation toward a single unique site within a genome would have broad use as a tool to study the effects of specific epigenetic changes on transcription. A targeted enzyme might also be useful in a therapy for diseases with an epigenetic component or as a means to site-specifically label DNA. Previous studies have sought to target methyltransferase activity by fusing DNA binding proteins to methyltransferases. However, the methyltransferase domain remains active even when the DNA binding protein is unbound, resulting in significant off-target methylation. A better strategy would make methyltransferase activity contingent upon the DNA binding protein's association with its DNA binding site. We have designed targeted methyltransferases by fusing zinc fingers to the fragments of artificially-bisected, assembly-compromised methyltransferases. The zinc fingers' binding sites flank the desired target site for methylation. Zinc finger binding localizes the two fragments near each other encouraging their assembly only over the desired site. Through a combination of molecular modeling and experimental optimization in E. coli, we created an engineered methyltransferase derived from M. HhaI with 50-60% methylation at a target site and nearly undetectable levels of methylation at a non-target M. HhaI site (1.462.4%). Using a restriction digestion assay, we demonstrate that localization of both fragments synergistically increases methylation at the target site, illustrating the promise of our approach.	[Chaikind, Brian] Johns Hopkins Univ, Chem Biol Interface Grad Program, Baltimore, MD 21218 USA; [Kilambi, Krishna Praneeth; Gray, Jeffrey J.; Ostermeier, Marc] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Chaikind, B (corresponding author), Johns Hopkins Univ, Chem Biol Interface Grad Program, Baltimore, MD 21218 USA.	oster@jhu.edu	Ostermeier, Marc/A-2697-2010; Gray, Jeffrey J./B-5682-2008	Ostermeier, Marc/0000-0003-0900-3665; Gray, Jeffrey J./0000-0001-6380-2324; Kilambi, Krishna Praneeth/0000-0003-4848-2611	National Institute of General Medicine at the National Institutes of Health [R01 GM066972, GM078221]; Chemistry-Biology Interface program training grant from the National Institute of General Medical Sciences at the National Institutes of Health [T32 GM080189]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078221, T32GM080189, R01GM066972] Funding Source: NIH RePORTER	National Institute of General Medicine at the National Institutes of Health; Chemistry-Biology Interface program training grant from the National Institute of General Medical Sciences at the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by funding from the National Institute of General Medicine at the National Institutes of Health [R01 GM066972 to M.O., GM078221 to J.J.G.]. Brian Chaikind was supported in part by the Chemistry-Biology Interface program training grant from the National Institute of General Medical Sciences at the National Institutes of Health [T32 GM080189]. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beerli RR, 1998, P NATL ACAD SCI USA, V95, P14628, DOI 10.1073/pnas.95.25.14628; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Bujnicki JM, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-3; Carvin CD, 2003, NUCLEIC ACIDS RES, V31, P6493, DOI 10.1093/nar/gkg853; Chen T, 2006, GENE EXPRESSION REGU, P377, DOI DOI 10.1007/978-0-387-40049-5_23; CHENG XD, 1993, CELL, V74, P299, DOI 10.1016/0092-8674(93)90421-L; Choe W, 2005, BIOCHEM BIOPH RES CO, V334, P1233, DOI 10.1016/j.bbrc.2005.07.017; Darii MV, 2009, BBA-PROTEINS PROTEOM, V1794, P1654, DOI 10.1016/j.bbapap.2009.07.016; ElrodErickson M, 1996, STRUCTURE, V4, P1171, DOI 10.1016/S0969-2126(96)00125-6; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Horsthemke B, 2008, ADV GENET, V61, P225, DOI 10.1016/S0065-2660(07)00008-9; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kitazawa R, 2007, MOL ENDOCRINOL, V21, P148, DOI 10.1210/me.2006-0205; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li FY, 2007, NUCLEIC ACIDS RES, V35, P100, DOI 10.1093/nar/gkl1035; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; MCCLELLAND M, 1994, NUCLEIC ACIDS RES, V22, P3640, DOI 10.1093/nar/22.17.3640; McNamara AR, 2002, NUCLEIC ACIDS RES, V30, P3818, DOI 10.1093/nar/gkf501; Meister GE, 2008, BIOCHEM BIOPH RES CO, V377, P226, DOI 10.1016/j.bbrc.2008.09.099; Meister GE, 2010, NUCLEIC ACIDS RES, V38, P1749, DOI 10.1093/nar/gkp1126; Michnick SW, 2000, METHOD ENZYMOL, V328, P208, DOI 10.1016/S0076-6879(00)28399-7; Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103; Nile CJ, 2008, ARTHRITIS RHEUM, V58, P2686, DOI 10.1002/art.23758; Nomura W, 2007, J AM CHEM SOC, V129, P8676, DOI 10.1021/ja0705588; Pogribny IP, 2000, CANCER RES, V60, P588; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Sambrook J., 2001, MOL CLONING LAB MANU; Shieh FK, 2006, J MOL BIOL, V362, P516, DOI 10.1016/j.jmb.2006.07.030; Slaska-Kiss K, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-17; Smith AE, 2008, J BIOL CHEM, V283, P9878, DOI 10.1074/jbc.M710393200; van der Gun BTF, 2010, BIOCONJUGATE CHEM, V21, P1239, DOI 10.1021/bc1000388; van Vlodrop IJH, 2011, CLIN CANCER RES, V17, P4225, DOI 10.1158/1078-0432.CCR-10-3394; Vlahovicek K, 2000, BIOINFORMATICS, V16, P1044, DOI 10.1093/bioinformatics/16.11.1044; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Xu GL, 1997, NAT GENET, V17, P376, DOI 10.1038/ng1297-376; Zhang X, 2010, PROSTATE, V70, P765, DOI 10.1002/pros.21109; Zohar H, 2011, NANOSCALE, V3, P3027, DOI 10.1039/c1nr10280j	39	24	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44852	10.1371/journal.pone.0044852	http://dx.doi.org/10.1371/journal.pone.0044852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984575	Green Published, Green Submitted, gold			2022-12-27	WOS:000308638700092
J	Schwartz, CL; Heumann, JM; Dawson, SC; Hoenger, A				Schwartz, Cindi L.; Heumann, John M.; Dawson, Scott C.; Hoenger, Andreas			A Detailed, Hierarchical Study of Giardia lamblia's Ventral Disc Reveals Novel Microtubule-Associated Protein Complexes	PLOS ONE			English	Article							ELECTRON-MICROSCOPE TOMOGRAPHY; CRYOELECTRON TOMOGRAPHY; MOLECULAR ARCHITECTURE; BINUCLEATE PARASITE; ATTACHMENT; INTESTINALIS; CYTOSKELETON; FLAGELLA; ANNEXIN; MODEL	Giardia lamblia is a flagellated, unicellular parasite of mammals infecting over one billion people worldwide. Giardia's two-stage life cycle includes a motile trophozoite stage that colonizes the host small intestine and an infectious cyst form that can persist in the environment. Similar to many eukaryotic cells, Giardia contains several complex microtubule arrays that are involved in motility, chromosome segregation, organelle transport, maintenance of cell shape and transformation between the two life cycle stages. Giardia trophozoites also possess a unique spiral microtubule array, the ventral disc, made of approximately 50 parallel microtubules and associated microribbons, as well as a variety of associated proteins. The ventral disc maintains trophozoite attachment to the host intestinal epithelium. With the help of a combined SEM/microtome based slice and view method called 3View (R) (Gatan Inc., Pleasanton, CA), we present an entire trophozoite cell reconstruction and describe the arrangement of the major cytoskeletal elements. To aid in future analyses of disc-mediated attachment, we used electron-tomography of freeze-substituted, plastic-embedded trophozoites to explore the detailed architecture of ventral disc microtubules and their associated components. Lastly, we examined the disc microtubule array in three dimensions in unprecedented detail using cryo-electron tomography combined with internal sub-tomogram volume averaging of repetitive domains. We discovered details of protein complexes stabilizing microtubules by attachment to their inner and outer wall. A unique tri-laminar microribbon structure is attached vertically to the disc microtubules and is connected to neighboring microribbons via crossbridges. This work provides novel insight into the structure of the ventral disc microtubules, microribbons and associated proteins. Knowledge of the components comprising these structures and their three-dimensional organization is crucial toward understanding how attachment via the ventral disc occurs in vivo.	[Schwartz, Cindi L.; Heumann, John M.; Hoenger, Andreas] Univ Colorado, Dept MCD Biol, Boulder Lab Electron Microscopy Cells 3D, Boulder, CO 80309 USA; [Dawson, Scott C.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA	University of Colorado System; University of Colorado Boulder; University of California System; University of California Davis	Schwartz, CL (corresponding author), Univ Colorado, Dept MCD Biol, Boulder Lab Electron Microscopy Cells 3D, Boulder, CO 80309 USA.	andreas.hoenger@colorado.edu		Hoenger, Andreas/0000-0001-9176-6658; Dawson, Scott/0000-0002-0843-1759	National Institutes of Health-National Center for Research Resources [RR000592]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000592] Funding Source: NIH RePORTER	National Institutes of Health-National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work has been supported by a National Institutes of Health-National Center for Research Resources grant (RR000592) to AH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; AMOS LA, 1974, J CELL SCI, V14, P523; Bauer B, 1999, FEMS MICROBIOL LETT, V173, P147, DOI 10.1111/j.1574-6968.1999.tb13496.x; Bouchet-Marquis C, 2012, J STRUCT BIOL, V177, P119, DOI 10.1016/j.jsb.2011.10.007; Bouchet-Marquis C, 2011, MICRON, V42, P152, DOI 10.1016/j.micron.2010.07.003; CHRETIEN D, 1991, ORGANIZATION, V71, P161; Cope J, 2010, J STRUCT BIOL, V170, P257, DOI 10.1016/j.jsb.2009.12.004; Cotton JA, 2011, INT J PARASITOL, V41, P925, DOI 10.1016/j.ijpara.2011.05.002; CROSSLEY R, 1983, J CELL SCI, V59, P81; CROSSLEY R, 1983, J CELL SCI, V62, P419; Cyrklaff M, 2007, J EXP MED, V204, P1281, DOI 10.1084/jem.20062405; Davids BJ, 2008, INT J PARASITOL, V38, P353, DOI 10.1016/j.ijpara.2007.08.012; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Garvalov BK, 2006, J CELL BIOL, V174, P759, DOI 10.1083/jcb.200606074; Gilbert P.F.C., 1972, ELECT TOMOGRAPHY MET, V182, P89; Hagen KD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001442; Hansen WR, 2006, EUKARYOT CELL, V5, P781, DOI 10.1128/EC.5.4.781-783.2006; Hoenger A, 2000, J MOL BIOL, V297, P1087, DOI 10.1006/jmbi.2000.3627; HOLBERTON DV, 1981, J CELL SCI, V47, P139; HOLBERTON DV, 1981, J CELL SCI, V47, P167; HOLBERTON DV, 1974, J EXP BIOL, V60, P207; HOLBERTON DV, 1973, J CELL SCI, V13, P11; HOOPS HJ, 1983, J CELL BIOL, V97, P902, DOI 10.1083/jcb.97.3.902; House SA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002167; Hu K, 2002, J CELL BIOL, V156, P1039, DOI 10.1083/jcb.200112086; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; Koning RI, 2008, J STRUCT BIOL, V161, P459, DOI 10.1016/j.jsb.2007.08.011; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Land KM, 1999, DRUG RESIST UPDATE, V2, P289, DOI 10.1054/drup.1999.0104; Lechtreck KF, 2002, J CELL SCI, V115, P1511; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McDonald K, 2010, METHOD CELL BIOL, V96, P671, DOI 10.1016/S0091-679X(10)96028-7; McIntosh JR, 2009, J MOL BIOL, V394, P177, DOI 10.1016/j.jmb.2009.09.033; Mercogliano CP, 2006, J MOL BIOL, V355, P211, DOI 10.1016/j.jmb.2005.10.026; Mueller JC, 1974, SCANNING ELECT MICRO; NARCISI EM, 1994, J PARASITOL, V80, P468, DOI 10.2307/3283419; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Nicastro D, 2011, P NATL ACAD SCI USA, V108, pE845, DOI 10.1073/pnas.1106178108; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; NOHRIA A, 1992, MOL BIOCHEM PARASIT, V56, P27, DOI 10.1016/0166-6851(92)90151-9; Nohynkova E, 2006, EUKARYOT CELL, V5, P753, DOI 10.1128/EC.5.4.753-761.2006; O'Toole ET, 1999, MOL BIOL CELL, V10, P2017, DOI 10.1091/mbc.10.6.2017; Palm D, 2005, MOL BIOCHEM PARASIT, V141, P199, DOI 10.1016/j.molbiopara.2005.03.005; PEATTIE DA, 1990, PARASITOL TODAY, V6, P52, DOI 10.1016/0169-4758(90)90070-K; Sagolla MS, 2006, J CELL SCI, V119, P4889, DOI 10.1242/jcs.03276; Sanchez T, 2011, SCIENCE, V333, P456, DOI 10.1126/science.1203963; Sandberg K, 2003, J STRUCT BIOL, V144, P61, DOI 10.1016/j.jsb.2003.09.013; Sandblad L, 2006, CELL, V127, P1415, DOI 10.1016/j.cell.2006.11.025; Savioli L, 2006, TRENDS PARASITOL, V22, P203, DOI 10.1016/j.pt.2006.02.015; SHERWIN T, 1989, CELL, V57, P211, DOI 10.1016/0092-8674(89)90959-8; Slocik JM, 2005, SMALL, V1, P1048, DOI 10.1002/smll.200500172; Sui HX, 2006, NATURE, V442, P475, DOI 10.1038/nature04816; TAYLOR KA, 1974, SCIENCE, V186, P1036, DOI 10.1126/science.186.4168.1036; Thompson RCA, 2000, INT J PARASITOL, V30, P1259, DOI 10.1016/S0020-7519(00)00127-2; Vickerman K, 1976, COMP CELL BIOL KINET, V1; Weiland MEL, 2005, INT J PARASITOL, V35, P617, DOI 10.1016/j.ijpara.2004.12.009; Weiland MEL, 2003, INT J PARASITOL, V33, P1341, DOI 10.1016/S0020-7519(03)00201-7; West JB, 2010, RESP PHYSIOL NEUROBI, V170, P202, DOI 10.1016/j.resp.2009.12.010; Woessner DJ, 2012, EUKARYOT CELL, V11, P292, DOI 10.1128/EC.05262-11; Xiong QR, 2009, J STRUCT BIOL, V168, P378, DOI 10.1016/j.jsb.2009.08.016	61	34	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43783	10.1371/journal.pone.0043783	http://dx.doi.org/10.1371/journal.pone.0043783			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984443	Green Published, Green Submitted, gold			2022-12-27	WOS:000308638700030
J	Sharp, SY; Roe, SM; Kazlauskas, E; Cikotiene, I; Workman, P; Matulis, D; Prodromou, C				Sharp, Swee Y.; Roe, S. Mark; Kazlauskas, Egidijus; Cikotiene, Inga; Workman, Paul; Matulis, Daumantas; Prodromou, Chrisostomos			Co-Crystalization and In Vitro Biological Characterization of 5-Aryl-4-(5-Substituted-2-4-Dihydroxyphenyl)-1,2,3-Thiadiazole Hsp90 Inhibitors	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; BREAST-CANCER; CHAPERONE; 17-ALLYLAMINO-17-DEMETHOXYGELDANAMYCIN; POTENT; PHARMACOKINETICS; EXPLOITATION; HYDROQUINONE; DEGRADATION; METABOLISM	A potential therapeutic strategy for targeting cancer that has gained much interest is the inhibition of the ATP binding and ATPase activity of the molecular chaperone Hsp90. We have determined the structure of the human Hsp90 alpha N-terminal domain in complex with a series of 5-aryl-4-(5-substituted-2-4-dihydroxyphenyl)-1,2,3-thiadiazoles. The structures provide the molecular details for the activity of these inhibitors. One of these inhibitors, ICPD 34, causes a structural change that affects a mobile loop, which adopts a conformation similar to that seen in complexes with ADP, rather than the conformation generally seen with the pyrazole/isoxazole-resorcinol class of inhibitors. Competitive binding to the Hsp90 N-terminal domain was observed in a biochemical assay, and these compounds showed antiproliferative activity and induced apoptosis in the HCT116 human colon cancer cell line. These inhibitors also caused induction of the heat shock response with the upregulation of Hsp72 and Hsp27 protein expression and the depletion of Hsp90 clients, CRAF, ERBB2 and CDK4, thus confirming that antiproliferative activity was through the inhibition of Hsp90. The presence of increased levels of the cleavage product of PARP indicated apoptosis in response to Hsp90 inhibitors. This work provides a framework for the further optimization of thiadiazole inhibitors of Hsp90. Importantly, we demonstrate that the thiadiazole inhibitors display a more limited core set of interactions relative to the clinical trial candidate NVP-AUY922, and consequently may be less susceptible to resistance derived through mutations in Hsp90.	[Sharp, Swee Y.; Workman, Paul] Inst Canc Res, Haddow Labs, Div Canc Therapeut, Canc Res UK Canc Therapeut Unit, Sutton, Surrey, England; [Roe, S. Mark] Univ Sussex, Brighton, Falmer, England; [Kazlauskas, Egidijus; Matulis, Daumantas] Vilnius State Univ, Lab Biothermodynam & Drug Design, Inst Biotechnol, Vilnius, Lithuania; [Cikotiene, Inga] Vilnius State Univ, Fac Chem, Dept Organ Chem, Vilnius, Lithuania; [Prodromou, Chrisostomos] Univ Sussex, Genome Damage & Stabil Ctr, Brighton, Falmer, England	Cancer Research UK; University of London; Institute of Cancer Research - UK; University of Sussex; Vilnius University; Vilnius University; University of Sussex	Sharp, SY (corresponding author), Inst Canc Res, Haddow Labs, Div Canc Therapeut, Canc Res UK Canc Therapeut Unit, Sutton, Surrey, England.	chris.prodromou@sussex.ac.uk	Matulis, Daumantas/F-9367-2010; Prodromou, Chrisostomos/ABA-9133-2021; Cikotiene, Inga/F-1658-2010	Matulis, Daumantas/0000-0002-6178-6276; Prodromou, Chrisostomos/0000-0003-4320-1147; Cikotiene, Inga/0000-0002-8062-3907; Roe, Mark/0000-0002-7371-9855; Kazlauskas, Egidijus/0000-0001-8430-7349	Diamond Light Source; Wellcome Trust senior investigator award [095605/Z11/Z]; Cancer Research UK program [C309/A8274]; NHS; Royal Marsden Hospital;  [FP7-REGPOT-2009-1];  [245721];  [TD0905];  [CM0804]; Cancer Research UK [11566] Funding Source: researchfish; Medical Research Council [G0801130B] Funding Source: researchfish	Diamond Light Source; Wellcome Trust senior investigator award(Wellcome Trust); Cancer Research UK program(Cancer Research UK); NHS; Royal Marsden Hospital(Royal Society of New ZealandMarsden Fund (NZ)); ; ; ; ; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors acknowledge support from the Diamond Light Source and the Wellcome Trust senior investigator award (LHP), 095605/Z11/Z. This study was also supported by Cancer Research UK program grant number C309/A8274 to PW. PW is a Cancer Research UK Life Fellow. They also acknowledge NHS funding to the NIHR Biomedical Research Centre at The Institute of Cancer Research and Royal Marsden Hospital. DM acknowledges FP7-REGPOT-2009-1 grant "MoBiLi", agreement no.: 245721, and the COST projects TD0905 and CM0804. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banerji U, 2005, J CLIN ONCOL, V23, P4152, DOI 10.1200/JCO.2005.00.612; Brough PA, 2008, J MED CHEM, V51, P196, DOI 10.1021/jm701018h; Cheung KMJ, 2005, BIOORG MED CHEM LETT, V15, P3338, DOI 10.1016/j.bmcl.2005.05.046; Chiosis G, 2006, EXPERT OPIN THER TAR, V10, P37, DOI 10.1517/14728222.10.1.37; Chiosis G, 2001, CHEM BIOL, V8, P289, DOI 10.1016/S1074-5521(01)00015-1; Chiosis G, 2006, CURR TOP MED CHEM, V6, P1183, DOI 10.2174/156802606777812013; Cikotiene I, 2009, BIOORG MED CHEM LETT, V19, P1089, DOI 10.1016/j.bmcl.2009.01.003; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dymock BW, 2005, J MED CHEM, V48, P4212, DOI 10.1021/jm050355z; Eccles SA, 2008, CANCER RES, V68, P2850, DOI 10.1158/0008-5472.CAN-07-5256; Egorin MJ, 2001, CANCER CHEMOTH PHARM, V47, P291, DOI 10.1007/s002800000242; Egorin MJ, 1998, CANCER RES, V58, P2385; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ge J, 2006, J MED CHEM, V49, P4606, DOI 10.1021/jm0603116; Goetz MP, 2005, J CLIN ONCOL, V23, P1078, DOI 10.1200/JCO.2005.09.119; Guo WC, 2005, CANCER RES, V65, P10006, DOI 10.1158/0008-5472.CAN-05-2029; Hostein I, 2001, CANCER RES, V61, P4003; Howes R, 2006, ANAL BIOCHEM, V350, P202, DOI 10.1016/j.ab.2005.12.023; Jensen MR, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1996; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kaur G, 2004, CLIN CANCER RES, V10, P4813, DOI 10.1158/1078-0432.CCR-03-0795; Kelland LR, 1999, J NATL CANCER I, V91, P1940, DOI 10.1093/jnci/91.22.1940; Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7; Maloney A, 2002, EXPERT OPIN BIOL TH, V2, P3, DOI 10.1517/14712598.2.1.3; Millson SH, 2011, FASEB J; Modi S, 2011, CLIN CANCER RES, V17, P5132, DOI 10.1158/1078-0432.CCR-11-0072; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Pacey S, 2006, HANDB EXP PHARM, V172, P331; Pacey S, 2011, CLIN CANCER RES, V17, P1561, DOI 10.1158/1078-0432.CCR-10-1927; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Prodromou C, 1996, PROTEINS, V25, P517, DOI 10.1002/prot.13; Prodromou C, 2009, ACS CHEM BIOL, V4, P289, DOI 10.1021/cb9000316; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; Schulte TW, 1998, CANCER CHEMOTH PHARM, V42, P273, DOI 10.1007/s002800050817; Sharp SY, 2007, MOL CANCER THER, V6, P1198, DOI 10.1158/1535-7163.MCT-07-0149; Sharp SY, 2007, CANCER RES, V67, P2206, DOI 10.1158/0008-5472.CAN-06-3473; Smith NF, 2006, MOL CANCER THER, V5, P1628, DOI 10.1158/1535-7163.MCT-06-0041; Travers J, 2012, DRUG DISCOV TODAY, V17, P242, DOI 10.1016/j.drudis.2011.12.021; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Wright L, 2004, CHEM BIOL, V11, P775, DOI 10.1016/j.chembiol.2004.03.033; Xu WP, 2007, CLIN CANCER RES, V13, P1625, DOI 10.1158/1078-0432.CCR-06-2966	48	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44642	10.1371/journal.pone.0044642	http://dx.doi.org/10.1371/journal.pone.0044642			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984537	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000308638700075
J	Walter, J; Hausmann, S; Drepper, T; Puls, M; Eggert, T; Dihne, M				Walter, Janine; Hausmann, Sascha; Drepper, Thomas; Puls, Michael; Eggert, Thorsten; Dihne, Marcel			Flavin Mononucleotide-Based Fluorescent Proteins Function in Mammalian Cells without Oxygen Requirement	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; PREDICTS RADIATION RESPONSE; REPORTER PROTEINS; HYPOXIA PROMOTES; TUMOR HYPOXIA; TRANSPLANTATION; SURVIVAL; BACTERIA; CULTURE; GROWTH	Usage of the enhanced green fluorescent protein (eGFP) in living mammalian cells is limited to aerobic conditions due to requirement of oxygen during chromophore formation. Since many diseases or disease models are associated with acute or chronic hypoxia, eGFP-labeling of structures of interest in experimental studies might be unreliable leading to biased results. Thus, a chromophore yielding a stable fluorescence under hypoxic conditions is desirable. The fluorescence of flavin mononucleotide (FMN)-based fluorescent proteins (FbFPs) does not require molecular oxygen. Recently, the advantages of FbFPs for several bacterial strains and yeasts were described, specifically, their usage as a real time fluorescence marker in bacterial expression studies and their ability of chromophore formation under anaerobic conditions. Our objective was to verify if FbFPs also function in mammalian cells in order to potentially broaden the repertoire of chromophores with ones that can reliably be used in mammalian studies under hypoxic conditions. In the present study, we demonstrate for the first time, that FbFPs can be expressed in different mammalian cells, among them murine neural stem cells during proliferative and differentiated stages. Fluorescence intensities were comparable to eGFP. In contrast to eGFP, the FbFP fluorescence did not decrease when cells were exposed to defined hypoxic conditions neither in proliferating nor in differentiated cells. Thus, FbFPs can be regarded as an alternative to eGFP in studies that target cellular structures which are exposed to hypoxic conditions.	[Walter, Janine; Dihne, Marcel] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurol & Epileptol, Baden Baden, Germany; [Hausmann, Sascha; Puls, Michael; Eggert, Thorsten] Evocatal GmbH, Dusseldorf, North Rhine Wes, Germany; [Walter, Janine] Univ Dusseldorf, Dept Neurol, Dusseldorf, North Rhine Wes, Germany; [Drepper, Thomas] Univ Dusseldorf, Inst Mol Enzyme Technol, Dusseldorf, North Rhine Wes, Germany; [Drepper, Thomas] Forschungszentrum Julich, D-52425 Julich, North Rhine Wes, Germany	Eberhard Karls University of Tubingen; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich	Walter, J (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurol & Epileptol, Baden Baden, Germany.	Janine.Walter@googlemail.com	drepper, thomas/ABB-4717-2020; Drepper, Thomas/ABA-8291-2020	drepper, thomas/0000-0002-0096-8084; Drepper, Thomas/0000-0002-0096-8084				Ambros JT, 2007, TRANSPL INT, V20, P219, DOI 10.1111/j.1432-2277.2006.00418.x; BALIN AK, 1984, J EXP MED, V160, P152, DOI 10.1084/jem.160.1.152; Basciano L, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-12; Boyle Robert George, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P281; Brahimi-Horn MC, 2007, J MOL MED-JMM, V85, P1301, DOI 10.1007/s00109-007-0281-3; Briggs WR, 2002, TRENDS PLANT SCI, V7, P204, DOI 10.1016/S1360-1385(02)02245-8; Celaya RB, 2005, PHOTOCHEM PHOTOBIOL, V81, P73, DOI 10.1562/2004-08-22-IR-282.1; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Charlier N, 2002, MOL BRAIN RES, V104, P21, DOI 10.1016/S0169-328X(02)00198-5; Choi CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018499; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Daadi MM, 2009, MOL THER, V17, P1282, DOI 10.1038/mt.2009.104; Danovaro R, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-30; Dougherty CJ, 2008, MOL VIS, V14, P471; Drepper T, 2007, NAT BIOTECHNOL, V25, P443, DOI 10.1038/nbt1293; Drepper T, 2010, APPL ENVIRON MICROB, V76, P5990, DOI 10.1128/AEM.00701-10; Fyles AW, 1998, RADIOTHER ONCOL, V48, P149, DOI 10.1016/S0167-8140(98)00044-9; Grahl N, 2010, MED MYCOL, V48, P1, DOI 10.3109/13693780902947342; Hockel M, 1996, CANCER RES, V56, P4509; Howard RS, PRACT NEUROL, V11, P4; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; Kain SR, 1999, DRUG DISCOV TODAY, V4, P304, DOI 10.1016/S1359-6446(99)01330-6; Kanichai M, 2008, J CELL PHYSIOL, V216, P708, DOI 10.1002/jcp.21446; Krauss U, 2005, PHYS CHEM CHEM PHYS, V7, P2804, DOI 10.1039/b504554a; Krohn KA, 2008, J NUCL MED, V49, p129S, DOI 10.2967/jnumed.107.045914; Kuchimaru T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015736; Laitinen A, 2011, METHODS MOL BIOL, V698, P63, DOI 10.1007/978-1-60761-999-4_6; Lamm K, 1996, Audiol Neurootol, V1, P148; Lobo LA, 2011, FEMS MICROBIOL LETT, V317, P67, DOI 10.1111/j.1574-6968.2011.02212.x; Losi A, 2002, BIOPHYS J, V82, P2627, DOI 10.1016/S0006-3495(02)75604-X; Losi A, 2012, ANNU REV PLANT BIOL, V63, P49, DOI 10.1146/annurev-arplant-042811-105538; Mengesha A, 2010, CURR GENE THER, V10, P15; Nagayama T, 1999, J NEUROSCI, V19, P2987; Nordsmark M, 1996, RADIOTHER ONCOL, V41, P31, DOI 10.1016/S0167-8140(96)91811-3; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Piekarski T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-265; Potzkei J, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-28; Prado-Lopez S, 2010, STEM CELLS, V28, P407, DOI 10.1002/stem.295; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; ROSENBAUM DM, 1994, ANN NEUROL, V36, P864, DOI 10.1002/ana.410360610; Ryan RM, 2006, BIOESSAYS, V28, P84, DOI 10.1002/bies.20336; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Sun XL, 2011, MOL IMAGING BIOL, V13, P399, DOI 10.1007/s11307-010-0420-z; TANNOCK I, 1981, BRIT J CANCER, V43, P245, DOI 10.1038/bjc.1981.37; Theus MH, 2008, EXP NEUROL, V210, P656, DOI 10.1016/j.expneurol.2007.12.020; Tielker D, 2009, EUKARYOT CELL, V8, P913, DOI 10.1128/EC.00394-08; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vordermark D, 2001, NEOPLASIA, V3, P527, DOI 10.1038/sj.neo.7900192; Wei Ming Q, 2008, Genet Vaccines Ther, V6, P8, DOI 10.1186/1479-0556-6-8; Zimmer M, 2002, CHEM REV, V102, P759, DOI 10.1021/cr010142r	51	32	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43921	10.1371/journal.pone.0043921	http://dx.doi.org/10.1371/journal.pone.0043921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984451	Green Published, gold, Green Submitted			2022-12-27	WOS:000308638700032
J	Walter, WD; Anderson, CW; VerCauteren, KC				Walter, W. David; Anderson, Charles W.; VerCauteren, Kurt C.			Evaluation of Remote Delivery of Passive Integrated Transponder (PIT) Technology to Mark Large Mammals	PLOS ONE			English	Article							WHITE-TAILED DEER; TOPICAL TREATMENT; CAPTURE; SYSTEM; WILD; IMMUNOCONTRACEPTION; IDENTIFICATION; ACARICIDE; MIGRATION; IXODIDAE	Methods to individually mark and identify free-ranging wildlife without trapping and handling would be useful for a variety of research and management purposes. The use of Passive Integrated Transponder technology could be an efficient method for collecting data for mark-recapture analysis and other strategies for assessing characteristics about populations of various wildlife species. Passive Integrated Transponder tags (PIT) have unique numbered frequencies and have been used to successfully mark and identify mammals. We tested for successful injection of PIT and subsequent functioning of PIT into gelatin blocks using 4 variations of a prototype dart. We then selected the prototype dart that resulted in the least depth of penetration in the gelatin block to assess the ability of PIT to be successfully implanted into muscle tissue of white-tailed deer (Odocoileus virginianus) post-mortem and long-term in live, captive Rocky Mountain elk (Cervus elaphus). The prototype dart with a 12.7 mm (0.5 inch) needle length and no powder charge resulted in the shallowest mean (+/- SD) penetration depth into gelatin blocks of 27.0 mm (+/-5.6 mm) with 2.0 psi setting on the Dan-Inject CO2-pressured rifle. Eighty percent of PIT were successfully injected in the muscle mass of white-tailed deer post-mortem with a mean (+/- SD) penetration depth of 22.2 mm (+/-3.8 mm; n = 6). We injected PIT successfully into 13 live, captive elk by remote delivery at about 20 m that remained functional for 7 months. We successfully demonstrated that PIT could be remotely delivered in darts into muscle mass of large mammals and remain functional for >6 months. Although further research is warranted to fully develop the technique, remote delivery of PIT technology to large mammals is possible using prototype implant darts.	[Walter, W. David; Anderson, Charles W.; VerCauteren, Kurt C.] US Fish & Wildlife Serv, USDA, Anim & Plant Hlth Inspect Serv, Natl Wildlife Res Ctr, Ft Collins, CO USA	United States Department of Agriculture (USDA); United States Department of the Interior; US Fish & Wildlife Service	Walter, WD (corresponding author), US Geol Survey, Cooperat Fish & Wildlife Res Unit, University Pk, PA USA.	wdwalter@psu.edu			National Wildlife Research Center of the United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services	National Wildlife Research Center of the United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services	Funding for this research was provided by the National Wildlife Research Center of the United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RA, 2008, J ANIM ECOL, V77, P1115, DOI 10.1111/j.1365-2656.2008.01447.x; [Anonymous], 2007, HDB WILDLIFE CHEM IM; Bishop CJ, 2011, DEV AUTOMATED DEVICE; Boarman WI, 1998, WILDLIFE SOC B, V26, P886; Bubb DH, 2002, HYDROBIOLOGIA, V483, P225, DOI 10.1023/A:1021352217332; Carling MD, 2003, J MAMMAL, V84, P1237, DOI 10.1644/BRB-116; Cattet MRL, 2006, WILDLIFE SOC B, V34, P741, DOI 10.2193/0091-7648(2006)34[741:EOTPFI]2.0.CO;2; Delsink AK, 2007, J S AFR VET ASSOC, V78, P25; DeNicola AJ, 1996, WILDLIFE SOC B, V24, P301; ELBIN SB, 1994, WILDLIFE SOC B, V22, P677; FAGERSTONE KA, 1987, J WILDLIFE MANAGE, V51, P294, DOI 10.2307/3801005; Freitag A, 2001, BIRD STUDY, V48, P102, DOI 10.1080/00063650109461207; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; GEORGIADIS N, 1994, J HERED, V85, P100, DOI 10.1093/oxfordjournals.jhered.a111405; Gibbons JW, 2004, BIOSCIENCE, V54, P447, DOI 10.1641/0006-3568(2004)054[0447:PTSTAI]2.0.CO;2; Gionfriddo JP, 2011, WILDLIFE SOC B, V35, P149, DOI 10.1002/wsb.17; Haulton SM, 2001, WILDLIFE SOC B, V29, P255; Jacobson HA, 1997, WILDLIFE SOC B, V25, P547; Karesh WB, 2007, CONSERV BIOL, V1, P261; Kerry Knowles, 1993, Proceedings of the NIPR Symposium on Polar Biology, V6, P62; Kilpatrick HJ, 1996, WILDLIFE SOC B, V24, P306; Kreeger TJ, 2002, WILDLIFE SOC B, V30, P968; MACE RD, 1994, WILDLIFE SOC B, V22, P74; Morgan JB, 2004, J ANIM SCI, V82, P3308; Morley CG, 2002, NEW ZEAL J ZOOL, V29, P143, DOI 10.1080/03014223.2002.9518297; Newey S, 2009, WILDLIFE BIOL, V15, P405, DOI 10.2981/08-083; PENGILLY D, 1994, FISH RES, V19, P293, DOI 10.1016/0165-7836(94)90045-0; Pound JM, 2000, J MED ENTOMOL, V37, P588, DOI 10.1603/0022-2585-37.4.588; RICE WR, 1977, J WILDLIFE MANAGE, V41, P197, DOI 10.2307/3800595; Rogers LM, 2002, MAMMAL REV, V32, P63, DOI 10.1046/j.1365-2907.2002.00096.x; Rutberg AT, 2004, WILDLIFE RES, V35, P494; Ryser A, 2005, WILDLIFE SOC B, V33, P721, DOI 10.2193/0091-7648(2005)33[721:ARTSFT]2.0.CO;2; SCHOOLEY RL, 1993, J MAMMAL, V74, P480, DOI 10.2307/1382406; Silvy Nova J., 2005, P339; Stafford KC, 2009, VECTOR-BORNE ZOONOT, V9, P371, DOI 10.1089/vbz.2008.0161; Stein FJ, 2003, J AM VET MED ASSOC, V223, P1316, DOI 10.2460/javma.2003.223.1316; Walter WD, 2002, WILDLIFE SOC B, V30, P908; Wyneken Jeanette, 2010, Herpetological Review, V41, P448; Zimmerman J. L., 2008, P W VIRGINIA ACAD SC, V79, P1	39	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44838	10.1371/journal.pone.0044838	http://dx.doi.org/10.1371/journal.pone.0044838			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984572	Green Published, Green Submitted, gold			2022-12-27	WOS:000308638700090
J	Ramasamy, A; Kuokkanen, M; Vedantam, S; Gajdos, ZK; Alves, AC; Lyon, HN; Ferreira, MAR; Strachan, DP; Zhao, JH; Abramson, MJ; Brown, MA; Coin, L; Dharmage, SC; Duffy, DL; Haahtela, T; Heath, AC; Janson, C; Kahonen, M; Khaw, KT; Laitinen, J; Le Souef, P; Lehtimaki, T; Madden, PAF; Marks, GB; Martin, NG; Matheson, MC; Palmer, CD; Palotie, A; Pouta, A; Robertson, CF; Viikari, J; Widen, E; Wjst, M; Jarvis, DL; Montgomery, GW; Thompson, PJ; Wareham, N; Eriksson, J; Jousilahti, P; Laitinen, T; Pekkanen, J; Raitakari, OT; O'Connor, GT; Salomaa, V; Jarvelin, MR; Hirschhorn, JN				Ramasamy, Adaikalavan; Kuokkanen, Mikko; Vedantam, Sailaja; Gajdos, Zofia K.; Alves, Alexessander Couto; Lyon, Helen N.; Ferreira, Manuel A. R.; Strachan, David P.; Zhao, Jing Hua; Abramson, Michael J.; Brown, Matthew A.; Coin, Lachlan; Dharmage, Shyamali C.; Duffy, David L.; Haahtela, Tari; Heath, Andrew C.; Janson, Christer; Kahonen, Mika; Khaw, Kay-Tee; Laitinen, Jaana; Le Souef, Peter; Lehtimaki, Terho; Madden, Pamela A. F.; Marks, Guy B.; Martin, Nicholas G.; Matheson, Melanie C.; Palmer, Cameron D.; Palotie, Aarno; Pouta, Anneli; Robertson, Colin F.; Viikari, Jorma; Widen, Elisabeth; Wjst, Matthias; Jarvis, Deborah L.; Montgomery, Grant W.; Thompson, Philip J.; Wareham, Nick; Eriksson, Johan; Jousilahti, Pekka; Laitinen, Tarja; Pekkanen, Juha; Raitakari, Olli T.; O'Connor, George T.; Salomaa, Veikko; Jarvelin, Marjo-Riitta; Hirschhorn, Joel N.		Australian Asthma Genetics	Genome-Wide Association Studies of Asthma in Population-Based Cohorts Confirm Known and Suggested Loci and Identify an Additional Association near HLA	PLOS ONE			English	Article							CARDIOVASCULAR RISK; ROR-ALPHA; VARIANTS; GENETICS; LUNG; SUSCEPTIBILITY; METAANALYSIS; ALLERGY; HEALTH; HEART	Rationale: Asthma has substantial morbidity and mortality and a strong genetic component, but identification of genetic risk factors is limited by availability of suitable studies. Objectives: To test if population-based cohorts with self-reported physician-diagnosed asthma and genome-wide association (GWA) data could be used to validate known associations with asthma and identify novel associations. Methods: The APCAT (Analysis in Population-based Cohorts of Asthma Traits) consortium consists of 1,716 individuals with asthma and 16,888 healthy controls from six European-descent population-based cohorts. We examined associations in APCAT of thirteen variants previously reported as genome-wide significant (P < 5x10(-8)) and three variants reported as suggestive (P < 5 x 10(-7)). We also searched for novel associations in APCAT (Stage 1) and followed-up the most promising variants in 4,035 asthmatics and 11,251 healthy controls (Stage 2). Finally, we conducted the first genome-wide screen for interactions with smoking or hay fever. Main Results: We observed association in the same direction for all thirteen previously reported variants and nominally replicated ten of them. One variant that was previously suggestive, rs11071559 in RORA, now reaches genome-wide significance when combined with our data (P = 2.4x10(-9)). We also identified two genome-wide significant associations: rs13408661 near IL1RL1/IL18R1 (PStage1+Stage2 = 1.1x10(-9)), which is correlated with a variant recently shown to be associated with asthma (rs3771180), and rs9268516 in the HLA region (PStage1+Stage2 = 1.1x10(-8)), which appears to be independent of previously reported associations in this locus. Finally, we found no strong evidence for gene-environment interactions with smoking or hay fever status. Conclusions: Population-based cohorts with simple asthma phenotypes represent a valuable and largely untapped resource for genetic studies of asthma.	[Kuokkanen, Mikko; Jousilahti, Pekka; Salomaa, Veikko] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Ramasamy, Adaikalavan; Alves, Alexessander Couto; Coin, Lachlan; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England; [Ramasamy, Adaikalavan] Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England; [Vedantam, Sailaja; Gajdos, Zofia K.; Lyon, Helen N.; Palmer, Cameron D.; Hirschhorn, Joel N.] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Vedantam, Sailaja; Gajdos, Zofia K.; Lyon, Helen N.; Palmer, Cameron D.; Hirschhorn, Joel N.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Vedantam, Sailaja; Gajdos, Zofia K.; Lyon, Helen N.; Palmer, Cameron D.; Hirschhorn, Joel N.] Broad Inst, Cambridge, MA USA; [Strachan, David P.] Univ London, Div Community Hlth Sci, London, England; [Ferreira, Manuel A. R.; Duffy, David L.; Martin, Nicholas G.; Montgomery, Grant W.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Zhao, Jing Hua; Wareham, Nick] Addenbrookes Hosp, MRC Epidemiol Unit, Inst Metab Sci, Cambridge, England; [Abramson, Michael J.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld, Australia; [Dharmage, Shyamali C.; Matheson, Melanie C.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Heath, Andrew C.; Madden, Pamela A. F.] Washington Univ, Sch Med, St Louis, MO USA; [Haahtela, Tari] Helsinki Univ Hosp, Skin & Allergy Hosp, Helsinki, Finland; [Janson, Christer] Uppsala Univ, Dept Med Sci Resp Med & Allergol, Uppsala, Sweden; [Kahonen, Mika] Tampere Univ Hosp, Dept Clin Physiol, Tampere, Finland; [Khaw, Kay-Tee] Addenbrookes Hosp, Clin Gerontol Unit, Cambridge, England; [Laitinen, Jaana] Finnish Inst Occupat Hlth, Oulu, Finland; [Le Souef, Peter] Princess Margaret Hosp Children, Sch Paediat & Child Hlth, Perth, WA, Australia; [Lehtimaki, Terho] Univ Tampere, Dept Clin Chem, FIN-33101 Tampere, Finland; [Marks, Guy B.] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia; [Palotie, Aarno] Wellcome Trust Sanger Inst, Hinxton, England; [Palotie, Aarno; Widen, Elisabeth] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland; [Palotie, Aarno] Broad Inst MIT & Harvard, Cambridge, MA USA; [Palotie, Aarno] Univ Cent Hosp, Helsinki, Finland; [Palotie, Aarno] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Pouta, Anneli] Natl Inst Hlth & Welf, Dept Children Young People & Families, Helsinki, Finland; [Pouta, Anneli] Univ Oulu, Inst Clin Med Obstet & Gynecol, Oulu, Finland; [Robertson, Colin F.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Viikari, Jorma] Univ Turku, Dept Med, Turku, Finland; [Wjst, Matthias] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Munich, Germany; [Jarvis, Deborah L.; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Ctr Environm & Hlth, MRC Hlth Protect Agcy HPA, London, England; [Thompson, Philip J.] Univ Western Australia, Ctr Asthma Allergy & Resp Res, Perth, WA 6009, Australia; [Thompson, Philip J.] Univ Western Australia, Lung Inst Western Australia, Perth, WA 6009, Australia; [Eriksson, Johan] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Eriksson, Johan] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Laitinen, Tarja] Turku Univ Hosp, Dept Pulm Dis & Clin Allergol, FIN-20520 Turku, Finland; [Eriksson, Johan] Folkhalsan Res Ctr, Helsinki, Finland; [Pekkanen, Juha] Natl Inst Hlth & Welf THL, Dept Environm Hlth, Kuopio, Finland; [Pekkanen, Juha] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Med, Turku, Finland; [Raitakari, Olli T.] Turku Univ Hosp, Dept Clin Physiol, FIN-20520 Turku, Finland; [O'Connor, George T.] Boston Univ, Sch Med, Dept Med, Ctr Pulm, Boston, MA 02118 USA; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [O'Connor, George T.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Finland National Institute for Health & Welfare; Imperial College London; University of London; King's College London; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of London; QIMR Berghofer Medical Research Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Monash University; University of Queensland; University of Melbourne; Washington University (WUSTL); University of Helsinki; Helsinki University Central Hospital; Uppsala University; Tampere University; Tampere University Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Finnish Institute of Occupational Health; University of Western Australia; Tampere University; University of Sydney; Woolcock Institute of Medical Research; Wellcome Trust Sanger Institute; University of Helsinki; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Finland National Institute for Health & Welfare; University of Oulu; Murdoch Children's Research Institute; University of Turku; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Imperial College London; University of Western Australia; University of Western Australia; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Turku; Folkhalsan Research Center; Finland National Institute for Health & Welfare; University of Eastern Finland; University of Turku; University of Turku; Boston University; University of Oulu; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Oulu; Harvard University; Harvard Medical School	Salomaa, V (corresponding author), Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland.	veikko.salomaa@thl.fi; m.jarvelin@imperial.ac.uk; joelh@broadinstitute.org	Brown, Matthew A/E-5749-2010; Abramson, Michael/AAQ-2671-2020; Martin, Nicholas/R-9235-2019; Coin, Lachlan JM/A-9001-2014; Matheson, Melanie C/O-4721-2015; Raitakari, Olli/AAQ-7389-2021; Lehtimäki, Terho/AAD-1094-2022; Le Souef, Peter N/H-5256-2014; Khaw, Kay-Tee/AAZ-3209-2021; Montgomery, Grant W/B-7148-2008; Ferreira, Manuel A R/D-3609-2013; Ramasamy, Adaikalavan/G-2632-2010; Marks, Guy B./F-5058-2013; Jarvis, Deborah/E-6494-2011; Coin, Lachlan/O-4976-2019; Duffy, David L/B-7392-2013; Kuokkanen, Mikko/M-8247-2016	Brown, Matthew A/0000-0003-0538-8211; Abramson, Michael/0000-0002-9954-0538; Martin, Nicholas/0000-0003-4069-8020; Coin, Lachlan JM/0000-0002-4300-455X; Matheson, Melanie C/0000-0002-5822-3499; Lehtimäki, Terho/0000-0002-2555-4427; Montgomery, Grant W/0000-0002-4140-8139; Ferreira, Manuel A R/0000-0001-9059-1825; Ramasamy, Adaikalavan/0000-0002-7598-2892; Marks, Guy B./0000-0002-8976-8053; Coin, Lachlan/0000-0002-4300-455X; Duffy, David L/0000-0001-7227-632X; Kuokkanen, Mikko/0000-0003-4375-9327; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Couto Alves, Alex/0000-0001-8519-7356; Dharmage, Shyamali/0000-0001-6063-1937; O'Connor, George/0000-0002-6476-3926; Le Souef, Peter/0000-0003-0930-1654; Kahonen, Mika/0000-0002-4510-7341; Palotie, Aarno/0000-0002-2527-5874; Jarvis, Deborah/0000-0002-1753-3896; Eriksson, Johan/0000-0002-2516-2060	European Commission [018996, LSH-2004-1.2.5-1, 223367]; Department of Health, UK; National Health and Medical Research Council, Australia (NHMRC) [613627, 455836]; Academy of Finland Center of Excellence in Complex Disease Genetics [213506, 129680]; Wellcome Trust [089062]; European Community; ENGAGE Consortium [201413]; Academy of Finland [129287, 134839, 129494, 139635]; Samfundet Folkhalsan; Finnish Diabetes Research Foundation; Finska Lakaresallskapet; Finnish Foundation for Cardiovascular Research; Yrjo Jahnsson Foundation; Foundation Liv och Halsa; Foundation of the Finnish Anti-Tuberculosis Association; Foundation of the Allergy Association; Biocenter Oulu, University of Oulu; National Heart Lung and Blood Institute (NHLBI) - National Institutes of Health [5R01HL087679-02, 1RL1MH083268-01]; American Asthma Foundation; MRC [G0901214] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K05AA017688] Funding Source: NIH RePORTER; Medical Research Council [G0801056B, G0901214, G0401527, G1000143, MC_U106179471] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); Department of Health, UK; National Health and Medical Research Council, Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Academy of Finland Center of Excellence in Complex Disease Genetics(Academy of Finland); Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission); ENGAGE Consortium; Academy of Finland(Academy of Finland); Samfundet Folkhalsan; Finnish Diabetes Research Foundation; Finska Lakaresallskapet; Finnish Foundation for Cardiovascular Research; Yrjo Jahnsson Foundation; Foundation Liv och Halsa; Foundation of the Finnish Anti-Tuberculosis Association; Foundation of the Allergy Association; Biocenter Oulu, University of Oulu; National Heart Lung and Blood Institute (NHLBI) - National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Asthma Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Please see Supplementary Methods S1 for the details of the many charities, governmental bodies and scientific funding organisations that supported the study recruitment, phenotyping, DNA collection and genotyping for the studies involved in the discovery stage (Stage1) and replication stage (Stage2). The personal research funding supports are listed as follows: AR was supported through the European Commission (through project GABRIEL - contract #018996 under the Integrated Program LSH-2004-1.2.5-1) and the Department of Health, UK. ACA was funded by the European Commission, Framework 7 (grant #223367). The National Health and Medical Research Council, Australia (NHMRC) supported MARF through a project grant (#613627), MAB via a Principal Research Fellowship (#455836) and SCD, DLD, NGM, MCM and GWM via a fellowship scheme. AP acknowledges funding from The Academy of Finland Center of Excellence in Complex Disease Genetics (#213506 and 129680), the Wellcome Trust (#089062), the European Community's Framework 7 Programme and the ENGAGE Consortium (#201413). The Academy of Finland supported EW (#129287, #134839) and VS (#129494, #139635). JE was supported through Academy of Finland, Samfundet Folkhalsan, Finnish Diabetes Research Foundation, Finska Lakaresallskapet, Finnish Foundation for Cardiovascular Research; Yrjo Jahnsson Foundation and Foundation Liv och Halsa. TL was supported by Foundation of the Finnish Anti-Tuberculosis and Allergy Associations. M-RJ has received financial support from the Academy of Finland, Biocenter Oulu, University of Oulu and National Heart Lung and Blood Institute (NHLBI) - National Institutes of Health (#5R01HL087679-02 through the STAMPEED program 1RL1MH083268-01). JNH was supported by a grant from the American Asthma Foundation for analysis of Framingham SHARe data for association with asthma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; AROMAA A, 2004, BASELINE RESULTS HLT; Barnes KC, 2010, CURR OPIN ALLERGY CL, V10, P427, DOI 10.1097/ACI.0b013e32833de6ee; Barnett SBL, 2011, J ALLERGY CLIN IMMUN, V127, P145, DOI 10.1016/j.jaci.2010.10.020; Borish L, 2008, ANN ALLERG ASTHMA IM, V101, P1, DOI 10.1016/S1081-1206(10)60826-5; Bousquet J, 2005, B WORLD HEALTH ORGAN, V83, P548; Burney P, 1997, AM J RESP CRIT CARE, V156, P1773; Chen MH, 2010, BIOINFORMATICS, V26, P580, DOI 10.1093/bioinformatics/btp710; Delerive P, 2001, EMBO REP, V2, P42, DOI 10.1093/embo-reports/kve007; DUFFY DL, 1990, AM REV RESPIR DIS, V142, P1351, DOI 10.1164/ajrccm/142.6_Pt_1.1351; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Ferreira MAR, 2011, EUR J HUM GENET, V19, P458, DOI 10.1038/ejhg.2010.191; Ferreira MAR, 2011, LANCET IN PRESS; Galanter J, 2008, AM J RESP CRIT CARE, V177, P1194, DOI 10.1164/rccm.200711-1644OC; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Hirota T, 2011, NAT GENET; Jaradat M, 2006, AM J RESP CRIT CARE, V174, P1299, DOI 10.1164/rccm.200510-1672OC; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Li XN, 2010, J ALLERGY CLIN IMMUN, V125, P328, DOI 10.1016/j.jaci.2009.11.018; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Melen E, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-86; Meyers DA, 2010, J ALLERGY CLIN IMMUN, V126, P439, DOI 10.1016/j.jaci.2010.07.012; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Myint PK, 2005, EUR RESPIR J, V26, P494, DOI 10.1183/09031936.05.00023605; NIEMINEN MM, 1991, CHEST, V100, P70, DOI 10.1378/chest.100.1.70; Noguchi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002170; Raitakari OT, 2008, INT J EPIDEMIOL, V37, P1220, DOI 10.1093/ije/dym225; Rantakallio P, 1969, ACTA PAEDIAT SC S193, V193, P191; Rogers AJ, 2009, AM J RESP CRIT CARE, V179, P1084, DOI 10.1164/rccm.200812-1860OC; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; So HC, 2011, GENET EPIDEMIOL, V35, P310, DOI 10.1002/gepi.20579; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; Torgerson DG, 2011, NAT GENET; van Beijsterveldt CEM, 2007, EUR RESPIR J, V29, P516, DOI 10.1183/09031936.00065706; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Wan YI, 2012, THORAX; Weidinger S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000166; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208	46	83	85	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e44008	10.1371/journal.pone.0044008	http://dx.doi.org/10.1371/journal.pone.0044008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028483	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000309973900004
J	Xiong, J; Zhou, T				Xiong, Jie; Zhou, Tong			Gene Regulatory Network Inference from Multifactorial Perturbation Data Using both Regression and Correlation Analyses	PLOS ONE			English	Article							EXPRESSION DATA; BIOLOGY; SYSTEMS; SIMULATION	An important problem in systems biology is to reconstruct gene regulatory networks (GRNs) from experimental data and other a priori information. The DREAM project offers some types of experimental data, such as knockout data, knockdown data, time series data, etc. Among them, multifactorial perturbation data are easier and less expensive to obtain than other types of experimental data and are thus more common in practice. In this article, a new algorithm is presented for the inference of GRNs using the DREAM4 multifactorial perturbation data. The GRN inference problem among p genes is decomposed into p x (p-1) different regression problems. In each of the regression problems, the expression level of a target gene is predicted solely from the expression level of a potential regulation gene. For different potential regulation genes, different weights for a specific target gene are constructed by using the sum of squared residuals and the Pearson correlation coefficient. Then these weights are normalized to reflect effort differences of regulating distinct genes. By appropriately choosing the parameters of the power law, we constructe a 0-1 integer programming problem. By solving this problem, direct regulation genes for an arbitrary gene can be estimated. And, the normalized weight of a gene is modified, on the basis of the estimation results about the existence of direct regulations to it. These normalized and modified weights are used in queuing the possibility of the existence of a corresponding direct regulation. Computation results with the DREAM4 In Silico Size 100 Multifactorial subchallenge show that estimation performances of the suggested algorithm can even outperform the best team. Using the real data provided by the DREAM5 Network Inference Challenge, estimation performances can be ranked third. Furthermore, the high precision of the obtained most reliable predictions shows the suggested algorithm may be helpful in guiding biological experiment designs.	[Xiong, Jie; Zhou, Tong] Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China; [Zhou, Tong] Tsinghua Univ, Tsinghua Natl Lab Informat Sci & Technol TNList, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Xiong, J (corresponding author), Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China.	xiongj08@mails.tsinghua.edu.cn	Zhou, Tong/AAD-1593-2019		973 Program [2012CB316504, 2009CB320602]; National Natural Science Foundation of China [61174122, 61021063, 60721003, 60625305]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The reported work was financially supported in part by the 973 Program under Grant 2012CB316504 and 2009CB320602 and by the National Natural Science Foundation of China under Grants 61174122, 61021063, 60721003, and 60625305. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Andrecut M, 2008, INT J MOD PHYS C, V19, P283, DOI 10.1142/S0129183108012091; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Cantone I, 2009, CELL, V137, P172, DOI 10.1016/j.cell.2009.01.055; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ferrazzi F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S5-S2; Hempel S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-292; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Klamt S, 2010, BIOINFORMATICS, V26, P2160, DOI 10.1093/bioinformatics/btq342; MacLean D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009901; Martin S, 2007, BIOINFORMATICS, V23, P866, DOI 10.1093/bioinformatics/btm021; Menendez P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014147; Nemhauser GL., 1988, INTEGER COMBINATORIA, DOI [10.1002/9781118627372, DOI 10.1002/9781118627372]; Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37; Pinna A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012912; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Wang YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031194; Weisberg S, 1981, APPL LINEAR REGRESSI; Wolsey L.A., 1988, INTEGER PROGRAMMING; Zhou T, 2010, BIOINFORMATICS, V26, P2020, DOI 10.1093/bioinformatics/btq325	21	21	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e43819	10.1371/journal.pone.0043819	http://dx.doi.org/10.1371/journal.pone.0043819			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028471	Green Published, gold			2022-12-27	WOS:000309392800003
J	Chae, YK; Neagu, S; Kim, J; Smyrlis, A; Gooptu, M; Tester, W				Chae, Young Kwang; Neagu, Stefan; Kim, Jongoh; Smyrlis, Athanasios; Gooptu, Mahasweta; Tester, William			Association between Common Allergic Symptoms and Cancer in the NHANES III Female Cohort	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; PRIMARY LUNG-CANCER; UNITED-STATES; COMMUNITY INCOME; IMMUNE-SYSTEM; BREAST-CANCER; RISK; ASTHMA; ATOPY; DISEASE	Background: Previous epidemiological studies have investigated the association between allergic symptoms and cancer occurrence. However, the role of allergy in cancer has been elusive, especially for the female population. Methods: We examined the relationship between cancer prevalence and common allergic symptoms of rhinoconjunctivitis (RC) and wheezing (WZ) among NHANES III female participants. Results: Among 4600 people, 36.3% (n = 1669) did not have any allergic symptoms (NO), while 47.6% (n = 2188) reported RC, and 16.2% (n = 743), WZ. The proportion of cancer among NO groups was 5.43% (91/1669), among RC group, 7.63% (167/2188), and among WZ group, 11.23% (83/743) (RC group- OR 1.44 with 95% CI 1.00-2.08; p = 0.05 while for WZ group- OR 2.20 with 95% CI 1.27-3.80; p = 0.01). After adjusting for all the possible confounding variables including age, smoking, or COPD, having symptoms of RC (AOR 1.49 with 95% CI 1.12-2.36; p = 0.01) or WC (AOR 2.08 with 95% CI 1.11-3.89; p = 0.02) demonstrated consistent strong association with cancer. Among nonsmokers (n = 2505, 54.5%) only symptoms of RC showed association with cancer (AOR 1.51 with 95% CI 1.00-2.28; p = 0.05). Among former or current smokers (n = 2094, 45.5%), only symptoms of WZ demonstrated association with cancer (AOR 2.38 with 95% CI 1.16-4.87; p = 0.02). Among different types of cancers, odds of having breast cancer among participants with symptoms of RC or WZ were approximately twice the odds of having breast cancer among participants without any of these symptoms. AOR for RC group was 1.89 with 95% CI 1.04-3.42 and p = 0.04 while AOR for WC group was 2.08 with 95% CI 0.90-4.78 and p = 0.08. Conclusions: In summary, we found associations between common allergic symptoms like rhinitis/conjunctivitis and wheezing and prevalence of cancer, specifically between rhinitis/conjunctivitis and breast cancer that were not found in previous studies. Larger prospective studies are required to validate our findings.	[Neagu, Stefan] Christiana Care Hlth Syst, Dept Med, Newark, DE 19718 USA; [Chae, Young Kwang] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA; [Kim, Jongoh] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Smyrlis, Athanasios; Gooptu, Mahasweta; Tester, William] Albert Einstein Med Ctr, Dept Med, Philadelphia, PA 19141 USA	Christiana Care Health System; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Yeshiva University	Neagu, S (corresponding author), Christiana Care Hlth Syst, Dept Med, Newark, DE 19718 USA.	neagustefan@yahoo.com						ALDERSON M, 1974, LANCET, V2, P1475; ALLEGRA J, 1976, CANCER RES, V36, P3225; AMLOT PL, 1983, BRIT J CANCER, V48, P209, DOI 10.1038/bjc.1983.176; Bergmann RL, 2000, CLIN EXP ALLERGY, V30, P1740, DOI 10.1046/j.1365-2222.2000.00927.x; BILEK O, 1975, NEOPLASMA, V22, P441; Boffetta P, 2002, EUR RESPIR J, V19, P127, DOI 10.1183/09031936.02.00245802; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Boyd C, 1999, J CLIN ONCOL, V17, P2244, DOI 10.1200/JCO.1999.17.7.2244; BRANDES LJ, 1994, J NATL CANCER I, V86, P770, DOI 10.1093/jnci/86.10.770; Brenner AV, 2002, INT J CANCER, V99, P252, DOI 10.1002/ijc.10320; Castaing M, 2005, AM J EPIDEMIOL, V162, P542, DOI 10.1093/aje/kwi241; Chen W, 2008, ALLERGY, V63, P1418, DOI 10.1111/j.1398-9995.2008.01880.x; COCKCROFT DW, 1979, ANN ALLERGY, V43, P345; ERIKSSON NE, 1995, ALLERGY, V50, P718, DOI 10.1111/j.1398-9995.1995.tb01212.x; FISHERMAN EW, 1960, J ALLERGY, V31, P74, DOI 10.1016/0021-8707(60)90026-5; FORD RM, 1978, ANN ALLERGY, V40, P240; Gabriel R, 1972, Br J Clin Pract, V26, P202; GALLAGHER RP, 1983, BRIT J CANCER, V48, P853, DOI 10.1038/bjc.1983.277; Hedderson MM, 2003, CANCER CAUSE CONTROL, V14, P619, DOI 10.1023/A:1025686913626; Holly EA, 2003, AM J EPIDEMIOL, V158, P432, DOI 10.1093/aje/kwg174; HUGHES WF, 1979, ANN ALLERGY, V43, P163; Jensen-Jarolim E, 2008, ALLERGY, V63, P610, DOI 10.1111/j.1398-9995.2008.01645.x; JOHNSON KJ, 1966, J LANCET, V86, P5; KALLEN B, 1993, EUR RESPIR J, V6, P694; Keibel A, 2009, CURR PHARM DESIGN, V15, P1949, DOI 10.2174/138161209788453167; Lewis SA, 2001, J ALLERGY CLIN IMMUN, V107, P615, DOI 10.1067/mai.2001.113523; Lindelof B, 2005, ALLERGY, V60, P1116, DOI 10.1111/j.1398-9995.2005.00808.x; LOGAN J, 1953, N Z Med J, V52, P210; MACKAY WD, 1966, BRIT J CANCER, V20, P434, DOI 10.1038/bjc.1966.52; Mackillop WJ, 2000, CANCER-AM CANCER SOC, V89, P901, DOI 10.1002/1097-0142(20000815)89:4<901::AID-CNCR25>3.0.CO;2-I; MCDUFFIE HH, 1991, CHEST, V99, P404, DOI 10.1378/chest.99.2.404; MCDUFFIE HH, 1988, CHEST, V93, P241, DOI 10.1378/chest.93.2.241; MCWHORTER WP, 1988, CANCER-AM CANCER SOC, V62, P451, DOI 10.1002/1097-0142(19880715)62:2<451::AID-CNCR2820620234>3.0.CO;2-D; MEERS PD, 1973, LANCET, V1, P884; MILLS PK, 1992, AM J EPIDEMIOL, V136, P287, DOI 10.1093/oxfordjournals.aje.a116494; Ming ME, 2004, J AM ACAD DERMATOL, V50, P357, DOI 10.1016/j.jaad.2003.09.024; Nadalin V, 2003, INT J CANCER, V106, P566, DOI 10.1002/ijc.11240; Nathan RA, 2007, ALLERGY ASTHMA PROC, V28, P3, DOI 10.2500/aap.2007.28.2934; Parimon T, 2007, AM J RESP CRIT CARE, V175, P712, DOI 10.1164/rccm.200608-1125OC; PETROIANU A, 1995, J INT MED RES, V23, P358, DOI 10.1177/030006059502300505; PRATTER MR, 1983, CHEST, V84, P42, DOI 10.1378/chest.84.1.42; ROBINETTE CD, 1978, J CHRON DIS, V31, P619, DOI 10.1016/0021-9681(78)90022-X; SANCHEZBORGES M, 1986, CLIN IMMUNOL IMMUNOP, V41, P314, DOI 10.1016/0090-1229(86)90002-4; Santillan AA, 2003, CANCER CAUSE CONTROL, V14, P327, DOI 10.1023/A:1023982402137; Schuz J, 1999, BRIT J CANCER, V80, P585, DOI 10.1038/sj.bjc.6690395; Schuz J, 2003, INT J CANCER, V105, P255, DOI 10.1002/ijc.11054; Schwartzbaum J, 2003, INT J CANCER, V106, P423, DOI 10.1002/ijc.11230; SEVERSON RK, 1989, J CLIN EPIDEMIOL, V42, P995, DOI 10.1016/0895-4356(89)90165-0; SHAPIRO S, 1973, LANCET, V1, P1055; Sigurgeirsson B, 1991, AM J CONTACT DERMATI, V2, P235; Talbot-Smith A, 2003, AM J EPIDEMIOL, V157, P606, DOI 10.1093/aje/kwg020; TOREN K, 1993, CHEST, V104, P600, DOI 10.1378/chest.104.2.600; Turner MC, 2005, AM J EPIDEMIOL, V162, P212, DOI 10.1093/aje/kwi193; Turner MC, 2006, INT J CANCER, V118, P3124, DOI 10.1002/ijc.21752; URE D M J, 1969, Scottish Medical Journal, V14, P51; VENA JE, 1985, AM J EPIDEMIOL, V122, P66, DOI 10.1093/oxfordjournals.aje.a114087; VESTERINEN E, 1993, INT J EPIDEMIOL, V22, P976, DOI 10.1093/ije/22.6.976; Wanner A, 1996, AM J RESP CRIT CARE, V154, P1868, DOI 10.1164/ajrccm.154.6.8970383; Wen WQ, 2000, CANCER CAUSE CONTROL, V11, P303, DOI 10.1023/A:1008958724739; Wigertz A, 2007, AM J EPIDEMIOL, V166, P941, DOI 10.1093/aje/kwm203	60	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e42896	10.1371/journal.pone.0042896	http://dx.doi.org/10.1371/journal.pone.0042896			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028435	Green Submitted, gold, Green Published			2022-12-27	WOS:000311313900003
J	Bourguignon, T; Sobotnik, J; Sillam-Dusses, D; Jiros, P; Hanus, R; Roisin, Y; Miura, T				Bourguignon, Thomas; Sobotnik, Jan; Sillam-Dusses, David; Jiros, Pavel; Hanus, Robert; Roisin, Yves; Miura, Toru			Developmental Pathways of Psammotermes hybostoma (Isoptera: Rhinotermitidae): Old Pseudergates Make up a New Sterile Caste	PLOS ONE			English	Article							FORMOSAN SUBTERRANEAN TERMITE; JUVENILE-HORMONE TITERS; WORKER CASTE; EVOLUTION; DIFFERENTIATION; REPRODUCTIVES; MORPHOLOGY; PHYLOGENY; SOLDIERS; SYSTEM	Background: Ergonomic efficiency is in termites maximized by task partitioning among specialized castes. The isopteran caste systems can be classified as either (i) linear, when tasks are performed by pluripotent immatures (pseudergates), retaining the ability to develop into winged imagoes or (ii) bifurcated, with the presence of a true worker caste, which diverges early and permanently from the sexual (nymph/alate) line. Principal Findings: Here, we report on the ontogenetic potentialities of the highly polymorphic sand termite Psammotermes hybostoma. Beside numerous pluripotent pseudergates, constituting the main work force, some larger non-feeding apterous immatures, also occur. These individuals are unable to proceed to the winged imago stage, but store large amounts of fat and also give rise to large soldiers. Soldiers therefore originate from a wide range of apterous instars, consequently being highly polymorphic. Conclusions: The caste system of P. hybostoma is essentially linear, as in other basal Rhinotermitidae, but is distinguished by the late bifurcation leading to large apterous immatures. Because these large worker-like individuals deviate late and do not perform worker tasks, they cannot be considered homologous to the true workers of Termitidae and advanced Rhinotermitidae, but they provide a novel example of the evolution of sterile immatures in termites.	[Sobotnik, Jan; Sillam-Dusses, David; Jiros, Pavel; Hanus, Robert] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic; [Bourguignon, Thomas; Miura, Toru] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan; [Bourguignon, Thomas; Hanus, Robert; Roisin, Yves] Univ Libre Bruxelles, Brussels, Belgium; [Sobotnik, Jan] Czech Univ Life Sci, Fac Forestry & Wood Sci, Prague, Czech Republic; [Sillam-Dusses, David] Univ Paris 06, Lab Ecol & Evolut, Paris, France; [Sillam-Dusses, David] IBIOS, BIOEMCO, UMR 211, IRD, Bondy, France; [Sillam-Dusses, David] Univ Paris 13, Lab Ethol Expt & Comparee, Villetaneuse, France	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Hokkaido University; Universite Libre de Bruxelles; Czech University of Life Sciences Prague; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paris 13	Sobotnik, J (corresponding author), Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic.	sobotnik@uochb.cas.cz	Hanus, Robert/D-4765-2013; Miura, Toru/P-2456-2019; Sillam-Dussès, David/AAI-5942-2021	Hanus, Robert/0000-0002-7054-1975; Miura, Toru/0000-0002-7456-4402; Sillam-Dusses, David/0000-0001-5027-8703; Roisin, Yves/0000-0001-6635-3552; Sobotnik, Jan/0000-0002-8581-637X; Bourguignon, Thomas/0000-0002-4035-8977	Czech Science Foundation [P506/10/1570]; Institute of Organic Chemistry and Biochemistry [Z40550506]; Japan Society for Promotion of Science [22-00393]; Ministry of Education, Culture, Sports, Science and Technology of Japan [21677001]; Grants-in-Aid for Scientific Research [21677001] Funding Source: KAKEN	Czech Science Foundation(Grant Agency of the Czech Republic); Institute of Organic Chemistry and Biochemistry; Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Financial support for this study was received from the Czech Science Foundation (project P506/10/1570; http://www.gacr.cz/); the Institute of Organic Chemistry and Biochemistry (project Z40550506; http://www.uochb.cz); Japan Society for Promotion of Science (postdoctoral fellowship to TB, 22-00393; www.jsps.go.jp/english/); Grants-in-Aid for Young Scientists, the Ministry of Education, Culture, Sports, Science and Technology of Japan(project 21677001; www.jsps.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T., 1987, P125; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Bourguignon T, 2009, EVOL DEV, V11, P659, DOI 10.1111/j.1525-142X.2009.00373.x; BUCHLJ HARRO H. R., 1958, ANN SCI NAT ZOOL, V20, P263; CLEMENT GERMAINE, 1952, ANN SCI NAT ZOOL LLE SER, V14, P95; COATON W G H, 1973, Cimbebasia Series A, V3, P19; Cornette R, 2008, J INSECT PHYSIOL, V54, P922, DOI 10.1016/j.jinsphys.2008.04.017; Engel MS, 2009, AM MUS NOVIT, P1, DOI 10.1206/651.1; GRASSE PP, 1947, CR HEBD ACAD SCI, V224, P219; Heath H, 1927, J MORPHOL PHYSIOL, V43, P387, DOI 10.1002/jmor.1050430206; HIGASHI M, 1991, P ROY SOC B-BIOL SCI, V246, P25, DOI 10.1098/rspb.1991.0120; Howard KJ, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P97, DOI 10.1007/978-90-481-3977-4_5; Inward DJG, 2007, MOL PHYLOGENET EVOL, V44, P953, DOI 10.1016/j.ympev.2007.05.014; Korb J, 2012, J INSECT PHYSIOL, V58, P376, DOI 10.1016/j.jinsphys.2011.12.016; Krasulova J, 2012, J CHEM ECOL, V38, P557, DOI 10.1007/s10886-012-0123-9; Legendre F, 2008, MOL PHYLOGENET EVOL, V48, P615, DOI 10.1016/j.ympev.2008.04.017; Leniaud L, 2011, EVOL DEV, V13, P138, DOI 10.1111/j.1525-142X.2011.00464.x; Liu YX, 2005, ENVIRON ENTOMOL, V34, P557, DOI 10.1603/0046-225X-34.3.557; Lo N, 2004, INSECT SOC, V51, P365, DOI 10.1007/s00040-004-0759-8; Luamba J.L.N., 1980, Biologie et Ecologie Mediterraneenne, V7, P169; Mao LX, 2005, ANN ENTOMOL SOC AM, V98, P340, DOI 10.1603/0013-8746(2005)098[0340:FSTIRS]2.0.CO;2; Miller EM, 1942, B U MIAMI, V15, P3; Miura T, 2005, EVOL DEV, V7, P122, DOI 10.1111/j.1525-142X.2005.05014.x; Miura T, 2004, INSECT SOC, V51, P247, DOI 10.1007/s00040-003-0736-2; Miura T, 2000, ECOL RES, V15, P83, DOI 10.1046/j.1440-1703.2000.00320.x; Noirot C., 1985, Current Themes in Tropical Science, V3, P41; Noirot C., 1985, Current Themes in Tropical Science, V3, P75; NOIROT C, 1987, EXPERIENTIA, V43, P851, DOI 10.1007/BF01951642; NOIROT C, 1988, SOCIOBIOLOGY, V14, P15; Noirot Ch., 1969, P311; NOIROT CHARLES, 1955, ANN SCI NAT ZOOL, V17, P399; Parmentier D, 2003, J MORPHOL, V255, P69, DOI 10.1002/jmor.10047; RENOUX J, 1976, INSECT SOC, V23, P287; ROISIN Y, 1991, ETHOL ECOL EVOL, V3, P327, DOI 10.1080/08927014.1991.9525361; ROISIN Y, 1988, ZOOMORPHOLOGY, V107, P339, DOI 10.1007/BF00312217; Roisin Y, 1999, INSECT SOC, V46, P273, DOI 10.1007/s000400050146; ROISIN Y, 1994, AM NAT, V143, P751, DOI 10.1086/285631; Roisin Y, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P95; Roisin Y, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P133, DOI 10.1007/978-90-481-3977-4_6; Roonwal ML, 1988, INDIAN J ENTOMOL, V47, P455; Rupf T, 2008, NATURWISSENSCHAFTEN, V95, P811, DOI 10.1007/s00114-008-0387-7; Sillam-Dusses D, 2011, J CHEM ECOL, V37, P179, DOI 10.1007/s10886-011-9910-y; Stys Pavel, 1999, Acta Societatis Zoologicae Bohemicae, V63, P483; Thompson GJ, 2000, J EVOLUTION BIOL, V13, P869, DOI 10.1046/j.1420-9101.2000.00237.x; Watson J.A.L., 1981, Sociobiology, V6, P101; WATSON JAL, 1977, AUST J ZOOL, V25, P25, DOI 10.1071/ZO9770025	46	12	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e44527	10.1371/journal.pone.0044527	http://dx.doi.org/10.1371/journal.pone.0044527			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028554	Green Published, gold, Green Submitted			2022-12-27	WOS:000309742800011
J	Choi, K; Yu, C				Choi, Kyungwho; Yu, Choongho			Highly Doped Carbon Nanotubes with Gold Nanoparticles and Their Influence on Electrical Conductivity and Thermopower of Nanocomposites	PLOS ONE			English	Article							WORK FUNCTION; THERMOELECTRIC PROPERTIES; POLYMER COMPOSITES; FILMS; TRANSPARENT; PERFORMANCE; NETWORKS; ENHANCEMENT; ELECTRONICS; TRANSPORT	Carbon nanotubes (CNTs) are often used as conductive fillers in composite materials, but electrical conductivity is limited by the maximum filler concentration that is necessary to maintain composite structures. This paper presents further improvement in electrical conductivity by precipitating gold nanoparticles onto CNTs. In our composites, the concentrations of CNTs and poly (vinyl acetate) were respectively 60 and 10 vol%. Four different gold concentrations, 0, 10, 15, or 20 vol% were used to compare the influence of the gold precipitation on electrical conductivity and thermopower of the composites. The remaining portion was occupied by poly(3,4-ethylenedioxythiophene) poly(styrenesulfonate), which debundled and stabilized CNTs in water during synthesis processes. The concentrations of gold nanoparticles are below the percolation threshold of similar composites. However, with 15-vol% gold, the electrical conductivity of our composites was as high as similar to 6x10(5) S/m, which is at least similar to 500% higher than those of similar composites as well as orders of magnitude higher than those of other polymer composites containing CNTs and gold particles. According to our analysis with a variable range hopping model, the high conductivity can be attributed to gold doping on CNT networks. Additionally, the electrical properties of composites made of different types of CNTs were also compared.	[Choi, Kyungwho; Yu, Choongho] Texas A&M Univ, Dept Mech Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Choi, K (corresponding author), Texas A&M Univ, Dept Mech Engn, College Stn, TX 77843 USA.	chyu@tamu.edu		Choi, Kyungwho/0000-0002-4011-0402	US Air Force Office of Scientific Research under the auspices of Dr. Charles Lee, II-VI Foundation [FA9550-09-1-0609]; Pioneer Research Center Program through the National Research Foundation of Korea [2011-0001645]; Ministry of Education, Science and Technology	US Air Force Office of Scientific Research under the auspices of Dr. Charles Lee, II-VI Foundation; Pioneer Research Center Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	The authors gratefully acknowledge financial support from the US Air Force Office of Scientific Research (FA9550-09-1-0609) under the auspices of Dr. Charles Lee, II-VI Foundation, and the Pioneer Research Center Program through the National Research Foundation of Korea (2011-0001645) and funded by the Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago H, 1999, J PHYS CHEM B, V103, P8116, DOI 10.1021/jp991659y; Carroll DL, 2005, SYNTHETIC MET, V155, P694, DOI 10.1016/j.synthmet.2005.08.031; Choi HC, 2002, J AM CHEM SOC, V124, P9058, DOI 10.1021/ja026824t; Collins PG, 2000, SCI AM, V283, P62, DOI 10.1038/scientificamerican1200-62; Dai HJ, 1996, SCIENCE, V272, P523, DOI 10.1126/science.272.5261.523; Derycke V, 2001, NANO LETT, V1, P453, DOI 10.1021/nl015606f; Devadoss A, 2011, ANAL CHEM, V83, P2383, DOI 10.1021/ac102697c; Forster RJ, 2003, J ELECTROANAL CHEM, V554, P345, DOI 10.1016/S0022-0728(03)00258-4; Geng HZ, 2007, NANO, V2, P157, DOI 10.1142/S1793292007000532; Hecht DS, 2011, NANOTECHNOLOGY, V22; Hellstrom SL, 2009, ACS NANO, V3, P1423, DOI 10.1021/nn9002456; Hu XJ, 2004, ITHERM 2004, VOL 1, P63, DOI 10.1109/ITHERM.2004.1319155; Kim D, 2010, ACS NANO, V4, P513, DOI 10.1021/nn9013577; Kim JY, 2002, SYNTHETIC MET, V126, P311, DOI 10.1016/S0379-6779(01)00576-8; Kong BS, 2007, J PHYS CHEM C, V111, P8377, DOI 10.1021/jp071297r; Kong BS, 2009, CHEM COMMUN, P2174, DOI 10.1039/b821920f; Kongkanand A, 2007, NANO LETT, V7, P676, DOI 10.1021/nl0627238; Kymakis E, 2003, J APPL PHYS, V93, P1764, DOI 10.1063/1.1535231; Kymakis E, 2006, J APPL PHYS, V99, DOI 10.1063/1.2189931; Lee NS, 2001, DIAM RELAT MATER, V10, P265, DOI 10.1016/S0925-9635(00)00478-7; Li J, 1999, APPL PHYS LETT, V75, P367, DOI 10.1063/1.124377; Liu XM, 2008, NANO LETT, V8, P2613, DOI 10.1021/nl0729734; Meng CZ, 2010, ADV MATER, V22, P535, DOI 10.1002/adma.200902221; Park W, 2012, J HEAT TRANS-T ASME, V134, DOI 10.1115/1.4005201; Podhajecka K, 2008, MACROMOL SYMP, V268, P72, DOI 10.1002/masy.200850815; Reyes-Reyes M, 2010, J PHYS CHEM C, V114, P20220, DOI 10.1021/jp107386x; RIVIERE JC, 1966, APPL PHYS LETT, V8, P172, DOI 10.1063/1.1754539; Rowe D. M., 1995, CRC HDB THERMOELECTR; Ryu Y, 2012, J MATER CHEM, V22, P6959, DOI [10.1039/c2jm16000e, 10.1039/c2jm16000c]; Ryu Y, 2011, SOLID STATE COMMUN, V151, P1932, DOI 10.1016/j.ssc.2011.09.022; Ryu YT, 2011, CARBON, V49, P4745, DOI 10.1016/j.carbon.2011.06.082; SACHTLER WM, 1966, SURF SCI, V5, P221, DOI 10.1016/0039-6028(66)90083-5; Shiraishi M, 2001, CARBON, V39, P1913, DOI 10.1016/S0008-6223(00)00322-5; Sun JP, 2002, APPL PHYS A-MATER, V75, P479, DOI [10.1007/s003390201403, 10.1007/S003390201403]; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954; Yang SB, 2010, J PHYS CHEM C, V114, P9296, DOI 10.1021/jp102066k; Yao Q, 2010, ACS NANO, V4, P2445, DOI 10.1021/nn1002562; Yu C, 2011, ACS NANO, V5, P7885, DOI 10.1021/nn202868a; Yu CH, 2011, ACS NANO, V5, P1297, DOI 10.1021/nn102999h; Yu C, 2008, NANO LETT, V8, P4428, DOI 10.1021/nl802345s; Zhang B, 2010, ACS APPL MATER INTER, V2, P3170, DOI 10.1021/am100654p	41	29	29	3	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44977	10.1371/journal.pone.0044977	http://dx.doi.org/10.1371/journal.pone.0044977			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024778	Green Published, gold, Green Submitted			2022-12-27	WOS:000308860100036
J	Filgueiras, LR; Martins, JO; Serezani, CH; Capelozzi, VL; Montes, MBA; Jancar, S				Filgueiras, Luciano R., Jr.; Martins, Joilson O.; Serezani, Carlos H.; Capelozzi, Vera L.; Montes, Marlise B. A.; Jancar, Sonia			Sepsis-Induced Acute Lung Injury (ALI) Is Milder in Diabetic Rats and Correlates with Impaired NFkB Activation	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; MELLITUS; PHAGOCYTOSIS; DYSFUNCTION; PULMONARY; INSULIN	Acute lung injury (ALI) develops in response to a direct insult to the lung or secondarily to a systemic inflammatory response, such as sepsis. There is clinical evidence that the incidence and severity of ALI induced by direct insult are lower in diabetics. In the present study we investigated whether the same occurs in ALI secondarily to sepsis and the molecular mechanisms involved. Diabetes was induced in male Wistar rats by alloxan and sepsis by caecal ligation and puncture surgery (CLP). Six hours later, the lungs were examined for oedema and cell infiltration in bronchoalveolar lavage. Alveolar macrophages (AMs) were cultured in vitro for analysis of I kappa B and p65 subunit of NF kappa B phosphorylation and MyD88 and SOCS-1 mRNA. Diabetic rats were more susceptible to sepsis than non-diabetics. In non-diabetic rats, the lung presented oedema, leukocyte infiltration and increased COX2 expression. In diabetic rats these inflammatory events were significantly less intense. To understand why diabetic rats despite being more susceptible to sepsis develop milder ALI, we examined the NF kappa B activation in AMs of animals with sepsis. Whereas in non-diabetic rats the phosphorylation of I kappa B and p65 subunit occurred after 6 h of sepsis induction, this did not occur in diabetics. Moreover, in AMs from diabetic rats the expression of MyD88 mRNA was lower and that of SOCS-1 mRNA was increased compared with AMs from non-diabetic rats. These results show that ALI secondary to sepsis is milder in diabetic rats and this correlates with impaired activation of NF kappa B, increased SOCS-1 and decreased MyD88 mRNA.	[Filgueiras, Luciano R., Jr.; Montes, Marlise B. A.; Jancar, Sonia] Univ Sao Paulo, Dept Immunol, Inst Biomed Sci, Sao Paulo, Brazil; [Martins, Joilson O.] Univ Sao Paulo, Dept Clin & Toxicol Analyses, Fac Pharmaceut Sci, Sao Paulo, Brazil; [Serezani, Carlos H.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN USA; [Capelozzi, Vera L.] Univ Sao Paulo, Fac Med, Dept Pathol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Indiana University System; Indiana University Bloomington; Universidade de Sao Paulo	Filgueiras, LR (corresponding author), Univ Sao Paulo, Dept Immunol, Inst Biomed Sci, Sao Paulo, Brazil.	sojancar@icb.usp.br	Capelozzi, Vera Luiza/C-6363-2013; Jancar, Sonia/C-5153-2012; Martins, Joilson O./G-4367-2011; , Capelozzi/N-1737-2019; serezani, C. Henrique/H-1675-2013	Jancar, Sonia/0000-0001-7983-3459; Martins, Joilson O./0000-0003-2630-7038; , Capelozzi/0000-0001-9732-5853; delmonte, samuel/0000-0002-3289-4577; serezani, C. Henrique/0000-0002-5363-415X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); National Institutes of Health [NIH R00HL103777-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL103777] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and National Institutes of Health (NIH R00HL103777-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba-Loureiro TC, 2007, BRAZ J MED BIOL RES, V40, P1037, DOI 10.1590/S0100-879X2006005000143; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; BERNARD GR, 1994, INTENS CARE MED, V20, P225, DOI 10.1007/BF01704707; Esper AM, 2009, CRIT CARE, V13, DOI 10.1186/cc7717; Fernandez-Valverde SL, 2011, DIABETES, V60, P1825, DOI 10.2337/db11-0171; Ferracini M, 2010, MOL IMMUNOL, V47, P1974, DOI 10.1016/j.molimm.2010.04.018; Geerlings SE, 2000, ADV EXP MED BIOL, V485, P255; Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1016/S0928-8244(99)00142-X; Hargreaves DC, 2005, J CLIN IMMUNOL, V25, P503, DOI 10.1007/s10875-005-8065-4; Hizume DC, 2007, SHOCK, V27, P584, DOI 10.1097/01.shk.0000248594.79012.d6; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Martins JO, 2010, SHOCK, V33, P76, DOI 10.1097/SHK.0b013e3181a85ec4; Menezes SLS, 2005, J APPL PHYSIOL, V98, P1777, DOI 10.1152/japplphysiol.01182.2004; Moss M, 2000, CRIT CARE MED, V28, P2187, DOI 10.1097/00003246-200007000-00001; Noursadeghi M, 2000, J ROY COLL PHYS LOND, V34, P432; Rocco PRM, 2008, CURR OPIN CRIT CARE, V14, P50, DOI 10.1097/MCC.0b013e3282f2405b; Salomao R, 2008, SHOCK, V30, P73, DOI 10.1097/SHK.0b013e318181af2a; Santiago VR, 2010, CRIT CARE MED, V38, P2207, DOI 10.1097/CCM.0b013e3181f3e076; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Serezani CH, 2011, J CLIN INVEST, V121, P671, DOI 10.1172/JCI43302; Spiller F, 2012, DIABETES, V61, P1584, DOI 10.2337/db11-0825; Szkudelski T, 2001, PHYSIOL RES, V50, P537	23	43	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44987	10.1371/journal.pone.0044987	http://dx.doi.org/10.1371/journal.pone.0044987			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024779	Green Published, gold, Green Submitted			2022-12-27	WOS:000308860100037
J	Garmyn, D; Augagneur, Y; Gal, L; Vivant, AL; Piveteau, P				Garmyn, Dominique; Augagneur, Yoann; Gal, Laurent; Vivant, Anne-Laure; Piveteau, Pascal			Listeria monocytogenes Differential Transcriptome Analysis Reveals Temperature-Dependent Agr Regulation and Suggests Overlaps with Other Regulons	PLOS ONE			English	Article							VIRULENCE GENES; SIGMA-B; BACILLUS-SUBTILIS; BIOFILM FORMATION; EXPRESSION; PRFA; IDENTIFICATION; GROWTH; ACID; DIFFUSION	Listeria monocytogenes is a ubiquitous, opportunistic pathogenic organism. Environmental adaptation requires constant regulation of gene expression. Among transcriptional regulators, AgrA is part of an auto-induction system. Temperature is an environmental cue critical for in vivo adaptation. In order to investigate how temperature may affect AgrA-dependent transcription, we compared the transcriptomes of the parental strain L. monocytogenes EGD-e and its Delta agrA mutant at the saprophytic temperature of 25 degrees C and in vivo temperature of 37 degrees C. Variations of transcriptome were higher at 37 degrees C than at 25 degrees C. Results suggested that AgrA may be involved in the regulation of nitrogen transport, amino acids, purine and pyrimidine biosynthetic pathways and phage-related functions. Deregulations resulted in a growth advantage at 37 degrees C, but affected salt tolerance. Finally, our results suggest overlaps with PrfA, sigma B, sigma H and CodY regulons. These overlaps may suggest that through AgrA, Listeria monocytogenes integrates information on its biotic environment.	[Garmyn, Dominique; Augagneur, Yoann; Vivant, Anne-Laure; Piveteau, Pascal] Univ Bourgogne, UMR1347, Dijon, France; [Garmyn, Dominique; Augagneur, Yoann; Gal, Laurent; Vivant, Anne-Laure; Piveteau, Pascal] INRA, UMR 1347, F-21034 Dijon, France; [Gal, Laurent] AgroSup Dijon, UMR1347, Dijon, France	Institut Agro; AgroSup Dijon; Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Garmyn, D (corresponding author), Univ Bourgogne, UMR1347, Dijon, France.	piveteau@u-bourgognre.fr	gal, laurent/A-2824-2011; augagneur, yoann/L-2000-2015	gal, laurent/0000-0001-6598-7262; augagneur, yoann/0000-0002-6816-5931; Garmyn, Dominique/0000-0003-4693-6026	local authorities grant support (Conseil Regional de Bourgogne Grant) [PARI Agrale 11]	local authorities grant support (Conseil Regional de Bourgogne Grant)(Region Bourgogne-Franche-Comte)	This work was funded by local authorities grant support (Conseil Regional de Bourgogne Grant number PARI Agrale 11 [http://region-bourgogne.fr/Leplan-d-actions-regional-pour-l-innovation-PARI,40,4438]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abachin E, 2002, MOL MICROBIOL, V43, P1, DOI 10.1046/j.1365-2958.2002.02723.x; Autret N, 2003, INFECT IMMUN, V71, P4463, DOI 10.1128/IAI.71.8.4463-4471.2003; Begley M, 2002, APPL ENVIRON MICROB, V68, P6005, DOI 10.1128/AEM.68.12.6005-6012.2002; Bennett HJ, 2007, MOL MICROBIOL, V63, P1453, DOI 10.1111/j.1365-2958.2007.05597.x; Bierne H, 2007, MICROBIOL MOL BIOL R, V71, P377, DOI 10.1128/MMBR.00039-06; Bublitz M, 2009, MOL MICROBIOL, V71, P1509, DOI 10.1111/j.1365-2958.2009.06619.x; Burguiere P, 2005, J BACTERIOL, V187, P6019, DOI 10.1128/JB.187.17.6019-6030.2005; Cabanes D, 2004, MOL MICROBIOL, V51, P1601, DOI 10.1111/j.1365-2958.2003.03945.x; CHAKRABORTY T, 1992, J BACTERIOL, V174, P568, DOI 10.1128/jb.174.2.568-574.1992; Chan YC, 2007, APPL ENVIRON MICROB, V73, P6484, DOI 10.1128/AEM.00897-07; Chaturongakul S, 2011, APPL ENVIRON MICROB, V77, P187, DOI 10.1128/AEM.00952-10; Cossart P, 2012, P NAT AC SC US, V108, P19484; Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002; Formstone A, 2008, J BACTERIOL, V190, P1812, DOI 10.1128/JB.01394-07; Garcia E, 1996, J FOOD PROTECT, V59, P950, DOI 10.4315/0362-028X-59.9.950; Garmyn Dominique, 2009, Commun Integr Biol, V2, P371; Glaser P, 2001, SCIENCE, V294, P849; Gray MJ, 2006, INFECT IMMUN, V74, P2505, DOI 10.1128/IAI.74.5.2505-2512.2006; Hain T, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-20; Hense BA, 2007, NAT REV MICROBIOL, V5, P230, DOI 10.1038/nrmicro1600; Hu Y, 2007, APPL ENVIRON MICROB, V73, P7967, DOI 10.1128/AEM.01085-07; Hu Y, 2007, APPL ENVIRON MICROB, V73, P7981, DOI 10.1128/AEM.01281-07; Ivy RA, 2012, APPL ENVIRON MICROB, V78, P3824, DOI 10.1128/AEM.00051-12; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; Kamp HD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002153; Kathariou S, 2002, J FOOD PROTECT, V65, P1811, DOI 10.4315/0362-028X-65.11.1811; LEIMEISTERWACHTER M, 1992, J BACTERIOL, V174, P947, DOI 10.1128/jb.174.3.947-952.1992; Lyautey E, 2007, CAN J MICROBIOL, V53, P1158, DOI 10.1139/W07-084; Mandin P, 2005, MOL MICROBIOL, V57, P1367, DOI 10.1111/j.1365-2958.2005.04776.x; Marr AK, 2006, J BACTERIOL, V188, P3887, DOI 10.1128/JB.01978-05; MERRICK MJ, 1995, MICROBIOL REV, V59, P604, DOI 10.1128/MMBR.59.4.604-622.1995; Milohanic E, 2003, MOL MICROBIOL, V47, P1613, DOI 10.1046/j.1365-2958.2003.03413.x; Murray EGD, 1926, J PATHOL BACTERIOL, V29, P407, DOI 10.1002/path.1700290409; Nadon CA, 2002, INFECT IMMUN, V70, P3948, DOI 10.1128/IAI.70.7.3948-3952.2002; Nightingale KK, 2004, APPL ENVIRON MICROB, V70, P4458, DOI 10.1128/AEM.70.8.4458-4467.2004; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Olier M, 2003, INFECT IMMUN, V71, P1217, DOI 10.1128/IAI.71.3.1217-1224.2003; Piveteau P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024881; Redfield RJ, 2002, TRENDS MICROBIOL, V10, P365, DOI 10.1016/S0966-842X(02)02400-9; Renier S, 2011, ENVIRON MICROBIOL, V13, P835, DOI 10.1111/j.1462-2920.2010.02378.x; Riedel CU, 2009, MOL MICROBIOL, V71, P1177, DOI 10.1111/j.1365-2958.2008.06589.x; Rieu A, 2007, APPL ENVIRON MICROB, V73, P6125, DOI 10.1128/AEM.00608-07; Schwab U, 2005, FEMS MICROBIOL LETT, V245, P329, DOI 10.1016/j.femsle.2005.03.025; Stoll R, 2010, MICROBIOL-SGM, V156, P1069, DOI 10.1099/mic.0.034934-0; Stritzker J, 2004, INFECT IMMUN, V72, P5622, DOI 10.1128/IAI.72.10.5622-5629.2004; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; van der Veen S, 2007, MICROBIOL-SGM, V153, P3593, DOI 10.1099/mic.0.2007/006361-0; van Teeffelen S, 2011, EMBO J, V30, P4856, DOI 10.1038/emboj.2011.430; Wels M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-330; WELSHIME.HJ, 1968, J BACTERIOL, V95, P300, DOI 10.1128/JB.95.2.300-303.1968; WELSHIMER HJ, 1960, J BACTERIOL, V80, P316, DOI 10.1128/JB.80.3.316-320.1960; WELSHIMER HJ, 1971, APPL MICROBIOL, V21, P516, DOI 10.1128/AEM.21.3.516-519.1971; Williams T, 2005, FEMS MICROBIOL LETT, V252, P287, DOI 10.1016/j.femsle.2005.09.011; Xayarath B, 2009, MOL MICROBIOL, V74, P956, DOI 10.1111/j.1365-2958.2009.06910.x	54	33	33	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e43154	10.1371/journal.pone.0043154	http://dx.doi.org/10.1371/journal.pone.0043154			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024744	Green Published, Green Submitted, gold			2022-12-27	WOS:000308860100002
J	Hasim, A; Abudula, M; Aimiduo, R; Ma, JQ; Jiao, Z; Akula, G; Wang, T; Abudula, A				Hasim, Ayshamgul; Abudula, Mangnishahan; Aimiduo, Reshalaiti; Ma, Jun-Qi; Jiao, Zhen; Akula, Gulzareye; Wang, Ting; Abudula, Abulizi			Post-Transcriptional and Epigenetic Regulation of Antigen Processing Machinery (APM) Components and HLA-I in Cervical Cancers from Uighur Women	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; HUMAN-PAPILLOMAVIRUS; MOLECULAR-MECHANISMS; DOWN-REGULATION; EXPRESSION; METHYLATION; GENES; ASSOCIATION; CARCINOMAS; ACTIVATION	Normal function of human leukocyte antigen class I (HLA-I) and antigen processing machinery (APM) proteins is required for T cell-mediated anti-tumor or antiviral immunity, whereas the tumor survival indicates a failure of the host in immune surveillance associated with the dysfunction in antigen presentation, mainly due to the deregulation in HLA-I and APM expression or function. The posttranscriptional regulation of HLA-I and APM expression may associate with epigenetic modifications in cancer development which was not described so far. Here we showed that the development of cervical intraepithelial neoplasia (CIN) and cervical squamous cell carcinoma (CSCC) in Uighur women was accompanied with the partial or total loss of protein expression of HLA-I, beta 2-m and APM components, including the transporter associated with antigen processing (TAP1/2), low molecular mass protein (LMP2, LMP7), endoplasmic reticulum aminopeptidase 1(ERAP1), chaperone molecules include calreticulin (CLR), calnexin (CNX) and ERp57, and this was proved again by analysis of transcription of the same genes in addition to three genes HLA-A, B and C coding for HLA-I. By bisulfite sequencing approach, we identified target CpG islands methylated at the gene promoter region of TAP1, TAP2, LMP7, tapasin and ERp57 in cervical carcinoma cells. Further analysis of CpG site specific methylation of these genes in cases of CSCC and CIN demonstrated an inverse correlation of altered CpG island methylation of TAP1, LMP7, and ERp57 with changes in protein expression. Moreover, promoter methylation of these genes was significantly higher in cases positive for human papillomavirus 16 (HPV 16) than negative ones. Our results suggested that epigenetic modifications are responsible for the aberrant expression of certain HLA-I and APM genes, and may help to understand unrevealed mechanisms of tumor escape from immune surveillance in cervical carcinogenesis.	[Hasim, Ayshamgul; Aimiduo, Reshalaiti; Wang, Ting] Med Univ Xinjiang, Dept Pathol, Coll Basic Med, Urumqi, Peoples R China; [Abudula, Mangnishahan] Med Univ Xinjiang, Ctr Oncol, Affiliated Hosp 1, Urumqi, Peoples R China; [Ma, Jun-Qi] Med Univ Xinjiang, Dept Gynecol, Affiliated Hosp 1, Urumqi, Peoples R China; [Jiao, Zhen] Hosp Xinjiang Uighur Autonomous Reg, Dept Gynecol, Urumqi, Peoples R China; [Akula, Gulzareye; Abudula, Abulizi] Med Univ Xinjiang, Key Labs Mol Biol & Endem Dis Xinjiang Uighur Aut, Urumqi, Peoples R China		Hasim, A (corresponding author), Med Univ Xinjiang, Dept Pathol, Coll Basic Med, Urumqi, Peoples R China.	abulizi_de@126.com			Xinjiang Uighur Autonomous Region Fund [2009211B14]; National Natural Science Foundation of China [81060164]	Xinjiang Uighur Autonomous Region Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported with funding from the Xinjiang Uighur Autonomous Region Fund (2009211B14) and National Natural Science Foundation of China (81060164). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhya D, 2010, J BIOSCIENCES, V35, P647, DOI 10.1007/s12038-010-0072-9; Ayshamgul H, 2010, JCLIN EXP PATHOL, V26, P684; Ayshamgul Hasim, 2010, Chinese Journal of Pathology, V39, P703, DOI 10.3760/cma.j.issn.0529-5807.2010.10.014; Burd EM, 2003, CLIN MICROBIOL REV, V16, P1, DOI 10.1128/CMR.16.1.1-17.2003; Castellsague Xavier, 2003, J Natl Cancer Inst Monogr, P20; Cathro HP, 2010, CANCER IMMUNOL IMMUN, V59, P465, DOI 10.1007/s00262-009-0765-9; Corneanu LM, 2011, ROM J MORPHOL EMBRYO, V52, P89; Hasim A, 2011, CHINESE MED J-PEKING, V124, P341, DOI 10.3760/cma.j.issn.0366-6999.2011.03.004; [阿仙姑·哈斯木 HASIMU Axiangu], 2011, [肿瘤, Tumor], V31, P432; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; IARC. International Agency on Research on Cancer, 1995, MON CANC HUM PAP, V64; Khan ANH, 2008, CANCER IMMUNOL IMMUN, V57, P647, DOI 10.1007/s00262-007-0402-4; Knutson KL, 2005, CANCER IMMUNOL IMMUN, V54, P721, DOI 10.1007/s00262-004-0653-2; Kuzmin I, 2003, CANCER RES, V63, P1888; Lee HW, 2011, J GASTROINTEST SURG, V15, P1336, DOI 10.1007/s11605-011-1545-3; Liu Q, 2009, SCAND J GASTROENTERO, V44, P960, DOI 10.1080/00365520902998679; Lou Y, 2008, CLIN CANCER RES, V14, P1494, DOI 10.1158/1078-0432.CCR-07-1066; Ma Qi, 2010, Chinese Journal of Pathology, V39, P255, DOI 10.3760/cma.j.issn.0529-5807.2010.04.010; Manning J, 2008, IMMUNOLOGY, V123, P218, DOI 10.1111/j.1365-2567.2007.02689.x; Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6; Mehta AM, 2008, CANCER IMMUNOL IMMUN, V57, P197, DOI 10.1007/s00262-007-0362-8; Moretta L, 2005, IMMUNOL LETT, V100, P7, DOI 10.1016/j.imlet.2005.07.004; Nie Xiao-rui, 2009, Zhonghua Yufang Yixue Zazhi, V43, P571, DOI 10.3760/cma.j.issn.0253-9624.2009.07.009; Nie Y, 2001, CARCINOGENESIS, V22, P1615, DOI 10.1093/carcin/22.10.1615; Olk-Batz C, 2011, BLOOD, V117, P4871, DOI 10.1182/blood-2010-08-298968; Rincon-Orozco B, 2009, CANCER RES, V69, P8718, DOI 10.1158/0008-5472.CAN-09-0550; Sanchez CJ, 2011, CANCER IMMUNOL IMMUN, V60, P1, DOI 10.1007/s00262-010-0898-x; Seliger B, 2006, INT J CANCER, V118, P129, DOI 10.1002/ijc.21312; Seliger B, 2000, IMMUNOL TODAY, V21, P455, DOI 10.1016/S0167-5699(00)01692-3; Sigalotti L, 2004, CANCER RES, V64, P9167, DOI 10.1158/0008-5472.CAN-04-1442; STAM NJ, 1990, INT IMMUNOL, V2, P113, DOI 10.1093/intimm/2.2.113; Suzuk Lalai, 2006, J XINJIANG MED U, V29, P569; Tanaka K, 2011, INT J ONCOL, V1274; Tomasi TB, 2006, CANCER IMMUNOL IMMUN, V55, P1159, DOI 10.1007/s00262-006-0164-4; Wang L, 2010, AM J CLIN NUTR, V91, P1359, DOI 10.3945/ajcn.2009.28858; Watson NFS, 2006, INT J CANCER, V118, P6, DOI 10.1002/ijc.21303; Yang BH, 2004, INT J CANCER, V109, P418, DOI 10.1002/ijc.11719	37	39	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44952	10.1371/journal.pone.0044952	http://dx.doi.org/10.1371/journal.pone.0044952			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024775	Green Published, Green Submitted, gold			2022-12-27	WOS:000308860100033
J	Majeed, W; Zhang, Y; Xue, Y; Ranade, S; Blue, RN; Wang, Q; He, QF				Majeed, Waqar; Zhang, Yan; Xue, Yong; Ranade, Saurabh; Blue, Ryan Nastashia; Wang, Qiang; He, Qingfang			RpaA Regulates the Accumulation of Monomeric Photosystem I and PsbA under High Light Conditions in Synechocystis sp PCC 6803	PLOS ONE			English	Article							SP STRAIN PCC-6803; CYCLIC ADP-RIBOSE; PHYSIOLOGICAL SIGNIFICANCE; INDUCIBLE POLYPEPTIDES; STATE TRANSITIONS; GENE-EXPRESSION; STOICHIOMETRY; CYANOBACTERIA; PHOTOPROTECTION; PHOTOINHIBITION	The response regulator RpaA was examined by targeted mutagenesis under high light conditions in Synechocystis sp. PCC 6803. A significant reduction in chlorophyll fluorescence from photosystem I at 77 K was observed in the RpaA mutant cells under high light conditions. Interestingly, the chlorophyll fluorescence emission from the photosystem I trimers at 77 K are similar to that of the wild type, while the chlorophyll fluorescence from the photosystem I monomers was at a much lower level in the mutant than in the wild type under high light conditions. The RpaA inactivation resulted in a dramatic reduction in the monomeric photosystem I and the D1 protein but not the CP47 content. However, there is no significant difference in the transcript levels of psaA or psbA or other genes examined, most of which are involved in photosynthesis, pigment biosynthesis, or stress responses. Under high light conditions, the growth of the mutant was affected, and both the chlorophyll content and the whole-chain oxygen evolution capability of the mutant were found to be significantly lower than those of the wild type, respectively. We propose that RpaA regulates the accumulation of the monomeric photosystem I and the D1 protein under high light conditions. This is the first report demonstrating that inactivation of a stress response regulator has specifically reduced the monomeric photosystem I. It suggests that PS I monomers and PS I trimers can be regulated independently for acclimation of cells to high light stress.	[Majeed, Waqar; Xue, Yong; Ranade, Saurabh; Blue, Ryan Nastashia; He, Qingfang] Univ Arkansas, Dept Appl Sci, Little Rock, AR 72204 USA; [Zhang, Yan; He, Qingfang] Shandong Acad Agr Sci, High Tech Res Ctr, Jinan, Shandong, Peoples R China; [Wang, Qiang] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Hubei Province, Peoples R China	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; Shandong Academy of Agricultural Sciences; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Majeed, W (corresponding author), Univ Arkansas, Dept Appl Sci, Little Rock, AR 72204 USA.	qfhe@ualr.edu	Wang, Qiang/P-7806-2016; He, Qingfang/I-4181-2013; Majeed, Waqar/K-9802-2016	Wang, Qiang/0000-0002-7388-4703; Xue, Yong/0000-0002-9091-3772	National Science Foundation [MCB 1120153]; Program on Key Basic Research Project [2011CB200902]	National Science Foundation(National Science Foundation (NSF)); Program on Key Basic Research Project	This work was supported by National Science Foundation grant MCB 1120153 (http://www.nsf.gov/) and by Program on Key Basic Research Project (2011CB200902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARO EM, 1993, PLANT PHYSIOL, V103, P835, DOI 10.1104/pp.103.3.835; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Asada K., 1994, Causes of photooxidative stress and amelioration of defense systems in plants., P77; Ashby MK, 2002, FEMS MICROBIOL LETT, V214, P25; Ashby MK, 1999, FEMS MICROBIOL LETT, V181, P253, DOI 10.1016/S0378-1097(99)00547-9; Bailey S, 2008, PHOTOCHEM PHOTOBIOL, V84, P1410, DOI 10.1111/j.1751-1097.2008.00453.x; Bald D, 1996, PHOTOSYNTH RES, V49, P103, DOI 10.1007/BF00117661; Cunningham FX, 2010, J BACTERIOL, V192, P1700, DOI 10.1128/JB.01434-09; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; Fuhrmann E, 2009, PLANT PHYSIOL, V149, P735, DOI 10.1104/pp.108.132373; Fujimori T, 2005, PLANT PHYSIOL, V139, P408, DOI 10.1104/pp.105.064782; Fujimori T, 2005, J BIOL CHEM, V280, P22191, DOI 10.1074/jbc.M500369200; Gill RT, 2002, J BACTERIOL, V184, P3671, DOI 10.1128/JB.184.13.3671-3681.2002; Halliwell B., 1999, FREE RADICAL BIO MED, P1, DOI DOI 10.1093/ACPROF:OSO/9780198717478.001.0001; He QF, 1998, P NATL ACAD SCI USA, V95, P5830, DOI 10.1073/pnas.95.10.5830; He QF, 2001, J BIOL CHEM, V276, P306, DOI 10.1074/jbc.M008686200; Herranen M, 2005, PLANT CELL PHYSIOL, V46, P1484, DOI 10.1093/pcp/pci160; Hihara Y, 2001, PLANT CELL, V13, P793, DOI 10.1105/tpc.13.4.793; Hihara Y, 1998, PLANT PHYSIOL, V117, P1205, DOI 10.1104/pp.117.4.1205; Hsiao HY, 2004, J BACTERIOL, V186, P3882, DOI 10.1128/JB.186.12.3882-3888.2004; Huang LX, 2002, J BACTERIOL, V184, P6845, DOI 10.1128/JB.184.24.6845-6858.2002; Jantaro S, 2006, J BIOL CHEM, V281, P30865, DOI 10.1074/jbc.M606252200; Joshua S, 2004, PLANT PHYSIOL, V135, P2112, DOI 10.1104/pp.104.046110; Karapetyan NV, 1999, FEBS LETT, V460, P395, DOI 10.1016/S0014-5793(99)01352-6; Leckie CP, 1998, P NATL ACAD SCI USA, V95, P15837, DOI 10.1073/pnas.95.26.15837; Melis A, 1999, TRENDS PLANT SCI, V4, P130, DOI 10.1016/S1360-1385(99)01387-4; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; MORAN R, 1982, PLANT PHYSIOL, V69, P1376, DOI 10.1104/pp.69.6.1376; Mulo P, 1998, PLANT PHYSIOL, V117, P483, DOI 10.1104/pp.117.2.483; Murakami A, 1997, PLANT CELL PHYSIOL, V38, P392, DOI 10.1093/oxfordjournals.pcp.a029181; Muramatsu M, 2009, MICROBIOL-SGM, V155, P989, DOI 10.1099/mic.0.024018-0; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Ogawa T, 2002, J BIOL CHEM, V277, P28981, DOI 10.1074/jbc.M204175200; Ozaki H, 2007, PLANT CELL PHYSIOL, V48, P451, DOI 10.1093/pcp/pcm015; PETER GF, 1991, J BIOL CHEM, V266, P16745; Sambrook, 2001, MOL CLONING LAB MANU, V3rd; SHEN GZ, 1993, PLANT CELL, V5, P1853, DOI 10.1105/tpc.5.12.1853; SHEN GZ, 1994, J BIOL CHEM, V269, P13904; Shumskaya MA, 2005, J BIOL CHEM, V280, P21531, DOI 10.1074/jbc.m412174200; Sonoike K, 2001, PLANT CELL PHYSIOL, V42, P379, DOI 10.1093/pcp/pce046; Takai N, 2006, P NATL ACAD SCI USA, V103, P12109, DOI 10.1073/pnas.0602955103; TSIOTIS G, 1995, EUR J BIOCHEM, V231, P823, DOI 10.1111/j.1432-1033.1995.tb20767.x; Tu CJ, 2004, J BACTERIOL, V186, P3889, DOI 10.1128/JB.186.12.3889-3902.2004; van Thor JJ, 1998, BOT ACTA, V111, P430, DOI 10.1111/j.1438-8677.1998.tb00731.x; Wang Q, 2008, PLANT PHYSIOL, V147, P1239, DOI 10.1104/pp.108.121087; Wang Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010432; Wu Y, 1997, SCIENCE, V278, P2126, DOI 10.1126/science.278.5346.2126	47	14	14	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45139	10.1371/journal.pone.0045139	http://dx.doi.org/10.1371/journal.pone.0045139			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024802	Green Submitted, Green Published, gold			2022-12-27	WOS:000308860100060
J	Tucci, S; Herebian, D; Sturm, M; Seibt, A; Spiekerkoetter, U				Tucci, Sara; Herebian, Diran; Sturm, Marga; Seibt, Annette; Spiekerkoetter, Ute			Tissue-Specific Strategies of the Very-Long Chain Acyl-CoA Dehydrogenase-Deficient (VLCAD(-/-)) Mouse to Compensate a Defective Fatty Acid beta-Oxidation	PLOS ONE			English	Article							MUSCLE-FIBER TYPES; SKELETAL-MUSCLE; LYSINE ACETYLATION; MYOSIN ISOFORMS; COENZYME-A; MICE; EXPRESSION; CARNITINE; HEART; MITOCHONDRIA	Very long-chain acyl-CoA dehydrogenase (VLCAD)-deficiency is the most common long-chain fatty acid oxidation disorder presenting with heterogeneous phenotypes. Similar to many patients with VLCADD, VLCAD-deficient mice (VLCAD(-/-)) remain asymptomatic over a long period of time. In order to identify the involved compensatory mechanisms, wild-type and VLCAD(-/-) mice were fed one year either with a normal diet or with a diet in which medium-chain triglycerides (MCT) replaced long-chain triglycerides, as approved intervention in VLCADD. The expression of the mitochondrial long-chain acyl-CoA dehydrogenase (LCAD) and medium-chain acyl-CoA dehydrogenase (MCAD) was quantified at mRNA and protein level in heart, liver and skeletal muscle. The oxidation capacity of the different tissues was measured by LC-MS/MS using acyl-CoA substrates with a chain length of 8 to 20 carbons. Moreover, in white skeletal muscle the role of glycolysis and concomitant muscle fibre adaptation was investigated. In one year old VLCAD(-/-) mice MCAD and LCAD play an important role in order to compensate deficiency of VLCAD especially in the heart and in the liver. However, the white gastrocnemius muscle develops alternative compensatory mechanism based on a different substrate selection and increased glucose oxidation. Finally, the application of an MCT diet over one year has no effects on LCAD or MCAD expression. MCT results in the VLCAD(-/-) mice only in a very modest improvement of medium-chain acyl-CoA oxidation capacity restricted to cardiac tissue. In conclusion, VLCAD(-/-) mice develop tissue-specific strategies to compensate deficiency of VLCAD either by induction of other mitochondrial acyl-CoA dehydrogenases or by enhancement of glucose oxidation. In the muscle, there is evidence of a muscle fibre type adaptation with a predominance of glycolytic muscle fibres. Dietary modification as represented by an MCT-diet does not improve these strategies long-term.	[Tucci, Sara; Herebian, Diran; Sturm, Marga; Seibt, Annette; Spiekerkoetter, Ute] Univ Childrens Hosp, Dept Gen Pediat & Neonatol, Dusseldorf, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Tucci, S (corresponding author), Univ Childrens Hosp, Dept Gen Pediat & Neonatol, Dusseldorf, Germany.	sara.tucci@med.uni-duesseldorf.de	Herebian, Diran/A-1440-2017	Dr. Herebian, Diran/0000-0002-8528-0122; Spiekerkoetter, Ute/0000-0002-5385-6705	Deutsche Forschungsgemeinschaft (DFG) [SFB 575, SFB 612]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The study was financially supported by grants from the Deutsche Forschungsgemeinschaft (DFG: SFB 575 and SFB 612). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold GL, 2009, MOL GENET METAB, V96, P85, DOI 10.1016/j.ymgme.2008.09.008; Benard G, 2006, AM J PHYSIOL-CELL PH, V291, pC1172, DOI 10.1152/ajpcell.00195.2006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chegary M, 2009, BBA-MOL CELL BIOL L, V1791, P806, DOI 10.1016/j.bbalip.2009.05.006; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Exil VJ, 2006, AM J PHYSIOL-HEART C, V290, pH1289, DOI 10.1152/ajpheart.00811.2005; Exil VJ, 2003, CIRC RES, V93, P448, DOI 10.1161/01.RES.0000088786.19197.E4; Forner F, 2006, MOL CELL PROTEOMICS, V5, P608, DOI 10.1074/mcp.M500298-MCP200; Gelinas R, 2011, AM J PHYSIOL-HEART C, V301, pH813, DOI 10.1152/ajpheart.01275.2010; GLATZ JFC, 1984, BIOCHIM BIOPHYS ACTA, V794, P454, DOI 10.1016/0005-2760(84)90012-2; Goetzman ES, 2005, MOL GENET METAB, V84, P39, DOI 10.1016/j.ymgme.2004.09.010; Gregersen N, 2001, HUM MUTAT, V18, P169, DOI 10.1002/humu.1174.abs; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; He M, 2007, AM J HUM GENET, V81, P87, DOI 10.1086/519219; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Kompare M, 2008, SEMIN PEDIATR NEUROL, V15, P140, DOI 10.1016/j.spen.2008.05.008; Le WP, 2000, BBA-MOL CELL BIOL L, V1485, P121, DOI 10.1016/S1388-1981(00)00034-2; Lefaucheur L, 2010, MEAT SCI, V84, P257, DOI 10.1016/j.meatsci.2009.05.004; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lindner M, 2010, J INHERIT METAB DIS, V33, P521, DOI 10.1007/s10545-010-9076-8; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mathur A, 1999, CIRCULATION, V99, P1337, DOI 10.1161/01.CIR.99.10.1337; MATSUBARA Y, 1989, J BIOL CHEM, V264, P16321; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Mohanty JG, 1997, J IMMUNOL METHODS, V202, P133, DOI 10.1016/S0022-1759(96)00244-X; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Nouws J, 2010, CELL METAB, V12, P283, DOI 10.1016/j.cmet.2010.08.002; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Primassin S, 2008, PEDIATR RES, V63, P632, DOI 10.1203/PDR.0b013e31816ff6f0; Primassin S, 2010, J INHERIT METAB DIS, V33, P237, DOI 10.1007/s10545-010-9105-7; Quiroz-Rothe E, 2004, MICROSC RES TECHNIQ, V65, P43, DOI 10.1002/jemt.20090; Schafer C, 2007, AM J PHYSIOL-GASTR L, V292, pG1089, DOI 10.1152/ajpgi.00088.2006; SCHIAFFINO S, 1994, J APPL PHYSIOL, V77, P493, DOI 10.1152/jappl.1994.77.2.493; Spiekerkoetter U, 2006, HORM METAB RES, V38, P625, DOI 10.1055/s-2006-954581; Spiekerkoetter U, 2005, PEDIATR RES, V57, P760, DOI 10.1203/01.PDR.0000157915.26049.47; Spiekerkoetter U, 2004, EUR J CLIN INVEST, V34, P191, DOI 10.1111/j.1365-2362.2004.01308.x; Spiekerkoetter U, 2003, J PEDIATR-US, V143, P335, DOI 10.1067/S0022-3476(03)00292-0; ter Veld F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006449; Tucci S, 2011, AM J CLIN NUTR, V94, P439, DOI 10.3945/ajcn.111.012948; Tucci S, 2010, FEBS J, V277, P4699, DOI 10.1111/j.1742-4658.2010.07876.x; Tucci S, 2010, MOL GENET METAB, V101, P40, DOI 10.1016/j.ymgme.2010.05.005; Wang H, 1999, EUR J APPL PHYSIOL O, V80, P22, DOI 10.1007/s004210050553; Werdich AA, 2007, AM J PHYSIOL-HEART C, V292, pH2202, DOI 10.1152/ajpheart.00382.2006; Wilcken B, 2003, NEW ENGL J MED, V348, P2304, DOI 10.1056/NEJMoa025225; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	47	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45429	10.1371/journal.pone.0045429	http://dx.doi.org/10.1371/journal.pone.0045429			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024820	Green Submitted, Green Published, gold			2022-12-27	WOS:000308860100078
J	Holman, EC; Campbell, LJ; Hines, J; Crews, CM				Holman, Edna C.; Campbell, Leah J.; Hines, John; Crews, Craig M.			Microarray Analysis of microRNA Expression during Axolotl Limb Regeneration	PLOS ONE			English	Article							HAIR CELL REGENERATION; EMBRYONIC STEM-CELLS; GENE-EXPRESSION; ADULT NEWT; RETINA REGENERATION; NOTCH LIGAND; URODELE LIMB; SMALL RNAS; INNER-EAR; DIFFERENTIATION	Among vertebrates, salamanders stand out for their remarkable capacity to quickly regrow a myriad of tissues and organs after injury or amputation. The limb regeneration process in axolotls (Ambystoma mexicanum) has been well studied for decades at the cell-tissue level. While several developmental genes are known to be reactivated during this epimorphic process, less is known about the role of microRNAs in urodele amphibian limb regeneration. Given the compelling evidence that many microRNAs tightly regulate cell fate and morphogenetic processes through development and adulthood by modulating the expression (or re-expression) of developmental genes, we investigated the possibility that microRNA levels change during limb regeneration. Using two different microarray platforms to compare the axolotl microRNA expression between mid-bud limb regenerating blastemas and non-regenerating stump tissues, we found that miR-21 was overexpressed in mid-bud blastemas compared to stump tissue. Mature A. mexicanum ("Amex") miR-21 was detected in axolotl RNA by Northern blot and differential expression of Amex-miR-21 in blastema versus stump was confirmed by quantitative RT-PCR. We identified the Amex Jagged1 as a putative target gene for miR-21 during salamander limb regeneration. We cloned the full length 3'UTR of Amex-Jag1, and our in vitro assays demonstrated that its single miR-21 target recognition site is functional and essential for the response of the Jagged1 gene to miR-21 levels. Our findings pave the road for advanced in vivo functional assays aimed to clarify how microRNAs such as miR-21, often linked to pathogenic cell growth, might be modulating the redeployment of developmental genes such as Jagged1 during regenerative processes.	[Holman, Edna C.; Campbell, Leah J.; Hines, John; Crews, Craig M.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Crews, Craig M.] Yale Univ, Dept Chem, New Haven, CT USA; [Crews, Craig M.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	Holman, EC (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	craig.crews@yale.edu	Holman, Edna/D-1536-2011; Crews, Craig M./ABH-9346-2020	Holman, Edna/0000-0001-6949-5003; Crews, Craig M./0000-0002-8456-2005; Campbell, Leah/0000-0002-1666-2143	National Institutes of Health [GM094944]; Army Research Office (Army US) [W911NF-07-1-0252]; National Science Foundation, Division of Biological Infrastructure [NSF-DBI-0443496]; National Institutes of Health, National Center for Research Resources [NIH-NCRR-R24RR16344]; NIH [GM094944]; Ellison Medical Foundation; NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094944] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Office (Army US); National Science Foundation, Division of Biological Infrastructure(National Science Foundation (NSF)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by the National Institutes of Health (GM094944) and the Army Research Office (Army US #W911NF-07-1-0252). The Ambystoma Genetic Stock Center is supported by the National Science Foundation, Division of Biological Infrastructure (NSF-DBI-0443496). The Sal-Site is supported by the National Institutes of Health, National Center for Research Resources (NIH-NCRR-R24RR16344). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. Mohamed Bouzaffour (Yale University) for his expertise and assistance in the implementation of the reporter assays. We thank the NIH (GM094944) and the Ellison Medical Foundation for their support and Exiqon Life Sciences for their assistance in microRNA microarray profiling/qPCR validation for miR-21 expression. We acknowledge the services of the NSF-funded Ambystoma Genetic Stock Center and the resources available at the Sal-Site.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bely AE, 2010, TRENDS ECOL EVOL, V25, P161, DOI 10.1016/j.tree.2009.08.005; Blower PE, 2008, MOL CANCER THER, V7, P1, DOI 10.1158/1535-7163.MCT-07-0573; Brockes JR, 2002, NAT REV MOL CELL BIO, V3, P566, DOI 10.1038/nrm881; Brown D, 2005, PRECURSOR MIRNAS SUC; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; CREWS L, 1995, P ROY SOC B-BIOL SCI, V259, P161, DOI 10.1098/rspb.1995.0024; Crosnier C, 2000, HEPATOLOGY, V32, P574, DOI 10.1053/jhep.2000.16600; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Esquela-Kerscher A, 1995, NAT REV CANCER, V6, P259; Garcia-Arraras J.E., 1993, HDB ENDOCRINE RES TR, P207; GARDINER DM, 1995, DEVELOPMENT, V121, P1731; Gardiner DM, 1999, SEMIN CELL DEV BIOL, V10, P385, DOI 10.1006/scdb.1999.0325; Gardiner DM, 1998, AM ZOOL, V38, P659; GHOSH S, 1994, INT J DEV BIOL, V38, P479; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hashimi ST, 2009, BLOOD, V114, P404, DOI 10.1182/blood-2008-09-179150; Imokawa Y, 1997, P NATL ACAD SCI USA, V94, P9159, DOI 10.1073/pnas.94.17.9159; Katoh M, 2006, INT J MOL MED, V17, P681; Kawakami Y, 2006, GENE DEV, V20, P3232, DOI 10.1101/gad.1475106; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Levesque M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001227; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LO DC, 1993, P NATL ACAD SCI USA, V90, P7230, DOI 10.1073/pnas.90.15.7230; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Makarev E, 2006, MOL VIS, V12, P1386; McGlinn E, 2005, MECH DEVELOP, V122, P1218, DOI 10.1016/j.mod.2005.06.012; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Mitashov VI, 1996, INT J DEV BIOL, V40, P833; Monaghan JR, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-1; Nakamura K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012058; Nye HLD, 2003, DEV DYNAM, V226, P280, DOI 10.1002/dvdy.10236; O'STEEN W. KEITH, 1958, JOUR MORPHOL, V103, P435, DOI 10.1002/jmor.1051030303; OBERPRILLER JO, 1974, J EXP ZOOL, V187, P249, DOI 10.1002/jez.1401870208; Pearson H, 2001, NATURE, V414, P388, DOI 10.1038/35106653; Rarnkissoon SH, 2006, MOL CELL PROBE, V20, P1, DOI 10.1016/j.mcp.2005.07.004; REYER RW, 1954, Q REV BIOL, V29, P1, DOI 10.1086/399936; Sato F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005540; Scotto-Lavino E, 2006, NAT PROTOC, V1, P2742, DOI 10.1038/nprot.2006.481; Sehm T, 2009, DEV BIOL, V334, P468, DOI 10.1016/j.ydbio.2009.08.008; Smith JJ, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-181; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Tanaka EM, 2003, CURR OPIN GENET DEV, V13, P497, DOI 10.1016/j.gde.2003.08.003; TANK PW, 1976, J MORPHOL, V150, P117, DOI 10.1002/jmor.1051500106; Taylor RR, 2005, J COMP NEUROL, V484, P105, DOI 10.1002/cne.20450; Thatcher EJ, 2010, RNA BIOL, V7, P333, DOI 10.4161/rna.7.3.12085; Thomson JM, 2007, METHOD ENZYMOL, V427, P107, DOI 10.1016/S0076-6879(07)27006-5; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Torok MA, 1999, J EXP ZOOL, V284, P197, DOI 10.1002/(SICI)1097-010X(19990701)284:2<197::AID-JEZ9>3.0.CO;2-F; Torok MA, 1998, DEV BIOL, V200, P225, DOI 10.1006/dbio.1998.8956; Tsonis PA, 2004, EXP EYE RES, V78, P161, DOI 10.1016/j.exer.2003.10.022; Tsonis PA, 2007, BIOCHEM BIOPH RES CO, V362, P940, DOI 10.1016/j.bbrc.2007.08.077; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vecchione A, 2010, ENDOCR-RELAT CANCER, V17, pF37, DOI 10.1677/ERC-09-0163; Wang YM, 2009, CANCER RES, V69, P4093, DOI 10.1158/0008-5472.CAN-09-0309; Whitehead GG, 2005, SCIENCE, V310, P1957, DOI 10.1126/science.1117637; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723	60	27	27	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e41804	10.1371/journal.pone.0041804	http://dx.doi.org/10.1371/journal.pone.0041804			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028429	Green Published, Green Submitted, gold			2022-12-27	WOS:000308788700003
J	Tritt, A; Eisen, JA; Facciotti, MT; Darling, AE				Tritt, Andrew; Eisen, Jonathan A.; Facciotti, Marc T.; Darling, Aaron E.			An Integrated Pipeline for de Novo Assembly of Microbial Genomes	PLOS ONE			English	Article							SEQUENCING DATA; ALGORITHM; REARRANGEMENTS; CONSTRUCTION; ALIGNMENT; MAUVE; TOOL	Remarkable advances in DNA sequencing technology have created a need for de novo genome assembly methods tailored to work with the new sequencing data types. Many such methods have been published in recent years, but assembling raw sequence data to obtain a draft genome has remained a complex, multi-step process, involving several stages of sequence data cleaning, error correction, assembly, and quality control. Successful application of these steps usually requires intimate knowledge of a diverse set of algorithms and software. We present an assembly pipeline called A5 (Andrew And Aaron's Awesome Assembly pipeline) that simplifies the entire genome assembly process by automating these stages, by integrating several previously published algorithms with new algorithms for quality control and automated assembly parameter selection. We demonstrate that A5 can produce assemblies of quality comparable to a leading assembly algorithm, SOAPdenovo, without any prior knowledge of the particular genome being assembled and without the extensive parameter tuning required by the other assembly algorithm. In particular, the assemblies produced by A5 exhibit 50% or more reduction in broken protein coding sequences relative to SOAPdenovo assemblies. The A5 pipeline can also assemble Illumina sequence data from libraries constructed by the Nextera (transposon-catalyzed) protocol, which have markedly different characteristics to mechanically sheared libraries. Finally, A5 has modest compute requirements, and can assemble a typical bacterial genome on current desktop or laptop computer hardware in under two hours, depending on depth of coverage.	[Tritt, Andrew; Eisen, Jonathan A.; Facciotti, Marc T.; Darling, Aaron E.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Eisen, Jonathan A.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Eisen, Jonathan A.] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Facciotti, Marc T.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Tritt, A (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.	aarondarling@ucdavis.edu	Facciotti, Marc/AAF-9227-2020; Eisen, Jonathan A./H-2706-2019; Darling, Aaron/G-8119-2017	Facciotti, Marc/0000-0003-4453-3274; Eisen, Jonathan A./0000-0002-0159-2197; Darling, Aaron/0000-0003-2397-7925	National Science Foundation award [ER 0949453]	National Science Foundation award(National Science Foundation (NSF))	This work was supported by National Science Foundation award ER 0949453. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Bergeron A, 2006, LECT NOTES COMPUT SC, V4175, P163; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Calabrese PP, 2003, BIOINFORMATICS, V19, pi74, DOI 10.1093/bioinformatics/btg1008; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Darling AE, 2011, BIOINFORMATICS, V27, P2756, DOI 10.1093/bioinformatics/btr451; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dayarian A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-345; Deng M, 2009, SPIE, V7492; Earl D, 2011, GENOME RES, V21, P2224, DOI 10.1101/gr.126599.111; Ester M, 1996, IEEE COMPUTER    NOV, V96; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Gupta MR, 2010, FOUND TRENDS SIGNAL, V4, P223, DOI 10.1561/2000000034; Haas BJ, 2004, BIOINFORMATICS, V20, P3643, DOI 10.1093/bioinformatics/bth397; Hartman AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009605; Imelfort M, 2011, SASSY UNPUB; Kao WC, 2011, GENOME RES, V21, P1181, DOI 10.1101/gr.111351.110; Kao WC, 2009, GENOME RES, V19, P1884, DOI 10.1101/gr.095299.109; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r116; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Koren S, 2011, BIOINFOMATICS; Lassmann T, 2009, BIOINFORMATICS, V25, P2839, DOI 10.1093/bioinformatics/btp527; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Peng Y, 2010, LECT N BIOINFORMAT, V6044, P426, DOI 10.1007/978-3-642-12683-3_28; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Phillippy AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r55; Pop M, 2009, BRIEF BIOINFORM, V10, P354, DOI 10.1093/bib/bbp026; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; Seemann T, 2011, VELVETOPTIMISE UNPUB; Simpson JT, 2010, BIOINFORMATICS, V26, pi367, DOI 10.1093/bioinformatics/btq217; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Zeitouni B, 2010, BIOINFORMATICS, V26, P1895, DOI 10.1093/bioinformatics/btq293; [No title captured]	35	348	355	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e42304	10.1371/journal.pone.0042304	http://dx.doi.org/10.1371/journal.pone.0042304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028432	Green Submitted, Green Published, gold			2022-12-27	WOS:000308788700005
J	Bhandari, RK; Haque, MM; Skinner, MK				Bhandari, Ramji K.; Haque, Md. M.; Skinner, Michael K.			Global Genome Analysis of the Downstream Binding Targets of Testis Determining Factor SRY and SOX9	PLOS ONE			English	Article							SEX-DETERMINING REGION; GONADAL DEVELOPMENT; EMBRYONIC TESTIS; Y-CHROMOSOME; IN-VIVO; GENE; MICE; DIFFERENTIATION; TRANSCRIPTION; PROTEIN	A major event in mammalian male sex determination is the induction of the testis determining factor Sry and its downstream gene Sox9. The current study provides one of the first genome wide analyses of the downstream gene binding targets for SRY and SOX9 to help elucidate the molecular control of Sertoli cell differentiation and testis development. A modified ChIP-Chip analysis using a comparative hybridization was used to identify 71 direct downstream binding targets for SRY and 109 binding targets for SOX9. Interestingly, only 5 gene targets overlapped between SRY and SOX9. In addition to the direct response element binding gene targets, a large number of atypical binding gene targets were identified for both SRY and SOX9. Bioinformatic analysis of the downstream binding targets identified gene networks and cellular pathways potentially involved in the induction of Sertoli cell differentiation and testis development. The specific DNA sequence binding site motifs for both SRY and SOX9 were identified. Observations provide insights into the molecular control of male gonadal sex determination.	[Bhandari, Ramji K.; Haque, Md. M.; Skinner, Michael K.] Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA	Washington State University	Bhandari, RK (corresponding author), Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA.	skinner@wsu.edu		Bhandari, Ramji/0000-0001-5608-7254	United States National Institutes of Health	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a United States National Institutes of Health grant to MKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arango NA, 1999, CELL, V99, P409, DOI 10.1016/S0092-8674(00)81527-5; Barrionuevo F, 2006, BIOL REPROD, V74, P195, DOI 10.1095/biolreprod.105.045930; Bhandari RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019935; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bowles J, 2010, DEV CELL, V19, P440, DOI 10.1016/j.devcel.2010.08.010; Bradford ST, 2009, BIOL REPROD, V80, P1178, DOI 10.1095/biolreprod.108.071480; Clement TM, 2007, REPRODUCTION, V134, P455, DOI 10.1530/REP-06-0341; Clement TM, 2011, BIOL REPROD, V85, P277, DOI 10.1095/biolreprod.110.090282; Cui SY, 2004, DEVELOPMENT, V131, P4095, DOI 10.1242/dev.01266; Cupp AS, 2003, BIOL REPROD, V68, P2033, DOI 10.1095/biolreprod.102.012617; daSilva SM, 1996, NAT GENET, V14, P62, DOI 10.1038/ng0996-62; De Santa Barbara P, 1998, MOL CELL BIOL, V18, P6653, DOI 10.1128/MCB.18.11.6653; DiNapoli L, 2008, MOL ENDOCRINOL, V22, P1, DOI 10.1210/me.2007-0250; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Hardle W, 1977, APPL STAT, V44, P258; HARLEY VR, 1994, NUCLEIC ACIDS RES, V22, P1500, DOI 10.1093/nar/22.8.1500; JOST A, 1970, PHILOS T ROY SOC B, V259, P119, DOI 10.1098/rstb.1970.0052; JOST A, 1953, RECENT PROG HORM RES, V8, P379; JOST A, 1947, ARCH ANAT MICROSC MO, V36, P244; Kashimada K, 2011, FASEB J, V25, P3561, DOI 10.1096/fj.11-184333; Kashimada K, 2010, DEVELOPMENT, V137, P3921, DOI 10.1242/dev.048983; Kim Y, 2007, P NATL ACAD SCI USA, V104, P16558, DOI 10.1073/pnas.0702581104; Kim Y, 2006, DEV DYNAM, V235, P2292, DOI 10.1002/dvdy.20894; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Levine E, 2000, BIOL REPROD, V62, P132, DOI 10.1095/biolreprod62.1.132; Levine E, 2000, BIOL REPROD, V62, P477, DOI 10.1095/biolreprod62.3.477; MCELREAVEY K, 1993, P NATL ACAD SCI USA, V90, P3368, DOI 10.1073/pnas.90.8.3368; Murphy M, 2010, AUK, V127, P1, DOI 10.1525/auk.2010.127.1.1; Nef Serge, 2009, Journal of Biology (London), V8, P74, DOI 10.1186/jbiol173; Nilsson EE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011637; O'Neill LP, 2006, NAT GENET, V38, P835, DOI 10.1038/ng1820; Ohe K, 2002, P NATL ACAD SCI USA, V99, P1146, DOI 10.1073/pnas.022645899; Ohno S, 1979, Recent Prog Horm Res, V35, P449; PAGE DC, 1987, CELL, V51, P1091, DOI 10.1016/0092-8674(87)90595-2; PAGE DC, 1987, NATURE, V328, P437, DOI 10.1038/328437a0; PONTIGGIA A, 1994, EMBO J, V13, P6115, DOI 10.1002/j.1460-2075.1994.tb06958.x; Schmahl J, 2004, DEVELOPMENT, V131, P3627, DOI 10.1242/dev.01239; Sekido R, 2004, DEV BIOL, V274, P271, DOI 10.1016/j.ydbio.2004.07.011; Sekido R, 2009, TRENDS GENET, V25, P19, DOI 10.1016/j.tig.2008.10.008; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Small CL, 2005, BIOL REPROD, V72, P492, DOI 10.1095/biolreprod.104.033696; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Thevenet L, 2005, J BIOL CHEM, V280, P38625, DOI 10.1074/jbc.M504127200; Toedling J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-221; Tukey JW, 1977, EXPLORATORY DATA ANA; WACHTEL SS, 1975, NATURE, V257, P235, DOI 10.1038/257235a0; Wilhelm D, 2007, J BIOL CHEM, V282, P10553, DOI 10.1074/jbc.M609578200; Wilhelm D, 2007, PHYSIOL REV, V87, P1, DOI 10.1152/physrev.00009.2006	51	43	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43380	10.1371/journal.pone.0043380	http://dx.doi.org/10.1371/journal.pone.0043380			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984422	Green Published, Green Submitted, gold			2022-12-27	WOS:000308738500012
J	Caliman, A; Carneiro, LS; Leal, JJF; Farjalla, VF; Bozelli, RL; Esteves, FA				Caliman, Adriano; Carneiro, Luciana S.; Leal, Joao J. F.; Farjalla, Vinicius F.; Bozelli, Reinaldo L.; Esteves, Francisco A.			Community Biomass and Bottom up Multivariate Nutrient Complementarity Mediate the Effects of Bioturbator Diversity on Pelagic Production	PLOS ONE			English	Article							ECOSYSTEM FUNCTION; SPECIES-RICHNESS; FRESH-WATER; BIOGEOCHEMICAL PROCESSES; HABITAT STRUCTURE; BIODIVERSITY LOSS; MARINE-SEDIMENTS; PLANT DIVERSITY; COASTAL LAGOONS; DENSITY	Tests of the biodiversity and ecosystem functioning (BEF) relationship have focused little attention on the importance of interactions between species diversity and other attributes of ecological communities such as community biomass. Moreover, BEF research has been mainly derived from studies measuring a single ecosystem process that often represents resource consumption within a given habitat. Focus on single processes has prevented us from exploring the characteristics of ecosystem processes that can be critical in helping us to identify how novel pathways throughout BEF mechanisms may operate. Here, we investigated whether and how the effects of biodiversity mediated by non-trophic interactions among benthic bioturbator species vary according to community biomass and ecosystem processes. We hypothesized that (1) bioturbator biomass and species richness interact to affect the rates of benthic nutrient regeneration [dissolved inorganic nitrogen (DIN) and total dissolved phosphorus (TDP)] and consequently bacterioplankton production (BP) and that (2) the complementarity effects of diversity will be stronger on BP than on nutrient regeneration because the former represents a more integrative process that can be mediated by multivariate nutrient complementarity. We show that the effects of bioturbator diversity on nutrient regeneration increased BP via multivariate nutrient complementarity. Consistent with our prediction, the complementarity effects were significantly stronger on BP than on DIN and TDP. The effects of the biomass-species richness interaction on complementarity varied among the individual processes, but the aggregated measures of complementarity over all ecosystem processes were significantly higher at the highest community biomass level. Our results suggest that the complementarity effects of biodiversity can be stronger on more integrative ecosystem processes, which integrate subsidiary "simpler" processes, via multivariate complementarity. In addition, reductions in community biomass may decrease the strength of interspecific interactions so that the enhanced effects of biodiversity on ecosystem processes can disappear well before species become extinct.	[Caliman, Adriano; Carneiro, Luciana S.; Leal, Joao J. F.; Farjalla, Vinicius F.; Bozelli, Reinaldo L.; Esteves, Francisco A.] Univ Fed Rio de Janeiro, CCS, Inst Biol, Dept Ecol, Rio De Janeiro, Brazil; [Leal, Joao J. F.] Ctr Fed Educ Tecnol Quim, Rio De Janeiro, Brazil; [Esteves, Francisco A.] Nucleo Pesquisas Ecol & Desenvolvimento Socio Amb, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Caliman, A (corresponding author), Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Bot Ecol & Zool, BR-59072970 Natal, RN, Brazil.	caliman@cb.ufrn.br	Caliman, Adriano/A-8668-2008; Bozelli, Reinaldo/S-6414-2019; Bozelli, Reinaldo L/G-1805-2012; Farjalla, Vinicius F/V-4351-2019; Farjalla, Vinicius/G-4945-2010	Caliman, Adriano/0000-0001-9218-5601; Bozelli, Reinaldo L/0000-0001-9916-1629; Farjalla, Vinicius F/0000-0003-4084-5983; Farjalla, Vinicius/0000-0003-4084-5983	Brazilian Council of Research and Technology (CNPq); Coordination for the Improvement of Higher Level Education (CAPES)	Brazilian Council of Research and Technology (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Level Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants and scholarships provided by Brazilian Council of Research and Technology (CNPq-www.cnpq.br) and Coordination for the Improvement of Higher Level Education (CAPES-www.capes.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DC, 2011, ECOLOGY, V92, P1013, DOI 10.1890/i0012-9658-92-5-1013; Aller RC, 1998, DEEP-SEA RES PT I, V45, P133, DOI 10.1016/S0967-0637(97)00049-6; Alves JM, 2010, AQUAT ECOL, V44, P421, DOI 10.1007/s10452-009-9302-3; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bengtsson J, 1998, APPL SOIL ECOL, V10, P191, DOI 10.1016/S0929-1393(98)00120-6; Biles CL, 2003, J EXP MAR BIOL ECOL, V285, P165, DOI 10.1016/S0022-0981(02)00525-7; Biles CL, 2002, HYDROL EARTH SYST SC, V6, P999, DOI 10.5194/hess-6-999-2002; Bozelli RL, 2009, LIMNOLOGICA, V39, P306, DOI 10.1016/j.limno.2009.06.004; Bracken MES, 2006, ECOLOGY, V87, P2397, DOI 10.1890/0012-9658(2006)87[2397:SDENUV]2.0.CO;2; Bulling MT, 2010, PHILOS T R SOC B, V365, P2107, DOI 10.1098/rstb.2010.0022; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Caliman A, 2010, BRAZ J BIOL, V70, P803, DOI 10.1590/S1519-69842010000400011; Caliman A, 2009, THESIS U FEDERAL RIO; Caliman A, 2007, J N AM BENTHOL SOC, V26, P450, DOI 10.1899/06-050.1; Caliman A, 2011, OIKOS, V120, P1639, DOI 10.1111/j.1600-0706.2011.19362.x; Caliman A, 2010, BIODIVERS CONSERV, V19, P651, DOI 10.1007/s10531-009-9725-0; CALLISTO M, 1998, ECOLOGIA LAGOAS COST, P479; Cardinale BJ, 2004, OIKOS, V104, P437, DOI 10.1111/j.0030-1299.2004.13254.x; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Cottingham KL, 2005, FRONT ECOL ENVIRON, V3, P145, DOI 10.1890/1540-9295(2005)003[0145:KWTDTL]2.0.CO;2; Covich AP, 2004, BIOSCIENCE, V54, P767, DOI 10.1641/0006-3568(2004)054[0767:TROBIT]2.0.CO;2; De Haas EM, 2005, FRESHWATER BIOL, V50, P770, DOI 10.1111/j.1365-2427.2005.01356.x; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Duffy JE, 2003, ECOL LETT, V6, P637; Emmerson MC, 2001, NATURE, V411, P73, DOI 10.1038/35075055; Esteves FA, 2008, BRAZ J BIOL, V68, P967, DOI 10.1590/S1519-69842008000500006; Farjalla V. F., 2006, Braz. J. Biol., V66, P383, DOI 10.1590/S1519-69842006000300002; Figueiredo-Barros MP, 2006, ESTUAR COAST SHELF S, V69, P87, DOI 10.1016/j.ecss.2006.03.023; Figueiredo-Barros MP, 2009, CAN J FISH AQUAT SCI, V66, P1649, DOI 10.1139/F09-111; Flecker AS, 1999, COPEIA, P495, DOI 10.2307/1447498; Gamfeldt L, 2008, INT REV HYDROBIOL, V93, P550, DOI 10.1002/iroh.200711022; Gamfeldt L, 2008, ECOLOGY, V89, P1223, DOI 10.1890/06-2091.1; Gilbertson WW, 2012, FEMS MICROBIOL ECOL; Giller PS, 2004, OIKOS, V104, P423, DOI 10.1111/j.0030-1299.2004.13253.x; Godbold JA, 2011, P ROY SOC B-BIOL SCI, V278, P2510, DOI 10.1098/rspb.2010.2414; Godbold JA, 2009, MAR ECOL PROG SER, V396, P273, DOI 10.3354/meps08401; Golterman HL, 1978, METHODS PHYS CHEM AN; Gotelli NJ, 2013, ECOSIMR 1 00; GRANELI W, 1979, HYDROBIOLOGIA, V66, P149, DOI 10.1007/BF00032045; Griffin JN, 2008, ECOLOGY, V89, P298, DOI 10.1890/07-1220.1; Griffiths GJK, 2008, ECOLOGY, V89, P2986, DOI 10.1890/08-0685.1; GUREVITCH J, 1992, AM NAT, V140, P539, DOI 10.1086/285428; He JS, 2005, BASIC APPL ECOL, V6, P505, DOI 10.1016/j.baae.2005.04.002; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.2307/177062; Hiddink JG, 2009, OIKOS, V118, P1892, DOI 10.1111/j.1600-0706.2009.17556.x; Hillebrand H, 2009, ECOL LETT, V12, P1405, DOI 10.1111/j.1461-0248.2009.01388.x; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Ieno EN, 2006, MAR ECOL PROG SER, V311, P263, DOI 10.3354/meps311263; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Jolliffe PA, 2000, J ECOL, V88, P371, DOI 10.1046/j.1365-2745.2000.00470.x; Kristensen E, 2000, HYDROBIOLOGIA, V426, P1, DOI 10.1023/A:1003980226194; Kristensen E, 2012, MAR ECOL PROG SER, V446, P285, DOI 10.3354/meps09506; Leal JJF, 2003, INT REV HYDROBIOL, V88, P167, DOI 10.1002/iroh.200390012; Lohrer AM, 2004, NATURE, V431, P1092, DOI 10.1038/nature03042; Loreau M, 1998, OIKOS, V82, P600, DOI 10.2307/3546381; Maestre FT, 2012, J ECOL, V100, P317, DOI 10.1111/j.1365-2745.2011.01918.x; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; Marinelli RL, 2003, ESTUAR COAST SHELF S, V57, P179, DOI 10.1016/S0272-7714(02)00342-6; Marquard E, 2009, J ECOL, V97, P696, DOI 10.1111/j.1365-2745.2009.01521.x; Massol F, 2011, ECOL LETT, V14, P313, DOI 10.1111/j.1461-0248.2011.01588.x; Mermillod-Blondin F, 2005, J EXP MAR BIOL ECOL, V315, P187, DOI 10.1016/j.jembe.2004.09.013; Mermillod-Blondin F, 2006, AQUAT SCI, V68, P434, DOI 10.1007/s00027-006-0858-x; Mermillod-Blondin F, 2011, J N AM BENTHOL SOC, V30, P770, DOI 10.1899/10-121.1; Meysman FJR, 2006, TRENDS ECOL EVOL, V21, P688, DOI 10.1016/j.tree.2006.08.002; Moore JW, 2006, BIOSCIENCE, V56, P237, DOI 10.1641/0006-3568(2006)056[0237:AEEIS]2.0.CO;2; Mouillot D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017476; Naeem S, 2012, SCIENCE, V336, P1401, DOI 10.1126/science.1215855; Palmer MA, 2000, BIOSCIENCE, V50, P1062, DOI 10.1641/0006-3568(2000)050[1062:LBASBA]2.0.CO;2; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Peter H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023225; Peter H, 2011, ISME J, V5, P351, DOI 10.1038/ismej.2010.119; Raffaelli DG, 2006, MAR ECOL PROG SER, V311, P285, DOI 10.3354/meps311285; Rangel TFLVB, 2006, GLOBAL ECOL BIOGEOGR, V15, P321, DOI 10.1111/j.1466-822x.2006.00237.x; Reiss J, 2009, TRENDS ECOL EVOL, V24, P505, DOI 10.1016/j.tree.2009.03.018; Rosenberg MS, 2000, METAWIN STAT SOFTWAR; Rosenfeld JS, 2002, CONSERV BIOL, V16, P837, DOI 10.1046/j.1523-1739.2002.01080.x; Schindler DE, 2002, OIKOS, V98, P177, DOI 10.1034/j.1600-0706.2002.980201.x; Schmid B, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P61; Schmitz OJ, 2008, ECOLOGY, V89, P2436, DOI 10.1890/07-1030.1; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; SOLORZANO L, 1969, LIMNOL OCEANOGR, V14, P799, DOI 10.4319/lo.1969.14.5.0799; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Stief P, 2006, ECOLOGY, V87, P3152, DOI 10.1890/0012-9658(2006)87[3152:TIEOPF]2.0.CO;2; Sundareshwar PV, 2003, SCIENCE, V299, P563, DOI 10.1126/science.1079100; Sundback K, 2003, MAR ECOL PROG SER, V246, P115, DOI 10.3354/meps246115; Teal LR, 2008, AQUAT BIOL, V2, P207, DOI 10.3354/ab00052; Teal LR, 2010, MAR ECOL PROG SER, V414, P27, DOI 10.3354/meps08736; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Vaughn CC, 2010, BIOSCIENCE, V60, P25, DOI 10.1525/bio.2010.60.1.7; Waldbusser GG, 2004, LIMNOL OCEANOGR, V49, P1482, DOI 10.4319/lo.2004.49.5.1482; WHITING GJ, 1993, NATURE, V364, P794, DOI 10.1038/364794a0; Wootton JT, 2005, ANNU REV ECOL EVOL S, V36, P419, DOI 10.1146/annurev.ecolsys.36.091704.175535; Zavaleta ES, 2010, P NATL ACAD SCI USA, V107, P1443, DOI 10.1073/pnas.0906829107	101	4	7	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44925	10.1371/journal.pone.0044925	http://dx.doi.org/10.1371/journal.pone.0044925			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984586	gold, Green Published, Green Submitted			2022-12-27	WOS:000308738500095
J	Josse, AR; Garcia-Bailo, B; Fischer, K; El-Sohemy, A				Josse, Andrea R.; Garcia-Bailo, Bibiana; Fischer, Karina; El-Sohemy, Ahmed			Novel Effects of Hormonal Contraceptive Use on the Plasma Proteome	PLOS ONE			English	Article							DOSE ORAL-CONTRACEPTIVES; RISK-FACTORS; CARDIOVASCULAR-DISEASE; CLINICAL PROTEOMICS; VITAMIN-C; HEALTH; POPULATION; BENEFITS; METAANALYSIS; ASSOCIATION	Background: Hormonal contraceptive (HC) use may increase cardiometabolic risk; however, the effect of HC on emerging cardiometabolic and other disease risk factors is not clear. Objectives: To determine the association between HC use and plasma proteins involved in established and emerging disease risk pathways. Method: Concentrations of 54 high-abundance plasma proteins were measured simultaneously by LC-MRM/MS in 783 women from the Toronto Nutrigenomics and Health Study. C-reactive protein (CRP) was measured separately. ANCOVA was used to test differences in protein concentrations between users and non-users, and among HC users depending on total hormone dose. Linear regression was used to test the association between duration (years) of HC use and plasma protein concentrations. Principal components analysis (PCA) was used to identify plasma proteomic profiles in users and non-users. Results: After Bonferroni correction, 19 proteins involved in inflammation, innate immunity, coagulation and blood pressure regulation were significantly different between users and non-users (P<0.0009). These differences were replicated across three distinct ethnocultural groups. Traditional markers of glucose and lipid metabolism were also significantly higher among HC users. Neither hormone dose nor duration of use affected protein concentrations. PCA identified 4 distinct proteomic profiles in users and 3 in non-users. Conclusion: HC use was associated with different concentrations of plasma proteins along various disease-related pathways, and these differences were present across different ethnicities. Aside from the known effect of HC on traditional biomarkers of cardiometabolic risk, HC use also affects numerous proteins that may be biomarkers of dysregulation in inflammation, coagulation and blood pressure.	[Josse, Andrea R.; Garcia-Bailo, Bibiana; Fischer, Karina; El-Sohemy, Ahmed] Univ Toronto, Fac Med, Dept Nutr Sci, Toronto, ON, Canada; [Fischer, Karina] ETH, Dept Agr & Food Sci, Inst Food Nutr & Hlth, Zurich, Switzerland	University of Toronto; Swiss Federal Institutes of Technology Domain; ETH Zurich	Josse, AR (corresponding author), Univ Toronto, Fac Med, Dept Nutr Sci, Toronto, ON, Canada.	a.el.sohemy@utoronto.ca		Josse, Andrea/0000-0002-7247-9466; El-Sohemy, Ahmed/0000-0002-8877-6414	Advanced Food and Materials Network (AFMNet); Canadian Institutes of Health Research (CIHR); Canadian Diabetes Association (CDA) Post-Doctoral fellowships; Ontario Graduate Scholarship; Canada Research Chair in Nutrigenomics	Advanced Food and Materials Network (AFMNet); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association (CDA) Post-Doctoral fellowships; Ontario Graduate Scholarship(Ontario Graduate Scholarship); Canada Research Chair in Nutrigenomics	Funding for the research was obtained from the Advanced Food and Materials Network (AFMNet). ARJ is funded by Canadian Institutes of Health Research (CIHR) and Canadian Diabetes Association (CDA) Post-Doctoral fellowships; BGB is funded by an Ontario Graduate Scholarship; AES is supported by a Canada Research Chair in Nutrigenomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L, 2005, J PHYSIOL-LONDON, V563, P23, DOI 10.1113/jphysiol.2004.080473; Apweiler R, 2009, CLIN CHEM LAB MED, V47, P724, DOI 10.1515/CCLM.2009.167; Asleh R, 2005, VASC HEALTH RISK MAN, V1, P19, DOI 10.2147/vhrm.1.1.19.58930; Baillargeon JP, 2005, J CLIN ENDOCR METAB, V90, P3863, DOI 10.1210/jc.2004-1958; Baird DT, 2005, HUM REPROD UPDATE, V11, P513, DOI 10.1093/humupd/dmi019; Cahill L, 2009, AM J EPIDEMIOL, V170, P464, DOI 10.1093/aje/kwp156; DeClercq Vanessa, 2008, Cardiovascular & Hematological Disorders - Drug Targets, V8, P228, DOI 10.2174/187152908785849080; DELECINANA MA, 2006, CEREBROVASC DIS, V21, P48; Du Y, 2011, J ADOLESCENT HEALTH, V48, P331, DOI 10.1016/j.jadohealth.2011.01.004; Ekmekci OB, 2006, CLIN CHIM ACTA, V368, P77, DOI 10.1016/j.cca.2005.12.015; Fan NJ, 2012, CAN J GASTROENTEROL, V26, P41, DOI 10.1155/2012/645218; Folsom AR, 2001, THROMB HAEMOSTASIS, V86, P366; Foulds HJA, 2012, J HYPERTENS, V30, P359, DOI 10.1097/HJH.0b013e32834f0b86; Frempong BA, 2008, J CLIN ENDOCR METAB, V93, P2097, DOI 10.1210/jc.2007-2599; Garcia-Bailo B, 2012, AM J CLIN NUTR, V95, P352, DOI 10.3945/ajcn.111.022657; Gerszten RE, 2008, AM J PHYSIOL-LUNG C, V295, pL16, DOI 10.1152/ajplung.00044.2008; Gronich N, 2011, CAN MED ASSOC J, V183, pE1319, DOI 10.1503/cmaj.110463; Gruys E, 2005, J Zhejiang Univ Sci B, V6, P1045, DOI 10.1631/jzus.2005.B1045; Haider Z, 2009, BEST PRACT RES CL OB, V23, P249, DOI 10.1016/j.bpobgyn.2008.12.003; Hemingway H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000286; Hortin GL, 2008, CLIN CHEM, V54, P1608, DOI 10.1373/clinchem.2008.108175; Huber JC, 2008, EXPERT OPIN PHARMACO, V9, P2317, DOI 10.1517/14656566.9.13.2317 ; Hurwitz BE, 2009, GYNECOL ENDOCRINOL, V25, P441, DOI 10.1080/09513590902770149; Katayama H, 2009, GENOME MED, V1, DOI 10.1186/gm47; Khader YS, 2003, CONTRACEPTION, V68, P11, DOI 10.1016/S0010-7824(03)00073-8; Kim J, 1978, FACTOR ANAL STAT MET; Kluft C, 2007, CLIMACTERIC, V10, P32, DOI 10.1080/13697130701598548; Kuzyk MA, 2009, MOL CELL PROTEOMICS, V8, P1860, DOI 10.1074/mcp.M800540-MCP200; Kwok S, 2009, CLIN ENDOCRINOL, V71, P727, DOI 10.1111/j.1365-2265.2009.03580.x; Lear SA, 2012, OBESITY SILVER SPRIN; Levy AP, 2010, ANTIOXID REDOX SIGN, V12, P293, DOI 10.1089/ars.2009.2793; Li GH, 2010, MED RES REV, DOI 31:n/a; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Obisesan K A, 2002, West Afr J Med, V21, P197; Pitteri SJ, 2009, GENOME MED, V1, DOI 10.1186/gm121; Salgado FJ, 2011, ACUTE PHASE PROTEINS AS EARLY NON-SPECIFIC BIOMARKERS OF HUMAN AND VETERINARY DISEASES, P127; Shen YF, 2005, PROTEOMICS, V5, P4034, DOI 10.1002/pmic.200401246; Soska V, 2011, SCAND J CLIN LAB INV, V71, P94, DOI 10.3109/00365513.2011.553240; Williams JK, 2004, INT J FERTIL WOMEN M, V49, P30	41	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45162	10.1371/journal.pone.0045162	http://dx.doi.org/10.1371/journal.pone.0045162			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984625	gold, Green Published, Green Submitted			2022-12-27	WOS:000308738500123
J	Siddique, MM; Bikman, BT; Wang, LP; Ying, L; Reinhardt, E; Shui, GH; Wenk, MR; Summers, SA				Siddique, Monowarul M.; Bikman, Benjamin T.; Wang, Liping; Ying, Li; Reinhardt, Erin; Shui, Guanghou; Wenk, Markus R.; Summers, Scott A.			Ablation of Dihydroceramide Desaturase Confers Resistance to Etoposide-Induced Apoptosis In Vitro	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; HUMAN GLIOMA-CELLS; CERAMIDE ACCUMULATION; CASPASE-3 ACTIVATION; BIOSYNTHESIS; PROTEIN; PHOSPHATASE; CANCER; STRESS; GROWTH	Sphingolipid biosynthesis is potently upregulated by factors associated with cellular stress, including numerous chemotherapeutics, inflammatory cytokines, and glucocorticoids. Dihydroceramide desaturase 1 (Des1), the third enzyme in the highly conserved pathway driving sphingolipid biosynthesis, introduces the 4,5-trans-double bond that typifies most higher-order sphingolipids. Surprisingly, recent studies have shown that certain chemotherapeutics and other drugs inhibit Des1, giving rise to a number of sphingolipids that lack the characteristic double bond. In order to assess the effect of an altered sphingolipid profile (via Des1 inhibition) on cell function, we generated isogenic mouse embryonic fibroblasts lacking both Des1 alleles. Lipidomic profiling revealed that these cells contained higher levels of dihydroceramide than wildtype fibroblasts and that complex sphingolipids were comprised predominantly of the saturated backbone (e. g. sphinganine vs. sphingosine, dihydrosphingomyelin vs. sphingomyelin, etc.). Des1 ablation activated pro-survival and anabolic signaling intermediates (e.g. Akt/PKB, mTOR, MAPK, etc.) and provided protection from apoptosis caused by etoposide, a chemotherapeutic that induces sphingolipid synthesis by upregulating several sphingolipid biosynthesizing enzymes. These data reveal that the double bond present in most sphingolipids has a profound impact on cell survival pathways, and that the manipulation of Des1 could have important effects on apoptosis.	[Siddique, Monowarul M.; Bikman, Benjamin T.; Ying, Li; Reinhardt, Erin; Summers, Scott A.] Duke Natl Univ Singapore, Program Cardiovasc & Metab Dis, Grad Sch Med, Singapore, Singapore; [Bikman, Benjamin T.] Brigham Young Univ, Dept Physiol & Dev Biol, Provo, UT 84602 USA; [Wang, Liping; Summers, Scott A.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC USA; [Shui, Guanghou; Wenk, Markus R.] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore	National University of Singapore; Brigham Young University; Duke University; National University of Singapore	Siddique, MM (corresponding author), Duke Natl Univ Singapore, Program Cardiovasc & Metab Dis, Grad Sch Med, Singapore, Singapore.	mobin.siddique@duke-nus.edu.sg; scott.summers@duke-nus.edu.sg	/AAE-5384-2020; Wenk, Markus Rene/D-1441-2014; Bikman, Benjamin/AAT-9606-2021	Li, Ying/0000-0002-6859-7208; Shui, Guanghou/0000-0002-1621-9643	National Medical Research Council [IRG09may004]; National Institutes of Health [R01DK081456-01]; Singapore Ministry of Education Academic Research Fund -NUS Signature Research Program; Agency for Science, Technology and Research, Singapore; Ministry of Health, Singapore; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081456] Funding Source: NIH RePORTER	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore Ministry of Education Academic Research Fund -NUS Signature Research Program(Ministry of Education, SingaporeNational University of Singapore); Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); Ministry of Health, Singapore(Ministry of Health-Singapore); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Medical Research Council (IRG09may004); the National Institutes of Health grant R01DK081456-01 (SAS); the Singapore Ministry of Education Academic Research Fund -NUS Signature Research Program funded by the Agency for Science, Technology and Research, Singapore, and the Ministry of Health, Singapore (SAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery K, 2008, STEM CELLS DEV, V17, P1195, DOI 10.1089/scd.2008.0063; Bikman BT, 2012, J BIOL CHEM, V287, P17426, DOI 10.1074/jbc.M112.359950; Cadena DL, 1997, BIOCHEMISTRY-US, V36, P6960, DOI 10.1021/bi970091l; Coll T, 2008, J BIOL CHEM, V283, P11107, DOI 10.1074/jbc.M708700200; Dai Q, 2004, ONCOGENE, V23, P3650, DOI 10.1038/sj.onc.1207430; Dbaibo GS, 1998, J CLIN INVEST, V102, P329, DOI 10.1172/JCI1180; deChaves EIP, 1997, J BIOL CHEM, V272, P3028, DOI 10.1074/jbc.272.5.3028; Devlin CM, 2011, J BIOL CHEM, V286, P38069, DOI 10.1074/jbc.M111.297994; Dimanche-Boitrel MT, 2011, RECENT PAT ANTI-CANC, V6, P284, DOI 10.2174/157489211796957838; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; Fabrias G, 2012, PROG LIPID RES, V51, P82, DOI 10.1016/j.plipres.2011.12.002; Furuya H, 2011, CANCER METAST REV, V30, P567, DOI 10.1007/s10555-011-9304-1; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gomez-Munoz A, 2010, ADV EXP MED BIOL, V688, P118; Gonzalez-Pertusa JA, 2010, ENDOCRINOLOGY, V151, P1487, DOI 10.1210/en.2009-0975; Grandela C, 2008, STEM CELL RES, V1, P116, DOI 10.1016/j.scr.2007.10.003; Hannun YA, 2000, TRENDS CELL BIOL, V10, P73, DOI 10.1016/S0962-8924(99)01694-3; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; Hayashi H, 2006, J BIOL CHEM, V281, P1332, DOI 10.1074/jbc.M505905200; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Hu W, 2011, J BIOL CHEM, V286, P16596, DOI 10.1074/jbc.M110.186916; Huwiler A, 2006, CURR PHARM DESIGN, V12, P4625, DOI 10.2174/138161206779010422; Idkowiak-Baldys J, 2010, BIOCHEM J, V427, P265, DOI 10.1042/BJ20091589; Karpinich NO, 2002, J BIOL CHEM, V277, P16547, DOI 10.1074/jbc.M110629200; Kraveka JM, 2007, J BIOL CHEM, V282, P16718, DOI 10.1074/jbc.M700647200; Levkau B, 1998, MOL CELL, V1, P553, DOI 10.1016/S1097-2765(00)80055-6; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Mizutani Y, 2004, FEBS LETT, V563, P93, DOI 10.1016/S0014-5793(04)00274-1; Mukhopadhyay A, 2009, FASEB J, V23, P751, DOI 10.1096/fj.08-120550; Omae F, 2004, BIOCHEM J, V379, P687, DOI 10.1042/BJ20031425; Osawa Y, 2005, J BIOL CHEM, V280, P27879, DOI 10.1074/jbc.M503002200; Oskouian B, 2006, P NATL ACAD SCI USA, V103, P17384, DOI 10.1073/pnas.0600050103; Perry DK, 2000, J BIOL CHEM, V275, P9078, DOI 10.1074/jbc.275.12.9078; Ravid T, 2003, AM J PHYSIOL-LUNG C, V284, pL1082, DOI 10.1152/ajplung.00172.2002; Renert AF, 2009, J PROTEOME RES, V8, P4810, DOI 10.1021/pr9005316; Sawada M, 2001, ONCOGENE, V20, P1368, DOI 10.1038/sj.onc.1204207; Sawada N, 2000, CELL DEATH DIFFER, V7, P761, DOI 10.1038/sj.cdd.4400711; Seumois G, 2007, J LEUKOCYTE BIOL, V81, P1477, DOI 10.1189/jlb.0806529; Signorelli P, 2009, CANCER LETT, V282, P238, DOI 10.1016/j.canlet.2009.03.020; SPIEGEL S, 1993, ADV LIPID RES, V25, P105; Stratford S, 2004, J BIOL CHEM, V279, P36608, DOI 10.1074/jbc.M406499200; Summers SA, 2005, DIABETES, V54, P591, DOI 10.2337/diabetes.54.3.591; Summers SA, 2010, CURR OPIN LIPIDOL, V21, P128, DOI 10.1097/MOL.0b013e3283373b66; Taha TA, 2005, FASEB J, V19, P482, DOI 10.1096/fj.05-4412fje; Thomas RL, 1999, J BIOL CHEM, V274, P30580, DOI 10.1074/jbc.274.43.30580; Vieira CR, 2010, CHEM BIOL, V17, P766, DOI 10.1016/j.chembiol.2010.05.023; von Haefen C, 2002, ONCOGENE, V21, P4009, DOI 10.1038/sj.onc.1205497; Wang H, 2008, MOL CANCER THER, V7, P2967, DOI 10.1158/1535-7163.MCT-08-0549; Weng LP, 2001, HUM MOL GENET, V10, P599, DOI 10.1093/hmg/10.6.599; Yart A, 2001, J BIOL CHEM, V276, P8856, DOI 10.1074/jbc.M006966200; Yin D, 2000, J NEUROSURG, V93, P289, DOI 10.3171/jns.2000.93.2.0289; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	53	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44042	10.1371/journal.pone.0044042	http://dx.doi.org/10.1371/journal.pone.0044042			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984457	gold, Green Submitted, Green Published			2022-12-27	WOS:000308638700038
J	Strange, RW; Hough, MA; Antonyuk, SV; Hasnain, SS				Strange, Richard W.; Hough, Michael A.; Antonyuk, Svetlana V.; Hasnain, S. Samar			Structural Evidence for a Copper-Bound Carbonate Intermediate in the Peroxidase and Dismutase Activities of Superoxide Dismutase	PLOS ONE			English	Article							HYDROXYL RADICAL PRODUCTION; CU,ZN-SUPEROXIDE DISMUTASE; HYDROGEN-PEROXIDE; ACTIVE-SITE; ANION-BINDING; INORGANIC-PHOSPHATE; BICARBONATE; BOVINE; CU,ZN; MECHANISM	Copper-zinc superoxide dismutase (SOD) is of fundamental importance to our understanding of oxidative damage. Its primary function is catalysing the dismutation of superoxide to O-2 and H2O2. SOD also reacts with H2O2, leading to the formation of a strong copper-bound oxidant species that can either inactivate the enzyme or oxidise other substrates. In the presence of bicarbonate (or CO2) and H2O2, this peroxidase activity is enhanced and produces the carbonate radical. This freely diffusible reactive oxygen species is proposed as the agent for oxidation of large substrates that are too bulky to enter the active site. Here, we provide direct structural evidence, from a 2.15 angstrom resolution crystal structure, of (bi) carbonate captured at the active site of reduced SOD, consistent with the view that a bound carbonate intermediate could be formed, producing a diffusible carbonate radical upon reoxidation of copper. The bound carbonate blocks direct access of substrates to Cu(I), suggesting that an adjunct to the accepted mechanism of SOD catalysed dismutation of superoxide operates, with Cu(I) oxidation by superoxide being driven via a proton-coupled electron transfer mechanism involving the bound carbonate rather than the solvent. Carbonate is captured in a different site when SOD is oxidised, being located in the active site channel adjacent to the catalytically important Arg143. This is the probable route of diffusion from the active site following reoxidation of the copper. In this position, the carbonate is poised for re-entry into the active site and binding to the reduced copper.	[Strange, Richard W.; Hough, Michael A.; Antonyuk, Svetlana V.; Hasnain, S. Samar] Univ Liverpool, Fac Hlth & Life Sci, Inst Integrat Biol, Mol Biophys Grp, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Strange, RW (corresponding author), Univ Liverpool, Fac Hlth & Life Sci, Inst Integrat Biol, Mol Biophys Grp, Liverpool L69 3BX, Merseyside, England.	r.strange@liv.ac.uk; s.s.hasnain@liv.ac.uk	Hough, Michael/H-4409-2013; Antonyuk, Svetlana V/B-6002-2013; Antonyuk, Svetlana/W-5159-2019	Antonyuk, Svetlana/0000-0002-2779-9946; Hough, Michael/0000-0001-7377-6713	Motor Neuron Disease Association U.K. [6055]	Motor Neuron Disease Association U.K.	This work was supported by the Motor Neuron Disease Association U.K., grant number 6055 (R. W. S., S. S. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERBOOM TPM, 1978, EUR J BIOCHEM, V84, P413, DOI 10.1111/j.1432-1033.1978.tb12182.x; Augusto O, 2002, FREE RADICAL BIO MED, V32, P841, DOI 10.1016/S0891-5849(02)00786-4; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bonini MG, 2009, J BIOL CHEM, V284, P14618, DOI 10.1074/jbc.M804644200; BRAY RC, 1974, BIOCHEM J, V139, P43, DOI 10.1042/bj1390043; CABELLI DE, 1989, J BIOL CHEM, V264, P9967; CARUGO KD, 1994, FEBS LETT, V349, P93, DOI 10.1016/0014-5793(94)00651-2; Chandran K, 2010, BIOCHEMISTRY-US, V49, P10616, DOI 10.1021/bi1010305; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DEFREITAS DM, 1987, INORG CHEM, V26, P2788; DESIDERI A, 1988, J INORG BIOCHEM, V33, P91, DOI 10.1016/0162-0134(88)80037-0; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Elam JS, 2003, J BIOL CHEM, V278, P21032, DOI 10.1074/jbc.M300484200; Ellerby LM, 1996, J AM CHEM SOC, V118, P6556, DOI 10.1021/ja953845x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferraroni M, 1998, J BIOL INORG CHEM, V3, P411, DOI 10.1007/s007750050251; Geers C, 2000, PHYSIOL REV, V80, P681, DOI 10.1152/physrev.2000.80.2.681; GETZOFF ED, 1983, NATURE, V306, P287, DOI 10.1038/306287a0; Goss SPA, 1999, J BIOL CHEM, V274, P28233, DOI 10.1074/jbc.274.40.28233; Hart PJ, 1999, BIOCHEMISTRY-US, V38, P2167, DOI 10.1021/bi982284u; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; HODGSON EK, 1975, BIOCHEMISTRY-US, V14, P5299, DOI 10.1021/bi00695a011; HODGSON EK, 1975, BIOCHEMISTRY-US, V14, P5294, DOI 10.1021/bi00695a010; Jewett SL, 1999, FREE RADICAL BIO MED, V26, P905, DOI 10.1016/S0891-5849(98)00274-3; Jewett SL, 2000, BIOCHEM BIOPH RES CO, V274, P57, DOI 10.1006/bbrc.2000.3092; Karunakaran C, 2004, J BIOL CHEM, V279, P32534, DOI 10.1074/jbc.M314272200; Kurahashi T, 2001, J AM CHEM SOC, V123, P9268, DOI 10.1021/ja015953r; Lambert LA, 2005, COMP BIOCHEM PHYS B, V142, P129, DOI 10.1016/j.cbpb.2005.07.007; Leone M, 1998, BIOCHEMISTRY-US, V37, P4459, DOI 10.1021/bi971878e; Liochev SI, 2004, P NATL ACAD SCI USA, V101, P743, DOI 10.1073/pnas.0307635100; Liochev SI, 1999, FREE RADICAL BIO MED, V27, P1444, DOI 10.1016/S0891-5849(99)00190-2; Liochev SI, 2004, ARCH BIOCHEM BIOPHYS, V421, P255, DOI 10.1016/j.abb.2003.11.015; Liochev SI, 2010, FREE RADICAL BIO MED, V48, P1565, DOI 10.1016/j.freeradbiomed.2010.02.036; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Medinas DB, 2007, IUBMB LIFE, V59, P255, DOI 10.1080/15216540701230511; Medinas DB, 2010, FREE RADICAL BIO MED, V49, P682, DOI 10.1016/j.freeradbiomed.2010.04.040; Medinas DB, 2009, CHEM RES TOXICOL, V22, P639, DOI 10.1021/tx800287m; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramirez DC, 2005, FREE RADICAL BIO MED, V38, P201, DOI 10.1016/j.freeradbiomed.2004.10.008; Sankarapandi S, 1999, J BIOL CHEM, V274, P1226, DOI 10.1074/jbc.274.3.1226; SATO K, 1992, J BIOL CHEM, V267, P25371; SETTE M, 1992, BIOCHEMISTRY-US, V31, P12410, DOI 10.1021/bi00164a016; Smirnov VV, 2006, J AM CHEM SOC, V128, P16424, DOI 10.1021/ja066369r; Strange RW, 2006, J MOL BIOL, V356, P1152, DOI 10.1016/j.jmb.2005.11.081; Strater N, 1999, P NATL ACAD SCI USA, V96, P11151, DOI 10.1073/pnas.96.20.11151; TAINER JA, 1982, J MOL BIOL, V160, P181, DOI 10.1016/0022-2836(82)90174-7; UCHIDA K, 1994, J BIOL CHEM, V269, P2405; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; YIM MB, 1990, P NATL ACAD SCI USA, V87, P5006, DOI 10.1073/pnas.87.13.5006; Zhang H, 2000, J BIOL CHEM, V275, P14038, DOI 10.1074/jbc.275.19.14038; Zhang H, 2003, J BIOL CHEM, V278, P24078, DOI 10.1074/jbc.M302051200; Zhang HB, 2002, J BIOL CHEM, V277, P49767, DOI 10.1074/jbc.M204005200	53	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44811	10.1371/journal.pone.0044811	http://dx.doi.org/10.1371/journal.pone.0044811			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984565	gold, Green Published, Green Accepted			2022-12-27	WOS:000308638700086
J	Gao, SG; Roberts, HK; Wang, XJ				Gao, Shouguo; Roberts, Herbert Keith; Wang, Xujing			Cross Tissue Trait-Pathway Network Reveals the Importance of Oxidative Stress and Inflammation Pathways in Obesity-Induced Diabetes in Mouse	PLOS ONE			English	Article							INSULIN-RESISTANCE; GENE-EXPRESSION; METABOLISM; CENTRALITY; GLUCOSE; HUMANS	Complex disorders often involve dysfunctions in multiple tissue organs. Elucidating the communication among them is important to understanding disease pathophysiology. In this study we integrate multiple tissue gene expression and quantitative trait measurements of an obesity-induced diabetes mouse model, with databases of molecular interaction networks, to construct a cross tissue trait-pathway network. The animals belong to two strains of mice (BTBR or B6), of two obesity status (obese or lean), and at two different ages (4 weeks and 10 weeks). Only 10 week obese BTBR animals are diabetic. The expression data was first utilized to determine the state of every pathway in each tissue, which is subsequently utilized to construct a pathway co-expression network and to define trait-relevant and trait-linking pathways. Among the six tissues profiled, the adipose contains the largest number of trait-linking pathways. Among the eight traits measured, the body weight and plasma insulin level possess the most number of relevant and linking pathways. Topological analysis of the trait-pathway network revealed that the glycolysis/gluconeogenesis pathway in liver and the insulin signaling pathway in muscle are of top importance to the information flow in the network, with the highest degrees and betweenness centralities. Interestingly, pathways related to metabolism and oxidative stress actively interact with many other pathways in all animals, whereas, among the 10 week animals, the inflammation pathways were preferentially interactive in the diabetic ones only. In summary, our method offers a systems approach to delineate disease trait relevant intra-and cross tissue pathway interactions, and provides insights to the molecular basis of the obesity-induced diabetes.	[Gao, Shouguo; Roberts, Herbert Keith; Wang, Xujing] Univ Alabama Birmingham, Dept Phys, Birmingham, AL 35294 USA; [Gao, Shouguo; Wang, Xujing] Univ Alabama Birmingham, Comprehens Diabet Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Wang, XJ (corresponding author), Univ Alabama Birmingham, Dept Phys, Birmingham, AL 35294 USA.	xujingw@uab.edu			United States National Institutes of Health (NIH) [NIH-DK080100]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080100] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by United States National Institutes of Health (NIH) NIH-DK080100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Batagelj V, 2004, MATH VIS, P77; Bordonaro M, 2009, VITAM HORM, V80, P563, DOI 10.1016/S0083-6729(08)00619-5; Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Dobrin R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r55; Donath MY, 2003, J MOL MED-JMM, V81, P455, DOI 10.1007/s00109-003-0450-y; Fasshauer M, 2004, J ENDOCRINOL, V181, P129, DOI 10.1677/joe.0.1810129; Frayn KN, 2003, BIOCHEM SOC T, V31, P1115, DOI 10.1042/BST0311115; Gao S, 2009, ONLINE J BIOINFORMAT, V10, P191; Gao S, 2012, OMICS IN PRESS; Gao S, 2011, BIOINF BIOM WORKSH B; Gao SG, 2007, BIOINFORMATICS, V23, P3100, DOI 10.1093/bioinformatics/btm460; Gao Shouguo, 2009, J Comput Sci Syst Biol, V2, P133; Gaster M, 2009, BIOCHEM BIOPH RES CO, V387, P651, DOI 10.1016/j.bbrc.2009.07.064; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guan YF, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000165; Hu Haiyan, 2008, Pac Symp Biocomput, P255; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Karlsson HKR, 2007, CELL BIOCHEM BIOPHYS, V48, P103, DOI 10.1007/s12013-007-0030-9; Keller MP, 2008, GENOME RES, V18, P706, DOI 10.1101/gr.074914.107; Koshiyama H, 2006, MED HYPOTHESES, V67, P307, DOI 10.1016/j.mehy.2006.02.033; Lage K, 2008, P NATL ACAD SCI USA, V105, P20870, DOI 10.1073/pnas.0810772105; Li Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004346; Lin HM, 2009, J BIOL CHEM, V284, P12246, DOI 10.1074/jbc.M805379200; Lusis AJ, 2008, NAT REV GENET, V9, P819, DOI 10.1038/nrg2468; Maliackal Poulo Joy AB, 2005, J BIOMEDICINE BIOTEC; Mirela D, 2009, PROTEIN TYROSINE PHO; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Ogawa Wataru, 2006, Nihon Rinsho, V64, P1381; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Olsson AH, 2011, EUR J ENDOCRINOL, V164, P765, DOI 10.1530/EJE-10-0995; Palumbo PJ, 2004, CLEV CLIN J MED, V71, P385, DOI 10.3949/ccjm.71.5.385; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Rocheleau JV, 2002, J BIOL CHEM, V277, P30914, DOI 10.1074/jbc.M202314200; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SUHAIL M, 1989, ACTA DIABETOL LAT, V26, P315, DOI 10.1007/BF02624643; TODESCO T, 1991, AM J CLIN NUTR, V54, P860, DOI 10.1093/ajcn/54.5.860; Vodenik B, 2009, Transplant Proc, V41, pS31, DOI 10.1016/j.transproceed.2009.06.159; Webber J, 1998, ABNORMALITIES GLUCOS, P191; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wilcox R.R., 2003, APPLYING CONT STAT T, DOI [10.1016/B978-012751541-0/50029-8, DOI 10.1016/B978-012751541-0/50029-8, DOI 10.1198/TECH.2004.S233]; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Yoav Benjamini, 2001, Behavioural Brain Research, V125, P279, DOI 10.1016/S0166-4328(01)00297-2	50	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e44544	10.1371/journal.pone.0044544	http://dx.doi.org/10.1371/journal.pone.0044544			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028558	Green Published, gold, Green Submitted			2022-12-27	WOS:000309742800013
J	Piret, SE; Esapa, CT; Gorvin, CM; Head, R; Loh, NY; Devuyst, O; Thomas, G; Brown, SDM; Brown, M; Croucher, P; Cox, R; Thakker, RV				Piret, Sian E.; Esapa, Christopher T.; Gorvin, Caroline M.; Head, Rosie; Loh, Nellie Y.; Devuyst, Olivier; Thomas, Gethin; Brown, Steve D. M.; Brown, Matthew; Croucher, Peter; Cox, Roger; Thakker, Rajesh V.			A Mouse Model of Early-Onset Renal Failure Due to a Xanthine Dehydrogenase Nonsense Mutation	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; TUBULOINTERSTITIAL FIBROSIS; CLASSICAL XANTHINURIA; DEFICIENT MICE; I XANTHINURIA; GENE-FUNCTION; GENOME-WIDE; DRIVEN; IDENTIFICATION; DYSPLASIA	Chronic kidney disease (CKD) is characterized by renal fibrosis that can lead to end-stage renal failure, and studies have supported a strong genetic influence on the risk of developing CKD. However, investigations of the underlying molecular mechanisms are hampered by the lack of suitable hereditary models in animals. We therefore sought to establish hereditary mouse models for CKD and renal fibrosis by investigating mice treated with the chemical mutagen N-ethyl-N-nitrosourea, and identified a mouse with autosomal recessive renal failure, designated RENF. Three-week old RENF mice were smaller than their littermates, whereas at birth they had been of similar size. RENF mice, at 4-weeks of age, had elevated concentrations of plasma urea and creatinine, indicating renal failure, which was associated with small and irregularly shaped kidneys. Genetic studies using DNA from 10 affected mice and 91 single nucleotide polymorphisms mapped the Renf locus to a 5.8Mbp region on chromosome 17E1.3. DNA sequencing of the xanthine dehydrogenase (Xdh) gene revealed a nonsense mutation at codon 26 that co-segregated with affected RENF mice. The Xdh mutation resulted in loss of hepatic XDH and renal Cyclooxygenase-2 (COX-2) expression. XDH mutations in man cause xanthinuria with undetectable plasma uric acid levels and three RENF mice had plasma uric acid levels below the limit of detection. Histological analysis of RENF kidney sections revealed abnormal arrangement of glomeruli, intratubular casts, cellular infiltration in the interstitial space, and interstitial fibrosis. TUNEL analysis of RENF kidney sections showed extensive apoptosis predominantly affecting the tubules. Thus, we have established a mouse model for autosomal recessive early-onset renal failure due to a nonsense mutation in Xdh that is a model for xanthinuria in man. This mouse model could help to increase our understanding of the molecular mechanisms associated with renal fibrosis and the specific roles of XDH and uric acid.	[Piret, Sian E.; Esapa, Christopher T.; Gorvin, Caroline M.; Head, Rosie; Loh, Nellie Y.; Brown, Matthew; Thakker, Rajesh V.] Univ Oxford, Nuffield Dept Clin Med, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Devuyst, Olivier] Univ Zurich, Inst Physiol, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Thomas, Gethin; Brown, Matthew] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Woolloongabba, Qld, Australia; [Croucher, Peter] Garvan Inst Med Res, Sydney, NSW, Australia	University of Oxford; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Queensland; Garvan Institute of Medical Research	Piret, SE (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England.	rajesh.thakker@ndm.ox.ac.uk	Brown, Matthew A/E-5749-2010; Thomas, Gethin P/A-3624-2011; Gorvin, Caroline/T-2406-2019	Brown, Matthew A/0000-0003-0538-8211; Gorvin, Caroline/0000-0002-1361-9174; Piret, Sian/0000-0002-3586-7654; Croucher, Peter/0000-0002-7102-2413; Devuyst, Olivier/0000-0003-3744-4767; Thomas, Gethin/0000-0001-9081-3686; Thakker, Rajesh/0000-0002-1438-3220; Cox, Roger/0000-0001-7170-5014	Medical Research Council UK [G0600702/1, G9825289, G1000467]; European Union program grants, EuReGene (FP6) [05085]; TREAT-OA (FP7) [200800]; NCCR Kidney; CH (Swiss National Science Foundation); ZIHP (Zurich Center for 298 Integrative Human Physiology); Medical Research Council [G1000467, G9825289, MC_U142684172, MC_U142661184] Funding Source: researchfish; MRC [G9825289, MC_U142661184, MC_U142684172, G1000467] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union program grants, EuReGene (FP6); TREAT-OA (FP7); NCCR Kidney; CH (Swiss National Science Foundation); ZIHP (Zurich Center for 298 Integrative Human Physiology); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council UK (G0600702/1, G9825289 and G1000467), and the European Union program grants, EuReGene (FP6) (05085) and TREAT-OA (FP7) (200800). OD is supported by the NCCR Kidney, CH (Swiss National Science Foundation) and the ZIHP (Zurich Center for 298 Integrative Human Physiology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Arozena A, 2008, ANNU REV GENOM HUM G, V9, P49, DOI 10.1146/annurev.genom.9.081307.164224; Barbaric I, 2008, PHYSIOL GENOMICS, V32, P311, DOI 10.1152/physiolgenomics.00116.2007; Barbaric I, 2007, J AM ASSOC LAB ANIM, V46, P44; Bosman EA, 2009, DEV BIOL, V328, P285, DOI 10.1016/j.ydbio.2009.01.030; Esapa CT, 2012, J BONE MINER RES, V27, P413, DOI 10.1002/jbmr.547; Fakhrai-Rad H, 2002, HUM MUTAT, V19, P479, DOI 10.1002/humu.10078; Gavett SH, 1999, J CLIN INVEST, V104, P721, DOI 10.1172/JCI6890; Gok F, 2003, NEPHROL DIAL TRANSPL, V18, P2278, DOI 10.1093/ndt/gfg385; Harding B, 2009, ENDOCR-RELAT CANCER, V16, P1313, DOI 10.1677/ERC-09-0082; He C, 2012, MOL BIOSYST, V8, P1585, DOI 10.1039/c2mb05503a; Hewitson TD, 2009, AM J PHYSIOL-RENAL, V296, pF1239, DOI 10.1152/ajprenal.90521.2008; Hough TA, 2004, P NATL ACAD SCI USA, V101, P13566, DOI 10.1073/pnas.0405516101; Ichida K, 1997, J CLIN INVEST, V99, P2391, DOI 10.1172/JCI119421; Jurecka A, 2010, J INHERIT METAB DIS, V33, pS21, DOI 10.1007/s10545-009-9011-z; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Keays DA, 2006, MAMM GENOME, V17, P230, DOI 10.1007/s00335-005-0101-4; Levartovsky D, 2000, KIDNEY INT, V57, P2215, DOI 10.1046/j.1523-1755.2000.00082.x; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; Norwood VF, 2000, KIDNEY INT, V58, P2291, DOI 10.1046/j.1523-1755.2000.00413.x; O'Seaghdha CM, 2012, NAT REV NEPHROL, V8, P89, DOI 10.1038/nrneph.2011.189; Ohtsubo T, 2004, CIRC RES, V95, P1118, DOI 10.1161/01.RES.0000149571.96304.36; Ohtsubo T, 2009, HYPERTENSION, V54, P868, DOI 10.1161/HYPERTENSIONAHA.109.135152; Piret SE, 2011, J ENDOCRINOL, V211, P211, DOI 10.1530/JOE-11-0193; Quwailid MM, 2004, MAMM GENOME, V15, P585, DOI 10.1007/s00335-004-2379-z; Rampoldi L, 2011, KIDNEY INT, V80, P338, DOI 10.1038/ki.2011.134; Rodriguez MM, 2004, PEDIATR DEVEL PATHOL, V7, P17, DOI 10.1007/s10024-003-3029-2; Rohatgi R, 2010, CURR OPIN NEPHROL HY, V19, P65, DOI 10.1097/MNH.0b013e32833327f3; Sakamoto N, 2001, HUM GENET, V108, P279, DOI 10.1007/s004390100477; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Tzur S, 2010, HUM GENET, V128, P345, DOI 10.1007/s00439-010-0861-0; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; WU XW, 1994, P NATL ACAD SCI USA, V91, P742, DOI 10.1073/pnas.91.2.742; Zarbalis K, 2007, P NATL ACAD SCI USA, V104, P14002, DOI 10.1073/pnas.0702618104	33	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45217	10.1371/journal.pone.0045217	http://dx.doi.org/10.1371/journal.pone.0045217			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024809	Green Published, gold, Green Accepted			2022-12-27	WOS:000308860100067
J	Potvin, J; Goldbogen, JA; Shadwick, RE				Potvin, Jean; Goldbogen, Jeremy A.; Shadwick, Robert E.			Metabolic Expenditures of Lunge Feeding Rorquals Across Scale: Implications for the Evolution of Filter Feeding and the Limits to Maximum Body Size	PLOS ONE			English	Article							FIN WHALES; BALAENOPTERA-PHYSALUS; ENERGY-EXPENDITURE; AQUATIC LOCOMOTION; HUMPBACK WHALES; PLASMA LACTATE; BOWHEAD WHALE; MINKE WHALES; PERFORMANCE; BEHAVIOR	Bulk-filter feeding is an energetically efficient strategy for resource acquisition and assimilation, and facilitates the maintenance of extreme body size as exemplified by baleen whales (Mysticeti) and multiple lineages of bony and cartilaginous fishes. Among mysticetes, rorqual whales (Balaenopteridae) exhibit an intermittent ram filter feeding mode, lunge feeding, which requires the abandonment of body-streamlining in favor of a high-drag, mouth-open configuration aimed at engulfing a very large amount of prey-laden water. Particularly while lunge feeding on krill (the most widespread prey preference among rorquals), the effort required during engulfment involve short bouts of high-intensity muscle activity that demand high metabolic output. We used computational modeling together with morphological and kinematic data on humpback (Megaptera noveaangliae), fin (Balaenoptera physalus), blue (Balaenoptera musculus) and minke (Balaenoptera acutorostrata) whales to estimate engulfment power output in comparison with standard metrics of metabolic rate. The simulations reveal that engulfment metabolism increases across the full body size of the larger rorqual species to nearly 50 times the basal metabolic rate of terrestrial mammals of the same body mass. Moreover, they suggest that the metabolism of the largest body sizes runs with significant oxygen deficits during mouth opening, namely, 20% over maximum (V) over dot O(2)at the size of the largest blue whales, thus requiring significant contributions from anaerobic catabolism during a lunge and significant recovery after a lunge. Our analyses show that engulfment metabolism is also significantly lower for smaller adults, typically one-tenth to one-half (V) over dot O-2 vertical bar max. These results not only point to a physiological limit on maximum body size in this lineage, but also have major implications for the ontogeny of extant rorquals as well as the evolutionary pathways used by ancestral toothed whales to transition from hunting individual prey items to filter feeding on prey aggregations.	[Potvin, Jean] St Louis Univ, Dept Phys, St Louis, MO 63103 USA; [Goldbogen, Jeremy A.] Cascadia Res Collect, Olympia, WA USA; [Shadwick, Robert E.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada	Saint Louis University; University of British Columbia	Potvin, J (corresponding author), St Louis Univ, Dept Phys, St Louis, MO 63103 USA.	potvinj@slu.edu	Goldbogen, Jeremy A./H-4287-2019	Goldbogen, Jeremy A./0000-0002-4170-7294	United States Navy; Office of Naval Research; Natural Sciences and Engineering Research Council of Canada (NSERC)	United States Navy(United States Department of Defense); Office of Naval Research(Office of Naval Research); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	J. Goldbogen was supported by funding from the United States Navy and Office of Naval Research awarded to J. Calambokidis and Cascadia Research Collective. R. Shadwick was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlborn B. K., 2004, ZOOLOGICAL PHYS; Ahlborn BK, 2009, CAN J ZOOL, V87, P124, DOI 10.1139/Z08-144; Alexander RM, 2005, J EXP BIOL, V208, P1645, DOI 10.1242/jeb.01484; Alexander RM, 1998, PALAEONTOLOGY, V41, P1231; Alexander RM., 2003, PRINCIPLES ANIMAL LO; [Anonymous], 1999, REV DOLPHIN HYDRODYN; Arnold PW, 2005, MEM QUEENSL MUS; Ash C. E., 1953, Norsk Hvalfangsttidende Sandefjord, V42, P387; Bailey Helen, 2010, Endangered Species Research, V10, P93, DOI 10.3354/esr00239; Batchelor G.K., 2000, INTRO FLUID DYNAMICS, DOI DOI 10.1017/CBO9780511800955; Biewener AA, 2005, J EXP BIOL, V208, P1665, DOI 10.1242/jeb.01520; BLIX AS, 1995, ACTA PHYSIOL SCAND, V153, P61, DOI 10.1111/j.1748-1716.1995.tb09834.x; Bohonak A. J., 2004, RMA SOFTWARE REDUCED; BOSE N, 1989, PROC R SOC SER B-BIO, V237, P175, DOI 10.1098/rspb.1989.0043; Boyd IL, 2002, MARINE MAMMAL BIOLOGY: AN EVOLUTIONARY APPROACH, P247; Brodie Paul F., 2001, P345; BRODIE PF, 1993, CAN J ZOOL, V71, P2546, DOI 10.1139/z93-348; Cochran BC, 1991, EXPT INVESTIGATION A, P171; Costa Daniel P., 1999, P176; Croll DA, 2001, COMP BIOCHEM PHYS A, V129, P797, DOI 10.1016/S1095-6433(01)00348-8; Croll DA, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P202; DANIEL TL, 1984, AM ZOOL, V24, P121; DANIEL TL, 1985, J EXP BIOL, V119, P149; DANIEL TL, 1989, J EXP BIOL, V143, P245; Demere TA, 2008, SYST BIOL, V57, P15, DOI 10.1080/10635150701884632; Domenici P, 2001, COMP BIOCHEM PHYS A, V131, P169, DOI 10.1016/S1095-6433(01)00465-2; Friedlaender AS, 2009, MAR ECOL PROG SER, V395, P91, DOI 10.3354/meps08003; Friedlaender AS, 2009, MAR MAMMAL SCI, V25, P402, DOI 10.1111/j.1748-7692.2008.00263.x; Goldbogen JA, 2011, J EXP BIOL, V214, P131, DOI 10.1242/jeb.048157; Goldbogen JA, 2006, J EXP BIOL, V209, P1231, DOI 10.1242/jeb.02135; Goldbogen JA, 2008, J EXP BIOL, V211, P3712, DOI 10.1242/jeb.023366; Goldbogen JA, 2007, MAR ECOL PROG SER, V349, P289, DOI 10.3354/meps07066; Goldbogen JA, 2012, FUNCT ECOL, V26, P216, DOI 10.1111/j.1365-2435.2011.01905.x; Goldbogen JA, 2011, INTEGR COMP BIOL, V51, pE193; Goldbogen JA, 2010, AM SCI, V98, P124, DOI 10.1511/2010.83.124; Goldbogen JA, 2010, P R SOC B, V277, P861, DOI 10.1098/rspb.2009.1680; Higham TE, 2007, INTEGR COMP BIOL, V47, P82, DOI 10.1093/icb/icm021; Hill RW, 2008, ANIMAL PHYSL; Kanatous SB, 2002, J EXP BIOL, V205, P3601; KERMACK KA, 1948, J EXP BIOL, V25, P237; KLEIBER M, 1961, Annu Rev Physiol, V23, P5; Kleiber M., 1975, FIRE LIFE INTRO ANIM; LAMBERTSEN R, 1995, J MAMMAL, V76, P877, DOI 10.2307/1382758; Lambertsen RH, 2005, J MAMMAL, V86, P342, DOI 10.1644/BER-123.1; LAMBERTSEN RH, 1983, J MAMMAL, V64, P76, DOI 10.2307/1380752; LOCKYER C, 1986, MAR MAMMAL SCI, V2, P169, DOI 10.1111/j.1748-7692.1986.tb00039.x; Lockyer C, 1981, GEN PAPERS LARGE CET, V3, P379; Lockyer C., 1976, ICES J MAR SCI, V36, P259, DOI DOI 10.1093/ICESJMS/36.3.259; Lockyer C, 2007, J MAR BIOL ASSOC UK, V87, P1035, DOI 10.1017/S0025315407054720; Macha JM, 1993, SIMPLE APPROXIMATE M, V1993; Mackintosh N. A., 1929, Discovery Reports Cambridge, V1, P257; Mackintosh N. A., 1942, Discovery Reports Cambridge, V22, P197; Matthews L. H, 1937, DISCOVERY REP, V22, P197; McNab BK, 2009, P NATL ACAD SCI USA, V106, P12184, DOI 10.1073/pnas.0904000106; Munk MM, 1924, SOME TABLES FACTOR A, P197; Nemoto T., 1970, P241; Nishiwaki M., 1951, Scientific Reports of the Whales Research Institute Tokyo, VNo. 5, P91; Nowacek D.P., 2011, PLOS ONE, V6; ORTON LS, 1987, CAN J ZOOL, V65, P2898, DOI 10.1139/z87-440; Parr WCH, 2012, J THEOR BIOL, V301, P1, DOI 10.1016/j.jtbi.2012.01.030; Pennycuick C. J., 1992, NEWTON RULES BIOL; Perrine D, 2009, NATL GEOGR, V216, P65; PERRINE D, 2009, NATL GEOGR, V216, P70; PIVORUNAS A, 1977, J MORPHOL, V151, P299, DOI 10.1002/jmor.1051510207; Potvin J, 2010, J THEOR BIOL, V267, P437, DOI 10.1016/j.jtbi.2010.08.026; Potvin J, 2009, J R SOC INTERFACE, V6, P1005, DOI 10.1098/rsif.2008.0492; Pyenson ND, 2012, NATURE, V485, P498, DOI 10.1038/nature11135; Pyenson ND, 2011, J MAMM EVOL, V18, P269, DOI 10.1007/s10914-011-9170-1; Quiring Daniel P., 1943, JOUR MAMMAL, V24, P39, DOI 10.2307/1374778; Sarpkaya T., 1981, MECH WAVE FORCES OFF, DOI 10.1115/1.3162189; Sato K, 2007, P R SOC B, V274, P471, DOI 10.1098/rspb.2006.0005; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Schulte H. W., 1916, MEMOIRS AM MUSEUM NA, V1, P389; Shaffer SA, 1997, J EXP BIOL, V200, P3091; Sigurjonsson Johann, 1997, Journal of Northwest Atlantic Fishery Science, V22, P271; Simon M, 2009, P ROYAL SOC B; Sousa-Lima RS, 2010, MAR MAMMAL SCI, V26, P977, DOI 10.1111/j.1748-7692.2010.00373.x; STRICKLAND JH, 1990, J AIRCRAFT, V27, P501, DOI 10.2514/3.25311; Tuckerman, 1925, INERTIA FACTORS ELLI; Van Wassenbergh S, 2009, J R SOC INTERFACE, V6, P149, DOI 10.1098/rsif.2008.0311; Vikingsson G., 1988, REP INT WHAL COMMN, V38, P323; Vogel S, 2008, INTEGR COMP BIOL, V48, P702, DOI 10.1093/icb/icn014; Ware C, 2011, MAR MAMMAL SCI, V27, P587, DOI 10.1111/j.1748-7692.2010.00427.x; Watanabe YY, 2011, J ANIM ECOL, V80, P57, DOI 10.1111/j.1365-2656.2010.01760.x; Watkins WA, 1996, MAR MAMMAL SCI, V12, P564; Weibel ER, 2005, J EXP BIOL, V208, P1635, DOI 10.1242/jeb.01548; Werth AJ, 2004, J EXP BIOL, V207, P3569, DOI 10.1242/jeb.01202; Werth AJ., 2000, FEEDING FORM FUNCTIO, P475, DOI [10.1016/B978-012632590-4/50017-4, DOI 10.1016/B978-012632590-4/50017-4]; Werth AJ, 2007, ANAT REC, V290, P546, DOI 10.1002/ar.20538; Werth Alexander J., 2001, Bulletin of the Museum of Comparative Zoology, V156, P189; Wiedenmann J, 2011, ECOL MODEL, V222, P3366, DOI 10.1016/j.ecolmodel.2011.07.013; Wiley D, 2011, BEHAVIOUR, V148, P575, DOI 10.1163/000579511X570893; Williams TM, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P191; WILLIAMS TM, 1989, J COMP PHYSIOL A, V164, P815, DOI 10.1007/BF00616753; Williams TM, 2004, INT CONGR SER, V1275, P351, DOI 10.1016/j.ics.2004.08.069; Williams TM, 1999, PHILOS T R SOC B, V354, P193, DOI 10.1098/rstb.1999.0371; WILLIAMS TM, 1993, J EXP BIOL, V179, P31; Wilson JF., 2003, DYNAMICS OFFSHORE ST; Woodward BL, 2006, J MORPHOL, V267, P1284, DOI 10.1002/jmor.10474	99	64	64	1	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44854	10.1371/journal.pone.0044854	http://dx.doi.org/10.1371/journal.pone.0044854			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024769	Green Published, gold, Green Submitted			2022-12-27	WOS:000308860100027
J	Rudnicki, M; Perco, P; Neuwirt, H; Noppert, SJ; Leierer, J; Sunzenauer, J; Eder, S; Zoja, C; Eller, K; Rosenkranz, AR; Muller, GA; Mayer, B; Mayer, G				Rudnicki, Michael; Perco, Paul; Neuwirt, Hannes; Noppert, Susie-Jane; Leierer, Johannes; Sunzenauer, Judith; Eder, Susanne; Zoja, Carlamaria; Eller, Kathrin; Rosenkranz, Alexander R.; Mueller, Gerhard A.; Mayer, Bernd; Mayer, Gert			Increased Renal Versican Expression Is Associated with Progression of Chronic Kidney Disease	PLOS ONE			English	Article							MEMBRANOUS NEPHROPATHY; CELL-PROLIFERATION; PROSTATE-CANCER; P-SELECTIN; BINDING; GROWTH; GLOMERULONEPHRITIS; PROTEOGLYCAN; ACCUMULATION; PROTEINURIA	Novel prognostic markers for progression of kidney disease are needed to distinguish patients who might benefit from a more aggressive nephroprotective therapy. Expression of the proteoglycan versican was evaluated in renal transcriptomics profiles and in an independent set of 74 renal biopsies. Versican levels were correlated to histologic damage scores and to renal outcome, and versican expression and regulation was evaluated in vitro. In transcriptomics profiles of renal tissue versican was positively correlated with (i) histological parameters in kidney biopsies, (ii) progressive decline of renal function in proteinuric kidney diseases, and (iii) impaired renal function and histology scores in diabetic nephropathy. In an independent cohort of 74 biopsies of glomerular diseases renal RNA levels of versican isoforms V0 and V1, but not V2 and V3 correlated significantly with creatinine after a mean follow up time of 53 months. Versican isoforms V0 and V1 together with serum creatinine at time of biopsy and the degree of glomerulosclerosis predicted 20% and 24% of the variability of creatinine at follow up, which was significantly more than serum creatinine and histological parameters alone (16%). However, when patients with acute kidney failure at time of biopsy (n = 5) were excluded, the additive predictive value of versican V1 was only marginally higher (35%) than creatinine and glomerulosclerosis alone (34%). Versican isoforms V0 and V1 were primarily expressed in vitro in proximal tubule cells and in fibroblasts. The results in humans were confirmed in three rodent models of kidney disease, in which renal versican expression was significantly upregulated as compared to corresponding controls. These data show for the first time an association of renal versican isoform V0 and V1 expression with progressive renal disease.	[Rudnicki, Michael; Neuwirt, Hannes; Noppert, Susie-Jane; Leierer, Johannes; Sunzenauer, Judith; Eder, Susanne; Eller, Kathrin; Rosenkranz, Alexander R.; Mayer, Gert] Med Univ Innsbruck, Deptartment Internal Med Nephrol & Hypertens 5, Innsbruck, Austria; [Perco, Paul; Mayer, Bernd] Emergentec Biodev GmbH, Vienna, Austria; [Zoja, Carlamaria] Ctr Anna Maria Astori, Mario Negri Inst Pharmacol Res, Bergamo, Italy; [Eller, Kathrin; Rosenkranz, Alexander R.] Med Univ Graz, Deptartment Internal Med, Clin Div Nephrol & Hemodialysis, Graz, Austria; [Mueller, Gerhard A.] Univ Gottingen, Dept Med Nephrol & Rheumatol, Gottingen, Germany	Medical University of Innsbruck; Emergentec Biodevelopment GmbH; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Medical University of Graz; University of Gottingen	Rudnicki, M (corresponding author), Med Univ Innsbruck, Deptartment Internal Med Nephrol & Hypertens 5, Innsbruck, Austria.	michael.rudnicki@i-med.ac.at	Perco, Paul/U-2489-2019; Neuwirt, Hannes/AAF-1090-2019; zoja, carlamaria/ABF-5896-2020; Rudnicki, Michael/D-5288-2013	Perco, Paul/0000-0003-2087-5691; zoja, carlamaria/0000-0003-2507-8894; Neuwirt, Hannes/0000-0003-1064-0098; Leierer, Johannes/0000-0002-7884-9827; Mayer, Gert/0000-0002-5039-543X; Eller, Kathrin/0000-0002-6214-5008	European Community's Seventh Framework Programme (FP7) [241544]	European Community's Seventh Framework Programme (FP7)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under the grant agreement 241544 (SysKid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellezza I, 2006, AM J PATHOL, V169, P2199, DOI 10.2353/ajpath.2006.060171; BodeLesniewska B, 1996, J HISTOCHEM CYTOCHEM, V44, P303, DOI 10.1177/44.4.8601689; DAMICO G, 1992, AM J KIDNEY DIS, V20, P315, DOI 10.1016/S0272-6386(12)70293-7; Dours-Zimmermann MT, 2009, J NEUROSCI, V29, P7731, DOI 10.1523/JNEUROSCI.4158-08.2009; DOURSZIMMERMANN MT, 1994, J BIOL CHEM, V269, P32992; Einecke G, 2010, J CLIN INVEST, V120, P1862, DOI 10.1172/JCI41789; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Henger A, 2004, KIDNEY INT, V65, P904, DOI 10.1111/j.1523-1755.2004.00499.x; Hirose J, 2001, J BIOL CHEM, V276, P5228, DOI 10.1074/jbc.M007542200; Hladunewich MA, 2009, CLIN J AM SOC NEPHRO, V4, P1417, DOI 10.2215/CJN.01330209; Kawashima H, 2000, J BIOL CHEM, V275, P35448, DOI 10.1074/jbc.M003387200; KLOCKER H, 1992, AM J HUM GENET, V50, P1318; Kogan I, 2006, CANCER RES, V66, P3531, DOI 10.1158/0008-5472.CAN-05-2183; Kronenberg F, 2009, NAT REV NEPHROL, V5, P677, DOI 10.1038/nrneph.2009.173; Massoner P, 2008, PROSTATE, V68, P1165, DOI 10.1002/pros.20785; Melk A, 2005, KIDNEY INT, V68, P2667, DOI 10.1111/j.1523-1755.2005.00738.x; Meyer TW, 2003, KIDNEY INT, V63, P774, DOI 10.1046/j.1523-1755.2003.00795.x; Miquel-Serra L, 2006, LAB INVEST, V86, P889, DOI 10.1038/labinvest.3700449; Nikitovic D, 2006, IUBMB LIFE, V58, P47, DOI 10.1080/15216540500531713; Perco P, 2009, TRANSPLANTATION, V87, P290, DOI 10.1097/TP.0b013e318191b4c0; Reich HN, 2007, J AM SOC NEPHROL, V18, P3177, DOI 10.1681/ASN.2007050526; REMUZZI G, 1985, KIDNEY INT, V28, P21, DOI 10.1038/ki.1985.113; Ricciardelli C, 2002, CLIN CANCER RES, V8, P1054; Ricciardelli C, 1998, CLIN CANCER RES, V4, P963; Rosenkranz AR, 1999, J CLIN INVEST, V103, P649, DOI 10.1172/JCI5183; Rudnicki M, 2009, LAB INVEST, V89, P337, DOI 10.1038/labinvest.2008.158; Sakko AJ, 2001, CANCER RES, V61, P926; Schmid H, 2006, DIABETES, V55, P2993, DOI 10.2337/db06-0477; Schuttert JB, 2003, PFLUG ARCH EUR J PHY, V446, P387, DOI 10.1007/s00424-003-1026-y; Sheng W, 2006, MOL BIOL CELL, V17, P2009, DOI 10.1091/mbc.E05-10-0951; Sheng W, 2005, MOL BIOL CELL, V16, P1330, DOI 10.1091/mbc.e04-04-0295; Theocharis AD, 2008, CONNECT TISSUE RES, V49, P230, DOI 10.1080/03008200802147571; True LD, 2009, PROSTATE, V69, P149, DOI 10.1002/pros.20861; Wight TN, 2004, CIRC RES, V94, P1158, DOI 10.1161/01.RES.0000126921.29919.51; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; Zoja C, 2002, J AM SOC NEPHROL, V13, P2898, DOI 10.1097/01.ASN.0000034912.55186.EC; Zoja C, 2010, AM J PHYSIOL-RENAL, V299, pF1203, DOI 10.1152/ajprenal.00045.2010	37	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44891	10.1371/journal.pone.0044891	http://dx.doi.org/10.1371/journal.pone.0044891			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024773	Green Published, Green Submitted, gold			2022-12-27	WOS:000308860100031
J	Singh, NP; Singh, UP; Guan, HB; Nagarkatti, P; Nagarkatti, M				Singh, Narendra P.; Singh, Udai P.; Guan, Hongbing; Nagarkatti, Prakash; Nagarkatti, Mitzi			Prenatal Exposure to TCDD Triggers Significant Modulation of microRNA Expression Profile in the Thymus That Affects Consequent Gene Expression	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; NF-KAPPA-B; 24-WEEK-OLD SNF1 MICE; T-CELLS; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; AH RECEPTOR; DOWN-REGULATION; CANCER-CELLS; FAS LIGAND; ESTROGEN-RECEPTOR	Background: MicroRNAs (miRs) are a class of small RNAs that regulate gene expression. There are over 700 miRs encoded in the mouse genome and modulate most of the cellular pathways and functions by controlling gene expression. However, there is not much known about the pathophysiological role of miRs. TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin), an environmental contaminant is well known to induce severe toxicity (acute and chronic) with long-term effects. Also, in utero exposure of fetus to TCDD has been shown to cause thymic atrophy and alterations in T cell differentiation. It is also relevant to understand "the fetal basis of adult disease'' hypothesis, which proposes that prenatal exposure to certain forms of nutritional and environmental stress can cause increased susceptibility to clinical disorders later in life. In the current study, therefore, we investigated the effects of prenatal exposure to TCDD on miR profile in fetal thymocytes and searched for their possible role in causing thymic atrophy and alterations in the expression of apoptotic genes. Methodology/Principal Findings: miR arrays of fetal thymocytes post exposure to TCDD and vehicle were performed. Of the 608 mouse miRs screened, 78 miRs were altered more than 1.5 fold and 28 miRs were changed more than 2 fold in fetal thymocytes post-TCDD exposure when compared to vehicle controls. We validated the expression of several of the miRs using RT-PCR. Furthermore, several of the miRs that were downregulated contained highly complementary sequence to the 3'-UTR region of AhR, CYP1A1, Fas and FasL. Also, the Ingenuity Pathway Analysis software and database was used to analyze the 78 miRs that exhibited significant expression changes and revealed that as many as 15 pathways may be affected. Conclusions/Significance: These studies revealed that TCDD-mediated alterations in miR expression may be involved in the regulation of its toxicity including cancer, hepatic injury, apoptosis, and cellular development.	[Singh, Narendra P.; Singh, Udai P.; Guan, Hongbing; Nagarkatti, Prakash; Nagarkatti, Mitzi] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Singh, NP (corresponding author), Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	mnagark@uscmed.sc.edu		Nagarkatti, Prakash/0000-0003-2663-0759; Singh, Udai/0000-0002-7048-4325	NIH grants [R01 ES09098, P01AT003961, R01AT006888, R01ES019313, R01MH094755]; VA Merit Award [1I01BX001357]; National Center for Complementary & Integrative Health [P01AT003961, R01AT006888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019313, R01ES009098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094755] Funding Source: NIH RePORTER	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported in part by NIH grants R01 ES09098, P01AT003961, R01AT006888, R01ES019313, R01MH094755 and VA Merit Award 1I01BX001357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpiainen S, 2005, MOL PHARMACOL, V67, P1325, DOI 10.1124/mol.104.008078; Avissar-Whiting M, 2010, REPROD TOXICOL, V29, P401, DOI 10.1016/j.reprotox.2010.04.004; Bandi N, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-55; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; BERTAZZI P A, 1989, Medicina del Lavoro, V80, P316; BIHRER V, 2011, AM J GASTROENTEROL; BLAYLOCK BL, 1992, TOXICOL APPL PHARM, V112, P207, DOI 10.1016/0041-008X(92)90189-Y; Bock KW, 2006, BIOCHEM PHARMACOL, V72, P393, DOI 10.1016/j.bcp.2006.01.017; Boverhof DR, 2004, MOL PHARMACOL, V66, P1662, DOI 10.1124/mol.104.002915; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Camacho IA, 2005, J IMMUNOL, V175, P90, DOI 10.4049/jimmunol.175.1.90; Camacho IA, 2004, ARCH TOXICOL, V78, P290, DOI 10.1007/s00204-003-0538-8; Camacho IA, 2004, TOXICOL SCI, V78, P96, DOI 10.1093/toxsci/kfh048; Camacho IA, 2002, ARCH TOXICOL, V76, P570, DOI 10.1007/s00204-002-0390-2; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Dearstyne EA, 2002, TOXICOLOGY, V170, P139, DOI 10.1016/S0300-483X(01)00542-X; Denison MS, 1998, B ENVIRON CONTAM TOX, V61, P557, DOI 10.1007/PL00002973; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Dietert RR, 2008, HUM EXP TOXICOL, V27, P129, DOI 10.1177/0960327108090753; Dong W, 2001, NEUROSCI LETT, V303, P169, DOI 10.1016/S0304-3940(01)01743-8; DURRIN LK, 1987, J CELL BIOCHEM, V35, P153, DOI 10.1002/jcb.240350208; ESSER C, 1994, INT ARCH ALLERGY IMM, V104, P126, DOI 10.1159/000236719; Faith R E, 1979, Ann N Y Acad Sci, V320, P564, DOI 10.1111/j.1749-6632.1979.tb13177.x; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Fisher MT, 2005, MOL PHARMACOL, V67, P327, DOI 10.1124/mol.104.005868; FRAZIER DE, 1994, BIOCHEM PHARMACOL, V47, P2039, DOI 10.1016/0006-2952(94)90079-5; Fukushima Tamio, 2007, Journal of Toxicological Sciences, V32, P401, DOI 10.2131/jts.32.401; Garcia AI, 2011, EMBO MOL MED, V3, P279, DOI 10.1002/emmm.201100136; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Gonzalez FJ, 1998, DRUG METAB DISPOS, V26, P1194; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Gu WY, 2011, ARCH VIROL, V156, P1161, DOI 10.1007/s00705-011-0974-3; Halappanavar S, 2011, TOXICOLOGY, V285, P133, DOI 10.1016/j.tox.2011.04.011; HOLSAPPLE MP, 1991, ANNU REV PHARMACOL, V31, P73; Izzotti A, 2009, FASEB J, V23, P806, DOI 10.1096/fj.08-121384; Jenkins S, 2007, REPROD TOXICOL, V23, P391, DOI 10.1016/j.reprotox.2006.10.004; Kamath AB, 1999, TOXICOL APPL PHARM, V160, P141, DOI 10.1006/taap.1999.8753; Kamath AB, 1998, TOXICOL APPL PHARM, V150, P117, DOI 10.1006/taap.1998.8390; Kamath AB, 1997, TOXICOL APPL PHARM, V142, P367, DOI 10.1006/taap.1996.8049; Kerkvliet NI, 2002, INT IMMUNOPHARMACOL, V2, P277, DOI 10.1016/S1567-5769(01)00179-5; Khudayberdiev Sharof, 2009, Commun Integr Biol, V2, P411; Kim S, 2008, J BIOL CHEM, V283, P18158, DOI 10.1074/jbc.M800186200; Kiyohara C, 1998, PHARMACOGENETICS, V8, P315, DOI 10.1097/00008571-199808000-00005; Komagata S, 2009, MOL PHARMACOL, V76, P702, DOI 10.1124/mol.109.056986; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Krupa A, 2010, J AM SOC NEPHROL, V21, P438, DOI 10.1681/ASN.2009050530; Krutovskikh VA, 2010, BIOESSAYS, V32, P894, DOI 10.1002/bies.201000040; LEDER A, 1990, P NATL ACAD SCI USA, V87, P9178, DOI 10.1073/pnas.87.23.9178; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Ma Li ping, 2011, Beijing Da Xue Xue Bao Yi Xue Ban, V43, P129; Maccani MA, 2010, EPIGENETICS-US, V5, P583, DOI 10.4161/epi.5.7.12762; Malik AI, 2012, ENV MOL MUTAGEN; Marcucci G, 2011, BLOOD, V117, P1121, DOI 10.1182/blood-2010-09-191312; Mardin W, 2009, ANN SURG ONCOL, V16, P3183, DOI 10.1245/s10434-009-0623-1; Marlowe JL, 2005, J CELL BIOCHEM, V96, P1174, DOI 10.1002/jcb.20656; Mees ST, 2009, ANN SURG ONCOL, V16, P2339, DOI 10.1245/s10434-009-0531-4; Mimura J, 2003, BBA-GEN SUBJECTS, V1619, P263, DOI 10.1016/S0304-4165(02)00485-3; Moffat ID, 2007, TOXICOL SCI, V99, P470, DOI 10.1093/toxsci/kfm189; Mustafa A, 2009, TOXICOL SCI, V112, P133, DOI 10.1093/toxsci/kfp177; Mustafa A, 2009, BIRTH DEFECTS RES A, V85, P828, DOI 10.1002/bdra.20603; Nakamura Y, 2011, MOL CELL BIOL, V31, P3019, DOI 10.1128/MCB.05178-11; Nakano H, 2010, INT J CANCER, V127, P1072, DOI 10.1002/ijc.25143; NEBERT DW, 1993, ANN NY ACAD SCI, V685, P624, DOI 10.1111/j.1749-6632.1993.tb35928.x; Noonan EJ, 2010, ONCOTARGET, V1, P349, DOI 10.18632/oncotarget.167; OKEY AB, 1994, TOXICOL LETT, V70, P1, DOI 10.1016/0378-4274(94)90139-2; OLNES MJ, 1994, EXP CLIN IMMUNOGENET, V11, P102; Ostling P, 2011, CANCER RES, V71, P1956, DOI 10.1158/0008-5472.CAN-10-2421; Pan YZ, 2009, DRUG METAB DISPOS, V37, P2112, DOI 10.1124/dmd.109.027680; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Phillips DIW, 2006, LUPUS, V15, P794, DOI 10.1177/0961203306069354; Pogribny IP, 2007, MUTAT RES-FUND MOL M, V619, P30, DOI 10.1016/j.mrfmmm.2006.12.006; Qin XM, 2010, P NATL ACAD SCI USA, V107, P3240, DOI 10.1073/pnas.0914882107; Robertus JL, 2009, MODERN PATHOL, V22, P547, DOI 10.1038/modpathol.2009.10; Sassen S, 2008, VIRCHOWS ARCH, V452, P1, DOI 10.1007/s00428-007-0532-2; Schickel R, 2010, MOL CELL, V38, P908, DOI 10.1016/j.molcel.2010.05.018; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Singh NP, 2008, MOL PHARMACOL, V73, P1722, DOI 10.1124/mol.107.043406; Singh NP, 2007, MOL PHARMACOL, V72, P1508, DOI 10.1124/mol.107.038984; Singh NP, 2007, MOL PHARMACOL, V71, P145, DOI 10.1124/mol.106.028365; Singh NP, 2011, MOL NUTR FOOD RES, V55, P209, DOI 10.1002/mnfr.201000206; Sulentic CEW, 1998, MOL PHARMACOL, V53, P623, DOI 10.1124/mol.53.4.623; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takemoto K, 2004, ARCH TOXICOL, V78, P309, DOI 10.1007/s00204-004-0550-7; Tian Y, 1999, J BIOL CHEM, V274, P510, DOI 10.1074/jbc.274.1.510; Tijet N, 2006, MOL PHARMACOL, V69, P140, DOI 10.1124/mol.105.018705; Tsuchiya Y, 2006, CANCER RES, V66, P9090, DOI 10.1158/0008-5472.CAN-06-1403; Uno S, 2004, TOXICOL APPL PHARM, V196, P410, DOI 10.1016/j.taap.2004.01.014; Viluksela M, 2000, CANCER RES, V60, P6911; Wyde ME, 2004, TOXICOL SCI, V82, P34, DOI 10.1093/toxsci/kfh233; Yamamoto Y, 2009, BIOMARKERS, V14, P529, DOI 10.3109/13547500903150771; Yoshioka W, 2011, TOXICOL SCI; Zhang JJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-211; Zhang XX, 2011, J BIOL CHEM, V286, P1429, DOI 10.1074/jbc.M110.146530; Zhang XJ, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-46; Zhu H, 2008, BIOCHEM PHARMACOL, V76, P582, DOI 10.1016/j.bcp.2008.06.007	100	50	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45054	10.1371/journal.pone.0045054	http://dx.doi.org/10.1371/journal.pone.0045054			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024791	Green Published, Green Submitted, gold			2022-12-27	WOS:000308860100049
J	Farrelly, MC; Nonnemaker, JM; Watson, KA				Farrelly, Matthew C.; Nonnemaker, James M.; Watson, Kimberly A.			The Consequences of High Cigarette Excise Taxes for Low-Income Smokers	PLOS ONE			English	Article							SMOKING; PRICES; INCREASES; POOR; DEMAND	Background: To illustrate the burden of high cigarette excise taxes on low-income smokers. Methodology/Principal Findings: Using data from the New York and national Adult Tobacco Surveys from 2010-2011, we estimated how smoking prevalence, daily cigarette consumption, and share of annual income spent on cigarettes vary by annual income (less than $ 30,000; $ 30,000-$ 59,999; and more than $ 60,000). The 2010-2011 sample includes 7,536 adults and 1,294 smokers from New York and 3,777 adults and 748 smokers nationally. Overall, smoking prevalence is lower in New York (16.1%) than nationally (22.2%) and is strongly associated with income in New York and nationally (P<.001). Smoking prevalence ranges from 12.2% to 33.7% nationally and from 10.1% to 24.3% from the highest to lowest income group. In 2010-2011, the lowest income group spent 23.6% of annual household income on cigarettes in New York (up from 11.6% in 2003-2004) and 14.2% nationally. Daily cigarette consumption is not related to income. Conclusions/Significance: Although high cigarette taxes are an effective method for reducing cigarette smoking, they can impose a significant financial burden on low-income smokers.	[Farrelly, Matthew C.; Nonnemaker, James M.; Watson, Kimberly A.] Res Triangle Inst RTI Int, Res Triangle Pk, NC USA	Research Triangle Institute	Farrelly, MC (corresponding author), Res Triangle Inst RTI Int, Res Triangle Pk, NC USA.	mcf@rti.org		nonnemaker, james/0000-0003-1044-7482; Farrelly, Matthew/0000-0002-6035-1596	New York State Department of Health	New York State Department of Health	Funding for the research was provided by the New York State Department of Health, http://www.health.ny.gov/. The funders had no role in the study design, data collection and analysis.	[Anonymous], 2006, TOBACCO CONTROL POLI; Barbeau EM, 2004, AM J PUBLIC HEALTH, V94, P269, DOI 10.2105/AJPH.94.2.269; Borren P, 1992, Health Econ, V1, P245, DOI 10.1002/hec.4730010406; Borren P, 1992, J PUBLIC ECON, V1, P245; Centers for Disease Control and Prevention, 2007, BEST PRACT COMPR TOB; Chaloupka FJ, 2000, HANDB ECON, V17, P1539; Colman GJ, 2008, J POLICY ANAL MANAG, V27, P376, DOI 10.1002/pam.20329; Connelly RT, 2009, APPL ECON, V41, P2255, DOI 10.1080/00036840701222637; Danaei G, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000248; Davis K., 2006, CIGARETTE PURCHASING; DeCicca P., 2010, NATL BUREAU EC RES W; Evans W, 1999, TAX POLICY EC, P1, DOI [10.1086/tpe.13.20061866, DOI 10.1086/TPE.13.20061866]; Farrelly MC, 2008, AM J PUBLIC HEALTH, V98, P582, DOI 10.2105/AJPH.2007.132647; Farrelly MC, 2008, AM J PUBLIC HEALTH, V98, P304, DOI 10.2105/AJPH.2006.106377; Farrelly MC, 2001, SOUTH ECON J, V68, P156, DOI 10.2307/1061518; Farrelly MC, 2003, STATE CIGARETTE EXCI; Franks P, 2007, AM J PUBLIC HEALTH, V97, P1873, DOI 10.2105/AJPH.2006.090134; Gallet CA, 2003, HEALTH ECON, V12, P821, DOI 10.1002/hec.765; Goolsble A, 2010, AM ECON J-ECON POLIC, V2, P131, DOI 10.1257/pol.2.1.131; Gruber J, 2004, STAT TOB CONTR 2010, V88, P1958; Hyland A, 2005, AM J PUBLIC HEALTH, V95, P994, DOI 10.2105/AJPH.2004.057687; Keeler TE, 1996, J HEALTH ECON, V15, P499, DOI 10.1016/S0167-6296(96)00498-5; Merriman D, 2002, APPL ECON LETT, V9, P493, DOI 10.1080/13504850110095468; *RTI INT, 2011, 2011 IND EV REP; RTI International, 2011, 2010 IND EV REP; Siahpush M, 2009, AM J PREV MED, V36, P285, DOI 10.1016/j.amepre.2008.11.013; Singh GK, 2006, INT J EPIDEMIOL, V35, P969, DOI 10.1093/ije/dyl083; TOWNSEND J, 1994, BMJ-BRIT MED J, V309, P923, DOI 10.1136/bmj.309.6959.923; WARNER KE, 1978, J AM STAT ASSOC, V73, P314, DOI 10.2307/2286658; WASSERMAN J, 1991, J HEALTH ECON, V10, P43, DOI 10.1016/0167-6296(91)90016-G	30	59	59	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43838	10.1371/journal.pone.0043838	http://dx.doi.org/10.1371/journal.pone.0043838			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005GJ	22984447	Green Submitted, Green Published, gold			2022-12-27	WOS:000308738500025
J	Kawano, M; Kawaji, H; Grandjean, V; Kiani, J; Rassoulzadegan, M				Kawano, Mitsuoki; Kawaji, Hideya; Grandjean, Valerie; Kiani, Jafar; Rassoulzadegan, Minoo			Novel Small Noncoding RNAs in Mouse Spermatozoa, Zygotes and Early Embryos	PLOS ONE			English	Article							PIWI-INTERACTING RNAS; SPERM; INHERITANCE; MICRORNAS; OOCYTES; SIRNAS; SERVER	The recent discovery of a significant amount of RNA in spermatozoa contradicted the previously held belief that paternal contribution was limited to one copy of the genome. Furthermore, detection of RNA in sperm raised the intriguing question of its possible role in embryonic development. The possibility that RNAs may serve as epigenetic determinants was supported by experiments showing inheritance of epigenetic traits in mice mediated by RNA. We used high-throughput, large-scale sequencing technology to analyze sperm RNA. The RNA sequences generated were diverse in terms of length and included mRNAs, rRNAs, piRNAs, and miRNAs. We studied two small noncoding RNAs enriched in mature sperm, designated sperm RNAs (spR) -12 and -13. They are both encoded in a piRNA locus on chromosome 17, but neither their length (20-21 nt), nor their sequences correspond to known piRNAs or miRNAs. They are resistant to periodate-oxidation-mediated reaction, implying that they undergo terminal post-transcriptional modification. Both were detected in sperm and ovulated unfertilized oocytes, present in one-cell embryos and maintained in preimplantation stages, but not at later differentiation stages. These findings offer a new perspective regarding a possibly important role for gamete-specific small RNAs in early embryogenesis.	[Kawano, Mitsuoki; Kawaji, Hideya] RIKEN Om Sci Ctr, Yokohama, Kanagawa, Japan; [Kawano, Mitsuoki] Hokkaido Univ, Grad Sch Dent Med, Sapporo, Hokkaido, Japan; [Grandjean, Valerie; Kiani, Jafar; Rassoulzadegan, Minoo] Fac Med Nice, INSERM, U636, F-06034 Nice, France; [Grandjean, Valerie; Kiani, Jafar; Rassoulzadegan, Minoo] Univ Nice Sophia Antipolis, Lab Genet Dev Normal & Pathol, Nice, France	RIKEN; Hokkaido University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Kawano, M (corresponding author), Niigata Univ Pharm & Appl Life Sci, Dept Appl Life Sci, Niigata, Japan.	mkawano@nupals.ac.jp	Grandjean, Valerie/O-3935-2016; Kawano, Mitsuoki/GLS-2569-2022; Rassoulzadegan, Minoo/O-7939-2016; Kawaji, Hideya/N-5116-2015; Kawano, Mitsuoki/AAT-7600-2020	Kawano, Mitsuoki/0000-0003-1570-0491; Kawaji, Hideya/0000-0002-0575-0308; Kiani, Jafar/0000-0002-5907-5846; Valerie, GRANDJEAN/0000-0003-1661-7411	RIKEN OSC research grant from MEXT (YH); Ligue Nationale Contre le Cancer; Agence Nationale de la Recherche;  [20770145]	RIKEN OSC research grant from MEXT (YH); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Agence Nationale de la Recherche(French National Research Agency (ANR)); 	The study was supported in part by grants from the RIKEN OSC research grant from MEXT (YH), the Grant-in-Aid for Young Scientists (B) (MK, 20770145), and by grants from Ligue Nationale Contre le Cancer and Agence Nationale de la Recherche (MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanai M, 2006, BIOL REPROD, V75, P877, DOI 10.1095/biolreprod.106.056499; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cheng AG, 2009, OLIGONUCLEOTIDES, V19, P203, DOI 10.1089/oli.2008.0176; Grandjean V, 2009, DEVELOPMENT, V136, P3647, DOI 10.1242/dev.041061; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Kawaji H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-157; Kramer JA, 1997, MOL HUM REPROD, V3, P473, DOI 10.1093/molehr/3.6.473; Krawetz SA, 2005, NAT REV GENET, V6, P633, DOI 10.1038/nrg1654; Krawetz SA, 2011, HUM REPROD, V26, P3401, DOI 10.1093/humrep/der329; Lakshmi SS, 2008, NUCLEIC ACIDS RES, V36, pD173, DOI 10.1093/nar/gkm696; Perry ACF, 1999, SCIENCE, V284, P1180, DOI 10.1126/science.284.5417.1180; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Suh N, 2011, DEVELOPMENT, V138, P1653, DOI 10.1242/dev.056234; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wagner KD, 2008, DEV CELL, V14, P962, DOI 10.1016/j.devcel.2008.03.009; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	22	81	86	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44542	10.1371/journal.pone.0044542	http://dx.doi.org/10.1371/journal.pone.0044542			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984523	Green Published, gold			2022-12-27	WOS:000308738500063
J	Klassen, K; Martineau, AR; Wilkinson, RJ; Cooke, G; Courtney, AP; Hickson, M				Klassen, Karen; Martineau, Adrian R.; Wilkinson, Robert J.; Cooke, Graham; Courtney, Alan P.; Hickson, Mary			The Effect of Tenofovir on Vitamin D Metabolism in HIV-Infected Adults Is Dependent on Sex and Ethnicity	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; PARATHYROID-HORMONE; D DEFICIENCY; TUBULAR DYSFUNCTION; HYPERPARATHYROIDISM; OSTEOPOROSIS; PREVALENCE; PREDICTORS; DIETARY; WOMEN	Background: Tenofovir has been associated with renal phosphate wasting, reduced bone mineral density, and higher parathyroid hormone levels. The aim of this study was to carry out a detailed comparison of the effects of tenofovir versus non-tenofovir use on calcium, phosphate and, vitamin D, parathyroid hormone (PTH), and bone mineral density. Methods: A cohort study of 56 HIV-1 infected adults at a single centre in the UK on stable antiretroviral regimes comparing biochemical and bone mineral density parameters between patients receiving either tenofovir or another nucleoside reverse transcriptase inhibitor. Principal Findings: In the unadjusted analysis, there was no significant difference between the two groups in PTH levels (tenofovir mean 5.9 pmol/L, 95% confidence intervals 5.0 to 6.8, versus non-tenofovir; 5.9, 4.9 to 6.9; p = 0.98). Patients on tenofovir had significantly reduced urinary calcium excretion (median 3.01 mmol/24 hours) compared to non-tenofovir users (4.56; p < 0.0001). Stratification of the analysis by age and ethnicity revealed that non-white men but not women, on tenofovir had higher PTH levels than non-white men not on tenofovir (mean difference 3.1 pmol/L, 95% CI 5.3 to 0.9; p = 0.007). Those patients with optimal 25-hydroxyvitamin D (>75 nmol/L) on tenofovir had higher 1,25-dihydroxyvitamin D [1,25(OH)(2)D] (median 48 pg/mL versus 31; p = 0.012), fractional excretion of phosphate (median 26.1%, versus 14.6; p = 0.025) and lower serum phosphate (median 0.79 mmol/L versus 1.02; p = 0.040) than those not taking tenofovir. Conclusions: The effects of tenofovir on PTH levels were modified by sex and ethnicity in this cohort. Vitamin D status also modified the effects of tenofovir on serum concentrations of 1,25(OH)(2)D and phosphate.	[Klassen, Karen] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Klassen, Karen; Courtney, Alan P.; Hickson, Mary] Imperial Coll Healthcare NHS Trust, London, England; [Martineau, Adrian R.; Wilkinson, Robert J.; Cooke, Graham] Univ London Imperial Coll Sci Technol & Med, Dept Med, London SW7 2AZ, England; [Martineau, Adrian R.] Univ London, Barts & London Med Sch Med & Dent, London, England; [Wilkinson, Robert J.] MRC Natl Inst Med Res, London, England	Queensland University of Technology (QUT); Imperial College London; Imperial College London; University of London; MRC National Institute for Medical Research	Klassen, K (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.	k.klassen@qut.edu.au	Hickson, Mary/D-3672-2011; Martineau, Adrian R/A-3083-2010; Klassen, Karen/I-3812-2012	Hickson, Mary/0000-0001-7996-0095; Klassen, Karen/0000-0001-6739-7610; Cooke, Graham/0000-0001-6475-5056; Wilkinson, Robert/0000-0002-2753-1800	Wellcome Trust [088316]; Medical Research Council [U.1175.02.002.00014.01]; Medical Research Council [MC_U117588499] Funding Source: researchfish; MRC [MC_U117588499] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Imperial College Healthcare Charity, RJW is supported by the Wellcome Trust (088316) and Medical Research Council U.1175.02.002.00014.01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspray TJ, 2005, BONE, V36, P710, DOI 10.1016/j.bone.2005.01.002; Bech A, 2012, HIV MED; Berndt T, 2009, PHYSIOLOGY, V24, P17, DOI 10.1152/physiol.00034.2008; Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb; Burnett SAM, 2006, J BONE MINER RES, V21, P1187, DOI 10.1359/JBMR.060507; Childs KE, 2010, AIDS RES HUM RETROV, V26, P855, DOI 10.1089/aid.2009.0308; Daria P, 2011, AIDS, V25, P1430, DOI 10.1097/QAD.0b013e328349060e; Fausto A, 2006, BONE, V38, P893, DOI 10.1016/j.bone.2005.11.001; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Health Do, 1991, DIETARY REFERENCE VA; Heaney RP, 2003, J AM COLL NUTR, V22, P142, DOI 10.1080/07315724.2003.10719287; Hoare J, 2004, NATL DIET NUTR SURVE; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hypponen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860; Izzedine H, 2009, NAT REV NEPHROL, V5, P564, DOI 10.1038/nrneph.2009.142; Masia M, 2012, AIDS RES HUM RETROV, V28, P242, DOI [10.1089/aid.2011.0052, 10.1089/AID.2011.0052]; Maunsell Z, 2005, CLIN CHEM, V51, P1683, DOI 10.1373/clinchem.2005.052936; MAWER EB, 1990, CLIN CHIM ACTA, V190, P199, DOI 10.1016/0009-8981(90)90174-Q; Mueller NJ, 2010, AIDS, V24, P1127, DOI 10.1097/QAD.0b013e328337b161; NELSON M, 1988, Journal of Human Nutrition and Dietetics, V1, P115, DOI 10.1111/j.1365-277X.1988.tb00443.x; Perrot S, 2009, JCR-J CLIN RHEUMATOL, V15, P72, DOI 10.1097/RHU.0b013e31819c20d8; Prentice A, 2008, BONE, V42, P788, DOI 10.1016/j.bone.2007.11.014; Rodriguez-Novoa S, 2009, CLIN INFECT DIS, V48, pE108, DOI 10.1086/598507; Rosenvinge MM, 2010, JAIDS-J ACQ IMM DEF, V54, P496, DOI 10.1097/QAI.0b013e3181caebaa; Saidenberg-Kermanac'h N, 2011, JOINT BONE SPINE, V78, P306, DOI 10.1016/j.jbspin.2010.11.007; Stellbrink HJ, 2010, CLIN INFECT DIS, V51, P963, DOI 10.1086/656417; van Vonderen MGA, 2009, AIDS, V23, P1367, DOI 10.1097/QAD.0b013e32832c4947; Williams John, 2006, J Infect, V52, pe107, DOI 10.1016/j.jinf.2005.07.014; Woodward CLN, 2009, HIV MED, V10, P482, DOI 10.1111/j.1468-1293.2009.00716.x	29	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44845	10.1371/journal.pone.0044845	http://dx.doi.org/10.1371/journal.pone.0044845			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984574	Green Published, Green Submitted, gold			2022-12-27	WOS:000308738500091
J	Shimura, H; Itoh, K; Sugiyama, A; Ichijo, S; Ichijo, M; Furuya, F; Nakamura, Y; Kitahara, K; Kobayashi, K; Yukawa, Y; Kobayashi, T				Shimura, Hiroki; Itoh, Katsuhiko; Sugiyama, Atsushi; Ichijo, Sayaka; Ichijo, Masashi; Furuya, Fumihiko; Nakamura, Yuji; Kitahara, Ken; Kobayashi, Kazuhiko; Yukawa, Yasuhiro; Kobayashi, Tetsuro			Absorption of Radionuclides from the Fukushima Nuclear Accident by a Novel Algal Strain	PLOS ONE			English	Article							CELL-WALL; CONTAMINATION; STRONTIUM; KELP	Large quantities of radionuclides have leaked from the Fukushima Daiichi Nuclear Power Plant into the surrounding environment. Effective prevention of health hazards resulting from radiation exposure will require the development of efficient and economical methods for decontaminating radioactive wastewater and aquatic ecosystems. Here we describe the accumulation of water-soluble radionuclides released by nuclear reactors by a novel strain of alga. The newly discovered green microalgae, Parachlorella sp. binos (Binos) has a thick alginate-containing extracellular matrix and abundant chloroplasts. When this strain was cultured with radioiodine, a light-dependent uptake of radioiodine was observed. In dark conditions, radioiodine uptake was induced by addition of hydrogen superoxide. High-resolution secondary ion mass spectrometry (SIMS) showed a localization of accumulated iodine in the cytosol. This alga also exhibited highly efficient incorporation of the radioactive isotopes strontium and cesium in a light-independent manner. SIMS analysis showed that strontium was distributed in the extracellular matrix of Binos. Finally we also showed the ability of this strain to accumulate radioactive nuclides from water and soil samples collected from a heavily contaminated area in Fukushima. Our results demonstrate that Binos could be applied to the decontamination of iodine, strontium and cesium radioisotopes, which are most commonly encountered after nuclear reactor accidents.	[Shimura, Hiroki; Yukawa, Yasuhiro] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Environm Med, Chuo Ku, Yamanashi, Japan; [Shimura, Hiroki; Ichijo, Sayaka; Ichijo, Masashi; Furuya, Fumihiko; Kobayashi, Tetsuro] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Internal Med 3, Chuo Ku, Yamanashi, Japan; [Itoh, Katsuhiko] Kitasato Inst, Kitasato Acad Res Org, Dept Business Dev, Sagamihara, Kanagawa, Japan; [Sugiyama, Atsushi; Nakamura, Yuji; Kitahara, Ken] Toho Univ, Sch Med, Dept Pharmacol, Ota Ku, Tokyo, Japan; [Kobayashi, Kazuhiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Global Agr Sci, Bunkyo Ku, Tokyo, Japan; [Yukawa, Yasuhiro] Japan Biomass Corp, Kashiwa, Chiba, Japan	University of Yamanashi; University of Yamanashi; Kitasato University; University of Tokyo	Shimura, H (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Environm Med, Chuo Ku, Yamanashi, Japan.	tetsurou@yamanashi.ac.jp	Kobayashi, Kazuhiko/AAN-7096-2020		Grants-in-Aid for Scientific Research [24651074] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Bolsunovsky A, 2011, J ENV RADIOACT; Brumfiel G, 2011, NATURE, V474, P135, DOI 10.1038/474135a; Colin C, 2003, J BIOL CHEM, V278, P23545, DOI 10.1074/jbc.M300247200; Davis TA, 2003, WATER RES, V37, P4311, DOI 10.1016/S0043-1354(03)00293-8; Endo S, 2012, J ENVIRON RADIOACTIV, V111, P18, DOI 10.1016/j.jenvrad.2011.11.006; Guerquin-Kern JL, 2005, BBA-GEN SUBJECTS, V1724, P228, DOI 10.1016/j.bbagen.2005.05.013; Japan Biomass Corporation, 2011, Japan patent, Patent No. [PCT/JP2009/65025, PCTJP200965025]; Krejci MR, 2011, CHEMSUSCHEM, V4, P470, DOI 10.1002/cssc.201000448; Kupper FC, 2008, P NATL ACAD SCI USA, V105, P6954, DOI 10.1073/pnas.0709959105; Moysich KB, 2002, LANCET ONCOL, V3, P269, DOI 10.1016/S1470-2045(02)00727-1; Nuclear and Industrial Safety Agency, REG EV COND REACT CO; PATTERSON CO, 1973, PLANT PHYSIOL, V51, P104, DOI 10.1104/pp.51.1.104; Peplow M, 2011, NATURE, V471, P562, DOI 10.1038/471562a; Sato I, 2011, J TOXICOL SCI, V36, P829, DOI 10.2131/jts.36.829; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vinichuk MM, 2005, J ENVIRON RADIOACTIV, V78, P77, DOI 10.1016/j.jenvrad.2004.02.008; Yablokov AV, 2009, ANN NY ACAD SCI, V1181, P5, DOI [10.1111/j.1749-6632.2009.04821.x, 10.1111/j.1749-6632.2009.04820.x]; Yamamoto M, 2005, PLANTA, V221, P766, DOI 10.1007/s00425-005-1486-8; Yamamoto M, 2003, J PHYCOL, V39, P172, DOI 10.1046/j.1529-8817.2003.02052.x	19	41	42	4	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44200	10.1371/journal.pone.0044200	http://dx.doi.org/10.1371/journal.pone.0044200			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984475	gold, Green Published, Green Submitted			2022-12-27	WOS:000308738500036
J	Basavaraj, S; Yan, J				Basavaraj, Sidhesh; Yan, Jun			Prepulse Inhibition of Acoustic Startle Reflex as a Function of the Frequency Difference between Prepulse and Background Sounds in Mice	PLOS ONE			English	Article							AUDITORY-CORTEX; RATS; STIMULATION; MODULATION; SYSTEM; BRAIN; DISCRIMINATION; ENVIRONMENTS; INTENSITY; EVOCATION	Background: Prepulse inhibition (PPI) depicts the effects of a weak sound preceding strong acoustic stimulus on acoustic startle response (ASR). Previous studies suggest that PPI is influenced by physical parameters of prepulse sound such as intensity and preceding time. The present study characterizes the impact of prepulse tone frequency on PPI. Methods: Seven female C57BL mice were used in the present study. ASR was induced by a 100 dB SPL white noise burst. After assessing the effect of background sounds (white noise and pure tones) on ASR, PPI was tested by using prepulse pure tones with the background tone of either 10 or 18 kHz. The inhibitory effect was assessed by measuring and analyzing the changes in the first peak-to-peak magnitude, root mean square value, duration and latency of the ASR as the function of frequency difference between prepulse and background tones. Results: Our data showed that ASR magnitude with pure tone background varied with tone frequency and was smaller than that with white noise background. Prepulse tone systematically reduced ASR as the function of the difference in frequency between prepulse and background tone. The 0.5 kHz difference appeared to be a prerequisite for inducing substantial ASR inhibition. The frequency dependence of PPI was similar under either a 10 or 18 kHz background tone. Conclusion: PPI is sensitive to frequency information of the prepulse sound. However, the critical factor is not tone frequency itself, but the frequency difference between the prepulse and background tones.	[Basavaraj, Sidhesh; Yan, Jun] Univ Calgary, Fac Med, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada	University of Calgary	Basavaraj, S (corresponding author), Univ Calgary, Fac Med, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada.	juyan@ucalgary.ca			Canadian Institute of Health Research; Natural Sciences and Engineering Research Council of Canada; Alberta Innovates - Health Solutions	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates - Health Solutions	Funding: 1. The Canadian Institute of Health Research (http://www.cihr.ca/e/193.html), 2. The Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp), 3. The Alberta Innovates - Health Solutions (http://www.aihealthsolutions.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey PJ, 2002, BRIT MED BULL, V63, P135, DOI 10.1093/bmb/63.1.135; BLUMENTHAL TD, 1987, PSYCHOPHYSIOLOGY, V24, P320, DOI 10.1111/j.1469-8986.1987.tb00302.x; BLUMENTHAL TD, 1989, PSYCHOPHYSIOLOGY, V26, P158, DOI 10.1111/j.1469-8986.1989.tb03148.x; Blumenthal TD, 1996, BIOL PSYCHOL, V44, P85, DOI 10.1016/0301-0511(96)05214-3; BLUMENTHAL TD, 1995, PERCEPT PSYCHOPHYS, V57, P487, DOI 10.3758/BF03213074; BRAFF D, 1978, PSYCHOPHYSIOLOGY, V15, P339, DOI 10.1111/j.1469-8986.1978.tb01390.x; BROWN P, 1991, BRAIN, V114, P1891, DOI 10.1093/brain/114.4.1891; BUCKLAND G, 1969, J COMP PHYSIOL PSYCH, V67, P493, DOI 10.1037/h0027307; Carlson S, 2001, HANDBOOK OF MOUSE AUDITORY RESEARCH: FROM BEHAVIOR TO MOLECULAR BIOLOGY, P83; Clause A, 2011, J NEUROSCI METH, V200, P63, DOI 10.1016/j.jneumeth.2011.05.027; Crippa Alessandro, 2010, Open Neuroimag J, V4, P16, DOI 10.2174/1874440001004010016; DAVIS M, 1982, J NEUROSCI, V2, P791; DAWSON ME, 1993, J ABNORM PSYCHOL, V102, P633, DOI 10.1037/0021-843X.102.4.633; Du Y, 2011, J NEUROSCI, V31, P13644, DOI 10.1523/JNEUROSCI.1292-11.2011; Fendt M, 2001, PSYCHOPHARMACOLOGY, V156, P216, DOI 10.1007/s002130100794; GERRARD RL, 1990, J EXP PSYCHOL-ANIM B, V16, P106, DOI 10.1037/0097-7403.16.1.106; HOFFMAN HS, 1963, SCIENCE, V141, P928, DOI 10.1126/science.141.3584.928; HOFFMAN HS, 1964, J COMP PHYSIOL PSYCH, V58, P132, DOI 10.1037/h0045324; HOFFMAN HS, 1980, PSYCHOL REV, V87, P175, DOI 10.1037/0033-295X.87.2.175; HOFFMAN HS, 1968, J ACOUST SOC AM, V43, P269, DOI 10.1121/1.1910776; HOFFMAN HS, 1965, J COMP PHYSIOL PSYCH, V60, P53, DOI 10.1037/h0022325; ISON JR, 1971, J COMP PHYSIOL PSYCH, V75, P435, DOI 10.1037/h0030934; Jennings PD, 1996, PSYCHOPHYSIOLOGY, V33, P148, DOI 10.1111/j.1469-8986.1996.tb02118.x; Koch M, 1997, BEHAV BRAIN RES, V89, P35, DOI 10.1016/S0166-4328(97)02296-1; LANE SJ, 1991, PSYCHOPHYSIOLOGY, V28, P579, DOI 10.1111/j.1469-8986.1991.tb01997.x; Larrauri Jose, 2006, EXS, V98, P245; Lee YL, 1996, J NEUROSCI, V16, P3775; Li L, 2009, NEUROSCI BIOBEHAV R, V33, P1157, DOI 10.1016/j.neubiorev.2009.02.001; Morgane PJ, 2006, NEUROSCI BIOBEHAV R, V30, P119, DOI 10.1016/j.neubiorev.2005.04.020; Paylor R, 1997, PSYCHOPHARMACOLOGY, V132, P169, DOI 10.1007/s002130050333; PINCKNEY LA, 1976, ANIM LEARN BEHAV, V4, P467, DOI 10.3758/BF03214441; Plappert CF, 2004, BEHAV BRAIN RES, V152, P403, DOI 10.1016/j.bbr.2003.10.025; POWELL EW, 1974, BEHAV BIOL, V12, P149, DOI 10.1016/S0091-6773(74)91162-6; REIJMERS LGJE, 1994, BRAIN RES, V667, P144, DOI 10.1016/0006-8993(94)91727-2; SCHWARTZ GM, 1976, J EXP PSYCHOL ANIM B, V2, P28, DOI 10.1037/0097-7403.2.1.28; Sloan AM, 2009, HEARING RES, V251, P60, DOI 10.1016/j.heares.2009.02.009; STITT CL, 1973, J COMP PHYSIOL PSYCH, V84, P207, DOI 10.1037/h0035056; STITT CL, 1974, J COMP PHYSIOL PSYCH, V86, P826, DOI 10.1037/h0036419; Swerdlow NR, 2001, PSYCHOPHARMACOLOGY, V156, P194, DOI 10.1007/s002130100799; VALLSSOLE J, 1995, NEUROSCI LETT, V195, P97, DOI 10.1016/0304-3940(94)11790-P; Willott JF, 2008, HEARING RES, V235, P60, DOI 10.1016/j.heares.2007.10.006; WILLOTT JF, 1994, BEHAV NEUROSCI, V108, P703, DOI 10.1037/0735-7044.108.4.703; Wright BA, 2009, PHILOS T R SOC B, V364, P301, DOI 10.1098/rstb.2008.0262; Yang G, 2007, HEARING RES, V226, P244, DOI 10.1016/j.heares.2006.06.013; Yee BK, 2005, BEHAV BRAIN RES, V163, P265, DOI 10.1016/j.bbr.2005.05.013; Yeomans JS, 1995, BRAIN RES REV, V21, P301, DOI 10.1016/0165-0173(96)00004-5; Zhang YF, 2005, HEARING RES, V201, P145, DOI 10.1016/j.heares.2004.10.003	47	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e45123	10.1371/journal.pone.0045123	http://dx.doi.org/10.1371/journal.pone.0045123			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984620	Green Published, gold, Green Submitted			2022-12-27	WOS:000308638700110
J	Norden, J; Grieskamp, T; Christoffels, VM; Moorman, AFM; Kispert, A				Norden, Julia; Grieskamp, Thomas; Christoffels, Vincent M.; Moorman, Antoon F. M.; Kispert, Andreas			Partial Absence of Pleuropericardial Membranes in Tbx18- and Wt1-Deficient Mice	PLOS ONE			English	Article							PERICARDIAL DEFECTS; CONGENITAL ABSENCE; GENE	The pleuropericardial membranes are fibro-serous walls that separate the pericardial and pleural cavities and anchor the heart inside the mediastinum. Partial or complete absence of pleuropericardial membranes is a rare human disease, the etiology of which is poorly understood. As an attempt to better understand these defects, we wished to analyze the cellular and molecular mechanisms directing the separation of pericardial and pleural cavities by pleuropericardial membranes in the mouse. We found by histological analyses that both in Tbx18- and Wt1-deficient mice the pleural and pericardial cavities communicate due to a partial absence of the pleuropericardial membranes in the hilus region. We trace these defects to a persisting embryonic connection between these cavities, the pericardioperitoneal canals. Furthermore, we identify mesenchymal ridges in the sinus venosus region that tether the growing pleuropericardial membranes to the hilus of the lung, and thus, close the pericardioperitoneal canals. In Tbx18-deficient embryos these mesenchymal ridges are not established, whereas in Wt1-deficient embryos the final fusion process between these tissues and the body wall does not occur. We suggest that this fusion is an active rather than a passive process, and discuss the interrelation between closure of the pericardioperitoneal canals, lateral release of the pleuropericardial membranes from the lateral body wall, and sinus horn development.	[Norden, Julia; Grieskamp, Thomas; Kispert, Andreas] Hannover Med Sch, Inst Mol Biol, OE5250, D-30623 Hannover, Germany; [Christoffels, Vincent M.; Moorman, Antoon F. M.] Univ Amsterdam, Acad Med Ctr, Dept Anat Embryol & Physiol, NL-1105 AZ Amsterdam, Netherlands	Hannover Medical School; University of Amsterdam; Academic Medical Center Amsterdam	Norden, J (corresponding author), Hannover Med Sch, Inst Mol Biol, OE5250, D-30623 Hannover, Germany.	kispert.andreas@mh-hannover.de			European Community [LSHM-CT-2005-018630]; German Research Foundation (DFG) [KFO136]	European Community(European Commission); German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by grants from the European Community's Sixth Framework Programme contract ('HeartRepair' LSHM-CT-2005-018630), the German Research Foundation (DFG) for the Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy) and for the Clinical Research Group KFO136 at Hannover Medical School to A. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bussen M, 2004, GENE DEV, V18, P1209, DOI 10.1101/gad.300104; Christoffels VM, 2006, CIRC RES, V98, P1555, DOI 10.1161/01.RES.0000227571.84189.65; Faridah Y, 2002, INT J CARDIOVAS IMAG, V18, P67, DOI 10.1023/A:1014350814067; Frick H, 1949, Z ANAT ENTWICKLUNGS, V114, P230; Kraus F, 2001, MECH DEVELOP, V100, P83, DOI 10.1016/S0925-4773(00)00494-9; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Norden J, 2010, CIRC RES, V106, P1212, DOI 10.1161/CIRCRESAHA.110.217455; OYAMADA A, 1953, AMA AM J DIS CHILD, V85, P182, DOI 10.1001/archpedi.1953.02050070191007; Perna G., 1909, ANAT ANZEIGER, V35, P323; Sadler T.W., 2003, MED EMBRYOLOGIE NORM; Saffirio C, 2007, ANN THORAC SURG, V84, P2137, DOI 10.1016/j.athoracsur.2007.06.103; Salzer GM, 1959, ANAT EMBRYOL BERL, V121, P54; Salzer GM, 1960, ANAT EMBRYOL BERL, V122, P232; Sunderland S, 1944, BRIT HEART J, V6, P167; USKOW N, 1883, ARCH MIKROSK ANAT, V22, P143; VESELY T, 1989, SURG RADIOL ANAT, V11, P171, DOI 10.1007/BF02096477; Wiese C, 2009, CIRC RES, V104, P388, DOI 10.1161/CIRCRESAHA.108.187062	18	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e45100	10.1371/journal.pone.0045100	http://dx.doi.org/10.1371/journal.pone.0045100			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984617	Green Published, gold, Green Submitted			2022-12-27	WOS:000308638700109
J	Opazo, R; Ortuzar, F; Navarrete, P; Espejo, R; Romero, J				Opazo, Rafael; Ortuzar, Felipe; Navarrete, Paola; Espejo, Romilio; Romero, Jaime			Reduction of Soybean Meal Non-Starch Polysaccharides and alpha-Galactosides by Solid-State Fermentation Using Cellulolytic Bacteria Obtained from Different Environments	PLOS ONE			English	Article							ANTINUTRITIONAL FACTORS; PROTEIN ENRICHMENT; TEMPERATURE; OLIGOSACCHARIDES; AMPLIFICATION; STREPTOMYCES; POPULATIONS; DIVERSITY; AQUAFEEDS; DIGESTION	Soybean meal (SBM) is an important protein source in animal feed. However, the levels of SBM inclusion are restricted in some animal species by the presence of antinutritional factors (ANFs), including non-starch polysaccharides (NSPs) and alpha-galactosides (GOSs). The aim of this study was to reduce the soybean meal NSPs and GOSs by solid-state fermentation (SSF) using a combination of cellulolytic bacteria isolated from different environments (termites, earthworms, corn silage and bovine ruminal content). To analyse the key enzymatic activities, the isolates were grown in minimal media containing NSPs extracted from SBM. The selected bacterial strains belonged to the genera Streptomyces, Cohnella and Cellulosimicrobium. SSF resulted in a reduction of nearly 24% in the total NSPs, 83% of stachyose and 69% of raffinose and an increase in the protein content. These results suggest that cellulolytic bacteria-based SSF processing facilitates SBM nutritional improvement. In addition, the use of fermented SBM in animal diets can be recommended.	[Opazo, Rafael; Ortuzar, Felipe; Navarrete, Paola; Espejo, Romilio; Romero, Jaime] Univ Chile, INTA, Lab Biotecnol, Santiago, Chile	Universidad de Chile	Opazo, R (corresponding author), Univ Chile, INTA, Lab Biotecnol, Santiago, Chile.	jromero@inta.uchile.cl	navarrete, paola/B-5371-2014; Romero, Jaime/I-2816-2013; Espejo, Romilio T/J-3183-2015	navarrete, paola/0000-0003-0692-2324; Romero, Jaime/0000-0001-9614-2393; Espejo, Romilio T/0000-0003-0495-4576	CONICYT-Chile [FONDECYT 1080480/110253]; CORFO [INNOVA CHILE 05CT6PPT-09]; CONICYT	CONICYT-Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); CORFO; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This investigation was supported by grants FONDECYT 1080480/110253 from CONICYT-Chile and INNOVA CHILE 05CT6PPT-09 from CORFO. R. Opazo was supported by fellowships from CONICYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039331; AOAC, 2002, OFFICIAL METHODS ANA, V15th, DOI DOI 10.1007/978-3-642-31241-0; Bhat MK, 2000, BIOTECHNOL ADV, V18, P355, DOI 10.1016/S0734-9750(00)00041-0; Carrico JA, 2005, J CLIN MICROBIOL, V43, P5483, DOI 10.1128/JCM.43.11.5483-5490.2005; Carter C. G., 1994, Aquaculture and Fisheries Management, V25, P37, DOI 10.1111/j.1365-2109.1994.tb00664.x; Choct M, 2010, ASIAN AUSTRAL J ANIM, V23, P1386, DOI 10.5713/ajas.2010.90222; CHURCH FC, 1980, MYCOLOGIA, V72, P279, DOI 10.2307/3759251; Dharmaraj S, 2010, AFR J MICROBIOL RES, V4, P240; Dunn O. J., 2009, NONPARAMETRIC STAT, P189; El-Naggar MY, 2009, J MICROBIOL BIOTECHN, V19, P468, DOI 10.4014/jmb.0807.457; ENGLYST HN, 1994, ANALYST, V119, P1497, DOI 10.1039/an9941901497; Francis G, 2001, AQUACULTURE, V199, P197, DOI 10.1016/S0044-8486(01)00526-9; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Giannoccaro E, 2006, J FOOD SCI, V71, pC59, DOI 10.1111/j.1365-2621.2006.tb12389.x; Gonzalez N, 2003, J MICROBIOL METH, V55, P91, DOI 10.1016/S0167-7012(03)00110-6; Graminha EBN, 2008, ANIM FEED SCI TECH, V144, P1, DOI 10.1016/j.anifeedsci.2007.09.029; HENDRICKS CW, 1995, APPL ENVIRON MICROB, V61, P2016, DOI 10.1128/AEM.61.5.2016-2019.1995; Huisman MMH, 1998, CARBOHYD POLYM, V37, P87, DOI 10.1016/S0144-8617(97)00111-2; Jezierny D, 2010, ANIM FEED SCI TECH, V157, P111, DOI 10.1016/j.anifeedsci.2010.03.001; Karr-Lilienthal LK, 2005, LIVEST PROD SCI, V97, P1, DOI 10.1016/j.livprodsci.2005.01.015; Kaufman L, 2008, INTRODUCTION, P1; Killham K., 2007, SOIL MICROBIOLOGY EC, P120; Kim SW, 2010, J ANIM SCI, V88, P214, DOI 10.2527/jas.2009-1993; Knudsen KEB, 1997, ANIM FEED SCI TECH, V67, P319, DOI 10.1016/S0377-8401(97)00009-6; LeBlanc JG, 2004, APPL MICROBIOL BIOT, V65, P119, DOI 10.1007/s00253-003-1532-z; LONSANE BK, 1985, ENZYME MICROB TECH, V7, P258, DOI 10.1016/0141-0229(85)90083-3; LOQUET M, 1984, APPL BIOCHEM BIOTECH, V9, P377, DOI 10.1007/BF02798984; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Magne F, 2006, FEMS MICROBIOL ECOL, V57, P128, DOI 10.1111/j.1574-6941.2006.00097.x; McCracken VJ, 2001, J NUTR, V131, P1862, DOI 10.1093/jn/131.6.1862; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; NIGAM P, 1994, J BASIC MICROB, V34, P405, DOI 10.1002/jobm.3620340607; NITISINPRASERT S, 1991, J APPL BACTERIOL, V71, P154, DOI 10.1111/j.1365-2672.1991.tb02972.x; Oh HW, 2008, ANTON LEEUW INT J G, V93, P437, DOI 10.1007/s10482-007-9210-2; OLLI JJ, 1994, ACTA AGR SCAND A-AN, V44, P50, DOI 10.1080/09064709409410181; Pandey A, 2003, BIOCHEM ENG J, V13, P81, DOI 10.1016/S1369-703X(02)00121-3; Perez J., 2002, International Microbiology, V5, P53, DOI 10.1007/s10123-002-0062-3; Poulsen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016763; Prajapati JB, 2008, FUNCT FOOD NUTRA SER, P1; Refstie S, 2005, AQUACULTURE, V246, P331, DOI 10.1016/j.aquaculture.2005.01.001; Brasil APR, 2010, FOOD CHEM, V118, P251, DOI 10.1016/j.foodchem.2009.04.124; ROUSSOS S, 1994, OLEAGINEUX, V49, P235; Ruijssenaars HJ, 2001, APPL MICROBIOL BIOT, V55, P143, DOI 10.1007/s002530000477; Russell JB, 2009, FEMS MICROBIOL ECOL, V67, P183, DOI 10.1111/j.1574-6941.2008.00633.x; Smits JP, 1998, ENZYME MICROB TECH, V22, P50, DOI 10.1016/S0141-0229(97)00103-8; Soccol CR, 2003, BIOCHEM ENG J, V13, P205, DOI 10.1016/S1369-703X(02)00133-X; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Tirado O, 2005, J MAR BIOL ASSOC UK, V85, P269, DOI 10.1017/S002531540501115Xh; Ugwuanyi JO, 2008, BIORESOURCE TECHNOL, V99, P6974, DOI 10.1016/j.biortech.2008.01.025; Vargas-Garcia MC, 2010, WASTE MANAGE, V30, P771, DOI 10.1016/j.wasman.2009.12.019; Villas-Boas SG, 2002, ANIM FEED SCI TECH, V98, P1, DOI 10.1016/S0377-8401(02)00017-2; Wei H, 2009, CURR OPIN BIOTECH, V20, P330, DOI 10.1016/j.copbio.2009.05.008; Wenzel M, 2002, J APPL MICROBIOL, V92, P32, DOI 10.1046/j.1365-2672.2002.01502.x; Wilson DB, 2011, CURR OPIN MICROBIOL, V14, P259, DOI 10.1016/j.mib.2011.04.004; Wilson Robert P., 2002, P143; Zhou Z, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S8; Zubkov MV, 1999, APPL ENVIRON MICROB, V65, P3251	59	20	24	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44783	10.1371/journal.pone.0044783	http://dx.doi.org/10.1371/journal.pone.0044783			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984557	Green Published, gold, Green Submitted			2022-12-27	WOS:000308638700082
J	Engreitz, JM; Agarwala, V; Mirny, LA				Engreitz, Jesse M.; Agarwala, Vineeta; Mirny, Leonid A.			Three-Dimensional Genome Architecture Influences Partner Selection for Chromosomal Translocations in Human Disease	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; SPATIAL-ORGANIZATION; SEQUENCING REVEALS; MULTIPLE-MYELOMA; GENE; REARRANGEMENTS; PROXIMITY; BCR; ABL; EXPRESSION	Chromosomal translocations are frequent features of cancer genomes that contribute to disease progression. These rearrangements result from formation and illegitimate repair of DNA double-strand breaks (DSBs), a process that requires spatial colocalization of chromosomal breakpoints. The "contact first" hypothesis suggests that translocation partners colocalize in the nuclei of normal cells, prior to rearrangement. It is unclear, however, the extent to which spatial interactions based on three-dimensional genome architecture contribute to chromosomal rearrangements in human disease. Here we intersect Hi-C maps of three-dimensional chromosome conformation with collections of 1,533 chromosomal translocations from cancer and germline genomes. We show that many translocation-prone pairs of regions genome-wide, including the cancer translocation partners BCR-ABL and MYC-IGH, display elevated Hi-C contact frequencies in normal human cells. Considering tissue specificity, we find that translocation breakpoints reported in human hematologic malignancies have higher Hi-C contact frequencies in lymphoid cells than those reported in sarcomas and epithelial tumors. However, translocations from multiple tissue types show significant correlation with Hi-C contact frequencies, suggesting that both tissue-specific and universal features of chromatin structure contribute to chromosomal alterations. Our results demonstrate that three-dimensional genome architecture shapes the landscape of rearrangements directly observed in human disease and establish Hi-C as a key method for dissecting these effects.	[Engreitz, Jesse M.; Agarwala, Vineeta; Mirny, Leonid A.] MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Engreitz, Jesse M.; Agarwala, Vineeta] Broad Inst, Cambridge, MA USA; [Agarwala, Vineeta] Harvard Univ, Biophys Program, Grad Sch Arts & Sci, Cambridge, MA 02138 USA; [Mirny, Leonid A.] MIT, Dept Phys, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT)	Mirny, LA (corresponding author), MIT, Harvard MIT Div Hlth Sci & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leonid@mit.edu	Mirny, Leonid/ABE-8083-2020	Mirny, Leonid/0000-0002-0785-5410	National Human Genome Research Institute [T32 HG002295]; National Defense Science and Engineering Graduate Fellowship Program; Fannie and John Hertz Foundation; Medical Scientist Training Program; National Institute of General Medical Sciences [5T32 GM008313]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008313, T32GM007753] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Defense Science and Engineering Graduate Fellowship Program; Fannie and John Hertz Foundation; Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JE was supported by the National Human Genome Research Institute (grant T32 HG002295), the National Defense Science and Engineering Graduate Fellowship Program, and the Fannie and John Hertz Foundation. VA was supported by the Medical Scientist Training Program and the National Institute of General Medical Sciences (grant 5T32 GM008313). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRUSHDI A, 1983, SCIENCE, V222, P390, DOI 10.1126/science.6414084; Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chesi M, 1997, NAT GENET, V16, P260, DOI 10.1038/ng0797-260; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; De S, 2011, NAT STRUCT MOL BIOL, V18, P950, DOI 10.1038/nsmb.2089; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Ge HY, 2011, BIOINFORMATICS, V27, P1922, DOI 10.1093/bioinformatics/btr310; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; Khalidi HS, 1999, CANCER GENET CYTOGEN, V109, P58, DOI 10.1016/S0165-4608(98)00153-8; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; KOEFFLER HP, 1981, NEW ENGL J MED, V304, P1201, DOI 10.1056/NEJM198105143042004; Kozubek S, 1999, CHROMOSOMA, V108, P426, DOI 10.1007/s004120050394; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lukasova E, 1997, HUM GENET, V100, P525, DOI 10.1007/s004390050547; Malgeri U, 2000, CANCER RES, V60, P4058; Mani RS, 2010, NAT REV GENET, V11, P819, DOI 10.1038/nrg2883; Mani RS, 2009, SCIENCE, V326, P1230, DOI 10.1126/science.1178124; Mathas S, 2009, P NATL ACAD SCI USA, V106, P5831, DOI 10.1073/pnas.0900912106; Meaburn KJ, 2007, SEMIN CANCER BIOL, V17, P80, DOI 10.1016/j.semcancer.2006.10.008; Mitelman F., MITELMAN DATABASE CH; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Neves H, 1999, BLOOD, V93, P1197, DOI 10.1182/blood.V93.4.1197.404k33_1197_1207; NOWELL PC, 1960, SCIENCE, V132, P1497; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Parada LA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r44; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; ROWLEY JD, 1980, ANNU REV GENET, V14, P17, DOI 10.1146/annurev.ge.14.120180.000313; Simonis M, 2009, NAT METHODS, V6, P837, DOI [10.1038/NMETH.1391, 10.1038/nmeth.1391]; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002	39	85	87	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e44196	10.1371/journal.pone.0044196	http://dx.doi.org/10.1371/journal.pone.0044196			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028501	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900005
J	Schuler, PK; Haegeli, LM; Saguner, AM; Wolber, T; Tanner, FC; Jenni, R; Corti, N; Luscher, TF; Brunckhorst, C; Duru, F				Schuler, Pia K.; Haegeli, Laurent M.; Saguner, Ardan M.; Wolber, Thomas; Tanner, Felix C.; Jenni, Rolf; Corti, Natascia; Luescher, Thomas F.; Brunckhorst, Corinna; Duru, Firat			Predictors of Appropriate ICD Therapy in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy: Long Term Experience of a Tertiary Care Center	PLOS ONE			English	Article							CARDIOVERTER-DEFIBRILLATOR THERAPY; SUDDEN CARDIAC DEATH; IMPLANTABLE DEFIBRILLATOR; YOUNG-PEOPLE; DYSPLASIA; DYSPLASIA/CARDIOMYOPATHY; DIAGNOSIS; REGISTRY; PREVENTION; HEART	Introduction: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a rare genetically transmitted disease prone to ventricular arrhythmias. We therefore investigated the clinical, echocardiographical and electrophysiological predictors of appropriate implantable cardioverter defibrillator (ICD) therapy in patients with ARVC. Methods: A retrospective analysis was performed in 26 patients (median age of 40 years at diagnosis, 21 males and 5 females) with ARVC who underwent ICD implantation. Results: Over a median (range) follow-up period of 10 (2.7, 37) years, appropriate ICD therapy for ventricular arrhythmias was documented in 12 (46%) out of 26 patients. In all patients with appropriate ICD therapy the ICD was originally inserted for secondary prevention. Median time from ICD implantation to ICD therapy was 9 months (range 3.6, 54 months). History of heart failure was a significant predictor of appropriate ICD therapy (p = 0.033). Left ventricular disease involvement (p = 0.059) and age at implantation (p = 0.063) were borderline significant predictors. Patients with syncope at time of diagnosis were significantly less likely to receive ICD therapy (p = 0.02). Invasive electrophysiological testing was not significantly associated with appropriate ICD therapy. Conclusion: In our cohort of patients with ARVC, history of heart failure was a significant predictor of appropriate ICD therapy, whereas left ventricular involvement and age at time of ICD implantation were of borderline significance. These predictors should be tested in larger prospective cohorts to optimize ICD therapy in this rare cardiomyopathy.	[Schuler, Pia K.; Haegeli, Laurent M.; Saguner, Ardan M.; Wolber, Thomas; Tanner, Felix C.; Jenni, Rolf; Luescher, Thomas F.; Brunckhorst, Corinna; Duru, Firat] Univ Zurich Hosp, Clin Cardiol, Cardiovas Ctr, CH-8091 Zurich, Switzerland; [Schuler, Pia K.] Univ Hosp Muenster, Dept Cardiol & Angiol, Adult Congenital & Valvular Heart Dis Ctr, Munster, Germany; [Wolber, Thomas; Tanner, Felix C.; Jenni, Rolf; Luescher, Thomas F.; Duru, Firat] Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland; [Corti, Natascia] Univ Zurich Hosp, Div Clin Pharmacol & Toxicol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Munster; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University Zurich Hospital	Haegeli, LM (corresponding author), Univ Zurich Hosp, Clin Cardiol, Cardiovas Ctr, CH-8091 Zurich, Switzerland.	laurent.haegeli@usz.ch	Saguner, Ardan M./AAV-3624-2020; rolf jenni, MSEE/B-2334-2015	Duru, Firat/0000-0002-4748-0158; Jenni, Rolf/0000-0002-2609-6915	Schwyzer Foundation; Medtronic; Biotronik; St. Jude; Boston Scientific	Schwyzer Foundation; Medtronic(Medtronic); Biotronik; St. Jude(St. Jude Medical); Boston Scientific(Boston Scientific)	This study was supported by a donation by the Schwyzer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; There are no conflicts of interest involved other than research grants to the institution from Medtronic, Biotronik, St. Jude and Boston Scientific not directly related to this project. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Berul CI, 2008, J AM COLL CARDIOL, V51, P1685, DOI 10.1016/j.jacc.2008.01.033; Bhonsale A, 2011, J AM COLL CARDIOL, V58, P1485, DOI 10.1016/j.jacc.2011.06.043; Corrado D, 2003, CIRCULATION, V108, P3084, DOI 10.1161/01.CIR.0000103130.33451.D2; CORRADO D, 1990, AM J MED, V89, P588, DOI 10.1016/0002-9343(90)90176-E; Corrado D, 1998, NEW ENGL J MED, V339, P364, DOI 10.1056/NEJM199808063390602; Corrado D, 2001, CARDIOVASC RES, V50, P399, DOI 10.1016/S0008-6363(01)00254-1; Corrado D, 2010, CIRCULATION, V122, P1144, DOI 10.1161/CIRCULATIONAHA.109.913871; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Hodgkinson KA, 2005, J AM COLL CARDIOL, V45, P400, DOI 10.1016/j.jacc.2004.08.068; JENNI R, 1981, EUR HEART J, V2, P217, DOI 10.1093/oxfordjournals.eurheartj.a061197; Komura M, 2010, INT HEART J, V51, P34, DOI 10.1536/ihj.51.34; KULLO IJ, 1995, MAYO CLIN PROC, V70, P541, DOI 10.4065/70.6.541; Lemola K, 2005, HEART, V91, P1167, DOI 10.1136/hrt.2004.038620; Link M S, 1997, J Interv Card Electrophysiol, V1, P41, DOI 10.1023/A:1009714718034; MARCUS FI, 1982, CIRCULATION, V65, P384, DOI 10.1161/01.CIR.65.2.384; Marcus F, 2010, AM J CARDIOL, V105, P1036, DOI 10.1016/j.amjcard.2009.11.033; Marcus FI, 2010, CIRCULATION, V121, P1533, DOI 10.1161/CIRCULATIONAHA.108.840827; Marcus FI, 2009, HEART RHYTHM, V6, P984, DOI 10.1016/j.hrthm.2009.03.013; Marcus GM, 2009, J AM COLL CARDIOL, V54, P609, DOI 10.1016/j.jacc.2009.04.052; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; MCKENNA WJ, 1994, BRIT HEART J, V71, P215; Nicolosi GL, 2008, TRATTATO ECOCARDIOGR; Piccini JP, 2005, HEART RHYTHM, V2, P1188, DOI 10.1016/j.hrthm.2005.08.022; PINAMONTI B, 1995, AM HEART J, V129, P412, DOI 10.1016/0002-8703(95)90029-2; Pinamonti B, 2011, EUR HEART J, V32, P1105, DOI 10.1093/eurheartj/ehr040; Roguin A, 2004, J AM COLL CARDIOL, V43, P1843, DOI 10.1016/j.jacc.2004.01.030; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; SHEN WK, 1995, AM J CARDIOL, V76, P148, DOI 10.1016/S0002-9149(99)80047-2; Tabib A, 1999, EUR HEART J, V20, P900, DOI 10.1053/euhj.1998.1403; Tandri H, 2008, AM HEART J, V155, P147, DOI 10.1016/j.ahj.2007.08.011; Tavernier R, 2001, HEART, V85, P53, DOI 10.1136/heart.85.1.53; THIENE G, 1988, NEW ENGL J MED, V318, P129, DOI 10.1056/NEJM198801213180301; Wichter T, 2004, CIRCULATION, V109, P1503, DOI 10.1161/01.CIR.0000121738.88273.43; Zipes DP, 2006, CIRCULATION, V114, pE385, DOI 10.1161/CIRCULATIONAHA.106.178233	35	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e39584	10.1371/journal.pone.0039584	http://dx.doi.org/10.1371/journal.pone.0039584			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23028419	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517500002
J	Castillo, AB; Blundo, JT; Chen, JC; Lee, KL; Yereddi, NR; Jang, E; Kumar, S; Tang, WJ; Zarrin, S; Kim, JB; Jacobs, CR				Castillo, Alesha B.; Blundo, Jennifer T.; Chen, Julia C.; Lee, Kristen L.; Yereddi, Nikitha Reddy; Jang, Eugene; Kumar, Shefali; Tang, W. Joyce; Zarrin, Sarah; Kim, Jae-Beom; Jacobs, Christopher R.			Focal Adhesion Kinase Plays a Role in Osteoblast Mechanotransduction In Vitro but Does Not Affect Load-Induced Bone Formation In Vivo	PLOS ONE			English	Article							PROTEIN-TYROSINE KINASE; SIGNAL-TRANSDUCTION PATHWAYS; CELL-MIGRATION; MECHANICAL STIMULATION; FAK; INTEGRIN; REGENERATION; EXPRESSION; MICE; FLOW	A healthy skeleton relies on bone's ability to respond to external mechanical forces. The molecular mechanisms by which bone cells sense and convert mechanical stimuli into biochemical signals, a process known as mechanotransduction, are unclear. Focal adhesions play a critical role in cell survival, migration and sensing physical force. Focal adhesion kinase (FAK) is a non-receptor protein tyrosine kinase that controls focal adhesion dynamics and can mediate reparative bone formation in vivo and osteoblast mechanotransduction in vitro. Based on these data, we hypothesized that FAK plays a role in load-induced bone formation. To test this hypothesis, we performed in vitro fluid flow experiments and in vivo bone loading studies in FAK-/- clonal lines and conditional FAK knockout mice, respectively. FAK-/- osteoblasts showed an ablated prostaglandin E-2 (PGE(2)) response to fluid flow shear. This effect was reversed with the re-expression of wild-type FAK. Re-expression of FAK containing site-specific mutations at Tyr-397 and Tyr-925 phosphorylation sites did not rescue the phenotype, suggesting that these sites are important in osteoblast mechanotransduction. Interestingly, mice in which FAK was conditionally deleted in osteoblasts and osteocytes did not exhibit altered load-induced periosteal bone formation. Together these data suggest that although FAK is important in mechanically-induced signaling in osteoblasts in vitro, it is not required for an adaptive response in vivo, possibly due to a compensatory mechanism that does not exist in the cell culture system.	[Castillo, Alesha B.; Tang, W. Joyce; Zarrin, Sarah; Jacobs, Christopher R.] Vet Affairs Palo Alto Hlth Care Syst, Dept Rehabil Res & Dev, Ctr Tissue Regenerat Repair & Restorat, Palo Alto, CA USA; [Castillo, Alesha B.; Kim, Jae-Beom] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA; [Castillo, Alesha B.; Blundo, Jennifer T.; Jacobs, Christopher R.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Blundo, Jennifer T.; Chen, Julia C.; Lee, Kristen L.; Yereddi, Nikitha Reddy; Jang, Eugene; Kumar, Shefali; Jacobs, Christopher R.] Columbia Univ, Dept Biomed Engn, New York, NY USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University; Columbia University	Castillo, AB (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Dept Rehabil Res & Dev, Ctr Tissue Regenerat Repair & Restorat, Palo Alto, CA USA.	alesha.castillo@stanford.edu	Castillo, Alesha B./AAC-9961-2019; Castillo, Alesha B/A-8728-2014	Castillo, Alesha B./0000-0002-1371-7567; Castillo, Alesha B/0000-0002-1371-7567; Jang, Eugene/0000-0002-9808-2678	Stanford Center on Longevity Postdoctoral Fellowship; National Institutes of Health (NIH) [AR45989, AR54156]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045989] Funding Source: NIH RePORTER	Stanford Center on Longevity Postdoctoral Fellowship; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a Stanford Center on Longevity Postdoctoral Fellowship (ABC) and National Institutes of Health (NIH) grants AR45989 (CRJ) and AR54156 (CRJ). The Stanford Center on Longevity Postdoctoral Fellowship provided salary support for Dr. Alesha Castillo. NIH grants AR45989 and AR54156 provided support for consumables, reagents, cell culture work and animal husbandry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; Buckbinder L, 2007, P NATL ACAD SCI USA, V104, P10619, DOI 10.1073/pnas.0701421104; Cary Leslie A., 1999, Frontiers in Bioscience, V4, pD102, DOI 10.2741/Cary; Castillo AB, 2006, BONE, V39, P1087, DOI 10.1016/j.bone.2006.04.026; Chen CS, 2004, ANNU REV BIOMED ENG, V6, P275, DOI 10.1146/annurev.bioeng.6.040803.140040; CHOW JWM, 1994, AM J PHYSIOL, V267, pE287, DOI 10.1152/ajpendo.1994.267.2.E287; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Colnot C, 2009, J BONE MINER RES, V24, P274, DOI 10.1359/JBMR.081003; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Delmas P, 2004, FASEB J, V18, P740, DOI 10.1096/fj.03-0319fje; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; Hungerford JE, 1996, J CELL BIOL, V135, P1383, DOI 10.1083/jcb.135.5.1383; ILIC D, 1995, BIOCHEM BIOPH RES CO, V209, P300, DOI 10.1006/bbrc.1995.1503; ILLC D, 1995, NATURE, V377, P539; Ishida T, 1996, CIRC RES, V79, P310, DOI 10.1161/01.RES.79.2.310; Jacobs CR, 1998, J BIOMECH, V31, P969, DOI 10.1016/S0021-9290(98)00114-6; Kapur S, 2003, BONE, V32, P241, DOI 10.1016/S8756-3282(02)00979-1; Kim JB, 2007, BONE, V41, P39, DOI 10.1016/j.bone.2007.01.024; Kim JB, 2007, J BONE MINER RES, V22, P1913, DOI 10.1359/JBMR.070802; KleinNulend J, 1995, BIOCHEM BIOPH RES CO, V217, P640, DOI 10.1006/bbrc.1995.2822; Lean JM, 1996, AM J PHYSIOL-ENDOC M, V270, pE937, DOI 10.1152/ajpendo.1996.270.6.E937; Lee DY, 2009, J BIOL CHEM; Lee HS, 2000, J BONE MINER RES, V15, P1501, DOI 10.1359/jbmr.2000.15.8.1501; Leucht P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000390; Li S, 1997, J BIOL CHEM, V272, P30455, DOI 10.1074/jbc.272.48.30455; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Litzenberger JB, 2009, CELLULAR MOL BIOENGI; Ma A, 2001, MOL BIOL CELL, V12, P1; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Miyauchi A, 2006, J BONE MINER METAB, V24, P498, DOI 10.1007/s00774-006-0716-x; Monfoulet L, 2009, CALCIF TISSUE INT; Nguyen KT, 2009, KNOCKOUT PYK2 IMPROV; Orr AW, 2004, FRONT BIOSCI-LANDMRK, V9, P1254, DOI 10.2741/1239; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Petzold T, 2009, AM J PHYSL CELL PHYS; Pirone DM, 2006, J CELL BIOL, V174, P277, DOI 10.1083/jcb.200510062; Rezzonico R, 2003, J BONE MINER RES, V18, P1863, DOI 10.1359/jbmr.2003.18.10.1863; Robling AG, 2002, BONE, V31, P562, DOI 10.1016/S8756-3282(02)00871-2; Robling AG, 2002, FASEB J, V16, P324, DOI 10.1096/fj.02-0393fje; Santos A, 2009, BIOCH BIOPHYS RES CO; SASAKI H, 1995, J BIOL CHEM, V270, P21206, DOI 10.1074/jbc.270.36.21206; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; Sieg DJ, 1999, J CELL SCI, V112, P2677; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Weis SM, 2008, J CELL BIOL, V181, P43, DOI 10.1083/jcb.200710038; Wen HA, 2009, INT WOUND J, V6, P149, DOI 10.1111/j.1742-481X.2009.00591.x; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Xiong WC, 1997, J CELL BIOL, V139, P529, DOI 10.1083/jcb.139.2.529; Xu LH, 1996, CELL GROWTH DIFFER, V7, P413; Young SRL, 2009, J BONE MINER RES, V24, P411, DOI 10.1359/JBMR.081102	56	33	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e43291	10.1371/journal.pone.0043291	http://dx.doi.org/10.1371/journal.pone.0043291			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028449	Green Submitted, Green Published, gold			2022-12-27	WOS:000309392800001
J	Lugar, PL; Love, C; Grammer, AC; Dave, SS; Lipsky, PE				Lugar, Patricia L.; Love, Cassandra; Grammer, Amrie C.; Dave, Sandeep S.; Lipsky, Peter E.			Molecular Characterization of Circulating Plasma Cells in Patients with Active Systemic Lupus Erythematosus	PLOS ONE			English	Article							INTERFERON-INDUCIBLE GENE; PERIPHERAL-BLOOD CELLS; LYMPHOCYTE EGRESS; BONE-MARROW; DISEASE-ACTIVITY; B-LYMPHOCYTES; EXPRESSION; DIFFERENTIATION; MAINTENANCE; BLIMP-1	Systemic lupus erythematosus (SLE) is a generalized autoimmune disease characterized by abnormal B cell activation and the occurrence of increased frequencies of circulating plasma cells (PC). The molecular characteristics and nature of circulating PC and B cells in SLE have not been completely characterized. Microarray analysis of gene expression was used to characterize circulating PC in subjects with active SLE. Flow cytometry was used to sort PC and comparator B cell populations from active SLE blood, normal blood and normal tonsil. The gene expression profiles of the sorted B cell populations were then compared. SLE PC exhibited a similar gene expression signature as tonsil PC. The differences in gene expression between SLE PC and normal tonsil PC and tonsil plasmablasts (PB) suggest a mature Ig secreting cell phenotype in the former population. Despite this, SLE PC differed in expression of about half the genes from previously published gene expression profiles of normal bone marrow PC, indicating that these cells had not achieved a fully mature status. Abnormal expression of several genes, including CXCR4 and S1P(1), suggests a mechanism for the persistence of SLE PC in the circulation. All SLE B cell populations revealed an interferon (IFN) gene signature previously only reported in unseparated SLE peripheral blood mononuclear cells. These data indicate that SLE PC are a unique population of Ig secreting cells with a gene expression profile indicative of a mature, but not fully differentiated phenotype.	[Lugar, Patricia L.; Grammer, Amrie C.; Lipsky, Peter E.] NIH, Autoimmun Branch, Bethesda, MD 20892 USA; [Love, Cassandra; Dave, Sandeep S.] Duke Univ, Inst Genome Sci & Policy, Durham, NC USA	National Institutes of Health (NIH) - USA; Duke University	Lugar, PL (corresponding author), Duke Univ, Div Pulm Allergy & Crit Care, Durham, NC 27706 USA.	patricia.lugar@duke.edu		Grammer, Amrie/0000-0001-7142-2284	intramural NIH funding	intramural NIH funding	The research work was performed at the National Institutes of Health (NIH) and NIH Clinical Center and funded through intramural NIH funding. The NIH had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Angelin-Duclos C, 2000, J IMMUNOL, V165, P5462, DOI 10.4049/jimmunol.165.10.5462; Anolik JH, 2004, ARTHRITIS RHEUM-US, V50, P3580, DOI 10.1002/art.20592; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Calame KL, 2003, ANNU REV IMMUNOL, V21, P205, DOI 10.1146/annurev.immunol.21.120601.141138; Calame KL, 2001, NAT IMMUNOL, V2, P1103, DOI 10.1038/ni1201-1103; Cassese G, 2003, J IMMUNOL, V171, P1684, DOI 10.4049/jimmunol.171.4.1684; De Vos J, 2006, IMMUNOL REV, V210, P86, DOI 10.1111/j.0105-2896.2006.00362.x; DiLillo DJ, 2008, J IMMUNOL, V180, P361, DOI 10.4049/jimmunol.180.1.361; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ferraro AJ, 2008, EUR J IMMUNOL, V38, P292, DOI 10.1002/eji.200737557; Gerl V, 2010, ANN RHEUM DIS; Grammer AC, 2003, ARTHRITIS RES THER, V5, pS22, DOI 10.1186/ar1009; Grammer AC, 2004, ARTHRITIS RES THER, V6, P28, DOI 10.1186/ar1155; Grammer AC, 2003, J CLIN INVEST, V112, P1506, DOI 10.1172/JCI200319301; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Illei GG, 2010, ARTHRITIS RHEUM-US, V62, P542, DOI 10.1002/art.27221; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Jacobi AM, 2010, ANN RHEUM DIS, V69, P305, DOI 10.1136/ard.2008.096495; Jacobi AM, 2003, ARTHRITIS RHEUM, V48, P1332, DOI 10.1002/art.10949; Jacobi AM, 2008, ARTHRITIS RHEUM-US, V58, P1762, DOI 10.1002/art.23498; Kabashima K, 2006, J EXP MED, V203, P2683, DOI 10.1084/jem.20061289; Kuhn A, 2009, ARCH DERMATOL RES, V301, P71, DOI 10.1007/s00403-008-0891-9; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lin KI, 2003, IMMUNOL REV, V194, P19, DOI 10.1034/j.1600-065X.2003.00040.x; LIU YJ, 1988, EUR J IMMUNOL, V18, P355, DOI 10.1002/eji.1830180306; Longo NS, 2009, BLOOD, V113, P3706, DOI 10.1182/blood-2008-10-183632; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Medina F, 2002, BLOOD, V99, P2154, DOI 10.1182/blood.V99.6.2154; Moser K, 2006, IMMUNOL LETT, V103, P83, DOI 10.1016/j.imlet.2005.09.009; Nakayama Y, 2006, J CELL BIOCHEM, V99, P1308, DOI 10.1002/jcb.20952; Odendahl M, 2000, J IMMUNOL, V165, P5970, DOI 10.4049/jimmunol.165.10.5970; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pham TH, 2010, J EXP MED, V207, pS11; Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619; Piskurich JF, 2000, NAT IMMUNOL, V1, P526, DOI 10.1038/82788; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; ROMAN C, 1990, PROG CLIN BIOL RES, V352, P241; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shapiro-Shelef M, 2005, J EXP MED, V202, P1471, DOI 10.1084/jem.20051611; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Tang J, 2008, LUPUS, V17, P805, DOI 10.1177/0961203308089694; Tarte K, 2003, BLOOD, V102, P592, DOI 10.1182/blood-2002-10-3161; TERSTAPPEN LWMM, 1990, BLOOD, V76, P1739; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang HJ, 2005, CELL IMMUNOL, V235, P117, DOI 10.1016/j.cellimm.2005.08.031; Wols HAM, 2002, J IMMUNOL, V169, P4213, DOI 10.4049/jimmunol.169.8.4213; Zhan FH, 2003, BLOOD, V101, P1128, DOI 10.1182/blood-2002-06-1737; Zhang J, 2009, BLOOD, V113, P4586, DOI 10.1182/blood-2008-09-178186	52	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44362	10.1371/journal.pone.0044362	http://dx.doi.org/10.1371/journal.pone.0044362			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028528	gold, Green Submitted, Green Published			2022-12-27	WOS:000309392800007
J	Scala, A; Auconi, P; Scazzocchio, M; Caldarelli, G; McNamara, JA; Franchi, L				Scala, Antonio; Auconi, Pietro; Scazzocchio, Marco; Caldarelli, Guido; McNamara, James A.; Franchi, Lorenzo			Using Networks To Understand Medical Data: The Case of Class III Malocclusions	PLOS ONE			English	Article							BIOLOGY	A system of elements that interact or regulate each other can be represented by a mathematical object called a network. While network analysis has been successfully applied to high-throughput biological systems, less has been done regarding their application in more applied fields of medicine; here we show an application based on standard medical diagnostic data. We apply network analysis to Class III malocclusion, one of the most difficult to understand and treat orofacial anomaly. We hypothesize that different interactions of the skeletal components can contribute to pathological disequilibrium; in order to test this hypothesis, we apply network analysis to 532 Class III young female patients. The topology of the Class III malocclusion obtained by network analysis shows a strong co-occurrence of abnormal skeletal features. The pattern of these occurrences influences the vertical and horizontal balance of disharmony in skeletal form and position. Patients with more unbalanced orthodontic phenotypes show preponderance of the pathological skeletal nodes and minor relevance of adaptive dentoalveolar equilibrating nodes. Furthermore, by applying Power Graphs analysis we identify some functional modules among orthodontic nodes. These modules correspond to groups of tightly inter-related features and presumably constitute the key regulators of plasticity and the sites of unbalance of the growing dentofacial Class III system. The data of the present study show that, in their most basic abstraction level, the orofacial characteristics can be represented as graphs using nodes to represent orthodontic characteristics, and edges to represent their various types of interactions. The applications of this mathematical model could improve the interpretation of the quantitative, patient-specific information, and help to better targeting therapy. Last but not least, the methodology we have applied in analyzing orthodontic features can be applied easily to other fields of the medical science.	[Scala, Antonio; Auconi, Pietro; Scazzocchio, Marco; Caldarelli, Guido] Ist Sistemi Complessi Udr La Sapienza, Rome, Italy; [Scala, Antonio; Caldarelli, Guido] London Inst Math Sci, London, England; [Caldarelli, Guido] IMT Lucca Inst Adv Studies, NATWORKS Unit Study Nat Networks, Lucca, Italy; [McNamara, James A.; Franchi, Lorenzo] Univ Michigan, Sch Dent, Dept Orthodont & Pediat Dent, Ann Arbor, MI 48109 USA; [McNamara, James A.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI USA; [McNamara, James A.] Univ Michigan, Ctr Human Growth & Dev, Ann Arbor, MI 48109 USA; [Franchi, Lorenzo] Univ Florence, Dept Orthodont, Florence, Italy	IMT School for Advanced Studies Lucca; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Florence	Scala, A (corresponding author), Ist Sistemi Complessi Udr La Sapienza, Rome, Italy.	antonio.scala@phys.uniroma1.it	Scala, Antonio/H-9153-2019; Franchi, Lorenzo/B-2730-2009; Scala, Antonio/A-2098-2012; Scala, Antonio/GRS-5823-2022; Caldarelli, Guido/AAB-8206-2022; Caldarelli, Guido/A-5274-2010	Scala, Antonio/0000-0002-3414-2686; Scala, Antonio/0000-0002-3414-2686; Auconi, Pietro/0000-0001-8380-2698; Caldarelli, Guido/0000-0001-9377-3616; FRANCHI, LORENZO/0000-0002-2072-460X				Albert R, 2007, PLANT CELL, V19, P3327, DOI 10.1105/tpc.107.054700; Auconi P, 2011, ORTHOD CRANIOFAC RES, V14, P189, DOI 10.1111/j.1601-6343.2011.01523.x; Baccetti T, 2005, ANGLE ORTHOD, V75, P510; Baccetti T, 2007, AM J ORTHOD DENTOFAC, V132, P171, DOI 10.1016/j.ajodo.2005.07.031; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; BATTAGEL JM, 1994, EUR J ORTHODONT, V16, P71, DOI 10.1093/ejo/16.1.71; Berthold MR, 2007, STUDIES CLASSIFICATI; Betzenberger D, 1999, ANGLE ORTHOD, V69, P27; Bonanno G, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046130; Buchanan M, 2010, PHYS WORLD, V23, P22; Bui C, 2006, ANGLE ORTHOD, V76, P564; Caldarelli G., 2007, SCALE FREE NETWORKS; Franchi L, 1998, ANGLE ORTHOD, V68, P497; FREER TJ, 1973, AM J ORTHOD DENTOFAC, V64, P155, DOI 10.1016/S0002-9416(73)90307-2; Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Ma'ayan A, 2005, ANNU REV BIOPH BIOM, V34, P319, DOI 10.1146/annurev.biophys.34.040204.144415; Mesarovic M. D., 2004, Systems Biology, V1, P19, DOI 10.1049/sb:20045010; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Reyes BC, 2006, ANGLE ORTHOD, V76, P577; Royer L, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000108; Sanborn RT, 1955, ANGLE ORTHOD, V24, P208; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Solow B, 1980, Br J Orthod, V7, P145; Staley RN, 1995, TXB ORTHODONTICS, P98; Steilzig-Eisenhauer A, 2002, AM J ORTHOD DENTOFAC, V122, P27, DOI 10.1067/mod.2002.123632; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	30	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44521	10.1371/journal.pone.0044521	http://dx.doi.org/10.1371/journal.pone.0044521			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028552	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000309392800010
J	Pereda, J; Perez, S; Escobar, J; Arduini, A; Asensi, M; Serviddio, G; Sabater, L; Aparisi, L; Sastre, J				Pereda, Javier; Perez, Salvador; Escobar, Javier; Arduini, Alessandro; Asensi, Miguel; Serviddio, Gaetano; Sabater, Luis; Aparisi, Luis; Sastre, Juan			Obese Rats Exhibit High Levels of Fat Necrosis and Isoprostanes in Taurocholate-Induced Acute Pancreatitis	PLOS ONE			English	Article							OXIDATIVE STRESS; ASCITIC FLUID; ACINAR-CELLS; INFLAMMATORY RESPONSE; INSULIN-RESISTANCE; ADIPOSE-TISSUE; THROMBOXANE RECEPTORS; BILIARY PANCREATITIS; PERITONEAL-LAVAGE; DEFICIENT MICE	Background: Obesity is a prognostic factor for severity in acute pancreatitis in humans. Our aim was to assess the role of oxidative stress and abdominal fat in the increased severity of acute pancreatitis in obese rats. Methodology: Taurocholate-induced acute pancreatitis was performed in lean and obese Zucker rats. Levels of reduced glutathione, oxidized glutathione, L-cysteine, cystine, and S-adenosylmethionine were measured in pancreas as well as the activities of serine/threonine protein phosphatases PP1 and PP2A and tyrosin phosphatases. Isoprostane, malondialdehyde, triglyceride, and free fatty acid levels and lipase activity were measured in plasma and ascites. Lipase activity was measured in white adipose tissue with and without necrosis and confirmed by western blotting. Findings: Under basal conditions obese rats exhibited lower reduced glutathione levels in pancreas and higher triglyceride and free fatty acid levels in plasma than lean rats. S-adenosyl methionine levels were markedly increased in pancreas of obese rats. Acute pancreatitis in obese rats led to glutathione oxidation and lower reduced glutathione levels in pancreas together with decreased activities of redox-sensitive phosphatases PP1, and PP2A. S-adenosyl methionine levels decreased but cystine levels increased markedly in pancreas upon pancreatitis. Acute pancreatitis triggered an increase in isoprostane levels in plasma and ascites in obese rats. Free fatty acid levels were extremely high in pancreatitis-associated ascitic fluid from obese rats and lipase was bound with great affinity to white adipose tissue, especially to areas of necrosis. Conclusions: Our results show that oxidative stress occurs locally and systemically in obese rats with pancreatitis favouring inactivation of protein phosphatases in pancreas, which would promote up-regulation of pro-inflammatory cytokines, and the increase of isoprostanes which might cause powerful pulmonary and renal vasoconstriction. Future studies are needed to confirm the translational relevance of the present findings obtained in a rat model of taurocholate-induced pancreatic damage and necrosis.	[Pereda, Javier; Perez, Salvador; Escobar, Javier; Arduini, Alessandro; Asensi, Miguel; Sastre, Juan] Univ Valencia, Sch Pharm, Dept Physiol, Valencia, Spain; [Escobar, Javier] Univ Hosp Materno Infantil La Fe, Div Neonatol, Valencia, Spain; [Serviddio, Gaetano] Univ Foggia, Dept Med & Occupat Sci, Foggia, Italy; [Sabater, Luis] Univ Valencia, Univ Clin Hosp, Dept Surg, Valencia, Spain; [Aparisi, Luis] Univ Clin Hosp, Lab Pancreat Funct, Valencia, Spain	University of Valencia; University of Foggia; University of Valencia	Sastre, J (corresponding author), Univ Valencia, Sch Pharm, Dept Physiol, Valencia, Spain.	juan.sastre@uv.es	serviddio, gaetano/C-7629-2011; Pérez, Salvador/N-5943-2014; Miralles, Miguel A Asensi/I-2756-2015; Pereda, Javier/N-2424-2014	serviddio, gaetano/0000-0002-6424-7841; Pérez, Salvador/0000-0003-0766-1744; Miralles, Miguel A Asensi/0000-0003-1922-7777; Pereda, Javier/0000-0002-8690-8938; Arduini, Alessandro/0000-0002-0038-8741; Escobar, Javier/0000-0002-5044-991X	Spanish Ministry of Science and Innovation [SAF2009-09500, SAF2006-06963, CSD-2007-00020]; FEDER; University of Valencia [UV-INV-AE11-42462]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER(European Commission); University of Valencia	This work was supported by grants (SAF2009-09500, SAF2006-06963, and CSD-2007-00020) from the Spanish Ministry of Science and Innovation together with FEDER funds to JS and grant UV-INV-AE11-42462 from the University of Valencia to JP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsfasser G, 2002, DIGEST DIS SCI, V47, P1793, DOI 10.1023/A:1016496612906; Araki H, 2008, GUT, V57, P1431, DOI 10.1136/gut.2007.135665; Artwohl M, 2004, FASEB J, V18, P146, DOI 10.1096/fj.03-0301fje; Baggaley EM, 2008, AM J PHYSIOL-CELL PH, V295, pC1247, DOI 10.1152/ajpcell.00083.2008; BANERJEE M, 1992, AM J PHYSIOL, V263, pH660, DOI 10.1152/ajpheart.1992.263.3.H660; Basu S, 2010, MOL CELLS, V30, P383, DOI 10.1007/s10059-010-0157-1; Booth DM, 2011, GASTROENTEROLOGY, V140, P2116, DOI 10.1053/j.gastro.2011.02.054; CLEARY MP, 1980, AM J PHYSIOL, V238, pE284, DOI 10.1152/ajpendo.1980.238.3.E284; Cnop M, 2001, DIABETES, V50, P1771, DOI 10.2337/diabetes.50.8.1771; Crosswhite P, 2010, J HYPERTENS, V28, P201, DOI 10.1097/HJH.0b013e328332bcdb; Davies SS, 2011, FREE RADICAL BIO MED, V50, P559, DOI 10.1016/j.freeradbiomed.2010.11.023; de Dios I, 2006, J PATHOL, V210, P234, DOI 10.1002/path.2037; De Waele B, 2006, PANCREAS, V32, P343, DOI 10.1097/01.mpa.0000220857.55378.7b; den Boer M, 2004, ARTERIOSCL THROM VAS, V24, P644, DOI 10.1161/01.ATV.0000116217.57583.6e; deVries JE, 1997, J LIPID RES, V38, P1384; Ellis MP, 2009, BRIT J SURG, V96, P74, DOI 10.1002/bjs.6414; Escobar J, 2009, CURR PHARM DESIGN, V15, P3027, DOI 10.2174/138161209789058075; Folch E, 1999, ANN SURG, V230, P792, DOI 10.1097/00000658-199912000-00008; Folch E, 2000, FREE RADICAL BIO MED, V28, P1286, DOI 10.1016/S0891-5849(00)00245-8; Franco-Pons N, 2010, J PATHOL, V221, P175, DOI 10.1002/path.2691; Fujita M, 2001, PANCREAS, V22, P409, DOI 10.1097/00006676-200105000-00012; Gukovskaya AS, 2002, GASTROENTEROLOGY, V122, P974, DOI 10.1053/gast.2002.32409; Gutierrez PT, 2008, GUT, V57, P642, DOI 10.1136/gut.2007.127472; Jarvis LA, 2006, DEVELOPMENT, V133, P1133, DOI 10.1242/dev.02255; Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11; LEE PC, 1979, SURG GYNECOL OBSTET, V148, P39; Leung PS, 2009, ANTIOXID REDOX SIGN, V11, P135, DOI 10.1089/ars.2008.2109; Lu KK, 2003, FASEB J, V17, pA56, DOI 10.1096/fj.01-0752fje; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Martinez J, 2006, PANCREATOLOGY, V6, P206, DOI 10.1159/000092104; Martinez J, 1999, PANCREAS, V19, P15, DOI 10.1097/00006676-199907000-00002; Martinez J, 2004, PANCREATOLOGY, V4, P42, DOI 10.1159/000077025; Mitsuhashi S, 2001, BIOCHEM BIOPH RES CO, V287, P328, DOI 10.1006/bbrc.2001.5596; Mohler ER, 1996, BIOCHEM BIOPH RES CO, V225, P915, DOI 10.1006/bbrc.1996.1272; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; Mueed I, 2008, J THORAC CARDIOV SUR, V135, P131, DOI 10.1016/j.jtcvs.2007.06.023; Murr MM, 2002, J SURG RES, V106, P308, DOI 10.1006/jsre.2002.6474; NEUSCHWANDERTETRI BA, 1992, J CLIN INVEST, V89, P109, DOI 10.1172/JCI115550; NIEDERAU C, 1988, GASTROENTEROLOGY, V95, P1648, DOI 10.1016/S0016-5085(88)80091-X; Niederau C, 1996, FREE RADICAL BIO MED, V20, P877, DOI 10.1016/0891-5849(95)02153-1; Odinokova IV, 2009, GUT, V58, P431, DOI 10.1136/gut.2007.147207; Pandol SJ, 2007, GASTROENTEROLOGY, V133, P1056; Papachristou GI, 2006, PANCREATOLOGY, V6, P279, DOI 10.1159/000092689; PAPPAS TN, 1981, CLIN CHEM, V27, P358; Pereda J, 2008, FREE RADICAL BIO MED, V44, P1599, DOI 10.1016/j.freeradbiomed.2008.01.018; Pereda J, 2006, CURR MED CHEM, V13, P2775, DOI 10.2174/092986706778522011; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; Pfister SL, 2011, AM J PHYSIOL-HEART C, V300, pH2064, DOI 10.1152/ajpheart.01135.2010; Platell C, 2001, J GASTROEN HEPATOL, V16, P689, DOI 10.1046/j.1440-1746.2001.02497.x; PORTER KA, 1991, INT J PANCREATOL, V10, P247; Pou KM, 2007, CIRCULATION, V116, P1234, DOI 10.1161/CIRCULATIONAHA.107.710509; Ramudo L, 2005, CRIT CARE MED, V33, P143, DOI 10.1097/01.CCM.0000150654.13653.5B; Satoh A, 1999, PANCREAS, V19, P268, DOI 10.1097/00006676-199910000-00007; Schnekenburger J, 2005, GUT, V54, P1445, DOI 10.1136/gut.2004.063164; SCHOENBERG MH, 1992, FREE RADICAL BIO MED, V12, P515, DOI 10.1016/0891-5849(92)90104-O; Segersvaerd R, 2008, OBESITY, V16, P23, DOI 10.1038/oby.2007.27; Segersvard R, 2001, SCAND J GASTROENTERO, V36, P658, DOI 10.1080/003655201750163213; Sempere L, 2008, PANCREATOLOGY, V8, P257, DOI 10.1159/000134273; Sennello JA, 2008, P NATL ACAD SCI USA, V105, P8085, DOI 10.1073/pnas.0804091105; Takacs P, 2001, FASEB J, V15, P279; TAKAHASHI K, 1992, J CLIN INVEST, V90, P136, DOI 10.1172/JCI115826; TOSKES PP, 1990, GASTROENTEROL CLIN N, V19, P783; TRAYHURN P, 1984, CLIN ENDOCRINOL META, V13, P451, DOI 10.1016/S0300-595X(84)80033-X; Urakawa H, 2003, J CLIN ENDOCR METAB, V88, P4673, DOI 10.1210/jc.2003-030202; Wang Y, 2009, GUT, V58, P422, DOI 10.1136/gut.2007.146258; Wei YZ, 2008, AM J PHYSIOL-REG I, V294, pR673, DOI 10.1152/ajpregu.00561.2007; WONG SHY, 1987, CLIN CHEM, V33, P214; Yu JH, 2005, FREE RADICAL BIO MED, V39, P590, DOI 10.1016/j.freeradbiomed.2005.04.019; Zhang XP, 2008, DIGEST DIS SCI, V53, P297, DOI 10.1007/s10620-007-9866-5	69	27	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44383	10.1371/journal.pone.0044383	http://dx.doi.org/10.1371/journal.pone.0044383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028532	Green Submitted, Green Published, gold			2022-12-27	WOS:000311313900024
J	Debats, NB; Kingma, I; Beek, PJ; Smeets, JBJ				Debats, Nienke B.; Kingma, Idsart; Beek, Peter J.; Smeets, Jeroen B. J.			Moving the Weber Fraction: The Perceptual Precision for Moment of Inertia Increases with Exploration Force	PLOS ONE			English	Article							SIGNAL-DEPENDENT NOISE; MECHANICAL INVARIANTS; HAPTIC PERCEPTION; DYNAMIC TOUCH; HAND; WEIGHT; OBJECT; MASS; DISCRIMINATION; INTEGRATION	How does the magnitude of the exploration force influence the precision of haptic perceptual estimates? To address this question, we examined the perceptual precision for moment of inertia (i.e., an object's "angular mass") under different force conditions, using the Weber fraction to quantify perceptual precision. Participants rotated a rod around a fixed axis and judged its moment of inertia in a two-alternative forced-choice task. We instructed different levels of exploration force, thereby manipulating the magnitude of both the exploration force and the angular acceleration. These are the two signals that are needed by the nervous system to estimate moment of inertia. Importantly, one can assume that the absolute noise on both signals increases with an increase in the signals' magnitudes, while the relative noise (i.e., noise/signal) decreases with an increase in signal magnitude. We examined how the perceptual precision for moment of inertia was affected by this neural noise. In a first experiment we found that a low exploration force caused a higher Weber fraction (22%) than a high exploration force (13%), which suggested that the perceptual precision was constrained by the relative noise. This hypothesis was supported by the result of a second experiment, in which we found that the relationship between exploration force and Weber fraction had a similar shape as the theoretical relationship between signal magnitude and relative noise. The present study thus demonstrated that the amount of force used to explore an object can profoundly influence the precision by which its properties are perceived.	[Debats, Nienke B.; Kingma, Idsart; Beek, Peter J.; Smeets, Jeroen B. J.] Vrije Univ Amsterdam, Fac Human Movement Sci, Res Inst Move, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Debats, NB (corresponding author), Vrije Univ Amsterdam, Fac Human Movement Sci, Res Inst Move, Amsterdam, Netherlands.	N.B.Debats@vu.nl	Smeets, Jeroen/B-4198-2008	Smeets, Jeroen/0000-0002-3794-0579; Beek, Peter/0000-0002-0917-8548	Netherlands Organization for Scientific Research Grant [NWO/MaGW 400-07-185]	Netherlands Organization for Scientific Research Grant(Netherlands Organization for Scientific Research (NWO))	This research was supported in part by the Netherlands Organization for Scientific Research Grant NWO/MaGW 400-07-185. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	BRODIE EE, 1985, AM J PSYCHOL, V98, P469, DOI 10.2307/1422630; Debats NB, 2010, J NEUROPHYSIOL, V104, P2821, DOI 10.1152/jn.01029.2009; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Goldstein E. B, 2002, SENSATION PERCEPTION; Goossens HHLM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002508; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Harrison SJ, 2011, J EXP PSYCHOL HUMAN, V37, P193, DOI 10.1037/a0020407; JOHANSSON RS, 1983, TRENDS NEUROSCI, V6, P27, DOI 10.1016/0166-2236(83)90011-5; Jones KE, 2002, J NEUROPHYSIOL, V88, P1533, DOI 10.1152/jn.2002.88.3.1533; Kaim L, 2010, ATTEN PERCEPT PSYCHO, V72, P823, DOI 10.3758/APP.72.3.823; Kingma I, 2004, J EXP PSYCHOL HUMAN, V30, P346, DOI 10.1037/0096-1523.30.2.346; KNOWLES WB, 1966, HUM FACTORS, V8, P209, DOI 10.1177/001872086600800303; KREIFELDT JG, 1979, SCIENCE, V206, P588, DOI 10.1126/science.493965; LEDERMAN SJ, 1993, ACTA PSYCHOL, V84, P29, DOI 10.1016/0001-6918(93)90070-8; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; Ross H., 1986, FECHNER DAY 86, P71; ROSS HE, 1982, PERCEPT PSYCHOPHYS, V31, P429, DOI 10.3758/BF03204852; ROSS HE, 1987, Q J EXP PSYCHOL-A, V39, P77, DOI 10.1080/02724988743000042; SEKULER RW, 1974, AM J PSYCHOL, V87, P255, DOI 10.2307/1422019; SOLOMON HY, 1988, J EXP PSYCHOL HUMAN, V14, P404, DOI 10.1037/0096-1523.14.3.404; Tiest WMB, 2010, LECT NOTES COMPUT SC, V6191, P29, DOI 10.1007/978-3-642-14064-8_5; Tiest WMB, 2010, ATTEN PERCEPT PSYCHO, V72, P1144, DOI 10.3758/APP.72.4.1144; Turvey MT, 1996, AM PSYCHOL, V51, P1134, DOI 10.1037/0003-066X.51.11.1134; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; van Beers RJ, 2004, J NEUROPHYSIOL, V91, P1050, DOI 10.1152/jn.00652.2003; van Beers RJ, 2002, PHILOS T R SOC B, V357, P1137, DOI 10.1098/rstb.2002.1101; van de Langenberg R, 2006, J EXP PSYCHOL HUMAN, V32, P1093, DOI 10.1037/0096-1523.32.5.1093; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931	30	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e42941	10.1371/journal.pone.0042941	http://dx.doi.org/10.1371/journal.pone.0042941			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	019MC	23028437	gold, Green Published, Green Submitted			2022-12-27	WOS:000309742800003
J	Lahtz, C; Bates, SE; Jiang, Y; Li, AX; Wu, XW; Hahn, MA; Pfeifer, GP				Lahtz, Christoph; Bates, Steven E.; Jiang, Yong; Li, Arthur X.; Wu, Xiwei; Hahn, Maria A.; Pfeifer, Gerd P.			Gamma Irradiation Does Not Induce Detectable Changes in DNA Methylation Directly following Exposure of Human Cells	PLOS ONE			English	Article							BIOLOGICAL HALF-LIFE; IONIZING-RADIATION; INDUCED MUTATIONS; CANCER INCIDENCE; GENE-EXPRESSION; HYPERMETHYLATION; RADIOTHERAPY; CARCINOMA; CS-137; ASSAY	Environmental chemicals and radiation have often been implicated in producing alterations of the epigenome thus potentially contributing to cancer and other diseases. Ionizing radiation, released during accidents at nuclear power plants or after atomic bomb explosions, is a potentially serious health threat for the exposed human population. This type of high-energy radiation causes DNA damage including single- and double-strand breaks and induces chromosomal rearrangements and mutations, but it is not known if ionizing radiation directly induces changes in the epigenome of irradiated cells. We treated normal human fibroblasts and normal human bronchial epithelial cells with different doses of gamma-radiation emitted from a cesium 137 (Cs-137) radiation source. After a seven-day recovery period, we analyzed global DNA methylation patterns in the irradiated and control cells using the methylated-CpG island recovery assay (MIRA) in combination with high-resolution microarrays. Bioinformatics analysis revealed only a small number of potential methylation changes with low fold-difference ratios in the irradiated cells. These minor methylation differences seen on the microarrays could not be verified by COBRA (combined bisulfite restriction analysis) or bisulfite sequencing of selected target loci. Our study shows that acute gamma-radiation treatment of two types of human cells had no appreciable direct effect on DNA cytosine methylation patterns in exposed cells.	[Lahtz, Christoph; Bates, Steven E.; Jiang, Yong; Hahn, Maria A.; Pfeifer, Gerd P.] City Hope Natl Med Ctr, Dept Canc Biol, Beckman Res Inst, Duarte, CA USA; [Li, Arthur X.] City Hope Natl Med Ctr, Dept Informat Sci, Duarte, CA USA; [Wu, Xiwei] City Hope Natl Med Ctr, Dept Mol Med, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; City of Hope	Lahtz, C (corresponding author), City Hope Natl Med Ctr, Dept Canc Biol, Beckman Res Inst, Duarte, CA USA.	gpfeifer@coh.org		Lahtz, Christoph/0000-0002-0432-9773; Jiang, Yong/0000-0002-1198-1807	U.S. Army RDECOM Acquisition Center, Natick Contracting Division, Natick, MA [W911QY-10-C-0176]	U.S. Army RDECOM Acquisition Center, Natick Contracting Division, Natick, MA	This material is based upon work supported by the U.S. Army RDECOM Acquisition Center, Natick Contracting Division, Natick, MA under Contract No. W911QY-10-C-0176. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baylin SB, 2001, HUM MOL GENET, V10, P687, DOI 10.1093/hmg/10.7.687; Brenner DJ, 2000, CANCER, V88, P398, DOI 10.1002/(SICI)1097-0142(20000115)88:2<398::AID-CNCR22>3.0.CO;2-V; Charles M, 2001, J Radiol Prot, V21, P83, DOI 10.1088/0952-4746/21/1/609; Cologne JE, 1999, RADIAT RES, V152, P364, DOI 10.2307/3580221; CRYER MA, 1972, HEALTH PHYS, V23, P394; Dubrova YE, 2002, AM J HUM GENET, V71, P801, DOI 10.1086/342729; FELDBERG RS, 1981, INT J RADIAT BIOL, V40, P11, DOI 10.1080/713858228; Fornace AJ, 1999, GENE EXPRESSION, V7, P387; Gilbert ES, 2000, RADIAT RES, V154, P246, DOI 10.1667/0033-7587(2000)154[0246:LCIMW]2.0.CO;2; Goans RE, 2005, HEALTH PHYS, V89, P505, DOI 10.1097/01.HP.0000172144.94491.84; HASANEN E, 1971, ANN CLIN RES, V3, P236; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Ilnytskyy Y, 2011, MUTAT RES-FUND MOL M, V714, P113, DOI 10.1016/j.mrfmmm.2011.06.014; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; KLEINERMAN RA, 1995, CANCER, V76, P442, DOI 10.1002/1097-0142(19950801)76:3<442::AID-CNCR2820760315>3.0.CO;2-L; Kodama Y., 2012, INT J RAD BIOL; Lahtz C, 2011, J MOL CELL BIOL, V3, P51, DOI 10.1093/jmcb/mjq053; Laird PW, 2005, HUM MOL GENET, V14, pR65, DOI 10.1093/hmg/ddi113; Lichter MD, 2000, ARCH DERMATOL, V136, P1007, DOI 10.1001/archderm.136.8.1007; MARKOWITZ EH, 1970, GENETICS, V64, P313; O'Hagan HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000155; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Rauch T, 2005, LAB INVEST, V85, P1172, DOI 10.1038/labinvest.3700311; Rauch TA, 2008, P NATL ACAD SCI USA, V105, P252, DOI 10.1073/pnas.0710735105; Rauch TA, 2010, METHODS, V52, P213, DOI 10.1016/j.ymeth.2010.03.004; Rauch Tibor A., 2009, V507, P65, DOI 10.1007/978-1-59745-522-0_6; Ron E, 1998, RADIAT RES, V150, pS30, DOI 10.2307/3579806; Ron E, 1999, INT J CANCER, V82, P795, DOI 10.1002/(SICI)1097-0215(19990909)82:6<795::AID-IJC4>3.3.CO;2-B; Sont WN, 2001, AM J EPIDEMIOL, V153, P309, DOI 10.1093/aje/153.4.309; Spotheim-Maurizot M, 2010, MUTAT RES, V711, P41; Stohl A., 2011, ATMOS CHEM PHYS DISC, V11, P28319, DOI DOI 10.5194/ACPD-11-28319-2011; Vizir IY, 1999, J HERED, V90, P412, DOI 10.1093/jhered/90.3.412; Wu XW, 2010, CANCER RES, V70, P2718, DOI 10.1158/0008-5472.CAN-09-3631; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Yap J, 2002, INT J RADIAT ONCOL, V52, P1231, DOI 10.1016/S0360-3016(01)02799-7; Yasunari TJ, 2011, P NATL ACAD SCI USA, V108, P19530, DOI 10.1073/pnas.1112058108; Yeh HC, 2001, AM J EPIDEMIOL, V153, P749, DOI 10.1093/aje/153.8.749	37	27	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44858	10.1371/journal.pone.0044858	http://dx.doi.org/10.1371/journal.pone.0044858			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024770	Green Published, gold, Green Submitted			2022-12-27	WOS:000308860100028
J	Perreault, C				Perreault, Charles			The Pace of Cultural Evolution	PLOS ONE			English	Article							MILLENNIAL-SCALE; MODERN LIFE; RATES; IDENTIFICATION; ARCHITECTURE; PUNISHMENT; FREQUENCY; HOLOCENE; RECORD; TIME	Today, humans inhabit most of the world's terrestrial habitats. This observation has been explained by the fact that we possess a secondary inheritance mechanism, culture, in addition to a genetic system. Because it is assumed that cultural evolution occurs faster than biological evolution, humans can adapt to new ecosystems more rapidly than other animals. This assumption, however, has never been tested empirically. Here, I compare rates of change in human technologies to rates of change in animal morphologies. I find that rates of cultural evolution are inversely correlated with the time interval over which they are measured, which is similar to what is known for biological rates. This correlation explains why the pace of cultural evolution appears faster when measured over recent time periods, where time intervals are often shorter. Controlling for the correlation between rates and time intervals, I show that (1) cultural evolution is faster than biological evolution; (2) this effect holds true even when the generation time of species is controlled for; and (3) culture allows us to evolve over short time scales, which are normally accessible only to short-lived species, while at the same time allowing for us to enjoy the benefits of having a long life history.	Santa Fe Inst, Santa Fe, NM 87501 USA	The Santa Fe Institute	Perreault, C (corresponding author), Santa Fe Inst, Santa Fe, NM 87501 USA.	cperreault@santafe.edu	lionel, Scotto/K-8141-2012		Social Sciences and Humanities Research Council of Canada Doctoral Fellowship [752-2006-2301]	Social Sciences and Humanities Research Council of Canada Doctoral Fellowship(Social Sciences and Humanities Research Council of Canada (SSHRC))	The work was supported by a Social Sciences and Humanities Research Council of Canada Doctoral Fellowship [752-2006-2301] http://www.sshrc-crsh.gc.ca/home-accueil-eng.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANKLIN M, 1993, NATURE, V364, P203, DOI 10.1038/364203a0; [Anonymous], 1996, J ARCHAEOL METHOD TH, DOI [10.1007/BF02229401, DOI 10.1007/BF02229401]; Barker G., 1985, PREHISTORIC FARMING; Betts CM, 2006, AM ANTIQUITY, V71, P233, DOI 10.2307/40035904; BOEHM C, 1993, CURR ANTHROPOL, V34, P227, DOI 10.1086/204166; Bond G, 1997, SCIENCE, V278, P1257, DOI 10.1126/science.278.5341.1257; BOOKSTEIN FL, 1987, PALEOBIOLOGY, V13, P446; Boone J.L., 1984, HIST ARCHEOL, V18, P76; Booner JT, 1989, EVOLUTION CULTURE AN; BOYD R, 1995, ETHOL SOCIOBIOL, V16, P125, DOI 10.1016/0162-3095(94)00073-G; Boyd R., 1985, CULTURE EVOLUTIONARY; Boyd Robert, 1996, Proceedings of the British Academy, V88, P77; Brantingham PJ, 2010, J ARCHAEOL SCI, V37, P3211, DOI 10.1016/j.jas.2010.07.021; Cadle John E., 1993, P281; Cavalli-Sforza LL., 1981, CULTURAL TRANSMISSIO; Clarke G, 2003, SCIENCE, V301, P922, DOI 10.1126/science.1085921; Dean LG, 2012, SCIENCE, V335, P1114, DOI 10.1126/science.1213969; Deetz James, 1967, INVITATION ARCHAEOLO; Diehl MW, 1997, J FIELD ARCHAEOL, V24, P179, DOI 10.1179/009346997792208212; Ditlevsen PD, 1996, NATURE, V379, P810, DOI 10.1038/379810a0; Dodd C., 1984, NATL MUSEUM MAN MERC, P181; Drybred A, 1993, PHASE 1 ARCHAEOLOGIC, P289; Elston R.G., 2008, ARCHAEOLOGICAL PAPER, V12, P103; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fitzgerald W, 1982, NATL MUSEUM MAN MERC, V111; Foster T, 1969, SASKATCHEWAN ARCHAEO, P6; GINGERICH PD, 1987, CAN J ZOOL, V65, P1053, DOI 10.1139/z87-169; GINGERICH PD, 1993, AM J SCI, V293A, P453, DOI 10.2475/ajs.293.A.453; GINGERICH PD, 1983, SCIENCE, V222, P159, DOI 10.1126/science.222.4620.159; Gingerich PD, 2001, GENETICA, V112, P127, DOI 10.1023/A:1013311015886; Gould S. J., 1989, WONDERFUL LIFE BURGE; GOULD SJ, 1984, SCIENCE, V226, P994, DOI 10.1126/science.6505682; Grant P. R., 1986, ECOLOGY EVOLUTION DA; Greenhill SJ, 2010, P ROY SOC B-BIOL SCI, V277, P2443, DOI 10.1098/rspb.2010.0051; Hart JP, 2009, J ANTHROPOL ARCHAEOL, V28, P367, DOI 10.1016/j.jaa.2009.07.001; Hendry AP, 2008, MOL ECOL, V17, P20, DOI 10.1111/j.1365-294X.2007.03428.x; Hendry AP, 1999, EVOLUTION, V53, P1637, DOI 10.1111/j.1558-5646.1999.tb04550.x; Henrich J, 2003, EVOL ANTHROPOL, V12, P123, DOI 10.1002/evan.10110; Henrich J, 1998, EVOL HUM BEHAV, V19, P215, DOI 10.1016/S1090-5138(98)00018-X; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Hoard RJ, 2003, PLAINS ANTHROPOL, V48, pIV; Hoard RJ, 1992, THESIS U MISSOURI CO; Hoard RJ, 2003, PLAINS ANTHROPOL, V48, P1; Hughes SS, 1998, J ARCHAEOL METHOD TH, V5, P345, DOI 10.1007/BF02428421; Kapp L., 1987, CRAFT JAPANESE SWORD; Kenyon I, 1980, ARCHAEOLOGY E N AM, V8, P11; Kinnison MT, 2001, GENETICA, V112, P145, DOI 10.1023/A:1013375419520; Little B, 1992, HIST ARCHAEOL, V26, P85; Martin G., 2000, TECHNOLOGICAL INNOVA, P90; Mathew S, 2011, P NATL ACAD SCI US; McElreath R, 2003, CURR ANTHROPOL, V44, P122, DOI 10.1086/345689; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; Mesoudi A, 2011, CULTURAL EVOLUTION; Mesoudi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018239; Monroe JC, 2004, J JAMESTOWN REDISCOV, V2; Nettle D, 1999, LINGUA, V108, P119, DOI 10.1016/S0024-3841(98)00047-3; OBrien M., 1998, PREHISTORY MISSOURI; OBrien MJ, 2000, APPL EVOLUTIONARY AR; Pagel M, 2007, NATURE, V449, P717, DOI 10.1038/nature06176; Pyszczyk HW, 1999, PLAINS ANTHROPOL, V44, P163, DOI 10.1080/2052546.1999.11931954; Richerson PJ, 2010, P NATL ACAD SCI USA, V107, P8985, DOI 10.1073/pnas.0914631107; Richerson PJ., 2005, NOT GENES ALONE CULT; Richerson PJ, 1998, CURR ANTHROPOL, V39, P638; Roenke K, 1978, NW ANTHR RES NOTES; Rogers DS, 2008, P NATL ACAD SCI USA, V105, P3416, DOI 10.1073/pnas.0711802105; Rogers E.M., 1995, DIFFUSION INNOVATION; Roopnarine PD, 2003, ANNU REV ECOL EVOL S, V34, P605, DOI 10.1146/annurev.ecolsys.34.011802.132407; Sheets HD, 2001, PALEOBIOLOGY, V27, P429, DOI 10.1666/0094-8373(2001)027<0429:UCPTAD>2.0.CO;2; Shennan S, 2002, GENES MEMES HUMN HIS; Shott M, 1990, BRIDGEPORT TOWNSHIP, P59; Shott MJ, 1996, INTERD CONT, P279; Steele J, 2010, J ARCHAEOL SCI, V37, P1348, DOI 10.1016/j.jas.2009.12.039; Steffensen JP, 2008, SCIENCE, V321, P680, DOI 10.1126/science.1157707; STIGER M, 2001, HUNTER GATHERER ARCH; Surovell TA, 2009, J ARCHAEOL SCI, V36, P1715, DOI 10.1016/j.jas.2009.03.029; Tennie C, 2009, PHILOS T R SOC B, V364, P2405, DOI 10.1098/rstb.2009.0052; TOMASELLO M, 1993, BEHAV BRAIN SCI, V16, P495, DOI 10.1017/S0140525X0003123X; TORRENCE R, 1993, WORLD ARCHAEOL, V24, P467, DOI 10.1080/00438243.1993.9980220; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wang YJ, 2008, NATURE, V451, P1090, DOI 10.1038/nature06692; Warrick G, 2000, J WORLD PREHIST, V14, P415, DOI 10.1023/A:1011137725917; WILSHUSEN RH, 1989, AM ANTIQUITY, V54, P826, DOI 10.2307/280688	83	64	68	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45150	10.1371/journal.pone.0045150	http://dx.doi.org/10.1371/journal.pone.0045150			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	007AD	23024804	Green Submitted, Green Published, gold			2022-12-27	WOS:000308860100062
J	Ruhwald, M; Andersen, ES; Christensen, PB; Moessner, BK; Weis, N				Ruhwald, Morten; Andersen, Ellen Sloth; Christensen, Peer Brehm; Moessner, Belinda Klemmensen; Weis, Nina			IP-10 Can Be Measured in Dried Plasma Spots in Patients with Chronic Hepatitis C Infection	PLOS ONE			English	Article							PREDICTIVE-VALUE; LIVER FIBROSIS; BLOOD SPOTS; VIRUS-RNA; HCV; INFLAMMATION; CHEMOKINES; CORRELATE	The chemokine IP-10 (CXCL10) is a candidate marker for hepatitis C virus (HCV) fibrosis monitoring. The aim of this proof-ofconcept study is to assess if IP-10 measurements from dried plasma spots (DPS) are accurate in HCV-infected patients with either minimal or significant fibrosis. We measured IP-10 levels in plasma and DPS of 21 HCV-infected patients with cirrhosis and 19 patients with no/little fibrosis (determined with FibroScan). Cirrhotic patients had significantly higher levels of IP-10 compared to patients with minimal fibrosis. DPS and plasma measurements of IP-10 are comparable and the correlation was excellent (r(2) = 0.97, p<0.0001). The DPS based method for IP-10 detection performs well in HCV-infected patients with either minimal or significant fibrosis.	[Ruhwald, Morten] Copenhagen Univ Hosp, Clin Res Ctr, Copenhagen, Denmark; [Andersen, Ellen Sloth; Weis, Nina] Copenhagen Univ Hosp, Dept Infect Dis, Copenhagen, Denmark; [Andersen, Ellen Sloth] Copenhagen Univ Hosp, Rigshosp, Dept Infect Dis, Copenhagen, Denmark; [Christensen, Peer Brehm; Moessner, Belinda Klemmensen] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark; [Weis, Nina] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Copenhagen	Ruhwald, M (corresponding author), Copenhagen Univ Hosp, Clin Res Ctr, Copenhagen, Denmark.	mruhwald@gmail.com	Ruhwald, Morten/E-5757-2012; Weis, Nina/GLT-4232-2022; Christensen, Peer B./B-8042-2015	Christensen, Peer Brehm/0000-0003-1394-058X; Weis, Nina/0000-0002-3133-2724	Danish National Advanced Technology Foundation	Danish National Advanced Technology Foundation	The work was supported by the Danish National Advanced Technology Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabye MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039228; Andersen ES, 2011, EUR J CLIN MICROBIOL, V30, P761, DOI 10.1007/s10096-010-1149-y; Askarieh G, 2010, HEPATOLOGY, V51, P1523, DOI 10.1002/hep.23509; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Beinhardt S, 2012, GASTROENTEROLOGY, V142, P78, DOI 10.1053/j.gastro.2011.09.039; Casrouge A, 2011, J CLIN INVEST, V121, P308, DOI 10.1172/JCI40594; Darling JM, 2011, HEPATOLOGY, V53, P14, DOI 10.1002/hep.24056; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Lai M, 2011, AM J GASTROENTEROL, V106, P2121, DOI 10.1038/ajg.2011.343; Li K, 2012, HEPATOLOGY, V55, P666, DOI 10.1002/hep.24763; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Mei JV, 2001, J NUTR, V131, p1631S, DOI 10.1093/jn/131.5.1631S; Reiberger T, 2008, ANTIVIR THER, V13, P969; Ruhwald M, 2012, EXPERT REV MOL DIAGN, V12, P175, DOI [10.1586/ERM.11.97, 10.1586/erm.11.97]; Santos C, 2012, J VIROL METHODS, V179, P17, DOI 10.1016/j.jviromet.2011.06.012; Skogstrand K, 2005, CLIN CHEM, V51, P1854, DOI 10.1373/clinchem.2005.052241; Vergniol J, 2011, GASTROENTEROLOGY, V140, P1970, DOI 10.1053/j.gastro.2011.02.058; You CR, 2011, GUT LIVER, V5, P506, DOI 10.5009/gnl.2011.5.4.506; Zeremski M, 2008, HEPATOLOGY, V48, P1440, DOI 10.1002/hep.22500; Zeremski M, 2011, J HEPATOL, V55, P545, DOI 10.1016/j.jhep.2010.12.033; Zeremski M, 2009, J INFECT DIS, V200, P1774, DOI 10.1086/646614; Zhou X.H., 2002, STAT METHODS DIAGNOS, DOI 10.1002/9780470317082	22	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45181	10.1371/journal.pone.0045181	http://dx.doi.org/10.1371/journal.pone.0045181			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024806	gold, Green Submitted, Green Published			2022-12-27	WOS:000308860100064
J	Li, J; Ang, M; Cheung, CMG; Vania, M; Chan, ASY; Waduthantri, S; Yang, H; Chee, SP				Li, Jing; Ang, Marcus; Cheung, Chui Ming Gemmy; Vania, Maya; Chan, Anita Sook Yee; Waduthantri, Samanthila; Yang, Henry; Chee, Soon Phaik			Aqueous Cytokine Changes Associated with Posner-Schlossman Syndrome with and without Human Cytomegalovirus	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ANTERIOR UVEITIS; IMMUNOCOMPETENT PATIENTS; INFECTION; HUMOR; PROFILES; IL-10; REACTIVATION; EXPRESSION; LATENCY	Aim: To study the differences in aqueous cytokines in Posner-Schlossman Syndrome (PSS) patients with and without human cytomegalovirus (CMV) DNA in the aqueous humor. Methods: This is a prospective study. Fifty-three uveitis patients with clinical signs of PSS were enrolled and aqueous humor samples were collected. Fourteen PSS patients were positive of CMV DNA in the aqueous by polymerase chain reaction (PCR) analysis. These eyes were negative of common ocular pathogens such as herpes simplex virus, varicella-zoster virus, rubella virus and toxoplasma. Twenty-five otherwise healthy cataract patients were enrolled as controls. Cytokine concentration was measured by a magnetic color-bead-based multiplex assay and analyzed using statistical and classification approaches. Results: The average age of 53 PSS patients was 48.74 +/- 13.43 years (yrs) (mean 6 standard deviation) and 66.3 +/- 15.0 yrs for the controls. The median CMV viral DNA copy number was 26000/mL aqueous (range 1400 to 85000 copies/mL) in 14 CMV positive patients as determined by quantitative PCR. PSS aqueous had significantly higher Interleukin (IL)-8 (CXCL8), monocyte chemotactic protein-1 (CCL2), macrophage inhibitory protein 1-beta (CCL4), granulocyte colony-stimulating factor (GCSF) and transforming growth factor-beta (TGF-beta) levels than controls after adjusted by age and gender. IL-2, IL-12, tumor necrosis factor-alpha (TNF-alpha) and interferon-alpha (IFN-alpha) levels were significantly lower in PSS aqueous than controls. No difference between CMV positive PSS and CMV negative PSS aqueous was observed. Over 97% of PSS samples were distinguished from controls by elevated CXCL10 (> 500 ng/mL), CXCL8 (> 30 ng/mL) and CCL2 (> 60 ng/mL) levels. Conclusion: PSS eyes were characterized by elevated aqueous chemokine concentration. The presence of CMV viral DNA was not associated with significant change of the type of cytokine expression in PSS patients.	[Li, Jing; Ang, Marcus; Vania, Maya; Chan, Anita Sook Yee; Waduthantri, Samanthila; Chee, Soon Phaik] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Ophthalmol, Shanghai 200030, Peoples R China; [Li, Jing] Singapore Eye Res Inst, Ocular Inflammat Grp, Singapore, Singapore; [Ang, Marcus; Cheung, Chui Ming Gemmy; Chan, Anita Sook Yee; Waduthantri, Samanthila; Chee, Soon Phaik] Singapore Natl Eye Ctr, Ocular Inflammat Serv, Singapore, Singapore; [Ang, Marcus; Cheung, Chui Ming Gemmy; Chan, Anita Sook Yee; Waduthantri, Samanthila; Chee, Soon Phaik] Singapore Natl Eye Ctr, Serv Immunol, Singapore, Singapore; [Yang, Henry] Canc Sci Inst Singapore, Singapore, Singapore; [Chee, Soon Phaik] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117595, Singapore; [Chan, Anita Sook Yee] Singapore Gen Hosp, Dept Pathol, Singapore 0316, Singapore	Shanghai Jiao Tong University; National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; Singapore National Eye Center; National University of Singapore; Singapore General Hospital	Li, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Ophthalmol, Shanghai 200030, Peoples R China.	chee.soon.phaik@snec.com.sg		Cheung, Chui Ming Gemmy/0000-0003-3358-3516	Singapore Biomedical Research Council [SigN 09-026]; Singapore National Medical Research Council [NMRC/EDG/0050/2009, NMRC/CG/SERI/2010]	Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Singapore National Medical Research Council(National Medical Research Council, Singapore)	This study was supported by grants from Singapore Biomedical Research Council (SigN 09-026), Singapore National Medical Research Council (NMRC/EDG/0050/2009) and centre grant (NMRC/CG/SERI/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JK, 2006, AM J OPHTHALMOL, V142, P429, DOI 10.1016/j.ajo.2006.04.016; Anshu A, 2009, OPHTHALMOLOGY, V116, P624, DOI 10.1016/j.ophtha.2008.10.031; Calder VL, 1999, INVEST OPHTH VIS SCI, V40, P2019; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Chee SP, 2010, BRIT J OPHTHALMOL, V94, P1648, DOI 10.1136/bjo.2009.167767; Chee SP, 2008, AM J OPHTHALMOL, V145, P834, DOI 10.1016/j.ajo.2007.12.015; Chee SP, 2007, OPHTHALMOLOGY, V114, P798, DOI 10.1016/j.ophtha.2006.07.057; Chee SP, 2008, AM J OPHTHALMOL, V146, P883, DOI 10.1016/j.ajo.2008.09.001; Chee SP, 2011, GRAEFES ARCH CLIN EX; Cheung CMG, 2012, MOL VIS, V18, P830; Chua J, 2012, MOL VIS, V18, P431; Cook CH, 2003, CRIT CARE MED, V31, P1923, DOI 10.1097/01.CCM.0000070222.11325.C4; Cook CH, 2006, J VIROL, V80, P9151, DOI 10.1128/JVI.00216-06; Crough T, 2009, CLIN MICROBIOL REV, V22, P76, DOI 10.1128/CMR.00034-08; Curnow SJ, 2005, INVEST OPHTH VIS SCI, V46, P4251, DOI 10.1167/iovs.05-0444; El-Asrar AM, 2011, CLIN IMMUNOL; Hwang YS, 2011, GRAEF ARCH CLIN EXP, V249, P103, DOI 10.1007/s00417-010-1510-y; Hwang YS, 2010, GRAEF ARCH CLIN EXP, V248, P263, DOI 10.1007/s00417-009-1195-2; Jaber S, 2005, CHEST, V127, P233, DOI 10.1378/chest.127.1.233; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; Kongyai N, 2012, EYE LOND; Kuchtey J, 2010, INVEST OPHTH VIS SCI, V51, P6441, DOI 10.1167/iovs.10-5216; Lacomba MS, 2000, ARCH OPHTHALMOL-CHIC, V118, P768, DOI 10.1001/archopht.118.6.768; Lahmar I, 2009, J INFECT DIS, V199, P1239, DOI 10.1086/597478; Lawlor G, 2010, INFLAMM BOWEL DIS, V16, P1620, DOI 10.1002/ibd.21275; Miyanaga M, 2010, BRIT J OPHTHALMOL, V94, P336, DOI 10.1136/bjo.2008.156422; Muhaya M, 1998, CLIN EXP IMMUNOL, V111, P123; Ooi KGJ, 2006, INVEST OPHTH VIS SCI, V47, P272, DOI 10.1167/iovs.05-0790; Shazly TA, 2011, SEMIN OPHTHALMOL, V26, P282, DOI 10.3109/08820538.2011.605821; Sinclair J, 2008, J CLIN VIROL, V41, P180, DOI 10.1016/j.jcv.2007.11.014; Soderberg-Naucler C, 2008, J CLIN VIROL, V41, P218, DOI 10.1016/j.jcv.2007.11.009; Takase H, 2006, INVEST OPHTH VIS SCI, V47, P1557, DOI 10.1167/iovs.05-0836; Toro AI, 1996, RES VIROLOGY, V147, P233, DOI 10.1016/0923-2516(96)89654-3; van Boxtel LAA, 2007, OPHTHALMOLOGY, V114, P1358, DOI 10.1016/j.ophtha.2006.09.035; Verdonk RC, 2010, AM J PATHOL, V176, P3098, DOI 10.2353/ajpath.2010.100101; von Muller L, 2008, MED MICROBIOL IMMUN, V197, P75, DOI 10.1007/s00430-008-0087-0; Yamauchi Y, 2007, OCUL IMMUNOL INFLAMM, V15, P399, DOI 10.1080/09273940701486795; Zamir E, 2011, CLIN EXP OPHTHALMOL, V39, P913, DOI 10.1111/j.1442-9071.2011.02577.x	38	41	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44453	10.1371/journal.pone.0044453	http://dx.doi.org/10.1371/journal.pone.0044453			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028541	gold, Green Published, Green Submitted			2022-12-27	WOS:000308788700020
J	Isikman, SO; Greenbaum, A; Luo, W; Coskun, AF; Ozcan, A				Isikman, Serhan O.; Greenbaum, Alon; Luo, Wei; Coskun, Ahmet F.; Ozcan, Aydogan			Giga-Pixel Lensfree Holographic Microscopy and Tomography Using Color Image Sensors	PLOS ONE			English	Article							ON-CHIP MICROSCOPY; OPTICAL DIFFRACTION TOMOGRAPHY; DUAL-AXIS TOMOGRAPHY; DIGITAL HOLOGRAPHY; CELL-PHONE; RECONSTRUCTION; RESOLUTION; SUPERRESOLUTION; SYSTEM	We report Giga-pixel lensfree holographic microscopy and tomography using color sensor-arrays such as CMOS imagers that exhibit Bayer color filter patterns. Without physically removing these color filters coated on the sensor chip, we synthesize pixel super-resolved lensfree holograms, which are then reconstructed to achieve,350 nm lateral resolution, corresponding to a numerical aperture of similar to 0.8, across a field-of-view of similar to 20.5 mm(2). This constitutes a digital image with similar to 0.7 Billion effective pixels in both amplitude and phase channels (i.e., similar to 1.4 Giga-pixels total). Furthermore, by changing the illumination angle (e.g., +/- 50 degrees) and scanning a partially-coherent light source across two orthogonal axes, super-resolved images of the same specimen from different viewing angles are created, which are then digitally combined to synthesize tomographic images of the object. Using this dual-axis lensfree tomographic imager running on a color sensor-chip, we achieve a 3D spatial resolution of similar to 0.35 mu mx 0.35 mu m x similar to 2 mu m, in x, y and z, respectively, creating an effective voxel size of similar to 0.03 mu m(3) across a sample volume of similar to 5 mm(3), which is equivalent to.150 Billion voxels. We demonstrate the proof-of-concept of this lensfree optical tomographic microscopy platform on a color CMOS image sensor by creating tomograms of micro-particles as well as a wild-type C. elegans nematode.	[Isikman, Serhan O.; Greenbaum, Alon; Luo, Wei; Coskun, Ahmet F.; Ozcan, Aydogan] Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90024 USA; [Ozcan, Aydogan] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA; [Ozcan, Aydogan] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA USA; [Ozcan, Aydogan] Univ Calif Los Angeles, Sch Med, Dept Surg, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Isikman, SO (corresponding author), Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90024 USA.	ozcan@ucla.edu	Coskun, Ahmet F./K-2084-2013; Ozcan, Aydogan/I-2608-2013; Luo, Wei/I-7660-2017	Coskun, Ahmet F./0000-0002-5797-1524; Ozcan, Aydogan/0000-0002-0717-683X; Luo, Wei/0000-0002-4828-0721	Presidential Early Career Award for Scientists and Engineers (PECASE); ARO Young Investigator Award; National Science Foundation (NSF) CAREER Award; Office of Naval Research Young Investigator Award; National Institutes of Health (NIH) Director's New Innovator Award from Office of The Director, NIH [DP2OD006427]; NSF BISH program [0754880, 0930501]; Div Of Chem, Bioeng, Env, & Transp Sys [0954482] Funding Source: National Science Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006427] Funding Source: NIH RePORTER	Presidential Early Career Award for Scientists and Engineers (PECASE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARO Young Investigator Award; National Science Foundation (NSF) CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Office of Naval Research Young Investigator Award(Office of Naval Research); National Institutes of Health (NIH) Director's New Innovator Award from Office of The Director, NIH; NSF BISH program; Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	A. Ozcan gratefully acknowledges the support of the Presidential Early Career Award for Scientists and Engineers (PECASE), ARO Young Investigator Award, National Science Foundation (NSF) CAREER Award, the Office of Naval Research Young Investigator Award 2009 and the National Institutes of Health (NIH) Director's New Innovator Award DP2OD006427 from the Office of The Director, NIH. The authors also acknowledge the support of the NSF BISH program (under Awards # 0754880 and 0930501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NOK 808 PUREVIEW; Arslan I, 2006, ULTRAMICROSCOPY, V106, P994, DOI 10.1016/j.ultramic.2006.05.010; Bishara W, 2011, LAB CHIP, V11, P1276, DOI 10.1039/c0lc00684j; Bishara W, 2010, OPT EXPRESS, V18, P11181, DOI 10.1364/OE.18.011181; Brady DJ, 2012, NATURE, V486, P386, DOI 10.1038/nature11150; Brady DJ, 2009, OPT EXPRESS, V17, P13040, DOI 10.1364/OE.17.013040; Brady David J., 2009, OPTICAL IMAGING SPEC; Breslauer DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006320; Charriere F, 2006, OPT EXPRESS, V14, P7005, DOI 10.1364/OE.14.007005; Coskun AF, 2011, ANALYST, V136, P3512, DOI 10.1039/c0an00926a; Cuche E, 1999, OPT LETT, V24, P291, DOI 10.1364/OL.24.000291; Debailleul M, 2008, MEAS SCI TECHNOL, V19, DOI 10.1088/0957-0233/19/7/074009; GABOR D, 1948, NATURE, V161, P777, DOI 10.1038/161777a0; Garcia-Sucerquia J, 2006, OPT LETT, V31, P1211, DOI 10.1364/OL.31.001211; Goodman J. W., 2005, INTRO FOURIER OPTICS; Greenbaum A, 2012, NAT METHODS, V9, P889, DOI 10.1038/nmeth.2114; Greenbaum A, 2012, LAB CHIP, V12, P1242, DOI 10.1039/c2lc21072j; Greenbaum A, 2012, OPT EXPRESS, V20, P3129, DOI 10.1364/OE.20.003129; Grilli S, 2001, OPT EXPRESS, V9, P294, DOI 10.1364/OE.9.000294; Guo PY, 2005, J OPT SOC AM A, V22, P2338, DOI 10.1364/JOSAA.22.002338; Hardie RC, 1998, OPT ENG, V37, P247, DOI 10.1117/1.601623; Isikman SO, 2011, LAB CHIP, V11, P2222, DOI 10.1039/c1lc20127a; Isikman SO, 2011, P NATL ACAD SCI USA, V108, P7296, DOI 10.1073/pnas.1015638108; Isikman SO, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3548564; Javidi B, 2005, OPT EXPRESS, V13, P4492, DOI 10.1364/OPEX.13.004492; Khademhosseinieh B, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3405719; Lange D, 2005, SENSOR ACTUAT B-CHEM, V107, P904, DOI 10.1016/j.snb.2004.12.039; Lineback R, CMOS IMAGE SENSORS R; Liu JP, 2009, OPT LETT, V34, P250, DOI 10.1364/OL.34.000250; Martinez-Leon L, 2005, APPL OPTICS, V44, P3977, DOI 10.1364/AO.44.003977; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Messaoudil C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-288; Mudanyali O, 2010, LAB CHIP, V10, P2419, DOI 10.1039/c004829a; Mudanyali O, 2010, LAB CHIP, V10, P1417, DOI 10.1039/c000453g; Ntziachristos V, 2010, NAT METHODS, V7, P603, DOI [10.1038/NMETH.1483, 10.1038/nmeth.1483]; Oh C, 2010, OPT EXPRESS, V18, P4717, DOI 10.1364/OE.18.004717; Oh WY, 2006, OPT EXPRESS, V14, P8675, DOI 10.1364/OE.14.008675; Pang S, 2010, LAB CHIP, V10, P411, DOI 10.1039/b919004j; Park SC, 2003, IEEE SIGNAL PROC MAG, V20, P21, DOI 10.1109/MSP.2003.1203207; Psaltis D, 2006, NATURE, V442, P381, DOI 10.1038/nature05060; Radermacher M, 2006, WEIGHTED BACK PROJEC, P245; Seo S, 2010, ANAL CHEM, V82, P4621, DOI 10.1021/ac1007915; Smith ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017150; Su TW, 2010, ANAL CHEM, V82, P8307, DOI 10.1021/ac101845q; Sung YJ, 2009, OPT EXPRESS, V17, P266, DOI 10.1364/OE.17.000266; Tseng D, 2010, LAB CHIP, V10, P1787, DOI 10.1039/c003477k; Wolf E., 1969, Optics Communications, V1, P153, DOI 10.1016/0030-4018(69)90052-2; Xu WB, 2001, P NATL ACAD SCI USA, V98, P11301, DOI 10.1073/pnas.191361398; Yamaguchi I, 2002, OPT LETT, V27, P1108, DOI 10.1364/OL.27.001108; Zhu HY, 2012, ANALYST, V137, P2541, DOI 10.1039/c2an35071h; Zhu HY, 2011, ANAL CHEM, V83, P6641, DOI 10.1021/ac201587a; Zhu HY, 2011, LAB CHIP, V11, P315, DOI [10.1039/c0lc00358a, 10.1039/c01c00358a]	52	45	45	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45044	10.1371/journal.pone.0045044	http://dx.doi.org/10.1371/journal.pone.0045044			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984606	Green Published, gold, Green Submitted			2022-12-27	WOS:000308738500108
J	Kallberg, Y; Segerstolpe, A; Lackmann, F; Persson, B; Wieslander, L				Kallberg, Yvonne; Segerstolpe, Asa; Lackmann, Fredrik; Persson, Bengt; Wieslander, Lars			Evolutionary Conservation of the Ribosomal Biogenesis Factor Rbm19/Mrd1: Implications for Function	PLOS ONE			English	Article							RNA-RECOGNITION MOTIF; ENCEPHALITOZOON-CUNICULI; SECONDARY STRUCTURE; BINDING PROTEINS; SPLICING FACTORS; MOLECULAR-BASIS; SEQUENCE; SUBUNIT; DOMAINS; SPECIFICITY	Ribosome biogenesis in eukaryotes requires coordinated folding and assembly of a pre-rRNA into sequential pre-rRNA-protein complexes in which chemical modifications and RNA cleavages occur. These processes require many small nucleolar RNAs (snoRNAs) and proteins. Rbm19/Mrd1 is one such protein that is built from multiple RNA-binding domains (RBDs). We find that Rbm19/Mrd1 with five RBDs is present in all branches of the eukaryotic phylogenetic tree, except in animals and Choanoflagellates, that instead have a version with six RBDs and Microsporidia which have a minimal Rbm19/Mrd1 protein with four RBDs. Rbm19/Mrd1 therefore evolved as a multi-RBD protein very early in eukaryotes. The linkers between the RBDs have conserved properties; they are disordered, except for linker 3, and position the RBDs at conserved relative distances from each other. All but one of the RBDs have conserved properties for RNA-binding and each RBD has a specific consensus sequence and a conserved position in the protein, suggesting a functionally important modular design. The patterns of evolutionary conservation provide information for experimental analyses of the function of Rbm19/Mrd1. In vivo mutational analysis confirmed that a highly conserved loop 5-beta 4-strand in RBD6 is essential for function.	[Kallberg, Yvonne] Karolinska Inst, Ctr Mol Med, Sci Life Lab, Stockholm, Sweden; [Segerstolpe, Asa; Lackmann, Fredrik; Wieslander, Lars] Stockholm Univ, Dept Mol Biol & Funct Genom, S-10691 Stockholm, Sweden; [Persson, Bengt] Linkoping Univ, Swedish eSci Res Ctr, IFM Bioinformat, Linkoping, Sweden; [Persson, Bengt] Karolinska Inst, Sci Life Lab, Dept Cell & Mol Biol, Stockholm, Sweden	Karolinska Institutet; Stockholm University; Linkoping University; Swedish e-Science Research Centre (SeRC); Karolinska Institutet	Kallberg, Y (corresponding author), Karolinska Inst, Ctr Mol Med, Sci Life Lab, Stockholm, Sweden.	Lars.Wieslander@molbio.su.se	Wieslander, Lars/B-4670-2016	Wieslander, Lars/0000-0003-3271-6946; Persson, Bengt/0000-0003-3165-5344	Swedish Research Council; Carl Tryggers Stiftelse; Linkoping University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Tryggers Stiftelse; Linkoping University	This work was supported by the Swedish Research Council, Carl Tryggers Stiftelse, and Linkoping University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auweter SD, 2006, EMBO J, V25, P163, DOI 10.1038/sj.emboj.7600918; Auweter SD, 2006, NUCLEIC ACIDS RES, V34, P4943, DOI 10.1093/nar/gkl620; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Biderre C, 1997, J EUKARYOT MICROBIOL, V44, p76S, DOI 10.1111/j.1550-7408.1997.tb05790.x; Bingham J, 2000, BIOINFORMATICS, V16, P660, DOI 10.1093/bioinformatics/16.7.660; BIRNEY E, 1993, NUCLEIC ACIDS RES, V21, P5803, DOI 10.1093/nar/21.25.5803; Bjork P, 2002, MOL BIOL CELL, V13, P3683, DOI 10.1091/mbc.E02-03-0138; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Califice S, 2012, PLANT PHYSIOL, V158, P546, DOI 10.1104/pp.111.189019; Cao YQ, 2011, RES MICROBIOL, V162, P729, DOI 10.1016/j.resmic.2011.05.004; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Datta PP, 2007, MOL CELL, V28, P434, DOI 10.1016/j.molcel.2007.08.026; De Gaudenzi J, 2005, EUKARYOT CELL, V4, P2106, DOI 10.1128/EC.4.12.2106-2114.2005; Dominguez C, 2006, NUCLEIC ACIDS RES, V34, P3634, DOI 10.1093/nar/gkl488; ElAntak L, 2007, J BIOL CHEM, V282, P8165, DOI 10.1074/jbc.M610860200; Gatehouse HS, 1998, J INVERTEBR PATHOL, V71, P97, DOI 10.1006/jipa.1997.4737; Ginisty H, 2001, J BIOL CHEM, V276, P14338, DOI 10.1074/jbc.M011120200; Hage Aziz El, 2004, RNA Biol, V1, P10; HARTSKEERL RA, 1993, NUCLEIC ACIDS RES, V21, P1489, DOI 10.1093/nar/21.6.1489; Jin SB, 2002, J BIOL CHEM, V277, P18431, DOI 10.1074/jbc.M112395200; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lorenzen JA, 2005, GENE EXPR PATTERNS, V6, P45, DOI 10.1016/j.modgep.2005.05.001; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Lundkvist P, 2009, MOL CELL BIOL, V29, P5763, DOI 10.1128/MCB.00428-09; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Maruyama K, 1999, NUCLEIC ACIDS RES, V27, P2029, DOI 10.1093/nar/27.9.2029; Mayer AN, 2003, DEVELOPMENT, V130, P3917, DOI 10.1242/dev.00600; Mullineux ST, 2012, BIOCHIMIE, DOI j.biochi.2012.02.001; Nagai K, 1995, Nucleic Acids Symp Ser, P1; Pancevac C, 2010, NUCLEIC ACIDS RES, V38, P3119, DOI 10.1093/nar/gkq002; Peyretaillade E, 1998, NUCLEIC ACIDS RES, V26, P3513, DOI 10.1093/nar/26.15.3513; Peyretaillade E, 2011, RES MICROBIOL, V162, P598, DOI 10.1016/j.resmic.2011.03.004; Saijou E, 2004, NUCLEIC ACIDS RES, V32, P1028, DOI 10.1093/nar/gkh264; Segerstolpe A, 2008, NUCLEIC ACIDS RES, V36, P4364, DOI 10.1093/nar/gkn384; SHAMOO Y, 1995, NUCLEIC ACIDS RES, V23, P725, DOI 10.1093/nar/23.5.725; Sharma MR, 2005, MOL CELL, V18, P319, DOI 10.1016/j.molcel.2005.03.028; Tintaru AM, 2007, EMBO REP, V8, P756, DOI 10.1038/sj.embor.7401031; Varani G, 1998, ANNU REV BIOPH BIOM, V27, P407, DOI 10.1146/annurev.biophys.27.1.407; Wang LX, 2008, BIOINFORMATICS, V24, P1401, DOI 10.1093/bioinformatics/btn132; WISE JA, 1991, METHODS ENZYMOL, V194, P405; Zhang J, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-115	44	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43786	10.1371/journal.pone.0043786	http://dx.doi.org/10.1371/journal.pone.0043786			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984444	Green Published, Green Submitted, gold			2022-12-27	WOS:000308738500022
J	Park, CH; Kim, KT				Park, Choon-Ho; Kim, Kyong-Tai			Apoptotic Phosphorylation of Histone H3 on Ser-10 by Protein Kinase C delta	PLOS ONE			English	Article							PKC-DELTA; ACTIVATION; CHROMATIN; IDENTIFICATION; SENSITIVITY; SURVIVAL	Phosphorylation of histone H3 on Ser-10 is regarded as an epigenetic mitotic marker and is tightly correlated with chromosome condensation during both mitosis and meiosis. However, it was also reported that histone H3 Ser-10 phosphorylation occurs when cells are exposed to various death stimuli, suggesting a potential role in the regulation of apoptosis. Here we report that histone H3 Ser-10 phosphorylation is mediated by the pro-apoptotic kinase protein kinase C (PKC) delta during apoptosis. We observed that PKC delta robustly phosphorylates histone H3 on Ser-10 both in vitro and in vivo. Ectopic expression of catalytically active PKC delta efficiently induces condensed chromatin structure in the nucleus. We also discovered that activation of PKC delta is required for histone H3 Ser-10 phosphorylation after treatment with DNA damaging agents during apoptosis. Collectively, these findings suggest that PKC delta is the kinase responsible for histone H3 Ser-10 phosphoryation during apoptosis and thus contributes to chromatin condensation together with other apoptosis-related histone modifications. As a result, histone H3 Ser-10 phosphorylation can be designated a new 'apoptotic histone code' mediated by PKC delta.	[Park, Choon-Ho; Kim, Kyong-Tai] Pohang Univ Sci & Technol, Dept Life Sci, Div Mol & Life Sci, Pohang, South Korea; [Kim, Kyong-Tai] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Park, CH (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Div Mol & Life Sci, Pohang, South Korea.	ktk@postech.ac.kr		KIM, KYONG-TAI/0000-0001-7292-2627	National Research Foundation of Korea (NRF) [20110027957, 20110031234, 20120005830]; National Research Foundation of Korea (NRF) (WCU program) [R31-10105]; Brain Korea 21 program; National Frontier Research Program of the Korean Ministry of Education, Science and Technology [20110031517]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); National Research Foundation of Korea (NRF) (WCU program); Brain Korea 21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); National Frontier Research Program of the Korean Ministry of Education, Science and Technology	This work was supported by the National Research Foundation of Korea (NRF) (No. 20110027957, 20110031234, 20120005830, and WCU program R31-10105). This work was also supported by the Brain Korea 21 program and the National Frontier Research Program (20110031517) of the Korean Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek SH, 2011, MOL CELL, V42, P274, DOI 10.1016/j.molcel.2011.03.022; Bharti A, 1998, MOL CELL BIOL, V18, P6719, DOI 10.1128/MCB.18.11.6719; Bode Ann M, 2005, Sci STKE, V2005, pre4, DOI 10.1126/stke.2812005re4; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; Fullgrabe J, 2010, CELL DEATH DIFFER, V17, P1238, DOI 10.1038/cdd.2010.58; Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Goto H, 2002, GENES CELLS, V7, P11, DOI 10.1046/j.1356-9597.2001.00498.x; Grant PA, 2001, GENOME BIOL, V2; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hu Y, 2007, CELL DEATH DIFFER, V14, P2035, DOI 10.1038/sj.cdd.4402214; HUG H, 1993, BIOCHEM J, V291, P329, DOI 10.1042/bj2910329; Hurd PJ, 2009, J BIOL CHEM, V284, P16575, DOI 10.1074/jbc.M109.005421; Kang TH, 2007, MOL CELL BIOL, V27, P8533, DOI 10.1128/MCB.00018-07; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee YJ, 2002, CELL GROWTH DIFFER, V13, P237; Leitges M, 2001, J CLIN INVEST, V108, P1505; Mecklenbrauker I, 2004, NATURE, V431, P456, DOI 10.1038/nature02955; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Park CH, 2011, MOL BIOL CELL, V22, P1398, DOI 10.1091/mbc.E10-08-0717; Perez-Cadahia B, 2010, CURR OPIN DRUG DISC, V13, P613; Preuss U, 2003, NUCLEIC ACIDS RES, V31, P878, DOI 10.1093/nar/gkg176; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Wang D, 2004, J BIOL CHEM, V279, P20622, DOI 10.1074/jbc.M402547200; Waring P, 1997, J BIOL CHEM, V272, P17929, DOI 10.1074/jbc.272.29.17929; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Yoshida K, 2003, EMBO J, V22, P1431, DOI 10.1093/emboj/cdg134; Yoshida K, 2002, J BIOL CHEM, V277, P48372, DOI 10.1074/jbc.M205485200	36	28	28	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44307	10.1371/journal.pone.0044307	http://dx.doi.org/10.1371/journal.pone.0044307			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984491	Green Published, gold, Green Submitted			2022-12-27	WOS:000308738500046
J	Pires, RH; Karsai, A; Saraiva, MJ; Damas, AM; Kellermayer, MSZ				Pires, Ricardo H.; Karsai, Arpad; Saraiva, Maria J.; Damas, Ana M.; Kellermayer, Miklos S. Z.			Distinct Annular Oligomers Captured along the Assembly and Disassembly Pathways of Transthyretin Amyloid Protofibrils	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; IN-VITRO; PROTEIN AGGREGATION; ALZHEIMERS-DISEASE; FIBRIL FORMATION; PRION PROTEIN; WILD-TYPE; PH; INTERMEDIATE; DENATURATION	Background: Defects in protein folding may lead to severe degenerative diseases characterized by the appearance of amyloid fibril deposits. Cytotoxicity in amyloidoses has been linked to poration of the cell membrane that may involve interactions with amyloid intermediates of annular shape. Although annular oligomers have been detected in many amyloidogenic systems, their universality, function and molecular mechanisms of appearance are debated. Methodology/Principal Findings: We investigated with high-resolution in situ atomic force microscopy the assembly and disassembly of transthyretin (TTR) amyloid protofibrils formed of the native protein by pH shift. Annular oligomers were the first morphologically distinct intermediates observed in the TTR aggregation pathway. Morphological analysis suggests that they can assemble into a double-stack of octameric rings with a 16 +/- 2 nm diameter, and displaying the tendency to form linear structures. According to light scattering data coupled to AFM imaging, annular oligomers appeared to undergo a collapse type of structural transition into spheroid oligomers containing 8-16 monomers. Disassembly of TTR amyloid protofibrils also resulted in the rapid appearance of annular oligomers but with a morphology quite distinct from that observed in the assembly pathway. Conclusions/Significance: Our observations indicate that annular oligomers are key dynamic intermediates not only in the assembly but also in the disassembly of TTR protofibrils. The balance between annular and more compact forms of aggregation could be relevant for cytotoxicity in amyloidogenic disorders.	[Pires, Ricardo H.; Kellermayer, Miklos S. Z.] Semmelweis Univ, Fac Med, Dept Biophys & Radiat Biol, H-1085 Budapest, Hungary; [Pires, Ricardo H.; Saraiva, Maria J.; Damas, Ana M.] Univ Porto, Inst Mol & Cell Biol, P-4100 Oporto, Portugal; [Karsai, Arpad] Univ Pecs, Dept Biophys, Pecs, Hungary; [Saraiva, Maria J.; Damas, Ana M.] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4100 Oporto, Portugal	Semmelweis University; Universidade do Porto; University of Pecs; Universidade do Porto	Pires, RH (corresponding author), Semmelweis Univ, Fac Med, Dept Biophys & Radiat Biol, H-1085 Budapest, Hungary.	pires.ricardo@med.semmelweis-univ.hu; amdamas@ibmc.up.pt; kellermayer.miklos@med.semmelweis-univ.hu	Saraiva, Maria João/K-3907-2013	Saraiva, Maria João/0000-0002-3360-6899; Kellermayer, Miklos/0000-0002-5553-6553	Hungarian Science Foundation [OTKA K73256, K84133]; Hungarian National Office of Research and Technology [NANOAMI KFKT-1-2006-0021, OMFB-380/2006]; Hungarian Medical Research Council [ETT-229/09]; Hungarian National Development Agency [TAMOP-4.2.1.B-09/1/KMR-2010-0001]; EU [037525]; Calouste Gulbenkian Foundation (Portugal)	Hungarian Science Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian National Office of Research and Technology(National Office for Research and Technology); Hungarian Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Hungarian National Development Agency; EU(European Commission); Calouste Gulbenkian Foundation (Portugal)	This work was supported by grants from the Hungarian Science Foundation (OTKA K73256 and K84133, http://www.otka.hu), the Hungarian National Office of Research and Technology (NANOAMI KFKT-1-2006-0021, OMFB-380/2006), the Hungarian Medical Research Council (ETT-229/09, http://www.ett.hu), Hungarian National Development Agency (TAMOP-4.2.1.B-09/1/KMR-2010-0001, http://www.nfu.hu) to MSK and Project no. 037525 EURAMY (FP6-LIFESCIHEALTH-6, http://cordis.europa.eu) from EU to AMD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RHP acknowledges the award of a travel grant from the Calouste Gulbenkian Foundation (Portugal). We are thankful to Dr. Karoly Modos for useful discussions regarding the DLS measurements and data analysis.	Agocs G, 2010, FEBS LETT, V584, P1139, DOI 10.1016/j.febslet.2010.01.058; Ahmed M, 1942, NAT STRUCT MOL BIOL, V17, P561; Almeida MR, 1997, ENDOCRINE, V6, P309, DOI 10.1007/BF02820508; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; Blake C, 1996, STRUCTURE, V4, P989, DOI 10.1016/S0969-2126(96)00104-9; BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; BRYAN RK, 1990, FUND THEOR, V39, P221; Capone R, 2009, NEUROTOX RES, V16, P1, DOI 10.1007/s12640-009-9033-1; Cardoso I, 2002, J MOL BIOL, V317, P683, DOI 10.1006/jmbi.2002.5441; Carnally SM, 2008, BIOCHEM BIOPH RES CO, V372, P752, DOI 10.1016/j.bbrc.2008.05.100; Carrotta R, 2005, J BIOL CHEM, V280, P30001, DOI 10.1074/jbc.M500052200; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Damas AM, 2000, J STRUCT BIOL, V130, P290, DOI 10.1006/jsbi.2000.4273; Demuro A, 2011, J CELL BIOL, V195, P515, DOI 10.1083/jcb.201104133; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; Diociaiuti M, 2006, BIOPHYS J, V91, P2275, DOI 10.1529/biophysj.105.079475; Hill SE, 2009, BIOPHYS J, V96, P3781, DOI 10.1016/j.bpj.2009.01.044; Ishimaru D, 2003, BIOCHEMISTRY-US, V42, P9022, DOI 10.1021/bi034218k; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Kelly JW, 1997, ADV PROTEIN CHEM, V50, P161, DOI 10.1016/S0065-3233(08)60321-6; Kobori T, 2009, J BIOL CHEM, V284, P35507, DOI 10.1074/jbc.M109.060228; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Kumar S, 2009, J MOL BIOL, V385, P1266, DOI 10.1016/j.jmb.2008.11.033; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Lasagna-Reeves CA, 2011, J BIOL CHEM, V286, P22122, DOI 10.1074/jbc.M111.236257; Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; Last NB, 2011, P NATL ACAD SCI USA, V108, P9460, DOI 10.1073/pnas.1102356108; Liu K, 2000, NAT STRUCT BIOL, V7, P754; Malisauskas M, 2003, J MOL BIOL, V330, P879, DOI 10.1016/S0022-2836(03)00551-5; Modler AJ, 2004, AMYLOID, V11, P215, DOI 10.1080/13506120400014831; Modler AJ, 2003, J MOL BIOL, V325, P135, DOI 10.1016/S0022-2836(02)01175-0; Mukhopadhyay S, 2006, J MOL BIOL, V358, P935, DOI 10.1016/j.jmb.2006.02.006; Orte A, 2008, P NATL ACAD SCI USA, V105, P14424, DOI 10.1073/pnas.0803086105; Pires RH, 2011, J MOL RECOGNIT, V24, P467, DOI 10.1002/jmr.1112; Pountney DL, 2004, J NEUROCHEM, V90, P502, DOI 10.1111/j.1471-4159.2004.02533.x; Quintas A, 1997, FEBS LETT, V418, P297, DOI 10.1016/S0014-5793(97)01398-7; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; Saraiva Maria Joao Mascarenhas, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402004647; SARAIVA MJM, 1995, HUM MUTAT, V5, P191; Saraiva MJM, 2001, HUM MUTAT, V17, P493, DOI 10.1002/humu.1132; Sbrana F, 2007, EUR BIOPHYS J BIOPHY, V36, P727, DOI 10.1007/s00249-007-0159-x; Shahi P, 2007, BIOCHEMISTRY-US, V46, P7365, DOI 10.1021/bi7001136; Sokolowski F, 2003, J BIOL CHEM, V278, P40481, DOI 10.1074/jbc.M304391200; Srinivasan R, 2004, AMYLOID, V11, P10, DOI 10.1080/13506120410001667872; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Stefani M, 2012, PROG NEUROBIOL, DOI [10.1016/j.pneurobio.2012.1003.1002, DOI 10.1016/J.PNEUROBIO.2012.1003.1002]; Vendrely C, 2005, BBA-GEN SUBJECTS, V1724, P355, DOI 10.1016/j.bbagen.2005.05.017; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; Yamaguchi I, 2001, BIOCHEMISTRY-US, V40, P8499, DOI 10.1021/bi0027128; Zheng J, 2008, J PHYS CHEM B, V112, P6856, DOI 10.1021/jp711335b; Zhu M, 2004, J BIOL CHEM, V279, P24452, DOI 10.1074/jbc.M400004200	54	37	37	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44992	10.1371/journal.pone.0044992	http://dx.doi.org/10.1371/journal.pone.0044992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984597	Green Submitted, Green Published, gold			2022-12-27	WOS:000308738500103
J	Shao, CR; Sun, B; DeVoe, DL; Colombini, M				Shao, Chenren; Sun, Bing; DeVoe, Don L.; Colombini, Marco			Dynamics of Ceramide Channels Detected Using a Microfluidic System	PLOS ONE			English	Article							FORMS CHANNELS; ION CHANNELS; MEMBRANES; C-2-CERAMIDE; APOPTOSIS; PRESSURE; PROTEINS; LIPIDS	Ceramide, a proapoptotic sphingolipid, has been shown to form channels, in mitochondrial outer membranes, large enough to translocate proteins. In phospholipid membranes, electrophysiological studies and electron microscopic visualization both report that these channels form in a range of sizes with a modal value of 10 nm in diameter. A hydrogen bonded barrel-like structure consisting of hundreds of ceramide molecules has been proposed for the structure of the channel and this is supported by electrophysiological studies and molecular dynamic simulations. To our knowledge, the mechanical strength and deformability of such a large diameter but extremely thin cylindrical structure has never been reported. Here we present evidence for a reversible mechanical distortion of the cylinder following the addition of La3+. A microfluidic system was used to repeatedly lower and then restore the conductance by alternatively perfusing La3+ and EDTA. Although aspects of the kinetics of conductance drop and recovery are consistent with a disassembly/diffusion/reassembly model, others are inconsistent with the expected time scale of lateral diffusion of disassembled channel fragments in the membrane. The presence of a residual conductance following La3+ treatment and the relationship between the residual conductance and the initial conductance were both indicative of a distortion/recovery process in analogy with a pressure-induced distortion of a flexible cylinder.	[Shao, Chenren; DeVoe, Don L.] Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA; [Sun, Bing; Colombini, Marco] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Shao, CR (corresponding author), Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA.	colombini@umd.edu	DeVoe, Don L/A-2891-2011; Colombini, Marco/A-1540-2014	DeVoe, Don L/0000-0002-7740-9993; 	National Science Foundation [MCB-1023008, CBET0966407]; National Institutes of Health of the United States of America [R21EB009485, R21EB011750]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB011750, R21EB009485] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1023008] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health of the United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the National Science Foundation [MCB-1023008] and [CBET0966407] and by the National Institutes of Health [R21EB009485] and [R21EB011750] of the United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anishkin A, 2006, BIOPHYS J, V90, P2414, DOI 10.1529/biophysj.105.071977; Basanez G, 1999, P NATL ACAD SCI USA, V96, P5492, DOI 10.1073/pnas.96.10.5492; Cantor RS, 1999, CHEM PHYS LIPIDS, V101, P45, DOI 10.1016/S0009-3084(99)00054-7; Colombini M, 2010, BBA-BIOENERGETICS, V1797, P1239, DOI 10.1016/j.bbabio.2010.01.021; Ermakov YA, 2010, BIOPHYS J, V98, P1018, DOI 10.1016/j.bpj.2009.11.044; Ganesan V, 2010, FEBS LETT, V584, P2128, DOI 10.1016/j.febslet.2010.02.032; Ganesan V, 2010, APOPTOSIS, V15, P553, DOI 10.1007/s10495-009-0449-0; Gullingsrud J, 2004, BIOPHYS J, V86, P3496, DOI 10.1529/biophysj.103.034322; Heimburg T, 2010, BIOPHYS CHEM, V150, P2, DOI 10.1016/j.bpc.2010.02.018; Heimburg T, 2007, BIOPHYS J, V92, P3159, DOI 10.1529/biophysj.106.099754; Hromada LP, 2008, LAB CHIP, V8, P602, DOI 10.1039/b716388f; KAGAWA Y, 1971, J BIOL CHEM, V246, P5477; Linke WA, 2000, HISTOL HISTOPATHOL, V15, P799, DOI 10.14670/HH-15.799; Samanta S, 2011, BBA-BIOMEMBRANES, V1808, P1196, DOI 10.1016/j.bbamem.2011.01.007; Shao CR, 2011, ANN BIOMED ENG, V39, P2242, DOI 10.1007/s10439-011-0323-4; Siskind LJ, 2008, J BIOL CHEM, V283, P6622, DOI 10.1074/jbc.M706115200; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Siskind LJ, 2005, J BIOENERG BIOMEMBR, V37, P227, DOI 10.1007/s10863-005-6632-2; Siskind LJ, 2003, BIOPHYS J, V85, P1560, DOI 10.1016/S0006-3495(03)74588-3; Siskind LJ, 2002, J BIOL CHEM, V277, P26796, DOI 10.1074/jbc.M200754200; Siskind LJ, 2000, J BIOL CHEM, V275, P38640, DOI 10.1074/jbc.C000587200	21	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43513	10.1371/journal.pone.0043513	http://dx.doi.org/10.1371/journal.pone.0043513			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984432	Green Published, Green Submitted, gold			2022-12-27	WOS:000308738500016
J	Yao, B; Zhang, L; Liang, SD; Zhang, C				Yao, Bo; Zhang, Lin; Liang, Shide; Zhang, Chi			SVMTriP: A Method to Predict Antigenic Epitopes Using Support Vector Machine to Integrate Tri-Peptide Similarity and Propensity	PLOS ONE			English	Article							B-CELL EPITOPES; PROTEINS; DETERMINANTS; SEQUENCES; DATABASE; LOCATION; PROGRAM; CURVES; SITES; SCALE	Identifying protein surface regions preferentially recognizable by antibodies (antigenic epitopes) is at the heart of new immuno-diagnostic reagent discovery and vaccine design, and computational methods for antigenic epitope prediction provide crucial means to serve this purpose. Many linear B-cell epitope prediction methods were developed, such as BepiPred, ABCPred, AAP, BCPred, BayesB, BEOracle/BROracle, and BEST, towards this goal. However, effective immunological research demands more robust performance of the prediction method than what the current algorithms could provide. In this work, a new method to predict linear antigenic epitopes is developed; Support Vector Machine has been utilized by combining the Tri-peptide similarity and Propensity scores (SVMTriP). Applied to non-redundant B-cell linear epitopes extracted from IEDB, SVMTriP achieves a sensitivity of 80.1% and a precision of 55.2% with a five-fold cross-validation. The AUC value is 0.702. The combination of similarity and propensity of tri-peptide subsequences can improve the prediction performance for linear B-cell epitopes. Moreover, SVMTriP is capable of recognizing viral peptides from a human protein sequence background. A web server based on our method is constructed for public use. The server and all datasets used in the current study are available at http://sysbio.unl.edu/SVMTriP.	[Yao, Bo; Zhang, Chi] Univ Nebraska, Sch Biol Sci, Ctr Plant Sci & Innovat, Lincoln, NE 68583 USA; [Zhang, Lin] Univ Nebraska, Dept Stat, Lincoln, NE USA; [Liang, Shide] Osaka Univ, Immunol Frontier Res Ctr, Syst Immunol Lab, Suita, Osaka, Japan	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Osaka University	Yao, B (corresponding author), Univ Nebraska, Sch Biol Sci, Ctr Plant Sci & Innovat, Lincoln, NE 68583 USA.	shideliang@hotmail.com; czhang5@unl.edu	Liang, Shide/AAO-7663-2021; Zhang, Chi/C-4996-2009	Liang, Shide/0000-0003-2255-9887; Zhang, Chi/0000-0002-1827-8137	University of Nebraska, Lincoln, NE	University of Nebraska, Lincoln, NE	The work was supported by funding under Chi Zhang's startup funds from University of Nebraska, Lincoln, NE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix AJP, 1999, VACCINE, V18, P311, DOI 10.1016/S0264-410X(99)00329-1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Chen J, 2007, AMINO ACIDS, V33, P423, DOI 10.1007/s00726-006-0485-9; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Gao JZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040104; GETZOFF ED, 1988, ADV IMMUNOL, V43, P1; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; JOACHIMS T, 1999, MAKING LARGE SCALE S; KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Lei ZD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-291; MILICH DR, 1989, ADV IMMUNOL, V45, P195, DOI 10.1016/S0065-2776(08)60694-X; Odorico M, 2003, J MOL RECOGNIT, V16, P20, DOI 10.1002/jmr.602; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; PELLEQUER JL, 1993, IMMUNOL LETT, V36, P83, DOI 10.1016/0165-2478(93)90072-A; PELLEQUER JL, 1993, J MOL GRAPH MODEL, V11, P204, DOI 10.1016/0263-7855(93)80074-2; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Saha S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-79; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Schonbach C, 2000, NUCLEIC ACIDS RES, V28, P222, DOI 10.1093/nar/28.1.222; Vergara IA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-265; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Wang YL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-251; Wee LJK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S21	28	186	190	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45152	10.1371/journal.pone.0045152	http://dx.doi.org/10.1371/journal.pone.0045152			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984622	Green Published, gold			2022-12-27	WOS:000308738500120
J	Costantino, G; Ceriani, E; Rusconi, AM; Podda, GM; Montano, N; Duca, P; Cattaneo, M; Casazza, G				Costantino, Giorgio; Ceriani, Elisa; Rusconi, Anna Maria; Podda, Gian Marco; Montano, Nicola; Duca, Piergiorgio; Cattaneo, Marco; Casazza, Giovanni			Bleeding Risk during Treatment of Acute Thrombotic Events with Subcutaneous LMWH Compared to Intravenous Unfractionated Heparin; A Systematic Review	PLOS ONE			English	Review							MOLECULAR-WEIGHT HEPARIN; ACUTE CORONARY SYNDROMES; ACUTE MYOCARDIAL-INFARCTION; PULMONARY-EMBOLISM; CLINICAL-OUTCOMES; ANTITHROMBOTIC THERAPY; VENOUS THROMBOSIS; INITIAL TREATMENT; RANDOMIZED TRIAL; UNSTABLE ANGINA	Background: Low Molecular Weight Heparins (LMWH) are at least as effective antithrombotic drugs as Unfractionated Heparin (UFH). However, it is still unclear whether the safety profiles of LMWH and UFH differ. We performed a systematic review to compare the bleeding risk of fixed dose subcutaneous LMWH and adjusted dose UFH for treatment of venous thromboembolism (VTE) or acute coronary syndromes (ACS). Major bleeding was the primary end point. Methods: Electronic databases (MEDLINE, EMBASE, and the Cochrane Library) were searched up to May 2010 with no language restrictions. Randomized controlled trials in which subcutaneous LMWH were compared to intravenous UFH for the treatment of acute thrombotic events were selected. Two reviewers independently screened studies and extracted data on study design, study quality, incidence of major bleeding, patients' characteristics, type, dose and number of daily administrations of LMWH, co-treatments, study end points and efficacy outcome. Pooled odds ratios (OR) and 95% confidence intervals (CI) were calculated using the random effects model. Results: Twenty-seven studies were included. A total of 14,002 patients received UFH and 14,635 patients LMWH. Overall, no difference in major bleeding was observed between LMWH patients and UFH (OR = 0.79, 95% CI 0.60-1.04). In patients with VTE LMWH appeared safer than UFH, (OR = 0.68, 95% CI 0.47-1.00). Conclusion: The results of our systematic review suggest that the use of LMWH in the treatment of VTE might be associated with a reduction in major bleeding compared with UFH. The choice of which heparin to use to minimize bleeding risk must be based on the single patient, taking into account the bleeding profile of different heparins in different settings.	[Costantino, Giorgio; Ceriani, Elisa; Rusconi, Anna Maria; Montano, Nicola] Univ Milan, Osped L Sacco, Dipartimento Sci Clin L Sacco, Unita Operat Med Interna 2, Milan, Italy; [Podda, Gian Marco; Cattaneo, Marco; Casazza, Giovanni] Univ Milan, Unita Operat Med 3, Osped San Paolo, Dipartimento Med Chirurg & Odonotoiatria, Milan, Italy	University of Milan; Luigi Sacco Hospital; San Paolo-Polo Universitaria Hospital; University of Milan	Costantino, G (corresponding author), Univ Milan, Osped L Sacco, Dipartimento Sci Clin L Sacco, Unita Operat Med Interna 2, Milan, Italy.	giorgic@libero.it	costantino, giorgio/AAC-6441-2022; podda, Gianmarco/AAK-4498-2020; Casazza, Giovanni/G-3661-2012; Cattaneo, Marco/AAT-4080-2020; Duca, Piergiorgio/S-7525-2017	costantino, giorgio/0000-0002-6391-3849; podda, Gianmarco/0000-0002-1791-8905; Casazza, Giovanni/0000-0003-3718-1784; Montano, Nicola/0000-0001-9206-0075; Duca, Piergiorgio/0000-0003-4499-8805; Cattaneo, Marco/0000-0002-7343-4534				[Anonymous], 1991, Thromb Haemost, V65, P251; [Anonymous], 2003, STAT STAT SOFTW REL; Antman EM, 2005, AM HEART J, V149, P217, DOI 10.1016/j.ahj.2004.08.038; Belcaro G, 1999, ANGIOLOGY, V50, P781; Breddin HK, 2001, NEW ENGL J MED, V344, P626, DOI 10.1056/NEJM200103013440902; Campos Jose Victoria, 2002, Arch Cardiol Mex, V72, P209; Claudio Correia L C, 1995, Arq Bras Cardiol, V65, P475; Cohen M, 1997, NEW ENGL J MED, V337, P447, DOI 10.1056/NEJM199708143370702; Cohen M, 2002, AM HEART J, V144, P470, DOI 10.1067/mhj.2002.126115; de Lemos JA, 2004, EUR HEART J, V25, P1688, DOI 10.1016/j.ehj.2004.06.028; de Llano LAP, 2003, ARCH BRONCONEUMOL, V39, P341; Decousus H, 1998, NEW ENGL J MED, V338, P409, DOI 10.1056/NEJM199802123380701; DeEugenio D, 2007, PHARMACOTHERAPY, V27, P691, DOI 10.1592/phco.27.5.691; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Erkens PMG, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001100.pub3; Ferguson JJ, 2004, JAMA-J AM MED ASSOC, V292, P45; Fiessinger JN, 1996, THROMB HAEMOSTASIS, V76, P195; Findik S, 2002, RESPIRATION, V69, P440, DOI 10.1159/000064023; Goldhaber SZ, 1998, ARCH INTERN MED, V158, P2325, DOI 10.1001/archinte.158.21.2325; Goodman SG, 2003, CIRCULATION, V107, P238, DOI 10.1161/01.CIR.0000050144.67910.13; GURFINKEL EP, 1995, J AM COLL CARDIOL, V26, P313, DOI 10.1016/0735-1097(95)80001-W; Harenberg J, 2000, THROMB HAEMOSTASIS, V83, P652; HARENBERG J, 1990, HAEMOSTASIS, V20, P205; Harrington RA, 2008, CHEST, V133, p670S, DOI 10.1378/chest.08-0691; HULL RD, 1992, NEW ENGL J MED, V326, P975, DOI 10.1056/NEJM199204093261502; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jimenez D, 2009, THROMB HAEMOSTASIS, V102, P153, DOI 10.1160/TH09-01-0003; Kakkar VV, 2003, THROMB HAEMOSTASIS, V89, P674; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Kim JH, 2005, CIRC J, V69, P159, DOI 10.1253/circj.69.159; Kirchmaier CM, 1998, INT ANGIOL, V17, P135; Koopman MMW, 1996, NEW ENGL J MED, V334, P682, DOI 10.1056/NEJM199603143341102; Levine M, 1996, NEW ENGL J MED, V334, P677, DOI 10.1056/NEJM199603143341101; Lim W, 2006, ANN INTERN MED, V144, P673, DOI 10.7326/0003-4819-144-9-200605020-00011; LINDMARKER P, 1994, THROMB HAEMOSTASIS, V72, P186; Loke YK, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-32; Luomanmaki K, 1996, J INTERN MED, V240, P85, DOI 10.1046/j.1365-2796.1996.18845000.x; Magee KD, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002132; Malhotra S, 2001, INT J CLIN PHARM TH, V39, P110; Manoukian SV, 2007, J AM COLL CARDIOL, V49, P1362, DOI 10.1016/j.jacc.2007.02.027; Merli G, 2001, ANN INTERN MED, V134, P191, DOI 10.7326/0003-4819-134-3-200102060-00009; Meyer G, 1995, THROMB HAEMOSTASIS, V74, P1432; Montalescot G, 2003, AM J CARDIOL, V91, P925, DOI 10.1016/S0002-9149(03)00105-X; Moreno-Palomares J J, 2001, An Med Interna, V18, P364; Murphy SA, 2007, EUR HEART J, V28, P2077, DOI 10.1093/eurheartj/ehm224; PRANDONI P, 1992, LANCET, V339, P441, DOI 10.1016/0140-6736(92)91054-C; PRIME CARE Study Investigators Group, 2005, Indian Heart J, V57, P648; Quinlan DJ, 2004, ANN INTERN MED, V140, P175, DOI 10.7326/0003-4819-140-3-200402030-00008; Riess H, 2003, THROMB HAEMOSTASIS, V90, P252, DOI 10.1160/TH02-09-0061; Sabatine MS, 2005, CIRCULATION, V111, P2042, DOI 10.1161/01.CIR.0000162477.70955.5F; Silvain J, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e553; Simonneau G, 1997, NEW ENGL J MED, V337, P663, DOI 10.1056/NEJM199709043371002; SIMONNEAU G, 1993, ARCH INTERN MED, V153, P1541, DOI 10.1001/archinte.153.13.1541; Stricker H, 1999, THROMB HAEMOSTASIS, V82, P1227; tenCate JW, 1997, NEW ENGL J MED, V337, P657; THERY C, 1992, CIRCULATION, V85, P1380, DOI 10.1161/01.CIR.85.4.1380; Zhang Ye, 2004, Di Yi Jun Yi Da Xue Xue Bao, V24, P81	57	13	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44553	10.1371/journal.pone.0044553	http://dx.doi.org/10.1371/journal.pone.0044553			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984525	Green Published, gold, Green Submitted			2022-12-27	WOS:000308638700069
J	Jun, G; Moncaster, JA; Koutras, C; Seshadri, S; Buros, J; McKee, AC; Levesque, G; Wolf, PA; St George-Hyslop, P; Goldstein, LE; Farrer, LA				Jun, Gyungah; Moncaster, Juliet A.; Koutras, Carolina; Seshadri, Sudha; Buros, Jacqueline; McKee, Ann C.; Levesque, Georges; Wolf, Philip A.; St George-Hyslop, Peter; Goldstein, Lee E.; Farrer, Lindsay A.			delta-Catenin Is Genetically and Biologically Associated with Cortical Cataract and Future Alzheimer-Related Structural and Functional Brain Changes	PLOS ONE			English	Article							SUSCEPTIBILITY VARIANTS; COMMON VARIANTS; FRAMINGHAM; DISEASE; PROTEIN; HERITABILITY; GENE; AGE; PRESENILIN-1; LINKAGE	Multiple lines of evidence suggest that specific subtypes of age-related cataract (ARC) and Alzheimer disease (AD) are related etiologically. To identify shared genetic factors for ARC and AD, we estimated co-heritability of quantitative measures of cataract subtypes with AD-related brain MRI traits among 1,249 members of the Framingham Eye Study who had a brain MRI scan approximately ten years after the eye exam. Cortical cataract (CC) was found to be co-heritable with future development of AD and with several MRI traits, especially temporal horn volume (THV, rho = 0.24, P<10(-4)). A genome-wide association study using 187,657 single nucleotide polymorphisms (SNPs) for the bivariate outcome of CC and THV identified genome-wide significant association with CTNND2 SNPs rs17183619, rs13155993 and rs13170756 (P<2.6x10(-7))(.) These SNPs were also significantly associated with bivariate outcomes of CC and scores on several highly heritable neuropsychological tests (5.7x10(-9) <= P<3.7x10(-6)). Statistical interaction was demonstrated between rs17183619 and APP SNP rs2096488 on CC (P = 0.0015) and CC-THV (P = 0.038). A rare CTNND2 missense mutation (G810R) 249 base pairs from rs17183619 altered delta-catenin localization and increased secreted amyloid-beta(1-42) in neuronal cell culture. Immunohistopathological analysis of lens tissue obtained from two autopsy-confirmed AD subjects and two non-AD controls revealed elevated expression of delta-catenin in epithelial and cortical regions of lenses from AD subjects compared to controls. Our findings suggest that genetic variation in delta catenin may underlie both cortical lens opacities in mid-life and subsequent MRI and cognitive changes that presage the development of AD.	[Jun, Gyungah; Buros, Jacqueline; Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Med Biomed Genet, Boston, MA 02118 USA; [Jun, Gyungah; Buros, Jacqueline; Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Med Biomed Genet, Boston, MA USA; [Jun, Gyungah; Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA; [Jun, Gyungah; Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Ophthalmol, Boston, MA USA; [Jun, Gyungah; Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Biostat, Boston, MA 02118 USA; [Jun, Gyungah; Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Moncaster, Juliet A.; Goldstein, Lee E.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Moncaster, Juliet A.; Goldstein, Lee E.] Boston Univ, Sch Publ Hlth, Dept Psychiat, Boston, MA USA; [Seshadri, Sudha; McKee, Ann C.; Wolf, Philip A.; Goldstein, Lee E.; Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Seshadri, Sudha; McKee, Ann C.; Wolf, Philip A.; Goldstein, Lee E.; Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Neurol, Boston, MA USA; [McKee, Ann C.; Goldstein, Lee E.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [McKee, Ann C.; Goldstein, Lee E.] Boston Univ, Sch Publ Hlth, Dept Pathol & Lab Med, Boston, MA USA; [Wolf, Philip A.; Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Epidemiol, Boston, MA 02118 USA; [Wolf, Philip A.; Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Seshadri, Sudha; Wolf, Philip A.] Boston Univ, Sch Med, Framingham Heart Study, Boston, MA 02118 USA; [Seshadri, Sudha; Wolf, Philip A.] Boston Univ, Sch Publ Hlth, Framingham Heart Study, Boston, MA USA; [McKee, Ann C.; Goldstein, Lee E.; Farrer, Lindsay A.] Boston Univ, Sch Med, Alzheimers Dis Ctr, Boston, MA 02118 USA; [McKee, Ann C.; Goldstein, Lee E.; Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Alzheimers Dis Ctr, Boston, MA USA; [Koutras, Carolina; St George-Hyslop, Peter] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [McKee, Ann C.] Bedford Vet Adm Hosp, Geriatr Res Educ Clin Ctr, Bedford, MA USA; [Levesque, Georges] Univ Laval, CHUL, Neurosci Res Ctr, Quebec City, PQ, Canada; [St George-Hyslop, Peter] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England	Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Framingham Heart Study; Boston University; Framingham Heart Study; Boston University; Boston University; University of Toronto; Geriatric Research Education & Clinical Center; Laval University; University of Cambridge	Jun, G (corresponding author), Boston Univ, Sch Med, Dept Med Biomed Genet, Boston, MA 02118 USA.	gyungah@bu.edu; farrer@bu.edu	Farrer, Lindsay/AAS-1035-2020	Farrer, Lindsay/0000-0001-5533-4225; Buros, Jacqueline/0000-0001-9588-4889; Wolf, Philip/0000-0002-3628-301X; Moncaster, Juliet/0000-0002-7849-4325; Jun, Gyungah/0000-0002-3230-8697; Koutras, Carolina/0000-0002-9854-8458; Goldstein, Lee/0000-0001-8419-9800; Seshadri, Sudha/0000-0001-6135-2622	National Institute on Aging [R01-AG025259, R01-AG33193, R01-AG081220, R01-AG16495, R01-AG033040, P30-AG13846]; National Institute of General Medical Science [R01-GM75986]; Wellcome Trust; Medical Research Council; Canadian Institutes of Health Research; Alzheimer Society of Ontario; Ontario Research Fund; National Heart, Lung, and Blood Institute's Framingham Heart Study [N01-HC-25195]; Affymetrix, Inc [N02-HL-64278]; United States Public Health Service Resource grants from National Center for Research Resources [RR03655, RR163736]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033193, P30AG013846, R01AG025259, R01AG033040, R01AG008122, R01AG016495] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alzheimer Society of Ontario; Ontario Research Fund; National Heart, Lung, and Blood Institute's Framingham Heart Study(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Affymetrix, Inc; United States Public Health Service Resource grants from National Center for Research Resources; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants from the National Institute on Aging (R01-AG025259, R01-AG33193, R01-AG081220, R01-AG16495, R01-AG033040, and P30-AG13846), National Institute of General Medical Science (R01-GM75986), Wellcome Trust, Medical Research Council, Canadian Institutes of Health Research, Alzheimer Society of Ontario, and Ontario Research Fund. This work was also supported by the National Heart, Lung, and Blood Institute's Framingham Heart Study (contract N01-HC-25195) and its contract with Affymetrix, Inc, for genotyping services (contract N02-HL-64278). The results of this study were obtained by using the software package S. A. G. E. and the Boston University Linux Cluster for Genetic Analysis (LinGA) which are supported by United States Public Health Service Resource grants RR03655 and RR163736, respectively, from the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Andersson ME, 2007, MOL VIS, V13, P993; [Anonymous], 2011, ALZHEIMERS DIS FACTS; Au R, 2004, EXP AGING RES, V30, P333, DOI 10.1080/03610730490484380; Blacker D, 2007, ARCH NEUROL-CHICAGO, V64, P862, DOI 10.1001/archneur.64.6.862; Choi Seung-Hoan, 2011, BMC Proc, V5 Suppl 9, pS79, DOI 10.1186/1753-6561-5-S9-S79; Cooper MA, 2009, J COMP NEUROL, V514, P310, DOI 10.1002/cne.22030; DAWBER TR, 1966, CIRCULATION, V34, P553, DOI 10.1161/01.CIR.34.4.553; De Jager PL, 2011, NEUROBIOL A IN PRESS; DeCarli C, 2005, NEUROBIOL AGING, V26, P491, DOI 10.1016/j.neurobiolaging.2004.05.004; Dhaenens CM, 2004, NEUROSCI LETT, V368, P290, DOI 10.1016/j.neulet.2004.07.040; Duparc RH, 2006, DEV BIOL, V300, P647, DOI 10.1016/j.ydbio.2006.07.045; Elias MF, 2000, ARCH NEUROL-CHICAGO, V57, P808, DOI 10.1001/archneur.57.6.808; Elston Robert C, 2004, Hum Genomics, V1, P456; FARMER ME, 1987, PSYCHOL REP, V60, P1023, DOI 10.2466/pr0.1987.60.3c.1023; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Farrer LA, 1997, NEUROLOGIST, V3, P13, DOI 10.1097/00127893-199701000-00003; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Frederikse PH, 2002, AM J PATHOL, V161, P1985, DOI 10.1016/S0002-9440(10)64475-6; Frederikse PH, 1998, CURR EYE RES, V17, P947, DOI 10.1076/ceyr.17.9.947.5135; Frederikse PH, 2000, CURR EYE RES, V20, P462, DOI 10.1076/0271-3683(200006)20:6;1-Y;FT462; Georgakopoulos A, 1999, MOL CELL, V4, P893, DOI 10.1016/S1097-2765(00)80219-1; Goldstein LE, 2003, LANCET, V361, P1258, DOI 10.1016/S0140-6736(03)12981-9; Hatzfeld M, 1996, J CELL SCI, V109, P2767; Hiller R, 2003, OPHTHALMOLOGY, V110, P578, DOI 10.1016/S0161-6420(02)01762-1; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Jack CR, 2003, NEUROLOGY, V60, P253, DOI 10.1212/01.WNL.0000042480.86872.03; JACOBS DM, 1995, NEUROLOGY, V45, P957, DOI 10.1212/WNL.45.5.957; JANSSENS MJJ, 1979, EUPHYTICA, V28, P601, DOI 10.1007/BF00038926; Jun G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000584; Keen KJ, 2003, STAT MED, V22, P3229, DOI 10.1002/sim.1559; Kouchi Z, 2009, J BIOL CHEM, V284, P1954, DOI 10.1074/jbc.M806250200; Levesque G, 1999, J NEUROCHEM, V72, P999, DOI 10.1046/j.1471-4159.1999.0720999.x; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liauw J, 2002, MOL BRAIN RES, V109, P56, DOI 10.1016/S0169-328X(02)00491-6; Matter C, 2009, NEURON, V64, P320, DOI 10.1016/j.neuron.2009.09.026; Melov S, 2005, FREE RADICAL BIO MED, V38, P258, DOI 10.1016/j.freeradbiomed.2004.10.023; Moncaster JA, NONINVASIVE OC UNPUB; Moncaster JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010659; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; National Eye Institute, 2009, NAT PLAN EYE VIS RES; Potkin SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006501; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Restituito S, 2011, J NEUROSCI, V31, P12083, DOI 10.1523/JNEUROSCI.2513-11.2011; Sanfilippo PG, 2010, SURV OPHTHALMOL, V55, P561, DOI 10.1016/j.survophthal.2010.07.003; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Sherva R, 2011, CURR PSYCHIAT REP, V13, P138, DOI 10.1007/s11920-011-0184-4; Shiels A, 2010, MOL VIS, V16, P2007; So HC, 2011, GENET EPIDEMIOL, V35, P447, DOI 10.1002/gepi.20593; So HC, 2011, GENET EPIDEMIOL, V35, P310, DOI 10.1002/gepi.20579; Stahl B, 1999, J BIOL CHEM, V274, P9141, DOI 10.1074/jbc.274.14.9141; TAYLOR HR, 1989, AUST NZ J OPHTHALMOL, V17, P81, DOI 10.1111/j.1442-9071.1989.tb00492.x; von Otter M, 2010, NEUROMOL MED, V12, P229, DOI 10.1007/s12017-009-8103-0; Wang T, 2007, ANN HUM GENET, V71, P96, DOI 10.1111/j.1469-1809.2006.00303.x; Wang T, 2005, GENET EPIDEMIOL, V29, P12, DOI 10.1002/gepi.20075; WEST SK, 1988, INVEST OPHTH VIS SCI, V29, P73; Zhou JH, 1997, NEUROREPORT, V8, P1489, DOI 10.1097/00001756-199704140-00033	59	45	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43728	10.1371/journal.pone.0043728	http://dx.doi.org/10.1371/journal.pone.0043728			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984439	Green Submitted, Green Published, gold			2022-12-27	WOS:000308638700028
J	Kling, D; Egeland, T; Mostad, P				Kling, Daniel; Egeland, Thore; Mostad, Petter			Using Object Oriented Bayesian Networks to Model Linkage, Linkage Disequilibrium and Mutations between STR Markers	PLOS ONE			English	Article							IDENTIFICATION; PATERNITY	In a number of applications there is a need to determine the most likely pedigree for a group of persons based on genetic markers. Adequate models are needed to reach this goal. The markers used to perform the statistical calculations can be linked and there may also be linkage disequilibrium (LD) in the population. The purpose of this paper is to present a graphical Bayesian Network framework to deal with such data. Potential LD is normally ignored and it is important to verify that the resulting calculations are not biased. Even if linkage does not influence results for regular paternity cases, it may have substantial impact on likelihood ratios involving other, more extended pedigrees. Models for LD influence likelihoods for all pedigrees to some degree and an initial estimate of the impact of ignoring LD and/or linkage is desirable, going beyond mere rules of thumb based on marker distance. Furthermore, we show how one can readily include a mutation model in the Bayesian Network; extending other programs or formulas to include such models may require considerable amounts of work and will in many case not be practical. As an example, we consider the two STR markers vWa and D12S391. We estimate probabilities for population haplotypes to account for LD using a method based on data from trios, while an estimate for the degree of linkage is taken from the literature. The results show that accounting for haplotype frequencies is unnecessary in most cases for this specific pair of markers. When doing calculations on regular paternity cases, the markers can be considered statistically independent. In more complex cases of disputed relatedness, for instance cases involving siblings or so-called deficient cases, or when small differences in the LR matter, independence should not be assumed. (The networks are freely available at http://arken.umb.no/similar to dakl/BayesianNetworks.)	[Kling, Daniel; Egeland, Thore] Norwegian Inst Publ Hlth, Dept Family Genet, Oslo, Norway; [Kling, Daniel; Egeland, Thore] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Mostad, Petter] Chalmers Univ Technol & Math Sci, Gothenburg, Sweden	Norwegian Institute of Public Health (NIPH); Norwegian University of Life Sciences; Chalmers University of Technology	Kling, D (corresponding author), Norwegian Inst Publ Hlth, Dept Family Genet, Oslo, Norway.	daniel.kling@fhi.no	Mostad, Petter/AAB-9960-2021	Mostad, Petter/0000-0002-2569-6070	Norwegian Institute of Public Health	Norwegian Institute of Public Health	The work was funded by the Norwegian Institute of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Biedermann A, 2006, FORENSIC SCI INT, V163, P18, DOI 10.1016/j.forsciint.2005.11.001; Brenner CH, 1997, GENETICS, V145, P535; Buckleton J.S., 2004, FORENSIC DNA EVIDENC; Budowle B, 2011, INT J LEGAL MED, V125, P101, DOI 10.1007/s00414-010-0516-7; Dawid AP, 2007, FORENSIC SCI INT, V169, P195, DOI 10.1016/j.forsciint.2006.08.028; Egeland T, 2000, FORENSIC SCI INT, V110, P47, DOI 10.1016/S0379-0738(00)00147-X; Egeland T, 2008, FORENSIC SCI INT-GEN, V2, P219, DOI 10.1016/j.fsigen.2008.02.006; Gill P, 2011, FORENSIC SCI INT-GEN, V6, P477; Gill P, 2006, FORENSIC SCI INT, V163, P155, DOI 10.1016/j.forsciint.2005.11.025; Gomes RR, 2009, GENET MOL RES, V8, P273, DOI 10.4238/vol8-1gmr555; Hepler AB, 2008, FORENSIC SCI INT-GEN, V2, P166, DOI 10.1016/j.fsigen.2007.12.003; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Kling D, 2012, FORENSIC SCI INT-GEN, V6, P616, DOI 10.1016/j.fsigen.2012.01.012; Kling D, 2012, FORENSIC SCI INT-GEN, V6, P322, DOI 10.1016/j.fsigen.2011.07.007; Koller D., 1997, P 13 C UNC ART INT U, P302; Lauritzen SL, 2003, STAT SCI, V18, P489, DOI 10.1214/ss/1081443232; O'Connor KL, 2011, FORENSIC SCI INT-GEN, V5, P538, DOI 10.1016/j.fsigen.2010.09.003; Phillips C, 2011, FORENSIC SCI INT-GEN, V5, P155, DOI 10.1016/j.fsigen.2010.02.003; Skare O, 2009, BIOINFORMATICS, V25, P2376, DOI 10.1093/bioinformatics/btp418; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Taroni F., 2014, BAYESIAN NETWORKS PR, VSecond, DOI 10.1002/0470091754; Tillmar AO, 2011, FORENSIC SCI INT-GEN, V5, P506, DOI 10.1016/j.fsigen.2010.11.004	24	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43873	10.1371/journal.pone.0043873	http://dx.doi.org/10.1371/journal.pone.0043873			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984448	Green Published, gold, Green Submitted			2022-12-27	WOS:000308638700031
J	Porazinska, DL; Giblin-Davis, RM; Powers, TO; Thomas, WK				Porazinska, Dorota L.; Giblin-Davis, Robin M.; Powers, Thomas O.; Thomas, W. Kelley			Nematode Spatial and Ecological Patterns from Tropical and Temperate Rainforests	PLOS ONE			English	Article							CRYPTIC DIVERSITY; BIODIVERSITY; COMMUNITIES; GENERATION; NUMBER; PLANT	Large scale diversity patterns are well established for terrestrial macrobiota (e.g. plants and vertebrates), but not for microscopic organisms (e.g. nematodes). Due to small size, high abundance, and extensive dispersal, microbiota are assumed to exhibit cosmopolitan distributions with no biogeographical patterns. This assumption has been extrapolated from local spatial scale studies of a few taxonomic groups utilizing morphological approaches. Recent molecularly-based studies, however, suggest something quite opposite. Nematodes are the most abundant metazoans on earth, but their diversity patterns are largely unknown. We conducted a survey of nematode diversity within three vertical strata (soil, litter, and canopy) of rainforests at two contrasting latitudes in the North American meridian (temperate: the Olympic National Forest, WA, U.S.A and tropical: La Selva Biological Station, Costa Rica) using standardized sampling designs and sample processing protocols. To describe nematode diversity, we applied an ecometagenetic approach using 454 pyrosequencing. We observed that: 1) nematode communities were unique without even a single common species between the two rainforests, 2) nematode communities were unique among habitats in both rainforests, 3) total species richness was 300% more in the tropical than in the temperate rainforest, 4) 80% of the species in the temperate rainforest resided in the soil, whereas only 20% in the tropics, 5) more than 90% of identified species were novel. Overall, our data provided no support for cosmopolitanism at both local (habitats) and large (rainforests) spatial scales. In addition, our data indicated that biogeographical patterns typical of macrobiota also exist for microbiota.	[Porazinska, Dorota L.; Giblin-Davis, Robin M.] Univ Florida, Inst Food & Agr Sci, Ft Lauderdale Res & Educ Ctr, Ft Lauderdale, FL 33314 USA; [Powers, Thomas O.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA; [Thomas, W. Kelley] Univ New Hampshire, Hubbard Ctr Genome Studies, Durham, NH 03824 USA	State University System of Florida; University of Florida; University of Nebraska System; University of Nebraska Lincoln; University System Of New Hampshire; University of New Hampshire	Porazinska, DL (corresponding author), Univ Florida, Inst Food & Agr Sci, Ft Lauderdale Res & Educ Ctr, Ft Lauderdale, FL 33314 USA.	dorotalp@ufl.edu		Giblin-Davis, Robin/0000-0002-8861-8678	United States Department of Agriculture/Cooperative State Research, Education, and Extension Service - Tropical and Subtropical Agricultural Research [2006-04347, 2008-34135 -19505]; National Science Foundation - Biodiversity Surveys and Inventories [DEB-0450537]; University of Florida Open-Access Publishing Fund	United States Department of Agriculture/Cooperative State Research, Education, and Extension Service - Tropical and Subtropical Agricultural Research; National Science Foundation - Biodiversity Surveys and Inventories(National Science Foundation (NSF)); University of Florida Open-Access Publishing Fund	This work has been supported by the United States Department of Agriculture/Cooperative State Research, Education, and Extension Service - Tropical and Subtropical Agricultural Research (grants 2006-04347 and 2008-34135 -19505), the National Science Foundation (DEB-0450537) - Biodiversity Surveys and Inventories. Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amaral-Zettler Linda, 2010, P223; Baas-Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN, P263; Beijerinck M, 1918, JB KONINKLIJKE AKAD; Bik HM, 2012, MOL ECOL, V21, P1048, DOI 10.1111/j.1365-294X.2011.05297.x; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Boag B, 1998, BIODIVERS CONSERV, V7, P617, DOI 10.1023/A:1008852301349; Chao A, 2000, STAT SINICA, V10, P227; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; COLWELL R. K, 2009, ESTIMATES STAT ESTIM; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; DELEY P, 2006, WORMBOOK, DOI DOI 10.1895/WORMBOOK.1.41.1; Derycke S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013716; Derycke S, 2010, ZOOL SCR, V39, P276, DOI 10.1111/j.1463-6409.2009.00420.x; Fenchel T, 2004, BIOSCIENCE, V54, P777, DOI 10.1641/0006-3568(2004)054[0777:TUOSSP]2.0.CO;2; Fenchel T, 1997, OIKOS, V80, P220, DOI 10.2307/3546589; Finlay BJ, 1996, Q REV BIOL, V71, P221, DOI 10.1086/419370; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Fonseca VG, 2010, CARBON NANOTUBES LON, V1, DOI [10.1038/ncomms1095, DOI 10.1038/NCOMMS1095]; Fontaneto D, 2006, GLOBAL ECOL BIOGEOGR, V15, P153, DOI 10.1111/j.1466-822X.2006.00193.x; Fulthorpe RR, 2008, ISME J, V2, P901, DOI 10.1038/ismej.2008.55; Guil N, 2009, SYST BIODIVERS, V7, P259, DOI 10.1017/S1477200009003016; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; JENKINS W. R., 1964, PLANT DIS REP, V48, P692; Kiontke KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-339; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Medinger R, 2010, MOL ECOL, V19, P32, DOI 10.1111/j.1365-294X.2009.04478.x; Neher DA, 2010, ANNU REV PHYTOPATHOL, V48, P371, DOI 10.1146/annurev-phyto-073009-114439; Nolte V, 2010, MOL ECOL, V19, P2908, DOI 10.1111/j.1365-294X.2010.04669.x; Porazinska DL, 2012, J NEMATOL IN PRESS, V44; Porazinska DL, 2010, ZOOTAXA, P55, DOI 10.11646/zootaxa.2427.1.6; Porazinska DL, 2010, MOL ECOL, V19, P5521, DOI 10.1111/j.1365-294X.2010.04891.x; Porazinska DL, 2010, MOL ECOL RESOUR, V10, P666, DOI 10.1111/j.1755-0998.2009.02819.x; Porazinska DL, 2009, MOL ECOL RESOUR, V9, P1439, DOI 10.1111/j.1755-0998.2009.02611.x; Powers TO, 2009, MOL ECOL, V18, P985, DOI 10.1111/j.1365-294X.2008.04075.x; Robeson MS, 2011, P NATL ACAD SCI USA, V108, P4406, DOI 10.1073/pnas.1012678108; Sollins Phillip, 1994, P34; Sudhaus W, 2007, ZOOTAXA, P45, DOI 10.11646/zootaxa.1456.1.2; Taylor JW, 2006, PHILOS T R SOC B, V361, P1947, DOI 10.1098/rstb.2006.1923; VIGLIERCHIO DR, 1983, J NEMATOL, V15, P438; Wardle D., 2002, COMMUNITIES ECOSYSTE; Wu TH, 2011, P NATL ACAD SCI USA, V108, P17720, DOI 10.1073/pnas.1103824108; YEATES GW, 1993, J NEMATOL, V25, P315; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	46	49	52	4	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44641	10.1371/journal.pone.0044641	http://dx.doi.org/10.1371/journal.pone.0044641			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984536	gold, Green Published			2022-12-27	WOS:000308638700074
J	Shi, Y; Luo, GJ; Zhang, L; Shi, J; Zhang, DQ; Chen, JM; Chen, XB; Li, ZD; Zhao, Q				Shi, Yun; Luo, Guo-jun; Zhang, Li; Shi, Ji; Zhang, Dao-quan; Chen, Jian-min; Chen, Xiao-bo; Li, Zhuo-dong; Zhao, Qing			Interaction between Alcohol Consumption and CYP 2C19 Gene Polymorphism in Relation to Oesophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; NORTHWESTERN CHINA; POOR METABOLIZERS; CANCER; POPULATION; RISK; SUSCEPTIBILITY; FREQUENCIES; SMOKING; ENZYMES	Objectives: The purpose of this study is to explore the relationship between the interactions of CYP2C19 gene polymorphisms and several environmental factors and oesophageal squamous cell carcinoma (OSCC). Methods: In a case-control study of OSCC patients (n = 350) and healthy controls (n = 350), we investigated the roles of polymorphism in the CYP2C19 gene by the use of polymerase chain reaction - restriction fragment length polymorphism (PCR - RFLP) analysis. Results: The CYP2C19*3 AG+AA genotype was significantly more prevalent in OSCC patients (10.0% versus 3.43%; P<0.01). Multiple logistic regression analysis showed drinking (OR: 5.603, 95% CI: 3.431-11.112; P = 0.005) and smoking (OR: 4.341, 95% CI: 3.425-10.241; P = 0.001) was the independent risk factor of OSCC respectively, and there were significant interaction between CYP2C19*3 and drinking (OR: 8.747, 95% CI: 6.321-18.122; P = 0.009). Conclusions: The CYP2C19*3 polymorphism and OSCC were synergistically and significantly associated in Chinese Han patients.	[Shi, Yun; Luo, Guo-jun; Zhang, Li; Shi, Ji; Chen, Xiao-bo; Li, Zhuo-dong; Zhao, Qing] Kunming Gen Hosp Chengdu Mil Reg, Dept Chest Surg, Kunming, Yunnan Province, Peoples R China; [Zhang, Dao-quan] Sixtieth Cent Hosp Peoples Liberat Army, Dept Chest Surg, Dali, Yunnan Province, Peoples R China; [Chen, Jian-min] Fifty Ninth Cent Hosp Peoples Liberat Army, Dept Chest Surg, Kaiyuan, Yunnan Province, Peoples R China	Kunming General Hospital	Shi, Y (corresponding author), Kunming Gen Hosp Chengdu Mil Reg, Dept Chest Surg, Kunming, Yunnan Province, Peoples R China.	kmzyylgj@126.com						Afsar NA, 2010, BASIC CLIN PHARMACOL, V107, P570, DOI 10.1111/j.1742-7843.2009.00531.x; Ashfield-Watt PAL, 2004, PUBLIC HEALTH NUTR, V7, P257, DOI 10.1079/PHN2003524; Bozina N, 2009, ARH HIG RADA TOKSIKO, V60, P217, DOI 10.2478/10004-1254-60-2009-1885; Bye H, 2011, CARCINOGENESIS, V32, P1855, DOI 10.1093/carcin/bgr211; CHEN KL, 1995, B CHIN CANC, V4, P7; CHEN W, 2003, CANC RES CLIN, V15, P5; Ercan B, 2008, CELL BIOCHEM FUNCT, V26, P309, DOI 10.1002/cbf.1437; Fava C, 2008, HYPERTENSION, V52, P373, DOI 10.1161/HYPERTENSIONAHA.108.114199; Fichtlscherer S, 2004, CIRCULATION, V109, P178, DOI 10.1161/01.CIR.0000105763.51286.7F; Imig JD, 2000, MOL BIOTECHNOL, V16, P233, DOI 10.1385/MB:16:3:233; Isomura Y, 2010, J GASTROENTEROL, V45, P1045, DOI 10.1007/s00535-010-0246-0; Lundell K, 2008, CURR DRUG METAB, V9, P323, DOI 10.2174/138920008784220574; Matejcic M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029366; Node K, 2001, J BIOL CHEM, V276, P15983, DOI 10.1074/jbc.M100439200; Shi WX, 2004, WORLD J GASTROENTERO, V10, P1961, DOI 10.3748/wjg.v10.i13.463; Tanaka F, 2010, GUT, V59, P1457, DOI 10.1136/gut.2009.205724; Xie HG, 2001, ANNU REV PHARMACOL, V41, P815, DOI 10.1146/annurev.pharmtox.41.1.815; Xie XA, 2011, CLIN CHEM LAB MED, V49, P55, DOI 10.1515/CCLM.2011.024; Yadav SS, 2010, MUTAT RES-FUND MOL M, V684, P49, DOI 10.1016/j.mrfmmm.2009.11.010; Yang YN, 2010, CLIN APPL THROMB-HEM, V16, P579, DOI 10.1177/1076029610364522; Zheng ST, 2011, EUR J GASTROEN HEPAT, V23, P1087, DOI 10.1097/MEG.0b013e32834a14d9; Zheng ST, 2010, EUR J GASTROEN HEPAT, V22, P917, DOI 10.1097/MEG.0b013e3283313d8b	22	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43412	10.1371/journal.pone.0043412	http://dx.doi.org/10.1371/journal.pone.0043412			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984423	Green Submitted, Green Published, gold			2022-12-27	WOS:000308638700019
J	Staff, L; Hurd, P; Reale, L; Seoighe, C; Rockwood, A; Gehring, C				Staff, Lee; Hurd, Patricia; Reale, Lara; Seoighe, Cathal; Rockwood, Alyn; Gehring, Chris			The Hidden Geometries of the Arabidopsis thaliana Epidermis	PLOS ONE			English	Article							CELL FATE; MESOPHYLL; SHAPE	The quest for the discovery of mathematical principles that underlie biological phenomena is ancient and ongoing. We present a geometric analysis of the complex interdigitated pavement cells in the Arabidopsis thaliana (Col.) adaxial epidermis with a view to discovering some geometric characteristics that may govern the formation of this tissue. More than 2,400 pavement cells from 10, 17 and 24 day old leaves were analyzed. These interdigitated cells revealed a number of geometric properties that remained constant across the three age groups. In particular, the number of digits per cell rarely exceeded 15, irrespective of cell area. Digit numbers per 100 mu m(2) cell area reduce with age and as cell area increases, suggesting early developmental programming of digits. Cell shape proportions as defined by length: width ratios were highly conserved over time independent of the size and, interestingly, both the mean and the medians were close to the golden ratio 1.618034. With maturity, the cell area: perimeter ratios increased from a mean of 2.0 to 2.4. Shape properties as defined by the medial axis transform (MAT) were calculated and revealed that branch points along the MAT typically comprise one large and two small angles. These showed consistency across the developmental stages considered here at 140 degrees (+/- 5 degrees) for the largest angles and 110 degrees (+/- 5 degrees) for the smaller angles. Voronoi diagram analyses of stomatal center coordinates revealed that giant pavement cells (>= 500 mu m(2)) tend to be arranged along Voronoi boundaries suggesting that they could function as a scaffold of the epidermis. In addition, we propose that pavement cells have a role in spacing and positioning of the stomata in the growing leaf and that they do so by growing within the limits of a set of 'geometrical rules'.	[Staff, Lee; Hurd, Patricia; Rockwood, Alyn] King Abdullah Univ Sci & Technol, Geometr Modeling & Sci Visualizat Ctr, Thuwal, Saudi Arabia; [Reale, Lara] Univ Perugia, Dept Appl Biol, I-06100 Perugia, Italy; [Seoighe, Cathal] Natl Univ Ireland, Sch Math Stat & Appl Math, Galway, Ireland; [Gehring, Chris] King Abdullah Univ Sci & Technol, Div Chem Life Sci & Engn, Thuwal, Saudi Arabia	King Abdullah University of Science & Technology; University of Perugia; Ollscoil na Gaillimhe-University of Galway; King Abdullah University of Science & Technology	Staff, L (corresponding author), King Abdullah Univ Sci & Technol, Geometr Modeling & Sci Visualizat Ctr, Thuwal, Saudi Arabia.	christoph.gehring@KAUST.edu.sa		REALE, Lara/0000-0001-7570-3972; Gehring, Christoph/0000-0003-4355-4591	KAUST	KAUST(King Abdullah University of Science & Technology)	The project was funded by KAUST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atela P, 2011, MATH MODEL NAT PHENO, V6, P173, DOI 10.1051/mmnp/20116207; BIERHORST DW, 1977, AM J BOT, V64, P125, DOI 10.2307/2442101; Bird SM, 2003, NEW PHYTOL, V157, P9, DOI 10.1046/j.1469-8137.2003.00543.x; BLUM H, 1973, J THEOR BIOL, V38, P205, DOI 10.1016/0022-5193(73)90175-6; Chandra P, 2012, FIBONACCI NUMBER; Delaunay B, 1934, B ACAD SCI URSS, V6, P793; Dong JA, 2010, CURR TOP DEV BIOL, V91, P267, DOI 10.1016/S0070-2153(10)91009-0; Fu Y, 2005, CELL, V120, P687, DOI 10.1016/j.cell.2004.12.026; Glover BJ, 2010, ENCY LIFE SCI ELS; Hussey PJ, 2006, ANNU REV PLANT BIOL, V57, P109, DOI 10.1146/annurev.arplant.57.032905.105206; Kuhlemeier C, 2007, TRENDS PLANT SCI, V12, P143, DOI 10.1016/j.tplants.2007.03.004; Lai LB, 2005, PLANT CELL, V17, P2754, DOI 10.1105/tpc.105.034116; Larkin JC, 1997, PLANT CELL, V9, P1109, DOI 10.1105/tpc.9.7.1109; MELARAGNO JE, 1993, PLANT CELL, V5, P1661, DOI 10.1105/tpc.5.11.1661; Nadeau JA, 2009, CURR OPIN PLANT BIOL, V12, P29, DOI 10.1016/j.pbi.2008.10.006; Newell AC, 2008, PLANT SIGNAL BEHAV, V3, P586, DOI 10.4161/psb.3.8.6223; Panteris E, 2005, NEW PHYTOL, V167, P721, DOI 10.1111/j.1469-8137.2005.01464.x; Peterson KM, 2010, PLANT CELL, V22, P296, DOI 10.1105/tpc.109.072777; PYKE KA, 1991, PLANT PHYSIOL, V96, P1193, DOI 10.1104/pp.96.4.1193; Qian PP, 2009, PLANT CELL REP, V28, P1147, DOI 10.1007/s00299-009-0729-8; Roeder AHK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000367; Sachs T., 1991, PATTERN FORMATION PL, P101; Saglamyurek E, 2011, NATURE, V469, P512, DOI 10.1038/nature09719; Serna L, 2002, DEV BIOL, V241, P24, DOI 10.1006/dbio.2001.0506; Serna L, 2009, BIOESSAYS, V31, P865, DOI 10.1002/bies.200800231; Shimada T, 2011, CELL MOL LIFE SCI, V68, P2081, DOI 10.1007/s00018-011-0685-7; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Van Volkenburgh E, 1999, PLANT CELL ENVIRON, V22, P1463, DOI 10.1046/j.1365-3040.1999.00514.x; Zhang CH, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-27	29	21	21	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43546	10.1371/journal.pone.0043546	http://dx.doi.org/10.1371/journal.pone.0043546			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984433	Green Published, gold, Green Submitted			2022-12-27	WOS:000308638700025
J	Yu, PL; Shen, FC; Zhang, XF; Cao, RS; Zhao, XD; Liu, PF; Tu, HM; Yang, XZ; Shi, RH; Zhang, HJ				Yu, Pengli; Shen, Fangcheng; Zhang, Xiaofei; Cao, Risheng; Zhao, Xiaodan; Liu, Pengfei; Tu, Huiming; Yang, Xiaozhong; Shi, Ruihua; Zhang, Hongjie			Association of Single Nucleotide Polymorphisms of IL23R and IL17 with Ulcerative Colitis Risk in a Chinese Han Population	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; TH17 CELLS; SUSCEPTIBILITY; GENE; IL-23; HUNGARIAN; VARIANT; IL-17	Background: Previous studies implicated that IL23R and IL17 genes play an important role in autoimmune inflammation. Genome-wide association studies have also identified multiple single nucleotide polymorphisms (SNPs) in the IL23R gene region associated with inflammatory bowel diseases. This study examined the association of IL23R and IL17A gene SNPs with ulcerative colitis susceptibility in a population in China. Methodology: A total of 270 ulcerative colitis and 268 healthy controls were recruited for the analyses of 23 SNPs in the IL23R and IL17A regions. Genomic DNA was extracted and analysis of these 23 SNPs using ligase detection reaction allelic (LDR) technology. Genotype and allele associations were calculated using SPSS 13.0 software package. Principal Findings: Compared to the healthy controls, the variant alleles IL23R rs7530511, and rs11805303 showed a statistically significant difference for ulcerative colitis susceptibility (0.7% vs 3.3%, P = 0.002; 60.4% vs 53.2%, P = 0.0017, respectively). The linkage disequilibrium (LD) patterns of these SNPs were measured and three LD blocks from the SNPs of IL23R and one block from those of IL17A were identified. A novel association with ulcerative colitis susceptibility occurred in haplotypes of IL23R (Block1 H3 P = 0.02; Block2 H2 P = 0.019; Block3 H4 P = 0.029) and IL17A (H4 P = 0.034). Pair-wise analyses showed an interaction between the risk haplotypes in IL23R and IL17A (P = 0.014). Conclusions: Our study demonstrated that rs7530511, and rs11805303 of IL23R were significantly associated with ulcerative colitis susceptibility in the Chinese population. The most noticeable finding was the linkage of IL23R and IL17A gene region to ulcerative colitis risk due to the gene-gene interaction.	[Yu, Pengli; Shen, Fangcheng; Zhang, Xiaofei; Cao, Risheng; Zhao, Xiaodan; Shi, Ruihua; Zhang, Hongjie] Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China; [Liu, Pengfei] Peoples Hosp Jiangyin, Dept Gastroenterol, Jiangyin, Peoples R China; [Tu, Huiming] Fourth Peoples Hosp Wuxi, Dept Gastroenterol, Wuxi, Peoples R China; [Yang, Xiaozhong] First Hosp Huaian, Dept Gastroenterol, Huaian, Peoples R China	Nanjing Medical University; Jiangnan University	Yu, PL (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China.	ruihuashi@126.com; hjzhang06@163.com			National Natural Science Foundation of China [30771039]; Key Medical Personnel of Jiangsu Province [RC2011063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Medical Personnel of Jiangsu Province	This work was supported by the National Natural Science Foundation of China (no. 30771039) (http://www.nsfc.gov.cn/Portal0/default152.htm) and the Key Medical Personnel of Jiangsu Province (no. RC2011063) (http://www.jswst.gov.cn/gb/jsswst/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, INFLAMM BOWEL DIS, V15, P1090, DOI 10.1002/ibd.20894; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Arisawa T, 2008, J CLIN IMMUNOL, V28, P44, DOI 10.1007/s10875-007-9125-8; Bailey SL, 2007, NAT IMMUNOL, V8, P172, DOI 10.1038/ni1430; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Buning C, 2007, ALIMENT PHARM THERAP, V26, P1025, DOI 10.1111/j.1365-2036.2007.03446.x; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Dambacher J, 2009, GUT, V58, P1207, DOI 10.1136/gut.2007.130112; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Duvallet E, 2011, ANN MED, V43, P503, DOI 10.3109/07853890.2011.577093; Einarsdottir E, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-8; Ferguson LR, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/539461; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Furuya T, 2007, CLIN RHEUMATOL, V26, P2137, DOI 10.1007/s10067-007-0745-4; Glas J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000819; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hazlett J, 2011, GENES IMMUN; Head Kathleen A, 2003, Altern Med Rev, V8, P247; Huber AK, 2008, J CLIN ENDOCR METAB, V93, P1077, DOI 10.1210/jc.2007-2190; Hundorfean G, 2012, INFLAMM BOWEL DIS, V18, P180, DOI 10.1002/ibd.21677; Jurgens M, 2010, AM J GASTROENTEROL, V105, P1811, DOI 10.1038/ajg.2010.95; Kim SW, 2011, GUT, V60, P1527, DOI 10.1136/gut.2011.238477; Lacher M, 2010, ACTA PAEDIATR, V99, P727, DOI 10.1111/j.1651-2227.2009.01680.x; Lakatos PL, 2008, DIGEST LIVER DIS, V40, P867, DOI 10.1016/j.dld.2008.03.022; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lappalainen M, 2008, INFLAMM BOWEL DIS, V14, P1118, DOI 10.1002/ibd.20431; Lees CW, 2011, GUT, V60, P1739, DOI 10.1136/gut.2009.199679; Lewis JD, 2008, INFLAMM BOWEL DIS, V14, P1660, DOI 10.1002/ibd.20520; Liu ZJ, 2009, WORLD J GASTROENTERO, V15, P5784, DOI 10.3748/wjg.15.5784; Magyari Lili, 2009, Orvosi Hetilap, V150, P81, DOI 10.1556/OH.2009.28445; McGovern DPB, 2009, INFLAMM BOWEL DIS, V15, P883, DOI 10.1002/ibd.20855; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nordang GBN, 2009, RHEUMATOLOGY, V48, P367, DOI 10.1093/rheumatology/ken512; Oliver J, 2007, CLIN GASTROENTEROL H, V5, P977, DOI 10.1016/j.cgh.2007.05.002; Pidasheva S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025038; Ramsey CD, 2005, GENES IMMUN, V6, P236, DOI 10.1038/sj.gene.6364170; Roberts RL, 2007, AM J GASTROENTEROL, V102, P2754, DOI 10.1111/j.1572-0241.2007.01525.x; Sakamoto Juichi, 2005, Nihon Rinsho, V63, P744; Sarra M, 2010, INFLAMM BOWEL DIS, V16, P1808, DOI 10.1002/ibd.21248; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Schmechel S, 2008, INFLAMM BOWEL DIS, V14, P204, DOI 10.1002/ibd.20315; Schmidt-Weber CB, 2007, J ALLERGY CLIN IMMUN, V120, P247, DOI 10.1016/j.jaci.2007.06.039; Shen W, 2010, NEUROCHEM RES, V35, P940, DOI 10.1007/s11064-009-0091-9; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Tremelling M, 2007, GASTROENTEROLOGY, V132, P1657, DOI 10.1053/j.gastro.2007.02.051; Wang JY, 2009, ALLERGY, V64, P1056, DOI 10.1111/j.1398-9995.2009.01950.x; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zelante T, 2007, EUR J IMMUNOL, V37, P2695, DOI 10.1002/eji.200737409	50	22	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44380	10.1371/journal.pone.0044380	http://dx.doi.org/10.1371/journal.pone.0044380			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984500	gold, Green Published, Green Submitted			2022-12-27	WOS:000308638700056
J	Moran, PM; Rouse, JL; Cross, B; Corcoran, R; Schurmann, M				Moran, Paula M.; Rouse, Jennifer L.; Cross, Benjamin; Corcoran, Rhiannon; Schuermann, Martin			Kamin Blocking Is Associated with Reduced Medial-Frontal Gyrus Activation: Implications for Prediction Error Abnormality in Schizophrenia	PLOS ONE			English	Article							CONDITIONED BLOCKING; SUSTAINED ATTENTION; LEARNING-THEORY; AM I; FMRI; PSYCHOSIS; AMPHETAMINE; UNCERTAINTY; DOPAMINE; SYMPTOMS	The following study used 3-T functional magnetic resonance imaging (fMRI) to investigate the neural signature of Kamin blocking. Kamin blocking is an associative learning phenomenon seen where prior association of a stimulus (A) with an outcome blocks subsequent learning to an added stimulus (B) when both stimuli are later presented together (AB) with the same outcome. While there are a number of theoretical explanations of Kamin blocking, it is widely considered to exemplify the use of prediction error in learning, where learning occurs in proportion to the difference between expectation and outcome. In Kamin blocking as stimulus A fully predicts the outcome no prediction error is generated by the addition of stimulus B to form the compound stimulus AB, hence learning about it is "blocked". Kamin blocking is disrupted in people with schizophrenia, their relatives and healthy individuals with high psychometrically-defined schizotypy. This disruption supports suggestions that abnormal prediction error is a core deficit that can help to explain the symptoms of schizophrenia. The present study tested 9 healthy volunteers on an f-MRI adaptation of Oades' "mouse in the house task", the only task measuring Kamin blocking that shows disruption in schizophrenia patients that has been independently replicated. Participant's Kamin blocking scores were found to inversely correlate with Kamin-blocking-related activation within the prefrontal cortex, specifically the medial frontal gyrus. The medial frontal gyrus has been associated with the psychological construct of uncertainty, which we suggest is consistent with disrupted Kamin blocking and demonstrated in people with schizophrenia. These data suggest that the medial frontal gyrus merits further investigation as a potential locus of reduced Kamin blocking and abnormal prediction error in schizophrenia.	[Moran, Paula M.; Rouse, Jennifer L.; Schuermann, Martin] Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England; [Corcoran, Rhiannon] Univ Nottingham, Sch Community Hlth Sci, Div Psychiat, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Moran, PM (corresponding author), Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England.	paula.moran@nottingham.ac.uk		Moran, Paula/0000-0001-6655-4784	University of Nottingham School of Psychology studentship	University of Nottingham School of Psychology studentship	JLR was supported by a University of Nottingham School of Psychology studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batsell WR, 1999, J EXP PSYCHOL ANIM B, V25, P374, DOI 10.1037/0097-7403.25.3.374; Bender S, 2001, SCHIZOPHR RES, V49, P157, DOI 10.1016/S0920-9964(00)00040-2; Carter RM, 2006, NEUROIMAGE, V29, P1007, DOI 10.1016/j.neuroimage.2005.09.011; CORCORAN R, 1995, SCHIZOPHR RES, V17, P5, DOI 10.1016/0920-9964(95)00024-G; Corcoran R, 2010, PSYCHOL MED, V40, P1233, DOI 10.1017/S003329170999211X; Corlett PR, 2007, J PSYCHOPHARMACOL, V21, P238, DOI 10.1177/0269881107077716; Corlett PR, 2004, NEURON, V44, P877, DOI 10.1016/j.neuron.2004.11.022; CRIDER A, 1982, BIOL PSYCHIAT, V17, P351; Demeter E, 2011, NEUROIMAGE, V54, P1518, DOI 10.1016/j.neuroimage.2010.09.026; Elliott R, 1998, NEUROIMAGE, V8, P17, DOI 10.1006/nimg.1998.0344; Fletcher PC, 2001, NAT NEUROSCI, V4, P1043, DOI 10.1038/nn733; Gilbert SJ, 2007, SCIENCE, V317, P43, DOI 10.1126/science.1140801; Haselgrove M, CLIN APPL LEARNING T, Vxi, P224; Holroyd CB, 2004, NAT NEUROSCI, V7, P497, DOI 10.1038/nn1238; Jones SH, 1997, BEHAV BRAIN RES, V88, P103, DOI 10.1016/S0166-4328(97)02312-7; JONES SH, 1990, BRIT J PSYCHOL, V81, P95, DOI 10.1111/j.2044-8295.1990.tb02348.x; JONES SH, 1992, BIOL PSYCHIAT, V32, P739, DOI 10.1016/0006-3223(92)90078-E; Kamin L. J., 1968, MIAMI S PREDICTION B, P9; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Kim J, 2006, NEUROIMAGE, V31, P376, DOI 10.1016/j.neuroimage.2005.11.035; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Mameli F, 2010, BEHAV BRAIN RES, V211, P164, DOI 10.1016/j.bbr.2010.03.024; Mason O, 2006, SCHIZOPHR RES, V82, P203, DOI 10.1016/j.schres.2005.12.845; Moran PM, 2008, PROG NEURO-PSYCHOPH, V32, P116, DOI 10.1016/j.pnpbp.2007.07.021; Moran PM, 2003, J PSYCHIAT RES, V37, P155, DOI 10.1016/S0022-3956(02)00099-7; O'Tuathaigh CMP, 2003, BEHAV PHARMACOL, V14, P315, DOI 10.1097/01.fbp.0000080416.18561.3e; OADES RD, 1987, BRAIN RES, V406, P136, DOI 10.1016/0006-8993(87)90778-5; Oades RD, 1996, J PSYCHIAT RES, V30, P369, DOI 10.1016/0022-3956(96)00006-4; Oades RD, 2000, SCHIZOPHR RES, V41, P291, DOI 10.1016/S0920-9964(00)91039-9; OHAD D, 1987, PSYCHOBIOLOGY, V15, P137; Owen LA, 2003, J PSYCHOPHARMACOL, V17, pA42; Platek SM, 2004, COGNITIVE BRAIN RES, V19, P114, DOI 10.1016/j.cogbrainres.2003.11.014; Pomarol-Clotet E, 2010, MOL PSYCHIATR, V15, P823, DOI 10.1038/mp.2009.146; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Rodriguez PF, 2006, HUM BRAIN MAPP, V27, P306, DOI 10.1002/hbm.20186; Roiser JP, 2009, PSYCHOL MED, V39, P199, DOI 10.1017/S0033291708003863; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Serra AM, 2001, SCHIZOPHR RES, V48, P273, DOI 10.1016/S0920-9964(00)00141-9; Smith A, 2006, NETWORK-COMP NEURAL, V17, P61, DOI 10.1080/09548980500361624; Smith AJ, 2007, NEUROPSYCHOPHARMACOL, V32, P54, DOI 10.1038/sj.npp.1301086; Talairach J., 1988, COPLANAR STEREOTAXIC, P122; Tobler PN, 2006, J NEUROPHYSIOL, V95, P301, DOI 10.1152/jn.00762.2005; Turner DC, 2004, CEREB CORTEX, V14, P872, DOI 10.1093/cercor/bhh046; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Volz KG, 2004, J PSYCHOPHYSIOL, V18, P201; Volz KG, 2004, NEUROIMAGE, V21, P848, DOI 10.1016/j.neuroimage.2003.10.028; Volz KG, 2003, NEUROIMAGE, V19, P271, DOI 10.1016/S1053-8119(03)00122-8; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500	50	5	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43905	10.1371/journal.pone.0043905	http://dx.doi.org/10.1371/journal.pone.0043905			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	23028415	Green Published, gold			2022-12-27	WOS:000308221300032
J	Fujiwara, T; Yokoyama, H; Okitsu, Y; Kamata, M; Fukuhara, N; Onishi, Y; Fujimaki, S; Takahashi, S; Ishizawa, K; Bresnick, EH; Harigae, H				Fujiwara, Tohru; Yokoyama, Hisayuki; Okitsu, Yoko; Kamata, Mayumi; Fukuhara, Noriko; Onishi, Yasushi; Fujimaki, Shinichi; Takahashi, Shinichiro; Ishizawa, Kenichi; Bresnick, Emery H.; Harigae, Hideo			Gene Expression Profiling Identifies HOXB4 as a Direct Downstream Target of GATA-2 in Human CD34+Hematopoietic Cells	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; TRANSCRIPTION FACTOR GATA-2; SEVERE APLASTIC-ANEMIA; NF-Y; STIMULATING FACTOR; DIFFERENTIATION; PROLIFERATION; EXPANSION; PROMOTER; GROWTH	Aplastic anemia is characterized by a reduced hematopoietic stem cell number. Although GATA-2 expression was reported to be decreased in CD34-positive cells in aplastic anemia, many questions remain regarding the intrinsic characteristics of hematopoietic stem cells in this disease. In this study, we identified HOXB4 as a downstream target of GATA-2 based on expression profiling with human cord blood-derived CD34-positive cells infected with control or GATA-2 lentiviral shRNA. To confirm the functional link between GATA-2 and HOXB4, we conducted GATA-2 gain-of-function and loss-of-function experiments, and HOXB4 promoter analysis, including luciferase assay, in vitro DNA binding analysis and quantitative ChIP analysis, using K562 and CD34-positive cells. The analyses suggested that GATA-2 directly regulates HOXB4 expression through the GATA sequence in the promoter region. Furthermore, we assessed GATA-2 and HOXB4 expression in CD34-positive cells from patients with aplastic anemia (n = 10) and idiopathic thrombocytopenic purpura (n = 13), and demonstrated that the expression levels of HOXB4 and GATA-2 were correlated in these populations (r = 0.6573, p<0.01). Our results suggested that GATA-2 directly regulates HOXB4 expression in hematopoietic stem cells, which may play an important role in the development and/or progression of aplastic anemia.	[Fujiwara, Tohru; Yokoyama, Hisayuki; Okitsu, Yoko; Kamata, Mayumi; Fukuhara, Noriko; Onishi, Yasushi; Fujimaki, Shinichi; Ishizawa, Kenichi; Harigae, Hideo] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan; [Yokoyama, Hisayuki] Sendai Med Ctr, Dept Hematol, Sendai, Miyagi, Japan; [Takahashi, Shinichiro] Kitasato Univ, Sch Allied Hlth Sci, Div Hematol, Sagamihara, Kanagawa 228, Japan; [Bresnick, Emery H.] Univ Wisconsin, Sch Med & Publ Hlth, Wisconsin Inst Med Res, Dept Cell & Regenerat Biol, Madison, WI USA	Tohoku University; Kitasato University; University of Wisconsin System; University of Wisconsin Madison	Harigae, H (corresponding author), Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan.	harigae@med.tohoku.ac.jp	Fujiwara, Tohru/GOG-9775-2022; 寿行, 横山/AAF-7015-2019; Takahashi, Shinichiro/AAX-7125-2020	Takahashi, Shinichiro/0000-0003-0011-6065; Yokoyama, Hisayuki/0000-0001-7658-0687				ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Bacigalupo A, 2000, BLOOD, V95, P1931, DOI 10.1182/blood.V95.6.1931; Bresnick EH, 2010, J BIOL CHEM, V285, P31087, DOI 10.1074/jbc.R110.159079; Brun ACM, 2004, BLOOD, V103, P4126, DOI 10.1182/blood-2003-10-3557; Bungartz G, 2012, BLOOD, V119, P1380, DOI 10.1182/blood-2011-06-359406; CAMITTA BM, 1976, BLOOD, V48, P63; Cassel DL, 2000, BLOOD CELL MOL DIS, V26, P587, DOI 10.1006/bcmd.2000.0337; EVANS T, 1988, P NATL ACAD SCI USA, V85, P5976, DOI 10.1073/pnas.85.16.5976; Ezoe S, 2002, BLOOD, V100, P3512, DOI 10.1182/blood-2002-04-1177; Fan R, 2012, BLOOD IN PRESS; Fang XD, 2004, J BIOL CHEM, V279, P5444, DOI 10.1074/jbc.M306241200; Fujimaki S, 2001, BRIT J HAEMATOL, V113, P52, DOI 10.1046/j.1365-2141.2001.02736.x; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Fujiwara T, 2006, BRIT J HAEMATOL, V135, P583, DOI 10.1111/j.1365-2141.2006.06340.x; Giannola DM, 2000, J EXP MED, V192, P1479, DOI 10.1084/jem.192.10.1479; Harigae H, 2006, TOHOKU J EXP MED, V210, P1, DOI 10.1620/tjem.210.1; Harigae H, 2006, INT J HEMATOL, V84, P38, DOI 10.1532/IJH97.06020; Huang DY, 2004, NUCLEIC ACIDS RES, V32, P3935, DOI 10.1093/nar/gkh719; Huang Z, 2009, MOL CELL BIOL, V29, P5168, DOI 10.1128/MCB.00482-09; Im Hogune, 2004, Methods Mol Biol, V284, P129; Jiang J, 2010, BLOOD, V116, P711, DOI 10.1182/blood-2009-07-235341; Kim MS, 2008, ONCOGENE, V27, P3624, DOI 10.1038/sj.onc.1211021; Kirito K, 2003, BLOOD, V102, P3172, DOI 10.1182/blood-2003-03-0944; Klump H, 2005, ANN NY ACAD SCI, V1044, P6, DOI 10.1196/annals.1349.002; Kumano K, 2001, BLOOD, V98, P3283, DOI 10.1182/blood.V98.12.3283; Lee HM, 2010, BLOOD, V116, P720, DOI 10.1182/blood-2009-11-253872; Lim KC, 2000, NAT GENET, V25, P209, DOI 10.1038/76080; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; MARTIN DIK, 1990, NATURE, V344, P444, DOI 10.1038/344444a0; Mitsuma A, 2005, BBA-GENE STRUCT EXPR, V1727, P125, DOI 10.1016/j.bbaexp.2004.12.007; Orkin SH, 2008, CELL, V132, P712, DOI 10.1016/j.cell.2008.02.013; Oshima M, 2011, BLOOD, V117, pE142, DOI 10.1182/blood-2010-12-323212; Rodrigues NP, 2005, BLOOD, V106, P477, DOI 10.1182/blood-2004-08-2989; Schiedlmeier B, 2003, BLOOD, V101, P1759, DOI 10.1182/blood-2002-03-0767; Solomou EE, 2007, BLOOD, V110, P1603, DOI 10.1182/blood-2007-01-066258; Tang Y, 2009, BRIT J HAEMATOL, V144, P603, DOI 10.1111/j.1365-2141.2008.07509.x; Trompouki E, 2011, CELL, V147, P577, DOI 10.1016/j.cell.2011.09.044; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; Xu YY, 2009, EXP HEMATOL, V37, P1393, DOI 10.1016/j.exphem.2009.09.005; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650; Young NS, 2008, CURR OPIN HEMATOL, V15, P162, DOI 10.1097/MOH.0b013e3282fa7470; Young NS, 2010, BIOL BLOOD MARROW TR, V16, pS119, DOI 10.1016/j.bbmt.2009.09.013; Yu XP, 2005, J BIOL CHEM, V280, P35184, DOI 10.1074/jbc.M508138200; Yuasa H, 2005, EMBO J, V24, P1976, DOI 10.1038/sj.emboj.7600679; Zeng WH, 2004, BLOOD, V103, P325, DOI 10.1182/blood-2003-02-0490; Zhu J, 2003, BLOOD, V102, P2420, DOI 10.1182/blood-2003-01-0251	48	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e40959	10.1371/journal.pone.0040959	http://dx.doi.org/10.1371/journal.pone.0040959			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028422	gold, Green Submitted, Green Published			2022-12-27	WOS:000309554700001
J	Harkonen, T; Harding, KC; Wilson, S; Baimukanov, M; Dmitrieva, L; Svensson, CJ; Goodman, SJ				Harkonen, Tero; Harding, Karin C.; Wilson, Susan; Baimukanov, Mirgaliy; Dmitrieva, Lilia; Svensson, Carl Johan; Goodman, Simon J.			Collapse of a Marine Mammal Species Driven by Human Impacts	PLOS ONE			English	Article							CANINE-DISTEMPER VIRUS; SOUTHERN CASPIAN SEA; PHOCA-CASPICA; RINGED SEAL; BALTIC SEA; MONK SEAL; MNEMIOPSIS-LEIDYI; TROPHIC CASCADES; POPULATION; CONSEQUENCES	Understanding historical roles of species in ecosystems can be crucial for assessing long term human impacts on environments, providing context for management or restoration objectives, and making conservation evaluations of species status. In most cases limited historical abundance data impedes quantitative investigations, but harvested species may have long-term data accessible from hunting records. Here we make use of annual hunting records for Caspian seals (Pusa caspica) dating back to the mid-19th century, and current census data from aerial surveys, to reconstruct historical abundance using a hind-casting model. We estimate the minimum numbers of seals in 1867 to have been 1-1.6 million, but the population declined by at least 90% to around 100,000 individuals by 2005, primarily due to unsustainable hunting throughout the 20th century. This collapse is part of a broader picture of catastrophic ecological change in the Caspian over the 20th Century. Our results combined with fisheries data show that the current biomass of top predators in the Caspian is much reduced compared to historical conditions. The potential for the Caspian and other similar perturbed ecosystems to sustain natural resources of much greater biological and economic value than at present depends on the extent to which a number of anthropogenic impacts can be harnessed.	[Harkonen, Tero] Swedish Museum Nat Hist, S-10405 Stockholm, Sweden; [Harding, Karin C.; Svensson, Carl Johan] Gothenburg Univ, Dept Marine Ecol, Gothenburg, Sweden; [Wilson, Susan] Tara Seal Res Ctr, Killyleagh, County Down, North Ireland; [Baimukanov, Mirgaliy] Inst Hydrobiol & Ecol, Alma Ata, Kazakhstan; [Dmitrieva, Lilia; Goodman, Simon J.] Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England	Swedish Museum of Natural History; University of Gothenburg; Institute of Hydrobiology & Ecology; University of Leeds	Harkonen, T (corresponding author), Swedish Museum Nat Hist, S-10405 Stockholm, Sweden.	tero.harkonen@nrm.se	Harding, Karin/F-9957-2013	Harding, Karin/0000-0003-1527-0903; Goodman, Simon/0000-0003-4118-8575; Svensson, Carl Johan/0000-0002-8265-9313	United Kingdom government's Department of Environment, Food and Rural Affairs (DEFRA) Darwin Initiative scheme [162-15-24]; Centre of Theoretical Biology at the University of Gothenburg, Sweden; United Kingdom government's Department of Environment, Food and Rural Affairs (DEFRA) Darwin Initiative scheme [162-15-24]; Centre of Theoretical Biology at the University of Gothenburg, Sweden	United Kingdom government's Department of Environment, Food and Rural Affairs (DEFRA) Darwin Initiative scheme; Centre of Theoretical Biology at the University of Gothenburg, Sweden; United Kingdom government's Department of Environment, Food and Rural Affairs (DEFRA) Darwin Initiative scheme; Centre of Theoretical Biology at the University of Gothenburg, Sweden	This study was supported by a grant from the United Kingdom government's Department of Environment, Food and Rural Affairs (DEFRA) Darwin Initiative scheme (grant 162-15-24). KCH was financed by the Centre of Theoretical Biology at the University of Gothenburg, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, PUSA CASPICA VERS 20; [Anonymous], RUSS FED FISH AG REP; Badamshin BI, 1961, P M ICHTH COMM AC SC, V12, P170; Bredhult C, 2008, REPROD TOXICOL, V25, P247, DOI 10.1016/j.reprotox.2007.11.008; Caspian Environment Programme, 2007, CASP SEAL CONS ACT P; Caswell, 2000, MATRIX POPULATION MO; COOPER CF, 1983, SCIENCE, V219, P969, DOI 10.1126/science.219.4587.969; Daskalov GM, 2007, ICES J MAR SCI, V64, P503, DOI 10.1093/icesjms/fsl047; Dorofeev SV, 1928, PUBLICATIONS FISHERI, V3, P5; DUMONT H, 1995, NATURE, V377, P673, DOI 10.1038/377673a0; Eybatov T, 1997, P 1 BION WORKSH BORD, P95; Eybatov T, 2002, CASPIAN PHOCA CASPIC; Forsyth MA, 1998, VET REC, V143, P662; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Fulton TL, 2010, J BIOGEOGR, V37, P814, DOI 10.1111/j.1365-2699.2010.02271.x; GERRODETTE T, 1990, CONSERV BIOL, V4, P423, DOI 10.1111/j.1523-1739.1990.tb00317.x; Gucu AC, 2004, BIOL CONSERV, V116, P417, DOI 10.1016/S0006-3207(03)00234-9; Harding Karin C., 2007, NAMMCO Scientific Publications, V6, P33; Harding KC, 2002, ECOL LETT, V5, P727, DOI 10.1046/j.1461-0248.2002.00390.x; Harding KC, 1999, AMBIO, V28, P619; Harding KC, 2005, AM NAT, V166, P722, DOI 10.1086/497580; Harding KC, 1995, CAN J FISH AQUAT SCI, V52, P2347, DOI 10.1139/f95-827; HARKONEN T, 1991, OPHELIA, V34, P191; Harkonen T, 2008, AMBIO, V37, P356, DOI 10.1579/07-R-345.1; Harkonen T, 2006, DIS AQUAT ORGAN, V68, P115, DOI 10.3354/dao068115; Harkonen Tero, 2007, NAMMCO Scientific Publications, V6, P57; HEIDEJORGENSEN MP, 1988, MAR MAMMAL SCI, V4, P231, DOI 10.1111/j.1748-7692.1988.tb00204.x; HELLE E, 1980, ANN ZOOL FENN, V17, P147; IUCN, 2001, 2001 IUCN RED LIST C; Ivanov Vladimir P., 2000, Biological Invasions, V2, P255, DOI 10.1023/A:1010098624728; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kajiwara N, 2002, ENVIRON POLLUT, V117, P391, DOI 10.1016/S0269-7491(01)00200-7; Kennedy S, 2000, EMERG INFECT DIS, V6, P637, DOI 10.3201/eid0606.000613; KJELLQWIST SA, 1995, ICES J MAR SCI, V52, P197, DOI 10.1016/1054-3139(95)80035-2; Kokko H, 1999, ANN ZOOL FENN, V36, P65; Kosarev A.N., 1994, CASPIAN SEA, DOI DOI 10.1111/jai.14038; Kouraev AV, 2004, J MARINE SYST, V47, P89, DOI 10.1016/j.jmarsys.2003.12.011; Kouraev AV, 2003, POLAR RES, V22, P43, DOI 10.1111/j.1751-8369.2003.tb00094.x; Kovacs KM, 2011, MAR MAMMAL SCI, V28, P428; Krylov V.I., 1990, Finnish Game Research, V47, P32; Kuiken T, 2006, VET PATHOL, V43, P321, DOI 10.1354/vp.43-3-321; Lander RH, 1980, NMFFSTNWC3 NOAA US D, V1; LAWS R. M., 1957, PROC ZOOL SOC LONDON, V129, P315; Lunneryd S-G, 2004, 20048 FINF SWED BOAR, P8; Mamedov EV, 2006, ICES J MAR SCI, V63, P1665, DOI 10.1016/j.icesjms.2006.07.005; McClenachan L, 2008, P ROY SOC B-BIOL SCI, V275, P1351, DOI 10.1098/rspb.2007.1757; Meier HEM, 2004, AMBIO, V33, P249, DOI 10.1639/0044-7447(2004)033[0249:SDOBSI]2.0.CO;2; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Ohashi K, 2001, VET MICROBIOL, V82, P203, DOI 10.1016/S0378-1135(01)00371-6; Osterblom H, 2007, ECOSYSTEMS, V10, P877, DOI 10.1007/s10021-007-9069-0; Peasnall B, 2002, ENCY PREHISTORY, V8, P198; Piletskii AM, 1990, SOME REMARKS BIOL EC, P58; Popov L., 1979, FAO FISHERIES SERIES, VII, P74; Reeves R.R., 1998, NAMMCO SCI PUBL, V1, P9, DOI [10.7557/3.2979, DOI 10.7557/3.2979]; REIJNDERS PJH, 1985, BIOL CONSERV, V31, P75, DOI 10.1016/0006-3207(85)90035-7; REIJNDERS PJH, 1978, NETH J SEA RES, V12, P164, DOI 10.1016/0077-7579(78)90003-0; Roohi A, 2010, BIOL INVASIONS, V12, P2343, DOI 10.1007/s10530-009-9648-4; Sklabinskij N, 1891, SVEDENIJA TIULENIEJ; Smith T., 1987, CANADIAN B FISHERIES, V216, P1; Strukova E, 2010, STUDY EC BIORESOURCE; Sundqvist L, AMBIO IN PRESS; Tonder M, 2004, FISHERIES MANAG ECOL, V11, P283, DOI 10.1111/j.1365-2400.2004.00389.x; Wilson SC, IMPLICATIONS C UNPUB; Yousefian M, 2003, FISH PHYSIOL BIOCHEM, V29, P127, DOI 10.1023/B:FISH.0000035921.70639.fb	64	20	21	1	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e43130	10.1371/journal.pone.0043130	http://dx.doi.org/10.1371/journal.pone.0043130			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028446	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388400006
J	Lam, WWT; Ye, M; Fielding, R				Lam, Wendy W. T.; Ye, Michelle; Fielding, Richard			Trajectories of Quality of Life among Chinese Patients Diagnosed with Nasopharynegeal Cancer	PLOS ONE			English	Article							BREAST-CANCER; FUNCTIONAL-ASSESSMENT; PSYCHOLOGICAL DISTRESS; EUROPEAN-ORGANIZATION; CARCINOMA PATIENTS; 1ST YEAR; SATISFACTION; VALIDATION; OPTIMISM; WOMEN	Objective: This secondary longitudinal analysis describes distinct quality of life trajectories during eight months of radiation therapy (RT) among patients with nasopharyngeal cancer (NPC) and examines factors differentiating these trajectories. Methods: 253 Chinese patients with NPC scheduled for RT were assessed at pre-treatment, and 4 months and 8 months later on QoL (Chinese version of the FACT-G), optimism, pain, eating function, and patient satisfaction. Latent growth mixture modelling identified different trajectories within each of four QoL domains: Physical, Emotional, Social/family, and Functional well-being. Multinomial logistic regression compared optimism, pain, eating function, and patient satisfaction by trajectories adjusted for demographic and medical characteristics. Results: We identified three distinct trajectories for physical and emotional QoL domains, four trajectories for social/family, and two trajectories for functional domains. Within each domain most patients (physical (77%), emotional (85%), social/family (55%) and functional (63%)) experienced relatively stable high levels of well-being over the 8-month period. Different Physical trajectory patterns were predicted by pain and optimism, whereas for Emotion-domain trajectories pain, optimism, eating enjoyment, patient satisfaction with information, and gender were predictive. Age, appetite, optimism, martial status, and household income predicted Social/family trajectories; household income, eating enjoyment, optimism, and patient satisfaction with information predicted Functional trajectories. Conclusion: Most patients with NPC showed high stable QoL during radiotherapy. Optimism predicted good QoL. Symptom impacts varied by QoL domain. Information satisfaction was protective in emotional and functional well-being, reflecting the importance in helping patients to establish a realistic expectation of treatment impacts.	[Lam, Wendy W. T.; Ye, Michelle; Fielding, Richard] Univ Hong Kong, Sch Publ Hlth, Ctr Psychooncol Res & Teaching, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Fielding, R (corresponding author), Univ Hong Kong, Sch Publ Hlth, Ctr Psychooncol Res & Teaching, Hong Kong, Hong Kong, Peoples R China.	fielding@hku.hk	Lam, Wendy Wing Tak/C-4319-2009	Lam, Wendy Wing Tak/0000-0003-2383-0149	Hong Kong Government Health Services Research Committee (HSRC) [821005]	Hong Kong Government Health Services Research Committee (HSRC)	This project was supported by grants from the Hong Kong Government Health Services Research Committee (HSRC#821005) and a donation from Mr. C.S. Suen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Bjordal K, 1999, J CLIN ONCOL, V17, P1008, DOI 10.1200/JCO.1999.17.3.1008; Bonanno GA, 2005, CURR DIR PSYCHOL SCI, V14, P135, DOI 10.1111/j.0963-7214.2005.00347.x; Brucker PS, 2005, EVAL HEALTH PROF, V28, P192, DOI 10.1177/0163278705275341; Burkett V Shannon, 2007, J Cancer Surviv, V1, P167, DOI 10.1007/s11764-007-0017-y; CARVER CS, 1993, J PERS SOC PSYCHOL, V65, P375, DOI 10.1037/0022-3514.65.2.375; CELLA DF, 1993, J CLIN ONCOL, V11, P570, DOI 10.1200/JCO.1993.11.3.570; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chang VT, 2000, CANCER-AM CANCER SOC, V88, P1175, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1175::AID-CNCR30>3.0.CO;2-N; DEMBER WN, 1989, CURR PSYCHOL RES REV, V8, P102, DOI 10.1007/BF02686675; Dunn LB, 2012, EUR J ONCOL NURS, V16, P1, DOI 10.1016/j.ejon.2011.01.003; Enders CK, 2001, EDUC PSYCHOL MEAS, V61, P713, DOI 10.1177/0013164401615001; Epping-Jordan JE, 1999, HEALTH PSYCHOL, V18, P315, DOI 10.1037/0278-6133.18.4.315; Fang FM, 2002, INT J RADIAT ONCOL, V53, P959, DOI 10.1016/S0360-3016(02)02838-9; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th ed; He GP, 2005, CANCER NURS, V28, P179; Helgeson VS, 2004, HEALTH PSYCHOL, V23, P3, DOI 10.1037/0278-6133.23.1.3; Henselmans I, 2010, HEALTH PSYCHOL, V29, P160, DOI 10.1037/a0017806; HO JHC, 1978, INT J RADIAT ONCOL, V4, P182; Holzner B, 2004, ACTA ONCOL, V43, P153, DOI 10.1080/02841860310023453; Huber GF, 2007, LARYNGOSCOPE, V117, P559, DOI 10.1097/MLG.0b013e31802ca4c2; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jung T, 2008, SOC PERSONAL PSYCHOL, V2, P302, DOI 10.1111/j.1751-9004.2007.00054.x; Karnell LH, 2000, HEAD NECK-J SCI SPEC, V22, P6, DOI 10.1002/(SICI)1097-0347(200001)22:1<6::AID-HED2>3.3.CO;2-G; Lam WWT, 2012, HEALTH EDUC RES, V27, P767, DOI 10.1093/her/cys087; Lam WWT, 2007, PSYCHO-ONCOL, V16, P904, DOI 10.1002/pon.1147; Lam WWT, 2012, BREAST CANCER RES TR, V131, P957, DOI 10.1007/s10549-011-1798-2; Lam WWT, 2010, PSYCHO-ONCOLOGY, V19, P1044, DOI 10.1002/pon.1658; Lam WWT, 2009, PSYCHO-ONCOLOGY, V18, P1189, DOI 10.1002/pon.1403; Lam WWT, 2005, QUAL LIFE RES, V14, P1187, DOI 10.1007/s11136-004-2391-5; Lam WWT, 2003, PSYCHO-ONCOL, V12, P127, DOI 10.1002/pon.621; Law CC, 2008, J PAIN SYMPTOM MANAG, V35, P203, DOI 10.1016/j.jpainsymman.2007.03.013; Lee AWM, 1999, INT J CANCER, V84, P179, DOI 10.1002/(SICI)1097-0215(19990420)84:2<179::AID-IJC15>3.0.CO;2-6; Lee PWH, 2007, CANCER-AM CANCER SOC, V109, P1344, DOI 10.1002/cncr.22539; Lovell SJ, 2005, HEAD NECK-J SCI SPEC, V27, P864, DOI 10.1002/hed.20250; Miller DL, 1996, J CLIN PSYCHOL MED S, V3, P115, DOI 10.1007/BF01996132; Muthen LK, 2007, MPLUS USERS GUIDE, P197; Mystakidou K, 2008, DEPRESS ANXIETY, V25, P730, DOI 10.1002/da.20319; Pow EHN, 2006, INT J RADIAT ONCOL, V66, P981, DOI 10.1016/j.ijrobp.2006.06.013; Rose JH, 2009, CANCER, V115, P4298, DOI 10.1002/cncr.24584; Thienthong Somboon, 2006, Journal of the Medical Association of Thailand, V89, P1120; Visser MRM, 1998, SUPPORT CARE CANCER, V6, P101, DOI 10.1007/s005200050142; Wolf M H, 1978, J Behav Med, V1, P391, DOI 10.1007/BF00846695; Wong WS, 2008, PSYCHO-ONCOL, V17, P292, DOI 10.1002/pon.1247; Wong WS, 2008, ACTA ONCOL, V47, P71, DOI 10.1080/02841860701441814; Wong WS, 2007, QUAL LIFE RES, V16, P53, DOI 10.1007/s11136-006-9106-z; Wong WS, 2009, MED CARE, V47, P875, DOI 10.1097/MLR.0b013e3181a393cf; Wu Y, 2007, QUAL LIFE RES, V16, P65, DOI 10.1007/s11136-006-9113-0; Yu CLM, 2000, CANCER, V88, P1715, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1715::AID-CNCR28>3.3.CO;2-B; Yu CLM, 2001, CANCER, V92, P2126, DOI 10.1002/cncr.1554; Yu CLM, 2000, THESIS U HONG KONG H; Yu LMC, 2003, QUAL LIFE RES, V12, P41	53	16	16	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44022	10.1371/journal.pone.0044022	http://dx.doi.org/10.1371/journal.pone.0044022			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	040HS	23028484	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900012
J	Wilmer, A; de Lussanet, M; Lappe, M				Wilmer, Andreas; de Lussanet, Marc; Lappe, Markus			Time-Delayed Mutual Information of the Phase as a Measure of Functional Connectivity	PLOS ONE			English	Article							FALSE DISCOVERY RATE; MODEL-FREE MEASURE; WHOLE-HEAD MEG; LAG SYNCHRONIZATION; BRAIN CONNECTIVITY; EVOKED-RESPONSES; EEG; MAGNETOENCEPHALOGRAPHY; NOISE; SENSITIVITY	We propose a time-delayed mutual information of the phase for detecting nonlinear synchronization in electrophysiological data such as MEG. Palus already introduced the mutual information as a measure of synchronization [1]. To obtain estimates on small data-sets as reliably as possible, we adopt the numerical implementation as proposed by Kraskov and colleagues [2]. An embedding with a parametric time-delay allows a reconstruction of arbitrary nonstationary connective structures so-called connectivity patterns - in a wide class of systems such as coupled oscillatory or even purely stochastic driven processes [3]. By using this method we do not need to make any assumptions about coupling directions, delay times, temporal dynamics, nonlinearities or underlying mechanisms. For verifying and refining the methods we generate synthetic data-sets by a mutual amplitude coupled network of Rossler oscillators with an a-priori known connective structure. This network is modified in such a way, that the power-spectrum forms a 1/f power law, which is also observed in electrophysiological recordings. The functional connectivity measure is tested on robustness to additive uncorrelated noise and in discrimination of linear mixed input data. For the latter issue a suitable de-correlation technique is applied. Furthermore, the compatibility to inverse methods for a source reconstruction in MEG such as beamforming techniques is controlled by dedicated dipole simulations. Finally, the method is applied on an experimental MEG recording.	[Wilmer, Andreas; de Lussanet, Marc; Lappe, Markus] Univ Munster, Dept Psychol, Otto Creutzfeldt Ctr Cognit & Behav Neurosci OCC, Munster, Germany	University of Munster	Wilmer, A (corresponding author), Univ Munster, Dept Psychol, Otto Creutzfeldt Ctr Cognit & Behav Neurosci OCC, Munster, Germany.	andreas.wilmer@uni-muenster.de	de Lussanet, Marc H.E./H-2437-2013	de Lussanet, Marc H.E./0000-0003-3754-6675				Atmanspacher H, 2008, COGN NEURODYNAMICS, V2, P297, DOI 10.1007/s11571-008-9067-8; Barnes GR, 2004, HUM BRAIN MAPP, V23, P120, DOI 10.1002/hbm.20047; Barnes GR, 2003, HUM BRAIN MAPP, V18, P1, DOI 10.1002/hbm.10072; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blinowska KJ, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.050902; Brookes MJ, 2008, NEUROIMAGE, V39, P1788, DOI 10.1016/j.neuroimage.2007.09.050; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Chumbley J, 2010, NEUROIMAGE, V49, P3057, DOI 10.1016/j.neuroimage.2009.10.090; Chumbley JR, 2009, NEUROIMAGE, V44, P62, DOI 10.1016/j.neuroimage.2008.05.021; Cover T. M., 1991, ELEMENTS INFORM THEO; David O, 2005, NEUROIMAGE, V25, P756, DOI 10.1016/j.neuroimage.2004.12.030; David O, 2006, NEUROIMAGE, V30, P1255, DOI 10.1016/j.neuroimage.2005.10.045; Deco G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000092; DEMUNCK JC, 1992, IEEE T BIO-MED ENG, V39, P791, DOI 10.1109/10.148387; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Friston KJ, 2010, NEUROIMAGE, V52, P752, DOI 10.1016/j.neuroimage.2009.12.068; Friston KJ, 2000, PHILOS T R SOC B, V355, P215, DOI 10.1098/rstb.2000.0560; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Fuchs M, 1998, ELECTROEN CLIN NEURO, V107, P93, DOI 10.1016/S0013-4694(98)00046-7; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; GILDEN DL, 1995, SCIENCE, V267, P1837, DOI 10.1126/science.7892611; Goldenholz DM, 2009, HUM BRAIN MAPP, V30, P1077, DOI 10.1002/hbm.20571; Gomez-Herrero G, 2010, ABS10080539 CORR; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Hadjipapas A, 2005, CLIN NEUROPHYSIOL, V116, P1300, DOI 10.1016/j.clinph.2005.01.014; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Hillebrand A, 2005, HUM BRAIN MAPP, V25, P199, DOI 10.1002/hbm.20102; Hillebrand A, 2002, NEUROIMAGE, V16, P638, DOI 10.1006/nimg.2002.1102; Hinrichs H, 2008, HUM BRAIN MAPP, V29, P193, DOI 10.1002/hbm.20382; Hlavackova-Schindler K, 2007, PHYS REP, V441, P1, DOI 10.1016/j.physrep.2006.12.004; Huang MX, 1999, PHYS MED BIOL, V44, P423, DOI 10.1088/0031-9155/44/2/010; Hyvarinen A., 2001, NEURAL COMPUTING SUR, V2; JANSEN BH, 1995, BIOL CYBERN, V73, P357, DOI 10.1007/BF00199471; KAMINSKI MJ, 1991, BIOL CYBERN, V65, P203, DOI 10.1007/BF00198091; Kiebel SJ, 2006, NEUROIMAGE, V30, P1273, DOI 10.1016/j.neuroimage.2005.12.055; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Le van Quyen M, 1999, PHYSICA D, V127, P250; Le van Quyen M, 1998, BRAIN RES, V792, P24, DOI 10.1016/S0006-8993(98)00102-4; Le Van Quyen M, 2001, J NEUROSCI METH, V111, P83, DOI 10.1016/S0165-0270(01)00372-7; Le Van Quyen M, 2007, TRENDS NEUROSCI, V30, P365, DOI 10.1016/j.tins.2007.05.006; Linkenkaer-Hansen K, 2001, J NEUROSCI, V21, P1370; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Nalatore H, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.031123; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Nolte G, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.051913; Nolte G, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.234101; Oostenveld R., 2011, COMPUTATIONAL INTELL; Palus M, 1997, PHYS LETT A, V235, P341, DOI 10.1016/S0375-9601(97)00635-X; Penny WD, 2004, NEUROIMAGE, V22, P1157, DOI 10.1016/j.neuroimage.2004.03.026; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pikovsky A., 2003, SYNCHRONIZATION UNIV; Pine J, 2006, HIST MEA DEV, P3; Quiroga RQ, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041903; Quraan MA, 2011, HUM BRAIN MAPP, V32, P812, DOI 10.1002/hbm.21068; Robinson SE, 1998, BIOMAG 2000, P1; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Rosenblum M., 2001, HDB BIOL PHYS, V4, P279; Rosenblum MG, 1996, PHYS REV LETT, V76, P1804, DOI 10.1103/PhysRevLett.76.1804; Rosenblum MG, 1997, PHYS REV LETT, V78, P4193, DOI 10.1103/PhysRevLett.78.4193; ROSSLER OE, 1976, PHYS LETT A, V57, P397, DOI 10.1016/0375-9601(76)90101-8; RULKOV NF, 1995, PHYS REV E, V51, P980, DOI 10.1103/PhysRevE.51.980; Sakkalis V, 2011, COMPUT BIOL MED, V41, P1110, DOI 10.1016/j.compbiomed.2011.06.020; Schack B, 1999, INT J PSYCHOPHYSIOL, V31, P219, DOI 10.1016/S0167-8760(98)00052-X; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Sekihara K, 2002, IEEE T BIO-MED ENG, V49, P1534, DOI 10.1109/TBME.2002.805485; Seth AK, 2008, COGN NEURODYNAMICS, V2, P49, DOI 10.1007/s11571-007-9031-z; Singer W, 1999, NATURE, V397, P391, DOI 10.1038/17021; Stam CJ, 2003, HUM BRAIN MAPP, V19, P63, DOI 10.1002/hbm.10106; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Steinberg C, 2012, J COGNITIVE NEUROSCI, V24, P17, DOI 10.1162/jocn_a_00067; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; Tallon-Baudry C, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0008.2001; Tass P, 1998, PHYS REV LETT, V81, P3291, DOI 10.1103/PhysRevLett.81.3291; Toga A.W., 2002, BRAIN MAPPING METHOD; Uhlhaas PJ, 2010, TRENDS COGN SCI, V14, P72, DOI 10.1016/j.tics.2009.12.002; Uhlhaas PJ, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.017.2009; Vakorin V., 2011, FRONT SYST NEUROSCI, V5, P1; Vakorin VA, 2009, J NEUROSCI METH, V184, P152, DOI 10.1016/j.jneumeth.2009.07.014; Van Quyen ML, 2003, J PHYSIOL-PARIS, V97, P629, DOI 10.1016/j.jphysparis.2004.01.019; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; Victor JD, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051903; Vinck M, 2011, NEUROIMAGE, V55, P1548, DOI 10.1016/j.neuroimage.2011.01.055; Vrba J, 2002, PHYSICA C, V368, P1, DOI 10.1016/S0921-4534(01)01131-5; Wibral M, 2011, PROG BIOPHYS MOL BIO, V105, P80, DOI 10.1016/j.pbiomolbio.2010.11.006; Wiener N, 1956, THEORY PREDICTION 10; Wilmer A, 2010, COGN NEURODYNAMICS, V4, P133, DOI 10.1007/s11571-010-9107-z	94	16	16	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44633	10.1371/journal.pone.0044633	http://dx.doi.org/10.1371/journal.pone.0044633			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028571	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900032
J	Nadjar, Y; Gordon, P; Corcia, P; Bensimon, G; Pieroni, L; Meininger, V; Salachas, F				Nadjar, Yann; Gordon, Paul; Corcia, Philippe; Bensimon, Gilbert; Pieroni, Laurence; Meininger, Vincent; Salachas, Francois			Elevated Serum Ferritin Is Associated with Reduced Survival in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							IRON HOMEOSTASIS; ALS; HFE; CONSEQUENCES	Background: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder caused by the loss of motor neurons. Its etiology remains unknown, but several hypothesis have been raised to explain motor neuron death, including oxidative stress. Dysregulation of cellular iron metabolism can lead to increased oxidative stress, and existing data argue for a role of iron metabolism in ALS pathophysiology. Methods: We performed a retrospective analysis of iron metabolism (IM) variables (serum levels of iron, transferrin, ferritin, and TSC for Transferrin Saturation Coefficient) in a cohort of 694 ALS patients and 297 healthy controls. Results: Serum ferritin levels and TSC were higher, whereas serum transferrin levels were lower in ALS patients than controls. In addition, patients with a high level serum ferritin had a shorter survival time compared to those with low level serum ferritin (618 days versus 921 days for men subgroup; p = .007). Site of onset and ALS-FRS score were not associated with IM variables. Conclusion: This study suggests that ALS patients may have increased iron storage, as measured by increased serum ferritin and TSC. Elevated serum ferritin may also have a deleterious impact on survival in ALS.	[Nadjar, Yann; Gordon, Paul; Meininger, Vincent; Salachas, Francois] Hop La Pitie Salpetriere, APHP, Ctr Reference Malad Rares SLA, Paris, France; [Corcia, Philippe] Univ Tours, Ctr SLA, CHU Tours, Tours, France; [Bensimon, Gilbert] Hop La Pitie Salpetriere, Dept Clin Pharmacol, Paris, France; [Bensimon, Gilbert] UPMC Pharmacol, UMR 7211, Paris 6, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Tours; Universite de Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Nadjar, Y (corresponding author), Hop La Pitie Salpetriere, APHP, Ctr Reference Malad Rares SLA, Paris, France.	ynadjar@gmail.com	Pieroni, Laurence/AAA-4583-2019	Gordon, Paul/0000-0001-5714-9875				Arosio P, 2002, FREE RADICAL BIO MED, V33, P457, DOI 10.1016/S0891-5849(02)00842-0; Barber SC, 2006, BBA-MOL BASIS DIS, V1762, P1051, DOI 10.1016/j.bbadis.2006.03.008; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; de Aguilar JLG, 2007, J NEUROCHEM, V101, P1153, DOI 10.1111/j.1471-4159.2006.04408.x; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Dupuis L, 2011, LANCET NEUROL, V10, P75, DOI 10.1016/S1474-4422(10)70224-6; Gandon Y, 2004, LANCET, V363, P357, DOI 10.1016/S0140-6736(04)15436-6; Goodall EF, 2005, NEUROLOGY, V65, P934, DOI 10.1212/01.wnl.0000176032.94434.d4; Goodall EF, 2008, J NEUROL, V255, P1652, DOI 10.1007/s00415-008-0945-0; INCE PG, 1994, NEUROSCI LETT, V182, P87, DOI 10.1016/0304-3940(94)90213-5; Jeong SY, 2009, J NEUROSCI, V29, P570, DOI 10.1523/JNEUROSCI.5443-08.2009; Kuhle J, 2009, EUR J NEUROL; Mitchell JD, 2007, LANCET, V369, P2031, DOI 10.1016/S0140-6736(07)60944-1; Mitchell RM, 2010, MUSCLE NERVE, V42, P95, DOI 10.1002/mus.21625; Mizuno Y, 2006, ACTA NEUROPATHOL, V112, P597, DOI 10.1007/s00401-006-0122-4; Nappi AJ, 2000, CELL MOL BIOL, V46, P637; Qureshi Muddasir, 2008, Open Neurol J, V2, P51, DOI 10.2174/1874205X00802010051; Restagno G, 2007, J NEUROL NEUROSUR PS, V78, P327, DOI 10.1136/jnnp.2006.092338; Sutedja NA, 2007, ARCH NEUROL-CHICAGO, V64, P63, DOI 10.1001/archneur.64.1.63; Wang XS, 2004, J NEUROL SCI, V227, P27, DOI 10.1016/j.jns.2004.08.003	20	62	64	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45034	10.1371/journal.pone.0045034	http://dx.doi.org/10.1371/journal.pone.0045034			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024788	Green Submitted, gold, Green Published			2022-12-27	WOS:000308860100046
J	Thomas, LW; Lam, C; Clark, RE; White, MRH; Spiller, DG; Moots, RJ; Edwards, SW				Thomas, Luke W.; Lam, Connie; Clark, Richard E.; White, Michael R. H.; Spiller, David G.; Moots, Robert J.; Edwards, Steven W.			Serine 162, an Essential Residue for the Mitochondrial Localization, Stability and Anti-Apoptotic Function of Mcl-1	PLOS ONE			English	Article							NEUTROPHIL APOPTOSIS; CELL LEUKEMIA-1; EXPRESSION; INHIBITION; SURVIVAL; CANCER; CHEMOSENSITIZATION; PHOSPHORYLATION; DIFFERENTIATION; ACTIVATION	Mcl-1 is an anti-apoptotic member of the Bcl-2 family that plays a key role in normal development, but also in pathologies such as cancer. It has some unusual properties compared to other anti-apoptotic members of the Bcl-2 family, and its expression and function are dynamically regulated by a variety of post-transcriptional and post-translational processes. Of note, Mcl-1 protein has a very short half life, and its stability and function may be regulated by reversible phosphorylation. There is also evidence to suggest that it may be localized to different subcellular compartments. The aim of this work was to determine whether residues within the PEST region of Mcl-1 that may undergo reversible phosphorylation, also regulate its subcellular distribution. We show that EGFP: Mcl-1 localizes mainly to the mitochondria of HeLa cells, with some additional cytoplasmic and nuclear localization. The mutations, S64A, S64E, S121A, S159A, T163A and T163E did not significantly affect the localization of Mcl-1. However, mutation of Ser162 to the phospho-null residue, Alanine resulted in an essentially nuclear localization, with some cytoplasmic but no mitochondrial localization. This mutant Mcl-1 protein, S162A, showed significantly decreased stability and it decreased the ability to protect against Bak-induced apoptosis. These data identify a new molecular determinant of Mcl-1 function, localization and stability that may be important for understanding the role of this protein in disease.	[Thomas, Luke W.; Lam, Connie; White, Michael R. H.; Spiller, David G.; Edwards, Steven W.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Clark, Richard E.] Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England; [Moots, Robert J.] Univ Liverpool, Inst Aging & Chron Dis, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool; University of Liverpool	Thomas, LW (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.	w.edwards@liv.ac.uk	Moots, Robert/AAM-8091-2020; Spiller, David G/I-3645-2012	Spiller, David Geoffrey/0000-0003-2502-6787; White, Michael/0000-0002-3617-3232; Edwards, Steven/0000-0002-7074-0552	Arthritis Research UK; Leukaemia and Lymphoma Research; Biotechnology and Biological Sciences Research Council [BB/E012965/1] Funding Source: researchfish; BBSRC [BB/E012965/1] Funding Source: UKRI	Arthritis Research UK(Versus Arthritis); Leukaemia and Lymphoma Research; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank Arthritis Research UK and Leukaemia and Lymphoma Research for generous financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichberger KJ, 2005, BLOOD, V105, P3303, DOI 10.1182/blood-2004-02-0749; Akgul C, 2000, FEBS LETT, V478, P72, DOI 10.1016/S0014-5793(00)01809-3; Akgul C, 2009, CELL MOL LIFE SCI, V66, P1326, DOI 10.1007/s00018-008-8637-6; Chou CH, 2006, MOL BIOL CELL, V17, P3952, DOI 10.1091/mbc.E06-04-0319; Clohessy JG, 2004, BRIT J HAEMATOL, V125, P655, DOI 10.1111/j.1365-2141.2004.04949.x; Cross A, 2008, BLOOD, V111, P878, DOI 10.1182/blood-2007-05-087833; Day CL, 2005, J BIOL CHEM, V280, P4738, DOI 10.1074/jbc.M411434200; Derouet M, 2006, J IMMUNOL, V176, P957, DOI 10.4049/jimmunol.176.2.957; Derouet M, 2004, J BIOL CHEM, V279, P26915, DOI 10.1074/jbc.M313875200; Ding QQ, 2008, CANCER RES, V68, P6109, DOI 10.1158/0008-5472.CAN-08-0579; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Domina AM, 2000, J BIOL CHEM, V275, P21688, DOI 10.1074/jbc.M000915200; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; Edwards SW, 2004, BIOCHEM SOC T, V32, P489, DOI 10.1042/BST0320489; Fleischer B, 2006, INT J ONCOL, V28, P25; Inoshita S, 2002, J BIOL CHEM, V277, P43730, DOI 10.1074/jbc.M207951200; Jamil S, 2005, BIOCHEM J, V387, P659, DOI 10.1042/BJ20041596; Jamil S, 2010, CELL CYCLE, V9, P2843, DOI 10.4161/cc.9.14.12354; Kobayashi S, 2007, J BIOL CHEM, V282, P18407, DOI 10.1074/jbc.M610010200; Kodama Y, 2009, GASTROENTEROLOGY, V136, P1423, DOI 10.1053/j.gastro.2008.12.064; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Leuenroth SJ, 2000, J LEUKOCYTE BIOL, V68, P158; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Morel C, 2009, MOL CELL BIOL, V29, P3845, DOI 10.1128/MCB.00279-09; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Moulding DA, 2000, BLOOD, V96, P1756, DOI 10.1182/blood.V96.5.1756.h8001756_1756_1763; Moulding DA, 1998, BLOOD, V92, P2495, DOI 10.1182/blood.V92.7.2495.2495_2495_2502; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Rinkenberger JL, 2000, GENE DEV, V14, P23; Sano M, 2001, EXP CELL RES, V266, P114, DOI 10.1006/excr.2001.5203; Subramaniam D, 2008, AM J PHYSIOL-GASTR L, V294, pG1025, DOI 10.1152/ajpgi.00602.2007; Thomas LW, 2010, FEBS LETT, V584, P2981, DOI 10.1016/j.febslet.2010.05.061; Ulrich-Pur H, 2005, WIEN KLIN WOCHENSCHR, V117, P136, DOI 10.1007/s00508-004-0278-7; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Xue LY, 2005, ONCOGENE, V24, P6987, DOI 10.1038/sj.onc.1208837; YANG T, 1995, J CELL BIOL, V128, P1173, DOI 10.1083/jcb.128.6.1173; Yoon JH, 2002, CANCER RES, V62, P6500; Zhang B, 2002, BLOOD, V99, P1885, DOI 10.1182/blood.V99.6.1885; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	39	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45088	10.1371/journal.pone.0045088	http://dx.doi.org/10.1371/journal.pone.0045088			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024798	Green Published, Green Submitted, gold			2022-12-27	WOS:000308860100056
J	Boyce, T; Holmes, A				Boyce, Tammy; Holmes, Alison			Addressing Health Inequalities in the Delivery of the Human Papillomavirus Vaccination Programme: Examining the Role of the School Nurse	PLOS ONE			English	Article							HPV VACCINATION; QUALITATIVE RESEARCH; SYSTEMATIC REVIEWS; PARENTAL ATTITUDES; PUBLIC-HEALTH; URBAN AREA; IMMUNIZATION; MANCHESTER; CHALLENGES; BREAST	Background: HPV immunisation of adolescent girls is expected to have a significant impact in the reduction of cervical cancer. UK The HPV immunisation programme is primarily delivered by school nurses. We examine the role of school nurses in delivering the HPV immunisation programme and their impact on minimising health inequalities in vaccine uptake. Methods and Findings: A rapid evidence assessment (REA) and semi-structured interviews with health professionals were conducted and analysed using thematic analysis. 80 health professionals from across the UK are interviewed, primarily school nurses and HPV immunisation programme coordinators. The REA identified 2,795 articles and after analysis and hand searches, 34 relevant articles were identified and analysed. Interviews revealed that health inequalities in HPV vaccination uptake were mainly related to income and other social factors in contrast to published research which emphasises potential inequalities related to ethnicity and/or religion. Most school nurses interviewed understood local health inequalities and made particular efforts to target girls who did not attend or missed doses. Interviews also revealed maintaining accurate and consistent records influenced both school nurses' understanding and efforts to target inequalities in HPV vaccination uptake. Conclusions: Despite high uptake in the UK, some girls remain at risk of not being vaccinated with all three doses. School nurses played a key role in reducing health inequalities in the delivery of the HPV programme. Other studies identified religious beliefs and ethnicity as potentially influencing HPV vaccination uptake but interviews for this research found this appeared not to have occurred. Instead school nurses stated girls who were more likely to be missed were those not in education. Improving understanding of the delivery processes of immunisation programmes and this impact on health inequalities can help to inform solutions to increase uptake and address health inequalities in childhood and adolescent vaccination programmes.	[Boyce, Tammy; Holmes, Alison] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Med, Natl Ctr Infect Prevent & Management, London, England	Imperial College London	Boyce, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Med, Natl Ctr Infect Prevent & Management, London, England.	tboyce@imperial.ac.uk			Sanofi Pasteur MSD; National Institute for Health Research (NIHR) Biomedical Research Centre Funding Scheme at Imperial College; National Centre for Infection Prevention and Management; UK Clinical Research Collaboration; NIHR; MRC [G0800777] Funding Source: UKRI; Medical Research Council [G0800777] Funding Source: researchfish	Sanofi Pasteur MSD; National Institute for Health Research (NIHR) Biomedical Research Centre Funding Scheme at Imperial College; National Centre for Infection Prevention and Management; UK Clinical Research Collaboration; NIHR(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	TB received funding from Sanofi Pasteur MSD to carry out the research; TB was one of the authors of The Marmot Review's Fair Society Healthy Lives report. TB has no financial relationships with any organisations that might have an interest in the submitted work in the previous three years and no other relationships or activities that could appear to have influenced the submitted work. AH is funded by grants from the National Institute for Health Research (NIHR) Biomedical Research Centre Funding Scheme at Imperial College and the National Centre for Infection Prevention and Management, which is funded by the UK Clinical Research Collaboration. AH is also affiliated with the Imperial Centre for Patient Safety and Service Quality, which is funded by the NIHR. The funders had no role in the design, conduct or publication of the research. Sanofi Pasteur MSD granted the authors freedom to make public and publish all study results. The authors retain full control of all the data and the content of the article.	Adams M, 2007, VACCINE, V25, P3007, DOI 10.1016/j.vaccine.2007.01.016; [Anonymous], 2011, ANN HPV VACC COV ENG; Ashmore J., 2007, EURO SURVEILL, V12; Asthana S, 2006, MILBANK Q, V84, P577, DOI 10.1111/j.1468-0009.2006.00459.x; Baker D, 2011, J EPIDEMIOL COMMUN H, V65, P346, DOI 10.1136/jech.2008.085142; Barbour RS, 2003, J EVAL CLIN PRACT, V9, P179, DOI 10.1046/j.1365-2753.2003.00371.x; Birmingham City Council, 2010, IND MULT DEPR 2010; Brabin L, 2006, VACCINE, V24, P3087, DOI 10.1016/j.vaccine.2006.01.048; Brabin L, 2008, BRIT MED J, V336, P1056, DOI 10.1136/bmj.39541.534109.BE; Brabin L, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-20; Brabin L, 2011, VACCINE, V29, P3192, DOI 10.1016/j.vaccine.2011.02.038; Cabinet Office, 2010, INCL HLTH IMPR WAY W; Chase E., 2010, PROMOTING HLTH CHILD; Coombes R, 2000, NURS TIMES, V96, P13; Cunningham PJ, 2011, MED CARE RES REV, V68, P34, DOI 10.1177/1077558710385468; Department of Health, 2011, CERV CANC JAB UPT IN; Department of Health and Health Protection Agency, 2012, ANN HPV VACC COV ENG; DiCicco-Bloom B, 2006, MED EDUC, V40, P314, DOI 10.1111/j.1365-2929.2006.02418.x; Egger M, 2003, Health Technol Assess, V7, P1; End Child Poverty, 2011, CHILD POV MAP UK 1; Fagot JP, 2011, VACCINE, V29, P3610, DOI 10.1016/j.vaccine.2011.02.064; FEDER GS, 1993, BRIT J GEN PRACT, V43, P281; Field P., 1995, QUALITATIVE RES METH; Gottvall M, 2011, VACCINE, V29, P4576, DOI 10.1016/j.vaccine.2011.04.054; Greenhalgh T, 2005, BRIT MED J, V331, P1064, DOI 10.1136/bmj.38636.593461.68; Harden A., 2005, INT J SOC RES METHOD, V8, P257, DOI DOI 10.1080/13645570500155078; Harris V, 1998, CANC REGISTRATION ST, P182; Hawker JI, 2007, VACCINE, V25, P7516, DOI 10.1016/j.vaccine.2007.08.043; Hilton S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-226; Jenkins M, 2004, NO TRAVELLERS REPORT; Kelly MP, 2005, EC APPRAISAL PUBLIC; Kumar VM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-172; Lawrence Helen, 2007, Emerg Nurse, V15, P12; Limia A, 2011, EURO SURVEILL, V16; London Health Observatory and Health Protection Agency 92008, LOND SEX HLTH IND; Marlow LAV, 2009, J EPIDEMIOL COMMUN H, V63, P1010, DOI 10.1136/jech.2008.085886; Marlow LAV, 2007, VACCINE, V25, P1945, DOI 10.1016/j.vaccine.2007.01.059; Marlow LAV, 2009, VACCINE, V27, P2483, DOI 10.1016/j.vaccine.2009.02.057; Marlow LAV, 2009, HUM VACCINES, V5, P105, DOI 10.4161/hv.5.2.7368; Maxwell Joseph, 2005, QUALITATIVE RES SOCI; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Mixer RE, 2007, J EPIDEMIOL COMMUN H, V61, P797, DOI 10.1136/jech.2005.045633; Morse JM, 1998, QUAL HEALTH RES, V8, P147, DOI 10.1177/104973239800800201; Moser K, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2025; Muscat M, 2011, J INFECT DIS, V204, P1293, DOI 10.1093/infdis/jir519; Ogilvie G, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000270; Paul-Ebhohimhen Virginia, 2010, Community Pract, V83, P30; Pollack AE, 2007, B WORLD HEALTH ORGAN, V85, P57, DOI 10.2471/BLT.06.034397; Quinn M, 2005, CANC ATLAS UK IRELAN; Roberts C, 2006, TIMES ED SUPPLEMENT; Roberts SA, 2011, EPIDEMIOL INFECT, V139, P400, DOI 10.1017/S095026881000066X; Royal College of Nursing, 2005, SCH NURS RES CENS SU; Scottish Executive, 2001, FAIR ALL IMPR HLTH E; Shack L, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-271; Srinivasan R, 2006, THORAX, V61, P247, DOI 10.1136/thx.2004.036269; Stiennon R, 2012, RIGHT STRATEGY TACTI; Stretch R, 2008, BRIT J CANCER, V99, P1908, DOI 10.1038/sj.bjc.6604766; Stronegger WJ, 2010, EUR J PUBLIC HEALTH, V20, P354, DOI 10.1093/eurpub/ckp188; Teddlie C, 2007, J MIX METHOD RES, V1, P77, DOI 10.1177/2345678906292430; Teutsch SM, 2011, HEALTH AFFAIR, V30, P349, DOI 10.1377/hlthaff.2010.0593; The Information Centre Workforce and Facilities Team, 2010, NHS WORKF SUMM STAFF; Vandermeulen C, 2008, PEDIATRICS, V121, pE428, DOI 10.1542/peds.2007-1415; Wainwright P, 2000, J ADV NURS, V32, P1083, DOI 10.1046/j.1365-2648.2000.01579.x; Wallace A, 2004, POLICY POLIT, V32, P455, DOI 10.1332/0305573042009444; Wallace LA, 2004, ARCH DIS CHILD, V89, P1041, DOI 10.1136/adc.2003.043687; Walsh CD, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-368; Warren CAB, 2001, HDB INTERVIEW RES, P91; Watt A, 2008, INT J TECHNOL ASSESS, V24, P133, DOI 10.1017/S0266462308080185; WEISS ROBERT S., 1994, LEARNING STRANGERS A, P55; Weller DP, 2009, BRIT J CANCER, V101, pS55, DOI 10.1038/sj.bjc.6605391; Wright JA, 2006, EUR J PUBLIC HEALTH, V16, P137, DOI 10.1093/eurpub/cki194	71	43	43	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e43416	10.1371/journal.pone.0043416	http://dx.doi.org/10.1371/journal.pone.0043416			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005ZK	23028452	Green Published, gold			2022-12-27	WOS:000308788700010
J	Hwang, SG; Park, J; Park, JY; Park, CH; Lee, KH; Cho, JW; Hwang, JI; Seong, JY				Hwang, Sun Gwan; Park, Jinah; Park, Joo Young; Park, Cheol Hyoung; Lee, Ki-Ho; Cho, Jeong Woo; Hwang, Jong-Ik; Seong, Jae Young			Anti-Cancer Activity of a Novel Small Molecule Compound That Simultaneously Activates p53 and Inhibits NF-kappa B Signaling	PLOS ONE			English	Article							ANCHORAGE-INDEPENDENT GROWTH; TRANSCRIPTION FACTOR; INDUCED PHOSPHORYLATION; SESQUITERPENE LACTONE; CELL-GROWTH; CANCER; APOPTOSIS; RAS; REQUIREMENT; SUPPRESSION	The p53 and NF-kappa B pathways play important roles in diverse cellular functions, including cell growth, apoptosis, and tumorigenesis. Mutations that inactivate the p53 gene and constitutive NF-kappa B pathway activation are common occurrences in human cancers. Although many drugs are being developed that selectively activate p53 or inhibit NF-kappa B, there are few drug candidates that can do both. Simultaneous activation of p53 and inhibition of the NF-kappa B pathway is therefore a prime target for new cancer drug development. This study is the first report of a high-throughput approach with mass compounds that concurrently target both pathways. Using a cell-based screening assay and a library of 200,000 synthetic compounds, we identified 9 small molecules that simultaneously inhibit NF-kappa B and activate p53. One of these compounds, N-2, increased the expression of p53 target genes, including p21 and GADD45a. In addition, N-2 inhibited the transcriptional activity of NF-kappa B, concomitantly repressing interleukin-6 and monocyte chemotactic protein-1 (MCP-1) expression. When cell lines derived from a diverse range of cancers were treated in vitro with N-2, we observed increased cell death. N-2 also significantly inhibited allograft growth in murine models of melanoma and lung carcinoma. Our findings suggest that N-2 may act as a bivalent anti-cancer agent through simultaneous modulation of NF-kappa B and p53 activities.	[Hwang, Sun Gwan; Park, Joo Young; Park, Cheol Hyoung; Lee, Ki-Ho; Cho, Jeong Woo] SK Biopharmaceut Co Ltd, Drug Dev Ctr, Taejon, South Korea; [Hwang, Sun Gwan; Hwang, Jong-Ik; Seong, Jae Young] Korea Univ, Grad Sch Med, Lab Prot Coupled Receptors G, Seoul, South Korea; [Park, Jinah] KRIBB, Korean Bioinformat Ctr, Taejon, South Korea	SK Group; Korea University; Korea University Medicine (KU Medicine); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Hwang, SG (corresponding author), SK Biopharmaceut Co Ltd, Drug Dev Ctr, Taejon, South Korea.	jyseong@korea.ac.kr	Seong, Jae Young/A-5794-2012	Seong, Jae Young/0000-0002-3312-6924; Hwang, Jong-Ik/0000-0002-0729-1782	SK Biopharmaceuticals Co., Ltd.; Brain Research Center of the 21st Century Frontier Research Program [2011K00277]	SK Biopharmaceuticals Co., Ltd.; Brain Research Center of the 21st Century Frontier Research Program(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by SK Biopharmaceuticals Co., Ltd., and grants (2011K00277) from the Brain Research Center of the 21st Century Frontier Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Basseres DS, 2010, CANCER RES, V70, P3537, DOI 10.1158/0008-5472.CAN-09-4290; Blaydes JP, 1998, ONCOGENE, V16, P3317, DOI 10.1038/sj.onc.1201880; Bork PM, 1997, FEBS LETT, V402, P85, DOI 10.1016/S0014-5793(96)01502-5; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Chenette EJ, 2009, NAT REV DRUG DISCOV, V8, DOI 10.1038/nrd3060; COLBURN NH, 1978, CANCER RES, V38, P624; de Lange J, 2012, ONCOGENE, V31, P1105, DOI 10.1038/onc.2011.309; Dey A, 2008, CELL DEATH DIFFER, V15, P263, DOI 10.1038/sj.cdd.4402257; Dey A, 2008, NAT REV DRUG DISCOV, V7, P1031, DOI 10.1038/nrd2759; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Finco TS, 1997, J BIOL CHEM, V272, P24113, DOI 10.1074/jbc.272.39.24113; Gasparian AV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002530; Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043; Gilmore TD, 2006, ONCOGENE, V25, P6887, DOI 10.1038/sj.onc.1209982; Gu HY, 2008, MOL CANCER THER, V7, P3298, DOI 10.1158/1535-7163.MCT-08-0212; Gurova KV, 2005, P NATL ACAD SCI USA, V102, P17448, DOI 10.1073/pnas.0508888102; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hwang SG, 2002, J BIOL CHEM, V277, P2923, DOI 10.1074/jbc.M109113200; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Jiang YX, 2001, ONCOGENE, V20, P2254, DOI 10.1038/sj.onc.1204293; Jones Edward, 2007, J Inflamm (Lond), V4, P23, DOI 10.1186/1476-9255-4-23; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; Liu G, 2009, J IMMUNOL, V182, P5063, DOI 10.4049/jimmunol.0803526; Lu WG, 2001, ONCOGENE, V20, P3206, DOI 10.1038/sj.onc.1204412; Mayo MW, 2000, BBA-REV CANCER, V1470, pM55, DOI 10.1016/S0304-419X(00)00002-0; McCarthy N, 2011, NAT REV CANCER, V11, P4, DOI 10.1038/nrc2987; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Rong JJ, 2010, CANCER LETT, V296, P55, DOI 10.1016/j.canlet.2010.03.016; Saha MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030215; Saha MN, 2010, MOL CANCER THER, V9, P3041, DOI 10.1158/1535-7163.MCT-10-0471; Sakamoto K, 2010, EXPERT OPIN THER TAR, V14, P593, DOI 10.1517/14728221003769903; Sharma HW, 1996, ANTICANCER RES, V16, P589; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Sohn TA, 2002, CARCINOGENESIS, V23, P949, DOI 10.1093/carcin/23.6.949; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wang WG, 2005, CANCER BIOL THER, V4, P893, DOI 10.4161/cbt.4.8.2134; Wang Y, 2010, CANCER LETT, V295, P110, DOI 10.1016/j.canlet.2010.02.019; Wuerzberger-Davis SM, 2007, ONCOGENE, V26, P641, DOI 10.1038/sj.onc.1209815; Xia Y, 2012, NAT CELL BIOL; Xie SQ, 2001, J BIOL CHEM, V276, P36194, DOI 10.1074/jbc.M104157200; Zhou JB, 2008, BREAST CANCER RES TR, V111, P419, DOI 10.1007/s10549-007-9798-y	57	13	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44259	10.1371/journal.pone.0044259	http://dx.doi.org/10.1371/journal.pone.0044259			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028510	gold, Green Published, Green Submitted			2022-12-27	WOS:000308788700017
J	Di Gaetano, C; Voglino, F; Guarrera, S; Fiorito, G; Rosa, F; Di Blasio, AM; Manzini, P; Dianzani, I; Betti, M; Cusi, D; Frau, F; Barlassina, C; Mirabelli, D; Magnani, C; Glorioso, N; Bonassi, S; Piazza, A; Matullo, G				Di Gaetano, Cornelia; Voglino, Floriana; Guarrera, Simonetta; Fiorito, Giovanni; Rosa, Fabio; Di Blasio, Anna Maria; Manzini, Paola; Dianzani, Irma; Betti, Marta; Cusi, Daniele; Frau, Francesca; Barlassina, Cristina; Mirabelli, Dario; Magnani, Corrado; Glorioso, Nicola; Bonassi, Stefano; Piazza, Alberto; Matullo, Giuseppe			An Overview of the Genetic Structure within the Italian Population from Genome-Wide Data	PLOS ONE			English	Article							MTDNA HAPLOGROUP-H; Y-CHROMOSOME; HIGH-RESOLUTION; PATTERNS; ORIGIN; SUBSTRUCTURE; DIVERSITY; ANCESTRY; ASSOCIATION; EUROPEANS	In spite of the common belief of Europe as reasonably homogeneous at genetic level, advances in high-throughput genotyping technology have resolved several gradients which define different geographical areas with good precision. When Northern and Southern European groups were considered separately, there were clear genetic distinctions. Intra-country genetic differences were also evident, especially in Finland and, to a lesser extent, within other European populations. Here, we present the first analysis using the 125,799 genome-wide Single Nucleotide Polymorphisms (SNPs) data of 1,014 Italians with wide geographical coverage. We showed by using Principal Component analysis and model-based individual ancestry analysis, that the current population of Sardinia can be clearly differentiated genetically from mainland Italy and Sicily, and that a certain degree of genetic differentiation is detectable within the current Italian peninsula population. Pair-wise F-ST statistics Northern and Southern Italy amounts approximately to 0.001 between, and around 0.002 between Northern Italy and Utah residents with Northern and Western European ancestry (CEU). The Italian population also revealed a fine genetic substructure underscoring by the genomic inflation (Sardinia vs. Northern Italy = 3.040 and Northern Italy vs. CEU = 1.427), warning against confounding effects of hidden relatedness and population substructure in association studies.	[Di Gaetano, Cornelia; Piazza, Alberto; Matullo, Giuseppe] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy; [Di Gaetano, Cornelia; Voglino, Floriana; Guarrera, Simonetta; Fiorito, Giovanni; Rosa, Fabio; Piazza, Alberto; Matullo, Giuseppe] Human Genet Fdn HuGeF, Turin, Italy; [Di Blasio, Anna Maria] Ist Auxol Italiano, Cusano Milanino, Italy; [Manzini, Paola] San Giovanni Molinette Hosp, Banca Sangue, Turin, Italy; [Dianzani, Irma; Betti, Marta] Univ Piemonte Orientale, Dept Hlth Sci, Novara, Italy; [Cusi, Daniele; Frau, Francesca; Barlassina, Cristina] Univ Milan, Dept Med Surg & Dent, Milan, Italy; [Cusi, Daniele; Frau, Francesca; Barlassina, Cristina] Fdn Filarete, Genom & Bioinformat Unit, Milan, Italy; [Mirabelli, Dario] Univ Turin, Canc Epidemiol Unit, Turin, Italy; [Mirabelli, Dario] CPO Piemonte, Turin, Italy; [Magnani, Corrado] Univ Piemonte Orientale, Dept Translat Med, Novara, Italy; [Glorioso, Nicola] Univ Sassari, AOU, Hypertens & Related Dis Ctr, I-07100 Sassari, Italy; [Bonassi, Stefano] IRCCS San Raffaele Pisana, Unit Clin & Mol Epidemiol, Rome, Italy	University of Turin; IRCCS Istituto Auxologico Italiano; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Eastern Piedmont Amedeo Avogadro; University of Milan; University of Turin; Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte; University of Eastern Piedmont Amedeo Avogadro; University of Sassari; IRCCS San Raffaele Pisana	Di Gaetano, C (corresponding author), Univ Turin, Dept Genet Biol & Biochem, Turin, Italy.	cornelia.digaetano@unito.it	Matullo, Giuseppe/K-6383-2016; Di Gaetano, Cornelia/AAA-5477-2019; Rosa, Fabio/AGI-6840-2022; Bonassi, Stefano/ABI-6281-2020; Guarrera, Simonetta/AAB-8482-2022; Betti, Marta/K-4395-2016	Matullo, Giuseppe/0000-0003-0674-7757; Di Gaetano, Cornelia/0000-0001-8938-7093; Rosa, Fabio/0000-0002-8335-4482; Bonassi, Stefano/0000-0003-3833-6717; Betti, Marta/0000-0002-1372-6666; Barlassina, Cristina/0000-0001-7407-2697; Betti, Marta/0000-0003-0846-4988; Fiorito, Giovanni/0000-0002-7651-5452; Piazza, Alberto/0000-0002-2355-4183	Human Genetic Foundation (HuGeF) of Turin; Associazione Italiana per la Ricerca sul Cancro (AIRC); non-profit Buzzi Unicem Foundation for mesothelioma research; HYPERGENES project [FP7 - HEALTH-2007-201550]; InterOmics an Italian Flagship project; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR); Consiglio Nazionale delle Ricerche (CNR)	Human Genetic Foundation (HuGeF) of Turin; Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); non-profit Buzzi Unicem Foundation for mesothelioma research; HYPERGENES project; InterOmics an Italian Flagship project; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Consiglio Nazionale delle Ricerche (CNR)(Consiglio Nazionale delle Ricerche (CNR))	The main supporter of this project was the Human Genetic Foundation (HuGeF) of Turin (to M.G.). This study used data from grants funded by Associazione Italiana per la Ricerca sul Cancro (AIRC) AIRC 2007, and the non-profit Buzzi Unicem Foundation for mesothelioma research (to B.S.), HYPERGENES project (funded by the Seventh Framework Programme FP7 - HEALTH-2007-201550) and InterOmics an Italian Flagship project (funded by Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) and Consiglio Nazionale delle Ricerche (CNR) (to C.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2007, AM J HUM GENET, V80, P759, DOI 10.1086/512822; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; AMMERMAN AJ, 1984, NEOLITHIC TRANSITION; Balanovsky O, 2008, AM J HUM GENET, V82, P236, DOI 10.1016/j.ajhg.2007.09.019; BARBUJANI G, 1995, P NATL ACAD SCI USA, V92, P9171, DOI 10.1073/pnas.92.20.9171; Betti M, 2009, INT J HYG ENVIR HEAL, V212, P322, DOI 10.1016/j.ijheh.2008.08.001; Bonifazi C., 2000, INT J POPULATION GEO, V6, P111, DOI DOI 10.1002/(SICI)1099-1220(200003/04)6:2<111::AID-IJPG172>3.0.CO;2-L; Bosch E, 2001, AM J HUM GENET, V68, P1019, DOI 10.1086/319521; Bosch N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008269; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cann HM, 2002, SCIENCE, V296, P261; Capelli C, 2003, CURR BIOL, V13, P979, DOI 10.1016/S0960-9822(03)00373-7; Capelli C, 2007, MOL PHYLOGENET EVOL, V44, P228, DOI 10.1016/j.ympev.2006.11.030; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza LL, 2007, ANNU REV GENOM HUM G, V8, P1, DOI 10.1146/annurev.genom.8.080706.092403; CAVALLISFORZA LL, 1993, EUR J HUM GENET, V1, P3; Deng LB, 2008, HUM MUTAT, V29, P1209, DOI 10.1002/humu.20775; Development Core Team R, 2008, R LANG ENV STAT COMP; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Di Giacomo F, 2003, MOL PHYLOGENET EVOL, V28, P387, DOI 10.1016/S1055-7903(03)00016-2; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hao K, 2004, EUR J HUM GENET, V12, P1001, DOI 10.1038/sj.ejhg.5201273; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Humphreys K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022547; Huyghe JR, 2011, EUR J HUM GENET, V19, P347, DOI 10.1038/ejhg.2010.179; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Keller A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1701; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Loogvali EL, 2004, MOL BIOL EVOL, V21, P2012, DOI 10.1093/molbev/msh209; Maca-Meyer N, 2003, ANN HUM GENET, V67, P329, DOI 10.1046/j.1469-1809.2003.00045.x; Malyarchuk BA, 2002, ANN HUM GENET, V66, P261, DOI 10.1017/S0003480002001161; MANTEL N, 1967, CANCER RES, V27, P209; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; McEvoy BP, 2009, GENOME RES, V19, P804, DOI 10.1101/gr.083394.108; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Morelli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010419; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; O'Dushlaine CT, 2010, EUR J HUM GENET, V18, P1248, DOI 10.1038/ejhg.2010.87; PIAZZA A, 1988, ANN HUM GENET, V52, P203, DOI 10.1111/j.1469-1809.1988.tb01098.x; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000505; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sajantila A, 1996, P NATL ACAD SCI USA, V93, P12035, DOI 10.1073/pnas.93.21.12035; Salm MPA, 2012, GENOME RES, V22, P1144, DOI 10.1101/gr.126037.111; Salmela E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016747; Salvi E, 2011, HYPERTENSION; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Tian C, 2009, MOL MED, V15, P371, DOI 10.2119/molmed.2009.00094; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Winney B, 2011, EUR J HUM GENET	61	46	47	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43759	10.1371/journal.pone.0043759	http://dx.doi.org/10.1371/journal.pone.0043759			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984441	Green Published, gold, Green Submitted			2022-12-27	WOS:000308738500021
J	Lai, XS; Wang, JY; Nabar, NR; Pan, SQ; Tang, CZ; Huang, Y; Hao, MF; Yang, ZH; Ma, CM; Zhang, J; Chew, H; He, ZQ; Yang, JJ; Su, BG; Zhang, J; Liang, J; Sneed, KB; Zhou, SF				Lai, Xinsheng; Wang, Jiayou; Nabar, Neel R.; Pan, Sanqiang; Tang, Chunzhi; Huang, Yong; Hao, Mufeng; Yang, Zhonghua; Ma, Chunmei; Zhang, Jin; Chew, Helen; He, Zhenquan; Yang, Junjun; Su, Baogui; Zhang, Jian; Liang, Jun; Sneed, Kevin B.; Zhou, Shu-Feng			Proteomic Response to Acupuncture Treatment in Spontaneously Hypertensive Rats	PLOS ONE			English	Article							ROSTRAL VENTROLATERAL MEDULLA; RESEARCH-PROGRAM SHARP; OXIDATIVE STRESS; STOP HYPERTENSION; NADPH OXIDASES; BLOOD-PRESSURE; HEART-DISEASE; DOUBLE-BLIND; MECHANISMS; UPDATE	Previous animal and clinical studies have shown that acupuncture is an effective alternative treatment in the management of hypertension, but the mechanism is unclear. This study investigated the proteomic response in the nervous system to treatment at the Taichong (LR3) acupoint in spontaneously hypertensive rats (SHRs). Unanesthetized rats were subject to 5-min daily acupuncture treatment for 7 days. Blood pressure was monitored over 7 days. After euthanasia on the 7th day, rat medullas were dissected, homogenized, and subject to 2D gel electrophoresis and MALDI-TOF analysis. The results indicate that blood pressure stabilized after the 5th day of acupuncture, and compared with non-acupoint treatment, Taichong-acupunctured rat's systolic pressure was reduced significantly (P<0.01), though not enough to bring blood pressure down to normal levels. The different treatment groups also showed differential protein expression: the 2D images revealed 571+/-15 proteins in normal SD rats' medulla, 576+/-31 proteins in SHR's medulla, 597644 proteins in medulla of SHR after acupuncturing Taichong, and 616+/-18 proteins in medulla of SHR after acupuncturing non-acupoint. In the medulla of Taichong group, compared with non-acupoint group, seven proteins were down-regulated: heat shock protein-90, synapsin-1, pyruvate kinase isozyme, NAD-dependent deacetylase sirtuin-2, protein kinase C inhibitor protein 1, ubiquitin hydrolase isozyme L1, and myelin basic protein. Six proteins were up-regulated: glutamate dehydrogenase 1, aldehyde dehydrogenase 2, glutathione S-transferase M5, Rho GDP dissociation inhibitor 1, DJ-1 protein and superoxide dismutase. The altered expression of several proteins by acupuncture has been confirmed by ELISA, Western blot and qRT-PCR assays. The results indicate an increase in antioxidant enzymes in the medulla of the SHRs subject to acupuncture, which may provide partial explanation for the antihypertensive effect of acupuncture. Further studies are warranted to investigate the role of oxidative stress modulation by acupuncture in the treatment of hypertension.	[Lai, Xinsheng; Tang, Chunzhi; Yang, Junjun] Guangzhou Univ Chinese Med, Sch Acupuncture & Moxibust, Dept Acupuncture & Moxibust, Guangzhou, Guangdong, Peoples R China; [Wang, Jiayou; Hao, Mufeng; Yang, Zhonghua; Ma, Chunmei; Zhang, Jin; He, Zhenquan] Guangzhou Univ Chinese Med, Sch Fundamental Med Sci, Dept Human Anat, Guangzhou, Guangdong, Peoples R China; [Nabar, Neel R.; Chew, Helen; Liang, Jun; Zhou, Shu-Feng] Univ S Florida, Coll Pharm, Dept Pharmaceut Sci, Tampa, FL USA; [Pan, Sanqiang; Su, Baogui] Jinan Univ, Sch Med, Dept Human Anat, Guangzhou, Guangdong, Peoples R China; [Huang, Yong] So Med Univ, Sch Chinese Med, Dept Acupuncture & Moxibust, Guangzhou, Guangdong, Peoples R China; [Zhang, Jian] Third Hosp Nanchang, Dept Surg, Nanchang, Jiangxi, Peoples R China; [Sneed, Kevin B.] Univ S Florida, Coll Pharm, Dept Pharmacotherapeut & Clin Res, Tampa, FL USA	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; State University System of Florida; University of South Florida; Jinan University; Southern Medical University - China; State University System of Florida; University of South Florida	Lai, XS (corresponding author), Guangzhou Univ Chinese Med, Sch Acupuncture & Moxibust, Dept Acupuncture & Moxibust, Guangzhou, Guangdong, Peoples R China.	xmishu@126.com; szhou@health.usf.edu	Zhou, Shu-Feng/E-3166-2013; Wang, Jiayou/AAN-4760-2021	Zhou, Shu-Feng/0000-0002-5542-6119; Wang, Jiayou/0000-0001-9697-2004; Nabar, Neel/0000-0002-9704-3570	National 973 program of China [2006CB504505]; Natural Science Foundation of China [90709027]; University of South Florida College of Pharmacy Startup Fund	National 973 program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of South Florida College of Pharmacy Startup Fund	The authors appreciate the support by the National 973 program of China (Grant No. 2006CB504505), the Natural Science Foundation of China (Grant No. 90709027), and University of South Florida College of Pharmacy Startup Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKHMEDOV TI, 1993, TERAPEVT ARKH, V65, P22; ANSHELEVICH YV, 1985, TERAPEVT ARKH, V57, P42; Benter IF, 2011, J CARDIOVASC PHARM, V57, P559, DOI 10.1097/FJC.0b013e31821324b6; Bertoia ML, 2011, HYPERTENSION, V58, P361, DOI 10.1161/HYPERTENSIONAHA.111.175463; Bobkova A S, 1991, Vopr Kurortol Fizioter Lech Fiz Kult, P29; Boshtam M, 2002, INT J VITAM NUTR RES, V72, P309, DOI 10.1024/0300-9831.72.5.309; Burke A, 2006, J ALTERN COMPLEM MED, V12, P639, DOI 10.1089/acm.2006.12.639; Cantwell SL, 2010, TOP COMPANION ANIM M, V25, P53, DOI 10.1053/j.tcam.2009.10.006; Chiu YJ, 1997, CLIN EXP HYPERTENS, V19, P1047, DOI 10.3109/10641969709083204; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; CHRISTE ME, 1994, J MOL CELL CARDIOL, V26, P1371, DOI 10.1006/jmcc.1994.1155; Colombari E, 2001, HYPERTENSION, V38, P549, DOI 10.1161/01.HYP.38.3.549; Datla SR, 2010, HYPERTENSION, V56, P325, DOI 10.1161/HYPERTENSIONAHA.109.142422; DeLano FA, 2005, AM J PHYSIOL-HEART C, V288, pH805, DOI 10.1152/ajpheart.00696.2004; Duan Dong-mei, 2008, Zhongguo Zhen Jiu, V28, P369; Engelhard YN, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.05.008; Friedemann T, 2011, LASERS MED SCI; Harrison DG, 2009, MED CLIN N AM, V93, P621, DOI 10.1016/j.mcna.2009.02.015; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Huang H, 1992, J Tradit Chin Med, V12, P133; Huang Xue-Kuan, 2008, Zhen Ci Yan Jiu, V33, P183; Huang YL, 2005, ACUPUNCTURE ELECTRO, V30, P263, DOI 10.3727/036012905815901235; Hwang HS, 2008, EVID-BASED COMPL ALT, V2011, P1; Kalish LA, 2004, CONTROL CLIN TRIALS, V25, P76, DOI 10.1016/j.cct.2003.08.006; Kaplan NM, 2006, HYPERTENSION, V48, P815, DOI 10.1161/01.HYP.0000241069.80574.76; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kim DD, 2006, MICROCIRCULATION, V13, P577, DOI 10.1080/10739680600885210; Kim LW, 2010, ALTERN THER HEALTH M, V16, P18; Kishi T, 2004, CIRCULATION, V109, P2357, DOI 10.1161/01.CIR.0000128695.49900.12; Kizhakekuttu TJ, 2010, CARDIOVASC THER, V28, pe20, DOI 10.1111/j.1755-5922.2010.00137.x; Kumar A, 2009, PHARMACOL THERAPEUT, V124, P259, DOI 10.1016/j.pharmthera.2009.07.003; LI P, 1983, ACUPUNCTURE ELECTRO, V8, P45, DOI 10.3727/036012983816715019; Liu CZ, 2006, NEUROSCI LETT, V393, P45, DOI 10.1016/j.neulet.2005.09.049; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Macklin EA, 2006, HYPERTENSION, V48, P838, DOI 10.1161/01.HYP.0000241090.28070.4c; Meng XZ, 2011, BRAIN RES, V1414, P58, DOI 10.1016/j.brainres.2011.08.004; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Park JM, 2010, J ALTERN COMPLEM MED, V16, P883, DOI 10.1089/acm.2009.0427; Perez-Vizcaino F, 2009, PHARMACOL REP, V61, P67, DOI 10.1016/S1734-1140(09)70008-8; Peterson JR, 2006, CURR HYPERTENS REP, V8, P232, DOI 10.1007/s11906-006-0056-1; Pimenta E, 2012, HYPERTENS RES, V35, P148, DOI 10.1038/hr.2011.190; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Stocker SD, 2008, CLIN EXP PHARMACOL P, V35, P695, DOI 10.1111/j.1440-1681.2007.04835.x; SUGIOKA K, 1977, AM J CHINESE MED, V5, P39, DOI 10.1142/S0192415X77000051; Wang F, 2011, PEPTIDES, V32, P2394, DOI 10.1016/j.peptides.2011.10.019; YAO T, 1993, SCAND J REHABIL MED, P7; Yin C, 2007, NEUROL RES, V29, pS98, DOI 10.1179/016164107X172220; Yu YP, 2010, BRAIN RES, V1336, P58, DOI 10.1016/j.brainres.2010.04.020; Zhang WG, 2000, P NATL ACAD SCI USA, V97, P9765, DOI 10.1073/pnas.170160397; Zhang Y, 2011, NEUROCHEM RES, V36, P2104, DOI 10.1007/s11064-011-0534-y; Zhou Y, 1995, Zhen Ci Yan Jiu, V20, P55	51	37	42	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44216	10.1371/journal.pone.0044216	http://dx.doi.org/10.1371/journal.pone.0044216			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984478	gold, Green Published, Green Submitted			2022-12-27	WOS:000308738500038
J	Mikryukov, A; Moss, T				Mikryukov, Alexander; Moss, Tom			Agonistic and Antagonistic Roles for TNIK and MINK in Non-Canonical and Canonical Wnt Signalling	PLOS ONE			English	Article							N-TERMINAL KINASE; NCK-INTERACTING KINASE; CONVERGENT EXTENSION; XENOPUS EMBRYOS; STE20 KINASE; BETA-CATENIN; STE20-RELATED KINASE; PLANAR POLARITY; ADAPTER PROTEIN; GENE-EXPRESSION	Wnt signalling is a key regulatory factor in animal development and homeostasis and plays an important role in the establishment and progression of cancer. Wnt signals are predominantly transduced via the Frizzled family of serpentine receptors to two distinct pathways, the canonical beta-catenin pathway and a non-canonical pathway controlling planar cell polarity and convergent extension. Interference between these pathways is an important determinant of cellular and phenotypic responses, but is poorly understood. Here we show that TNIK (Traf2 and Nck-interacting kinase) and MINK (Misshapen/NIKs-related kinase) MAP4K signalling kinases are integral components of both canonical and non-canonical pathways in Xenopus. xTNIK and xMINK interact and are proteolytically cleaved in vivo to generate Kinase domain fragments that are active in signal transduction, and Citron-NIK-Homology (CNH) Domain fragments that are suppressive. The catalytic activity of the Kinase domain fragments of both xTNIK and xMINK mediate non-canonical signalling. However, while the Kinase domain fragments of xTNIK also mediate canonical signalling, the analogous fragments derived from xMINK strongly antagonize this signalling. Our data suggest that the proteolytic cleavage of xTNIK and xMINK determines their respective activities and is an important factor in controlling the balance between canonical and non-canonical Wnt signalling in vivo.	[Mikryukov, Alexander; Moss, Tom] Univ Laval, Canc Res Ctr, Lab Growth & Dev, Quebec City, PQ, Canada; [Mikryukov, Alexander; Moss, Tom] Univ Laval, Dept Mol Biol Med Biochem & Pathol, Quebec City, PQ, Canada; [Mikryukov, Alexander; Moss, Tom] Quebec Univ Hosp Ctr, Res Ctr, Quebec City, PQ, Canada	Laval University; Laval University	Mikryukov, A (corresponding author), Univ Toronto, MaRS Ctr, Keller Lab, Toronto, ON, Canada.	Tom.Moss@crhdq.ulaval.ca		Moss, Thomas (Tom)/0000-0003-2047-4783; Mikryukov, Alexander/0000-0002-7632-9529	National Research Council of Canada (NSERC) [194618-07]; Les Fonds quebecois de la recherche sur la nature et les technologies (FQRNT)	National Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Les Fonds quebecois de la recherche sur la nature et les technologies (FQRNT)(FQRNT)	This work was supported by the National Research Council of Canada (NSERC) grant #194618-07 and by a scholarship to A. M. from Les Fonds quebecois de la recherche sur la nature et les technologies (FQRNT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Becker E, 2000, MOL CELL BIOL, V20, P1537, DOI 10.1128/MCB.20.5.1537-1545.2000; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Bokoch GM, 1996, J BIOL CHEM, V271, P25746, DOI 10.1074/jbc.271.42.25746; Bowes JB, 2010, NUCLEIC ACIDS RES, V38, pD607, DOI 10.1093/nar/gkp953; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dan I, 2000, FEBS LETT, V469, P19, DOI 10.1016/S0014-5793(00)01247-3; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Fagotto F, 1997, DEVELOPMENT, V124, P453; Fanto M, 2004, J CELL SCI, V117, P527, DOI 10.1242/jcs.00973; Fu CA, 1999, J BIOL CHEM, V274, P30729, DOI 10.1074/jbc.274.43.30729; Gingras MC, 2002, MOL CELL BIOL, V22, P41, DOI 10.1128/MCB.22.1.41-56.2002; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; HEMMATIBRIVANLOU A, 1990, DEVELOPMENT, V110, P325; Hu YM, 2004, J BIOL CHEM, V279, P54387, DOI 10.1074/jbc.M404497200; Islam N, 1996, TRENDS GENET, V12, P459, DOI 10.1016/0168-9525(96)99990-4; James Richard G., 2008, V468, P131, DOI 10.1007/978-1-59745-249-6_10; JOWETT T, 1994, TRENDS GENET, V10, P73, DOI 10.1016/0168-9525(94)90220-8; Kanai-Azuma M, 1999, MECH DEVELOP, V89, P155, DOI 10.1016/S0925-4773(99)00193-8; Kiefer JC, 2005, DEV DYNAM, V233, P695, DOI 10.1002/dvdy.20359; Klein TJ, 2005, ANNU REV CELL DEV BI, V21, P155, DOI 10.1146/annurev.cellbio.21.012704.132806; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Lee RHK, 2007, EMBO J, V26, P3592, DOI 10.1038/sj.emboj.7601781; Liu HZ, 1999, CURR BIOL, V9, P101, DOI 10.1016/S0960-9822(99)80023-2; Mahmoudi T, 2009, EMBO J, V28, P3329, DOI 10.1038/emboj.2009.285; MCMAHON AP, 1989, CELL, V58, P1075, DOI 10.1016/0092-8674(89)90506-0; Nakano K, 2000, J BIOL CHEM, V275, P20533, DOI 10.1074/jbc.M001009200; Nicke B, 2005, MOL CELL, V20, P673, DOI 10.1016/j.molcel.2005.10.038; Niehrs C, 2001, NATURE, V413, P787, DOI 10.1038/35101682; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Paricio N, 1999, EMBO J, V18, P4669, DOI 10.1093/emboj/18.17.4669; Poinat P, 2002, CURR BIOL, V12, P622, DOI 10.1016/S0960-9822(02)00764-9; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Ruan WJ, 1999, NEURON, V24, P595, DOI 10.1016/S0896-6273(00)81115-0; Satow R, 2010, J BIOL CHEM, V285, P26289, DOI 10.1074/jbc.M109.090597; Schohl A, 2003, EMBO J, V22, P3303, DOI 10.1093/emboj/cdg328; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Su YC, 1998, GENE DEV, V12, P2371, DOI 10.1101/gad.12.15.2371; Su YC, 1997, EMBO J, V16, P1279, DOI 10.1093/emboj/16.6.1279; Su YC, 2000, MOL CELL BIOL, V20, P4736, DOI 10.1128/MCB.20.13.4736-4744.2000; Tada M, 2002, SEMIN CELL DEV BIOL, V13, P251, DOI 10.1016/S1084-9521(02)00052-6; Taira K, 2004, J BIOL CHEM, V279, P49488, DOI 10.1074/jbc.M406370200; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123; Wallingford JB, 2001, DEVELOPMENT, V128, P2581; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wallingford JB, 2001, INT J DEV BIOL, V45, P225; Wright JH, 2003, MOL CELL BIOL, V23, P2068, DOI 10.1128/MCB.23.6.2068-2082.2003; Xue YZ, 2001, DEVELOPMENT, V128, P1559; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008; Yanai I, 2011, DEV CELL, V20, P483, DOI 10.1016/j.devcel.2011.03.015; Yao ZB, 1999, J BIOL CHEM, V274, P2118, DOI 10.1074/jbc.274.4.2118	56	16	16	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43330	10.1371/journal.pone.0043330	http://dx.doi.org/10.1371/journal.pone.0043330			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984420	gold, Green Published, Green Submitted			2022-12-27	WOS:000308638700018
J	Safdie, F; Brandhorst, S; Wei, M; Wang, WJ; Lee, C; Hwang, S; Conti, PS; Chen, TC; Longo, VD				Safdie, Fernando; Brandhorst, Sebastian; Wei, Min; Wang, Weijun; Lee, Changhan; Hwang, Saewon; Conti, Peter S.; Chen, Thomas C.; Longo, Valter D.			Fasting Enhances the Response of Glioma to Chemo- and Radiotherapy	PLOS ONE			English	Article							MALIGNANT GLIOMAS; CANCER-RISK; TEMOZOLOMIDE; GLUCOSE; GLIOBLASTOMA; 2-DEOXY-D-GLUCOSE; CHEMOTHERAPY; CONCOMITANT; PROTECTION; CELLS	Background: Glioma, including anaplastic astrocytoma and glioblastoma multiforme (GBM) are among the most commonly diagnosed malignant adult brain tumors. GBM is a highly invasive and angiogenic tumor, resulting in a 12 to 15 months median survival. The treatment of GBM is multimodal and includes surgical resection, followed by adjuvant radio-and chemotherapy. We have previously reported that short-term starvation (STS) enhances the therapeutic index of chemo-treatments by differentially protecting normal cells against and/or sensitizing tumor cells to chemotoxicity. Methodology and Principal Findings: To test the effect of starvation on glioma cells in vitro, we treated primary mouse glia, murine GL26, rat C6 and human U251, LN229 and A172 glioma cells with Temozolomide in ad lib and STS mimicking conditions. In vivo, mice with subcutaneous or intracranial models of GL26 glioma were starved for 48 hours prior to radio- or chemotherapy and the effects on tumor progression and survival were measured. Starvation-mimicking conditions sensitized murine, rat and human glioma cells, but not primary mixed glia, to chemotherapy. In vivo, starvation for 48 hours, which causes a significant reduction in blood glucose and circulating insulin-like growth factor 1 (IGF-1) levels, sensitized both subcutaneous and intracranial glioma models to radio-and chemotherapy. Conclusion: Starvation-induced cancer sensitization to radio-or chemotherapy leads to extended survival in the in vivo glioma models tested. These results indicate that fasting and fasting-mimicking interventions could enhance the efficacy of existing cancer treatments against aggressive glioma in patients.	[Safdie, Fernando; Brandhorst, Sebastian; Wei, Min; Lee, Changhan; Hwang, Saewon; Longo, Valter D.] Univ So Calif, Sch Gerontol, Longev Inst, Los Angeles, CA 90089 USA; [Safdie, Fernando; Brandhorst, Sebastian; Wei, Min; Lee, Changhan; Hwang, Saewon; Longo, Valter D.] Univ So Calif, Sch Gerontol, Dept Biol Sci, Los Angeles, CA USA; [Wang, Weijun; Chen, Thomas C.] USC Keck Sch Med, USC Norris Neurooncol Program, Los Angeles, CA USA; [Conti, Peter S.] USC Keck Sch Med, Mol Imaging Ctr, Dept Radiol, Los Angeles, CA USA; [Brandhorst, Sebastian] Univ Duisburg Essen, Fac Biol, Ctr Med Biotechnol, Essen, Germany	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Duisburg Essen	Safdie, F (corresponding author), Univ So Calif, Sch Gerontol, Longev Inst, Los Angeles, CA 90089 USA.	vlongo@usc.edu	Wei, Min/GSI-8510-2022	Wei, Min/0000-0002-2649-9271	NIH/NIA [AG20642, AG025135]; Bakewell Foundation; V Foundation for Cancer Research; USC Norris Cancer Center pilot grant; NCRR grant [S10RR017964-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG034906, R01AG020642, R01AG025135] Funding Source: NIH RePORTER	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Bakewell Foundation; V Foundation for Cancer Research; USC Norris Cancer Center pilot grant; NCRR grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study is funded, in part, by NIH/NIA grants AG20642 and AG025135, The Bakewell Foundation, The V Foundation for Cancer Research and a USC Norris Cancer Center pilot grant to VDL. The Molecular Imaging Center at USC is supported in part by NCRR grant S10RR017964-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Apontes P, 2011, ONCOTARGET, V2, P222, DOI 10.18632/oncotarget.248; Aronen HJ, 2000, CLIN CANCER RES, V6, P2189; FEARON KCH, 1988, AM J CLIN NUTR, V47, P42, DOI 10.1093/ajcn/47.1.42; Fisher PG, 2005, JAMA-J AM MED ASSOC, V293, P615, DOI 10.1001/jama.293.5.615; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Friedman HS, 2000, CLIN CANCER RES, V6, P2585; Greenspan RJ, 2001, NAT REV GENET, V2, P383, DOI 10.1038/35072018; Gupta T, 2002, LANCET ONCOL, V3, P557, DOI 10.1016/S1470-2045(02)00853-7; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hegi ME, 2008, J CLIN ONCOL, V26, P4189, DOI 10.1200/JCO.2007.11.5964; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Kari F W, 1999, J Nutr Health Aging, V3, P92; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Kreisl TN, 2009, SEMIN RADIAT ONCOL, V19, P150, DOI 10.1016/j.semradonc.2009.02.003; Kroger N, 1998, BONE MARROW TRANSPL, V21, P1171, DOI 10.1038/sj.bmt.1701245; Lee C, 2011, ONCOGENE; Lee C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003293; Lee CH, 2010, CANCER RES, V70, P1564, DOI 10.1158/0008-5472.CAN-09-3228; LEWIS C, 1994, DRUG SAFETY, V11, P153, DOI 10.2165/00002018-199411030-00002; Mitchell JR, 2010, AGING CELL, V9, P40, DOI 10.1111/j.1474-9726.2009.00532.x; Mohanti BK, 1996, INT J RADIAT ONCOL, V35, P103, DOI 10.1016/S0360-3016(96)85017-6; Mutter N, 2006, EXPERT REV ANTICANC, V6, P1187, DOI 10.1586/14737140.6.8.1187; Newlands ES, 1997, CANCER TREAT REV, V23, P35, DOI 10.1016/S0305-7372(97)90019-0; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Oudard S, 1997, ANTICANCER RES, V17, P1903; Prins RM, 2003, CANCER RES, V63, P8487; Purow B, 2009, NAT REV NEUROL, V5, P419, DOI 10.1038/nrneurol.2009.96; Pyrko P, 2007, CANCER RES, V67, P9809, DOI 10.1158/0008-5472.CAN-07-0625; Raffaghello L, 2008, P NATL ACAD SCI USA, V105, P8215, DOI 10.1073/pnas.0708100105; Rapp K, 2006, DIABETOLOGIA, V49, P945, DOI 10.1007/s00125-006-0207-6; Roslin M, 2003, J NEURO-ONCOL, V61, P151, DOI 10.1023/A:1022106910017; Safdie FM, 2009, AGING-US, V1, P988, DOI 10.18632/aging.100114; Seyfried TN, 2003, BRIT J CANCER, V89, P1375, DOI 10.1038/sj.bjc.6601269; SINGH SP, 1990, INT J RADIAT BIOL, V58, P791, DOI 10.1080/09553009014552171; Srivastava DK, 1998, J BIOL CHEM, V273, P21203, DOI 10.1074/jbc.273.33.21203; STEVENS MFG, 1987, CANCER RES, V47, P5846; Stocks T, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000201; Strohman R, 2002, SCIENCE, V296, P701, DOI 10.1126/science.1070534; Stupp R, 2002, J CLIN ONCOL, V20, P1375, DOI 10.1200/JCO.20.5.1375; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Villano JL, 2009, CANCER CHEMOTH PHARM, V64, P647, DOI 10.1007/s00280-009-1050-5; WARBURG O, 1956, SCIENCE, V124, P269; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yu H, 2000, JNCI-J NATL CANCER I, V92, P1472, DOI 10.1093/jnci/92.18.1472; ZIMMERMAN HM, 1955, AM J PATHOL, V31, P1; Zitvogel L, 2011, NAT REV CLIN ONCOL, V8, P151, DOI 10.1038/nrclinonc.2010.223	46	135	144	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44603	10.1371/journal.pone.0044603	http://dx.doi.org/10.1371/journal.pone.0044603			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984531	gold, Green Submitted, Green Published			2022-12-27	WOS:000308638700071
J	Zhang, YC; Gao, M; Singer, SD; Fei, ZJ; Wang, H; Wang, XP				Zhang, Yucheng; Gao, Min; Singer, Stacy D.; Fei, Zhangjun; Wang, Hua; Wang, Xiping			Genome-Wide Identification and Analysis of the TIFY Gene Family in Grape	PLOS ONE			English	Article							EVOLUTIONARY ANALYSIS; JASMONATE; ARABIDOPSIS; DUPLICATION; EXPRESSION; RESISTANCE; PROTEINS; SEQUENCE; DEFENSE; STRESS	Background: The TIFY gene family constitutes a plant-specific group of genes with a broad range of functions. This family encodes four subfamilies of proteins, including ZML, TIFY, PPD and JASMONATE ZIM-Domain (JAZ) proteins. JAZ proteins are targets of the SCFCOI1 complex, and function as negative regulators in the JA signaling pathway. Recently, it has been reported in both Arabidopsis and rice that TIFY genes, and especially JAZ genes, may be involved in plant defense against insect feeding, wounding, pathogens and abiotic stresses. Nonetheless, knowledge concerning the specific expression patterns and evolutionary history of plant TIFY family members is limited, especially in a woody species such as grape. Methodology/Principal Findings: A total of two TIFY, four ZML, two PPD and 11 JAZ genes were identified in the Vitis vinifera genome. Phylogenetic analysis of TIFY protein sequences from grape, Arabidopsis and rice indicated that the grape TIFY proteins are more closely related to those of Arabidopsis than those of rice. Both segmental and tandem duplication events have been major contributors to the expansion of the grape TIFY family. In addition, synteny analysis between grape and Arabidopsis demonstrated that homologues of several grape TIFY genes were found in the corresponding syntenic blocks of Arabidopsis, suggesting that these genes arose before the divergence of lineages that led to grape and Arabidopsis. Analyses of microarray and quantitative real-time RT-PCR expression data revealed that grape TIFY genes are not a major player in the defense against biotrophic pathogens or viruses. However, many of these genes were responsive to JA and ABA, but not SA or ET. Conclusion: The genome-wide identification, evolutionary and expression analyses of grape TIFY genes should facilitate further research of this gene family and provide new insights regarding their evolutionary history and regulatory control.	[Zhang, Yucheng; Gao, Min; Wang, Xiping] NW A&F Univ, Minist Agr, Key Lab Hort Plant Biol & Germplasm Innovat NW Ch, Coll Hort, Yangling, Shaanxi, Peoples R China; [Zhang, Yucheng; Wang, Hua] NW A&F Univ, Coll Enol, Shaanxi Engn Res Ctr Viti Viniculture, Yangling, Shaanxi, Peoples R China; [Gao, Min; Wang, Xiping] NW A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Singer, Stacy D.] Univ Alberta, Dept Agr Food & Nutrit Sci, Edmonton, AB, Canada; [Fei, Zhangjun] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Fei, Zhangjun] USDA Robert W Holley Ctr Agr & Hlth, Ithaca, NY USA	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China; University of Alberta; Cornell University; Boyce Thompson Institute for Plant Research; United States Department of Agriculture (USDA)	Wang, H (corresponding author), NW A&F Univ, Coll Enol, Shaanxi Engn Res Ctr Viti Viniculture, Yangling, Shaanxi, Peoples R China.	wanghua@nwsuaf.edu.cn; wangxiping@nwsuaf.edu.cn	Fei, Zhangjun/H-5152-2012; Ye, Miaomiao/A-9123-2016; Ye, Miaomiao/G-8865-2015	Ye, Miaomiao/0000-0002-5546-1133; 	National Natural Science Foundation of China [30871701, 31071782, 30671446]; Program for New Century Excellent Talents in University [NCET-07-0702]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Natural Science Foundation of China (30871701, 31071782 and 30671446), as well as the Program for New Century Excellent Talents in University (NCET-07-0702). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertazzi G, 2009, PLANT SCI, V176, P792, DOI 10.1016/j.plantsci.2009.03.001; Bai YH, 2011, GENOMICS, V98, P128, DOI 10.1016/j.ygeno.2011.05.002; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Chung HS, 2009, PHYTOCHEMISTRY, V70, P1547, DOI 10.1016/j.phytochem.2009.08.022; Cramer GR, 2007, FUNCT INTEGR GENOMIC, V7, P111, DOI 10.1007/s10142-006-0039-y; D'Onofrio C, 2009, FUNCT PLANT BIOL, V36, P323, DOI 10.1071/FP08280; Davies WJ, 1991, ABSCISIC ACID PHYSL; Demianski AJ, 2012, MOL PLANT PATHOL, V13, P46, DOI 10.1111/j.1364-3703.2011.00727.x; Devoto A, 2005, PHYSIOL PLANTARUM, V123, P161, DOI 10.1111/j.1399-3054.2004.00418.x; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Espinoza C, 2007, FUNCT INTEGR GENOMIC, V7, P95, DOI 10.1007/s10142-006-0031-6; FEYS BJF, 1994, PLANT CELL, V6, P751, DOI 10.1105/tpc.6.5.751; Foito A, 2009, PLANT BIOTECHNOL J, V7, P719, DOI 10.1111/j.1467-7652.2009.00437.x; Fung RWM, 2008, PLANT PHYSIOL, V146, P236, DOI 10.1104/pp.107.108712; Giraud E, 2012, PLANT CELL ENVIRON, V35, P405, DOI 10.1111/j.1365-3040.2011.02379.x; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Hren M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-460; Hurley I, 2005, EVOL DEV, V7, P556, DOI 10.1111/j.1525-142X.2005.05059.x; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Katsir L, 2008, CURR OPIN PLANT BIOL, V11, P428, DOI 10.1016/j.pbi.2008.05.004; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Koyama K, 2010, FUNCT INTEGR GENOMIC, V10, P367, DOI 10.1007/s10142-009-0145-8; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li WY, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-90; Ling KS, 2004, J GEN VIROL, V85, P2099, DOI 10.1099/vir.0.80007-0; Lyons E, 2008, PLANT PHYSIOL, V148, P1772, DOI 10.1104/pp.108.124867; Melotto M, 2008, PLANT J, V55, P979, DOI 10.1111/j.1365-313X.2008.03566.x; Merdinoglu D, 2003, ACTA HORTIC, P451, DOI 10.17660/ActaHortic.2003.603.57; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Paterson AH, 2012, PLANT GEN DIVER, V1, P195, DOI DOI 10.1007/978-3-7091-1130-7_13; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Pilon-Smits EAH, 1999, PLANT PHYSIOL BIOCH, V37, P313, DOI 10.1016/S0981-9428(99)80030-8; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Shikata M, 2004, J EXP BOT, V55, P631, DOI 10.1093/jxb/erh078; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Staswick PE, 2008, TRENDS PLANT SCI, V13, P66, DOI 10.1016/j.tplants.2007.11.011; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Tattersall EAR, 2007, FUNCT INTEGR GENOMIC, V7, P317, DOI 10.1007/s10142-007-0051-x; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; Vanholme B, 2007, TRENDS PLANT SCI, V12, P239, DOI 10.1016/j.tplants.2007.04.004; Vega A, 2011, PLANT MOL BIOL, V77, P261, DOI 10.1007/s11103-011-9807-8; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Wasternack C, 1997, TRENDS PLANT SCI, V2, P302, DOI 10.1016/S1360-1385(97)89952-9; White DWR, 2006, P NATL ACAD SCI USA, V103, P13238, DOI 10.1073/pnas.0604349103; Wise Roger P., 2007, V406, P347; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wong FP, 2001, PLANT DIS, V85, P649, DOI 10.1094/PDIS.2001.85.6.649; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Xu GX, 2012, P NATL ACAD SCI USA, V109, P1187, DOI 10.1073/pnas.1109047109; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708; Ye HY, 2009, PLANT MOL BIOL, V71, P291, DOI 10.1007/s11103-009-9524-8; Zhang JinJin, 2003, Journal of Fruit Science, V20, P178; Zhang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032153	62	644	663	22	198	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44465	10.1371/journal.pone.0044465	http://dx.doi.org/10.1371/journal.pone.0044465			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984514	gold, Green Published, Green Submitted			2022-12-27	WOS:000308638700062
J	Belmonte, L; Youmba, SB; Bertiaux-Vandaele, N; Antonietti, M; Lecleire, S; Zalar, A; Gourcerol, G; Leroi, AM; Dechelotte, P; Coeffier, M; Ducrotte, P				Belmonte, Liliana; Youmba, Stephanie Beutheu; Bertiaux-Vandaele, Nathalie; Antonietti, Michel; Lecleire, Stephane; Zalar, Alberto; Gourcerol, Guillaume; Leroi, Anne-Marie; Dechelotte, Pierre; Coeffier, Moise; Ducrotte, Philippe			Role of Toll Like Receptors in Irritable Bowel Syndrome: Differential Mucosal Immune Activation According to the Disease Subtype	PLOS ONE			English	Article							INTESTINAL PERMEABILITY; EXPRESSION; TLR4; GUT; RECOGNITION; ASSOCIATION; GLUTAMINE; GAMMA	Background: The irritable bowel syndrome (IBS) is a functional gastrointestinal disorder whose pathogenesis is not completely understood. Its high prevalence and the considerable effects on quality of life make IBS a disease with high social cost. Recent studies suggest that low grade mucosal immune activation, increased intestinal permeability and the altered host-microbiota interactions that modulate innate immune response, contribute to the pathophysiology of IBS. However, the understanding of the precise molecular pathophysiology remains largely unknown. Methodology and Findings: In this study our objective was to evaluate the TLR expression as a key player in the innate immune response, in the colonic mucosa of IBS patients classified into the three main subtypes (with constipation, with diarrhea or mixed). TLR2 and TLR4 mRNA expression was assessed by real time RT-PCR while TLRs protein expression in intestinal epithelial cells was specifically assessed by flow cytometry and immunofluorescence. Mucosal inflammatory cytokine production was investigated by the multiplex technology. Here we report that the IBS-Mixed subgroup displayed a significant up-regulation of TLR2 and TLR4 in the colonic mucosa. Furthermore, these expressions were localized in the epithelial cells, opening new perspectives for a potential role of epithelial cells in host-immune interactions in IBS. In addition, the increased TLR expression in IBS-M patients elicited intracellular signaling pathways resulting in increased expression of the mucosal proinflammatory cytokines IL-8 and IL1 beta. Conclusions: Our results provide the first evidence of differential expression of TLR in IBS patients according to the disease subtype. These results offer further support that microflora plays a central role in the complex pathophysiology of IBS providing novel pharmacological targets for this chronic gastrointestinal disorder according to bowel habits.	[Belmonte, Liliana; Youmba, Stephanie Beutheu; Lecleire, Stephane; Gourcerol, Guillaume; Leroi, Anne-Marie; Dechelotte, Pierre; Coeffier, Moise; Ducrotte, Philippe] Univ Rouen, INSERM, U1073, Rouen, France; [Belmonte, Liliana; Youmba, Stephanie Beutheu; Lecleire, Stephane; Gourcerol, Guillaume; Leroi, Anne-Marie; Dechelotte, Pierre; Coeffier, Moise; Ducrotte, Philippe] Univ Rouen, Inst Res & Innovat Biomed, Rouen, France; [Belmonte, Liliana] Natl Acad Med Buenos Aires, Consejo Nacl Invest Cient & Tecn, Immunol Lab, IIHema, Buenos Aires, DF, Argentina; [Bertiaux-Vandaele, Nathalie; Antonietti, Michel; Lecleire, Stephane; Zalar, Alberto; Ducrotte, Philippe] Rouen Univ Hosp, Dept Gastroenterol, Rouen, France; [Gourcerol, Guillaume; Leroi, Anne-Marie] Rouen Univ Hosp, Dept Physiol, Rouen, France; [Dechelotte, Pierre; Coeffier, Moise] Rouen Univ Hosp, Nutr Unit, Rouen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Universite de Rouen Normandie; Buenos Aires National Academy of Medicine; IIHEMA - Instituto de Investigaciones Hematologicas; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); CHU de Rouen; CHU de Rouen; CHU de Rouen	Belmonte, L (corresponding author), Univ Rouen, INSERM, U1073, Rouen, France.	liliana.belmonte-zalar@inv.univ-rouen.fr		Gourcerol, Guillaume/0000-0001-8220-9155; Coeffier, Moise/0000-0002-7469-2682	Institut National de la Sante et de la Recherche Medicale Unit U1073, University of Rouen, France; Ministry of Sciences and Technology of Buenos Aires, Argentina	Institut National de la Sante et de la Recherche Medicale Unit U1073, University of Rouen, France; Ministry of Sciences and Technology of Buenos Aires, Argentina	The study was supported by the Institut National de la Sante et de la Recherche Medicale Unit U1073, University of Rouen, France and Ministry of Sciences and Technology of Buenos Aires, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbara G, 2002, GUT, V51, pI41, DOI 10.1136/gut.51.suppl_1.i41; Brint EK, 2011, AM J GASTROENTEROL, V106, P329, DOI 10.1038/ajg.2010.438; Camilleri M, 2007, NEUROGASTROENT MOTIL, V19, P545, DOI 10.1111/j.1365-2982.2007.00925.x; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Coeffier M, 2003, AM J PHYSIOL-GASTR L, V285, pG266, DOI 10.1152/ajpgi.00385.2002; Cremon C, 2009, AM J GASTROENTEROL, V104, P392, DOI 10.1038/ajg.2008.94; Drossman DA, 2005, GASTROENTEROLOGY, V128, P580, DOI 10.1053/j.gastro.2004.12.006; Dubuquoy L, 2003, GASTROENTEROLOGY, V124, P1265, DOI 10.1016/S0016-5085(03)00271-3; Dunlop SP, 2006, AM J GASTROENTEROL, V101, P1288, DOI 10.1111/j.1572-0241.2006.00672.x; Frolova L, 2008, J HISTOCHEM CYTOCHEM, V56, P267, DOI 10.1369/jhc.7A7303.2007; Gribar SC, 2008, MOL MED, V14, P645, DOI 10.2119/2008-00035.Gribar; Hausmann M, 2002, GASTROENTEROLOGY, V122, P1987, DOI 10.1053/gast.2002.33662; JUNG HC, 1995, J CLIN INVEST, V95, P55, DOI 10.1172/JCI117676; Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Lecleire S, 2008, J NUTR, V138, P2481, DOI 10.3945/jn.108.099127; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; McKernan DP, 2011, ALIMENT PHARM THER, V33, P1045, DOI 10.1111/j.1365-2036.2011.04624.x; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Ohman L, 2009, AM J GASTROENTEROL, V104, P1205, DOI 10.1038/ajg.2009.116; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Sato S, 2000, J IMMUNOL, V165, P7096, DOI 10.4049/jimmunol.165.12.7096; Shibolet O, 2007, AM J PHYSIOL-GASTR L, V292, pG1469, DOI 10.1152/ajpgi.00531.2006; SRIKANTH CV, 2008, INTERDISCIP PERSPECT; Su CG, 1999, J CLIN INVEST, V104, P383, DOI 10.1172/JCI7145; Szebeni B, 2007, J PEDIATR GASTR NUTR, V45, P187, DOI 10.1097/MPG.0b013e318064514a; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Thompson WG, 1999, GUT, V45, P43; Zalar A, 2010, ANTIVIR RES, V87, P269, DOI 10.1016/j.antiviral.2010.05.005	32	95	105	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42777	10.1371/journal.pone.0042777	http://dx.doi.org/10.1371/journal.pone.0042777			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	23028414	gold, Green Published, Green Submitted			2022-12-27	WOS:000308063700022
J	Andersen, JM; Barrangou, R; Abou Hachem, M; Lahtinen, SJ; Goh, YJ; Svensson, B; Klaenhammer, TR				Andersen, Joakim Mark; Barrangou, Rodolphe; Abou Hachem, Maher; Lahtinen, Sampo J.; Goh, Yong-Jun; Svensson, Birte; Klaenhammer, Todd R.			Transcriptional Analysis of Prebiotic Uptake and Catabolism by Lactobacillus acidophilus NCFM	PLOS ONE			English	Article							FRUCTOOLIGOSACCHARIDE UTILIZATION; GALACTO-OLIGOSACCHARIDES; COMPARATIVE GENOMICS; FUNCTIONAL-ANALYSIS; DOUBLE-BLIND; SYSTEM; METABOLISM; PROBIOTICS; OPERON; INTEGRATION	The human gastrointestinal tract can be positively modulated by dietary supplementation of probiotic bacteria in combination with prebiotic carbohydrates. Here differential transcriptomics and functional genomics were used to identify genes in Lactobacillus acidophilus NCFM involved in the uptake and catabolism of 11 potential prebiotic compounds consisting of alpha- and beta-linked galactosides and glucosides. These oligosaccharides induced genes encoding phosphoenolpyruvate-dependent sugar phosphotransferase systems (PTS), galactoside pentose hexuronide (GPH) permease, and ATP-binding cassette (ABC) transporters. PTS systems were upregulated primarily by di- and tri-saccharides such as cellobiose, isomaltose, isomaltulose, panose and gentiobiose, while ABC transporters were upregulated by raffinose, Polydextrose, and stachyose. A single GPH transporter was induced by lactitol and galactooligosaccharides (GOS). The various transporters were associated with a number of glycoside hydrolases from families 1, 2, 4, 13, 32, 36, 42, and 65, involved in the catabolism of various alpha- and beta-linked glucosides and galactosides. Further subfamily specialization was also observed for different PTS-associated GH1 6-phospho-beta-glucosidases implicated in the catabolism of gentiobiose and cellobiose. These findings highlight the broad oligosaccharide metabolic repertoire of L. acidophilus NCFM and establish a platform for selection and screening of both probiotic bacteria and prebiotic compounds that may positively influence the gastrointestinal microbiota.	[Andersen, Joakim Mark; Goh, Yong-Jun; Klaenhammer, Todd R.] N Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC 27695 USA; [Andersen, Joakim Mark; Abou Hachem, Maher; Svensson, Birte] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Barrangou, Rodolphe] DuPont Nutr & Hlth, Madison, WI USA; [Lahtinen, Sampo J.] DuPont Nutr & Hlth, Kantvik, Finland	University of North Carolina; North Carolina State University; Technical University of Denmark; DuPont	Klaenhammer, TR (corresponding author), N Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC 27695 USA.	klaenhammer@ncsu.edu	Abou Hachem, Maher/M-4772-2019; Barrangou, Rodolphe/I-2878-2014	Abou Hachem, Maher/0000-0001-8250-1842; Barrangou, Rodolphe/0000-0002-0648-3504; Andersen, Joakim/0000-0001-8902-8162; Goh, Yong Jun/0000-0001-7998-8469; Svensson, Birte/0000-0002-2993-8196	Danisco United States of America; North Carolina Dairy Foundation; Danish Strategic Research Council; Danisco A/S; FoSu grant; Technical University of Denmark; Dupont Nutrition and Health	Danisco United States of America; North Carolina Dairy Foundation; Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Danisco A/S; FoSu grant; Technical University of Denmark; Dupont Nutrition and Health	This research was funded by Danisco United States of America, North Carolina Dairy Foundation and the FoSu grant from the Danish Strategic Research Council to the project "Gene discovery and molecular interactions in prebiotics/probiotics systems. Focus on carbohydrate prebiotics". J.M.A. is funded by a joint Ph.D. stipend from Danisco A/S, the FoSu grant, and the Technical University of Denmark. R. B. and S. L. are employed by DuPont Nutrition and Health, a commercial manufacturer of Lactobacillus acidophilus NCFM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dupont Nutrition and Health funded portions of the project and two primary contributing authors, R. B. and S. L. are research scientists employed by DuPont Nutrition and Health. This association had no impact on the scientific integrity of the experiments, objectivity of the data generated or validity of the scientific conclusions made from this study. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abbott DW, 2010, MOL MICROBIOL, V77, P183, DOI 10.1111/j.1365-2958.2010.07199.x; Altermann E, 2005, P NATL ACAD SCI USA, V102, P3906, DOI 10.1073/pnas.0409188102; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen JM, 2011, P NATL ACAD SCI USA, V108, P17785, DOI 10.1073/pnas.1114152108; Barrangou R, 2006, P NATL ACAD SCI USA, V103, P3816, DOI 10.1073/pnas.0511287103; Barrangou R, 2003, P NATL ACAD SCI USA, V100, P8957, DOI 10.1073/pnas.1332765100; Bjorklund M, 2012, AGE, V34, P987, DOI 10.1007/s11357-011-9294-5; Callanan M, 2008, J BACTERIOL, V190, P727, DOI 10.1128/JB.01295-07; Callaway T. R., 2008, Animal Health Research Reviews, V9, P217, DOI 10.1017/S1466252308001540; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; DANIELS L, 1975, APPL MICROBIOL, V29, P710, DOI 10.1128/AEM.29.5.710-711.1975; Davis LMG, 2010, INT J FOOD MICROBIOL, V144, P285, DOI 10.1016/j.ijfoodmicro.2010.10.007; Davis LMG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025200; Francl AL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-77; Fredslund F, 2011, J MOL BIOL, V412, P466, DOI 10.1016/j.jmb.2011.07.057; Goffin D, 2011, CRIT REV FOOD SCI, V51, P394, DOI 10.1080/10408391003628955; Goh YJ, 2007, APPL ENVIRON MICROB, V73, P5716, DOI 10.1128/AEM.00805-07; Goh YJ, 2009, APPL ENVIRON MICROB, V75, P3093, DOI 10.1128/AEM.02502-08; Grimoud J, 2010, INT J FOOD MICROBIOL, V144, P42, DOI 10.1016/j.ijfoodmicro.2010.09.007; Hedin C, 2007, P NUTR SOC, V66, P307, DOI 10.1017/S0029665107005563; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kimmel SA, 1998, INT J FOOD MICROBIOL, V40, P87, DOI 10.1016/S0168-1605(98)00023-3; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Kootte RS, 2012, DIABETES OBES METAB, V14, P112, DOI 10.1111/j.1463-1326.2011.01483.x; Kukkonen K, 2007, J ALLERGY CLIN IMMUN, V119, P192, DOI 10.1016/j.jaci.2006.09.009; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAW J, 1995, J BACTERIOL, V177, P7011, DOI 10.1128/jb.177.24.7011-7018.1995; Leyer GJ, 2009, PEDIATRICS, V124, pE172, DOI 10.1542/peds.2008-2666; Macfarlane GT, 2008, J APPL MICROBIOL, V104, P305, DOI 10.1111/j.1365-2672.2007.03520.x; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Majumder A, 2011, PROTEOMICS, V11, P3470, DOI 10.1002/pmic.201100115; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Makelainen H, 2009, LETT APPL MICROBIOL, V49, P666, DOI 10.1111/j.1472-765X.2009.02698.x; Makelainen HS, 2007, J FOOD SCI, V72, pM153, DOI 10.1111/j.1750-3841.2007.00350.x; Mohamadzadeh M, 2011, P NATL ACAD SCI USA, V108, P4623, DOI 10.1073/pnas.1005066107; Nakai H, 2009, FEBS J, V276, P7353, DOI 10.1111/j.1742-4658.2009.07445.x; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; O'Sullivan O, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-50; Ouwehand AC, 2009, BRIT J NUTR, V101, P367, DOI 10.1017/S0007114508003097; Petersen A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-245; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pfeiler EA, 2007, J BACTERIOL, V189, P4624, DOI 10.1128/JB.00337-07; Reid G, 2003, J CLIN GASTROENTEROL, V37, P105, DOI 10.1097/00004836-200308000-00004; Ringel-Kulka T, 2011, J CLIN GASTROENTEROL, V45, P518, DOI 10.1097/MCG.0b013e31820ca4d6; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Russell WM, 2001, APPL ENVIRON MICROB, V67, P4361, DOI 10.1128/AEM.67.9.4361-4364.2001; Rycroft CE, 2001, LETT APPL MICROBIOL, V32, P156, DOI 10.1046/j.1472-765x.2001.00875.x; Saburi W, 2006, BBA-PROTEINS PROTEOM, V1764, P688, DOI 10.1016/j.bbapap.2006.01.012; Saulnier DAA, 2007, APPL ENVIRON MICROB, V73, P1753, DOI 10.1128/AEM.01151-06; Scarpellini E, 2010, INTERN EMERG MED, V5, pS53, DOI 10.1007/s11739-010-0450-1; Schouler C, 2009, J BACTERIOL, V191, P388, DOI 10.1128/JB.01052-08; Tang MLK, 2010, CURR OPIN PEDIATR, V22, P626, DOI 10.1097/MOP.0b013e32833d9728; WALKER DC, 1994, J BACTERIOL, V176, P5330, DOI 10.1128/JB.176.17.5330-5340.1994; Wiesmann C, 1997, J MOL BIOL, V269, P851, DOI 10.1006/jmbi.1997.1084; Zhong J, 2000, AM J CLIN NUTR, V72, P1503	55	60	64	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44409	10.1371/journal.pone.0044409	http://dx.doi.org/10.1371/journal.pone.0044409			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028535	gold, Green Published			2022-12-27	WOS:000309388400024
J	Takemura, Y; Imai, S; Kojima, H; Katagi, M; Yamakawa, I; Kasahara, T; Urabe, H; Terashima, T; Yasuda, H; Chan, L; Kimura, H; Matsusue, Y				Takemura, Yoshinori; Imai, Shinji; Kojima, Hideto; Katagi, Miwako; Yamakawa, Isamu; Kasahara, Toshiyuki; Urabe, Hiroshi; Terashima, Tomoya; Yasuda, Hitoshi; Chan, Lawrence; Kimura, Hiroshi; Matsusue, Yoshitaka			Brain-Derived Neurotrophic Factor from Bone Marrow-Derived Cells Promotes Post-Injury Repair of Peripheral Nerve	PLOS ONE			English	Article							SPINAL-CORD-INJURY; STEM-CELLS; AXONAL REGENERATION; FUNCTIONAL RECOVERY; NEUROPATHIC PAIN; IN-VIVO; BDNF; RECEPTOR; NEURONS; MOUSE	Brain-derived neurotrophic factor (BDNF) stimulates peripheral nerve regeneration. However, the origin of BNDF and its precise effect on nerve repair have not been clarified. In this study, we examined the role of BDNF from bone marrow-derived cells (BMDCs) in post-injury nerve repair. Control and heterozygote BDNF knockout mice (BDNF+/-) received a left sciatic nerve crush using a cerebral blood clip. Especially, for the evaluation of BDNF from BMDCs, studies with bone marrow transplantation (BMT) were performed before the injury. We evaluated nerve function using a rotarod test, sciatic function index (SFI), and motor nerve conduction velocity (MNCV) simultaneously with histological nerve analyses by immunohistochemistry before and after the nerve injury until 8 weeks. BDNF production was examined by immunohistochemistry and mRNA analyses. After the nerve crush, the controls showed severe nerve dysfunction evaluated at 1 week. However, nerve function was gradually restored and reached normal levels by 8 weeks. By immunohistochemistry, BDNF expression was very faint before injury, but was dramatically increased after injury at 1 week in the distal segment from the crush site. BDNF expression was mainly co-localized with CD45 in BMDCs, which was further confirmed by the appearance of GFP-positive cells in the BMT study. Variant analysis of BDNF mRNA also confirmed this finding. BDNF+/- mice showed a loss of function with delayed histological recovery and BDNF+/+ -> RBDNF+/- BMT mice showed complete recovery both functionally and histologically. These results suggested that the attenuated recovery of the BDNF+/- mice was rescued by the transplantation of BMCs and that BDNF from BMDCs has an essential role in nerve repair.	[Takemura, Yoshinori; Kojima, Hideto; Katagi, Miwako; Kimura, Hiroshi] Shiga Univ Med Sci, Dept Mol Genet Med, Otsu, Shiga 52021, Japan; [Takemura, Yoshinori; Imai, Shinji; Kasahara, Toshiyuki; Matsusue, Yoshitaka] Shiga Univ Med Sci, Dept Orthopaed Surg, Otsu, Shiga 52021, Japan; [Yamakawa, Isamu; Urabe, Hiroshi; Terashima, Tomoya] Shiga Univ Med Sci, Dept Internal Med, Otsu, Shiga 52021, Japan; [Yasuda, Hitoshi] Shiga Univ Med Sci, Dept Community Life Nursing, Otsu, Shiga 52021, Japan; [Chan, Lawrence] Baylor Coll Med, Dept Med, Div Diabet Endocrinol & Metab, Houston, TX 77030 USA	Shiga University of Medical Science; Shiga University of Medical Science; Shiga University of Medical Science; Shiga University of Medical Science; Baylor College of Medicine	Kojima, H (corresponding author), Shiga Univ Med Sci, Dept Mol Genet Med, Otsu, Shiga 52021, Japan.	kojima@belle.shiga-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [18390100]; Shiga University of Medical Science [1515503L]; US National Institutes of Health [HL-51586]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051586] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Shiga University of Medical Science(Shiga University of Medical Science); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Grant-in-Aid (#18390100 to H. Kojima) for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, by the President's Discretionary Fund from Shiga University of Medical Science (#1515503L to H. Kojima), and by a grant (HL-51586) from the US National Institutes of Health (to LC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; ANTON ES, 1994, P NATL ACAD SCI USA, V91, P2795, DOI 10.1073/pnas.91.7.2795; BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; Boyd JG, 2003, EXP NEUROL, V183, P610, DOI 10.1016/S0014-4886(03)00183-3; Chen CJ, 2007, EXP NEUROL, V204, P443, DOI 10.1016/j.expneurol.2006.12.004; Cordeira J, 2011, MOL NEUROBIOL, V44, P441, DOI 10.1007/s12035-011-8212-2; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Elfar JC, 2008, J BONE JOINT SURG AM, V90A, P1644, DOI 10.2106/JBJS.G.00557; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Fu KY, 2011, ARTIF ORGANS, V35, P363, DOI 10.1111/j.1525-1594.2010.01105.x; Fukuoka T, 2001, J NEUROSCI, V21, P4891, DOI 10.1523/JNEUROSCI.21-13-04891.2001; Garcia N, 2010, J PERIPHER NERV SYST, V15, P40, DOI 10.1111/j.1529-8027.2010.00250.x; Geremia NM, 2009, EXP NEUROL; Gorski JA, 2003, J NEUROSCI, V23, P6856; Haastert K, 2006, NEUROBIOL DIS, V21, P138, DOI 10.1016/j.nbd.2005.06.020; Harris VK, 2012, J NEUROL SCI; Kasahara T, 2010, BONE, V47, P617, DOI 10.1016/j.bone.2010.06.014; Ladak A, 2011, EXP NEUROL, V228, P242, DOI 10.1016/j.expneurol.2011.01.013; Lin YT, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-126; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; Liu QR, 2006, BRAIN RES, V1067, P1, DOI 10.1016/j.brainres.2005.10.004; Lopatina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017899; MEYER M, 1992, J CELL BIOL, V119, P45, DOI 10.1083/jcb.119.1.45; Ozmen S, 2002, PLAST RECONSTR SURG, V109, P1760; Poblete-Naredo I, 2011, NEUROCHEM INT, V59, P1133, DOI 10.1016/j.neuint.2011.10.002; Sasaki M, 2009, J NEUROSCI, V29, P14932, DOI 10.1523/JNEUROSCI.2769-09.2009; Seddon HJ, 1942, BRIT MED J, V1942, P237, DOI 10.1136/bmj.2.4260.237; Tan AM, 2008, J NEUROSCI, V28, P13173, DOI 10.1523/JNEUROSCI.3142-08.2008; Uchida K, 1998, J NEUROL, V245, P781, DOI 10.1007/s004150050287; Walsh S, 2009, NEUROSURGERY, V65, pA80, DOI 10.1227/01.NEU.0000335651.93926.2F	31	24	25	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44592	10.1371/journal.pone.0044592	http://dx.doi.org/10.1371/journal.pone.0044592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028564	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388400028
J	Flockhart, DTT; Martin, TG; Norris, DR				Flockhart, D. T. Tyler; Martin, Tara G.; Norris, D. Ryan			Experimental Examination of Intraspecific Density-Dependent Competition during the Breeding Period in Monarch Butterflies (Danaus plexippus)	PLOS ONE			English	Article							POPULATION-DYNAMICS; PROTOZOAN PARASITE; ASCLEPIAS-SYRIACA; L LEPIDOPTERA; MILKWEED; SIZE; FLUCTUATIONS; NYMPHALIDAE; TEMPERATURE; FECUNDITY	A central goal of population ecology is to identify the factors that regulate population growth. Monarch butterflies (Danaus plexippus) in eastern North America re-colonize the breeding range over several generations that result in population densities that vary across space and time during the breeding season. We used laboratory experiments to measure the strength of density-dependent intraspecific competition on egg laying rate and larval survival and then applied our results to density estimates of wild monarch populations to model the strength of density dependence during the breeding season. Egg laying rates did not change with density but larvae at high densities were smaller, had lower survival, and weighed less as adults compared to lower densities. Using mean larval densities from field surveys resulted in conservative estimates of density-dependent population reduction that varied between breeding regions and different phases of the breeding season. Our results suggest the highest levels of population reduction due to density-dependent intraspecific competition occur early in the breeding season in the southern portion of the breeding range. However, we also found that the strength of density dependence could be almost five times higher depending on how many life-stages were used as part of field estimates. Our study is the first to link experimental results of a density-dependent reduction in vital rates to observed monarch densities in the wild and show that the effects of density dependent competition in monarchs varies across space and time, providing valuable information for developing robust, year-round population models in this migratory organism.	[Flockhart, D. T. Tyler; Norris, D. Ryan] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Martin, Tara G.] CSIRO Ecosyst Sci, Dutton Pk, Qld, Australia	University of Guelph; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Flockhart, DTT (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	dflockha@uoguelph.ca	Martin, Tara/M-1897-2016; Flockhart, D. T. Tyler/C-3132-2018	Martin, Tara/0000-0001-7165-9812; Flockhart, D. T. Tyler/0000-0002-5832-8610	N.E.W. Zoological Society, Inc.; Natural Sciences and Engineering Council of Canada	N.E.W. Zoological Society, Inc.; Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding was provided by a Conservation Grant from the N.E.W. Zoological Society, Inc. (to DTTF) and the Natural Sciences and Engineering Council of Canada (to DTTF, DRN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer SM, 1999, J INVERTEBR PATHOL, V74, P76, DOI 10.1006/jipa.1999.4853; Altizer SM, 2000, ECOL ENTOMOL, V25, P125, DOI 10.1046/j.1365-2311.2000.00246.x; Atterholt AL, 2010, J ENTOMOL SCI, V45, P366, DOI 10.18474/0749-8004-45.4.366; Bartel RA, 2011, ECOLOGY, V92, P342, DOI 10.1890/10-0489.1; Bates D., 2011, IME4 LINEAR MIXED EF; BELLOWS TS, 1981, J ANIM ECOL, V50, P139, DOI 10.2307/4037; BORKIN SS, 1982, GREAT LAKES ENTOMOL, V15, P199; Brower LP, 2012, INSECT CONSERV DIVER, V5, P95, DOI 10.1111/j.1752-4598.2011.00142.x; BROWER LINCOLN P., 1961, PHYSIOL ZOOL, V34, P287; Brower Lincoln P., 1995, Journal of the Lepidopterists' Society, V49, P304; CALVERT WH, 1979, SCIENCE, V204, P847, DOI 10.1126/science.204.4395.847; Cockrell B.J., 1993, NAT HIS LOS-SERIES, P233; DEMPSTER JP, 1983, BIOL REV, V58, P461, DOI 10.1111/j.1469-185X.1983.tb00396.x; Drury KLS, 2005, AM NAT, V166, P731, DOI 10.1086/497542; FOWLER CW, 1981, ECOLOGY, V62, P602, DOI 10.2307/1937727; Goehring L, 2002, ECOL ENTOMOL, V27, P674, DOI 10.1046/j.1365-2311.2002.00454.x; Hartzler RG, 2000, CROP PROT, V19, P363, DOI 10.1016/S0261-2194(00)00024-7; Hartzler RG, 2010, CROP PROT, V29, P1542, DOI 10.1016/j.cropro.2010.07.018; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Hughes Patrick R., 1993, American Entomologist, V39, P109; Lindsey E, 2009, ECOL ENTOMOL, V34, P551, DOI 10.1111/j.1365-2311.2009.01107.x; Lynch SP, 1993, BIOL CONSERVATION MO, P107; MALCOLM SB, 1993, NAT HIS LOS-SERIES, P253; McLaughlin JF, 2002, OECOLOGIA, V132, P538, DOI 10.1007/s00442-002-0997-2; Miller NG, 2011, BIOL LETTERS, V7, P43, DOI 10.1098/rsbl.2010.0525; NICHOLSON AJ, 1954, AUST J ZOOL, V2, P9, DOI 10.1071/ZO9540009; Nowicki P, 2009, OECOLOGIA, V161, P227, DOI 10.1007/s00442-009-1373-2; Oberhauser Karen, 2012, American Entomologist, V58, P19; Oberhauser KS, 1997, FUNCT ECOL, V11, P166, DOI 10.1046/j.1365-2435.1997.00074.x; Oberhauser KS, 2001, P NATL ACAD SCI USA, V98, P11913, DOI 10.1073/pnas.211234298; Pickens BA, 2007, J ZOOL, V273, P229, DOI 10.1111/j.1469-7998.2007.00341.x; Pleasants JM, 2013, INSECT CONSERV DIVER, V6, P135, DOI 10.1111/j.1752-4598.2012.00196.x; Poisot T, 2010, DGITIZE PLOT DIGITIZ; Polis GA, 1998, ECOLOGY, V79, P490, DOI 10.2307/176948; Prysby MD, 2004, MONARCH BUTTERFLY BIOLOGY AND CONSERVATION, P9; Prysby MD, 2004, MONARCH BUTTERFLY BIOLOGY AND CONSERVATION, P27; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Riley TJ, 1993, BIOL CONSERVATION MO, P269; Rodenhouse NL, 2003, P ROY SOC B-BIOL SCI, V270, P2105, DOI 10.1098/rspb.2003.2438; Roy DB, 2001, J ANIM ECOL, V70, P201, DOI 10.1046/j.1365-2656.2001.00480.x; Sibly RM, 2005, SCIENCE, V309, P607, DOI 10.1126/science.1110760; SWENGEL AB, 1995, AM MIDL NAT, V134, P205, DOI 10.2307/2426291; Therneau T., 2011, COXME MIXED EFFECTS; Varley G.C., 1973, INSECT POPULATION EC; Wassenaar LI, 1998, P NATL ACAD SCI USA, V95, P15436, DOI 10.1073/pnas.95.26.15436; Watt AD, 1999, OIKOS, V87, P411, DOI 10.2307/3546759; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; ZALUCKI MP, 1982, J ZOOL, V198, P103; ZALUCKI MP, 1981, RES POPUL ECOL, V23, P318, DOI 10.1007/BF02515634; Zalucki MP, 2001, ECOL ENTOMOL, V26, P212, DOI 10.1046/j.1365-2311.2001.00313.x; ZALUCKI MP, 1982, J AUST ENTOMOL SOC, V21, P241	51	35	35	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45080	10.1371/journal.pone.0045080	http://dx.doi.org/10.1371/journal.pone.0045080			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984614	gold, Green Published, Green Submitted			2022-12-27	WOS:000308738500115
J	Haldar, S; Sankhyan, N; Sharma, N; Bansal, A; Jain, V; Gupta, VK; Juneja, M; Mishra, D; Kapil, A; Singh, UB; Gulati, S; Kalra, V; Tyagi, JS				Haldar, Sagarika; Sankhyan, Naveen; Sharma, Neera; Bansal, Anjali; Jain, Vitul; Gupta, V. K.; Juneja, Monica; Mishra, Devendra; Kapil, Arti; Singh, Urvashi B.; Gulati, Sheffali; Kalra, Veena; Tyagi, Jaya Sivaswami			Detection of Mycobacterium tuberculosis GlcB or HspX Antigens or devR DNA Impacts the Rapid Diagnosis of Tuberculous Meningitis in Children	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; PULMONARY TUBERCULOSIS; ANTIBODY-RESPONSES; PROTEIN; COMPLEX; METAANALYSIS; PERFORMANCE; EXPRESSION; INCIPIENT; LUNG	Background: Tuberculous meningitis (TBM) is the most common form of neurotuberculosis and the fifth most common form of extrapulmonary TB. Early diagnosis and prompt treatment are the cornerstones of effective disease management. The accurate diagnosis of TBM poses a challenge due to an extensive differential diagnosis, low bacterial load and paucity of cerebrospinal fluid (CSF) especially in children. Methodology/Principal Findings: We describe the utility of ELISA and qPCR for the detection of Mycobacterium tuberculosis (M. tb) proteins (GlcB, HspX, MPT51, Ag85B and PstS1) and DNA for the rapid diagnosis of TBM. CSF filtrates (n = 532) derived from children were classified as 'Definite' TBM (M. tb culture positive, n = 29), 'Probable and Possible' TBM (n = 165) and 'Not-TBM' including other cases of meningitis or neurological disorders (n = 338). ROC curves were generated from ELISA and qPCR data of 'Definite' TBM and Non-Tuberculous infectious meningitis (NTIM) samples and cut-off values were derived to provide >= 95% specificity. devR qPCR, GlcB, HspX and PstS1 ELISAs showed 100% (88; 100) sensitivity and 96-97% specificity in 'Definite' TBM samples. The application of these cut-offs to 'Probable and Possible' TBM groups yielded excellent sensitivity (98%, 94; 99) and specificity (98%, 96; 99) for qPCR and for GlcB, HspX and MPT51 antigen ELISAs (sensitivity 92-95% and specificity 93-96%). A test combination of qPCR with GlcB and HspX ELISAs accurately detected all TBM samples at a specificity of similar to 90%. Logistic regression analysis indicated that these tests significantly added value to the currently used algorithms for TBM diagnosis. Conclusions: The detection of M. tb GlcB/HspX antigens/devR DNA in CSF is likely to improve the utility of existing algorithms for TBM diagnosis and also hasten the speed of diagnosis.	[Haldar, Sagarika; Jain, Vitul; Tyagi, Jaya Sivaswami] All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India; [Sankhyan, Naveen; Gulati, Sheffali; Kalra, Veena] All India Inst Med Sci, Dept Pediat, New Delhi, India; [Sharma, Neera; Bansal, Anjali; Gupta, V. K.] Dr Ram Manohar Lohia Hosp, Dept Biochem, New Delhi, India; [Sharma, Neera; Bansal, Anjali; Gupta, V. K.] Dr Ram Manohar Lohia Hosp, Dept Pediat, New Delhi, India; [Juneja, Monica; Mishra, Devendra] Maulana Azad Med Coll, Dept Pediat, New Delhi, India; [Juneja, Monica; Mishra, Devendra] Lok Nayak Hosp, New Delhi, India; [Kapil, Arti; Singh, Urvashi B.] All India Inst Med Sci, Dept Microbiol, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; Maulana Azad Medical College; All India Institute of Medical Sciences (AIIMS) New Delhi	Haldar, S (corresponding author), Translat Hlth Sci & Technol Inst, Ctr Biodesign, Natl Biodesign Alliance Programme, Gurgaon, Haryana, India.	jstyagi@aiims.ac.in	SANKHYAN, NAVEEN/AAP-6531-2021; Jain, Vitul/AAP-9467-2020; Mishra, Devendra/C-4881-2014	Jain, Vitul/0000-0002-8396-8329; Mishra, Devendra/0000-0002-6810-3095; Juneja, Monica/0000-0003-1894-7801	Department of Biotechnology, Government of India (DBT); DBT	Department of Biotechnology, Government of India (DBT)(Department of Biotechnology (DBT) India); DBT(Department of Biotechnology (DBT) India)	SH and JST are thankful to the Department of Biotechnology, Government of India (DBT) for a Senior Research Fellowship and a Tata Innovation Fellowship, respectively. Financial assistance to JST, US and AK from the DBT for implementing the project is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GLOB TUB CONTR; Bothamley G H, 1995, Eur Respir J Suppl, V20, p676s; BOTHAMLEY GH, 1992, THORAX, V47, P270, DOI 10.1136/thx.47.4.270; BOTHAMLEY GH, 1992, J INFECT DIS, V166, P182, DOI 10.1093/infdis/166.1.182; Bretl DJ, 2011, MICROBIOL MOL BIOL R, V75, P566, DOI 10.1128/MMBR.05004-11; Chakraborty A. K., 2000, Indian Journal of Tuberculosis, V47, P9; Chakravorty S, 2006, FEMS MICROBIOL LETT, V257, P306, DOI 10.1111/j.1574-6968.2006.00187.x; CHANDRAMUKI A, 1989, J CLIN MICROBIOL, V27, P821, DOI 10.1128/JCM.27.5.821-825.1989; Flores LL, 2011, CLIN VACCINE IMMUNOL, V18, P1616, DOI 10.1128/CVI.05205-11; Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075; Haldar S, 2009, J MED MICROBIOL, V58, P616, DOI 10.1099/jmm.0.006015-0; HARBOE M, 1992, J INFECT DIS, V166, P874, DOI 10.1093/infdis/166.4.874; Heemskerk D, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-25; Jatana S K, 2000, Indian Pediatr, V37, P375; Kashyap RS, 2005, CLIN DIAGN LAB IMMUN, V12, P752, DOI 10.1128/CDLI.12.6.752-758.2005; Kashyap RS, 2004, NEUROL INDIA, V52, P359; Kumar P, 2008, J CLIN MICROBIOL, V46, P2824, DOI 10.1128/JCM.00210-08; Kumar R, 1999, ARCH DIS CHILD, V81, P221, DOI 10.1136/adc.81.3.221; Kunnath-Velayudhan S, 2010, P NATL ACAD SCI USA, V107, P14703, DOI 10.1073/pnas.1009080107; Malen H, 2008, SCAND J IMMUNOL, V67, P245, DOI 10.1111/j.1365-3083.2007.02064.x; Marais S, 2010, LANCET INFECT DIS, V10, P803, DOI 10.1016/S1473-3099(10)70138-9; NAGAI S, 1991, INFECT IMMUN, V59, P372, DOI 10.1128/IAI.59.1.372-382.1991; Ohara N, 1997, INFECT IMMUN, V65, P3680, DOI 10.1128/IAI.65.9.3680-3685.1997; Pai NP, 2012, DISCOV MED, V13, P35; Rock RB, 2008, CLIN MICROBIOL REV, V21, P243, DOI 10.1128/CMR.00042-07; Rock RB, 2005, J INFECT DIS, V192, P2054, DOI 10.1086/498165; Ryan GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011108; Saini DK, 2002, PROTEIN EXPRES PURIF, V25, P203, DOI 10.1006/prep.2002.1628; Samanich KM, 1998, J INFECT DIS, V178, P1534, DOI 10.1086/314438; Sharma D, 2006, FEMS IMMUNOL MED MIC, V48, P329, DOI 10.1111/j.1574-695X.2006.00160.x; Shi L, 2004, INFECT IMMUN, V72, P2420, DOI 10.1128/IAI.72.4.2420-2424.2004; Singh KK, 2005, CLIN DIAGN LAB IMMUN, V12, P354, DOI 10.1128/CDLI.12.2.354-358.2005; Steingart KR, 2009, CLIN VACCINE IMMUNOL, V16, P260, DOI 10.1128/CVI.00355-08; Tandon PN, 1978, HDB CLIN NEUROLOGY I, V33, P195; Thuong Nguyen Thuy Thuong, 2008, PLoS Pathog, V4, pe1000229, DOI 10.1371/journal.ppat.1000229; Wanchu A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002071; *WHO, 2011, POL STAT COMM SER TE; WIKER HG, 1992, MICROBIOL REV, V56, P648, DOI 10.1128/MMBR.56.4.648-661.1992; Wilkins E. G. L., 1994, P367	39	33	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44630	10.1371/journal.pone.0044630	http://dx.doi.org/10.1371/journal.pone.0044630			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984534	Green Published, Green Submitted, gold			2022-12-27	WOS:000308738500070
J	Hartman, AL; Santos, P; Dolce, A; Hardwick, JM				Hartman, Adam L.; Santos, Polan; Dolce, Alison; Hardwick, J. Marie			The mTOR Inhibitor Rapamycin Has Limited Acute Anticonvulsant Effects in Mice	PLOS ONE			English	Article							KETOGENIC DIET; MAMMALIAN TARGET; TUBEROUS SCLEROSIS; SIGNALING PATHWAY; MOUSE MODEL; CHILDHOOD EPILEPSY; KAINIC ACID; SEIZURES; TOPIRAMATE; CURRENTS	Objective: The mammalian target of rapamycin (mTOR) pathway integrates signals from different nutrient sources, including amino acids and glucose. Compounds that inhibit mTOR kinase activity such as rapamycin and everolimus can suppress seizures in some chronic animal models and in patients with tuberous sclerosis. However, it is not known whether mTOR inhibitors exert acute anticonvulsant effects in addition to their longer term antiepileptogenic effects. To gain insights into how rapamycin suppresses seizures, we investigated the anticonvulsant activity of rapamycin using acute seizure tests in mice. Methods: Following intraperitoneal injection of rapamycin, normal four-week-old male NIH Swiss mice were evaluated for susceptibility to a battery of acute seizure tests similar to those currently used to screen potential therapeutics by the US NIH Anticonvulsant Screening Program. To assess the short term effects of rapamycin, mice were seizure tested in <= 6 hours of a single dose of rapamycin, and for longer term effects of rapamycin, mice were tested after 3 or more daily doses of rapamycin. Results: The only seizure test where short-term rapamycin treatment protected mice was against tonic hindlimb extension in the MES threshold test, though this protection waned with longer rapamycin treatment. Longer term rapamycin treatment protected against kainic acid-induced seizure activity, but only at late times after seizure onset. Rapamycin was not protective in the 6 Hz or PTZ seizure tests after short or longer rapamycin treatment times. In contrast to other metabolism-based therapies that protect in acute seizure tests, rapamycin has limited acute anticonvulsant effects in normal mice. Significance: The efficacy of rapamycin as an acute anticonvulsant agent may be limited. Furthermore, the combined pattern of acute seizure test results places rapamycin in a third category distinct from both fasting and the ketogenic diet, and which is more similar to drugs acting on sodium channels.	[Hartman, Adam L.; Santos, Polan; Dolce, Alison; Hardwick, J. Marie] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Hartman, Adam L.; Hardwick, J. Marie] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Hartman, AL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.	Ahartma2@jhmi.edu; hardwick@jhu.edu	Hartman, Adam/W-9782-2019	Hartman, Adam/0000-0001-5672-3409	National Institute of Neurological Disorders and Stroke [K08NS070931, RO1NS037402]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS070931, R01NS037402] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The project described was supported by Grant Numbers K08NS070931 (ALH) and RO1NS037402 (JMH) from the National Institute of Neurological Disorders and Stroke. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Barton ME, 2001, EPILEPSY RES, V47, P217, DOI 10.1016/S0920-1211(01)00302-3; Berg AT, 2009, ANN NEUROL, V65, P510, DOI 10.1002/ana.21642; Buckmaster PS, 2011, J NEUROSCI, V31, P2337, DOI 10.1523/JNEUROSCI.4852-10.2011; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Chachua T, 2011, EPILEPSIA, V52, P1666, DOI 10.1111/j.1528-1167.2011.03220.x; Chow DK, 2009, NAT NEUROSCI, V12, P116, DOI 10.1038/nn.2255; CRAMER CL, 1994, LIFE SCI, V54, pPL271, DOI 10.1016/0024-3205(94)00845-0; Dalby NO, 1997, EPILEPSY RES, V28, P63, DOI 10.1016/S0920-1211(97)00031-4; Daoud D, 2007, EPILEPSIA, V48, P834, DOI 10.1111/j.1528-1167.2006.00976.x; Eshleman JS, 2002, CANCER RES, V62, P7291; Gibbs JW, 2000, EPILEPSIA, V41, pS10; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Hartman AL, 2008, EPILEPSIA, V49, P334, DOI 10.1111/j.1528-1167.2007.01430.x; Hartman AL, 2007, EPILEPSIA, V48, P31, DOI 10.1111/j.1528-1167.2007.00914.x; Hartman AL, 2010, EPILEPSIA, V51, P1395, DOI 10.1111/j.1528-1167.2010.02577.x; Hernandez D, 2012, NEURON, V74, P277, DOI 10.1016/j.neuron.2012.02.020; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Huang XX, 2010, NEUROBIOL DIS, V40, P193, DOI 10.1016/j.nbd.2010.05.024; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Kaminski RM, 2004, NEUROPHARMACOLOGY, V46, P1097, DOI 10.1016/j.neuropharm.2004.02.010; Kasap B, 2011, PEDIATR TRANSPLANT, V15, P673, DOI 10.1111/j.1399-3046.2011.01575.x; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Klitgaard H, 1998, EUR J PHARMACOL, V353, P191, DOI 10.1016/S0014-2999(98)00410-5; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Ljungberg MC, 2009, DIS MODEL MECH, V2, P389, DOI 10.1242/dmm.002386; McDaniel SS, 2011, EPILEPSIA, V52, pe7, DOI 10.1111/j.1528-1167.2011.02981.x; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; Morrison RS, 1996, J NEUROSCI, V16, P1337; Muller-Schwarze AB, 1999, NEUROREPORT, V10, P1517, DOI 10.1097/00001756-199905140-00023; Neal EG, 2008, LANCET NEUROL, V7, P500, DOI 10.1016/S1474-4422(08)70092-9; Orlova KA, 2010, ANN NY ACAD SCI, V1184, P87, DOI 10.1111/j.1749-6632.2009.05117.x; Potter WB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008996; Raffo E, 2011, NEUROBIOL DIS, V43, P322, DOI 10.1016/j.nbd.2011.03.021; Ran I, 2009, J NEUROSCI, V29, P5605, DOI 10.1523/JNEUROSCI.5355-08.2009; Ruegg S, 2007, EPILEPSY RES, V77, P85, DOI 10.1016/j.eplepsyres.2007.09.009; Russ SA, 2012, PEDIATRICS, V129, P256, DOI 10.1542/peds.2010-1371; Ryther RC, 2012, CURR NEUROL NEUROSCI; Samala R, 2008, EPILEPSY RES, V81, P119, DOI 10.1016/j.eplepsyres.2008.05.001; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Smith M, 2007, NEUROTHERAPEUTICS, V4, P12, DOI 10.1016/j.nurt.2006.11.009; Stefani A, 1996, EUR J PHARMACOL, V307, P113, DOI 10.1016/0014-2999(96)00265-8; STEPPUHN KG, 1993, J PHARMACOL EXP THER, V265, P1063; Sunnen CN, 2011, EPILEPSIA, V52, P2065, DOI 10.1111/j.1528-1167.2011.03280.x; Talos DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035885; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Taverna S, 1999, J PHARMACOL EXP THER, V288, P960; UHLEMANN ER, 1972, J PHARMACOL EXP THER, V180, P231; Wang CC, 2011, NEURON, V72, P789, DOI 10.1016/j.neuron.2011.09.023; White HS, 1997, EPILEPSY RES, V28, P167, DOI 10.1016/S0920-1211(97)00045-4; Wong M, 2010, EPILEPSY CURR, V11, P66; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Zhang XL, 2000, EPILEPSIA, V41, pS52; Zhao Q, 2004, PEDIATR RES, V55, P498, DOI 10.1203/01.PDR.0000112032.47575.D1	60	41	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45156	10.1371/journal.pone.0045156	http://dx.doi.org/10.1371/journal.pone.0045156			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984623	gold, Green Submitted, Green Published			2022-12-27	WOS:000308738500121
J	Khandrika, L; Koul, S; Meacham, RB; Koul, HK				Khandrika, Lakshmipathi; Koul, Sweaty; Meacham, Randall B.; Koul, Hari K.			Kidney Injury Molecule-1 Is Up-Regulated in Renal Epithelial Cells in Response to Oxalate In Vitro and in Renal Tissues in Response to Hyperoxaluria In Vivo	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CALCIUM-OXALATE; HK-2 CELLS; LLC-PK1 CELLS; URINARY BIOMARKER; CRYSTAL-FORMATION; DNA-SYNTHESIS; TREATED RATS; LINE; KIM-1	Oxalate is a metabolic end product excreted by the kidney. Mild increases in urinary oxalate are most commonly associated with Nephrolithiasis. Chronically high levels of urinary oxalate, as seen in patients with primary hyperoxaluria, are driving factor for recurrent renal stones, and ultimately lead to renal failure, calcification of soft tissue and premature death. In previous studies others and we have demonstrated that high levels of oxalate promote injury of renal epithelial cells. However, methods to monitor oxalate induced renal injury are limited. In the present study we evaluated changes in expression of Kidney Injury Molecule-1 (KIM-1) in response to oxalate in human renal cells (HK2 cells) in culture and in renal tissue and urine samples in hyperoxaluric animals which mimic in vitro and in vivo models of hyper-oxaluria. Results presented, herein demonstrate that oxalate exposure resulted in increased expression of KIM-1 m RNA as well as protein in HK2 cells. These effects were rapid and concentration dependent. Using in vivo models of hyperoxaluria we observed elevated expression of KIM-1 in renal tissues of hyperoxaluric rats as compared to normal controls. The increase in KIM-1 was both at protein and mRNA level, suggesting transcriptional activation of KIM-1 in response to oxalate exposure. Interestingly, in addition to increased KIM-1 expression, we observed increased levels of the ectodomain of KIM-1 in urine collected from hyperoxaluric rats. To the best of our knowledge our studies are the first direct demonstration of regulation of KIM-1 in response to oxalate exposure in renal epithelial cells in vitro and in vivo. Our results suggest that detection of KIM-1 over-expression and measurement of the ectodomain of KIM-1 in urine may hold promise as a marker to monitor oxalate nephrotoxicity in hyperoxaluria.	[Khandrika, Lakshmipathi; Koul, Sweaty; Meacham, Randall B.; Koul, Hari K.] Univ Colorado Denver, Sch Med, Dept Surg, Div Urol,Program Urosci,Signal Transduct & Mol Ur, Aurora, CO USA; [Koul, Hari K.] Univ Colorado Denver, Ctr Comprehens Canc, Univ Colorado, Aurora, CO USA; [Koul, Hari K.] Denver Vet Adm Med Ctr, Denver, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Khandrika, L (corresponding author), Univ Colorado Denver, Sch Med, Dept Surg, Div Urol,Program Urosci,Signal Transduct & Mol Ur, Aurora, CO USA.	hari.koul@ucdenver.edu			National Institutes of Health [NIH-RO1-DK-54084]; Department of Surgery Academic Enrichment Funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054084] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Surgery Academic Enrichment Funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by a research grant to HKK from National Institutes of Health (NIH-RO1-DK-54084) and the Department of Surgery Academic Enrichment Funds (HKK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailly V, 2002, J BIOL CHEM, V277, P39739, DOI 10.1074/jbc.M200562200; Bhandari A, 2002, J UROLOGY, V168, P253, DOI 10.1016/S0022-5347(05)64903-8; BOEVE ER, 1993, J UROLOGY, V149, P893, DOI 10.1016/S0022-5347(17)36254-7; Bonventre JV, 2009, NEPHROL DIAL TRANSPL, V24, P3265, DOI 10.1093/ndt/gfp010; CHAPLIN AJ, 1975, HISTOCHEM J, V7, P451, DOI 10.1007/BF01003882; Chaturvedi LS, 2002, J BIOL CHEM, V277, P13321, DOI 10.1074/jbc.M108203200; de Water R, 1999, AM J KIDNEY DIS, V33, P761, DOI 10.1016/S0272-6386(99)70231-3; Habibzadegah-Tari P, 2005, UROL RES, V33, P440, DOI 10.1007/s00240-005-0505-3; HAGEN L, 1993, CLIN CHEM, V39, P134; Han WK, 2005, J AM SOC NEPHROL, V16, P1126, DOI 10.1681/ASN.2004070530; Hoppe B, 2009, KIDNEY INT, V75, P1264, DOI 10.1038/ki.2009.32; Huang MY, 2005, KIDNEY INT, V68, P497, DOI 10.1111/j.1523-1755.2005.00427.x; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; Ichimura T, 2008, J CLIN INVEST, V118, P1657, DOI 10.1172/JCI34487; Iida S, 1999, J UROLOGY, V162, P1480, DOI 10.1016/S0022-5347(05)68344-9; Jeong BC, 2005, UROL RES, V33, P87, DOI 10.1007/s00240-004-0451-5; KHAN SR, 1995, J UROLOGY, V153, P811, DOI 10.1016/S0022-5347(01)67728-0; Khandrika L, 2008, J UROLOGY, V179, P2057, DOI 10.1016/j.juro.2008.01.007; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; KOUL H, 1994, BIOCHEM BIOPH RES CO, V205, P1632, DOI 10.1006/bbrc.1994.2854; Koul H, 1996, ITAL J MINER ELECT M, V10, P67; Koul HK, 2008, AIP CONF PROC, V1049, P120, DOI 10.1063/1.2998006; Koul HK, 2002, J BIOL CHEM, V277, P36845, DOI 10.1074/jbc.M200832200; Koul S, 2002, KIDNEY INT, V61, P525, DOI 10.1046/j.1523-1755.2002.00163.x; Koul S, 2008, UROL RES, V36, P1, DOI 10.1007/s00240-007-0130-4; Li Y, 2009, AM J PHYSIOL-RENAL, V296, pF1080, DOI 10.1152/ajprenal.90727.2008; Lieske JC, 1997, KIDNEY INT, V51, P679, DOI 10.1038/ki.1997.98; McConnell N, 2002, BJU INT, V89, P835, DOI 10.1046/j.1464-410X.2002.02739.x; Monico CG, 2002, KIDNEY INT, V62, P392, DOI 10.1046/j.1523-1755.2002.00468.x; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Sheriffs IN, 2001, J CLIN PATHOL, V54, P517, DOI 10.1136/jcp.54.7.517; WHARTON R, 1990, CLIN NEPHROL, V34, P116; Williams EL, 2009, HUM MUTAT, V30, P910, DOI 10.1002/humu.21021; Yamaguchi S, 2005, INT J UROL, V12, P290, DOI 10.1111/j.1442-2042.2005.01038.x; Zhang J, 2008, TOXICOL PATHOL, V36, P397, DOI 10.1177/0192623308315832; Zhang ZW, 2007, J AM SOC NEPHROL, V18, P2704, DOI 10.1681/ASN.2007030325	36	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44174	10.1371/journal.pone.0044174	http://dx.doi.org/10.1371/journal.pone.0044174			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984472	Green Submitted, Green Published, gold			2022-12-27	WOS:000308738500034
J	Lecours, MP; Segura, M; Fittipaldi, N; Rivest, S; Gottschalk, M				Lecours, Marie-Pier; Segura, Mariela; Fittipaldi, Nahuel; Rivest, Serge; Gottschalk, Marcelo			Immune Receptors Involved in Streptococcus suis Recognition by Dendritic Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; MYCOBACTERIUM-TUBERCULOSIS; INFLAMMATORY RESPONSES; PATHOGEN RECOGNITION; VIRULENCE FACTORS; INNATE IMMUNITY; ZOONOTIC AGENT; MOUSE MODEL; T-CELLS; INFECTION	Streptococcus suis is an important swine pathogen and an emerging zoonotic agent of septicemia and meningitis. Knowledge on host immune responses towards S. suis, and strategies used by this pathogen for subversion of these responses is scarce. The objective of this study was to identify the immune receptors involved in S. suis recognition by dendritic cells (DCs). Production of cytokines and expression of co-stimulatory molecules by DCs were shown to strongly rely on MyD88-dependent signaling pathways, suggesting that DCs recognize S. suis and become activated mostly through Toll-like receptor (TLR) signaling. Supporting this fact, TLR2(-/-) DCs were severely impaired in the release of several cytokines and the surface expression of CD86 and MHC-II. The release of IL-12p70 and CXC10, and the expression of CD40 were found to depend on signaling by both TLR2 and TLR9. The release of IL-23 and CXCL1 were partially dependent on NOD2. Finally, despite the fact that MyD88 signaling was crucial for DC activation and maturation, MyD88-dependent pathways were not implicated in S. suis internalization by DCs. This first study on receptors involved in DC activation by S. suis suggests a major involvement of MyD88 signaling pathways, mainly (but not exclusively) through TLR2. A multimodal recognition involving a combination of different receptors seems essential for DC effective response to S. suis.	[Lecours, Marie-Pier; Segura, Mariela; Gottschalk, Marcelo] Univ Montreal, Fac Vet Med, Dept Pathol & Microbiol, St Hyacinthe, PQ J2S 7C6, Canada; [Fittipaldi, Nahuel] Methodist Hosp Syst, Dept Pathol & Genom Med, Houston, TX USA; [Rivest, Serge] CHU Laval, Lab Endocrinol & Genom, Ste Foy, PQ, Canada	Universite de Montreal; The Methodist Hospital System; The Methodist Hospital - Houston; Laval University	Lecours, MP (corresponding author), Univ Montreal, Fac Vet Med, Dept Pathol & Microbiol, St Hyacinthe, PQ J2S 7C6, Canada.	marcelo.gottschalk@umontreal.ca	Segura, Mariela/AAG-5708-2020; Gottschalk, Marcelo/I-8116-2012	Rivest, Serge/0000-0002-6082-770X; Fittipaldi, Nahuel/0000-0001-9553-3798	Natural Sciences and Engineering Research Council of Canada (NSERC) [154280, 380299]; NSERC [342150-07]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) grant #154280 as well as Discovery Accelerator Supplement #380299 to Marcelo Gottschalk and NSERC grant #342150-07 to Mariela Segura. Marie-Pier Lecours is the recipient of a NSERC doctoral award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Baums Christoph Georg, 2009, Animal Health Research Reviews, V10, P65, DOI 10.1017/S146625230999003X; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; Chabot-Roy G, 2006, MICROB PATHOGENESIS, V41, P21, DOI 10.1016/j.micpath.2006.04.001; Clarke TB, 2011, IMMUNOL REV, V243, P9, DOI 10.1111/j.1600-065X.2011.01039.x; Corr SC, 2007, FEMS IMMUNOL MED MIC, V50, P380, DOI 10.1111/j.1574-695X.2007.00264.x; Costa A, 2012, J IMMUNOL, V188, P1953, DOI 10.4049/jimmunol.1102543; de Jong EC, 2005, SPRINGER SEMIN IMMUN, V26, P289, DOI 10.1007/s00281-004-0167-1; Dessing MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007993; Dominguez-Punaro MC, 2007, J IMMUNOL, V179, P1842, DOI 10.4049/jimmunol.179.3.1842; Dominguez-Punaro MD, 2010, INFECT IMMUN, V78, P5074, DOI 10.1128/IAI.00698-10; Echchannaoui H, 2002, J INFECT DIS, V186, P798, DOI 10.1086/342845; Ferwerda G, 2005, PLOS PATHOG, V1, P279, DOI 10.1371/journal.ppat.0010034; Fittipaldi N, 2008, MOL MICROBIOL, V70, P1120, DOI 10.1111/j.1365-2958.2008.06463.x; Fittipaldi N, 2008, INFECT IMMUN, V76, P3587, DOI 10.1128/IAI.01568-07; Fittipaldi N, 2012, FUTURE MICROBIOL, V7, P259, DOI [10.2217/FMB.11.149, 10.2217/fmb.11.149]; Fittipaldi N, 2011, EMERG INFECT DIS, V17, P2239, DOI 10.3201/eid1712.110609; Gottschalk M, 2000, VET MICROBIOL, V76, P259, DOI 10.1016/S0378-1135(00)00250-9; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; Graveline R, 2007, INT IMMUNOL, V19, P375, DOI 10.1093/intimm/dxm003; Henneke P, 2002, J IMMUNOL, V169, P3970, DOI 10.4049/jimmunol.169.7.3970; Kapetanovic R, 2007, INFECT IMMUN, V75, P830, DOI 10.1128/IAI.01199-06; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kobisch M, 1995, J RECH PORCINE FR, V27, P97; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Lecours MP, 2011, J INFECT DIS, V204, P919, DOI 10.1093/infdis/jir415; Lecours MP, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-72; Lee KS, 2007, CELL IMMUNOL, V245, P103, DOI 10.1016/j.cellimm.2007.04.003; Letiembre M, 2005, INFECT IMMUN, V73, P8397, DOI 10.1128/IAI.73.12.8397-8401.2005; Ley K, 2003, MICROCIRCULATION, V10, P289, DOI 10.1038/sj.mn.7800194; Liu XJ, 2010, GLIA, V58, P839, DOI 10.1002/glia.20968; Loof TG, 2008, INFECT IMMUN, V76, P2785, DOI 10.1128/IAI.01680-07; Lun SC, 2003, MICROB PATHOGENESIS, V34, P27, DOI 10.1016/S0882-4010(02)00192-4; Ma L, 2009, CELL MOL IMMUNOL, V6, P199, DOI 10.1038/cmi.2009.27; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Mancuso G, 2004, J IMMUNOL, V172, P6324, DOI 10.4049/jimmunol.172.10.6324; McNeela EA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001191; Meijerink M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035849; Opitz B, 2004, J BIOL CHEM, V279, P36426, DOI 10.1074/jbc.M403861200; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schreur PJW, 2010, VET MICROBIOL, V143, P363, DOI 10.1016/j.vetmic.2009.12.010; Segura M, 2004, FRONT BIOSCI-LANDMRK, V9, P1157, DOI 10.2741/1287; Segura M, 2006, FEMS IMMUNOL MED MIC, V47, P92, DOI 10.1111/j.1574-695X.2006.00067.x; Shida K, 2009, IMMUNOLOGY, V128, pe858, DOI 10.1111/j.1365-2567.2009.03095.x; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Stockinger B, 1996, J EXP MED, V183, P891, DOI 10.1084/jem.183.3.891; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; Takamatsu D, 2001, PLASMID, V45, P101, DOI 10.1006/plas.2000.1510; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tam MA, 2009, IMMUNOLOGY, V128, P429, DOI 10.1111/j.1365-2567.2009.03128.x; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; Underhill DM, 2007, IMMUNOL REV, V219, P75, DOI 10.1111/j.1600-065X.2007.00548.x; van Beelen AJ, 2007, IMMUNITY, V27, P660, DOI 10.1016/j.immuni.2007.08.013; van Vliet SJ, 2007, CURR OPIN IMMUNOL, V19, P435, DOI 10.1016/j.coi.2007.05.006; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zheng H, 2012, VET MICROBIOL, V156, P147, DOI 10.1016/j.vetmic.2011.10.014	63	30	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44746	10.1371/journal.pone.0044746	http://dx.doi.org/10.1371/journal.pone.0044746			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984550	Green Published, gold, Green Submitted			2022-12-27	WOS:000308738500079
J	Sun, FJ; Zhang, YQ; Wang, L; Yan, XJ; Tan, YF; Guo, ZB; Qiu, JF; Yang, RF; Xia, PY; Zhou, DS				Sun, Fengjun; Zhang, Yiquan; Wang, Li; Yan, Xiaojuan; Tan, Yafang; Guo, Zhaobiao; Qiu, Jingfu; Yang, Ruifu; Xia, Peiyuan; Zhou, Dongsheng			Molecular Characterization of Direct Target Genes and cis-Acting Consensus Recognized by Quorum-Sensing Regulator AphA in Vibrio parahaemolyticus	PLOS ONE			English	Article							CONTROLS BIOFILM FORMATION; VIRULENCE ACTIVATOR APHA; GENOME SEQUENCE; III SECRETION; CHOLERAE; HARVEYI; EXPRESSION; REPRESSION; PLASMID; BINDING	Background: AphA is the master quorum-sensing (QS) regulator operating at low cell density in vibrios. Molecular regulation of target genes by AphA has been characterized in Vibrio harveyi and V. cholerae, but it is still poorly understood in V. parahaemolyticus. Methodology/Principal Findings: The AphA proteins are extremely conserved in V. parahaemolyticus, Vibrio sp. Ex25, Vibrio sp. EJY3, V. harveyi, V. vulnificus, V. splendidus, V. anguillarum, V. cholerae, and V. furnissii. The above nine AphA orthologs appear to recognize conserved cis-acting DNA signals which can be represented by two consensus constructs, a 20 bp box sequence and a position frequency matrix. V. parahaemolyticus AphA represses the transcription of ahpA, qrr4, and opaR through direct AphA-target promoter DNA association, while it inhibits the qrr2-3 transcription in an indirect manner. Translation and transcription starts, core promoter elements for sigma factor recognition, Shine-Dalgarno sequences for ribosome recognition, and AphA-binding sites (containing corresponding AphA box-like sequences) were determined for the three direct AphA targets ahpA, qrr4, and opaR in V. parahaemolyticus. Conclusions/Significance: AphA-mediated repression of ahpA, qrr2-4, and opaR was characterized in V. parahaemolyticus by using multiple biochemical and molecular experiments. The computational promoter analysis indicated the conserved mechanism of transcriptional regulation of QS regulator-encoding genes ahpA, qrr4, and opaR in vibrios.	[Sun, Fengjun; Xia, Peiyuan] Third Mil Med Univ, Southwest Hosp, Dept Pharm, Chongqing, Peoples R China; [Sun, Fengjun; Zhang, Yiquan; Wang, Li; Yan, Xiaojuan; Tan, Yafang; Guo, Zhaobiao; Yang, Ruifu; Zhou, Dongsheng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Wang, Li; Yan, Xiaojuan; Qiu, Jingfu] Chongqing Med Univ, Sch Publ Hlth, Chongqing, Peoples R China	Army Medical University; Beijing Institute of Microbiology & Epidemiology; Chongqing Medical University	Sun, FJ (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Pharm, Chongqing, Peoples R China.	py_xia@yahoo.com.cn; dongshengzhou1977@gmail.com	Zhang, Yiquan/AAP-3311-2021; Yang, Ruifu/A-2273-2011	Zhang, Yiquan/0000-0003-3935-4079; Yang, Ruifu/0000-0003-3219-7269; Zhou, Dongsheng/0000-0003-3827-5969	National Natural Science Foundation of China [31170127]; National Basic Research Program of China [2009CB522604]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	Financial support was provided by the National Natural Science Foundation of China (31170127), and by the National Basic Research Program of China (2009CB522604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews GP, 1996, INFECT IMMUN, V64, P2180, DOI 10.1128/IAI.64.6.2180-2187.1996; BALBAS P, 1986, GENE, V50, P3, DOI 10.1016/0378-1119(86)90307-0; Casselli T, 2008, INFECT IMMUN, V76, P2202, DOI 10.1128/IAI.01704-07; Chatterjee J, 1996, MOL MICROBIOL, V20, P415, DOI 10.1111/j.1365-2958.1996.tb02628.x; Chen CY, 2003, GENOME RES, V13, P2577, DOI 10.1101/gr.1295503; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; De Silva RS, 2005, J BIOL CHEM, V280, P13779, DOI 10.1074/jbc.M413781200; Faruque SM, 2006, P NATL ACAD SCI USA, V103, P6350, DOI 10.1073/pnas.0601277103; Gode-Potratz CJ, 2011, J BACTERIOL; Hammer BK, 2003, MOL MICROBIOL, V50, P101, DOI 10.1046/j.1365-2958.2003.03688.x; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Henke JM, 2004, J BACTERIOL, V186, P6902, DOI 10.1128/JB.186.20.6902-6914.2004; Henke JM, 2004, J BACTERIOL, V186, P3794, DOI 10.1128/JB.186.12.3794-3805.2004; Hiyoshi H, 2010, INFECT IMMUN, V78, P1772, DOI 10.1128/IAI.01051-09; Kovacikova G, 2005, MOL MICROBIOL, V57, P420, DOI 10.1111/j.1365-2958.2005.04700.x; Kovacikova G, 2004, MOL MICROBIOL, V53, P129, DOI 10.1111/j.1365-2958.2004.04121.x; Kovacikova G, 2003, J BACTERIOL, V185, P4825, DOI 10.1128/JB.185.16.4825-4836.2003; Kovacikova G, 2002, MOL MICROBIOL, V46, P1135, DOI 10.1046/j.1365-2958.2002.03229.x; Kovacikova G, 2001, MOL MICROBIOL, V41, P393, DOI 10.1046/j.1365-2958.2001.02518.x; Le Roux F, 2009, ENVIRON MICROBIOL, V11, P1959, DOI 10.1111/j.1462-2920.2009.01918.x; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Lim B, 2006, MOL MICROBIOL, V60, P331, DOI 10.1111/j.1365-2958.2006.05106.x; Lin BC, 2010, ENV MICROBIOL REP, V2, P81, DOI 10.1111/j.1758-2229.2009.00100.x; Lin W, 2005, J BACTERIOL, V187, P3013, DOI 10.1128/JB.187.9.3013-3019.2005; Lin W, 2007, MOL MICROBIOL, V64, P953, DOI 10.1111/j.1365-2958.2007.05693.x; Lux TM, 2011, J BACTERIOL; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Naka H, 2011, INFECT IMMUN, V79, P2889, DOI 10.1128/IAI.05138-11; PARALES RE, 1993, GENE, V133, P23, DOI 10.1016/0378-1119(93)90220-W; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Pompeani AJ, 2008, MOL MICROBIOL, V70, P76, DOI 10.1111/j.1365-2958.2008.06389.x; Roh H, 2012, J BACTERIOL, V194, P2773, DOI 10.1128/JB.00303-12; Rutherford ST, 2011, GENE DEV, V25, P397, DOI 10.1101/gad.2015011; Sawabe T, 2007, J BACTERIOL, V189, P7932, DOI 10.1128/JB.00693-07; Shao CP, 2011, J BACTERIOL, V193, P2557, DOI 10.1128/JB.01259-10; Shao Y, 2012, MOL MICROBIOL, V83, P599, DOI 10.1111/j.1365-2958.2011.07959.x; Tamayo R, 2010, INFECT IMMUN, V78, P3560, DOI 10.1128/IAI.00048-10; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teng SW, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.30; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Tsou AM, 2010, INFECT IMMUN, V78, P461, DOI 10.1128/IAI.00590-09; Tu KC, 2008, MOL MICROBIOL, V70, P896, DOI 10.1111/j.1365-2958.2008.06452.x; Tu KC, 2007, GENE DEV, V21, P221, DOI 10.1101/gad.1502407; Tu KC, 2010, MOL CELL, V37, P567, DOI 10.1016/j.molcel.2010.01.022; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; Vezzi A, 2005, SCIENCE, V307, P1459, DOI 10.1126/science.1103341; Waters CA, 2008, J BACTERIOL, V190, P2527, DOI 10.1128/JB.01756-07; Waters CM, 2006, GENE DEV, V20, P2754, DOI 10.1101/gad.1466506; Waters CM, 2010, APPL ENVIRON MICROB, V76, P4996, DOI 10.1128/AEM.00886-10; Yang MH, 2010, INFECT IMMUN, V78, P697, DOI 10.1128/IAI.00429-09; Yeung P S Marie, 2004, Foodborne Pathog Dis, V1, P74, DOI 10.1089/153531404323143594; Zhang YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034622; Zhang YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025484; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	55	32	40	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44210	10.1371/journal.pone.0044210	http://dx.doi.org/10.1371/journal.pone.0044210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984476	Green Published, Green Submitted, gold			2022-12-27	WOS:000308738500037
J	Downie, H; Holden, N; Otten, W; Spiers, AJ; Valentine, TA; Dupuy, LX				Downie, Helen; Holden, Nicola; Otten, Wilfred; Spiers, Andrew J.; Valentine, Tracy A.; Dupuy, Lionel X.			Transparent Soil for Imaging the Rhizosphere	PLOS ONE			English	Article							ESCHERICHIA-COLI; GROWTH; MICROSCOPY; MODEL; COLONIZATION; ARCHITECTURE; ARABIDOPSIS; TRANSPORT; ECOSYSTEM; SILICA	Understanding of soil processes is essential for addressing the global issues of food security, disease transmission and climate change. However, techniques for observing soil biology are lacking. We present a heterogeneous, porous, transparent substrate for in situ 3D imaging of living plants and root-associated microorganisms using particles of the transparent polymer, Nafion, and a solution with matching optical properties. Minerals and fluorescent dyes were adsorbed onto the Nafion particles for nutrient supply and imaging of pore size and geometry. Plant growth in transparent soil was similar to that in soil. We imaged colonization of lettuce roots by the human bacterial pathogen Escherichia coli O157:H7 showing micro-colony development. Micro-colonies may contribute to bacterial survival in soil. Transparent soil has applications in root biology, crop genetics and soil microbiology.	[Downie, Helen; Holden, Nicola; Valentine, Tracy A.; Dupuy, Lionel X.] James Hutton Inst, Dundee, Scotland; [Downie, Helen; Otten, Wilfred; Spiers, Andrew J.] Univ Abertay Dundee, SIMBIOS Ctr, Dundee, Scotland	James Hutton Institute; University of Abertay Dundee	Downie, H (corresponding author), James Hutton Inst, Dundee, Scotland.	Lionel.Dupuy@Hutton.ac.uk	Holden, Nicola/B-3038-2009; Valentine, Tracy A/C-2666-2009; Holden, Nicola/L-1653-2019; Otten, Wilfried/H-7168-2019; Dupuy, Lionel X/C-4433-2008; Spiers, Andrew/I-3535-2012; Otten, Wilfred/A-3990-2012	Holden, Nicola/0000-0002-7904-4529; Valentine, Tracy A/0000-0002-9064-2896; Holden, Nicola/0000-0002-7904-4529; Otten, Wilfried/0000-0002-3847-9825; Dupuy, Lionel X/0000-0001-5221-9037; Spiers, Andrew/0000-0003-0463-8629; Otten, Wilfred/0000-0002-3847-9825; Laurie, Helen/0000-0002-8974-1168	University of Abertay Dundee; James Hutton Institute; Scottish Government Rural and Environment Science and Analytical Services Division (RESAS, Workpackage 3.3)	University of Abertay Dundee; James Hutton Institute; Scottish Government Rural and Environment Science and Analytical Services Division (RESAS, Workpackage 3.3)	This work was funded by a joint studentship from the University of Abertay Dundee and the James Hutton Institute and the Scottish Government Rural and Environment Science and Analytical Services Division (RESAS, Workpackage 3.3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOTTOMLEY PA, 1986, P NATL ACAD SCI USA, V83, P87, DOI 10.1073/pnas.83.1.87; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; BUDWIG R, 1994, EXP FLUIDS, V17, P350, DOI 10.1007/BF01874416; CEYNOWA J, 1984, ANGEW MAKROMOL CHEM, V121, P97, DOI 10.1002/apmc.1984.051210109; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; de Dorlodot S, 2007, TRENDS PLANT SCI, V12, P474, DOI 10.1016/j.tplants.2007.08.012; de Villeneuve VWA, 2005, SCIENCE, V309, P1231, DOI 10.1126/science.1113207; Declerck S, 1998, MYCOLOGIA, V90, P579, DOI 10.2307/3761216; Dumais J, 2002, PLANT J, V31, P229, DOI 10.1046/j.1365-313X.2001.01350.x; Dupuy L, 2010, P NATL ACAD SCI USA, V107, P2711, DOI 10.1073/pnas.0906322107; Eickhorst T, 2008, SOIL BIOL BIOCHEM, V40, P1284, DOI 10.1016/j.soilbio.2007.06.019; Federici F, 2012, NATURE METH IN PRESS; Federici F, 2012, NAT METHODS, V9, P483, DOI [10.1038/nmeth.1940, 10.1038/NMETH.1940]; French A, 2009, PLANT PHYSIOL, V150, P1784, DOI 10.1104/pp.109.140558; Friman O, 2008, I S BIOMED IMAGING, P1047, DOI 10.1109/ISBI.2008.4541179; Gregory PJ, 2003, PLANT SOIL, V255, P351, DOI 10.1023/A:1026179919689; Habteselassie MY, 2010, J FOOD PROTECT, V73, P2001, DOI 10.4315/0362-028X-73.11.2001; Haynes JG, 2004, NEW PHYTOL, V163, P661, DOI 10.1111/j.1469-8137.2004.01138.x; Holden N. J., 2010, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V5, P1, DOI 10.1079/PAVSNNR20105047; Holden N, 2009, FEMS MICROBIOL REV, V33, P689, DOI 10.1111/j.1574-6976.2008.00153.x; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Iskander MG, 2002, J GEOTECH GEOENVIRON, V128, P262, DOI 10.1061/(ASCE)1090-0241(2002)128:3(262); Koenig M, 2006, MED IMAGING 2006 VIS; Kurup S, 2005, PLANT J, V42, P444, DOI 10.1111/j.1365-313X.2005.02386.x; LAL R, 2002, ENCY SOIL SCI; Leis AP, 2005, APPL ENVIRON MICROB, V71, P4801, DOI 10.1128/AEM.71.8.4801-4808.2005; Low AS, 2006, ENVIRON MICROBIOL, V8, P1033, DOI 10.1111/j.1462-2920.2006.00995.x; Malamy JE, 2005, PLANT CELL ENVIRON, V28, P67, DOI 10.1111/j.1365-3040.2005.01306.x; MANNHEIMER RJ, 1993, GROUND WATER, V31, P781, DOI 10.1111/j.1745-6584.1993.tb00851.x; Massa GD, 2003, PLANT J, V33, P435, DOI 10.1046/j.1365-313X.2003.01637.x; Mauritz KA, 2004, CHEM REV, V104, P4535, DOI 10.1021/cr0207123; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Miransari M, 2011, APPL MICROBIOL BIOT, V92, P875, DOI 10.1007/s00253-011-3521-y; Pansu M, 2006, HDB SOIL ANAL, P755; Preibisch S, 2010, NAT METHODS, V7, P418, DOI 10.1038/nmeth0610-418; RIEBERER S, 1992, ULTRAMICROSCOPY, V41, P225, DOI 10.1016/0304-3991(92)90111-V; Salerno HLS, 2011, J POLYM SCI B; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Schmidt S, 2011, ROOT RESPONSES SOIL; Schroth MH, 1996, SOIL SCI SOC AM J, V60, P1331, DOI 10.2136/sssaj1996.03615995006000050007x; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Thomas G.W., 1982, METHODS SOIL ANAL; Van Nguyen T, 2007, J ELECTROCHEMICAL SO, V154, P4; XUE T, 1989, J MEMBRANE SCI, V45, P261, DOI 10.1016/S0376-7388(00)80518-9; Young IM, 2004, SCIENCE, V304, P1634, DOI 10.1126/science.1097394	45	118	124	7	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44276	10.1371/journal.pone.0044276	http://dx.doi.org/10.1371/journal.pone.0044276			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984484	Green Published, Green Submitted, gold			2022-12-27	WOS:000308638700051
J	Florez, JC; Jablonski, KA; McAteer, JB; Franks, PW; Mason, CC; Mather, K; Horton, E; Goldberg, R; Dabelea, D; Kahn, SE; Arakaki, RF; Shuldiner, AR; Knowler, WC				Florez, Jose C.; Jablonski, Kathleen A.; McAteer, Jarred B.; Franks, Paul W.; Mason, Clinton C.; Mather, Kieren; Horton, Edward; Goldberg, Ronald; Dabelea, Dana; Kahn, Steven E.; Arakaki, Richard F.; Shuldiner, Alan R.; Knowler, William C.		Diabetes Prevention Program Res	Effects of Genetic Variants Previously Associated with Fasting Glucose and Insulin in the Diabetes Prevention Program	PLOS ONE			English	Article							PLASMA-GLUCOSE; PROINSULIN LEVELS; FOLLOW-UP; LOCI; POLYMORPHISM; HOMEOSTASIS; SCAN; MTNR1B	Common genetic variants have been recently associated with fasting glucose and insulin levels in white populations. Whether these associations replicate in pre-diabetes is not known. We extended these findings to the Diabetes Prevention Program, a clinical trial in which participants at high risk for diabetes were randomized to placebo, lifestyle modification or metformin for diabetes prevention. We genotyped previously reported polymorphisms (or their proxies) in/near G6PC2, MTNR1B, GCK, DGKB, GCKR, ADCY5, MADD, CRY2, ADRA2A, FADS1, PROX1, SLC2A2, GLIS3, C2CD4B, IGF1, and IRS1 in 3,548 Diabetes Prevention Program participants. We analyzed variants for association with baseline glycemic traits, incident diabetes and their interaction with response to metformin or lifestyle intervention. We replicated associations with fasting glucose at MTNR1B (P<0.001), G6PC2 (P=0.002) and GCKR (P=0.001). We noted impaired beta-cell function in carriers of glucose-raising alleles at MTNR1B (P<0.001), and an increase in the insulinogenic index for the glucose-raising allele at G6PC2 (P<0.001). The association of MTNR1B with fasting glucose and impaired beta-cell function persisted at 1 year despite adjustment for the baseline trait, indicating a sustained deleterious effect at this locus. We also replicated the association of MADD with fasting proinsulin levels (P<0.001). We detected no significant impact of these variants on diabetes incidence or interaction with preventive interventions. The association of several polymorphisms with quantitative glycemic traits is replicated in a cohort of high-risk persons. These variants do not have a detectable impact on diabetes incidence or response to metformin or lifestyle modification in the Diabetes Prevention Program.	[Florez, Jose C.; McAteer, Jarred B.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Florez, Jose C.; McAteer, Jarred B.] Massachusetts Gen Hosp, Diabet Unit, Diabet Res Ctr, Boston, MA 02114 USA; [Florez, Jose C.; McAteer, Jarred B.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Florez, Jose C.; Horton, Edward] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Jablonski, Kathleen A.] George Washington Univ, Ctr Biostat, Rockville, MD USA; [Franks, Paul W.] Lund Univ, Dept Clin Sci, Lund Univ Diabet Ctr, Malmo, Sweden; [Franks, Paul W.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Mason, Clinton C.; Knowler, William C.] NIDDKD, Diabet Epidemiol & Clin Res Sect, Phoenix, AZ USA; [Mather, Kieren] Indiana Univ Sch Med, Div Endocrinol, Indianapolis, IN USA; [Horton, Edward] Joslin Diabet Ctr, Boston, MA 02215 USA; [Goldberg, Ronald] Univ Miami, Lipid Disorders Clin, Div Endocrinol Diabet & Metab, Miami, FL USA; [Goldberg, Ronald] Univ Miami, Diabet Res Inst, Miami, FL USA; [Dabelea, Dana] Univ Colorado, Dept Prevent Med & Biometr, Denver, CO 80202 USA; [Dabelea, Dana] Univ Colorado, Hlth Sci Ctr, Denver, CO USA; [Kahn, Steven E.] VA Puget Sound Hlth Care Syst, Dept Med, Div Metab Endocrinol & Nutr, Seattle, WA USA; [Kahn, Steven E.] Univ Washington, Seattle, WA 98195 USA; [Arakaki, Richard F.] Univ Hawaii, Dept Med Clin Res, Honolulu, HI 96822 USA; [Shuldiner, Alan R.] Univ Maryland, Sch Med, Dept Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; George Washington University; Lund University; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Indiana University System; Indiana University Bloomington; Harvard University; Joslin Diabetes Center, Inc.; University of Miami; University of Miami; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; University of Hawaii System; University System of Maryland; University of Maryland Baltimore	Florez, JC (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	jcflorez@partners.org	Uwaifo, Gabriel I/M-2361-2016; Mather, Kieren/ABE-4117-2020; de Bakker, Paul IW/B-8730-2009; Franks, Paul/AAA-3300-2020	Uwaifo, Gabriel I/0000-0002-6962-9304; de Bakker, Paul IW/0000-0001-7735-7858; Shuldiner, Alan/0000-0001-9921-4305; Kahn, Steven/0000-0001-7307-9002; Franks, Paul/0000-0002-0520-7604; Hill, James/0000-0003-4690-2264	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health [U01DK048489]; NIDDK; Indian Health Service; Office of Research on Minority Health; National Institute of Child Health and Human Development; National Institute on Aging; Office of Research on Women's Health; Centers for Disease Control and Prevention; American Diabetes Association; intramural research program of the NIDDK [R01 DK072041]; Swedish Research Council; Novo Nordisk; Swedish Diabetes Association; Swedish Heart-Lung Foundation; McKesson BioServices Corp.; Matthews Media Group, Inc.; Henry M. Jackson Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075078] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Indian Health Service(United States Department of Health & Human Services); Office of Research on Minority Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); American Diabetes Association(American Diabetes Association); intramural research program of the NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk(Novo Nordisk); Swedish Diabetes Association; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); McKesson BioServices Corp.; Matthews Media Group, Inc.; Henry M. Jackson Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health provided funding to the clinical centers and the Coordinating Center for the design and conduct of the study, and the collection, management, analysis, and interpretation of the data, through Award Number U01DK048489. The Southwestern American Indian Centers were supported directly by the NIDDK and the Indian Health Service. The General Clinical Research Center Program, National Center for Research Resources, and the Department of Veterans Affairs supported data collection at many of the clinical centers. Funding for data collection and participant support was also provided by the Office of Research on Minority Health, the National Institute of Child Health and Human Development, the National Institute on Aging, the Office of Research on Women's Health, the Centers for Disease Control and Prevention, and the American Diabetes Association. This research was also supported, in part, by the intramural research program of the NIDDK, and by R01 DK072041 to JCF, KAJ and ARS. PWF was supported by the Swedish Research Council, Novo Nordisk, Swedish Diabetes Association, and the Swedish Heart-Lung Foundation. The Investigators gratefully acknowledge the commitment and dedication of the participants of the DPP. The opinions expressed are those of the investigators and do not necessarily reflect the official views of the funding agencies. A complete list of Centers, investigators, and staff can be found in the Appendix. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JCF has received consulting honoraria from Novartis, Pfizer and Eli Lilly. Bristol-Myers Squibb and Parke-Davis provided medication. LifeScan Inc., Health O Meter, Hoechst Marion Roussel, Inc., Merck-Medco Managed Care, Inc., Merck and Co., Nike Sports Marketing, Slim Fast Foods Co., and Quaker Oats Co. donated materials, equipment, or medicines for concomitant conditions. McKesson BioServices Corp., Matthews Media Group, Inc., and the Henry M. Jackson Foundation provided support services under subcontract with the Coordinating Center. The authors also received funding from the commercial source Novo Nordisk. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	[Anonymous], 2000, Diabetes Care, V23, P1619; Bouatia-Naji N, 2008, SCIENCE, V320, P1085, DOI 10.1126/science.1156849; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Bray GA, 1999, DIABETES CARE, V22, P623; Chen WM, 2008, J CLIN INVEST, V118, P2620, DOI 10.1172/JCI34566; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Hivert MF, 2011, DIABETES, V60, P1340, DOI 10.2337/db10-1119; Ingelsson E, 2010, DIABETES, V59, P1266, DOI [10.2337/DB09-1568, 10.2337/db09-1568]; Jensen AC, 2011, DIABETES, V60, P1617, DOI 10.2337/db10-1393; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; Majithia AR, 2011, DIABETOLOGIA, V54, P2570, DOI 10.1007/s00125-011-2234-1; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meigs JB, 2002, DIABETES, V51, P833, DOI 10.2337/diabetes.51.3.833; Moore AF, 2008, DIABETES, V57, P2503, DOI 10.2337/db08-0284; Orho-Melander M, 2008, DIABETES, V57, P3112, DOI 10.2337/db08-0516; Panhuysen CIM, 2003, DIABETOLOGIA, V46, P579, DOI 10.1007/s00125-003-1066-z; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Renstrom F, 2011, DIABETES, V60, P345, DOI 10.2337/db10-0933; Rose CS, 2009, DIABETOLOGIA, V52, P2122, DOI 10.1007/s00125-009-1463-z; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Sparso T, 2008, DIABETOLOGIA, V51, P70, DOI 10.1007/s00125-007-0865-z; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Tang K, 1999, P NATL ACAD SCI USA, V96, P10016, DOI 10.1073/pnas.96.18.10016; Utzschneider KM, 2009, DIABETES CARE, V32, P335, DOI 10.2337/dc08-1478; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Walford GA, 2011, DIABETOLOGIA; Weedon MN, 2006, AM J HUM GENET, V79, P991, DOI 10.1086/509517; Yang QH, 2010, DIABETES CARE, V33, P2370, DOI 10.2337/dc10-0898	31	31	34	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44424	10.1371/journal.pone.0044424	http://dx.doi.org/10.1371/journal.pone.0044424			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984506	Green Submitted, Green Published, gold			2022-12-27	WOS:000308638700060
J	Hampson, M; Tokoglu, F; Shen, XL; Scheinost, D; Papademetris, X; Constable, RT				Hampson, Michelle; Tokoglu, Fuyuze; Shen, Xilin; Scheinost, Dustin; Papademetris, Xenophon; Constable, R. Todd			Intrinsic Brain Connectivity Related to Age in Young and Middle Aged Adults	PLOS ONE			English	Article							LIFE-SPAN; FUNCTIONAL CONNECTIVITY; MEMORY PERFORMANCE; EMOTIONAL FACES; DEFAULT NETWORK; WORKING-MEMORY; CORTICAL HUBS; OLDER-ADULTS; SMALL-WORLD; BLOOD-FLOW	Age-related variations in resting state connectivity of the human brain were examined from young adulthood through middle age. A voxel-based network measure, degree, was used to assess age-related differences in tissue connectivity throughout the brain. Increases in connectivity with age were found in paralimbic cortical and subcortical regions. Decreases in connectivity were found in cortical regions, including visual areas and the default mode network. These findings differ from those of recent developmental studies examining earlier growth trajectories, and are consistent with known changes in cognitive function and emotional processing during mature aging. The results support and extend previous findings that relied on a priori definitions of regions of interest for their analyses. This approach of applying a voxel-based measure to examine the functional connectivity of individual tissue elements over time, without the need for a priori region of interest definitions, provides an important new tool in brain science.	[Hampson, Michelle; Tokoglu, Fuyuze; Shen, Xilin; Papademetris, Xenophon; Constable, R. Todd] Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA; [Scheinost, Dustin; Papademetris, Xenophon; Constable, R. Todd] Yale Univ, Dept Biomed Engn, New Haven, CT USA	Yale University; Yale University	Hampson, M (corresponding author), Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA.	michelle.hampson@yale.edu	Scheinost, Dustin/Q-2857-2018; Shen, Xilin/F-4349-2011; Constable, R. Todd/ABE-8038-2021; Hampson, Michelle/K-6732-2015	Scheinost, Dustin/0000-0002-6301-1167; Constable, R. Todd/0000-0001-5661-9521; Hampson, Michelle/0000-0003-3173-4210; Shen, Xilin/0000-0003-1006-7404	National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health [RO1EB009666-02, R01 EB006494]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009666, R01EB006494] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health (grant numbers: RO1EB009666-02, R01 EB006494, funder's website: http://www.nibib.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bentourkia M, 2000, J NEUROL SCI, V181, P19, DOI 10.1016/S0022-510X(00)00396-8; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burdette JH, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00023; Cabeza R, 2004, CEREB CORTEX, V14, P364, DOI 10.1093/cercor/bhg133; Carstensen LL, 2000, J PERS SOC PSYCHOL, V79, P644, DOI 10.1037//0022-3514.79.4.644; Charles ST, 2003, J EXP PSYCHOL GEN, V132, P310, DOI 10.1037/0096-3445.132.2.310; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Grady CL, 2007, NEUROPSYCHOLOGY, V21, P371, DOI 10.1037/0894-4105.21.3.371; GRADY CL, 1994, J NEUROSCI, V14, P1450, DOI 10.1523/JNEUROSCI.14-03-01450.1994; Grady CL, 2006, J COGNITIVE NEUROSCI, V18, P227, DOI 10.1162/jocn.2006.18.2.227; Gross JJ, 1997, PSYCHOL AGING, V12, P590, DOI 10.1037/0882-7974.12.4.590; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Jelsing J, 2006, BRAIN RES BULL, V70, P322, DOI 10.1016/j.brainresbull.2006.06.009; LABOUVIEVIEF G, 1989, HUM DEV, V32, P279, DOI 10.1159/000276480; Lacadie CM, 2008, NEUROIMAGE, V42, P717, DOI 10.1016/j.neuroimage.2008.04.240; LAWTON MP, 1992, PSYCHOL AGING, V7, P171, DOI 10.1037/0882-7974.7.2.171; Levine LJ, 1997, PSYCHOL AGING, V12, P514, DOI 10.1037/0882-7974.12.3.514; Martuzzi R, 2011, NEUROIMAGE; Martuzzi R, 2010, NEUROIMAGE, V49, P823, DOI 10.1016/j.neuroimage.2009.07.028; Mather M, 2003, PSYCHOL SCI, V14, P409, DOI 10.1111/1467-9280.01455; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Orgeta V, 2009, AGING MENT HEALTH, V13, P818, DOI 10.1080/13607860902989661; Papademetris X, 2004, LECT NOTES COMPUT SC, V3216, P763; Park DC, 1996, PSYCHOL AGING, V11, P621, DOI 10.1037/0882-7974.11.4.621; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raz N, 2004, NEUROBIOL AGING, V25, P377, DOI 10.1016/S0197-4580(03)00118-0; Salthouse TA, 2003, PSYCHOL AGING, V18, P91, DOI 10.1037/0882-7974.18.1.91; Salvador Raymond, 2010, Front Neuroinform, V4, P115, DOI 10.3389/fninf.2010.00115; Sambataro F, 2010, NEUROBIOL AGING, V31, P839, DOI 10.1016/j.neurobiolaging.2008.05.022; Scheinost D, 2012, NEUROIMAGE; Shen X, 2010, NEUROIMAGE, V50, P1027, DOI 10.1016/j.neuroimage.2009.12.119; SONG M, 2009, EMBC 2009 ANN INT C, P2212; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Thomas RC, 2006, PSYCHOL AGING, V21, P821, DOI 10.1037/0882-7974.21.4.821; TOMASI D, 2011, NEUROIMAGE; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Wen W, 2011, J NEUROSCI, V31, P1204, DOI 10.1523/JNEUROSCI.4085-10.2011	55	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44067	10.1371/journal.pone.0044067	http://dx.doi.org/10.1371/journal.pone.0044067			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	003VE	22984460	gold, Green Published, Green Submitted			2022-12-27	WOS:000308638700042
J	MacPherson, P; Corbett, EL; Makombe, SD; van Oosterhout, JJ; Manda, E; Choko, AT; Thindwa, D; Squire, SB; Mann, GH; Lalloo, DG				MacPherson, Peter; Corbett, Elizabeth L.; Makombe, Simon D.; van Oosterhout, Joep J.; Manda, Eddie; Choko, Augustine T.; Thindwa, Deus; Squire, S. Bertel; Mann, Gillian H.; Lalloo, David G.			Determinants and Consequences of Failure of Linkage to Antiretroviral Therapy at Primary Care Level in Blantyre, Malawi: A Prospective Cohort Study	PLOS ONE			English	Article							PUBLIC-HEALTH APPROACH; SUB-SAHARAN AFRICA; SOUTH-AFRICA; FOLLOW-UP; TUBERCULOSIS SERVICES; INCOME COUNTRIES; HIV CARE; SCALE-UP; MORTALITY; DURBAN	Background: Poor rates of linkage from HIV diagnosis to ART initiation are a major barrier to universal coverage of ART in sub-Saharan Africa, with reasons for failure poorly understood. In the first study of this kind at primary care level, we investigated the pathway to care in the Malawian National Programme, one of the strongest in Africa. Methods and Findings: A prospective cohort study was undertaken at two primary care clinics in Blantyre, Malawi. Newly diagnosed HIV-positive adults (>15 years) were followed for 6-months to assess completion of eligibility assessments, initiation of ART and death. Two hundred and eighty participants were followed for 82.6 patient-years. ART eligibility assessments were problematic: only 134 (47.9%) received same day WHO staging and 121 (53.2%) completed assessments by 6-months. Completion of CD4 measurement (stage 1/2 only) was 81/153 (52.9%). By 6-months, 87/280 (31.1%) had initiated ART with higher uptake in participants who were ART eligible (68/91, 74.7%), and among participants who received same-day staging (52/134 [38.8%] vs. 35/146 [24.0%] p = 0.007). Non-completion of ART eligibility assessments (adjusted hazard ratio: 0.11, 95% CI: 0.06-0.21) was associated with failure to initiate ART. Retention in pre-ART care for non-ART initiators was low (55/193 [28.5%]). Of the 15 (5.4%) deaths, 11 (73.3%) occurred after ART initiation. Conclusions: Although uptake of ART was high and prompt for patients with known eligibility, there was frequent failure to complete eligibility assessment and poor retention in pre-ART care. HIV care programmes should urgently evaluate the way patients are linked to ART. In particular, there is a critical need for simplified, same-day ART eligibility assessments, reduced requirements for hospital visits, and active defaulter follow-up.	[MacPherson, Peter; Squire, S. Bertel; Mann, Gillian H.; Lalloo, David G.] Univ Liverpool, Liverpool Sch Trop Med, Clin Grp, Liverpool L3 5QA, Merseyside, England; [MacPherson, Peter; Corbett, Elizabeth L.; Choko, Augustine T.; Thindwa, Deus] Malawi Liverpool Wellcome Trust Clin Res Programm, HIV & TB Grp, Blantyre, Malawi; [Corbett, Elizabeth L.] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1E 7HT, England; [Makombe, Simon D.] Minist Hlth, HIV Unit, Lilongwe, Malawi; [van Oosterhout, Joep J.] Univ Malawi, Coll Med, Blantyre, Malawi; [Manda, Eddie] Blantyre Dist Hlth Off, Blantyre, Malawi	Liverpool School of Tropical Medicine; University of Liverpool; University of Malawi; University of London; London School of Hygiene & Tropical Medicine; University of Malawi	MacPherson, P (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Clin Grp, Liverpool L3 5QA, Merseyside, England.	p.macpherson@liverpool.ac.uk	MacPherson, Peter/AHD-2477-2022	MacPherson, Peter/0000-0002-0329-9613; Corbett, Elizabeth/0000-0002-3552-3181; Squire, Stephen/0000-0001-7173-9038; Thindwa, Deus/0000-0003-4845-7862; Lalloo, David/0000-0001-7680-2200	Wellcome Trust [WT089673]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (grant number: WT089673). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amuron B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-290; April MD, 2009, JAIDS-J ACQ IMM DEF, V51, P310, DOI 10.1097/QAI.0b013e3181a248e6; Ayalon L, 2009, ARCH INTERN MED, V169, P2156, DOI 10.1001/archinternmed.2009.386; Bassett IV, 2010, AIDS, V24, pS37, DOI 10.1097/01.aids.0000366081.91192.1c; Bassett IV, 2009, JAIDS-J ACQ IMM DEF, V51, P135, DOI 10.1097/QAI.0b013e3181a44ef2; Baveewo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019089; Benson T, 2006, C INT ASS AGR EC IAA; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Cohen T, 2011, LANCET, V378, P204, DOI 10.1016/S0140-6736(11)60896-9; COLEBUNDERS R, 1987, LANCET, V1, P492; Harries AD, 2006, LANCET, V367, P1870, DOI 10.1016/S0140-6736(06)68809-0; Harries AD, 2011, JAIDS-J ACQ IMM DEF, V57, pS64, DOI 10.1097/QAI.0b013e31821f6bab; Harries AD, 2010, TROP MED INT HEALTH, V15, P70, DOI 10.1111/j.1365-3156.2010.02506.x; HIV & AIDS Unit-Ministry of Health of Malawi, 2011, Q PROGR REP; Ingle SM, 2010, AIDS, V24, P2717, DOI 10.1097/QAD.0b013e32833fb71f; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Kaplan R, 2008, AIDS, V22, P1679, DOI 10.1097/QAD.0b013e32830ebcee; Karcher H, 2007, TROP MED INT HEALTH, V12, P687, DOI 10.1111/j.1365-3156.2007.01830.x; Kemp JR, 2007, B WORLD HEALTH ORGAN, V85, P580, DOI 10.2471/BLT.06.033167; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Lawn SD, 2010, CURR OPIN HIV AIDS, V5, P18, DOI 10.1097/COH.0b013e328333850f; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; Lowrance DW, 2008, JAIDS-J ACQ IMM DEF, V49, P287, DOI 10.1097/QAI.0b013e3181893ef0; MacPherson P, 2012, TROP MED INT HEALTH, V17, P507, DOI 10.1111/j.1365-3156.2011.02946.x; Micek MA, 2009, JAIDS-J ACQ IMM DEF, V52, P397, DOI 10.1097/QAI.0b013e3181ab73e2; Ministry of Health of Malawi, 2011, MAL GUID CLIN MAN HI; National AIDS Commission, 2005, NAT EST HHIV AIDS MA; National Statistics Office of Malawi, 1998, INT HOUS SURV; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Schouten EJ, 2011, LANCET, V378, P282, DOI 10.1016/S0140-6736(10)62303-3; Simwaka BN, 2007, INT J TUBERC LUNG D, V11, P65; Tayler-Smith K, 2010, T ROY SOC TROP MED H, V104, P313, DOI 10.1016/j.trstmh.2010.01.007; UNAIDS, 2010, GLOB REP UNAIDS REP; Wanyenze RK, 2011, AIDS BEHAV, V15, P751, DOI 10.1007/s10461-010-9704-1; Zachariah R, 2011, TROP MED INT HEALTH, V16, P37, DOI 10.1111/j.1365-3156.2010.02669.x; Zachariah R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000121	37	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44794	10.1371/journal.pone.0044794	http://dx.doi.org/10.1371/journal.pone.0044794			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984560	Green Accepted, gold, Green Published			2022-12-27	WOS:000308638700083
J	Sripada, L; Tomar, D; Prajapati, P; Singh, R; Singh, AK; Singh, R				Sripada, Lakshmi; Tomar, Dhanendra; Prajapati, Paresh; Singh, Rochika; Singh, Arun Kumar; Singh, Rajesh			Systematic Analysis of Small RNAs Associated with Human Mitochondria by Deep Sequencing: Detailed Analysis of Mitochondrial Associated miRNA	PLOS ONE			English	Article							NUAGE FORMATION; PROTEIN IMPORT; STRESS; LIFE; IDENTIFICATION; BIOGENESIS; EXPRESSION; DISORDERS; MICRORNAS; CYTOPLASM	Mitochondria are one of the central regulators of many cellular processes beyond its well established role in energy metabolism. The inter-organellar crosstalk is critical for the optimal function of mitochondria. Many nuclear encoded proteins and RNA are imported to mitochondria. The translocation of small RNA (sRNA) including miRNA to mitochondria and other sub-cellular organelle is still not clear. We characterized here sRNA including miRNA associated with human mitochondria by cellular fractionation and deep sequencing approach. Mitochondria were purified from HEK293 and HeLa cells for RNA isolation. The sRNA library was generated and sequenced using Illumina system. The analysis showed the presence of unique population of sRNA associated with mitochondria including miRNA. Putative novel miRNAs were characterized from unannotated sRNA sequences. The study showed the association of 428 known, 196 putative novel miRNAs to mitochondria of HEK293 and 327 known, 13 putative novel miRNAs to mitochondria of HeLa cells. The alignment of sRNA to mitochondrial genome was also studied. The targets were analyzed using DAVID to classify them in unique networks using GO and KEGG tools. Analysis of identified targets showed that miRNA associated with mitochondria regulates critical cellular processes like RNA turnover, apoptosis, cell cycle and nucleotide metabolism. The six miRNAs (counts >1000) associated with mitochondria of both HEK293 and HeLa were validated by RT-qPCR. To our knowledge, this is the first systematic study demonstrating the associations of sRNA including miRNA with mitochondria that may regulate site-specific turnover of target mRNA important for mitochondrial related functions.	[Sripada, Lakshmi; Tomar, Dhanendra; Prajapati, Paresh; Singh, Arun Kumar; Singh, Rajesh] Indian Inst Adv Res, Sch Biol Sci & Biotechnol, Dept Cell Biol, Gandhinagar, India; [Singh, Rochika] Indian Inst Adv Res, Sch Biol Sci & Biotechnol, Dept Human Hlth & Dis, Gandhinagar, India		Sripada, L (corresponding author), Indian Inst Adv Res, Sch Biol Sci & Biotechnol, Dept Cell Biol, Gandhinagar, India.	rsingh@iiar.res.in	Tomar, Dhanendra/A-1050-2012; Tomar, Dhanendra/H-3358-2019; Prajapati, Paresh/P-1058-2019	Tomar, Dhanendra/0000-0002-3144-7257; Tomar, Dhanendra/0000-0002-3144-7257; Prajapati, Paresh/0000-0002-3734-4662; Singh, Rajesh/0000-0002-4986-3486	Department of Biotechnology, Govt. of India [BT/PR12906/AGR/36/638/2009]; CSIR (Council of Scientific & Industrial Research), Govt. of India; UGC (University Grants Commission), Govt. of India	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); CSIR (Council of Scientific & Industrial Research), Govt. of India; UGC (University Grants Commission), Govt. of India	This work was supported by Department of Biotechnology, Govt. of India (BT/PR12906/AGR/36/638/2009). Dhanendra Tomar received Senior Research Fellowship from CSIR (Council of Scientific & Industrial Research), Govt. of India. Lakshmi Sripada received Junior Research Fellowship from UGC (University Grants Commission), Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Aravin AA, 2011, DEV CELL, V20, P287, DOI 10.1016/j.devcel.2011.03.003; Atorino L, 2003, J CELL BIOL, V163, P777, DOI 10.1083/jcb.200304112; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Baltzer C, 2010, MITOCHONDRION, V10, P589, DOI 10.1016/j.mito.2010.07.009; Bandiera S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020746; Barrey E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020220; Bian Z, 2010, CELL RES, V20, P1076, DOI 10.1038/cr.2010.119; Burroughs AM, 2011, RNA BIOL, V8, P158, DOI 10.4161/rna.8.1.14300; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Cande C, 2004, J CELL SCI, V117, P4461, DOI 10.1242/jcs.01356; Chatterjee A, 2011, CANCER PREV RES, V4, P638, DOI 10.1158/1940-6207.CAPR-10-0326; Cloonan SM, 2011, CURRENT OPINION IMMU; DiMauro S, 2011, SEMIN FETAL NEONAT M, V16, P181, DOI 10.1016/j.siny.2011.04.010; Endo T, 2003, J CELL SCI, V116, P3259, DOI 10.1242/jcs.00667; Ernoult-Lange M, 2012, BIOCHIMIE; Goetzman ES, 2011, PROG MOL BIOL TRANSL, V100, P389, DOI 10.1016/B978-0-12-384878-9.00010-8; Guerra-Assuncao JA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-133; Ha Tai-You, 2011, Immune Netw, V11, P11, DOI [10.4110/in.2011.11.3.135, 10.4110/in.2011.11.1.11]; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Hernandez-Cid A, 2012, IUBMB LIFE, V64, P521, DOI 10.1002/iub.1052; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Huang L, 2011, J BIOL CHEM, V286, P24219, DOI 10.1074/jbc.M111.240259; Hwang AB, 2011, AGING-US, V3, P304, DOI 10.18632/aging.100292; Kaldi K, 1998, BIOFACTORS, V8, P221, DOI 10.1002/biof.5520080308; Kamp DW, 2011, ONCOLOGY-NY, V25, P400; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kren BT, 2009, RNA BIOL, V6, P65, DOI 10.4161/rna.6.1.7534; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lindstrom MS, 2008, J BIOL CHEM, V283, P15568, DOI 10.1074/jbc.M801151200; Maniataki E, 2005, RNA, V11, P849, DOI 10.1261/rna.2210805; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; Ouyang YB, 2011, MITOCHONDRION; Puranam RS, 2001, MOL CELL BIOL, V21, P548, DOI 10.1128/MCB.21.2.548-561.2001; Rubio MAT, 2011, WIRES RNA, V2, P802, DOI 10.1002/wrna.93; Rudel S, 2011, NUCLEIC ACIDS RES, V39, P2330, DOI 10.1093/nar/gkq1032; Sano E, 2008, BBA-MOL CELL RES, V1783, P1036, DOI 10.1016/j.bbamcr.2007.12.009; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Schneider A, 2011, ANNU REV BIOCHEM, V80, P1033, DOI 10.1146/annurev-biochem-060109-092838; Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003; Seitz Herve, 2011, Silence, V2, P4, DOI 10.1186/1758-907X-2-4; Sieber F, 2011, INT REV CEL MOL BIO, V287, P145, DOI 10.1016/B978-0-12-386043-9.00004-9; Smirnov A, 2011, GENE DEV, V25, P1289, DOI 10.1101/gad.624711; Tomar D, 2012, BBA-MOL CELL RES, V1823, P316, DOI 10.1016/j.bbamcr.2011.11.015; Wang C, 2011, EXPERT OPIN THER TAR, V15, P647, DOI 10.1517/14728222.2011.561321; Wang G, 2010, CELL, V142, P456, DOI 10.1016/j.cell.2010.06.035; Watanabe T, 2011, DEV CELL, V20, P364, DOI 10.1016/j.devcel.2011.01.005; Yan Z, 2011, NUCLEIC ACIDS RES, V39, P6596, DOI 10.1093/nar/gkr298; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004677	54	111	117	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44873	10.1371/journal.pone.0044873	http://dx.doi.org/10.1371/journal.pone.0044873			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984580	Green Published, Green Submitted, gold			2022-12-27	WOS:000308638700095
J	Taloyan, M; Aronsson, G; Leineweber, C; Hanson, LM; Alexanderson, K; Westerlund, H				Taloyan, Marina; Aronsson, Gunnar; Leineweber, Constanze; Hanson, Linda Magnusson; Alexanderson, Kristina; Westerlund, Hugo			Sickness Presenteeism Predicts Suboptimal Self-Rated Health and Sickness Absence: A Nationally Representative Study of the Swedish Working Population	PLOS ONE			English	Article							SILENT-MYOCARDIAL-ISCHEMIA; SERIOUS CORONARY EVENTS; ILLNESS; MORTALITY; ILL; ATTENDANCE; WORKPLACE; STRESS	Background: Earlier studies have suggested that sickness presenteeism (SP) may be a risk factor for future health problems. The purpose of the present study was to test this in a nationally representative prospective study of Swedish workers. Methods: Prospective cohort with a representative sample of the Swedish working population surveyed in 2008 and 2010. Odds ratios (OR) with 95% confidence intervals (CI) were calculated using logistic regression. Results: Those who reported more than 7 days of SP had higher risk of suboptimal SRH compared to those who reported no SP (OR = 5.95; 95% CI 4.98-7.12), also after adjustment for confounders (OR = 1.64; 95% CI 1.30-2.06). Those who reported 1-7 days of SP also had an increased risk before and after adjustments. Inclusion of self-rated physical and psychological work capacity did not attenuate the associations, whereas of emotional exhaustion attenuated the ORs to non-significance for both outcomes, indicating that the health consequences associated with SP are largely related to mental health. Conclusion: The results strengthen earlier findings suggesting that SP can be a risk factor for future suboptimal general health and sickness absence, particularly through mental health problems. This indicates that asking about SP could yield important information for employers, occupational health practitioners and GPs, possibly leading to more timely intervention that could decrease the risk of future sickness absence and more serious health problems, especially in the mental domain. Further studies of the possible causal pathways between SP and future health development are also warranted, especially since going to work is often seen as desirable also for those with poor health.	[Taloyan, Marina; Leineweber, Constanze; Hanson, Linda Magnusson; Westerlund, Hugo] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Aronsson, Gunnar] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden; [Alexanderson, Kristina; Westerlund, Hugo] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden	Stockholm University; Stockholm University; Karolinska Institutet	Taloyan, M (corresponding author), Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden.	marina.taloyan@stressforskning.su.se	Leineweber, Constanze/Z-1330-2019; Alexanderson, Kristina A/J-3429-2013; Aronsson, Gunnar/ABF-3405-2020; Aronsson, Gunnar/ABE-7189-2020; Leineweber, Constanze/G-7052-2012; Hanson, Linda L Magnusson/D-2435-2017; Westerlund, Hugo/A-3049-2012	Leineweber, Constanze/0000-0001-8433-2405; Hanson, Linda L Magnusson/0000-0002-2908-1903; Westerlund, Hugo/0000-0002-8806-5698; Aronsson, Gunnar/0000-0003-3664-1814; Alexanderson, Kristina/0000-0002-9313-3413	Swedish Council for Working Life and Social Research (FAS) [2005-0734]; Swedish Research Council [825-2009-6192]; FAS [2007-1143]; Stockholm Stress Center, an FAS center of excellence [2009-1758]	Swedish Council for Working Life and Social Research (FAS)(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council(Swedish Research CouncilEuropean Commission); FAS; Stockholm Stress Center, an FAS center of excellence	This work was supported by the Swedish Council for Working Life and Social Research (FAS)(grant #2005-0734) and the Swedish Research Council (grant #825-2009-6192). The analyses and writing of the report was supported in part by a grant from FAS (#2007-1143) and in part through Stockholm Stress Center, an FAS center of excellence (grant #2009-1758). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronsson G, 2005, J OCCUP ENVIRON MED, V47, P958, DOI 10.1097/01.jom.0000177219.75677.17; Aronsson G, 2000, J EPIDEMIOL COMMUN H, V54, P502, DOI 10.1136/jech.54.7.502; Aronsson G, 2011, INT ARCH OCCUPATIONA; ARONSSON G, 1997, ARBETSMARKNAD ARBETS, V3, P193; Bergstrom G, 2009, INT ARCH OCC ENV HEA, V82, P1179, DOI 10.1007/s00420-009-0433-6; Bergstrom G, 2009, J OCCUP ENVIRON MED, V51, P629, DOI [10.1097/JOM.0b913e3181a8281b, 10.1097/JOM.0b013e3181a8281b]; Bracewell Lisa M, 2010, N Z Med J, V123, P31; Brenninkmeijer V, 2003, OCCUP ENVIRON MED, V60, P16; Caverley N, 2007, J MANAGE STUD, V44, P2; DEANFIELD JE, 1984, LANCET, V2, P1001; Demerouti E, 2009, CAREER DEV INT, V14, P50, DOI 10.1108/13620430910933574; Dew K, 2005, SOC SCI MED, V60, P2273, DOI 10.1016/j.socscimed.2004.10.022; Floderus B, 2005, J REHABIL MED, V37, P291, DOI 10.1080/16501970510034422; Grinyer A, 2000, HEALTH RISK SOC, V2, P7, DOI 10.1080/136985700111413; Gustafsson K, 2011, INT J OCCUP MED ENV, V24, P153, DOI 10.2478/s13382-011-0013-3; Gustafsson PE, 2010, J EPIDEMIOLOGY COMMU; Hansen CD, 2008, SOC SCI MED, V67, P956, DOI 10.1016/j.socscimed.2008.05.022; Hosmer D., 2002, APPL LOGISTIC REGRES; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Insurance S, 2008, J WORKPLACE HLTH MAN; Johansson G, 2004, SOC SCI MED, V58, P1857, DOI 10.1016/S0277-9536(03)00407-6; Johns G, 2010, J ORGAN BEHAV, V31, P519, DOI 10.1002/job.630; Kivimaki M, 2005, AM J PUBLIC HEALTH, V95, P98, DOI 10.2105/AJPH.2003.035873; KRISTENSEN TS, 1991, SOC SCI MED, V32, P15, DOI 10.1016/0277-9536(91)90122-S; Lack DM, 2011, AAOHN J, V59, P77, DOI 10.3928/08910162-20110126-01; Leineweber C, 2011, J OCCUP REHABIL, V21, P17, DOI 10.1007/s10926-010-9249-1; Lovell V., 2004, NO TIME BE SICK WHY; MARMOT M, 1995, J EPIDEMIOL COMMUN H, V49, P124, DOI 10.1136/jech.49.2.124; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; McKevitt C, 1997, J PUBLIC HEALTH MED, V19, P295, DOI 10.1093/oxfordjournals.pubmed.a024633; McKevitt C, 1997, J ROY SOC MED, V90, P491, DOI 10.1177/014107689709000907; Miilunpalo S, 1997, J CLIN EPIDEMIOL, V50, P517, DOI 10.1016/S0895-4356(97)00045-0; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; ROZANSKI A, 1988, NEW ENGL J MED, V318, P1005, DOI 10.1056/NEJM198804213181601; Schultz AB, 2007, J OCCUP REHABIL, V17, P547, DOI 10.1007/s10926-007-9096-x; Vahtera J, 2004, BMJ-BRIT MED J, V328, P555, DOI 10.1136/bmj.37972.496262.0D; Vingard E, 2004, SCAND J PUBLIC HEALT, V32, P216, DOI 10.1080/14034950410021907; Virtanen M, 2003, OCCUP ENVIRON MED, V60, P948, DOI 10.1136/oem.60.12.948; Westerlund H, 2009, J OCCUP ENVIRON MED, V51, P1099, DOI 10.1097/JOM.0b013e3181b350e1; Wikman A, 2005, J EPIDEMIOL COMMUN H, V59, P450, DOI 10.1136/jech.2004.025346	41	113	117	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44721	10.1371/journal.pone.0044721	http://dx.doi.org/10.1371/journal.pone.0044721			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	003VE	22984547	Green Submitted, Green Published, gold			2022-12-27	WOS:000308638700079
J	Tsafnat, N; Gerald, JDF; Le, HN; Stachurski, ZH				Tsafnat, Naomi; Gerald, John D. Fitz; Le, Hai N.; Stachurski, Zbigniew H.			Micromechanics of Sea Urchin Spines	PLOS ONE			English	Article							AMORPHOUS CALCIUM-CARBONATE; STRENGTH; GROWTH; DESIGN; MODEL	The endoskeletal structure of the Sea Urchin, Centrostephanus rodgersii, has numerous long spines whose known functions include locomotion, sensing, and protection against predators. These spines have a remarkable internal microstructure and are made of single-crystal calcite. A finite-element model of the spine's unique porous structure, based on micro-computed tomography (microCT) and incorporating anisotropic material properties, was developed to study its response to mechanical loading. Simulations show that high stress concentrations occur at certain points in the spine's architecture; brittle cracking would likely initiate in these regions. These analyses demonstrate that the organization of single-crystal calcite in the unique, intricate morphology of the sea urchin spine results in a strong, stiff and lightweight structure that enhances its strength despite the brittleness of its constituent material.	[Tsafnat, Naomi] Univ New S Wales, Sch Mech & Mfg Engn, Sydney, NSW, Australia; [Gerald, John D. Fitz] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Le, Hai N.; Stachurski, Zbigniew H.] Australian Natl Univ, Res Sch Engn, Canberra, ACT, Australia	University of New South Wales Sydney; Australian National University; Australian National University	Tsafnat, N (corresponding author), Univ New S Wales, Sch Mech & Mfg Engn, Sydney, NSW, Australia.	n.tsafnat@unsw.edu.au	Stachurski, Zbigniew/ABB-5555-2021; Stachurski, Zbigniew/ABB-3542-2021; Tsafnat, Naomi/F-9710-2012	Stachurski, Zbigniew/0000-0002-1317-0178; Tsafnat, Naomi/0000-0002-6687-3731				Abou Chakra M, 2011, PALEOBIOLOGY, V37, P686, DOI 10.1666/10012.1; Abou Chakra M, 2011, J THEOR BIOL, V285, P113, DOI 10.1016/j.jtbi.2011.06.019; Bejan A., 2000, SHAPE STRUCTURE ENG; Bejan A, 2010, PHILOS T R SOC B, V365, P1335, DOI 10.1098/rstb.2009.0302; BERMAN A, 1990, SCIENCE, V250, P664, DOI 10.1126/science.250.4981.664; BURKHARDT A, 1983, ZOOMORPHOLOGY, V102, P189, DOI 10.1007/BF00310347; Chen CC, 2001, AM MINERAL, V86, P1525; Donovan Stephen K., 1999, P565; Jiang B-Y, 2008, LAS EL 2008 2008 C Q, P1; KARAM GN, 1994, MAT SCI ENG C-BIOMIM, V2, P113, DOI 10.1016/0928-4931(94)90039-6; Lawn B, 1993, CAMBRIDGE AB SOLID S, V2nd, DOI 10.10177cbo9780511623127; Lorente S, 2010, INT J HEAT MASS TRAN, V53, P2963, DOI 10.1016/j.ijheatmasstransfer.2010.03.038; Magdans U, 2004, EUR J MINERAL, V16, P261, DOI 10.1127/0935-1221/2004/0016-0261; Newnham R. E., 2005, PROPERTIES MAT; Politi Y, 2004, SCIENCE, V306, P1161, DOI 10.1126/science.1102289; Politi Y, 2008, P NATL ACAD SCI USA, V105, P17362, DOI 10.1073/pnas.0806604105; Russ J. C., 1984, FUNDAMENTALS ENERGY; Seto J, 2012, P NATL ACAD SCI USA, V109, P3699, DOI 10.1073/pnas.1109243109; Stock SR, 2010, ECHINODERMS: DURHAM, P263; Stock S.R., 2006, DEV XRAY TOMOGRAPHY, VV; STRATHMANN RR, 1981, PALEOBIOLOGY, V7, P400, DOI 10.1017/S0094837300004693; Stupp SI, 1997, SCIENCE, V277, P1242, DOI 10.1126/science.277.5330.1242; Sugarman B, 1967, J MATER SCI, V2, P275, DOI 10.1007/BF00555385; Tsafnat N, 2008, FUEL, V87, P2983, DOI 10.1016/j.fuel.2008.03.027; Woodward AE., 1989, ATLAS POLYM MORPHOLO; Zachos LG, 2009, J THEOR BIOL, V259, P646, DOI 10.1016/j.jtbi.2009.04.007	26	20	20	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44140	10.1371/journal.pone.0044140	http://dx.doi.org/10.1371/journal.pone.0044140			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984468	Green Submitted, Green Published, gold			2022-12-27	WOS:000308638700045
J	Barth, T; Schmidt, D; Botteron, C; Nguyen, TTT; Ritter, U; Mannel, DN; Lechner, A				Barth, Thomas; Schmidt, Dominic; Botteron, Catherine; Nguyen, Trang T. T.; Ritter, Uwe; Maennel, Daniela N.; Lechner, Anja			An Early Reduction in Treg Cells Correlates with Enhanced Local Inflammation in Cutaneous Leishmaniasis in CCR6-Deficient Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; TH17 CELLS; C57BL/6 MICE; BETA-2-MICROGLOBULIN-DEFICIENT MICE; MUCOSAL LEISHMANIASIS; SUSCEPTIBLE MICE; IMMUNITY; RECEPTOR; CCR6; CHEMOKINE	Resistance to Leishmania major infection is dependent on the development of a cell-mediated Th1 immune response in resistant C57BL/6 mice whereas Th2-prone BALB/c mice develop non-healing lesions after infection. The chemokine receptor CCR6 is shared by anti-inflammatory regulatory T cells and pro-inflammatory Th17 cells. In a recent study we showed that C57BL/6 mice deficient in CCR6 exhibited enhanced footpad swelling and impaired T helper cell migration indicated by reduced recruitment of total T helper cells into the skin after infection and a reduced delayed type hypersensitivity reaction. Based on these findings we tested whether the lack of CCR6 alters Treg or Th17 cell responses during the course of Leishmania major infection. When we analyzed T cell subsets in the lymph nodes of CCR6-deficient mice, Th17 cell numbers were not different. However, reduced numbers of Treg cells paralleled with a stronger IFN gamma response. Furthermore, the early increase in IFN gamma-producing cells correlated with increased local tissue inflammation at later time points. Our data indicate an important role of CCR6 for Treg cells and a redundant role for Th17 cells in a Th1 cell-driven anti-parasitic immune response against Leishmania major parasites in resistant C57BL/6 mice.	[Barth, Thomas; Schmidt, Dominic; Botteron, Catherine; Nguyen, Trang T. T.; Ritter, Uwe; Maennel, Daniela N.; Lechner, Anja] Univ Regensburg, Inst Immunol, Regensburg, Germany; [Botteron, Catherine] Univ Regensburg, Inst Pediat, Regensburg, Germany	University of Regensburg; University of Regensburg	Lechner, A (corresponding author), Univ Regensburg, Inst Immunol, Regensburg, Germany.	anja.lechner@klinik.uni-regensburg.de			Deutsche Forschungsgemeinschaft [LE 2435/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the project grant LE 2435/1-1 of the Deutsche Forschungsgemeinschaft (www.dfg.de) awarded to A. Lechner. The funding organization had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Belkaid Y, 2002, J IMMUNOL, V168, P3992, DOI 10.4049/jimmunol.168.8.3992; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Belkaid Y, 2001, J EXP MED, V194, P1497, DOI 10.1084/jem.194.10.1497; Boaventura VS, 2010, EUR J IMMUNOL, V40, P2830, DOI 10.1002/eji.200940115; Brewig N, 2009, J IMMUNOL, V182, P774, DOI 10.4049/jimmunol.182.2.774; Brodskyn CI, 1997, J IMMUNOL, V159, P4467; Cahalan MD, 2006, NAT IMMUNOL, V7, P329, DOI 10.1038/ni0406-329; Campbell JJ, 2007, J IMMUNOL, V178, P3358, DOI 10.4049/jimmunol.178.6.3358; Comerford I, 2010, BIOESSAYS, V32, P1067, DOI 10.1002/bies.201000063; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; Ebert LM, 2002, J IMMUNOL, V168, P65, DOI 10.4049/jimmunol.168.1.65; FACCIOLI LH, 1990, AGENTS ACTIONS, V30, P344, DOI 10.1007/BF01966298; Faria DR, 2009, PARASITE IMMUNOL, V31, P432, DOI 10.1111/j.1365-3024.2009.01125.x; Gu XG, 2008, EXP HEMATOL, V36, P1417, DOI 10.1016/j.exphem.2008.06.003; Guilliams M, 2007, J IMMUNOL, V179, P2748, DOI 10.4049/jimmunol.179.5.2748; Herath S, 2003, PARASITE IMMUNOL, V25, P559, DOI 10.1111/j.0141-9838.2004.00668.x; Huber M, 1998, INFECT IMMUN, V66, P3968, DOI 10.1128/IAI.66.8.3968-3970.1998; Ji JX, 2005, J IMMUNOL, V174, P7147, DOI 10.4049/jimmunol.174.11.7147; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI13543; Kim JS, 2011, J EXP MED, V208, P2201, DOI 10.1084/jem.20110680; Kitamura K, 2010, J IMMUNOL, V185, P3295, DOI 10.4049/jimmunol.1001156; Kleinewietfeld M, 2005, BLOOD, V105, P2877, DOI 10.1182/blood-2004-07-2505; Kostka SL, 2009, J IMMUNOL, V182, P3039, DOI 10.4049/jimmunol.0713598; Kryczek I, 2011, J IMMUNOL, V186, P4388, DOI 10.4049/jimmunol.1003251; Lechner A, 2007, MICROBES INFECT, V9, P291, DOI 10.1016/j.micinf.2006.12.002; Lehtimaki S, 2010, J INVEST DERMATOL, V130, P2743, DOI 10.1038/jid.2010.208; Machado P, 2002, EUR J DERMATOL, V12, P449; Mizgerd JP, 2001, J IMMUNOL, V166, P4042, DOI 10.4049/jimmunol.166.6.4042; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; OVERATH P, 1993, IMMUNOL LETT, V37, P13, DOI 10.1016/0165-2478(93)90126-M; Pitta MGR, 2009, J CLIN INVEST, V119, P2379, DOI 10.1172/JCI38813; Potzl J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002951; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Rivino L, 2010, J EXP MED, V207, P565, DOI 10.1084/jem.20091021; Sallusto F, 1999, EUR J IMMUNOL, V29, P2037, DOI 10.1002/(SICI)1521-4141(199906)29:06<2037::AID-IMMU2037>3.0.CO;2-V; Scott P, 1996, EXP PARASITOL, V84, P178, DOI 10.1006/expr.1996.0103; SOLBACH W, 1986, J IMMUNOL, V137, P702; Sommer F, 1998, INT IMMUNOL, V10, P1853, DOI 10.1093/intimm/10.12.1853; Thomas MJ, 2002, J IMMUNOL, V168, P216, DOI 10.4049/jimmunol.168.1.216; Uzonna JE, 2004, J EXP MED, V199, P1559, DOI 10.1084/jem.20040172; Valmori D, 2010, P NATL ACAD SCI USA, V107, P19402, DOI 10.1073/pnas.1008247107; Varona R, 2001, J CLIN INVEST, V107, pR37, DOI 10.1172/JCI11297; Villares R, 2009, EUR J IMMUNOL, V39, P1671, DOI 10.1002/eji.200839123; WANG ZE, 1993, J IMMUNOL, V151, P2077; Wilhelm P, 2001, J IMMUNOL, V166, P4012, DOI 10.4049/jimmunol.166.6.4012; Wu WH, 2010, EUR J IMMUNOL, V40, P2517, DOI 10.1002/eji.201040484; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	51	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e44499	10.1371/journal.pone.0044499	http://dx.doi.org/10.1371/journal.pone.0044499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028548	Green Submitted, Green Published, gold			2022-12-27	WOS:000309973900011
J	Verdoodt, B; Vogt, M; Schmitz, I; Liffers, ST; Tannapfel, A; Mirmohammadsadegh, A				Verdoodt, Berlinda; Vogt, Markus; Schmitz, Inge; Liffers, Sven-Thorsten; Tannapfel, Andrea; Mirmohammadsadegh, Alireza			Salinomycin Induces Autophagy in Colon and Breast Cancer Cells with Concomitant Generation of Reactive Oxygen Species	PLOS ONE			English	Article							DEATH; APOPTOSIS; KINASE; RESISTANCE; ROLES; ROS; METASTASIS; ACTIVATION; EXPRESSION; CROSSTALK	Background: Salinomycin is a polyether ionophore antibiotic that has recently been shown to induce cell death in human cancer cells displaying multiple mechanisms of drug resistance. The underlying mechanisms leading to cell death after salinomycin treatment have not been well characterized. We therefore investigated the role of salinomycin in caspase dependent and independent cell death in colon cancer (SW480, SW620, RKO) and breast cancer cell lines (MCF-7, T47D, MDA-MB-453). Methodology/Principal Findings: We detected features of apoptosis in all cell lines tested, but the executor caspases 3 and 7 were only strongly activated in RKO and MDA-MB-453 cells. MCF-7 and SW620 cells instead presented features of autophagy such as cytoplasmic vacuolization and LC3 processing. Caspase proficient cell lines activated autophagy at lower salinomycin concentrations and before the onset of caspase activation. Salinomycin also led to the formation of reactive oxygen species (ROS) eliciting JNK activation and induction of the transcription factor JUN. Salinomycin mediated cell death could be partially inhibited by the free radical scavenger N-acetyl-cysteine, implicating ROS formation in the mechanism of salinomycin toxicity. Conclusions: Our data indicate that, in addition to its previously reported induction of caspase dependent apoptosis, the initiation of autophagy is an important and early effect of salinomycin in tumor cells.	[Verdoodt, Berlinda; Vogt, Markus; Schmitz, Inge; Liffers, Sven-Thorsten; Tannapfel, Andrea; Mirmohammadsadegh, Alireza] Ruhr Univ Bochum, Inst Pathol, Bochum, Germany	Ruhr University Bochum	Mirmohammadsadegh, A (corresponding author), Ruhr Univ Bochum, Inst Pathol, Univ Str 150, Bochum, Germany.	alireza.mirmohammadsadegh@rub.de			Ministry for Innovation, Science and Research of Nordrhein-Westfalen; Protein Research Unit Ruhr within Europe, PURE	Ministry for Innovation, Science and Research of Nordrhein-Westfalen; Protein Research Unit Ruhr within Europe, PURE	This work was funded by the Ministry for Innovation, Science and Research of Nordrhein-Westfalen, and by the Protein Research Unit Ruhr within Europe, PURE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Castedo M, 2002, CELL DEATH DIFFER, V9, P99, DOI 10.1038/sj/cdd/4400978; Chen YQ, 2007, J CELL SCI, V120, P4155, DOI 10.1242/jcs.011163; Dalby KN, 2010, AUTOPHAGY, V6, P322, DOI 10.4161/auto.6.3.11625; DALTON AJ, 1955, ANAT REC, V121, P281; DANFORTH HD, 1977, POULTRY SCI, V56, P926, DOI 10.3382/ps.0560926; Daugschies A, 1998, VET PARASITOL, V76, P163, DOI 10.1016/S0304-4017(97)00203-3; Duan WJ, 2011, BIOL PHARM BULL, V34, P47, DOI 10.1248/bpb.34.47; Ferguson HA, 2003, J BIOL CHEM, V278, P45793, DOI 10.1074/jbc.M307979200; Fuchs D, 2010, BIOCHEM BIOPH RES CO, V394, P1098, DOI 10.1016/j.bbrc.2010.03.138; Fuchs D, 2009, BIOCHEM BIOPH RES CO, V390, P743, DOI 10.1016/j.bbrc.2009.10.042; Ghosh D, 2011, J PROTEOME RES, V10, P4373, DOI 10.1021/pr2005617; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Huerta S, 2007, J SURG RES, V142, P184, DOI 10.1016/j.jss.2006.12.551; Ishiguro T, 2012, BIOCHEM BIOPH RES CO, V418, P199, DOI 10.1016/j.bbrc.2011.10.123; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kim MJ, 2011, J BIOL CHEM, V286, P12924, DOI 10.1074/jbc.M110.138958; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Koneri K, 2007, ANTICANCER RES, V27, P1453; Lee YJ, 2011, KOREAN J PHYSIOL PHA, V15, P1, DOI 10.4196/kjpp.2011.15.1.1; Li DD, 2009, ONCOGENE, V28, P886, DOI 10.1038/onc.2008.441; Moretti L, 2007, AUTOPHAGY, V3, P142, DOI 10.4161/auto.3607; Munafo DB, 2001, J CELL SCI, V114, P3619; Ndozangue-Touriguine O, 2008, ONCOGENE, V27, P6012, DOI 10.1038/onc.2008.197; Oak PS, 2012, INT J CANCER, V131, P2808, DOI 10.1002/ijc.27595; Riccioni R, 2010, BLOOD CELL MOL DIS, V45, P86, DOI 10.1016/j.bcmd.2010.03.008; Sato K, 2007, CANCER RES, V67, P9677, DOI 10.1158/0008-5472.CAN-07-1462; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Schneider M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-96; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Sun T, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-161; Takeda K, 2003, CELL STRUCT FUNCT, V28, P23; Tang QL, 2011, CANCER LETT, V311, P113, DOI 10.1016/j.canlet.2011.07.016; Temkin V, 2007, IMMUNOL REV, V220, P8, DOI 10.1111/j.1600-065X.2007.00560.x; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; White E, 2010, CURR OPIN CELL BIOL, V22, P212, DOI 10.1016/j.ceb.2009.12.008; Wong CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009996; Wu YT, 2008, AUTOPHAGY, V4, P457, DOI 10.4161/auto.5662; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103; Zhou FF, 2011, FEBS J, V278, P403, DOI 10.1111/j.1742-4658.2010.07965.x	45	72	77	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44132	10.1371/journal.pone.0044132	http://dx.doi.org/10.1371/journal.pone.0044132			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028492	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400019
J	Strier, KB; Ives, AR				Strier, Karen B.; Ives, Anthony R.			Unexpected Demography in the Recovery of an Endangered Primate Population	PLOS ONE			English	Article							MURIQUIS BRACHYTELES-HYPOXANTHUS; VIABILITY ANALYSIS; NATIONAL-PARK; VITAL-RATES; CONSERVATION; DYNAMICS; GROWTH; VARIABILITY; COMPONENTS; RESOURCE	Assessments of the status of endangered species have focused on population sizes, often without knowledge of demographic and behavioral processes underlying population recovery. We analyzed demographic data from a 28-year study of a critically endangered primate, the northern muriqui, to investigate possible changes in demographic rates as this population recovered from near extirpation. As the population increased from 60 to nearly 300 individuals, its growth rate declined due to increased mortality and male-biased birth sex ratios; the increased mortality was not uniform across ages and sexes, and there has been a recent increase in mortality of prime-aged males. If not for a concurrent increase in fertility rates, the population would have stabilized at 200 individuals instead of continuing to grow. The unexpected increase in fertility rates and in adult male mortality can be attributed to the muriquis' expansion of their habitat by spending more time on the ground. The demographic consequences of this behavioral shift must be incorporated into management tactics for this population and emphasize the importance of understanding demographic rates in the recovery of endangered species.	[Strier, Karen B.] Univ Wisconsin, Dept Anthropol, Madison, WI 53706 USA; [Ives, Anthony R.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Strier, KB (corresponding author), Univ Wisconsin, Dept Anthropol, Madison, WI 53706 USA.	kbstrier@wisc.edu	Ives, Anthony/A-5698-2008; Strier, Karen B./AAJ-3482-2020	Ives, Anthony/0000-0001-9375-9523; Strier, Karen/0000-0003-2520-9110	National Science Foundation [BNS 8305322, BCS 8619442, BCS 8958298, BCS 9414129, BCS 0621788, BCS 0921013, DEB-0816613]; National Geographic Society; Liz Claiborne and Art Ortenberg Foundation; Fulbright Foundation; Joseph Henry Fund of the National Academy of Sciences, World Wildlife Fund [213]; L.S.B. Leakey Foundation; Chicago Zoological Society; Lincoln Park Zoo Neotropic Fund; Margot Marsh Biodiversity Foundation; Conservation International; Graduate School of the University of Wisconsin-Madison; Division Of Behavioral and Cognitive Sci [0921013] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); Liz Claiborne and Art Ortenberg Foundation; Fulbright Foundation; Joseph Henry Fund of the National Academy of Sciences, World Wildlife Fund; L.S.B. Leakey Foundation; Chicago Zoological Society; Lincoln Park Zoo Neotropic Fund; Margot Marsh Biodiversity Foundation; Conservation International; Graduate School of the University of Wisconsin-Madison; Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	Financial support for the study was from the National Science Foundation (BNS 8305322, BCS 8619442, BCS 8958298, BCS 9414129, BCS 0621788, BCS 0921013, DEB-0816613), National Geographic Society, Liz Claiborne and Art Ortenberg Foundation, Fulbright Foundation, Sigma Xi Grants-in-Aid, Grant #213 from the Joseph Henry Fund of the National Academy of Sciences, World Wildlife Fund, L.S.B. Leakey Foundation, Chicago Zoological Society, Lincoln Park Zoo Neotropic Fund, Margot Marsh Biodiversity Foundation, Conservation International, the Graduate School of the University of Wisconsin-Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann J, 2005, BEHAV ECOL SOCIOBIOL, V57, P490, DOI 10.1007/s00265-004-0870-x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Boubli JP, 2011, ECOTROPICA, V17, P53; Campbell CJ, 2005, INT J PRIMATOL, V26, P1039, DOI 10.1007/s10764-005-6457-1; Caswell H, 1989, MATRIX POPULATION MO; Chapman CA, 2009, CAM S BIO EVOL ANTHR, V57, P463; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Chirakkal H, 2010, ECOL APPL, V20, P783, DOI 10.1890/09-0560.1; Coulson T, 2005, J ANIM ECOL, V74, P789, DOI 10.1111/j.1365-2656.2005.00975.x; Coulson T, 2001, TRENDS ECOL EVOL, V16, P219, DOI 10.1016/S0169-5347(01)02137-1; Cowlishaw G., 2000, PRIMATE CONSERVATION; Eberhardt LL, 2002, ECOLOGY, V83, P2841, DOI 10.2307/3072020; Erhart EM, 2008, AM J PHYS ANTHROPOL, V136, P183, DOI 10.1002/ajpa.20793; Flather CH, 2011, TRENDS ECOL EVOL, V26, P307, DOI 10.1016/j.tree.2011.03.001; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Gamelon M, 2011, EVOLUTION, V65, P3100, DOI 10.1111/j.1558-5646.2011.01366.x; Gelman A., 2007, DATA ANAL USING REGR; Gough KF, 2006, ORYX, V40, P434, DOI 10.1017/S0030605306001189; Isaac NJB, 2004, P ROY SOC B-BIOL SCI, V271, P1135, DOI 10.1098/rspb.2004.2724; Mendes Sergio L., 2005, Neotropical Primates, V13, P7; Mittermeier Russell A., 2009, Primate Conservation, V24, P1; Morris WF, 2011, AM NAT, V177, pE14, DOI 10.1086/657443; Mourthe IMC, 2007, AM J PRIMATOL, V69, P706, DOI 10.1002/ajp.20405; Nunn CL, 2006, INFECT DIS PRIMATES; package R, 2008, LME4 LIN MIX EFF MOD; Pusey AE, 2007, CONSERV BIOL, V21, P623, DOI 10.1111/j.1523-1739.2007.00704.x; *R DEV COR TEAM, 2008, R FDN STAT COMP VIEN; Reed TE, 2010, P ROY SOC B-BIOL SCI, V277, P3391, DOI 10.1098/rspb.2010.0771; Robbins MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019788; Rudran R, 2003, INT J PRIMATOL, V24, P925, DOI 10.1023/A:1026241625910; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Sibly RM, 2002, PHILOS T ROY SOC B, V357, P1149, DOI 10.1098/rstb.2002.1130; Silk JB, 2008, P ROY SOC B-BIOL SCI, V275, P1761, DOI 10.1098/rspb.2008.0340; Sinclair ARE, 2003, PHILOS T R SOC B, V358, P1729, DOI 10.1098/rstb.2003.1359; STRAM DO, 1994, BIOMETRICS, V50, P1171, DOI 10.2307/2533455; Strier Karen B., 2006, Primate Conservation, V20, P53, DOI 10.1896/0898-6207.20.1.53; Strier KB, 2006, AM J PHYS ANTHROPOL, V130, P227, DOI 10.1002/ajpa.20366; Strier Karen B., 2012, P125; Strier KB, 2010, METHODS ECOL EVOL, V1, P199, DOI 10.1111/j.2041-210X.2010.00023.x; Strier KB, 2000, ANIM BEHAV, V59, P849, DOI 10.1006/anbe.1999.1387; Struhsaker TT, 2008, INT J PRIMATOL, V29, P19, DOI 10.1007/s10764-007-9146-4; Tabacow FP, 2009, AM ANTHROPOL, V111, P238, DOI 10.1111/j.1548-1433.2009.01116.x; Tabacow Fernando P., 2009, Neotropical Primates, V16, P67; VALLE CMC, 1984, PRIMATOLOGIA BRASIL, P271	44	18	18	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e44407	10.1371/journal.pone.0044407	http://dx.doi.org/10.1371/journal.pone.0044407			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	019MC	23028534	Green Submitted, Green Published, gold			2022-12-27	WOS:000309742800010
J	Negroni, J; Meunier, N; Monnerie, R; Salesse, R; Baly, C; Caillol, M; Congar, P				Negroni, Julia; Meunier, Nicolas; Monnerie, Regine; Salesse, Roland; Baly, Christine; Caillol, Monique; Congar, Patrice			Neuropeptide Y Enhances Olfactory Mucosa Responses to Odorant in Hungry Rats	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; INCREASES FOOD-INTAKE; YY1 RECEPTOR; PEPTIDE-YY; IMMUNOHISTOCHEMICAL LOCALIZATION; NUTRITIONAL-STATUS; SENSORY NEURONS; PRECURSOR CELLS; XENOPUS-LAEVIS; SWEET TASTE	Neuropeptide Y (NPY) plays an important role in regulating appetite and hunger in vertebrates. In the hypothalamus, NPY stimulates food intake under the control of the nutritional status. Previous studies have shown the presence of NPY and receptors in rodent olfactory system, and suggested a neuroproliferative role. Interestingly, NPY was also shown to directly modulate olfactory responses evoked by a food-related odorant in hungry axolotls. We have recently demonstrated that another nutritional cue, insulin, modulates the odorant responses of the rat olfactory mucosa (OM). Therefore, the aim of the present study was to investigate the potential effect of NPY on rat OM responses to odorants, in relation to the animal's nutritional state. We measured the potential NPY modulation of OM responses to odorant, using electro-olfactogram (EOG) recordings, in fed and fasted adult rats. NPY application significantly and transiently increased EOG amplitudes in fasted but not in fed rats. The effects of specific NPY-receptor agonists were similarly quantified, showing that NPY operated mainly through Y1 receptors. These receptors appeared as heterogeneously expressed by olfactory neurons in the OM, and western blot analysis showed that they were overexpressed in fasted rats. These data provide the first evidence that NPY modulates the initial events of odorant detection in the rat OM. Because this modulation depends on the nutritional status of the animal, and is ascribed to NPY, the most potent orexigenic peptide in the central nervous system, it evidences a strong supplementary physiological link between olfaction and nutritional processes.	[Negroni, Julia; Meunier, Nicolas; Monnerie, Regine; Salesse, Roland; Baly, Christine; Caillol, Monique; Congar, Patrice] INRA, Neurobiol Olfact & Modelisat & Imagerie UR1197, Jouy En Josas, France; [Negroni, Julia; Meunier, Nicolas; Monnerie, Regine; Salesse, Roland; Baly, Christine; Caillol, Monique; Congar, Patrice] NeuroSud Paris, IFR144, Gif Sur Yvette, France; [Meunier, Nicolas] Univ Versailles, F-78000 Versailles, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Negroni, J (corresponding author), INRA, Neurobiol Olfact & Modelisat & Imagerie UR1197, Jouy En Josas, France.	patrice.congar@jouy.inra.fr		Baly, Christine/0000-0002-8966-9522	Institut National de la Recherche Agronomique (INRA); INRA	Institut National de la Recherche Agronomique (INRA); INRA	This work was funded by the Institut National de la Recherche Agronomique (INRA). JN was supported by a post-doctoral grant from the INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aime P, 2007, BEHAV BRAIN RES, V179, P258, DOI 10.1016/j.bbr.2007.02.012; ALLEN YS, 1983, SCIENCE, V221, P877, DOI 10.1126/science.6136091; Apelbaum AF, 2005, REGUL PEPTIDES, V129, P49, DOI 10.1016/j.regpep.2005.01.003; Apelbaum AF, 2003, CHEM SENSES, V28, P389, DOI 10.1093/chemse/28.5.389; Baly C, 2007, BRAIN RES, V1129, P130, DOI 10.1016/j.brainres.2006.10.030; Breunig E, 2010, J NEUROSCI, V30, P8965, DOI 10.1523/JNEUROSCI.4030-09.2010; Cabrele C, 2000, J PEPT SCI, V6, P97, DOI 10.1002/(SICI)1099-1387(200003)6:3<97::AID-PSC236>3.0.CO;2-E; Cabrele C, 2000, J BIOL CHEM, V275, P36043, DOI 10.1074/jbc.M000626200; Caillol M, 2003, BRAIN RES, V960, P48, DOI 10.1016/S0006-8993(02)03755-1; CHAPUT M, 1976, CHEM SENS FLAV, V2, P189, DOI 10.1093/chemse/2.2.189; Chen H, 2009, OBESITY, V17, P1356, DOI 10.1038/oby.2009.56; Crespi EJ, 2004, J NEUROENDOCRINOL, V16, P279, DOI 10.1111/j.0953-8194.2004.01168.x; Czesnik D, 2007, P NATL ACAD SCI US; DANGER JM, 1990, FUNDAM CLIN PHARM, V4, P307, DOI 10.1111/j.1472-8206.1990.tb00497.x; Doyle KL, 2008, J NEUROCHEM, V105, P641, DOI 10.1111/j.1471-4159.2007.05188.x; Doyle KL, 2012, J NEUROSCI RES, V90, P1126, DOI 10.1002/jnr.23008; DUCLAUX R, 1973, PHYSIOL BEHAV, V10, P1029, DOI 10.1016/0031-9384(73)90184-4; Eckard CP, 2001, MOLECULES, V6, P448, DOI 10.3390/60500448; Edwards CMB, 1999, J ENDOCRINOL, V160, pR7, DOI 10.1677/joe.0.160R007; Eva C, 2006, FRONT NEUROENDOCRIN, V27, P308, DOI 10.1016/j.yfrne.2006.07.002; Fadool DA, 2000, J NEUROPHYSIOL, V83, P2332, DOI 10.1152/jn.2000.83.4.2332; Gehlert DR, 1999, NEUROPEPTIDES, V33, P329, DOI 10.1054/npep.1999.0057; Getchell TV, 2006, PSYSL BEHAV; Gicquiaux H, 2002, J BIOL CHEM, V277, P6645, DOI 10.1074/jbc.M107224200; Grove KL, 2003, MOL BRAIN RES, V113, P133, DOI 10.1016/S0169-328X(03)00093-7; Hansel DE, 2001, J NEUROSCI RES, V66, P1, DOI 10.1002/jnr.1191; Hansel DE, 2001, NATURE, V410, P940, DOI 10.1038/35073601; Hardy AB, 2005, ENDOCRINOLOGY, V146, P4042, DOI 10.1210/en.2005-0020; Holliday ND, 2005, MOL PHARMACOL, V67, P655, DOI 10.1124/mol.104.006114; Holliday ND, 2003, BRIT J PHARMACOL, V139, P501, DOI 10.1038/sj.bjp.0705276; Howell OW, 2005, J NEUROCHEM, V93, P560, DOI 10.1111/j.1471-4159.2005.03057.x; Howell OW, 2003, J NEUROCHEM, V86, P646, DOI 10.1046/j.1471-4159.2003.01895.x; INUI A, 1991, AM J PHYSIOL, V261, pR588, DOI 10.1152/ajpregu.1991.261.3.R588; Jia CH, 2012, MOL CELL NEUROSCI, V49, P158, DOI 10.1016/j.mcn.2011.11.004; Jia CH, 2010, NEUROBIOL DIS, V38, P405, DOI 10.1016/j.nbd.2010.02.013; Julliard AK, 2007, BEHAV BRAIN RES, V183, P123, DOI 10.1016/j.bbr.2007.05.033; Jyotaki M, 2010, ENDOCR J, V57, P467, DOI 10.1507/endocrj.K10E-095; Kalra SP, 2004, NEUROPEPTIDES, V38, P201, DOI 10.1016/j.npep.2004.06.003; Kanekar S, 2009, J NEUROSCI RES, V87, P1424, DOI 10.1002/jnr.21954; Kopp J, 2002, NEUROSCIENCE, V111, P443, DOI 10.1016/S0306-4522(01)00463-8; Lacroix MC, 2008, J NEUROENDOCRINOL, V20, P1176, DOI 10.1111/j.1365-2826.2008.01777.x; Lindner D, 2008, NUTRITION, V24, P907, DOI 10.1016/j.nut.2008.06.025; Mao YK, 1996, AM J PHYSIOL-GASTR L, V271, pG36, DOI 10.1152/ajpgi.1996.271.1.G36; MCDONALD JK, 1988, CRIT REV NEUROBIOL, V4, P97; Michel MC, 1998, PHARMACOL REV, V50, P143; Migita K, 2001, BRAIN RES, V889, P23, DOI 10.1016/S0006-8993(00)03092-4; Montani G, 2006, EUR J NEUROSCI, V24, P20, DOI 10.1111/j.1460-9568.2006.04878.x; MORLEY JE, 1987, AM J PHYSIOL, V253, pR516, DOI 10.1152/ajpregu.1987.253.3.R516; MORLEY JE, 1987, AM J PHYSIOL, V252, pR599, DOI 10.1152/ajpregu.1987.252.3.R599; Mousley A, 2006, J NEUROSCI, V26, P7707, DOI 10.1523/JNEUROSCI.1977-06.2006; Nassel DR, 2011, PEPTIDES, V32, P1335, DOI 10.1016/j.peptides.2011.03.013; Naveilhan P, 1998, NEUROSCIENCE, V87, P289, DOI 10.1016/S0306-4522(98)00141-9; Niki M, 2010, RESULTS PROBL CELL D, V52, P101, DOI 10.1007/978-3-642-14426-4_9; PAGER J, 1972, PHYSIOL BEHAV, V9, P573, DOI 10.1016/0031-9384(72)90014-5; POLAK JM, 1984, PEPTIDES, V5, P79, DOI 10.1016/0196-9781(84)90267-5; Prud'homme MJ, 2009, NEUROSCIENCE, V162, P1287, DOI 10.1016/j.neuroscience.2009.05.043; Reuter D, 1998, J NEUROSCI, V18, P6623; Rolls ET, 2005, PHYSIOL BEHAV, V85, P45, DOI 10.1016/j.physbeh.2005.04.012; Savigner A, 2009, J NEUROPHYSIOL, V101, P2898, DOI 10.1152/jn.91169.2008; Scott JW, 1999, CHEM SENSES, V24, P679, DOI 10.1093/chemse/24.6.679; Scott JW, 2002, MICROSC RES TECHNIQ, V58, P152, DOI 10.1002/jemt.10133; SHEIKH SP, 1990, J BIOL CHEM, V265, P8304; Silva AP, 2002, CLIN CHIM ACTA, V326, P3, DOI 10.1016/S0009-8981(02)00301-7; Soll RM, 2001, EUR J BIOCHEM, V268, P2828, DOI 10.1046/j.1432-1327.2001.02161.x; Stanic D, 2006, J COMP NEUROL, V499, P357, DOI 10.1002/cne.21046; STANLEY BG, 1985, P NATL ACAD SCI USA, V82, P3940, DOI 10.1073/pnas.82.11.3940; Thorsell A, 2002, NEUROPEPTIDES, V36, P182, DOI 10.1054/npep.2002.0897; Tong J, 2011, J NEUROSCI, V31, P5841, DOI 10.1523/JNEUROSCI.5680-10.2011; UBINK R, 1994, NEUROSCIENCE, V60, P709, DOI 10.1016/0306-4522(94)90499-5; Volkoff H, 2005, GEN COMP ENDOCR, V142, P3, DOI 10.1016/j.ygcen.2004.11.001; Wolak ML, 2003, J COMP NEUROL, V464, P285, DOI 10.1002/cne.10823; Xu B, 1998, REGUL PEPTIDES, V75-6, P391, DOI 10.1016/S0167-0115(98)00093-7	72	29	29	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45266	10.1371/journal.pone.0045266	http://dx.doi.org/10.1371/journal.pone.0045266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024812	Green Submitted, gold, Green Published			2022-12-27	WOS:000308860100070
J	Fonseca, MJ; Santos, CL; Costa, P; Lencastre, L; Tavares, F				Fonseca, Maria Joao; Santos, Catarina L.; Costa, Patricio; Lencastre, Leonor; Tavares, Fernando			Increasing Awareness about Antibiotic Use and Resistance: A Hands-On Project for High School Students	PLOS ONE			English	Article							BACTERIAL-RESISTANCE; PRACTICAL WORK; KNOWLEDGE; ATTITUDES; SCIENCE; MICROBES; BELIEFS; IMPACT; FLU	Background: Health-promoting education is essential to foster an informed society able to make decisions about socio-scientific issues based on scientifically sustained criteria. Antibiotic resistance is currently a major public health issue. Considering that irrational antibiotic use has been associated with the development and widespread of antibiotic resistant bacteria, educational interventions to promote prudent antibiotic consumption are required. Methodology/Principal Findings: This study focuses on the outcomes of an interventional program implemented at the University of Porto, Portugal, to promote awareness about antibiotic resistance at high school levels (15-17 year old). The project Microbiology recipes: antibiotics a la carte articulates a set of wet and dry lab activities designed to promote the participants' understanding of concepts and processes underlying antibiotics' production and activity, such as the notion of mechanisms of action of antibiotics. Following a mix-method approach based on a pre-/post design, the effectiveness of this project was assessed by gathering data from surveys, direct observation and analysis of artifacts of 42 high school students (aged 15 and 16 years). The results indicate that the participants developed a more comprehensive picture of antibiotic resistance. The project was shown to promote more sophisticated conceptualizations of bacteria and antibiotics, increased awareness about the perils of antibiotic resistance, and enhanced consciousness towards measures that can be undertaken to mitigate the problem. The participants regarded their experiences as enjoyable and useful, and believed that the project contributed to improve their understanding and raise their interest about the issues discussed. Furthermore, there were also improvements in their procedural skills concerning the laboratory techniques performed. Conclusions/Significance: This study evidences the possibility of increasing high school students' awareness about the consequences of antibiotic resistance and the importance of judicious antibiotic use. The findings inform about the educational benefits of incorporating hands-on activities in science education programs.	[Fonseca, Maria Joao; Tavares, Fernando] Univ Porto, Fac Ciencias, Dept Biol, P-4100 Oporto, Portugal; [Fonseca, Maria Joao; Santos, Catarina L.] Univ Porto, IBMC, P-4100 Oporto, Portugal; [Fonseca, Maria Joao; Tavares, Fernando] Univ Porto, CIBIO Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal; [Costa, Patricio; Lencastre, Leonor] Univ Porto, Fac Psicol Ciencias Educ, Vairao, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto	Fonseca, MJ (corresponding author), Univ Porto, Fac Ciencias, Dept Biol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	mjfonseca@ibmc.up.pt	Tavares, Fernando/C-3375-2013; lencastre, leonor/K-4044-2013; Costa, Patrício/A-3072-2013	Tavares, Fernando/0000-0001-9913-1155; lencastre, leonor/0000-0002-8648-3191; Costa, Patrício/0000-0002-1201-9177; Fonseca, Maria Joao/0000-0002-5138-875X; Lopes dos Santos, Catarina/0000-0002-4273-1077	Fundacao para a Ciencia e Tecnologia (FCT, Portugal) [PTDC/AGR-PRO/111857/2009]; FCT [SFRH/BD/37389/2007, SFRH/BPD/62978/2009]	Fundacao para a Ciencia e Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by a research grant (PTDC/AGR-PRO/111857/2009) from Fundacao para a Ciencia e Tecnologia (FCT, Portugal). MJF and CLS are supported by the FCT fellowships SFRH/BD/37389/2007 and SFRH/BPD/62978/2009, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbo L, 2011, INFECT CONT HOSP EP, V32, P714, DOI 10.1086/660761; Abrahams I., 2011, PRACTICAL WORK SECON; Abrahams I, 2009, INT J SCI EDUC, V31, P2335, DOI 10.1080/09500690802342836; Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009; Bandiera M, 2007, CONTRIBUTIONS FROM SCIENCE EDUCATION RESEARCH, P213, DOI 10.1007/978-1-4020-5032-9_16; Belongia EA, 2005, EMERG INFECT DIS, V11, P912; Braund M, 2006, CURRIC J, V17, P213, DOI 10.1080/09585170600909662; Brookes-Howell L, 2011, J GEN INTERN MED, P1; Buke C, 2005, J INFECTION, V51, P135, DOI 10.1016/j.jinf.2004.12.001; Byrne J, 2011, INT J SCI EDUC, V33, P1927, DOI 10.1080/09500693.2010.536999; Cebotarenco N, 2008, HEALTH EDUC RES, V23, P146, DOI 10.1093/her/cym008; Coenen S, 2009, J ANTIMICROB CHEMOTH, V64, P200, DOI 10.1093/jac/dkp135; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cohen L., 2011, RES METHODS ED; Crowe A, 2008, CBE-LIFE SCI EDUC, V7, P368, DOI 10.1187/cbe.08-05-0024; Davey P, 2002, CLIN MICROBIOL INFEC, V8, P43, DOI 10.1046/j.1469-0691.8.s.2.6.x; de Sande-Bruinsma NV, 2008, EMERG INFECT DIS, V14, P1722, DOI 10.3201/eid1411.070467; Dernain AL, 2006, J IND MICROBIOL BIOT, V33, P486, DOI 10.1007/s10295-005-0076-x; Direccao Geral da Inovacao e de Desenvolvimento Curricular, 2004, PROGR BIOL 12 AN CUR; Direccao Geral de Inovacao e de Desenvolvimento Curricular, 2001, PROGR BIOL GEOL 10 1; Direccao Geral de Inovacao e de Desenvolvimento Curricular, 2003, PROGR BIOL GEOL 11 1; Finkelstein JA, 2008, PEDIATRICS, V121, pE15, DOI 10.1542/peds.2007-0819; Fonseca MJ, 2011, AM BIOL TEACH, V73, P342, DOI 10.1525/abt.2011.73.6.7; Goodwin C.J., 2009, RES PSYCHOL METHODS; Gravetter F. J., 2009, RES METHODS BEHAV SC; Grigoryan L, 2007, PHARMACOEPIDEM DR S, V16, P1234, DOI 10.1002/pds.1479; Hawkey PM, 1998, BRIT MED J, V317, P657, DOI 10.1136/bmj.317.7159.657; Hill T, 2006, STAT METHODS APPL CO; Hofstein A, 2004, SCI EDUC, V88, P28, DOI 10.1002/sce.10106; Huttner B, 2010, LANCET INFECT DIS, V10, P17, DOI 10.1016/S1473-3099(09)70305-6; Jayaraman R, 2009, CURR SCI INDIA, V96, P1475; Jones MG, 2008, SCHOOL SCI MATH, V108, P263, DOI 10.1111/j.1949-8594.2008.tb17836.x; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Knox K.L., 2003, J SCI EDUC TECHNOL, V12, P471, DOI DOI 10.1023/B:JOST.0000006306.97336.C5; Krapp A, 2011, INT J SCI EDUC, V33, P27, DOI 10.1080/09500693.2010.518645; Krippendorff K, 2018, CONTENT ANAL INTRO I; Krist AC, 2007, AM BIOL TEACH, V69, P94, DOI 10.1662/0002-7685(2007)69[94:EEOARI]2.0.CO;2; Lecky DM, 2010, J ANTIMICROB CHEMOTH, V65, P2674, DOI 10.1093/jac/dkq356; Longtin S, 2004, J BIOL EDUC, V39, P32, DOI 10.1080/00219266.2004.9655952; Lord T., 2007, J COLL SCI TEACH, V37, P40; Markowitz DG, 2004, J SCI EDUC TECHNOL, V13, P395, DOI DOI 10.1023/B:JOST.0000045467.67907.7b; McNulty CAM, 2007, J ANTIMICROB CHEMOTH, V60, pI63, DOI 10.1093/jac/dkm161; McNulty CAM, 2007, J ANTIMICROB CHEMOTH, V59, P727, DOI 10.1093/jac/dkl558; Milandri M, 2004, PEDIATR INFECT DIS J, V23, P1077, DOI 10.1097/01.inf.0000145756.58944.f9; Molstad S, 2008, LANCET INFECT DIS, V8, P125, DOI 10.1016/S1473-3099(08)70017-3; Moore B, 2009, CRITICAL THINKING FO; National Research Council (NRC), 1996, NAT SCI ED STAND; Oppenheim A. N., 1992, QUESTIONNAIRE DESIGN; Orzech KM, 2008, ANNU REV ANTHROPOL, V37, P267, DOI 10.1146/annurev.anthro.37.081407.085205; Packer J., 2004, Annals of Leisure Research, V7, P54; Peker D, 2009, RES SCI EDUC, P1; Rudduck J, 2007, IMPROV LEARN TLRP, P1; Sabuncu E, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000084; Saleem M, 2010, NAT PROD REP, V27, P238, DOI 10.1039/b916096e; Schunk DH, 2012, HANDBOOK OF RESEARCH ON STUDENT ENGAGEMENT, P219, DOI 10.1007/978-1-4614-2018-7_10; Simonneaux L, 2000, INT J SCI EDUC, V22, P619, DOI 10.1080/095006900289705; Tibell LAE, 2010, CBE-LIFE SCI EDUC, V9, P25, DOI 10.1187/cbe.08-09-0055; Toplis R, 2011, RES SCI EDUC, P1; Wassmer GT, 2006, AM BIOL TEACH, V68, P476, DOI 10.1662/0002-7685(2006)68[476:WFYA]2.0.CO;2; Weber R.P., 1990, BASIC CONTENT ANAL, V2nd ed., DOI 10.4135/9781412983488; Weil D. K., 2004, CRITICAL THINKING LE; Wellington J, 2005, SCI TECHNOL EDUC LIB, V29, P99; Who (World Health Organization), 2000, WHO ANN REP INF DIS	63	15	15	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44699	10.1371/journal.pone.0044699	http://dx.doi.org/10.1371/journal.pone.0044699			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005GJ	22984544	Green Published, Green Submitted, gold			2022-12-27	WOS:000308738500075
J	Liu, SJ; Chougule, NP; Vijayendran, D; Bonning, BC				Liu, Sijun; Chougule, Nanasaheb P.; Vijayendran, Diveena; Bonning, Bryony C.			Deep Sequencing of the Transcriptomes of Soybean Aphid and Associated Endosymbionts	PLOS ONE			English	Article							PEA APHID; ACYRTHOSIPHON-PISUM; WOLBACHIA INFECTIONS; HEMIPTERA APHIDIDAE; HORIZONTAL TRANSFER; GENE-EXPRESSION; GENOME; BUCHNERA; SYMBIONT; IDENTIFICATION	Background: The soybean aphid has significantly impacted soybean production in the U. S. Transcriptomic analyses were conducted for further insight into leads for potential novel management strategies. Methodology/Principal Findings: Transcriptomic data were generated from whole aphids and from 2,000 aphid guts using an Illumina GAII sequencer. The sequence data were assembled de novo using the Velvet assembler. In addition to providing a general overview, we demonstrate (i) the use of the Multiple-k/Multiple-C method for de novo assembly of short read sequences, followed by BLAST annotation of contigs for increased transcript identification: From 400,000 contigs analyzed, 16,257 non-redundant BLAST hits were identified; (ii) analysis of species distributions of top non-redundant hits: 80% of BLAST hits (minimum e-value of 1.0-E3) were to the pea aphid or other aphid species, representing about half of the pea aphid genes; (iii) comparison of relative depth of sequence coverage to relative transcript abundance for genes with high (membrane alanyl aminopeptidase N) or low transcript abundance; (iv) analysis of the Buchnera transcriptome: Transcripts from 57.6% of the genes from Buchnera aphidicola were identified; (v) identification of Arsenophonus and Wolbachia as potential secondary endosymbionts; (vi) alignment of full length sequences from RNA-seq data for the putative salivary gland protein C002, the silencing of which has potential for aphid management, and the putative Bacillus thuringiensis Cry toxin receptors, aminopeptidase N and alkaline phosphatase. Conclusions/Significance: This study provides the most comprehensive data set to date for soybean aphid gene expression: This work also illustrates the utility of short-read transcriptome sequencing and the Multiple-k/Multiple-C method followed by BLAST annotation for rapid identification of target genes for organisms for which reference genome sequences are not available, and extends the utility to include the transcriptomes of endosymbionts.	[Liu, Sijun; Chougule, Nanasaheb P.; Vijayendran, Diveena; Bonning, Bryony C.] Iowa State Univ, Dept Entomol, Ames, IA 50011 USA	Iowa State University	Liu, SJ (corresponding author), Iowa State Univ, Dept Entomol, Ames, IA 50011 USA.	bbonning@iastate.edu	Chougule, Nanasaheb/D-6485-2013		Iowa State University Center for Integrated Animal Genomics	Iowa State University Center for Integrated Animal Genomics	Funding for this project was provided by the Iowa State University Center for Integrated Animal Genomics http://www.ciag.iastate.edu/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Augustinos AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028695; Bai XD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011370; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Blackman R.L., 2000, J ECON ENTOMOL, V2; Brisson JA, 2010, INSECT MOL BIOL, V19, P63, DOI 10.1111/j.1365-2583.2009.00935.x; Burke GR, 2011, INSECT MOL BIOL, V20, P357, DOI 10.1111/j.1365-2583.2011.01070.x; Charles H, 1999, MOL BIOL EVOL, V16, P1820, DOI 10.1093/oxfordjournals.molbev.a026096; Christiaens O, 2010, INSECT MOL BIOL, V19, P187, DOI 10.1111/j.1365-2583.2009.00957.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cortes T, 2010, INSECT MOL BIOL, V19, P123, DOI 10.1111/j.1365-2583.2009.00931.x; Cristofoletti PT, 2006, FEBS J, V273, P5574, DOI 10.1111/j.1742-4658.2006.05547.x; Dale RP, 2010, INSECT MOL BIOL, V19, P141, DOI 10.1111/j.1365-2583.2009.00975.x; Doudoumis V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S3; Fenn K, 2006, PLOS PATHOG, V2, P887, DOI 10.1371/journal.ppat.0020094; Gauthier JP, 2007, BIOINFORMATICS, V23, P783, DOI 10.1093/bioinformatics/btl682; Gelbart WM, 1999, NUCLEIC ACIDS RES, V27, P85, DOI 10.1093/nar/27.1.85; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; Gil R, 2002, P NATL ACAD SCI USA, V99, P4454, DOI 10.1073/pnas.062067299; Godfray HCJ, 2010, INSECT MOL BIOL, V19, P1, DOI 10.1111/j.1365-2583.2009.00980.x; Gomez-Valero L, 2004, J BACTERIOL, V186, P6626, DOI 10.1128/JB.186.19.6626-6633.2004; Hansen AK, 2011, P NATL ACAD SCI USA, V108, P2849, DOI 10.1073/pnas.1013465108; Hill CB, 2010, J ECON ENTOMOL, V103, P509, DOI 10.1603/EC09179; Hill CB, 2009, CROP SCI, V49, P1193, DOI 10.2135/cropsci2008.09.0561; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Jamnongluk W, 2002, CURR MICROBIOL, V45, P255, DOI 10.1007/s00284-002-3746-1; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Jones RT, 2011, APPL ENVIRON MICROB, V77, P8345, DOI 10.1128/AEM.05974-11; Kanost M.R., 2005, P247; Kim C. S., 2008, Agricultural and Resource Economics Review, V37, P227; Kim KS, 2008, CROP SCI, V48, P923, DOI 10.2135/cropsci2007.08.0447; Kondo N, 2002, P NATL ACAD SCI USA, V99, P14280, DOI 10.1073/pnas.222228199; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Li HR, 2011, J INVERTEBR PATHOL, V107, P69, DOI 10.1016/j.jip.2011.02.001; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lo N, 2007, INT J SYST EVOL MICR, V57, P654, DOI 10.1099/ijs.0.64515-0; McCornack BP, 2004, J ECON ENTOMOL, V97, P854, DOI 10.1603/0022-0493(2004)097[0854:DOSAHA]2.0.CO;2; McNulty SN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011029; Michel AP, 2009, ENVIRON ENTOMOL, V38, P1301, DOI 10.1603/022.038.0442; MILES PW, 1989, APHIDS THEIR BIOL NA, VC, P23; Moran NA, 2005, APPL ENVIRON MICROB, V71, P3302, DOI 10.1128/AEM.71.6.3302-3310.2005; Mutti NS, 2008, P NATL ACAD SCI USA, V105, P9965, DOI 10.1073/pnas.0708958105; Mutti NS, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.3801; Nakabachi A, 2010, INSECT MOL BIOL, V19, P175, DOI 10.1111/j.1365-2583.2009.00985.x; Ollivier M, 2010, INSECT MOL BIOL, V19, P33, DOI 10.1111/j.1365-2583.2009.00976.x; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Price DRG, 2010, INSECT MOL BIOL, V19, P97, DOI 10.1111/j.1365-2583.2009.00918.x; Ragsdale DW, 2007, J ECON ENTOMOL, V100, P1258, DOI 10.1603/0022-0493(2007)100[1258:ETFSAH]2.0.CO;2; Ragsdale DW, 2004, ANN ENTOMOL SOC AM, V97, P204, DOI 10.1603/0013-8746(2004)097[0204:SABINA]2.0.CO;2; Ramsey JS, 2010, INSECT MOL BIOL, V19, P241, DOI 10.1111/j.1365-2583.2009.00945.x; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Rider SD, 2010, INSECT MOL BIOL, V19, P201, DOI 10.1111/j.1365-2583.2009.00972.x; Russell JA, 2005, APPL ENVIRON MICROB, V71, P7987, DOI 10.1128/AEM.71.12.7987-7994.2005; Russell JA, 2003, MOL ECOL, V12, P1061, DOI 10.1046/j.1365-294X.2003.01780.x; Sakurai M, 2005, APPL ENVIRON MICROB, V71, P4069, DOI 10.1128/AEM.71.7.4069-4075.2005; Shigenobu S, 2010, INSECT MOL BIOL, V19, P47, DOI 10.1111/j.1365-2583.2009.00944.x; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Soberon M, 2009, CELL MOL LIFE SCI, V66, P1337, DOI 10.1007/s00018-008-8330-9; Srinivasan DG, 2010, INSECT MOL BIOL, V19, P229, DOI 10.1111/j.1365-2583.2009.00960.x; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Sylvester E.S., 1989, World Crop Pests, V2C, P65; Tagu D, 2010, CR BIOL, V333, P464, DOI 10.1016/j.crvi.2010.03.006; Tamborindeguy C, 2010, INSECT MOL BIOL, V19, P259, DOI 10.1111/j.1365-2583.2009.00956.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vinuelas J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-143; Wang RY, 2006, PLANT DIS, V90, P920, DOI 10.1094/PD-90-0920; Wang Z, 2009, EUR J ENTOMOL, V106, P49, DOI 10.14411/eje.2009.007; Wille BD, 2009, ENVIRON ENTOMOL, V38, P110, DOI 10.1603/022.038.0113; Wilson ACC, 2010, INSECT MOL BIOL, V19, P249, DOI 10.1111/j.1365-2583.2009.00942.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	71	35	43	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45161	10.1371/journal.pone.0045161	http://dx.doi.org/10.1371/journal.pone.0045161			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984624	Green Published, Green Submitted, gold			2022-12-27	WOS:000308738500122
J	Mahiane, GS; Ouifki, R; Brand, H; Delva, W; Welte, A				Mahiane, Guy Severin; Ouifki, Rachid; Brand, Hilmarie; Delva, Wim; Welte, Alex			A General HIV Incidence Inference Scheme Based on Likelihood of Individual Level Data and a Population Renewal Equation	PLOS ONE			English	Article							AGE-SPECIFIC PREVALENCE; INCIDENCE RATES; INFECTION; SEROPREVALENCE; WOMEN	We derive a new method to estimate the age specific incidence of an infection with a differential mortality, using individual level infection status data from successive surveys. The method consists of a) an SI-type model to express the incidence rate in terms of the prevalence and its derivatives as well as the difference in mortality rate, and b) a maximum likelihood approach to estimate the prevalence and its derivatives. Estimates can in principle be obtained for any chosen age and time, and no particular assumptions are made about the epidemiological or demographic context. This is in contrast with earlier methods for estimating incidence from prevalence data, which work with aggregated data, and the aggregated effect of demographic and epidemiological rates over the time interval between prevalence surveys. Numerical simulation of HIV epidemics, under the presumption of known excess mortality due to infection, shows improved control of bias and variance, compared to previous methods. Our analysis motivates for a) effort to be applied to obtain accurate estimates of excess mortality rates as a function of age and time among HIV infected individuals and b) use of individual level rather than aggregated data in order to estimate HIV incidence rates at times between two prevalence surveys.	[Mahiane, Guy Severin; Ouifki, Rachid; Brand, Hilmarie; Delva, Wim; Welte, Alex] Univ Stellenbosch, S African Ctr Epidemiol Modelling & Anal, ZA-7600 Stellenbosch, South Africa; [Delva, Wim] Univ Ghent, Int Ctr Reprod Hlth, B-9000 Ghent, Belgium	National Research Foundation - South Africa; Stellenbosch University; Ghent University	Mahiane, GS (corresponding author), Univ Stellenbosch, S African Ctr Epidemiol Modelling & Anal, ZA-7600 Stellenbosch, South Africa.	sgmahiane@sun.ac.za	Ouifki, Rachid/A-4064-2017	Ouifki, Rachid/0000-0001-7697-1792; Delva, Wim/0000-0001-8054-1904	Institut National de la Sante et de la Recherche Medicale (INSERM, France); Canadian International Development Agency (CIDA, Canada)	Institut National de la Sante et de la Recherche Medicale (INSERM, France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Canadian International Development Agency (CIDA, Canada)	This research was supported by Institut National de la Sante et de la Recherche Medicale (INSERM, France) and the Canadian International Development Agency (CIDA, Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES AE, 1994, STAT MED, V13, P1881, DOI 10.1002/sim.4780131809; ADES AE, 1995, J ACQ IMMUN DEF SYND, V9, P490; [Anonymous], STAT COMMUN INFECT D; Artzrouni M, 2002, AIDS, V16, pW1; Balasubramanian R, 2010, BIOMETRICS, V66, P1, DOI 10.1111/j.1541-0420.2009.01242.x; BATTER V, 1994, AIDS, V8, P811, DOI 10.1097/00002030-199406000-00014; Bhattacharya M, 2010, INDIAN J PUBLIC HLTH, V52, P21; BROOKMEYER R, 1995, AM J EPIDEMIOL, V141, P166, DOI 10.1093/oxfordjournals.aje.a117404; Brunet RC, 1999, THEOR POPUL BIOL, V56, P76, DOI 10.1006/tpbi.1999.1415; Brunet RC, 1996, THEOR POPUL BIOL, V50, P209, DOI 10.1006/tpbi.1996.0029; Busch MP, 2010, AIDS, V24, P2763, DOI 10.1097/QAD.0b013e32833f1142; Gregson S, 1996, AIDS, V10, P1689, DOI 10.1097/00002030-199612000-00014; Hallett TB, 2008, PLOS MED, V5, P611, DOI 10.1371/journal.pmed.0050080; Hallett TB, 2011, CURR OPIN HIV AIDS, V6, P102, DOI 10.1097/COH.0b013e328343bfdb; Hallett TB, 2010, AIDS, V24, P147, DOI 10.1097/QAD.0b013e32833062dc; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Kaplan EH, 1999, OPER RES, V47, P29, DOI 10.1287/opre.47.1.29; Karita E, 2007, AIDS, V21, P403, DOI 10.1097/QAD.0b013e32801481b7; Kassanjee R, 2012, EPIDEMIOLOGY, V23, P721, DOI 10.1097/EDE.0b013e3182576c07; KEIDING N, 1991, J R STAT SOC A STAT, V154, P371, DOI 10.2307/2983150; Lopman B, 2010, J EPIDEMIOL COMMUN H, V64, P330, DOI 10.1136/jech.2008.081554; Lopman BA, 2006, PLOS MED, V3, P1273, DOI 10.1371/journal.pmed.0030312; McDougal JS, 2006, AIDS RES HUM RETROV, V22, P945, DOI 10.1089/aid.2006.22.945; McWalter TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007368; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; PODGOR MJ, 1986, STAT MED, V5, P573, DOI 10.1002/sim.4780050604; R Development Core Team, 2007, R LANG ENV STAT COMP; Rehle TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011094; Sakarovitch C, 2007, JAIDS-J ACQ IMM DEF, V45, P115, DOI 10.1097/QAI.0b013e318050d277; Sakarovitch C, 2007, STAT MED, V26, P320, DOI 10.1002/sim.2540; Welte A, 2010, EURO SURVEILL, V15, p[pii, 19589]; White RG, 2007, EPIDEMIOL INFECT, V135, P922, DOI 10.1017/S0950268806007680; Williams B, 2001, STAT MED, V20, P2003, DOI 10.1002/sim.840	34	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44377	10.1371/journal.pone.0044377	http://dx.doi.org/10.1371/journal.pone.0044377			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984497	Green Published, Green Submitted, gold			2022-12-27	WOS:000308738500050
J	Oberley-Deegan, RE; Steffan, JJ; Rove, KO; Pate, KM; Weaver, MW; Spasojevic, I; Frederick, B; Raben, D; Meacham, RB; Crapo, JD; Koul, HK				Oberley-Deegan, Rebecca E.; Steffan, Joshua J.; Rove, Kyle O.; Pate, Kathryn M.; Weaver, Michael W.; Spasojevic, Ivan; Frederick, Barbara; Raben, David; Meacham, Randall B.; Crapo, James D.; Koul, Hari K.			The Antioxidant, MnTE-2-PyP, Prevents Side-Effects Incurred by Prostate Cancer Irradiation	PLOS ONE			English	Article							CATALYTIC ANTIOXIDANT; RAT MODEL; RADIATION; INJURY; RADIOTHERAPY; PORPHYRINS; PROTECTS; GROWTH; DAMAGE; CELLS	Prostate cancer is the most commonly diagnosed cancer, with an estimated 240,000 new cases reported annually in the United States. Due to early detection and advances in therapies, more than 90% of patients will survive 10 years post diagnosis and treatment. Radiation is a treatment option often used to treat localized disease; however, while radiation is very effective at killing tumor cells, normal tissues are damaged as well. Potential side-effects due to prostate cancer-related radiation therapy include bowel inflammation, erectile dysfunction, urethral stricture, rectal bleeding and incontinence. Currently, radiation therapy for prostate cancer does not include the administration of therapeutic agents to reduce these side effects and protect normal tissues from radiation-induced damage. In the current study, we show that the small molecular weight antioxidant, MnTE-2-PyP, protects normal tissues from radiation-induced damage in the lower abdomen in rats. Specifically, MnTE-2-PyP protected skin, prostate, and testes from radiation-induced damage. MnTE-2-PyP also protected from erectile dysfunction, a persistent problem regardless of the type of radiation techniques used because the penile neurovascular bundles lay in the peripheral zones of the prostate, where most prostate cancers reside. Based on previous studies showing that MnTE-2-PyP, in combination with radiation, further reduces subcutaneous tumor growth, we believe that MnTE-2-PyP represents an excellent radioprotectant in combination radiotherapy for cancer in general and specifically for prostate cancer.	[Oberley-Deegan, Rebecca E.; Pate, Kathryn M.; Weaver, Michael W.; Crapo, James D.] Natl Jewish Hlth, Dept Med, Div Pulm, Denver, CO USA; [Steffan, Joshua J.; Rove, Kyle O.; Meacham, Randall B.; Koul, Hari K.] Univ Colorado, Sch Med, Dept Surg, Program Urosci,Div Urol, Aurora, CO USA; [Steffan, Joshua J.; Koul, Hari K.] Denver Vet Adm Med Ctr, Denver, CO USA; [Spasojevic, Ivan] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Spasojevic, Ivan] Duke Canc Inst, PD PD Bioanalyt Core Lab, Durham, NC USA; [Frederick, Barbara; Raben, David] Univ Colorado, Hlth Sci Ctr, Dept Canc Biol, Radiat & Canc Biol Div, Aurora, CO USA; [Koul, Hari K.] Univ Colorado, Ctr Comprehens Canc, Aurora, CO USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Duke University; Duke University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Oberley-Deegan, RE (corresponding author), Natl Jewish Hlth, Dept Med, Div Pulm, Denver, CO USA.	Hari.Koul@ucdenver.edu			Department of Defense Award United States Army Medical Research and Materiel CommandUSAMRMC [07355003]; University of Colorado Academic Enrichment Funds	Department of Defense Award United States Army Medical Research and Materiel CommandUSAMRMC; University of Colorado Academic Enrichment Funds	This work was supported in part by the Department of Defense Award United States Army Medical Research and Materiel CommandUSAMRMC proposal #07355003 (JC) and through University of Colorado Academic Enrichment Funds (HK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batinic-Haberle I, 1998, J BIOL CHEM, V273, P24521, DOI 10.1074/jbc.273.38.24521; Batinic-Haberle I, 2011, FREE RADICAL BIO MED, V51, P1035, DOI 10.1016/j.freeradbiomed.2011.04.046; Batinic-Haberle I, 2010, ANTIOXID REDOX SIGN, V13, P877, DOI 10.1089/ars.2009.2876; Cooperberg MR, 2010, J CLIN ONCOL, V28, P1117, DOI 10.1200/JCO.2009.26.0133; Dall'Era JE, 2008, INT J IMPOT RES, V20, P307, DOI 10.1038/ijir.2008.1; Day BJ, 1995, J PHARMACOL EXP THER, V275, P1227; Day BJ, 1999, FREE RADICAL BIO MED, V26, P730, DOI 10.1016/S0891-5849(98)00261-5; Day BJ, 1997, ARCH BIOCHEM BIOPHYS, V347, P256, DOI 10.1006/abbi.1997.0341; Elliott SP, 2011, WORLD J UROL, V29, P35, DOI 10.1007/s00345-010-0603-x; Ferrer-Sueta G, 2003, J BIOL CHEM, V278, P27432, DOI 10.1074/jbc.M213302200; Gauter-Fleckenstein B, 2010, FREE RADICAL BIO MED, V48, P1034, DOI 10.1016/j.freeradbiomed.2010.01.020; Gridley DS, 2007, ANTICANCER RES, V27, P3101; Hall EJ, 2006, RADIOBIOLOGY RADIOLO, V6th; Hei TK, 2008, J PHARM PHARMACOL, V60, P943, DOI 10.1211/jpp.60.8.0001; Katz A, 2007, CANCER NURS, V30, P302, DOI 10.1097/01.NCC.0000281726.87490.f2; Kimura M, 2012, J SEX MED; Kimura M, 2011, J SEX MED, V8, P2215, DOI 10.1111/j.1743-6109.2011.02351.x; Mao XW, 2009, CURR EYE RES, V34, P62, DOI 10.1080/02713680802546948; Merlin SL, 2001, INT J IMPOT RES, V13, P104, DOI 10.1038/sj.ijir.3900652; Oberley-Deegan RE, 2009, AM J RESP CELL MOL, V41, P170, DOI 10.1165/rcmb.2008-0138OC; Oury TD, 2001, AM J RESP CELL MOL, V25, P164, DOI 10.1165/ajrcmb.25.2.4235; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Spasojevic I, 2008, FREE RADICAL BIO MED, V45, P943, DOI 10.1016/j.freeradbiomed.2008.05.015; Sullivan L, 2009, RADIOTHER ONCOL, V91, P232, DOI 10.1016/j.radonc.2008.11.013; Tse HM, 2004, FREE RADICAL BIO MED, V36, P233, DOI 10.1016/j.freeradbiomed.2003.10.029; van der Wielen GJ, 2009, J SEX MED, V6, P1908, DOI 10.1111/j.1743-6109.2009.01272.x; Vujaskovic Z, 2002, FREE RADICAL BIO MED, V33, P857, DOI 10.1016/S0891-5849(02)00980-2; Zhao W, 2007, BRIT J RADIOL, V80, pS23, DOI 10.1259/bjr/18237646	28	38	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44178	10.1371/journal.pone.0044178	http://dx.doi.org/10.1371/journal.pone.0044178			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984473	Green Submitted, Green Published, gold			2022-12-27	WOS:000308738500035
J	Wang, K; Zhao, XH; Kuang, CY; Qian, DH; Wang, H; Jiang, H; Deng, MY; Huang, L				Wang, Kui; Zhao, Xiaohui; Kuang, Chunyan; Qian, Dehui; Wang, Hang; Jiang, Hong; Deng, Mengyang; Huang, Lan			Overexpression of SDF-1 alpha Enhanced Migration and Engraftment of Cardiac Stem Cells and Reduced Infarcted Size via CXCR4/PI3K Pathway	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; MYOCARDIAL-INFARCTION; PHOSPHOINOSITIDE 3-KINASE; SIGNAL-TRANSDUCTION; HEART; ACTIVATION; REGENERATION; RECEPTORS; THERAPY; KINASES	Cardiac stem cells (CSCs) can home to the infarcted area and regenerate myocardium. Stromal cell-derived factor-1 alpha/C-X-C chemokine receptor type 4 (SDF-1 alpha/CXCR4) axis is pivotal in inducing CSCs migration. However, the mechanisms remain unclear. This study set out to detect if SDF-1 alpha promotes migration and engraftment of CSCs through the CXCR4/PI3K (phosphatidylinositol 3-kinase) pathway. In the in vitro experiment, c-kit+ cells were isolated from neonatal mouse heart fragment culture by magnetic cell sorting. Fluorescence-activated cell sorting results demonstrated that a few c-kit+ cells expressed CD45 (4.54%) and Sca-1 (2.58%), the hematopoietic stem cell marker. Conditioned culture could induce c-kit+ cells multipotent differentiation, which was confirmed by cardiac troponin I (cTn-I), alpha-smooth muscle actin (alpha-SMA), and von Willebrand factor (vWF) staining. In vitro chemotaxis assays were performed using Transwell cell chambers to detect CSCs migration. The results showed that the cardiomyocytes infected with rAAV1-SDF-1 alpha-eGFP significantly increased SDF-1 alpha concentration, 5-fold more in supernatant than that in the control group, and subsequently attracted more CSCs migration. This effect was diminished by administration of AMD3100 (10 mg/ml, CXCR4 antagonist) or LY294002 (20 mmol/L, PI3K inhibitor). In myocardial infarction mice, overexpression of SDF-1 alpha in the infarcted area by rAAV1-SDF-1 alpha-eGFP infection resulted in more CSCs retention to the infarcted myocardium, a higher percentage of proliferation, and reduced infarcted area which was attenuated by AMD3100 or ly294002 pretreatment. These results indicated that overexpression of SDF-1 alpha enhanced CSCs migration in vitro and engraftment of transplanted CSCs and reduced infarcted size via CXCR4/PI3K pathway.	[Wang, Kui; Zhao, Xiaohui; Kuang, Chunyan; Qian, Dehui; Wang, Hang; Jiang, Hong; Deng, Mengyang; Huang, Lan] Third Mil Med Univ, Xinqiao Hosp, PLA, Inst Cardiovasc Dis, Chongqing, Peoples R China	Army Medical University	Wang, K (corresponding author), Third Mil Med Univ, Xinqiao Hosp, PLA, Inst Cardiovasc Dis, Chongqing, Peoples R China.	zxhwn2002@yahoo.com.cn		Huang, Lan/0000-0001-9594-4722	National Natural Science Foundation of China [30800480]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Grant from National Natural Science Foundation of China (30800480, http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Alsayed Y, 2007, BLOOD, V109, P2708, DOI 10.1182/blood-2006-07-035857; Andino LM, 2008, J GENE MED, V10, P132, DOI 10.1002/jgm.1131; Barile L, 2007, PROG CARDIOVASC DIS, V50, P31, DOI 10.1016/j.pcad.2007.03.005; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Carr CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025669; Downward J, 1998, SCIENCE, V279, P673, DOI 10.1126/science.279.5351.673; Ellison GM, 2011, J AM COLL CARDIOL, V58, P977, DOI 10.1016/j.jacc.2011.05.013; Fischer KM, 2011, CIRC RES, V108, P960, DOI 10.1161/CIRCRESAHA.110.237156; Frati C, 2011, CURR PHARM DESIGN, V17, P3252; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; Guo HD, 2011, TISSUE ENG PT A, V17, P45, DOI [10.1089/ten.tea.2010.0124, 10.1089/ten.TEA.2010.0124]; Hillyer P, 2003, CLIN EXP IMMUNOL, V134, P431, DOI 10.1111/j.1365-2249.2003.02323.x; Huang PH, 2010, ARTERIOSCL THROM VAS, V30, P869, DOI 10.1161/ATVBAHA.109.200618; Koninckx R, 2011, CELL MOL LIFE SCI, V68, P2141, DOI 10.1007/s00018-010-0560-y; Kuang D, 2008, BASIC RES CARDIOL, V103, P265, DOI 10.1007/s00395-007-0690-z; Li M, 2008, CIRC RES, V102, P677, DOI 10.1161/CIRCRESAHA.107.161737; Li QH, 2011, BASIC RES CARDIOL, V106, P849, DOI 10.1007/s00395-011-0180-1; Ma J, 2005, BASIC RES CARDIOL, V100, P217, DOI 10.1007/s00395-005-0521-z; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Miyamoto S, 2010, STEM CELLS DEV, V19, P105, DOI 10.1089/scd.2009.0041; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Sotsios Y, 1999, J IMMUNOL, V163, P5954; Takamiya M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025265; Tang JM, 2011, CARDIOVASC RES, V91, P402, DOI 10.1093/cvr/cvr053; Tang JM, 2009, EXP CELL RES, V315, P3521, DOI 10.1016/j.yexcr.2009.09.026; Tang XL, 2010, CIRCULATION, V121, P293, DOI 10.1161/CIRCULATIONAHA.109.871905; Tang YL, 2007, BIOCHEM BIOPH RES CO, V359, P877, DOI 10.1016/j.bbrc.2007.05.216; Theiss HD, 2011, STEM CELL RES, V7, P244, DOI 10.1016/j.scr.2011.05.003; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030503; Yu J, 2010, J CARDIOVASC PHARM, V55, P496, DOI 10.1097/FJC.0b013e3181d7a384; Zakharova L, 2010, CARDIOVASC RES, V87, P40, DOI 10.1093/cvr/cvq027; Zhao XH, 2008, MICROVASC RES, V75, P45, DOI 10.1016/j.mvr.2007.02.009; Zheng H, 2007, J CARDIOVASC PHARM, V50, P274, DOI 10.1097/FJC.0b013e318093ec8f; Zheng H, 2010, J CELL PHYSIOL, V223, P757, DOI 10.1002/jcp.22086	40	37	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43922	10.1371/journal.pone.0043922	http://dx.doi.org/10.1371/journal.pone.0043922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984452	Green Published, gold, Green Submitted			2022-12-27	WOS:000308638700033
J	Kekkonen, J; Wikstrom, M; Brommer, JE				Kekkonen, Jaana; Wikstrom, Mikael; Brommer, Jon E.			Heterozygosity in an Isolated Population of a Large Mammal Founded by Four Individuals Is Predicted by an Individual-Based Genetic Model	PLOS ONE			English	Article							WHITE-TAILED DEER; DIVERSITY; BOVINE; SIZE; DNA; MICROSATELLITES; MARKERS; CONSEQUENCES; BOTTLENECKS	Background: Within-population genetic diversity is expected to be dramatically reduced if a population is founded by a low number of individuals. Three females and one male white-tailed deer Odocoileus virginianus, a North American species, were successfully introduced in Finland in 1934 and the population has since been growing rapidly, but remained in complete isolation from other populations. Methodology/Principal Findings: Based on 14 microsatellite loci, the expected heterozygosity H was 0.692 with a mean allelic richness (AR) of 5.36, which was significantly lower than what was found in Oklahoma, U. S. A. (H = 0.742; AR = 9.07), demonstrating that a bottleneck occurred. Observed H was in line with predictions from an individual-based model where the genealogy of the males and females in the population were tracked and the population's demography was included. Conclusion: Our findings provide a rare within-population empirical test of the founder effect and suggest that founding a population by a small number of individuals need not have a dramatic impact on heterozygosity in an iteroparous species.	[Kekkonen, Jaana; Brommer, Jon E.] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Brommer, Jon E.] Novia Univ Appl Sci, ARONIA Coastal Zone Res Team, Ekenas, Finland; [Brommer, Jon E.] Abo Akad Univ, Ekenas, Finland	University of Helsinki; Novia University of Applied Sciences; Abo Akademi University	Brommer, JE (corresponding author), Univ Helsinki, Dept Biosci, Helsinki, Finland.	jon.brommer@helsinki.fi	Brommer, Jon E/C-3613-2008	Brommer, Jon E/0000-0002-2435-2612	Oskar Oflund Stiftelse, Societas pro Fauna et Flora Fennica; Ella and Georg Ehrnrooth Foundation; Academy of Finland [1131390]	Oskar Oflund Stiftelse, Societas pro Fauna et Flora Fennica; Ella and Georg Ehrnrooth Foundation; Academy of Finland(Academy of Finland)	Funding was provided by Oskar Oflund Stiftelse, Societas pro Fauna et Flora Fennica, The Ella and Georg Ehrnrooth Foundation and the Academy of Finland (1131390). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F.W., 1986, P57; Amos W, 2001, HEREDITY, V87, P257, DOI 10.1046/j.1365-2540.2001.00940.x; Anderson JD, 2002, J WILDLIFE MANAGE, V66, P67, DOI 10.2307/3802872; BANCROFT DR, 1995, PHILOS T R SOC B, V347, P263, DOI 10.1098/rstb.1995.0026; BISHOP MD, 1994, GENETICS, V136, P619; BREZINSKY L, 1993, ANIM GENET, V24, P75, DOI 10.1111/j.1365-2052.1993.tb00936.x; Buchanan F. C., 1993, Animal Genetics, V24, P145, DOI 10.1111/j.1365-2052.1993.tb00269.x; Carrol S.P, 2008, CONSERVATION BIOL EV; Comer CE, 2005, J WILDLIFE MANAGE, V69, P332, DOI 10.2193/0022-541X(2005)069&lt;0332:FGSASO&gt;2.0.CO;2; Cornuet JM, 1996, GENETICS, V144, P2001; DEWOODY JA, 1995, J HERED, V86, P317, DOI 10.1093/oxfordjournals.jhered.a111593; DeYoung RW, 2003, MOL ECOL, V12, P3237, DOI 10.1046/j.1365-294X.2003.01996.x; Dunham Jason, 1999, Conservation Ecology, V3, pUnpaginated; Elphinstone MS, 2003, MOL ECOL NOTES, V3, P317, DOI 10.1046/j.1471-8286.2003.00397.x; England PR, 2003, CONSERV GENET, V4, P595, DOI 10.1023/A:1025639811865; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falconer D. S., 1996, INTRO QUANTITATIVE G; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Franklin I.R., 1980, CONSERVATION BIOL EV; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hailer F, 2006, BIOL LETTERS, V2, P316, DOI 10.1098/rsbl.2006.0453; Halls LK, 1984, WHITE TAILED DEER; Harris RB, 2002, WILDLIFE SOC B, V30, P634; Hartl DL, 2006, PRINCIPLES POPULATIO; Hedrick PW, 2000, GENETICS POPULATIONS; JOHNSON DL, 1977, GENETICS, V87, P581; Jones KC, 2000, CALIF FISH GAME, V86, P115; Kaeuffer R, 2007, P ROY SOC B-BIOL SCI, V274, P527, DOI 10.1098/rspb.2006.3743; Kekkonen J, 2011, BIOL CONSERV, V144, P2931, DOI 10.1016/j.biocon.2011.08.012; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Lippe C, 2006, MOL ECOL, V15, P1769, DOI 10.1111/j.1365-294X.2006.02902.x; Masters RE, 2012, ECOLOGY MANAGEMENT D; McCullough D.R., 1979, GEORGE RESERVE DEER; Miller BF, 2010, J MAMMAL, V91, P681, DOI 10.1644/09-MAMM-A-258.1; MOORE SS, 1992, ANIM GENET, V23, P463, DOI 10.1111/j.1365-2052.1992.tb02168.x; MOORE SS, 1994, MAMM GENOME, V5, P84, DOI 10.1007/BF00292333; MOTRO U, 1982, EVOLUTION, V36, P1059, DOI 10.1111/j.1558-5646.1982.tb05474.x; NELSON ME, 1993, J MAMMAL, V74, P316, DOI 10.2307/1382386; Nygren K.F.A., 1984, P561; Ortego J, 2007, BIOL LETTERS, V3, P585, DOI 10.1098/rsbl.2007.0268; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pemberton JM, 1996, PHILOS T R SOC B, V351, P745, DOI 10.1098/rstb.1996.0069; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RYMAN N, 1981, OIKOS, V36, P257, DOI 10.2307/3544622; STEFFEN P, 1993, ANIM GENET, V24, P121, DOI 10.1111/j.1365-2052.1993.tb00252.x; Topping C, 2003, ANN ZOOL FENN, V40, P255; VAIMAN D, 1992, ANIM GENET, V23, P537, DOI 10.1111/j.1365-2052.1992.tb00175.x	49	27	27	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e43482	10.1371/journal.pone.0043482	http://dx.doi.org/10.1371/journal.pone.0043482			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028456	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388900002
J	Hereward, JP; Walter, GH				Hereward, James P.; Walter, Gimme H.			Molecular Interrogation of the Feeding Behaviour of Field Captured Individual Insects for Interpretation of Multiple Host Plant Use	PLOS ONE			English	Article							PHYTOPHAGOUS INSECTS; BIOLOGICAL-CONTROL; DNA; HEMIPTERA; PCR; PREDATORS; HERBIVORE; MIRIDAE; CHOICE	The way in which herbivorous insect individuals use multiple host species is difficult to quantify under field conditions, but critical to understanding the evolutionary processes underpinning insect-host plant relationships. In this study we developed a novel approach to understanding the host plant interactions of the green mirid, Creontiades dilutus, a highly motile heteropteran bug that has been associated with many plant species. We combine quantified sampling of the insect across its various host plant species within particular sites and a molecular comparison between the insects' gut contents and available host plants. This approach allows inferences to be made as to the plants fed upon by individual insects in the field. Quantified sampling shows that this "generalist" species is consistently more abundant on two species in the genus Cullen (Fabaceae), its primary host species, than on any other of its numerous listed hosts. The chloroplast intergenic sequences reveal that C. dilutus frequently feeds on plants additional to the one from which it was collected, even when individuals were sampled from the primary host species. These data may be reconciled by viewing multiple host use in this species as an adaptation to survive spatiotemporally ephemeral habitats. The methodological framework developed here provides a basis from which new insights into the feeding behaviour and host plant relationships of herbivorous insects can be derived, which will benefit not only ecological interpretation but also our understanding of the evolution of these relationships.	[Hereward, James P.; Walter, Gimme H.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Hereward, James P.] Australian Cotton Res Inst, Cotton Catchment Communities Cooperat Res Ctr, Narrabri, NSW, Australia	University of Queensland	Hereward, JP (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.	j.hereward@uq.edu.au	Hereward, James P/K-8720-2012; Walter, Gimme/AAC-3635-2019	Hereward, James P/0000-0002-6468-6342; Walter, Gimme/0000-0003-1025-7101	Cotton Research and Development Corporation; Cotton Cathcment Communities Co-operative Research Centre, Australia; Cotton Catchment Communities CRC	Cotton Research and Development Corporation(Cotton R&D Corp); Cotton Cathcment Communities Co-operative Research Centre, Australia; Cotton Catchment Communities CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This project was funded through a Phd stipend awarded to JPH by the Cotton Research and Development Corporation and the Cotton Cathcment Communities Co-operative Research Centre, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JPH received funding from the Cotton Research and Development Corporation, and the Cotton Catchment Communities CRC. This PhD funding was for research on the ecology of a cotton pest insect, and has no bearing on the results and interpretation presented. This also does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borer M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-310; Chinajariyawong A, 1988, SAP SUCKING BUGS ATT; Colebatch G, 2001, INSECT BIOCHEM MOLEC, V31, P415, DOI 10.1016/S0965-1748(00)00136-3; DOYLE JJ, 1987, TAXON, V36, P715, DOI 10.2307/1221122; DRUMMOND AJ, 2010, GENEIOUS V 5 0; Feder JL, 2003, P NATL ACAD SCI USA, V100, P10314, DOI 10.1073/pnas.1730757100; Fournier V, 2008, OECOLOGIA, V157, P629, DOI 10.1007/s00442-008-1095-x; Gariepy TD, 2007, J APPL ENTOMOL, V131, P225, DOI 10.1111/j.1439-0418.2007.01145.x; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hoogendoorn M, 2001, MOL ECOL, V10, P2059, DOI 10.1046/j.1365-294X.2001.01316.x; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; JERMY T, 1984, AM NAT, V124, P609, DOI 10.1086/284302; Jurado-Rivera JA, 2009, P ROY SOC B-BIOL SCI, V276, P639, DOI 10.1098/rspb.2008.1264; Khan MH, 1999, ASPECTS BIOL ECOLOGY; Malausa T, 2007, MOL ECOL, V16, P4210, DOI 10.1111/j.1365-294X.2007.03457.x; Malipatil MB, 1997, AUST J ENTOMOL, V36, P1, DOI 10.1111/j.1440-6055.1997.tb01422.x; Manners AG, 2011, BIOL CONTROL, V58, P262, DOI 10.1016/j.biocontrol.2011.05.013; Manners AG, 2009, ARTHROPOD-PLANT INTE, V3, P87, DOI 10.1007/s11829-009-9059-6; Matsubayashi KW, 2010, ENTOMOL EXP APPL, V134, P1, DOI 10.1111/j.1570-7458.2009.00916.x; McColl SA, 2011, AUST J ENTOMOL, V50, P107, DOI 10.1111/j.1440-6055.2010.00800.x; Miles MM, 1996, IDENTIFICATION PEST; Miles P.W., 1972, Advances Insect Physiol, V9, P183, DOI 10.1016/S0065-2806(08)60277-5; Morton SR, 2011, J ARID ENVIRON, V75, P313, DOI 10.1016/j.jaridenv.2010.11.001; Mulatu B, 2004, OIKOS, V107, P231, DOI 10.1111/j.0030-1299.2004.13157.x; Navarro SP, 2010, ECOL ENTOMOL, V35, P18, DOI 10.1111/j.1365-2311.2009.01145.x; Northam WT, 2012, SCI TOTAL ENVIRON, V416, P225, DOI 10.1016/j.scitotenv.2011.11.083; Pettengill JB, 2010, AM J BOT, V97, P1391, DOI 10.3732/ajb.0900176; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Scheirs J, 2000, P ROY SOC B-BIOL SCI, V267, P2065, DOI 10.1098/rspb.2000.1250; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Threlfall C., 2005, AUSTR COTTONGROWER, V26, P55; Traugott M, 2012, B ENTOMOL RES, V102, P239, DOI 10.1017/S0007485311000551; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; VELASCO LRI, 1993, ENVIRON ENTOMOL, V22, P326, DOI 10.1093/ee/22.2.326; WALTER GH, 1994, AUST J ECOL, V19, P458, DOI 10.1111/j.1442-9993.1994.tb00512.x; Walter GH, 2003, INSECT PEST MANAGEME; Yoccoz NG, 2012, MOL ECOL, V21, P2031, DOI 10.1111/j.1365-294X.2012.05505.x; Zalucki Myron P., 2005, Insect Science, V12, P45, DOI 10.1111/j.1672-9609.2005.00007.x	40	30	32	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44435	10.1371/journal.pone.0044435	http://dx.doi.org/10.1371/journal.pone.0044435			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028538	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400025
J	Meng, J; Merino, LM; Shamlo, NB; Makeig, S; Robbins, K; Huang, YF				Meng, Jia; Merino, Lenis Mauricio; Shamlo, Nima Bigdely; Makeig, Scott; Robbins, Kay; Huang, Yufei			Characterization and Robust Classification of EEG Signal from Image RSVP Events with Independent Time-Frequency Features	PLOS ONE			English	Article							DYNAMICS	This paper considers the problem of automatic characterization and detection of target images in a rapid serial visual presentation (RSVP) task based on EEG data. A novel method that aims to identify single-trial event-related potentials (ERPs) in time-frequency is proposed, and a robust classifier with feature clustering is developed to better utilize the correlated ERP features. The method is applied to EEG recordings of a RSVP experiment with multiple sessions and subjects. The results show that the target image events are mainly characterized by 3 distinct patterns in the time-frequency domain, i.e., a theta band (4.3 Hz) power boosting 300-700 ms after the target image onset, an alpha band (12 Hz) power boosting 500-1000 ms after the stimulus onset, and a delta band (2 Hz) power boosting after 500 ms. The most discriminant time-frequency features are power boosting and are relatively consistent among multiple sessions and subjects. Since the original discriminant time-frequency features are highly correlated, we constructed the uncorrelated features using hierarchical clustering for better classification of target and non-target images. With feature clustering, performance (area under ROC) improved from 0.85 to 0.89 on within-session tests, and from 0.76 to 0.84 on cross-subject tests. The constructed uncorrelated features were more robust than the original discriminant features and corresponded to a number of local regions on the time-frequency plane.	[Merino, Lenis Mauricio; Huang, Yufei] Univ Texas San Antonio, Dept Elect & Comp Engn, San Antonio, TX 78249 USA; [Meng, Jia] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Meng, Jia] Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Shamlo, Nima Bigdely; Makeig, Scott] Univ Calif San Diego, Inst Neural Computat, Swartz Ctr Computat Neurosci, La Jolla, CA 92093 USA; [Robbins, Kay] Univ Texas San Antonio, Dept Comp Sci, San Antonio, TX USA; [Huang, Yufei] Univ Texas Hlth Sci Ctr San Antonio, Dept Biostat, San Antonio, TX 78229 USA	University of Texas System; University of Texas at San Antonio (UTSA); Massachusetts Institute of Technology (MIT); Northwell Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California San Diego; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas Health San Antonio	Huang, YF (corresponding author), Univ Texas San Antonio, Dept Elect & Comp Engn, San Antonio, TX 78249 USA.	yufei.huang@utsa.edu	Huang, Yufei/AAU-2891-2021	Meng, Jia/0000-0003-3455-205X	Army Research Laboratory Cognition; Neuroergononics Collaborative Technology Alliance Initiative	Army Research Laboratory Cognition; Neuroergononics Collaborative Technology Alliance Initiative	This work was supported by the Army Research Laboratory Cognition and Neuroergononics Collaborative Technology Alliance Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigdely-Shamlo N, 2008, IEEE T NEUR SYS REH, V16, P432, DOI 10.1109/TNSRE.2008.2003381; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; ERIKSEN CW, 1969, J EXP PSYCHOL, V79, P1, DOI 10.1037/h0026873; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Hild Kenneth E.  II, 2009, 2009 43rd Asilomar Conference on Signals, Systems and Computers, P51, DOI 10.1109/ACSSC.2009.5470175; Kirmizi-Alsan E, 2006, BRAIN RES, V1104, P114, DOI 10.1016/j.brainres.2006.03.010; Kisley MA, 2006, CLIN NEUROPHYSIOL, V117, P2549, DOI 10.1016/j.clinph.2006.08.003; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Niedermeyer E., 2011, NIEDERMEYERS ELECTRO, V6; Ozuysal M, 2010, IEEE T PATTERN ANAL, V32, P448, DOI 10.1109/TPAMI.2009.23; Ozuysal M., 2007, 2007 IEEE C COMP VIS, P1; Park MY, 2007, BIOSTATISTICS, V8, P212, DOI 10.1093/biostatistics/kxl002; Sajda P, SINGLE TRIAL ANAL EE; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; Tolosi L, 2011, BIOINFORMATICS, V27, P1986, DOI 10.1093/bioinformatics/btr300; Wolpaw JR, 2000, IEEE T REHABIL ENG, V8, P164, DOI 10.1109/TRE.2000.847807	18	14	14	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44464	10.1371/journal.pone.0044464	http://dx.doi.org/10.1371/journal.pone.0044464			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028544	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900026
J	Oliver, JD; Kaye, SJ; Tuckwell, D; Johns, AE; Macdonald, DA; Livermore, J; Warn, PA; Birch, M; Bromley, MJ				Oliver, Jason D.; Kaye, Sarah J.; Tuckwell, Danny; Johns, Anna E.; Macdonald, Darel A.; Livermore, Joanne; Warn, Peter A.; Birch, Mike; Bromley, Michael J.			The Aspergillus fumigatus Dihydroxyacid Dehydratase Ilv3A/IlvC Is Required for Full Virulence	PLOS ONE			English	Article							AMINO-ACID BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; FUNGAL-INFECTIONS; IN-VIVO; NIDULANS; METABOLISM; INHIBITORS; SURVIVAL; SYNTHASE; MUTANTS	Dihydroxyacid dehydratase (DHAD) is a key enzyme in the branched-chain amino acid biosynthetic pathway that exists in a variety of organisms, including fungi, plants and bacteria, but not humans. In this study we identified four putative DHAD genes from the filamentous fungus Aspergillus fumigatus by homology to Saccharomyces cerevisiae ILV3. Two of these genes, AFUA_2G14210 and AFUA_1G03550, initially designated AfIlv3A and AfIlv3B for this study, clustered in the same group as S. cerevisiae ILV3 following phylogenetic analysis. To investigate the functions of these genes, AfIlv3A and AfIlv3B were knocked out in A. fumigatus. Deletion of AfIlv3B gave no apparent phenotype whereas the Delta ilv3A strain required supplementation with isoleucine and valine for growth. Thus, AfIlv3A is required for branched-chain amino acid synthesis in A. fumigatus. A recombinant AfIlv3A protein derived from AFUA_2G14210 was shown to have DHAD activity in an in vitro assay, confirming that AfIlv3A is a DHAD. In addition we show that mutants lacking AfIlv3A and ilv3B exhibit reduced levels of virulence in murine infection models, emphasising the importance of branched-chain amino acid biosynthesis in fungal infections, and hence the potential of targeting this pathway with antifungal agents. Here we propose that AfIlv3A/AFUA_2G2410 be named ilvC.	[Johns, Anna E.; Macdonald, Darel A.; Livermore, Joanne; Warn, Peter A.; Bromley, Michael J.] Univ Manchester, Sch Translat Med, Manchester, Lancs, England; [Oliver, Jason D.; Kaye, Sarah J.; Tuckwell, Danny; Birch, Mike] F2G Ltd, Manchester, Lancs, England	University of Manchester	Bromley, MJ (corresponding author), Univ Manchester, Sch Translat Med, Manchester, Lancs, England.	mike.bromley@manchester.ac.uk		Bromley, Michael/0000-0002-7611-0201	F2G Limited	F2G Limited	The authors have read the journal's policy and have the following conflicts: Jason D. Oliver and Mike Birch are current employees and Sarah J. Kaye, Danny Tuckwell, and Michael J. Bromley are former employees of F2G Limited. Michael Bromley currently has a PhD student funded in part by F2G Limited. Peter Warn acts as a consultant to F2G Limited. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	ARMSTRONG FB, 1977, BIOCHIM BIOPHYS ACTA, V498, P282, DOI 10.1016/0304-4165(77)90266-5; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; Denning DW, 2010, TRENDS MICROBIOL, V18, P195, DOI 10.1016/j.tim.2010.02.004; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ferreira MED, 2006, EUKARYOT CELL, V5, P207, DOI 10.1128/EC.5.1.207-211.2006; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; FLINT DH, 1993, J BIOL CHEM, V268, P14732; FLINT DH, 1988, J BIOL CHEM, V263, P3558; FLINT DH, 1993, BIOORG CHEM, V21, P367, DOI 10.1006/bioo.1993.1031; Grandoni JA, 1998, J ANTIMICROB CHEMOTH, V42, P475, DOI 10.1093/jac/42.4.475; Hof H, 2008, MYCOSES, V51, P1, DOI 10.1111/j.1439-0507.2008.01522.x; KAKAR SN, 1964, GENETICS, V49, P213; KANAMORI M, 1963, J BIOL CHEM, V238, P998; Kim S, 2006, J BIOCHEM, V139, P591, DOI 10.1093/jb/mvj057; Kingsbury JM, 2004, MICROBIOL-SGM, V150, P1547, DOI 10.1099/mic.0.26928-0; Kingsbury JM, 2006, EUKARYOT CELL, V5, P816, DOI 10.1128/EC.5.5.816-824.2006; Kingsbury JM, 2010, MICROBIOL-SGM, V156, P929, DOI 10.1099/mic.0.034348-0; KIRITANI K, 1966, J BIOL CHEM, V241, P2042; Kohlhaw GB, 2003, MICROBIOL MOL BIOL R, V67, P1, DOI 10.1128/MMBR.67.1.1-15.2003; LIMBERG G, 1995, BIOORGAN MED CHEM, V3, P487, DOI 10.1016/0968-0896(95)00072-O; Mabey JE, 2004, NUCLEIC ACIDS RES, V32, pD401, DOI 10.1093/nar/gkh009; McCourt JA, 2006, AMINO ACIDS, V31, P173, DOI 10.1007/s00726-005-0297-3; MYERS JW, 1961, J BIOL CHEM, V236, P1414; OSMANI SA, 1987, J CELL BIOL, V104, P1495, DOI 10.1083/jcb.104.6.1495; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pitkanen HT, 2003, AMINO ACIDS, V24, P413, DOI 10.1007/s00726-002-0338-0; Richardson MD, 2005, J ANTIMICROB CHEMOTH, V56, P5, DOI 10.1093/jac/dki218; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; RYAN ED, 1974, J BACTERIOL, V120, P631, DOI 10.1128/JB.120.2.631-637.1974; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shimizu M, 2010, APPL ENVIRON MICROB, V76, P1507, DOI 10.1128/AEM.02135-09; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Tan S, 2006, AMINO ACIDS, V30, P195, DOI 10.1007/s00726-005-0254-1; VELASCO JA, 1993, GENE, V137, P179, DOI 10.1016/0378-1119(93)90004-M; XING RY, 1991, J BACTERIOL, V173, P2086, DOI 10.1128/jb.173.6.2086-2092.1991	35	23	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e43559	10.1371/journal.pone.0043559	http://dx.doi.org/10.1371/journal.pone.0043559			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028460	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900007
J	Umbach, AL; Zarkovic, J; Yu, JP; Ruckle, ME; McIntosh, L; Hock, JJ; Bingham, S; White, SJ; George, RM; Subbaiah, CC; Rhoads, DM				Umbach, Ann L.; Zarkovic, Jelena; Yu, Jianping; Ruckle, Michael E.; McIntosh, Lee; Hock, Jeffery J.; Bingham, Scott; White, Samuel J.; George, Rajani M.; Subbaiah, Chalivendra C.; Rhoads, David M.			Comparison of Intact Arabidopsis thaliana Leaf Transcript Profiles during Treatment with Inhibitors of Mitochondrial Electron Transport and TCA Cycle	PLOS ONE			English	Article							ALTERNATIVE OXIDASE GENE; OXIDATIVE STRESS; COMPLEX-I; ABIOTIC STRESS; DIFFERENTIAL EXPRESSION; RESPIRATORY-CHAIN; OXYGEN; METABOLISM; NUCLEAR; DEFENSE	Plant mitochondria signal to the nucleus leading to altered transcription of nuclear genes by a process called mitochondrial retrograde regulation (MRR). MRR is implicated in metabolic homeostasis and responses to stress conditions. Mitochondrial reactive oxygen species (mtROS) are a MRR signaling component, but whether all MRR requires ROS is not established. Inhibition of the cytochrome respiratory pathway by antimycin A (AA) or the TCA cycle by monofluoroacetate (MFA), each of which initiates MRR, can increase ROS production in some plant cells. We found that for AA and MFA applied to leaves of soil-grown Arabidopsis thaliana plants, ROS production increased with AA, but not with MFA, allowing comparison of transcript profiles under different ROS conditions during MRR. Variation in transcript accumulation over time for eight nuclear encoded mitochondrial protein genes suggested operation of both common and distinct signaling pathways between the two treatments. Consequences of mitochondrial perturbations for the whole transcriptome were examined by microarray analyses. Expression of 1316 and 606 genes was altered by AA and MFA, respectively. A subset of genes was similarly affected by both treatments, including genes encoding photosynthesis-related proteins. MFA treatment resulted in more down-regulation. Functional gene category (MapMan) and cluster analyses showed that genes with expression levels affected by perturbation from AA or MFA inhibition were most similarly affected by biotic stresses such as pathogens. Overall, the data provide further evidence for the presence of mtROS-independent MRR signaling, and support the proposed involvement of MRR and mitochondrial function in plant responses to biotic stress.	[Rhoads, David M.] Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA; [Umbach, Ann L.] Duke Univ, Dept Biol, Durham, NC USA; [Zarkovic, Jelena; Hock, Jeffery J.; Bingham, Scott; White, Samuel J.; George, Rajani M.; Subbaiah, Chalivendra C.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Yu, Jianping; Ruckle, Michael E.; McIntosh, Lee] Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA; [Yu, Jianping; Ruckle, Michael E.; McIntosh, Lee] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	University of Arizona; Duke University; Arizona State University; Arizona State University-Tempe; Michigan State University; Michigan State University	Rhoads, DM (corresponding author), Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA.	drhoads@cals.arizona.edu	George, Rajani Mary/AAM-7256-2020	George, Rajani Mary/0000-0002-9153-5523; Yu, Jianping/0000-0003-0466-3197	National Science Foundation [IBN0110768, IOB0344497, IOS0822521]; United States Department of Energy [DEFG0291ER20021]; Division Of Integrative Organismal Systems [1005394] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); United States Department of Energy(United States Department of Energy (DOE)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants from the National Science Foundation (www.nsf.gov; IBN0110768 to J.Y. and L.M. and IOB0344497 and IOS0822521 to D.M.R.) and the United States Department of Energy (www.energy.gov; DEFG0291ER20021 to L.M.). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amirsadeghi S, 2006, PLANT CELL PHYSIOL, V47, P1509, DOI 10.1093/pcp/pcl016; Bantseev V, 2006, ANN NY ACAD SCI, V1091, P17, DOI 10.1196/annals.1378.051; Baxter CJ, 2007, PLANT PHYSIOL, V143, P312, DOI 10.1104/pp.106.090431; Bechtold U, 2008, J EXP BOT, V59, P121, DOI 10.1093/jxb/erm289; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Bouche N, 2003, P NATL ACAD SCI USA, V100, P6843, DOI 10.1073/pnas.1037532100; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Camacho-Pereira J, 2009, PLANT PHYSIOL, V149, P1099, DOI 10.1104/pp.108.129247; Chandran D, 2009, PLANT PHYSIOL, V149, P1435, DOI 10.1104/pp.108.132985; Charlton WL, 2005, PLANT CELL REP, V23, P647, DOI 10.1007/s00299-004-0879-7; Clifton R, 2005, PLANT MOL BIOL, V58, P193, DOI 10.1007/s11103-005-5514-7; Clifton R, 2006, BBA-BIOENERGETICS, V1757, P730, DOI 10.1016/j.bbabio.2006.03.009; Dinakar C, 2010, PHYSIOL PLANTARUM, V139, P13, DOI 10.1111/j.1399-3054.2010.01346.x; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; Djajanegara I, 2002, PLANT MOL BIOL, V50, P735, DOI 10.1023/A:1019942720636; Dojcinovic D, 2003, THESIS ARIZONA STATE; Dutilleul C, 2003, PLANT CELL, V15, P1212, DOI 10.1105/tpc.009464; Ederli L, 2006, PLANT PHYSIOL, V142, P595, DOI 10.1104/pp.106.085472; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elhafez D, 2006, PLANT CELL PHYSIOL, V47, P43, DOI 10.1093/pcp/pci221; Erbs G, 2003, MOL PLANT PATHOL, V4, P421, DOI [10.1046/j.1364-3703.2003.00179.x, 10.1046/J.1364-3703.2003.00179.X]; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Finnegan PM, 2004, ADV PHOTO RESPIRAT, V17, P163; Gadjev I, 2006, PLANT PHYSIOL, V141, P436, DOI 10.1104/pp.106.078717; GALSTON AW, 1990, PLANT PHYSIOL, V94, P406, DOI 10.1104/pp.94.2.406; Garmier M, 2008, PLANT PHYSIOL, V148, P1324, DOI 10.1104/pp.108.125880; Gilliland A, 2003, PLANT PHYSIOL, V132, P1518, DOI 10.1104/pp.102.017640; Giraud E, 2009, PLANT PHYSIOL, V150, P1286, DOI 10.1104/pp.109.139782; Glawischnig E, 2007, PHYTOCHEMISTRY, V68, P401, DOI 10.1016/j.phytochem.2006.12.005; Gleason C, 2011, P NATL ACAD SCI USA, V108, P10768, DOI 10.1073/pnas.1016060108; Gray GR, 2004, PLANT CELL REP, V23, P497, DOI 10.1007/s00299-004-0848-1; Gutierres S, 1997, P NATL ACAD SCI USA, V94, P3436, DOI 10.1073/pnas.94.7.3436; Hausler RE, 2009, PLANT PHYSIOL, V149, P515, DOI 10.1104/pp.108.128124; Hanssen IM, 2011, PLANT PHYSIOL, V156, P301, DOI 10.1104/pp.111.173906; Heazlewood JL, 2004, PLANT CELL, V16, P241, DOI 10.1105/tpc.016055; Ho LHM, 2008, PLANT PHYSIOL, V147, P1858, DOI 10.1104/pp.108.121384; Holzinger A, 2006, MICRON, V37, P190, DOI 10.1016/j.micron.2005.10.015; Jaspers P, 2010, PHYSIOL PLANTARUM, V138, P405, DOI 10.1111/j.1399-3054.2009.01321.x; Jones AME, 2006, PLANT PHYSIOL, V142, P1603, DOI 10.1104/pp.106.086231; Karpova OV, 2002, PLANT CELL, V14, P3271, DOI 10.1105/tpc.005603; Katagiri Fumiaki, 2002, Arabidopsis Book, V1, pe0039, DOI 10.1199/tab.0039; Kim YS, 1998, PLANT CELL PHYSIOL, V39, P565, DOI 10.1093/oxfordjournals.pcp.a029406; Knepper Caleb, 2010, Arabidopsis Book, V8, pe012, DOI 10.1199/tab.0124; Krause M, 2004, MOL PLANT MICROBE IN, V17, P131, DOI 10.1094/MPMI.2004.17.2.131; KUMAR AM, 1992, P NATL ACAD SCI USA, V89, P10842, DOI 10.1073/pnas.89.22.10842; Lee BH, 2002, PLANT CELL, V14, P1235, DOI 10.1105/tpc.010433; Lister R, 2004, PLANT PHYSIOL, V134, P777, DOI 10.1104/pp.103.033910; Matsumura H, 2003, P NATL ACAD SCI USA, V100, P15718, DOI 10.1073/pnas.2536670100; Matsuo M, 2011, PLANT CELL PHYSIOL, V52, P333, DOI 10.1093/pcp/pcq192; Maxwell DP, 2002, PLANT J, V29, P269, DOI 10.1046/j.1365-313X.2002.01216.x; Maxwell DP, 1999, P NATL ACAD SCI USA, V96, P8271, DOI 10.1073/pnas.96.14.8271; McCourt P, 1998, METH MOL B, V82, P13; Miller G, 2007, PLANT PHYSIOL, V144, P1777, DOI 10.1104/pp.107.101436; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; Moschou PN, 2008, PLANT CELL, V20, P1708, DOI 10.1105/tpc.108.059733; Munekaga Y, 2004, NATURE, V429, P579, DOI 10.1038/nature02598; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Newton K, 2004, AUST J PUBL ADMIN, V63, P121; Noctor G, 2007, TRENDS PLANT SCI, V12, P125, DOI 10.1016/j.tplants.2007.01.005; Norman C, 2004, PLANT PHYSIOL, V134, P1; Oliver RP, 2004, MOL PLANT PATHOL, V5, P347, DOI 10.1111/j.1364-3703.2004.00228.x; op den Camp RGL, 2003, PLANT CELL, V15, P2320, DOI 10.1105/tpc.014662; Papadakis AK, 2005, PLANTA, V220, P826, DOI 10.1007/s00425-004-1400-9; Parsons HL, 1999, PLANT PHYSIOL, V121, P1309, DOI 10.1104/pp.121.4.1309; Pracharoenwattana I, 2005, PLANT CELL, V17, P2037, DOI 10.1105/tpc.105.031856; Queval G, 2008, J EXP BOT, V59, P135, DOI 10.1093/jxb/erm193; Rasmusson AG, 2009, PHYSIOL PLANTARUM, V137, P371, DOI 10.1111/j.1399-3054.2009.01252.x; Rhoads DM, 2007, MITOCHONDRION, V7, P177, DOI 10.1016/j.mito.2007.01.002; Rhoads DM, 2006, PLANT PHYSIOL, V141, P357, DOI 10.1104/pp.106.079129; Rumeau D, 2007, PLANT CELL ENVIRON, V30, P1041, DOI 10.1111/j.1365-3040.2007.01675.x; Sabar M, 2000, PLANT PHYSIOL, V124, P1239, DOI 10.1104/pp.124.3.1239; Saisho D, 1997, PLANT MOL BIOL, V35, P585, DOI 10.1023/A:1005818507743; Saisho D, 2001, J PLANT PHYSIOL, V158, P241, DOI 10.1078/0176-1617-00193; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Scharte J, 2005, PLANT CELL ENVIRON, V28, P1421, DOI 10.1111/j.1365-3040.2005.01380.x; Scheideler M, 2002, J BIOL CHEM, V277, P10555, DOI 10.1074/jbc.M104863200; Schonfeld C, 2004, J BIOL CHEM, V279, P50366, DOI 10.1074/jbc.M408477200; Shedge V, 2010, PLANT PHYSIOL, V152, P1960, DOI 10.1104/pp.109.152827; Shimmura S, 1997, INVEST OPHTH VIS SCI, V38, P620; Smith SM, 2004, PLANT PHYSIOL, V136, P2687, DOI 10.1104/pp.104.044347; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Subbaiah CC, 1998, PLANT PHYSIOL, V118, P759, DOI 10.1104/pp.118.3.759; Sweetlove LJ, 2002, PLANT J, V32, P891, DOI 10.1046/j.1365-313X.2002.01474.x; Tcherkez G, 2009, PLANT PHYSIOL, V151, P620, DOI 10.1104/pp.109.142976; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Turner JE, 2005, J BIOL CHEM, V280, P2780, DOI 10.1074/jbc.M407291200; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; Van Aken O, 2009, PHYSIOL PLANTARUM, V137, P354, DOI 10.1111/j.1399-3054.2009.01240.x; Vanlerberghe GC, 1996, PLANT PHYSIOL, V111, P589, DOI 10.1104/pp.111.2.589; VANLERBERGHE GC, 1994, PLANT PHYSIOL, V105, P867, DOI 10.1104/pp.105.3.867; Vanlerberghe GC, 1997, PLANT PHYSIOL, V113, P657, DOI 10.1104/pp.113.2.657; Vanlerberghe GC, 2002, PLANT PHYSIOL, V129, P1829, DOI 10.1104/pp.002691; Vanlerberghe GC, 2009, PHYSIOL PLANTARUM, V137, P392, DOI 10.1111/j.1399-3054.2009.01254.x; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Wang D, 2011, MOL PLANT, V4, P581, DOI 10.1093/mp/ssr053; Watkinson JI, 2003, PLANT PHYSIOL, V133, P1702, DOI 10.1104/pp.103.026914; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yao N, 2002, PLANT J, V30, P567, DOI 10.1046/j.1365-313X.2002.01314.x; Yoshida K, 2009, PLANT CELL PHYSIOL, V50, P1449, DOI 10.1093/pcp/pcp090; Yu JP, 2001, PLANT PHYSIOL BIOCH, V39, P345, DOI 10.1016/S0981-9428(01)01254-2; Zarkovic J, 2005, PLANT MOL BIOL, V57, P871, DOI 10.1007/s11103-005-3249-0; Zou JJ, 2005, MOL PLANT MICROBE IN, V18, P1161, DOI 10.1094/MPMI-18-1161	104	28	29	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44339	10.1371/journal.pone.0044339	http://dx.doi.org/10.1371/journal.pone.0044339			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028523	gold, Green Published, Green Submitted			2022-12-27	WOS:000311313900019
J	Dutra, CC; Koch, RL; Burkness, EC; Meissle, M; Romeis, J; Hutchison, WD; Fernandes, MG				Dutra, Carla C.; Koch, Robert L.; Burkness, Eric C.; Meissle, Michael; Romeis, Joerg; Hutchison, William D.; Fernandes, Marcos G.			Harmonia axyridis (Coleoptera: Coccinellidae) Exhibits Preference between Bt and Non-Bt Maize Fed Spodoptera frugiperda (Lepidoptera: Noctuidae)	PLOS ONE			English	Article							ASIAN LADY BEETLE; GENETICALLY-MODIFIED MAIZE; TRANSGENIC CORN; FALL ARMYWORM; RESISTANCE MANAGEMENT; NONTARGET ARTHROPODS; BIOLOGICAL-CONTROL; SWEET CORN; FED PREY; CRY1AB	A recent shift in managing insect resistance to genetically engineered (GE) maize consists of mixing non-GE seed with GE seed known as "refuge in a bag", which increases the likelihood of predators encountering both prey fed Bt and prey fed non-Bt maize. We therefore conducted laboratory choice-test feeding studies to determine if a predator, Harmonia axyridis, shows any preference between prey fed Bt and non-Bt maize leaves. The prey species was Spodoptera frugiperda, which were fed Bt maize (MON-810), expressing the single Cry1Ab protein, or non-Bt maize. The predators were third instar larvae and female adults of H. axyridis. Individual predators were offered Bt and non-Bt fed prey larvae that had fed for 24, 48 or 72 h. Ten and 15 larvae of each prey type were offered to third instar and adult predators, respectively. Observations of arenas were conducted at 1, 2, 3, 6, 15 and 24 h after the start of the experiment to determine the number and type of prey eaten by each individual predator. Prey larvae that fed on non-Bt leaves were significantly larger than larvae fed Bt leaves. Both predator stages had eaten nearly all the prey by the end of the experiment. However, in all combinations of predator stage and prey age, the number of each prey type consumed did not differ significantly. ELISA measurements confirmed the presence of Cry1Ab in leaf tissue (23-33 mu g/g dry weight) and S. frugiperda (2.1-2.2 mu g/g), while mean concentrations in H. axyridis were very low (0.01-0.2 mu g/g). These results confirm the predatory status of H. axyridis on S. frugiperda and that both H. axyridis adults and larvae show no preference between prey types. The lack of preference between Bt-fed and non-Bt-fed prey should act in favor of insect resistance management strategies using mixtures of GE and non-GE maize seed.	[Dutra, Carla C.] Fundacao Univ Fed Grande Dourados, Fac Ciencias Agr, Dourados, Brazil; [Koch, Robert L.] Minnesota Dept Agr, Div Plant Protect, St Paul, MN USA; [Burkness, Eric C.; Hutchison, William D.] Univ Minnesota, Dept Entomol, St Paul, MN USA; [Meissle, Michael; Romeis, Joerg] Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland; [Fernandes, Marcos G.] Fundacao Univ Fed Grande Dourados, Fac Ciencias Biol & Ambientais, Dourados, Brazil	Universidade Federal da Grande Dourados; University of Minnesota System; University of Minnesota Twin Cities; Swiss Federal Research Station Agroscope; Swiss Federal Research Station for Agroecology & Agriculture; Universidade Federal da Grande Dourados	Dutra, CC (corresponding author), Fundacao Univ Fed Grande Dourados, Fac Ciencias Agr, Dourados, Brazil.	hutch002@umn.edu	Meissle, Michael/C-3127-2009; Romeis, Joerg/J-5360-2013; Fernandes, Marcos/AAB-4726-2019	Meissle, Michael/0000-0002-5391-7715; Romeis, Joerg/0000-0003-3652-8360; Fernandes, Marcos/0000-0003-4377-5562; Hutchison, William D./0000-0001-9605-2996	Coordination for the Improvement of Higher Education Personnel (CAPES Foundation), Ministry of Education of Brazil [BEX 4904-11-7]	Coordination for the Improvement of Higher Education Personnel (CAPES Foundation), Ministry of Education of Brazil	Funding provided by Coordination for the Improvement of Higher Education Personnel (CAPES Foundation), Ministry of Education of Brazil for the doctoral grant (BEX 4904-11-7) to C.C. Dutra. The two maize hybrids for this trial were gifted by Monsanto Co. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abendroth L., 2011, CORN GROWTH DEV; Alvarez-Alfageme F, 2008, TRANSGENIC RES, V17, P943, DOI 10.1007/s11248-008-9177-4; Alvarez-Alfageme F, 2011, TRANSGENIC RES, V20, P467, DOI 10.1007/s11248-010-9430-5; Andow DA., 2008, COLLECT BIOSAF REV, V4, P142; Burkness EC, 2011, J ECON ENTOMOL, V104, P1476, DOI 10.1603/EC11081; Figueiredo MDC, 2006, PESQUI AGROPECU BRAS, V41, P1693, DOI 10.1590/S0100-204X2006001200002; Cruz I, 1995, 21 EMBR CNPMS; Daly T, 2005, ENVIRON ENTOMOL, V34, P1292, DOI 10.1603/0046-225X(2005)034[1292:EOBTTC]2.0.CO;2; Almeida Lúcia Massutti de, 2002, Rev. Bras. Zool., V19, P941, DOI 10.1590/S0101-81752002000300031; Dively GP, 2005, ENVIRON ENTOMOL, V34, P1267, DOI 10.1603/0046-225X(2005)034[1267:IOTVCL]2.0.CO;2; dos Santos KB, 2009, BIOL CONTROL, V50, P157, DOI 10.1016/j.biocontrol.2009.03.014; Dutton A, 2005, ENTOMOL EXP APPL, V114, P161, DOI 10.1111/j.1570-7458.2005.00239.x; Evans EW, 2009, BIOL CONTROL, V51, P255, DOI 10.1016/j.biocontrol.2009.05.011; Fernandes O. D., 2003, Revista Brasileira de Milho e Sorgo, V2, P25; Fernandes OA, 2007, SCI AGR, V64, P249, DOI 10.1590/S0103-90162007000300006; Galvan TL, 2006, PEST MANAG SCI, V62, P797, DOI 10.1002/ps.1223; Galvan TL, 2005, BIOL CONTROL, V34, P108, DOI 10.1016/j.biocontrol.2005.04.005; Galvan TL, 2005, J ECON ENTOMOL, V98, P780, DOI 10.1603/0022-0493-98.3.780; Head G, 2001, ENTOMOL EXP APPL, V99, P37, DOI 10.1023/A:1018913429026; Heimpel GE, 2005, ENVIRON ENTOMOL, V34, P512, DOI 10.1603/0046-225X-34.3.512; Hellmich Richard L., 2008, V5, P119, DOI 10.1007/978-1-4020-8373-0_5; Huang FN, 2011, ENTOMOL EXP APPL, V140, P1, DOI 10.1111/j.1570-7458.2011.01138.x; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Koch RL, 2006, BIOCONTROL, V51, P741, DOI 10.1007/s10526-006-9016-6; Koch RL, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.32; Koch RL, 2003, BIOL CONTROL, V28, P265, DOI 10.1016/S1049-9644(03)00102-6; Koch RL, 2011, CHECK LIST, V7, P476; Koch RL, 2006, NEOTROP ENTOMOL, V35, P421, DOI 10.1590/S1519-566X2006000400001; Li YC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022185, 10.1371/journal.pone.0026302]; Li YH, 2010, BIOL CONTROL, V53, P337, DOI 10.1016/j.biocontrol.2009.12.003; Lopez-Edwards M, 1999, FLA ENTOMOL, V82, P254, DOI 10.2307/3496577; Martinelli S, 2006, J ECON ENTOMOL, V99, P519, DOI 10.1603/0022-0493-99.2.519; Meier MS, 2001, BASIC APPL ECOL, V2, P35, DOI 10.1078/1439-1791-00034; Meissle M, 2005, TRANSGENIC RES, V14, P123, DOI 10.1007/s11248-004-6458-4; Mendes SM, 2011, PESQUI AGROPECU BRAS, V46, P239, DOI 10.1590/S0100-204X2011000300003; Musser FR, 2003, ENVIRON ENTOMOL, V32, P1131, DOI 10.1603/0046-225X-32.5.1131; Nguyen HT, 2007, J PLANT DIS PROTECT, V114, P82, DOI 10.1007/BF03356208; Onstad DW, 2011, J ECON ENTOMOL, V104, P343, DOI 10.1603/EC10388; Porcar M, 2010, B ENTOMOL RES, V100, P297, DOI 10.1017/S0007485309990290; Rauschen S, 2010, TRANSGENIC RES, V19, P727, DOI 10.1007/s11248-009-9351-3; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Sanders CJ, 2007, BIOL CONTROL, V40, P362, DOI 10.1016/j.biocontrol.2006.12.010; SAS Institute, 1996, SAS STAT SOFTW CHANG; Tian Jun-Ce, 2012, Transgenic Res, V21, P1303, DOI 10.1007/s11248-012-9604-4; Torres JB, 2008, TRANSGENIC RES, V17, P345, DOI 10.1007/s11248-007-9109-8; Torres JB, 2006, AGR FOREST ENTOMOL, V8, P191, DOI 10.1111/j.1461-9563.2006.00298.x; Vojtech E, 2005, TRANSGENIC RES, V14, P133, DOI 10.1007/s11248-005-2736-z; Wold SJ, 2001, J ENTOMOL SCI, V36, P177, DOI 10.18474/0749-8004-36.2.177; Wolfenbarger LL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002118	49	20	20	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44867	10.1371/journal.pone.0044867	http://dx.doi.org/10.1371/journal.pone.0044867			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024772	gold, Green Submitted, Green Published			2022-12-27	WOS:000308860100030
J	Legriel, S; Schraub, O; Azoulay, E; Hantson, P; Magalhaes, E; Coquet, I; Bretonniere, C; Gilhodes, O; Anguel, N; Megarbane, B; Benayoun, L; Schnell, D; Plantefeve, G; Charpentier, J; Argaud, L; Mourvillier, B; Galbois, A; Chalumeau-Lemoine, L; Rivoal, M; Durand, F; Geffroy, A; Simon, M; Stoclin, A; Pallot, JL; Arbelot, C; Nyunga, M; Lesieur, O; Troche, G; Bruneel, F; Cordoliani, YS; Bedos, JP; Pico, F				Legriel, Stephane; Schraub, Olivier; Azoulay, Elie; Hantson, Philippe; Magalhaes, Eric; Coquet, Isaline; Bretonniere, Cedric; Gilhodes, Olivier; Anguel, Nadia; Megarbane, Bruno; Benayoun, Laurent; Schnell, David; Plantefeve, Gaetan; Charpentier, Julien; Argaud, Laurent; Mourvillier, Bruno; Galbois, Arnaud; Chalumeau-Lemoine, Ludivine; Rivoal, Michel; Durand, Francois; Geffroy, Arnaud; Simon, Marc; Stoclin, Annabelle; Pallot, Jean-Louis; Arbelot, Charlotte; Nyunga, Martine; Lesieur, Olivier; Troche, Gilles; Bruneel, Fabrice; Cordoliani, Yves-Sebastien; Bedos, Jean-Pierre; Pico, Fernando		Critically III Posterior	Determinants of Recovery from Severe Posterior Reversible Encephalopathy Syndrome	PLOS ONE			English	Article							HYPERTENSIVE ENCEPHALOPATHY; STATUS EPILEPTICUS; RISK-FACTORS; HYPERGLYCEMIA; STROKE; IMPACT; CT	Objective: Few outcome data are available about posterior reversible encephalopathy syndrome (PRES). We studied 90-day functional outcomes and their determinants in patients with severe PRES. Design: 70 patients with severe PRES admitted to 24 ICUs in 2001-2010 were included in a retrospective cohort study. The main outcome measure was a Glasgow Outcome Scale (GOS) of 5 (good recovery) on day 90. Main Results: Consciousness impairment was the most common clinical sign, occurring in 66 (94%) patients. Clinical seizures occurred in 57 (81%) patients. Median mean arterial pressure was 122 (105-143) mmHg on scene. Cerebral imaging abnormalities were bilateral (93%) and predominated in the parietal (93%) and occipital (86%) white matter. Median number of brain areas involved was 4 (3-5). Imaging abnormalities resolved in 43 (88%) patients. Ischaemic and/or haemorrhagic complications occurred in 7 (14%) patients. The most common causes were drug toxicity (44%) and hypertensive encephalopathy (41%). On day 90, 11 (16%) patients had died, 26 (37%) had marked functional impairments (GOS, 2 to 4), and 33 (56%) had a good recovery (GOS, 5). Factors independently associated with GOS, 5 were highest glycaemia on day 1 (OR, 1.22; 95% CI, 1.02-1.45, p = 0.03) and time to causative-factor control (OR, 3.3; 95% CI, 1.04-10.46, p = 0.04), whereas GOS = 5 was associated with toxaemia of pregnancy (preeclampsia/eclampsia) (OR, 0.06; 95% CI, 0.01-0.38, p = 0.003). Conclusions: By day 90 after admission for severe PRES, 44% of survivors had severe functional impairments. Highest glycaemia on day 1 and time to causative-factor control were strong early predictors of outcomes, suggesting areas for improvement.	[Legriel, Stephane; Schraub, Olivier; Troche, Gilles; Bruneel, Fabrice; Bedos, Jean-Pierre] CH Versailles, Med Surg Intens Care Dept, Le Chesnay, France; [Azoulay, Elie; Schnell, David] CHU St Louis, Med Intens Care Dept, Paris, France; [Hantson, Philippe] Clin Univ St Luc, Dept Intens Care, B-1200 Brussels, Belgium; [Magalhaes, Eric; Pico, Fernando] CH Versailles Andre Mignot, Dept Neurol, Le Chesnay, France; [Magalhaes, Eric; Pico, Fernando] CH Versailles Andre Mignot, Stroke Ctr, Le Chesnay, France; [Coquet, Isaline] Hop Foch, Med Surg Intens Care Dept, Suresnes, France; [Bretonniere, Cedric] Hop Hotel Dieu, CHU Nantes, Dept Intens Care, Nantes, France; [Gilhodes, Olivier] CHI Creteil, Med Surg Intens Care Dept, Creteil, France; [Anguel, Nadia] CHU Bicetre, Med Intens Care Dept, Le Kremlin Bicetre, France; [Megarbane, Bruno] CHU Lariboisiere, Med Intens Care Dept, Paris, France; [Benayoun, Laurent] CHU Beaujon, Dept Surg Intens Care, Clichy, France; [Plantefeve, Gaetan] CH Victor Dupouy, Med Surg Intens Care Dept, Argenteuil, France; [Charpentier, Julien] CHU Cochin Port Royal, Med Intens Care Dept, Paris, France; [Argaud, Laurent] Hop Edouard Herriot, Hosp Civils Lyon, Lyon, France; [Mourvillier, Bruno] CHU Bichat, Med Intens Care Dept, Paris, France; [Galbois, Arnaud] CHU St Antoine, Med Intens Care Dept, Paris, France; [Chalumeau-Lemoine, Ludivine] CHU Tenon, Med Intens Care Dept, Paris, France; [Rivoal, Michel] CH Arpajon, Med Surg Intens Care Dept, Arpajon, France; [Geffroy, Arnaud] CHU Bichat, Dept Surg Intens Care, Paris, France; [Simon, Marc] Clin S Luxembourg Arlon, Dept Intens Care, Arlon, Belgium; [Stoclin, Annabelle] Inst Gustave Roussy, Med Surg Intens Care Dept, Villejuif, France; [Pallot, Jean-Louis] CH Andre Gregoire, Med Surg Intens Care Dept, Montreuil, France; [Arbelot, Charlotte] CHU Pitie Salpetriere, Dept Surg Intens Care, Paris, France; [Nyunga, Martine] CH Roubaix, Med Surg Intens Care Dept, Roubaix, France; [Lesieur, Olivier] CH La Rochelle, Med Surg Intens Care Dept, La Rochelle, France; [Cordoliani, Yves-Sebastien] Hop Prive Parly II, Dept Radiol, Le Chesnay, France	Centre Hospitalier de Versailles; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Centre Hospitalier de Versailles; Centre Hospitalier de Versailles; Hospital Foch; Nantes Universite; CHU de Nantes; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Legriel, S (corresponding author), CH Versailles, Med Surg Intens Care Dept, Site Andre Mignot, Le Chesnay, France.	slegriel@ch-versailles.fr	Legriel, Stephane/J-1307-2017; lesieur, olivier/X-7745-2019; schnell, david/AAG-2208-2020; legriel, stephane/H-5735-2019; Pilleul, Frank/I-3858-2014	Legriel, Stephane/0000-0003-4782-6734; lesieur, olivier/0000-0001-9135-2041; legriel, stephane/0000-0003-4782-6734; Megarbane, Bruno/0000-0002-2522-2764; Durand, Francois/0000-0002-0357-1090; MOURVILLIER, BRUNO/0000-0001-5227-1468; Dromain, Clarisse/0000-0002-2999-1958; Troche, Gilles/0000-0002-8150-6630; Wiertlewki, Sandrine/0000-0002-8678-3661; Rouby, Jean-Jacques/0000-0001-9092-4642	Hospital of Versailles	Hospital of Versailles	This study was supported by the Hospital of Versailles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alldredge BK, 2001, NEW ENGL J MED, V345, P631, DOI 10.1056/NEJMoa002141; Bartynski WS, 2008, AM J NEURORADIOL, V29, P1036, DOI 10.3174/ajnr.A0928; Bartynski WS, 2008, AM J NEURORADIOL, V29, P1043, DOI 10.3174/ajnr.A0929; Bartynski WS, 2007, AM J NEURORADIOL, V28, P1320, DOI 10.3174/ajnr.A0549; Bateman DE, 2001, J NEUROL NEUROSUR PS, V71, P13; Burnett MM, 2010, CLIN NEUROL NEUROSUR, V112, P886, DOI 10.1016/j.clineuro.2010.07.023; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Casey SO, 2000, AM J NEURORADIOL, V21, P1199; Fogelholm R, 2005, J NEUROL NEUROSUR PS, V76, P349, DOI 10.1136/jnnp.2003.034819; Gans J. de, 2002, New England Journal of Medicine, V347, P1549, DOI 10.1056/NEJMoa021334; Garg R, 2006, STROKE, V37, P267, DOI 10.1161/01.STR.0000195175.29487.30; Godoy DA, 2010, NEUROCRIT CARE, V13, P425, DOI 10.1007/s12028-010-9404-8; Hinchey J, 1996, NEW ENGL J MED, V334, P494, DOI 10.1056/NEJM199602223340803; JENNETT B, 1976, LANCET, V1, P1031; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Kaplan PW, 2006, J CLIN NEUROPHYSIOL, V23, P221, DOI 10.1097/01.wnp.0000220837.99490.66; Kozak OS, 2007, NEUROLOGY, V69, P894, DOI 10.1212/01.wnl.0000269780.45472.16; Lee VH, 2008, ARCH NEUROL-CHICAGO, V65, P205, DOI 10.1001/archneurol.2007.46; LeGall JR, 1996, JAMA-J AM MED ASSOC, V276, P802, DOI 10.1001/jama.276.10.802; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Legriel S, 2011, ANN UPD INTENS CARE, P631; Legriel S, 2008, NEUROCRIT CARE, V9, P247, DOI 10.1007/s12028-008-9096-5; Legriel S, 2011, INTENS CARE MED, V37, P1718, DOI 10.1007/s00134-011-2310-5; Legriel S, 2010, CRIT CARE MED, V38, P2295, DOI 10.1097/CCM.0b013e3181f859a6; Lowenstein DH, 1999, EPILEPSIA, V40, P120, DOI 10.1111/j.1528-1157.1999.tb02000.x; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Mayer SA, 2002, ARCH NEUROL-CHICAGO, V59, P205, DOI 10.1001/archneur.59.2.205; McKinney AM, 2007, AM J ROENTGENOL, V189, P904, DOI 10.2214/AJR.07.2024; Mueller-Mang C, 2009, NEURORADIOLOGY, V51, P373, DOI 10.1007/s00234-009-0504-0; Sala F, 1999, ANN NY ACAD SCI, V890, P133, DOI 10.1111/j.1749-6632.1999.tb07989.x; SCHWARTZ RB, 1995, AM J ROENTGENOL, V165, P627, DOI 10.2214/ajr.165.3.7645483; SCHWARTZ RB, 1992, AM J ROENTGENOL, V159, P379, DOI 10.2214/ajr.159.2.1632361; Servillo G, 2003, INTENS CARE MED, V29, P2323, DOI 10.1007/s00134-003-1901-1; Servillo G, 2007, INTENS CARE MED, V33, P230, DOI 10.1007/s00134-006-0459-0; TEASDALE G, 1974, LANCET, V2, P81; Todd MM, 2005, NEW ENGL J MED, V352, P135, DOI 10.1056/NEJMoa040975; TREIMAN DM, 1990, EPILEPSY RES, V5, P49, DOI 10.1016/0920-1211(90)90065-4; Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202; Vaughan CJ, 2000, LANCET, V356, P411, DOI 10.1016/S0140-6736(00)02539-3; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wippold FJ, 2008, AM J NEURORADIOL, V29, P1998	41	108	116	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44534	10.1371/journal.pone.0044534	http://dx.doi.org/10.1371/journal.pone.0044534			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024751	gold, Green Published, Green Submitted			2022-12-27	WOS:000308860100009
J	Takacs, AC; Swierzy, IJ; Luder, CGK				Takacs, Anna C.; Swierzy, Izabela J.; Lueder, Carsten G. K.			Interferon-gamma Restricts Toxoplasma gondii Development in Murine Skeletal Muscle Cells via Nitric Oxide Production and Immunity-Related GTPases	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; BINDING PROTEIN IGTP; INFLAMMATORY MYOPATHIES; HOST-RESISTANCE; IN-VIVO; INTRACELLULAR PATHOGEN; ACTIVATED MACROPHAGES; PRIMED MACROPHAGES; TRYPANOSOMA-CRUZI; ACUTE INFECTION	The apicomplexan parasite Toxoplasma gondii is regularly transmitted to humans via the ingestion of contaminated meat products from chronically infected livestock. This route of transmission requires intracellular development and long-term survival of the parasite within muscle tissue. In this study, we determined the cell-autonomous immunity of mature primary embryonic or C2C12 skeletal muscle cells (SkMCs) to infection with T. gondii. Non-activated SkMCs and control fibroblasts sustained parasite replication; however, interferon (IFN)-gamma significantly inhibited parasite growth in SkMCs but not in fibroblasts. Intracellular parasite replication was diminished by IFN-gamma whereas host cell invasion was not affected. Tumor necrosis factor (TNF) did not further increase the IFN-gamma-triggered host defense of SkMCs against Toxoplasma. Remarkably, IFN-gamma alone or in combination with TNF decreased the high level of T. gondii bradyzoite formation being observed in non-activated SkMCs. Stimulation of SkMCs with IFN-gamma strongly triggered expression of inducible nitric oxide synthase (iNOS) transcripts, and induced significantly higher levels of nitric oxide (NO) in SkMCs than in fibroblasts. Consequently, pharmacological inhibition of iNOS partially abrogated the IFN-gamma-induced toxoplasmacidal activity of SkMCs. In addition, SkMCs strongly up-regulated immunity-regulated GTPases (IRGs) following stimulation with IFN-gamma. IRGs accumulated on Toxoplasma-containing vacuoles in SkMCs in a parasite strain-dependent manner. Subsequent vacuole disruption and signs of degenerating parasites were regularly recognized in IFN-gamma-treated SkMCs infected with type II parasites. Together, murine SkMCs exert potent toxoplasmacidal activity after stimulation with IFN-gamma and have to be considered active participants in the local immune response against Toxoplasma in skeletal muscle.	[Takacs, Anna C.; Swierzy, Izabela J.; Lueder, Carsten G. K.] Univ Gottingen, Univ Med Ctr, Inst Med Microbiol, Gottingen, Germany	University of Gottingen	Takacs, AC (corresponding author), Univ Gottingen, Univ Med Ctr, Inst Med Microbiol, Gottingen, Germany.	clueder@gwdg.de			Federal Ministry of Education and Research (BMBF) (TOXONET consortium) [01KI0766, 01KI1002B]; Open-Access-Publication Fund of the Georg-August-University; German Research Council (DFG)	Federal Ministry of Education and Research (BMBF) (TOXONET consortium); Open-Access-Publication Fund of the Georg-August-University; German Research Council (DFG)(German Research Foundation (DFG))	This study was supported by the Federal Ministry of Education and Research (BMBF; TOXONET consortium, grant numbers 01KI0766 and 01KI1002B to CGKL). Publication of the study was supported by the Open-Access-Publication Fund of the Georg-August-University and the German Research Council (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS LB, 1990, J IMMUNOL, V144, P2725; Aline F, 2002, INFECT IMMUN, V70, P2368, DOI 10.1128/IAI.70.5.2368-2374.2002; BOHNE W, 1994, INFECT IMMUN, V62, P1761, DOI 10.1128/IAI.62.5.1761-1767.1994; Bryson-Richardson RJ, 2008, NAT REV GENET, V9, P632, DOI 10.1038/nrg2369; Collazo CM, 2002, INFECT IMMUN, V70, P6933, DOI 10.1128/IAI.70.12.6933-6939.2002; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; Cook AJC, 2000, BRIT MED J, V321, P142, DOI 10.1136/bmj.321.7254.142; Cuturic M, 1997, NEUROMUSCULAR DISORD, V7, P390, DOI 10.1016/S0960-8966(97)00098-9; Dubey JP, 1996, VET PATHOL, V33, P290, DOI 10.1177/030098589603300305; Englund P, 2001, AM J PATHOL, V159, P1263, DOI 10.1016/S0002-9440(10)62513-8; Fentress SJ, 2011, BIOESSAYS, V33, P693, DOI 10.1002/bies.201100054; Fentress SJ, 2010, CELL HOST MICROBE, V8, P484, DOI 10.1016/j.chom.2010.11.005; FERGUSON DJP, 1987, VIRCHOWS ARCH A, V411, P39, DOI 10.1007/BF00734512; Ferreira-da-Silva Mda F, 2009, INT J MED MICROBIOL, V299, P381; Fichera LE, 2004, INFECT IMMUN, V72, P359, DOI 10.1128/IAI.72.1.359-363.2004; GAZZINELLI RT, 1991, J IMMUNOL, V146, P286; GAZZINELLI RT, 1994, J IMMUNOL, V153, P2533; GHERARDI R, 1992, ANN NEUROL, V32, P535, DOI 10.1002/ana.410320409; GOEBELS N, 1992, J IMMUNOL, V149, P661; GROSS U, 1995, CLIN DIAGN LAB IMMUN, V2, P542, DOI 10.1128/CDLI.2.5.542-548.1995; Hayashi S, 1996, J IMMUNOL, V156, P1476; Hunn JP, 2011, MAMM GENOME, V22, P43, DOI 10.1007/s00335-010-9293-3; HUNTER CA, 1994, INFECT IMMUN, V62, P2818, DOI 10.1128/IAI.62.7.2818-2824.1994; Khaminets A, 2010, CELL MICROBIOL, V12, P939, DOI 10.1111/j.1462-5822.2010.01443.x; Khan IA, 1997, P NATL ACAD SCI USA, V94, P13955, DOI 10.1073/pnas.94.25.13955; Lees MP, 2010, J IMMUNOL, V184, P7040, DOI 10.4049/jimmunol.1000012; Li G, 2009, MOL BIOL EVOL, V26, P1619, DOI 10.1093/molbev/msp074; Ling YM, 2006, J EXP MED, V203, P2063, DOI 10.1084/jem.20061318; Luder CGK, 1999, EXP PARASITOL, V93, P23, DOI 10.1006/expr.1999.4421; Luder CGK, 2003, INT J PARASITOL, V33, P833, DOI 10.1016/S0020-7519(03)00092-4; Lykens JE, 2010, J IMMUNOL, V184, P877, DOI 10.4049/jimmunol.0902346; Machado FS, 2008, MICROBES INFECT, V10, P1558, DOI 10.1016/j.micinf.2008.09.009; Machado FS, 2000, CIRCULATION, V102, P3003, DOI 10.1161/01.CIR.102.24.3003; MacKenzie CR, 1999, EUR J IMMUNOL, V29, P3254, DOI 10.1002/(SICI)1521-4141(199910)29:10&lt;3254::AID-IMMU3254&gt;3.0.CO;2-0; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Melzer T, 2008, INFECT IMMUN, V76, P4883, DOI 10.1128/IAI.01288-07; Montoya JG, 1997, CLIN INFECT DIS, V24, P676, DOI 10.1093/clind/24.4.676; NATHAN CF, 1983, J EXP MED, V158, P670, DOI 10.1084/jem.158.3.670; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Plonquet A, 2003, MUSCLE NERVE, V27, P761, DOI 10.1002/mus.10376; Radke JR, 2006, PLOS PATHOG, V2, P964, DOI 10.1371/journal.ppat.0020105; Radke JR, 2003, MOL BIOCHEM PARASIT, V131, P119, DOI 10.1016/S0166-6851(03)00198-1; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; SchartonKersten TM, 1997, J EXP MED, V185, P1261, DOI 10.1084/jem.185.7.1261; Schluter D, 2001, INFECT IMMUN, V69, P7889, DOI 10.1128/IAI.69.12.7889-7893.2001; Seeber F, 1996, GENE, V169, P39, DOI 10.1016/0378-1119(95)00786-5; SIBLEY LD, 1991, J IMMUNOL, V147, P2340; SIMS TA, 1989, BRIT J EXP PATHOL, V70, P317; Steinfeldt T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000576; Suzuki Y, 1997, INFECT IMMUN, V65, P2339, DOI 10.1128/IAI.65.6.2339-2345.1997; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Taylor GA, 2000, P NATL ACAD SCI USA, V97, P751, DOI 10.1073/pnas.97.2.751; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Virreira Winter S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024434; Vutova P, 2007, CELL MICROBIOL, V9, P1556, DOI 10.1111/j.1462-5822.2007.00893.x; Wiendl H, 2000, ANN NEUROL, V48, P679, DOI 10.1002/1531-8249(200010)48:4<679::AID-ANA19>3.3.CO;2-M; Wiendl H, 2005, TRENDS IMMUNOL, V26, P373, DOI 10.1016/j.it.2005.05.003; Wiendl H, 2003, FASEB J, V17, P1892, DOI 10.1096/fj.03-0039fje; Yap GS, 1999, J EXP MED, V189, P1083, DOI 10.1084/jem.189.7.1083; Zhao YO, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000288; Zhao YO, 2009, MEM I OSWALDO CRUZ, V104, P234, DOI 10.1590/S0074-02762009000200016; Zhao Y, 2009, J IMMUNOL, V182, P3775, DOI 10.4049/jimmunol.0804190	62	23	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45440	10.1371/journal.pone.0045440	http://dx.doi.org/10.1371/journal.pone.0045440			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024821	gold, Green Submitted, Green Published			2022-12-27	WOS:000308860100079
J	Valim, CXR; Basso, LR; Almeida, FBD; Reis, TF; Damasio, ARL; Arruda, LK; Martinez, R; Roque-Barreira, MC; Oliver, C; Jamur, MC; Coelho, PSR				Valim, Clarissa X. R.; Basso, Luiz Roberto, Jr.; dos Reis Almeida, Fausto B.; Reis, Thaila Fernanda; Lima Damasio, Andre Ricardo; Arruda, Luisa Karla; Martinez, Roberto; Roque-Barreira, Maria Cristina; Oliver, Constance; Jamur, Maria Celia; Rodrigues Coelho, Paulo Sergio			Characterization of PbPga1, an Antigenic GPI-Protein in the Pathogenic Fungus Paracoccidioides brasiliensis	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; CELL-WALL PROTEINS; ASPERGILLUS-NIDULANS; CANDIDA-ALBICANS; PICHIA-PASTORIS; NEUROSPORA-CRASSA; ANCHORED PROTEINS; O-GLYCOSYLATION; FUSION PROTEINS; GENOME-WIDE	Paracoccidioides brasiliensis is the etiologic agent of paracoccidioidomycosis (PCM), one of the most prevalent mycosis in Latin America. P. brasiliensis cell wall components interact with host cells and influence the pathogenesis of PCM. Cell wall components, such as glycosylphosphatidylinositol (GPI)-proteins play a critical role in cell adhesion and host tissue invasion. Although the importance of GPI-proteins in the pathogenesis of other medically important fungi is recognized, little is known about their function in P. brasiliensis cells and PCM pathogenesis. We cloned the PbPga1 gene that codifies for a predicted GPI-anchored glycoprotein from the dimorphic pathogenic fungus P. brasiliensis. PbPga1 is conserved in Eurotiomycetes fungi and encodes for a protein with potential glycosylation sites in a serine/threonine-rich region, a signal peptide and a putative glycosylphosphatidylinositol attachment signal sequence. Specific chicken anti-rPbPga1 antibody localized PbPga1 on the yeast cell surface at the septum between the mother cell and the bud with stronger staining of the bud. The exposure of murine peritoneal macrophages to rPbPga1 induces TNF-alpha release and nitric oxide (NO) production by macrophages. Furthermore, the presence of O-glycosylation sites was demonstrated by beta-elimination under ammonium hydroxide treatment of rPbPga1. Finally, sera from PCM patients recognized rPbPga1 by Western blotting indicating the presence of specific antibodies against rPbPga1. In conclusion, our findings suggest that the PbPga1gene codifies for a cell surface glycoprotein, probably attached to a GPI-anchor, which may play a role in P. brasiliensis cell wall morphogenesis and infection. The induction of inflammatory mediators released by rPbPga1 and the reactivity of PCM patient sera toward rPbPga1 imply that the protein favors the innate mechanisms of defense and induces humoral immunity during P. brasiliensis infection.	[Valim, Clarissa X. R.; Basso, Luiz Roberto, Jr.; dos Reis Almeida, Fausto B.; Reis, Thaila Fernanda; Roque-Barreira, Maria Cristina; Oliver, Constance; Jamur, Maria Celia; Rodrigues Coelho, Paulo Sergio] Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Biagentes Patogen, Sao Paulo, Brazil; [Lima Damasio, Andre Ricardo] Fac Med Ribeirao Preto, Dept Bioquim & Imunol, Sao Paulo, Brazil; [Arruda, Luisa Karla; Martinez, Roberto] Fac Med Ribeirao Preto, Dept Clin Med, Sao Paulo, Brazil		Valim, CXR (corresponding author), Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Biagentes Patogen, Sao Paulo, Brazil.	pacoelho@fmrp.usp.br	Almeida, Fausto/N-6540-2013; Damasio, André RL/H-1162-2016; dos Reis, Thaila F/N-6237-2014; Roque-Barreira, Maria-Cristina/A-4552-2008; Arruda, L. Karla/D-5845-2013; Basso, Luiz/Q-2859-2017	Almeida, Fausto/0000-0002-3782-3698; Damasio, André RL/0000-0001-9304-3998; dos Reis, Thaila F/0000-0002-7776-977X; Roque-Barreira, Maria-Cristina/0000-0001-7425-0908; Arruda, L. Karla/0000-0002-7505-210X; Basso, Luiz/0000-0002-8541-4258	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP); CXRV; FBRA; TFR; ARLD; LRB; FAPESP [03/01440-2, 08/55831-6]; PSRC	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CXRV; FBRA; TFR; ARLD; LRB; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); PSRC	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP) predoctoral fellowships awarded to CXRV, FBRA, TFR, ARLD, a Conselho Nacional de Desenvolvimento Cientifico e Tecnologico postdoctoral fellowship awarded to LRB and FAPESP research grants (03/01440-2 and 08/55831-6) awarded to PSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; AREZZO F, 1987, ANAL BIOCHEM, V167, P387, DOI 10.1016/0003-2697(87)90181-3; Arruda C, 2002, CLIN IMMUNOL, V103, P185, DOI 10.1006/clim.2002.5207; Arruda C, 2007, MICROBES INFECT, V9, P308, DOI 10.1016/j.micinf.2006.12.005; Benard G, 2001, CYTOKINE, V13, P248, DOI 10.1006/cyto.2000.0824; Benard G, 2008, MYCOPATHOLOGIA, V165, P209, DOI 10.1007/s11046-007-9065-0; Bowman SM, 2006, EUKARYOT CELL, V5, P587, DOI 10.1128/EC.5.3.587-600.2006; Breinig F, 2002, APPL MICROBIOL BIOT, V58, P637, DOI 10.1007/s00253-002-0939-2; Bretthauer RK, 1999, BIOTECHNOL APPL BIOC, V30, P193; Brul S, 1997, ANTON LEEUW INT J G, V72, P229, DOI 10.1023/A:1000429208049; BRUMMER E, 1993, CLIN MICROBIOL REV, V6, P89, DOI 10.1128/CMR.6.2.89-117.1993; Calich VLG, 1998, BRAZ J MED BIOL RES, V31, P615, DOI 10.1590/S0100-879X1998000500003; CANO LE, 1994, INFECT IMMUN, V62, P1494, DOI 10.1128/IAI.62.4.1494-1496.1994; Cao W, 2009, J GEN APPL MICROBIOL, V55, P381, DOI 10.2323/jgam.55.381; Carvalho KC, 2008, CLIN VACCINE IMMUNOL, V15, P622, DOI 10.1128/CVI.00437-07; Castro ND, 2005, GENET MOL RES, V4, P326; Castro ND, 2009, FEMS YEAST RES, V9, P103, DOI 10.1111/j.1567-1364.2008.00463.x; Choi CJ, 2005, FUNGAL GENET BIOL, V42, P590, DOI 10.1016/j.fgb.2005.02.002; Colombo AL, 2011, MED MYCOL, V49, P785, DOI 10.3109/13693786.2011.577821; Coltri KC, 2006, MICROBES INFECT, V8, P704, DOI 10.1016/j.micinf.2005.09.008; Damveld RA, 2005, FUNGAL GENET BIOL, V42, P873, DOI 10.1016/j.fgb.2005.06.006; de Groot PWJ, 2009, FUNGAL GENET BIOL, V46, pS72, DOI 10.1016/j.fgb.2008.07.022; de Groot PWJ, 2003, YEAST, V20, P781, DOI 10.1002/yea.1007; De Groot PWJ, 2005, FUNGAL GENET BIOL, V42, P657, DOI 10.1016/j.fgb.2005.04.002; Almeida FBD, 2010, YEAST, V27, P67, DOI 10.1002/yea.1731; Dranginis AM, 2007, MICROBIOL MOL BIOL R, V71, P282, DOI 10.1128/MMBR.00037-06; Duman JG, 1998, BIOTECHNOL APPL BIOC, V28, P39; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; FRANCO M, 1987, J MED VET MYCOL, V25, P5; Frieman MB, 2004, MICROBIOL-SGM, V150, P3105, DOI 10.1099/mic.0.27420-0; Calich VLG, 2008, MYCOPATHOLOGIA, V165, P223, DOI 10.1007/s11046-007-9048-1; Gastebois A, 2010, EUKARYOT CELL, V9, P1294, DOI 10.1128/EC.00107-10; Gonzalez A, 2000, INFECT IMMUN, V68, P2546, DOI 10.1128/IAI.68.5.2546-2552.2000; Gonzalez A, 2003, MED MYCOL, V41, P391, DOI 10.1080/13693780310001610038; Goto M, 2007, BIOSCI BIOTECH BIOCH, V71, P1415, DOI 10.1271/bbb.70080; Gustafsson A, 2011, GLYCOBIOLOGY, V21, P1071, DOI 10.1093/glycob/cwr046; Hartl L, 2011, FUNGAL GENET BIOL, V48, P185, DOI 10.1016/j.fgb.2010.06.011; JENTOFT N, 1990, TRENDS BIOCHEM SCI, V15, P291, DOI 10.1016/0968-0004(90)90014-3; Jeong HY, 2004, MYCOLOGIA, V96, P52, DOI 10.2307/3761987; Karhawi ASK, 2000, MED MYCOL, V38, P225, DOI 10.1080/714030939; Klis FM, 2001, MED MYCOL, V39, P1, DOI 10.1080/744118876; Klis FM, 2009, FEMS YEAST RES, V9, P1013, DOI 10.1111/j.1567-1364.2009.00541.x; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Levdansky E, 2010, EUKARYOT CELL, V9, P1403, DOI 10.1128/EC.00126-10; Levitz SM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000758; Maddi A, 2010, EUKARYOT CELL, V9, P1766, DOI 10.1128/EC.00134-10; Mamoni RL, 2006, CYTOKINE, V35, P207, DOI 10.1016/j.cyto.2006.08.005; Martinet W, 1997, EUR J BIOCHEM, V247, P332, DOI 10.1111/j.1432-1033.1997.00332.x; Nather K, 2008, FEMS MICROBIOL LETT, V285, P137, DOI 10.1111/j.1574-6968.2008.01263.x; Oliveira SJ, 2002, MICROBES INFECT, V4, P139, DOI 10.1016/S1286-4579(01)01521-0; Peracoli MTS, 2003, MICROBES INFECT, V5, P413, DOI 10.1016/S1286-4579(03)00040-6; Pina A, 2004, INFECT IMMUN, V72, P2369, DOI 10.1128/IAI.72.4.2369-2378.2004; Pittet M, 2007, BBA-MOL CELL BIOL L, V1771, P405, DOI 10.1016/j.bbalip.2006.05.015; Proszynski TJ, 2004, MOL BIOL CELL, V15, P1533, DOI 10.1091/mbc.E03-07-0511; Rademaker GJ, 1998, ANAL BIOCHEM, V257, P149, DOI 10.1006/abio.1997.2548; Restrepo A, 2001, MED MYCOL, V39, P233, DOI 10.1080/714031028; Richard ML, 2007, EUKARYOT CELL, V6, P119, DOI 10.1128/EC.00297-06; Romano CC, 2002, CYTOKINE, V18, P149, DOI 10.1006/cyto.2002.0884; Rooney PJ, 2002, CELL MICROBIOL, V4, P127, DOI 10.1046/j.1462-5822.2002.00179.x; San-Blas G, 2002, MED MYCOL, V40, P225, DOI 10.1080/mmy.40.3.225.242; SCORER CA, 1993, GENE, V136, P111, DOI 10.1016/0378-1119(93)90454-B; Soares AMVC, 2001, IMMUNOLOGY, V102, P480, DOI 10.1046/j.1365-2567.2001.01179.x; Souto JT, 2000, AM J PATHOL, V156, P1811, DOI 10.1016/S0002-9440(10)65053-5; Van den Steen P, 1998, BBA-GEN SUBJECTS, V1425, P587, DOI 10.1016/S0304-4165(98)00113-5; Verstrepen KJ, 2006, MOL MICROBIOL, V60, P5, DOI 10.1111/j.1365-2958.2006.05072.x; Xie XF, 2010, YEAST, V27, P479, DOI 10.1002/yea.1787; Yamazaki H, 2008, FUNGAL GENET BIOL, V45, P963, DOI 10.1016/j.fgb.2008.02.008	67	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44792	10.1371/journal.pone.0044792	http://dx.doi.org/10.1371/journal.pone.0044792			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024763	Green Submitted, Green Published, gold			2022-12-27	WOS:000308860100021
J	Park, HO; Bae, J				Park, Ho-Oak; Bae, Jeehyeon			Disturbed Relaxin Signaling Pathway and Testicular Dysfunction in Mouse Offspring upon Maternal Exposure to Simazine	PLOS ONE			English	Article							DECREASES CELL-PROLIFERATION; NITRIC-OXIDE SYNTHASE; REPRODUCTIVE-TRACT; BINDING CELLS; IN-VITRO; ATRAZINE; RATS; TESTIS; SPERMATOGENESIS; RECEPTORS	Simazine is a triazine herbicide that is being widely applied worldwide and commonly detected in surface and groundwater. Despite its popular use in controlling weeds and algae, very limited information is available regarding its toxicity. In the present study, pregnant mice were orally exposed to low doses (0, 5, 50, or 500 mu g/kg body weight per day) of simazine during gestation and lactation, during which no overt maternal toxic response was detected, and their offspring was assessed. Simazine-exposed male offspring showed decreased body, testicular, and epididymis weight, increased testicular apoptosis, and decreased sperm concentrations. Differentially-expressed genes in the testes of male offspring exposed to simazine were identified by DNA microarray, revealing 775 upregulated and 791 downregulated genes; among these, the relaxin-family peptide receptor 1 (Rxfp1), which is the receptor for relaxin hormone, was significantly downregulated. In addition, the expression of target genes in the relaxin pathway, including nitric oxide synthase 2 (Nos2) and Nos3, was significantly decreased in simazine-exposed F1 testes. Moreover, simazine inhibited NO release, and knockdown of Rxfp1 blocked the inhibitory action of simazine on NO production in testicular Leydig cells. Therefore, the present study provides a better understanding of the toxicities associated with the widely used herbicide simazine at environmentally relevant doses by demonstrating that maternal exposure interferes with the pleotropic relaxin-NO signaling pathway, impairing normal development and reproductive activity of male offspring.	[Park, Ho-Oak; Bae, Jeehyeon] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea	Chung Ang University	Park, HO (corresponding author), Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea.	jeehyeon@cau.ac.kr		bae, jeehyeon/0000-0003-1995-1378	National Research Foundation of Korea; Korean government (MEST) [2010-0026211]	National Research Foundation of Korea(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea grant funded by the Korean government (MEST) (2010-0026211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarikwu SO, 2010, ARCH ENVIRON CON TOX, V58, P874, DOI 10.1007/s00244-009-9371-2; Agency EP, 2006, REREGISTRATION ELIGI; Andric SA, 2010, BIOL REPROD, V83, P434, DOI 10.1095/biolreprod.110.083626; Bathgate RA, 2005, ANN NY ACAD SCI, V1041, P61, DOI 10.1196/annals.1282.010; Belloni V, 2011, TOXICOLOGY, V279, P19, DOI 10.1016/j.tox.2010.07.002; Brevini Tiziana A. L., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P1; Cardoso LC, 2010, REPRODUCTION, V139, P185, DOI 10.1530/REP-09-0146; Carreau S, 1998, ANN ENDOCRINOL-PARIS, V59, P79; Chevrier C, 2011, ENVIRON HEALTH PERSP, V119, P1034, DOI 10.1289/ehp.1002775; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Feng S, 2007, CLIN CANCER RES, V13, P1695, DOI 10.1158/1078-0432.CCR-06-2492; Filonzi M, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-29; Foradori CD, 2009, BIOL REPROD, V81, P1099, DOI 10.1095/biolreprod.109.077453; Fraites MJP, 2011, REPROD TOXICOL, V32, P52, DOI 10.1016/j.reprotox.2011.04.003; Hovey RC, 2011, TOXICOL SCI, V119, P380, DOI 10.1093/toxsci/kfq337; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; Ivell R, 2002, SCIENCE, V295, P637, DOI 10.1126/science.1069234; Jee BC, 2003, GYNECOL OBSTET INVES, V56, P143, DOI 10.1159/000073773; Jurewicz J, 2009, INT J OCCUP MED ENV, V22, P305, DOI 10.2478/v10001-009-0036-1; Kim KR, 2002, TOXICOL IN VITRO, V16, P517, DOI 10.1016/S0887-2333(02)00047-4; Kmetic I, 2008, B ENVIRON CONTAM TOX, V81, P205, DOI 10.1007/s00128-008-9425-6; Kohsaka T, 1998, BIOL REPROD, V59, P991, DOI 10.1095/biolreprod59.4.991; Krajnc-Franken MAM, 2004, MOL CELL BIOL, V24, P687, DOI 10.1128/MCB.24.2.687-696.2004; KUENZI MJ, 1995, ENDOCRINOLOGY, V136, P1367, DOI 10.1210/en.136.4.1367; Lee NPY, 2008, ADV EXP MED BIOL, V636, P172, DOI 10.1007/978-0-387-09597-4_10; Manske MK, 2004, ARCH ENVIRON CON TOX, V46, P438, DOI 10.1007/s00244-003-3087-5; Marathe N, 2012, J BIOL CHEM, V287, P978, DOI 10.1074/jbc.M111.294959; MASINI E, 1994, J CLIN INVEST, V94, P1974, DOI 10.1172/JCI117549; Nguyen BT, 2003, MOL ENDOCRINOL, V17, P1075, DOI 10.1210/me.2002-0284; Nistri Silvia, 2003, Reprod Biol Endocrinol, V1, P5, DOI 10.1186/1477-7827-1-5; O'Bryan MK, 2000, BIOL REPROD, V63, P1285, DOI 10.1095/biolreprod63.5.1285; O'Donnell L, 2001, ENDOCR REV, V22, P289, DOI 10.1210/er.22.3.289; Ochoa-Acuna H, 2009, ENVIRON HEALTH PERSP, V117, P1619, DOI 10.1289/ehp.0900784; Pomerantz DK, 1998, ENDOCRINOLOGY, V139, P922, DOI 10.1210/en.139.3.922; Powell ER, 2011, TOXICOL IN VITRO, V25, P644, DOI 10.1016/j.tiv.2011.01.001; Rayner JL, 2007, TOXICOL APPL PHARM, V218, P238, DOI 10.1016/j.taap.2006.11.020; Riviere JE, 2011, TOXICOL SCI, V119, P224, DOI 10.1093/toxsci/kfq317; Rohr JR, 2010, ENVIRON HEALTH PERSP, V118, P20, DOI 10.1289/ehp.0901164; SALASNICH L, 1995, PHYS REV A, V51, P4281, DOI 10.1103/PhysRevA.51.4281; Shiraishi K, 2007, BJU INT, V99, P1086, DOI 10.1111/j.1464-410X.2007.06800.x; Swan SH, 2006, INT J ANDROL, V29, P62, DOI 10.1111/j.1365-2605.2005.00620.x; Victor-Costa AB, 2010, REPROD TOXICOL, V29, P323, DOI 10.1016/j.reprotox.2009.12.006; Weissman BA, 2007, AM J PHYSIOL-ENDOC M, V292, pE615, DOI 10.1152/ajpendo.00412.2006; Zamberlam G, 2011, MOL CELL ENDOCRINOL, V335, P189, DOI 10.1016/j.mce.2011.01.013	44	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44856	10.1371/journal.pone.0044856	http://dx.doi.org/10.1371/journal.pone.0044856			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984576	gold, Green Published, Green Submitted			2022-12-27	WOS:000308738500092
J	Tognetti, A; Berticat, C; Raymond, M; Faurie, C				Tognetti, Arnaud; Berticat, Claire; Raymond, Michel; Faurie, Charlotte			Sexual Selection of Human Cooperative Behaviour: An Experimental Study in Rural Senegal	PLOS ONE			English	Article							PARTNER CHOICE; CONDITIONAL COOPERATION; VOLUNTARY CONTRIBUTIONS; COMPETITIVE ALTRUISM; INDIRECT RECIPROCITY; BIOLOGICAL MARKETS; LEKKING BIRD; PUBLIC-GOODS; EVOLUTION; GENEROSITY	Human cooperation in large groups and between non-kin individuals remains a Darwinian puzzle. Investigations into whether and how sexual selection is involved in the evolution of cooperation represent a new and important research direction. Here, 69 groups of four men or four women recruited from a rural population in Senegal played a sequential public-good game in the presence of out-group observers, either of the same sex or of the opposite sex. At the end of the game, participants could donate part of their gain to the village school in the presence of the same observers. Both contributions to the public good and donations to the school, which reflect different components of cooperativeness, were influenced by the sex of the observers. The results suggest that in this non-Western population, sexual selection acts mainly on men's cooperative behaviour with non-kin, whereas women's cooperativeness is mainly influenced by nonsexual social selection.	[Tognetti, Arnaud; Berticat, Claire; Raymond, Michel; Faurie, Charlotte] Univ Montpellier 2, Montpellier, France; [Berticat, Claire; Raymond, Michel; Faurie, Charlotte] CNRS, Inst Evolutionary Sci, Montpellier, France	Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Tognetti, A (corresponding author), Univ Montpellier 2, Montpellier, France.	charlotte.faurie@univ-montp2.fr	Raymond, Michel/C-9049-2015	Raymond, Michel/0000-0002-1714-6984; Berticat, Claire/0000-0003-1305-5337	CNRS - France; Region Languedoc-Roussillon "Chercheur(se)s d'Avenir"	CNRS - France(Centre National de la Recherche Scientifique (CNRS)); Region Languedoc-Roussillon "Chercheur(se)s d'Avenir"(Region Occitanie)	This study was supported by the CNRS - France (http://www.cnrs.fr) and by the Region Languedoc-Roussillon "Chercheur(se)s d'Avenir". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.D., 2006, EVOL PSYCHOL-US, V4, P1; Amundsen T, 2000, TRENDS ECOL EVOL, V15, P149, DOI 10.1016/S0169-5347(99)01800-5; [Anonymous], 2010, R LANG ENV STAT COMP; Barclay P, 2007, P ROY SOC B-BIOL SCI, V274, P749, DOI 10.1098/rspb.2006.0209; Benz M, 2008, EXP ECON, V11, P268, DOI 10.1007/s10683-007-9192-y; Bowles S, 2006, SCIENCE, V314, P1569, DOI 10.1126/science.1134829; Boyd R, 2009, PHILOS T R SOC B, V364, P3281, DOI 10.1098/rstb.2009.0134; Charness G, 2011, GAME ECON BEHAV, V72, P77, DOI 10.1016/j.geb.2010.07.006; Chaudhuri A, 2011, EXP ECON, V14, P47, DOI 10.1007/s10683-010-9257-1; Chiang YS, 2010, EVOL HUM BEHAV, V31, P265, DOI 10.1016/j.evolhumbehav.2010.03.003; Clutton Brock TH, 1989, P ROY SOC LOND B BIO, V236, P339; Courtiol A, 2009, ANIM BEHAV, V78, P1405, DOI 10.1016/j.anbehav.2009.09.016; Duffy KG, 2007, CURR BIOL, V17, pR586, DOI 10.1016/j.cub.2007.06.001; Duval EH, 2007, AUK, V124, P1168, DOI 10.1642/0004-8038(2007)124[1168:CDALBO]2.0.CO;2; Farrelly Daniel, 2007, EVOLUTIONARY PSYCHOL, V5, P313, DOI DOI 10.1177/147470490700500205; Fehr E, 2004, NATURE, V432, P449, DOI 10.1038/432449a; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 2011, J PUBLIC ECON, V95, P1144, DOI 10.1016/j.jpubeco.2011.05.013; Fischbacher U, 2010, AM ECON REV, V100, P541, DOI 10.1257/aer.100.1.541; Flinn M, 2007, EVOLUTION MIND FUNDA, P249; Flinn MV, 2012, HUM NATURE-INT BIOS, V23, P68, DOI 10.1007/s12110-012-9135-y; Geary DC, 2000, PSYCHOL BULL, V126, P55, DOI 10.1037/0033-2909.126.1.55; Gintis H, 2001, J THEOR BIOL, V213, P103, DOI 10.1006/jtbi.2001.2406; Greig F, 2009, J ECON BEHAV ORGAN, V70, P1, DOI 10.1016/j.jebo.2008.12.006; Gurven M, 2000, EVOL HUM BEHAV, V21, P263, DOI 10.1016/S1090-5138(00)00032-5; Henrich J, 2000, AM ECON REV, V90, P973, DOI 10.1257/aer.90.4.973; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Iredale W, 2008, EVOL PSYCHOL-US, V6, P386, DOI 10.1177/147470490800600302; Keser C, 1996, ECON LETT, V50, P359, DOI 10.1016/0165-1765(95)00769-5; Keser C, 2000, SCAND J ECON, V102, P23, DOI 10.1111/1467-9442.00182; King Casas B, 2005, SCIENCE, V308, P78; Lamba S, 2011, P NATL ACAD SCI USA, V108, P14426, DOI 10.1073/pnas.1105186108; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; Llaurens V, 2009, J EVOLUTION BIOL, V22, P1854, DOI 10.1111/j.1420-9101.2009.01793.x; MCDONALD DB, 1989, ANIM BEHAV, V37, P1007, DOI 10.1016/0003-3472(89)90145-0; MCDONALD DB, 1989, AM NAT, V134, P709, DOI 10.1086/285007; Miller GF, 2007, Q REV BIOL, V82, P97, DOI 10.1086/517857; Nesse Randolph M., 2007, Biology Theory, V2, P143, DOI 10.1162/biot.2007.2.2.143; Nesse RM, 2010, EVOLUTION, CULTURE, AND THE HUMAN MIND, P137; NOE R, 1994, BEHAV ECOL SOCIOBIOL, V35, P1; NOE R, 1995, TRENDS ECOL EVOL, V10, P336, DOI 10.1016/S0169-5347(00)89123-5; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Ostrom E, 2003, RUSSELL SAGE TRUST, V6, P19; Phillips T, 2008, BRIT J PSYCHOL, V99, P555, DOI 10.1348/000712608X298467; Rege M, 2004, J PUBLIC ECON, V88, P1625, DOI 10.1016/S0047-2727(03)00021-5; Roberts G, 1998, P ROY SOC B-BIOL SCI, V265, P427, DOI 10.1098/rspb.1998.0312; Ronay R, 2010, SOC PSYCHOL PERS SCI, V1, P57, DOI 10.1177/1948550609352807; Roney JR, 2003, EVOL HUM BEHAV, V24, P365, DOI 10.1016/S1090-5138(03)00053-9; Rustagi D, 2010, SCIENCE, V330, P961, DOI 10.1126/science.1193649; Smith EA, 2000, EVOL HUM BEHAV, V21, P245, DOI 10.1016/S1090-5138(00)00031-3; Smith EA, 2003, BEHAV ECOL, V14, P116, DOI 10.1093/beheco/14.1.116; Sylwester K, 2010, BIOL LETTERS, V6, P659, DOI 10.1098/rsbl.2010.0209; Van Vugt M, 2013, BRIT J PSYCHOL, V104, P3, DOI 10.1111/j.2044-8295.2011.02093.x; Wedekind C, 2002, CURR BIOL, V12, P1012, DOI 10.1016/S0960-9822(02)00890-4; West Eberhard MJ, 1979, P AM PHILOS SOC, V123, P222; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; ZAHAVI A, 1995, J AVIAN BIOL, V26, P1, DOI 10.2307/3677205; [No title captured]	59	26	26	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44403	10.1371/journal.pone.0044403	http://dx.doi.org/10.1371/journal.pone.0044403			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005GJ	22984503	Green Published, gold, Green Submitted			2022-12-27	WOS:000308738500054
J	Chen, Q; Chen, TH; Li, WJ; Zhang, W; Zhu, JW; Li, Y; Huang, YJ; Shen, YM; Yu, CD				Chen, Qiang; Chen, Tenghui; Li, Wenjiao; Zhang, Wei; Zhu, Jingwei; Li, Yang; Huang, Yaojian; Shen, Yuemao; Yu, Chundong			Mycoepoxydiene Inhibits Lipopolysaccharide-Induced Inflammatory Responses through the of TRAF6 Polyubiquitination	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; TOLL-LIKE RECEPTORS; INNATE IMMUNITY; MAP KINASE; INTERLEUKIN-1; METABOLITES; ENDOTOXIN; PATHWAY; P38	Mycoepoxydiene (MED) is a polyketide isolated from a marine fungus associated with mangrove forests. MED has been shown to be able to induce cell cycle arrest and cancer cell apoptosis. However, its effects on inflammatory response are unclear. Herein we showed that MED exhibited inhibitory effect on inflammatory response induced by lipopolysaccharide (LPS). MED significantly inhibited LPS-induced expression of pro-inflammatory mediators such as tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-1 beta, IL-6, and nitric oxide (NO) in macrophages. MED inhibited LPS-induced nuclear translocation of nuclear factor (NF)-kappa B (NF-kappa B) p65, I kappa B degradation, I kappa B kinase (IKK) phosphorylation, and the activation of extracellular signal-regulated kinase (ERK), c-jun N-terminal kinase (JNK), and p38, suggesting that MED blocks the activation of both NF-kappa B and mitogen-activated protein kinase (MAPK) pathways. Furthermore, the effects of MED on LPS-induced activation of upstream signaling molecules such as transforming growth factor-beta-activated kinase 1 (TAK1), tumor necrosis factor receptor-associated factor 6 (TRAF6) and IL-1 receptor associated kinases1 (IRAK1) were investigated. MED significantly inhibited TAK1 phosphorylation and TRAF6 polyubiquitination, but not IRAK1 phosphorylation and TRAF6 dimerization, indicating that MED inhibits LPS-induced inflammatory responses at least in part through suppression of TRAF6 polyubiquitination. Moreover, MED protected mice from LPS-induced endotoxin shock by reducing serum inflammatory cytokines. These results suggest that MED is a potential lead compound for the development of a novel nonsteroidal antiinflammatory drug.	[Chen, Qiang; Chen, Tenghui; Li, Wenjiao; Zhang, Wei; Zhu, Jingwei; Li, Yang; Huang, Yaojian; Yu, Chundong] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China; [Shen, Yuemao] Shandong Univ, Sch Pharmaceut Sci, Jinan, Shandong, Peoples R China	Xiamen University; Shandong University	Chen, Q (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China.	yshen@sdu.edu.cn; cdyu@xmu.edu.cn	Huang, YJ/G-4624-2010; Li, Wenjiao/J-2198-2019; Yu, C/G-4626-2010; Shen, YM/G-4681-2010	Li, Wenjiao/0000-0003-1308-8489; Shen, Yuemao/0000-0002-3881-0135; Chen, Tenghui/0000-0003-0683-8974	National Basic Research Program of China (973 Program) [2009CB522200, 2010CB833802]; Natural Science Foundation of Fujian Province of China [2010J06014]; Natural Science Foundation of China [31170819, 90913024]; Youth Foundation of Health Department of Fujian Province [2010-2-84]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Foundation of Health Department of Fujian Province	This work was supported by grants from the National Basic Research Program of China (973 Program, 2009CB522200 and 2010CB833802); the Natural Science Foundation of Fujian Province of China (2010J06014); the Natural Science Foundation of China (31170819 and 90913024); and Youth Foundation of Health Department of Fujian Province (2010-2-84). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajizian SJ, 1999, J INFECT DIS, V179, P939, DOI 10.1086/314659; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Bian K, 2001, MOL PHARMACOL, V59, P939, DOI 10.1124/mol.59.4.939; Cai P, 1999, TETRAHEDRON LETT, V40, P1479, DOI 10.1016/S0040-4039(98)02700-2; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Chiou WF, 2011, BIOCHEM PHARMACOL, V81, P752, DOI 10.1016/j.bcp.2010.12.022; Gottipati S, 2008, CELL SIGNAL, V20, P269, DOI 10.1016/j.cellsig.2007.08.009; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hu J, 2002, J IMMUNOL, V168, P3910, DOI 10.4049/jimmunol.168.8.3910; Kang JY, 2011, ANNU REV BIOCHEM, V80, P917, DOI 10.1146/annurev-biochem-052909-141507; Karima R, 1999, MOL MED TODAY, V5, P123, DOI 10.1016/S1357-4310(98)01430-0; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Lee JC, 2000, IMMUNOPHARMACOLOGY, V47, P185, DOI 10.1016/S0162-3109(00)00206-X; Lin X, 2005, FEMS MICROBIOL LETT, V251, P53, DOI 10.1016/j.femsle.2005.07.025; Liu SQ, 2011, CELL RES, V21, P6, DOI 10.1038/cr.2010.170; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Manning AM, 2003, NAT REV DRUG DISCOV, V2, P554, DOI 10.1038/nrd1132; SZABO C, 1994, P NATL ACAD SCI USA, V91, P271, DOI 10.1073/pnas.91.1.271; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tun-Kyi A, 2011, NAT IMMUNOL, V12, P733, DOI 10.1038/ni.2069; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang JF, 2010, BIOORG MED CHEM LETT, V20, P7054, DOI 10.1016/j.bmcl.2010.09.105; Wertz IE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003350; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948	29	31	35	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44890	10.1371/journal.pone.0044890	http://dx.doi.org/10.1371/journal.pone.0044890			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984582	Green Published, Green Submitted, gold			2022-12-27	WOS:000308638700097
J	Miller, PE; Rambachan, A; Hubbard, RJ; Li, JB; Meyer, AE; Stephens, P; Mounts, AW; Rolfes, MA; Penn, CR				Miller, Paula E.; Rambachan, Aksharananda; Hubbard, Roderick J.; Li, Jiabai; Meyer, Alison E.; Stephens, Peter; Mounts, Anthony W.; Rolfes, Melissa A.; Penn, Charles R.			Supply of Neuraminidase Inhibitors Related to Reduced Influenza A (H1N1) Mortality during the 2009-2010 H1N1 Pandemic: An Ecological Study	PLOS ONE			English	Article							HOSPITALIZATION; METAANALYSIS; OSELTAMIVIR; EFFICACY; SAFETY; RISK	Background: The influenza A (H1N1) pandemic swept across the globe from April 2009 to August 2010 affecting millions. Many WHO Member States relied on antiviral drugs, specifically neuraminidase inhibitors (NAIs) oseltamivir and zanamivir, to treat influenza patients in critical condition. Such drugs have been found to be effective in reducing severity and duration of influenza illness, and likely reduced morbidity during the pandemic. However, it is less clear whether NAIs used during the pandemic reduced H1N1 mortality. Methods: Country-level data on supply of oseltamivir and zanamivir were used to predict H1N1 mortality (per 100,000 people) from July 2009 to August 2010 in forty-two WHO Member States. Poisson regression was used to model the association between NAI supply and H1N1 mortality, with adjustment for economic, demographic, and health-related confounders. Results: After adjustment for potential confounders, each 10% increase in kilograms of oseltamivir, per 100,000 people, was associated with a 1.6% reduction in H1N1 mortality over the pandemic period (relative rate (RR) = 0.84 per log increase in oseltamivir supply). While the supply of zanamivir was considerably less than that of oseltamivir in each Member State, each 10% increase in kilogram of active zanamivir, per 100,000, was associated with a 0.3% reduction in H1N1 mortality (RR = 0.97 per log increase). Conclusion: While there are limitations to the ecologic nature of these data, this analysis offers evidence of a protective relationship between antiviral drug supply and influenza mortality and supports a role for influenza antiviral use in future pandemics.	[Miller, Paula E.; Rambachan, Aksharananda; Hubbard, Roderick J.; Li, Jiabai; Meyer, Alison E.] St Olaf Coll, Dept Stat, Northfield, MN 55057 USA; [Stephens, Peter] IMS Hlth, London, England; [Mounts, Anthony W.; Penn, Charles R.] WHO, CH-1211 Geneva, Switzerland; [Rolfes, Melissa A.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA	Saint Olaf College; World Health Organization; University of Minnesota System; University of Minnesota Twin Cities	Miller, PE (corresponding author), St Olaf Coll, Dept Stat, Northfield, MN 55057 USA.	riede056@umn.edu		Rolfes, Melissa/0000-0002-0483-9941	National Science Foundation [DMS-0354308]	National Science Foundation(National Science Foundation (NSF))	This work was supported in part by National Science Foundation Grant # DMS-0354308. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], 2010, WHO GUID PHARM MAN P; Cooper NJ, 2003, BRIT MED J, V326, P1235, DOI 10.1136/bmj.326.7401.1235; FERGUSON NM, 2006, CARBON NANOTUBES LON, V442, P448, DOI DOI 10.1038/NATURE04795; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Hernan MA, 2011, CLIN INFECT DIS, V53, P277, DOI 10.1093/cid/cir400; Iglesias ALH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021838; Hsu J, 2012, ANN INTERN MED, V156, P512, DOI 10.7326/0003-4819-156-7-201204030-00411; Inglesby TV, 2006, BIOSECUR BIOTERROR, V4, P366, DOI 10.1089/bsp.2006.4.366; International Obesity Task Force, OB PREV WORLDW; Lee EH, 2010, CLIN INFECT DIS, V50, P1498, DOI 10.1086/652446; Makela MJ, 2000, J INFECTION, V40, P42, DOI 10.1053/jinf.1999.0602; Maliszewski PJ, 2011, GEOSPATIAL HEALTH, V6, P95, DOI 10.4081/gh.2011.161; Hernandez JM, 2010, J CLIN VIROL, V49, P145, DOI 10.1016/j.jcv.2010.07.001; Nguyen-Van-Tam JS, 2010, THORAX, V65, P645, DOI 10.1136/thx.2010.135210; Nikolopoulos G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019432; Nukiwa N, 2010, CLIN INFECT DIS, V51, P993, DOI 10.1086/656443; Sugaya N, 2011, J INFECTION, V63, P288, DOI 10.1016/j.jinf.2011.06.008; The Fund for Peace, FAIL STAT IND 2010; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; UNAIDS/WHO, UNAIDS REP GLOB AIDS; United Nations, UN CHILDR FUND CHILD; United Nations, UN POP DIV WORLD POP; United Nations, UN STAT DIV STAT DAT; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Viboud C, 2010, PLOS CURR; *WHO, CHANG REP REQ PAND H; World Health Organization, GLOB HLTH OBS; World Health Organization, WHO STAT INF SYST WH; Xi XM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-256; Yang P, 2010, J INFECTION, V61, P277, DOI 10.1016/j.jinf.2010.07.010	31	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43491	10.1371/journal.pone.0043491	http://dx.doi.org/10.1371/journal.pone.0043491			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984431	Green Published, gold, Green Submitted			2022-12-27	WOS:000308638700024
J	Papp, K; Vegh, P; Hobor, R; Szittner, Z; Voko, Z; Podani, J; Czirjak, L; Prechl, J				Papp, Krisztian; Vegh, Peter; Hobor, Renata; Szittner, Zoltan; Voko, Zoltan; Podani, Janos; Czirjak, Laszlo; Prechl, Jozsef			Immune Complex Signatures of Patients with Active and Inactive SLE Revealed by Multiplex Protein Binding Analysis on Antigen Microarrays	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; DOUBLE-STRANDED DNA; FIXING ANTIBODIES; DISEASE-ACTIVITY; IGG ANTIBODIES; ACTIVATION; PRODUCTS; BIOMARKERS; DIAGNOSIS; PATHWAY	Systemic lupus erythematosus is characterized by dysfunctional clearance of apoptotic debris and the development of pathogenic autoantibodies. While the complement system is also involved in the disease no attempt has been made to generate a comprehensive view of immune complex formation from various autoantigens. We increased the complexity of autoantibody profiles by measuring the binding of two complement proteins, C3 and C4, in addition to two antibody classes, IgG and IgM, to a collection of autoantigens. These complement components covalently bind to those microarray features where antibodies and other serum components induce complement activation. Using this technology, we compared functional serum antibody profiles of control subjects (n = 31) and patients with lupus erythematosus (n = 61) in the active (n = 22) and inactive (n = 39) phase of the disease. Multivariate analysis was applied to identify contributions of binding data on 25 antigens to the discrimination of the study groups. Receiver operating characteristic analysis was used to portray the discriminative property of each measured parameter for each antigen in pairwise group comparisons. Complement C3 and C4 deposition increased on autoantibody targets in spite of the decreased serum complement concentrations, and decreased on other autoantigens, demonstrating the imbalance of complement function in patients with lupus erythematosus. Our observations confirmed previously known markers of disease and showed that C3 and C4 deposition data were at least as powerful as Ig binding data in separating the study groups.	[Papp, Krisztian; Szittner, Zoltan] Eotvos Lorand Univ, Dept Immunol, Budapest, Hungary; [Papp, Krisztian; Vegh, Peter; Szittner, Zoltan; Prechl, Jozsef] Diagnosticum Ltd, Budapest, Hungary; [Hobor, Renata; Czirjak, Laszlo] Univ Pecs, Ctr Clin, Dept Rheumatol & Immunol, Pecs, Hungary; [Voko, Zoltan] Eotvos Lorand Univ, Dept Hlth Policy & Hlth Econ, Budapest, Hungary; [Voko, Zoltan] Syreon Res Inst, Budapest, Hungary; [Podani, Janos] Eotvos Lorand Univ, Dept Plant Systemat Ecol & Theoret Biol, Budapest, Hungary; [Prechl, Jozsef] Eotvos Lorand Univ, Hungarian Acad Sci, Immunol Res Grp, Budapest, Hungary	Eotvos Lorand University; University of Pecs; Eotvos Lorand University; Eotvos Lorand University; Eotvos Lorand University; Hungarian Academy of Sciences	Papp, K (corresponding author), Eotvos Lorand Univ, Dept Immunol, Budapest, Hungary.	jprechl@gmail.com	Vokó, Zoltán/O-3747-2019; Papp, Krisztián/B-2251-2009; Prechl, József/B-2094-2009; Vokó, Zoltán/H-1153-2017; Podani, Janos/G-3074-2014	Vokó, Zoltán/0000-0002-1004-1848; Papp, Krisztián/0000-0003-0619-8233; Prechl, József/0000-0003-3859-4353; Vokó, Zoltán/0000-0002-1004-1848; Podani, Janos/0000-0002-1452-1486; Vegh, Peter/0000-0002-0133-3240	National Development Agency [KMOP-1.1.1-08/1-2008-0028]; European Union; European Social Fund [TAMOP4.2.1./B-09/1/KMR-2010-0003]; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences	National Development Agency; European Union(European Commission); European Social Fund(European Social Fund (ESF)); Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by grant KMOP-1.1.1-08/1-2008-0028 from National Development Agency to Diagnosticum. The European Union and the European Social Fund have provided financial support to the project under the grant agreement no. TAMOP4.2.1./B-09/1/KMR-2010-0003. K. P is supported by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLOU SP, 1979, CLIN EXP IMMUNOL, V37, P58; BEAULIEU A, 1979, ARTHRITIS RHEUM, V22, P565, DOI 10.1002/art.1780220602; EDBERG JC, 1988, J IMMUNOL, V141, P4258; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; ESPARZA RH, 1985, J RHEUMATOL, V12, P1109; Fattal I, 2010, IMMUNOLOGY, V130, P337, DOI 10.1111/j.1365-2567.2010.03245.x; GHARAVI AE, 1981, J CLIN LAB IMMUNOL, V6, P251; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Katsumata Y, 2011, ARTHRITIS RHEUM-US, V63, P2436, DOI 10.1002/art.30401; Li QZ, 2007, CLIN EXP IMMUNOL, V147, P60, DOI 10.1111/j.1365-2249.2006.03251.x; Liu CC, 2009, CTS-CLIN TRANSL SCI, V2, P300, DOI 10.1111/j.1752-8062.2009.00135.x; Liu CC, 2009, BEST PRACT RES CL RH, V23, P507, DOI 10.1016/j.berh.2009.01.008; Manzi S, 2004, ARTHRITIS RHEUM-US, V50, P3596, DOI 10.1002/art.20561; Manzi S, 1996, ARTHRITIS RHEUM, V39, P1178, DOI 10.1002/art.1780390716; Navratil JS, 2006, ARTHRITIS RHEUM-US, V54, P670, DOI 10.1002/art.21627; Papp K, 2007, MOL CELL PROTEOMICS, V6, P133, DOI 10.1074/mcp.T600036-MCP200; Papp K, 2010, RHEUMATOLOGY, V49, P2273, DOI 10.1093/rheumatology/keq278; Podani J., 2001, SYN TAX 2000 COMPUTE; ROTHFIELD NF, 1967, J CLIN INVEST, V46, P1785, DOI 10.1172/JCI105669; SMEENK R, 1990, CLIN RHEUMATOL, V9, P100, DOI 10.1007/BF02205557; Sturfelt G, 2005, RHEUMATOLOGY, V44, P1227, DOI 10.1093/rheumatology/keh719; TEPPO AM, 1984, RHEUMATOL INT, V4, P173, DOI 10.1007/BF00541210; Thurman JM, 2006, J IMMUNOL, V176, P1305, DOI 10.4049/jimmunol.176.3.1305; Truedsson L, 2007, AUTOIMMUNITY, V40, P560, DOI 10.1080/08916930701510673; VALENTIJN RM, 1985, ARTHRITIS RHEUM, V28, P904, DOI 10.1002/art.1780280810; VALLE RR, 1985, CLIN IMMUNOL IMMUNOP, V34, P345, DOI 10.1016/0090-1229(85)90183-7; Witte T, 2008, CLIN REV ALLERG IMMU, V34, P345, DOI 10.1007/s12016-007-8046-x; Xu W, 2008, J IMMUNOL, V180, P7613, DOI 10.4049/jimmunol.180.11.7613; Zhen QL, 2005, J CLIN INVEST, V115, P3428, DOI 10.1172/JCI23587	29	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44824	10.1371/journal.pone.0044824	http://dx.doi.org/10.1371/journal.pone.0044824			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984570	Green Published, Green Submitted, gold			2022-12-27	WOS:000308638700089
J	Maiwald, M; Chan, ESY				Maiwald, Matthias; Chan, Edwin S-Y			The Forgotten Role of Alcohol: A Systematic Review and Meta-Analysis of the Clinical Efficacy and Perceived Role of Chlorhexidine in Skin Antisepsis	PLOS ONE			English	Article							SURGICAL PREPARATION SOLUTIONS; PROSPECTIVE RANDOMIZED-TRIAL; CULTURE CONTAMINATION RATES; 10-PERCENT POVIDONE-IODINE; CATHETER-SITE CARE; BLOOD-CULTURE; ISOPROPYL-ALCOHOL; PREVENTION; GLUCONATE; INFECTION	Background: Skin antisepsis is a simple and effective measure to prevent infections. The efficacy of chlorhexidine is actively discussed in the literature on skin antisepsis. However, study outcomes due to chlorhexidine-alcohol combinations are often attributed to chlorhexidine alone. Thus, we sought to review the efficacy of chlorhexidine for skin antisepsis and the extent of a possible misinterpretation of evidence. Methods: We performed a systematic literature review of clinical trials and systematic reviews investigating chlorhexidine compounds for blood culture collection, vascular catheter insertion and surgical skin preparation. We searched PubMed, CINAHL, the Cochrane Library, the Agency for Healthcare Research and Quality website, several clinical trials registries and a manufacturer website. We extracted data on study design, antiseptic composition, and the following outcomes blood culture contamination, catheter colonisation, catheter-related bloodstream infection and surgical site infection. We conducted meta-analyses of the clinical efficacy of chlorhexidine compounds and reviewed the appropriateness of the authors' attribution. Results: In all three application areas and for all outcomes, we found good evidence favouring chlorhexidine-alcohol over aqueous competitors, but not over competitors combined with alcohols. For blood cultures and surgery, we found no evidence supporting chlorhexidine alone. For catheters, we found evidence in support of chlorhexidine alone for preventing catheter colonisation, but not for preventing bloodstream infection. A range of 29 to 43% of articles attributed outcomes solely to chlorhexidine when the combination with alcohol was in fact used. Articles with ambiguous attribution were common (8-35%). Unsubstantiated recommendations for chlorhexidine alone instead of chlorhexidine-alcohol were identified in several practice recommendations and evidence-based guidelines. Conclusions: Perceived efficacy of chlorhexidine is often in fact based on evidence for the efficacy of the chlorhexidine-alcohol combination. The role of alcohol has frequently been overlooked in evidence assessments. This has broader implications for knowledge translation as well as potential implications for patient safety.	[Maiwald, Matthias] KK Womens & Childrens Hosp, Dept Pathol & Lab Med, Singapore, Singapore; [Maiwald, Matthias] Natl Univ Singapore, Dept Microbiol, Singapore 117548, Singapore; [Chan, Edwin S-Y] Singapore Clin Res Inst, Dept Epidemiol, Singapore, Singapore; [Chan, Edwin S-Y] Australasian Cochrane Ctr, Singapore Branch, Singapore, Singapore; [Maiwald, Matthias; Chan, Edwin S-Y] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore	KK Women's & Children's Hospital; National University of Singapore; Singapore Clinical Research Institute; National University of Singapore	Maiwald, M (corresponding author), KK Womens & Childrens Hosp, Dept Pathol & Lab Med, Singapore, Singapore.	matthias.maiwald@kkh.com.sg		Maiwald, Matthias/0000-0001-5448-8417				[Anonymous], 2011, REV MAN REVMAN COMP; Art G., 2007, JAVA, V12, P156, DOI [10.2309/java.12-3-12, DOI 10.2309/JAVA.12-3-12]; Astle CM, 2005, NEPHROL NURS J, V32, P517; Balamongkhon B, 2007, AM J INFECT CONTROL, V35, P585, DOI 10.1016/j.ajic.2006.12.002; Barenfanger J, 2004, J CLIN MICROBIOL, V42, P2216, DOI 10.1128/JCM.42.5.2216-2217.2004; Berry A R, 1982, J Hosp Infect, V3, P55, DOI 10.1016/0195-6701(82)90031-7; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; BROWN TR, 1984, SURG GYNECOL OBSTET, V158, P363; Caldeira D, 2011, J HOSP INFECT, V77, P223, DOI 10.1016/j.jhin.2010.10.015; Chaiyakunapruk N, 2003, CLIN INFECT DIS, V37, P764, DOI 10.1086/377265; Chaiyakunapruk N, 2002, ANN INTERN MED, V136, P792, DOI 10.7326/0003-4819-136-11-200206040-00007; Cheng K, 2009, FOOT ANKLE INT, V30, P992, DOI 10.3113/FAI.2009.0992; Cobbett S, 2000, AUSTR INFECT CONTROL, V5, P8; Darouiche RO, 2010, NEW ENGL J MED, V362, P18, DOI 10.1056/NEJMoa0810988; Edwards PS, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD003949.PUB2; FDA, 1994, FED REGISTER, V59, P31402; Fletcher N, 2007, J BONE JOINT SURG AM, V89A, P1605, DOI 10.2106/JBJS.F.00901; Garland JS, 2009, J PERINATOL, V29, P808, DOI 10.1038/jp.2009.161; GARLAND JS, 1995, PEDIATR INFECT DIS J, V14, P510, DOI 10.1097/00006454-199506000-00008; Hibbard JS, 2005, J INFUS MURS, V28, P194, DOI 10.1097/00129804-200505000-00008; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Humar A, 2000, CLIN INFECT DIS, V31, P1001, DOI 10.1086/318145; Ishizuka M, 2009, EUR SURG RES, V43, P286, DOI 10.1159/000231709; Kampf G, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-48; Kelly JW, 2005, 15 ANN SCI M SOC HEA; Langgartner J, 2004, INTENS CARE MED, V30, P1081, DOI 10.1007/s00134-004-2282-9; LARSON E, 1988, AM J INFECT CONTROL, V16, P253, DOI 10.1016/S0196-6553(88)80005-1; Lee I, 2010, INFECT CONT HOSP EP, V31, P1219, DOI 10.1086/657134; Legras A, 1997, REANIMATION URGENCES, V6, P5; Levin I, 2011, J WOMENS HEALTH, V20, P321, DOI 10.1089/jwh.2010.2391; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Madeo M, 2008, J HOSP INFECT, V69, P307, DOI 10.1016/j.jhin.2008.03.009; Mahid SS, 2006, BRIT J SURG, V93, P1315, DOI 10.1002/bjs.5596; MAKI DG, 1991, LANCET, V338, P339, DOI 10.1016/0140-6736(91)90479-9; Maki DG, 2001, 11 ANN SOC HEALTHC E; Malani A, 2007, INFECT CONT HOSP EP, V28, P892, DOI 10.1086/518456; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Marlowe L, 2010, INFECT CONT HOSP EP, V31, P171, DOI 10.1086/650201; McCall R., 2008, PHLEBOTOMY ESSENTIAL, P330; McLellan E, 2008, J INFECTION, V57, P459, DOI 10.1016/j.jinf.2008.08.012; Meffre C, 1996, INFECT CONTROL HO S2, V17, P26; Mimoz O, 1996, CRIT CARE MED, V24, P1818, DOI 10.1097/00003246-199611000-00010; Mimoz O, 1999, ANN INTERN MED, V131, P834, DOI 10.7326/0003-4819-131-11-199912070-00006; Mimoz O, 2007, ARCH INTERN MED, V167, P2066, DOI 10.1001/archinte.167.19.2066; National Institute for Health and Clinical Excellence (NICE), 2011, REV PROP CONS CLIN G; NHMRC, 2010, AUSTR GUID PREV CONT; Noorani A, 2010, BRIT J SURG, V97, P1614, DOI 10.1002/bjs.7214; O'Grady NP, 2011, CLIN INFECT DIS, V52, pE162, DOI 10.1093/cid/cir257; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; O'Grady NP, 2009, GUIDELINES IN PRESS; Ostrander RV, 2005, J BONE JOINT SURG AM, V87A, P980, DOI 10.2106/JBJS.D.01977; Paocharoen Veeraya, 2009, Journal of the Medical Association of Thailand, V92, P898; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Reichel M, 2009, ANTIMICROB AGENTS CH, V53, P4778, DOI 10.1128/AAC.00582-09; Rickard C, 2010, AUSTR GUIDELINES PRE; Rittle KH, 2006, J BONE JOINT SURG AM, V88A, P1160, DOI 10.2106/00004623-200605000-00034; Rotter ML, 1997, PREVENTION CONTROL N, P691; Saltzman MD, 2009, J BONE JOINT SURG AM, V91A, P1949, DOI 10.2106/JBJS.H.00768; Sheehan G, 1993, INT C ANT AG CHEM WA, P414; Sistla SC, 2010, CHEMOTHERAPY, V56, P261, DOI 10.1159/000319901; Small H, 2008, INFECT CONT HOSP EP, V29, P963, DOI 10.1086/590664; Stonecypher K, 2008, S ONLINE J NURS RES, V8, P12; Surgical Care and Outcomes Assessment Program (SCOAP), 2010, SCOAP COMM SPEAKS CH; Suwanpimolkul G, 2008, J INFECTION, V56, P354, DOI 10.1016/j.jinf.2008.03.001; Swenson BR, 2009, INFECT CONT HOSP EP, V30, P964, DOI 10.1086/605926; Tepus D, 2008, J NURS CARE QUAL, V23, P272, DOI 10.1097/01.NCQ.0000324593.84213.4f; Trautner BW, 2002, INFECT CONT HOSP EP, V23, P397, DOI 10.1086/502073; Valles J, 2008, INFECT CONT HOSP EP, V29, P847, DOI 10.1086/590259; Veiga DF, 2008, PLAST RECONSTR SURG, V122, p170E, DOI 10.1097/PRS.0b013e318186cd7f; Washer L, 2010, 5 DEC INT C HEALTHC; Wilson ML, 2007, M47A CLSI, V27	72	115	116	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44277	10.1371/journal.pone.0044277	http://dx.doi.org/10.1371/journal.pone.0044277			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22984485	Green Submitted, Green Published, gold			2022-12-27	WOS:000308463800050
J	Kim, SJ; Lee, JH; Kim, BS; So, HS; Park, R; Myung, NY; Um, JY; Hong, SH				Kim, Su-Jin; Lee, Jeong-Han; Kim, Beom-Su; So, Hong-Seob; Park, Raekil; Myung, Noh-Yil; Um, Jae-Young; Hong, Seung-Heon			(-)-Epigallocatechin-3-Gallate Protects against NO-Induced Ototoxicity through the Regulation of Caspase-1, Caspase-3, and NF-kappa B Activation	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; NUCLEAR-FACTOR; CELL-DEATH; INDUCED APOPTOSIS; ACOUSTIC OVERSTIMULATION; GUINEA-PIGS; TRANSCRIPTION FACTOR; RECRUITMENT DOMAIN; TEA CATECHINS; HAIR-CELLS	Excessive nitric oxide (NO) production is toxic to the cochlea and induces hearing loss. However, the mechanism through which NO induces ototoxicity has not been completely understood. The aim of this study was to gain further insight into the mechanism mediating NO-induced toxicity in auditory HEI-OC1 cells and in ex vivo analysis. We also elucidated whether and how epigallocatechin-3-gallate (EGCG), the main component of green tea polyphenols, regulates NO-induced auditory cell damage. To investigate NO-mediated ototoxicity, S-nitroso-N-acetylpenicillamine (SNAP) was used as an NO donor. SNAP was cytotoxic, generating reactive oxygen species, releasing cytochrome c, and activating caspase-3 in auditory cells. NO-induced ototoxicity also mediated the nuclear factor (NF)-kappa B/caspase-1 pathway. Furthermore, SNAP destroyed the orderly arrangement of the 3 outer rows of hair cells in the basal, middle, and apical turns of the organ of Corti from the cochlea of Sprague-Dawley rats at postnatal day 2. However, EGCG counteracted this ototoxicity by suppressing the activation of caspase-3/NF-kappa B and preventing the destruction of hair cell arrays in the organ of Corti. These findings may lead to the development of a model for pharmacological mechanism of EGCG and potential therapies against ototoxicity.	[Um, Jae-Young] Kyung Hee Univ, Coll Oriental Med, Seoul, South Korea; [Kim, Su-Jin] Daegu Hanny Univ, Dept Cosmeceut Sci, Kyungsan, Gyeoungbuk, South Korea; [Lee, Jeong-Han; So, Hong-Seob; Park, Raekil; Myung, Noh-Yil; Hong, Seung-Heon] Wonkwang Univ, Ctr Metab Funct Regulat, Iksan, Jeonbuk, South Korea; [Kim, Beom-Su] Wonkwang Univ, Wonkwang Bone Regenerat Res Inst, Iksan, Jeonbuk, South Korea	Kyung Hee University; Wonkwang University; Wonkwang University	Um, JY (corresponding author), Kyung Hee Univ, Coll Oriental Med, Seoul, South Korea.	jyum@khu.ac.kr; jooklim@wonkwang.ac.kr	Um, Jae-Young/G-8787-2013		National Research Foundation of Korea [NRF]; Korea government [MEST] [2011 0030717]; Ministry of Education, Science and Technology [2011-0010435]	National Research Foundation of Korea [NRF](National Research Foundation of Korea); Korea government [MEST](Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the National Research Foundation of Korea [NRF] grant funded by the Korea government [MEST] [No. 2011 0030717], and partly this research was supported by Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education, Science and Technology(2011-0010435). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DA, 2005, J NUTR BIOCHEM, V16, P705, DOI 10.1016/j.jnutbio.2005.06.007; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BAUER JA, 1991, J PHARMACOL EXP THER, V256, P249; Bharti AC, 2003, BLOOD, V101, P1053, DOI 10.1182/blood-2002-05-1320; Brenner D, 2009, CURR OPIN CELL BIOL, V21, P871, DOI 10.1016/j.ceb.2009.09.004; Brune B, 1998, EUR J PHARMACOL, V351, P261, DOI 10.1016/S0014-2999(98)00274-X; Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518; Chae JJ, 2008, BLOOD, V112, P1794, DOI 10.1182/blood-2008-01-134932; Chen YS, 2005, HEARING RES, V203, P94, DOI 10.1016/j.heares.2004.12.006; Christman JW, 2000, CHEST, V117, P1482, DOI 10.1378/chest.117.5.1482; Chtistophe M, 2006, CURR PHARM DESIGN, V12, P739, DOI 10.2174/138161206775474242; Chu SH, 2011, SCAND J GASTROENTERO, V46, P148, DOI 10.3109/00365521.2010.525255; D'Acquisto F, 2001, CELL DEATH DIFFER, V8, P144, DOI 10.1038/sj.cdd.4400784; Delivani P, 2006, CELL DEATH DIFFER, V13, P2007, DOI 10.1038/sj.cdd.4402049; Estrov Z, 2003, BLOOD, V102, P987, DOI 10.1182/blood-2002-11-3550; Faubel S, 2007, J PHARMACOL EXP THER, V322, P8, DOI 10.1124/jpet.107.119792; Fiscus RR, 2002, J CARDIAC SURG, V17, P336; Fiscus RR, 2002, NEUROSIGNALS, V11, P175, DOI 10.1159/000065431; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hanson JB, 2003, INT J PEDIATR OTORHI, V67, P585, DOI 10.1016/S0165-5876(03)00035-1; Heinrich UR, 2008, LARYNGOSCOPE, V118, P837, DOI 10.1097/MLG.0b013e31816381ae; Heinrich UR, 2008, LARYNGOSCOPE, V118, P1438, DOI 10.1097/MLG.0b013e3181739bd9; Heinrich UR, 2005, BRAIN RES, V1047, P85, DOI 10.1016/j.brainres.2005.04.023; Janssen-Heininger YMW, 2000, FREE RADICAL BIO MED, V28, P1317, DOI 10.1016/S0891-5849(00)00218-5; Javadov S, 2007, CELL PHYSIOL BIOCHEM, V20, P1, DOI 10.1159/000103747; Jeong HJ, 2003, ENDOCRINOLOGY, V144, P4080, DOI 10.1210/en.2003-0115; Jeong HJ, 2009, BIOL PHARM BULL, V32, P1027, DOI 10.1248/bpb.32.1027; Jiang HY, 2005, J NEUROSCI RES, V79, P644, DOI 10.1002/jnr.20392; Kalinec GM, 2003, AUDIOL NEURO-OTOL, V8, P177, DOI 10.1159/000071059; Katiyar SK, 2001, J LEUKOCYTE BIOL, V69, P719; Kaygusuz I, 2001, HEARING RES, V162, P43, DOI 10.1016/S0378-5955(01)00365-3; Lamkanfi M, 2004, J BIOL CHEM, V279, P24785, DOI 10.1074/jbc.M400985200; Lee SH, 2001, J BIOL CHEM, V276, P34495, DOI 10.1074/jbc.M101415200; Lee SK, 2009, BIOL PHARM BULL, V32, P1328, DOI 10.1248/bpb.32.1328; Liu W, 1998, NEUROREPORT, V9, P2609, DOI 10.1097/00001756-199808030-00034; Masuda M, 2006, BRAIN RES, V1068, P237, DOI 10.1016/j.brainres.2005.11.020; Nagashima R, 2007, NEUROCHEM INT, V51, P209, DOI 10.1016/j.neuint.2007.04.023; Nie GJ, 2002, ARCH BIOCHEM BIOPHYS, V397, P84, DOI 10.1006/abbi.2001.2636; Oh HM, 2004, FREE RADICAL BIO MED, V37, P463, DOI 10.1016/j.freeradbiomed.2004.04.042; Ohinata Y, 2000, BRAIN RES, V878, P163, DOI 10.1016/S0006-8993(00)02733-5; Schmitt NC, 2009, J NEUROSCI, V29, P3843, DOI 10.1523/JNEUROSCI.5842-08.2009; Schoonbroodt S, 1997, BIOCHEM J, V321, P777, DOI 10.1042/bj3210777; Sen N, 2004, CELL DEATH DIFFER, V11, P924, DOI 10.1038/sj.cdd.4401435; SHAFFER JE, 1992, J PHARMACOL EXP THER, V260, P286; Shi XR, 2007, HEARING RES, V224, P1, DOI 10.1016/j.heares.2006.10.011; Shishodia S, 2004, BIOCHEM PHARMACOL, V68, P1071, DOI 10.1016/j.bcp.2004.04.026; Suzuki M, 2000, J AGR FOOD CHEM, V48, P5649, DOI 10.1021/jf000313d; Takumida M, 2002, CURR OPIN NEUROL, V15, P11, DOI 10.1097/00019052-200202000-00003; Wang X, 2005, J NEUROSCI, V25, P11645, DOI 10.1523/JNEUROSCI.4181-05.2005; Watanabe K, 2000, ANTI-CANCER DRUG, V11, P401, DOI 10.1097/00001813-200006000-00011; Watanabe KI, 2002, ANTICANCER RES, V22, P4081; Yamamoto H, 2009, J NEUROSCI RES, V87, P1832, DOI 10.1002/jnr.22018; Zhang WH, 2003, P NATL ACAD SCI USA, V100, P16012, DOI 10.1073/pnas.2534856100; Zheng JL, 1996, EUR J NEUROSCI, V8, P1897, DOI 10.1111/j.1460-9568.1996.tb01333.x	55	8	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e43967	10.1371/journal.pone.0043967	http://dx.doi.org/10.1371/journal.pone.0043967			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028481	gold, Green Submitted, Green Published			2022-12-27	WOS:000309973900003
J	Li, ZJ; Zhu, YS; Childress, AR; Detre, JA; Wang, Z				Li, Zhengjun; Zhu, Yisheng; Childress, Anna Rose; Detre, John A.; Wang, Ze			Relations between BOLD fMRI-Derived Resting Brain Activity and Cerebral Blood Flow	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; OXYGEN-CONSUMPTION; DEFAULT-MODE; OXIDATIVE-METABOLISM; SIGNAL FLUCTUATIONS; NETWORKS; CORTEX; MRI; ACTIVATION; AMPLITUDE	Consistent resting brain activity patterns have been repeatedly demonstrated using measures derived from resting BOLD fMRI data. While those metrics are presumed to reflect underlying spontaneous brain activity (SBA), it is challenging to prove that association because resting BOLD fMRI metrics are purely model-free and scale-free variables. Cerebral blood flow (CBF) is typically closely coupled to brain metabolism and is used as a surrogate marker for quantifying regional brain function, including resting function. Assessing the correlations between resting BOLD fMRI measures and CBF correlation should provide a means of linking of those measures to the underlying SBA, and a means to quantify those scale-free measures. The purpose of this paper was to examine the CBF correlations of 3 widely used neuroimaging-based SBA measures, including seed-region based functional connectivity (FC), regional homogeneity (ReHo), and amplitude of low frequency fluctuation (ALFF). Test-retest data were acquired to check the stability of potential correlations across time. Reproducible posterior cingulate cortex (PCC) FC vs regional CBF correlations were found in much of the default mode network and visual cortex. Dorsal anterior cingulate cortex (ACC) FC vs CBF correlations were consistently found in bilateral prefrontal cortex. Both ReHo and ALFF were found to be reliably correlated with CBF in most of brain cortex. None of the assessed SBA measures was correlated with whole brain mean CBF. These findings suggest that resting BOLD fMRI-derived measures are coupled with regional CBF and are therefore linked to regional SBA.	[Childress, Anna Rose; Wang, Ze] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Li, Zhengjun; Zhu, Yisheng] Shanghai Jiao Tong Univ, Dept Biomed Engn, Shanghai 200030, Peoples R China; [Detre, John A.] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Shanghai Jiao Tong University; University of Pennsylvania; Pennsylvania Medicine	Wang, Z (corresponding author), Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA.	zewang@mail.med.upenn.edu	Wang, Ze/A-1043-2007		National Institute of Health [5R21DC011074-02, 1R03DA023496-01A1, DA015149, RR02305, 4R33DA026114-03]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025906, R03DA023496, R33DA026114, R01DA015149] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from National Institute of Health: 5R21DC011074-02, 1R03DA023496-01A1, DA015149, RR02305, and 4R33DA026114-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biswal BB, 1999, J COMPUT ASSIST TOMO, V23, P265, DOI 10.1097/00004728-199903000-00016; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chen YF, 2011, J MAGN RESON IMAGING, V33, P940, DOI 10.1002/jmri.22345; Chuang KH, 2008, NEUROIMAGE, V40, P1595, DOI 10.1016/j.neuroimage.2008.01.006; Clarke Donald D., 1999, P637; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; Detre JA, 2012, J MAGN RESON IMAGING, V35, P1026, DOI 10.1002/jmri.23581; Detre JA, 2009, CURR OPIN NEUROL, V22, P348, DOI 10.1097/WCO.0b013e32832d9505; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; FOX PT, 1988, SCIENCE, V241, P462, DOI 10.1126/science.3260686; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; Franklin TR, 2007, NEUROPSYCHOPHARMACOL, V32, P2301, DOI 10.1038/sj.npp.1301371; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Hoge RD, 1999, P NATL ACAD SCI USA, V96, P9403, DOI 10.1073/pnas.96.16.9403; Hong LE, 2009, ARCH GEN PSYCHIAT, V66, P431, DOI 10.1001/archgenpsychiatry.2009.2; HUDETZ AG, 1992, J CEREBR BLOOD F MET, V12, P491, DOI 10.1038/jcbfm.1992.67; Hyder F, 1998, J APPL PHYSIOL, V85, P554, DOI 10.1152/jappl.1998.85.2.554; Kannurpatti SS, 2008, NEUROIMAGE, V40, P1738, DOI 10.1016/j.neuroimage.2007.05.061; Kastrup A, 2002, NEUROIMAGE, V15, P74, DOI 10.1006/nimg.2001.0916; Kawahara Ichiro, 2010, No Shinkei Geka, V38, P645; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; KETY SS, 1945, AM J PHYSIOL, V143, P53, DOI 10.1152/ajplegacy.1945.143.1.53; Kim J, 2006, NEUROIMAGE, V31, P376, DOI 10.1016/j.neuroimage.2005.11.035; Kim SG, 1999, MAGN RESON MED, V41, P1152, DOI 10.1002/(SICI)1522-2594(199906)41:6<1152::AID-MRM11>3.0.CO;2-T; Li ZJ, 2012, J MAGN RESON IMAGING, V36, P344, DOI 10.1002/jmri.23670; Li Zhengjun, 2012, ANN M ORG HUM BRAIN; Lin AL, 2010, P NATL ACAD SCI USA, V107, P8446, DOI 10.1073/pnas.0909711107; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Marrett S, 1997, ADV EXP MED BIOL, V413, P205; McKiernan KA, 2006, NEUROIMAGE, V29, P1185, DOI 10.1016/j.neuroimage.2005.09.030; Paakki JJ, 2010, BRAIN RES, V1321, P169, DOI 10.1016/j.brainres.2009.12.081; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Raichle ME, 1998, P NATL ACAD SCI USA, V95, P765, DOI 10.1073/pnas.95.3.765; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rao H, 2007, ISMRM ANN M 2007 BER, P3234; Rengachary SS, 2005, PRINCIPLES NEUROSURG; Roy C S, 1890, J Physiol, V11, P85; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Troiani V, 2008, NEUROIMAGE, V40, P932, DOI 10.1016/j.neuroimage.2007.12.002; Uludag K, 2004, NEUROIMAGE, V23, P148, DOI 10.1016/j.neuroimage.2004.05.013; Wang JJ, 2005, RADIOLOGY, V235, P218, DOI 10.1148/radiol.2351031663; Wang Z, 2008, NEUROSCI LETT, V438, P275, DOI 10.1016/j.neulet.2008.04.084; Wang Z, 2008, MAGN RESON IMAGING, V26, P261, DOI 10.1016/j.mri.2007.07.003; Wang Z, 2008, NEUROIMAGE, V39, P973, DOI 10.1016/j.neuroimage.2007.09.045; Wang Z, 2007, J NEUROSCI, V27, P14035, DOI 10.1523/JNEUROSCI.2966-07.2007; Wang Z, 2012, MAGN RESON IMAGING, V30, P1409, DOI 10.1016/j.mri.2012.05.004; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zou QH, 2009, NEUROIMAGE, V48, P515, DOI 10.1016/j.neuroimage.2009.07.006	67	86	88	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44556	10.1371/journal.pone.0044556	http://dx.doi.org/10.1371/journal.pone.0044556			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028560	Green Published, Green Submitted, gold			2022-12-27	WOS:000309392800012
J	Clark, M; Spry, E; Daoh, K; Baion, D; Skordis-Worrall, J				Clark, Matthew; Spry, Emily; Daoh, Kisito; Baion, David; Skordis-Worrall, Jolene			Reductions in Inpatient Mortality following Interventions to Improve Emergency Hospital Care in Freetown, Sierra Leone	PLOS ONE			English	Article							COST-EFFECTIVENESS; PEDIATRIC CARE; HEALTH-CARE; CHILDREN; VACCINATION; MANAGEMENT; QUALITY; MALARIA; GUINEA; KENYA	Background: The demand for high quality hospital care for children in low resource countries is not being met. This paper describes a number of strategies to improve emergency care at a children's hospital and evaluates the impact of these on inpatient mortality. In addition, the cost-effectiveness of improving emergency care is estimated. Methods and Findings: A team of local and international staff developed a plan to improve emergency care for children arriving at The Ola During Children's Hospital, Freetown, Sierra Leone. Following focus group discussions, five priority areas were identified to improve emergency care; staff training, hospital layout, staff allocation, medical equipment, and medical record keeping. A team of international volunteers worked with local staff for six months to design and implement improvements in these five priority areas. The improvements were evaluated collectively rather than individually. Before the intervention, the inpatient mortality rate was 12.4%. After the intervention this improved to 5.9%. The relative risk of dying was 47% (95% CI 0.369-0.607) lower after the intervention. The estimated number of lives saved in the first two months after the intervention was 103. The total cost of the intervention was USD 29 714, the estimated cost per death averted was USD 148. There are two main limitation of the study. Firstly, the brevity of the study and secondly, the assumed homogeneity of the clinical cases that presented to the hospital before and after the intervention. Conclusions: This study demonstarted a signficant reductuion in inpatient mortality rate after an intervention to improve emergency hospital care If the findings of this paper could be reproduced in a larger more rigorous study, improving the quality of care in hospitals would be a very cost effective strategy to save children's lives in low resource settings.	[Clark, Matthew] Imperial Coll Healthcare NHS Trust, London W2 1NY, England; [Spry, Emily] Garrick Ind Ctr, Unit 14, Welbodi Partnership, London NW9 6AQ, England; [Daoh, Kisito] Minst Hlth & Sanitat, Freetown, Sierra Leone; [Baion, David] Ola Childrens Hosp, Freetown, Sierra Leone; [Skordis-Worrall, Jolene] UCL Ctr Int Hlth & Dev, Inst Child Hlth, London WC1N 1EH, England	Imperial College London; Ministry of Health & Sanitation Sierra Leone; University of London; University College London	Clark, M (corresponding author), Imperial Coll Healthcare NHS Trust, Praed St, London W2 1NY, England.	matthew@welbodipartnership.org		Skordis, Jolene/0000-0002-8633-0208	Cap Anamur; University of Leicester; ABM University Health Board	Cap Anamur; University of Leicester; ABM University Health Board	This study was funded by Cap Anamur, ABM University Health Board and The University of Leicester. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, LANCET, V377, P1393; Ayieko P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001018; Baltussen RMPM, 2002, HEALTH POLICY PLANN, V17, P42, DOI 10.1093/heapol/17.1.42; Biai S, 2007, BRIT MED J, V335, P862, DOI 10.1136/bmj.39345.467813.80; Duke T, 2008, LANCET, V372, P1328, DOI 10.1016/S0140-6736(08)61164-2; English M, 2004, LANCET, V364, P1622, DOI 10.1016/S0140-6736(04)17318-2; English M, 2004, LANCET, V363, P1948, DOI 10.1016/S0140-6736(04)16408-8; Esposito DH, 2011, CLIN INFECT DIS, V52, P171, DOI 10.1093/cid/ciq094; Kalter HD, 1997, B WORLD HEALTH ORGAN, V75, P65; Munga MA, 2008, TANZANIA J HLTH RES, V6, P51; Nolan T, 2001, LANCET, V357, P106, DOI 10.1016/S0140-6736(00)03542-X; Simoes EAF, 1997, B WORLD HEALTH ORGAN, V75, P43; Sinha A, 2007, LANCET, V369, P389, DOI 10.1016/S0140-6736(07)60195-0; Unicef, 2001, STAT WORLDS CHILDR 2; VanLerberghe W, 1997, TROP MED INT HEALTH, V2, P799, DOI 10.1046/j.1365-3156.1997.d01-382.x; Veirum JE, 2007, ACTA PAEDIATR, V96, P1526, DOI 10.1111/j.1651-2227.2007.00467.x; Yukich JO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-258	17	23	23	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e41458	10.1371/journal.pone.0041458	http://dx.doi.org/10.1371/journal.pone.0041458			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028427	Green Published, gold			2022-12-27	WOS:000309388400003
J	Lo Schiavo, V; Robert, P; Limozin, L; Bongrand, P				Lo Schiavo, Valentina; Robert, Philippe; Limozin, Laurent; Bongrand, Pierre			Quantitative Modeling Assesses the Contribution of Bond Strengthening, Rebinding and Force Sharing to the Avidity of Biomolecule Interactions	PLOS ONE			English	Article							RECEPTOR-LIGAND BONDS; BETA(2) INTEGRIN; TARGET-CELLS; ICAM-1 BONDS; ADHESION; BINDING; SPECTROSCOPY; SELECTIN; PARALLEL; KINETICS	Cell adhesion is mediated by numerous membrane receptors. It is desirable to derive the outcome of a cell-surface encounter from the molecular properties of interacting receptors and ligands. However, conventional parameters such as affinity or kinetic constants are often insufficient to account for receptor efficiency. Avidity is a qualitative concept frequently used to describe biomolecule interactions: this includes incompletely defined properties such as the capacity to form multivalent attachments. The aim of this study is to produce a working description of monovalent attachments formed by a model system, then to measure and interpret the behavior of divalent attachments under force. We investigated attachments between antibody-coated microspheres and surfaces coated with sparse monomeric or dimeric ligands. When bonds were subjected to a pulling force, they exhibited both a force-dependent dissociation consistent with Bell's empirical formula and a force- and time-dependent strengthening well described by a single parameter. Divalent attachments were stronger and less dependent on forces than monovalent ones. The proportion of divalent attachments resisting a force of 30 piconewtons for at least 5 s was 3.7 fold higher than that of monovalent attachments. Quantitative modeling showed that this required rebinding, i.e. additional bond formation between surfaces linked by divalent receptors forming only one bond. Further, experimental data were compatible with but did not require stress sharing between bonds within divalent attachments. Thus many ligand-receptor interactions do not behave as single-step reactions in the millisecond to second timescale. Rather, they exhibit progressive stabilization. This explains the high efficiency of multimerized or clustered receptors even when bonds are only subjected to moderate forces. Our approach provides a quantitative way of relating binding avidity to measurable parameters including bond maturation, rebinding and force sharing, provided these parameters have been determined. Also, this provides a quantitative description of the phenomenon of bond strengthening.	[Lo Schiavo, Valentina; Robert, Philippe; Limozin, Laurent; Bongrand, Pierre] Aix Marseille Univ, LAI, Marseille, France; [Lo Schiavo, Valentina; Robert, Philippe; Limozin, Laurent; Bongrand, Pierre] INSERM, UMR 1067, LAI, F-13258 Marseille, France; [Lo Schiavo, Valentina; Robert, Philippe; Limozin, Laurent; Bongrand, Pierre] CNRS, UMR 7333, LAI, Marseille, France; [Robert, Philippe; Bongrand, Pierre] Hop Conception, APHM, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Lo Schiavo, V (corresponding author), Aix Marseille Univ, LAI, Marseille, France.	pierre.bongrand@inserm.fr	Limozin, Laurent/P-7134-2016; Robert, Philippe/P-9597-2016; Bongrand, Pierre/C-4456-2013	Limozin, Laurent/0000-0001-9523-8086; Robert, Philippe/0000-0002-1343-994X; Bongrand, Pierre/0000-0001-6185-6572	Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); University	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University	Funding is academic, from Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique (CNRS) and University. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ANDRE P, 1990, J CELL SCI, V97, P335; Bartsch TF, 2009, CHEMPHYSCHEM, V10, P1541, DOI 10.1002/cphc.200900211; BEESON C, 1994, P NATL ACAD SCI USA, V91, P8842, DOI 10.1073/pnas.91.19.8842; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Bongrand P, 1999, REP PROG PHYS, V62, P921, DOI 10.1088/0034-4885/62/6/202; Bongrand P., 1984, CELL SURFACE DYNAMIC, P459; BYSTRYN JC, 1973, J EXP MED, V137, P301, DOI 10.1084/jem.137.2.301; Cambi A, 2006, MOL BIOL CELL, V17, P4270, DOI 10.1091/mbc.E05-12-1098; Chen SQ, 2001, P NATL ACAD SCI USA, V98, P950, DOI 10.1073/pnas.98.3.950; DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038; DETMERS PA, 1987, J CELL BIOL, V105, P1137, DOI 10.1083/jcb.105.3.1137; Doi M., 1988, THEORY POLYM DYNAMIC; Dudko OK, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.108101; Dudko OK, 2008, P NATL ACAD SCI USA, V105, P15755, DOI 10.1073/pnas.0806085105; Erdmann T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.108102; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Evans E, 2004, P NATL ACAD SCI USA, V101, P11281, DOI 10.1073/pnas.0401870101; Evans E, 2010, BIOPHYS J, V98, P1458, DOI 10.1016/j.bpj.2009.09.067; Eyring H, 1935, J CHEM PHYS, V3, P107, DOI 10.1063/1.1749604; FOOTE J, 1994, P NATL ACAD SCI USA, V91, P10370, DOI 10.1073/pnas.91.22.10370; Fuhrmann A, 2009, BIOPHYS J, V96, P5030, DOI 10.1016/j.bpj.2009.03.022; Glynn E., 1977, IMMUNOCHEMISTRY ADV, P240; GOLDMAN AJ, 1967, CHEM ENG SCI, V22, P653, DOI 10.1016/0009-2509(67)80048-4; Guo S, 2008, BIOPHYS J, V95, P3964, DOI 10.1529/biophysj.108.133900; HANGGI P, 1990, REV MOD PHYS, V62, P251, DOI 10.1103/RevModPhys.62.251; HOLOWKA DA, 1976, BIOCHEMISTRY-US, V15, P3379, DOI 10.1021/bi00660a033; HORNICK CL, 1972, IMMUNOCHEMISTRY, V9, P325, DOI 10.1016/0019-2791(72)90096-1; Hummer G, 2003, BIOPHYS J, V85, P5, DOI 10.1016/S0006-3495(03)74449-X; Irvine DJ, 2002, BIOPHYS J, V82, P120, DOI 10.1016/S0006-3495(02)75379-4; Jun CD, 2001, J BIOL CHEM, V276, P29019, DOI 10.1074/jbc.M103394200; Kim M, 2004, J CELL BIOL, V167, P1241, DOI 10.1083/jcb.200404160; Kinoshita K, 2010, BIOPHYS J, V98, P1467, DOI 10.1016/j.bpj.2009.12.4316; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; Loritz HM, 2011, J PHYS CHEM B, V115, P2582, DOI 10.1021/jp108280q; Marshall BT, 2005, BIOPHYS J, V88, P1458, DOI 10.1529/biophysj.104.050567; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; MCCLOSKEY MA, 1986, J CELL BIOL, V102, P2185, DOI 10.1083/jcb.102.6.2185; MILLER J, 1995, J EXP MED, V182, P1231, DOI 10.1084/jem.182.5.1231; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Pereverzev YV, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.010903; PIERRES A, 1995, J BIOL CHEM, V270, P26586, DOI 10.1074/jbc.270.44.26586; Pierres A, 2001, BIOPHYS J, V81, P25, DOI 10.1016/S0006-3495(01)75677-9; Pierres A, 2002, BIOPHYS J, V82, P3214, DOI 10.1016/S0006-3495(02)75664-6; Pierres A, 2007, FEBS LETT, V581, P1841, DOI 10.1016/j.febslet.2007.03.077; Pierres A, 2008, CELL MOL BIOENG, V1, P247, DOI 10.1007/s12195-008-0031-9; Pincet F, 2005, BIOPHYS J, V89, P4374, DOI 10.1529/biophysj.105.067769; Ray C, 2010, LANGMUIR, V26, P11951, DOI 10.1021/la101269q; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Robert P, 2008, BIOPHYS J, V95, P3999, DOI 10.1529/biophysj.108.135947; Robert P, 2012, BIOPHYS J, V102, P248, DOI 10.1016/j.bpj.2011.11.4018; Robert P, 2011, BIOPHYS J, V100, P2642, DOI 10.1016/j.bpj.2011.04.011; Robert P, 2009, BIOPHYS J, V96, P4642, DOI 10.1016/j.bpj.2009.03.020; Seifert U, 2000, PHYS REV LETT, V84, P2750, DOI 10.1103/PhysRevLett.84.2750; Seifert U, 2002, EUROPHYS LETT, V58, P792, DOI 10.1209/epl/i2002-00101-8; Sengupta K, 2009, SMALL, V5, P449, DOI 10.1002/smll.200800836; Serge A, 2008, NAT METHODS, V5, P687, DOI 10.1038/nmeth.1233; Sulchek TA, 2005, P NATL ACAD SCI USA, V102, P16638, DOI 10.1073/pnas.0505208102; Sulchek T, 2006, BIOPHYS J, V90, P4686, DOI 10.1529/biophysj.105.080291; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; VANKOOYK Y, 1994, J CELL BIOL, V124, P1061, DOI 10.1083/jcb.124.6.1061; Wierenga PA, 2006, J COLLOID INTERF SCI, V299, P850, DOI 10.1016/j.jcis.2006.03.016; WILLIAMS AF, 1991, NATURE, V352, P473, DOI 10.1038/352473a0; Yang J, 1999, THROMB HAEMOSTASIS, V81, P1; Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0; Zhang XH, 2002, BIOPHYS J, V83, P2270, DOI 10.1016/S0006-3495(02)73987-8; Zhu C, 2002, ANN BIOMED ENG, V30, P305, DOI 10.1114/1.1467923	68	19	19	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44070	10.1371/journal.pone.0044070	http://dx.doi.org/10.1371/journal.pone.0044070			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024747	Green Submitted, Green Published, gold			2022-12-27	WOS:000308860100005
J	Salazar, GA; Garcia, LJ; Jones, P; Jimenez, RC; Quinn, AF; Jenkinson, AM; Mulder, N; Martin, M; Hunter, S; Hermjakob, H				Salazar, Gustavo A.; Garcia, Leyla J.; Jones, Philip; Jimenez, Rafael C.; Quinn, Antony F.; Jenkinson, Andrew M.; Mulder, Nicola; Martin, Maria; Hunter, Sarah; Hermjakob, Henning			MyDas, an Extensible Java DAS Server	PLOS ONE			English	Article								A large number of diverse, complex, and distributed data resources are currently available in the Bioinformatics domain. The pace of discovery and the diversity of information means that centralised reference databases like UniProt and Ensembl cannot integrate all potentially relevant information sources. From a user perspective however, centralised access to all relevant information concerning a specific query is essential. The Distributed Annotation System (DAS) defines a communication protocol to exchange annotations on genomic and protein sequences; this standardisation enables clients to retrieve data from a myriad of sources, thus offering centralised access to end-users. We introduce MyDas, a web server that facilitates the publishing of biological annotations according to the DAS specification. It deals with the common functionality requirements of making data available, while also providing an extension mechanism in order to implement the specifics of data store interaction. MyDas allows the user to define where the required information is located along with its structure, and is then responsible for the communication protocol details.	[Salazar, Gustavo A.] Univ Cape Town, Dept Clin Lab Sci, Computat Biol Grp, ZA-7925 Cape Town, South Africa; [Garcia, Leyla J.; Jones, Philip; Jimenez, Rafael C.; Quinn, Antony F.; Jenkinson, Andrew M.; Martin, Maria; Hunter, Sarah; Hermjakob, Henning] European Bioinformat Inst, Hinxton, England	University of Cape Town; European Molecular Biology Laboratory (EMBL)	Salazar, GA (corresponding author), Univ Cape Town, Dept Clin Lab Sci, Computat Biol Grp, ZA-7925 Cape Town, South Africa.	ljgarcia@ebi.ac.uk	Castro, Leyla Jael G./AAB-3320-2020; Martín, María/HDL-9512-2022; Hermjakob, Henning/AFM-3497-2022	Castro, Leyla Jael G./0000-0003-3986-0510; Hermjakob, Henning/0000-0001-8479-0262; Jenkinson, Andrew/0000-0002-0703-6984; Hunter, Sarah/0000-0003-2453-0770; Jimenez, Rafael C/0000-0001-5404-7670; Quinn, Antony/0000-0002-0596-7638; Martin, Maria-Jesus/0000-0001-5454-2815; Mulder, Nicola J/0000-0003-4905-0941; Salazar, Gustavo A/0000-0001-9208-4966	European Commission grant Enfin [LSHG-CT-2005-518254]	European Commission grant Enfin	This work has been supported by the European Commission grant Enfin (LSHG-CT-2005-518254). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Down TA, 2011, BIOINFOMATICS; Finn RD, 2007, BIOINFORMATICS, V23, P1568, DOI 10.1093/bioinformatics/btl650; Goble C, 2008, J BIOMED INFORM, V41, P687, DOI 10.1016/j.jbi.2008.01.008; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jenkinson AM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S8-S3; Jimenez RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026345; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Moreno BG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-23; Villaveces J, 2011, DASTY3 WEB IN PRESS; Vizcaino JA, 2009, PROTEOMICS, V9, P4276, DOI 10.1002/pmic.200900402	11	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44180	10.1371/journal.pone.0044180	http://dx.doi.org/10.1371/journal.pone.0044180			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028496	Green Submitted, Green Published, gold			2022-12-27	WOS:000308788700015
J	Rasmussen, LD; Mathiesen, ER; Kronborg, G; Pedersen, C; Gerstoft, J; Obel, N				Rasmussen, Line D.; Mathiesen, Elisabeth R.; Kronborg, Gitte; Pedersen, Court; Gerstoft, Jan; Obel, Niels			Risk of Diabetes Mellitus in Persons with and without HIV: A Danish Nationwide Population-Based Cohort Study	PLOS ONE			English	Article							ORAL GLUCOSE-TOLERANCE; ANTIRETROVIRAL THERAPY; INSULIN-RESISTANCE; INFECTED PATIENTS; PROTEASE INHIBITORS; INDINAVIR; PREVALENCE; EXPOSURE; DENMARK	Objective: In a nationwide, population-based cohort study we assessed the risk of diabetes mellitus (DM) in HIV-infected individuals compared with the general population, and evaluated the impact of risk factors for DM in HIV-infected individuals. Methods: We identified 4,984 Danish-born HIV-infected individuals from the Danish HIV Cohort Study and a Danish born population-based age-and gender-matched comparison cohort of 19,936 individuals (study period: 1996-2009). Data on DM was obtained from the Danish National Hospital Registry and the Danish National Prescription Registry. Incidence rate ratios (IRR) and impact of risk factors including exposure to Highly Active Antiretroviral Therapy (HAART) and antiretroviral drugs were estimated by Poisson regression analyses. Results: In the period 1996-1999 risk of DM was higher in HIV-infected individuals compared to the comparison cohort (adjusted IRR: 2.83; 95%CI: 1.57-5.09), both before (adjusted IRR: 2.40; 95%CI: 1.03-5.62) and after HAART initiation (adjusted IRR: 3.24; 95% CI: 1.42-7.39). In the period 1999-2010 the risk of DM in HIV-infected individuals did not differ from that of the comparison cohort (adjusted IRR: 0.90; 95% CI: 0.72-1.13), although the risk was decreased before HAART-initiation (adjusted IRR: 0.45; 95% CI: 0.21-0.96). Increasing age, BMI and the presence of lipoatrophy increased the risk of DM, as did exposure to indinavir, saquinavir, stavudine and didanosine. Conclusion: Native HIV-infected individuals do not have an increased risk of developing DM compared to a native background population after year 1998. Some antiretroviral drugs, not used in modern antiretroviral treatment, seem to increase the risk of DM.	[Rasmussen, Line D.; Pedersen, Court] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark; [Mathiesen, Elisabeth R.] Rigshosp, Dept Endocrinol, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark; [Kronborg, Gitte] Copenhagen Univ Hosp, Dept Infect Dis, Hvidovre, Denmark; [Gerstoft, Jan; Obel, Niels] Rigshosp, Dept Infect Dis, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark	University of Southern Denmark; Odense University Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen	Rasmussen, LD (corresponding author), Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark.	linedahlerup@hotmail.com		Mathiesen, elisabeth/0000-0003-3279-0863; Obel, Niels/0000-0002-5031-0045	Preben and Anna Simonsen's Foundation; NOVO Nordic Foundation; University of Southern Denmark; Clinical Institute of Copenhagen University; Roche; Bristol-Myers Squibb; Merck Sharp Dohme; GlaxoSmithKline; Abbott; Boehringer Ingelheim; Janssen-Cilag; Swedish Orphan Drugs; Pharmasia	Preben and Anna Simonsen's Foundation; NOVO Nordic Foundation(Novo Nordisk Foundation); University of Southern Denmark; Clinical Institute of Copenhagen University; Roche(Roche Holding); Bristol-Myers Squibb(Bristol-Myers Squibb); Merck Sharp Dohme(Merck & Company); GlaxoSmithKline(GlaxoSmithKline); Abbott(Abbott Laboratories); Boehringer Ingelheim(Boehringer Ingelheim); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Swedish Orphan Drugs; Pharmasia	The authors thank Preben and Anna Simonsen's Foundation, the NOVO Nordic Foundation, University of Southern Denmark and the Clinical Institute of Copenhagen University for financial support of the Danish HIV cohort study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors read the journal's policy and declare the following potential conflicts of interest. N. Obel has received research funding from Roche, Bristol-Myers Squibb, Merck Sharp & Dohme, GlaxoSmithKline, Abbott, Boehringer Ingelheim, Janssen-Cilag and Swedish Orphan Drugs. C. Pedersen has received research funding from Abbott, Roche, Bristol-Myers Squibb, Merck Sharp & Dohme, GlaxoSmithKline, Swedish Orphan Drugs and Boehringer Ingelheim. J. Gerstoft has received research funding from Abbott, Roche, Bristol-Myers Squibb, Mecrk Sharp & Dohme, Pharmasia, GlaxoSmithKline, Swedish Orphan Drugs and Boehringer Ingelheim. E. R. Mathiesen, G. Kronborg and L. D. Rasmussen report no conflicts of interest. The potential conflicts of interest described above do not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Andersen TF, 1999, DAN MED BULL, V46, P263; Brambilla AM, 2003, AIDS, V17, P1993, DOI 10.1097/00002030-200309050-00022; Brown TT, 2005, ARCH INTERN MED, V165, P1179, DOI 10.1001/archinte.165.10.1179; Brown TT, 2005, AIDS, V19, P1375, DOI 10.1097/01.aids.0000181011.62385.91; Butt AA, 2009, AIDS, V23, P1227, DOI 10.1097/QAD.0b013e32832bd7af; Calza L, 2004, METAB SYNDR RELAT D, V2, P241, DOI 10.1089/met.2004.2.241; Capeau J, 2012, AIDS, V26, P303, DOI 10.1097/QAD.0b013e32834e8776; Danoff A, 2005, JAIDS-J ACQ IMM DEF, V39, P55, DOI 10.1097/01.qai.0000147659.80642.5a; De Wit S, 2008, DIABETES CARE, V31, P1224, DOI 10.2337/dc07-2013; Dube MP, 1997, LANCET, V350, P713, DOI 10.1016/S0140-6736(05)63513-1; Glumer C, 2004, DIABETES CARE, V27, P727, DOI 10.2337/diacare.27.3.727; Grinspoon S, 2003, CLIN INFECT DIS, V37, pS85, DOI 10.1086/375885; HARRIS MI, 1991, DIABETES CARE, V14, P639, DOI 10.2337/diacare.14.7.639; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hommel K, 2010, NEPHROL DIAL TRANSPL, V25, P947, DOI 10.1093/ndt/gfp571; Howard AA, 2010, JAIDS-J ACQ IMM DEF, V54, P152, DOI 10.1097/QAI.0b013e3181d0c911; Idiculla J, 2011, INT J GEN MED, V4, P73, DOI 10.2147/IJGM.S15818; Justman JE, 2003, JAIDS-J ACQ IMM DEF, V32, P298, DOI 10.1097/00126334-200303010-00009; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Ledergerber B, 2007, CLIN INFECT DIS, V45, P111, DOI 10.1086/518619; Lo YC, 2009, HIV MED, V10, P302, DOI 10.1111/j.1468-1293.2008.00687.x; Lohse N, 2005, SCAND J INFECT DIS, V37, P338, DOI 10.1080/00365540510031692; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Lumpkin M. M., 1997, REPORTS DIABETES HYP; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Noor MA, 2002, AIDS, V16, pF1, DOI 10.1097/00002030-200203290-00002; Noor MA, 2001, AIDS, V15, pF11, DOI 10.1097/00002030-200105040-00001; Obel N, 2009, INT J EPIDEMIOL, V38, P1202, DOI 10.1093/ije/dyn192; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Petersen I, 2011, DIABETOLOGIA, V54, P2016, DOI 10.1007/s00125-011-2128-2; Polsky S, 2011, ANTIVIR THER, V16, P181, DOI 10.3851/IMP1711; Safrin S, 1999, AIDS, V13, P2493, DOI 10.1097/00002030-199912240-00002; Statistics Denmark, POP EL; Tien PC, 2007, AIDS, V21, P1739, DOI 10.1097/QAD.0b013e32827038d0; Tsiodras S, 2000, ARCH INTERN MED, V160, P2050, DOI 10.1001/archinte.160.13.2050; Visnegarwala F, 2005, J INFECTION, V50, P331, DOI 10.1016/j.jinf.2004.06.001; Walli R, 1998, AIDS, V12, pF167, DOI 10.1097/00002030-199815000-00001	37	88	91	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44575	10.1371/journal.pone.0044575	http://dx.doi.org/10.1371/journal.pone.0044575			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984529	Green Submitted, Green Published, gold			2022-12-27	WOS:000308738500067
J	Bystrom, C; Sheng, SJ; Zhang, K; Caulfield, M; Clarke, NJ; Reitz, R				Bystrom, Cory; Sheng, Shijun; Zhang, Ke; Caulfield, Michael; Clarke, Nigel J.; Reitz, Richard			Clinical Utility of Insulin-Like Growth Factor 1 and 2; Determination by High Resolution Mass Spectrometry	PLOS ONE			English	Article							IGF-I ASSAYS; REFERENCE VALUES; PROTEINS; PLASMA; SERUM; RADIOIMMUNOASSAY; QUANTIFICATION; RADIORECEPTOR; THYROGLOBULIN; HYPOGLYCEMIA	Measurement of insulin-like growth factor-1 (IGF-I) has utility for the diagnosis and management of growth disorders, but inter-assay comparison of results has been complicated by a multitude of reference standards, antibodies, detection methods, and pre-analytical preparation strategies. We developed a quantitative LC-MS method for intact IGF-I, which has advantages in throughput and complexity when compared to mass spectrometric approaches that rely on stable isotope dilution analysis of tryptic peptides. Since the method makes use of full-scan data, the assay was easily extended to provide quantitative measurement of IGF-II using the same assay protocol. The validated LC-MS assay for IGF-I and IGF-II provides accurate results across the pediatric and adult reference range and is suitable for clinical use.	[Bystrom, Cory] Cleveland Heart Lab, Cleveland, OH USA; [Sheng, Shijun] Thermo Sci, San Jose, CA USA; [Zhang, Ke; Caulfield, Michael; Clarke, Nigel J.; Reitz, Richard] Quest Diagnost Nichols Inst, San Juan Capistrano, CA USA	Nichols Institute	Bystrom, C (corresponding author), Cleveland Heart Lab, Cleveland, OH USA.	Richard.e.reitz@questdiagnostics.com			Quest Diagnostics	Quest Diagnostics	Funding for this work was provided by Quest Diagnostics. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The manuscript was reviewed by IP attorneys before providing approval for publication. Patent rights for the methods used in this research have been applied for.	Addona TA, 2009, NAT BIOTECHNOL, V27, P633, DOI 10.1038/nbt.1546; Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Anderson NL, 2004, J PROTEOME RES, V3, P235, DOI 10.1021/pr034086h; Brabant G, 2003, HORM RES, V60, P53, DOI 10.1159/000071871; BREIER BH, 1991, J ENDOCRINOL, V128, P347, DOI 10.1677/joe.0.1280347; Bystrom CE, 2011, ANAL CHEM, V83, P9005, DOI 10.1021/ac201800g; Clemmons DR, 2007, PITUITARY, V10, P121, DOI 10.1007/s11102-007-0032-z; COTTERILL AM, 1992, J CLIN ENDOCR METAB, V74, P56, DOI 10.1210/jc.74.1.56; DAUGHADAY WH, 1980, J CLIN ENDOCR METAB, V51, P781, DOI 10.1210/jcem-51-4-781; Elmlinger MW, 2005, CLIN LAB, V51, P145; Frystyk J, 2010, GROWTH HORM IGF RES, V20, P8, DOI 10.1016/j.ghir.2009.09.004; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Hoofnagle AN, 2008, CLIN CHEM, V54, P1796, DOI 10.1373/clinchem.2008.109652; HORNER JM, 1978, J CLIN ENDOCR METAB, V47, P1287, DOI 10.1210/jcem-47-6-1287; Krebs A, 2008, CLIN CHEM LAB MED, V46, P1776, DOI 10.1515/CCLM.2008.349; Lofqvist C, 2001, J CLIN ENDOCR METAB, V86, P5870, DOI 10.1210/jc.86.12.5870; MORAND K, 1993, RAPID COMMUN MASS SP, V7, P738, DOI 10.1002/rcm.1290070811; Nedelkov D, 2003, FEBS LETT, V536, P130, DOI 10.1016/S0014-5793(03)00042-5; Pink D, 2005, J CLIN ONCOL, V23, P6809, DOI 10.1200/JCO.2005.02.4828; Renehan AG, 2003, GROWTH HORM IGF RES, V13, P341, DOI 10.1016/S1096-6374(03)00112-6; Spencer CA, 1998, J CLIN ENDOCR METAB, V83, P1121, DOI 10.1210/jc.83.4.1121; Wilton P, 1992, Acta Paediatr Suppl, V383, P137; Yu H, 1999, J CLIN LAB ANAL, V13, P166, DOI 10.1002/(SICI)1098-2825(1999)13:4<166::AID-JCLA5>3.3.CO;2-O; ZAPF J, 1981, J CLIN INVEST, V68, P1321, DOI 10.1172/JCI110379; Zhang NR, 2009, RAPID COMMUN MASS SP, V23, P1085, DOI 10.1002/rcm.3975	25	54	57	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43457	10.1371/journal.pone.0043457	http://dx.doi.org/10.1371/journal.pone.0043457			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984427	gold, Green Published, Green Submitted			2022-12-27	WOS:000308638700021
J	Gilbert, M; Jambal, L; Karesh, WB; Fine, A; Shiilegdamba, E; Dulam, P; Sodnomdarjaa, R; Ganzorig, K; Batchuluun, D; Tseveenmyadag, N; Bolortuya, P; Cardona, CJ; Leung, CYH; Peiris, JSM; Spackman, E; Swayne, DE; Joly, DO				Gilbert, Martin; Jambal, Losolmaa; Karesh, William B.; Fine, Amanda; Shiilegdamba, Enkhtuvshin; Dulam, Purevtseren; Sodnomdarjaa, Ruuragchaa; Ganzorig, Khuukhenbaatar; Batchuluun, Damdinjav; Tseveenmyadag, Natsagdorj; Bolortuya, Purevsuren; Cardona, Carol J.; Leung, Connie Y. H.; Peiris, J. S. Malik; Spackman, Erica; Swayne, David E.; Joly, Damien O.			Highly Pathogenic Avian Influenza Virus among Wild Birds in Mongolia	PLOS ONE			English	Article							TIME RT-PCR; H5N1 VIRUSES; HPAI H5N1; HONG-KONG; WATERFOWL; DUCKS; HEMAGGLUTININ; OUTBREAK; GEESE; INFECTIONS	Mongolia combines a near absence of domestic poultry, with an abundance of migratory waterbirds, to create an ideal location to study the epidemiology of highly pathogenic avian influenza virus (HPAIV) in a purely wild bird system. Here we present the findings of active and passive surveillance for HPAIV subtype H5N1 in Mongolia from 2005-2011, together with the results of five outbreak investigations. In total eight HPAIV outbreaks were confirmed in Mongolia during this period. Of these, one was detected during active surveillance employed by this project, three by active surveillance performed by Mongolian government agencies, and four through passive surveillance. A further three outbreaks were recorded in the neighbouring Tyva Republic of Russia on a lake that bisects the international border. No HPAIV was isolated (cultured) from 7,855 environmental fecal samples (primarily from ducks), or from 2,765 live, clinically healthy birds captured during active surveillance (primarily shelducks, geese and swans), while four HPAIVs were isolated from 141 clinically ill or dead birds located through active surveillance. Two low pathogenic avian influenza viruses (LPAIV) were cultured from ill or dead birds during active surveillance, while environmental feces and live healthy birds yielded 56 and 1 LPAIV respectively. All Mongolian outbreaks occurred in 2005 and 2006 (clade 2.2), or 2009 and 2010 (clade 2.3.2.1); all years in which spring HPAIV outbreaks were reported in Tibet and/or Qinghai provinces in China. The occurrence of outbreaks in areas deficient in domestic poultry is strong evidence that wild birds can carry HPAIV over at least moderate distances. However, failure to detect further outbreaks of clade 2.2 after June 2006, and clade 2.3.2.1 after June 2010 suggests that wild birds migrating to and from Mongolia may not be competent as indefinite reservoirs of HPAIV, or that HPAIV did not reach susceptible populations during our study.	[Gilbert, Martin; Jambal, Losolmaa; Karesh, William B.; Fine, Amanda; Shiilegdamba, Enkhtuvshin; Joly, Damien O.] Wildlife Conservat Soc, Bronx, NY USA; [Karesh, William B.] EcoHealth Alliance, New York, NY USA; [Dulam, Purevtseren; Sodnomdarjaa, Ruuragchaa; Ganzorig, Khuukhenbaatar; Batchuluun, Damdinjav] Avian Influenza Sect, State Cent Vet Lab, Transboundary Anim Dis Lab, Ulaanbaatar, Mongolia; [Tseveenmyadag, Natsagdorj] Mongolian Acad Sci, Inst Biol, Ulaanbaatar, Mongolia; [Bolortuya, Purevsuren] Natl Emergency Management Agcy, World Bank, Avian & Human Influenza Project, Ulaanbaatar, Mongolia; [Cardona, Carol J.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Leung, Connie Y. H.; Peiris, J. S. Malik] Univ Hong Kong, Sch Publ Hlth, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Spackman, Erica; Swayne, David E.] USDA ARS, SE Poultry Res Lab, Athens, GA 30605 USA	Wildlife Conservation Society; Mongolian Academy of Sciences; The World Bank; University of Minnesota System; University of Minnesota Twin Cities; University of Hong Kong; United States Department of Agriculture (USDA)	Gilbert, M (corresponding author), Wildlife Conservat Soc, Bronx, NY USA.	mgilbert@wcs.org	Swayne, David/AAP-7166-2020; Karesh, William/AAU-9084-2020; Peiris, Joseph Sriyal Malik/C-4380-2009	Karesh, William/0000-0001-6042-2860; Gilbert, Martin/0000-0002-9930-4383; Spackman, Erica/0000-0002-4935-2360; Shiilegdamba, Enkhtuvshin/0000-0003-1316-0591; Leung, Connie YH/0000-0003-1102-4684; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Swayne, David/0000-0001-7472-1992	National Institute of Allergy and Infectious Disease, National Institutes of Health, Department of Health and Human Services [HHSN266200700007C, HHSN266200700009C, HHSN266200700005C]; United States Agency for International Development (USAID); World Bank; Food and Agriculture Organization of the United Nations; Dunemere private foundation	National Institute of Allergy and Infectious Disease, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); World Bank(The World Bank India); Food and Agriculture Organization of the United Nations; Dunemere private foundation	Support for this project was provided by the National Institute of Allergy and Infectious Disease, National Institutes of Health, Department of Health and Human Services (Contracts HHSN266200700007C, HHSN266200700009C, and HHSN266200700005C), the United States Agency for International Development (USAID), the World Bank, and the Food and Agriculture Organization of the United Nations. DOJ was supported by generous funding from the Dunemere private foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2007, AVIAN DIS, V51, P161, DOI 10.1637/7602-041306R.1; Batbayar Nyambayar, 2011, Wildfowl, V61, P90; Brown JD, 2008, EMERG INFECT DIS, V14, P136, DOI 10.3201/eid1401.070740; Brown JD, 2006, EMERG INFECT DIS, V12, P1663, DOI 10.3201/eid1211.060652; Chan S., 2004, IMPORTANT BIRD AREAS; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chen HL, 2006, J VIROL, V80, P5976, DOI 10.1128/JVI.00110-06; Cui P, 2011, J ORNITHOL, V152, P83, DOI 10.1007/s10336-010-0552-6; Das A, 2006, J CLIN MICROBIOL, V44, P3065, DOI 10.1128/JCM.00639-06; Delaney S, 2005, GUIDELINES PARTICIPA; Ducatez MF, 2007, EMERG INFECT DIS, V13, P611, DOI 10.3201/eid1304.061356; Ellis TM, 2004, AVIAN PATHOL, V33, P492, DOI 10.1080/03079450400003601; FAO, 2007, GRIDDED LIVESTOCK WO; Gauthier-Clerc M, 2007, IBIS, V149, P202, DOI 10.1111/j.1474-919X.2007.00699.x; Hawkes LA, 2011, P NATL ACAD SCI USA, V108, P9516, DOI 10.1073/pnas.1017295108; HINSHAW VS, 1985, B WORLD HEALTH ORGAN, V63, P711; Islam MR, 2012, TRANSBOUND EMERG DIS, V59, P460, DOI 10.1111/j.1865-1682.2011.01297.x; Karesh WB, 2007, J WILDLIFE DIS, V43, pS55; Keawcharoen J, 2005, ACTA VIROL, V49, P277; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Komar N, 2008, EMERG INFECT DIS, V14, P1176, DOI 10.3201/eid1407.080161; Kwon YK, 2005, J WILDLIFE DIS, V41, P618, DOI 10.7589/0090-3558-41.3.618; Lee DH, 2011, J WILDLIFE DIS, V47, P994, DOI 10.7589/0090-3558-47.4.994; Lei FM, 2007, AVIAN DIS, V51, P568, DOI 10.1637/0005-2086(2007)51[568:COHIVI]2.0.CO;2; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Meyburg BU, 2010, RAPTORS SCI CONSERVA, P52; Minton Clive, 2005, Stilt, V48, P42; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Newman SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005729; Prosser DJ, 2009, IBIS, V151, P568, DOI 10.1111/j.1474-919X.2009.00932.x; Reid SM, 2011, TRANSBOUND EMERG DIS, V58, P76, DOI 10.1111/j.1865-1682.2010.01175.x; Runstadler JA, 2007, ARCH VIROL, V152, P1901, DOI 10.1007/s00705-007-0994-1; Siembieda JL, 2010, VECTOR-BORNE ZOONOT, V10, P793, DOI 10.1089/vbz.2009.0095; Sims L, 2005, TCPRAS3007 UN FAO, P1; Smith GJD, 2009, EMERG INFECT DIS, V15, P402, DOI 10.3201/eid1503.081190; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Spackman E, 2003, AVIAN DIS, V47, P1087, DOI 10.1637/0005-2086-47.s3.1087; Spackman E, 2003, AVIAN DIS, V47, P1079, DOI 10.1637/0005-2086-47.s3.1079; Spackman E, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-190; Spackman Erica, 2008, V436, P27, DOI 10.1007/978-1-59745-279-3_5; Stallknecht DE, 2009, REV SCI TECH OIE, V28, P59; Sturm-Ramirez KM, 2004, J VIROL, V78, P4892, DOI 10.1128/JVI.78.9.4892-4901.2004; Suarez DL, 1999, J VIROL, V73, P3567, DOI 10.1128/JVI.73.5.3567-3573.1999; SWAYNE D., 1998, LAB MANUAL ISOLATION, P150; Takekawa JY, 2010, AVIAN DIS, V54, P466, DOI 10.1637/8914-043009-Reg.1; Wingard J., 2006, MONGOLIA DISCUSSION; World Health Organization, 2011, UPD UN NOM SYST HIGH; World Health Organization, 2011, ARCH TABL CUM NUMB C; Zahler P, 2007, POVERTY HLTH ECOSYST, P89	50	32	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44097	10.1371/journal.pone.0044097	http://dx.doi.org/10.1371/journal.pone.0044097			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984464	Green Published, Green Submitted, gold			2022-12-27	WOS:000308638700044
J	Herzer, K; Carbow, A; Sydor, S; Sowa, JP; Biesterfeld, S; Hofmann, TG; Galle, PR; Gerken, G; Canbay, A				Herzer, Kerstin; Carbow, Anna; Sydor, Svenja; Sowa, Jan-Peter; Biesterfeld, Stefan; Hofmann, Thomas-Georg; Galle, Peter-Robert; Gerken, Guido; Canbay, Ali			Deficiency of the Promyelocytic Leukemia Protein Fosters Hepatitis C-Associated Hepatocarcinogenesis in Mice	PLOS ONE			English	Article							HUMAN HEPATOMA-CELLS; PML NUCLEAR-BODIES; LIVER-CANCER; APOPTOSIS; VIRUS; TRAIL; EXPRESSION; PATHWAYS; GROWTH; BETA	Overwhelming lines of epidemiological evidence have indicated that persistent infection with hepatitis C virus (HCV) is a major risk for the development of hepatocellular carcinoma (HCC). We have recently shown that HCV core protein mediates functional inactivation of the promyelocytic leukemia (PML) tumor suppressor pathway. However, the role of PML in HCC development yet remains unclear. To clarify the function of PML in liver carcinogenesis and HCV-associated pathogenesis we crossed PML-deficient mice with HCV transgene (HCV-Tg) expressing mice and treated the resulting animals with DEN/Phenobarbital, an established protocol for liver carcinogenesis. Seven months after treatment, livers were examined macroscopically and histologically. Genetic depletion of the tumor suppressor PML coincided with an increase in hepatocyte proliferation, resulting in development of multiple dysplastic nodules in 100% of the PML-deficient livers and of HCCs in 53%, establishing a tumor suppressive function of PML in the liver. In animals expressing the HCV-transgene in PML-deficient background, HCC development occurred even in 73%, while only 7% of their wildtype littermates developed HCC. The neoplastic nature of the tumors was confirmed by histology and expression of the HCC marker glutamine synthetase. Several pro-and antiapoptotic factors were tested for differential expression and liver carcinogenesis was associated with impaired expression of the proapoptotic molecule TRAIL in PML-deficient mice. In conclusion, this study provides first in vivo evidence that the tumor suppressor PML acts as an important barrier in liver carcinogenesis and HCV-dependent liver pathology.	[Herzer, Kerstin; Sydor, Svenja; Sowa, Jan-Peter; Gerken, Guido; Canbay, Ali] Univ Hosp, Dept Gastroenterol & Hepatol, Essen, Germany; [Carbow, Anna] Spital STS Ag, Dept Surg, Zweisimmern, Switzerland; [Biesterfeld, Stefan] Univ Hosp Dusseldorf, Dept Cytopathol, Dusseldorf, Germany; [Hofmann, Thomas-Georg] Univ Heidelberg Alliance, Deutsch Krebsforschungszentrum, Zentrum Mol Biol, Res Grp Cellular Senescence, Heidelberg, Germany; [Galle, Peter-Robert] Johannes Gutenberg Univ Mainz, Dept Med 1, Univ Med, D-6500 Mainz, Germany	University of Duisburg Essen; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Johannes Gutenberg University of Mainz	Herzer, K (corresponding author), Univ Hosp, Dept Gastroenterol & Hepatol, Essen, Germany.	kerstin.herzer@uk-essen.de	Sydor, Svenja/AAV-9951-2021; Sydor, Svenja/ABG-6622-2020; Galle, Peter/ABE-2872-2021; Canbay, Ali/AAL-9620-2020; Galle, Peter R/T-5292-2018; Sowa, Jan-Peter/AAQ-6318-2020	Sydor, Svenja/0000-0002-1349-8309; Galle, Peter/0000-0001-8294-0992; Galle, Peter R/0000-0001-8294-0992; Canbay, Ali/0000-0001-6069-7899; Sowa, Jan-Peter/0000-0003-2943-0015; Gerken, Guido/0000-0001-6734-5001	Deutsche Krebshilfe [108990]; Deutsche Forschungsgemeinschaft (DFG) [267/8-1]; Wilhelm Laupitz Foundation	Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Wilhelm Laupitz Foundation	Funding provided by Deutsche Krebshilfe grant no. 108990. This work was further supported by the Deutsche Forschungsgemeinschaft (DFG, grant 267/8-1), and the Wilhelm Laupitz Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzola Monica, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006926; Bartenschlager R, TRENDS MICROBIOL, V19, P95; Bernardi R, 2008, ONCOGENE, V27, P6299, DOI 10.1038/onc.2008.305; Castello G, CLIN IMMUNOL, V134, P237; Dechene A, HEPATOLOGY, V52, P1008; Everett RD, 2001, ONCOGENE, V20, P7266, DOI 10.1038/sj.onc.1204759; Gieseler RK, J VIRAL HEPAT; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Herr I, 2007, HEPATOLOGY, V46, P266, DOI 10.1002/hep.21740; Herzer K, 2007, LIVER INT, V27, P293, DOI 10.1111/j.1478-3231.2006.01422.x; Herzer K, 2005, CANCER RES, V65, P10830, DOI 10.1158/0008-5472.CAN-05-0880; Herzer K, 2005, HEPATOLOGY, V42, P183, DOI 10.1002/hep.20757; Herzer K, 2009, CANCER RES, V69, P855, DOI 10.1158/0008-5472.CAN-08-2831; Hofmann TG, 2003, CELL DEATH DIFFER, V10, P1290, DOI 10.1038/sj.cdd.4401313; Jacobson IM, CLIN GASTROENTEROL H, V8, P924; Jacobson IM, CLIN GASTROENTEROL H, V8, pe117; Kanzler S, 2001, ONCOGENE, V20, P5015, DOI 10.1038/sj.onc.1204544; Koike K, 2007, J GASTROEN HEPATOL, V22, pS108, DOI 10.1111/j.1440-1746.2006.04669.x; Koike Kazuhiko, 2005, Clin Gastroenterol Hepatol, V3, pS132, DOI 10.1016/S1542-3565(05)00700-7; Krieghoff-Henning E, 2008, BBA-MOL CELL RES, V1783, P2185, DOI 10.1016/j.bbamcr.2008.07.002; Lerat H, 2002, GASTROENTEROLOGY, V122, P352, DOI 10.1053/gast.2002.31001; Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562; McGivern DR, ONCOGENE, V30, P1969; Nash KL, WORLD J GASTROENTERO, V16, P4061; Regad T, 2001, ONCOGENE, V20, P7274, DOI 10.1038/sj.onc.1204854; Salomoni P, 2008, CELL RES, V18, P620, DOI 10.1038/cr.2008.58; Trivedi PJ, DIG DIS SCI, V56, P276; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Wang ZG, 1998, SCIENCE, V279, P1547; Washburn ML, GASTROENTEROLOGY, V140, P1334; Worns MA, DIG LIVER DIS S3, V42, pS302	31	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44474	10.1371/journal.pone.0044474	http://dx.doi.org/10.1371/journal.pone.0044474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984515	Green Published, Green Submitted, gold			2022-12-27	WOS:000308638700063
J	Ishii, H; Shimatsu, A; Okimura, Y; Tanaka, T; Hizuka, N; Kaji, H; Hanew, K; Oki, Y; Yamashiro, S; Takano, K; Chihara, K				Ishii, Hitoshi; Shimatsu, Akira; Okimura, Yasuhiko; Tanaka, Toshiaki; Hizuka, Naomi; Kaji, Hidesuke; Hanew, Kunihiko; Oki, Yutaka; Yamashiro, Sayuri; Takano, Koji; Chihara, Kazuo			Development and Validation of a New Questionnaire Assessing Quality of Life in Adults with Hypopituitarism: Adult Hypopituitarism Questionnaire (AHQ)	PLOS ONE			English	Article							HEALTH SURVEY; SF-36; TRANSLATION; ADAPTATION; DEFICIENCY	Objective: To develop and validate the Adult Hypopituitarism Questionnaire (AHQ) as a disease-specific, self-administered questionnaire for evaluation of quality of life (QOL) in adult patients with hypopituitarism. Methods: We developed and validated this new questionnaire, using a standardized procedure which included item development, pilot-testing and psychometric validation. Of the patients who participated in psychometric validation, those whose clinical conditions were judged to be stable were asked to answer the survey questionnaire twice, in order to assess test-retest reliability. Results: Content validity of the initial questionnaire was evaluated via two pilot tests. After these tests, we made minor revisions and finalized the initial version of the questionnaire. The questionnaire was constructed with two domains, one psycho-social and the other physical. For psychometric assessment, analyses were performed on the responses of 192 adult patients with various types of hypopituitarism. The intraclass correlations of the respective domains were 0.91 and 0.95, and the Cronbach's alpha coefficients were 0.96 and 0.95, indicating adequate test-retest reliability and internal consistency for each domain. For known-group validity, patients with hypopituitarism due to hypothalamic disorder showed significantly lower scores in 11 out of 13 sub-domains compared to those who had hypopituitarism due to pituitary disorder. Regarding construct validity, the domain structure was found to be almost the same as that initially hypothesized. Exploratory factor analysis (n = 228) demonstrated that each domain consisted of six and seven sub-domains. Conclusion: The AHQ showed good reliability and validity for evaluating QOL in adult patients with hypopituitarism.	[Ishii, Hitoshi; Yamashiro, Sayuri] Tenri Hosp, Dept Endocrinol, Tenri, Nara 632, Japan; [Shimatsu, Akira] Kyoto Med Ctr, Natl Hosp Org, Clin Res Inst, Kyoto, Japan; [Okimura, Yasuhiko] Kobe Womens Univ, Grad Sch Life Sci, Dept Nutr Metab & Food Sci, Kobe, Hyogo, Japan; [Hizuka, Naomi] Tokyo Womens Med Univ, Dept Med 2, Tokyo, Japan; [Tanaka, Toshiaki] Tanaka Growth Clin, Tokyo, Japan; [Kaji, Hidesuke] Univ Hyogo, Div Physiol Metab, Akashi, Hyogo, Japan; [Hanew, Kunihiko] Hanew Endocrine Clin, Sendai, Miyagi, Japan; [Oki, Yutaka] Hamamatsu Univ Sch Med, Dept Med, Hamamatsu, Shizuoka 4313192, Japan; [Takano, Koji] Univ Tokyo, Fac Med, Dept Nephrol & Endocrinol, Tokyo 113, Japan; [Chihara, Kazuo] Hyogo Prefectural Kakogawa Med Ctr, Dept Endocrinol & Diabet, Kakogawa, Hyogo, Japan	Tenri Hospital; Tokyo Women's Medical University; University of Hyogo; Hamamatsu University School of Medicine; University of Tokyo	Ishii, H (corresponding author), Tenri Hosp, Dept Endocrinol, Tenri, Nara 632, Japan.	hit@tenriyorozu.jp	Shimatsu, Akira/I-3856-2019		Public Health Research Foundation (Tokyo, Japan)	Public Health Research Foundation (Tokyo, Japan)	This study was funded by the Public Health Research Foundation (Tokyo, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chihara K, 2006, GROWTH HORM IGF RES, V16, P132, DOI 10.1016/j.ghir.2006.03.012; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Devellis RF, 1991, DEV THEORY APPL; Dupuy H.J., 1984, ASSESSMENT QUALITY L, P170; Fayers PM, 2007, QUALITY LIFE ASSESSM; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1045, DOI 10.1016/S0895-4356(98)00096-1; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Herschbach P, 2001, EUR J ENDOCRINOL, V145, P255, DOI 10.1530/eje.0.1450255; HUNT SM, 1981, SOC SCI MED-MED SOC, V15, P221, DOI 10.1016/0271-7123(81)90005-5; McDowell I., 1996, MEASURING HLTH GUIDE; McKenna SP, 1999, QUAL LIFE RES, V8, P373, DOI 10.1023/A:1008987922774; Revicki DA, 2000, QUAL LIFE RES, V9, P887, DOI 10.1023/A:1008996223999; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Suzukamo Y, 2006, GROWTH HORM IGF RES, V16, P340, DOI 10.1016/j.ghir.2006.09.002; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x; Woodhouse LJ, 2006, ENDOCR REV, V27, P287, DOI 10.1210/er.2004-0022	19	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44304	10.1371/journal.pone.0044304	http://dx.doi.org/10.1371/journal.pone.0044304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	003VE	22984490	Green Submitted, Green Published, gold			2022-12-27	WOS:000308638700053
J	Mewes, A; Franke, H; Singer, D				Mewes, Agneta; Franke, Heike; Singer, David			Organotypic Brain Slice Cultures of Adult Transgenic P301S Mice-A Model for Tauopathy Studies	PLOS ONE			English	Article							SURVIVAL-PROMOTING PEPTIDE; LONG-TERM POTENTIATION; CELL-DEATH; IN-VITRO; MICROGLIAL ACTIVATION; HIPPOCAMPAL SLICES; POSTISCHEMIC HYPOTHERMIA; ALZHEIMERS-DISEASE; MILD HYPOTHERMIA; CEREBRAL-CORTEX	Background: Organotypic brain slice cultures represent an excellent compromise between single cell cultures and complete animal studies, in this way replacing and reducing the number of animal experiments. Organotypic brain slices are widely applied to model neuronal development and regeneration as well as neuronal pathology concerning stroke, epilepsy and Alzheimer's disease (AD). AD is characterized by two protein alterations, namely tau hyperphosphorylation and excessive amyloid beta deposition, both causing microglia and astrocyte activation. Deposits of hyperphosphorylated tau, called neurofibrillary tangles (NFTs), surrounded by activated glia are modeled in transgenic mice, e. g. the tauopathy model P301S. Methodology/Principal Findings: In this study we explore the benefits and limitations of organotypic brain slice cultures made of mature adult transgenic mice as a potential model system for the multifactorial phenotype of AD. First, neonatal (P1) and adult organotypic brain slice cultures from 7- to 10-month-old transgenic P301S mice have been compared with regard to vitality, which was monitored with the lactate dehydrogenase (LDH)- and the MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assays over 15 days. Neonatal slices displayed a constant high vitality level, while the vitality of adult slice cultures decreased significantly upon cultivation. Various preparation and cultivation conditions were tested to augment the vitality of adult slices and improvements were achieved with a reduced slice thickness, a mild hypothermic cultivation temperature and a cultivation CO2 concentration of 5%. Furthermore, we present a substantial immunohistochemical characterization analyzing the morphology of neurons, astrocytes and microglia in comparison to neonatal tissue. Conclusion/Significance: Until now only adolescent animals with a maximum age of two months have been used to prepare organotypic brain slices. The current study provides evidence that adult organotypic brain slice cultures from 7- to 10-month-old mice independently of the transgenic modification undergo slow programmed cell death, caused by a dysfunction of the neuronal repair systems.	[Mewes, Agneta; Singer, David] Univ Leipzig, Ctr Biotechnol & Biomed BBZ, Inst Bioanalyt Chem, Leipzig, Germany; [Franke, Heike] Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, Leipzig, Germany	Leipzig University; Leipzig University	Mewes, A (corresponding author), Univ Leipzig, Ctr Biotechnol & Biomed BBZ, Inst Bioanalyt Chem, Leipzig, Germany.	david.singer@bbz.uni-leipzig.de			European Social Fund (ESF) [080937179]; initiative of the European Union; Free State of Saxony	European Social Fund (ESF)(European Social Fund (ESF)); initiative of the European Union; Free State of Saxony	The study was supported by the European Social Fund (ESF, grand number 080937179), an initiative of the European Union and the Free State of Saxony. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamchik Y, 2000, BRAIN RES PROTOC, V5, P153, DOI 10.1016/S1385-299X(00)00007-6; Alberdi E, 2010, CELL CALCIUM, V47, P264, DOI 10.1016/j.ceca.2009.12.010; Allen B, 2002, J NEUROSCI, V22, P9340; Barros LF, 2010, BRAIN RES REV, V63, P149, DOI 10.1016/j.brainresrev.2009.10.002; BERTRAND R, 1994, EXP CELL RES, V211, P314, DOI 10.1006/excr.1994.1093; BINGMANN D, 1982, EXP BRAIN RES, V48, P89; Braithwaite SP, 2010, NEUROBIOL DIS, V39, P311, DOI 10.1016/j.nbd.2010.04.015; Chechneva O, 2005, NEUROSCIENCE, V136, P343, DOI 10.1016/j.neuroscience.2005.07.058; Cronin M, 2006, FRONT BIOSCI-LANDMRK, V11, P2967, DOI 10.2741/2025; Cunningham TJ, 1998, J NEUROSCI, V18, P7047; De Simoni A, 2003, J PHYSIOL-LONDON, V550, P135, DOI 10.1113/jphysiol.2003.039099; DELRIO JA, 1991, NEUROSCIENCE, V43, P335, DOI 10.1016/0306-4522(91)90298-3; DEROUICHE A, 1993, EUR J NEUROSCI, V5, P122, DOI 10.1111/j.1460-9568.1993.tb00477.x; FERRER I, 1990, NEUROSCIENCE, V39, P451, DOI 10.1016/0306-4522(90)90281-8; FINLAY BL, 1992, J NEUROBIOL, V23, P1159, DOI 10.1002/neu.480230908; Finley M, 2004, BRAIN RES, V1001, P125, DOI 10.1016/j.brainres.2003.12.009; Franke H, 2003, NEUROCHEM INT, V42, P431, DOI 10.1016/S0197-0186(02)00134-1; Frantseva MV, 1999, J NEUROSCI METH, V89, P25, DOI 10.1016/S0165-0270(99)00030-8; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; GAHWILER BH, 1981, J NEUROSCI METH, V4, P329, DOI 10.1016/0165-0270(81)90003-0; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Greiner C, 1998, BRAIN RES, V786, P267, DOI 10.1016/S0006-8993(97)01465-0; Hailer NP, 2001, EUR J NEUROSCI, V14, P315, DOI 10.1046/j.0953-816x.2001.01649.x; Hailer NP, 1996, GLIA, V18, P319, DOI 10.1002/(SICI)1098-1136(199612)18:4<319::AID-GLIA6>3.0.CO;2-S; Halliday G, 2000, CLIN EXP PHARMACOL P, V27, P1, DOI 10.1046/j.1440-1681.2000.03200.x; Hassen GW, 2004, BRAIN RES PROTOC, V13, P135, DOI 10.1016/j.brainresprot.2004.03.004; HAWKINS RA, 1971, BIOCHEM J, V122, P13, DOI 10.1042/bj1220013; Heine C, 2012, NEUROSIGNAL IN PRESS; Huh PW, 2000, J NEUROSURG, V92, P91, DOI 10.3171/jns.2000.92.1.0091; Hulse RE, 2001, GLIA, V33, P169, DOI 10.1002/1098-1136(200102)33:2<169::AID-GLIA1016>3.0.CO;2-B; KLEINBERGERDORON N, 1990, BRAIN RES, V533, P239, DOI 10.1016/0006-8993(90)91345-H; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Lee VM, 1989, LOGIC CIRCUITS CARBO, V251, P675; Legradi A, 2011, BRAIN RES BULL, V84, P39, DOI 10.1016/j.brainresbull.2010.10.008; Leutgeb JK, 2005, NEUROSCIENCE, V131, P601, DOI 10.1016/j.neuroscience.2004.12.002; Leutgeb JK, 2003, J NEUROSCI METH, V130, P19, DOI 10.1016/S0165-0270(03)00228-0; Liang L, 2004, FEBS LETT, V566, P261, DOI 10.1016/j.febslet.2004.04.047; Lindroos MM, 2005, INT J DEV NEUROSCI, V23, P65, DOI 10.1016/j.ijdevneu.2004.08.003; Liu B, 2001, J NEUROCHEM, V77, P182, DOI 10.1046/j.1471-4159.2001.t01-1-00216.x; Liu D, 1999, MOL BRAIN RES, V68, P29, DOI 10.1016/S0169-328X(99)00063-7; Liu L, 2005, J NEUROCHEM, V92, P546, DOI 10.1111/j.1471-4159.2004.02909.x; Lossi L, 2009, PROG NEUROBIOL, V88, P221, DOI 10.1016/j.pneurobio.2009.01.002; Maier CM, 1998, STROKE, V29, P2171, DOI 10.1161/01.STR.29.10.2171; McKinney RA, 1997, NAT MED, V3, P990, DOI 10.1038/nm0997-990; Niblock MM, 2001, J NEUROSCI RES, V65, P455, DOI 10.1002/jnr.1174; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; Penfield S.W., 1928, SPECIAL CYTOLOGY FOR, P1033; Petito CK, 1998, J NEUROPATH EXP NEUR, V57, P231, DOI 10.1097/00005072-199803000-00004; Potter SM, 2001, J NEUROSCI METH, V110, P17, DOI 10.1016/S0165-0270(01)00412-5; Pringle AK, 1997, BRAIN RES, V755, P36, DOI 10.1016/S0006-8993(97)00089-9; Prins ML, 2008, J CEREBR BLOOD F MET, V28, P1, DOI 10.1038/sj.jcbfm.9600543; Ronicke R, 2009, N-S ARCH PHARMACOL, V379, P233, DOI 10.1007/s00210-008-0364-x; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Schneeberg J, 2009, EUR J PHARMACOL, V616, P81, DOI 10.1016/j.ejphar.2009.05.029; Schrag M, 2008, HIPPOCAMPUS, V18, P239, DOI 10.1002/hipo.20387; Schwartzkroin PA, 1981, ELECTROPHYSIOLOGY IS, P15; SPREAFICO R, 1995, J COMP NEUROL, V363, P281, DOI 10.1002/cne.903630209; Staal JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022040; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Su T, 2011, BRAIN RES, V1385, P68, DOI 10.1016/j.brainres.2011.01.115; Sundstrom L, 2005, DRUG DISCOV TODAY, V10, P993, DOI 10.1016/S1359-6446(05)03502-6; VALVERDE F, 1995, J NEUROSCI, V15, P5014; Wilhelmi E, 2002, ATLA-ALTERN LAB ANIM, V30, P275, DOI 10.1177/026119290203000304; Xiang ZM, 2000, J NEUROSCI METH, V98, P145, DOI 10.1016/S0165-0270(00)00197-7; Xu LJ, 2001, EXP NEUROL, V169, P416, DOI 10.1006/exnr.2001.7678; Yanamoto H, 1999, STROKE, V30, P2720, DOI 10.1161/01.STR.30.12.2720; Yoon JJ, 2010, BRAIN RES, V1353, P194, DOI 10.1016/j.brainres.2010.07.005; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zilberter Y, 2010, TRENDS PHARMACOL SCI, V31, P394, DOI 10.1016/j.tips.2010.06.005; Zou JY, 2005, BRAIN RES, V1034, P11, DOI 10.1016/j.brainres.2004.11.014	74	41	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e45017	10.1371/journal.pone.0045017	http://dx.doi.org/10.1371/journal.pone.0045017			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984603	Green Published, Green Submitted, gold			2022-12-27	WOS:000308638700104
J	van Balkom, IDC; Bresnahan, M; Vuijk, PJ; Hubert, J; Susser, E; Hoek, HW				van Balkom, Ingrid D. C.; Bresnahan, Michaeline; Vuijk, Pieter Jelle; Hubert, Jan; Susser, Ezra; Hoek, Hans W.			Paternal Age and Risk of Autism in an Ethnically Diverse, Non-Industrialized Setting: Aruba	PLOS ONE			English	Article							SPECTRUM DISORDERS; PERINATAL FACTORS; BIRTH-WEIGHT; POPULATION; PRETERM; TRAITS	Objective: The aim of this study was to examine paternal age in relation to risk of autism spectrum disorders (ASDs) in a setting other than the industrialized west. Design: A case-control study of Aruban-born children (1990-2003). Cases (N = 95) were identified at the Child and Adolescent Psychiatry Clinic, the only such clinic in Aruba; gender and age matched controls (N = 347) were gathered from public health records. Parental age was defined categorically (<= 29, 30-39, 40-49, >= 50y). The analysis was made, using conditional logistic regression. Results: Advanced paternal age was associated with increased risk of ASDs in offspring. In comparison to the youngest paternal age group (<= 29y), risk of autism increased 2.18 times for children born from fathers in their thirties, 2.71 times for fathers in their forties, and 3.22 thereafter. Conclusion: This study, part of the first epidemiologic study of autism in the Caribbean, contributes additional evidence, from a distinctive sociocultural setting, of the risk of ASD associated with increased paternal age.	[van Balkom, Ingrid D. C.] Lentis Psychiat Inst, Jonx Dept Youth Mental Hlth, Groningen, Netherlands; [van Balkom, Ingrid D. C.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Rob Giel Res Ctr, Groningen, Netherlands; [Bresnahan, Michaeline; Susser, Ezra; Hoek, Hans W.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Bresnahan, Michaeline; Susser, Ezra] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Vuijk, Pieter Jelle] Vrije Univ Amsterdam, Dept Clin Neuropsychol, Amsterdam, Netherlands; [Susser, Ezra] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA; [Hoek, Hans W.] Parnassia Bavo Psychiat Inst, The Hague, Netherlands	University of Groningen; Columbia University; New York State Psychiatry Institute; Vrije Universiteit Amsterdam; Columbia University; Parnassia Psychiatric Institute		idc.vanbalkom@lentis.nl	Vuijk, Pieter Jelle/H-2428-2013	Vuijk, Pieter/0000-0002-2181-5220; Hoek, Hans/0000-0001-6353-5465				Alter MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016715; Bailey A, 1998, J AUTISM DEV DISORD, V28, P369, DOI 10.1023/A:1026048320785; Bongaarts J, 2003, POP STUD-J DEMOG, V57, P321, DOI 10.1080/0032472032000137835; Buchmayer S, 2009, PEDIATRICS, V124, pE817, DOI 10.1542/peds.2008-3582; Buizer-Voskamp JE, 2011, SCHIZOPHR RES, V129, P128, DOI 10.1016/j.schres.2011.03.021; Buwe A, 2005, CYTOGENET GENOME RES, V111, P213, DOI 10.1159/000086892; Central Bureau of Statistics (CBS), 2002, CENS 2000 SPEC REP; Charman T, 2005, J AUTISM DEV DISORD, V35, P539, DOI 10.1007/s10803-005-5068-1; Cheslack-Postava K, 2011, PEDIATRICS, V127, P246, DOI 10.1542/peds.2010-2371; Constantino JN, 2005, BIOL PSYCHIAT, V57, P655, DOI 10.1016/j.biopsych.2004.12.014; Croen LA, 2007, ARCH PEDIAT ADOL MED, V161, P334, DOI 10.1001/archpedi.161.4.334; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Flanagan JM, 2006, AM J HUM GENET, V79, P67, DOI 10.1086/504729; Glasson EJ, 2004, ARCH GEN PSYCHIAT, V61, P618, DOI 10.1001/archpsyc.61.6.618; Grether JK, 2009, AM J EPIDEMIOL, V170, P1118, DOI 10.1093/aje/kwp247; Hultman CM, 2011, MOL PSYCHIATR, V16, P1203, DOI 10.1038/mp.2010.121; Larsson HJ, 2005, AM J EPIDEMIOL, V161, P916, DOI 10.1093/aje/kwi123; Lauritsen MB, 2005, J CHILD PSYCHOL PSYC, V46, P963, DOI 10.1111/j.1469-7610.2004.00391.x; Leonard H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017875; Parner ET, 2012, ANN EPIDEMIOL, V22, P143, DOI 10.1016/j.annepidem.2011.12.006; Puleo CM, 2008, MOL PSYCHIATR, V13, P243, DOI 10.1038/sj.mp.4002102; Reichenberg A, 2006, ARCH GEN PSYCHIAT, V63, P1026, DOI 10.1001/archpsyc.63.9.1026; Sasanfar R, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-2; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shah PS, 2010, AM J OBSTET GYNECOL, V202, P103, DOI 10.1016/j.ajog.2009.08.026; Shelton JF, 2010, AUTISM RES, V3, P30, DOI 10.1002/aur.116; Toro-Labrador G, 2003, CARIBB J SCI, V39, P11; Tough SC, 2002, PEDIATRICS, V109, P399, DOI 10.1542/peds.109.3.399; van Balkom IDC, 2009, J NEURODEV DISORD, V1, P197, DOI 10.1007/s11689-009-9011-1; Zhang X, 2010, J AUTISM DEV DISORD, V40, P1311, DOI 10.1007/s10803-010-0992-0	30	21	22	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e45090	10.1371/journal.pone.0045090	http://dx.doi.org/10.1371/journal.pone.0045090			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	003VE	22984615	Green Published, Green Submitted, gold			2022-12-27	WOS:000308638700108
J	Rodt, T; Luepke, M; Boehm, C; Hueper, K; Halter, R; Glage, S; Hoy, L; Wacker, F; Borlak, J; von Falck, C				Rodt, Thomas; Luepke, Matthias; Boehm, Claudia; Hueper, Katja; Halter, Roman; Glage, Silke; Hoy, Ludwig; Wacker, Frank; Borlak, Juergen; von Falck, Christian			Combined Micro-PET/Micro-CT Imaging of Lung Tumours in SPC-raf and SPC-myc Transgenic Mice	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; CANCER; PET; ADENOCARCINOMAS; QUANTIFICATION; IRRADIATION; PROGRESSION; BIOMARKERS; RODENTS; PHANTOM	Introduction SPC-raf and SPC-myc transgenic mice develop disseminated and circumscribed lung adenocarcinoma respectively, allowing for assessment of carcinogenesis and treatment strategies. The purpose of this study was to investigate the technical feasibility, the correlation of initial findings to histology and the administered radiation dose of combined micro-PET/micro-CT in these animal models. Material and Methods: 14 C57BL/6 mice (4 nontransgenic, 4 SPC-raf transgenic, 6 SPC-myc transgenic) were examined using micro-CT and F-18-Fluoro-deoxyglucose micro-PET in-vivo. Micro-PET data was corrected for random events and scatter prior to reconstruction with a 3D-FORE/2D-OSEM iterative algorithm. Rigid micro-PET/micro-CT registration was performed. Tumour-to-non-tumour ratios were calculated for different lung regions and focal lesions. Diffuse tumour growth was quantified using a semiautomated micro-CT segmentation routine reported earlier. Regional histologic tumour load was assessed using a 4-point rating scale. Gamma radiation dose was determined using thermoluminescence dosimeters. Results: Micro-CT allowed visualisation of diffuse and circumscribed tumours in SPC-raf and SPC-myc transgenic animals along with morphology, while micro-PET provided information on metabolism, but lacked morphologic detail. Mean tumour-to-non-tumour ratio was 2.47 for circumscribed lesions. No significant correlation could be shown between histological tumour load and tumour-to-nontumour ratio for diffuse tumours in SPC-raf transgenic animals. Calculation of the expected dose based on gamma dosimetry yielded approximately 140 mGy/micro-PET examination additional to approximately 200 mGy due to micro-CT. Conclusions: Combined micro-PET/micro-CT imaging allows for in-vivo assessment of lung tumours in SPC-raf and SPC-myc transgenic mice. The technique has potential for the evaluation of carcinogenesis and treatment strategies in circumscribed lung tumours.	[Rodt, Thomas; Hueper, Katja; Wacker, Frank; von Falck, Christian] Hannover Med Sch, Dept Diagnost & Intervent Radiol, D-3000 Hannover, Germany; [Luepke, Matthias; Boehm, Claudia] Univ Vet Med Hannover, Hannover, Germany; [Halter, Roman] Fraunhofer Inst Toxicol & Expt Med, Dept Pharmaceut Res & Med Biotechnol, Hannover, Germany; [Glage, Silke] Hannover Med Sch, Dept Lab Anim Sci, D-3000 Hannover, Germany; [Hoy, Ludwig] Hannover Med Sch, Inst Biometry, D-3000 Hannover, Germany; [Borlak, Juergen] Hannover Med Sch, Inst Pharmaco & Toxicogenom, D-3000 Hannover, Germany	Hannover Medical School; University of Veterinary Medicine Hannover, Foundation; Fraunhofer Gesellschaft; Hannover Medical School; Hannover Medical School; Hannover Medical School	Rodt, T (corresponding author), Hannover Med Sch, Dept Diagnost & Intervent Radiol, D-3000 Hannover, Germany.	Rodt.Thomas@mh-hannover.de	von Falck, Christian/AAO-2108-2020; Hueper, Katja/J-9566-2016	Hueper, Katja/0000-0002-3195-4400	German Research Foundation	German Research Foundation(German Research Foundation (DFG))	The publication of this study is supported by the German Research Foundation project "Open Access Publication". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson SA, 2003, MOL CANCER RES, V1, P445; Bartling SH, 2010, METHODS, V50, P42, DOI 10.1016/j.ymeth.2009.07.006; Chatterji B, 2007, PROTEOMICS, V7, P3980, DOI 10.1002/pmic.200700290; Chen Z, 2012, NATURE, V483, P613, DOI 10.1038/nature10937; Day RM, 2008, J RADIAT RES, V49, P361, DOI 10.1269/jrr.07121; Ehrhardt A, 2003, J CANCER RES CLIN, V129, P71, DOI 10.1007/s00432-002-0400-z; Ehrhardt A, 2001, BRIT J CANCER, V84, P813, DOI 10.1054/bjoc.2000.1676; Fei BW, 2006, MED PHYS, V33, P753, DOI 10.1118/1.2163831; Ford NL, 2005, MED PHYS, V32, P2888, DOI 10.1118/1.2013007; Funk T, 2004, MED PHYS, V31, P2680, DOI 10.1118/1.1781553; Fushiki H, 2009, CANCER SCI, V100, P1544, DOI 10.1111/j.1349-7006.2009.01199.x; Guo WY, 2007, NUCL MED COMMUN, V28, P804, DOI 10.1097/MNM.0b013e3282d25a0d; Johnston SM, 2010, P SOC PHOTO OPT INST, V7622; Kirsch DG, 2010, INT J RADIAT ONCOL, V76, P973, DOI 10.1016/j.ijrobp.2009.11.038; Kreissl MC, 2006, J NUCL MED, V47, P974; Kuntz J, 2010, PHYS MED BIOL, V55, P2069, DOI 10.1088/0031-9155/55/7/018; Lee YZ, 2011, ACAD RADIOL, V18, P588, DOI 10.1016/j.acra.2010.11.022; Memon AA, 2009, CANCER RES, V69, P873, DOI 10.1158/0008-5472.CAN-08-3118; MILLER GG, 1986, INT J RADIAT ONCOL, V12, P1971, DOI 10.1016/0360-3016(86)90134-3; Namati E, 2010, MED PHYS, V37, P4793, DOI 10.1118/1.3476454; Ramasamy K, 2011, CLIN CANCER RES, V17, P753, DOI 10.1158/1078-0432.CCR-10-2290; Ray P, 2011, J BIOSCIENCES, V36, P499, DOI 10.1007/s12038-011-9079-0; Rodt T, 2011, ACTA RADIOL, V52, P75, DOI 10.1258/ar.2010.100059; Rodt T, 2009, FRONT BIOSCI-LANDMRK, V14, P1939, DOI 10.2741/3353; Rutters H, 2006, PROTEOMICS, V6, P3127, DOI 10.1002/pmic.200500188; Schambach SJ, 2010, METHODS, V50, P2, DOI 10.1016/j.ymeth.2009.08.007; Schuster DP, 2004, AM J RESP CELL MOL, V30, P129, DOI 10.1165/rcmb.2003-0213TR; Taschereau R, 2007, MED PHYS, V34, P1026, DOI 10.1118/1.2558115; von Falck C, 2009, FRONT BIOSCI-LANDMRK, V14, P2193, DOI 10.2741/3371; Wong KP, 2011, J NUCL MED, V52, P800, DOI 10.2967/jnumed.110.085092; Zeraatkar N, 2011, MED PHYS, V38, P1217, DOI 10.1118/1.3547721	31	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44427	10.1371/journal.pone.0044427	http://dx.doi.org/10.1371/journal.pone.0044427			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028537	Green Published, Green Submitted, gold			2022-12-27	WOS:000309392800008
J	Kita, Y; Takamura, T; Misu, H; Ota, T; Kurita, S; Takeshita, Y; Uno, M; Matsuzawa-Nagata, N; Kato, K; Ando, H; Fujimura, A; Hayashi, K; Kimura, T; Ni, YH; Otoda, T; Miyamoto, K; Zen, Y; Nakanuma, Y; Kaneko, S				Kita, Yuki; Takamura, Toshinari; Misu, Hirofumi; Ota, Tsuguhito; Kurita, Seiichiro; Takeshita, Yumie; Uno, Masafumi; Matsuzawa-Nagata, Naoto; Kato, Ken-ichiro; Ando, Hitoshi; Fujimura, Akio; Hayashi, Koji; Kimura, Toru; Ni, Yinhua; Otoda, Toshiki; Miyamoto, Ken-ichi; Zen, Yoh; Nakanuma, Yasuni; Kaneko, Shuichi			Metformin Prevents and Reverses Inflammation in a Non-Diabetic Mouse Model of Nonalcoholic Steatohepatitis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; PLASMINOGEN-ACTIVATOR INHIBITOR-1; NECROSIS-FACTOR-ALPHA; PLACEBO-CONTROLLED TRIAL; TYPE-2 DIABETIC-PATIENTS; HEPATIC STELLATE CELLS; INSULIN-RESISTANCE; PROTEIN-KINASE; GENE-EXPRESSION; VITAMIN-E	Background: Optimal treatment for nonalcoholic steatohepatitis (NASH) has not yet been established, particularly for individuals without diabetes. We examined the effects of metformin, commonly used to treat patients with type 2 diabetes, on liver pathology in a non-diabetic NASH mouse model. Methodology/Principal Findings: Eight-week-old C57BL/6 mice were fed a methionine-and choline-deficient plus high fat (MCD+HF) diet with or without 0.1% metformin for 8 weeks. Co-administration of metformin significantly decreased fasting plasma glucose levels, but did not affect glucose tolerance or peripheral insulin sensitivity. Metformin ameliorated MCD+HF diet-induced hepatic steatosis, inflammation, and fibrosis. Furthermore, metformin significantly reversed hepatic steatosis and inflammation when administered after the development of experimental NASH. Conclusions/Significance: These histological changes were accompanied by reduced hepatic triglyceride content, suppressed hepatic stellate cell activation, and the downregulation of genes involved in fatty acid metabolism, inflammation, and fibrogenesis. Metformin prevented and reversed steatosis and inflammation of NASH in an experimental non-diabetic model without affecting peripheral insulin resistance.	[Kita, Yuki; Takamura, Toshinari; Misu, Hirofumi; Ota, Tsuguhito; Kurita, Seiichiro; Takeshita, Yumie; Uno, Masafumi; Kato, Ken-ichiro; Ni, Yinhua; Otoda, Toshiki; Kaneko, Shuichi] Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa 9201192, Japan; [Matsuzawa-Nagata, Naoto; Miyamoto, Ken-ichi] Kanazawa Univ, Grad Sch Med Sci, Dept Hosp Pharm, Kanazawa, Ishikawa 9201192, Japan; [Ando, Hitoshi; Fujimura, Akio] Jichi Med Univ, Sch Med, Dept Pharmacol, Div Clin Pharmacol, Shimotsuke, Tochigi, Japan; [Hayashi, Koji; Kimura, Toru] Dainippon Sumitomo Pharma Co Ltd, Genom Sci Labs, Osaka, Japan; [Zen, Yoh; Nakanuma, Yasuni] Kanazawa Univ, Grad Sch Med Sci, Dept Human Pathol, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University; Kanazawa University; Jichi Medical University; Dainippon Sumitomo Pharmaceutical Company; Kanazawa University	Takamura, T (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa 9201192, Japan.		ANDO, Hitoshi/O-8199-2016; NAGATA, Naoto/D-9261-2012; Yinhua, Ni/H-3079-2015	ANDO, Hitoshi/0000-0001-6179-9993; NAGATA, Naoto/0000-0002-2389-2334; Yinhua, Ni/0000-0001-7738-5971	Ministry of Education, Culture, Sports, Science, and Technology of Japan [C-23591301, B-23791022]; Grants-in-Aid for Scientific Research [23591301] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (C-23591301 to TT), and a Grant-in-aid for Young Scientists (B-23791022 to HM) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adachi M, 2008, HEPATOLOGY, V47, P677, DOI 10.1002/hep.21991; Aithal GP, 2008, GASTROENTEROLOGY, V135, P1176, DOI 10.1053/j.gastro.2008.06.047; ANFOSSO F, 1993, J CLIN INVEST, V91, P2185, DOI 10.1172/JCI116445; Basu R, 2008, DIABETES, V57, P24, DOI 10.2337/db07-0827; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; Bergheim I, 2006, GASTROENTEROLOGY, V130, P2099, DOI 10.1053/j.gastro.2006.03.020; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Bugianesi E, 2005, AM J GASTROENTEROL, V100, P1082, DOI 10.1111/j.1572-0241.2005.41583.x; Caligiuri A, 2008, HEPATOLOGY, V47, P668, DOI 10.1002/hep.21995; Chapman HA, 2004, J CLIN INVEST, V113, P148, DOI 10.1172/JCI200420729; CLARKE SD, 1993, J ANIM SCI, V71, P1957, DOI 10.2527/1993.7171957x; Ersoy C, 2008, DIABETES RES CLIN PR, V81, P56, DOI 10.1016/j.diabres.2008.02.006; Hamaguchi E, 2003, J PHARMACOL EXP THER, V307, P987, DOI 10.1124/jpet.103.054346; Hamaguchi E, 2010, DIABETES CARE, V33, P284, DOI 10.2337/dc09-0148; Heishi M, 2006, DIABETOLOGIA, V49, P1647, DOI 10.1007/s00125-006-0271-y; Inzucchi SE, 1998, NEW ENGL J MED, V338, P867, DOI 10.1056/NEJM199803263381303; Lin HZ, 2000, NAT MED, V6, P998, DOI 10.1038/79697; Ma LJ, 2004, DIABETES, V53, P336, DOI 10.2337/diabetes.53.2.336; Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Misu H, 2007, DIABETOLOGIA, V50, P268, DOI 10.1007/s00125-006-0489-8; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Mitsuyoshi H, 2009, HEPATOL RES, V39, P366, DOI 10.1111/j.1872-034X.2008.00464.x; Ota S, 2009, BIOCH BIOPHYS RES CO; Ota T, 2007, GASTROENTEROLOGY, V132, P282, DOI 10.1053/j.gastro.2006.10.014; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Stojanovic VR, 2012, SCI WORLD J, DOI 10.1100/2012/845046; Takamura T, 2004, DIABETOLOGIA, V47, P638, DOI 10.1007/s00125-004-1366-y; Takamura T, 2008, OBESITY SILVER SPRIN; Takeshita Y, 2006, METABOLISM, V55, P1464, DOI 10.1016/j.metabol.2006.06.016; Takeshita Y, 2008, EUR J PHARMACOL, V579, P426, DOI 10.1016/j.ejphar.2007.11.016; Uchinami H, 2006, HEPATOLOGY, V44, P420, DOI 10.1002/hep.21268; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	36	114	119	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e43056	10.1371/journal.pone.0043056	http://dx.doi.org/10.1371/journal.pone.0043056			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028442	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900004
J	Grueber, CE; Wallis, GP; King, TM; Jamieson, IG				Grueber, Catherine E.; Wallis, Graham P.; King, Tania M.; Jamieson, Ian G.			Variation at Innate Immunity Toll-Like Receptor Genes in a Bottlenecked Population of a New Zealand Robin	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL-SELECTION; HAPLOTYPE RECONSTRUCTION; POSITIVE SELECTION; INFECTIOUS-DISEASE; NEW-GENERATION; 2 TLR2; MHC; EVOLUTION; POLYMORPHISMS	Toll-like receptors (TLRs) are an ancient family of genes encoding transmembrane proteins that bind pathogen-specific molecules and initiate both innate and adaptive aspects of the immune response. Our goal was to determine whether these genes show sufficient genetic diversity in a bottlenecked population to be a useful addition or alternative to the more commonly employed major histocompatibility complex (MHC) genotyping in a conservation genetics context. We amplified all known avian TLR genes in a severely bottlenecked population of New Zealand's Stewart Island robin (Petroica australis rakiura), for which reduced microsatellite diversity was previously observed. We genotyped 17-24 birds from a reintroduced island population (including the 12 founders) for nine genes, seven of which were polymorphic. We observed a total of 24 single-nucleotide polymorphisms overall, 15 of which were non-synonymous, representing up to five amino-acid variants at a locus. One locus (TLR1LB) showed evidence of past directional selection. Results also confirmed a passerine duplication of TLR7. The levels of TLR diversity that we observe are sufficient to justify their further use in addressing conservation genetic questions, even in bottlenecked populations.	[Grueber, Catherine E.; Wallis, Graham P.; King, Tania M.; Jamieson, Ian G.] Univ Otago, Dept Zool, Dunedin, New Zealand; [Grueber, Catherine E.; King, Tania M.; Jamieson, Ian G.] Allan Wilson Ctr Mol Ecol & Evolut, Palmerston North, New Zealand	University of Otago; Massey University	Grueber, CE (corresponding author), Univ Otago, Dept Zool, POB 56, Dunedin, New Zealand.	catherine.grueber@otago.ac.nz	Jamieson, Ian G/E-1505-2011; King, Tania/C-2664-2018; Grueber, Catherine E./H-4707-2011; Wallis, Graham/E-5410-2011	Grueber, Catherine E./0000-0002-8179-1822; Wallis, Graham/0000-0002-6408-7868	Marsden Fund, University of Otago [UOO1009]; Landcare Research, University of Otago [C09X0503]; Allan Wilson Centre for Molecular Ecology and Evolution	Marsden Fund, University of Otago; Landcare Research, University of Otago; Allan Wilson Centre for Molecular Ecology and Evolution	This research received funding from the Marsden Fund (Contract no. UOO1009), Landcare Research (Contract no. C09X0503), University of Otago and the Allan Wilson Centre for Molecular Ecology and Evolution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Whitehouse K, 2006, TRENDS ECOL EVOL, V21, P433, DOI 10.1016/j.tree.2006.05.010; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alcaide M, 2011, MOL BIOL EVOL, V28, P1703, DOI 10.1093/molbev/msq351; Alcaide M, 2009, CONSERV GENET, V10, P1349, DOI 10.1007/s10592-008-9653-7; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen-Nissen E, 2007, J EXP MED, V204, P393, DOI 10.1084/jem.20061400; Babik W, 2010, MOL ECOL RESOUR, V10, P237, DOI 10.1111/j.1755-0998.2009.02788.x; Babik W, 2009, MOL ECOL RESOUR, V9, P713, DOI 10.1111/j.1755-0998.2009.02622.x; Balakrishnan CN, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-29; Barker FK, 2004, P NATL ACAD SCI USA, V101, P11040, DOI 10.1073/pnas.0401892101; Bergman IM, 2012, INT J IMMUNOGENET, V39, P68, DOI 10.1111/j.1744-313X.2011.01057.x; Boessenkool S, 2007, CONSERV GENET, V8, P705, DOI 10.1007/s10592-006-9219-5; Bollmer JL, 2010, J HERED, V101, P448, DOI 10.1093/jhered/esq018; Bonneaud C, 2012, MOL ECOL, V21, P2628, DOI 10.1111/j.1365-294X.2012.05551.x; Brownlie R, 2011, CELL TISSUE RES, V343, P121, DOI 10.1007/s00441-010-1026-0; Cormican P, 2009, DEV COMP IMMUNOL, V33, P967, DOI 10.1016/j.dci.2009.04.001; Downing T, 2010, J IMMUNOL, V184, P6993, DOI 10.4049/jimmunol.0903092; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ferrer-Admetlla A, 2008, J IMMUNOL, V181, P1315, DOI 10.4049/jimmunol.181.2.1315; Fleming C.A., 1950, T ROYAL SOC NZ, VZ78, P127; Galan M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-296; Garrigan D, 2003, EVOLUTION, V57, P1707; GRAUR D, 2000, FUNDAMENTALS MOL EVO; Harper G. A., 2009, Notornis, V56, P63; Hedrick PW, 2000, GENETICS POPULATIONS; Higgs R, 2006, INFECT IMMUN, V74, P1692, DOI 10.1128/IAI.74.3.1692-1698.2006; Hoshino K, 1999, J IMMUNOL, V162, P3749; Huang YH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-149; Hughes AL, 1998, ANNU REV GENET, V32, P415, DOI 10.1146/annurev.genet.32.1.415; Jamieson IG, 2011, CONSERV BIOL, V25, P115, DOI 10.1111/j.1523-1739.2010.01574.x; Jepson A, 1997, INFECT IMMUN, V65, P872, DOI 10.1128/IAI.65.3.872-876.1997; Kirk H, 2011, INT J MOL SCI, V12, P3966, DOI 10.3390/ijms12063966; Laws RJ, 2011, ANIM CONSERV, V14, P47, DOI 10.1111/j.1469-1795.2010.00388.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Moresco EMY, 2011, CURR BIOL, V21, pR488, DOI 10.1016/j.cub.2011.05.039; Netea MG, 2004, EUR J CLIN MICROBIOL, V23, P672, DOI 10.1007/s10096-004-1192-7; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Palermo S, 2009, ANIM GENET, V40, P289, DOI 10.1111/j.1365-2052.2008.01833.x; Pespeni MH, 2012, P ROY SOC B-BIOL SCI, V279, P1412, DOI 10.1098/rspb.2011.1823; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Radwan J, 2010, BIOL CONSERV, V143, P537, DOI 10.1016/j.biocon.2009.07.026; Ramasamy KT, 2011, J POULT SCI, V48, P168, DOI 10.2141/jpsa.011008; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Rozen S, 1998, PRIMER3; Ruan WK, 2012, MOL BIOL REP, V39, P3419, DOI 10.1007/s11033-011-1113-7; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Smyth RP, 2010, GENE, V469, P45, DOI 10.1016/j.gene.2010.08.009; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stow AJ, 2004, MOL ECOL, V13, P443, DOI 10.1046/j.1365-294X.2003.02060.x; Sutton JT, 2011, MOL ECOL, V20, P4408, DOI 10.1111/j.1365-294X.2011.05292.x; Takaki A, 2012, IMMUNOGENETICS, V64, P15, DOI 10.1007/s00251-011-0556-2; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor SS, 2007, J EVOLUTION BIOL, V20, P2035, DOI 10.1111/j.1420-9101.2007.01362.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Townsend SM, 2012, CONSERV GENET RESOUR, V4, P633, DOI 10.1007/s12686-012-9610-0; Tschirren B, 2011, J EVOLUTION BIOL, V24, P1232, DOI 10.1111/j.1420-9101.2011.02254.x; Tschirren B, 2012, EVOLUTION, V66, P720, DOI 10.1111/j.1558-5646.2011.01473.x; Turner AK, 2012, MOL ECOL, V21, P1632, DOI 10.1111/j.1365-294X.2012.05501.x; Uematsu Satoshi, 2008, V183, P1; Villasenor-Cardoso MI, 2011, PARASITE IMMUNOL, V33, P643, DOI 10.1111/j.1365-3024.2011.01327.x; Vinkler M, 2009, FOLIA ZOOL, V58, P15; Volmer C, 2011, J GEN VIROL, V92, P534, DOI 10.1099/vir.0.026443-0; Wlasiuk G, 2010, MOL BIOL EVOL, V27, P2172, DOI 10.1093/molbev/msq104; Zagalska-Neubauer M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-395	72	59	60	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45011	10.1371/journal.pone.0045011	http://dx.doi.org/10.1371/journal.pone.0045011			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024782	Green Published, gold, Green Submitted			2022-12-27	WOS:000308860100040
J	Garcia-Ayllon, MS; Millan, C; Serra-Basante, C; Bataller, R; Saez-Valero, J				Garcia-Ayllon, Maria-Salud; Millan, Cristina; Serra-Basante, Carol; Bataller, Ramon; Saez-Valero, Javier			Readthrough Acetylcholinesterase Is Increased in Human Liver Cirrhosis	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; BUTYRYLCHOLINESTERASE; EXPRESSION; APOPTOSIS; CHOLINESTERASES; INDUCTION; VARIANTS; PROTEIN; PLASMA; ROLES	Background & Aims: There have been many studies on plasma butyrylcholinesterase in liver dysfunction. However, no data is available about acetylcholinesterase in human cirrhosis, although profound changes have been described in cirrhotic rat models. Methods: Human serum and liver acetylcholinesterase and its molecular forms were determined enzymatically, after butyrylcholinesterase immunodepletion. The distinct species of acetylcholinesterase, with a distinct C-terminus, were determined by western blotting, and the level of liver transcripts by real-time PCR. Liver acetylcholinesterase was also evaluated by immunocytochemistry. Results: In patients with liver cirrhosis, the activity of plasma acetylcholinesterase (rich in light species), appeared to be apparently unaffected. However, the levels of the soluble readthrough (R) acetylcholinesterase form, an acetylcholinesterase species usually associated with stress and pathology, was increased compared to controls. Human liver acetylcholinesterase activity levels were also unchanged, but protein levels of the acetylcholinesterase-R and other acetylcholinesterase subunit species were increased in the cirrhotic liver. This increase in acetylcholinesterase protein expression in the cirrhotic liver was confirmed by PCR analysis. Immunohistological examination confirmed that acetylcholinesterase immunoreactivity is increased in parenchymal cells of the cirrhotic liver. Conclusions: We demonstrate significant changes in acetylcholinesterase at the protein and mRNA levels in liver cirrhosis, with no difference in enzymatic activity. The altered expression of acetylcholinesterase protein may reflect changes in its pathophysiological role.	[Garcia-Ayllon, Maria-Salud; Serra-Basante, Carol; Saez-Valero, Javier] Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alacant, Spain; [Garcia-Ayllon, Maria-Salud; Serra-Basante, Carol; Saez-Valero, Javier] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Alacant, Spain; [Garcia-Ayllon, Maria-Salud] Hosp Gen Univ Elche, Unidad Invest, Elche, Spain; [Millan, Cristina; Bataller, Ramon] Hosp Clin Barcelona, Liver Unit, IDIBAPS, Barcelona, Spain; [Bataller, Ramon] CIBERehd, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); CIBERNED; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Garcia-Ayllon, MS (corresponding author), Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alacant, Spain.	ms.garcia@umh.es; j.saez@umh.es	Sáez, Javier/K-5756-2014; GARCIA-AYLLON, MARIA-SALUD/M-4387-2019	Sáez, Javier/0000-0001-7480-320X; Bataller, Ramon/0000-0002-1119-7799; Garcia-Ayllon, Maria-Salud/0000-0001-5140-9752	Fundacion CIEN-Reina Sofia; Fondo de Investigaciones Sanitarias [PS09/00684, CP11/00312]; CIBERNED, Instituto de Salud Carlos III from Spain	Fundacion CIEN-Reina Sofia; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); CIBERNED, Instituto de Salud Carlos III from Spain	This work was supported by grants from Fundacion CIEN-Reina Sofia, Fondo de Investigaciones Sanitarias (PS09/00684), and CIBERNED, Instituto de Salud Carlos III from Spain to JSV; and Fondo de Investigaciones Sanitarias (CP11/00312) to MSGA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berson A, 2008, BRAIN, V131, P109, DOI 10.1093/brain/awm276; Birikh KR, 2003, P NATL ACAD SCI USA, V100, P283, DOI 10.1073/pnas.0135647100; Botella-Lopez A, 2008, INT J BIOCHEM CELL B, V40, P766, DOI 10.1016/j.biocel.2007.10.021; BURNETT W, 1960, GUT, V1, P294, DOI 10.1136/gut.1.4.294; CHATEL JM, 1993, P NATL ACAD SCI USA, V90, P2476, DOI 10.1073/pnas.90.6.2476; CHATONNET A, 1989, BIOCHEM J, V260, P625, DOI 10.1042/bj2600625; Cohen O, 2002, MOL PSYCHIATR, V7, P874, DOI 10.1038/sj.mp.4001103; Deutsch VR, 2002, EXP HEMATOL, V30, P1153, DOI 10.1016/S0301-472X(02)00900-1; Dobbertin A, 2009, J NEUROSCI, V29, P4519, DOI 10.1523/JNEUROSCI.3863-08.2009; Dori A, 2005, CEREB CORTEX, V15, P419, DOI 10.1093/cercor/bhh145; EDWARDS JA, 1982, J NEUROCHEM, V38, P1393, DOI 10.1111/j.1471-4159.1982.tb07918.x; Garcia-Ayllon MS, 2007, J NEUROCHEM, V101, P1701, DOI 10.1111/j.1471-4159.2007.04461.x; Garcia-Ayllon Maria-Salud, 2011, Front Mol Neurosci, V4, P22, DOI 10.3389/fnmol.2011.00022; Garcia-Ayllon MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008701; Garcia-Ayllon MS, 2006, HEPATOLOGY, V43, P444, DOI 10.1002/hep.21071; GEORGE ST, 1981, EUR J BIOCHEM, V121, P177, DOI 10.1111/j.1432-1033.1981.tb06447.x; Grisaru D, 1999, EUR J BIOCHEM, V264, P672, DOI 10.1046/j.1432-1327.1999.00693.x; Haertl R, 2011, J NEUROCHEM, V116, P1088, DOI 10.1111/j.1471-4159.2010.07164.x; Jennings LL, 2003, BIOCHEMISTRY-US, V42, P11083, DOI 10.1021/bi034756x; KARPEL R, 1994, EXP CELL RES, V210, P268, DOI 10.1006/excr.1994.1039; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Li B, 2000, J NEUROCHEM, V75, P1320, DOI 10.1046/j.1471-4159.2000.751320.x; Li B, 2008, J PHARMACOL EXP THER, V324, P1146, DOI 10.1124/jpet.107.133330; Manoharan I, 2007, CLIN CHIM ACTA, V378, P128, DOI 10.1016/j.cca.2006.11.005; Massoulie J, 2002, NEUROSIGNALS, V11, P130, DOI 10.1159/000065054; MASSOULIE J, 1993, PROG BRAIN RES, V98, P139; Mor I, 2008, J CELL MOL MED, V12, P479, DOI 10.1111/j.1582-4934.2008.00231.x; Perry C, 2007, LEUKEMIA, V21, P1472, DOI 10.1038/sj.leu.2404722; Santos SCR, 2007, J BIOL CHEM, V282, P25597, DOI 10.1074/jbc.M700569200; ROTUNDO RL, 1988, J BIOL CHEM, V263, P19398; Saez-Valero J, 2002, NEUROSCI LETT, V325, P199, DOI 10.1016/S0304-3940(02)00282-3; SAEZVALERO J, 1993, J NEUROSCI RES, V35, P678, DOI 10.1002/jnr.490350610; Sancho-Bru P, 2012, HEPATOLOGY, V55, P1931, DOI 10.1002/hep.25614; Small DH, 1996, NEUROCHEM INT, V28, P453, DOI 10.1016/0197-0186(95)00099-2; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; Sternfeld M, 2000, P NATL ACAD SCI USA, V97, P8647, DOI 10.1073/pnas.140004597; STIEGER S, 1987, J NEUROCHEM, V49, P460, DOI 10.1111/j.1471-4159.1987.tb02887.x; Weber U, 1999, CHEM-BIOL INTERACT, V119, P341, DOI 10.1016/S0009-2797(99)00045-9; Xie J, 2011, J MOL CELL BIOL, V3, P250, DOI 10.1093/jmcb/mjq047; Zhang XJ, 2002, CELL DEATH DIFFER, V9, P790, DOI 10.1038/sj.cdd.4401034; Zhang XJ, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00040; Zhao YJ, 2011, HEPATOLOGY, V53, P493, DOI 10.1002/hep.24079	42	28	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44598	10.1371/journal.pone.0044598	http://dx.doi.org/10.1371/journal.pone.0044598			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028565	Green Submitted, Green Published, gold			2022-12-27	WOS:000308788700025
J	Berendes, S; Adeyemi, O; Oladele, EA; Oresanya, OB; Okoh, F; Valadez, JJ				Berendes, Sima; Adeyemi, Olusegun; Oladele, Edward Adekola; Oresanya, Olusola Bukola; Okoh, Festus; Valadez, Joseph J.			Are Patent Medicine Vendors Effective Agents in Malaria Control? Using Lot Quality Assurance Sampling to Assess Quality of Practice in Jigawa, Nigeria	PLOS ONE			English	Article							SOUTH-EAST NIGERIA; RURAL TANZANIA; FALCIPARUM-MALARIA; ANTIMALARIAL-DRUGS; PRIVATE-SECTOR; CARE; SELLERS; URBAN; KENYA; AVAILABILITY	Background: Patent medicine vendors (PMV) provide antimalarial treatment and care throughout Sub-Saharan Africa, and can play an important role in the fight against malaria. Their close-to-client infrastructure could enable lifesaving artemisinin-based combination therapy (ACT) to reach patients in time. However, systematic assessments of drug sellers' performance quality are crucial if their role is to be managed within the health system. Lot quality assurance sampling (LQAS) could be an efficient method to monitor and evaluate PMV practice, but has so far never been used for this purpose. Methods: In support of the Nigeria Malaria Booster Program we assessed PMV practices in three Senatorial Districts (SDs) of Jigawa, Nigeria. A two-stage LQAS assessed whether at least 80% of PMV stores in SDs used national treatment guidelines. Acceptable sampling errors were set in consultation with government officials (alpha and beta <0.10). The hypergeometric formula determined sample sizes and cut-off values for SDs. A structured assessment tool identified high and low performing SDs for quality of care indicators. Findings: Drug vendors performed poorly in all SDs of Jigawa for all indicators. For example, all SDs failed for stocking and selling first-line antimalarials. PMV sold no longer recommended antimalarials, such as Chloroquine, Sulfadoxine-Pyrimethamine and oral Artesunate monotherapy. Most PMV were ignorant of and lacked training about new treatment guidelines that had endorsed ACTs as first-line treatment for uncomplicated malaria. Conclusion: There is urgent need to regularly monitor and improve the availability and quality of malaria treatment provided by medicine sellers in Nigeria; the irrational use of antimalarials in the ACT era revealed in this study bears a high risk of economic loss, death and development of drug resistance. LQAS has been shown to be a suitable method for monitoring malaria-related indicators among PMV, and should be applied in Nigeria and elsewhere to improve service delivery.	[Berendes, Sima; Adeyemi, Olusegun; Oladele, Edward Adekola; Valadez, Joseph J.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Oladele, Edward Adekola] LAUTECH Univ Teaching Hosp, Osogbo, Osun State, Nigeria; [Oresanya, Olusola Bukola; Okoh, Festus] Fed Minist Hlth, Natl Malaria Control Program, Abuja, Nigeria	Liverpool School of Tropical Medicine; University of Liverpool	Berendes, S (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.	berendes@liverpool.ac.uk	Oresanya, Olusola/AAV-5050-2020; Berendes, Sima/AAH-9616-2019	Oresanya, Olusola/0000-0002-8261-705X; Berendes, Sima/0000-0001-7000-868X; Valadez, Joseph/0000-0002-6575-6592; Oladele, Edward Adekola/0000-0003-4999-1397	National Malaria Control Programme of Nigeria; ExxonMobil Foundation; Liverpool School of Tropical Medicine International Health Group; Kenneth Newell Memorial Award	National Malaria Control Programme of Nigeria; ExxonMobil Foundation(Exxon Mobil Corporation); Liverpool School of Tropical Medicine International Health Group; Kenneth Newell Memorial Award	This work was supported by the National Malaria Control Programme of Nigeria and a grant from the ExxonMobil Foundation to the World Bank to support the Malaria Control Booster Project for Africa. It was also supported by funding through the Liverpool School of Tropical Medicine International Health Group, and a Kenneth Newell Memorial Award which financed the data entry cleaning and analysis. Neither funder had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuya TO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008937; ACT Watch, 2008, OUTL SURV REP BAS; Akuse RM, 2010, MALARIA RES TREATMEN, V2010; [Anonymous], 2012, NIG MAL IND SURV 201; [Anonymous], 2001, ANT DRUG COMB THER; [Anonymous], BRIXT HLTH LQAS SAMP; Berenson MLD, 2007, CONFIDENCE INTERVAL; Biedron C, 2010, INT J EPIDEMIOL, V39, P72, DOI 10.1093/ije/dyp363; Brieger WR, 2004, HEALTH POLICY PLANN, V19, P177, DOI 10.1093/heapol/czh021; Brooker S, 2005, TROP MED INT HEALTH, V10, P647, DOI 10.1111/j.1365-3156.2005.01446.x; Brugha R, 1998, HEALTH POLICY PLANN, V13, P107, DOI 10.1093/heapol/13.2.107; Brugha R, 1999, TROP MED INT HEALTH, V4, P402, DOI 10.1046/j.1365-3156.1999.00411.x; Buabeng KO, 2008, CLIN PHARMACOL THER, V84, P613, DOI 10.1038/clpt.2008.130; CSTS+, 2006, RAP HLTH FAC ASS 2 1; Dodge HF, 1929, BELL SYST TECH J, V8, P398; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Federal Ministry of Health, 2006, 5 YEAR STRAT PLAN 20; Federal Ministry of Health, 2011, FED REP NIG NAT POL; FOSTER SD, 1991, B WORLD HEALTH ORGAN, V69, P349; Gilpin U, 2006, ARTEMISININ COMBINAT; Goodman C, 2004, TROP MED INT HEALTH, V9, P655, DOI 10.1111/j.1365-3156.2004.01245.x; Goodman C, 2007, AM J TROP MED HYG, V77, P203, DOI 10.4269/ajtmh.2007.77.203; Goodman C, 2007, HEALTH POLICY PLANN, V22, P393, DOI 10.1093/heapol/czm033; Greer G, 2004, IMPROVING MANAGEMENT; HENDERSON RH, 1982, B WORLD HEALTH ORGAN, V60, P253; Hetzel MW, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-83; Hetzel MW, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-157; K Punith, 2008, Indian J Community Med, V33, P151, DOI 10.4103/0970-0218.42049; Kachur SP, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-25; Mangham LJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-155; Marsh VM, 2004, TROP MED INT HEALTH, V9, P451, DOI 10.1111/j.1365-3156.2004.01223.x; National Malaria Control Program, 2009, DET IMPL PLAN HLTH F; National Malaria Control Programme, 2011, IMPL GUID PAR BAS DI; Okeke TA, 2010, HEALTH POLICY, V95, P62, DOI 10.1016/j.healthpol.2009.11.005; Okeke TA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-260; Okeke TA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-97; Oladepo O, 2007, MALARIA TREATMENT PO, V11, P1; Oladepo O, 2008, MALARIA TREATMENT NI, P1; Onwujekwe O, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-22; Onwujekwe O, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-5; Palafox B, 2009, PRIVATE COMMERCIAL S; Pharmacists council of Nigeria, 2003, APPR PAT MED LIST; Robertson SE, 2006, SOC SCI MED, V63, P1648, DOI 10.1016/j.socscimed.2006.04.011; Robertson Susan E., 1997, World Health Statistics Quarterly, V50, P199; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2012, AFF MED FAC MAL 1 LI; Uzochukwu BSC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001788; Valadez J, 2002, DECENTRALIZED SUPERV; Valadez JJ, 1997, STUD FAMILY PLANN, V28, P143, DOI 10.2307/2138116; VALADEZ JJ, 1995, AM J PUBLIC HEALTH, V85, P1165, DOI 10.2105/AJPH.85.8_Pt_1.1165-a; Valadez JJ, 1996, INT J EPIDEMIOL, V25, P381, DOI 10.1093/ije/25.2.381; Valadez JJ, 1991, ASSESSING CHILD SURV; WHO, 2010, WORLD MALARIA REPORT 2010, P1; *WHO, 2006, PARTN MAL CONTR ENG; Wongsrichanalai C, 2008, EMERG INFECT DIS, V14, P716, DOI 10.3201/eid1405.071601; World Bank, 2006, PROJ APPR DOC PROP C	55	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44775	10.1371/journal.pone.0044775	http://dx.doi.org/10.1371/journal.pone.0044775			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005GJ	22984555	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000308738500082
J	Thanwisai, A; Tandhavanant, S; Saiprom, N; Waterfield, NR; Long, PK; Bode, HB; Peacock, SJ; Chantratita, N				Thanwisai, Aunchalee; Tandhavanant, Sarunporn; Saiprom, Natnaree; Waterfield, Nick R.; Phan Ke Long; Bode, Helge B.; Peacock, Sharon J.; Chantratita, Narisara			Diversity of Xenorhabdus and Photorhabdus spp. and Their Symbiotic Entomopathogenic Nematodes from Thailand	PLOS ONE			English	Article							HETERORHABDITIDAE; LUMINESCENS; ASYMBIOTICA; PHYLOGENY; SEQUENCES; PATHOGEN; DNA	Xenorhabdus and Photorhabdus spp. are bacterial symbionts of entomopathogenic nematodes (EPNs). In this study, we isolated and characterized Xenorhabdus and Photorhabdus spp. from across Thailand together with their associated nematode symbionts, and characterized their phylogenetic diversity. EPNs were isolated from soil samples using a Galleria-baiting technique. Bacteria from EPNs were cultured and genotyped based on recA sequence. The nematodes were identified based on sequences of 28S rDNA and internal transcribed spacer regions. A total of 795 soil samples were collected from 159 sites in 13 provinces across Thailand. A total of 126 EPNs isolated from samples taken from 10 provinces were positive for Xenorhabdus (n = 69) or Photorhabdus spp. (n = 57). Phylogenetic analysis separated the 69 Xenorhabdus isolates into 4 groups. Groups 1, 2 and 3 consisting of 52, 13 and 1 isolates related to X. stockiae, and group 4 consisting of 3 isolates related to X. miraniensis. The EPN host for isolates related to X. stockiae was S. websteri, and for X. miraniensis was S. khoisanae. The Photorhabdus species were identified as P. luminescens (n = 56) and P. asymbiotica (n = 1). Phylogenenic analysis divided P. luminescens into five groups. Groups 1 and 2 consisted of 45 and 8 isolates defined as subspecies hainanensis and akhurstii, respectively. One isolate was related to hainanensis and akhurstii, two isolates were related to laumondii, and one isolate was the pathogenic species P. asymbiotica subsp. australis. H. indica was the major EPN host for Photorhabdus. This study reveals the genetic diversity of Xenorhabdus and Photorhabdus spp. and describes new associations between EPNs and their bacterial symbionts in Thailand.	[Thanwisai, Aunchalee; Tandhavanant, Sarunporn; Saiprom, Natnaree; Peacock, Sharon J.; Chantratita, Narisara] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand; [Thanwisai, Aunchalee; Tandhavanant, Sarunporn; Peacock, Sharon J.; Chantratita, Narisara] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Waterfield, Nick R.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Phan Ke Long] Vietnam Acad Sci & Technol, Vietnam Natl Museum Nat, Hanoi, Vietnam; [Bode, Helge B.] Goethe Univ Frankfurt, Inst Mol Biosci, Frankfurt, Germany; [Peacock, Sharon J.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England	Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Bath; Vietnam Academy of Science & Technology (VAST); Goethe University Frankfurt; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Thanwisai, A (corresponding author), Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand.	narisara@tropmedres.ac	Bode, Helge B/F-7022-2014; Chantratita, Narisara/P-2169-2019; Tandhavanant, Sarunporn/Q-7376-2019; Tandhavanant, Sarunporn/R-7620-2019; Peacock, Sharon J/ABE-6331-2020	Bode, Helge B/0000-0001-6048-5909; Tandhavanant, Sarunporn/0000-0003-0261-3233; Tandhavanant, Sarunporn/0000-0003-0261-3233; Waterfield, Nicholas/0000-0002-8044-7763; Peacock, Sharon/0000-0002-1718-2782	European Commission [HEALTH-F3-2009-223328-GAMEXP]; PhD Sandwich Program of Commission on Higher Education, Ministry of Education of Thailand; Wellcome Trust Career Development award in Public Health and Tropical Medicine, UK [087769/Z/08/Z]; NIHR Cambridge Biomedical Research Centre; BBSRC [BB/E021328/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E021328/1] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); PhD Sandwich Program of Commission on Higher Education, Ministry of Education of Thailand; Wellcome Trust Career Development award in Public Health and Tropical Medicine, UK(Wellcome Trust); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the European Commission under the seventh Framework Programme Grant HEALTH-F3-2009-223328-GAMEXP. AT is supported by a scholarship under a PhD Sandwich Program of Commission on Higher Education, Ministry of Education of Thailand. NC is supported by a Wellcome Trust Career Development award in Public Health and Tropical Medicine, UK (grant 087769/Z/08/Z). SJP is supported by the NIHR Cambridge Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahantarig A, 2009, APPL ENVIRON MICROB, V75, P4627, DOI 10.1128/AEM.00221-09; AKHURST RJ, 1980, J GEN MICROBIOL, V121, P303; BEDDING RA, 1975, NEMATOLOGICA, V21, P109, DOI 10.1163/187529275X00419; Chaston JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027909; Dolinski C, 2008, MEM I OSWALDO CRUZ, V103, P150, DOI 10.1590/S0074-02762008000200005; Edgington S, 2011, J HELMINTHOL, V85, P381, DOI 10.1017/S0022149X10000702; Ferreira TD, 2011, J INVERTEBR PATHOL, V107, P164, DOI 10.1016/j.jip.2011.04.002; Gerrard JG, 2006, EMERG INFECT DIS, V12, P1562, DOI 10.3201/eid1210.060464; Goodrich-Blair H, 2007, MOL MICROBIOL, V64, P260, DOI 10.1111/j.1365-2958.2007.05671.x; Hominick WM, 1996, BIOCONTROL SCI TECHN, V6, P317, DOI 10.1080/09583159631307; Hominick WM, 1997, J HELMINTHOL, V71, P271, DOI 10.1017/S0022149X00016096; Joyce SA, 2008, ANGEW CHEM INT EDIT, V47, P1942, DOI 10.1002/anie.200705148; Kanga FN, 2012, J INVERTEBR PATHOL, V109, P41, DOI 10.1016/j.jip.2011.09.008; Lee MM, 2010, J INVERTEBR PATHOL, V104, P67, DOI 10.1016/j.jip.2010.01.005; Maneesakorn P, 2011, MOL PHYLOGENET EVOL, V59, P271, DOI 10.1016/j.ympev.2011.02.012; Nguyen KB, 2010, J INVERTEBR PATHOL, V103, P8, DOI 10.1016/j.jip.2009.09.004; Phan KL, 2003, NEMATOLOGY, V5, P367, DOI 10.1163/156854103769224368; RAINEY FA, 1995, INT J SYST BACTERIOL, V45, P379, DOI 10.1099/00207713-45-2-379; Sharma S, 2002, FEMS MICROBIOL LETT, V214, P241, DOI 10.1111/j.1574-6968.2002.tb11354.x; Stock SP, 2009, J INVERTEBR PATHOL, V100, P175, DOI 10.1016/j.jip.2008.11.011; Stock SP, 2001, J PARASITOL, V87, P877, DOI 10.2307/3285148; Szallas E, 1997, INT J SYST BACTERIOL, V47, P402, DOI 10.1099/00207713-47-2-402; Tailliez P, 2006, INT J SYST EVOL MICR, V56, P2805, DOI 10.1099/ijs.0.64287-0; Tailliez P, 2010, INT J SYST EVOL MICR, V60, P1921, DOI 10.1099/ijs.0.014308-0; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Waterfield NR, 2009, ANNU REV MICROBIOL, V63, P557, DOI 10.1146/annurev.micro.091208.073507; Weissfeld AS, 2005, J CLIN MICROBIOL, V43, P4152, DOI 10.1128/JCM.43.8.4152-4155.2005; WHITE G. F., 1927, SCIENCE, V66, P302, DOI 10.1126/science.66.1709.302-a	30	56	56	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43835	10.1371/journal.pone.0043835	http://dx.doi.org/10.1371/journal.pone.0043835			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984446	gold, Green Published, Green Submitted			2022-12-27	WOS:000308738500024
J	Patalay, R; Talbot, C; Alexandrov, Y; Lenz, MO; Kumar, S; Warren, S; Munro, I; Neil, MAA; Konig, K; French, PMW; Chu, A; Stamp, GWH; Dunsby, C				Patalay, Rakesh; Talbot, Clifford; Alexandrov, Yuriy; Lenz, Martin O.; Kumar, Sunil; Warren, Sean; Munro, Ian; Neil, Mark A. A.; Koenig, Karsten; French, Paul M. W.; Chu, Anthony; Stamp, Gordon W. H.; Dunsby, Chris			Multiphoton Multispectral Fluorescence Lifetime Tomography for the Evaluation of Basal Cell Carcinomas	PLOS ONE			English	Article							NONMELANOMA SKIN-CANCER; IN-VIVO; MICROSCOPY; TRENDS	We present the first detailed study using multispectral multiphoton fluorescence lifetime imaging to differentiate basal cell carcinoma cells (BCCs) from normal keratinocytes. Images were acquired from 19 freshly excised BCCs and 27 samples of normal skin (in & ex vivo). Features from fluorescence lifetime images were used to discriminate BCCs with a sensitivity/specificity of 79%/93% respectively. A mosaic of BCC fluorescence lifetime images covering >1 mm(2) is also presented, demonstrating the potential for tumour margin delineation. Using 10,462 manually segmented cells from the image data, we quantify the cellular morphology and spectroscopic differences between BCCs and normal skin for the first time. Statistically significant increases were found in the fluorescence lifetimes of cells from BCCs in all spectral channels, ranging from 19.9% (425-515 nm spectral emission) to 39.8% (620-655 nm emission). A discriminant analysis based diagnostic algorithm allowed the fraction of cells classified as malignant to be calculated for each patient. This yielded a receiver operator characteristic area under the curve for the detection of BCC of 0.83. We have used both morphological and spectroscopic parameters to discriminate BCC from normal skin, and provide a comprehensive base for how this technique could be used for BCC assessment in clinical practice.	[Patalay, Rakesh; Talbot, Clifford; Alexandrov, Yuriy; Lenz, Martin O.; Kumar, Sunil; Warren, Sean; Munro, Ian; Neil, Mark A. A.; French, Paul M. W.; Dunsby, Chris] Univ London Imperial Coll Sci Technol & Med, Dept Phys, Photon Grp, London, England; [Patalay, Rakesh; Chu, Anthony] Imperial Coll Healthcare NHS Trust, Dept Dermatol, London, England; [Dunsby, Chris] Imperial Coll Healthcare NHS Trust, Dept Med, London, England; [Koenig, Karsten] JenLab GmbH, Jena, Germany; [Stamp, Gordon W. H.] CRUK London Res Inst, London, England	Imperial College London; Imperial College London; Imperial College London; JenLab GmbH; Cancer Research UK	Patalay, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Phys, Photon Grp, S Kensington Campus, London, England.	christopher.dunsby@imperial.ac.uk	French, Paul/E-8649-2011; Warren, Sean C./A-9392-2016; Lenz, Martin/ABE-1640-2020; Neil, Mark A/B-1184-2010	Warren, Sean C./0000-0002-5253-7147; Neil, Mark A/0000-0002-7720-8868; French, Paul/0000-0002-0478-6755; Kumar, Sunil/0000-0001-8200-9671	European Commission [FP7-HEALTH-2007-A, 201577, PHOTONICS-4-LIFE, FP7-ICT-2007-2, 224014]; Institute of Chemical Biology EPSRC; Royal Society Wolfson Research Merit Award	European Commission(European CommissionEuropean Commission Joint Research Centre); Institute of Chemical Biology EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society Wolfson Research Merit Award(Royal Society of London)	The authors gratefully acknowledge funding from the European Commission (SKINSPECTION, FP7-HEALTH-2007-A, 201577 and PHOTONICS-4-LIFE, FP7-ICT-2007-2, 224014), the Institute of Chemical Biology EPSRC funded Doctoral Training Centre (SW) and a Royal Society Wolfson Research Merit Award (PF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benati E, 2011, SKIN RES TECHNOL, V17, P295, DOI 10.1111/j.1600-0846.2011.00496.x; Christenson LJ, 2005, JAMA-J AM MED ASSOC, V294, P681, DOI 10.1001/jama.294.6.681; Cicchi R, 2008, J BIOPHOTONICS, V1, P62, DOI 10.1002/jbio.200710003; Cicchi R, 2007, OPT EXPRESS, V15, P10135, DOI 10.1364/OE.15.010135; De Giorgi V, 2009, J EUR ACAD DERMATOL, V23, P314, DOI 10.1111/j.1468-3083.2008.03045.x; Demers AA, 2005, J AM ACAD DERMATOL, V53, P320, DOI 10.1016/j.jaad.2005.03.043; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Diepgen TL, 2002, BRIT J DERMATOL, V146, P1, DOI 10.1046/j.1365-2133.146.s61.2.x; Dimitrow E, 2009, EXP DERMATOL, V18, P509, DOI 10.1111/j.1600-0625.2008.00815.x; Koenig K, 1994, J Fluoresc, V4, P17, DOI 10.1007/BF01876650; Konig K, 2011, ADV DRUG DELIVER REV, V63, P388, DOI 10.1016/j.addr.2011.03.002; Konig K, 2003, J BIOMED OPT, V8, P432, DOI 10.1117/1.1577349; Levitt JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024765; Masters BR, 1997, BIOPHYS J, V72, P2405, DOI 10.1016/S0006-3495(97)78886-6; Mogensen M, 2007, DERMATOL SURG, V33, P1158, DOI 10.1111/j.1524-4725.2007.33251.x; Palero JA, 2007, BIOPHYS J, V93, P992, DOI 10.1529/biophysj.106.099457; Paoli J, 2008, J INVEST DERMATOL, V128, P1248, DOI 10.1038/sj.jid.5701139; Patalay R, 2011, BIOMED OPT EXPRESS, V2, P3295, DOI 10.1364/BOE.2.003295; Sanchez WY, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3466580; Santos AF, 2008, ASSAY DRUG DEV TECHN, V6, P693, DOI 10.1089/adt.2008.146; Seidenari S, 2012, EXPT DERMAT IN PRESS; Seidenari S, 2013, SKIN RES TECHNOL, V19, pE297, DOI 10.1111/j.1600-0846.2012.00643.x; Skala MC, 2007, P NATL ACAD SCI USA, V104, P19494, DOI 10.1073/pnas.0708425104; Staples MP, 2006, MED J AUSTRALIA, V184, P6, DOI 10.5694/j.1326-5377.2006.tb00086.x; Talbot CB, 2011, OPT EXPRESS, V19, P13848, DOI 10.1364/OE.19.013848; Teuchner K, 1999, PHOTOCHEM PHOTOBIOL, V70, P146, DOI 10.1562/0031-8655(1999)070<0146:FTPEFO>2.3.CO;2	26	41	43	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43460	10.1371/journal.pone.0043460	http://dx.doi.org/10.1371/journal.pone.0043460			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984428	Green Published, Green Submitted, gold			2022-12-27	WOS:000308638700022
J	Sobkowicz, P				Sobkowicz, Pawel			Discrete Model of Opinion Changes Using Knowledge and Emotions as Control Variables	PLOS ONE			English	Article							SZNAJD MODEL; CONSENSUS FORMATION; BOUNDED CONFIDENCE; CATASTROPHE-THEORY; PHASE-TRANSITIONS; DYNAMICS; LEADERS; IMPACT	We present a new model of opinion changes dependent on the agents emotional state and their information about the issue in question. Our goal is to construct a simple, yet nontrivial and flexible representation of individual attitude dynamics for agent based simulations, that could be used in a variety of social environments. The model is a discrete version of the cusp catastrophe model of opinion dynamics in which information is treated as the normal factor while emotional arousal (agitation level determining agent receptiveness and rationality) is treated as the splitting factor. Both variables determine the resulting agent opinion, which itself can be in favor of the studied position, against it, or neutral. Thanks to the flexibility of implementing communication between the agents, the model is potentially applicable in a wide range of situations. As an example of the model application, we study the dynamics of a set of agents communicating among themselves via messages. In the example, we chose the simplest, fully connected communication topology, to focus on the effects of the individual opinion dynamics, and to look for stable final distributions of agents with different emotions, information and opinions. Even for such simplified system, the model shows complex behavior, including phase transitions due to symmetry breaking by external propaganda.			Sobkowicz, P (corresponding author), KEN 94-140, Warsaw, Poland.	pawelsobko@gmail.com	Sobkowicz, Pawel/G-5276-2010	Sobkowicz, Pawel/0000-0002-7275-7235				Behera L, 2003, INT J MOD PHYS C, V14, P1331, DOI 10.1142/S0129183103005467; Ben-Naim E, 1996, PHYS REV E, V53; Bernardes AT, 2001, INT J MOD PHYS C, V12, P159, DOI 10.1142/S0129183101001584; BRADLEY MM, 1993, BEHAV NEUROSCI, V107, P970, DOI 10.1037/0735-7044.107.6.970; Briesemeister BB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023743; Byrne D. G., 2001, NONLINEAR DYNAMICS P, V5, P115, DOI DOI 10.1023/A:1026467401041; Castellano C, 2003, EUROPHYS LETT, V63, P153, DOI 10.1209/epl/i2003-00490-0; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; Chmiel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022207; Chow PT, 2012, AUTOMAT CONSTR, V22, P597, DOI 10.1016/j.autcon.2011.12.006; COX JT, 1986, ANN PROBAB, V14, P347, DOI 10.1214/aop/1176992521; Czaplicka A, 2010, ACTA PHYS POL A, V117, P688, DOI 10.12693/APhysPolA.117.688; Czaplicka A, 2012, INT J MOD C IN PRESS; Deffuant G, 2000, APPLICATIONS OF SIMULATION TO SOCIAL SCIENCES, P87, DOI 10.1142/S0219525900000078; Queiros SMD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018149; FLAY BR, 1978, BEHAV SCI, V23, P335, DOI 10.1002/bs.3830230404; Fortunato S, 2005, INT J MOD PHYS C, V16, P259, DOI 10.1142/S0129183105007078; Fortunato S, 2006, FRONTIERS COLL, P233; FRIJDA NH, 1988, AM PSYCHOL, V43, P349, DOI 10.1037/0003-066X.43.5.349; Fu F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016104; Galam S, 2002, PHYSICA A, V314, P256, DOI 10.1016/S0378-4371(02)01178-0; Hegselmann R, 2002, JASSS-J ARTIF SOC S, V5; HOLYST J, 2001, ANN REV COMPUTATIONA, V20, P531; Huang YK, 2007, J E ASIA SOC TRANSPO, V7, P918; Kacperski K, 2000, PHYSICA A, V287, P631, DOI 10.1016/S0378-4371(00)00398-8; Kacperski K, 1999, PHYSICA A, V269, P511, DOI 10.1016/S0378-4371(99)00174-0; Latane B, 1996, J COMMUN, V46, P13, DOI 10.1111/j.1460-2466.1996.tb01501.x; Latanu B., 1994, DYNAMICAL SYSTEMS SO, P219; Lee S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012522; Liu JH, 1998, POLIT BEHAV, V20, P105, DOI 10.1023/A:1024828729174; Lorenz J, 2007, INT J MOD PHYS C, V18, P1819, DOI 10.1142/S0129183107011789; NOWAK A, 1990, PSYCHOL REV, V97, P362, DOI 10.1037/0033-295X.97.3.362; Nowak A., 1996, MODELING SIMULATION, P249, DOI DOI 10.1007/978-94-015-8686-3_14; Oliva TA, 1978, ADV CONSUM RES, V5, P273; Petty R. E., 1998, HDB SOCIAL PSYCHOL, P323; Rosser JB, 2007, J ECON DYN CONTROL, V31, P3255, DOI 10.1016/j.jedc.2006.09.013; Sabatelli L, 2003, INT J MOD PHYS C, V14, P1223, DOI 10.1142/S0129183103005352; Sabatelli L, 2004, PHYSICA A, V334, P274, DOI 10.1016/j.physa.2003.10.062; Si XM, 2010, PHYSICA A, V389, P3711, DOI 10.1016/j.physa.2010.05.010; Skitka LJ, 2006, ANNU REV PSYCHOL, V57, P529, DOI 10.1146/annurev.psych.57.102904.190048; Slanina F, 2003, EUR PHYS J B, V35, P279, DOI 10.1140/epjb/e2003-00278-0; Sobkowicz P, 2010, EUR PHYS J B, V73, P633, DOI 10.1140/epjb/e2010-00039-0; Sobkowicz P, 2011, CULTURAL OPINION DYN; Sobkowicz P, 2012, SOC SCI COMPUT REV, V30, P448, DOI 10.1177/0894439312436512; Sobkowicz P, 2010, INT J MOD PHYS C, V21, P839, DOI 10.1142/S0129183110015518; Sobkowicz P, 2009, INT J MOD PHYS C, V20, P1645, DOI 10.1142/S0129183109014655; Sousa AO, 2005, PHYSICA A, V348, P701, DOI 10.1016/j.physa.2004.09.027; Stauffer D, 2002, EUR PHYS J B, V30, P587, DOI 10.1140/epjb/e2002-00418-0; Stauffer D, 2002, COMPUT PHYS COMMUN, V146, P93, DOI 10.1016/S0010-4655(02)00439-3; Stauffer D, 2001, J ARTIFICIAL SOC SOC, V5; Stehle J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023176; Stroud NJ, 2010, J COMMUN, V60, P556, DOI 10.1111/j.1460-2466.2010.01497.x; Sznajd-Weron K, 2000, INT J MOD PHYS C, V11, P1157, DOI 10.1142/S0129183100000936; TESSER A, 1980, HUM RELAT, V33, P393, DOI 10.1177/001872678003300604; TESSER A, 1994, DYNAMICAL SYSTEMS SO, P00095; Vallacher RR, 1997, PSYCHOL INQ, V8, P73, DOI 10.1207/s15327965pli0802_1; Vallacher RR, 2002, PERS SOC PSYCHOL REV, V6, P264, DOI 10.1207/S15327957PSPR0604_01; van der Maas HLJ, 2003, SOCIOL METHOD RES, V32, P125, DOI 10.1177/0049124103253773; VANDERMAAS HLJ, 1992, PSYCHOL REV, V99, P395, DOI 10.1037/0033-295X.99.3.395; Wagenmakers EJ, 2005, ENCY STAT BEHAV SCI; Walla P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026782; Weisbuch G, 2004, EUR PHYS J B, V38, P339, DOI 10.1140/epjb/e2004-00126-9; Weisbuch G., 2002, Complexity, V7, P55, DOI 10.1002/cplx.10031; Weisbuch G., 2003, HETEROGENOUS AGENTS, VVolume 521, P225, DOI [10.1007/978-3-642-55651-7_14, DOI 10.1007/978-3-642-55651-7_14]; ZEEMAN EC, 1976, SCI AM, V234, P65, DOI 10.1038/scientificamerican0476-65	67	25	25	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44489	10.1371/journal.pone.0044489	http://dx.doi.org/10.1371/journal.pone.0044489			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	003VE	22984516	Green Submitted, Green Published, gold			2022-12-27	WOS:000308638700064
J	Wadhwa, PD; Simhan, HN; Entringer, S; Buss, C; Smith, R; Hobel, CJ; Farhana, N; Shimmin, L; Hixson, JE; Sing, CF				Wadhwa, Pathik D.; Simhan, Hyagriv N.; Entringer, Sonja; Buss, Claudia; Smith, Roger; Hobel, Calvin J.; Farhana, Naveed; Shimmin, Lawrence; Hixson, James E.; Sing, Charles F.			Variation in the Maternal Corticotrophin Releasing Hormone-Binding Protein (CRH-BP) Gene and Birth Weight in Blacks, Hispanics and Whites	PLOS ONE			English	Article							FETAL-GROWTH; PREGNANCY; PLASMA; LOCALIZATION; PREECLAMPSIA; ASSOCIATION; UROCORTIN; PLACENTA; DISEASE; BLOOD	Background: Given the unique role of the corticotrophin-releasing hormone (CRH) system in human fetal development, the aim of our study was to estimate the association of birth weight with DNA sequence variation in three maternal genes involved in regulating CRH production, bioavailability and action: CRH, CRH-Binding Protein (CRH-BP), and CRH type 1 receptor (CRH-R1), respectively, in three racial groups (African-Americans, Hispanics, and non-Hispanic Whites). Methods: Our study was carried out on a population-based sample of 575 mother-child dyads. We resequenced the three genes in mouse-human hybrid somatic cell lines and selected SNPs for genotyping. Results: A significant association was observed in each race between birth weight and maternal CRH-BP SNP genotypes. Estimates of linkage disequilibrium and haplotypes established three common haplotypes marked by the rs1053989 SNP in all three races. This SNP predicted significant birth weight variation after adjustment for gestational age, maternal BMI, parity, and smoking. African American and Hispanic mothers carrying the A allele had infants whose birth weight was on average 254 and 302 grams, respectively, less than infants having C/C mothers. Non-Hispanic White mothers homozygous for the A allele had infants who were on average 148 grams less than those infants having A/C and C/C mothers. Conclusions: The magnitudes of the estimates of the birth weight effects are comparable to the combined effects of multiple SNPs reported in a recent meta-analysis of 6 GWAS studies and is quantitatively larger than that associated with maternal cigarette smoking. This effect was persistent across subpopulations that vary with respect to ancestry and environment.	[Wadhwa, Pathik D.] Univ Calif Irvine, Dept Psychiat, Irvine, CA 92717 USA; [Wadhwa, Pathik D.] Univ Calif Irvine, Dept Human Behav, Irvine, CA USA; [Wadhwa, Pathik D.; Entringer, Sonja; Buss, Claudia] Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA; [Wadhwa, Pathik D.] Univ Calif Irvine, Dept Obstet & Gynecol, Irvine, CA 92717 USA; [Wadhwa, Pathik D.] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA; [Simhan, Hyagriv N.] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [Smith, Roger] Univ Newcastle, Endocrine Unit, Mothers & Babies Res Ctr, Newcastle, NSW 2300, Australia; [Hobel, Calvin J.] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Dept Obstet Gynecol & Pediat, Los Angeles, CA 90048 USA; [Hobel, Calvin J.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Farhana, Naveed; Shimmin, Lawrence; Hixson, James E.] Univ Texas Hlth Sci Ctr, Dept Epidemiol Human Genet & Environm Sci, Houston, TX USA; [Sing, Charles F.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Newcastle; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Texas System; University of Texas Health Science Center Houston; University of Michigan System; University of Michigan	Wadhwa, PD (corresponding author), Univ Calif Irvine, Dept Psychiat, Irvine, CA 92717 USA.	pwadhwa@uci.edu	Buss, Claudia/ABC-3687-2020; Entringer, Sonja/ABB-9405-2020	Buss, Claudia/0000-0002-8738-3133; Sing, Charles/0000-0001-5872-7956; Hixson, James/0000-0002-0849-9315; Smith, Roger/0000-0003-4720-0280; Entringer, Sonja/0000-0002-9926-7076	United States Public Health Service (National Institutes of Health) [PO1 HD-047609, RO1 HD-060628]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060628] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD047609] Funding Source: NIH RePORTER	United States Public Health Service (National Institutes of Health)(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by United States Public Health Service (National Institutes of Health) grants PO1 HD-047609 and RO1 HD-060628 to PDW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2000, J CLIN ENDOCR METAB, V85, P755, DOI 10.1210/jc.85.2.755; Bale TL, 2004, P NATL ACAD SCI USA, V101, P3697, DOI 10.1073/pnas.0307324101; BATTAGLI.FC, 1967, J PEDIATR-US, V71, P159, DOI 10.1016/S0022-3476(67)80066-0; Bhattacharjee J, 2010, PLACENTA, V31, P423, DOI 10.1016/j.placenta.2010.02.015; Bowers K, 2011, PEDIATRICS, V127, pE1272, DOI 10.1542/peds.2010-2213; Clifton VL, 2000, PLACENTA, V21, P782, DOI 10.1053/plac.2000.0570; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Florio P, 2004, J CLIN ENDOCR METAB, V89, P4673, DOI 10.1210/jc.2004-0186; Florio P, 2007, FRONT BIOSCI-LANDMRK, V12, P551, DOI 10.2741/2081; Freathy RM, 2010, NAT GENET, V42, P430, DOI 10.1038/ng.567; Gao L, 2012, ENDOCRINOLOGY, V153, P1464, DOI 10.1210/en.2011-1673; Gardosi J, 2009, AM J OBSTET GYNECOL, V25, pe21, DOI DOI 10.1016/J.AJ0G.2009.04.035; Gillman MW, 2006, OBESITY, V14, P1647, DOI 10.1038/oby.2006.189; Godfrey KM, 2011, SEMIN REPROD MED, V29, P257, DOI 10.1055/s-0031-1275518; GOLAND RS, 1988, AM J OBSTET GYNECOL, V159, P884, DOI 10.1016/S0002-9378(88)80162-5; GOLAND RS, 1995, PLACENTA, V16, P375, DOI 10.1016/0143-4004(95)90095-0; Gouin K, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.11.013; Hutcheon JA, 2011, AM J EPIDEMIOL, V173, P459, DOI 10.1093/aje/kwq399; Kalantaridou SN, 2010, J REPROD IMMUNOL, V85, P33, DOI 10.1016/j.jri.2010.02.005; Kochanek KD, 2012, PEDIATRICS, V129, P338, DOI 10.1542/peds.2011-3435; La Merrill M, 2011, ANN EPIDEMIOL, V21, P413, DOI 10.1016/j.annepidem.2010.11.012; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Larkin JC, 2011, AM J OBSTET GYNECOL, V204, p[499, e491]; Mayor-Lynn K, 2011, REPROD SCI, V18, P46, DOI 10.1177/1933719110374115; MCLEAN M, 1995, NAT MED, V1, P460, DOI 10.1038/nm0595-460; Misra VK, 2011, OBESITY, V19, P1476, DOI 10.1038/oby.2011.43; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; OBRIEN GD, 1981, AM J OBSTET GYNECOL, V139, P540, DOI 10.1016/0002-9378(81)90514-7; PERKINS AV, 1993, J ENDOCRINOL, V138, P149, DOI 10.1677/joe.0.1380149; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; RILEY SC, 1991, J CLIN ENDOCR METAB, V72, P1001, DOI 10.1210/jcem-72-5-1001; Shimmin LC, 2007, DNA SEQUENCE, V18, P432, DOI 10.1080/10425170701388719; SMITH R, 1993, J CLIN ENDOCR METAB, V76, P1063, DOI 10.1210/jc.76.4.1063; Smith R, 1999, J CLIN ENDOCR METAB, V84, P2820, DOI 10.1210/jc.84.8.2820; Smith R, 2007, NEW ENGL J MED, V356, P271, DOI 10.1056/NEJMra061360; Smith R, 2007, FRONT BIOSCI, V12, P912, DOI 10.2741/2113; Smith R, 2012, ENDOCRINOLOGY, V153, P1572, DOI 10.1210/en.2012-1010; Wadhwa PD, 2004, AM J OBSTET GYNECOL, V191, P1063, DOI 10.1016/j.ajog.2004.06.070; Weir B. S., 1996, GENETIC DATA ANAL; Westphal NJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1878, DOI 10.2741/1931; Wolf JB, 2011, GENETICS, V189, P1069, DOI 10.1534/genetics.111.130591; WOODS RJ, 1994, J CLIN ENDOCR METAB, V78, P73, DOI 10.1210/jc.78.1.73; WOODS RJ, 1994, ENDOCRINOLOGY, V135, P768, DOI 10.1210/en.135.2.768; Zhao XJ, 1997, HORM METAB RES, V29, P373, DOI 10.1055/s-2007-979058	44	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43931	10.1371/journal.pone.0043931	http://dx.doi.org/10.1371/journal.pone.0043931			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984453	gold, Green Published, Green Accepted			2022-12-27	WOS:000308638700034
J	Hollis, VS; Holloway, JA; Harris, S; Spencer, D; van Berkel, C; Morgan, H				Hollis, Veronica S.; Holloway, Judith A.; Harris, Scott; Spencer, Daniel; van Berkel, Cees; Morgan, Hywel			Comparison of Venous and Capillary Differential Leukocyte Counts Using a Standard Hematology Analyzer and a Novel Microfluidic Impedance Cytometer	PLOS ONE			English	Article							COMPLETE BLOOD-COUNT; POINT; PARAMETERS; SAMPLES; ADULTS	Capillary blood sampling has been identified as a potentially suitable technique for use in diagnostic testing of the full blood count (FBC) at the point-of-care (POC), for which a recent need has been highlighted. In this study we assess the accuracy of capillary blood counts and evaluate the potential of a miniaturized cytometer developed for POC testing. Differential leukocyte counts in the normal clinical range from fingerprick (capillary) and venous blood samples were measured and compared using a standard hematology analyzer. The accuracy of our novel microfluidic impedance cytometer (MIC) was then tested by comparing same-site measurements to those obtained with the standard analyzer. The concordance between measurements of fingerprick and venous blood samples using the standard hematology analyzer was high, with no clinically relevant differences observed between the mean differential leukocyte counts. Concordance data between the MIC and the standard analyzer on same-site measurements presented significantly lower leukocyte counts determined by the MIC. This systematic undercount was consistent across the measured (normal) concentration range, suggesting that an internal correction factor could be applied. Differential leukocyte counts obtained from fingerprick samples accurately reflect those from venous blood, which confirms the potential of capillary blood sampling for POC testing of the FBC. Furthermore, the MIC device demonstrated here presents a realistic technology for the future development of FBC and related tests for use at the site of patient care.	[Hollis, Veronica S.; Spencer, Daniel; Morgan, Hywel] Univ Southampton, Fac Phys & Appl Sci, Southampton, Hants, England; [Holloway, Judith A.; Harris, Scott] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [van Berkel, Cees] Philips Res United Kingdom, Cambridge, England	University of Southampton; University of Southampton; Philips; Philips Research	Hollis, VS (corresponding author), Univ Southampton, Fac Phys & Appl Sci, Southampton, Hants, England.	vh@ecs.soton.ac.uk	Holloway, Judith A/A-1757-2010	Holloway, Judith A/0000-0002-2268-3071; Morgan, Hywel/0000-0003-4850-5676; Spencer, Daniel/0000-0003-3442-9924	Technology Strategy Board (TSB) Technologies for Health Call from the Technology Strategy Board [TP-AG054A]; Engineering and Physical Sciences Research Council; EPSRC [TS/G001405/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [TS/G001405/1] Funding Source: researchfish	Technology Strategy Board (TSB) Technologies for Health Call from the Technology Strategy Board; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was performed in collaboration with Phillips Research United Kingdom and supported by funding under the Technology Strategy Board (TSB) Technologies for Health Call (Ref TP-AG054A) from the Technology Strategy Board and the Engineering and Physical Sciences Research Council (http://www.innovateuk.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Briggs C, 2008, INT J LAB HEMATOL, V30, P105, DOI 10.1111/j.1751-553X.2008.01050.x; Briggs C, 2008, BRIT J HAEMATOL, V142, P904, DOI 10.1111/j.1365-2141.2008.07274.x; DAAE LNW, 1988, SCAND J CLIN LAB INV, V48, P723, DOI 10.3109/00365518809085796; Han XJ, 2012, ANAL CHEM, V84, P1070, DOI 10.1021/ac202700x; Hoffbrand AV, 2006, ESSENTIAL HAEMATOLOG, Vix; Holmes D, 2007, LAB CHIP, V7, P1048, DOI 10.1039/b707507n; Holmes D, 2009, LAB CHIP, V9, P2881, DOI 10.1039/b910053a; Jani IV, 2011, AIDS, V25, P807, DOI 10.1097/QAD.0b013e328344f424; Ledis SL, 1992, LYSING REAGENT SYSTE; Lewis SM, 2006, PRACTICAL HAEMATOLOG, Vxiii; MacLennan CA, 2007, AIDS, V21, P1643, DOI 10.1097/QAD.0b013e32823bcb03; Morgan H, 2007, J PHYS D APPL PHYS, V40, P61, DOI 10.1088/0022-3727/40/1/S10; Ozbek N, 2000, ACTA HAEMATOL-BASEL, V103, P226, DOI 10.1159/000041056; Pierelli L, 2010, VOX SANG, V98, P145, DOI 10.1111/j.1423-0410.2009.01256.x; Rao LV, 2008, CLIN CHIM ACTA, V389, P120, DOI 10.1016/j.cca.2007.12.006; Schalk E, 2007, VOX SANG, V93, P348, DOI 10.1111/j.1423-0410.2007.00978.x; Schlossman L, 1995, LEUCOCYTE TYPING; Sun T, 2009, MICROFLUID NANOFLUID, V6, P179, DOI 10.1007/s10404-008-0315-3; UDoHaH Services, 1992, FED REGISTER, V57, P7002; van Berkel C, 2011, LAB CHIP, V11, P1249, DOI 10.1039/c0lc00587h; Yang ZW, 2001, CLIN LAB HAEMATOL, V23, P155, DOI 10.1046/j.1365-2257.2001.00388.x; Zandecki M, 2007, INT J LAB HEMATOL, V29, P21, DOI 10.1111/j.1365-2257.2006.00871.x	23	29	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e43702	10.1371/journal.pone.0043702	http://dx.doi.org/10.1371/journal.pone.0043702			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028467	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000309388900005
J	Verma, D; Ye, NN; Meng, FJ; Sachs, F; Rahimzadeh, J; Hua, SZ				Verma, Deepika; Ye, Nannan; Meng, Fanjie; Sachs, Frederick; Rahimzadeh, Jason; Hua, Susan Z.			Interplay between Cytoskeletal Stresses and Cell Adaptation under Chronic Flow	PLOS ONE			English	Article							MECHANOSENSITIVE ION CHANNELS; FLUID SHEAR-STRESS; ACTIN CYTOSKELETON; ENDOTHELIAL-CELLS; MECHANICAL-STRESS; FOCAL ADHESIONS; FORCE GENERATION; LIVING CELLS; RHO; MECHANOTRANSDUCTION	Using stress sensitive FRET sensors we have measured cytoskeletal stresses in a-actinin and the associated reorganization of the actin cytoskeleton in cells subjected to chronic shear stress. We show that long-term shear stress reduces the average actinin stress and this effect is reversible with removal of flow. The flow-induced changes in cytoskeletal stresses are found to be dynamic, involving a transient decrease in stress (phase-I), a short-term increase (3-6 min) (Phase-II), followed by a longer-term decrease that reaches a minimum in similar to 20 min (Phase-III), before saturating. These changes are accompanied by reorganization of the actin cytoskeleton from parallel F-actin bundles to peripheral bundles. Blocking mechanosensitive ion channels (MSCs) with Gd3+ and GsMTx4 (a specific inhibitor) eliminated the changes in cytoskeletal stress and the corresponding actin reorganization, indicating that Ca2+ permeable MSCs participate in the signaling cascades. This study shows that shear stress induced cell adaptation is mediated via MSCs.	[Meng, Fanjie; Sachs, Frederick; Hua, Susan Z.] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA; [Verma, Deepika; Ye, Nannan; Rahimzadeh, Jason; Hua, Susan Z.] SUNY Buffalo, Dept Mech & Aerosp Engn, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Hua, SZ (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA.	zhua@buffalo.edu			National Institutes of Health (NIH) [DK77302, HL054887]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K25DK077302] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grant DK77302 (S.Z.H.). F. M. was supported by NIH HL054887 (F. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Asparuhova MB, 2009, SCAND J MED SCI SPOR, V19, P490, DOI 10.1111/j.1600-0838.2009.00928.x; Birukov KG, 2002, AM J RESP CELL MOL, V26, P453, DOI 10.1165/ajrcmb.26.4.4725; Bowman CL, 2007, TOXICON, V49, P249, DOI 10.1016/j.toxicon.2006.09.030; Brown AEX, 2009, CURR BIOL, V19, pR781, DOI 10.1016/j.cub.2009.06.054; Bursac P, 2005, NAT MATER, V4, P557, DOI 10.1038/nmat1404; Caldwell RA, 1998, AM J PHYSIOL-CELL PH, V275, pC619, DOI 10.1152/ajpcell.1998.275.2.C619; Chachisvilis M, 2006, P NATL ACAD SCI USA, V103, P15463, DOI 10.1073/pnas.0607224103; Chaudhuri O, 2007, NATURE, V445, P295, DOI 10.1038/nature05459; Duan Y, 2008, P NATL ACAD SCI USA, V105, P11418, DOI 10.1073/pnas.0804954105; Essig M, 2001, AM J PHYSIOL-RENAL, V281, pF751, DOI 10.1152/ajprenal.2001.281.4.F751; Footer MJ, 2007, P NATL ACAD SCI USA, V104, P2181, DOI 10.1073/pnas.0607052104; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Gardel ML, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.088102; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Giannone G, 2003, J CELL BIOL, V163, P409, DOI 10.1083/jcb.200302001; Hirata H, 2008, J CELL SCI, V121, P2795, DOI 10.1242/jcs.030320; Hua SZ, 2010, AM J PHYSIOL-CELL PH, V298, pC1424, DOI 10.1152/ajpcell.00503.2009; Imamura H, 1998, MOL BIOL CELL, V9, P2561, DOI 10.1091/mbc.9.9.2561; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Liu W, 2003, AM J PHYSIOL-RENAL, V285, pF998, DOI 10.1152/ajprenal.00067.2003; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; Matthews BD, 2004, BIOCHEM BIOPH RES CO, V313, P758, DOI 10.1016/j.bbrc.2003.12.005; Meng F, 2008, FEBS J, V275, P3072, DOI 10.1111/j.1742-4658.2008.06461.x; Meng FJ, 2011, J CELL SCI, V124, P261, DOI 10.1242/jcs.071928; Mott RE, 2007, AM J PHYSIOL-CELL PH, V293, pC1616, DOI 10.1152/ajpcell.00457.2006; Na S, 2008, P NATL ACAD SCI USA, V105, P6626, DOI 10.1073/pnas.0711704105; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; Osborn EA, 2006, AM J PHYSIOL-CELL PH, V290, pC444, DOI 10.1152/ajpcell.00218.2005; Oswald RE, 2002, J BIOL CHEM, V277, P34443, DOI 10.1074/jbc.M202715200; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Rahimzadeh J, 2011, AM J PHYSIOL-CELL PH, V301, pC646, DOI 10.1152/ajpcell.00099.2011; Resnick A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027058; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Rohatgi R, 2010, CURR OPIN NEPHROL HY, V19, P65, DOI 10.1097/MNH.0b013e32833327f3; Shiu YT, 2004, BIOPHYS J, V86, P2558, DOI 10.1016/S0006-3495(04)74311-8; Tzima E, 2006, CIRC RES, V98, P176, DOI 10.1161/01.RES.0000200162.94463.d7; Tzima E, 2001, EMBO J, V20, P4639, DOI 10.1093/emboj/20.17.4639; van der Pol L, 1998, TRENDS BIOTECHNOL, V16, P323, DOI 10.1016/S0167-7799(98)01209-8; Weinbaum S, 2010, AM J PHYSIOL-RENAL, V299, pF1220, DOI 10.1152/ajprenal.00453.2010; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; YANG XC, 1989, SCIENCE, V243, P1068, DOI 10.1126/science.2466333; Ziembicki J, 2005, AM J PHYSIOL-RENAL, V289, pF826, DOI 10.1152/ajprenal.00412.2004	46	20	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44167	10.1371/journal.pone.0044167	http://dx.doi.org/10.1371/journal.pone.0044167			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028495	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400021
J	Deutsch, D; Pietr, M; Knutsen, PM; Ahissar, E; Schneidman, E				Deutsch, Dudi; Pietr, Maciej; Knutsen, Per Magne; Ahissar, Ehud; Schneidman, Elad			Fast Feedback in Active Sensing: Touch-Induced Changes to Whisker-Object Interaction	PLOS ONE			English	Article							FUNCTIONAL PLASTICITY; RHYTHMIC WHISKING; RODENT WHISKING; FACIAL NUCLEUS; RAT; NEURONS; CORTEX; MOVEMENTS; LOCALIZATION; VIBRISSAE	Whisking mediated touch is an active sense whereby whisker movements are modulated by sensory input and behavioral context. Here we studied the effects of touching an object on whisking in head-fixed rats. Simultaneous movements of whiskers C1, C2, and D1 were tracked bilaterally and their movements compared. During free-air whisking, whisker protractions were typically characterized by a single acceleration-deceleration event, whisking amplitude and velocity were correlated, and whisk duration correlated with neither amplitude nor velocity. Upon contact with an object, a second acceleration-deceleration event occurred in about 25% of whisk cycles, involving both contacting (C2) and non-contacting (C1, D1) whiskers ipsilateral to the object. In these cases, the rostral whisker (C2) remained in contact with the object throughout the double-peak phase, which effectively prolonged the duration of C2 contact. These "touch-induced pumps'' (TIPs) were detected, on average, 17.9 ms after contact. On a slower time scale, starting at the cycle following first touch, contralateral amplitude increased while ipsilateral amplitude decreased. Our results demonstrate that sensory-induced motor modulations occur at various timescales, and directly affect object palpation.	[Deutsch, Dudi; Pietr, Maciej; Knutsen, Per Magne; Ahissar, Ehud; Schneidman, Elad] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Knutsen, Per Magne] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA	Weizmann Institute of Science; University of California System; University of California San Diego	Ahissar, E (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	ehud.ahissar@weizmann.ac.il; elad.schneidman@weizmann.ac.il		schneidman, elad/0000-0001-8653-9848	European Union [ICT-215910]; Israeli Science Foundation [749/10]; United States-Israel Binational Science Foundation [2007121]; Minerva Foundation; Federal German Ministry for Education and Research; Peter and Patricia Gruber foundation; Human Frontier Science Program; Horowitz Center for Complexity Science	European Union(European Commission); Israeli Science Foundation(Israel Science Foundation); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Minerva Foundation; Federal German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Peter and Patricia Gruber foundation; Human Frontier Science Program(Human Frontier Science Program); Horowitz Center for Complexity Science	This work was supported by European Union grant BIOTACT (ICT-215910), the Israeli Science Foundation Grant No. 749/10, the United States-Israel Binational Science Foundation Grant No. 2007121, the Minerva Foundation funded by the Federal German Ministry for Education and Research, and the Peter and Patricia Gruber foundation. PMK was supported by a Long-Term Fellowship from the Human Frontier Science Program. EA holds the Helen Diller Family Professorial Chair of Neurobiology. ES was supported by the Horowitz Center for Complexity Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; Ahissar E, 2003, CEREB CORTEX, V13, P53, DOI 10.1093/cercor/13.1.53; Ahissar E, 1998, NEUROPHARMACOLOGY, V37, P633, DOI 10.1016/S0028-3908(98)00068-9; Ahissar E, 2008, BIOL CYBERN, V98, P449, DOI 10.1007/s00422-008-0214-4; Bahar A, 2004, J NEUROPHYSIOL, V92, P3298, DOI 10.1152/jn.00198.2004; Berg RW, 2003, J NEUROPHYSIOL, V89, P104, DOI 10.1152/jn.00600.2002; Bermejo R, 1998, J NEUROSCI METH, V83, P89, DOI 10.1016/S0165-0270(98)00050-8; Bosman LWJ, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00053; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Cohen JD, 2008, J NEUROSCI, V28, P11205, DOI 10.1523/JNEUROSCI.2999-08.2008; Derdikman D, 2006, J NEUROSCI, V26, P9538, DOI 10.1523/JNEUROSCI.0918-06.2006; Deschenes M, 2011, CURR OPIN NEUROBIOL; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; DORFL J, 1985, ACTA ANAT, V121, P248; Ego-Stengel V, 2001, J NEUROPHYSIOL, V86, P422, DOI 10.1152/jn.2001.86.1.422; ERZURUMLU RS, 1979, J COMP NEUROL, V188, P75, DOI 10.1002/cne.901880107; Galloway EM, 2008, PROG BRAIN RES, V169, P251, DOI 10.1016/S0079-6123(07)00015-5; Gao PH, 2001, J NEUROSCI, V21, P5374, DOI 10.1523/JNEUROSCI.21-14-05374.2001; Haidarliu S, 2010, ANAT REC, V293, P1192, DOI 10.1002/ar.21156; Haiss F, 2005, J NEUROSCI, V25, P1579, DOI 10.1523/JNEUROSCI.3760-04.2005; Harish O, 2010, J NEUROPHYSIOL, V103, P2684, DOI 10.1152/jn.01016.2009; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; Harvey MA, 2001, SOMATOSENS MOT RES, V18, P211; Hemelt ME, 2008, J NEUROPHYSIOL, V100, P1245, DOI 10.1152/jn.90478.2008; Herfst LJ, 2008, J NEUROPHYSIOL, V99, P2821, DOI 10.1152/jn.01014.2007; Hill DN, 2008, J NEUROSCI, V28, P3438, DOI 10.1523/JNEUROSCI.5008-07.2008; Jenkinson EW, 2000, J NEUROPHYSIOL, V84, P1781, DOI 10.1152/jn.2000.84.4.1781; KILLACKEY HP, 1989, J COMP NEUROL, V282, P428, DOI 10.1002/cne.902820309; Kleinfeld D, 1999, SOMATOSENS MOT RES, V16, P69, DOI 10.1080/08990229970528; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; Knutsen PM, 2008, NEURON, V59, P35, DOI 10.1016/j.neuron.2008.05.013; Knutsen PM, 2006, J NEUROSCI, V26, P8451, DOI 10.1523/JNEUROSCI.1516-06.2006; Knutsen PM, 2009, TRENDS NEUROSCI, V32, P101, DOI 10.1016/j.tins.2008.10.002; Knutsen PM, 2005, J NEUROPHYSIOL, V93, P2294, DOI 10.1152/jn.00718.2004; Krupa DJ, 2001, J NEUROSCI, V21, P5752, DOI 10.1523/JNEUROSCI.21-15-05752.2001; Landers M, 2002, SOMATOSENS MOT RES, V19, P358, DOI 10.1080/0899022021000037818; Lee S, 2008, NAT NEUROSCI, V11, P1430, DOI 10.1038/nn.2227; Li YQ, 1997, J COMP NEUROL, V378, P283, DOI 10.1002/(SICI)1096-9861(19970210)378:2<283::AID-CNE10>3.0.CO;2-T; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; Mehta SB, 2007, PLOS BIOL, V5, P309, DOI 10.1371/journal.pbio.0050015; Mitchinson B, 2007, P R SOC B, V274, P1035, DOI 10.1098/rspb.2006.0347; Mitchinson B, 2011, PHILOS T R SOC B, V366, P3037, DOI 10.1098/rstb.2011.0156; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; Munz M, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00191; Neimark MA, 2003, J NEUROSCI, V23, P6499; Nguyen QT, 2005, NEURON, V45, P447, DOI 10.1016/j.neuron.2004.12.042; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; Pietr MD, 2010, J NEUROPHYSIOL, V104, P2532, DOI 10.1152/jn.01039.2009; Sachdev RNS, 2003, SOMATOSENS MOT RES, V20, P163, DOI 10.1080/08990220311000405208; Simony E, 2010, J NEUROSCI, V30, P8935, DOI 10.1523/JNEUROSCI.0172-10.2010; Szwed M, 2003, NEURON, V40, P621, DOI 10.1016/S0896-6273(03)00671-8; Timofeeva E, 2005, J NEUROSCI, V25, P9135, DOI 10.1523/JNEUROSCI.3073-05.2005; Towal RB, 2008, J NEUROPHYSIOL, V100, P740, DOI 10.1152/jn.01295.2007; Towal RB, 2006, J NEUROSCI, V26, P8838, DOI 10.1523/JNEUROSCI.0581-06.2006; Von Heimendahl M, 2007, PLOS BIOL, V5, P2696, DOI 10.1371/journal.pbio.0050305; WINESKI LE, 1983, J ZOOL, V200, P261; WISE SP, 1979, NEUROSCIENCE, V4, P65, DOI 10.1016/0306-4522(79)90218-5; WISE SP, 1977, J COMP NEUROL, V175, P129, DOI 10.1002/cne.901750202; Wolfe J, 2011, BEHAV NEUROSCI, V125, P900, DOI 10.1037/a0026165; WOOLSTON DC, 1983, NEUROSCI LETT, V36, P43, DOI 10.1016/0304-3940(83)90483-4; Yu CX, 2006, PLOS BIOL, V4, P819, DOI 10.1371/journal.pbio.0040124	61	45	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44272	10.1371/journal.pone.0044272	http://dx.doi.org/10.1371/journal.pone.0044272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028512	Green Published, gold			2022-12-27	WOS:000311313900016
J	Randremanana, R; Randrianirina, F; Gousseff, M; Dubois, N; Razafindratsimandresy, R; Hariniana, ER; Garin, B; Randriamanantena, A; Rakotonirina, HC; Ramparany, L; Ramarokoto, CE; Rakotomanana, F; Ratsitorahina, M; Rajatonirina, S; Talarmin, A; Richard, V				Randremanana, Rindra; Randrianirina, Frederique; Gousseff, Marie; Dubois, Natasha; Razafindratsimandresy, Richter; Hariniana, Elisoa Ratsima; Garin, Benoit; Randriamanantena, Arthur; Rakotonirina, Hanitra Clara; Ramparany, Lovasoa; Ramarokoto, Charles Emile; Rakotomanana, Fanjasoa; Ratsitorahina, Maherisoa; Rajatonirina, Soatiana; Talarmin, Antoine; Richard, Vincent			Case-Control Study of the Etiology of Infant Diarrheal Disease in 14 Districts in Madagascar	PLOS ONE			English	Article							ROTAVIRUS INFECTION; ESCHERICHIA-COLI; GASTROENTERITIS; CHILDREN; AFRICA; CAMPYLOBACTER; COUNTRIES	Background: Acute diarrhea is a major cause of childhood morbidity and mortality worldwide. Its microbiological causes and clinico-epidemiological aspects were examined during the rainy seasons from 2008 to 2009 in 14 districts in Madagascar. Methods: Stool specimens of 2196 children with acute diarrhea and 496 healthy children were collected in a community setting. Intestinal parasites were diagnosed by microscopy and bacteria by culturing methods. Rota-, astro and adenoviruses were identified using commercially available ELISA kits and rotaviruses were confirmed using reverse transcriptase polymerase chain reaction (RT-PCR). Results: Intestinal microorganisms were isolated from 54.6% of diarrheal patients and 45.9% of healthy subjects (p =<0.01). The most common pathogens in diarrheic patients were intestinal parasites (36.5%). Campylobacter spp. and Rotavirus were detected in 9.7% and 6.7% of diarrheic patients. The detection rates of Entamoeba histolytica, Trichomonas intestinalis and Giardia lamblia were much greater in diarrheal patients than in non diarrheal subjects (odds ratios of 5.1, 3.2, 1.7 respectively). The abundance of other enteropathogens among the non diarrheal group may indicate prolonged excretion or limited pathogenicity. Conclusion: In developing countries, where the lack of laboratory capacities is great, cross sectional studies of enteropathogens and their spatial distribution, including diarrheal and non diarrheal subjects, are interesting tools in order to advise regional policies on treatment and diarrheic patient management.	[Randremanana, Rindra; Gousseff, Marie; Randriamanantena, Arthur; Ramarokoto, Charles Emile; Rakotomanana, Fanjasoa; Ratsitorahina, Maherisoa; Rajatonirina, Soatiana; Richard, Vincent] Inst Pasteur Madagascar, Epidemiol Unit, Antananarivo, Madagascar; [Randrianirina, Frederique; Hariniana, Elisoa Ratsima] Inst Pasteur Madagascar, Clin Biol Ctr, Antananarivo, Madagascar; [Dubois, Natasha; Garin, Benoit; Rakotonirina, Hanitra Clara] Inst Pasteur Madagascar, Virol Unit, Antananarivo, Madagascar; [Razafindratsimandresy, Richter; Ramparany, Lovasoa] Inst Pasteur Madagascar, Mol Biol Unit, Antananarivo, Madagascar	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar	Richard, V (corresponding author), Inst Pasteur Madagascar, Epidemiol Unit, Antananarivo, Madagascar.	vrichard@pasteur.sn	Razafindratsimandresy, Richter/H-9881-2014	Ramarokoto, Charles Emile/0000-0001-7831-7057; Vincent, RICHARD/0000-0002-6961-1753; RAKOTOMANANA, Fanjasoa/0000-0002-3373-1075	TOTAL fondation; Institut Pasteur de Madagascar	TOTAL fondation; Institut Pasteur de Madagascar	Funding by TOTAL fondation and Institut Pasteur de Madagascar. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adiku TK, 2010, J INFECT DIS, V202, pS175, DOI 10.1086/653565; Areeshi M, 2008, ANN TROP MED PARASIT, V102, P309, DOI 10.1179/136485908X278793; Boschi-Pinto C, 2008, B WORLD HEALTH ORGAN, V86, P710, DOI 10.2471/BLT.07.050054; CASSEL-BERAUD A M, 1990, Archives de l'Institut Pasteur de Madagascar, V57, P223; CASSELBERAUD AM, 1993, J DIARRHOEAL DIS RES, V11, P82; Esona MD, 2003, J TROP PEDIATRICS, V49, P160, DOI 10.1093/tropej/49.3.160; Gomez-Duarte OG, 2009, DIAGN MICR INFEC DIS, V63, P1, DOI 10.1016/j.diagmicrobio.2008.09.006; Ketley JM, 1997, MICROBIOL-UK, V143, P5, DOI 10.1099/00221287-143-1-5; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Muller D, 2007, APPL ENVIRON MICROB, V73, P3380, DOI 10.1128/AEM.02855-06; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Rahouma A, 2011, AM J TROP MED HYG, V84, P886, DOI 10.4269/ajtmh.2011.11-0116; Randrianasolo L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-31; Reither K, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-104; Sdiri-Loulizi K, 2008, J CLIN MICROBIOL, V46, P1349, DOI 10.1128/JCM.02438-07; TAYLOR DN, 1992, CAMPLYLOBACTER JEJUNI, P20; Thapar N, 2004, LANCET, V363, P641, DOI 10.1016/S0140-6736(04)15599-2; Waggie Z, 2010, J INFECT DIS, V202, pS23, DOI 10.1086/653554; Wolfaardt M, 1997, J MED VIROL, V51, P290, DOI 10.1002/(SICI)1096-9071(199704)51:4&lt;290::AID-JMV6&gt;3.0.CO;2-0	19	34	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e44533	10.1371/journal.pone.0044533	http://dx.doi.org/10.1371/journal.pone.0044533			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028555	Green Published, gold, Green Submitted			2022-12-27	WOS:000309742800012
J	He, Y; Xu, TT; Fossheim, LE; Zhang, XH				He, Yang; Xu, Tingting; Fossheim, Leif E.; Zhang, Xiao-Hua			FliC, a Flagellin Protein, Is Essential for the Growth and Virulence of Fish Pathogen Edwardsiella tarda	PLOS ONE			English	Article							III SECRETION; ANGSTROM RESOLUTION; ESCHERICHIA-COLI; BIOFILM; POLYPHOSPHATE; REQUIREMENT; SALMONELLA; MOTILITIES; INSIGHTS; PROVIDES	Edwardsiella tarda is a flagellated Gram-negative bacterium which causes edwardsiellosis in fish. FliC, as a flagellar filament structural protein, is hypothesized to be involved in the pathogenesis of infection. In this study, a fliC in-frame deletion mutant of a virulent isolate of E. tarda was constructed through double crossover allelic exchange by means of the suicide vector pRE112, and its virulence-associated phenotypes and pathogenicity were tested. It was found that the deletion of fliC significantly decreased the diameter of flagella filaments. In addition, the mutant showed reduced pathogenicity to fish by increasing the LD50 value for 100-fold compared to the wild-type strain, as well as showed impaired bacterial growth, reduced motility, decreased biofilm formation and reduced levels of virulence-associated protein secretion involved in the type III secretion system (TTSS). The phenotypic characteristics of the fliC deletion mutant uncovered in this investigation suggest that fliC plays an essential role in normal flagellum function, bacterial growth, protein secretion by TTSS and bacterial virulence.	[He, Yang; Xu, Tingting; Fossheim, Leif E.; Zhang, Xiao-Hua] Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China	Ocean University of China	He, Y (corresponding author), Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China.	xhzhang@ouc.edu.cn			National High Technology Research Development Program of China (863 Programs) [2008AA092501]	National High Technology Research Development Program of China (863 Programs)(National High Technology Research and Development Program of China)	The work was supported by grants from the National High Technology Research Development Program of China (863 Programs, no. 2008AA092501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbass A, 2010, J FISH DIS, V33, P31, DOI 10.1111/j.1365-2761.2009.01086.x; Aizawa S, 2001, FEMS MICROBIOL LETT, V202, P157, DOI 10.1111/j.1574-6968.2001.tb10797.x; Austin B, 1989, METHODS MICROBIOLOGI; Dong Li, 2009, Marine Sciences (Beijing), V33, P57; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Gauthier A, 2005, ANTIMICROB AGENTS CH, V49, P4101, DOI 10.1128/AAC.49.10.4101-4109.2005; Ghelardi E, 2002, J BACTERIOL, V184, P6424, DOI 10.1128/JB.184.23.6424-6433.2002; Givaudan A, 2000, J BACTERIOL, V182, P107, DOI 10.1128/JB.182.1.107-115.2000; Honko AN, 2006, INFECT IMMUN, V74, P1113, DOI 10.1128/IAI.74.2.1113-1120.2006; Jiao XD, 2009, VACCINE, V27, P5195, DOI 10.1016/j.vaccine.2009.06.071; Lee DC, 2010, FISH PATHOL, V45, P17, DOI 10.3147/jsfp.45.17; Macnab R. M., 1987, ESCHERICHIA COLI SAL, V1, P732; Mashimo T, 2007, J BACTERIOL, V189, P5153, DOI 10.1128/JB.00061-07; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; MIMORI Y, 1995, J MOL BIOL, V249, P69, DOI 10.1006/jmbi.1995.0281; MORGAN DG, 1995, J MOL BIOL, V249, P88, DOI 10.1006/jmbi.1995.0282; Pallen MJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-9; Rao PSS, 2004, MOL MICROBIOL, V53, P573, DOI 10.1111/j.1365-2958.2004.04123.x; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Seung HC, 2011, FISH SHELLFISH IMMUN, V31, P58; Simon R, 1983, BIOTECHNOLOGY, V1, P787; Stepanovic S, 2007, APMIS, V115, P891, DOI 10.1111/j.1600-0463.2007.apm_630.x; Tambalo DD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-219; Tan YP, 2005, MICROBIOL-SGM, V151, P2301, DOI 10.1099/mic.0.28005-0; Tan YP, 2002, INFECT IMMUN, V70, P6475, DOI 10.1128/IAI.70.11.6475-6480.2002; Tunpiboonsak S, 2010, J MICROBIOL, V48, P63, DOI 10.1007/s12275-010-9138-5; Verjan N, 2005, APPL ENVIRON MICROB, V71, P5654, DOI 10.1128/AEM.71.9.5654-5658.2005; Wakimoto N, 2004, AM J TROP MED HYG, V71, P687, DOI 10.4269/ajtmh.2004.71.687; Wang QY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007646; Wardlaw A.C., 1985, PRACTICAL STAT EXPT; Young GM, 1999, P NATL ACAD SCI USA, V96, P6456, DOI 10.1073/pnas.96.11.6456; Zhang XH, 2000, J FISH DIS, V23, P93, DOI 10.1046/j.1365-2761.2000.00214.x	32	48	59	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45070	10.1371/journal.pone.0045070	http://dx.doi.org/10.1371/journal.pone.0045070			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024793	Green Submitted, Green Published, gold			2022-12-27	WOS:000308860100051
J	Kenchegowda, D; Harvey, SAK; Swamynathan, S; Lathrop, KL; Swamynathan, SK				Kenchegowda, Doreswamy; Harvey, Stephen A. K.; Swamynathan, Sudha; Lathrop, Kira L.; Swamynathan, Shivalingappa K.			Critical Role of Klf5 in Regulating Gene Expression during Post-Eyelid Opening Maturation of Mouse	PLOS ONE			English	Article							CORNEAL EPITHELIAL-CELLS; METALLOPROTEINASE GELATINASE B; CONJUNCTIVAL GOBLET CELLS; KRUPPEL-LIKE FACTOR-4; PAS DOMAIN PROTEIN; TRANSCRIPTION FACTORS; OCULAR SURFACE; MOLECULAR-BASIS; STROMAL EDEMA; UP-REGULATION	Background: Klf5 plays an important role in maturation and maintenance of the mouse ocular surface. Here, we quantify WT and Klf5-conditional null (Klf5CN) corneal gene expression, identify Klf5-target genes and compare them with the previously identified Klf4-target genes to understand the molecular basis for non-redundant functions of Klf4 and Klf5 in the cornea. Methodology/Principal Findings: Postnatal day-11 (PN11) and PN56 WT and Klf5CN corneal transcriptomes were quantified by microarrays to compare gene expression in maturing WT corneas, identify Klf5-target genes, and compare corneal Klf4-and Klf5-target genes. Whole-mount corneal immunofluorescent staining was employed to examine CD45+ cell influx and neovascularization. Effect of Klf5 on expression of desmosomal components was studied by immunofluorescent staining and transient co-transfection assays. Expression of 714 and 753 genes was increased, and 299 and 210 genes decreased in PN11 and PN56 Klf5CN corneas, respectively, with 366 concordant increases and 72 concordant decreases. PN56 Klf5CN corneas shared 241 increases and 98 decreases with those previously described in Klf4CN corneas. Xenobiotic metabolism related pathways were enriched among genes decreased in Klf5CN corneas. Expression of angiogenesis and immune response-related genes was elevated, consistent with neovascularization and CD45+ cell influx in Klf5CN corneas. Expression of 1574 genes was increased and 1915 genes decreased in WT PN56 compared with PN11 corneas. Expression of ECM-associated genes decreased, while that of solute carrier family members increased in WT PN56 compared with PN11 corneas. Dsg1a, Dsg1b and Dsp were down-regulated in Klf5CN corneas and their corresponding promoter activities were stimulated by Klf5 in transient co-transfection assays. Conclusions/Significance: Differences between PN11 and PN56 corneal Klf5-target genes reveal dynamic changes in functions of Klf5 during corneal maturation. Klf5 contributes to corneal epithelial homeostasis by regulating the expression of desmosomal components. Klf4- and Klf5-target genes are largely distinct, consistent with their non-redundant roles in the mouse cornea.	[Kenchegowda, Doreswamy; Harvey, Stephen A. K.; Swamynathan, Sudha; Lathrop, Kira L.; Swamynathan, Shivalingappa K.] Univ Pittsburgh, Dept Ophthalmol, Pittsburgh, PA 15260 USA; [Swamynathan, Shivalingappa K.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA USA; [Swamynathan, Shivalingappa K.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kenchegowda, D (corresponding author), Univ Maryland, Dept Med, Baltimore, MD 21201 USA.	Swamynathansk@upmc.edu		Swamynathan, Shivalingappa/0000-0002-9158-1511	National Eye Institute (NEI) K22 Career Development Award [EY016875]; Department of Ophthalmology, Core Grant for Vision Research [5P30 EY08098-19]; Research to Prevent Blindness; Eye and Ear Foundation, Pittsburgh; NATIONAL EYE INSTITUTE [P30EY008098, K22EY016875] Funding Source: NIH RePORTER	National Eye Institute (NEI) K22 Career Development Award; Department of Ophthalmology, Core Grant for Vision Research; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Eye and Ear Foundation, Pittsburgh; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute (NEI) K22 Career Development Award EY016875 (SKS), startup funds from the Department of Ophthalmology, Core Grant for Vision Research (5P30 EY08098-19), Research to Prevent Blindness and the Eye and Ear Foundation, Pittsburgh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary G, 2005, INVEST OPHTH VIS SCI, V46, P3109, DOI 10.1167/iovs.05-0053; Adhikary G, 2005, INVEST OPHTH VIS SCI, V46, P1219, DOI 10.1167/iovs.04-1285; Bell SM, 2011, DEV BIOL, V358, P79, DOI 10.1016/j.ydbio.2011.07.020; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Boesch JS, 1999, ARCH BIOCHEM BIOPHYS, V361, P223, DOI 10.1006/abbi.1998.0989; Bonanno JA, 2003, PROG RETIN EYE RES, V22, P69, DOI 10.1016/S1350-9462(02)00059-9; BONANNO JA, 2003, EYE CONTACT LENS, V29, pS192; BONANNO JA, 2003, EYE CONTACT LENS S, V29, pS26; Bonanno Joseph A, 2003, Eye Contact Lens, V29, pS7; Chiambaretta F, 2006, INVEST OPHTH VIS SCI, V47, P582, DOI 10.1167/iovs.05-0551; Chiambaretta F, 2004, MOL VIS, V10, P901; Chiambaretta F, 2002, INVEST OPHTH VIS SCI, V43, P3422; Chu PH, 2008, INVEST OPHTH VIS SCI, V49, P5314, DOI 10.1167/iovs.08-2209; Collinson JM, 2004, INVEST OPHTH VIS SCI, V45, P1101, DOI 10.1167/iovs.03-1118; Collinson JM, 2003, DEV BIOL, V255, P303, DOI 10.1016/S0012-1606(02)00095-7; Collinson JM, 2002, DEV DYNAM, V224, P432, DOI 10.1002/dvdy.10124; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Davis J, 2003, J CELL SCI, V116, P2157, DOI 10.1242/jcs.00441; Davis J, 2011, INVEST OPHTH VIS SCI, V52, P4158, DOI 10.1167/iovs.10-6726; Dora N, 2008, DEV DYNAM, V237, P1295, DOI 10.1002/dvdy.21528; Dwivedi DJ, 2005, INVEST OPHTH VIS SCI, V46, P3623, DOI 10.1167/iovs.05-0028; Fang XF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-11; Farkas RH, 2004, INVEST OPHTH VIS SCI, V45, P1410, DOI 10.1167/iovs.03-0872; Fragiadaki M, 2011, MOL BIOL CELL, V22, P1836, DOI 10.1091/mbc.E10-08-0669; Francesconi CM, 2000, INVEST OPHTH VIS SCI, V41, P1054; Gage PJ, 2009, DEV DYNAM, V238, P2149, DOI 10.1002/dvdy.22033; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; GIPSON IK, 1992, ACTA OPHTHALMOL, V70, P13; Gronert K, 2005, J BIOL CHEM, V280, P15267, DOI 10.1074/jbc.M410638200; Gupta D, 2011, INVEST OPHTHALMOL VI; Hai T, 2010, GENE EXPRESSION, V15, P1, DOI 10.3727/105221610X12819686555015; Harvey SAK, 2010, INVEST OPHTH VIS SCI, V51, P2917, DOI 10.1167/iovs.09-4498; Hausman RE, 2007, PROG RETIN EYE RES, V26, P162, DOI 10.1016/j.preteyeres.2006.11.001; Hay E.D., 1980, International Review of Cytology, V63, P263, DOI 10.1016/S0074-7696(08)61760-X; Hough RB, 2004, MOL CELL BIOL, V24, P1324, DOI 10.1128/MCB.24.3.1324-1340.2004; Kenchegowda D, 2011, DEV BIOL, V356, P5, DOI 10.1016/j.ydbio.2011.05.005; Klintworth GK, 2003, FRONT BIOSCI-LANDMRK, V8, pD687, DOI 10.2741/1018; Kloeckener-Gruissem B, 2008, AM J HUM GENET, V82, P772, DOI 10.1016/j.ajhg.2007.12.013; Kottke MD, 2006, J CELL SCI, V119, P797, DOI 10.1242/jcs.02888; Lambiase A, 2005, P NATL ACAD SCI USA, V102, P16795, DOI 10.1073/pnas.0508516102; Leiper LJ, 2009, INVEST OPHTH VIS SCI, V50, P1122, DOI 10.1167/iovs.08-2812; Lewitzky M, 2007, CURR OPIN BIOTECH, V18, P467, DOI 10.1016/j.copbio.2007.09.007; Li W, 2008, J PATHOL, V214, P114, DOI 10.1002/path.2256; Liao SY, 2003, J MED GENET, V40, P257, DOI 10.1136/jmg.40.4.257; Liesegang Thomas J., 2002, CLAO Journal, V28, P12; Litjens SHM, 2006, TRENDS CELL BIOL, V16, P376, DOI 10.1016/j.tcb.2006.05.004; Makino Y, 2001, NATURE, V414, P550, DOI 10.1038/35107085; Makino Y, 2007, J BIOL CHEM, V282, P14073, DOI 10.1074/jbc.M700732200; MANDELL RB, 1965, NATURE, V208, P292, DOI 10.1038/208292a0; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; Nagasaki T, 2003, INVEST OPHTH VIS SCI, V44, P558, DOI 10.1167/iovs.02-0705; Nakamura H, 2005, INVEST OPHTH VIS SCI, V46, P4092, DOI 10.1167/iovs.05-0324; Nakamura H, 2004, INVEST OPHTH VIS SCI, V45, P4327, DOI 10.1167/iovs.04-0353; Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X; Norman B, 2004, INVEST OPHTH VIS SCI, V45, P429, DOI 10.1167/iovs.03-0449; Parisi S, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-128; Sivak JM, 2000, DEV BIOL, V222, P41, DOI 10.1006/dbio.2000.9694; Sivak JM, 2004, MOL CELL BIOL, V24, P245, DOI 10.1128/MCB.24.1.245-257.2004; Sivak JM, 2002, PROG RETIN EYE RES, V21, P1, DOI 10.1016/S1350-9462(01)00015-5; Stasi K, 2007, INVEST OPHTH VIS SCI, V48, P727, DOI 10.1167/iovs.06-0497; Stucchi A, 2006, INFLAMM BOWEL DIS, V12, P581, DOI 10.1097/01.MIB.0000225338.14356.d5; Swamynathan SK, 2008, INVEST OPHTH VIS SCI, V49, P3360, DOI 10.1167/iovs.08-1811; Swamynathan SK, 2007, MOL CELL BIOL, V27, P182, DOI 10.1128/MCB.00846-06; Swamynathan Shivalingappa K., 2010, Human Genomics, V4, P263; Swamynathan S, 2011, INVEST OPHTH VIS SCI, V52, P1762, DOI 10.1167/iovs.10-6134; Tang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023691; Tergaonkar V, 2005, NAT CELL BIOL, V7, P921, DOI 10.1038/ncb1296; Ueta M, 2005, INVEST OPHTH VIS SCI, V46, P579, DOI 10.1167/iovs.04-1055; Vernes SC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002145; Vithana EN, 2006, NAT GENET, V38, P755, DOI 10.1038/ng1824; Wan HJ, 2008, DEVELOPMENT, V135, P2563, DOI 10.1242/dev.021964; Wolosin JM, 2004, INT J DEV BIOL, V48, P981, DOI 10.1387/ijdb.041876jw; Wu F, 2008, EXP EYE RES, V87, P214, DOI 10.1016/j.exer.2008.06.001; Young RD, 2009, INVEST OPHTH VIS SCI, V50, P4155, DOI 10.1167/iovs.09-3561; Zhang XH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001087; Zhao L, 2011, NUCLEIC ACIDS RES, V39, P4664, DOI 10.1093/nar/gkr024; Zieske JD, 2004, INT J DEV BIOL, V48, P903, DOI 10.1387/ijdb.041860jz	77	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44771	10.1371/journal.pone.0044771	http://dx.doi.org/10.1371/journal.pone.0044771			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024760	Green Accepted, gold, Green Published			2022-12-27	WOS:000308860100018
J	Park, JH; Ryoo, S; Kim, SJ; Kim, GM; Chung, CS; Lee, KH; Bang, OY				Park, Jae-Hyun; Ryoo, Sookyung; Kim, Suk Jae; Kim, Gyeong-Moon; Chung, Chin-Sang; Lee, Kwang Ho; Bang, Oh Young			Differential Risk Factors for Lacunar Stroke Depending on the MRI (White and Red) Subtypes of Microangiopathy	PLOS ONE			English	Article							SMALL VESSEL DISEASE; AMBULATORY BLOOD-PRESSURE; CEREBRAL MICROBLEEDS; PLASMA-FIBRINOGEN; BRAIN MICROBLEEDS; VISCOSITY; LESIONS; SILENT; AGE	Background: Leukoaraiosis and cerebral microbleeds (CMB), which represent cerebral microangiopathy, commonly coexist in patients with acute lacunar stroke. Since they may have different impacts on stroke prognosis and treatment, it is important to know the factors associated with leukoaraiosis-predominant vs. CMB-predominant microangiopathies. Methods: We prospectively recruited 226 patients with acute lacunar infarction and divided them into four groups according to the Fazekas' score and the presence of CMB: mild, red (predominant CMB), white (predominant leukoaraiosis) and severe microangiopathy groups. For comparison, we also evaluated 50 patients with intracerebral hemorrhage (ICH). We evaluated the clinical and laboratory findings of microangiopathy subtypes in patients with acute lacunar stroke and then compared them with those of primary ICH. Results: The risk factor profile was different among the groups. Patients with acute lacunar infarct but mild microangiopathy were younger, predominantly male, less hypertensive, and more frequently had smoking and heavy alcohol habits than other groups. The risk factor profile of red microangiopathy was similar to that of ICH but differed from that of white microangiopathy. The subjects in the white microangiopathy group were older and more frequently had diabetes than those in the red microangiopathy or ICH group. After adjustments for other factors, age [ odds ratio (OR) 1.13; 95% confidence interval (CI) 1.08-1.18; rho<0.001] and diabetes (OR 2.28; 95% CI 1.02-5.13; rho = 0.045) were independently associated with white microangiopathy, and age (OR 1.05; 95% CI 1.01-1.08; rho = 0.010) was independent predictor for red microangiopathy compared to mild microangiopathy. Conclusion: Patients with acute lacunar infarction have a different risk factor profile depending on microangiopathic findings. Our results indicate that diabetes may be an one of determinants of white (leukoaraiosis-predominant) microangiopathy, whereas smoking and alcohol habits in relatively young people may be a determinants of mild microangiopahic changes in patients with lacunar infarction.	[Park, Jae-Hyun; Ryoo, Sookyung; Kim, Suk Jae; Kim, Gyeong-Moon; Chung, Chin-Sang; Lee, Kwang Ho; Bang, Oh Young] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Park, JH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea.	nmboy@unitel.co.kr			Korean Healthcare Technology R&D Project, Ministry of Health Welfare [A110208]	Korean Healthcare Technology R&D Project, Ministry of Health Welfare	This study was supported by the Korean Healthcare Technology R&D Project, Ministry of Health & Welfare (A110208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Aono Y, 2007, ARTERIOSCL THROM VAS, V27, P963, DOI 10.1161/01.ATV.0000258947.17570.38; Ay H, 2005, ANN NEUROL, V58, P688, DOI 10.1002/ana.20617; Bang OY, 2007, CEREBROVASC DIS, V24, P520, DOI 10.1159/000110422; Bang OY, 2002, ARCH NEUROL-CHICAGO, V59, P259, DOI 10.1001/archneur.59.2.259; Cordonnier C, 2007, BRAIN, V130, P1988, DOI 10.1093/brain/awl387; Danesh J, 2000, EUR HEART J, V21, P515, DOI 10.1053/euhj.1999.1699; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Fisher M, 2010, STROKE, V41, P2782, DOI 10.1161/STROKEAHA.110.593657; Gouw AA, 2008, STROKE, V39, P1414, DOI 10.1161/STROKEAHA.107.498535; Gouw AA, 2011, J NEUROL NEUROSUR PS, V82, P126, DOI 10.1136/jnnp.2009.204685; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Henskens LHG, 2008, HYPERTENSION, V51, P62, DOI 10.1161/HYPERTENSIONAHA.107.100610; Jackson C, 2005, BRAIN, V128, P2507, DOI 10.1093/brain/awh636; Jeerakathil T, 2004, STROKE, V35, P1831, DOI 10.1161/01.STR.0000131809.35202.1b; Jeon SB, 2009, NEUROLOGY, V73, P1638, DOI 10.1212/WNL.0b013e3181bd110f; Khan U, 2007, J NEUROL NEUROSUR PS, V78, P702, DOI 10.1136/jnnp.2006.103549; Kidwell CS, 2009, NEUROLOGY, V73, P1614, DOI 10.1212/WNL.0b013e3181c17fa1; Kitamura A, 2006, STROKE, V37, P1374, DOI 10.1161/01.STR.0000221714.96986.5f; Lee SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025930; Lee SH, 2002, STROKE, V33, P2845, DOI 10.1161/01.STR.0000036092.23649.2E; Lominadze D, 2010, ACTA PHYSIOL, V198, P1, DOI 10.1111/j.1748-1716.2009.02037.x; Lovelock CE, 2010, STROKE, V41, P1222, DOI 10.1161/STROKEAHA.109.572594; Nascetti S, 2001, EUR J EPIDEMIOL, V17, P953, DOI 10.1023/A:1016216808365; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Roob G, 1999, NEUROLOGY, V52, P991, DOI 10.1212/WNL.52.5.991; Ryoo S, 2012, NEUROLOGY, V78, P888, DOI 10.1212/WNL.0b013e31824c4699; SCHNEIDER R, 1985, J NEUROL, V232, P357, DOI 10.1007/BF00313836; Shinohara Y, 2008, CEREBROVASC DIS, V26, P63, DOI 10.1159/000135654; Stevenson SF, 2010, STROKE, V41, pE434, DOI 10.1161/STROKEAHA.109.569855; Tsuda Y, 1997, J NEUROL SCI, V147, P49, DOI 10.1016/S0022-510X(96)05309-9	31	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44865	10.1371/journal.pone.0044865	http://dx.doi.org/10.1371/journal.pone.0044865			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024771	gold, Green Published, Green Submitted			2022-12-27	WOS:000308860100029
J	Yaseen, ZS; Gilmer, E; Modi, J; Cohen, LJ; Galynker, II				Yaseen, Zimri S.; Gilmer, Evan; Modi, Janki; Cohen, Lisa J.; Galynker, Igor I.			Emergency Room Validation of the Revised Suicide Trigger Scale (STS-3): A Measure of a Hypothesized Suicide Trigger State	PLOS ONE			English	Article							ADOLESCENTS AGED 13; RISK-FACTORS; PSYCHIATRIC-PATIENTS; ANXIETY DISORDERS; THOUGHTS; IDEATION; BEHAVIOR; VALIDITY; TIME; HOPELESSNESS	Background: The Suicide Trigger Scale (STS) was designed to measure the construct of an affective 'suicide trigger state.' This study aims to extend the inpatient setting validation study of the original Suicide Trigger Scale version 2 to the revised Suicide Trigger Scale version 3 (STS-3) in an acute psychiatric emergency room setting. Methods: The 42-item STS-3 and a brief psychological test battery were administered to 183 adult psychiatric patients with suicidal ideation or attempt in the psychiatric emergency room, and re-administered to subjects at 1 year follow up. Factor analysis, linear and logistic regressions were used to examine construct structure, divergent and convergent validity, and construct validity, respectively. Results: The STS-3 demonstrated strong internal consistency (Cronbach's alpha 0.94). Factor analysis yielded a three-factor solution, which explained 43.4% of the variance. Principal axis factor analysis was used to identify three reliable subscales: Frantic Hopelessness, Ruminative Flooding, and Near-Psychotic Somatization (Cronbach's alphas 0.90, 0.80, and 0.76, respectively). Significant positive associations were observed between Frantic Hopelessness and BSI depression and anxiety subscales, between Ruminative Flooding and BSI anxiety and paranoia subscales, and Near Psychotic Somatization and BSI somatization subscales. Suicidal subjects with suicide attempt history had mean scores 7 points higher than those without history of suicide attempts. Frantic hopelessness was a significant predictor of current suicide attempt when only attempts requiring at least some medical attention were considered. Conclusion: The STS-3 measures a distinct clinical entity, provisionally termed the 'suicide trigger state.' Scores on the STS-3 or select subscales appear to relate to degree of suicidality in terms of severity of ideation, history of attempt, and presence of substantive current attempts. Further study is required to confirm the factor structure and better understand the nature of these relations.	[Yaseen, Zimri S.; Gilmer, Evan; Modi, Janki] Beth Israel Deaconess Med Ctr, Dept Psychiat & Behav Sci, New York, NY 10003 USA; [Cohen, Lisa J.; Galynker, Igor I.] Beth Israel Deaconess Med Ctr, Albert Einstein Sch Med, Dept Psychiat & Behav Sci, New York, NY 10003 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Yeshiva University	Yaseen, ZS (corresponding author), Beth Israel Deaconess Med Ctr, Dept Psychiat & Behav Sci, New York, NY 10003 USA.	zsyaseen@gmail.com	Gilmer, Evan/B-3828-2014; Galynker, Igor/AAC-9629-2021	Gilmer, Evan/0000-0001-6795-2936; Yaseen, Zimri/0000-0003-4103-2511	American Foundation for Suicide Prevention (AFSP) [1-SRG-xxxx-00139]	American Foundation for Suicide Prevention (AFSP)	This study was funded in part by grant 1-SRG-xxxx-00139 awarded by the American Foundation for Suicide Prevention (AFSP) to Dr. Igor I. Galynker. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atlanta G, 2008, WISQARS FAT INJ MORT; BECK AT, 1979, J CONSULT CLIN PSYCH, V47, P343, DOI 10.1037/0022-006X.47.2.343; Ben-Ya'acov Y, 2004, PERS INDIV DIFFER, V36, P1257, DOI 10.1016/S0191-8869(03)00003-5; Bolton JM, 2008, DEPRESS ANXIETY, V25, P477, DOI 10.1002/da.20314; Brown GK, 2000, J CONSULT CLIN PSYCH, V68, P371, DOI 10.1037/0022-006X.68.3.371; Busch KA, 2003, J CLIN PSYCHIAT, V64, P14, DOI 10.4088/JCP.v64n0105; Chandler M. J., 1989, DEV PSYCHOPATHOL, V1, P257, DOI [10.1017/S0954579400000444, DOI 10.1017/S0954579400000444]; Chandler Michael, 1994, V64, P55; Chartrand H, 2012, DEPRESS ANXIETY, V29, P172, DOI 10.1002/da.20882; Chioqueta Andrea P, 2004, Crisis, V25, P3, DOI 10.1027/0227-5910.25.1.3; Clark LA, 1995, PSYCHOL ASSESSMENT, V7, P309, DOI 10.1037/1040-3590.7.3.309; Coleman D, 2007, CRISIS, V28, P198, DOI 10.1027/0227-5910.28.4.198; Corruble E, 2000, PSYCHOPATHOLOGY, V33, P307, DOI 10.1159/000029163; Cougle JR, 2009, J PSYCHIATR RES, V43, P825, DOI 10.1016/j.jpsychires.2008.12.004; Deisenhammer EA, 2009, J CLIN PSYCHIAT, V70, P19, DOI 10.4088/JCP.07m03904; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Diefenbach GJ, 2009, J NERV MENT DIS, V197, P92, DOI 10.1097/NMD.0b013e318196127c; Engin E, 2009, J PSYCHIATR MENT HLT, V16, P343, DOI 10.1111/j.1365-2850.2008.01377.x; FAWCETT J, 1990, AM J PSYCHIAT, V147, P1189; Fawcett J, 2006, TXB SUICIDE ASSESSME, P1; Floyd FJ, 1995, PSYCHOL ASSESSMENT, V7, P286, DOI 10.1037/1040-3590.7.3.286; Galynker I, 1996, J CLIN PSYCHIAT, V57, P402; GarciaCampayo J, 1997, MED CLIN-BARCELONA, V108, P321; Goodwin RD, 2001, PSYCHOPATHOLOGY, V34, P278, DOI 10.1159/000049326; Haaland VO, 2009, ACTA PSYCHIAT SCAND, V119, P383, DOI 10.1111/j.1600-0447.2008.01323.x; Hall RCW, 1999, PSYCHOSOMATICS, V40, P18, DOI 10.1016/S0033-3182(99)71267-3; Hendin H, 2004, SUICIDE LIFE-THREAT, V34, P386, DOI 10.1521/suli.34.4.386.53734; Hendin H, 2001, SUICIDE LIFE-THREAT, V31, P115, DOI 10.1521/suli.31.2.115.21515; Hendin H, 2007, J NERV MENT DIS, V195, P363, DOI 10.1097/NMD.0b013e318052264d; Hendin H, 2010, J NERV MENT DIS, V198, P220, DOI 10.1097/NMD.0b013e3181d13d14; Horesh N, 2004, J NERV MENT DIS, V192, P837, DOI 10.1097/01.nmd.0000146738.78222.e5; Ilgen MA, 2008, GEN HOSP PSYCHIAT, V30, P521, DOI 10.1016/j.genhosppsych.2008.09.003; JUHNKE GA, 1994, MEAS EVAL COUNS DEV, V27, P325; Katz C, 2011, J CLIN PSYCHIAT, V72, P1628, DOI 10.4088/JCP.10m06186blu; KAZDIN AE, 1983, J CONSULT CLIN PSYCH, V51, P504, DOI 10.1037/0022-006X.51.4.504; Kemper CJ, 2012, ASSESSMENT, V19, P89, DOI 10.1177/1073191111429389; Mann JJ, 1999, AM J PSYCHIAT, V156, P181; Motto J A, 1990, Crisis, V11, P52; Nimeus A, 2000, EUR PSYCHIAT, V15, P416, DOI 10.1016/S0924-9338(00)00512-5; Nock MK, 2002, J CLIN CHILD ADOLESC, V31, P48, DOI 10.1207/153744202753441666; Oquendo MA, 2006, ACTA PSYCHIAT SCAND, V114, P151, DOI 10.1111/j.1600-0447.2006.00829.x; Parisi P, 2009, NEUROLOGY, V73, P1713, DOI 10.1212/WNL.0b013e3181bd6af3; PATTERSON WM, 1983, PSYCHOSOMATICS, V24, P343, DOI 10.1016/S0033-3182(83)73213-5; Pompili M, 2009, J HEADACHE PAIN, V10, P283, DOI 10.1007/s10194-009-0134-2; Posner K, 2007, AM J PSYCHIAT, V164, P1035, DOI 10.1176/appi.ajp.164.7.1035; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; RIFAI AH, 1994, AM J PSYCHIAT, V151, P1687; ROST KM, 1992, GEN HOSP PSYCHIAT, V14, P322, DOI 10.1016/0163-8343(92)90066-J; Takahashi Y, 1995, Int Psychogeriatr, V7, P239, DOI 10.1017/S1041610295002006; Wang SJ, 2007, NEUROLOGY, V68, P1468, DOI 10.1212/01.wnl.0000260607.90634.d6; Wang SJ, 2009, NEUROLOGY, V72, P1146, DOI 10.1212/01.wnl.0000345362.91734.b3; WEISSMAN MM, 1989, NEW ENGL J MED, V321, P1209, DOI 10.1056/NEJM198911023211801; Woolley SB, 2008, J NERV MENT DIS, V196, P822, DOI 10.1097/NMD.0b013e31818b4e4f; Yaseen Z, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-110; Yaseen ZS, 2012, PLOS ONE IN PRESS; Zoroglu SS, 2003, PSYCHIAT CLIN NEUROS, V57, P119, DOI 10.1046/j.1440-1819.2003.01088.x	56	51	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45157	10.1371/journal.pone.0045157	http://dx.doi.org/10.1371/journal.pone.0045157			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	007AD	23024805	Green Published, Green Submitted, gold			2022-12-27	WOS:000308860100063
J	Qu, YY; Shi, SN; Zhou, H; Ma, Q; Li, XL; Zhang, XW; Zhou, JT				Qu, Yuanyuan; Shi, Shengnan; Zhou, Hao; Ma, Qiao; Li, Xinliang; Zhang, Xuwang; Zhou, Jiti			Characterization of a Novel Phenol Hydroxylase in Indoles Biotranformation from a Strain Arthrobacter sp W1	PLOS ONE			English	Article							BACTERIAL MULTICOMPONENT MONOOXYGENASES; PSEUDOMONAS-STUTZERI OX1; SOLVENT 2-PHASE SYSTEM; ESCHERICHIA-COLI; INDIGO FORMATION; SUBSTRATE-SPECIFICITY; CYTOCHROME-P450 2A6; OXIDATION; GENE; SITE	Background: Indigoids, as popular dyes, can be produced by microbial strains or enzymes catalysis. However, the new valuable products with their transformation mechanisms, especially inter-conversion among the intermediates and products have not been clearly identified yet. Therefore, it is necessary to investigate novel microbial catalytic processes for indigoids production systematically. Findings: A phenol hydroxylase gene cluster (4,606 bp) from Arthrobacter sp. W1 (PHw1) was obtained. This cluster contains six components in the order of KLMNOP, which exhibit relatively low sequence identities (37-72%) with known genes. It was suggested that indole and all the tested indole derivatives except for 3-methylindole were transformed to various substituted indigoid pigments, and the predominant color products derived from indoles were identified by spectrum analysis. One new purple product from indole, 2-(7-oxo-1H-indol-6(7H)-ylidene) indolin-3-one, should be proposed as the dimerization of isatin and 7-hydroxylindole at the C-2 and C-6 positions. Tunnel entrance and docking studies were used to predict the important amino acids for indoles biotransformation, which were further proved by site-directed mutagenesis. Conclusions/Significance: We showed that the phenol hydroxylase from genus Arthrobacter could transform indoles to indigoids with new chemical compounds being produced. Our work should show high insights into understanding the mechanism of indigoids bio-production.	[Qu, Yuanyuan; Zhou, Hao; Ma, Qiao; Li, Xinliang; Zhang, Xuwang; Zhou, Jiti] Dalian Univ Technol, Minist Educ, Sch Environm Sci & Technol, Key Lab Ind Ecol & Environm Engn, Dalian, Peoples R China; [Shi, Shengnan] Harbin Inst Technol, State Key Lab Urban Water Resource & Environm, Harbin 150006, Peoples R China	Dalian University of Technology; Harbin Institute of Technology	Qu, YY (corresponding author), Dalian Univ Technol, Minist Educ, Sch Environm Sci & Technol, Key Lab Ind Ecol & Environm Engn, Dalian, Peoples R China.	qyy@dlut.edu.cn	Ma, Qiao/L-1317-2015; zhou, hao/K-2701-2015; Zhang, Xuwang/L-7097-2019; ma, qiao/AAK-2605-2021	zhou, hao/0000-0002-3901-6582; Ma, Qiao/0000-0003-0614-2192	National Natural Science Foundation of China [51078054, 14 21176040]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 51078054; No. 14 21176040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cafaro V, 2005, APPL ENVIRON MICROB, V71, P4736, DOI 10.1128/AEM.71.8.4736-4743.2005; Carredano E, 2000, J MOL BIOL, V296, P701, DOI 10.1006/jmbi.1999.3462; Choi HS, 2003, BIOCHEM BIOPH RES CO, V306, P930, DOI 10.1016/S0006-291X(03)01087-8; Doukyu N, 2003, APPL MICROBIOL BIOT, V60, P720, DOI 10.1007/s00253-002-1187-1; Doukyu N, 2002, APPL MICROBIOL BIOT, V58, P543, DOI 10.1007/s00253-001-0919-y; Doukyu N, 1998, BIOSCI BIOTECH BIOCH, V62, P1075, DOI 10.1271/bbb.62.1075; Drewlo S, 2001, APPL ENVIRON MICROB, V67, P1964, DOI 10.1128/AEM.67.4.1964-1969.2001; ENSLEY BD, 1983, SCIENCE, V222, P167, DOI 10.1126/science.6353574; Gillam EMJ, 2000, BIOCHEMISTRY-US, V39, P13817, DOI 10.1021/bi001229u; Gillam EMJ, 1999, BIOCHEM BIOPH RES CO, V265, P469, DOI 10.1006/bbrc.1999.1702; Guengerich FP, 2004, J MED CHEM, V47, P3236, DOI 10.1021/jm030561b; HART S, 1992, J GEN MICROBIOL, V138, P211, DOI 10.1099/00221287-138-1-211; Hoessel R, 1999, NAT CELL BIOL, V1, P60, DOI 10.1038/9035; Huxtable R J, 2001, Mol Interv, V1, P141; Kim D, 2005, J BIOL CHEM, V280, P40319, DOI 10.1074/jbc.M508171200; Kim JY, 2005, LETT APPL MICROBIOL, V41, P163, DOI 10.1111/j.1472-765X.2005.01734.x; Kim JY, 2003, LETT APPL MICROBIOL, V36, P343, DOI 10.1046/j.1472-765X.2003.01279.x; Leahy JG, 2003, FEMS MICROBIOL REV, V27, P449, DOI 10.1016/S0168-6445(03)00023-8; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; McClay K, 2005, APPL ENVIRON MICROB, V71, P5476, DOI 10.1128/AEM.71.9.5476-5483.2005; MERMOD N, 1986, BIO-TECHNOL, V4, P321, DOI 10.1038/nbt0486-321; Meyer A, 2002, J BIOL CHEM, V277, P34161, DOI 10.1074/jbc.M205621200; MURDOCK D, 1993, BIO-TECHNOL, V11, P381, DOI 10.1038/nbt0393-381; Murray LJ, 2007, ACCOUNTS CHEM RES, V40, P466, DOI 10.1021/ar600040e; NORDLUND I, 1990, J BACTERIOL, V172, P6826, DOI 10.1128/jb.172.12.6826-6833.1990; Notomista E, 2003, J MOL EVOL, V56, P435, DOI 10.1007/s00239-002-2414-1; O'Connor KE, 1998, BIOTECHNOL LETT, V20, P219, DOI 10.1023/A:1005361415496; OConnor KE, 1997, APPL ENVIRON MICROB, V63, P4287, DOI 10.1128/AEM.63.11.4287-4291.1997; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Powlowski J, 1997, J BIOL CHEM, V272, P945, DOI 10.1074/jbc.272.2.945; Powlowski Justin, 1994, Biodegradation, V5, P219, DOI 10.1007/BF00696461; Qu YY, 2011, APPL MICROBIOL BIOT, V89, P655, DOI 10.1007/s00253-010-2874-y; Qu YY, 2010, BIORESOURCE TECHNOL, V101, P4527, DOI 10.1016/j.biortech.2010.01.033; Rosic NN, 2009, APPL MICROBIOL BIOT, V82, P203, DOI 10.1007/s00253-008-1812-8; Rui LY, 2005, APPL MICROBIOL BIOT, V66, P422, DOI 10.1007/s00253-004-1698-z; Sazinsky MH, 2006, ACCOUNTS CHEM RES, V39, P558, DOI 10.1021/ar030204v; Sazinsky MH, 2006, BIOCHEMISTRY-US, V45, P15392, DOI 10.1021/bi0618969; Sazinsky MH, 2004, J BIOL CHEM, V279, P30600, DOI 10.1074/jbc.M400710200; Smith J.A., 2000, CURRENT PROTOCOLS MO; Tang HZ, 2011, J BIOL CHEM, V286, P39179, DOI 10.1074/jbc.M111.283929; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang P, 2009, APPL BIOCHEM BIOTECH, V159, P623, DOI 10.1007/s12010-008-8494-7; Wu ZL, 2005, J BIOL CHEM, V280, P41090, DOI 10.1074/jbc.M508182200; Zhang ZG, 2009, J BIOTECHNOL, V139, P12, DOI 10.1016/j.jbiotec.2008.09.010	44	19	25	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44313	10.1371/journal.pone.0044313	http://dx.doi.org/10.1371/journal.pone.0044313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028517	Green Published, Green Submitted, gold			2022-12-27	WOS:000308788700019
J	Brucker, RM; Funkhouser, LJ; Setia, S; Pauly, R; Bordenstein, SR				Brucker, Robert M.; Funkhouser, Lisa J.; Setia, Shefali; Pauly, Rini; Bordenstein, Seth R.			Insect Innate Immunity Database (IIID): An Annotation Tool for Identifying Immune Genes in Insect Genomes	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE; SERINE-PROTEASE; DROSOPHILA; NASONIA; ACTIVATION; MELANIZATION; PATHWAYS; PREFERENCE; EVOLUTION; TOLL	The innate immune system is an ancient component of host defense. Since innate immunity pathways are well conserved throughout many eukaryotes, immune genes in model animals can be used to putatively identify homologous genes in newly sequenced genomes of non-model organisms. With the initiation of the "i5k" project, which aims to sequence 5,000 insect genomes by 2016, many novel insect genomes will soon become publicly available, yet few annotation resources are currently available for insects. Thus, we developed an online tool called the Insect Innate Immunity Database (IIID) to provide an open access resource for insect immunity and comparative biology research (http://www.vanderbilt.edu/IIID). The database provides users with simple exploratory tools to search the immune repertoires of five insect models (including Nasonia), spanning three orders, for specific immunity genes or genes within a particular immunity pathway. As a proof of principle, we used an initial database with only four insect models to annotate potential immune genes in the parasitoid wasp genus Nasonia. Results specify 306 putative immune genes in the genomes of N. vitripennis and its two sister species N. giraulti and N. longicornis. Of these genes, 146 were not found in previous annotations of Nasonia immunity genes. Combining these newly identified immune genes with those in previous annotations, Nasonia possess 489 putative immunity genes, the largest immune repertoire found in insects to date. While these computational predictions need to be complemented with functional studies, the IIID database can help initiate and augment annotations of the immune system in the plethora of insect genomes that will soon become available.	[Brucker, Robert M.; Funkhouser, Lisa J.; Setia, Shefali; Pauly, Rini; Bordenstein, Seth R.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Brucker, RM (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	s.bordenstein@vanderbilt.edu	Brucker, Robert/F-3052-2013	Brucker, Robert/0000-0002-0854-848X	NSF (National Science Foundation) [DEB 1046149]; Vanderbilt Discovery Grant; Direct For Biological Sciences [1046149] Funding Source: National Science Foundation	NSF (National Science Foundation)(National Science Foundation (NSF)); Vanderbilt Discovery Grant; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Support of this work was provided by NSF (National Science Foundation) award DEB 1046149 and a Vanderbilt Discovery Grant to SRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckage NE, 2008, INSECT IMMUNOLOTY; Blaul B, 2011, P ROY SOC B-BIOL SCI, V278, P3286, DOI 10.1098/rspb.2011.0001; Bordenstein SR, 2007, HEREDITY, V99, P278, DOI 10.1038/sj.hdy.6800994; Brucker RM, 2012, EVOLUTION, V66, P349, DOI 10.1111/j.1558-5646.2011.01454.x; Chafee ME, 2011, GENETICS, V187, P203, DOI 10.1534/genetics.110.120675; CHASAN R, 1989, CELL, V56, P391, DOI 10.1016/0092-8674(89)90242-0; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Clark ME, 2010, HEREDITY, V104, P289, DOI 10.1038/hdy.2009.152; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Desjardins CA, 2010, HEREDITY, V104, P270, DOI 10.1038/hdy.2009.145; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; KATSUMI Y, 1995, EUR J BIOCHEM, V228, P870, DOI 10.1111/j.1432-1033.1995.tb20334.x; Keller RG, 2010, INSECT MOL BIOL, V19, P109, DOI 10.1111/j.1365-2583.2009.00921.x; Lazzaro BP, 2009, PHILOS T R SOC B, V364, P15, DOI 10.1098/rstb.2008.0141; Leclerc V, 2006, EMBO REP, V7, P231, DOI 10.1038/sj.embor.7400592; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Loehlin DW, 2012, SCIENCE, V335, P943, DOI 10.1126/science.1215193; Loker ES, 2004, IMMUNOL REV, V198, P10, DOI 10.1111/j.0105-2896.2004.0117.x; Lynch JA, 2012, WIRES DEV BIOL, V1, P16, DOI 10.1002/wdev.3; Moussian B, 2005, CURR BIOL, V15, pR887, DOI 10.1016/j.cub.2005.10.026; Muhlia-Almazan A, 2008, J COMP PHYSIOL B, V178, P655, DOI 10.1007/s00360-008-0263-y; Niehuis O, 2011, HEREDITY, V107, P61, DOI 10.1038/hdy.2010.157; Obbard DJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000698; Parmakelis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008885; Robinson GE, 2011, SCIENCE, V331, P1386, DOI 10.1126/science.331.6023.1386; SCHNEIDER DS, 1994, DEVELOPMENT, V120, P1243; Tang HP, 2006, J BIOL CHEM, V281, P28097, DOI 10.1074/jbc.M601642200; Tian CH, 2010, J INSECT PHYSIOL, V56, P1857, DOI 10.1016/j.jinsphys.2010.08.004; Tian CH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-187; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Ye JL, 2010, TOXICON, V56, P101, DOI 10.1016/j.toxicon.2010.03.024; Zou Z, 2010, IMMUNITY, V32, P41, DOI 10.1016/j.immuni.2009.11.011	36	35	37	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45125	10.1371/journal.pone.0045125	http://dx.doi.org/10.1371/journal.pone.0045125			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984621	Green Published, gold			2022-12-27	WOS:000308738500119
J	El-Ferzli, GT; Dreher, M; Patel, RP; Ambalavanan, N				El-Ferzli, George T.; Dreher, Mackenzie; Patel, Rakesh P.; Ambalavanan, Namasivayam			ABO Blood Group Is Associated with Response to Inhaled Nitric Oxide in Neonates with Respiratory Failure	PLOS ONE			English	Article							PERSISTENT PULMONARY-HYPERTENSION; CONTROLLED-TRIAL; VENTILATION; SELECTIN; NEWBORN; INFANTS; RISK	Background: Inhaled nitric oxide (iNO) reduces death or need for extracorporeal membrane oxygenation (ECMO) in infants with persistent pulmonary hypertension of the newborn (PPHN). However, the response to iNO is variable and only 50-60% of infants demonstrate a response to iNO. It is not known why only some infants respond to iNO. Adults and children with blood groups B or AB do not respond as well to iNO as those with blood groups O/A. Methods/Principal Findings: To determine if blood group was associated with iNO response in newborn infants, a retrospective medical record review was done of infants admitted to a regional NICU from 2002-9 with a diagnosis of PPHN. Data were collected during the first twelve hours post-initiation of treatment. Of 86 infants diagnosed with PPHN, 23 infants had blood group A [18 received iNO], 21 had group B [18 with iNO], 40 had group O [36 with iNO], and 2 had group AB [both received iNO]. Change in PaO2/FiO(2) was less in infants with blood group A, of whom less than half were responders (Delta PaO2/FiO(2)>20%) at 12 h versus 90% of infants with either O or B. Race, sex, birth weight, gestational age, Apgar scores at 1 and 5 minutes, and baseline PaO2/FiO(2) were similar among groups. Outcomes including need for ECMO, death, length of ventilatory support, length of iNO use, and hospital stay were statistically not different by blood groups. Conclusions/Significance: Our results indicate that blood group influences iNO response in neonates. We hypothesize that either there is genetic linkage of the ABO gene locus with vasoregulatory genes, or that blood group antigens directly affect vascular reactivity.	[El-Ferzli, George T.; Dreher, Mackenzie; Ambalavanan, Namasivayam] Univ Alabama Birmingham, Dept Pediat, Ctr Free Radical Biol, Birmingham, AL USA; [El-Ferzli, George T.; Dreher, Mackenzie; Ambalavanan, Namasivayam] Univ Alabama Birmingham, Dept Pediat, Pulm Injury Repair Ctr, Birmingham, AL USA; [Patel, Rakesh P.] Univ Alabama Birmingham, Dept Pathol, Ctr Free Radical Biol, Birmingham, AL 35294 USA; [Patel, Rakesh P.] Univ Alabama Birmingham, Dept Pathol, Pulm Injury Repair Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	El-Ferzli, GT (corresponding author), Univ Alabama Birmingham, Dept Pediat, Ctr Free Radical Biol, Birmingham, AL USA.	ambal@uab.edu	Ambalavanan, Namasivayam/AAI-4088-2020; Ambalavanan, Namasivayam/AAL-3832-2020	Ambalavanan, Namasivayam/0000-0003-0731-9092; Patel, Rakesh/0000-0002-1526-4303	National Institutes of Health (NIH) [R01 HL092906]; IKARIA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092906] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IKARIA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded in part by National Institutes of Health (NIH) R01 HL092906 and Grant funding from IKARIA for trainee research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Barbalic M, 2010, HUM MOL GENET, V19, P1863, DOI 10.1093/hmg/ddq061; Cartron JP, 2001, TRANSFUS CLIN BIOL, V8, P163, DOI 10.1016/S1246-7820(01)00142-2; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Chung CM, 2010, PHARMACOGENOMICS J, V10, P537, DOI 10.1038/tpj.2009.70; Field D, 2005, PEDIATRICS, V115, P926, DOI 10.1542/peds.2004-1209; Finer NN, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000399.pub2; Kinsella JP, 1997, J PEDIATR-US, V131, P55, DOI 10.1016/S0022-3476(97)70124-0; McFadzean J, 1999, LANCET, V353, P1414, DOI 10.1016/S0140-6736(99)00705-9; Pare G, 2008, PLOS GENET, V4; Qi L, 2010, HUM MOL GENET, V19, P1856, DOI 10.1093/hmg/ddq057; Roberts JD, 1997, NEW ENGL J MED, V336, P605, DOI 10.1056/NEJM199702273360902; Wang YF, 2011, CHINESE MED J-PEKING, V124, P1156, DOI 10.3760/cma.j.issn.0366-6999.2011.08.006; Weimann J, 1998, LANCET, V351, P1786, DOI 10.1016/S0140-6736(05)78748-1; Wiggins KL, 2009, J THROMB HAEMOST, V7, P263, DOI 10.1111/j.1538-7836.2008.03243.x; Wu O, 2008, J THROMB HAEMOST, V6, P62; 1997, N ENGL J MED, V336, P597	16	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45164	10.1371/journal.pone.0045164	http://dx.doi.org/10.1371/journal.pone.0045164			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984626	Green Published, Green Submitted, gold			2022-12-27	WOS:000308738500124
J	Larson, CM; Pillsworth, EG; Haselton, MG				Larson, Christina M.; Pillsworth, Elizabeth G.; Haselton, Martie G.			Ovulatory Shifts in Women's Attractions to Primary Partners and Other Men: Further Evidence of the Importance of Primary Partner Sexual Attractiveness	PLOS ONE			English	Article							MENSTRUAL-CYCLE; PHYSICAL ATTRACTIVENESS; MATE PREFERENCES; MASCULINITY; INTERESTS; SYMMETRY; SCENT; INTERCOURSE; CONCEPTION; RETENTION	Previous research has documented shifts in women's attractions to their romantic partner and to men other than their partner across the ovulation cycle, contingent on the degree to which her partner displays hypothesized indicators of high-fitness genes. The current study set out to replicate and extend this finding. Forty-one couples in which the woman was naturally cycling participated. Female partners reported their feelings of in-pair attraction and extra-pair attraction on two occasions, once on a low-fertility day of the cycle and once on a high-fertility day of the cycle just prior to ovulation. Ovulation was confirmed using luteinizing hormone tests. We collected two measures of male partner sexual attractiveness. First, the women in the study rated their partner's sexual attractiveness. Second, we photographed the partners and had the photos independently rated for attractiveness. Shifts in women's in-pair attractions across the cycle were significantly moderated by women's ratings of partner sexual attractiveness, such that the less sexually attractive women rated their partner, the less in-pair attraction they reported at high fertility compared with low fertility (partial r = .37, p(dir) = .01). Shifts in women's extra-pair attractions across the cycle were significantly moderated by third-party ratings of partner attractiveness, such that the less attractive the partner was, the more extra-pair attraction women reported at high relative to low fertility (partial r = -.33, p(dir) = .03). In line with previous findings, we found support for the hypothesis that the degree to which a woman's romantic partner displays indicators of high-fitness genes affects women's attractions to their own partner and other men at high fertility.	[Larson, Christina M.; Haselton, Martie G.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Pillsworth, Elizabeth G.] Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90024 USA; [Haselton, Martie G.] Univ Calif Los Angeles, Dept Commun Studies, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Larson, CM (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA.	cmlarson1@ucla.edu	Pillsworth, Elizabeth G/C-3327-2011		National Science Foundation; University of California Los Angeles Council on Research Faculty Grants Program	National Science Foundation(National Science Foundation (NSF)); University of California Los Angeles Council on Research Faculty Grants Program	This research was supported by funding for Christina Larson from the National Science Foundation-funded University of California Los Angeles Interdisciplinary Relationship Science Program http://www.irsp.ucla.edu/, and was funded by grants from the University of California Los Angeles Council on Research Faculty Grants Program awarded to Martie Haselton http://www.senate.ucla.edu/committees/cor/fgp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARON A, 1992, J PERS SOC PSYCHOL, V63, P596, DOI 10.1037/0022-3514.63.4.596; Barber N, 1995, ETHOL SOCIOBIOL, V16, P395, DOI 10.1016/0162-3095(95)00068-2; DeBruine L, 2010, EVOL PSYCHOL-US, V8, P768; Dixson BJ, 2010, ARCH SEX BEHAV, V39, P798, DOI 10.1007/s10508-008-9441-y; Feinberg DR, 2006, HORM BEHAV, V49, P215, DOI 10.1016/j.yhbeh.2005.07.004; Frederick DA, 2007, PERS SOC PSYCHOL B, V33, P1167, DOI 10.1177/0146167207303022; Gangestad SW, 2008, P ROY SOC B-BIOL SCI, V275, P991, DOI 10.1098/rspb.2007.1425; Gangestad SW, 2007, J PERS SOC PSYCHOL, V92, P151, DOI 10.1037/0022-3514.92.1.151; Gangestad SW, 2010, EVOL HUM BEHAV, V31, P412, DOI 10.1016/j.evolhumbehav.2010.06.001; Gangestad SW, 1998, P ROY SOC B-BIOL SCI, V265, P927, DOI 10.1098/rspb.1998.0380; Gangestad SW, 2005, ANNU REV ANTHROPOL, V34, P523, DOI 10.1146/annurev.anthro.33.070203.143733; Gangestad SW, 2005, P ROY SOC B-BIOL SCI, V272, P2023, DOI 10.1098/rspb.2005.3112; Gangestad SW, 2002, P ROY SOC B-BIOL SCI, V269, P975, DOI 10.1098/rspb.2001.1952; Gangestad SW, 2000, BEHAV BRAIN SCI, V23, P573, DOI 10.1017/S0140525X0000337X; Gangestad SW, 2004, PSYCHOL SCI, V15, P203, DOI 10.1111/j.0956-7976.2004.01503010.x; Garver-Apgar CE, 2006, PSYCHOL SCI, V17, P830, DOI 10.1111/j.1467-9280.2006.01789.x; Guermandi E, 2001, OBSTET GYNECOL, V97, P92, DOI 10.1016/S0029-7844(00)01083-8; Haselton MG, 2006, HORM BEHAV, V49, P509, DOI 10.1016/j.yhbeh.2005.10.006; Havlicek J, 2009, PSYCHONEUROENDOCRINO, V34, P497, DOI 10.1016/j.psyneuen.2008.10.007; Lancaster JB, 2010, HUM BEH EV SOC 22 AN; Larson CM, I LOVE YOU IN PRESS; Little AC, 2007, HORM BEHAV, V51, P633, DOI 10.1016/j.yhbeh.2007.03.006; Lukaszewski AW, 2009, PERS INDIV DIFFER, V47, P191, DOI 10.1016/j.paid.2009.02.019; Pawlowski B, 2005, BIOL PSYCHOL, V70, P38, DOI 10.1016/j.biopsycho.2005.02.002; Penn DJ, 2002, P NATL ACAD SCI USA, V99, P11260, DOI 10.1073/pnas.162006499; Pillsworth E. G., 2006, ANN REV SEX RES, V17, P59, DOI DOI 10.1080/10532528.2006.10559837; Pillsworth EG, 2006, EVOL HUM BEHAV, V27, P247, DOI 10.1016/j.evolhumbehav.2005.10.002; Puts DA, 2005, EVOL HUM BEHAV, V26, P388, DOI 10.1016/j.evolhumbehav.2005.03.001; RICE WR, 1994, TRENDS ECOL EVOL, V9, P235, DOI 10.1016/0169-5347(94)90258-5; Rikowski A, 1999, P ROY SOC B-BIOL SCI, V266, P869, DOI 10.1098/rspb.1999.0717; Roney JR, 2011, PSYCHONEUROENDOCRINO, V36, P742, DOI 10.1016/j.psyneuen.2010.10.010; Rusbult CE, 1998, PERS RELATIONSHIP, V5, P357, DOI 10.1111/j.1475-6811.1998.tb00177.x; SIMPSON JA, 1991, J PERS SOC PSYCHOL, V60, P870, DOI 10.1037/0022-3514.60.6.870; Thornhill R, 1999, EVOL HUM BEHAV, V20, P175, DOI 10.1016/S1090-5138(99)00005-7; Thornhill R, 2003, BEHAV ECOL, V14, P668, DOI 10.1093/beheco/arg043; Thornhill R., 2008, EVOLUTIONARY BIOL HU; WILCOX AJ, 1995, NEW ENGL J MED, V333, P1517, DOI 10.1056/NEJM199512073332301; Wilcox AJ, 2001, CONTRACEPTION, V63, P211, DOI 10.1016/S0010-7824(01)00191-3	38	44	44	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44456	10.1371/journal.pone.0044456	http://dx.doi.org/10.1371/journal.pone.0044456			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005GJ	22984512	Green Published, Green Submitted, gold			2022-12-27	WOS:000308738500059
J	Hawkley, LC; Gu, YY; Luo, YJ; Cacioppo, JT				Hawkley, Louise C.; Gu, Yuanyuan; Luo, Yue-Jia; Cacioppo, John T.			The Mental Representation of Social Connections: Generalizability Extended to Beijing Adults	PLOS ONE			English	Article							UCLA LONELINESS SCALE; LIFE SATISFACTION; RISK-FACTORS; OLD-AGE; CHINESE; SELF; INDIVIDUALISM; PREFERENCES; DEPRESSION; VALIDITY	Social connections are essential for the survival of a social species like humans. People differ in the degree to which they are sensitive to perceived deficits in their social connections, but evidence suggests that they nevertheless construe the nature of their social connections similarly. This construal can be thought of as a mental representation of a multi-faceted social experience. A three-dimensional mental representation has been identified with the UCLA Loneliness Scale and consists of Intimate, Relational, and Collective Connectedness reflecting beliefs about one's individual, dyadic, and collective (group) social value, respectively. Moreover, this mental representation has been replicated with other scales and validated across age, gender, and racial/ethnic lines in U.S. samples. The purpose of this study is to evaluate the extent to which this three-dimensional representation applies to people whose social lives are experienced in a collectivistic rather than individualistic culture. To that end, we used confirmatory factor analyses to assess the fit of the three-dimensional mental structure to data collected from Chinese people living in China. Two hundred sixty-seven young adults (16-25 yrs) and 250 older adults (5065 yrs) in Beijing completed the revised UCLA Loneliness Scale and demographic and social activity questionnaires. Results revealed adequate fit of the structure to data from young and older Chinese adults. Moreover, the structure exhibited equivalent fit in young and older Chinese adults despite changes in the Chinese culture that exposed these two generations to different cultural experiences. Social activity variables that discriminated among the three dimensions in the Chinese samples corresponded well with variables that discriminated among the three dimensions in the U. S.-based samples, indicating cultural commonalities in the factors predicting dimensions of people's representations of their social connections. Equivalence of the three-dimensional structure is relevant for an understanding of cultural differences in the sources of loneliness and social connectedness.	[Hawkley, Louise C.; Cacioppo, John T.] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; [Hawkley, Louise C.; Cacioppo, John T.] Univ Chicago, Ctr Cognit & Social Neurosci, Chicago, IL 60637 USA; [Gu, Yuanyuan; Luo, Yue-Jia] Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	University of Chicago; University of Chicago; Beijing Normal University	Hawkley, LC (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA.	hawkley@uchicago.edu			National Institute on Aging [R01-AG036433-01, R01-AG034052]; John Templeton Foundation; National Key Technologies R D Program [2009BAI77B01]; National Natural Science Foundation of China [30930031]; NATIONAL INSTITUTE ON AGING [R01AG034052, R01AG036433] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); John Templeton Foundation; National Key Technologies R D Program(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by Grant R01-AG036433-01 and R01-AG034052 from the National Institute on Aging, the John Templeton Foundation, the National Key Technologies R & D Program (2009BAI77B01), and the National Natural Science Foundation of China (30930031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 1999, PERS SOC PSYCHOL B, V25, P482, DOI 10.1177/0146167299025004007; Boomsma DI, 2005, BEHAV GENET, V35, P745, DOI 10.1007/s10519-005-6040-8; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Cacioppo JT, 2006, J RES PERS, V40, P1054, DOI 10.1016/j.jrp.2005.11.007; Cacioppo JT., 2008, LONELINESS HUMAN NAT; Cacioppo JT, 2012, HDB SOCIAL IN PRESS; Carstensen LL, 1999, AM PSYCHOL, V54, P165, DOI 10.1037/0003-066X.54.3.165; Chou KL, 2004, INT J GERIATR PSYCH, V19, P449, DOI 10.1002/gps.1111; Cohen, 2007, HDB CULTURAL PSYCHOL, P307; DiTommaso E, 2005, SOC BEHAV PERSONAL, V33, P57, DOI 10.2224/sbp.2005.33.1.57; Egri CP, 2004, ORGAN SCI, V15, P210, DOI 10.1287/orsc.1030.0048; FREDRICKSON BL, 1990, PSYCHOL AGING, V5, P335, DOI 10.1037/0882-7974.5.3.335; Fung HH, 1999, PSYCHOL AGING, V14, P595, DOI 10.1037/0882-7974.14.4.595; Fung HH, 2001, PSYCHOL AGING, V16, P351, DOI 10.1037//0882-7974.16.2.351; Hansen M.H., 2008, EUROPEAN J E ASIAN S, V7, P75, DOI [10.1163/156805808X333929, DOI 10.1163/156805808X333929]; Hawkley LC, 2005, PSYCHOL SCI, V16, P798, DOI 10.1111/j.1467-9280.2005.01617.x; Hawkley LC, 2006, PSYCHOL AGING, V21, P152, DOI 10.1037/0882-7974.21.1.152; Hawkley LC, 2008, J GERONTOL B-PSYCHOL, V63, pS375, DOI 10.1093/geronb/63.6.S375; Hoitgraves TM, 2008, PERS SOC PSYCHOL REV, V12, P73, DOI 10.1177/1088868307309605; JOUBERT CE, 1990, PSYCHOL REP, V66, P1177, DOI 10.2466/PR0.66.4.1177-1178; Lai JS, 2006, QUAL LIFE RES, V15, P1179, DOI 10.1007/s11136-006-0060-6; LEARY MR, 1995, J PERS SOC PSYCHOL, V68, P518, DOI 10.1037/0022-3514.68.3.518; Liu J., 2006, LINGUISTICS J, V1, P127; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; MYERS DG, 1995, PSYCHOL SCI, V6, P10, DOI 10.1111/j.1467-9280.1995.tb00298.x; Ng KM, 2009, SEX ROLES, V60, P33, DOI 10.1007/s11199-008-9503-6; Oyserman D, 2002, PSYCHOL BULL, V128, P3, DOI 10.1037/0033-2909.128.1.3; Oyserman D, 2008, PSYCHOL BULL, V134, P311, DOI 10.1037/0033-2909.134.2.311; Peplau L. A., 1982, LONELINESS SOURCEBOO, P1; Pinquart M, 2003, ADV PSY RES, V19, P111; RUSSELL D, 1980, J PERS SOC PSYCHOL, V39, P472, DOI 10.1037/0022-3514.39.3.472; Russell DW, 1996, J PERS ASSESS, V66, P20, DOI 10.1207/s15327752jpa6601_2; Shaver Phillip, 1985, UNDERSTANDING PERSON, P193; Steiger JH, 2002, PSYCHOL METHODS, V7, P210, DOI 10.1037/1082-989X.7.2.210; van Staden W, 2010, CURR OPIN PSYCHIATR, V23, P524, DOI 10.1097/YCO.0b013e32833f2ff9; Wang KT, 2009, COUNS PSYCHOL, V37, P249, DOI 10.1177/0011000008315975; Wang Q, 1998, COGNITION, V69, P73, DOI 10.1016/S0010-0277(98)00061-4; Wen M, 2009, INT J COMP SOCIOL, V50, P155, DOI 10.1177/0020715208101597; Yang KM, 2008, AGEING SOC, V28, P305, DOI 10.1017/S0144686X07006848; Zhu Y, 2007, NEUROIMAGE, V34, P1310, DOI 10.1016/j.neuroimage.2006.08.047	40	27	27	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44065	10.1371/journal.pone.0044065	http://dx.doi.org/10.1371/journal.pone.0044065			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	003VE	23028486	Green Published, Green Submitted, gold			2022-12-27	WOS:000308638700041
J	Shi, WQ; Wang, GA; Han, WX				Shi, Weiqi; Wang, Guoan; Han, Wenxuan			Altitudinal Variation in Leaf Nitrogen Concentration on the Eastern Slope of Mount Gongga on the Tibetan Plateau, China	PLOS ONE			English	Article							PHYSIOLOGICAL-RESPONSES; STOICHIOMETRY; WORLDWIDE; POPULATIONS; GRADIENTS; PATTERNS; CARBON; PLANTS; SOIL	Mount Gongga spans 6500 m in elevation and has intact and continuous vertical vegetation belts, ranging from subtropical evergreen broad-leaved vegetation to an alpine frigid sparse grass and desert zone. Investigating the altitudinal trends in leaf nitrogen (N) on Mount Gongga can increase our understanding of the global biogeography of foliar N. In this study, 460 leaf samples from mosses, ferns, and seed plants were collected along an altitudinal gradient on the eastern slope of Mount Gongga, and the variation in leaf N concentration (mass basis) with elevation was analyzed. There are considerable differences in leaf N between mosses and ferns, mosses and seed plants, C-4 and C-3 plants, and evergreen and deciduous woody plants. The general altitudial pattern of leaf N in Mount Gongga plants was that leaf N kept increasing until an elevation of about 2200 m above sea level, with a corresponding mean annual temperature (MAT) of 8.5 degrees C, and then decreased with increasing elevation. However, the evergreen woody plants displayed a decline trend in leaf N across the altitude gradient. Our findings provide an insight into the altitudinal variation in leaf N.	[Wang, Guoan] China Agr Univ, Coll Resources & Environm Sci, Dept Environm Sci & Engn, Beijing 100094, Peoples R China; [Shi, Weiqi] Chinese Acad Trop Agr Sci, S Subtrop Crops Res Inst, Zhanjiang, Guangdong, Peoples R China; [Han, Wenxuan] China Agr Univ, Coll Resources & Environm Sci, Dept Ecol & Ecol Engn, Beijing 100094, Peoples R China	China Agricultural University; Chinese Academy of Tropical Agricultural Sciences; China Agricultural University	Wang, GA (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Dept Environm Sci & Engn, Beijing 100094, Peoples R China.	gawang@cau.edu.cn; hanwenxuan@cau.edu.cn	Han, Wenxuan/B-8791-2016	Han, Wenxuan/0000-0001-8678-7147	National Natural Science Foundation of China [40973006, 41173083]; Fundamental Research Funds of the National Non profit Research Institute for South Subtropical Crops Research Institute, Chinese Academy of Tropical Agricultural Sciences [SSCRI200912, 1251022011001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds of the National Non profit Research Institute for South Subtropical Crops Research Institute, Chinese Academy of Tropical Agricultural Sciences	This research was supported by grants from the National Natural Science Foundation of China (No. 40973006, 41173083) and supported by the Fundamental Research Funds of the National Non profit Research Institute for South Subtropical Crops Research Institute, Chinese Academy of Tropical Agricultural Sciences (SSCRI200912, 1251022011001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowman WD, 1999, ARCT ANTARCT ALP RES, V31, P191, DOI 10.2307/1552608; Bresson CC, 2011, TREE PHYSIOL, V31, P1164, DOI 10.1093/treephys/tpr084; Chen FB, 1993, RES ALPINE ECOLOGY E; Chen Y, 2011, EUR J NEUROL, V18, P1246, DOI 10.1111/j.1468-1331.2011.03367.x; FRIEND AD, 1989, FUNCT ECOL, V3, P117, DOI 10.2307/2389682; Han WX, 2011, ECOL LETT, V14, P788, DOI 10.1111/j.1461-0248.2011.01641.x; Han WX, 2012, GLOBAL ECOL BIOGEOGR, V21, P376, DOI 10.1111/j.1466-8238.2011.00677.x; Han WX, 2005, NEW PHYTOL, V168, P377, DOI 10.1111/j.1469-8137.2005.01530.x; He JS, 2006, OECOLOGIA, V149, P115, DOI 10.1007/s00442-006-0425-0; Hou X., 1982, CHINESE VEGETABLE GE; Hultine KR, 2000, OECOLOGIA, V123, P32, DOI 10.1007/s004420050986; KORNER C, 1989, OECOLOGIA, V81, P379, DOI 10.1007/BF00377088; Li CY, 2007, TREE PHYSIOL, V27, P399, DOI 10.1093/treephys/27.3.399; Li CY, 2006, SILVA FENN, V40, P5, DOI 10.14214/sf.348; Luo JX, 2006, FOREST ECOL MANAG, V221, P285, DOI 10.1016/j.foreco.2005.10.004; McGroddy ME, 2004, ECOLOGY, V85, P2390, DOI 10.1890/03-0351; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Zhong XH, 1997, RES FOREST MOUNT GON	19	16	24	5	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44628	10.1371/journal.pone.0044628	http://dx.doi.org/10.1371/journal.pone.0044628			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028570	gold, Green Published, Green Submitted			2022-12-27	WOS:000311313900031
J	Karmperis, AC; Aravossis, K; Tatsiopoulos, IP; Sotirchos, A				Karmperis, Athanasios C.; Aravossis, Konstantinos; Tatsiopoulos, Ilias P.; Sotirchos, Anastasios			On the Fair Division of Multiple Stochastic Pies to Multiple Agents within the Nash Bargaining Solution	PLOS ONE			English	Article							PROFIT; RISK; COORDINATION; MANAGEMENT; COST; GAME; COOPERATION; ALLOCATION; CONTRACT	The fair division of a surplus is one of the most widely examined problems. This paper focuses on bargaining problems with fixed disagreement payoffs where risk-neutral agents have reached an agreement that is the Nash-bargaining solution (NBS). We consider a stochastic environment, in which the overall return consists of multiple pies with uncertain sizes and we examine how these pies can be allocated with fairness among agents. Specifically, fairness is based on the Aristotle's maxim: "equals should be treated equally and unequals unequally, in proportion to the relevant inequality". In this context, fairness is achieved when all the individual stochastic surplus shares which are allocated to agents are distributed in proportion to the NBS. We introduce a novel algorithm, which can be used to compute the ratio of each pie that should be allocated to each agent, in order to ensure fairness within a symmetric or asymmetric NBS.	[Karmperis, Athanasios C.; Aravossis, Konstantinos; Tatsiopoulos, Ilias P.; Sotirchos, Anastasios] Natl Tech Univ Athens, Sch Mech Engn, Sect Ind Management & Operat Res, Athens, Greece; [Karmperis, Athanasios C.] Minist Def, Army Corps Engn, Athens, Greece	National Technical University of Athens	Karmperis, AC (corresponding author), Natl Tech Univ Athens, Sch Mech Engn, Sect Ind Management & Operat Res, Athens, Greece.	athkarmp@mail.ntua.gr		Karmperis, Athanasios C./0000-0001-6696-3692				Aristotle, 1984, COMPLETE WORKS ARIST; Baek SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038529; Barbanel JB, 2004, MATH SOC SCI, V48, P251, DOI 10.1016/j.mathsocsci.2004.03.006; BINMORE K, 1989, Q J ECON, V104, P753, DOI 10.2307/2937866; Binmore K, 2001, P BRIT ACAD, P149; Bughin J, 1999, EUR ECON REV, V43, P549, DOI 10.1016/S0014-2921(98)00036-1; Carraro C, 2005, 3642 WORLD BANK, P20; CHUN YS, 1988, MATH SOC SCI, V15, P231, DOI 10.1016/0165-4896(88)90009-1; Csoka P, 2011, IMPOSSIBILITY FAIR R; Csoka P, 2009, GAME ECON BEHAV, V67, P266, DOI 10.1016/j.geb.2008.11.001; Ding HP, 2011, INT J PROD ECON, V133, P70, DOI 10.1016/j.ijpe.2010.06.015; Gillies D.B., 1959, CONTRIBUTIONS THEORY, V4, P47; Guardiola LA, 2007, DECIS SUPPORT SYST, V44, P17, DOI 10.1016/j.dss.2006.12.015; Harsanyi J.C., 1959, CONTRIBUTIONS THEORY, V40, P324; HARSANYI JC, 1963, INT ECON REV, V4, P194, DOI 10.2307/2525487; Helbing D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012530; Hennet JC, 2010, INT J PROD ECON, V127, P112, DOI 10.1016/j.ijpe.2010.04.047; Hoefer M, 2013, INT J GAME THEORY, V42, P29, DOI 10.1007/s00182-011-0312-8; KALAI E, 1985, ECONOMETRICA, V53, P307, DOI 10.2307/1911238; Kalai E., 1977, International Journal of Game Theory, V6, P129, DOI 10.1007/BF01774658; Karmperis A.C., 2012, INT J MATH MODELS ME, V6, P209; Karmperis AC, 2012, RECENT RES APPL MATH, P20; Karmperis AC, 2012, WASTE MANAGE, V32, P194, DOI 10.1016/j.wasman.2011.09.001; KEPAPTSOGLOU Konstantinos, 2010, [交通运输系统工程与信息, Journal of Transporation Systems Engineering & Information Technology], V10, P53, DOI 10.1016/S1570-6672(09)60063-5; Kunter M, 2012, EUR J OPER RES, V216, P477, DOI 10.1016/j.ejor.2011.07.001; Li SJ, 2009, INT J PROD ECON, V120, P88, DOI 10.1016/j.ijpe.2008.07.015; Linh CT, 2009, EUR J OPER RES, V198, P822, DOI 10.1016/j.ejor.2008.10.019; Lo Nigro G, 2011, INT J PROD ECON, V131, P234, DOI 10.1016/j.ijpe.2009.08.014; Madani K, 2011, ADV WATER RESOUR, V34, P174, DOI 10.1016/j.advwatres.2010.10.003; Mitropoulou CC, 2011, RELIAB ENG SYST SAFE, V96, P1311, DOI 10.1016/j.ress.2011.04.002; MOULIN H, 1987, INT J GAME THEORY, V16, P161, DOI 10.1007/BF01756289; Nash JF, 1950, ECONOMETRICA, V18, P155, DOI 10.2307/1907266; Rausser GC, 2000, POLITICAL EC WATER P, P52; Renna P, 2011, ROBOT CIM-INT MANUF, V27, P405, DOI 10.1016/j.rcim.2010.08.009; Roth AE, 1979, LECT NOTES EC MATH S, V170, P19; Saleh Y, 2011, EUR J OPER RES, V215, P244, DOI 10.1016/j.ejor.2011.05.048; SCHMEIDL.D, 1969, SIAM J APPL MATH, V17, P1163, DOI 10.1137/0117107; Shapley LS, 2016, 17 VALUE N PERSON GA, V17, P307, DOI [10.1515/9781400881970-018, DOI 10.1515/9781400881970-018]; Shi CV, 2010, EUR J OPER RES, V206, P86, DOI 10.1016/j.ejor.2010.01.047; Supatgiat C., 2001, Computational Economics, V17, P93, DOI 10.1023/A:1011274413023; TIJS SH, 1986, MANAGE SCI, V32, P1015, DOI 10.1287/mnsc.32.8.1015; Tziralis G, 2009, MANAG DECIS ECON, V30, P393, DOI 10.1002/mde.1458; van den Brink R, 2011, J ENVIRON ECON MANAG, V63, P388; von Neumann J., 1947, THEORY GAMES EC BEHA, V2; Wong KKL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010331; Wu DD, 2010, INT J PROD RES, V48, P4919, DOI 10.1080/00207540903051684; Young H. P., 1985, International Journal of Game Theory, V14, P65, DOI 10.1007/BF01769885	47	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44535	10.1371/journal.pone.0044535	http://dx.doi.org/10.1371/journal.pone.0044535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024752	Green Published, gold, Green Submitted			2022-12-27	WOS:000308860100010
J	Vijayakumar, A; Wu, YJ; Buffin, NJ; Li, XS; Sun, H; Gordon, RE; Yakar, S; LeRoith, D				Vijayakumar, Archana; Wu, YingJie; Buffin, Nicholas J.; Li, Xiaosong; Sun, Hui; Gordon, Ronald E.; Yakar, Shoshana; LeRoith, Derek			Skeletal Muscle Growth Hormone Receptor Signaling Regulates Basal, but Not Fasting-Induced, Lipid Oxidation	PLOS ONE			English	Article							FATTY-ACID OXIDATION; MITOCHONDRIAL TRANSCRIPTION FACTOR; GENE-EXPRESSION; METABOLIC-CONTROL; PPAR-DELTA; PGC-1-ALPHA; EXERCISE; ACTIVATION; ALPHA; DIET	Background: Growth hormone (GH) stimulates whole-body lipid oxidation, but its regulation of muscle lipid oxidation is not clearly defined. Mice with a skeletal muscle-specific knockout of the GH receptor (mGHRKO model) are protected from high fat diet (HFD)-induced insulin resistance and display increased whole-body carbohydrate utilization. In this study we used the mGRHKO mice to investigate the role of muscle GHR signaling on lipid oxidation under regular chow (RC)- and HFD-fed conditions, and in response to fasting. Methodology/Principal Findings: Expression of lipid oxidation genes was analyzed by real-time PCR in the muscles of RC-and HFD-fed mice, and after 24 h fasting in the HFD-fed mice. Expression of lipid oxidation genes was lower in the muscles of the mGHRKO mice relative to the controls, irrespective of diet. However, in response to 24 h fasting, the HFD-fed mGHRKO mice displayed up-regulation of lipid oxidation genes similar to the fasted controls. When subjected to treadmill running challenge, the HFD-fed mGHRKO mice demonstrated increased whole-body lipid utilization. Additionally, under fasted conditions, the adipose tissue of the mGHRKO mice displayed increased lipolysis as compared to both the fed mGHRKO as well as the fasted control mice. Conclusions/Significance: Our data show that muscle GHR signaling regulates basal lipid oxidation, but not the induction of lipid oxidation in response to fasting. We further demonstrate that muscle GHR signaling is involved in muscle-adipose tissue cross-talk; however the mechanisms mediating this remain to be elucidated.	[Vijayakumar, Archana; Wu, YingJie; Buffin, Nicholas J.; Sun, Hui; Yakar, Shoshana; LeRoith, Derek] Mt Sinai Sch Med, Dept Med, Div Endocrinol Diabet & Bone Dis, New York, NY 10029 USA; [Wu, YingJie; Sun, Hui; Yakar, Shoshana] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, David B Kriser Dent Ctr, New York, NY USA; [Li, Xiaosong] Albert Einstein Coll Med, Dept Med, New York, NY USA; [Li, Xiaosong] Albert Einstein Coll Med, Dept Neurosci, New York, NY USA; [Gordon, Ronald E.] Mt Sinai Sch Med, Dept Pathol, New York, NY USA	Icahn School of Medicine at Mount Sinai; New York University; Yeshiva University; Yeshiva University; Icahn School of Medicine at Mount Sinai	Vijayakumar, A (corresponding author), Mt Sinai Sch Med, Dept Med, Div Endocrinol Diabet & Bone Dis, New York, NY 10029 USA.	derek.leroith@mssm.edu			National Institutes of Health grant [DK-20541]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020541] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	X.L. is supported by the National Institutes of Health grant DK-20541. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Arany Z, 2008, CURR OPIN GENET DEV, V18, P426, DOI 10.1016/j.gde.2008.07.018; Berryman DE, 2004, GROWTH HORM IGF RES, V14, P309, DOI 10.1016/j.ghir.2004.02.005; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Geng TY, 2010, AM J PHYSIOL-CELL PH, V298, pC572, DOI 10.1152/ajpcell.00481.2009; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gesing A, 2011, J GERONTOL A-BIOL, V66, P1062, DOI 10.1093/gerona/glr080; Gonzalez AA, 2004, AM J PHYSIOL-ENDOC M, V287, pE1032, DOI 10.1152/ajpendo.00172.2004; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Helge JW, 2007, J PHYSIOL-LONDON, V581, P1247, DOI 10.1113/jphysiol.2007.128348; Hondares E, 2007, BIOCHEM BIOPH RES CO, V354, P1021, DOI 10.1016/j.bbrc.2007.01.092; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Johansen T, 2003, HORM METAB RES, V35, P243, DOI 10.1055/s-2003-39481; Kim H, 2006, AM J PHYSIOL-ENDOC M, V290, pE1227, DOI 10.1152/ajpendo.00344.2005; Kleiner S, 2009, J BIOL CHEM, V284, P18624, DOI 10.1074/jbc.M109.008797; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Leick L, 2008, AM J PHYSIOL-ENDOC M, V294, pE463, DOI 10.1152/ajpendo.00666.2007; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Luque RM, 2006, ENDOCRINOLOGY, V147, P2754, DOI 10.1210/en.2005-1549; Mauras N, 2000, J CLIN ENDOCR METAB, V85, P1686, DOI 10.1210/jc.85.4.1686; MELMED S, 1984, J CLIN INVEST, V73, P1425, DOI 10.1172/JCI111347; Nahle Z, 2008, J BIOL CHEM, V283, P14317, DOI 10.1074/jbc.M706478200; Palacios OM, 2009, AGING-US, V1, P771, DOI 10.18632/aging.100075; Pasarica M, 2007, J CLIN ENDOCR METAB, V92, P4265, DOI 10.1210/jc.2007-0786; Peyreigne C, 2002, HORM RES, V58, P287, DOI 10.1159/000066448; RANDLE PJ, 1963, LANCET, V1, P785; Richelsen B, 2000, METABOLISM, V49, P906, DOI 10.1053/meta.2000.6738; ROMIJN JA, 1993, AM J PHYSIOL, V265, pE380, DOI 10.1152/ajpendo.1993.265.3.E380; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Schwartzbauer G, 1998, MOL GENET METAB, V63, P243, DOI 10.1006/mgme.1998.2685; Short KR, 2008, J CLIN ENDOCR METAB, V93, P597, DOI 10.1210/jc.2007-1814; Sjogren K, 2007, AM J PHYSIOL-ENDOC M, V293, pE364, DOI 10.1152/ajpendo.00054.2007; Sladek R, 1997, MOL CELL BIOL, V17, P5400, DOI 10.1128/MCB.17.9.5400; Vijayakumar A, 2012, DIABETES, V61, P94, DOI 10.2337/db11-0814; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Wang ZH, 2007, ENDOCRINOLOGY, V148, P2845, DOI 10.1210/en.2006-1313; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zhang LY, 2010, BBA-MOL CELL BIOL L, V1801, P1, DOI 10.1016/j.bbalip.2009.09.014; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200	44	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44777	10.1371/journal.pone.0044777	http://dx.doi.org/10.1371/journal.pone.0044777			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024761	Green Published, gold, Green Submitted			2022-12-27	WOS:000308860100019
J	Zhu, L; Su, M; Lucast, L; Liu, LJ; Netzer, WJ; Gandy, SE; Cai, DM				Zhu, Li; Su, Meng; Lucast, Louise; Liu, Lijuan; Netzer, William J.; Gandy, Samuel E.; Cai, Dongming			Dynamin 1 Regulates Amyloid Generation through Modulation of BACE-1	PLOS ONE			English	Article							ONSET ALZHEIMERS-DISEASE; PRECURSOR-PROTEIN; BETA-SECRETASE; CELL-SURFACE; IN-VIVO; ENDOCYTOSIS; PRESENILIN-1; INHIBITION; PATHWAYS; PHOSPHORYLATION	Background: Several lines of investigation support the notion that endocytosis is crucial for Alzheimer's disease (AD) pathogenesis. Substantial evidence have already been reported regarding the mechanisms underlying amyloid precursor protein (APP) traffic, but the regulation of beta-site APP-Cleaving Enzyme 1 (BACE-1) distribution among endosomes, TGN and plasma membrane remains unclear. Dynamin, an important adaptor protein that controls sorting of many molecules, has recently been associated with AD but its functions remain controversial. Here we studied possible roles for dynamin 1 (dyn1) in A beta biogenesis. Principal Findings: We found that genetic perturbation of dyn1 reduces both secreted and intracellular A beta levels in cell culture. There is a dramatic reduction in BACE-1 cleavage products of APP (sAPP beta and beta CTF). Moreover, dyn1 knockdown (KD) leads to BACE-1 redistribution from the Golgi-TGN/endosome to the cell surface. There is an increase in the amount of surface holoAPP upon dyn1 KD, with resultant elevation of alpha-secretase cleavage products sAPP alpha and alpha CTF. But no changes are seen in the amount of nicastrin (NCT) or PS1 N-terminal fragment (NTF) at cell surface with dyn1 KD. Furthermore, treatment with a selective dynamin inhibitor Dynasore leads to similar reduction in beta CTF and A beta levels, comparable to changes with BACE inhibitor treatment. But combined inhibition of BACE-1 and dyn1 does not lead to further reduction in A beta, suggesting that the A beta-lowering effects of dynamin inhibition are mainly mediated through regulation of BACE-1 internalization. A beta levels in dyn1(-/-) primary neurons, as well as in 3-month old dyn1 haploinsufficient animals with AD transgenic background are consistently reduced when compared to their wildtype counterparts. Conclusions: In summary, these data suggest a previously unknown mechanism by which dyn1 affects amyloid generation through regulation of BACE-1 subcellular localization and therefore its enzymatic activities.	[Zhu, Li; Su, Meng; Gandy, Samuel E.; Cai, Dongming] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Zhu, Li; Su, Meng; Gandy, Samuel E.; Cai, Dongming] Mt Sinai Sch Med, Alzheimers Dis Res Ctr, New York, NY USA; [Zhu, Li; Gandy, Samuel E.; Cai, Dongming] James J Peters Vet Affairs Med Ctr, Bronx, NY USA; [Lucast, Louise; Liu, Lijuan] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Lucast, Louise; Liu, Lijuan] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT USA; [Netzer, William J.] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; [Su, Meng] John Hopkins Med Ctr, Dept Pathol, Baltimore, MD USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Yale University; Yale University; Rockefeller University; Johns Hopkins University; Johns Hopkins Medicine	Zhu, L (corresponding author), Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA.	dongming.cai@mssm.edu		Cai, Dongming/0000-0002-0601-6826	Department of Veteran Affairs Career Development Award; Mount Sinai School of Medicine Friedman Brain Institute Seeding Fund	Department of Veteran Affairs Career Development Award; Mount Sinai School of Medicine Friedman Brain Institute Seeding Fund	The authors' studies are supported by Department of Veteran Affairs Career Development Award (to D.C.) and Mount Sinai School of Medicine Friedman Brain Institute Seeding Fund (to D.C.). The funders provide financial support to our studies. They had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidaralieva NJ, 2008, J HUM GENET, V53, P296, DOI 10.1007/s10038-008-0251-9; Bettens K, 2009, NEUROBIOL AGING, V30, P2000, DOI 10.1016/j.neurobiolaging.2008.02.003; BUXBAUM JD, 1990, P NATL ACAD SCI USA, V87, P6003, DOI 10.1073/pnas.87.15.6003; Cai DM, 2006, P NATL ACAD SCI USA, V103, P1941, DOI 10.1073/pnas.0510708103; Cai DM, 2003, J BIOL CHEM, V278, P3446, DOI 10.1074/jbc.M209065200; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Carey RM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-30; Chung C, 2010, J NEUROSCI, V30, P1363, DOI 10.1523/JNEUROSCI.3427-09.2010; Chyung JH, 2003, J BIOL CHEM, V278, P51035, DOI 10.1074/jbc.M304989200; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Kamagata E, 2009, BIOCHEM BIOPH RES CO, V379, P691, DOI 10.1016/j.bbrc.2008.12.147; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Kuwano R, 2006, HUM MOL GENET, V15, P2170, DOI 10.1093/hmg/ddl142; Lane RF, 2010, J NEUROSCI, V30, P13110, DOI 10.1523/JNEUROSCI.3872-10.2010; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; Levitan D, 2001, P NATL ACAD SCI USA, V98, P12186, DOI 10.1073/pnas.211321898; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Netzer WJ, 2003, P NATL ACAD SCI USA, V100, P12444, DOI 10.1073/pnas.1534745100; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; Tamayev R, 2011, EMBO MOL MED; von Arnim CAF, 2004, J CELL SCI, V117, P5437, DOI 10.1242/jcs.01422; Waring SC, 2008, ARCH NEUROL-CHICAGO, V65, P329, DOI 10.1001/archneur.65.3.329; Wen L, 2011, J CELL BIOL, V195, P765, DOI 10.1083/jcb.201105109; Wu J, 2011, CELL, V147, P615, DOI 10.1016/j.cell.2011.09.036; Xu HX, 1998, NAT MED, V4, P447, DOI 10.1038/nm0498-447; Yan RQ, 2001, J BIOL CHEM, V276, P36788, DOI 10.1074/jbc.M104350200; Yu CJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-19	35	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45033	10.1371/journal.pone.0045033	http://dx.doi.org/10.1371/journal.pone.0045033			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024787	gold, Green Published, Green Submitted			2022-12-27	WOS:000308860100045
J	Alfonsi, E; Hassani, S; Carpentier, FG; Le Clec'h, JY; Dabin, W; Van Canneyt, O; Fontaine, MC; Jung, JL				Alfonsi, Eric; Hassani, Sami; Carpentier, Francois-Gilles; Le Clec'h, Jean-Yves; Dabin, Willy; Van Canneyt, Olivier; Fontaine, Michael C.; Jung, Jean-Luc			A European Melting Pot of Harbour Porpoise in the French Atlantic Coasts Inferred from Mitochondrial and Nuclear Data	PLOS ONE			English	Article							SOUTHERN NORTH-SEA; PHOCOENA-PHOCOENA; POPULATION-STRUCTURE; CLIMATE-CHANGE; CONTROL REGION; EASTERN; CETACEANS; SOFTWARE; DIFFERENTIATION; VARIABILITY	Field surveys have reported a global shift in harbour porpoise distribution in European waters during the last 15 years, including a return to the Atlantic coasts of France. In this study, we analyzed genetic polymorphisms at a fragment of the mitochondrial control region (mtDNA CR) and 7 nuclear microsatellite loci, for 52 animals stranded and by-caught between 2000 and 2010 along the Atlantic coasts of France. The analysis of nuclear and mitochondrial loci provided contrasting results. The mtDNA revealed two genetically distinct groups, one closely related to the Iberian and African harbour porpoises, and the second related to individuals from the more northern waters of Europe. In contrast, nuclear polymorphisms did not display such a distinction. Nuclear markers suggested that harbour porpoises behaved as a randomly mating population along the Atlantic coasts of France. The difference between the two kinds of markers can be explained by differences in their mode of inheritance, the mtDNA being maternally inherited in contrast to nuclear loci that are bi-parentally inherited. Our results provide evidence that a major proportion of the animals we sampled are admixed individuals from the two genetically distinct populations previously identified along the Iberian coasts and in the North East Atlantic. The French Atlantic coasts are clearly the place where these two previously separated populations of harbour porpoises are now admixing. The present shifts in distribution of harbour porpoises along this coast is likely caused by habitat changes that will need to be further studied.	[Alfonsi, Eric; Carpentier, Francois-Gilles; Jung, Jean-Luc] Univ Europeenne Bretagne, Lab BioGeMME Biol & Genet Mammiferes Marins Leur, Brest, France; [Alfonsi, Eric; Carpentier, Francois-Gilles; Jung, Jean-Luc] Univ Bretagne Occidentale, Brest, France; [Alfonsi, Eric; Hassani, Sami; Le Clec'h, Jean-Yves] Oceanopolis, Lab Etude Mammiferes Marins, Brest, France; [Alfonsi, Eric] Univ Europeenne Bretagne, LEMAR, Brest, France; [Dabin, Willy; Van Canneyt, Olivier] Univ La Rochelle, CNRS, UMS 3462, Observ PELAGIS, La Rochelle, France; [Fontaine, Michael C.] Univ Paris 11, CNRS, Lab Ecol Systemat & Evolut, F-91405 Orsay, France; [Fontaine, Michael C.] Univ Paris 07, CNRS, MNHN, Musee Homme,UMR 5145, Paris, France	Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite	Alfonsi, E (corresponding author), Univ Europeenne Bretagne, Lab BioGeMME Biol & Genet Mammiferes Marins Leur, Brest, France.	jung@univ-brest.fr	Jung, Jean-Luc/H-5108-2011; Fontaine, Michael/G-5350-2011	Jung, Jean-Luc/0000-0002-8795-8056; Fontaine, Michael/0000-0003-1156-4154	ANRT (Association Nationale de la Recherche et de la Technologie); ANR NUTGENEVOL research project	ANRT (Association Nationale de la Recherche et de la Technologie)(French National Research Agency (ANR)); ANR NUTGENEVOL research project(French National Research Agency (ANR))	Eric Alfonsi is supported by a grant "Cifre" of the ANRT (Association Nationale de la Recherche et de la Technologie, http://www.anrt.asso.fr). MCF is currently a post-doc supported by the ANR NUTGENEVOL research project. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andersen LW, 2001, CONSERV GENET, V2, P309, DOI 10.1023/A:1012534212853; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; [Anonymous], 2006, SMALL CETACEANS EURO, P1; Berggren P, 2002, BIOL CONSERV, V103, P313, DOI 10.1016/S0006-3207(01)00142-2; Camphuysen Kees C. J., 2004, Lutra, V47, P113; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Chivers S. J., 2002, Journal of Cetacean Research and Management, V4, P111; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Donovan G. P., 1995, V16, P3; Duguy R., 1977, Report int Whal Commn, V27, P500; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fontaine MC, 2012, P NATL ACAD IN PRESS; Fontaine MC, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-30; Fontaine MC, 2010, P ROY SOC B-BIOL SCI, V277, P2829, DOI 10.1098/rspb.2010.0412; Gambaiani DD, 2009, J MAR BIOL ASSOC UK, V89, P179, DOI 10.1017/S0025315408002476; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gaskin D.E., 1984, REP INT WHAL COMMN, V34, P569; Goloboff P, 2008, CLADISTICS, V24, P91; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hammond PS, 2002, J APPL ECOL, V39, P361, DOI 10.1046/j.1365-2664.2002.00713.x; Herr H, 2009, BIOL CONSERV, V142, P2962, DOI 10.1016/j.biocon.2009.07.025; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hudson RD, 1998, MOL BIOL EVOL, V9, P138; Hudson RR, 2000, GENETICS, V155, P2011; Jayasankar P, 2008, CURR SCI INDIA, V94, P1513; Johnston DW, 2005, MAR ECOL PROG SER, V295, P279, DOI 10.3354/meps295279; Jung JL, 2009, J MAR BIOL ASSOC UK, V89, P1045, DOI 10.1017/S0025315409000307; Kiszka Jeremy, 2004, Lutra, V47, P33; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Koopman HN, 2002, PHYSIOL BIOCHEM ZOOL, V75, P498, DOI 10.1086/342799; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lischer H, 2009, PGDSPIDER V1 0 1 4; Lockyer C., 2003, NAMMCO Scientific Publications, V5, P71; Lockyer C, 2007, J MAR BIOL ASSOC UK, V87, P1035, DOI 10.1017/S0025315407054720; MacLeod CD, 2007, BIOL LETTERS, V3, P185, DOI 10.1098/rsbl.2006.0588; Murray J., 1910, REPORTS SCI EXPEDITI, P17; Northridge S, 1999, SCI COMM INT WHAL CO; Palacios DM, 2011, CLIMATE CHANGE VULNE, P69; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pikesley SK, 2012, J MAR BIOL ASSOC UK, V92, P1809, DOI 10.1017/S0025315411000464; Poulard JC, 2005, ICES J MAR SCI, V62, P1436, DOI 10.1016/j.icesjms.2005.04.017; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Read AJ., 1999, HDB MARINE MAMMALS, P323; Reijnders Peter J. H., 1992, Netherlands Journal of Aquatic Ecology, V26, P75, DOI 10.1007/BF02298029; Reijnders PJH, 2009, 16 ADV COMM M 16 BRU, P16; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rosel PE, 2003, CONSERV GENET, V4, P647, DOI 10.1023/A:1025666212967; ROSEL PE, 1995, CAN J FISH AQUAT SCI, V52, P1210, DOI 10.1139/f95-118; Rosel PE, 1999, MOL ECOL, V8, pS41, DOI 10.1046/j.1365-294X.1999.00758.x; Ryman N, 2006, MOL ECOL NOTES, V6, P600, DOI 10.1111/j.1471-8286.2006.01378.x; Santos MB, 2004, MAR MAMMAL SCI, V20, P1, DOI 10.1111/j.1748-7692.2004.tb01138.x; Santos MB, 2003, OCEANOGR MAR BIOL, V41, P355; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Siebert U, 2006, J SEA RES, V56, P65, DOI 10.1016/j.seares.2006.01.003; Simmonds MP, 2009, J MAR BIOL ASSOC UK, V89, P203, DOI 10.1017/S0025315408003196; SOUTHWARD AJ, 1995, J THERM BIOL, V20, P127, DOI 10.1016/0306-4565(94)00043-I; Stenson G.B., 2003, NAMMCO Scientific Publications, V5, P271; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; TAJIMA F, 1989, GENETICS, V123, P585; Thomsen F, 2006, HELGOLAND MAR RES, V60, P189, DOI 10.1007/s10152-006-0021-z; Tiedemann R, 1996, Z SAUGETIERKD, V61, P104; Tolley KA, 2006, MAR ECOL PROG SER, V327, P297, DOI 10.3354/meps327297; Tolley KA, 2001, J CETACEAN RES MANAG, V1, P265; Tolley KA, 2001, CONSERV GENET, V2, P349, DOI 10.1023/A:1012561811074; Tregenza NJC, 1997, ICES J MAR SCI, V54, P896, DOI 10.1006/jmsc.1996.0212; van der Meij Sancia E. T., 2006, Lutra, V49, P3; Viaud-Martinez KA, 2007, MAR ECOL PROG SER, V338, P281, DOI 10.3354/meps338281; Walton MJ, 1997, P ROY SOC B-BIOL SCI, V264, P89, DOI 10.1098/rspb.1997.0013; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wiemann A, 2010, CONSERV GENET, V11, P195, DOI 10.1007/s10592-009-0023-x	77	14	14	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44425	10.1371/journal.pone.0044425	http://dx.doi.org/10.1371/journal.pone.0044425			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984507	Green Published, Green Submitted, gold			2022-12-27	WOS:000308738500055
J	Cartwright, SP; Bill, RM; Hipkiss, AR				Cartwright, Stephanie P.; Bill, Roslyn M.; Hipkiss, Alan R.			L-Carnosine Affects the Growth of Saccharomyces cerevisiae in a Metabolism-Dependent Manner	PLOS ONE			English	Article							CHRONOLOGICAL LIFE-SPAN; INCREASED RESPIRATION; YEAST; MUSCLE; CELLS; TOR; HISTIDINE; ATP	The dipeptide L-carnosine (beta-alanyl-L-histidine) has been described as enigmatic: it inhibits growth of cancer cells but delays senescence in cultured human fibroblasts and extends the lifespan of male fruit flies. In an attempt to understand these observations, the effects of L-carnosine on the model eukaryote, Saccharomyces cerevisiae, were examined on account of its unique metabolic properties; S. cerevisiae can respire aerobically, but like some tumor cells, it can also exhibit a metabolism in which aerobic respiration is down regulated. L-Carnosine exhibited both inhibitory and stimulatory effects on yeast cells, dependent upon the carbon source in the growth medium. When yeast cells were not reliant on oxidative phosphorylation for energy generation (e. g. when grown on a fermentable carbon source such as 2% glucose), 10-30 mM L-carnosine slowed growth rates in a dose-dependent manner and increased cell death by up to 17%. In contrast, in media containing a non-fermentable carbon source in which yeast are dependent on aerobic respiration (e. g. 2% glycerol), L-carnosine did not provoke cell death. This latter observation was confirmed in the respiratory yeast, Pichia pastoris. Moreover, when deletion strains in the yeast nutrient-sensing pathway were treated with L-carnosine, the cells showed resistance to its inhibitory effects. These findings suggest that L-carnosine affects cells in a metabolism-dependent manner and provide a rationale for its effects on different cell types.	[Cartwright, Stephanie P.; Bill, Roslyn M.; Hipkiss, Alan R.] Aston Univ, Sch Hlth & Life Sci, Aston Res Ctr Hlth Ageing, Birmingham B4 7ET, W Midlands, England	Aston University	Cartwright, SP (corresponding author), Aston Univ, Sch Hlth & Life Sci, Aston Res Ctr Hlth Ageing, Birmingham B4 7ET, W Midlands, England.	r.m.bill@aston.ac.uk; alanandjill@lineone.net	Bill, Roslyn M/D-4554-2012	Bill, Roslyn M/0000-0003-1331-0852	BBSRC (Biotechnology and Biological Sciences Research Council) Targetted Priority Studentship in Ageing	BBSRC (Biotechnology and Biological Sciences Research Council) Targetted Priority Studentship in Ageing	This work was funded by a BBSRC (Biotechnology and Biological Sciences Research Council) Targetted Priority Studentship in Ageing to RMB supporting SPC. The authors also acknowledge Aston Research Centre for Healthy Ageing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2000, BIOCHEMISTRY-MOSCOW+, V65, P757; Asperger A, 2011, CANCER INVEST, V29, P272, DOI 10.3109/07357907.2010.550666; Bauer K, 2005, NEUROCHEM RES, V30, P1339, DOI 10.1007/s11064-005-8806-z; Bonander N, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-10; Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; Chen JCY, 2006, CURR GENET, V49, P281, DOI 10.1007/s00294-005-0055-9; Crabtree HG, 1929, BIOCHEM J, V23, P536, DOI 10.1042/bj0230536; DEDEKEN RH, 1966, J GEN MICROBIOL, V44, P149, DOI 10.1099/00221287-44-2-149; Diaz-Ruiz R, 2009, BBA-REV CANCER, V1796, P252, DOI 10.1016/j.bbcan.2009.07.003; Diaz-Ruiz R, 2011, BBA-BIOENERGETICS, V1807, P568, DOI 10.1016/j.bbabio.2010.08.010; Hipkiss AR, 2009, ADV FOOD NUTR RES, V57, P87, DOI 10.1016/S1043-4526(09)57003-9; Holliday R, 1996, BRIT J CANCER, V73, P966, DOI 10.1038/bjc.1996.189; Holliday R, 2000, BIOCHEMISTRY-MOSCOW+, V65, P843; IKEDA T, 1980, J BIOCHEM-TOKYO, V87, P179, DOI 10.1093/oxfordjournals.jbchem.a132723; Iovine B, 2012, CANCER LETT, V315, P122, DOI 10.1016/j.canlet.2011.07.021; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Lavoie H, 2008, EUKARYOT CELL, V7, P1127, DOI 10.1128/EC.00330-07; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; MANNION AF, 1992, EUR J APPL PHYSIOL O, V64, P47, DOI 10.1007/BF00376439; Mattanovich D, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-29; MCFARLAND GA, 1994, EXP CELL RES, V212, P167, DOI 10.1006/excr.1994.1132; Nagai K, 1986, Nihon Seirigaku Zasshi, V48, P741; Pepper ED, 2010, APPL ENVIRON MICROB, V76, P7925, DOI 10.1128/AEM.01369-10; QUINN PJ, 1992, MOL ASPECTS MED, V13, P379, DOI 10.1016/0098-2997(92)90006-L; Renner C, 2010, NEUROL RES, V32, P101, DOI 10.1179/016164109X12518779082237; Skinner C, 2010, APPL MICROBIOL BIOT, V88, P817, DOI 10.1007/s00253-010-2824-8; WARBURG O, 1956, SCIENCE, V124, P269; WERNERWASHBURNE M, 1993, MICROBIOL REV, V57, P383, DOI 10.1128/MMBR.57.2.383-401.1993; Yuneva AO, 2002, B EXP BIOL MED+, V133, P559, DOI 10.1023/A:1020273506970	29	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45006	10.1371/journal.pone.0045006	http://dx.doi.org/10.1371/journal.pone.0045006			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984600	gold, Green Published, Green Accepted			2022-12-27	WOS:000308738500106
J	Hauck, Y; Soler, C; Jault, P; Merens, A; Gerome, P; Mac Nab, C; Trueba, F; Bargues, L; Thien, HV; Vergnaud, G; Pourcel, C				Hauck, Yolande; Soler, Charles; Jault, Patrick; Merens, Audrey; Gerome, Patrick; Mac Nab, Christine; Trueba, Francois; Bargues, Laurent; Hoang Vu Thien; Vergnaud, Gilles; Pourcel, Christine			Diversity of Acinetobacter baumannii in Four French Military Hospitals, as Assessed by Multiple Locus Variable Number of Tandem Repeats Analysis	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; ANTIMICROBIAL SUSCEPTIBILITIES; IDENTIFICATION; STRAINS; INFECTIONS; COMPLEX; EPIDEMIOLOGY; BACTEREMIA; FOSFOMYCIN; OUTBREAK	Background: Infections by A. calcoaceticus-A. baumannii (ACB) complex isolates represent a serious threat for wounded and burn patients. Three international multidrug-resistant (MDR) clones (EU clone I-III) are responsible for a large proportion of nosocomial infections with A. baumannii but other emerging strains with high epidemic potential also occur. Methodology/Principal Findings: We automatized a Multiple locus variable number of tandem repeats (VNTR) analysis (MLVA) protocol and used it to investigate the genetic diversity of 136 ACB isolates from four military hospitals and one childrens hospital. Acinetobacter sp other than baumannii isolates represented 22.6% (31/137) with a majority being A. pittii. The genotyping protocol designed for A. baumannii was also efficient to cluster A. pittii isolates. Fifty-five percent of A. baumannii isolates belonged to the two international clones I and II, and we identified new clones which members were found in the different hospitals. Analysis of two CRISPR-cas systems helped define two clonal complexes and provided phylogenetic information to help trace back their emergence. Conclusions/Significance: The increasing occurrence of A. baumannii infections in the hospital calls for measures to rapidly characterize the isolates and identify emerging clones. The automatized MLVA protocol can be the instrument for such surveys. In addition, the investigation of CRISPR/cas systems may give important keys to understand the evolution of some highly successful clonal complexes.	[Hauck, Yolande; Vergnaud, Gilles; Pourcel, Christine] Univ Paris 11, Inst Genet & Microbiol, UMR8621, F-91405 Orsay, France; [Hauck, Yolande; Vergnaud, Gilles; Pourcel, Christine] CNRS, F-91405 Orsay, France; [Soler, Charles; Jault, Patrick; Mac Nab, Christine; Bargues, Laurent] HIA Percy, Lab Biol Clin, Clamart, France; [Merens, Audrey] HIA Begin, Lab Biol Clin, St Mande, France; [Gerome, Patrick] HIA Desgenettes, Serv Biol Med, Lyon, France; [Trueba, Francois] HIA Val de Grace, Serv Biol Med, Paris, France; [Hoang Vu Thien] Hop Armand Trousseau, APHP, Paris, France; [Vergnaud, Gilles] DGA MRIS Mission Rech & Innovat Sci, Bagneux, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Val-de-Grace Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite	Hauck, Y (corresponding author), Univ Paris 11, Inst Genet & Microbiol, UMR8621, F-91405 Orsay, France.	christine.pourcel@u-psud.fr	Vergnaud, Gilles/P-1304-2015; Pourcel, Christine/E-4949-2017; Vergnaud, Gilles/AAC-1162-2020	Vergnaud, Gilles/0000-0003-0913-194X; Pourcel, Christine/0000-0002-8951-466X; Vergnaud, Gilles/0000-0003-0913-194X; JAULT, Patrick/0000-0001-8021-9149				Adams MD, 2008, J BACTERIOL, V190, P8053, DOI 10.1128/JB.00834-08; Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; Berlau J, 1999, J HOSP INFECT, V42, P201, DOI 10.1053/jhin.1999.0602; Boo TW, 2009, J MED MICROBIOL, V58, P209, DOI 10.1099/jmm.0.004911-0; Carretto E, 2011, INFECT GENET EVOL, V11, P1319, DOI 10.1016/j.meegid.2011.04.024; Chakraborty S, 2010, MOL PHYLOGENET EVOL, V56, P878, DOI 10.1016/j.ympev.2010.05.020; Chuang YC, 2011, CLIN INFECT DIS, V52, P352, DOI 10.1093/cid/ciq154; Di Nocera PP, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-224; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; Dijkshoorn L, 1996, J CLIN MICROBIOL, V34, P1519, DOI 10.1128/JCM.34.6.1519-1525.1996; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Ecker JA, 2006, J CLIN MICROBIOL, V44, P2921, DOI 10.1128/JCM.00619-06; Falagas ME, 2008, CLIN INFECT DIS, V46, P1069, DOI 10.1086/527442; Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202; Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007; Gant VA, 2007, J ANTIMICROB CHEMOTH, V60, P294, DOI 10.1093/jac/dkm201; GERNERSMIDT P, 1991, J CLIN MICROBIOL, V29, P277, DOI 10.1128/JCM.29.2.277-282.1991; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Grissa I, 2009, METHODS MOL BIOL, V551, P105, DOI 10.1007/978-1-60327-999-4_9; Hamouda A, 2010, J CLIN MICROBIOL, V48, P2476, DOI 10.1128/JCM.02431-09; Higgins PG, 2010, J ANTIMICROB CHEMOTH, V65, P233, DOI 10.1093/jac/dkp428; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Houang ETS, 2001, J CLIN MICROBIOL, V39, P228, DOI 10.1128/JCM.39.1.228-234.2001; Iacono M, 2008, ANTIMICROB AGENTS CH, V52, P2616, DOI 10.1128/AAC.01643-07; Ko WC, 2008, J CLIN MICROBIOL, V46, P2052, DOI 10.1128/JCM.00014-08; La Scola B, 2006, J CLIN MICROBIOL, V44, P827, DOI 10.1128/JCM.44.3.827-832.2006; Lee YC, 2011, J ANTIMICROB CHEMOTH, V66, P1839, DOI 10.1093/jac/dkr200; Lin YC, 2008, J CLIN MICROBIOL, V46, P612, DOI 10.1128/JCM.01798-07; Lista F, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-33; Lu CL, 2011, ANTIMICROB AGENTS CH, V55, P4295, DOI 10.1128/AAC.00349-11; Magiorakos AP, 2011, CLIN MICROBIOL INFEC; Minandri F, 2012, J CLIN MICROBIOL, V50, P590, DOI 10.1128/JCM.05555-11; Nemec A, 2001, INT J SYST EVOL MICR, V51, P1891, DOI 10.1099/00207713-51-5-1891; Nemec A, 2011, RES MICROBIOL, V162, P393, DOI 10.1016/j.resmic.2011.02.006; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06; Petersen K, 2011, J CLIN MICROBIOL, V49, P159, DOI 10.1128/JCM.00766-10; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Pourcel C, 2011, J CLIN MICROBIOL, V49, P539, DOI 10.1128/JCM.02003-10; Sachdev D, 2010, MICROBIOL RES, V165, P627, DOI 10.1016/j.micres.2009.12.002; Scott P, 2007, CLIN INFECT DIS, V44, P1577, DOI 10.1086/518170; Seifert H, 2005, J CLIN MICROBIOL, V43, P4328, DOI 10.1128/JCM.43.9.4328-4335.2005; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Snitkin ES, 2011, P NATL ACAD SCI USA, V108, P13758, DOI 10.1073/pnas.1104404108; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Turton JF, 2009, EUR J CLIN MICROBIOL, V28, P499, DOI 10.1007/s10096-008-0659-3; Turton JF, 2011, J CLIN MICROBIOL, V49, P1260, DOI 10.1128/JCM.02335-10; Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805; van den Broek PJ, 2009, J CLIN MICROBIOL, V47, P3593, DOI 10.1128/JCM.00967-09; van Dessel H, 2004, RES MICROBIOL, V155, P105, DOI 10.1016/j.resmic.2003.10.003; Vergnaud G, 2009, METHODS MOL BIOL, V551, P141, DOI 10.1007/978-1-60327-999-4_12; Visca P, 2011, MICROBIOL-SGM, V157, P2582, DOI 10.1099/mic.0.047258-0; Wisplinghoff H, 2012, J INFECTION, V64, P282, DOI 10.1016/j.jinf.2011.12.008	53	32	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44597	10.1371/journal.pone.0044597	http://dx.doi.org/10.1371/journal.pone.0044597			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984530	gold, Green Published, Green Submitted			2022-12-27	WOS:000308738500068
J	Nogues, C; Leh, H; Lautru, J; Delelis, O; Buckle, M				Nogues, Claude; Leh, Herve; Lautru, Joseph; Delelis, Olivier; Buckle, Malcolm			Efficient Antifouling Surface for Quantitative Surface Plasmon Resonance Based Biosensor Analysis	PLOS ONE			English	Article							SELF-ASSEMBLED MONOLAYERS; GOLD NANOPARTICLES; PROTEIN ADSORPTION; HIV-1 INTEGRASE; MODEL SYSTEM; DNA; BINDING; HYBRIDIZATION; OLIGONUCLEOTIDES; LIGANDS	Non-specific binding to biosensor surfaces is a major obstacle to quantitative analysis of selective retention of analytes at immobilized target molecules. Although a range of chemical antifouling monolayers has been developed to address this problem, many macromolecular interactions still remain refractive to analysis due to the prevalent high degree of nonspecific binding. In this manuscript we explore the dynamic process of the formation of self-assembled monolayers and optimize physical and chemical properties thus reducing considerably non-specific binding while maintaining the integrity of the immobilized biomolecules. As a result, analysis of specific binding of analytes to immobilized target molecules is significantly facilitated.	[Nogues, Claude; Leh, Herve; Delelis, Olivier; Buckle, Malcolm] CNRS, ENS Cachan, LBPA, Cachan, France; [Lautru, Joseph] ENS Cachan, Inst Alembert, Cachan, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Nogues, C (corresponding author), CNRS, ENS Cachan, LBPA, Cachan, France.	buckle@lbpa.ens-cachan.fr			Eurotransbio financed project [Qubis ETB-2006-066]; CONCOURS NATIONAL aide a la creation d'entreprise de technologies innovantes du ministere de l'Enseignement superieur et de OSEO/ANVAR (Agence Nationale de la Valorisation de la Recherche); Association National pour la Recherche Scientifique (ANRS) [ANR-06-PCVI-0015-04 IMFOVIR]; Centre National de la Recherche Francaise (CNRS)	Eurotransbio financed project; CONCOURS NATIONAL aide a la creation d'entreprise de technologies innovantes du ministere de l'Enseignement superieur et de OSEO/ANVAR (Agence Nationale de la Valorisation de la Recherche)(French National Research Agency (ANR)); Association National pour la Recherche Scientifique (ANRS)(French National Research Agency (ANR)); Centre National de la Recherche Francaise (CNRS)	This work was supported by: 1) Eurotransbio financed project (Qubis ETB-2006-066). http://www.eurotransbio.eu; 2) CONCOURS NATIONAL 2008 aide a la creation d'entreprise de technologies innovantes du ministere de l'Enseignement superieur et de OSEO/ANVAR (Agence Nationale de la Valorisation de la Recherche). http://www.oseo.fr/; 3) Association National pour la Recherche Scientifique (ANRS) for support of the ANR-06-PCVI-0015-04 IMFOVIR. http://www.agence-nationale-recherche.fr; 4) Centre National de la Recherche Francaise (CNRS). http://www.cnrs.fr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouffartigues E, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm030; Bouffartigues E, 2007, NAT STRUCT MOL BIOL, V14, P441, DOI 10.1038/nsmb1233; Buckle M, 1996, P NATL ACAD SCI USA, V93, P889, DOI 10.1073/pnas.93.2.889; Caumont A, 1999, FEBS LETT, V455, P154, DOI 10.1016/S0014-5793(99)00859-5; Coffin J, 1997, RETROVIRUSES; Delelis O, 2008, J BIOL CHEM, V283, P27838, DOI 10.1074/jbc.M803257200; Demers LM, 2000, ANAL CHEM, V72, P5535, DOI 10.1021/ac0006627; Deprez E, 2000, BIOCHEMISTRY-US, V39, P9275, DOI 10.1021/bi000397j; Halperin A, 2006, J PHYS-CONDENS MAT, V18, pS463, DOI 10.1088/0953-8984/18/18/S01; Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z; Harris JM, 1992, POLYETHYLENE GLYCOL, P408; Herne TM, 1997, J AM CHEM SOC, V119, P8916, DOI 10.1021/ja9719586; Herrwerth S, 2003, J AM CHEM SOC, V125, P9359, DOI 10.1021/ja034820y; Hucknall A, 2009, ADV MATER, V21, P2441, DOI 10.1002/adma.200900383; Lahiri J, 1999, LANGMUIR, V15, P7186, DOI 10.1021/la9815650; Lahiri J, 1999, ANAL CHEM, V71, P777, DOI 10.1021/ac980959t; Nogues C, 2004, PHYS CHEM CHEM PHYS, V6, P4459, DOI 10.1039/b410862k; Nogues C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012152; Peled D, 2008, LANGMUIR, V24, P11842, DOI 10.1021/la801437n; Peled D, 2010, J PHYS CHEM B, V114, P8581, DOI 10.1021/jp104533q; Pertsin AJ, 1998, J PHYS CHEM B, V102, P4918, DOI 10.1021/jp9806617; Petrovykh DY, 2003, J AM CHEM SOC, V125, P5219, DOI 10.1021/ja029450c; PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032; Smolov M, 2006, FEBS J, V273, P1137, DOI 10.1111/j.1742-4658.2006.05139.x; Steel AB, 1998, ANAL CHEM, V70, P4670, DOI 10.1021/ac980037q; Storhoff JJ, 2002, P SOC PHOTO-OPT INS, V4937, P1, DOI 10.1117/12.476069; Xu J, 2005, J AM CHEM SOC, V127, P13227, DOI 10.1021/ja052352h	27	16	16	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44287	10.1371/journal.pone.0044287	http://dx.doi.org/10.1371/journal.pone.0044287			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984487	gold, Green Published, Green Submitted			2022-12-27	WOS:000308738500043
J	Comach, G; Teneza-Mora, N; Kochel, TJ; Espino, C; Sierra, G; Camacho, DE; Laguna-Torres, VA; Garcia, J; Chauca, G; Gamero, ME; Sovero, M; Bordones, S; Villalobos, I; Melchor, A; Halsey, ES				Comach, Guillermo; Teneza-Mora, Nimfa; Kochel, Tadeusz J.; Espino, Carlos; Sierra, Gloria; Camacho, Daria E.; Alberto Laguna-Torres, V.; Garcia, Josefina; Chauca, Gloria; Gamero, Maria E.; Sovero, Merly; Bordones, Slave; Villalobos, Iris; Melchor, Angel; Halsey, Eric S.			Sentinel Surveillance of Influenza-Like Illness in Two Hospitals in Maracay, Venezuela: 2006-2010	PLOS ONE			English	Article							ACUTE RESPIRATORY-INFECTIONS; VIRUS; EPIDEMIOLOGY; COMMUNITY; CHILDREN	Background: Limited information exists on the epidemiology of acute febrile respiratory illnesses in tropical South American countries such as Venezuela. The objective of the present study was to examine the epidemiology of influenza-like illness (ILI) in two hospitals in Maracay, Venezuela. Methodology/Principal Findings: We performed a prospective surveillance study of persons with ILI who presented for care at two hospitals in Maracay, Venezuela, from October 2006 to December 2010. A respiratory specimen and clinical information were obtained from each participant. Viral isolation and identification with immunofluorescent antibodies and molecular methods were employed to detect respiratory viruses such as adenovirus, influenza A and B, parainfluenza, and respiratory sincytial virus, among others. There were 916 participants in the study (median age: 17 years; range: 1 month - 86 years). Viruses were identified in 143 (15.6%) subjects, and one participant was found to have a co-infection with more than one virus. Influenza viruses, including pandemic H1N1 2009, were the most frequently detected pathogens, accounting for 67.4% (97/144) of the viruses detected. Adenovirus (15/144), parainfluenza virus (13/144), and respiratory syncytial virus (11/144) were also important causes of ILI in this study. Pandemic H1N1 2009 virus became the most commonly isolated influenza virus during its initial appearance in 2009. Two waves of the pandemic were observed: the first which peaked in August 2009 and the second - higher than the preceding - that peaked in October 2009. In 2010, influenza A/H3N2 re-emerged as the most predominant respiratory virus detected. Conclusions/Significance: Influenza viruses were the most commonly detected viral organisms among patients with acute febrile respiratory illnesses presenting at two hospitals in Maracay, Venezuela. Pandemic H1N1 2009 influenza virus did not completely replace other circulating influenza viruses during its initial appearance in 2009. Seasonal influenza A/H3N2 was the most common influenza virus in the post-pandemic phase.	[Comach, Guillermo; Espino, Carlos; Sierra, Gloria; Camacho, Daria E.] Univ Carabobo BIOMED UC, Inst Invest Biomed, Lab Reg Diag & Invest Dengue & Otras Enfermedades, Maracay, Venezuela; [Teneza-Mora, Nimfa; Kochel, Tadeusz J.] USN, Med Res Ctr, Silver Spring, MD USA; [Kochel, Tadeusz J.; Alberto Laguna-Torres, V.; Garcia, Josefina; Chauca, Gloria; Gamero, Maria E.; Sovero, Merly; Halsey, Eric S.] US Naval Med Res Unit Six NAMRU 6, Lima, Peru; [Bordones, Slave] Hosp Jose Maria Carabano Tosta, Inst Venezolano Seguros Sociales, Maracay, Venezuela; [Villalobos, Iris] Hosp Cent Maracay, Corp Salud Aragua CORPOSALUD ARAGUA, Maracay, Venezuela; [Melchor, Angel] Corp Salud Aragua CORPOSALUD ARAGUA, Direcc Epidemiol, Maracay, Venezuela	United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Medical Research Unit No. 6 (NAMRU-6)	Comach, G (corresponding author), Univ Carabobo BIOMED UC, Inst Invest Biomed, Lab Reg Diag & Invest Dengue & Otras Enfermedades, Maracay, Venezuela.	gcomach@yahoo.com	Halsey, Eric/AAC-8110-2022	Halsey, Eric/0000-0001-6291-8923; LAGUNA-TORRES, VICTOR ALBERTO/0000-0002-9507-6301; , Merly Sovero/0000-0002-4373-0295	United States Department of Defense, Global Emerging Infections Surveillance and Response System, a Division of the Armed Forces Health Surveillance Center [847705.82000.25GB.B0016]	United States Department of Defense, Global Emerging Infections Surveillance and Response System, a Division of the Armed Forces Health Surveillance Center(United States Department of Defense)	This study was funded by the United States Department of Defense, Global Emerging Infections Surveillance and Response System, a Division of the Armed Forces Health Surveillance Center, WORK UNIT NUMBER: 847705.82000.25GB.B0016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Laguna-Torres VA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006118; Beckett CG, 2004, CLIN INFECT DIS, V39, P443, DOI 10.1086/422314; Bellei N, 2008, J MED VIROL, V80, P1824, DOI 10.1002/jmv.21295; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; DENNY FW, 1986, AM J TROP MED HYG, V35, P1; Douce RW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022206; Echavarria M, 2010, EMERG INFECT DIS, V16, P311, DOI 10.3201/eid1602.091114; Gomez J, 2009, EUROSURVEILLANCE, V14, P1; Laguna-Torres VA, 2010, INFLUENZA OTHER RESP, V5, P123; Lambert SB, 2007, PEDIATRICS, V120, pe929, DOI 10.1542/peds.2006-3703; Leland DS, 2007, CLIN MICROBIOL REV, V20, P49, DOI 10.1128/CMR.00002-06; Lieberman D, 2010, CHEST, V138, P811, DOI 10.1378/chest.09-2717; Lin TY, 2004, J CLIN VIROL, V30, P81, DOI 10.1016/j.jcv.2003.08.014; Lindblade KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015826; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Ministerio del Poder Popular para la Salud, 2009, B EP SEM SEM EP, V52; Ministerio del Poder Popular para la Salud, 2008, B EP SEM SEM EP, V52; Ministerio del Poder Popular para la Salud, 2007, B EP SEM SEM EP, V52; Ministerio del Poder Popular para la Salud, 2006, B EP SEM SEM EP, V52; Ministerio del Poder Popular para la Salud, 2010, B EP SEM SEM EP, V52; MONTO A S, 1971, American Journal of Epidemiology, V94, P269; Monto AS, 2004, PEDIATR INFECT DIS J, V23, pS58, DOI 10.1097/01.inf.0000108193.91607.34; Monto AS, 2002, AM J MED, V112, p4S; Monto AS, 1995, AM J MED, V99, pS24, DOI 10.1016/S0002-9343(99)80307-6; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Salmon-Mulanovich G, 2011, INFLUENZA OTHER RESP, V5, P1, DOI 10.1111/j.1750-2659.2010.00160.x; Schout D, 2009, CLINICS, V64, P1025, DOI 10.1590/S1807-59322009001000014; Sovero M, 2010, AM J TROP MED HYG, V83, P708, DOI 10.4269/ajtmh.2010.09-0757; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Valero N, 2009, INVEST CLIN, V50, P359; World Health Organization, 2008, GLOB BURD DIS 2004 U; Yoshida LM, 2010, PEDIATR INFECT DIS J, V29, P75, DOI 10.1097/INF.0b013e3181af61e9	34	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44511	10.1371/journal.pone.0044511	http://dx.doi.org/10.1371/journal.pone.0044511			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984519	gold, Green Published, Green Submitted			2022-12-27	WOS:000308638700066
J	Kintscher, M; Breustedt, J; Miceli, S; Schmitz, D; Wozny, C				Kintscher, Michael; Breustedt, Joerg; Miceli, Stephanie; Schmitz, Dietmar; Wozny, Christian			Group II Metabotropic Glutamate Receptors Depress Synaptic Transmission onto Subicular Burst Firing Neurons	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; HIPPOCAMPAL OUTPUT SYNAPSES; MOSSY FIBER SYNAPSES; IN-VITRO; PYRAMIDAL NEURONS; RAT HIPPOCAMPUS; PRESYNAPTIC INHIBITION; EXCITATORY SYNAPSES; INTERICTAL ACTIVITY; AREA CA1	The subiculum (SUB) is a pivotal structure positioned between the hippocampus proper and various cortical and subcortical areas. Despite the growing body of anatomical and intrinsic electrophysiological data of subicular neurons, modulation of synaptic transmission in the SUB is not well understood. In the present study we investigated the role of group II metabotropic glutamate receptors (mGluRs), which have been shown to be involved in the regulation of synaptic transmission by suppressing presynaptic cAMP activity. Using field potential and patch-clamp whole cell recordings we demonstrate that glutamatergic transmission at CA1-SUB synapses is depressed by group II mGluRs in a cell-type specific manner. Application of the group II mGluR agonist (2S,1'R,2'R,3'R)-2-(2, 3-dicarboxycyclopropyl)glycine (DCG-IV) led to a significantly higher reduction of excitatory postsynaptic currents in subicular bursting cells than in regular firing cells. We further used low-frequency stimulation protocols and brief high-frequency bursts to test whether synaptically released glutamate is capable of activating presynaptic mGluRs. However, neither frequency facilitation is enhanced in the presence of the group II mGluR antagonist LY341495, nor is a test stimulus given after a high-frequency burst. In summary, we present pharmacological evidence for presynaptic group II mGluRs targeting subicular bursting cells, but both low- and high-frequency stimulation protocols failed to activate presynaptically located mGluRs.	[Kintscher, Michael; Breustedt, Joerg; Miceli, Stephanie; Schmitz, Dietmar; Wozny, Christian] Charite, Neurosci Res Ctr, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kintscher, M (corresponding author), Charite, Neurosci Res Ctr, D-13353 Berlin, Germany.	christian.wozny@charite.de	Wozny, Christian/A-1498-2015	Wozny, Christian/0000-0003-4220-2033; Kintscher, Michael/0000-0003-2355-1369; Schmitz, Dietmar/0000-0003-2741-5241; Miceli, Stephanie/0000-0001-8513-0549	Deutsche Forschungsgemeinschaft (DFG); Bundesministerium fur Bildung und Forschung (BMBF) [SFB618, SFB665]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	The work was supported by Deutsche Forschungsgemeinschaft (DFG) and Bundesministerium fur Bildung und Forschung (BMBF) grants to D. Schmitz (SFB618, SFB665, Cluster NeuroCure, Bernstein-Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GM, 2006, EPILEPSY RES, V71, P1, DOI 10.1016/j.eplepsyres.2006.05.012; Alexander GM, 2005, J NEUROPHYSIOL, V94, P163, DOI 10.1152/jn.01198.2004; Beed P, 2010, NEURON, V68, P1059, DOI 10.1016/j.neuron.2010.12.009; Behr J, 2009, PROG NEUROBIOL; Bendels MHK, 2008, J NEUROSCI METH, V175, P44, DOI 10.1016/j.jneumeth.2008.08.010; Billups B, 2005, J PHYSIOL-LONDON, V565, P885, DOI 10.1113/jphysiol.2005.086736; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; de la Prida LM, 2004, J NEUROSCI, V24, P5525, DOI 10.1523/JNEUROSCI.0309-04.2004; de la Prida LM, 2003, HIPPOCAMPUS, V13, P728, DOI 10.1002/hipo.10123; FABER DS, 1991, BIOPHYS J, V60, P1288, DOI 10.1016/S0006-3495(91)82162-2; Fabo D, 2008, BRAIN, V131, P485, DOI 10.1093/brain/awm297; Ferraguti F, 2006, CELL TISSUE RES, V326, P483, DOI 10.1007/s00441-006-0266-5; Fidzinski P, 2008, EUR J NEUROSCI, V27, P1111, DOI 10.1111/j.1460-9568.2008.06089.x; GEREAU RW, 1995, J NEUROSCI, V15, P6879; ISHIDA M, 1993, BRIT J PHARMACOL, V109, P1169, DOI 10.1111/j.1476-5381.1993.tb13745.x; Ishizuka N, 2001, J COMP NEUROL, V435, P89, DOI 10.1002/cne.1195; Kim Y, 2012, HIPPOCAMPUS, V22, P693, DOI 10.1002/hipo.20931; Knopp A, 2005, J COMP NEUROL, V483, P476, DOI 10.1002/cne.20460; Manzoni O, 1995, EUR J NEUROSCI, V7, P2518, DOI 10.1111/j.1460-9568.1995.tb01051.x; MASON A, 1993, BRAIN RES, V600, P174, DOI 10.1016/0006-8993(93)90418-M; Moore KA, 2003, P NATL ACAD SCI USA, V100, P14397, DOI 10.1073/pnas.1835831100; Naber PA, 2000, ANN NY ACAD SCI, V911, P392; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; O'Mara SM, 2001, PROG NEUROBIOL, V64, P129, DOI 10.1016/S0301-0082(00)00054-X; Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632; Price CJ, 2005, NEUROPHARMACOLOGY, V49, P45, DOI 10.1016/j.neuropharm.2005.05.009; Renger JJ, 2002, P NATL ACAD SCI USA, V99, P1041, DOI 10.1073/pnas.022618799; Rogawski MA, 2004, NAT REV NEUROSCI, V5, P553, DOI 10.1038/nrn1430; Rogawski MA, 2011, EPILEPSY CURR, V11, P56, DOI 10.5698/1535-7511-11.2.56; Rosoklija G, 2000, ARCH GEN PSYCHIAT, V57, P349, DOI 10.1001/archpsyc.57.4.349; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; Schoepp DD, 2001, J PHARMACOL EXP THER, V299, P12; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Shigemoto R, 1996, NATURE, V381, P523, DOI 10.1038/381523a0; Staff NP, 2000, J NEUROPHYSIOL, V84, P2398, DOI 10.1152/jn.2000.84.5.2398; Stewart M, 1997, BRAIN RES, V769, P71, DOI 10.1016/S0006-8993(97)00690-2; STEWART M, 1993, J NEUROPHYSIOL, V70, P232, DOI 10.1152/jn.1993.70.1.232; TAUBE JS, 1993, EXP BRAIN RES, V96, P304; Witter MP, 2000, ANN NY ACAD SCI, V911, P1; Wozny C, 2003, SCIENCE, V301, P463; Wozny C, 2008, J PHYSIOL-LONDON, V586, P2725, DOI 10.1113/jphysiol.2007.149203; Wozny C, 2008, J NEUROSCI, V28, P14358, DOI 10.1523/JNEUROSCI.4973-08.2008; Yokoi M, 1996, SCIENCE, V273, P645, DOI 10.1126/science.273.5275.645; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	44	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e45039	10.1371/journal.pone.0045039	http://dx.doi.org/10.1371/journal.pone.0045039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984605	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000308638700106
J	Pravincumar, P; Bader, DL; Knight, MM				Pravincumar, Priyanka; Bader, Dan L.; Knight, Martin M.			Viscoelastic Cell Mechanics and Actin Remodelling Are Dependent on the Rate of Applied Pressure	PLOS ONE			English	Article							ARTICULAR CHONDROCYTES; DEFORMATION; COMPRESSION; STRESS; CYTOSKELETON; NETWORKS; DYNAMICS; ORGANIZATION; BEHAVIOR; MODEL	Background: Living cells are subjected to external and internal mechanical stresses. The effects of these stresses on the deformation and subsequent biological response of the cells remains unclear. This study tested the hypothesis that the rate at which pressure (or stress) is applied influence the viscoelastic properties of the cell associated with differences in the dynamics of the actin cytoskeleton. Principal Finding: Micropipette aspiration was used to determine the instantaneous and equilibrium moduli and the viscosity of isolated chondrocytes based on the standard linear solid (SLS) model and a variation of this incorporating Boltzmann superposition. Cells were visualised for 180 seconds following aspiration to 7 cmH(2)O at 0.35, 0.70 and 5.48 cmH(2)O/sec. Cell recovery was then examined for a further 180 seconds once the pressure had been removed. Reducing the rate of application of pressure reduced the levels of cell deformation and recovery associated with a significant increase in modulus and viscosity. Using GFP transfection and confocal microscopy, we show that chondrocyte deformation involves distortion, disassembly and subsequent reassembly of the cortical actin cytoskeleton. At faster pressure rates, cell deformation produced an increase in cell volume associated with membrane bleb formation. GFP-actin transfection inhibited the pressure rate dependent variation in cell mechanics indicating that this behaviour is regulated by GFP-sensitive actin dynamics. Conclusion: We suggest that slower rates of aspiration pressure enable greater levels of cortical actin distortion. This is partially inhibited by GFP or faster aspiration rates leading to membrane bleb formation and an increase in cell volume. Thus the rate of application of pressure regulates the viscoelastic mechanical properties of living cells through pressure rate sensitive differences in actin dynamics. Therefore cells appear softer when aspirated at a faster rate in contrast to what is expected of a normal viscoelastic material.	[Pravincumar, Priyanka; Bader, Dan L.; Knight, Martin M.] Queen Mary Univ London, Sch Mat Sci & Engn, Inst Bioengn, London, England	University of London; Queen Mary University London	Pravincumar, P (corresponding author), Queen Mary Univ London, Sch Mat Sci & Engn, Inst Bioengn, London, England.	m.m.knight@qmul.ac.uk	Bader, Dan/ABF-1240-2020	Knight, Martin/0000-0003-3755-1597	UK Platform grant from the Engineering and Physical Sciences Research Council (EPSRC); Queen Mary University of London	UK Platform grant from the Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Queen Mary University of London	The research was partly supported by a UK Platform grant from the Engineering and Physical Sciences Research Council (EPSRC) entitled 'Mechanobiology for Tissue Engineering'. Priyanka Pravincumar is funded on a PhD studentship from Queen Mary University of London. No additional external funding was received for this study.	Bader DL, 2002, BIORHEOLOGY, V39, P69; BUSCHMANN MD, 1995, J CELL SCI, V108, P1497; Campbell JJ, 2007, MICROSC RES TECHNIQ, V70, P1034, DOI 10.1002/jemt.20513; Campbell JJ, 2007, BIOCHEM BIOPH RES CO, V361, P329, DOI 10.1016/j.bbrc.2007.06.185; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Chaudhuri O, 2007, NATURE, V445, P295, DOI 10.1038/nature05459; Chen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012035; Darling EM, 2006, OSTEOARTHR CARTILAGE, V14, P571, DOI 10.1016/j.joca.2005.12.003; Darling EM, 2008, J BIOMECH, V41, P454, DOI 10.1016/j.jbiomech.2007.06.019; Deibler M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022941; DiPaolo BC, 2010, AM J PHYSIOL-CELL PH, V299, pC345, DOI 10.1152/ajpcell.00379.2009; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Guilak F, 1999, OSTEOARTHR CARTILAGE, V7, P59, DOI 10.1053/joca.1998.0162; Guilak F, 2002, BIOPHYS J, V82, P720, DOI 10.1016/S0006-3495(02)75434-9; Haider MA, 2002, J BIOMECH ENG-T ASME, V124, P586, DOI 10.1115/1.1504444; Humphrey D, 2002, NATURE, V416, P413, DOI 10.1038/416413; INGBER DE, 1994, INT REV CYTOL, V150, P173; Janmey PA, 2004, TRENDS BIOCHEM SCI, V29, P364, DOI 10.1016/j.tibs.2004.05.003; Jones WR, 1999, J BIOMECH, V32, P119, DOI 10.1016/S0021-9290(98)00166-3; Keller H, 2002, EXP CELL RES, V277, P161, DOI 10.1006/excr.2002.5552; Keller HU, 2000, CELL MOTIL CYTOSKEL, V46, P247, DOI 10.1002/1097-0169(200008)46:4<247::AID-CM2>3.0.CO;2-8; Ketelaar T, 2004, PLANT PHYSIOL, V136, P3990, DOI 10.1104/pp.104.050799; Knight MM, 2002, BBA-GEN SUBJECTS, V1570, P1, DOI 10.1016/S0304-4165(02)00144-7; Koay EJ, 2003, J BIOMECH ENG-T ASME, V125, P334, DOI 10.1115/1.1572517; Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506; Laster SM, 1996, MICROSC RES TECHNIQ, V34, P272, DOI 10.1002/(SICI)1097-0029(19960615)34:3<272::AID-JEMT10>3.0.CO;2-J; Lee DA, 2000, BIORHEOLOGY, V37, P149; Leipzig ND, 2005, J BIOMECH, V38, P77, DOI 10.1016/j.jbiomech.2004.03.013; Lieleg O, 2009, CHEMPHYSCHEM, V10, P2813, DOI 10.1002/cphc.200900604; Loening AM, 2000, ARCH BIOCHEM BIOPHYS, V381, P205, DOI 10.1006/abbi.2000.1988; LUM H, 1994, AM J PHYSIOL, V267, pL223, DOI 10.1152/ajplung.1994.267.3.L223; Merryman WD, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3049821; Ofek G, 2010, BIOMECH MODEL MECHAN, V9, P153, DOI 10.1007/s10237-009-0166-1; Ohashi T, 2006, BIORHEOLOGY, V43, P201; SATO M, 1990, J BIOMECH ENG-T ASME, V112, P263, DOI 10.1115/1.2891183; SCHROEDER TE, 1978, DEV BIOL, V64, P342, DOI 10.1016/0012-1606(78)90085-4; THERET DP, 1988, J BIOMECH ENG-T ASME, V110, P190, DOI 10.1115/1.3108430; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; Trickey WR, 2004, J ORTHOPAED RES, V22, P131, DOI 10.1016/S0736-0266(03)00150-5; Trickey WR, 2000, J ORTHOPAED RES, V18, P891, DOI 10.1002/jor.1100180607; Wu JZ, 2000, ANN BIOMED ENG, V28, P318, DOI 10.1114/1.271; Xu JY, 2000, J BIOL CHEM, V275, P35886, DOI 10.1074/jbc.M002377200; Zhao RG, 2009, J BIOMECH, V42, P2768, DOI 10.1016/j.jbiomech.2009.07.035	43	50	51	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43938	10.1371/journal.pone.0043938	http://dx.doi.org/10.1371/journal.pone.0043938			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984454	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000308638700035
J	Brodland, GW; Veldhuis, JH				Brodland, G. Wayne; Veldhuis, Jim H.			The Mechanics of Metastasis: Insights from a Computational Model	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; TYPE-1 MATRIX-METALLOPROTEINASE; FINITE-ELEMENT MODEL; TUMOR-CELL; COMPUTER-SIMULATIONS; EMBRYONIC EPITHELIA; SURFACE TENSIONS; FORCE MICROSCOPY; CANCER-CELLS; IN-SILICO	Although it may seem obvious that mechanical forces are required to drive metastatic cell movements, understanding of the mechanical aspects of metastasis has lagged far behind genetic and biochemical knowledge. The goal of this study is to learn about the mechanics of metastasis using a cell-based finite element model that proved useful for advancing knowledge about the forces that drive embryonic cell and tissue movements. Metastasis, the predominant cause of cancer-related deaths, involves a series of mechanical events in which one or more cells dissociate from a primary tumour, migrate through normal tissue, traverse in and out of a multi-layer circulatory system vessel and resettle. The present work focuses on the dissemination steps, from dissociation to circulation. The model shows that certain surface tension relationships must be satisfied for cancerous cells to dissociate from a primary tumour and that these equations are analogous to those that govern dissociation of embryonic cells. For a dissociated cell to then migrate by invadopodium extension and contraction and exhibit the shapes seen in experiments, the invadopodium must generate a contraction equal to approximately twice that produced by the interfacial tension associated with surrounding cells. Intravasation through the wall of a vessel is governed by relationships akin to those in the previous two steps, while release from the vessel wall is governed by equations that involve surface and interfacial tensions. The model raises a number of potential research questions. It also identifies how specific mechanical properties and the sub-cellular structural components that give rise to them might be changed so as to thwart particular metastatic steps and thereby block the spread of cancer.	[Brodland, G. Wayne; Veldhuis, Jim H.] Univ Waterloo, Dept Civil & Environm Engn, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Brodland, GW (corresponding author), Univ Waterloo, Dept Civil & Environm Engn, Waterloo, ON N2L 3G1, Canada.	brodland@uwaterloo.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this project was provided by the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Alaoui-Jamali MA, 2011, AM J TRANSL RES, V3, P434; Andasari V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033726; Baker EL, 2010, BIOPHYS J, V99, P2048, DOI 10.1016/j.bpj.2010.07.051; Baum B, 2008, SEMIN CELL DEV BIOL, V19, P294, DOI 10.1016/j.semcdb.2008.02.001; Benko R, 2007, ANN BIOMED ENG, V35, P672, DOI 10.1007/s10439-006-9250-1; Bravo-Cordero JJ, 2011, CURR OPIN CELL BIOL; Brodland G. W., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P17, DOI 10.1080/10255840600554703; Brodland G. W., 2004, Applied Mechanics Review, V57, P47, DOI 10.1115/1.1583758; Brodland G. Wayne, 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P121, DOI 10.1080/10255840601124704; Brodland G. Wayne, 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P89; Brodland GW, 2010, P NATL ACAD SCI USA, V107, P22111, DOI 10.1073/pnas.1006591107; Brodland GW, 2010, HFSP J, V4, P142, DOI 10.2976/1.3338713; Brodland GW, 2009, HFSP J, V3, P273, DOI 10.2976/1.3175812; Brodland GW, 2006, INT J DEV BIOL, V50, P151, DOI 10.1387/ijdb.052040gb; Brodland GW, 2006, INT J PLASTICITY, V22, P965, DOI 10.1016/j.ijplas.2005.05.002; Brodland GW, 2002, J BIOMECH, V35, P673, DOI 10.1016/S0021-9290(02)00006-4; Brodland GW, 2002, J BIOMECH ENG-T ASME, V124, P188, DOI 10.1115/1.1449491; Brodland GW, 2000, J BIOMECH ENG-T ASME, V122, P402, DOI 10.1115/1.1288205; Brodland GW, 2011, IEEE T BIOMED ENG; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Calorini L, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-24; Chen HH, 2000, J BIOMECH ENG-T ASME, V122, P394, DOI 10.1115/1.1286563; Chen XG, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015003; CLAUSI DA, 1993, DEVELOPMENT, V118, P1013; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; DAVIDSON LA, 1995, DEVELOPMENT, V121, P2005; Davidson LA, 2008, CURR TOP DEV BIOL, V81, P113, DOI 10.1016/S0070-2153(07)81003-9; Eaton S, 2003, MECH DEVELOP, V120, P1257, DOI 10.1016/j.mod.2003.07.002; Eisenberg MC, 2011, P NATL ACAD SCI USA, V108, P20078, DOI 10.1073/pnas.1116327108; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Foty RA, 2004, INT J DEV BIOL, V48, P397, DOI 10.1387/ijdb.041810rf; Foty RA, 1996, DEVELOPMENT, V122, P1611; Geiger TR, 2009, BBA-REV CANCER, V1796, P293, DOI 10.1016/j.bbcan.2009.07.006; Golubkov VS, 2010, J BIOL CHEM, V285, P35740, DOI 10.1074/jbc.M110.165159; Hutson MS, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.148105; Izaguirre JA, 2004, BIOINFORMATICS, V20, P1129, DOI 10.1093/bioinformatics/bth050; Jia DX, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-94; Kam Y, 2012, J CELL PHYSIOL, V227, P431, DOI 10.1002/jcp.22766; Katoh M, 2005, ONCOL REP, V14, P1583; Keller R, 2003, DIFFERENTIATION, V71, P171, DOI 10.1046/j.1432-0436.2003.710301.x; Kerosuo L, 2012, SEMIN CELL DEV BIOL, V23, P320, DOI 10.1016/j.semcdb.2012.03.010; Klein TJ, 2005, ANNU REV CELL DEV BI, V21, P155, DOI 10.1146/annurev.cellbio.21.012704.132806; Krens SFG, 2011, CURR TOP DEV BIOL, V95, P189, DOI 10.1016/B978-0-12-385065-2.00006-2; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Logan D.L., 2011, 1 COURSE FINITE ELEM; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; McGrath DM, 2011, MAGN RESON MED; Menon S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017277; Moss NM, 2009, CANCER RES, V69, P7121, DOI 10.1158/0008-5472.CAN-08-4151; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Palmer TD, 2011, ADV DRUG DELIVER REV, V63, P568, DOI 10.1016/j.addr.2011.04.008; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Preziosi L., 2003, CANC MODELLING SIMUL; Puech PH, 2005, J CELL SCI, V118, P4199, DOI 10.1242/jcs.02547; Ramasubramanian A, 2006, ANN BIOMED ENG, V34, P1355, DOI 10.1007/s10439-006-9152-2; Ramis-Conde I, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/016008; Rejniak KA, 2012, MATH MED BIOL, V29, P1, DOI 10.1093/imammb/dqr029; Rejniak KA, 2011, WIRES SYST BIOL MED, V3, P115, DOI 10.1002/wsbm.102; Said N, 2009, CANCER METAST REV, V28, P327, DOI 10.1007/s10555-009-9197-4; Samavati N, 2011, J PATHOL INFORM, V2, P10; Sandersius SA, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015002; Sawyer CA, 2009, J APPL PHYS, V105, DOI 10.1063/1.3077211; Shibue T, 2011, SEMIN CANCER BIOL, V21, P99, DOI 10.1016/j.semcancer.2010.12.003; Shook D, 2003, MECH DEVELOP, V120, P1351, DOI 10.1016/j.mod.2003.06.005; Steinberg MS, 1997, J CELL PHYSIOL, V173, P135, DOI 10.1002/(SICI)1097-4652(199711)173:2<135::AID-JCP10>3.3.CO;2-Y; Strobl-Mazzulla P.H., 2012, SEMIN CANC BIOL; Swanson KR, 2011, CANCER RES, V71, P7366, DOI 10.1158/0008-5472.CAN-11-1399; Szabo A, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016010; Tanner C, 2011, MED PHYS, V38, P682, DOI 10.1118/1.3525837; Viens D, 2007, J BIOMECH ENG-T ASME, V129, P651, DOI 10.1115/1.2768375; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021	74	19	19	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e44281	10.1371/journal.pone.0044281	http://dx.doi.org/10.1371/journal.pone.0044281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028513	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900007
J	Pozo, C; Guillen-Gosalbez, G; Sorribas, A; Jimenez, L				Pozo, Carlos; Guillen-Gosalbez, Gonzalo; Sorribas, Albert; Jimenez, Laureano			Identifying the Preferred Subset of Enzymatic Profiles in Nonlinear Kinetic Metabolic Models via Multiobjective Global Optimization and Pareto Filters	PLOS ONE			English	Article							BIOCHEMICAL SYSTEMS-ANALYSIS; NORMAL CONSTRAINT METHOD; MULTICRITERIA OPTIMIZATION; ETHANOL; REPRESENTATION; DEFINITION; OPTIMALITY; NETWORKS; STRATEGY; LAW	Optimization models in metabolic engineering and systems biology focus typically on optimizing a unique criterion, usually the synthesis rate of a metabolite of interest or the rate of growth. Connectivity and non-linear regulatory effects, however, make it necessary to consider multiple objectives in order to identify useful strategies that balance out different metabolic issues. This is a fundamental aspect, as optimization of maximum yield in a given condition may involve unrealistic values in other key processes. Due to the difficulties associated with detailed non-linear models, analysis using stoichiometric descriptions and linear optimization methods have become rather popular in systems biology. However, despite being useful, these approaches fail in capturing the intrinsic nonlinear nature of the underlying metabolic systems and the regulatory signals involved. Targeting more complex biological systems requires the application of global optimization methods to non-linear representations. In this work we address the multi-objective global optimization of metabolic networks that are described by a special class of models based on the power-law formalism: the generalized mass action (GMA) representation. Our goal is to develop global optimization methods capable of efficiently dealing with several biological criteria simultaneously. In order to overcome the numerical difficulties of dealing with multiple criteria in the optimization, we propose a heuristic approach based on the epsilon constraint method that reduces the computational burden of generating a set of Pareto optimal alternatives, each achieving a unique combination of objectives values. To facilitate the post-optimal analysis of these solutions and narrow down their number prior to being tested in the laboratory, we explore the use of Pareto filters that identify the preferred subset of enzymatic profiles. We demonstrate the usefulness of our approach by means of a case study that optimizes the ethanol production in the fermentation of Saccharomyces cerevisiae.	[Pozo, Carlos; Guillen-Gosalbez, Gonzalo; Jimenez, Laureano] URV, ETSEQ, Dept Engn Quim EQ, Tarragona, Spain; [Sorribas, Albert] Univ Lleida, Inst Recerca Biomed Lleida IRBLLEIDA, Dept Ciencies Med Basiques, Lleida, Spain	Universitat Rovira i Virgili; Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida	Guillen-Gosalbez, G (corresponding author), URV, ETSEQ, Dept Engn Quim EQ, Tarragona, Spain.	gonzalo.guillen@urv.cat	Guillén-Gosálbez, Gonzalo/G-3531-2016; Fernández, Carlos Pozo/E-1051-2019; Sorribas, Albert/A-2181-2009; Pozo, Carlos/AAQ-3291-2020; Jimenez Esteller, Laureano/F-6782-2011	Guillén-Gosálbez, Gonzalo/0000-0001-6074-8473; Fernández, Carlos Pozo/0000-0002-5645-674X; Sorribas, Albert/0000-0002-7407-4075; Pozo, Carlos/0000-0002-5645-674X; Jimenez Esteller, Laureano/0000-0002-3186-7235	Spanish Ministry of Education and Science [DPI2008-04099, PHB2008-0090-PC, BFU2008-00196, CTQ2009-14420-C02]; Spanish Ministry of External Affairs [HS2007-0006, A/023551/09]; Spanish Ministry of Science and Innovation [ENE2011-28269-C03-03]; Generalitat de Catalunya (FI programs); Spanish Ministry of Education, Culture and Sport (FPU programs)	Spanish Ministry of Education and Science(Spanish Government); Spanish Ministry of External Affairs(Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya (FI programs)(Generalitat de Catalunya); Spanish Ministry of Education, Culture and Sport (FPU programs)	The authors wish to acknowledge support of this research work from the Spanish Ministry of Education and Science (projects DPI2008-04099, PHB2008-0090-PC, BFU2008-00196 and CTQ2009-14420-C02), the Spanish Ministry of External Affairs (projects HS2007-0006 and A/023551/09), the Spanish Ministry of Science and Innovation (ENE2011-28269-C03-03), the Generalitat de Catalunya (FI programs; http://www10.gencat.net/agaur_web/AppJava/a_beca.jsp?categoria=predoctorals&id_beca=16701) and the Spanish Ministry of Education, Culture and Sport (FPU programs; http://www.educacion.gob.es/educacion/universidades/convocatorias/titulados-doctores-profesores/fpu/convocatoria.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM S, 2000, HPL200098 HEWL PACK; Alvarez-Vasquez F, 2000, BIOTECHNOL BIOENG, V70, P82, DOI 10.1002/1097-0290(20001005)70:1&lt;82::AID-BIT10&gt;3.0.CO;2-V; Bergamini ML, 2005, COMPUT CHEM ENG, V29, P1914, DOI 10.1016/j.compchemeng.2005.04.003; Biegler LT, 2004, COMPUT CHEM ENG, V28, P1169, DOI 10.1016/j.compchemeng.2003.11.003; Branke E, 2004, LECT NOTES COMPUT SC, V3242, P722, DOI 10.1007/978-3-540-30217-9_73; Branke J, 2001, ADV ENG SOFTW, V32, P499, DOI 10.1016/S0965-9978(00)00110-1; Branke J., 2004, KNOWLEDGE INCORPORAT, P461; Cheng FY, 1998, AIAA J, V36, P1105, DOI 10.2514/2.488; CLOQUELL V, 1999, THESIS U POLITCNICA; CLOQUELL V, 2001, 17 C NAC ING PROYECT; Das I, 1998, SIAM J OPTIMIZ, V8, P631, DOI 10.1137/S1052623496307510; Das I, 1999, STRUCT OPTIMIZATION, V18, P30, DOI 10.1007/BF01210689; Deb K, 2005, LECT NOTES COMPUT SC, V3410, P150; Deb K., 2005, KANGAL REP, P1; DEB K, 2003, NAT COMP SER, P263; EHRGOTT M, 1998, MULTICRITERIA OPTIMI; Farina M, 2004, IEEE T SYST MAN CY A, V34, P315, DOI 10.1109/TSMCA.2004.824873; Guillen-Gosalbez G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-386; Handl J, 2007, IEEE ACM T COMPUT BI, V4, P279, DOI 10.1109/TCBB.2007.070203; Hatzimanikatis V, 1996, BIOTECHNOL BIOENG, V52, P485, DOI 10.1002/(SICI)1097-0290(19961120)52:4<485::AID-BIT4>3.0.CO;2-L; HEINRICH R, 2005, REGULATION CELLULAR; Kim IK, 2012, FEMS YEAST RES, V12, P228, DOI 10.1111/j.1567-1364.2011.00779.x; Li RD, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S12; Liu PK, 2008, BIOINFORMATICS, V24, P1085, DOI 10.1093/bioinformatics/btn075; Marin-Sanguino A, 2003, MATH BIOSCI, V184, P187, DOI 10.1016/S0025-5564(03)00046-4; Marin-Sanguino A, 2009, MATH BIOSCI, V218, P50, DOI 10.1016/j.mbs.2008.12.010; Mattson CA, 2004, ENG OPTIMIZ, V36, P721, DOI 10.1080/0305215042000274942; Mattson CA, 2003, AIAA J, V41, P1190, DOI 10.2514/2.2063; Messac A, 2004, AIAA J, V42, P2101, DOI 10.2514/1.8977; Messac A, 2003, STRUCT MULTIDISCIP O, V25, P86, DOI 10.1007/s00158-002-0276-1; MONTUSIEWICZ J, 1990, ENG COST PROD ECON, V20, P191, DOI 10.1016/0167-188X(90)90102-N; Parachin NS, 2011, METAB ENG, V13, P508, DOI 10.1016/j.ymben.2011.05.005; Polisetty PK, 2008, BIOTECHNOL BIOENG, V99, P1154, DOI 10.1002/bit.21679; Pozo C, 2011, IND ENG CHEM RES, V50, P5225, DOI 10.1021/ie101368k; Pozo C, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-137; Pozo C, 2010, COMPUT CHEM ENG, V34, P1719, DOI 10.1016/j.compchemeng.2010.03.001; SAVAGEAU MA, 1969, J THEOR BIOL, V25, P370, DOI 10.1016/S0022-5193(69)80027-5; SAVAGEAU MA, 1969, J THEOR BIOL, V25, P365, DOI 10.1016/S0022-5193(69)80026-3; SCHUSTER S, 1991, J MATH BIOL, V29, P443, DOI 10.1007/BF00160471; Sendin JOH, 2010, IET SYST BIOL, V4, P236, DOI 10.1049/iet-syb.2009.0045; Sendin OH, 2006, MATH COMP MODEL DYN, V12, P469, DOI 10.1080/13873950600723442; Sorribas A, 2010, J BIOTECHNOL, V149, P141, DOI 10.1016/j.jbiotec.2010.01.026; Vera J, 2003, BIOTECHNOL BIOENG, V83, P335, DOI 10.1002/bit.10676; Voit E. O., 2000, COMPUTATIONAL ANAL B; Voit EO, 2003, MATH BIOSCI, V182, P81, DOI 10.1016/S0025-5564(02)00162-1; VOIT EO, 1992, BIOTECHNOL BIOENG, V40, P572, DOI 10.1002/bit.260400504; Wu WH, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-145	47	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e43487	10.1371/journal.pone.0043487	http://dx.doi.org/10.1371/journal.pone.0043487			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028457	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388900003
J	During, L; Thorsen, M; Petersen, DSN; Koster, B; Jensen, TH; Holmberg, S				During, Louis; Thorsen, Michael; Petersen, Darima Sophia Njama; Koster, Brian; Jensen, Torben Heick; Holmberg, Steen			MRN1 Implicates Chromatin Remodeling Complexes and Architectural Factors in mRNA Maturation	PLOS ONE			English	Article							NUCLEAR RIBONUCLEOPROTEIN-PARTICLES; SWI/SNF-RELATED COMPLEXES; SACCHAROMYCES-CEREVISIAE; IN-VIVO; PRP19P-ASSOCIATED COMPLEX; PRP19-ASSOCIATED COMPLEX; SPLICEOSOME ACTIVATION; GENE-EXPRESSION; U6 SNRNA; YEAST	A functional relationship between chromatin structure and mRNA processing events has been suggested, however, so far only a few involved factors have been characterized. Here we show that rsc nhp6 Delta Delta mutants, deficient for the function of the chromatin remodeling factor RSC and the chromatin architectural proteins Nhp6A/Nhp6B, accumulate intron-containing pre-mRNA at the restrictive temperature. In addition, we demonstrate that rsc8-ts16 nhp6 Delta Delta cells contain low levels of U6 snRNA and U4/U6 di-snRNA that is further exacerbated after two hours growth at the restrictive temperature. This change in U6 snRNA and U4/U6 di-snRNA levels in rsc8-ts16 nhp6 Delta Delta cells is indicative of splicing deficient conditions. We identify MRN1 (multi-copy suppressor of rsc nhp6 Delta Delta) as a growth suppressor of rsc nhp6 Delta Delta synthetic sickness. Mrn1 is an RNA binding protein that localizes both to the nucleus and cytoplasm. Genetic interactions are observed between 2 mu m-MRN1 and the splicing deficient mutants snt309 Delta, prp3, prp4, and prp22, and additional genetic analyses link MRN1, SNT309, NHP6A/B, SWI/SNF, and RSC supporting the notion of a role of chromatin structure in mRNA processing.	[During, Louis; Thorsen, Michael; Petersen, Darima Sophia Njama; Koster, Brian; Holmberg, Steen] Univ Copenhagen, Dept Biol, Copenhagen BioCtr, Copenhagen, Denmark; [Jensen, Torben Heick] Aarhus Univ, Dept Mol Biol, Ctr mRNP Biogenesis & Metab, DK-8000 Aarhus, Denmark	University of Copenhagen; Aarhus University	Holmberg, S (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen BioCtr, Copenhagen, Denmark.	gensteen@bio.ku.dk	Holmberg, Steen/N-1128-2014; Jensen, Torben H/G-2954-2017	Holmberg, Steen/0000-0002-0262-3207; Jensen, Torben Heick/0000-0001-5127-1239	Faculty of Natural Sciences, University of Copenhagen; Danish National Research Foundation (Grundforskningsfonden); Danish Research Councils; Carlsberg Foundation; Manufacturer Vilhelm Pedersen and Wife Memorial Legacy	Faculty of Natural Sciences, University of Copenhagen; Danish National Research Foundation (Grundforskningsfonden)(Danmarks Grundforskningsfond); Danish Research Councils(Det Frie Forskningsrad (DFF)); Carlsberg Foundation(Carlsberg Foundation); Manufacturer Vilhelm Pedersen and Wife Memorial Legacy	L.D. was supported by a Ph.D. stipend from the Faculty of Natural Sciences, University of Copenhagen, T.H.J. was supported by the Danish National Research Foundation (Grundforskningsfonden), and S.H. was supported by grants from the Danish Research Councils, The Carlsberg Foundation and Manufacturer Vilhelm Pedersen and Wife Memorial Legacy (this support was granted on recommendation from the Novo Nordisk Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand E, 2008, CURR OPIN GENET DEV, V18, P145, DOI 10.1016/j.gde.2008.01.006; Angus-Hill ML, 2001, MOL CELL, V7, P741, DOI 10.1016/S1097-2765(01)00219-2; Anthony JG, 1997, RNA, V3, P1143; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; BLANTON S, 1992, MOL CELL BIOL, V12, P3939, DOI 10.1128/MCB.12.9.3939; Brewster NK, 2001, MOL CELL BIOL, V21, P3491, DOI 10.1128/MCB.21.10.3491-3502.2001; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Cao YX, 1997, MOL CELL BIOL, V17, P3323, DOI 10.1128/MCB.17.6.3323; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; Chai B, 2005, GENE DEV, V19, P1656, DOI 10.1101/gad.1273105; Chan SP, 2005, J BIOL CHEM, V280, P31190, DOI 10.1074/jbc.M505060200; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Chen CH, 2006, RNA, V12, P765, DOI 10.1261/rna.2292106; Chen HR, 1998, MOL CELL BIOL, V18, P2196, DOI 10.1128/MCB.18.4.2196; Chen YIG, 2007, NUCLEIC ACIDS RES, V35, P3928, DOI 10.1093/nar/gkm347; COOPER M, 1995, EMBO J, V14, P2066, DOI 10.1002/j.1460-2075.1995.tb07198.x; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; COSTIGAN C, 1994, MOL CELL BIOL, V14, P2391, DOI 10.1128/MCB.14.4.2391; Dellaire G, 2002, MOL CELL BIOL, V22, P5141, DOI 10.1128/MCB.22.14.5141-5156.2002; Du J, 1998, GENETICS, V150, P987; HERRICK D, 1990, MOL CELL BIOL, V10, P2269, DOI 10.1128/MCB.10.5.2269; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Hsu JM, 2003, MOL CELL BIOL, V23, P3202, DOI 10.1128/MCB.23.9.3202-3215.2003; HU J, 1994, NUCLEIC ACIDS RES, V22, P1724, DOI 10.1093/nar/22.9.1724; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JIMENEZ A, 1973, ANTIMICROB AGENTS CH, V3, P729, DOI 10.1128/AAC.3.6.729; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kruppa M, 2001, MOL CELL, V7, P309, DOI 10.1016/S1097-2765(01)00179-4; Lopez S, 2001, MOL CELL BIOL, V21, P3096, DOI 10.1128/MCB.21.9.3096-3104.2001; Lygerou Z, 1999, MOL CELL BIOL, V19, P2008; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Mayes AE, 1999, EMBO J, V18, P4321, DOI 10.1093/emboj/18.15.4321; MOENNE A, 1990, EMBO J, V9, P271, DOI 10.1002/j.1460-2075.1990.tb08105.x; Moore MJ, 2006, MOL CELL, V24, P903, DOI 10.1016/j.molcel.2006.12.006; Moreira JMA, 1999, EMBO J, V18, P2836, DOI 10.1093/emboj/18.10.2836; Moreira JMA, 2000, EMBO J, V19, P6804, DOI 10.1093/emboj/19.24.6804; Morillon A, 2003, CELL, V115, P425, DOI 10.1016/S0092-8674(03)00880-8; Neugebauer KM, 2002, J CELL SCI, V115, P3865, DOI 10.1242/jcs.00073; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Papoulas O, 2001, P NATL ACAD SCI USA, V98, P5728, DOI 10.1073/pnas.091533398; Parnell TJ, 2008, EMBO J, V27, P100, DOI 10.1038/sj.emboj.7601946; Paull TT, 1996, GENE DEV, V10, P2769, DOI 10.1101/gad.10.21.2769; Raghunathan PL, 1998, SCIENCE, V279, P857, DOI 10.1126/science.279.5352.857; ROSE M, 1984, GENE, V29, P113, DOI 10.1016/0378-1119(84)90172-0; RYMOND BC, 1993, P NATL ACAD SCI USA, V90, P848, DOI 10.1073/pnas.90.3.848; Segref A, 1997, EMBO J, V16, P3256, DOI 10.1093/emboj/16.11.3256; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Soutourina J, 2006, MOL CELL BIOL, V26, P4920, DOI 10.1128/MCB.00415-06; Szerlong H, 2003, EMBO J, V22, P3175, DOI 10.1093/emboj/cdg296; Tardiff DF, 2006, MOL CELL, V24, P917, DOI 10.1016/j.molcel.2006.12.002; Treich I, 1998, NUCLEIC ACIDS RES, V26, P3739, DOI 10.1093/nar/26.16.3739; Tyagi A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000470; VIJAYRAGHAVAN U, 1989, GENE DEV, V3, P1206, DOI 10.1101/gad.3.8.1206; Wang WD, 1998, P NATL ACAD SCI USA, V95, P492, DOI 10.1073/pnas.95.2.492; Wilson B, 2006, GENETICS, V172, P795, DOI 10.1534/genetics.105.047589; Wong MCVL, 2002, MOL CELL BIOL, V22, P4218, DOI 10.1128/MCB.22.12.4218-4229.2002; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706; Xie J, 1998, EMBO J, V17, P2938, DOI 10.1093/emboj/17.10.2938	65	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44373	10.1371/journal.pone.0044373	http://dx.doi.org/10.1371/journal.pone.0044373			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028530	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900022
J	Wang, LY; Li, ST; Dorf, ME				Wang, Lingyan; Li, Shitao; Dorf, Martin E.			NEMO Binds Ubiquitinated TANK-Binding Kinase 1 (TBK1) to Regulate Innate Immune Responses to RNA Viruses	PLOS ONE			English	Article							MEDIATED ANTIVIRAL RESPONSE; I INTERFERON-PRODUCTION; TUMOR-SUPPRESSOR CYLD; KAPPA-B; NEGATIVE REGULATOR; SIGNALING PATHWAY; PROTEIN; IRF3; ACTIVATION; LIGASE	RIG-I-like receptors (RLR) are intracellular sensors utilized by nearly all cell types for recognition of viral RNA, initiation of antiviral defense, and induction of type I interferons (IFN). TBK1 is a critical kinase implicated in RLR-dependent IFN transcription. Posttranslational modification of TBK1 by K63-linked ubiquitin is required for RLR driven signaling. However, the TBK1 ubiquitin acceptor sites and the function of ubiquitinated TBK1 in the signaling cascade are unknown. We now show that TBK1 is ubiquitinated on residues K69, K154, and K372 in response to infection with RNA virus. The K69 and K154 residues are critical for innate antiviral responses and IFN production. Ubiquitinated TBK1 recruits the downstream adaptor NEMO through ubiquitin binding domains. The assembly of the NEMO/TBK1 complex on the mitochondrial protein MAVS leads to activation of TBK1 kinase activity and phosphorylation of the transcription factor, interferon response factor 3. The combined results refine current views of RLR signaling, define the role of TBK1 polyubiquitination, and detail the mechanisms involved in signalosome assembly.	[Wang, Lingyan; Li, Shitao; Dorf, Martin E.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02215 USA	Harvard University; Harvard Medical School	Li, ST (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02215 USA.	shitao_li@hms.harvard.edu; dorf@hms.harvard.edu		Li, Shitao/0000-0002-1398-8519	Public Health Service [AI089829, NS057162, AI099860]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089829, R21AI099860, R56AI089829] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057162] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Public Health Service grants AI089829, NS057162 and AI099860. S.L. is a John and Virginia Kaneb fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alff PJ, 2008, J VIROL, V82, P9115, DOI 10.1128/JVI.00290-08; Barber GN, 2011, CURR OPIN IMMUNOL, V23, P10, DOI 10.1016/j.coi.2010.12.015; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Brennan K, 2010, CURR OPIN MICROBIOL, V13, P503, DOI 10.1016/j.mib.2010.05.007; Clark K, 2011, BIOCHEM J, V434, P93, DOI 10.1042/BJ20101701; Cui J, 2012, NAT IMMUNOL, V13, P387, DOI 10.1038/ni.2239; Di YW, 2008, CELL SIGNAL, V20, P705, DOI 10.1016/j.cellsig.2007.12.007; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Fenner BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008799; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Ikeda F, 2007, EMBO J, V26, P3451, DOI 10.1038/sj.emboj.7601773; Kawagoe T, 2009, NAT IMMUNOL, V10, P965, DOI 10.1038/ni.1771; Kawasaki T, 2011, IMMUNOL REV, V243, P61, DOI 10.1111/j.1600-065X.2011.01048.x; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Koo BK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001221; Lei CQ, 2010, IMMUNITY, V33, P878, DOI 10.1016/j.immuni.2010.11.021; Li ST, 2006, MOL CELL, V24, P497, DOI 10.1016/j.molcel.2006.10.015; Li ST, 2011, IMMUNITY, V35, P426, DOI 10.1016/j.immuni.2011.06.014; Li S, 2009, MOL CELL, V33, P30, DOI 10.1016/j.molcel.2008.11.023; Liu XY, 2011, J IMMUNOL, V187, P2559, DOI 10.4049/jimmunol.1100963; Ma X, 2012, P NATL ACAD SCI US; Ma YJ, 2012, J VIROL, V86, P2188, DOI 10.1128/JVI.05376-11; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; O'Neill LAJ, 2010, CURR BIOL, V20, pR328, DOI 10.1016/j.cub.2010.01.044; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Otsuka M, 2005, HEPATOLOGY, V41, P1004, DOI 10.1002/hep.20666; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Unterstab G, 2005, P NATL ACAD SCI USA, V102, P13640, DOI 10.1073/pnas.0502883102; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Yang K, 2006, MOL BIOL CELL, V17, P1461, DOI 10.1091/mbc.E05-09-0853; Zeng WW, 2009, MOL CELL, V36, P315, DOI 10.1016/j.molcel.2009.09.037; Zhang MY, 2008, J BIOL CHEM, V283, P18621, DOI 10.1074/jbc.M801451200; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465	40	20	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e43756	10.1371/journal.pone.0043756	http://dx.doi.org/10.1371/journal.pone.0043756			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028469	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900009
J	Chen, PP; Douglas, SD; Meshki, J; Tuluc, F				Chen, Panpan; Douglas, Steven D.; Meshki, John; Tuluc, Florin			Neurokinin 1 Receptor Mediates Membrane Blebbing and Sheer Stress-Induced Microparticle Formation in HEK293 Cells	PLOS ONE			English	Article							ENDOTHELIAL MICROPARTICLES; IN-VIVO; EXOSOMES; MICROVESICLES; CANCER; COMMUNICATION; INFORMATION; SECRETION; MECHANISM; DISEASES	Cell-derived microparticles participate in intercellular communication similar to the classical messenger systems of small and macro-molecules that bind to specialized membrane receptors. Microparticles have been implicated in the regulation of a variety of complex physiopathologic processes, such as thrombosis, the control of innate and adaptive immunity, and cancer. The neurokinin 1 receptor (NK1R) is a Gq-coupled receptor present on the membrane of a variety of tissues, including neurons in the central and peripheral nervous system, immune cells, endocrine and exocrine glands, and smooth muscle. The endogenous agonist of NK1R is the undecapeptide substance P (SP). We have previously described intracellular signaling mechanisms that regulate NK1R-mediated rapid cell shape changes in HEK293 cells and U373MG cells. In the present study, we show that the activation of NK1R in HEK293 cells, but not in U373MG cells, leads to formation of sheer-stress induced microparticles that stain positive with the membrane-selective fluorescent dye FM 2-10. SP-induced microparticle formation is independent of elevated intracellular calcium concentrations and activation of NK1R present on HEK293-derived microparticles triggers detectable calcium increase in SP-induced microparticles. The ROCK inhibitor Y27632 and the dynamin inhibitor dynasore inhibited membrane blebbing and microparticle formation in HEK293 cells, strongly suggesting that microparticle formation in this cell type is dependent on membrane blebbing.	[Chen, Panpan; Douglas, Steven D.; Meshki, John; Tuluc, Florin] Childrens Hosp Philadelphia, Res Inst, Div Allergy Immunol, Philadelphia, PA 19104 USA; [Douglas, Steven D.; Tuluc, Florin] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Tuluc, Florin] Childrens Hosp Philadelphia, Res Inst, Flow Cytometry Core Lab, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Chen, PP (corresponding author), Childrens Hosp Philadelphia, Res Inst, Div Allergy Immunol, Philadelphia, PA 19104 USA.	tuluc@email.chop.edu		Douglas, Steven/0000-0002-3748-3603	National Institutes of Health [U01MH090325, R01-MH049981]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grants U01MH090325 and R01-MH049981 (to SDD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Bailey S, 2006, J IMMUNOL METHODS, V311, P220, DOI 10.1016/j.jim.2006.02.005; Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Bhatnagar S, 2007, J BIOL CHEM, V282, P25779, DOI 10.1074/jbc.M702277200; Biro E, 2003, J THROMB HAEMOST, V1, P2561, DOI 10.1046/j.1538-7836.2003.00456.x; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; Castellana D, 2010, THROMB RES, V125, pS84, DOI 10.1016/S0049-3848(10)70021-9; Dignat-George F, 2011, ARTERIOSCL THROM VAS, V31, P27, DOI 10.1161/ATVBAHA.110.218123; Gabriel DA, 2010, SEMIN THROMB HEMOST, V36, P824, DOI 10.1055/s-0030-1267036; Gordon C, 2011, AM J RESP CRIT CARE, V184, P224, DOI 10.1164/rccm.201012-2061OC; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Key NS, 2010, THROMB RES, V125, pS80, DOI 10.1016/S0049-3848(10)70020-7; Lai JP, 2008, P NATL ACAD SCI USA, V105, P12605, DOI 10.1073/pnas.0806632105; Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Mause SF, 2010, CIRC RES, V107, P1047, DOI 10.1161/CIRCRESAHA.110.226456; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Meshki J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025332; Meshki J, 2009, J BIOL CHEM, V284, P9280, DOI 10.1074/jbc.M808825200; Meziani F, 2008, PHARMACOL REP, V60, P75; Montoro-Garcia S, 2011, BASIC RES CARDIOL, V106, P911, DOI 10.1007/s00395-011-0198-4; Morel O, 2011, ARTERIOSCL THROM VAS, V31, P15, DOI 10.1161/ATVBAHA.109.200956; Norman LL, 2010, BIOPHYS J, V99, P1726, DOI 10.1016/j.bpj.2010.07.031; NOVAK EJ, 1994, CYTOMETRY, V17, P135, DOI 10.1002/cyto.990170205; Nusbaum P, 2005, J BIOL CHEM, V280, P5843, DOI 10.1074/jbc.M413405200; Owens AP, 2011, CIRC RES, V108, P1284, DOI 10.1161/CIRCRESAHA.110.233056; Pelchen-Matthews A, 2004, TRENDS MICROBIOL, V12, P310, DOI 10.1016/j.tim.2004.05.004; Porto-Carreiro I, 2005, BLOOD CELL MOL DIS, V35, P143, DOI 10.1016/j.bcmd.2005.06.013; Rak J, 2010, SEMIN THROMB HEMOST, V36, P888, DOI 10.1055/s-0030-1267043; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Tuluc F, 2009, TRENDS IMMUNOL, V30, P271, DOI 10.1016/j.it.2009.03.006; VanWijk MJ, 2003, CARDIOVASC RES, V59, P277, DOI 10.1016/S0008-6363(03)00367-5; Vasina EM, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.94; Wang JG, 2011, BLOOD, V118, P2366, DOI 10.1182/blood-2011-01-330878; Zwicker JI, 2011, ARTERIOSCL THROM VAS, V31, P728, DOI 10.1161/ATVBAHA.109.200964	38	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45322	10.1371/journal.pone.0045322	http://dx.doi.org/10.1371/journal.pone.0045322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024816	gold, Green Published, Green Submitted			2022-12-27	WOS:000308860100074
J	Fang, CY; Huang, SY; Wu, CC; Hsu, HY; Chou, SP; Tsai, CH; Chang, Y; Takada, K; Chen, JY				Fang, Chih-Yeu; Huang, Sheng-Yen; Wu, Chung-Chun; Hsu, Hui-Yu; Chou, Sheng-Ping; Tsai, Ching-Hwa; Chang, Yao; Takada, Kenzo; Chen, Jen-Yang			The Synergistic Effect of Chemical Carcinogens Enhances Epstein-Barr Virus Reactivation and Tumor Progression of Nasopharyngeal Carcinoma Cells	PLOS ONE			English	Article							GENOME INSTABILITY; N-NITROSAMINES; HIGH-FREQUENCY; CLASS-I; EXPRESSION; GENE; EBV; ANTIBODY; ETIOLOGY; CANCER	Seroepidemiological studies imply a correlation between Epstein-Barr virus (EBV) reactivation and the development of nasopharyngeal carcinoma (NPC). N-nitroso compounds, phorbols, and butyrates are chemicals found in food and herb samples collected from NPC high-risk areas. These chemicals have been reported to be risk factors contributing to the development of NPC, however, the underlying mechanism is not fully understood. We have demonstrated previously that low dose N-methyl-N'-nitro-N-nitrosoguanidine (MNNG, 0.1 mu mg/ml) had a synergistic effect with 12-O-tetradecanoylphorbol-13-acetate (TPA) and sodium butyrate (SB) in enhancing EBV reactivation and genome instability in NPC cells harboring EBV. Considering that residents in NPC high-risk areas may contact regularly with these chemical carcinogens, it is vital to elucidate the relation between chemicals and EBV and their contributions to the carcinogenesis of NPC. In this study, we constructed a cell culture model to show that genome instability, alterations of cancer hallmark gene expression, and tumorigenicity were increased after recurrent EBV reactivation in NPC cells following combined treatment of TPA/SB and MNNG. NPC cells latently infected with EBV, NA, and the corresponding EBV-negative cell, NPC-TW01, were periodically treated with MNNG, TPA/SB, or TPA/SB combined with MNNG. With chemically-induced recurrent reactivation of EBV, the degree of genome instability was significantly enhanced in NA cells treated with a combination of TPA/SB and MNNG than those treated individually. The Matrigel invasiveness, as well as the tumorigenicity in mouse, was also enhanced in NA cells after recurrent EBV reactivation. Expression profile analysis by microarray indicates that many carcinogenesis-related genes were altered after recurrent EBV reactivation, and several aberrations observed in cell lines correspond to alterations in NPC lesions. These results indicate that cooperation between chemical carcinogens can enhance the reactivation of EBV and, over recurrent reactivations, lead to alteration of cancer hallmark gene expression with resultant enhancement of tumorigenesis in NPC.	[Fang, Chih-Yeu; Wu, Chung-Chun; Chou, Sheng-Ping; Chen, Jen-Yang] Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan Town, Miaoli County, Taiwan; [Huang, Sheng-Yen] Natl Tsing Hua Univ, Grad Program Biotechnol Med, Hsinchu, Taiwan; [Huang, Sheng-Yen] Natl Hlth Res Inst, Hsinchu, Taiwan; [Huang, Sheng-Yen; Hsu, Hui-Yu] Natl Tsing Hua Univ, Inst Biotechnol, Dept Life Sci, Hsinchu, Taiwan; [Tsai, Ching-Hwa; Chen, Jen-Yang] Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei, Taiwan; [Chang, Yao] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Tainan, Taiwan; [Takada, Kenzo] Hokkaido Univ, Inst Med Genet, Dept Tumor Virol, Sapporo, Hokkaido, Japan	National Health Research Institutes - Taiwan; National Tsing Hua University; National Health Research Institutes - Taiwan; National Tsing Hua University; National Taiwan University; National Health Research Institutes - Taiwan; Hokkaido University	Fang, CY (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan Town, Miaoli County, Taiwan.	cjy@nhri.org.tw	Chen, Jen-Yang/D-2085-2010; Chang, Yao/B-2653-2010; Fang, Chih-Yeu/AAH-5170-2021	Fang, Chih-Yeu/0000-0002-8280-3012	National Health Research Institutes and National Science Council, Taiwan [NSC96-3112-B-400-010, NSC97-3112-B400-007, NSC98-3112-B-400-002, NSC99-3112-B-400-009, NSC101-2325-B-400-023]	National Health Research Institutes and National Science Council, Taiwan	This work was supported in part by National Health Research Institutes and National Science Council, Taiwan (NSC96-3112-B-400-010, NSC97-3112-B400-007, NSC98-3112-B-400-002, NSC99-3112-B-400-009, NSC101-2325-B-400-023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AB RICKINSON, 2001, FIELDS VIROLOGY, P2575; Bahrenberg G, 2000, BIOCHEM BIOPH RES CO, V275, P783, DOI 10.1006/bbrc.2000.3393; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; BOUVIER G, 1991, IARC SCI PUBL, V105, P204; Chan ASC, 2000, CANCER RES, V60, P5365; Chang Y, 1999, J VIROL, V73, P8857, DOI 10.1128/JVI.73.10.8857-8866.1999; Chang YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039217; CHEN JY, 1989, J MED VIROL, V27, P269, DOI 10.1002/jmv.1890270403; CHEN JY, 1985, J MED VIROL, V16, P99, DOI 10.1002/jmv.1890160202; Chien YC, 2001, NEW ENGL J MED, V345, P1877, DOI 10.1056/NEJMoa011610; Chilosi M, 1998, AM J PATHOL, V152, P209; COCHET C, 1993, VIROLOGY, V197, P358, DOI 10.1006/viro.1993.1597; Cordes C, 2011, INT J ONCOL, V39, P185, DOI 10.3892/ijo.2011.1006; Crawford D, 2004, COMMUN ACM, V47, P5, DOI 10.1145/986213.986220; de-The G., 1982, HERPESVIRUSES, P25; DEVATHAIRE F, 1988, INT J CANCER, V42, P176, DOI 10.1002/ijc.2910420206; Dodd LE, 2006, CANCER EPIDEM BIOMAR, V15, P2216, DOI 10.1158/1055-9965.EPI-06-0455; Fang CY, 2009, INT J CANCER, V124, P2016, DOI 10.1002/ijc.24179; Feng BJ, 2007, INT J CANCER, V121, P1550, DOI 10.1002/ijc.22813; Feng P, 2000, J GEN VIROL, V81, P2417, DOI 10.1099/0022-1317-81-10-2417; Hadinoto V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000496; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haverkos HW, 2004, ONCOGENE, V23, P6492, DOI 10.1038/sj.onc.1207822; HEDDLE JA, 1991, ENVIRON MOL MUTAGEN, V18, P277, DOI 10.1002/em.2850180414; HENLE W, 1977, INT J CANCER, V20, P663, DOI 10.1002/ijc.2910200504; Hildesheim A, 2002, J NATL CANCER I, V94, P1780, DOI 10.1093/jnci/94.23.1780; HILDESHEIM A, 1993, EPIDEMIOL REV, V15, P466, DOI 10.1093/oxfordjournals.epirev.a036130; HIRAYAMA T, 1981, PREV MED, V10, P614, DOI 10.1016/0091-7435(81)90051-7; Ho J H, 1972, Adv Cancer Res, V15, P57, DOI 10.1016/S0065-230X(08)60372-3; Hoffmann D, 1996, CRIT REV TOXICOL, V26, P199, DOI 10.3109/10408449609017931; Hsu WL, 2009, CANCER EPIDEM BIOMAR, V18, P1218, DOI 10.1158/1055-9965.EPI-08-1175; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang SY, 2010, CHEM-BIOL INTERACT, V188, P623, DOI 10.1016/j.cbi.2010.09.020; Hui ABY, 1999, INT J CANCER, V82, P498, DOI 10.1002/(SICI)1097-0215(19990812)82:4<498::AID-IJC5>3.0.CO;2-S; IARC, 1997, WORK GROUP EV CARC R, P248; ITO Y, 1980, CANCER RES, V40, P4329; Ivanova T, 2004, INT J CANCER, V108, P882, DOI 10.1002/ijc.11652; Kristensen M, 1991, Ann Acad Med Singap, V20, P597; Lee CP, 2007, J VIROL, V81, P5166, DOI 10.1128/JVI.00120-07; LIN CT, 1990, LAB INVEST, V62, P713; Lo KW, 2004, CANCER CELL, V5, P423, DOI 10.1016/S1535-6108(04)00119-9; LUKA J, 1979, VIROLOGY, V94, P228, DOI 10.1016/0042-6822(79)90455-0; LYNN T, 1973, JPN J EXP MED, V43, P121; MARTELRENOIR D, 1995, J GEN VIROL, V76, P1401, DOI 10.1099/0022-1317-76-6-1401; McDermott AL, 2001, CLIN OTOLARYNGOL, V26, P82, DOI 10.1046/j.1365-2273.2001.00449.x; Mitacek EJ, 1999, CARCINOGENESIS, V20, P133, DOI 10.1093/carcin/20.1.133; Mutirangura A, 1997, BRIT J CANCER, V76, P770, DOI 10.1038/bjc.1997.460; Myzak MC, 2006, CURR DRUG TARGETS, V7, P443, DOI 10.2174/138945006776359467; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; OCKEN PR, 1969, J LIPID RES, V10, P460; OCONNELL JF, 1986, CANCER LETT, V30, P269, DOI 10.1016/0304-3835(86)90051-0; OKANO M, 1988, Clinical Microbiology Reviews, V1, P300; Oraldi M, 2011, CHEM-BIOL INTERACT, V191, P171, DOI 10.1016/j.cbi.2011.01.011; Patel M, 2008, LUNG CANCER, V59, P340, DOI 10.1016/j.lungcan.2007.08.033; POIRIER S, 1987, INT J CANCER, V39, P293, DOI 10.1002/ijc.2910390305; Saeki N, 2010, CLIN CANCER RES, V16, P3533, DOI 10.1158/1078-0432.CCR-09-3169; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; SbihLammali F, 1996, VIROLOGY, V222, P64, DOI 10.1006/viro.1996.0398; Sengupta S, 2006, CANCER RES, V66, P7999, DOI 10.1158/0008-5472.CAN-05-4399; Szaniawska B, 1996, CANCER LETT, V107, P205, DOI 10.1016/0304-3835(96)04369-8; Takano Y, 1999, J PATHOL, V189, P194; Wente MN, 2005, PANCREAS, V31, P119, DOI 10.1097/01.mpa.0000173459.81193.4d; Wong TS, 2002, CLIN CANCER RES, V8, P433; Wu CC, 2010, NUCLEIC ACIDS RES, V38, P1932, DOI 10.1093/nar/gkp1169; Ye L, 2011, CANCER LETT, V307, P6, DOI 10.1016/j.canlet.2011.03.007; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; ZENG Y, 1985, INT J CANCER, V36, P545, DOI 10.1002/ijc.2910360505; ZENG Y, 1985, ADV CANCER RES, V44, P121, DOI 10.1016/S0065-230X(08)60027-5; Zhao ZG, 2004, JPN J CLIN ONCOL, V34, P414, DOI 10.1093/jjco/hyh073; ZOU XN, 1994, INT J CANCER, V59, P155, DOI 10.1002/ijc.2910590202; ZURHAUSEN H, 1978, NATURE, V272, P373	73	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44810	10.1371/journal.pone.0044810	http://dx.doi.org/10.1371/journal.pone.0044810			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024765	gold, Green Submitted, Green Published			2022-12-27	WOS:000308860100023
J	Hansen, AN; Bendiksen, CD; Sylvest, L; Friis, T; Staerk, D; Jorgensen, FS; Olsen, CA; Houen, G				Hansen, Anders N.; Bendiksen, Christine D.; Sylvest, Lene; Friis, Tina; Staerk, Dan; Jorgensen, Flemming Steen; Olsen, Christian A.; Houen, Gunnar			Synthesis and Antiangiogenic Activity of N-Alkylated Levamisole Derivatives	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; THERAPEUTIC IMPLICATIONS; ANGIOGENESIS INHIBITOR; TYROSINE KINASES; CANCER-PATIENTS; IN-VITRO; DISEASE; RESVERATROL; MECHANISMS; SIRT1	Inhibition of angiogenesis is a promising addition to current cancer treatment strategies. Neutralization of vascular endothelial growth factor by monoclonal antibodies is clinically effective but may cause side effects due to thrombosis. Low molecular weight angiogenesis inhibitors are currently less effective than antibody treatment and are also associated with serious side effects. The discovery of new chemotypes with efficient antiangiogenic activity is therefore of pertinent interest. (S)-Levamisole hydrochloride, an anthelminthic drug approved for human use and with a known clinical profile, was recently shown to be an inhibitor of angiogenesis in vitro and exhibited tumor growth inhibition in mice. Here we describe the synthesis and in vitro evaluation of a series of N-alkylated analogues of levamisole with the aim of characterizing structure-activity relationships with regard to inhibition of angiogenesis. N-Methyllevamisole and p-bromolevamisole proved more effective than the parent compound, (S)-levamisole hydrochloride, with respect to inhibition of angiogenesis and induction of undifferentiated cluster morphology in human umbilical vein endothelial cells grown in co-culture with normal human dermal fibroblasts. Interestingly, the cluster morphology caused by N-methyllevamisole was different than the clusters observed for levamisole, and a third "cord-like" morphology resembling that of the known drug suramin was observed for an aniline-containing derivative. New chemotypes exhibiting antiangiogenic effects in vitro are thus described, and further investigation of their underlying mechanism of action is warranted.	[Hansen, Anders N.; Staerk, Dan; Jorgensen, Flemming Steen; Olsen, Christian A.] Univ Copenhagen, Fac Pharmaceut Sci, Dept Med Chem, Copenhagen, Denmark; [Bendiksen, Christine D.; Sylvest, Lene; Friis, Tina; Houen, Gunnar] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark	University of Copenhagen; Statens Serum Institut	Hansen, AN (corresponding author), Univ Copenhagen, Fac Pharmaceut Sci, Dept Med Chem, Copenhagen, Denmark.	cao@kemi.dtu.dk; gh@ssi.dk	Staerk, Dan/X-6110-2018	Staerk, Dan/0000-0003-0074-298X; Houen, Gunnar/0000-0002-5948-4156; Jorgensen, Flemming Steen/0000-0001-8040-2998; Olsen, Christian Adam/0000-0002-2953-8942	Danish Cancer Society; Familien Erichsen's Mindefond; Lundbeck Foundation; Lundbeck Foundation (Young Group Leader Fellowship); Danish Independent Research Council-Natural Sciences [10-080907]; Technical University of Denmark	Danish Cancer Society(Danish Cancer Society); Familien Erichsen's Mindefond; Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation (Young Group Leader Fellowship); Danish Independent Research Council-Natural Sciences; Technical University of Denmark	This work was supported by a scholarship from the Danish Cancer Society (CDB), and by Familien Erichsen's Mindefond (GH). CAO thanks the Lundbeck Foundation for a Young Group Leader Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Birgitte Simonsen (Faculty of Pharmaceutical Sciences) is gratefully acknowledged for assistance with analytical HPLC and optical rotation measurements. Dorthe Tange Olsen, Anne Mortensen, Jon Allan Norring and Brian Hauschildt (Statens Serum Institut) are gratefully acknowledged for technical assistance with the alkaline phosphatase assay and the co-culture assay. C.A.O. thanks the Lundbeck Foundation (Young Group Leader Fellowship), the Danish Independent Research Council-Natural Sciences (Steno Grant No. 10-080907), and the Technical University of Denmark for financial support.	Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; AMERY WKP, 1992, INT J IMMUNOPHARMACO, V14, P481, DOI 10.1016/0192-0561(92)90179-O; Bao P, 2009, J SURG RES, V153, P347, DOI 10.1016/j.jss.2008.04.023; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; BIGG DCH, 1977, J HETEROCYCLIC CHEM, V14, P603, DOI 10.1002/jhet.5570140413; BIGG DCH, 1977, J HETEROCYCLIC CHEM, V14, P607, DOI 10.1002/jhet.5570140414; BIGG DCH, 1977, J HETEROCYCLIC CHEM, V14, P989, DOI 10.1002/jhet.5570140608; Birman VB, 2006, ORG LETT, V8, P1351, DOI 10.1021/ol060065s; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Cabeza JA, 2006, ORGANOMETALLICS, V25, P1831, DOI 10.1021/om060042h; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chang L, 2011, BIOORG MED CHEM LETT, V21, P2297, DOI 10.1016/j.bmcl.2011.02.089; Chong CR, 2007, ACS CHEM BIOL, V2, P263, DOI 10.1021/cb600362d; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Cruciani Gabriele, 2005, MOL INTERACTION FIEL; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; DAMATO RJ, 1994, INVEST OPHTH VIS SCI, V35, P1996; De Bock K, 2011, NAT REV CLIN ONCOL, V8, P393, DOI 10.1038/nrclinonc.2011.83; DEBRABANDER M, 1992, ANTICANCER RES, V12, P177; DEBRABANDER M, 1992, INT J ONCOL, V1, P337; Eskens FALM, 2008, EUR J CANCER, V44, P2350, DOI 10.1016/j.ejca.2008.07.042; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; FOLKMAN J, 1971, J EXP MED, V133, P275, DOI 10.1084/jem.133.2.275; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Friis T, 2003, APMIS, V111, P658, DOI 10.1034/j.1600-0463.2003.1110609.x; Friis Tina, 2005, Angiogenesis, V8, P25, DOI 10.1007/s10456-005-3588-0; Friis T, 2006, APMIS, V114, P211, DOI 10.1111/j.1600-0463.2006.apm_189.x; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Goncalves V, 2007, J MED CHEM, V50, P5135, DOI 10.1021/jm0706970; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; INGBER D, 1990, NATURE, V348, P555, DOI 10.1038/348555a0; Johnson LN, 2009, Q REV BIOPHYS, V42, P1, DOI 10.1017/S0033583508004745; Jones MK, 1999, NAT MED, V5, P1418; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kerbel RS, 2006, SCIENCE, V312, P1171, DOI 10.1126/science.1125950; Ladomery MR, 2007, CANCER LETT, V249, P133, DOI 10.1016/j.canlet.2006.08.015; Li LN, 2009, BIOORGAN MED CHEM, V17, P7290, DOI 10.1016/j.bmc.2009.08.048; MacDonald ML, 2006, NAT CHEM BIOL, V2, P329, DOI 10.1038/nchembio790; MCGILL PE, 1976, LANCET, V1, P149; Nalluri SR, 2008, JAMA-J AM MED ASSOC, V300, P2277, DOI 10.1001/jama.2008.656; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; RAEYMAEK.AH, 1966, J MED CHEM, V9, P545, DOI 10.1021/jm00322a023; ROSENTHAL M, 1977, LANCET, V1, P904; Roskoski R, 2008, BIOCHEM BIOPH RES CO, V375, P287, DOI 10.1016/j.bbrc.2008.07.121; SCHUERMANS Y, 1975, LANCET, V1, P111; Shih T, 2006, CLIN THER, V28, P1779, DOI 10.1016/j.clinthera.2006.11.015; STEVENSON HC, 1991, J CLIN ONCOL, V9, P2052, DOI 10.1200/JCO.1991.9.11.2052; Sylvest L, 2010, APMIS, V118, P49, DOI 10.1111/j.1600-0463.2009.02561.x; Szekanecz Z, 2007, NAT CLIN PRACT RHEUM, V3, P635, DOI 10.1038/ncprheum0647; Taylor RN, 2009, REPROD SCI, V16, P140, DOI 10.1177/1933719108324893; THIENPON.D, 1966, NATURE, V209, P1024, DOI 10.1038/2091084a0; Timar J, 2008, ANTI-CANCER AGENT ME, V8, P462, DOI 10.2174/187152008784533035; Trapp J, 2007, CHEMMEDCHEM, V2, P1419, DOI 10.1002/cmdc.200700003; VANBELLE H, 1976, CLIN CHEM, V22, P972; VANBELLE H, 1976, GEN PHARMACOL, V7, P53, DOI 10.1016/0306-3623(76)90033-1; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; ZANIBONI A, 1990, MED ONCOL TUMOR PHAR, V7, P287	62	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45405	10.1371/journal.pone.0045405	http://dx.doi.org/10.1371/journal.pone.0045405			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024819	Green Published, Green Submitted, gold			2022-12-27	WOS:000308860100077
J	Xue, HP; Lu, Y; Lin, B; Chen, JX; Tang, F; Huang, G				Xue, Huiping; Lu, Yan; Lin, Bing; Chen, Jinxian; Tang, Feng; Huang, Gang			The Effect of XPD/ERCC2 Polymorphisms on Gastric Cancer Risk among Different Ethnicities: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; DNA-REPAIR GENES; NUCLEOTIDE EXCISION-REPAIR; ESOPHAGEAL ADENOCARCINOMA; XPD POLYMORPHISMS; SUSCEPTIBILITY; ASSOCIATION; CARCINOMA; POPULATION; STOMACH	Background: Potential xeroderma pigmentosum group D (XPD), also called excision repair cross-complimentary group two (ERCC2), Lys751Gln and Asp312Asn polymorphisms have been implicated in gastric cancer risk among different ethnicities. Methods: We aimed to explore the effect of XPD Lys751Gln and Asp312Asn polymorphisms on the susceptibility to gastric cancer among different ethnicities through a systematic review and meta-analysis. Each initially included article was scored for quality appraisal. Desirable data were extracted and registered into databases. 13 studies were ultimately eligible for the meta-analysis of Lys751Gln polymorphism and 9 studies for the meta-analysis of Asp312Asn polymorphism. We adopted the most probably appropriate genetic model (recessive model) for both Lys751Gln and Asp312Asn polymorphisms. Potential sources of heterogeneity were sought out via subgroup and sensitivity analyses, and publication biases were estimated. Results: Statistically significant findings were apparently noted in Asians but not in Caucasians for both XPD Lys751Gln and XPD Asp312Asn polymorphisms. A statistically significant finding could be seen in noncardia-type gastric cancer for XPD Lys751Gln polymorphism. A statistically significant finding could also be seen in high quality subgroup, small-and-moderate sample size subgroup, articles published after 2007, or PCR-RFLP genotyping subgroup for XPD Asp312Asn polymorphism. Conclusions: Our meta-analysis indicates that XPD Gln751Gln (CC) genotype and Asn312Asn (AA) genotype may seem to be more susceptible to gastric cancer in Asian populations but not in Caucasian populations, suggesting that the two genotypes may be important biomarkers of gastric cancer susceptibility for Asian populations, the assumption that needs to be further confirmed in well-designed studies among different ethnicities. Gln751Gln (CC) genotype may also be associated with noncardia-type gastric cancer risk, which should also be confirmed among different ethnicities in the future.	[Xue, Huiping] Shanghai Jiao Tong Univ, Minist Hlth,Div Gastroenterol & Hepatol, Key Lab Gastroenterol & Hepatol, Shanghai Inst Digest Dis,Sch Med,Renji Hosp, Shanghai, Peoples R China; [Lu, Yan] Shanghai Jiao Tong Univ, Sch Med, Int Peace Hosp Protect Mother & Child Hlth, Dept Med, Shanghai, Peoples R China; [Lin, Bing] Fudan Univ, Sch Med, Div Nutr, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Chen, Jinxian] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Gen Surg, Shanghai, Peoples R China; [Tang, Feng] Fudan Univ, Sch Med, Huashan Hosp, Div Pathol, Shanghai 200433, Peoples R China; [Huang, Gang] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Nucl Med, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Fudan University; Shanghai Jiao Tong University; Fudan University; Shanghai Jiao Tong University	Xue, HP (corresponding author), Shanghai Jiao Tong Univ, Minist Hlth,Div Gastroenterol & Hepatol, Key Lab Gastroenterol & Hepatol, Shanghai Inst Digest Dis,Sch Med,Renji Hosp, Shanghai, Peoples R China.	xue_huiping@126.com; huanggang_sjumed@163.com			National Natural Science Foundation of China [30830038, 30970842, 81071180]; "973'' Project [2012CB932604]; New Drug Discovery Project [2012ZX09506-001-005]; Key Project of Science and Technology Commission of Shanghai Municipality [10JC1410000]; Shanghai Leading Academic Discipline Project [S30203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "973'' Project(National Basic Research Program of China); New Drug Discovery Project; Key Project of Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work has been supported by The National Natural Science Foundation of China (grants 30830038, 30970842, and 81071180); "973'' Project (2012CB932604); New Drug Discovery Project (2012ZX09506-001-005); the Key Project of Science and Technology Commission of Shanghai Municipality (grants 10JC1410000); and the Shanghai Leading Academic Discipline Project (grant S30203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benhamou S, 2002, MUTAGENESIS, V17, P463, DOI 10.1093/mutage/17.6.463; Camargo MC, 2006, CANCER EPIDEM BIOMAR, V15, P1674, DOI 10.1158/1055-9965.EPI-06-0189; Canbay E, 2010, ANTICANCER RES, V30, P1359; Capella G, 2008, INT J EPIDEMIOL, V37, P1316, DOI 10.1093/ije/dyn145; Chen B, 2011, J CANCER RES CLIN, V137, P939, DOI 10.1007/s00432-010-0956-y; Chen ZP, 2011, MOL BIOL REP, V38, P1507, DOI 10.1007/s11033-010-0258-0; CRABTREE JE, 1995, J CLIN PATHOL, V48, P41, DOI 10.1136/jcp.48.1.41; de Boer J, 2000, CARCINOGENESIS, V21, P453, DOI 10.1093/carcin/21.3.453; Doecke J, 2008, INT J CANCER, V123, P174, DOI 10.1002/ijc.23410; Engin AB, 2011, MOL BIOL REP, V38, P5379, DOI 10.1007/s11033-011-0690-9; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Goode EL, 2002, CANCER EPIDEM BIOMAR, V11, P1513; HEIDL G, 1993, J CANCER RES CLIN, V120, P95, DOI 10.1007/BF01200731; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang WY, 2005, CARCINOGENESIS, V26, P1354, DOI 10.1093/carcin/bgi084; Hwang IR, 2002, GASTROENTEROLOGY, V123, P1793, DOI 10.1053/gast.2002.37043; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Kim MA, 2005, CANCER-AM CANCER SOC, V103, P1439, DOI 10.1002/cncr.20966; Kury S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-326; Long XD, 2010, MOL CARCINOGEN, V49, P611, DOI 10.1002/mc.20630; Lou Y, 2006, SHIJIE HUAREN XIAOHU, V14, P3143; Manuguerra M, 2006, AM J EPIDEMIOL, V164, P297, DOI 10.1093/aje/kwj189; Miller MC, 2001, TOXICOL LETT, V120, P269, DOI 10.1016/S0378-4274(01)00279-X; Minelli C, 2008, INT J EPIDEMIOL, V37, P136, DOI 10.1093/ije/dym234; Palli D, 2010, MUTAGENESIS, V25, P569, DOI 10.1093/mutage/geq042; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Paz-Elizur T, 2008, CANCER LETT, V266, P60, DOI 10.1016/j.canlet.2008.02.032; Ruzzo A, 2007, CLIN CHEM LAB MED, V45, P822, DOI 10.1515/CCLM.2007.143; Saito H, 2006, WORLD J SURG, V30, P1864, DOI 10.1007/s00268-005-0582-z; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; SUNG P, 1993, NATURE, V365, P852, DOI 10.1038/365852a0; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; Wang F, 2008, CANCER EPIDEM BIOMAR, V17, P507, DOI 10.1158/1055-9965.EPI-07-2507; Xue HP, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-102; Xue HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028083; Xue HP, 2011, AM J EPIDEMIOL, V173, P363, DOI 10.1093/aje/kwq378; Xue HP, 2010, J GASTROEN HEPATOL, V25, P1604, DOI 10.1111/j.1440-1746.2010.06428.x; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Ye WM, 2006, CARCINOGENESIS, V27, P1835, DOI 10.1093/carcin/bgl017; Yuan T, 2011, CANCER EPIDEMIOL, V35, P170, DOI 10.1016/j.canep.2010.08.008; Zhang Chuan-Zhen, 2009, Ai Zheng, V28, P1163; Zhou RongMiao, 2007, Tumor, V27, P118	42	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e43431	10.1371/journal.pone.0043431	http://dx.doi.org/10.1371/journal.pone.0043431			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028453	Green Published, Green Submitted, gold			2022-12-27	WOS:000308788700011
J	Hsu, CW; Chuang, SM; Wu, WL; Hou, MH				Hsu, Chun-Wei; Chuang, Show-Mei; Wu, Wen-Ling; Hou, Ming-Hon			The Crucial Role of Divalent Metal Ions in the DNA-Acting Efficacy and Inhibition of the Transcription of Dimeric Chromomycin A3	PLOS ONE			English	Article							BINDING DRUGS MITHRAMYCIN; IN-VITRO; C-MYC; COMPLEX; A(3); CLEAVAGE; ANALOGS; CYTOTOXICITY; SPECIFICITY; POLYAMINES	Chromomycin A3 (Chro) is capable of forming a stable dimeric complex via chelation with Ni(II), Fe(II) and Co(II). According to the circular dichroism study, the dimer conformations are significantly different among the Fe(II)-, Co(II)-, and Ni(II)containing dimeric Chro complexes; however, the dimer conformations were preserved at high temperatures. Furthermore, we conducted a systematic study to determine the effects of these divalent metal ions on the DNA-acting efficacy of dimeric Chro, including its DNA-binding affinity, DNA stabilization capacity, DNA cleavage activity, and the inhibition of transcription both in vitro and within cells. Kinetic analyses using surface plasmon resonance (SPR) showed that Ni-II(Chro)(2) exhibited the highest K-a with a value of 1.26 x 10(7) M-1, which is approximately 1.6- and 3.7-fold higher than the K-a values obtained for Co-II(Chro)(2) and Fe-II(Chro)(2), respectively. The T-m and Delta(G) values for the DNA duplex increased after the addition of drug complexes in the following order: Ni-II(Chro)(2)>Co-II(Chro)(2)>Fe-II(Chro)(2). In the DNA integrity assays, the DNA cleavage rate of Co-II(Chro)(2) (1.26 x 10(-3) s(-1)) is higher than those of Fe-II(Chro)(2) and Ni-II(Chro)(2), which were calculated to be 1 x 10(-4) and 3.1 x 10(-4) s(-1), respectively. Consistent with the SPR and UV melting results, Ni-II(Chro)(2) possesses the highest inhibitory effect on in vitro transcription and c-myc transcription within cells compared to Co-II(Chro)(2) and Fe-II(Chro)(2). By comparing the cytotoxicity among Co-II(Chro)(2), Fe-II(Chro)(2), and Ni-II(Chro)(2) to several cancer cell lines, our studies concluded that Ni-II(Chro)(2) displayed more potential antitumor activities than Co-II(Chro)(2) and Fe-II(Chro)(2) did due to its higher DNA-acting efficacy. Changes to the divalent metal ions in the dimeric Chro complexes have been correlated with improved anticancer profiles. The availability of new metal derivatives of Chro may introduce new possibilities for exploiting the unique properties of this class of compounds for therapeutic applications.	[Hsu, Chun-Wei; Wu, Wen-Ling; Hou, Ming-Hon] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan; [Chuang, Show-Mei] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Wu, Wen-Ling; Hou, Ming-Hon] Natl Chung Hsing Univ, Ctr Biotechnol, Taichung 40227, Taiwan; [Hou, Ming-Hon] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan	National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University	Hsu, CW (corresponding author), Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan.	mhho@dragon.nchu.edu.tw		Chuang, Show-Mei/0000-0003-2986-0736; Hou, Ming-hon/0000-0003-4170-1527	NSC (National Science Council) [100-2113-M-005-004-MY3]	NSC (National Science Council)(Ministry of Science and Technology, Taiwan)	This work was supported by the NSC (National Science Council) grant 100-2113-M-005-004-MY3 to M-HH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AICH P, 1992, BIOCHEMISTRY-US, V31, P2988, DOI 10.1021/bi00126a021; Barcelo F, 2010, BIOCHEMISTRY-US, V49, P10543, DOI 10.1021/bi101398s; Bianchi N, 1997, BIOCHEM J, V326, P919, DOI 10.1042/bj3260919; Bianchi N, 1999, BRIT J HAEMATOL, V104, P258, DOI 10.1046/j.1365-2141.1999.01173.x; CAMPBELL VW, 1994, AM J MED SCI, V307, P167, DOI 10.1097/00000441-199403000-00002; CANTOR CR, 1965, J MOL BIOL, V13, P65, DOI 10.1016/S0022-2836(65)80080-8; Chakrabarti S, 2000, J BIOMOL STRUCT DYN, V18, P209, DOI 10.1080/07391102.2000.10506659; Chang YM, 2012, INT J MOL SCI, V13, P3394, DOI 10.3390/ijms13033394; Chatterjee S, 2001, ANN NEUROL, V49, P345, DOI 10.1002/ana.71.abs; Chen SX, 2011, BIOCHEMISTRY-US, V50, P9340, DOI 10.1021/bi201291p; CONS BMG, 1989, BIOCHEM BIOPH RES CO, V160, P517, DOI 10.1016/0006-291X(89)92463-7; Devi PG, 2007, J INORG BIOCHEM, V101, P127, DOI 10.1016/j.jinorgbio.2006.08.018; DUPRIEST RW, 1973, ONCOLOGY-BASEL, V28, P147; FOLEY JF, 1972, J UROLOGY, V108, P439, DOI 10.1016/S0022-5347(17)60765-1; Gambari R, 2000, J PHARMACOL EXP THER, V294, P370; GAO XL, 1992, J MOL BIOL, V223, P259, DOI 10.1016/0022-2836(92)90730-8; Gao Y, 2011, CANCER RES, V71, P5182, DOI 10.1158/0008-5472.CAN-10-2016; Gochin M, 2000, STRUCT FOLD DES, V8, P441, DOI 10.1016/S0969-2126(00)00124-6; HARDENBOL P, 1992, BIOCHEM BIOPH RES CO, V185, P553, DOI 10.1016/0006-291X(92)91660-I; Hou MH, 2005, NUCLEIC ACIDS RES, V33, P1352, DOI 10.1093/nar/gki276; Hou MH, 2004, NUCLEIC ACIDS RES, V32, P2214, DOI 10.1093/nar/gkh549; Hou MH, 2001, NUCLEIC ACIDS RES, V29, P5121, DOI 10.1093/nar/29.24.5121; Hou MH, 2008, BIOCHEMISTRY-US, V47, P5493, DOI 10.1021/bi701915f; Hou MH, 2009, BIOCHEMISTRY-US, V48, P4691, DOI 10.1021/bi900092w; Huang HW, 1995, BIOCHIMIE, V77, P729, DOI 10.1016/0300-9084(96)88190-9; ITZHAKI L, 1990, BIOPOLYMERS, V29, P481, DOI 10.1002/bip.360290303; KENIRY MA, 1993, J MOL BIOL, V231, P753, DOI 10.1006/jmbi.1993.1324; Lahiri S, 2012, BIOMETALS, V25, P435, DOI 10.1007/s10534-011-9516-4; Lai Michael M. C., 2001, Antiviral Chemistry and Chemotherapy, V12, P143; Lu WJ, 2009, J INORG BIOCHEM, V103, P1626, DOI 10.1016/j.jinorgbio.2009.09.003; Majee S, 1997, BIOCHEMISTRY-US, V36, P2291, DOI 10.1021/bi9613281; MARKY LA, 1987, BIOPOLYMERS, V26, P1601, DOI 10.1002/bip.360260911; Merkel O, 2012, LEUKEMIA; Ming LJ, 2003, MED RES REV, V23, P697, DOI 10.1002/med.10052; Piestrzeniewicz M, 1998, ACTA BIOCHIM POL, V45, P127, DOI 10.18388/abp.1998_4295; Remsing LL, 2003, BIOCHEMISTRY-US, V42, P8313, DOI 10.1021/bi034091z; REUSSER F, 1975, BIOCHIM BIOPHYS ACTA, V383, P266, DOI 10.1016/0005-2787(75)90055-6; Rey NA, 2009, J INORG BIOCHEM, V103, P1323, DOI 10.1016/j.jinorgbio.2009.05.008; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; SASTRY M, 1995, J MOL BIOL, V251, P674, DOI 10.1006/jmbi.1995.0464; SASTRY M, 1993, BIOCHEMISTRY-US, V32, P6588, DOI 10.1021/bi00077a012; Scott D, 2011, INT J NANOMED, V6, P2757, DOI 10.2147/IJN.S25427; Seznec J, 2011, J NEURO-ONCOL, V101, P365, DOI 10.1007/s11060-010-0266-x; SHIRAISHI H, 1993, FREE RADICAL RES COM, V19, P315, DOI 10.3109/10715769309056520; Slavik M, 1975, Adv Pharmacol Chemother, V12, P1, DOI 10.1016/S1054-3589(08)60218-5; Song YM, 2006, J INORG BIOCHEM, V100, P1685, DOI 10.1016/j.jinorgbio.2006.06.001; Wang HF, 2009, EUR J MED CHEM, V44, P4509, DOI 10.1016/j.ejmech.2009.06.019; WHITE RJ, 1989, BIOCHEMISTRY-US, V28, P4277, DOI 10.1021/bi00436a024; Yuann JMP, 2012, BBA-PROTEINS PROTEOM, V1824, P1009, DOI 10.1016/j.bbapap.2012.05.011; ZAJAC AJ, 1985, CLIN EXP RHEUMATOL, V3, P75; Zihlif Malek, 2010, Cancer Genomics & Proteomics, V7, P323	51	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43792	10.1371/journal.pone.0043792	http://dx.doi.org/10.1371/journal.pone.0043792			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984445	gold, Green Published, Green Submitted			2022-12-27	WOS:000308738500023
J	Morrison, C; Simpkins, C; Castley, JG; Buckley, RC				Morrison, Clare; Simpkins, Clay; Castley, J. Guy; Buckley, Ralf C.			Tourism and the Conservation of Critically Endangered Frogs	PLOS ONE			English	Article							PROTECTED AREAS; RELATIVE IMPORTANCE; NATIONAL-PARK; BIODIVERSITY; COSTS; BENEFITS; COVERAGE; PAY	Protected areas are critical for the conservation of many threatened species. Despite this, many protected areas are acutely underfunded, which reduces their effectiveness significantly. Tourism is one mechanism to promote and fund conservation in protected areas, but there are few studies analyzing its tangible conservation outcomes for threatened species. This study uses the 415 IUCN critically endangered frog species to evaluate the contribution of protected area tourism revenue to conservation. Contributions were calculated for each species as the proportion of geographic range inside protected areas multiplied by the proportion of protected area revenues derived from tourism. Geographic ranges were determined from IUCN Extent of Occurrence maps. Almost 60% (239) of critically endangered frog species occur in protected areas. Higher proportions of total range are protected in Nearctic, Australasian and Afrotopical regions. Tourism contributions to protected area budgets ranged from 5-100%. These financial contributions are highest for developing countries in the Afrotropical, Indomalayan and Neotropical regions. Data for both geographic range and budget are available for 201 critically endangered frog species with proportional contributions from tourism to species protection ranging from 0.8-99%. Tourism's financial contributions to critically endangered frog species protection are highest in the Afrotropical region. This study uses a coarse measure but at the global scale it demonstrates that tourism has significant potential to contribute to global frog conservation efforts.	[Morrison, Clare; Castley, J. Guy; Buckley, Ralf C.] Griffith Univ, Griffith Sch Environm, Int Ctr Ecotourism Res, Nathan, Qld 4111, Australia; [Simpkins, Clay] Griffith Univ, Griffith Sch Environm, Environm Futures Ctr, Nathan, Qld 4111, Australia	Griffith University; Griffith University	Morrison, C (corresponding author), Griffith Univ, Griffith Sch Environm, Int Ctr Ecotourism Res, Nathan, Qld 4111, Australia.	c.morrison@griffith.edu.au	Castley, James Guy/A-7056-2010; Buckley, Ralf/G-7032-2014	Castley, James Guy/0000-0002-8418-5828; Buckley, Ralf/0000-0003-0442-5818	Griffith University in the Area of Strategic Investment in Sustainable Tourism	Griffith University in the Area of Strategic Investment in Sustainable Tourism	Funding for this project was provided by Griffith University in the Area of Strategic Investment in Sustainable Tourism. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SUSTAINABLE FINANCIN; [Anonymous], 2010, CONSERVATION TOURISM; Balmford A, 2003, ORYX, V37, P238, DOI 10.1017/S0030605303000413; Balmford A, 2003, P NATL ACAD SCI USA, V100, P1046, DOI 10.1073/pnas.0236945100; Biggs D., 2011, Conservation and Society, V9, P80, DOI 10.4103/0972-4923.79198; Bovarnick A, 2010, FINANCIAL SUSTAINABI; Brooks TM, 2004, BIOSCIENCE, V54, P1081, DOI 10.1641/0006-3568(2004)054[1081:CPBTGP]2.0.CO;2; Bruner AG, 2004, BIOSCIENCE, V54, P1119, DOI 10.1641/0006-3568(2004)054[1119:FCASOM]2.0.CO;2; Buckley R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000143; Buckley RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044134; Castley G, 2010, CONSERVATION TOURISM, P145, DOI 10.1079/9781845936655.0145; Convention on Biological Diversity, 2011, PREAMBL CONV BIOL DI; Eagles P, 2008, 2 M AD HOC OP END WO; Eagles P. F., 2002, SUSTAINABLE TOURISM; Flores M, 2008, FINANCIAL PLANNING N; Fuller RA, 2010, NATURE, V466, P365, DOI 10.1038/nature09180; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; Hall CM, 2010, J HERIT TOUR, V5, P253, DOI 10.1080/1743873X.2010.517843; Hayward MW, 2011, BIODIVERS CONSERV, V20, P2563, DOI 10.1007/s10531-011-0091-3; Herbert ME, 2010, CONSERV BIOL, V24, P1002, DOI 10.1111/j.1523-1739.2010.01460.x; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Isaacs JC, 2000, WILDLIFE SOC B, V28, P61; James A, 2001, BIOSCIENCE, V51, P43, DOI 10.1641/0006-3568(2001)051[0043:CWATCB]2.0.CO;2; James AN, 1999, NATURE, V401, P323, DOI 10.1038/43774; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Kuenzi C, 2008, INT RISK GOV COUNC B, V1, P155; Loucks C, 2008, J BIOGEOGR, V35, P1337, DOI 10.1111/j.1365-2699.2008.01899.x; Mbaiwa JE, 2003, J ARID ENVIRON, V54, P447, DOI 10.1006/jare.2002.1101; McKinney ML, 2002, CONSERV BIOL, V16, P539, DOI 10.1046/j.1523-1739.2002.00442.x; Naidoo R, 2005, P NATL ACAD SCI USA, V102, P16712, DOI 10.1073/pnas.0508036102; Okello MM, 2008, TOURISM MANAGE, V29, P751, DOI 10.1016/j.tourman.2007.08.003; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Rodrigues ASL, 2011, ANIM CONSERV, V14, P108, DOI 10.1111/j.1469-1795.2011.00451.x; Rodrigues Ana S.L., 2008, P125; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Saunders DL, 2002, CONSERV BIOL, V16, P30, DOI 10.1046/j.1523-1739.2002.99562.x; Steven R, 2011, THESIS GRIFFITH U AU; Tisdell C., 2001, Tourism Economics, V7, P233; Turpie J., 2010, SUSTAINABLE FINANCIN; UNDP (United Nations Development Program), 2011, ENV EN PROT AR; United Nations World Tourism Organisation, 2011, TOUR HIGHL; Verissimo D, 2009, ANIM CONSERV, V12, P549, DOI 10.1111/j.1469-1795.2009.00282.x; Vreugdenhil D., 2003, COMPREHENSIVE PROTEC; Walpole MJ, 2001, CONSERV BIOL, V15, P218, DOI 10.1046/j.1523-1739.2001.99231.x; Watson JEM, 2011, CONSERV BIOL, V25, P324, DOI 10.1111/j.1523-1739.2010.01587.x; WDPA Consortium, 2009, WORLD DAT PROT AR; White PCL, 2001, MAMMAL REV, V31, P151, DOI 10.1046/j.1365-2907.2001.00083.x; Wilkie DS, 2001, BIODIVERS CONSERV, V10, P691, DOI 10.1023/A:1016662027017; Wyman M, 2011, FORESTS, V2, P913, DOI 10.3390/f2040913; Zimbabwe Tourism Authority, 2000, ZIMB TOUR TRENDS STA	50	25	27	8	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43757	10.1371/journal.pone.0043757	http://dx.doi.org/10.1371/journal.pone.0043757			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984440	Green Published, gold, Green Submitted			2022-12-27	WOS:000308738500020
J	Hooley, JM; Siegle, G; Gruber, SA				Hooley, Jill M.; Siegle, Greg; Gruber, Staci A.			Affective and Neural Reactivity to Criticism in Individuals High and Low on Perceived Criticism	PLOS ONE			English	Article							EXPRESSED EMOTION; UNIPOLAR DEPRESSION; BEHAVIOR-THERAPY; RELAPSE; AMYGDALA; FMRI; PSYCHOPATHOLOGY; NEUROSCIENCE; PERSPECTIVE; DISORDERS	People who have remitted from depression are at increased risk for relapse if they rate their relatives as being critical of them on a simple self-report measure of Perceived Criticism (PC). To explore neural mechanisms associated with this we used functional magnetic resonance imaging (fMRI) to examine how people with different levels of PC responded to hearing criticism from their own mothers. To maximize variability in affective reactivity, depressed, recovered depressed, and healthy control participants (n = 33) were classified as high or low in PC based on a median split. They were then exposed to personally-relevant critical and praising comments from their mothers. Perceived Criticism levels were unrelated to depression status and to negative mood change after hearing criticism. However, compared to low PC participants, those who scored high on PC showed differential activation in a network of regions associated with emotion reactivity and regulation, including increased amygdala activity and decreased reactions in prefrontal regulatory regions when they heard criticism. This was not the case for praise. Criticism may be a risk factor for relapse because it helps to "train" pathways characteristic of depressive information processing. The Perceived Criticism measure may help identify people who are more susceptible to this vulnerability.	[Hooley, Jill M.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Siegle, Greg] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Gruber, Staci A.] Harvard Univ, McLean Hosp, Sch Med, Cognit & Clin Neuroimaging Core,Brain Imaging Ctr, Belmont, MA USA	Harvard University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; McLean Hospital	Hooley, JM (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	jmh@wjh.harvard.edu	Hooley, Jill M/A-3945-2013	Hooley, Jill M/0000-0002-1162-3540; Gruber, Staci/0000-0002-6921-677X	National Institute of Mental Health [R21MH0066746, MH082998]	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by a grant from the National Institute of Mental Health R21MH0066746) to Jill M. Hooley and MH082998 to Greg Siegle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 2009, HDB DEPRESSION; Beck A., 1987, MANUAL REVISED BECK; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Butzlaff RL, 1998, ARCH GEN PSYCHIAT, V55, P547, DOI 10.1001/archpsyc.55.6.547; Chambless DL, 2009, BEHAV THER, V40, P155, DOI 10.1016/j.beth.2008.05.005; Chambless DL, 1999, J CONSULT CLIN PSYCH, V67, P658, DOI 10.1037/0022-006X.67.5.658; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; Davidson RJ, 2000, AM PSYCHOL, V55, P1196, DOI 10.1037/0003-066X.55.11.1196; De Raedt R, 2010, COGN AFFECT BEHAV NE, V10, P50, DOI 10.3758/CABN.10.1.50; Fales CL, 2008, BIOL PSYCHIAT, V63, P377, DOI 10.1016/j.biopsych.2007.06.012; Fals-Stewart W, 2001, BEHAV THER, V32, P787, DOI 10.1016/S0005-7894(01)80021-6; First M. B., 1997, STRUCTURED CLIN INTE; Hooley JM, 2007, ANNU REV CLIN PSYCHO, V3, P329, DOI 10.1146/annurev.clinpsy.2.022305.095236; Hooley JM, 2006, J FAM PSYCHOL, V20, P386, DOI 10.1037/0893-3200.20.3.386; Hooley JM, 2009, PSYCHIAT RES-NEUROIM, V171, P106, DOI 10.1016/j.pscychresns.2008.04.001; Hooley JM, 2005, BIOL PSYCHIAT, V57, P809, DOI 10.1016/j.biopsych.2005.01.012; HOOLEY JM, 1991, J ABNORM PSYCHOL, V100, P94, DOI 10.1037/0021-843X.100.1.94; HOOLEY JM, 1986, BRIT J PSYCHIAT, V148, P642, DOI 10.1192/bjp.148.6.642; HOOLEY JM, 1989, J ABNORM PSYCHOL, V98, P229, DOI 10.1037/0021-843X.98.3.229; Kwon JH, 2006, CLIN PSYCHOL PSYCHOT, V13, P306, DOI 10.1002/cpp.500; Mayberg HS, 2003, NEUROIMAG CLIN N AM, V13, P805, DOI 10.1016/S1052-5149(03)00104-7; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; O'Farrell TJ, 1998, J CONSULT CLIN PSYCH, V66, P744, DOI 10.1037/0022-006X.66.5.744; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Peterson KM, 2010, J FAM PSYCHOL, V24, P97, DOI 10.1037/a0017950; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Price JL, 2012, TRENDS COGN SCI, V16, P61, DOI 10.1016/j.tics.2011.12.011; Ramel W, 2007, BIOL PSYCHIAT, V61, P231, DOI 10.1016/j.biopsych.2006.05.004; Renshaw KD, 2003, J CLIN PSYCHOL, V59, P411, DOI 10.1002/jclp.10048; Renshaw KD, 2008, CLIN PSYCHOL REV, V28, P521, DOI 10.1016/j.cpr.2007.09.002; Renshaw KD, 2010, BEHAV THER, V41, P364, DOI 10.1016/j.beth.2009.06.003; Schlosser DA, 2010, SCHIZOPHR RES, V118, P69, DOI 10.1016/j.schres.2010.01.017; Segal ZV, 2006, ARCH GEN PSYCHIAT, V63, P749, DOI 10.1001/archpsyc.63.7.749; Siegle GJ, 2006, AM J PSYCHIAT, V163, P735, DOI 10.1176/appi.ajp.163.4.735; Siegle GJ, 2002, BIOL PSYCHIAT, V51, P693, DOI 10.1016/S0006-3223(02)01314-8; Siegle GJ, 2007, BIOL PSYCHIAT, V61, P198, DOI 10.1016/j.biopsych.2006.05.048; Smith DA, 2008, BEHAV THER, V39, P300, DOI 10.1016/j.beth.2007.09.002; Tarrier N, 1999, PSYCHOL MED, V29, P801, DOI 10.1017/S0033291799008569; VAUGHN CE, 1976, BRIT J PSYCHIAT, V129, P125, DOI 10.1192/bjp.129.2.125; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	42	36	37	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44412	10.1371/journal.pone.0044412	http://dx.doi.org/10.1371/journal.pone.0044412			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	003VE	22984504	gold, Green Published, Green Accepted			2022-12-27	WOS:000308638700058
J	Katzenberger, RJ; Rach, EA; Anderson, AK; Ohler, U; Wassarman, DA				Katzenberger, Rebeccah J.; Rach, Elizabeth A.; Anderson, Ashley K.; Ohler, Uwe; Wassarman, David A.			The Drosophila Translational Control Element (TCE) Is Required for High-Level Transcription of Many Genes That Are Specifically Expressed in Testes	PLOS ONE			English	Article							RNA-POLYMERASE-II; DEVELOPMENTAL REGULATION; PROMOTER ELEMENT; CORE PROMOTERS; MESSENGER-RNA; SPERMATOGENESIS; BINDING; MELANOGASTER; TAFS; MECHANISMS	To investigate the importance of core promoter elements for tissue-specific transcription of RNA polymerase II genes, we examined testis-specific transcription in Drosophila melanogaster. Bioinformatic analyses of core promoter sequences from 190 genes that are specifically expressed in testes identified a 10 bp A/T-rich motif that is identical to the translational control element (TCE). The TCE functions in the 59 untranslated region of Mst(3) CGP mRNAs to repress translation, and it also functions in a heterologous gene to regulate transcription. We found that among genes with focused initiation patterns, the TCE is significantly enriched in core promoters of genes that are specifically expressed in testes but not in core promoters of genes that are specifically expressed in other tissues. The TCE is variably located in core promoters and is conserved in melanogaster subgroup species, but conservation dramatically drops in more distant species. In transgenic flies, short (300400 bp) genomic regions containing a TCE directed testis-specific transcription of a reporter gene. Mutation of the TCE significantly reduced but did not abolish reporter gene transcription indicating that the TCE is important but not essential for transcription activation. Finally, mutation of testis-specific TFIID (tTFIID) subunits significantly reduced the transcription of a subset of endogenous TCE-containing but not TCE-lacking genes, suggesting that tTFIID activity is limited to TCE-containing genes but that tTFIID is not an obligatory regulator of TCE-containing genes. Thus, the TCE is a core promoter element in a subset of genes that are specifically expressed in testes. Furthermore, the TCE regulates transcription in the context of short genomic regions, from variable locations in the core promoter, and both dependently and independently of tTFIID. These findings set the stage for determining the mechanism by which the TCE regulates testis-specific transcription and understanding the dual role of the TCE in translational and transcriptional regulation.	[Katzenberger, Rebeccah J.; Anderson, Ashley K.; Wassarman, David A.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, Madison, WI 53715 USA; [Rach, Elizabeth A.; Ohler, Uwe] Duke Univ, Dept Biostat, Inst Genome Sci & Policy, Durham, NC USA; [Rach, Elizabeth A.; Ohler, Uwe] Duke Univ, Dept Bioinformat & Comp Sci, Durham, NC USA	University of Wisconsin System; University of Wisconsin Madison; Duke University; Duke University	Katzenberger, RJ (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, Madison, WI 53715 USA.	uwe.ohler@duke.edu; dawassarman@wisc.edu			National Institutes of Health (NIH) [R01-HG004065]; National Science Foundation (NSF) [MCB-1118456]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004065] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by National Institutes of Health (NIH) grant R01-HG004065 (to U.O.) and National Science Foundation (NSF) grant MCB-1118456 (to D. A. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Che DS, 2005, BIOINFORMATICS, V21, P2909, DOI 10.1093/bioinformatics/bti425; Chen X, 2005, SCIENCE, V310, P869, DOI 10.1126/science.1118101; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DeJong J, 2006, GENE, V366, P39, DOI 10.1016/j.gene.2005.10.012; Down TA, 2007, PLOS COMPUT BIOL, V3, P95, DOI 10.1371/journal.pcbi.0030007; FitzGerald PC, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r53; Freiman RN, 2009, BBA-GENE REGUL MECH, V1789, P161, DOI 10.1016/j.bbagrm.2009.01.005; Gershenzon NI, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-161; GLASER RL, 1986, EMBO J, V5, P747, DOI 10.1002/j.1460-2075.1986.tb04277.x; Goodrich JA, 2010, NAT REV GENET, V11, P549, DOI 10.1038/nrg2847; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Hiller M, 2004, DEVELOPMENT, V131, P5297, DOI 10.1242/dev.01314; Hiller MA, 2001, GENE DEV, V15, P1021, DOI 10.1101/gad.869101; Hochheimer A, 2002, CARBON NANOTUBES LON, V420, P429; Honeycutt E, 2004, GENET RES, V83, P177, DOI 10.1017/S0016672304006780; Jacobi UG, 2007, EMBO J, V26, P3900, DOI 10.1038/sj.emboj.7601822; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Katzenberger RJ, 2006, MOL CELL BIOL, V26, P9256, DOI 10.1128/MCB.01125-06; KEMPE E, 1993, DEV GENET, V14, P449, DOI 10.1002/dvg.1020140606; KUHN R, 1988, EMBO J, V7, P447, DOI 10.1002/j.1460-2075.1988.tb02832.x; Lim CY, 2004, GENE DEV, V18, P1606, DOI 10.1101/gad.1193404; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JI, 2001, DEVELOPMENT, V128, P1671; Metcalf CE, 2007, DEV DYNAM, V236, P2836, DOI 10.1002/dvdy.21294; MICHIELS F, 1989, EMBO J, V8, P1559, DOI 10.1002/j.1460-2075.1989.tb03540.x; Muller F, 2004, EMBO J, V23, P2, DOI 10.1038/sj.emboj.7600027; Ni T, 2010, NAT METHODS, V7, P521, DOI [10.1038/nmeth.1464, 10.1038/NMETH.1464]; Ohler U, 2002, GENOME BIOL, V3, P87, DOI DOI 10.1186/GB-2002-3-12-RESEARCH0087; Ohler U, 2010, DEVELOPMENT, V137, P15, DOI 10.1242/dev.035493; Parisi M, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r40; Rach EA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r73; Reddi PP, 1999, BIOL REPROD, V61, P1256, DOI 10.1095/biolreprod61.5.1256; Renkawitz-Pohl R., 2005, P157; Santel A, 2000, NUCLEIC ACIDS RES, V28, P1439, DOI 10.1093/nar/28.6.1439; Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963; SCHAFER M, 1990, EMBO J, V9, P4519, DOI 10.1002/j.1460-2075.1990.tb07903.x; Schafer M, 1995, DEV BIOL, V172, P344, DOI 10.1006/dbio.1995.8049; Skawran B, 2005, MOL CELL BIOCHEM, V276, P159, DOI 10.1007/s11010-005-3801-x; Tora L, 2002, GENE DEV, V16, P673, DOI 10.1101/gad.976402; White-Cooper H, 2010, REPRODUCTION, V139, P11, DOI 10.1530/REP-09-0083; Yamashita A, 2008, GENE, V427, P93, DOI 10.1016/j.gene.2008.08.018	46	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e45009	10.1371/journal.pone.0045009	http://dx.doi.org/10.1371/journal.pone.0045009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984601	Green Submitted, Green Published, gold			2022-12-27	WOS:000308638700103
J	Patel, TR; Butler, G; McFarlane, A; Xie, I; Overall, CM; Stetefeld, J				Patel, Trushar R.; Butler, Georgina; McFarlane, Ainsley; Xie, Irene; Overall, Christopher M.; Stetefeld, Joerg			Site Specific Cleavage Mediated by MMPs Regulates Function of Agrin	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; BASAL LAMINA; BINDING; DOMAIN; RECEPTOR; DYSTROGLYCAN; ACTIVATION; EXPRESSION; INHIBITORS; MECHANISM	Background: Agrin is the key inducer of postsynaptic differentiations at the neuromuscular junction. The multidomain heparan sulfate proteoglycan is mediating via its N-terminal segment the interaction with laminin, whereas the C-terminal portion is responsible for Dystroglycan binding and clustering of the Acetylcholine receptor. Matrix metalloproteinases (MMP) are known to play essential roles in matrix remodeling, degradation and regulation of extracellular signaling networks. Principal Findings: Site-specific processing of Agrin provides key insight into regulatory effects of Matrix metalloproteinases (MMPs). Here, we present a detailed study of agrin processing by different MMPs together with a molecular understanding of binding and cleavage at both terminal fragments. The data suggest for a regulatory effect of MMP cleavage at particularly important functional sites of agrin. Cleave of agrin abolishes the agrin-laminin complex formation and the Acetylcholine receptor clustering at the neuromuscular junction. Conclusion/Significance: Agrin is a target of specific MMP processing resulting in agrin subfragments with different regulatory activities. MMP processing is a powerful tool to regulate extracellular signaling networks.	[Patel, Trushar R.; McFarlane, Ainsley; Xie, Irene; Stetefeld, Joerg] Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada; [Butler, Georgina; Overall, Christopher M.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V5Z 1M9, Canada	University of Manitoba; University of British Columbia	Patel, TR (corresponding author), Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada.	stetefel@cc.umanitoba.ca	Patel, Trushar R/F-2776-2011; Stetefeld, Joerg/H-7630-2017; Patel, Trushar R./AAB-6250-2020; Butler, Georgina/GQP-7553-2022	Patel, Trushar R/0000-0003-0627-2923; Stetefeld, Joerg/0000-0003-1478-3248; Patel, Trushar R./0000-0003-0627-2923; Butler, Georgina/0000-0003-1172-1578	Canadian Institute of Health Research (CIHR); Manitoba Institute of Child Health	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Manitoba Institute of Child Health	This work was supported by an Operating Grant from the Canadian Institute of Health Research (CIHR) and the Manitoba Institute of Child Health. TRP is a CIHR postdoctoral fellow and JS is a Canada Research Chair in Structural Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banyai L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010758; Bertini I, 2006, ANGEW CHEM INT EDIT, V45, P7952, DOI 10.1002/anie.200603100; Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURDEN SJ, 1979, J CELL BIOL, V82, P412, DOI 10.1083/jcb.82.2.412; Burgess RW, 2000, J CELL BIOL, V151, P41, DOI 10.1083/jcb.151.1.41; Butler GS, 2009, BIOCHEMISTRY-US, V48, P10830, DOI 10.1021/bi901656f; Dean RA, 2007, MOL CELL BIOL, V27, P8454, DOI 10.1128/MCB.00821-07; Denzer AJ, 1997, J CELL BIOL, V137, P671, DOI 10.1083/jcb.137.3.671; DENZER AJ, 1995, J CELL BIOL, V131, P1547, DOI 10.1083/jcb.131.6.1547; Denzer AJ, 1997, CELL TISSUE RES, V290, P357, DOI 10.1007/s004410050941; Fowlkes John L., 1995, Progress in Growth Factor Research, V6, P255, DOI 10.1016/0955-2235(95)00017-8; FUKAI F, 1995, BIOCHEMISTRY-US, V34, P11453, DOI 10.1021/bi00036a018; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Hilgenberg LGW, 2006, CELL, V125, P359, DOI 10.1016/j.cell.2006.01.052; Iyer S, 2007, J BIOL CHEM, V282, P364, DOI 10.1074/jbc.M607625200; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Kleiner DE, 1999, CANCER CHEMOTH PHARM, V43, pS42, DOI 10.1007/s002800051097; Luckman SP, 2011, AUTOIMMUN DIS, V2011, DOI 10.4061/2011/151258; Mascarenhas JB, 2005, MATRIX BIOL, V23, P507, DOI 10.1016/j.matbio.2004.11.003; Mascarenhas JB, 2003, EMBO J, V22, P529, DOI 10.1093/emboj/cdg041; Maskos K, 2003, MOL BIOTECHNOL, V25, P241, DOI 10.1385/MB:25:3:241; McFarlane AA, 2009, PROTEIN SCI, V18, P2421, DOI 10.1002/pro.276; Moll J, 2001, NATURE, V413, P302, DOI 10.1038/35095054; Morrison CJ, 2009, CURR OPIN CELL BIOL, V21, P645, DOI 10.1016/j.ceb.2009.06.006; MURPHY G, 1982, BIOCHEM J, V203, P209, DOI 10.1042/bj2030209; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Neumann FR, 2001, MOL CELL NEUROSCI, V17, P208, DOI 10.1006/mcne.2000.0932; Noell S, 2012, CELL TISSUE RES, V347, P429, DOI 10.1007/s00441-011-1321-4; Philippsen A, 2005, ACTA CRYSTALLOGR D, V61, P374, DOI 10.1107/S0907444904034390; Reif R, 2007, FASEB J, V21, P3468, DOI 10.1096/fj.07-8800com; Scotton P, 2006, J BIOL CHEM, V281, P36835, DOI 10.1074/jbc.M607887200; Sole S, 2004, J NEUROPATH EXP NEUR, V63, P338, DOI 10.1093/jnen/63.4.338; Stetefeld J, 2005, TRENDS BIOCHEM SCI, V30, P515, DOI 10.1016/j.tibs.2005.07.001; Stetefeld J, 2004, STRUCTURE, V12, P503, DOI 10.1016/j.str.2004.02.001; Stetefeld J, 2001, NAT STRUCT BIOL, V8, P705, DOI 10.1038/90422; VanSaun M, 2000, J NEUROBIOL, V43, P140, DOI 10.1002/(SICI)1097-4695(200005)43:2<140::AID-NEU4>3.3.CO;2-B; Vansaun M, 2003, J NEUROCYTOL, V32, P1129, DOI 10.1023/B:NEUR.0000021907.68461.9c; Wang H, 2012, SYNAPSE; Werle MJ, 2003, J NEUROCYTOL, V32, P905, DOI 10.1023/B:NEUR.0000020631.69804.f5	43	21	22	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43669	10.1371/journal.pone.0043669	http://dx.doi.org/10.1371/journal.pone.0043669			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984437	Green Published, gold, Green Submitted			2022-12-27	WOS:000308638700026
J	Yermakova, A; Vance, DJ; Mantis, NJ				Yermakova, Anastasiya; Vance, David J.; Mantis, Nicholas J.			Sub-Domains of Ricin's B Subunit as Targets of Toxin Neutralizing and Non-Neutralizing Monoclonal Antibodies	PLOS ONE			English	Article							GALACTOSE-BINDING; A-CHAIN; EUKARYOTIC RIBOSOMES; LECTINS ABRIN; IN-VITRO; TOXICITY; MICE; IDENTIFICATION; INTOXICATION; MECHANISM	The B subunit (RTB) of ricin toxin is a galactose (Gal)-/N-acetylgalactosamine (GalNac)-specific lectin that mediates attachment, entry, and intracellular trafficking of ricin in host cells. Structurally, RTB consists of two globular domains with identical folding topologies. Domains 1 and 2 are each comprised of three homologous sub-domains (alpha, beta, gamma) that likely arose by gene duplication from a primordial carbohydrate recognition domain (CRD), although only sub-domains 1 alpha and 2 gamma retain functional lectin activity. As part of our ongoing effort to generate a comprehensive B cell epitope map of ricin, we report the characterization of three new RTB-specific monoclonal antibodies (mAbs). All three mAbs, JB4, B/J F9 and C/M A2, were initially identified based on their abilities to neutralize ricin in a Vero cell cytotoxicty assay and to partially (or completely) block ricin attachment to cell surfaces. However, only JB4 proved capable of neutralizing ricin in a macrophage apoptosis assay and in imparting passive immunity to mice in a model of systemic intoxication. Using a combination of techniques, including competitive ELISAs, pepscan analysis, differential reactivity by Western blot, as well as affinity enrichment of phage displayed peptides, we tentatively localized the epitopes recognized by the non-neutralizing mAbs B/J F9 and C/M A2 to sub-domains 2 alpha and 2 beta, respectively. Furthermore, we propose that the epitope recognized by JB4 is within sub-domain 2 gamma, adjacent to RTB's high affinity Gal/GalNAc CRD. These data suggest that recognition of RTB's subdomains 1 alpha and 2 gamma are critical determinants of antibody neutralizing activity and protective immunity to ricin.	[Yermakova, Anastasiya; Vance, David J.; Mantis, Nicholas J.] New York State Dept Hlth, Wadsworth Ctr, Div Infect Dis, Albany, NY USA; [Yermakova, Anastasiya; Mantis, Nicholas J.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Yermakova, A (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Div Infect Dis, Albany, NY USA.	nmantis@wadsworth.org	Vance, David/ABF-5998-2020	Vance, David/0000-0002-9913-7722; Mantis, Nicholas/0000-0002-5083-8640	National Institutes of Health (USA) [AI081053, AI097688]; Wadsworth Center's Biodefense and Emerging Infectious Diseases program [T32AI055429]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI097688, T32AI055429, R21AI081053] Funding Source: NIH RePORTER	National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wadsworth Center's Biodefense and Emerging Infectious Diseases program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported through National Institutes of Health (USA) grants AI081053 and AI097688 to NJM. AY was the recipient of a pre-doctoral fellowship from the Wadsworth Center's Biodefense and Emerging Infectious Diseases program (T32AI055429; PI-McDonough). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audi J, 2005, JAMA-J AM MED ASSOC, V294, P2342, DOI 10.1001/jama.294.18.2342; CHANH TC, 1995, VACCINE, V13, P479, DOI 10.1016/0264-410X(94)00020-N; CHANH TC, 1993, IMMUNOL INVEST, V22, P63, DOI 10.3109/08820139309066194; COLOMBATTI M, 1986, HYBRIDOMA, V5, P9, DOI 10.1089/hyb.1986.5.9; COLOMBATTI M, 1987, J IMMUNOL, V138, P3339; Dai JX, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.196584; Dertzbaugh MT, 2005, HYBRIDOMA, V24, P236, DOI 10.1089/hyb.2005.24.236; ENDO Y, 1987, J BIOL CHEM, V262, P8128; ENDO Y, 1987, J BIOL CHEM, V262, P5908; FODSTAD O, 1976, BRIT J CANCER, V34, P418, DOI 10.1038/bjc.1976.187; FRANZ DR, 1997, TXB MILITARY MED, P631; Furukawa-Stoffer TL, 1999, HYBRIDOMA, V18, P505; Gage E, 2011, TOXINS, V3, P1131, DOI 10.3390/toxins3091131; Guo JW, 2006, HYBRIDOMA, V25, P225, DOI 10.1089/hyb.2006.25.225; Guo JW, 2005, HYBRIDOMA, V24, P263, DOI 10.1089/hyb.2005.24.263; KATZIN BJ, 1991, PROTEINS, V10, P251, DOI 10.1002/prot.340100309; Kelly-Cirino CD, 2009, INFECT IMMUN, V77, P4859, DOI 10.1128/IAI.00117-09; LEMLEY PV, 1994, HYBRIDOMA, V13, P417, DOI 10.1089/hyb.1994.13.417; Maddaloni M, 2004, J IMMUNOL, V172, P6221, DOI 10.4049/jimmunol.172.10.6221; Mantis NJ, 2006, INFECT IMMUN, V74, P3455, DOI 10.1128/IAI.02088-05; Mantis NJ, 2005, ADV DRUG DELIVER REV, V57, P1424, DOI 10.1016/j.addr.2005.01.017; McGuinness CR, 2006, INFECT IMMUN, V74, P3463, DOI 10.1128/IAI.00324-06; MONTFORT W, 1987, J BIOL CHEM, V262, P5398; Neal LM, 2011, VACCINE, V29, P681, DOI 10.1016/j.vaccine.2010.11.030; Neal LM, 2010, INFECT IMMUN, V78, P552, DOI 10.1128/IAI.00796-09; NEWTON DL, 1992, J BIOL CHEM, V267, P11917; O'Hara JM, 2012, CURR TOP MICROBIOL, V357, P209, DOI 10.1007/82_2011_193; O'Hara JM, 2010, VACCINE, V28, P7035, DOI 10.1016/j.vaccine.2010.08.020; Olsnes S, 2004, TOXICON, V44, P361, DOI 10.1016/j.toxicon.2004.05.003; Pauly D, 2009, ANALYST, V134, P2028, DOI 10.1039/b911525k; Pelat T, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-60; Pincus SH, 2002, COMPARATIVE MED, V52, P530; Prigent J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020166; ROBERTS LM, 1985, J BIOL CHEM, V260, P5682; RUTENBER E, 1987, NATURE, V326, P624, DOI 10.1038/326624a0; RUTENBER E, 1991, PROTEINS, V10, P240, DOI 10.1002/prot.340100308; SANDVIG K, 1976, J BIOL CHEM, V251, P3977; SIMMONS BM, 1986, J BIOL CHEM, V261, P7912; Smallshaw JE, 2002, VACCINE, V20, P3422, DOI 10.1016/S0264-410X(02)00312-2; Smallshaw JE, 2012, CURR TOP MICROBIOL, V357, P259, DOI 10.1007/82_2011_156; Spooner RA, 2012, CURR TOP MICROBIOL, V357, P19, DOI 10.1007/82_2011_154; Stirpe F, 2004, TOXICON, V44, P371, DOI 10.1016/j.toxicon.2004.05.004; SWIMMER C, 1992, P NATL ACAD SCI USA, V89, P3756, DOI 10.1073/pnas.89.9.3756; Wang YG, 2007, BIOTECHNOL LETT, V29, P1811, DOI 10.1007/s10529-007-9478-3; Yermakova A, 2011, VACCINE, V29, P7925, DOI 10.1016/j.vaccine.2011.08.075; ZENTZ C, 1978, BIOCHIM BIOPHYS ACTA, V536, P18, DOI 10.1016/0005-2795(78)90047-8	46	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44317	10.1371/journal.pone.0044317	http://dx.doi.org/10.1371/journal.pone.0044317			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984492	gold, Green Submitted, Green Published			2022-12-27	WOS:000308638700054
J	Giakoumis, D; Drosou, A; Cipresso, P; Tzovaras, D; Hassapis, G; Gaggioli, A; Riva, G				Giakoumis, Dimitris; Drosou, Anastasios; Cipresso, Pietro; Tzovaras, Dimitrios; Hassapis, George; Gaggioli, Andrea; Riva, Giuseppe			Using Activity-Related Behavioural Features towards More Effective Automatic Stress Detection	PLOS ONE			English	Article							EMOTION; RECOGNITION; INTELLIGENCE	This paper introduces activity-related behavioural features that can be automatically extracted from a computer system, with the aim to increase the effectiveness of automatic stress detection. The proposed features are based on processing of appropriate video and accelerometer recordings taken from the monitored subjects. For the purposes of the present study, an experiment was conducted that utilized a stress-induction protocol based on the stroop colour word test. Video, accelerometer and biosignal (Electrocardiogram and Galvanic Skin Response) recordings were collected from nineteen participants. Then, an explorative study was conducted by following a methodology mainly based on spatiotemporal descriptors (Motion History Images) that are extracted from video sequences. A large set of activity-related behavioural features, potentially useful for automatic stress detection, were proposed and examined. Experimental evaluation showed that several of these behavioural features significantly correlate to self-reported stress. Moreover, it was found that the use of the proposed features can significantly enhance the performance of typical automatic stress detection systems, commonly based on biosignal processing.	[Giakoumis, Dimitris; Tzovaras, Dimitrios] Ctr Res & Technol Hellas, Informat & Telemat Inst, Thessaloniki, Greece; [Giakoumis, Dimitris; Hassapis, George] Aristotle Univ Thessaloniki, Dept Elect & Comp Engn, GR-54006 Thessaloniki, Greece; [Drosou, Anastasios] Univ London Imperial Coll Sci Technol & Med, Dept Elect & Elect Engn, London, England; [Cipresso, Pietro; Gaggioli, Andrea; Riva, Giuseppe] IRCCS Ist Auxol Italiano, Appl Technol Neuropsychol Lab, Milan, Italy; [Gaggioli, Andrea; Riva, Giuseppe] Catholic Univ, Dept Psychol, Milan, Italy	Centre for Research & Technology Hellas; Aristotle University of Thessaloniki; Imperial College London; IRCCS Istituto Auxologico Italiano; Catholic University of the Sacred Heart	Giakoumis, D (corresponding author), Ctr Res & Technol Hellas, Informat & Telemat Inst, Thessaloniki, Greece.	dgiakoum@iti.gr	Drosou, Anastasios/AAV-5969-2020; Riva, Giuseppe/C-5917-2008; Gaggioli, Andrea/B-4643-2013; Hassapis, George/Y-6975-2019; Cipresso, Pietro/G-4676-2011; Tzovaras, Dimitrios/ABB-9576-2021; Gaggioli, Andrea/AAA-2678-2020	Riva, Giuseppe/0000-0003-3657-106X; Gaggioli, Andrea/0000-0001-7818-7598; Cipresso, Pietro/0000-0002-0662-7678; Tzovaras, Dimitrios/0000-0001-6915-6722; Gaggioli, Andrea/0000-0001-7818-7598; Giakoumis, Dimitrios/0000-0003-1844-186X	European project, "INTERSTRESS - Interreality in the management and treatment of stress-related disorders'' [FP7-247685]	European project, "INTERSTRESS - Interreality in the management and treatment of stress-related disorders''	This study has been made possible thanks to partial funding from European project, "INTERSTRESS - Interreality in the management and treatment of stress-related disorders'' (FP7-247685). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amighi-Kestenberg J, 1999, MEANING MOVEMENT DEV; Barreto A, 2007, LECT NOTES COMPUT SC, V4796, P29; Bobick AF, 2001, IEEE T PATTERN ANAL, V23, P257, DOI 10.1109/34.910878; Chajut E, 2003, J PERS SOC PSYCHOL, V85, P231, DOI 10.1037/0022-3514.85.2.231; Chechko N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005537; Chrousos GP, 1998, J CLIN ENDOCR METAB, V83, P1842, DOI 10.1210/jc.83.6.1842; Cipresso P., 2011, 2011 5th International Conference on Pervasive Computing Technologies for Healthcare (PervasiveHealth 2011), P320, DOI 10.4108/icst.pervasivehealth.2011.246018; COHEN S, 1995, PSYCHOSOM MED, V57, P423, DOI 10.1097/00006842-199509000-00002; Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685; Comaniciu D, 2000, PROC CVPR IEEE, P142, DOI 10.1109/CVPR.2000.854761; Damasio AR, 2003, LOOKING SPINOZA JOY; EKMAN P, 1979, ANNU REV PSYCHOL, V30, P527, DOI 10.1146/annurev.ps.30.020179.002523; FRIESEN WV, 1979, J NONVERBAL BEHAV, V4, P97, DOI 10.1007/BF01006354; Gaggioli A, 2013, PERS UBIQUIT COMPUT, V17, P241, DOI 10.1007/s00779-011-0465-2; Giakoumis D, 2011, IEEE T AFFECT COMPUT, V2, P119, DOI 10.1109/T-AFFC.2011.4; Gillham, 2008, DEV QUESTIONNAIRE RE; Glowinski D, 2011, IEEE T AFFECT COMPUT, V2, P106, DOI 10.1109/T-AFFC.2011.7; Goldberger L, 1993, HDB STRESS; Healey JA, 2005, IEEE T INTELL TRANSP, V6, P156, DOI 10.1109/TITS.2005.848368; Hickey L, 1996, J PSYCHOSOM RES, V40, P553, DOI 10.1016/0022-3999(95)00558-7; HOBFOLL SE, 1989, AM PSYCHOL, V44, P513, DOI 10.1037/0003-066X.44.3.513; JENSEN AR, 1981, CC/SOC BEHAV SCI, P20; Kapoor A, 2007, INT J HUM-COMPUT ST, V65, P724, DOI 10.1016/j.ijhcs.2007.02.003; Karthikeyan P., 2011, 2011 Proceedings of IEEE 7th International Colloquium on Signal Processing & its Applications (CSPA 2011), P420, DOI 10.1109/CSPA.2011.5759914; KENDON A, 1972, AM J PSYCHOL, V85, P441, DOI 10.2307/1420845; Kestenberg J., 1979, ROLE MOVEMENT PATTER; Kim J, 2008, IEEE T PATTERN ANAL, V30, P2067, DOI 10.1109/TPAMI.2008.26; La Barre F, 2011, CLIN SOC WORK J, V39, P180, DOI 10.1007/s10615-010-0284-3; Levy DM, 1944, AM J ORTHOPSYCHIAT, V14, P644, DOI 10.1111/j.1939-0025.1944.tb06500.x; Liang Wen Chien, 2007, 2007 INT C GER TECHN; Lupien SJ, 2007, BRAIN COGNITION, V65, P209, DOI 10.1016/j.bandc.2007.02.007; MacLeod CM, 2000, TRENDS COGN SCI, V4, P383, DOI 10.1016/S1364-6613(00)01530-8; Magagnin V, 2010, COMPUT CARDIOL CONF, V37, P145; Martinez HP, 2010, ARTHROSCOPIC TECHNIQ, P15; Mauri M, 2010, IEEE ENG MED BIO, P3563, DOI 10.1109/IEMBS.2010.5627465; McNeill D, 2005, GESTURE THOUGHT, Vxii; MEHRABIAN A, 1969, PSYCHOL BULL, V71, P359, DOI 10.1037/h0027349; Mehrabian Albert, 2007, NONVERBAL COMMUNICAT, V1st; PEACOCK EJ, 1990, STRESS MEDICINE, V6, P227, DOI 10.1002/smi.2460060308; Picard RW, 2010, EMOT REV, V2, P250, DOI 10.1177/1754073910364256; Picard RW, 2002, INTERACT COMPUT, V14, P141, DOI 10.1016/S0953-5438(01)00055-8; Picard RW, 2001, IEEE T PATTERN ANAL, V23, P1175, DOI 10.1109/34.954607; Picard RW, 1997, FIRST INTERNATIONAL SYMPOSIUM ON WEARABLE COMPUTERS - DIGEST OF PAPERS, P90, DOI 10.1109/ISWC.1997.629924; Picard RW, 1997, BT TECHNOL J, V15, P150, DOI 10.1023/A:1018643815520; RIGAS G, 2009, EMBC 2009 ANN INT C, P1306; Setz C, 2010, IEEE T INF TECHNOL B, V14, P410, DOI 10.1109/TITB.2009.2036164; van den Broek EL, 2009, APPL ERGON, V40, P1055, DOI 10.1016/j.apergo.2009.04.012; Viola P, 2004, INT J COMPUT VISION, V57, P137, DOI 10.1023/B:VISI.0000013087.49260.fb; Wallbott HG, 1998, EUR J SOC PSYCHOL, V28, P879, DOI 10.1002/(SICI)1099-0992(1998110)28:6<879::AID-EJSP901>3.0.CO;2-W; Witkin G, 2002, MALE STRESS SURVIVAL; Zeng ZH, 2009, IEEE T PATTERN ANAL, V31, P39, DOI 10.1109/TPAMI.2008.52	51	44	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e43571	10.1371/journal.pone.0043571	http://dx.doi.org/10.1371/journal.pone.0043571			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014PP	23028461	gold, Green Published			2022-12-27	WOS:000309388400010
J	Gritsun, TA; le Feber, J; Rutten, WLC				Gritsun, Taras A.; le Feber, Joost; Rutten, Wim L. C.			Growth Dynamics Explain the Development of Spatiotemporal Burst Activity of Young Cultured Neuronal Networks in Detail	PLOS ONE			English	Article							CORTICAL-NEURONS; RAT; SYNAPSES; CORTEX; ADHESION; MODELS; CELLS	A typical property of isolated cultured neuronal networks of dissociated rat cortical cells is synchronized spiking, called bursting, starting about one week after plating, when the dissociated cells have sufficiently sent out their neurites and formed enough synaptic connections. This paper is the third in a series of three on simulation models of cultured networks. Our two previous studies [26,27] have shown that random recurrent network activity models generate intra- and inter-bursting patterns similar to experimental data. The networks were noise or pacemaker-driven and had Izhikevich-neuronal elements with only short-term plastic (STP) synapses (so, no long-term potentiation, LTP, or depression, LTD, was included). However, elevated pre-phases (burst leaders) and after-phases of burst main shapes, that usually arise during the development of the network, were not yet simulated in sufficient detail. This lack of detail may be due to the fact that the random models completely missed network topology. and a growth model. Therefore, the present paper adds, for the first time, a growth model to the activity model, to give the network a time dependent topology and to explain burst shapes in more detail. Again, without LTP or LTD mechanisms. The integrated growth-activity model yielded realistic bursting patterns. The automatic adjustment of various mutually interdependent network parameters is one of the major advantages of our current approach. Spatio-temporal bursting activity was validated against experiment. Depending on network size, wave reverberation mechanisms were seen along the network boundaries, which may explain the generation of phases of elevated firing before and after the main phase of the burst shape. In summary, the results show that adding topology and growth explain burst shapes in great detail and suggest that young networks still lack/do not need LTP or LTD mechanisms.	[Gritsun, Taras A.; le Feber, Joost; Rutten, Wim L. C.] Univ Twente, Neural Engn Dept, Inst Biomed Engn MIRA, NL-7500 AE Enschede, Netherlands	University of Twente	Rutten, WLC (corresponding author), Univ Twente, Neural Engn Dept, Inst Biomed Engn MIRA, POB 217, NL-7500 AE Enschede, Netherlands.	w.l.c.rutten@utwente.nl			European Union Marie-Curie Neurovers-IT project [MRTN-CT-2005-019247]	European Union Marie-Curie Neurovers-IT project	The work presented in this paper was funded by the European Union Marie-Curie Neurovers-IT project (MRTN-CT-2005-019247). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettencourt LMA, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021915; Bonifazi P, 2009, SCIENCE, V326, P1419, DOI 10.1126/science.1175509; Graham BP, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-S1-S9; Gritsun T, 2011, BIOL CYBERN, V105, P197, DOI 10.1007/s00422-011-0457-3; Gritsun T, 2008, MEA M 2008, P26; Gritsun TA, 2010, BIOL CYBERN, V102, P293, DOI 10.1007/s00422-010-0366-x; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; ICHIKAWA M, 1993, NEUROSCI RES, V16, P95, DOI 10.1016/0168-0102(93)90076-3; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Kitano K, 2007, J COMPUT NEUROSCI, V23, P237, DOI 10.1007/s10827-007-0030-1; Koene RA, 2009, NEUROINFORMATICS, V7, P195, DOI 10.1007/s12021-009-9052-3; le Feber J, 2007, J NEURAL ENG, V4, P54, DOI 10.1088/1741-2560/4/2/006; le Feber J, 2009, BIOPHYS J, V96, P3443, DOI 10.1016/j.bpj.2009.01.013; MANOR Y, 1991, BIOPHYS J, V60, P1424, DOI 10.1016/S0006-3495(91)82179-8; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Marom S, 2002, Q REV BIOPHYS, V35, P63, DOI 10.1017/S0033583501003742; MEIER JH, 1992, IEEE T BIO-MED ENG, V39, P122, DOI 10.1109/10.121643; Muller TH, 1997, J NEUROPHYSIOL, V77, P3218, DOI 10.1152/jn.1997.77.6.3218; Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.026118; PARNAVELAS JG, 1980, BRAIN RES, V193, P373, DOI 10.1016/0006-8993(80)90171-7; Ramakers GJA, 2001, DEV BRAIN RES, V126, P163, DOI 10.1016/S0165-3806(00)00148-6; Robertson R, 2007, NEUROCOMPUTING, V70, P1619, DOI 10.1016/j.neucom.2006.10.053; Ruardij TG, 2000, IEEE T BIO-MED ENG, V47, P1593, DOI 10.1109/10.887940; Ruardij TG, 2003, MED BIOL ENG COMPUT, V41, P227, DOI 10.1007/BF02344894; Samsonovich AV, 2003, J NEUROSCI RES, V71, P173, DOI 10.1002/jnr.10475; SCOTT DW, 1979, BIOMETRIKA, V66, P605, DOI 10.1093/biomet/66.3.605; Segev R, 2000, NEURAL NETWORKS, V13, P185, DOI 10.1016/S0893-6080(99)00084-2; Sernagor E, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00011; Stegenga J, 2008, IEEE T BIOMED ENG; Stegenga J, 2009, IEEE T BIO-MED ENG, V56, P1220, DOI 10.1109/TBME.2008.2006856; Tetzlaff C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001013; van Ooyen A, 2011, NAT REV NEUROSCI, V12, P311, DOI 10.1038/nrn3031; van Pelt J, 2004, IEEE T BIO-MED ENG, V51, P2051, DOI 10.1109/TBME.2004.827936; Van Pelt J, 2004, NEUROSCI LETT, V361, P86, DOI 10.1016/j.neulet.2003.12.062; van Pelt J, 2002, NETWORK-COMP NEURAL, V13, P261, DOI 10.1088/0954-898X/13/3/302; VANPELT J, 2003, BRAIN MIND, V4, P51, DOI DOI 10.1023/A:1024160131897; Voigt T, 2005, J NEUROSCI, V25, P4605, DOI 10.1523/JNEUROSCI.3803-04.2005; Voigt T, 2001, J NEUROSCI, V21, P8895, DOI 10.1523/JNEUROSCI.21-22-08895.2001; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wieringa PA, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016001; Wiertz RWF, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056003; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; YAVIN E, 1973, J CELL BIOL, V57, P232, DOI 10.1083/jcb.57.1.232; Zubler F, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.025.2009	46	21	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e43352	10.1371/journal.pone.0043352	http://dx.doi.org/10.1371/journal.pone.0043352			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028450	Green Published, gold			2022-12-27	WOS:000309388400008
J	Zhou, Y; Ni, HP; Li, MH; Sanzari, JK; Diffenderfer, ES; Lin, LY; Kennedy, AR; Weissman, D				Zhou, Yu; Ni, Houping; Li, Minghong; Sanzari, Jenine K.; Diffenderfer, Eric S.; Lin, Liyong; Kennedy, Ann R.; Weissman, Drew			Effect of Solar Particle Event Radiation and Hindlimb Suspension on Gastrointestinal Tract Bacterial Translocation and Immune Activation	PLOS ONE			English	Article							INTERNATIONAL-SPACE-STATION; CYTOKINE PRODUCTION; SOLUBLE CD14; BINDING PROTEIN; HIV-INFECTION; PLASMA-LEVELS; FLIGHT; SPACEFLIGHT; RESPONSES; MODEL	The environmental conditions that could lead to an increased risk for the development of an infection during prolonged space flight include: microgravity, stress, radiation, disturbance of circadian rhythms, and altered nutritional intake. A large body of literature exists on the impairment of the immune system by space flight. With the advent of missions outside the Earth's magnetic field, the increased risk of adverse effects due to exposure to radiation from a solar particle event (SPE) needs to be considered. Using models of reduced gravity and SPE radiation, we identify that either 2 Gy of radiation or hindlimb suspension alone leads to activation of the innate immune system and the two together are synergistic. The mechanism for the transient systemic immune activation is a reduced ability of the GI tract to contain bacterial products. The identification of mechanisms responsible for immune dysfunction during extended space missions will allow the development of specific countermeasures.	[Zhou, Yu; Ni, Houping; Li, Minghong; Weissman, Drew] Univ Penn, Dept Med, Perelman Sch Med, Div Infect Dis, Philadelphia, PA 19104 USA; [Sanzari, Jenine K.; Diffenderfer, Eric S.; Lin, Liyong; Kennedy, Ann R.] Univ Penn, Dept Radiat Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Weissman, D (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Div Infect Dis, Philadelphia, PA 19104 USA.	drew@mail.med.upenn.edu	Lin, Liyong/I-1195-2019	Lin, Liyong/0000-0002-0820-8063	National Space Biomedical Research Institute (NSBRI) through NASA [NCC 9-58]	National Space Biomedical Research Institute (NSBRI) through NASA	This research was funded by a grant from the National Space Biomedical Research Institute (NSBRI) through NASA NCC 9-58, http://www.nsbri.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andra J, 2009, ADV EXP MED BIOL, V667, P39, DOI 10.1007/978-1-4419-1603-7_4; Aponte VM, 2006, LIFE SCI, V79, P1317, DOI 10.1016/j.lfs.2006.04.007; Aviles H, 2005, NEUROIMMUNOMODULAT, V12, P173, DOI 10.1159/000084850; Aviles H, 2003, J APPL PHYSIOL, V95, P73, DOI 10.1152/japplphysiol.00968.2002; Baqai FP, 2009, J APPL PHYSIOL, V106, P1935, DOI 10.1152/japplphysiol.91361.2008; Belay T, 2002, J ALLERGY CLIN IMMUN, V110, P262, DOI 10.1067/mai.2002.126459; BERRY WD, 1991, J INTERFERON RES, V11, P243, DOI 10.1089/jir.1991.11.243; Blanc S, 2001, J EXP BIOL, V204, P4107; Bolke E, 2001, CLIN CHIM ACTA, V303, P49, DOI 10.1016/S0009-8981(00)00373-9; Borchers AT, 2002, NUTRITION, V18, P889, DOI 10.1016/S0899-9007(02)00913-9; Budagov R S, 2000, Radiats Biol Radioecol, V40, P188; Bukh AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021275; Cano R, 2010, J MOL MED, V88, P487, DOI 10.1007/s00109-009-0582-9; Caradonna L, 2002, CURR PHARM DESIGN, V8, P995, DOI 10.2174/1381612024606983; Cena H, 2003, EUR J NUTR, V42, P99, DOI 10.1007/s00394-003-0392-8; CHAPES SK, 1993, J LEUKOCYTE BIOL, V54, P227, DOI 10.1002/jlb.54.3.227; Crucian BE, 2000, J INTERF CYTOK RES, V20, P547, DOI 10.1089/10799900050044741; Crucian B, 2009, J LEUKOCYTE BIOL, V86, P1017, DOI 10.1189/jlb.0709500; DURNOVA GN, 1976, AVIAT SPACE ENVIR MD, V47, P588; Elson CO, 2005, IMMUNOL REV, V206, P260, DOI 10.1111/j.0105-2896.2005.00291.x; Gioannini TL, 2007, IMMUNOL RES, V39, P249, DOI 10.1007/s12026-007-0069-0; GOULD CL, 1987, AVIAT SPACE ENVIR MD, V58, P983; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Hellweg CE, 2007, NATURWISSENSCHAFTEN, V94, P517, DOI 10.1007/s00114-006-0204-0; Holub M, 2006, FOLIA MICROBIOL, V51, P469, DOI 10.1007/BF02931593; Hu SW, 2009, HEALTH PHYS, V96, P465, DOI 10.1097/01.HP.0000339020.92837.61; Huang Hong, 2007, J Inflamm (Lond), V4, P22; Jagannathan M, 2009, J IMMUNOL, V183, P7461, DOI 10.4049/jimmunol.0901517; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Kariko K, 2004, J CEREBR BLOOD F MET, V24, P1288, DOI 10.1097/01.WCB.0000145666.68576.71; Kaur I, 2008, CLIN VACCINE IMMUNOL, V15, P1523, DOI 10.1128/CVI.00065-08; Kiang JG, 2010, RADIAT RES, V173, P319, DOI 10.1667/RR1892.1; Kim MHY, 2009, HEALTH PHYS, V97, P68, DOI 10.1097/01.HP.0000346799.65001.9c; Klaus DM, 2006, TRENDS BIOTECHNOL, V24, P131, DOI 10.1016/j.tibtech.2006.01.008; Lee PI, 2009, J INFECT DIS, V199, P1664, DOI 10.1086/598953; Levine DS, 1998, AVIAT SPACE ENVIR MD, V69, P172; Mallis MM, 2005, AVIAT SPACE ENVIR MD, V76, pB94; Medvedev AE, 2006, J ENDOTOXIN RES, V12, P133, DOI 10.1179/096805106X102255; Morey-Holton E, 2005, ADV SPACE B, V10, P7, DOI 10.1016/S1569-2574(05)10002-1; Morukov V B, 2010, Fiziol Cheloveka, V36, P19; Musacchia X J, 1985, Physiologist, V28, pS237; NASH PV, 1992, EXP CELL RES, V202, P125, DOI 10.1016/0014-4827(92)90411-Z; NASH PV, 1991, EXP CELL RES, V195, P353, DOI 10.1016/0014-4827(91)90384-7; NASH PV, 1992, J APPL PHYSIOL, V73, pS186; Ni H, 2011, RADIAT RES, V175, P485, DOI 10.1667/RR2373.1; Novikova N, 2006, RES MICROBIOL, V157, P5, DOI 10.1016/j.resmic.2005.07.010; Obermeier F, 2005, GASTROENTEROLOGY, V129, P913, DOI 10.1053/j.gastro.2005.06.061; Palmer JL, 2011, J BURN CARE RES, V32, P317, DOI 10.1097/BCR.0b013e31820aafa9; Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205; Pecaut MJ, 2000, AM J PHYSIOL-REG I, V279, pR2072, DOI 10.1152/ajpregu.2000.279.6.R2072; Pierson DL, 2005, BRAIN BEHAV IMMUN, V19, P235, DOI 10.1016/j.bbi.2004.08.001; Pierson DL, 1996, FEMS IMMUNOL MED MIC, V16, P273, DOI 10.1111/j.1574-695X.1996.tb00146.x; PIERSON DL, 1995, J MED VET MYCOL, V33, P145; Ran XZ, 2007, J TRAUMA, V62, P193, DOI 10.1097/01.ta.0000215434.24726.72; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Schafer C, 2002, ALCOHOL ALCOHOLISM, V37, P81, DOI 10.1093/alcalc/37.1.81; Schaffer M, 2002, J SURG RES, V107, P93, DOI 10.1006/jsre.2002.6494; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Shearer WT, 2005, J ALLERGY CLIN IMMUN, V115, P1297, DOI 10.1016/j.jaci.2005.03.003; Shi CM, 2006, MED SCI MONITOR, V12, pRA1; Smart DF, 2003, ADV SPACE RES-SERIES, V32, P109, DOI 10.1016/S0273-1177(03)90377-2; Sonnenfeld G, 2003, ADV SPACE RES-SERIES, V32, P1473, DOI 10.1016/S0273-1177(03)90383-8; Sonnenfeld G, 2002, NUTRITION, V18, P899, DOI 10.1016/S0899-9007(02)00903-6; Srinivasan A, 2007, J LEUKOCYTE BIOL, V81, P403, DOI 10.1189/jlb.0306194; STEFFEN JM, 1986, AVIAT SPACE ENVIR MD, V57, P162; Stowe RP, 2011, AVIAT SPACE ENVIR MD, V82, P627, DOI 10.3357/ASEM.2980.2011; TAYLOR GR, 1974, AEROSPACE MED, V45, P824; Uri JJ, 2005, ACTA ASTRONAUT, V56, P883, DOI 10.1016/j.actaastro.2005.01.014; Wang KX, 2007, P NATL ACAD SCI USA, V104, P14777, DOI 10.1073/pnas.0703236104; Wilson JW, 1999, RADIAT MEAS, V30, P361, DOI 10.1016/S1350-4487(99)00063-3; WURFEL MM, 1995, J EXP MED, V181, P1743, DOI 10.1084/jem.181.5.1743; WURFEL MM, 1994, J EXP MED, V180, P1025, DOI 10.1084/jem.180.3.1025; Yin DL, 2000, J EXP MED, V191, P1423, DOI 10.1084/jem.191.8.1423	73	32	33	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44329	10.1371/journal.pone.0044329	http://dx.doi.org/10.1371/journal.pone.0044329			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028522	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388400023
J	Martin, JE; Buffetaut, E; Naksri, W; Lauprasert, K; Claude, J				Martin, Jeremy E.; Buffetaut, Eric; Naksri, Wilailuck; Lauprasert, Komsorn; Claude, Julien			Gavialis from the Pleistocene of Thailand and Its Relevance for Drainage Connections from India to Java	PLOS ONE			English	Article							MAMMALIAN FAUNAS; EVOLUTION; MIOCENE; GHARIAL; AGES; ASIA	Background: The genus Gavialis comprises a single living but endangered species, G. gangeticus, as well as fossil species recorded in the Miocene to Pleistocene deposits of the Indian subcontinent. The genus is also represented in the Pleistocene deposits of Java by the species G. bengawanicus, which was recently recognized to be valid. Surprisingly, no detailed report of the genus exists between these two provinces and the recent evolutionary history of Gavialis is not understood. Methodology/Principal Findings: We report new material consisting of skull and mandibular remains of Gavialis from the Early Pleistocene of Khok Sung, Nakhon Ratchasima Province, northeastern Thailand. The Gavialis material described herein is attributed to Gavialis cf. bengawanicus and sheds new light on the occurrence of the genus in mainland SE Asia. Conclusions/Significance: Comparison of this new material with other species referred to the genus Gavialis led us to preliminary restrict the content of the genus to three species, namely G. gangeticus Gmelin, G. bengawanicus Dubois and G. lewisi Lull. The occurrence of G. cf. bengawanicus in Thailand allows us to propose a scenario for the dispersal of Gavialis from Indo-Pakistan to Indonesia, thus bridging a geographical gap between these two provinces. Dispersal by sea appears a less likely possibility than dispersal through fluvial drainages.	[Martin, Jeremy E.] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Martin, Jeremy E.; Naksri, Wilailuck; Lauprasert, Komsorn] Mahasarakham Univ, Palaeontol Res & Educ Ctr, Maha Sarakham, Thailand; [Buffetaut, Eric] Ctr Natl Rech Sci, Ecole Normale Super, Geol Lab, Unite Mixte Rech 8538, Paris, France; [Lauprasert, Komsorn] Mahasarakham Univ, Fac Sci, Dept Biol, Maha Sarakham, Thailand; [Claude, Julien] Univ Montpellier 2, Inst Rech Dev, Ctr Natl Rech Sci, Inst Sci Evolut Montpellier, Montpellier, France	University of Bristol; Mahasarakham University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Mahasarakham University; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Martin, JE (corresponding author), Univ Bristol, Sch Earth Sci, Bristol, Avon, England.	j.e.martin@bristol.ac.uk	Claude, julien/G-7411-2016; Martin, Jeremy/L-4542-2016; Lauprasert, Komsorn/W-4059-2019	Claude, julien/0000-0002-9267-1228; Martin, Jeremy/0000-0001-9159-645X; 	Mahasarakham University; Marie Curie Fellowship	Mahasarakham University; Marie Curie Fellowship(European Commission)	This work was supported by Mahasarakham University fiscal year 2010. JEM is funded by a Marie Curie Fellowship, FP7 framework. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwood SW, 2002, SYST PARASITOL, V51, P1, DOI 10.1023/A:1012988516995; Bourret RL, 1941, TORTUES INDOCHINE; Brochu CA, 1997, SYST BIOL, V46, P479, DOI 10.2307/2413693; Brochu CA, 2003, ANNU REV EARTH PL SC, V31, P357, DOI 10.1146/annurev.earth.31.100901.141308; Brookfield ME, 1998, GEOMORPHOLOGY, V22, P285, DOI 10.1016/S0169-555X(97)00082-2; Buckland W., 1828, T GEOLOGICAL SOC LON, V2, P377; Buffetaut E., 1982, Geobios Memoire Special (Lyon), P127; CAUTLEY PT, 1836, ASIATIC RES, V19, P32; Chaimanee Y, 2005, 252005 DMR; Claude J, 2011, ANN PALEONTOL, V3-4, P113; Clift W., 1828, T GEOLOGICAL SOC L 2, V2, P369; De Vis CW, 1905, ANN QUEENSLAND MUSEU, V6, P26; Delfino M, 2010, J VERTEBR PALEONTOL, V30, P427, DOI 10.1080/02724631003617910; Dubois E., 1908, TIJDSCHR KON NED A 2, V25, P1235; Ducrocq S, 1995, J SOUTHE ASIAN EARTH, V12, P65, DOI 10.1016/0743-9547(95)00021-6; DUCROCQ S, 1994, PALAEOGEOGR PALAEOCL, V108, P149, DOI 10.1016/0031-0182(94)90027-2; Falconer H., 1840, T GEOLOGICAL SOC LON, V2, P499; Gmelin J.F., 1789, CAROLI LINNE SYSTEMA, V1, P1033; Grote PJ, 2007, COUR FOR SEKENBG, V258, P171; Hanta R, 2008, J VERTEBR PALEONTOL, V28, P1182, DOI 10.1671/0272-4634-28.4.1182; Hay O.P., 1930, CARNEGIE I WASHINGTO, V390, P1; Hutchison C.S., 1989, GEOLOGICAL EVOLUTION, DOI DOI 10.1038/NMETH.4285; Janensch W, 1911, GEOLOGISCHE PALAONTO, P61; Kotsakis T., 2005, RENDICONTI SOC PALEO, V2, P201; Lacassin R, 1998, GEOLOGY, V26, P703, DOI 10.1130/0091-7613(1998)026<0703:HRLASS>2.3.CO;2; Langston W., 1965, U CALIFORNIA PUBLICA, V52, P1; Leslie AJ, 2001, CROCODILIAN BIOLOGY AND EVOLUTION, P265; Lull RS, 1944, AM J SCI, V242, P417, DOI 10.2475/ajs.242.8.417; Lydekker R., 1886, PALAEONTOLOGIA INDIC, V3, P209; MARTIN BGH, 1977, J ZOOL, V182, P541; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; MOLNAR R E, 1982, Memoirs of the Queensland Museum, V20, P675; Molnar Ralph E., 1993, P344; MOOK CHARLES C., 1932, AMER MUS NOVILATES [NEW YORK], V514, P1; NORELL M A, 1989, Postilla, P1; Oppel M., 1811, ORDNUNG FAMILIEN GAT; Pilgrim G. E., 1912, Mem Geol Surv India Pal Ind, V4; Piras P, 2010, EVOL DEV, V12, P568, DOI 10.1111/j.1525-142X.2010.00442.x; Rauhe M, 1999, FOSSIL VERTEBRATES OF ARABIA, P163; Setiyabudi E., 2009, J FOSSIL RES, V42, P1; Singh L.A.K., 1982, British Journal of Herpetology, V6, P259; Steel R., 1973, HDB PALAOHERPETOL 16; Stevenson C., 2010, CROCODILES STATUS SU, P139; Taplin L.E., 1985, P403; ter Haar C., 1934, TOELICHTING BIJ BLAD; TONG H., 2006, 2005 HEYUAN INT DIN, P183; Tougard C, 2006, QUATERNARY SCI REV, V25, P126, DOI 10.1016/j.quascirev.2005.04.010; Trutnau L., 2006, CROCODILIANS THEIR N; van der Maarel FH, 1932, WETEN MEDEDEELINGEN, V15; Velez-Juarbe J, 2007, P ROY SOC B-BIOL SCI, V274, P1245, DOI 10.1098/rspb.2006.0455; von Koenigswald GHR, 1935, KONINKLIJKE NEDERLAN, V38, P188; Wermuth H., 1953, Mitteilungen aus dem Zoologischen Museum in Berlin, V29, P375; WHITAKER R., 2007, IGUANA, V14, P25; Woodruff DS, 2009, J BIOGEOGR, V36, P803, DOI 10.1111/j.1365-2699.2008.02071.x	54	21	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44541	10.1371/journal.pone.0044541	http://dx.doi.org/10.1371/journal.pone.0044541			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028557	Green Published, gold			2022-12-27	WOS:000311313900030
J	Mezil, L; Berruyer-Pouyet, C; Cabaud, O; Josselin, E; Combes, S; Brunel, JM; Viens, P; Collette, Y; Birnbaum, D; Lopez, M				Mezil, Lynda; Berruyer-Pouyet, Carole; Cabaud, Olivier; Josselin, Emmanuelle; Combes, Sebastien; Brunel, Jean-Michel; Viens, Patrice; Collette, Yves; Birnbaum, Daniel; Lopez, Marc			Tumor Selective Cytotoxic Action of a Thiomorpholin Hydroxamate Inhibitor (TMI-1) in Breast Cancer	PLOS ONE			English	Article							STEM-CELLS; KINASE; RESISTANCE; ALPHA; GEMCITABINE; PATHWAYS; MEDIATE; TARGET; ENZYME; DRUGS	Background: Targeted therapies, associated with standard chemotherapies, have improved breast cancer care. However, primary and acquired resistances are frequently observed and the development of new concepts is needed. High-throughput approaches to identify new active and safe molecules with or without an "a priori'' are currently developed. Also, repositioning already-approved drugs in cancer therapy is of growing interest. The thiomorpholine hydroxamate compound TMI-1 has been previously designed to inhibit metalloproteinase activity for the treatment of rheumatoid arthritis. We present here the repositioning of TMI-1 drug in breast cancer. Methodology/Principal Findings: We tested the effect of TMI-1 on luminal, basal and ERBB2-overexpressing breast tumor cell lines and on MMTV-ERBB2/neu tumor evolution. We measured the effects on i) cell survival, ii) cell cycle, iii) extrinsic and intrinsic apoptotic pathways, iv) association with doxorubicin, docetaxel and lapatinib, v) cancer stem cells compartment. In contrast with conventional cytotoxic drugs, TMI-1 was highly selective for tumor cells and cancer stem cells at submicromolar range. All non-malignant cells tested were resistant even at high concentration. TMI-1 was active on triple negative (TN) and ERBB2-overexpressing breast tumor cell lines, and was also highly efficient on human and murine "primary'' ERBB2-overexpressing cells. Treatment of transgenic MMTV-ERBB2/neu mice with 100 mg/kg/day TMI-1 alone induced tumor apoptosis, inhibiting mammary gland tumor occurrence and development. No adverse effects were noticed during the treatment. This compound had a strong synergistic effect in association with docetaxel, doxorubicin and lapatinib. We showed that TMI-1 mediates its selective effects by caspase-dependent apoptosis. TMI-1 was efficient in 34/40 tumor cell lines of various origins (ED50: 0.6 mu M to 12.5 mu M). Conclusions/Significance: This is the first demonstration of the tumor selective cytotoxic action of a thiomorpholin hydroxamate compound. TMI-1 is a novel repositionable drug not only for the treatment of adverse prognosis breast cancers but also for other neoplasms.	[Mezil, Lynda; Cabaud, Olivier; Josselin, Emmanuelle; Combes, Sebastien; Brunel, Jean-Michel; Viens, Patrice; Collette, Yves; Birnbaum, Daniel; Lopez, Marc] Aix Marseille Univ, CRCM, Marseille, France; [Mezil, Lynda; Cabaud, Olivier; Josselin, Emmanuelle; Birnbaum, Daniel; Lopez, Marc] CNRS, INSERM, Oncol Mol Lab, U1068,UMR7258, Marseille, France; [Combes, Sebastien; Brunel, Jean-Michel; Collette, Yves] CNRS, INSERM, Lab iSCB, U1068,UMR7258, Marseille, France; [Mezil, Lynda; Cabaud, Olivier; Josselin, Emmanuelle; Combes, Sebastien; Brunel, Jean-Michel; Viens, Patrice; Collette, Yves; Birnbaum, Daniel; Lopez, Marc] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Berruyer-Pouyet, Carole] Aix Marseille Univ, CIML, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Lopez, M (corresponding author), Aix Marseille Univ, CRCM, Marseille, France.	marc.lopez@inserm.fr	Viens, Patrice/Q-8499-2018; COLLETTE, Yves/F-2270-2013	Viens, Patrice/0000-0003-1511-1048; COLLETTE, Yves/0000-0001-5359-7099; jean michel, brunel/0000-0002-9355-8980; BERRUYER, Carole/0000-0003-0244-8071	INSERM; Institut Paoli-Calmettes; Ligue Nationale Contre le Cancer (LNCC); Institut National du Cancer; Algerian government	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Paoli-Calmettes; Ligue Nationale Contre le Cancer (LNCC)(Ligue nationale contre le cancer); Institut National du Cancer(Institut National du Cancer (INCA) France); Algerian government	This work was supported by INSERM, Institut Paoli-Calmettes, and grants from Ligue Nationale Contre le Cancer (LNCC) (Label 2010-2012) (http://www.ligue-cancer.net/) and Institut National du Cancer (AO-translationnelle 2009) (http://www.e-cancer.fr/). LM is supported by the Algerian government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bost F, 2012, CURR OPIN ONCOL, V24, P103, DOI 10.1097/CCO.0b013e32834d8155; BOUCHARD L, 1989, CELL, V57, P931, DOI 10.1016/0092-8674(89)90331-0; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Cussac D, 2004, BLOOD, V103, P1464; Dave B, 2009, J MAMMARY GLAND BIOL, V14, P79, DOI 10.1007/s10911-009-9117-9; Debatin KM, 2004, ONCOGENE, V23, P2950, DOI 10.1038/sj.onc.1207558; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Fridman JS, 2007, CLIN CANCER RES, V13, P1892, DOI 10.1158/1078-0432.CCR-06-2116; Galmarini Carlos Maria, 2004, BMC Pharmacology, V4, P8, DOI 10.1186/1471-2210-4-8; Ginestier C, 2007, ONCOGENE, V26, P7163, DOI 10.1038/sj.onc.1210528; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Higgins MJ, 2011, J CLIN INVEST, V121, P3797, DOI 10.1172/JCI57152; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Howe LR, 2002, CANCER RES, V62, P5405; Ignatoski KMW, 1999, BREAST CANCER RES TR, V54, P173, DOI 10.1023/A:1006135331912; Jordheim LP, 2006, CANCER CHEMOTH PHARM, V58, P547, DOI 10.1007/s00280-006-0195-8; Kenny PA, 2007, EXPERT OPIN THER TAR, V11, P1287, DOI 10.1517/14728222.11.10.1287; Kenny PA, 2007, J CLIN INVEST, V117, P337, DOI 10.1172/JCI29518; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Liu M, 2005, CANCER RES, V65, P5325, DOI 10.1158/0008-5472.CAN-04-4589; Liu SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388; Malicet Cedric, 2003, Mol Cancer, V2, P37, DOI 10.1186/1476-4598-2-37; McDermott SP, 2010, MOL ONCOL, V4, P404, DOI 10.1016/j.molonc.2010.06.005; Moss ML, 2008, NAT CLIN PRACT RHEUM, V4, P300, DOI 10.1038/ncprheum0797; Moulick K, 2011, NAT CHEM BIOL, V7, P818, DOI 10.1038/nchembio.670; Nebbioso A, 2005, NAT MED, V11, P77, DOI 10.1038/nm1161; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Robert G, 2006, CANCER RES, V66, P7516, DOI 10.1158/0008-5472.CAN-05-3189; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Temime-Smaali N, 2008, EMBO J, V27, P1513, DOI 10.1038/emboj.2008.74; Thabet MM, 2006, CURR OPIN INVEST DR, V7, P1014; Weir SJ, 2012, CANCER RES, V72, P1055, DOI 10.1158/0008-5472.CAN-11-3439; Witters L, 2008, CANCER RES, V68, P7083, DOI 10.1158/0008-5472.CAN-08-0739; Wong ST, 2009, PHARMACOTHERAPY, V29, P954, DOI 10.1592/phco.29.8.954; Zhang YH, 2004, INT IMMUNOPHARMACOL, V4, P1845, DOI 10.1016/j.intimp.2004.08.003; Zhang YH, 2004, J PHARMACOL EXP THER, V309, P348, DOI 10.1124/jpet.103.059675; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024	41	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e43409	10.1371/journal.pone.0043409	http://dx.doi.org/10.1371/journal.pone.0043409			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028451	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900006
J	Boini, KM; Xia, M; Abais, JM; Xu, M; Li, CX; Li, PL				Boini, Krishna M.; Xia, Min; Abais, Justine M.; Xu, Ming; Li, Cai-xia; Li, Pin-Lan			Acid Sphingomyelinase Gene Knockout Ameliorates Hyperhomocysteinemic Glomerular Injury in Mice Lacking Cystathionine-beta-Synthase	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CELL-DEATH; PODOCYTE INJURY; CYSTIC-FIBROSIS; RENAL FIBROSIS; CERAMIDE; HOMOCYSTEINE; INFLAMMATION; APOPTOSIS; RATS	Acid sphingomyelinase (ASM) has been implicated in the development of hyperhomocysteinemia (hHcys)-induced glomerular oxidative stress and injury. However, it remains unknown whether genetically engineering of ASM gene produces beneficial or detrimental action on hHcys-induced glomerular injury. The present study generated and characterized the mice lacking cystathionine beta-synthase (Cbs) and Asm mouse gene by cross breeding Cbs(+/-) and Asm(+/-) mice. Given that the homozygotes of Cbs(-/-/)Asm(-/-) mice could not survive for 3 weeks. Cbs(+/-/)Asm(+/+), Cbs(+/-/)Asm(+/-) and Cbs(+/-/)Asm(-/-) as well as their Cbs wild type littermates were used to study the role of Asm(-/-) under a background of Cbs(+/-) with hHcys. HPLC analysis revealed that plasma Hcys level was significantly elevated in Cbs heterozygous (Cbs(+/-)) mice with different copies of Asm gene compared to Cbs(+/+) mice with different Asm gene copies. Cbs(+/-/)Asm(+/+) mice had significantly increased renal Asm activity, ceramide production and O-2 center dot(-) level compared to Cbs(+/+/)Asm(+/+), while Cbs(+/-/)Asm(-/-) mice showed significantly reduced renal Asm activity, ceramide production and O-2 center dot(-) level due to increased plasma Hcys levels. Confocal microscopy demonstrated that colocalization of podocin with ceramide was much lower in Cbs(+/-/)Asm(-/-) mice compared to Cbs(+/-/)Asm(+/+) mice, which was accompanied by a reduced glomerular damage index, albuminuria and proteinuria in Cbs(+/-/)Asm(-/-) mice. Immunofluorescent analyses of the podocin, nephrin and desmin expression also illustrated less podocyte damages in the glomeruli from Cbs(+/-/)Asm(-/-) mice compared to Cbs(+/-/)Asm(+/+) mice. In in vitro studies of podocytes, hHcys-enhanced O-2 center dot(-) production, desmin expression, and ceramide production as well as decreases in VEGF level and podocin expression in podocytes were substantially attenuated by prior treatment with amitriptyline, an Asm inhibitor. In conclusion, Asm gene knockout or corresponding enzyme inhibition protects the podocytes and glomeruli from hHcys-induced oxidative stress and injury.	[Boini, Krishna M.; Xia, Min; Abais, Justine M.; Xu, Ming; Li, Cai-xia; Li, Pin-Lan] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA	Virginia Commonwealth University	Boini, KM (corresponding author), Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Med Coll Virginia Campus, Richmond, VA 23284 USA.	pli@vcu.edu	Xia, Min/C-2084-2012		National Institutes of Health [DK54927, HL091464, HL57244, HL075316]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091464, R29HL057244, R01HL057244, R01HL075316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants DK54927, HL091464, HL57244 and HL075316 from the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achar E, 2009, KIDNEY INT, V75, P596, DOI 10.1038/ki.2008.578; Becker KA, 2010, AM J RESP CELL MOL, V42, P716, DOI 10.1165/rcmb.2009-0174OC; Boini KM, 2011, AM J PATHOL, V179, P2210, DOI 10.1016/j.ajpath.2011.07.019; Boini KM, 2010, J PHARMACOL EXP THER, V334, P839, DOI 10.1124/jpet.110.168815; Carnicer R, 2008, FRONT BIOSCI, V13, P5155, DOI 10.2741/3071; Chen YF, 2002, CIRCULATION, V106, P1275, DOI 10.1161/01.CIR.0000027586.64231.1B; Dhami R, 2010, CELL PHYSIOL BIOCHEM, V26, P749, DOI 10.1159/000322342; Dimanche-Boitrel MT, 2005, DRUG RESIST UPDATE, V8, P5, DOI 10.1016/j.drup.2005.02.003; Ernest S, 2005, PHYSIOL GENOMICS, V21, P404, DOI 10.1152/physiolgenomics.00199.2004; Fillet M, 2002, J CHROMATOGR A, V949, P225, DOI 10.1016/S0021-9673(01)01422-4; Floege J, 1995, J CLIN INVEST, V96, P2809, DOI 10.1172/JCI118351; Foster RR, 2005, AM J PHYSIOL-RENAL, V288, pF48, DOI 10.1152/ajprenal.00146.2004; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Garcia-Ruiz C, 2003, J CLIN INVEST, V111, P197, DOI 10.1172/JCI200316010; Grassme H, 2003, ONCOGENE, V22, P5457, DOI 10.1038/sj.onc.1206540; HORINOUCHI K, 1995, NAT GENET, V10, P288, DOI 10.1038/ng0795-288; Husain M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000019642.55998.69; Ingram AJ, 2004, KIDNEY INT, V66, P733, DOI 10.1111/j.1523-1755.2004.00795.x; Kang DH, 2003, CURR OPIN NEPHROL HY, V12, P43, DOI 10.1097/00041552-200301000-00008; Kawachi H, 2000, KIDNEY INT, V57, P1949, DOI 10.1046/j.1523-1755.2000.00044.x; Kornhuber J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023852; Lee H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019783; Moles A, 2010, AM J PATHOL, V177, P1214, DOI 10.2353/ajpath.2010.091257; Nagase M, 2006, HYPERTENSION, V47, P1084, DOI 10.1161/01.HYP.0000222003.28517.99; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; RAIJ L, 1984, KIDNEY INT, V26, P137, DOI 10.1038/ki.1984.147; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448, DOI 10.1056/NEJM199811123392007; Robert K, 2003, J BIOL CHEM, V278, P31504, DOI 10.1074/jbc.M213036200; Sen U, 2011, AM J PHYSIOL-CELL PH, V300, pC155, DOI 10.1152/ajpcell.00143.2010; Sen U, 2009, AM J PHYSIOL-RENAL, V297, pF410, DOI 10.1152/ajprenal.00145.2009; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Ueda N, 2000, AM J MED, V108, P403, DOI 10.1016/S0002-9343(00)00311-9; van der Wouden Els A., 2004, Journal of Pharmacological and Toxicological Methods, V50, P13, DOI 10.1016/j.vascn.2004.03.004; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; Yi F, 2006, KIDNEY INT, V70, P88, DOI 10.1038/sj.ki.5001517; Yi F, 2004, KIDNEY INT, V66, P1977, DOI 10.1111/j.1523-1755.2004.00968.x; Yi F, 2009, HYPERTENSION, V53, P90, DOI 10.1161/HYPERTENSIONAHA.108.115675; Yu ZF, 2000, J MOL NEUROSCI, V15, P85, DOI 10.1385/JMN:15:2:85; Yuan HT, 2003, AM J PATHOL, V163, P2289, DOI 10.1016/S0002-9440(10)63586-9; Zhang C, 2010, BBA-MOL CELL RES, V1803, P482, DOI 10.1016/j.bbamcr.2009.12.006; Zhang C, 2010, FREE RADICAL BIO MED, V48, P1109, DOI 10.1016/j.freeradbiomed.2010.01.029	46	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45020	10.1371/journal.pone.0045020	http://dx.doi.org/10.1371/journal.pone.0045020			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024785	Green Published, gold			2022-12-27	WOS:000308860100043
J	Haka, AS; Potteaux, S; Fraser, H; Randolph, GJ; Maxfield, FR				Haka, Abigail S.; Potteaux, Stephane; Fraser, Haley; Randolph, Gwendalyn J.; Maxfield, Frederick R.			Quantitative Analysis of Monocyte Subpopulations in Murine Atherosclerotic Plaques by Multiphoton Microscopy	PLOS ONE			English	Article							CELLS; MICE; GENERATION; EMIGRATION; DISEASE; LESIONS	The progressive accumulation of monocyte-derived cells in the atherosclerotic plaque is a hallmark of atherosclerosis. However, it is now appreciated that monocytes represent a heterogeneous circulating population of cells that differ in functionality. New approaches are needed to investigate the role of monocyte subpopulations in atherosclerosis since a detailed understanding of their differential mobilization, recruitment, survival and emigration during atherogenesis is of particular importance for development of successful therapeutic strategies. We present a novel methodology for the in vivo examination of monocyte subpopulations in mouse models of atherosclerosis. This approach combines cellular labeling by fluorescent beads with multiphoton microscopy to visualize and monitor monocyte subpopulations in living animals. First, we show that multiphoton microscopy is an accurate and timesaving technique to analyze monocyte subpopulation trafficking and localization in plaques in excised tissues. Next, we demonstrate that multiphoton microscopy can be used to monitor monocyte subpopulation trafficking in atherosclerotic plaques in living animals. This novel methodology should have broad applications and facilitate new insights into the pathogenesis of atherosclerosis and other inflammatory diseases.	[Haka, Abigail S.; Fraser, Haley; Maxfield, Frederick R.] Weill Cornell Med Coll, Dept Biochem, New York, NY USA; [Potteaux, Stephane; Randolph, Gwendalyn J.] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY USA; [Potteaux, Stephane; Randolph, Gwendalyn J.] Mt Sinai Sch Med, Inst Immunol, New York, NY USA	Cornell University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Haka, AS (corresponding author), Weill Cornell Med Coll, Dept Biochem, New York, NY USA.	frmaxfie@med.cornell.edu	Maxfield, Fred/M-6747-2019	Maxfield, Fred/0000-0003-4396-8866; Potteaux, Stephane/0000-0003-3068-8769	National Institutes of Health from National Institute of Allergy and Infectious Diseases [RO1 AI06741]; Experimental Therapeutics Institute at Mount Sinai School of Medicine; NIH NRSA post-doctoral training fellowship; Fondation pour 1 Recherche Medicale (France); European Society of Cardiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK027083] Funding Source: NIH RePORTER	National Institutes of Health from National Institute of Allergy and Infectious Diseases; Experimental Therapeutics Institute at Mount Sinai School of Medicine; NIH NRSA post-doctoral training fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation pour 1 Recherche Medicale (France); European Society of Cardiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by National Institutes of Health RO1 AI06741 from National Institute of Allergy and Infectious Diseases and a grant from the Experimental Therapeutics Institute at Mount Sinai School of Medicine to G.J.R. A.S.H. was supported by an NIH NRSA post-doctoral training fellowship. S.P. was funded in part by Fondation pour 1 Recherche Medicale (France) and a 2007 Norman Alpert Visiting Scientist Award from the European Society of Cardiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown E, 2003, NAT MED, V9, P796, DOI 10.1038/nm879; Debarre D, 2006, NAT METHODS, V3, P47, DOI 10.1038/NMETH813; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Ding SF, 2010, AM J PHYSIOL-HEART C, V298, pH2121, DOI 10.1152/ajpheart.00308.2009; Dunn K. W., 2007, CURR PROTOC CYTOM, P19; Feig JE, 2007, PLOS ONE; Feig JE, 2011, P NATL ACAD SCI USA, V108, P7166, DOI 10.1073/pnas.1016086108; FRANKEN PA, 1961, PHYS REV LETT, V7, P118, DOI 10.1103/PhysRevLett.7.118; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Ingersoll MA, 2012, IMMUNOBIOLOGY; Jacob MP, 2001, PATHOL BIOL, V49, P326, DOI 10.1016/S0369-8114(01)00151-1; Ji N, 2010, NAT METHODS, V7, P141, DOI 10.1038/NMETH.1411; Kircher MF, 2008, CIRCULATION, V117, P388, DOI 10.1161/CIRCULATIONAHA.107.719765; Ko ACT, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3353960; KOSTNER GM, 1989, CIRCULATION, V80, P1313, DOI 10.1161/01.CIR.80.5.1313; Lilledahl MB, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2772652; Llodra J, 2004, P NATL ACAD SCI USA, V101, P11779, DOI 10.1073/pnas.0403259101; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Potteaux S, 2011, J CLIN INVEST, V121, P2025, DOI 10.1172/JCI43802; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rothstein EC, 2006, J MICROSC-OXFORD, V222, P58, DOI 10.1111/j.1365-2818.2006.01570.x; Swirski FK, 2009, ARTERIOSCL THROM VAS, V29, P1424, DOI 10.1161/ATVBAHA.108.180521; Tacke F, 2006, J EXP MED, V203, P583, DOI 10.1084/jem.20052119; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; van Gils JM, 2012, NAT IMMUNOL, V13, P136, DOI 10.1038/ni.2205; van Zandvoort M, 2004, J VASC RES, V41, P54, DOI 10.1159/000076246; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Yu WM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2800337; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899; Zoumi A, 2004, BIOPHYS J, V87, P2778, DOI 10.1529/biophysj.104.042887	33	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44823	10.1371/journal.pone.0044823	http://dx.doi.org/10.1371/journal.pone.0044823			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024767	Green Submitted, Green Published, gold			2022-12-27	WOS:000308860100025
J	Valdez, LD; Macri, PA; Braunstein, LA				Daniel Valdez, Lucas; Alejandro Macri, Pablo; Adriana Braunstein, Lidia			Temporal Percolation of the Susceptible Network in an Epidemic Spreading	PLOS ONE			English	Article							SIR DYNAMICS	In this work, we study the evolution of the susceptible individuals during the spread of an epidemic modeled by the susceptible-infected-recovered (SIR) process spreading on the top of complex networks. Using an edge-based compartmental approach and percolation tools, we find that a time-dependent quantity Phi(S)(t), namely, the probability that a given neighbor of a node is susceptible at time t, is the control parameter of a node void percolation process involving those nodes on the network not-reached by the disease. We show that there exists a critical time t(c) above which the giant susceptible component is destroyed. As a consequence, in order to preserve a macroscopic connected fraction of the network composed by healthy individuals which guarantee its functionality, any mitigation strategy should be implemented before this critical time t(c). Our theoretical results are confirmed by extensive simulations of the SIR process.	[Daniel Valdez, Lucas; Alejandro Macri, Pablo; Adriana Braunstein, Lidia] Univ Nacl Mar del Plata, Fac Ciencias Exactas & Nat, Dept Fis, Inst Invest Fis Mar del Plata, Mar Del Plata, Buenos Aires, Argentina; [Adriana Braunstein, Lidia] Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA	National University of Mar del Plata; Boston University	Valdez, LD (corresponding author), Univ Nacl Mar del Plata, Fac Ciencias Exactas & Nat, Dept Fis, Inst Invest Fis Mar del Plata, Mar Del Plata, Buenos Aires, Argentina.	ldvaldes@mdp.edu.ar						ANDERSON R M, 1991; Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016591; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Braunstein LA, 2007, INT J BIFURCAT CHAOS, V17, P2215, DOI 10.1142/S0218127407018361; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; Colizza V, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-34; Dorogovtsev SN, 2008, REV MOD PHYS, V80, P1275, DOI 10.1103/RevModPhys.80.1275; GRASSBERGER P, 1983, MATH BIOSCI, V63, P157, DOI 10.1016/0025-5564(82)90036-0; Kenah E, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036113; Lagorio C, 2009, PHYSICA A, V388, P755, DOI 10.1016/j.physa.2008.10.045; LEATH PL, 1976, PHYS REV B, V14, P5046, DOI 10.1103/PhysRevB.14.5046; Lindquist J, 2011, J MATH BIOL, V62, P143, DOI 10.1007/s00285-010-0331-2; Miller JC, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.010101; Miller JC, 2012, J R SOC INTERFACE, V9, P890, DOI 10.1098/rsif.2011.0403; Miller JC, 2011, J MATH BIOL, V62, P349, DOI 10.1007/s00285-010-0337-9; Newman MEJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.108701; Newman MEJ, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.021904; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Parshani R, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.258701; Valdez LD, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.036108; Volz E, 2008, J MATH BIOL, V56, P293, DOI 10.1007/s00285-007-0116-4	22	24	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44188	10.1371/journal.pone.0044188	http://dx.doi.org/10.1371/journal.pone.0044188			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028498	Green Published, Green Submitted, gold			2022-12-27	WOS:000308788700016
J	Borg, C; de Jong, PJ				Borg, Charmaine; de Jong, Peter J.			Feelings of Disgust and Disgust-Induced Avoidance Weaken following Induced Sexual Arousal in Women	PLOS ONE			English	Article							CONTAMINATION SENSITIVITY; VAGINISMUS; DYSPAREUNIA; BEHAVIOR; DISEASE; RISK; SELF	Background: Sex and disgust are basic, evolutionary relevant functions that are often construed as paradoxical. In general the stimuli involved in sexual encounters are, at least out of context strongly perceived to hold high disgust qualities. Saliva, sweat, semen and body odours are among the strongest disgust elicitors. This results in the intriguing question of how people succeed in having pleasurable sex at all. One possible explanation could be that sexual engagement temporarily reduces the disgust eliciting properties of particular stimuli or that sexual engagement might weaken the hesitation to actually approach these stimuli. Methodology: Participants were healthy women (n = 90) randomly allocated to one of three groups: the sexual arousal, the non-sexual positive arousal, or the neutral control group. Film clips were used to elicit the relevant mood state. Participants engaged in 16 behavioural tasks, involving sex related (e. g., lubricate the vibrator) and non-sex related (e. g., take a sip of juice with a large insect in the cup) stimuli, to measure the impact of sexual arousal on feelings of disgust and actual avoidance behaviour. Principal Findings: The sexual arousal group rated the sex related stimuli as less disgusting compared to the other groups. A similar tendency was evident for the non-sex disgusting stimuli. For both the sex and non-sex related behavioural tasks the sexual arousal group showed less avoidance behaviour (i.e., they conducted the highest percentage of tasks compared to the other groups). Significance: This study has investigated how sexual arousal interplays with disgust and disgust eliciting properties in women, and has demonstrated that this relationship goes beyond subjective report by affecting the actual approach to disgusting stimuli. Hence, this could explain how we still manage to engage in pleasurable sexual activity. Moreover, these findings suggest that low sexual arousal might be a key feature in the maintenance of particular sexual dysfunctions.	[Borg, Charmaine; de Jong, Peter J.] Univ Groningen, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands	University of Groningen	Borg, C (corresponding author), Univ Groningen, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands.	c.borg@med.umcg.nl	de Jong, Peter/ABB-1750-2020; de Jong, Peter/E-9095-2014	de Jong, Peter/0000-0002-3512-3663; de Jong, Peter/0000-0002-3512-3663; Borg, Charmaine/0000-0002-0122-1118	University of Groningen; University Medical Centre Groningen; Malta Government [MGSS_PHD_2008-12]	University of Groningen; University Medical Centre Groningen; Malta Government	The University of Groningen and University Medical Centre Groningen support this study, together with Malta Government Scholarship Scheme grant number MGSS_PHD_2008-12 which partially funds the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariely D, 2006, J BEHAV DECIS MAKING, V19, P87, DOI 10.1002/bdm.501; Borg C, 2013, SOC COGN AFFECT NEUR, V8, P351, DOI 10.1093/scan/nss006; Borg C, 2010, J SEX MED, V7, P2149, DOI 10.1111/j.1743-6109.2010.01800.x; Connolly KM, 2008, PERS INDIV DIFFER, V44, P898, DOI 10.1016/j.paid.2007.10.020; Curtis V, 2004, P ROY SOC B-BIOL SCI, V271, pS131, DOI 10.1098/rsbl.2003.0144; Curtis V, 2011, PHILOS T R SOC B, V366, P389, DOI 10.1098/rstb.2010.0117; de Jong PJ, 2009, ARCH SEX BEHAV, V38, P244, DOI 10.1007/s10508-007-9240-x; Ditto PH, 2006, J BEHAV DECIS MAKING, V19, P99, DOI 10.1002/bdm.520; Fergus TA, 2009, J ANXIETY DISORD, V23, P703, DOI 10.1016/j.janxdis.2009.02.009; Fessler DMT, 2003, APPETITE, V41, P31, DOI 10.1016/S0195-6663(03)00037-0; HAIDT J, 1994, PERS INDIV DIFFER, V16, P701, DOI 10.1016/0191-8869(94)90212-7; Koukounas E, 1997, BEHAV RES THER, V35, P221, DOI 10.1016/S0005-7967(96)00097-6; Olatunji BO, 2008, J RES PERS, V42, P1243, DOI 10.1016/j.jrp.2008.03.009; ROZIN P, 1995, J RES PERS, V29, P318, DOI 10.1006/jrpe.1995.1019; Rozin P., 2008, HDB EMOTIONS, P637; Salvatore S, 2011, EUR J OBSTET GYN R B, V156, P131, DOI 10.1016/j.ejogrb.2011.01.028; Stevenson RJ, 2011, ARCH SEX BEHAV, V40, P79, DOI 10.1007/s10508-009-9529-z; van der Velde J, 2001, BEHAV RES THER, V39, P395, DOI 10.1016/S0005-7967(00)00007-3; van Overveld M, 2010, PERS INDIV DIFFER, V49, P706, DOI 10.1016/j.paid.2010.06.008; van Overveld WJM, 2006, PERS INDIV DIFFER, V41, P1241, DOI 10.1016/j.paid.2006.04.021	20	69	69	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44111	10.1371/journal.pone.0044111	http://dx.doi.org/10.1371/journal.pone.0044111			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005GJ	22984465	Green Published, gold, Green Submitted			2022-12-27	WOS:000308738500030
J	Pascalis, H; Temmam, S; Turpin, M; Rollot, O; Flahault, A; Carrat, F; de Lamballerie, X; Gerardin, P; Dellagi, K				Pascalis, Herve; Temmam, Sarah; Turpin, Magali; Rollot, Olivier; Flahault, Antoine; Carrat, Fabrice; de Lamballerie, Xavier; Gerardin, Patrick; Dellagi, Koussay			Intense Co-Circulation of Non-Influenza Respiratory Viruses during the First Wave of Pandemic Influenza pH1N1/2009: A Cohort Study in Reunion Island	PLOS ONE			English	Article							SYNCYTIAL VIRUS; SWINE-ORIGIN; INFECTIONS; TRANSMISSION; ASSAYS; CHILDREN; ADULTS; PCR; HIV	Objective: The aim of the present study was to weigh up, at the community level, the respective roles played by pandemic Influenza (pH1N1) virus and co-circulating human Non-Influenza Respiratory Viruses (NIRVs) during the first wave of the 2009 pH1N1 pandemic. Methods: A population-based prospective cohort study was conducted in Reunion Island during the austral winter 2009 (weeks 30-44) that allowed identification of 125 households with at least one member who developed symptoms of Influenza-like illness (ILI). Three consecutive nasal swabs were collected from each household member (443 individuals) on day 0, 3 and 8 post-ILI report and tested for pH1N1 and 15 NIRVs by RT-PCR. Results: Two successive waves of viral infections were identified: a first wave (W33-37) when pH1N1 was dominant and co-circulated with NIRVs, sharply interrupted by a second wave (W38-44), almost exclusively composed of NIRVs, mainly human Rhinoviruses (hRV) and Coronaviruses (hCoV). Data suggest that some interference may occur between NIRVs and pH1N1 when they co-circulate within the same household, where NIRVs were more likely to infect pH1N1 negative individuals than pH1N1 positive peers (relative risk: 3.13, 95% CI: 1.80-5.46, P<0.001). Viral shedding was significantly shorter (P = 0.035) in patients who were co-infected by pH1N1 and NIRV or by two different NIRVs compared to those who were infected with only one virus, whatever this virus was (pH1N1 or NIRVs). Although intense co-circulation of NIRVs (especially hRV) likely brought pH1N1 under the detection threshold, it did not prevent spread of the pandemic Influenza virus within the susceptible population nor induction of an extensive herd immunity to it. Conclusion: Our results suggest that NIRV co-infections during Influenza epidemics may act as cofactors that contribute to shape an outbreak and modulate the attack rate. They further warrant broad spectrum studies to fully understand viral epidemics.	[Pascalis, Herve; Temmam, Sarah; Turpin, Magali; Dellagi, Koussay] Ctr Rech & Veille Malad Emergentes Ocean Indien C, St Clotilde, Reunion, France; [Pascalis, Herve; Turpin, Magali; Dellagi, Koussay] IRD, St Clotilde, Reunion, France; [Rollot, Olivier; Gerardin, Patrick] Univ St Pierre, CHR, CIC EC, INSERM,URMLR, St Pierre, Reunion, France; [Temmam, Sarah] Univ Lyon 1, CNRS, Ecol Microbienne UMR 5557, F-69365 Lyon, France; [de Lamballerie, Xavier] Univ Mediterranee, IRD, Unite Virus Emergents UMR S 190, Marseille, France; [Carrat, Fabrice] Univ Paris 06, INSERM, Epidemiol Malad Infect & Modelisat UMR S 707, Paris, France; [Flahault, Antoine] EHESP, Rennes, France	Institut de Recherche pour le Developpement (IRD); CHU Reunion; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Ecole des Hautes Etudes en Sante Publique (EHESP)	Pascalis, H (corresponding author), Ctr Rech & Veille Malad Emergentes Ocean Indien C, St Clotilde, Reunion, France.	koussay.dellagi@ird.fr	Carrat, Fabrice/AAU-8480-2020; TEMMAM, Sarah/AAX-3717-2021; Pascalis, Herve/M-9410-2019; Pascalis, Herve/F-5726-2014	Carrat, Fabrice/0000-0002-8672-7918; TEMMAM, Sarah/0000-0003-3655-9220; Pascalis, Herve/0000-0002-6822-7311; Pascalis, Herve/0000-0002-6822-7311; Abid, sayda/0000-0003-2488-1431	CPER-ERDF (Contrat Programme Etat-Region and European Regional Development Fund); INSERM/IMMI (L'Institut de Microbiologie et des Maladies Infectieuses); CRVOI (The Centre for Research and Intelligence on Emerging Diseases in the Indian Ocean); CPER-ERDF (Contrat Programme Etat-Region and European Regional Development Fund); INSERM/IMMI (L'Institut de Microbiologie et des Maladies Infectieuses); CRVOI (The Centre for Research and Intelligence on Emerging Diseases in the Indian Ocean)	CPER-ERDF (Contrat Programme Etat-Region and European Regional Development Fund); INSERM/IMMI (L'Institut de Microbiologie et des Maladies Infectieuses); CRVOI (The Centre for Research and Intelligence on Emerging Diseases in the Indian Ocean); CPER-ERDF (Contrat Programme Etat-Region and European Regional Development Fund); INSERM/IMMI (L'Institut de Microbiologie et des Maladies Infectieuses); CRVOI (The Centre for Research and Intelligence on Emerging Diseases in the Indian Ocean)	This study was supported by funds from CPER-ERDF (Contrat Programme Etat-Region and European Regional Development Fund), INSERM/IMMI (L'Institut de Microbiologie et des Maladies Infectieuses) and CRVOI (The Centre for Research and Intelligence on Emerging Diseases in the Indian Ocean). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; Laguna-Torres VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011719; Anestad G, 2011, MED HYPOTHESES, V77, P1132, DOI 10.1016/j.mehy.2011.09.021; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Bibby DF, 2011, J MED VIROL, V83, P1469, DOI 10.1002/jmv.22125; Brunstein JD, 2008, J CLIN MICROBIOL, V46, P97, DOI 10.1128/JCM.01117-07; BVS, 2010, B VEILLE SANITAIRE; Casalegno JS, 2010, CLIN MICROBIOL INFEC, V16, P326, DOI 10.1111/j.1469-0691.2010.03167.x; D'Ortenzio E, 2010, CLIN MICROBIOL INFEC, V16, P309, DOI 10.1111/j.1469-0691.2010.03171.x; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Dellagi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025738; Drummond AJ, 2010, GENEIOUS V5 3; Esposito S, 2011, VIROLOGY J, V8; Flasche S, 2011, EPIDEMICS-NETH, V3, P125, DOI 10.1016/j.epidem.2011.03.005; Follin P, 2009, EUROSURVEILLANCE, V14; Ford ES, 2009, CURR OPIN HIV AIDS, V4, P206, DOI 10.1097/COH.0b013e328329c68c; Freymuth F, 2006, J MED VIROL, V78, P1498, DOI 10.1002/jmv.20725; Gharabaghi F, 2011, CLIN MICROBIOL INFEC, V17, P1900, DOI 10.1111/j.1469-0691.2011.03529.x; Gonzalez JP, 2010, ECOHEALTH, V7, P237, DOI 10.1007/s10393-010-0326-x; Graham AL, 2007, TRENDS PARASITOL, V23, P284, DOI 10.1016/j.pt.2007.04.005; GRAHAM NMH, 1990, EPIDEMIOL REV, V12, P149, DOI 10.1093/oxfordjournals.epirev.a036050; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Ki CS, 2008, J VIROL METHODS; Larios OE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021335; Li H, 2007, J CLIN MICROBIOL, V45, P2105, DOI 10.1128/JCM.00210-07; Li JG, 2012, J INFECTION, V64, P96, DOI 10.1016/j.jinf.2011.10.011; Linde A, 2009, EUROSURVEILLANCE, V14, P2; Ninove L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016142; Ninove L, 2010, VECTOR-BORNE ZOONOT, V10, P237, DOI 10.1089/vbz.2009.0110; Nisii C, 2010, J CLIN MICROBIOL, V48, P3383, DOI 10.1128/JCM.01179-10; Nougairede A, 2009, PLOS CURR, V1; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Razanajatovo NH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017579; Sapin G, 2001, B SOC PATHOL EXOT, V94, P3; Schnepf N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023514; Stensballe LG, 2003, PEDIATR INFECT DIS J, V22, pS21, DOI 10.1097/00006454-200302001-00004; Suess T, 2010, AM J EPIDEMIOL, V171, P1157, DOI 10.1093/aje/kwq071; To KKW, 2010, J MED VIROL, V82, P1, DOI 10.1002/jmv.21664; Tregoning JS, 2010, CLIN MICROBIOL REV, V23, P74, DOI 10.1128/CMR.00032-09; Waiboci LW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020320; Wang W, 2009, J VIROL METHODS, V162, P40, DOI 10.1016/j.jviromet.2009.07.004; Yang X.Y., 2012, PLOS ONE, V7	42	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44755	10.1371/journal.pone.0044755	http://dx.doi.org/10.1371/journal.pone.0044755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984554	Green Published, gold, Green Submitted			2022-12-27	WOS:000308738500081
J	Jensen, B; Boukens, BJD; Postma, AV; Gunst, QD; van den Hoff, MJB; Moorman, AFM; Wang, T; Christoffels, VM				Jensen, Bjarke; Boukens, Bastiaan J. D.; Postma, Alex V.; Gunst, Quinn D.; van den Hoff, Maurice J. B.; Moorman, Antoon F. M.; Wang, Tobias; Christoffels, Vincent M.			Identifying the Evolutionary Building Blocks of the Cardiac Conduction System	PLOS ONE			English	Article							T-BOX GENES; ATRIOVENTRICULAR-CANAL FORMATION; HEART DEVELOPMENT; ELECTRICAL ACTIVATION; CHAMBER FORMATION; AVIAN HEART; MOUSE HEART; EXPRESSION; TISSUES; ELECTROCARDIOGRAPHY	The endothermic state of mammals and birds requires high heart rates to accommodate the high rates of oxygen consumption. These high heart rates are driven by very similar conduction systems consisting of an atrioventricular node that slows the electrical impulse and a His-Purkinje system that efficiently activates the ventricular chambers. While ectothermic vertebrates have similar contraction patterns, they do not possess anatomical evidence for a conduction system. This lack amongst extant ectotherms is surprising because mammals and birds evolved independently from reptile-like ancestors. Using conserved genetic markers, we found that the conduction system design of lizard (Anolis carolinensis and A. sagrei), frog (Xenopus laevis) and zebrafish (Danio rerio) adults is strikingly similar to that of embryos of mammals (mouse Mus musculus, and man) and chicken (Gallus gallus). Thus, in ectothermic adults, the slow conducting atrioventricular canal muscle is present, no fibrous insulating plane is formed, and the spongy ventricle serves the dual purpose of conduction and contraction. Optical mapping showed base-to-apex activation of the ventricles of the ectothermic animals, similar to the activation pattern of mammalian and avian embryonic ventricles and to the His-Purkinje systems of the formed hearts. Mammalian and avian ventricles uniquely develop thick compact walls and septum and, hence, form a discrete ventricular conduction system from the embryonic spongy ventricle. Our study uncovers the evolutionary building plan of heart and indicates that the building blocks of the conduction system of adult ectothermic vertebrates and embryos of endotherms are similar.	[Jensen, Bjarke; Boukens, Bastiaan J. D.; Postma, Alex V.; Gunst, Quinn D.; van den Hoff, Maurice J. B.; Moorman, Antoon F. M.; Christoffels, Vincent M.] Univ Amsterdam, Acad Med Ctr, Dept Anat Embryol & Physiol, NL-1105 AZ Amsterdam, Netherlands; [Jensen, Bjarke; Wang, Tobias] Aarhus Univ, Dept Biol Sci, Aarhus, Denmark	University of Amsterdam; Academic Medical Center Amsterdam; Aarhus University	Jensen, B (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Anat Embryol & Physiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	v.m.christoffels@amc.uva.nl	Postma, Alex V/H-4806-2019; Jensen, Bjarke/I-7490-2019; Wang, Tobias/I-7946-2013; Jensen, Bjarke/GQI-3989-2022	Postma, Alex V/0000-0003-4874-2487; Jensen, Bjarke/0000-0002-7750-8035; Wang, Tobias/0000-0002-4350-3682; Boukens, Bastiaan J/0000-0001-6449-145X; van den Hoff, Maurice/0000-0002-3837-8055	European Community ['CardioGeNet' 223463]; Netherlands Heart Foundation [NHS 2008B062]; Danish Council for Independent Research \ Natural Sciences	European Community(European Commission); Netherlands Heart Foundation(Netherlands Heart Foundation); Danish Council for Independent Research \ Natural Sciences(Det Frie Forskningsrad (DFF))	This work was supported by grants from the European Community's Seventh Framework Programme contract ('CardioGeNet' 223463 to VMC) and the Netherlands Heart Foundation (NHS 2008B062 to VMC). Tobias Wang and Bjarke Jensen were supported by The Danish Council for Independent Research vertical bar Natural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanhaanen WTJ, 2010, CIRC RES, V107, P728, DOI 10.1161/CIRCRESAHA.110.222992; Aanhaanen WTJ, 2009, CIRC RES, V104, P1267, DOI 10.1161/CIRCRESAHA.108.192450; ANDERSON RH, 1974, CIRCULATION, V50, P911, DOI 10.1161/01.CIR.50.5.911; ARBEL ER, 1977, AM J PHYSIOL, V232, pH24, DOI 10.1152/ajpheart.1977.232.1.H24; Auman HJ, 2007, PLOS BIOL, V5, P604, DOI 10.1371/journal.pbio.0050053; Azarov JE, 2007, COMP BIOCHEM PHYS A, V146, P310, DOI 10.1016/j.cbpa.2006.10.036; Bakker ML, 2008, CIRC RES, V102, P1340, DOI 10.1161/CIRCRESAHA.107.169565; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; BEYER EC, 1990, J BIOL CHEM, V265, P14439; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Burggren W., 2010, VERTEBRATE CARDIOVAS; BURGGREN WW, 1978, J PHYSIOL-LONDON, V278, P349, DOI 10.1113/jphysiol.1978.sp012308; Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408; Chi NC, 2008, PLOS BIOL, V6, P1006, DOI 10.1371/journal.pbio.0060109; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Christian E, 1999, COMP BIOCHEM PHYS A, V123, P17, DOI 10.1016/S1095-6433(99)00024-0; Christoffels VM, 2010, CIRC RES, V106, P240, DOI 10.1161/CIRCRESAHA.109.205419; Christoffels VM, 2009, CIRC-ARRHYTHMIA ELEC, V2, P195, DOI 10.1161/CIRCEP.108.829341; Chuck ET, 2004, ANAT REC PART A, V280A, P990, DOI 10.1002/ar.a.20083; DAVIES F, 1946, BIOL REV, V21, P173, DOI 10.1111/j.1469-185X.1946.tb00323.x; DILLON S, 1981, SCIENCE, V214, P453, DOI 10.1126/science.6974891; DURRER D, 1970, CIRCULATION, V41, P899, DOI 10.1161/01.CIR.41.6.899; FURMAN K. I., 1960, S AFRICAN JOUR MED SCI, V25, P109; Gibson-Brown JJ, 1998, MECH DEVELOP, V74, P165, DOI 10.1016/S0925-4773(98)00056-2; GOURDIE RG, 1993, CIRC RES, V72, P278, DOI 10.1161/01.RES.72.2.278; GRAY SW, 1950, AM J PHYSIOL, V162, P249, DOI 10.1152/ajplegacy.1950.162.1.249; Hall CE, 2004, DEVELOPMENT, V131, P581, DOI 10.1242/dev.00947; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harris AS, 1941, AM J PHYSIOL, V134, P0319; HEATONJONES TG, 1994, J ZOO WILDLIFE MED, V25, P40; Hoogaars WMH, 2004, CARDIOVASC RES, V62, P489, DOI 10.1016/j.cardiores.2004.01.030; Houweling AC, 2005, DEV DYNAM, V233, P1076, DOI 10.1002/dvdy.20423; Houweling AC, 2002, ANAT RECORD, V266, P93, DOI 10.1002/ar.10042; Kokubo N, 2010, EVOL DEV, V12, P34, DOI 10.1111/j.1525-142X.2009.00389.x; Kolditz DP, 2008, CIRCULATION, V117, P1508, DOI 10.1161/CIRCULATIONAHA.107.726315; Koshiba-Takeuchi K, 2009, NATURE, V461, P95, DOI 10.1038/nature08324; Lewis T, 1916, PHILOS T R SOC LON B, V207, P221, DOI 10.1098/rstb.1916.0006; Lillywhite HB, 1999, COMP BIOCHEM PHYS A, V124, P369, DOI 10.1016/S1095-6433(99)00129-4; Ma LJ, 2005, DEVELOPMENT, V132, P5601, DOI 10.1242/dev.02156; Martinez-Palomo A, 1980, HEARTS HEART LIKE OR, P171; MCDONALD HS, 1971, COMP BIOCHEM PHYSIOL, V40, P881, DOI 10.1016/0300-9629(71)90277-5; Meek WJ, 1912, AM J PHYSIOL, V31, P31; Miquerol L, 2004, CARDIOVASC RES, V63, P77, DOI 10.1016/j.cardiores.2004.03.007; Miquerol L, 2011, CARDIOVASC RES, V91, P232, DOI 10.1093/cvr/cvr069; Moorman AFM, 2004, ANN NY ACAD SCI, V1015, P171, DOI 10.1196/annals.1302.014; Moorman AFM, 2003, PHYSIOL REV, V83, P1223, DOI 10.1152/physrev.00006.2003; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Moorman AFM, 2005, CARDIOVASCULAR DEVELOPMENT AND CONGENITAL MALFORMATIONS: MOLECULAR AND GENETIC MECHANISMS, P84; MULLEN RK, 1974, COMP BIOCHEM PHYSIOL, V49, P647, DOI 10.1016/0300-9629(74)90892-5; MULLEN RK, 1967, PHYSIOL ZOOL, V40, P114, DOI 10.1086/physzool.40.2.30152446; MURAKAMI T, 1985, JPN J VET SCI, V47, P73; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; NOSEDA V, 1962, EXPERIENTIA, V18, P380, DOI 10.1007/BF02172263; NOSEDA V, 1963, NATURE, V197, P816, DOI 10.1038/197816a0; PETERS JA, 1966, PHYSIOL ZOOL, V39, P193, DOI 10.1086/physzool.39.3.30152847; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Poss KD, 2010, NAT REV GENET, V11, P710, DOI 10.1038/nrg2879; Reckova M, 2003, CIRC RES, V93, P77, DOI 10.1161/01.RES.0000079488.91342.B7; Rentschler S, 2002, P NATL ACAD SCI USA, V99, P10464, DOI 10.1073/pnas.162301699; Sanger TJ, 2008, J MORPHOL, V269, P129, DOI 10.1002/jmor.10563; Sedmera D, 2005, MICROSC MICROANAL, V11, P209, DOI 10.1017/S1431927605050452; Sedmera D, 2003, AM J PHYSIOL-HEART C, V284, pH1152, DOI 10.1152/ajpheart.00870.2002; Sedmera D, 2011, CARDIOVASC RES, V91, P252, DOI 10.1093/cvr/cvr062; Singh R, 2011, CELL MOL LIFE SCI; Sizarov A, 2011, CIRC-ARRHYTHMIA ELEC, V4, P532, DOI 10.1161/CIRCEP.111.963421; Sizarov A, 2011, CIRCULATION, V123, P1125, DOI 10.1161/CIRCULATIONAHA.110.980607; Skovgaard N, 2009, AM J PHYSIOL-REG I, V296, pR774, DOI 10.1152/ajpregu.90466.2008; Somi S, 2004, ANAT REC PART A, V279A, P636, DOI 10.1002/ar.a.20031; Soufan AT, 2007, J MICROSC-OXFORD, V225, P269, DOI 10.1111/j.1365-2818.2007.01742.x; Syme DA, 2002, J EXP BIOL, V205, P1843; Takabatake Y, 2000, MECH DEVELOP, V91, P433, DOI 10.1016/S0925-4773(99)00329-9; Takei Y, 2011, GEN COMP ENDOCR, V171, P258, DOI 10.1016/j.ygcen.2011.02.021; Vaikshnoraite M A, 2008, Zh Evol Biokhim Fiziol, V44, P173; Valderrabano M, 2006, CIRCULATION, V114, P543, DOI 10.1161/CIRCULATIONAHA.106.633727; Valentinuzzi M E, 1969, J Electrocardiol, V2, P245, DOI 10.1016/S0022-0736(69)80084-1; Vaykshnorayte MA, 2011, COMP BIOCHEM PHYS A, V159, P39, DOI 10.1016/j.cbpa.2011.01.016; Verhoeven MC, 2011, BIRTH DEFECTS RES A, V91, P435, DOI 10.1002/bdra.20804; Wessels A, 1996, CIRC RES, V78, P110, DOI 10.1161/01.RES.78.1.110; Yamada M, 2000, DEV BIOL, V228, P95, DOI 10.1006/dbio.2000.9927; Zhao-Xian W, 1991, COMP BIOCH PHYSL A, V98A, P89	81	80	81	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44231	10.1371/journal.pone.0044231	http://dx.doi.org/10.1371/journal.pone.0044231			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984480	Green Published, gold, Green Submitted			2022-12-27	WOS:000308638700050
J	Miersch, C; Doring, F				Miersch, Claudia; Doering, Frank			Sex Differences in Carbohydrate Metabolism Are Linked to Gene Expression in Caenorhabditis elegans	PLOS ONE			English	Article							MALE MATING-BEHAVIOR; GENOME-WIDE ANALYSIS; C-ELEGANS; TRANSCRIPTION FACTOR; TREHALOSE METABOLISM; BODY-COMPOSITION; CELL LINEAGES; LIFE-SPAN; NEMATODE; SPERM	The male and the hermaphrodite forms of the nematode Caenorhabditis elegans (C. elegans) differ markedly in anatomy, nervous system and behavior at adulthood. Using the male mutants fog-2, him-5, and him-8, we compared body proportions and composition, and aspects of carbohydrate metabolism and gene expression between the C. elegans sexes in three adult stages. In all experiments, both sexes were grown on the same plate and separated using flow cytometry. The fat to fat-free mass ratio and the body volume-adjusted fat mass is similar between the sexes, although the body size is more than 50% smaller in adult males than in age-matched hermaphrodites. The volume-adjusted total RNA content is approximately 2-fold lower in males. Biochemical and NMR-based analyses reveal higher trehalose levels and much lower glucose levels in males than in hermaphrodites. The resulting trehalose-to-glucose ratio is 5.4-fold higher in males. These sex differences are reflected in gene expression data because the genes encoding key enzymes of the glycolysis and trehalose synthesis pathways are more highly expressed in males than in hermaphrodites. Notably, expression of the phosphofructokinase gene (C50F4.2) is 29-fold higher in males. Comparative analysis of gene expression data identifies 285 male-specific and 160 hermaphrodite-specific genes. These include transcription factor and C-type lectin-encoding genes. More than 35% of all C-type lectin genes are more highly expressed in males. The expression of many C-type lectin genes differs by a factor of >100 between the sexes. In conclusion, we found sex differences in carbohydrate metabolism that are linked to gene expression and identified certain lectin genes that are differentially expressed by the C. elegans sexes.	[Miersch, Claudia; Doering, Frank] Univ Kiel, Inst Human Nutr & Food Sci, Dept Mol Prevent, Kiel, Germany	University of Kiel	Miersch, C (corresponding author), Univ Kiel, Inst Human Nutr & Food Sci, Dept Mol Prevent, Kiel, Germany.	sek@molprev.uni-kiel.de			Deutsche Forschungsgemeinschaft in the context of the Cluster of Excellence "Inflammation at Interfaces" at the University of Kiel; German Ministry of Education and Research [BMBF 0315681]	Deutsche Forschungsgemeinschaft in the context of the Cluster of Excellence "Inflammation at Interfaces" at the University of Kiel; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by a structural grand from the Deutsche Forschungsgemeinschaft in the context of the Cluster of Excellence "Inflammation at Interfaces" at the University of Kiel and by a grant form the German Ministry of Education and Research (BMBF 0315681). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andachi Y, 2004, GENES CELLS, V9, P331, DOI 10.1111/j.1356-9597.2004.00725.x; Azevedo RBR, 2002, GENETICS, V162, P755; Barr MM, 1999, NATURE, V401, P386, DOI 10.1038/43916; Baugh LR, 2003, DEVELOPMENT, V130, P889, DOI 10.1242/dev.00302; Behm CA, 1997, INT J PARASITOL, V27, P215, DOI 10.1016/S0020-7519(96)00151-8; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonnet X, 1998, P ROY SOC B-BIOL SCI, V265, P179, DOI 10.1098/rspb.1998.0280; Boos M, 2002, BIRD STUDY, V49, P212, DOI 10.1080/00063650209461268; BRENNER S, 1974, GENETICS, V77, P71; Chu DS, 2006, NATURE, V443, P101, DOI 10.1038/nature05050; Crowe JH, 2000, NAT BIOTECHNOL, V18, P145, DOI 10.1038/72580; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; EMMONS SW, 1997, C ELEGANS, V2, P295; Gems D, 1996, NATURE, V379, P723, DOI 10.1038/379723a0; Gems D, 2000, GENETICS, V154, P1597; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; Hardaker LA, 2001, J NEUROBIOL, V49, P303, DOI 10.1002/neu.10014; Hirose T, 2003, DEVELOPMENT, V130, P1089, DOI 10.1242/dev.00330; HODGKIN J, 1979, GENETICS, V91, P67; Hodgkin J., 1988, NEMATODE CAENORHABDI, P243; Honda Y, 2010, AGING CELL, V9, P558, DOI 10.1111/j.1474-9726.2010.00582.x; Honjoh S, 2011, C EL M 2011; HOPE IA, 1994, DEVELOPMENT, V120, P505; Inoue H, 2010, MOL CELL BIOL, V30, P3453, DOI 10.1128/MCB.01459-09; Jagdale GB, 2005, J PARASITOL, V91, P988, DOI 10.1645/GE-504R.1; Jain NK, 2009, PROTEIN SCI, V18, P24, DOI 10.1002/pro.3; Jiang M, 2001, P NATL ACAD SCI USA, V98, P218, DOI 10.1073/pnas.011520898; Jonassen T, 2002, J BIOL CHEM, V277, P45020, DOI 10.1074/jbc.M204758200; Jones KT, 2009, DIS MODEL MECH, V2, P224, DOI 10.1242/dmm.001933; Kagoshima H, 1999, DEV GENES EVOL, V209, P59, DOI 10.1007/s004270050227; Kilpatrick DC, 2002, BBA-GEN SUBJECTS, V1572, P187, DOI 10.1016/S0304-4165(02)00308-2; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; Kirchengast S, 2010, J LIFE SCI, V2, P1, DOI [DOI 10.1371/journal.pmed.0040097, 10.1080/09751270.2010.11885146, DOI 10.1080/09751270.2010.11885146]; Klapper M, 2011, J LIPID RES, V52, P1281, DOI 10.1194/jlr.D011940; Kormish JD, 2005, DEV BIOL, V287, P35, DOI 10.1016/j.ydbio.2005.08.027; Lamitina ST, 2005, AM J PHYSIOL-CELL PH, V288, pC467, DOI 10.1152/ajpcell.00451.2004; LaMunyon CW, 1998, P ROY SOC B-BIOL SCI, V265, P1997, DOI 10.1098/rspb.1998.0531; Lee KH, 2007, CURR BIOL, V17, P1858, DOI 10.1016/j.cub.2007.10.015; Lindberg J, GENOMICS, V95, P1; Lints R, 2002, GENE DEV, V16, P2390, DOI 10.1101/gad.1012602; Lipton J, 2004, J NEUROSCI, V24, P7427, DOI 10.1523/JNEUROSCI.1746-04.2004; LIU KS, 1995, NEURON, V14, P79, DOI 10.1016/0896-6273(95)90242-2; LOER CM, 1993, J NEUROSCI, V13, P5407, DOI 10.1523/JNEUROSCI.13-12-05407.1993; MAH KB, 1992, BEHAV NEURAL BIOL, V58, P211, DOI 10.1016/0163-1047(92)90496-Q; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Mukai C, 2004, BIOL REPROD, V71, P540, DOI 10.1095/biolreprod.103.026054; Pasche B, 2005, INFECT IMMUN, V73, P5952, DOI 10.1128/IAI.73.9.5952-5960.2005; Pellerone FI, 2003, INT J PARASITOL, V33, P1195, DOI 10.1016/S0020-7519(03)00173-5; Peterson R N, 1969, Biol Reprod, V1, P238, DOI 10.1095/biolreprod1.3.238; Phillips CM, 2005, CELL, V123, P1051, DOI 10.1016/j.cell.2005.09.035; Pickett CL, 2007, DEV BIOL, V310, P226, DOI 10.1016/j.ydbio.2007.07.034; Portman DS, 2007, ADV GENET, V59, P1, DOI 10.1016/S0065-2660(07)59001-2; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Salomon MP, 2009, GENETICS, V183, P685, DOI 10.1534/genetics.109.107383; SCHEDL T, 1988, GENETICS, V119, P43; Schulenburg H, 2008, IMMUNOBIOLOGY, V213, P237, DOI 10.1016/j.imbio.2007.12.004; Schulte-Hostedde AI, 2001, CAN J ZOOL, V79, P1016, DOI 10.1139/cjz-79-6-1016; SHEN MM, 1988, CELL, V54, P1019, DOI 10.1016/0092-8674(88)90117-1; SMITH DWE, 1989, BIOL REV, V64, P1, DOI 10.1111/j.1469-185X.1989.tb00635.x; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1980, DEV BIOL, V78, P542, DOI 10.1016/0012-1606(80)90352-8; Takahashi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004104; Thoemke K, 2005, DEV BIOL, V284, P500, DOI 10.1016/j.ydbio.2005.05.017; van den Berg MCW, 2006, GENETICS, V173, P677, DOI 10.1534/genetics.106.056093; Vellai T, 2006, GENETICS, V174, P309, DOI 10.1534/genetics.106.061499; Vemuganti SA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-285; WARD S, 1983, DEV BIOL, V98, P70, DOI 10.1016/0012-1606(83)90336-6; WARD S, 1979, DEV BIOL, V73, P304, DOI 10.1016/0012-1606(79)90069-1; Zarse K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004062; Zhang FF, 2011, GENETICS, V188, P753, DOI 10.1534/genetics.111.129064	72	10	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44748	10.1371/journal.pone.0044748	http://dx.doi.org/10.1371/journal.pone.0044748			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984551	Green Published, Green Submitted, gold			2022-12-27	WOS:000308638700080
J	Rate, A; Bosco, A; McKenna, KL; Holt, PG; Upham, JW				Rate, Angela; Bosco, Anthony; McKenna, Kathy L.; Holt, Patrick G.; Upham, John W.			Airway Epithelial Cells Condition Dendritic Cells to Express Multiple Immune Surveillance Genes	PLOS ONE			English	Article							LUNG INFLAMMATION; DIFFERENTIAL EXPRESSION; CHEMOKINE RECEPTORS; CROSS-PRESENTATION; MATURATION; RECRUITMENT; ACTIVATION; MONOCYTES; RESPONSES; ALLERGEN	Increasing evidence suggests that crosstalk between airway epithelial cells (AEC) and adjacent dendritic cells (DC) tightly regulates airway mucosal DC function in steady state. AEC are known to express multiple immmuno-modulatory factors, though detailed information on how this influences human DC function remains incomplete. We recently demonstrated using an in vitro coculture model that AEC alter differentiation of monocytes into DC in a manner that inhibits expression of potentially damaging Th2 effector function. In the current study, we have extended these findings to examine other aspects of DC function. Using micro-array technology we show that multiple genes important for immune surveillance are significantly over expressed in purified AEC-conditioned DC, compared to control DC. These findings were confirmed by quantitative real time PCR or flow cytometry in an independent sample set. In particular, AEC-conditioned DC showed selective upregulation of chemokines that recruit Th1 cells, but minimal change in chemokines linked to Th2 cell recruitment. AEC-conditioned DC were also characterized by enhanced expression of complement family genes (C1QB, C2, CD59 and SERPING1), Fcc receptor genes (FCGR1A, FCGR2A, FCGR2B and FCGR2C), signaling lymphocytic activation molecule family member 1 (SLAM), programmed death ligands 1 and 2, CD54 and CD200R1, relative to control DC. These findings suggest that AEC conditioning facilitates the capacity of DC to react to danger signals, to enhance leukocyte recruitment, especially of Th1 effector cells, and to interact with other immune cell populations while minimizing the risks of excessive inflammation leading to tissue damage.	[Rate, Angela; Bosco, Anthony; McKenna, Kathy L.; Holt, Patrick G.] Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; [Rate, Angela; Bosco, Anthony; McKenna, Kathy L.; Holt, Patrick G.] Univ Western Australia, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Upham, John W.] Univ Queensland, Sch Med, Brisbane, Qld, Australia	Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Queensland	Rate, A (corresponding author), Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia.	j.upham@uq.edu.au	Holt, Patrick G/H-1548-2011; Bosco, Anthony/AAC-6900-2022; Upham, John/F-4420-2010	Holt, Patrick G/0000-0003-1193-0935; Upham, John/0000-0002-0017-3433; Bosco, Anthony/0000-0002-4335-615X	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, MUCOSAL IMMUNOL, V3, P81; Amigorena S, 2002, J EXP MED, V195, pF1, DOI 10.1084/jem.20011925; Beaty SR, 2007, J IMMUNOL, V178, P1882, DOI 10.4049/jimmunol.178.3.1882; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bleck B, 2008, J CLIN IMMUNOL, V28, P147, DOI 10.1007/s10875-007-9149-0; Bleck B, 2006, J IMMUNOL, V176, P7431, DOI 10.4049/jimmunol.176.12.7431; Bolstad BM, 2005, STAT BIOL HEALTH, P33; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Boruchov AM, 2005, J CLIN INVEST, V115, P2914, DOI 10.1172/JCI24772; Carballido JM, 1997, J IMMUNOL, V159, P4316; Castellano G, 2004, BLOOD, V103, P3813, DOI 10.1182/blood-2003-09-3046; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; Cochand L, 1999, AM J RESP CELL MOL, V21, P547, DOI 10.1165/ajrcmb.21.5.3785; Demedts IK, 2005, AM J RESP CELL MOL, V32, P177, DOI 10.1165/rcmb.2004-0279OC; Hammad H, 2011, ALLERGY, V66, P579, DOI 10.1111/j.1398-9995.2010.02528.x; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Holt PG, 2008, NAT IMMUNOL, V9, P1011, DOI 10.1038/ni0908-1011; Holt PG, 2004, CURR OPIN ALLERGY CL, V4, P39, DOI 10.1097/01.all.0000113677.18759.dc; HOLT PG, 1994, J IMMUNOL, V153, P256; Huang Y, 2006, J BIOL CHEM, V281, P27398, DOI 10.1074/jbc.M603690200; Imai T, 1999, INT IMMUNOL, V11, P81, DOI 10.1093/intimm/11.1.81; Jahnsen FL, 2001, THORAX, V56, P823, DOI 10.1136/thorax.56.11.823; Landsman L, 2007, J IMMUNOL, V178, P2000, DOI 10.4049/jimmunol.178.4.2000; Lebre MC, 2005, IMMUNOL CELL BIOL, V83, P525, DOI 10.1111/j.1440-1711.2005.01365.x; Liu Y, 2006, J IMMUNOL, V177, P8440, DOI 10.4049/jimmunol.177.12.8440; Longhi MP, 2007, EUR J IMMUNOL, V37, P1266, DOI 10.1002/eji.200636755; Matsumoto K, 2004, J IMMUNOL, V172, P2530, DOI 10.4049/jimmunol.172.4.2530; Mayer AK, 2008, EUR J IMMUNOL, V38, P1689, DOI 10.1002/eji.200737936; McWilliam AS, 1996, J EXP MED, V184, P2429, DOI 10.1084/jem.184.6.2429; Nauta AJ, 2004, J IMMUNOL, V173, P3044, DOI 10.4049/jimmunol.173.5.3044; Parlato S, 2001, BLOOD, V98, P3022, DOI 10.1182/blood.V98.10.3022; Petersen SV, 2000, MOL IMMUNOL, V37, P803, DOI 10.1016/S0161-5890(01)00004-9; Pichavant M, 2006, J IMMUNOL, V177, P5912, DOI 10.4049/jimmunol.177.9.5912; Rate A, 2009, J IMMUNOL, V182, P72, DOI 10.4049/jimmunol.182.1.72; Regamey N, 2007, AM J RESP CELL MOL, V37, P75, DOI 10.1165/rcmb.2006-0235OC; Reis ES, 2007, IMMUNOBIOLOGY, V212, P151, DOI 10.1016/j.imbio.2006.11.010; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Samsom JN, 2005, J IMMUNOL, V174, P5279, DOI 10.4049/jimmunol.174.9.5279; Smits HH, 2002, J IMMUNOL, V168, P1710, DOI 10.4049/jimmunol.168.4.1710; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Stumbles PA, 2001, J IMMUNOL, V167, P228, DOI 10.4049/jimmunol.167.1.228; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Upham JW, 2006, CURR DRUG TARGETS, V7, P541, DOI 10.2174/138945006776818647; Upham JW, 2002, CLIN EXP ALLERGY, V32, P818, DOI 10.1046/j.1365-2222.2002.01375.x; van Kooten C, 2008, MOL IMMUNOL, V45, P4064, DOI 10.1016/j.molimm.2008.07.015; Vegh Z, 2003, INT IMMUNOPHARMACOL, V3, P345, DOI 10.1016/S1567-5769(02)00234-5; Ward C, 2009, THORAX, V64, P430, DOI 10.1136/thx.2008.104067	48	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44941	10.1371/journal.pone.0044941	http://dx.doi.org/10.1371/journal.pone.0044941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984588	Green Published, gold, Green Submitted			2022-12-27	WOS:000308638700101
J	Rodriguez-Castaneda, G; Hof, AR; Jansson, R; Harding, LE				Rodriguez-Castaneda, Genoveva; Hof, Anouschka R.; Jansson, Roland; Harding, Larisa E.			Predicting the Fate of Biodiversity Using Species' Distribution Models: Enhancing Model Comparability and Repeatability	PLOS ONE			English	Article							CLIMATE-CHANGE; GEOGRAPHIC DISTRIBUTIONS; CONSERVATION; PERFORMANCE; THREATS; SIZES; RANGE; AREA	Species distribution modeling (SDM) is an increasingly important tool to predict the geographic distribution of species. Even though many problems associated with this method have been highlighted and solutions have been proposed, little has been done to increase comparability among studies. We reviewed recent publications applying SDMs and found that seventy nine percent failed to report methods that ensure comparability among studies, such as disclosing the maximum probability range produced by the models and reporting on the number of species occurrences used. We modeled six species of Falco from northern Europe and demonstrate that model results are altered by (1) spatial bias in species' occurrence data, (2) differences in the geographic extent of the environmental data, and (3) the effects of transformation of model output to presence/absence data when applying thresholds. Depending on the modeling decisions, forecasts of the future geographic distribution of Falco ranged from range contraction in 80% of the species to no net loss in any species, with the best model predicting no net loss of habitat in Northern Europe. The fact that predictions of range changes in response to climate change in published studies may be influenced by decisions in the modeling process seriously hampers the possibility of making sound management recommendations. Thus, each of the decisions made in generating SDMs should be reported and evaluated to ensure conclusions and policies are based on the biology and ecology of the species being modeled.	[Rodriguez-Castaneda, Genoveva] SUNY Stony Brook, Stony Brook, NY 11794 USA; [Hof, Anouschka R.; Jansson, Roland; Harding, Larisa E.] Umea Univ, Dept Ecol & Environm Sci, Landscape Ecol Grp, Umea, Sweden; [Hof, Anouschka R.] Swedish Univ Agr Sci SLU, Dept Wildlife Fish & Environm Studies, Umea, Sweden	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Umea University; Swedish University of Agricultural Sciences	Rodriguez-Castaneda, G (corresponding author), SUNY Stony Brook, Stony Brook, NY 11794 USA.	genoveva@life.bio.sunysb.edu	Jansson, Roland/B-7972-2013; Hof, Anouschka R/V-5994-2019	Jansson, Roland/0000-0003-1767-7010; Hof, Anouschka R/0000-0001-6743-0089	Umea University; Nordic Council of Ministers	Umea University; Nordic Council of Ministers	This work was supported by a young researcher award from Umea University (to RJ) and a grant from the Nordic Council of Ministers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2010, J BIOGEOGR, V37, P1378, DOI 10.1111/j.1365-2699.2010.02290.x; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Benito Garzon M, 2008, APPL VEG SCI, V11, P169, DOI 10.3170/2008-7-18348; Bennett P. M., 2002, OX ECOL EV; Bradley BA, 2012, DIVERS DISTRIB, V18, P425, DOI 10.1111/j.1472-4642.2011.00875.x; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Donalisio MR, 2011, ACTA TROP, V119, P125, DOI 10.1016/j.actatropica.2011.04.019; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fernandez Miguel A., 2009, Biodiversity Informatics, V6, P36; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; Gaston KJ, 2009, J APPL ECOL, V46, P1, DOI 10.1111/j.1365-2664.2008.01596.x; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Graham CH, 2006, GLOBAL ECOL BIOGEOGR, V15, P578, DOI 10.1111/j.1466-8238.2006.00257.x; Grinnell J., 1917, Auk Cambridge Mass, V34; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Hof AR, 2012, DIVERS DISTRIB, V18, P554, DOI 10.1111/j.1472-4642.2011.00876.x; Jakob SS, 2009, MOL BIOL EVOL, V26, P907, DOI 10.1093/molbev/msp012; Jimenez-Valverde A, 2011, GLOBAL ECOL BIOGEOGR, V20, P114, DOI 10.1111/j.1466-8238.2010.00574.x; Jimenez-Valverde A, 2010, ECOL RES, V25, P947, DOI 10.1007/s11284-010-0753-8; Kinnard C, 2011, NATURE, V479, P509, DOI 10.1038/nature10581; Larson SR, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.11001; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; McPherson JM, 2004, J APPL ECOL, V41, P811, DOI 10.1111/j.0021-8901.2004.00943.x; Nogues-Bravo D, 2009, GLOBAL ECOL BIOGEOGR, V18, P521, DOI 10.1111/j.1466-8238.2009.00476.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2008, EVOLUTION, V62, P173, DOI 10.1111/j.1558-5646.2007.00258.x; Peterson AT, 2002, CARBON NANOTUBES LON, V416; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Portner HO, 2002, J EXP BIOL, V205, P2217; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Sundseth K, 2009, EUROPEAN COMMISSION; Svensson L, 1999, BIRD GUIDE MOST COMP; Thomas CD, 2011, METHODS ECOL EVOL, V2, P125, DOI 10.1111/j.2041-210X.2010.00065.x; Thuiller W, 2004, ECOGRAPHY, V27, P165, DOI 10.1111/j.0906-7590.2004.03673.x; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Vaughan IP, 2005, J APPL ECOL, V42, P720, DOI 10.1111/j.1365-2664.2005.01052.x; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Wollan AK, 2008, J BIOGEOGR, V35, P2298, DOI 10.1111/j.1365-2699.2008.01965.x	48	47	47	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44402	10.1371/journal.pone.0044402	http://dx.doi.org/10.1371/journal.pone.0044402			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984502	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000308638700057
J	Bourdes, A; Rudder, S; East, AK; Poole, PS				Bourdes, Alexandre; Rudder, Steven; East, Alison K.; Poole, Philip S.			Mining the Sinorhizobium meliloti Transportome to Develop FRET Biosensors for Sugars, Dicarboxylates and Cyclic Polyols	PLOS ONE			English	Article							EXTRACYTOPLASMIC-SOLUTE-RECEPTOR; LEGUMINOSARUM BV TRIFOLII; RIBOSE-BINDING-PROTEIN; RHIZOBIUM-LEGUMINOSARUM; ACID-BINDING; FLUORESCENT NANOSENSORS; RHODOBACTER-CAPSULATUS; HAEMOPHILUS-INFLUENZAE; MYOINOSITOL CATABOLISM; CRYSTAL-STRUCTURES	Background: Forster resonance energy transfer (FRET) biosensors are powerful tools to detect biologically important ligands in real time. Currently FRET bisosensors are available for twenty-two compounds distributed in eight classes of chemicals (two pentoses, two hexoses, two disaccharides, four amino acids, one nucleobase, two nucleotides, six ions and three phytoestrogens). To expand the number of available FRET biosensors we used the induction profile of the Sinorhizobium meliloti transportome to systematically screen for new FRET biosensors. Methodology/Principal Findings: Two new vectors were developed for cloning genes for solute-binding proteins (SBPs) between those encoding FRET partner fluorescent proteins. In addition to a vector with the widely used cyan and yellow fluorescent protein FRET partners, we developed a vector using orange (mOrange2) and red fluorescent protein (mKate2) FRET partners. From the sixty-nine SBPs tested, seven gave a detectable FRET signal change on binding substrate, resulting in biosensors for D-quinic acid, myo-inositol, L-rhamnose, L-fucose, beta-diglucosides (cellobiose and gentiobiose), D-galactose and C4-dicarboxylates (malate, succinate, oxaloacetate and fumarate). To our knowledge, we describe the first two FRET biosensor constructs based on SBPs from Tripartite ATP-independent periplasmic (TRAP) transport systems. Conclusions/Significance: FRET based on orange (mOrange2) and red fluorescent protein (mKate2) partners allows the use of longer wavelength light, enabling deeper penetration of samples at lower energy and increased resolution with reduced back-ground auto-fluorescence. The FRET biosensors described in this paper for four new classes of compounds; (i) cyclic polyols, (ii) L-deoxy sugars, (iii) beta-linked disaccharides and (iv) C4-dicarboxylates could be developed to study metabolism in vivo.	[Bourdes, Alexandre; Rudder, Steven; East, Alison K.; Poole, Philip S.] John Innes Ctr, Dept Mol Microbiol, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Poole, PS (corresponding author), John Innes Ctr, Dept Mol Microbiol, Norwich, Norfolk, England.	philip.poole@jic.ac.uk		Rudder, Steven/0000-0003-0050-9037	Biotechnology and Biological Science Research Council UK [BB/F004753/1]; BBSRC [BB/F004753/1, BBS/E/J/000C0642] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0642, BB/F004753/1] Funding Source: researchfish	Biotechnology and Biological Science Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding was provided by the Biotechnology and Biological Science Research Council UK grant no BB/F004753/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bagaria A, 2011, PROTEINS, V79, P1352, DOI 10.1002/prot.22965; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bermejo C, 2011, BIOCHEM J, V438, P1, DOI 10.1042/BJ20110428; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; BJORKMAN AJ, 1994, J BIOL CHEM, V269, P30206; Capela D, 2001, P NATL ACAD SCI USA, V98, P9877, DOI 10.1073/pnas.161294398; Cuneo MJ, 2006, J MOL BIOL, V362, P259, DOI 10.1016/j.jmb.2006.06.084; Cuneo MJ, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-20; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Deuschle K, 2005, PROTEIN SCI, V14, P2304, DOI 10.1110/ps.051508105; Deuschle K, 2006, PLANT CELL, V18, P2314, DOI 10.1105/tpc.106.044073; Dumbrepatil AB, 2010, ANALYST, V135, P2879, DOI 10.1039/c0an00385a; East AK, 2008, ADV APPL MICROBIOL, V64, P137, DOI 10.1016/S0065-2164(08)00405-X; Fehr M, 2005, MOL CELL BIOL, V25, P11102, DOI 10.1128/MCB.25.24.11102-11112.2005; Fehr M, 2005, BIOCHEM SOC T, V33, P287, DOI 10.1042/BST0330287; Fehr M, 2003, J BIOL CHEM, V278, P19127, DOI 10.1074/jbc.M301333200; Fehr M, 2002, P NATL ACAD SCI USA, V99, P9846, DOI 10.1073/pnas.142089199; Fischer M, 2010, TRENDS MICROBIOL, V18, P471, DOI 10.1016/j.tim.2010.06.009; Forward JA, 1997, J BACTERIOL, V179, P5482, DOI 10.1128/jb.179.17.5482-5493.1997; Fukami-Kobayashi K, 1999, J MOL BIOL, V286, P279, DOI 10.1006/jmbi.1998.2454; Galbraith MP, 1998, MICROBIOL-SGM, V144, P2915, DOI 10.1099/00221287-144-10-2915; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Gonin S, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-11; Gu H, 2006, FEBS LETT, V580, P5885, DOI 10.1016/j.febslet.2006.09.048; Ha JS, 2007, APPL ENVIRON MICROB, V73, P7408, DOI 10.1128/AEM.01080-07; Horler RSP, 2009, J BIOL CHEM, V284, P31156, DOI 10.1074/jbc.M109.054296; Johnston JW, 2008, J BIOL CHEM, V283, P855, DOI 10.1074/jbc.M706603200; Kaper T, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-11; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Lager I, 2003, FEBS LETT, V553, P85, DOI 10.1016/S0014-5793(03)00976-1; Lee SJ, 2007, TRENDS MICROBIOL, V15, P389, DOI 10.1016/j.tim.2007.08.002; Mauchline TH, 2006, P NATL ACAD SCI USA, V103, P17933, DOI 10.1073/pnas.0606673103; Morinaga T, 2010, MICROBIOL-SGM, V156, P1538, DOI 10.1099/mic.0.037499-0; Muller A, 2006, J BIOL CHEM, V281, P22212, DOI 10.1074/jbc.M603463200; Mulligan C, 2011, FEMS MICROBIOL REV, V35, P68, DOI 10.1111/j.1574-6976.2010.00236.x; Okada S, 2009, PROTEIN SCI, V18, P2518, DOI 10.1002/pro.266; Okumoto S, 2005, P NATL ACAD SCI USA, V102, P8740, DOI 10.1073/pnas.0503274102; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Pereira CS, 2008, MOL MICROBIOL, V70, P1223, DOI 10.1111/j.1365-2958.2008.06477.x; POOLE PS, 1994, MICROBIOL-SGM, V140, P2787, DOI 10.1099/00221287-140-10-2787; Prell J, 2006, TRENDS MICROBIOL, V14, P161, DOI 10.1016/j.tim.2006.02.005; Ramachandran VK, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r106; Richardson JS, 2007, J BACTERIOL, V189, P8437, DOI 10.1128/JB.01032-07; Richardson JS, 2004, J BACTERIOL, V186, P8433, DOI 10.1128/JB.186.24.8433-8442.2004; Rucktooa P, 2007, J MOL BIOL, V370, P93, DOI 10.1016/j.jmb.2007.04.047; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; SHAW JG, 1991, MOL MICROBIOL, V5, P3055, DOI 10.1111/j.1365-2958.1991.tb01865.x; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Taga ME, 2001, MOL MICROBIOL, V42, P777, DOI 10.1046/j.1365-2958.2001.02669.x; WALMSLEY AR, 1992, J BIOL CHEM, V267, P8064; White J, 2007, PLANT PHYSIOL, V144, P604, DOI 10.1104/pp.107.097741; Wlodkowic D, 2011, METHOD CELL BIOL, V102, P105, DOI 10.1016/B978-0-12-374912-3.00005-5; Young JPW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r34	55	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e43578	10.1371/journal.pone.0043578	http://dx.doi.org/10.1371/journal.pone.0043578			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028462	Green Published, Green Submitted, gold			2022-12-27	WOS:000309554700003
J	D'Onghia, G; Maiorano, P; Carlucci, R; Capezzuto, F; Carluccio, A; Tursi, A; Sion, L				D'Onghia, Gianfranco; Maiorano, Porzia; Carlucci, Roberto; Capezzuto, Francesca; Carluccio, Angela; Tursi, Angelo; Sion, Letizia			Comparing Deep-Sea Fish Fauna between Coral and Non-Coral "Megahabitats" in the Santa Maria di Leuca Cold-Water Coral Province (Mediterranean Sea)	PLOS ONE			English	Article							NORTHERN IONIAN SEA; FEEDING-HABITS; HATTON BANK; ATLANTIC; REEFS; COMMUNITIES; BEHAVIOR; ASSOCIATIONS; ASSEMBLAGES; MEGAFAUNA	Two experimental longline surveys were carried out in the Santa Maria di Leuca (SML) cold-water coral province (Mediterranean Sea) during May-June and September-October 2010 to investigate the effect of corals on fish assemblages. Two types of "megahabitat" characterized by the virtual absence of fishing were explored. One was characterized by complex topography including mesohabitats with carbonate mounds and corals. The other type of megahabitat, although characterized by complex topographic features, lacks carbonate mounds and corals. The fishing vessel was equipped with a 3,000 m monofilament longline with 500 hooks and snoods of 2.5 m in length. A total of 9 hauls, using about 4,500 hooks, were carried out both in the coral megahabitat and in the non-coral megahabitat during each survey. The fish Leucoraja fullonica and Pteroplatytrygon violacea represent new records for the SML coral province. The coral by-catch was only obtained in the coral megahabitat in about 55% of the stations investigated in both surveys. The total catches and the abundance indices of several species were comparable between the two habitat typologies. The species contributing most to the dissimilarity between the two megahabitat fish assemblages were Pagellus bogaraveo, Galeus melastomus, Etmopterus spinax and Helicolenus dactylopterus for density and P. bogaraveo, Conger conger, Polyprion americanus and G. melastomus for biomass. P. bogaraveo was exclusively collected in the coral megahabitat, whereas C. conger, H. dactylopterus and P. americanus were found with greater abundance in the coral than in the non-coral megahabitat. Differences in the sizes between the two megahabitats were detected in E. spinax, G. melastomus, C. conger and H. dactylopterus. Although these differences most probably related to the presence-absence of corals, both megahabitats investigated play the role of attraction-refuge for deep-sea fish fauna, confirming the important role of the whole SML coral province as a refuge area from fishing.	[D'Onghia, Gianfranco; Maiorano, Porzia; Carlucci, Roberto; Capezzuto, Francesca; Carluccio, Angela; Tursi, Angelo; Sion, Letizia] Univ Bari Aldo Moro, Dept Biol, CoNISMa, Bari, Italy	CoNISMa; Universita degli Studi di Bari Aldo Moro	D'Onghia, G (corresponding author), Univ Bari Aldo Moro, Dept Biol, CoNISMa, Bari, Italy.	g.donghia@biologia.uniba.it	SION, LETIZIA/E-4205-2015; Carlucci, Roberto/C-5728-2009; Carlucci, Roberto/ABC-7196-2020	SION, LETIZIA/0000-0002-0308-1841; Carlucci, Roberto/0000-0002-9287-6936; D'Onghia, Gianfranco/0000-0003-0952-9472; CAPEZZUTO, Francesca/0000-0002-1498-0228; Tursi, Angelo Raffaele/0000-0002-7776-2738	EU 7FP CoralFISH project	EU 7FP CoralFISH project	This study was supported by the EU 7FP CoralFISH project (www.eu-fp7-coralfish.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auster PJ, 2005, ERLANGEN EARTH C SER, P747, DOI 10.1007/3-540-27673-4_39; Baker KD, 2012, DEEP-SEA RES PT I, V65, P171, DOI 10.1016/j.dsr.2012.03.012; Bianchi G., 1999, FAO SPECIES IDENTIFI; Bourcier M, 1973, TETHYS, V4, P811; Budillon G, 2010, DEEP-SEA RES PT II, V57, P441, DOI 10.1016/j.dsr2.2009.08.017; Buhl-Mortensen L, 2004, SYMBIOSIS, V37, P33; Buhl-Mortensen L, 2010, MAR ECOL-EVOL PERSP, V31, P21, DOI 10.1111/j.1439-0485.2010.00359.x; Capezzuto F, 2012, DEEP-SEA RES PT I, V59, P1, DOI 10.1016/j.dsr.2011.10.006; Carbonara P., 2003, Biologia Marina Mediterranea, V10, P102; Carlier A, 2009, MAR ECOL PROG SER, V397, P125, DOI 10.3354/meps08361; CONOVER W. J, 1980, PRACTICAL NONPARAMET; Consoli P, 2010, J APPL ICHTHYOL, V26, P583, DOI 10.1111/j.1439-0426.2010.01467.x; Corselli C, 2010, DEEP-SEA RES PT II, V57, P323, DOI 10.1016/j.dsr2.2009.08.018; Costello MJ, 2009, MAR ECOL PROG SER, V397, P253, DOI 10.3354/meps08317; Costello MJ, 2005, ERLANGEN EARTH C SER, P771, DOI 10.1007/3-540-27673-4_41; D'Onghia G, 1998, ITAL J ZOOL, V65, P287, DOI 10.1080/11250009809386834; D'Onghia G., 2003, Journal of Northwest Atlantic Fishery Science, V31, P263; D'Onghia G, 2011, MAR ECOL PROG SER, V443, P95, DOI 10.3354/meps09432; D'Onghia G, 2010, DEEP-SEA RES PT II, V57, P397, DOI 10.1016/j.dsr2.2009.08.022; DOnghia G, 1995, ANN I OCEANOGR PARIS, V71, P35; Du Preez C, 2011, MAR ECOL PROG SER, V425, P217, DOI 10.3354/meps09005; Munoz PD, 2011, J MAR BIOL ASSOC UK, V91, P939, DOI 10.1017/S0025315410001773; Fossa JH, 2005, ERLANGEN EARTH C SER, P359, DOI 10.1007/3-540-27673-4_18; Foubert A, 2005, ERLANGEN EARTH C SER, P403, DOI 10.1007/3-540-27673-4_20; Freese JL, 2003, MAR FISH REV, V65, P38; Freiwald A, 2002, FACIES, V47, P179, DOI 10.1007/BF02667712; Freiwald A., 2004, COLD WATER CORAL REE; Freiwald A, 2009, OCEANOGRAPHY, V22, P58, DOI 10.5670/oceanog.2009.06; Gorley C.K., 2006, GETTING STARTED PRIM; Greene HG, 1999, OCEANOL ACTA, V22, P663, DOI 10.1016/S0399-1784(00)88957-4; Husebo A, 2002, HYDROBIOLOGIA, V471, P91, DOI 10.1023/A:1016549203368; Indennidate A., 2010, BIOL MAR MEDITERR, V17, P340; Krieger KJ, 2002, HYDROBIOLOGIA, V471, P83, DOI 10.1023/A:1016597119297; Le Guilloux E, 2009, DEEP-SEA RES PT II, V56, P2394, DOI 10.1016/j.dsr2.2009.04.014; Maiorano P, 2010, CHEM ECOL, V26, P219, DOI 10.1080/02757541003693987; Mastrototaro F, 2010, DEEP-SEA RES PT II, V57, P412, DOI 10.1016/j.dsr2.2009.08.021; Matarrese A., 1996, Cybium, V20, P197; Matarrese A, 1998, ITAL J ZOOL, V65, P203, DOI 10.1080/11250009809386814; MESSING C G, 1990, Palaios, V5, P15, DOI 10.2307/3514994; Mianzan HW, 1996, FISH RES, V27, P69, DOI 10.1016/0165-7836(95)00459-9; Morato T, 2001, B MAR SCI, V69, P1073; Morato T, 1999, LIFE MAR SCI A, V17A, P51, DOI 10.1111/j.1439-0426.2010.01467.x; Mortensen PB, 2008, DEEP-SEA RES PT II, V55, P142, DOI 10.1016/j.dsr2.2007.09.018; MORTENSEN PB, 1995, SARSIA, V80, P145, DOI 10.1080/00364827.1995.10413586; Mortensen PB, 2000, THESIS U BERGEN; Nouar A, 2000, CAH BIOL MAR, V41, P313; Reed JK, 2006, B MAR SCI, V78, P343; Roberts JM, 2008, FACIES, V54, P297, DOI 10.1007/s10347-008-0140-x; Roberts J. M., 2009, COLD WATER CORALS BI, DOI [10.1017/CBO9780511581588, DOI 10.1017/CBO9780511581588]; Roberts JM, 2003, 2 INT S DEEP SEA COR, P483; Ross SW, 2007, DEEP-SEA RES PT I, V54, P975, DOI 10.1016/j.dsr.2007.03.010; Sampaio I, 2012, J MAR BIOL ASSOC UK, V92, P1547, DOI 10.1017/S0025315412000045; Savini A, 2010, DEEP-SEA RES PT II, V57, P326, DOI 10.1016/j.dsr2.2009.08.014; Sion L., 2003, Biologia Marina Mediterranea, V10, P935; Soffker M, 2011, DEEP-SEA RES PT I, V58, P818, DOI 10.1016/j.dsr.2011.06.002; Stergiou KI, 2001, REV FISH BIOL FISHER, V11, P217, DOI 10.1023/A:1020556722822; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Sulak KJ, 2007, CONSERVATION AND ADAPTIVE MANAGEMENT OF SEAMOUNT AND DEEP-SEA CORAL ECOSYSTEMS, P65; Taviani M, 2005, ERLANGEN EARTH C SER, P137, DOI 10.1007/3-540-27673-4_7; Tissot BN, 2006, FISH B-NOAA, V104, P167; Tunesi L, 1997, ATT 12 C ASS IT OC L, V1, P61; Tursi A., 1993, Cybium, V17, P187; Tursi A, 2004, CHEM ECOL, V20, pS107, DOI 10.1080/02757540310001629170; Uiblein F, 2003, MAR ECOL PROG SER, V257, P223, DOI 10.3354/meps257223; Vertino A, 2010, DEEP-SEA RES PT II, V57, P380, DOI 10.1016/j.dsr2.2009.08.023; Wulff JL, 2006, CAN J ZOOL, V84, P146, DOI 10.1139/Z06-019; Xavier JC, 2010, J MAR BIOL ASSOC UK, V90, P493, DOI 10.1017/S0025315409990555; Yoklavich MM, 2000, FISH B-NOAA, V98, P625	68	53	54	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e445090	10.1371/journal.pone.0044509	http://dx.doi.org/10.1371/journal.pone.0044509			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028551	Green Submitted, gold, Green Published			2022-12-27	WOS:000309554700013
J	Daghino, S; Murat, C; Sizzano, E; Girlanda, M; Perotto, S				Daghino, Stefania; Murat, Claude; Sizzano, Elisa; Girlanda, Mariangela; Perotto, Silvia			Fungal Diversity Is Not Determined by Mineral and Chemical Differences in Serpentine Substrates	PLOS ONE			English	Article							MICROBIAL COMMUNITY COMPOSITION; GENETIC DIVERSITY; BACTERIAL COMMUNITIES; CENOCOCCUM-GEOPHILUM; SOILS; ECTOMYCORRHIZAL; IDENTIFICATION; ASBESTOS; REVEAL; PLANT	The physico-chemical properties of serpentine soils lead to strong selection of plant species. Whereas many studies have described the serpentine flora, little information is available on the fungal communities dwelling in these sites. Asbestos minerals, often associated with serpentine rocks, can be weathered by serpentine-isolated fungi, suggesting an adaptation to this substrate. In this study, we have investigated whether serpentine substrates characterized by the presence of rocks with distinct mineral composition could select for different fungal communities. Both fungal isolation and 454 pyrosequencing of amplicons obtained from serpentine samples following direct DNA extraction revealed some fungal taxa shared by the four ophiolitic substrates, but also highlighted several substrate-specific taxa. Bootstrap analysis of 454 OTU abundances indicated weak clustering of fungal assemblages from the different substrates, which did not match substrate classification based on exchangeable macronutrients and metals. Intra-substrate variability, as assessed by DGGE profiles, was similar across the four serpentine substrates, and comparable to inter-substrate variability. These findings indicate the absence of a correlation between the substrate ( mineral composition and available cations) and the diversity of the fungal community. Comparison of culture-based and culture-independent methods supports the higher taxonomic precision of the former, as complementation of the better performance of the latter.	[Daghino, Stefania; Sizzano, Elisa; Girlanda, Mariangela; Perotto, Silvia] Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy; [Daghino, Stefania; Perotto, Silvia] Univ Turin, Interdept Ctr G Scansetti Studies Asbestos & Othe, Turin, Italy; [Murat, Claude] Lorraine Univ Interact Arbres Microorganismes, Inst Natl Rech Agron, Unite Mixte Rech, Ctr Nancy, Champenoux, France	University of Turin; University of Turin; INRAE	Daghino, S (corresponding author), Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy.	stefania.daghino@unito.it	Murat, Claude/AAA-5226-2020; Daghino, Stefania/AAO-7718-2021	Murat, Claude/0000-0003-0685-7307; PEROTTO, Silvia/0000-0003-0121-1806; DAGHINO, Stefania/0000-0001-5722-1558	Regione Piemonte; University of Torino; Fondazione San Paolo	Regione Piemonte(Regione Piemonte); University of Torino; Fondazione San Paolo(Compagnia di San Paolo)	Dr. Daghino was supported by a fellowship from Regione Piemonte. Local funding by the University of Torino and Fondazione San Paolo is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; [Anonymous], 2006, RENDICONTI SOC GEOL; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bent SJ, 2008, ISME J, V2, P689, DOI 10.1038/ismej.2008.44; Brady KU, 2005, ANNU REV ECOL EVOL S, V36, P243, DOI 10.1146/annurev.ecolsys.35.021103.105730; Branco S, 2010, MOL ECOL, V19, P5566, DOI 10.1111/j.1365-294X.2010.04913.x; Branco S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011757; Brooks R. R., 1987, SERPENTINE ITS VEGET; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Burford Euan P., 2003, Mycologist, V17, P98, DOI 10.1017/S0269915X03003112; COMPAGNONI R, 1985, AM MINERAL, V70, P767; Daghino S, 2008, FEMS MICROBIOL LETT, V285, P242, DOI 10.1111/j.1574-6968.2008.01239.x; Daghino S, 2009, FEMS MICROBIOL ECOL, V69, P132, DOI 10.1111/j.1574-6941.2009.00695.x; DeGrood SH, 2005, SOIL BIOL BIOCHEM, V37, P1427, DOI 10.1016/j.soilbio.2004.12.013; Dickie IA, 2010, NEW PHYTOL, V188, P916, DOI 10.1111/j.1469-8137.2010.03473.x; Domsch KH, 2007, COMPENDIUM SOIL FUNG; Escarre J, 2000, NEW PHYTOL, V145, P429, DOI 10.1046/j.1469-8137.2000.00599.x; Favero-Longo SE, 2006, PLANT BIOSYST, V140, P190, DOI 10.1080/11263500600756546; Fierer N, 2007, APPL ENVIRON MICROB, V73, P7059, DOI 10.1128/AEM.00358-07; Fitzsimons MS, 2010, PLANT SOIL, V330, P393, DOI 10.1007/s11104-009-0213-9; Fornero E, 2009, SCI TOTAL ENVIRON, V407, P1010, DOI 10.1016/j.scitotenv.2008.10.021; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gladish S, 2010, CAN J FOREST RES, V40, P1671, DOI 10.1139/X10-092; Goncalves SC, 2007, MYCORRHIZA, V17, P677, DOI 10.1007/s00572-007-0145-2; Goncalves SC, 2009, MYCORRHIZA, V19, P221, DOI 10.1007/s00572-008-0211-4; Groppo C, 2005, J TOXICOL ENV HEAL A, V68, P1, DOI 10.1080/15287390590523867; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jones J.B., 2001, LAB GUIDE CONDUCTING, DOI [DOI 10.1201/9781420025293, 10.1201/9781420025293]; Jumpponen A, 2009, NEW PHYTOL, V184, P438, DOI 10.1111/j.1469-8137.2009.02990.x; Jumpponen A, 2010, MOL ECOL, V19, P41, DOI 10.1111/j.1365-294X.2009.04483.x; Kazakou E, 2008, BIOL REV, V83, P495, DOI 10.1111/j.1469-185X.2008.00051.x; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lazarus BE, 2011, PLANT SOIL, V342, P327, DOI 10.1007/s11104-010-0698-2; Lentendu G, 2011, FUNGAL DIVERS, V49, P113, DOI 10.1007/s13225-011-0101-5; Luis P, 2005, GEODERMA, V128, P18, DOI 10.1016/j.geoderma.2004.12.023; Mello A, 2011, MYCOLOGIA, V103, P1184, DOI 10.3852/11-027; Mengoni A, 2004, MICROB ECOL, V48, P209, DOI 10.1007/s00248-003-0149-1; Moser AM, 2009, PLANT SOIL, V315, P185, DOI 10.1007/s11104-008-9743-9; Motta R, 2001, J VEG SCI, V12, P219, DOI 10.2307/3236606; Murat C, 2005, FEMS MICROBIOL LETT, V245, P307, DOI 10.1016/j.femsle.2005.03.019; Nilsson RH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000059; Nilsson RH, 2009, FEMS MICROBIOL LETT, V296, P97, DOI 10.1111/j.1574-6968.2009.01618.x; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Oline DK, 2006, APPL ENVIRON MICROB, V72, P6965, DOI 10.1128/AEM.00690-06; Podani J., 2001, SYNTAX 2000 COMPUTER; Porter TM, 2011, NEW PHYTOL, V192, P775, DOI 10.1111/j.1469-8137.2011.03838.x; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Rajakaruna N., 2008, GEN ECOLOGY ENCY ECO, V2nd, P1201; Reeder J, 2009, NAT METHODS, V6, P636, DOI 10.1038/nmeth0909-636; Roccotiello E, 2010, FRESEN ENVIRON BULL, V19, P2420; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Schechter SP, 2008, MOL ECOL, V17, P3198, DOI 10.1111/j.1365-294X.2008.03828.x; Schipper LA, 2004, PLANT SOIL, V262, P151, DOI 10.1023/B:PLSO.0000037027.56794.08; Simonovicova A, 2004, INT BIODETER BIODEGR, V54, P7, DOI 10.1016/j.ibiod.2003.11.004; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sterflinger K, 2000, GEOMICROBIOL J, V17, P97, DOI 10.1080/01490450050023791; Suihko ML, 2007, SYST APPL MICROBIOL, V30, P494, DOI 10.1016/j.syapm.2007.05.001; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; Urban A, 2008, MYCORRHIZA, V18, P339, DOI 10.1007/s00572-008-0189-y; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315	65	20	21	1	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e44233	10.1371/journal.pone.0044233	http://dx.doi.org/10.1371/journal.pone.0044233			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028507	Green Published, gold			2022-12-27	WOS:000309388900008
J	Ben-Tzvi, O; Abelson, A; Gaines, SD; Bernardi, G; Beldade, R; Sheehy, MS; Paradis, GL; Kiflawi, M				Ben-Tzvi, Ofer; Abelson, Avigdor; Gaines, Steven D.; Bernardi, Giacomo; Beldade, Ricardo; Sheehy, Michael S.; Paradis, Georges L.; Kiflawi, Moshe			Evidence for Cohesive Dispersal in the Sea	PLOS ONE			English	Article							CORAL-REEF FISHES; GREAT-BARRIER-REEF; POPULATION CONNECTIVITY; ELEMENTAL SIGNATURES; MARINE POPULATIONS; SWIMMING ABILITIES; DEMERSAL FISHES; PELAGIC LARVAE; OTOLITHS; RECRUITMENT	As with many marine species, the vast majority of coral-reef fishes have a bipartite life cycle consisting of a dispersive larval stage and a benthic adult stage. While the potentially far-reaching demographic and ecological consequences of marine dispersal are widely appreciated, little is known of the structure of the larval pool and of the dispersive process itself. Utilizing Palindrome Sequence Analysis of otolith micro-chemistry (PaSA;) we show that larvae of Neopomacentrus miryae (Pomacentridae) appear to remain in cohesive cohorts throughout their entire pelagic larval duration (PLD; similar to 28 days). Genetically, we found cohort members to be maternally (mtDNA) unrelated. While physical forcing cannot be negated as contributing to initial cohort formation, the small scale of the observed spatial structure suggests that some behavioral modification may be involved from a very early age. This study contributes to our ongoing re-evaluation of the processes that structure marine populations and communities and the spatial scales at which they operate.	[Ben-Tzvi, Ofer; Kiflawi, Moshe] Interuniv Inst Marine Sci Eilat, Elat, Israel; [Ben-Tzvi, Ofer; Abelson, Avigdor] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, IL-69978 Tel Aviv, Israel; [Gaines, Steven D.; Sheehy, Michael S.; Paradis, Georges L.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Bernardi, Giacomo; Beldade, Ricardo] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Paradis, Georges L.] Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA; [Kiflawi, Moshe] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel	Tel Aviv University; University of California System; University of California Santa Barbara; University of California System; University of California Santa Cruz; University of California System; University of California Santa Barbara; Ben Gurion University	Ben-Tzvi, O (corresponding author), Interuniv Inst Marine Sci Eilat, Elat, Israel.	obentzvi@gmail.com	Beldade, Ricardo/B-3724-2012; Gaines, Steven/Y-3234-2019; KIFLAWI, MOSHE/AAH-7991-2021; Bernardi, Giacomo/F-6346-2011	Beldade, Ricardo/0000-0003-1911-0122; Bernardi, Giacomo/0000-0002-8249-4678; Kiflawi, Moshe/0000-0002-9705-6486	Israel Science Foundation [283/06]; David and Lucille Packard Foundation; Gordon and Betty Moore Foundation; US-Israel Bi-National Science Foundation (BSF); The Red Sea Marine Peace Park (RSMPP) program of the US agency for international development; Middle Eastern Regional Cooperation (USAID-MERC); A. W. Mellon Foundation; Boxenbaum-Neta Foundation	Israel Science Foundation(Israel Science Foundation); David and Lucille Packard Foundation(The David & Lucile Packard Foundation); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); US-Israel Bi-National Science Foundation (BSF)(US-Israel Binational Science Foundation); The Red Sea Marine Peace Park (RSMPP) program of the US agency for international development; Middle Eastern Regional Cooperation (USAID-MERC)(United States Agency for International Development (USAID)); A. W. Mellon Foundation; Boxenbaum-Neta Foundation	US-Israel Bi-National Science Foundation (BSF) URL: http://www.bsf. org.il/ BSFPublic/Default.aspx The Red Sea Marine Peace Park (RSMPP) program of the US agency for international development URL: http://ww w.mfa.gov.il/MFA/Archive/Communiques/1997/BINATIONAL%20RED%20SEA%20MARINE%20PEACE%20PARK%20-% 20Oct-97 Middle Eastern Regional Cooperation (USAID-MERC) URL:http://www.usaid.go v/our_work/merc/program_description.html. Boxenbaum-Neta Foundation URL (Hebrew): http://www.aev.co.il/default.asp?catid = %7B80DE5766-C4B6-4705-A1AA-CCBBA6CEC902%7D. Israel Science Foundation grant 283/06 URL: http://www.isf.org.il/. A. W. Mellon Foundation URL: http://www.mellon.org/.PISCO, the Partnership for Interdisciplinary Studies of Coastal Oceans, funded by the David and Lucille Packard and the Gordon and Betty Moore Foundations. URL: http://www.piscoweb.org/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bay LK, 2006, MAR BIOL, V149, P1247, DOI 10.1007/s00227-006-0276-6; Ben-Tzvi O, 2008, MAR ECOL PROG SER, V359, P229, DOI 10.3354/meps07343; Ben-Tzvi O, 2007, LIMNOL OCEANOGR-METH, V5, P97, DOI 10.4319/lom.2007.5.97; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Campana SE, 2001, CAN J FISH AQUAT SCI, V58, P30, DOI 10.1139/f00-177; CAMPANA SE, 1995, MAR ECOL PROG SER, V122, P115, DOI 10.3354/meps122115; Cowen RK, 2007, OCEANOGRAPHY, V20, P14, DOI 10.5670/oceanog.2007.26; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fisher R, 2000, MAR ECOL PROG SER, V202, P163, DOI 10.3354/meps202163; GAINES SD, 1992, NATURE, V360, P579, DOI 10.1038/360579a0; Gaines SD, 2007, OCEANOGRAPHY, V20, P90, DOI 10.5670/oceanog.2007.32; Gaylord B, 2000, AM NAT, V155, P769, DOI 10.1086/303357; HEDGECOCK D, 1994, GENETICS AND EVOLUTION OF AQUATIC ORGANISMS, P122; Hedgecock D, 2007, OCEANOGRAPHY, V20, P70, DOI 10.5670/oceanog.2007.30; JAN RQ, 1992, B I ZOOL ACAD SINICA, V31, P231; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; LEE WJ, 1995, J MOL EVOL, V41, P54; Leis JM, 2006, ADV MAR BIOL, V51, P57, DOI 10.1016/S0065-2881(06)51002-8; Leis JM, 2010, ICHTHYOL RES, V57, P325, DOI 10.1007/s10228-010-0177-z; Leis JM, 1997, MAR ECOL PROG SER, V159, P165, DOI 10.3354/meps159165; Leis JM, 2004, MAR FRESHW BEHAV PHY, V37, P65, DOI 10.1080/10236240410001705761; Leis JM, 1998, ENVIRON BIOL FISH, V53, P259, DOI 10.1023/A:1007424719764; Leis JM, 2003, MAR ECOL PROG SER, V252, P239, DOI 10.3354/meps252239; Patterson HM, 2004, MAR ECOL PROG SER, V270, P229, DOI 10.3354/meps270229; ROUGHGARDEN J, 1988, SCIENCE, V241, P1460, DOI 10.1126/science.11538249; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Ruttenberg BI, 2005, MAR ECOL PROG SER, V297, P273, DOI 10.3354/meps297273; Selkoe KA, 2008, FISH FISH, V9, P363, DOI 10.1111/j.1467-2979.2008.00300.x; Siegel DA, 2008, P NATL ACAD SCI USA, V105, P8974, DOI 10.1073/pnas.0802544105; Siegel DA, 2003, MAR ECOL PROG SER, V260, P83, DOI 10.3354/meps260083; Stobutzki IC, 1997, MAR ECOL PROG SER, V149, P35, DOI 10.3354/meps149035; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Thorrold Simon R., 2002, P243, DOI 10.1016/B978-012615185-5/50015-3; Thorrold SR, 2007, OCEANOGRAPHY, V20, P80, DOI 10.5670/oceanog.2007.31; Warner RR, 2005, LIMNOL OCEANOGR, V50, P1529, DOI 10.4319/lo.2005.50.5.1529	35	23	23	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e42672	10.1371/journal.pone.0042672	http://dx.doi.org/10.1371/journal.pone.0042672			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028433	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900002
J	Fasanaro, P; Romani, S; Voellenkle, C; Maimone, B; Capogrossi, MC; Martelli, F				Fasanaro, Pasquale; Romani, Sveva; Voellenkle, Christine; Maimone, Biagina; Capogrossi, Maurizio C.; Martelli, Fabio			ROD1 Is a Seedless Target Gene of Hypoxia-Induced miR-210	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; MICRORNA; DIFFERENTIATION; EXPRESSION; IDENTIFICATION; RECOGNITION; REGULATOR; SURVIVAL; BINDING; SITES	Most metazoan microRNA (miRNA) target sites have perfect pairing to the "seed" sequence, a highly conserved region centering on miRNA nucleotides 2-7. Thus, complementarity to this region is a necessary requirement for target prediction algorithms. However, also non-canonical miRNA binding can confer target regulation. Here, we identified a seedless target of miR-210, a master miRNA of the hypoxic response. We analyzed 20 genes that were inversely correlated to miR-210 expression and did not display any complementarity with miR-210 seed sequence. We validated ROD1 (Regulator of Differentiation 1, also named PTBP3, Polypyrimidine Tract Binding protein 3) as a miR-210 seedless transcript enriched in miR-210-containing RNA-induced silencing complexes. ROD1 was not indirectly targeted by a miR-210-induced miRNA. Conversely, we identified a "centered" miR-210 binding site in ROD1 involving 10 consecutive bases in the central portion of miR-210. Reporter assays showed that miR-210 inhibited ROD1 by the direct binding to this sequence, demonstrating that ROD1 is a bona fide seedless target of miR-210. As expected, both ROD1 mRNA and protein were down-modulated upon hypoxia in a miR-210 dependent manner. ROD1 targeting by miR-210 was biologically significant: the rescue of ROD1 inhibition significantly increased hypoxia-induced cell death. These data highlight the importance of ROD1 regulation by miR-210 for cell homeostasis.	[Fasanaro, Pasquale; Maimone, Biagina; Capogrossi, Maurizio C.] Ist Dermopat Immacolata IRCCS, Rome, Italy; [Romani, Sveva] IRCCS Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy; [Voellenkle, Christine; Martelli, Fabio] IRCCS Policlin San Donato, Milan, Italy	IRCCS Istituto Dermopatico dell'Immacolata (IDI); IRCCS Casa Sollievo Della Sofferenza; IRCCS Policlinico San Donato	Fasanaro, P (corresponding author), Ist Dermopat Immacolata IRCCS, Rome, Italy.	fabio.martelli@grupposandonato.it	Voellenkle, Christine/AAD-3092-2021; Martelli, Fabio/AAL-3788-2020; Voellenkle, Christine/J-8144-2016	Martelli, Fabio/0000-0002-8624-7738; Voellenkle, Christine/0000-0003-0824-060X	Ministero della Salute; Associazione Italiana per la Ricerca sul Cancro [AIRC IG-11436]	Ministero della Salute(Ministry of Health, Italy); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was partly supported by Ministero della Salute and Associazione Italiana per la Ricerca sul Cancro (AIRC IG-11436). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bianchi N, 2009, BMB REP, V42, P493, DOI 10.5483/BMBRep.2009.42.8.493; Chan YC, 2012, MICROCIRCULATION, V19, P215, DOI 10.1111/j.1549-8719.2011.00154.x; Chi SW, 2012, NAT STRUCT MOL BIOL, V19, P321, DOI 10.1038/nsmb.2230; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Crosby ME, 2009, CANCER RES, V69, P1221, DOI 10.1158/0008-5472.CAN-08-2516; Devlin C, 2011, IUBMB LIFE, V63, P94, DOI [10.1002/iub.00427, 10.1002/iub.427]; Elefant N, 2011, BIOINFORMATICS, V27, P3093, DOI 10.1093/bioinformatics/btr534; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fasanaro P, 2006, FASEB J, V20, P1242, DOI 10.1096/fj.05-4695fje; Fasanaro P, 2010, PHARMACOL THERAPEUT, V125, P92, DOI 10.1016/j.pharmthera.2009.10.003; Fasanaro P, 2009, J BIOL CHEM, V284, P35134, DOI 10.1074/jbc.M109.052779; Forman JJ, 2010, CELL CYCLE, V9, P1533, DOI 10.4161/cc.9.8.11202; Hosoda T, 2011, CIRCULATION, V123, P1287, DOI 10.1161/CIRCULATIONAHA.110.982918; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Kane NM, 2010, ARTERIOSCL THROM VAS, V30, P1389, DOI 10.1161/ATVBAHA.110.204800; Kosaka N, 2008, BRIT J HAEMATOL, V142, P293, DOI 10.1111/j.1365-2141.2008.07151.x; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lorenzen JM, 2011, CLIN J AM SOC NEPHRO, V6, P1540, DOI 10.2215/CJN.00430111; Magenta A, 2011, CELL DEATH DIFFER, V18, P1628, DOI 10.1038/cdd.2011.42; Matkovich SJ, 2011, CIRC RES, V108, P18, DOI 10.1161/CIRCRESAHA.110.233528; Mutharasan RK, 2011, AM J PHYSIOL-HEART C, V301, pH1519, DOI 10.1152/ajpheart.01080.2010; Sadvakassova G, 2009, J CELL PHYSIOL, V220, P672, DOI 10.1002/jcp.21817; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Thomson DW, 2011, NUCLEIC ACIDS RES, V39, P6845, DOI 10.1093/nar/gkr330; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Voellenkle C, 2012, RNA, V18, P472, DOI 10.1261/rna.027615.111; Wang WX, 2010, RNA, V16, P394, DOI 10.1261/rna.1905910; Yamamoto H, 1999, MOL CELL BIOL, V19, P3829; Zhang Z, 2009, CELL CYCLE, V8, P2756, DOI 10.4161/cc.8.17.9387	31	30	32	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44651	10.1371/journal.pone.0044651	http://dx.doi.org/10.1371/journal.pone.0044651			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024754	gold, Green Published, Green Submitted			2022-12-27	WOS:000308860100012
J	Pakpoor, J; Handel, AE; Giovannoni, G; Dobson, R; Ramagopalan, SV				Pakpoor, Julia; Handel, Adam E.; Giovannoni, Gavin; Dobson, Ruth; Ramagopalan, Sreeram V.			Meta-Analysis of the Relationship between Multiple Sclerosis and Migraine	PLOS ONE			English	Article							PRIMARY HEADACHES; INTERFERON-BETA; BRAIN-STEM; PREVALENCE; THERAPY; HEALTH; IMPACT; RISK	Background: Studies investigating a proposed association between multiple sclerosis (MS) and migraine have produced conflicting results and a great range in the prevalence rate of migraine in MS patients. By meta-analysing all available data we aimed to establish an overall estimate of any association in order to more accurately inform clinicians and care-givers about a potential association between MS and migraine. Methods: Pubmed and EMBASE were searched to identify suitable studies. Studies were included if they were a case-control study or cohort study in which controls were not reported to have another neurological condition, were available in English, and specified migraine as a headache sub-type. The odds ratio (OR) of migraine in MS patients vs. controls was calculated using the inverse variance with random effects model in Review Manager 5.1. Results: Eight studies were selected for inclusion, yielding a total of 1864 MS patients and 261563 control subjects. We found a significant association between migraine and MS (OR = 2.60, 95% CI 1.12-6.04), although there was significant heterogeneity. Sensitivity analysis showed that migraine without aura was associated with MS OR = 2.29 (95% CI 1.14-4.58), with no significant heterogeneity. Conclusions: MS patients are more than twice as likely to report migraine as controls. Care providers should be alerted to ask MS patients about migraine in order to treat it and potentially improve quality of life. Future work should further investigate the temporal relationship of this association and relationship to the clinical characteristics of MS.	[Pakpoor, Julia; Handel, Adam E.; Ramagopalan, Sreeram V.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Pakpoor, Julia; Handel, Adam E.; Ramagopalan, Sreeram V.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci Clin Neurol, Oxford OX3 9DU, England; [Giovannoni, Gavin; Dobson, Ruth; Ramagopalan, Sreeram V.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England; [Ramagopalan, Sreeram V.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of London; Queen Mary University London; University of London; London School of Hygiene & Tropical Medicine	Pakpoor, J (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford, England.	ruth.dobson@qmul.ac.uk; s.ramagopalan@qmul.ac.uk		Handel, Adam/0000-0001-8385-6346	Bayer Schering Pharma; Biogen Idec; Merck Serono; Novartis; UCB; Merz Pharmaceuticals; LLC; Teva Pharmaceutical Industries Ltd.-sanofi-aventis; GW Pharma; Ironwood; ABN/Multiple Sclerosis Society of Great Britain Clinical Research Fellowship; Multiple Sclerosis Society of Canada Scientific Research Foundation; Multiple Sclerosis Society of the United Kingdom; National Institute for Health Research [ACF-2011-18-008] Funding Source: researchfish	Bayer Schering Pharma(Bayer AG); Biogen Idec(Biogen); Merck Serono(Merck & Company); Novartis(Novartis); UCB(UCB Pharma SA); Merz Pharmaceuticals; LLC; Teva Pharmaceutical Industries Ltd.-sanofi-aventis(Sanofi-Aventis); GW Pharma; Ironwood; ABN/Multiple Sclerosis Society of Great Britain Clinical Research Fellowship; Multiple Sclerosis Society of Canada Scientific Research Foundation; Multiple Sclerosis Society of the United Kingdom; National Institute for Health Research(National Institute for Health Research (NIHR))	Miss Pakpoor reports no disclosures. Dr. Handel reports no disclosures. Dr. Giovannoni serves on scientific advisory boards for Merck Serono and Biogen Idec and Vertex Pharmaceuticals; served on the editorial board of Multiple Sclerosis; has received speaker honoraria from Bayer Schering Pharma, Merck Serono, Biogen Idec, Pfizer Inc, Teva Pharmaceutical Industries Ltd.-sanofiaventis, Vertex Pharmaceuticals, Genzyme Corporation, Ironwood, and Novartis; has served as a consultant for Bayer Schering Pharma, Biogen Idec, GlaxoSmithKline, Merck Serono, Protein Discovery Laboratories, Teva Pharmaceutical Industries Ltd.-sanofi-aventis, UCB, Vertex Pharmaceuticals, GW Pharma, Novartis, and FivePrime; serves on the speakers bureau for Merck Serono; and has received research support from Bayer Schering Pharma, Biogen Idec, Merck Serono, Novartis, UCB, Merz Pharmaceuticals, LLC, Teva Pharmaceutical Industries Ltd.-sanofi-aventis, GW Pharma, and Ironwood. Dr. Dobson is funded by a joint ABN/Multiple Sclerosis Society of Great Britain Clinical Research Fellowship. Dr. Ramagopalan receives research support from the Multiple Sclerosis Society of Canada Scientific Research Foundation and the Multiple Sclerosis Society of the United Kingdom. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aydemir N, 2011, SEIZURE-EUR J EPILEP, V20, P679, DOI 10.1016/j.seizure.2011.06.017; Bigal ME, 2008, HEADACHE, V48, P7, DOI 10.1111/j.1526-4610.2007.00969.x; Compston N, 1952, Q J MED, V21, P135; D'Amico D, 2004, CEPHALALGIA, V24, P980, DOI 10.1111/j.1468-2982.2004.00790.x; Gee JR, 2005, HEADACHE, V45, P670, DOI 10.1111/j.1526-4610.2005.05136.x; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Katsiari CG, 2011, HEADACHE, V51, P1398, DOI 10.1111/j.1526-4610.2011.01962.x; Kister I, 2012, MULT SCLER J, V18, P90, DOI 10.1177/1352458511416487; Kister I, 2010, J HEADACHE PAIN, V11, P417, DOI 10.1007/s10194-010-0237-9; La Mantia L, 2006, MULT SCLER J, V12, P476, DOI 10.1191/1352458506ms1298oa; La Mantia L, 2009, NEUROL SCI, V30, pS23, DOI 10.1007/s10072-009-0053-7; Lipton RB, 2007, NEUROLOGY, V68, P343, DOI 10.1212/01.wnl.0000252808.97649.21; Merkler D, 2009, ANN NEUROL, V66, P355, DOI 10.1002/ana.21746; Nicoletti A, 2008, CEPHALALGIA, V28, P1163, DOI 10.1111/j.1468-2982.2008.01662.x; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Pollmann W, 2002, NEUROLOGY, V59, P636, DOI 10.1212/WNL.59.4.636; Putzki N, 2009, EUR J NEUROL, V16, P262, DOI 10.1111/j.1468-1331.2008.02406.x; Ried Karin, 2006, Aust Fam Physician, V35, P635; ROLAK LA, 1990, J NEUROL, V237, P300, DOI 10.1007/BF00314746; Rosati G, 2001, NEUROL SCI, V22, P117, DOI 10.1007/s100720170011; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Stewart WF, 1996, NEUROLOGY, V47, P52, DOI 10.1212/WNL.47.1.52; Tortorella P, 2006, J NEUROL SCI, V244, P137, DOI 10.1016/j.jns.2006.01.015; Vacca G, 2007, NEUROL SCI, V28, P133, DOI 10.1007/s10072-007-0805-1; Villani V, 2012, HEADACHE, V52, P1130, DOI 10.1111/j.1526-4610.2012.02146.x; WATKINS SM, 1969, J NEUROL NEUROSUR PS, V32, P35, DOI 10.1136/jnnp.32.1.35; Zorzon M, 2003, NEUROL SCI, V24, P242, DOI 10.1007/s10072-003-0147-6	27	34	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45295	10.1371/journal.pone.0045295	http://dx.doi.org/10.1371/journal.pone.0045295			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024814	Green Published, gold, Green Submitted			2022-12-27	WOS:000308860100072
J	Shipman, M; Lubick, K; Fouchard, D; Guram, R; Grieco, P; Jutila, M; Dratz, EA				Shipman, Matt; Lubick, Kirk; Fouchard, David; Guram, Rajani; Grieco, Paul; Jutila, Mark; Dratz, Edward A.			Proteomic and Systems Biology Analysis of Monocytes Exposed to Securinine, a GABA(A) Receptor Antagonist and Immune Adjuvant	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; ACID-BINDING PROTEINS; NF-KAPPA-B; BLOOD MONONUCLEAR-CELLS; COXIELLA-BURNETII; L-PLASTIN; DENDRITIC CELLS; CHOLESTEROL-METABOLISM; THIOREDOXIN REDUCTASE; IDENTIFICATION DATA	Securinine, a GABA(A) receptor antagonist, has been reported to enhance monocyte cell killing of Coxiella burnetii without obvious adverse effects in vivo. We employed multiplex 2D gel electrophoresis using Zdyes, a new generation of covalently linked fluorescent differential protein detection dyes to analyze changes in the monocyte proteome in response to Securinine. Securinine antagonism of GABA(A) receptors triggers the activation of p38. We used the differential protein expression results to guide a search of the literature and network analysis software to construct a systems biology model of the effect of Securinine on monocytes. The model suggests that various metabolic modulators (fatty acid binding protein 5, inosine 5'-monophosphate dehydrogenase, and thioredoxin) are at least partially reshaping the metabolic landscape within the monocytes. The actin bundling protein L-plastin, and the Ca2+ binding protein S100A4 also appear to have important roles in the immune response stimulated by Securinine. Fatty acid binding protein 5 (FABP5) may be involved in effecting lipid raft composition, inflammation, and hormonal regulation of monocytes, and the model suggests that FABP5 may be a central regulator of metabolism in activated monocytes. The model also suggests that the heat shock proteins have a significant impact on the monocyte immune response. The model provides a framework to guide future investigations into the mechanisms of Securinine action and with elaboration may help guide development of new types of immune adjuvants.	[Shipman, Matt; Fouchard, David; Guram, Rajani; Grieco, Paul; Dratz, Edward A.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Lubick, Kirk; Jutila, Mark] Montana State Univ, Dept Vet Mol Biol, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Shipman, M (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.	mshipman@chemistry.montana.edu			Department of Defense grant [W81XWH-07-2-0048]; National Institutes of Health (NIH) Cobre grant [1P20RR024237]; NIH grant [2R42RR021790A1]; Murdock Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024237] Funding Source: NIH RePORTER	Department of Defense grant(United States Department of Defense); National Institutes of Health (NIH) Cobre grant; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Murdock Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Department of Defense grant #W81XWH-07-2-0048; National Institutes of Health (NIH) Cobre grant #1P20RR024237; NIH grant #2R42RR021790A1; and the Murdock Charitable Trust. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam S, 2006, MOL IMMUNOL, V43, P1432, DOI 10.1016/j.molimm.2005.07.025; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arthur JC, 2007, J IMMUNOL, V179, P6291, DOI 10.4049/jimmunol.179.9.6291; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Ausiello CM, 2006, MICROBES INFECT, V8, P714, DOI 10.1016/j.micinf.2005.09.007; BACA OG, 1993, INFECT IMMUN, V61, P4232, DOI 10.1128/IAI.61.10.4232-4239.1993; Bae TJ, 2004, PROTEOMICS, V4, P3536, DOI 10.1002/pmic.200400952; Barry R, 2003, PROTEOMIC ANAL SULFO; Barry RC, 2006, ELECTROPHORESIS, V27, P2970, DOI 10.1002/elps.200500851; Benarafa C, 2007, J EXP MED, V204, P1901, DOI 10.1084/jem.20070494; Bertini R, 1999, J EXP MED, V189, P1783, DOI 10.1084/jem.189.11.1783; BEUTLER JA, 1985, BRAIN RES, V330, P135, DOI 10.1016/0006-8993(85)90014-9; Billiet L, 2005, J BIOL CHEM, V280, P40310, DOI 10.1074/jbc.M503644200; Binder RJ, 2005, NAT IMMUNOL, V6, P593, DOI 10.1038/ni1201; Binder RJ, 2001, J BIOL CHEM, V276, P17163, DOI 10.1074/jbc.M011547200; Bishop SC, 2007, CURR CANCER DRUG TAR, V7, P369, DOI 10.2174/156800907780809778; Bjurstrom H, 2008, J NEUROIMMUNOL, V205, P44, DOI 10.1016/j.jneuroim.2008.08.017; Boye K, 2008, INT J CANCER, V123, P1301, DOI 10.1002/ijc.23617; Broquet AH, 2003, J BIOL CHEM, V278, P21601, DOI 10.1074/jbc.M302326200; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Byrd CA, 1999, P NATL ACAD SCI USA, V96, P5645, DOI 10.1073/pnas.96.10.5645; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Cao H, 2006, DIABETES, V55, P1915, DOI 10.2337/db05-1496; Chavez-Salinas S, 2008, VIRUS RES, V138, P111, DOI 10.1016/j.virusres.2008.08.012; Chen H, 2003, IMMUNITY, V19, P95, DOI 10.1016/S1074-7613(03)00172-9; Cooley J, 2001, BIOCHEMISTRY-US, V40, P15762, DOI 10.1021/bi0113925; Craig R, 2006, J PROTEOME RES, V5, P1843, DOI 10.1021/pr0602085; Craig R, 2005, RAPID COMMUN MASS SP, V19, P1844, DOI 10.1002/rcm.1992; Craig R, 2004, J PROTEOME RES, V3, P1234, DOI 10.1021/pr049882h; Cui JF, 2006, PROTEOMICS, V6, P5953, DOI 10.1002/pmic.200500460; Dang PMC, 2006, J CLIN INVEST, V116, P2033, DOI 10.1172/JCI27544; Daxecker H, 2002, CLIN CHIM ACTA, V318, P71, DOI 10.1016/S0009-8981(01)00801-4; DAYTON JS, 1994, J IMMUNOL, V152, P984; Delanote V, 2005, ACTA PHARMACOL SIN, V26, P769, DOI 10.1111/j.1745-7254.2005.00145.x; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dratz EA, 2009, USA patent 9/1/2009, Patent No. [#7,582,260, 7582260]; Dratz EA, 2008, Novel Optical Labeling Molecules for Proteomics and Other Biological Analyses, Patent No. [PCT application US2008/059963, 2008059963]; Dratz EA, 2010, Novel Zwitterionic Fluorescent Dyes for Labeling in Proteomic and Other Biological Analyses. Methods Claims, Patent No. [USA patent issued, Number 7,833,799, 7833799]; Dukhanina EA, 2008, B EXP BIOL MED+, V145, P78, DOI 10.1007/s10517-008-0003-z; El Mezayen R, 2007, IMMUNOL LETT, V111, P36, DOI 10.1016/j.imlet.2007.04.011; Emberley ED, 2004, BIOCHEM CELL BIOL, V82, P508, DOI 10.1139/O04-052; Fenyo D, 2007, J PROTEOME RES, V6, P1997, DOI 10.1021/pr070025y; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Gadgil HS, 2003, PROTEOMICS, V3, P1767, DOI 10.1002/pmic.200300532; Go YM, 2007, AM J PATHOL, V171, P1670, DOI 10.2353/ajpath.2007.070218; GORG A, 1998, 2 DIMENSIONAL ELECTR; Han J, 2004, J PROTEOME RES, V3, P807, DOI 10.1021/pr049945w; Hirota K, 1999, J BIOL CHEM, V274, P27891, DOI 10.1074/jbc.274.39.27891; Hofmeister-Mueller V, 2009, CANCER IMMUNOL IMMUN, V58, P1265, DOI 10.1007/s00262-008-0640-0; Howe D, 2006, CELL MICROBIOL, V8, P496, DOI 10.1111/j.1462-5822.2005.00641.x; Howe D, 2005, ANN NY ACAD SCI, V1063, P123, DOI 10.1196/annals.1355.020; Hsu HY, 2007, MOL PHARMACOL, V71, P344, DOI 10.1124/mol.106.024240; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hunter-Lavin C, 2004, BIOCHEM BIOPH RES CO, V324, P511, DOI 10.1016/j.bbrc.2004.09.075; Izuhara K, 2008, CELL MOL LIFE SCI, V65, P2541, DOI 10.1007/s00018-008-8049-7; Jain J, 2004, BIOCHEM PHARMACOL, V67, P767, DOI 10.1016/j.bcp.2003.09.043; Jones SL, 1998, P NATL ACAD SCI USA, V95, P9331, DOI 10.1073/pnas.95.16.9331; Jonsson CA, 2002, CELL IMMUNOL, V216, P93, DOI 10.1016/S0008-8749(02)00502-6; Karp NA, 2005, J PROTEOME RES, V4, P1867, DOI 10.1021/pr050084g; Kol A, 2000, J IMMUNOL, V164, P13, DOI 10.4049/jimmunol.164.1.13; Kriajevska M, 2002, J BIOL CHEM, V277, P5229, DOI 10.1074/jbc.M110976200; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; Li N, 2003, PROTEOMICS, V3, P536, DOI 10.1002/pmic.200390067; Li ZH, 2006, CANCER RES, V66, P5173, DOI 10.1158/0008-5472.CAN-05-3087; Liu FZ, 2004, BIOSCI BIOTECH BIOCH, V68, P894, DOI 10.1271/bbb.68.894; Lubick K, 2007, J LEUKOCYTE BIOL, V82, P1062, DOI 10.1189/jlb.0407255; Lukashova V, 2001, J BIOL CHEM, V276, P24113, DOI 10.1074/jbc.M100720200; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Maeda K, 2003, DIABETES, V52, P300, DOI 10.2337/diabetes.52.2.300; Mainiero F, 2000, IMMUNITY, V12, P7, DOI 10.1016/S1074-7613(00)80154-5; Mangan MSJ, 2008, TISSUE ANTIGENS, V72, P1, DOI 10.1111/j.1399-0039.2008.01059.x; Meshkini A, 2008, TOXICOL IN VITRO, V22, P1503, DOI 10.1016/j.tiv.2008.05.005; Moosavi MA, 2005, INT J BIOCHEM CELL B, V37, P2366, DOI 10.1016/j.biocel.2005.04.020; Oshizawa T, 2003, J BIOCHEM, V134, P827, DOI 10.1093/jb/mvg208; Osterloh A, 2007, J BIOL CHEM, V282, P4669, DOI 10.1074/jbc.M608666200; Pabst MJ, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-13; Panjwani NN, 2002, J IMMUNOL, V168, P2997, DOI 10.4049/jimmunol.168.6.2997; Pedersen SK, 2003, J PROTEOME RES, V2, P303, DOI 10.1021/pr025588i; Pereira SR, 2005, PROTEOMICS, V5, P1186, DOI 10.1002/pmic.200400988; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Rajagopal D, 2006, EUR J IMMUNOL, V36, P828, DOI 10.1002/eji.200535326; Rana S, 2010, FASEB J, V24, P2126, DOI 10.1096/fj.09-148999; Reyes-Garcia MG, 2007, J NEUROIMMUNOL, V188, P64, DOI 10.1016/j.jneuroim.2007.05.013; Rivard CJ, 2007, J BIOL CHEM, V282, P6644, DOI 10.1074/jbc.M609432200; Saba JA, 2007, J PROTEOME RES, V6, P2211, DOI 10.1021/pr070031u; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Samoilis G, 2007, J PROTEOME RES, V6, P3032, DOI 10.1021/pr070077n; Semov A, 2005, J BIOL CHEM, V280, P20833, DOI 10.1074/jbc.M412653200; Shang LM, 2006, J BIOL CHEM, V281, P1876, DOI 10.1074/jbc.M509901200; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shui H, 2009, MOL BIOL REPORTS; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Tarabykina S, 2007, CURR CANCER DRUG TAR, V7, P217, DOI 10.2174/156800907780618329; Tseng M-Y, 2009, ORAL ONCOLOGY; Wabnitz GH, 2007, EUR J IMMUNOL, V37, P649, DOI 10.1002/eji.200636320; Wang J, 1999, J BIOL CHEM, V274, P24349, DOI 10.1074/jbc.274.34.24349; Wang RB, 2006, BLOOD, V107, P1636, DOI 10.1182/blood-2005-06-2559; Wang Y, 2005, J IMMUNOL, V174, P3306, DOI 10.4049/jimmunol.174.6.3306; Williams CH, 2000, EUR J BIOCHEM, V267, P6101, DOI 10.1046/j.1432-1327.2000.01700.x; Woods DE, 2005, PEDIATR PULM, V39, P141, DOI 10.1002/ppul.20167; Yasumatsu R, 2006, AM J PHYSIOL-LUNG C, V291, pL619, DOI 10.1152/ajplung.00507.2005; Zeng WL, 2000, J CELL BIOCHEM, V78, P519, DOI 10.1002/1097-4644(20000915)78:4<519::AID-JCB1>3.0.CO;2-V; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276; Zimmer DB, 2003, MICROSC RES TECHNIQ, V60, P552, DOI 10.1002/jemt.10297	106	11	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e41278	10.1371/journal.pone.0041278	http://dx.doi.org/10.1371/journal.pone.0041278			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028424	Green Published, gold, Green Submitted			2022-12-27	WOS:000308788700002
J	Ginsberg, MR; Rubin, RA; Falcone, T; Ting, AH; Natowicz, MR				Ginsberg, Matthew R.; Rubin, Robert A.; Falcone, Tatiana; Ting, Angela H.; Natowicz, Marvin R.			Brain Transcriptional and Epigenetic Associations with Autism	PLOS ONE			English	Article							COPY-NUMBER VARIATION; DE-NOVO MUTATIONS; SPECTRUM DISORDERS; GENE-EXPRESSION; CHILDREN; NETWORK; GENOME; PATHOPHYSIOLOGY; DYSFUNCTION; VARIANTS	Background: Autism is a common neurodevelopmental syndrome. Numerous rare genetic etiologies are reported; most cases are idiopathic. Methodology/Principal Findings: To uncover important gene dysregulation in autism we analyzed carefully selected idiopathic autistic and control cerebellar and BA19 (occipital) brain tissues using high resolution whole genome gene expression and whole genome DNA methylation microarrays. No changes in DNA methylation were identified in autistic brain but gene expression abnormalities in two areas of metabolism were apparent: down-regulation of genes of mitochondrial oxidative phosphorylation and of protein translation. We also found associations between specific behavioral domains of autism and specific brain gene expression modules related to myelin/myelination, inflammation/immune response and purinergic signaling. Conclusions/Significance: This work highlights two largely unrecognized molecular pathophysiological themes in autism and suggests differing molecular bases for autism behavioral endophenotypes.	[Ginsberg, Matthew R.; Natowicz, Marvin R.] Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Rubin, Robert A.] Whittier Coll, Dept Math, Whittier, CA USA; [Falcone, Tatiana; Natowicz, Marvin R.] Cleveland Clin, Neurol Inst, Cleveland, OH 44106 USA; [Ting, Angela H.; Natowicz, Marvin R.] Cleveland Clin, Genom Med Inst, Cleveland, OH 44106 USA; [Natowicz, Marvin R.] Cleveland Clin, Pathol & Lab Med Inst, Cleveland, OH 44106 USA; [Natowicz, Marvin R.] Cleveland Clin, Inst Pediat, Cleveland, OH 44106 USA	Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Ginsberg, MR (corresponding author), Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA.	natowim@ccf.org		Falcone, Tatiana/0000-0002-4431-6782	Cleveland Clinic Research Program Committee; Autism Research Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER	Cleveland Clinic Research Program Committee; Autism Research Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by grants from the Cleveland Clinic Research Program Committee and the Autism Research Institute (www.autism.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostou E, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-4; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Burnstock G, 2011, CURR TOP MED CHEM, V11, P973, DOI 10.2174/156802611795347627; Chahrour MH, 2012, PLOS GENET, V8, P236, DOI 10.1371/journal.pgen.1002635; Chauhan A, 2011, J NEUROCHEM, V117, P209, DOI 10.1111/j.1471-4159.2011.07189.x; Cheung C, 2009, J CHILD PSYCHOL PSYC, V50, P1102, DOI 10.1111/j.1469-7610.2009.02086.x; Darnell JC, 2011, CURR OPIN GENET DEV, V21, P465, DOI 10.1016/j.gde.2011.05.002; Devlin B, 2012, CURR OPIN GENET DEV, V22, P229, DOI 10.1016/j.gde.2012.03.002; Fatemi SH, 2012, CEREBELLUM, V11, P777, DOI 10.1007/s12311-012-0355-9; Filipovic-Sadic S, 2010, CLIN CHEM, V56, P399, DOI 10.1373/clinchem.2009.136101; Garbett K, 2008, NEUROBIOL DIS, V30, P303, DOI 10.1016/j.nbd.2008.01.012; Geschwind DH, 2011, TRENDS COGN SCI, V15, P409, DOI 10.1016/j.tics.2011.07.003; Gillis RF, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-12; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Giulivi C, 2010, JAMA-J AM MED ASSOC, V304, P2389, DOI 10.1001/jama.2010.1706; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Gregg JP, 2008, GENOMICS, V91, P22, DOI 10.1016/j.ygeno.2007.09.003; Gregory SG, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-62; Haas RH, 2010, DEV DISABIL RES REV, V16, P144, DOI 10.1002/ddrr.112; Hazlett EA, 2004, NEUROPSYCHOBIOLOGY, V49, P115, DOI 10.1159/000076719; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jiang YH, 2004, AM J MED GENET A, V131A, P1, DOI 10.1002/ajmg.a.30297; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Levitt P, 2009, J CLIN INVEST, V119, P747, DOI 10.1172/JCI37934; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Levy SE, 2009, LANCET, V374, P1627, DOI 10.1016/S0140-6736(09)61376-3; Nagarajan RP, 2008, AUTISM RES, V1, P169, DOI 10.1002/aur.24; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Nguyen A, 2010, FASEB J, V24, P3036, DOI 10.1096/fj.10-154484; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Onore C, 2012, BRAIN BEHAV IMMUN, V26, P383, DOI 10.1016/j.bbi.2011.08.007; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Ring HA, 1999, BRAIN, V122, P1305, DOI 10.1093/brain/122.7.1305; Sakai Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002166; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sbacchi S, 2010, CURR GENOMICS, V11, P136, DOI 10.2174/138920210790886880; Voineagu I, 2012, NEUROBIOL DIS, V45, P69, DOI 10.1016/j.nbd.2011.07.017; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wintle RF, 2011, AUTISM RES, V4, P89, DOI 10.1002/aur.173; Xin YR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011357; Xu HC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-499; Xu LM, 2012, NUCLEIC ACIDS RES, V40, pD1016, DOI 10.1093/nar/gkr1145	43	110	111	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44736	10.1371/journal.pone.0044736	http://dx.doi.org/10.1371/journal.pone.0044736			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984548	gold, Green Published, Green Submitted			2022-12-27	WOS:000308738500077
J	Schiotis, R; Bartolome, N; Sanchez, A; Szczypiorska, M; Sanz, J; Cuende, E; Estevez, EC; Martinez, A; Tejedor, D; Artieda, M; Buzoianu, A; Mulero, J				Schiotis, Ruxandra; Bartolome, Nerea; Sanchez, Alejandra; Szczypiorska, Magdalena; Sanz, Jesus; Cuende, Eduardo; Collantes Estevez, Eduardo; Martinez, Antonio; Tejedor, Diego; Artieda, Marta; Buzoianu, Anca; Mulero, Juan			Both Baseline Clinical Factors and Genetic Polymorphisms Influence the Development of Severe Functional Status in Ankylosing Spondylitis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RADIOGRAPHIC SEVERITY; SUSCEPTIBILITY LOCI; DISEASE SEVERITY; HLA-B27; ERAP1; CONCORDANCE; DISABILITY; PREDICTION; ONSET	Functional severity in ankylosing spondylitis (AS) patients is variable and difficult to predict early. The aim of our study was to assess whether a combination of baseline clinical factors and genetic markers may predict the development of severe functional status in AS. We performed a cross-sectional association study on AS patients included in the Spanish National Registry of Spondyloarthropathies-REGISPONSER. Bath Ankylosing Spondylitis Functional Index (BASFI) was standardized by adjusting for disease duration since the first symptoms (BASFI/t). We considered as severe functional status the values of BASFI/t in the top of the 60th (p60), 65th (p65), 70th (p70), and 75th (p75) percentile. We selected 384 single nucleotide polymorphisms (SNPs) distributed in 190 genes to be analyzed. The study cohort included 456 patients with mean age 50.8(+/- 10.5) years and with mean disease duration since first symptoms 24.7 (+/- 10.1) years. Older age at disease onset and neck pain at baseline showed statistical significant association with severe BASFI/t. Polymorphisms associated in the allele frequencies test with severe BASFI/t in all classifications were: rs2542151 (p60 [P=.04], p65 [P=.04], p70 [P=.001] and p75 [P=.001]) and rs2254441 (p60 [P=.004], p65 [P=.02], p70 [P=.01] and p75 [P<.001]).. Genotype association, after adjustment for covariates, found an association in three of the four patients' classifications for rs2542151 and in two of the classifications for rs2254441. Forward logistic regression did not identify any model with a good predictive power for severe functional development. In our study we identified clinical factors and 24 polymorphisms associated with development of severe functional status in AS patients. Validation of these results in other cohorts is required.	[Schiotis, Ruxandra; Buzoianu, Anca] Iuliu Hatieganu Univ Med & Pharm, Dept Pharmacol, Cluj Napoca, Romania; [Schiotis, Ruxandra] SCBI Rheumatol Dept, Cluj Napoca, Romania; [Schiotis, Ruxandra; Collantes Estevez, Eduardo] Univ Hosp Reina Sofia IMIBIC, Dept Rheumatol, Cordoba, Spain; [Bartolome, Nerea; Szczypiorska, Magdalena; Martinez, Antonio; Tejedor, Diego; Artieda, Marta] Progenika Biopharma SA, Dept R D, Derio Vizcaya, Spain; [Sanchez, Alejandra; Sanz, Jesus; Mulero, Juan] Univ Hosp, Dept Rheumatol, Madrid, Spain; [Cuende, Eduardo] Univ Hosp Principe de Asturias, Dept Rheumatol, Madrid, Spain	Iuliu Hatieganu University of Medicine & Pharmacy; Grifols; Prince of Asturias University Hospital	Schiotis, R (corresponding author), Iuliu Hatieganu Univ Med & Pharm, Dept Pharmacol, Cluj Napoca, Romania.	Elena.Schiotis@umfcluj.ro	Buzoianu, Anca D/M-1050-2017; Sanz, Jesús Sanz/H-8795-2017; Sánchez, Alejandra/G-7826-2012; Buzoianu, Anca D./I-3139-2016; Collantes-Estevez, Eduardo/ABI-3550-2020; Collantes-Estevez, Eduardo/M-9549-2019; schiotis, ruxandra/AAO-5265-2020	Buzoianu, Anca D/0000-0002-3511-2788; Sanz, Jesús Sanz/0000-0001-8740-0063; Sánchez, Alejandra/0000-0003-4620-6744; Collantes-Estevez, Eduardo/0000-0002-7647-6289; 	Ministerio de Ciencia e Innovacion of Spain [Proyect PSE-01000-2006-1]; Progenika Biopharma S.A.; Pfizer	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Progenika Biopharma S.A.; Pfizer(Pfizer)	This work was supported by the Ministerio de Ciencia e Innovacion of Spain [Proyect PSE-01000-2006-1] and by Progenika Biopharma S.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare the following interests: M.S., N.B., M.A., A.M. and D.T. are currently employees of Progenika Biopharma, SA. A.S. is supported by an unrestricted grant from Pfizer. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. All other authors have declared no conflicts of interest.	AMOR B, 1994, J RHEUMATOL, V21, P1883; Ariza-Ariza R, 2009, J RHEUMATOL, V36, P2512, DOI 10.3899/jrheum.090481; Assassi S, 2011, J RHEUMATOL, V38, P87, DOI 10.3899/jrheum.100469; Bartolome N, 2012, RHEUMATOLOGY, V51, P1471, DOI 10.1093/rheumatology/kes056; Boonen A, 2009, J RHEUMATOL, V36, P1249, DOI 10.3899/jrheum.080831; Brophy S, 2004, J RHEUMATOL, V31, P1775; Brophy S, 2001, J RHEUMATOL, V28, P2283; Brown MA, 1998, ARTHRITIS RHEUM, V41, P588, DOI 10.1002/1529-0131(199804)41:4<588::AID-ART5>3.0.CO;2-0; Brown MA, 2003, ARTHRITIS RHEUM, V48, P2234, DOI 10.1002/art.11106; Brown MA, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2692; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cakar E, 2009, CLIN RHEUMATOL, V28, P1309, DOI 10.1007/s10067-009-1249-1; CALIN A, 1994, J RHEUMATOL, V21, P2281; Cansu DU, 2011, CLIN RHEUMATOL, V30, P557, DOI 10.1007/s10067-010-1665-2; CARETTE S, 1983, ARTHRITIS RHEUM, V26, P186, DOI 10.1002/art.1780260210; Carter N, 2000, RHEUMATOLOGY, V39, P445, DOI 10.1093/rheumatology/39.4.445; Cho SY, 2008, KOR J LAB MED, V28, P239, DOI 10.3343/kjlm.2008.28.3.239; Collantes E, 2007, RHEUMATOLOGY, V46, P1309, DOI 10.1093/rheumatology/kem084; Day TG, 2008, ARTHRITIS RHEUM-US, V58, P2142, DOI 10.1002/art.23604; Doran MF, 2003, J RHEUMATOL, V30, P316; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Falkenbach A, 2003, J RHEUMATOL, V30, P2186; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Gensler LS, 2008, ANN RHEUM DIS, V67, P233, DOI 10.1136/ard.2007.072512; Goedecke V, 2003, GENES IMMUN, V4, P74, DOI 10.1038/sj.gene.6363930; Grainger DJ, 1999, OSTEOPOROSIS INT, V9, P398, DOI 10.1007/s001980050163; Guo C, 2012, SCAND J RHEUMATOL, V41, P29, DOI 10.3109/03009742.2011.600700; Hamersma J, 2001, ARTHRITIS RHEUM, V44, P1396, DOI 10.1002/1529-0131(200106)44:6<1396::AID-ART233>3.0.CO;2-A; Harvey D, 2009, HUM MOL GENET, V18, P4204, DOI 10.1093/hmg/ddp371; Kamiya M, 2001, SPINE, V26, P1264, DOI 10.1097/00007632-200106010-00017; KHAN MA, 1978, TISSUE ANTIGENS, V11, P434, DOI 10.1111/j.1399-0039.1978.tb01280.x; Landewe R, 2009, ANN RHEUM DIS, V68, P863, DOI 10.1136/ard.2008.091793; Lin ZM, 2012, NAT GENET, V44, P73, DOI 10.1038/ng.1005; Low YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001012; Moore F, 2009, DIABETES, V58, P1283, DOI 10.2337/db08-1510; Morgan AR, 2010, TISSUE ANTIGENS, V76, P119, DOI 10.1111/j.1399-0039.2010.01493.x; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; OLERUP O, 1994, TISSUE ANTIGENS, V43, P253, DOI 10.1111/j.1399-0039.1994.tb02334.x; Paynter RA, 2006, CANCER EPIDEM BIOMAR, V15, P2533, DOI 10.1158/1055-9965.EPI-06-0219; Reich D, 2005, NAT GENET, V37, P1113, DOI 10.1038/ng1646; Robertson LP, 2004, RHEUMATOLOGY, V43, P1565, DOI 10.1093/rheumatology/keh386; Rudwaleit M, 2004, ANN RHEUM DIS, V63, P665, DOI 10.1136/ard.2003.016386; Rueda B, 2008, ANN RHEUM DIS, V67, P1451, DOI 10.1136/ard.2007.080283; SCHLOSSTEIN L, 1973, NEW ENGL J MED, V288, P704, DOI 10.1056/NEJM197304052881403; Szczypiorska M, 2011, RHEUMATOLOGY, V50, P1969, DOI 10.1093/rheumatology/ker229; Vander Cruyssen B, 2010, RHEUMATOLOGY, V49, P73, DOI 10.1093/rheumatology/kep174; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Vang T, 2008, ANNU REV IMMUNOL, V26, P29, DOI 10.1146/annurev.immunol.26.021607.090418; Ward MM, 2009, ARTHRIT RHEUM-ARTHR, V61, P859, DOI 10.1002/art.24585; Wollina U, 2011, CURR OPIN RHEUMATOL, V23, P50, DOI 10.1097/BOR.0b013e328341152f	50	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43428	10.1371/journal.pone.0043428	http://dx.doi.org/10.1371/journal.pone.0043428			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984424	Green Published, Green Submitted, gold			2022-12-27	WOS:000308738500013
J	Zhai, GJ; Yan, KW; Ji, XX; Xu, WR; Yang, JL; Xiong, FX; Su, J; McNutt, MA; Yang, H				Zhai, Guojun; Yan, Kaowen; Ji, Xiaoxu; Xu, Wenrui; Yang, Jiuling; Xiong, Fuxia; Su, Jing; McNutt, Michael A.; Yang, Hua			LAPTM4B Allele*2 Is a Marker of Poor Prognosis for Gallbladder Carcinoma	PLOS ONE			English	Article							GENE POLYMORPHISM; OVEREXPRESSION; SUSCEPTIBILITY; RESISTANCE; EXPRESSION; SURVIVAL; CANCER	Background: Lysosomal protein transmembrane 4 beta (LAPTM4B) is a novel cancer-related gene which has two alleles designated LAPTM4B*1 and LAPTM4B*2. In this study we investigated the correlation of LAPTM4B genotype with prognosis and clinicopathologic features in patients who had undergone curative resection for gallbladder carcinoma (GBC). Methodology/Principal Findings: PCR assay was performed to determine the LAPTM4B genotype in 85 patients. The correlation of LAPTM4B genotype with clinicopathologic parameters was assessed with the Chi-squared test. Differences in patient survival were determined by the Kaplan-Meier method. Multivariate analysis of prognostic factors was carried out with Cox regression analysis. Patients with LAPTM4B *2 had both significantly shorter overall survival (OS) and shorter disease-free survival (DFS) (both P < 0.001). Multivariate analysis showed that LAPTM4B genotype is a prognostic factor for OS and DFS (both P < 0.001). Conclusions/Significance: LAPTM4B allele *2 is a risk factor associated with poor prognosis in patients with resected GBC, and LAPTM4B status may be therefore be useful preoperatively as an adjunct in evaluation of the operability of GBC.	[Zhai, Guojun] Peking Univ, Hosp 3, Dept Intervent Radiol & Vasc Surg, Beijing 100871, Peoples R China; [Yan, Kaowen; Xu, Wenrui; Yang, Jiuling; Yang, Hua] Peking Univ, Sch Basic Med Sci, Dept Cell Biol, Beijing 100871, Peoples R China; [Ji, Xiaoxu] Peking Univ, Hosp 3, Dept Gen Surg, Beijing 100871, Peoples R China; [Xiong, Fuxia] Loma Linda Univ, Dept Pharmacol, Loma Linda, CA 92350 USA; [Su, Jing; McNutt, Michael A.] Peking Univ, Sch Basic Med Sci, Dept Pathol, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Loma Linda University; Peking University	Zhai, GJ (corresponding author), Peking Univ, Hosp 3, Dept Intervent Radiol & Vasc Surg, Beijing 100871, Peoples R China.	yanghua@bjmu.edu.cn		Yang, Jiuling/0000-0002-5301-6976	National Nature Science Fund [31000622]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20100001120043]	National Nature Science Fund(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from the National Nature Science Fund (No. 31000622) and Specialized Research Fund for the Doctoral Program of Higher Education of China (20100001120043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng XJ, 2008, ANN ONCOL, V19, P527, DOI 10.1093/annonc/mdm469; Fong Y, 2000, ANN SURG, V232, P557, DOI 10.1097/00000658-200010000-00011; Gabbi C, 2010, P NATL ACAD SCI USA, V107, P14763, DOI 10.1073/pnas.1009483107; HENSON DE, 1992, CANCER, V70, P1493, DOI 10.1002/1097-0142(19920915)70:6<1493::AID-CNCR2820700608>3.0.CO;2-U; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lazcano-Ponce EC, 2001, CA-CANCER J CLIN, V51, P349, DOI 10.3322/canjclin.51.6.349; Li L, 2010, ONCOGENE, V29, P5785, DOI 10.1038/onc.2010.303; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Liu XR, 2009, CANCER SCI, V100, P2335, DOI 10.1111/j.1349-7006.2009.01346.x; Liu Y, 2007, ANN ONCOL, V18, P311, DOI 10.1093/annonc/mdl394; MATSUMOTO Y, 1992, AM J SURG, V163, P239, DOI 10.1016/0002-9610(92)90109-5; Meng FL, 2010, INT J GYNECOL CANCER, V20, P745, DOI 10.1111/IGC.0b013e3181e02f90; Meng FL, 2011, CANCER-AM CANCER SOC, V117, P2652, DOI 10.1002/cncr.25833; Misra S, 2003, LANCET ONCOL, V4, P167, DOI 10.1016/S1470-2045(03)01021-0; Shao GZ, 2003, ONCOGENE, V22, P5060, DOI 10.1038/sj.onc.1206832; Wang S, 2012, ANN ONCOL, V23, P1864, DOI 10.1093/annonc/mdr538; Yang H, 2012, PLOS ONE, V4; Yang H, 2012, MED ONCOL, V29, P2809, DOI 10.1007/s12032-012-0173-4; Yang H, 2010, CANCER LETT, V294, P236, DOI 10.1016/j.canlet.2010.02.006; Yang H, 2010, J SURG ONCOL, V101, P363, DOI 10.1002/jso.21489; Yang H, 2010, J CANCER RES CLIN, V136, P275, DOI 10.1007/s00432-009-0659-4; Yang Y, 2008, ONCOL REP, V20, P1077, DOI 10.3892/or_00000112; Yin MZ, 2012, INT J GYNECOL CANCER, V22, P54, DOI 10.1097/IGC.0b013e318234f9ac; Yin MZ, 2011, INT J CANCER, V129, P629, DOI 10.1002/ijc.25689; Zhai GJ, 2012, MED ONCOL, V29, P2744, DOI 10.1007/s12032-011-0139-y; Zhou L, 2008, CANCER LETT, V264, P209, DOI 10.1016/j.canlet.2008.01.025; Zhou L, 2007, EUR J CANCER, V43, P809, DOI 10.1016/j.ejca.2006.10.025; Zhou L, 2010, HEPATO-GASTROENTEROL, V57, P207; Zhou L, 2010, AM J SURG, V199, P515, DOI 10.1016/j.amjsurg.2009.03.031	29	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45290	10.1371/journal.pone.0045290	http://dx.doi.org/10.1371/journal.pone.0045290			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984631	Green Published, gold, Green Submitted			2022-12-27	WOS:000308738500129
J	Wu, CY; Taneyhill, LA				Wu, Chyong-Yi; Taneyhill, Lisa A.			Annexin A6 Modulates Chick Cranial Neural Crest Cell Emigration	PLOS ONE			English	Article							VI; CADHERIN6B; EXPRESSION; MIGRATION; COMPLEX; SNAIL2; EXPORT; GOLGI	The vertebrate neural crest is a population of migratory cells that originates in the dorsal aspect of the embryonic neural tube. These cells undergo an epithelial-to-mesencyhmal transition (EMT), delaminate from the neural tube and migrate extensively to generate an array of differentiated cell types. Elucidating the gene regulatory networks involved in neural crest cell induction, migration and differentiation are thus crucial to understanding vertebrate development. To this end, we have identified Annexin A6 as an important regulator of chick midbrain neural crest cell emigration. Annexin proteins comprise a family of calcium-dependent, membrane-binding molecules that mediate a variety of cellular and physiological processes including cell adhesion, migration and invasion. Our data indicate that Annexin A6 is expressed in the proper spatio-temporal pattern in the chick midbrain to play a potential role in neural crest cell ontogeny. To investigate Annexin A6 function, we have depleted or overexpressed Annexin A6 in the developing midbrain neural crest cell population. Our results show that knock-down or overexpression of Annexin A6 reduces or expands the migratory neural crest cell domain, respectively. Importantly, this phenotype is not due to any change in cell proliferation or cell death but can be correlated with changes in the size of the premigratory neural crest cell population and with markers associated with EMT. Taken together, our data indicate that Annexin A6 plays a pivotal role in modulating the formation of cranial migratory neural crest cells during vertebrate development.	[Wu, Chyong-Yi; Taneyhill, Lisa A.] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Wu, CY (corresponding author), Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.	ltaney@umd.edu	Taneyhill, Lisa/K-1815-2013		National Institutes of Health [R00 HD055034]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R00HD055034] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by a grant from the National Institutes of Health (R00 HD055034) to L. A. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila-Sakar AJ, 1998, BBA-PROTEIN STRUCT M, V1387, P103, DOI 10.1016/S0167-4838(98)00111-3; Avila-Sakar AJ, 2000, J STRUCT BIOL, V130, P54, DOI 10.1006/jsbi.2000.4246; Babiychuk EB, 2006, BIOCHEM J, V397, P407, DOI 10.1042/BJ20060056; CAO X, 1993, BIOCHEM BIOPH RES CO, V197, P556, DOI 10.1006/bbrc.1993.2515; Coles EG, 2007, DEV BIOL, V312, P533, DOI 10.1016/j.ydbio.2007.09.056; Creutz CE, 2005, BIOCHEMISTRY-US, V44, P13795, DOI 10.1021/bi051160w; Cubells L, 2008, J BIOL CHEM, V283, P10174, DOI 10.1074/jbc.M706618200; Cubells L, 2007, TRAFFIC, V8, P1568, DOI 10.1111/j.1600-0854.2007.00640.x; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Grewal T, 2006, BIOESSAYS, V28, P1211, DOI 10.1002/bies.20503; Grewal T, 2010, INT J BIOCHEM CELL B, V42, P580, DOI 10.1016/j.biocel.2009.12.020; Grewal T, 2009, CELL SIGNAL, V21, P847, DOI 10.1016/j.cellsig.2009.01.031; Itasaki N, 1999, NAT CELL BIOL, V1, pE203, DOI 10.1038/70231; Jhingory S, 2010, DEV BIOL, V344, P896, DOI 10.1016/j.ydbio.2010.06.006; Kalcheim C, 1999, NEURAL CREST; Monastyrskaya K, 2009, J BIOL CHEM, V284, P17227, DOI 10.1074/jbc.M109.004457; Sakwe AM, 2011, EXP CELL RES, V317, P823, DOI 10.1016/j.yexcr.2010.12.008; SMYTHE E, 1994, J CELL BIOL, V124, P301, DOI 10.1083/jcb.124.3.301; Taneyhill LA, 2007, DEVELOPMENT, V134, P1481, DOI 10.1242/dev.02834; de Muga SV, 2009, ONCOGENE, V28, P363, DOI 10.1038/onc.2008.386; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75; Wu CY, 2011, DEV DYNAM, V240, P2309, DOI 10.1002/dvdy.22735	23	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44903	10.1371/journal.pone.0044903	http://dx.doi.org/10.1371/journal.pone.0044903			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984583	gold, Green Published, Green Submitted			2022-12-27	WOS:000308638700098
J	Gielis, J; Caratelli, D; Fougerolle, Y; Ricci, PE; Tavkelidze, I; Gerats, T				Gielis, Johan; Caratelli, Diego; Fougerolle, Yohan; Ricci, Paolo Emilio; Tavkelidze, Ilia; Gerats, Tom			Universal Natural Shapes: From Unifying Shape Description to Simple Methods for Shape Analysis and Boundary Value Problems	PLOS ONE			English	Article							SCATTERING; GROWTH	Gielis curves and surfaces can describe a wide range of natural shapes and they have been used in various studies in biology and physics as descriptive tool. This has stimulated the generalization of widely used computational methods. Here we show that proper normalization of the Levenberg-Marquardt algorithm allows for efficient and robust reconstruction of Gielis curves, including self-intersecting and asymmetric curves, without increasing the overall complexity of the algorithm. Then, we show how complex curves of k-type can be constructed and how solutions to the Dirichlet problem for the Laplace equation on these complex domains can be derived using a semi-Fourier method. In all three methods, descriptive and computational power and efficiency is obtained in a surprisingly simple way.	[Gielis, Johan] Univ Antwerp, Dept Biosci Engn, B-2020 Antwerp, Belgium; [Gielis, Johan; Gerats, Tom] Radboud Univ Nijmegen, Sect Plant Genet, Inst Wetland & Water Res, Fac Sci, NL-6525 ED Nijmegen, Netherlands; [Caratelli, Diego] Delft Univ Technol, Int Res Ctr Telecommun & Radar, Delft, Netherlands; [Fougerolle, Yohan] Univ Bourgogne, CNRS, Lab Le2i, UMC 5158, Le Creusot, France; [Ricci, Paolo Emilio] Campus Biomed Univ, Rome, Italy; [Tavkelidze, Ilia] I Javakhishvili Tbilisi State Univ, I Vekua Inst Appl Math, Tbilisi, Georgia	University of Antwerp; Radboud University Nijmegen; Delft University of Technology; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; University Campus Bio-Medico - Rome Italy; Ivane Javakhishvili Tbilisi State University	Gielis, J (corresponding author), Univ Antwerp, Dept Biosci Engn, B-2020 Antwerp, Belgium.	johan.gielis@ua.ac.be	Gielis, JOhan/AAK-2564-2020; Caratelli, Diego/J-3178-2013; Gielis, Johan/ABD-7862-2020; Gerats, Tom/A-3528-2012	Caratelli, Diego/0000-0003-2454-2632; Gielis, Johan/0000-0002-4536-3839; 				Antonelli P. L., 1993, FUNDAMENTAL THEORIES, V58; Arnold VI, 1998, COMMUNICATION   0307; Bera N, 2008, EUR PHYS J D, V46, P41, DOI 10.1140/epjd/e2007-00282-6; Biswas A, 2004, GRAPH MODELS, V66, P133, DOI 10.1016/j.gmod.2004.01.003; Bokhabrine Y., 2007, 2007 IEEE INT C IM P, V2, pII; Caratelli D, 2010, APPL MATH COMPUT, V216, P556, DOI 10.1016/j.amc.2010.01.077; Caratelli D., 2010, LECT NOTES TBILISI I; Caratelli D, 2010, COMPUT MATH APPL, V59, P176, DOI 10.1016/j.camwa.2009.07.060; CARLESON L, 1966, ACTA MATH-UPPSALA, V116, P135, DOI 10.1007/BF02392815; Cervantes E, 2010, J PLANT PHYSIOL, V167, P408, DOI 10.1016/j.jplph.2009.09.013; Chen B. Y., 1984, SERIES PURE MATH, V1; Chern S. S., 2000, MATH FRONTIERS PERSP, P33; D'Arcy Thompson W, 1917, GROWTH FORM; Faisal TR, 2010, J BIONIC ENG, V7, pS11, DOI 10.1016/S1672-6529(09)60212-2; Fougerolle YD, 2006, IEEE IMAGE PROC, P2193, DOI 10.1109/ICIP.2006.312975; Fougerolle Y. D., 2009, P GRAPP 2009 INT C C; Fougerolle YD, 2005, IEEE T VIS COMPUT GR, V11, P529, DOI 10.1109/TVCG.2005.72; Gielis J, 2003, AM J BOT, V90, P333, DOI 10.3732/ajb.90.3.333; Gielis J, 2005, KRAGUJEVAC J MATH, V28, P55; Gielis J., 2003, INVENTING CIRCLE; Gielis J., 2004, P INT C COMP COMM CO, P265; Gielis J, 2010, HIST MECH MACH SCI, V11, P29, DOI 10.1007/978-90-481-9091-1_3; Goenner H.F.M, 2008, ARXIV08114529; Gross A. D., 1988, Second International Conference on Computer Vision (IEEE Cat. No.88CH2664-1), P690, DOI 10.1109/CCV.1988.590052; Guitart R, 2009, GABRIEL LAME PEREGRI, V44, P119; Hadjidemetriou S, 2009, LECT NOTES COMPUT SC, V5762, P665, DOI 10.1007/978-3-642-04271-3_81; Haesen S, 2005, NATO SC S SS III C S, V197, P197; Huclova S, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/36/365405; Janner A, 2006, ACTA CRYSTALLOGR A, V62, P270, DOI 10.1107/S010876730601748X; JANNER A, 1992, ACTA CRYSTALLOGR A, V48, P884, DOI 10.1107/S0108767392005166; Janner A, 2001, CRYST ENG, V4, P119, DOI 10.1016/S1463-0184(01)00005-3; Koiso M., 2008, FORMA, V28, P1; Lame G., 1818, EXAMEN DIFFERENTES M; Lestrel PE, 2011, P 1 S BIOL IN PRESS; Loria G, 1902, SPEZIELLE ALGEBRAISC; Natalini P, 2008, NUMER ALGORITHMS, V49, P299, DOI 10.1007/s11075-008-9201-z; Niklas KJ, 2004, BIOL REV, V79, P871, DOI 10.1017/S1464793104006499; Richardson JS, 2008, RNA, V14, P465, DOI 10.1261/rna.657708; Ronse de Craene L, 2010, FLORA DIAGRAMS; Round F. E., 1990, DIATOMS BIOL MORPHOL; Schrodinger E, 1940, WISEN NATUURKUNDIG T, P2; Simeoni M, 2009, SUP DIEL RES ANT ANT, P1, DOI [10.1109/APS.2009.5171981, DOI 10.1109/APS.2009.5171981]; Tassadit A, 2011, SUPERLATTICE MICROST, V49, P288, DOI 10.1016/j.spmi.2010.07.003; Thom R., 1972, STRUCTURAL STABILITY; Thompson A.C., 1996, ENCY MATH ITS APPL, V63; Verstraelen L., 1991, GEOMETRY TOPOLOGY SU, V3, P304; Verstraelen L, 2008, MURC SPAIN WORKSH DI; Vinogradov SS, 2009, ELECTROMAGNETICS, V29, P268, DOI 10.1080/02726340902718526; Voisin S, 2009, IEEE IMAGE PROC, P529, DOI 10.1109/ICIP.2009.5413905; WALSBY AE, 1980, NATURE, V283, P69, DOI 10.1038/283069a0; Yajima T, 2009, P ROY SOC A-MATH PHY, V465, P1763, DOI 10.1098/rspa.2008.0453	52	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e29324	10.1371/journal.pone.0029324	http://dx.doi.org/10.1371/journal.pone.0029324			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23028417	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517500001
J	Kiddle, SJ; Thambisetty, M; Simmons, A; Riddoch-Contreras, J; Hye, A; Westman, E; Pike, I; Ward, M; Johnston, C; Lupton, MK; Lunnon, K; Soininen, H; Kloszewska, I; Tsolaki, M; Vellas, B; Mecocci, P; Lovestone, S; Newhouse, S; Dobson, R				Kiddle, Steven John; Thambisetty, Madhav; Simmons, Andrew; Riddoch-Contreras, Joanna; Hye, Abdul; Westman, Eric; Pike, Ian; Ward, Malcolm; Johnston, Caroline; Lupton, Michelle Katharine; Lunnon, Katie; Soininen, Hilkka; Kloszewska, Iwona; Tsolaki, Magda; Vellas, Bruno; Mecocci, Patrizia; Lovestone, Simon; Newhouse, Stephen; Dobson, Richard		Alzheimers Dis Neuroimaging Initia	Plasma Based Markers of [C-11] PiB-PET Brain Amyloid Burden	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; CLUSTERIN CONCENTRATION; BIOMARKERS; MRI; CLASSIFICATION; PREDICTION; DEPOSITION; CORTISOL; LEVEL	Changes in brain amyloid burden have been shown to relate to Alzheimer's disease pathology, and are believed to precede the development of cognitive decline. There is thus a need for inexpensive and non-invasive screening methods that are able to accurately estimate brain amyloid burden as a marker of Alzheimer's disease. One potential method would involve using demographic information and measurements on plasma samples to establish biomarkers of brain amyloid burden; in this study data from the Alzheimer's Disease Neuroimaging Initiative was used to explore this possibility. Sixteen of the analytes on the Rules Based Medicine Human Discovery Multi-Analyte Profile 1.0 panel were found to associate with [C-11]-PiB PET measurements. Some of these markers of brain amyloid burden were also found to associate with other AD related phenotypes. Thirteen of these markers of brain amyloid burden - c-peptide, fibrinogen, alpha-1-antitrypsin, pancreatic polypeptide, complement C3, vitronectin, cortisol, AXL receptor kinase, interleukin-3, interleukin-13, matrix metalloproteinase-9 total, apolipoprotein E and immunoglobulin E - were used along with co-variates in multiple linear regression, and were shown by cross-validation to explain > 30% of the variance of brain amyloid burden. When a threshold was used to classify subjects as PiB positive, the regression model was found to predict actual PiB positive individuals with a sensitivity of 0.918 and a specificity of 0.545. The number of APOE epsilon 4 alleles and plasma apolipoprotein E level were found to contribute most to this model, and the relationship between these variables and brain amyloid burden was explored.	[Kiddle, Steven John; Simmons, Andrew; Westman, Eric; Johnston, Caroline; Lovestone, Simon; Newhouse, Stephen; Dobson, Richard] S London & Maudsley Natl Hlth Serv Fdn Trust, Natl Inst Hlth Res, Biomed Res Ctr Mental Hlth, London, England; [Kiddle, Steven John; Simmons, Andrew; Riddoch-Contreras, Joanna; Hye, Abdul; Westman, Eric; Johnston, Caroline; Lupton, Michelle Katharine; Lunnon, Katie; Lovestone, Simon; Newhouse, Stephen; Dobson, Richard] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Thambisetty, Madhav] NIA, Lab Behav Neurosci, Baltimore, MD 21224 USA; [Pike, Ian; Ward, Malcolm] Proteome Sci Plc, Surrey, England; [Soininen, Hilkka] Univ Eastern Finland, Sch Neurol, Kuopio, Finland; [Soininen, Hilkka] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Kloszewska, Iwona] Med Univ Lodz, Dept Old Age Psychiat & Psychot Disorders, Lodz, Poland; [Tsolaki, Magda] Aristotle Univ Thessaloniki, G Papanicolaou Hosp, Dept Neurol 3, GR-54006 Thessaloniki, Greece; [Vellas, Bruno] Toulouse Univ Hosp, Dept Geriatr Med, Grontople Toulouse, Toulouse, France; [Mecocci, Patrizia] Univ Perugia, Inst Gerontol & Geriatr, I-06100 Perugia, Italy	South London & Maudsley NHS Trust; University of London; King's College London; University of London; King's College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Medical University Lodz; Aristotle University of Thessaloniki; George Papanikolaou General Hospital of Thessaloniki; CHU de Toulouse; University of Perugia	Kiddle, SJ (corresponding author), S London & Maudsley Natl Hlth Serv Fdn Trust, Natl Inst Hlth Res, Biomed Res Ctr Mental Hlth, London, England.	steven.kiddle@kcl.ac.uk; richard.j.dobson@kcl.ac.uk	Levey, Allan/F-2104-2011; Dobson, Richard j/C-9269-2011; Preda, Adrian/K-8889-2013; Westman, Eric/H-5771-2011; Mecocci, Patrizia/W-2116-2019; Lunnon, Katie/C-4638-2012; Simmons, Andrew/B-8848-2008; Hsiung, Robin/AAT-1661-2021; Newhouse, Stephen J/C-9330-2011; Kiddle, Steven/H-3463-2012	Levey, Allan/0000-0002-3153-502X; Dobson, Richard j/0000-0003-4224-9245; Preda, Adrian/0000-0003-3373-2438; Westman, Eric/0000-0002-3115-2977; Mecocci, Patrizia/0000-0003-0729-5246; Lunnon, Katie/0000-0001-7570-6065; Simmons, Andrew/0000-0003-2306-5811; Hsiung, Robin/0000-0002-8017-0856; Newhouse, Stephen J/0000-0002-1843-9842; Hye, Abdul/0000-0003-2237-4823; Pike, Ian/0000-0002-3071-0041; Tsolaki, Magda/0000-0002-2072-8010; Lupton, Michelle/0000-0002-7274-7299; Lovestone, Simon/0000-0003-0473-4565; Ward, Malcolm/0000-0003-2164-6938; Kiddle, Steven/0000-0003-4350-7437	ADNI (National Institutes of Health) [U01 AG024904]; National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; Northern California Institute for Research and Education; National Institutes of Health [P30 AG010129, K01 AG030514]; InnoMed (Innovative Medicines in Europe); European Union; National Institutes for Health Research Biomedical Research Centre for Mental Health at the South London; Maudsley National Health Service Foundation Trust and Institute of Psychiatry, King's College London; Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd; Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; Takeda Pharmaceutical Company; Alzheimers Research UK [ART-PG2010-4, ART-ESG2006-3, ART-PG2000-1] Funding Source: researchfish; Medical Research Council [G0400061] Funding Source: researchfish; National Institute for Health Research [RP-PG-0606-1045] Funding Source: researchfish; MRC [G0400061] Funding Source: UKRI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001998, UL1TR000117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG030514, P30AG019610, U01AG024904, P30AG013846, ZIAAG000200, P30AG010129] Funding Source: NIH RePORTER	ADNI (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Northern California Institute for Research and Education; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); InnoMed (Innovative Medicines in Europe); European Union(European Commission); National Institutes for Health Research Biomedical Research Centre for Mental Health at the South London; Maudsley National Health Service Foundation Trust and Institute of Psychiatry, King's College London; Abbott(Abbott Laboratories); Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca(AstraZeneca); Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); BioClinica, Inc.; Biogen Idec Inc.(Biogen); Bristol-Myers Squibb Company(Bristol-Myers Squibb); Eisai Inc.(Eisai Co Ltd); Elan Pharmaceuticals Inc.; Eli Lilly and Company(Eli Lilly); F. Hoffmann-La Roche Ltd(Hoffmann-La Roche); Genentech, Inc.(Roche HoldingGenentech); GE Healthcare(General ElectricGE Healthcare); Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.(Johnson & JohnsonJohnson & Johnson USA); Medpace, Inc.; Merck Co., Inc.(Merck & Company); Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation(Novartis); Pfizer Inc.(Pfizer); Servier(Servier); Synarc Inc.; Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Alzheimer's Disease Neuroimaging Initiative (ADNI) data collection and sharing for this project was funded by the ADNI (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by National Institutes of Health grants P30 AG010129 and K01 AG030514. This study was supported by InnoMed (Innovative Medicines in Europe www.imi.europa.eu/) an Integrated Project funded by the European Union of the Sixth Framework program priority FP6-2004-LIFESCIHEALTH-5, Life Sciences, Genomics and Biotechnology for Health. This study was also supported by funds from the National Institutes for Health Research Biomedical Research Centre for Mental Health at the South London and Maudsley National Health Service Foundation Trust and Institute of Psychiatry, King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Intellectual property has been registered on the use of plasma proteins for use as biomarkers for AD by King's College London and Proteome Sciences, with SL and M. Thambisetty named as inventors. IP and MW were full-time employees of Proteome Sciences, London, United Kingdom, at the time of their contribution to the work described in this manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. Patent Title Methods and Compositions Relating to Alzheimer's Disease Subject Covers utility of around 30 proteins, specifically listing 16 in the Dependent claims for diagnosis of Alzheimer's disease Filing Proteome Sciences with King's Business United Kingdom Priority GB0421639.6 dated 29/09/2004 PCT Application PCT/GB2005/003756 dated 29/09/2005 Application in Europe, Japan, United States, Australia, and Canada, dated 15/03/2007 to 16/10/2007. In addition Alzheimer's Disease Neuroimaging Initiative recieved funding from: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aisen PS, 2011, NEUROLOGY, V76, P280, DOI 10.1212/WNL.0b013e318207b1b9; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bemelmans KJ, 2007, ACTA NEUROPSYCHIATR, V19, P231, DOI 10.1111/j.1601-5215.2006.00172.x; de la Monte SM, 2005, J ALZHEIMERS DIS, V7, P45; Doecke JD, ARCH NEUROL; EVANS AE, 1993, HUM GENET, V92, P191; Ewers M, 2012, CEREB CORTEX, V22, P1993, DOI 10.1093/cercor/bhr271; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Greco SJ, 2009, BIOCHEM BIOPH RES CO, V380, P98, DOI 10.1016/j.bbrc.2009.01.041; Grimmer T, 2009, BIOL PSYCHIAT, V65, P927, DOI 10.1016/j.biopsych.2009.01.027; Gromping U, 2006, J STAT SOFTW, V17, DOI 10.18637/jss.v017.i01; Gupta VB, 2011, NEUROLOGY, V76, P1091, DOI 10.1212/WNL.0b013e318211c352; Hye A, 2006, BRAIN, V129, P3042, DOI 10.1093/brain/awl279; Jagust WJ, 2009, NEUROLOGY, V73, P1193, DOI 10.1212/WNL.0b013e3181bc010c; Jagust WJ, 2010, ALZHEIMERS DEMENT, V6, P221, DOI 10.1016/j.jalz.2010.03.003; Johnstone D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034341; Kim S, 2011, PPCOR PARTIAL SEMIPA; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Koivunen J, 2008, DEMENT GERIATR COGN, V26, P378, DOI 10.1159/000163927; Lee BK, 2008, AM J PSYCHIAT, V165, P1456, DOI 10.1176/appi.ajp.2008.07091532; Lindeman RH, 1980, INTRO BIVARIATE MULT, P120; Lorenzl S, 2003, NEUROCHEM INT, V43, P191, DOI 10.1016/S0197-0186(03)00004-4; Lovestone S, 2009, ANN NY ACAD SCI, V1180, P36, DOI 10.1111/j.1749-6632.2009.05064.x; Lunnon K, 2012, J ALZHEIMERS DIS, V30, P685, DOI 10.3233/JAD-2012-111592; Lyketsos CG, 2004, ALZ DIS ASSOC DIS, V18, P171; Maier M, 2008, J NEUROSCI, V28, P6333, DOI 10.1523/JNEUROSCI.0829-08.2008; Mold M, 2012, J ALZHEIMERS DIS, V29, P875, DOI 10.3233/JAD-2012-120076; Nishiyama E, 1996, DEMENTIA, V7, P256, DOI 10.1159/000106889; O'Bryant SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028092; O'Bryant SE, 2010, ARCH NEUROL-CHICAGO, V67, P1077, DOI 10.1001/archneurol.2010.215; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Reiman EM, 2011, J ALZHEIMERS DIS, V26, P321, DOI 10.3233/JAD-2011-0059; Siest G, 2000, CLIN CHEM LAB MED, V38, P721, DOI 10.1515/CCLM.2000.102; Simmons A, 2011, INT J GERIATR PSYCH, V26, P75, DOI 10.1002/gps.2491; Simmons A, 2009, ANN NY ACAD SCI, V1180, P47, DOI 10.1111/j.1749-6632.2009.05063.x; Slooter AJC, 1998, NEUROSCI LETT, V248, P21, DOI 10.1016/S0304-3940(98)00339-5; Soares HD, ARCH NEUROL; Stevenson M., EPIR R PACKAGE ANAL; Szczepanik AM, 2001, J NEUROIMMUNOL, V113, P49, DOI 10.1016/S0165-5728(00)00404-5; Thambisetty M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028527; Thambisetty M, 2012, NEUROIMAGE, V59, P212, DOI 10.1016/j.neuroimage.2011.07.056; Thambisetty M, 2010, J ALZHEIMERS DIS, V22, P1099, DOI 10.3233/JAD-2010-101350; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; Thambisetty M, 2008, J NEUROL, V255, P1712, DOI 10.1007/s00415-008-0006-8; Trojanowski JQ, 2010, ALZHEIMERS DEMENT, V6, P230, DOI 10.1016/j.jalz.2010.03.008; Vemuri P, 2009, NEUROLOGY, V73, P287, DOI 10.1212/WNL.0b013e3181af79e5; Warnes GR, 2011, GPLOTS VARIOUS R PRO; Westman E, 2013, BRAIN TOPOGR, V26, P9, DOI 10.1007/s10548-012-0246-x; Westman E, 2012, NEUROIMAGE, V62, P229, DOI 10.1016/j.neuroimage.2012.04.056; WETTERLING T, 1994, CLIN INVESTIGATOR, V72, P196; Zambrano A, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-82; Zhang RL, 2004, PROTEOMICS, V4, P244, DOI 10.1002/pmic.200300495	53	66	67	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e44260	10.1371/journal.pone.0044260	http://dx.doi.org/10.1371/journal.pone.0044260			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028511	Green Submitted, gold, Green Published			2022-12-27	WOS:000309554700010
J	Busceti, CL; Bucci, D; Molinaro, G; Di Pietro, P; Zangrandi, L; Gradini, R; Moratalla, R; Battaglia, G; Bruno, V; Nicoletti, F; Fornai, F				Busceti, Carla Letizia; Bucci, Domenico; Molinaro, Gemma; Di Pietro, Paola; Zangrandi, Luca; Gradini, Roberto; Moratalla, Rosario; Battaglia, Giuseppe; Bruno, Valeria; Nicoletti, Ferdinando; Fornai, Francesco			Lack or Inhibition of Dopaminergic Stimulation Induces a Development Increase of Striatal Tyrosine Hydroxylase-Positive Interneurons	PLOS ONE			English	Article							NIGROSTRIATAL DEGENERATION; POSTNATAL-DEVELOPMENT; PARKINSONS-DISEASE; GENE-TRANSCRIPTION; RAT STRIATUM; NEURONS; RECEPTORS; RELEASE; NUMBER; INNERVATION	We examined the role of endogenous dopamine (DA) in regulating the number of intrinsic tyrosine hydroxylase-positive (TH+) striatal neurons using mice at postnatal day (PND) 4 to 8, a period that corresponds to the developmental peak in the number of these neurons. We adopted the strategy of depleting endogenous DA by a 2-day treatment with alpha-methyl-p-tyrosine (alpha MpT, 150 mg/kg, i.p.). This treatment markedly increased the number of striatal TH+ neurons, assessed by stereological counting, and the increase was highly correlated to the extent of DA loss. Interestingly, TH+ neurons were found closer to the clusters of DA fibers after DA depletion, indicating that the concentration gradient of extracellular DA critically regulates the distribution of striatal TH+ neurons. A single i.p. injection of the D1 receptor antagonist, SCH23390 (0.1 mg/kg), the D2/D3 receptor antagonist, raclopride (0.1 mg/kg), or the D4 receptor antagonist, L-745,870 (5 mg/kg) in mice at PND4 also increased the number of TH+ neurons after 4 days. Treatment with the D1-like receptor agonist SKF38393 (10 mg/kg) or with the D2-like receptor agonist, quinpirole (1 mg/kg) did not change the number of TH+ neurons. At least the effects of SCH23390 were prevented by a combined treatment with SKF38393. Immunohistochemical analysis indicated that striatal TH+ neurons expressed D2 and D4 receptors, but not D1 receptors. Moreover, treatment with the alpha 4 beta 2 receptor antagonist dihydro-beta-erythroidine (DH beta E) (3.2 mg/kg) also increased the number of TH+ neurons. The evidence that DH beta E mimicked the action of SCH23390 in increasing the number of TH+ neurons supports the hypothesis that activation of D1 receptors controls the number of striatal TH+ neurons by enhancing the release of acetylcholine. These data demonstrate for the first time that endogenous DA negatively regulates the number of striatal TH+ neurons by direct and indirect mechanisms mediated by multiple DA receptor subtypes.	[Busceti, Carla Letizia; Bucci, Domenico; Molinaro, Gemma; Di Pietro, Paola; Zangrandi, Luca; Gradini, Roberto; Battaglia, Giuseppe; Bruno, Valeria; Nicoletti, Ferdinando; Fornai, Francesco] IRCCS Neuromed, Pozzilli, Italy; [Gradini, Roberto] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Moratalla, Rosario] CSIC, Inst Cajal, Dept Funct & Syst Neurobiol, E-28002 Madrid, Spain; [Bruno, Valeria; Nicoletti, Ferdinando] Univ Roma La Sapienza, Dept Physiol & Pharmacol, Rome, Italy; [Fornai, Francesco] Univ Pisa, Dept Human Morphol & Appl Biol, Pisa, Italy	IRCCS Neuromed; Sapienza University Rome; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Sapienza University Rome; University of Pisa	Fornai, F (corresponding author), IRCCS Neuromed, Pozzilli, Italy.	francesco.fornai@med.unipi.it	Bucci, Domenico/AAA-5475-2019; Nicoletti, Ferdinando/K-4410-2016; FORNAI, FRANCESCO/AAA-5312-2019; Busceti, Carla Letizia/F-9941-2011; Di Pietro, Paola/K-5137-2016; Molinaro, Gemma/G-8822-2011; Battaglia, Giuseppe/A-7709-2010; Nicoletti, Ferdinando/T-4898-2019; bruno, Valeria/F-3146-2012; Busceti, Carla Letizia/K-6485-2016; Bucci, Domenico/G-6747-2011; Moratalla, Rosario V/H-9280-2015; Nicoletti, Ferdinando/A-2446-2010	Bucci, Domenico/0000-0003-3239-2435; FORNAI, FRANCESCO/0000-0002-3883-5084; Di Pietro, Paola/0000-0003-1327-1961; Battaglia, Giuseppe/0000-0001-7571-3417; bruno, Valeria/0000-0003-4231-0739; Busceti, Carla Letizia/0000-0002-1417-1893; Moratalla, Rosario V/0000-0002-7623-8010; NICOLETTI, Ferdinando/0000-0003-3366-7269; Zangrandi, Luca/0000-0003-4374-6665; Nicoletti, Ferdinando/0000-0003-0917-443X				ANDERSEN SL, 1993, J NEUROCHEM, V61, P2247, DOI 10.1111/j.1471-4159.1993.tb07466.x; AOSAKI T, 1994, SCIENCE, V265, P412, DOI 10.1126/science.8023166; Battaglia G, 2006, J NEUROSCI, V26, P7222, DOI 10.1523/JNEUROSCI.1595-06.2006; Bedard A, 2002, NEUROSCI LETT, V328, P213, DOI 10.1016/S0304-3940(02)00530-X; Bedard A, 2006, EXP BRAIN RES, V170, P501, DOI 10.1007/s00221-005-0233-5; Betarbet R, 1997, J NEUROSCI, V17, P6761; BIRD ED, 1980, ACTA PSYCHIAT SCAND, V61, P63, DOI 10.1111/acps.1980.61.s280.63; Busceti CL, 2008, J NEURAL TRANSM, V115, P1375, DOI 10.1007/s00702-008-0112-x; CABOCHE J, 1991, DEV BRAIN RES, V58, P111, DOI 10.1016/0165-3806(91)90243-C; Cossette M, 1999, NEUROSCI RES, V34, P51, DOI 10.1016/S0168-0102(99)00029-2; Cossette M, 2004, EUR J NEUROSCI, V20, P2089, DOI 10.1111/j.1460-9568.2004.03661.x; CRAWLEY JN, 1984, NEUROCHEM INT, V6, P755, DOI 10.1016/0197-0186(84)90007-X; DAMSMA G, 1990, EUR J PHARMACOL, V186, P335, DOI 10.1016/0014-2999(90)90456-G; DUBACH M, 1987, NEUROSCI LETT, V75, P205, DOI 10.1016/0304-3940(87)90298-9; GERFEN CR, 1992, TRENDS NEUROSCI, V15, P133, DOI 10.1016/0166-2236(92)90355-C; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Huot P, 2007, J NEUROCHEM, V101, P1441, DOI 10.1111/j.1471-4159.2006.04430.x; Huot P, 2007, BRAIN, V130, P222, DOI 10.1093/brain/awl332; KILBOURNE EJ, 1991, DEV BRAIN RES, V58, P143, DOI 10.1016/0165-3806(91)90247-G; King MA, 2002, METHODS, V28, P293, DOI 10.1016/S1046-2023(02)00235-9; Kreitzer AC, 2009, ANNU REV NEUROSCI, V32, P127, DOI 10.1146/annurev.neuro.051508.135422; Levesque M, 2003, J CHEM NEUROANAT, V26, P271, DOI 10.1016/j.jchemneu.2003.07.001; Li JH, 2004, J NEUROCHEM, V90, P1117, DOI 10.1111/j.1471-4159.2004.02569.x; Lim J, 2000, MOL CELL BIOCHEM, V212, P51, DOI 10.1023/A:1007148719497; Masuda M, 2011, EUR J NEUROSCI, V34, P1355, DOI 10.1111/j.1460-9568.2011.07873.x; Meredith GE, 1999, EUR J NEUROSCI, V11, P3585, DOI 10.1046/j.1460-9568.1999.00774.x; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; OLSON L, 1972, BRAIN RES, V44, P283, DOI 10.1016/0006-8993(72)90385-X; Palfi S, 2002, J NEUROSCI, V22, P4942, DOI 10.1523/JNEUROSCI.22-12-04942.2002; Pisani A, 2000, J NEUROSCI, V20, part. no.; Porritt MJ, 2000, LANCET, V356, P44, DOI 10.1016/S0140-6736(00)02437-5; RESTANI P, 1990, PHARMACOL RES, V22, P343, DOI 10.1016/1043-6618(90)90732-S; Romano G, 2007, J CELL PHYSIOL, V211, P431, DOI 10.1002/jcp.20949; SPOKES EGS, 1979, ADV NEUROL, V23, P481; Tande D, 2006, BRAIN, V129, P1194, DOI 10.1093/brain/awl041; TASHIRO Y, 1989, NEUROSCI LETT, V97, P6, DOI 10.1016/0304-3940(89)90130-4; TENNYSON VM, 1972, BRAIN RES, V46, P251, DOI 10.1016/0006-8993(72)90019-4; Tinti C, 1997, J BIOL CHEM, V272, P19158, DOI 10.1074/jbc.272.31.19158; Tinti C, 1996, J BIOL CHEM, V271, P25375, DOI 10.1074/jbc.271.41.25375; Zhou FM, 2001, NAT NEUROSCI, V4, P1224, DOI 10.1038/nn769	40	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44025	10.1371/journal.pone.0044025	http://dx.doi.org/10.1371/journal.pone.0044025			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028485	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900013
J	Liu, G; Mac Gabhann, F; Popel, AS				Liu, Gang; Mac Gabhann, Feilim; Popel, Aleksander S.			Effects of Fiber Type and Size on the Heterogeneity of Oxygen Distribution in Exercising Skeletal Muscle	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; EXTENSOR DIGITORUM LONGUS; INTERSTITIAL FLUID VOLUME; BLOOD-FLOW; MICROVASCULAR NETWORKS; COMPUTATIONAL MODEL; OXIDATIVE CAPACITY; VEGF GRADIENTS; SHEAR-STRESS; TRANSPORT	The process of oxygen delivery from capillary to muscle fiber is essential for a tissue with variable oxygen demand, such as skeletal muscle. Oxygen distribution in exercising skeletal muscle is regulated by convective oxygen transport in the blood vessels, oxygen diffusion and consumption in the tissue. Spatial heterogeneities in oxygen supply, such as microvascular architecture and hemodynamic variables, had been observed experimentally and their marked effects on oxygen exchange had been confirmed using mathematical models. In this study, we investigate the effects of heterogeneities in oxygen demand on tissue oxygenation distribution using a multiscale oxygen transport model. Muscles are composed of different ratios of the various fiber types. Each fiber type has characteristic values of several parameters, including fiber size, oxygen consumption, myoglobin concentration, and oxygen diffusivity. Using experimentally measured parameters for different fiber types and applying them to the rat extensor digitorum longus muscle, we evaluated the effects of heterogeneous fiber size and fiber type properties on the oxygen distribution profile. Our simulation results suggest a marked increase in spatial heterogeneity of oxygen due to fiber size distribution in a mixed muscle. Our simulations also suggest that the combined effects of fiber type properties, except size, do not contribute significantly to the tissue oxygen spatial heterogeneity. However, the incorporation of the difference in oxygen consumption rates of different fiber types alone causes higher oxygen heterogeneity compared to control cases with uniform fiber properties. In contrast, incorporating variation in other fiber type-specific properties, such as myoglobin concentration, causes little change in spatial tissue oxygenation profiles.	[Liu, Gang; Popel, Aleksander S.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Syst Biol Lab, Baltimore, MD 21205 USA; [Mac Gabhann, Feilim] Johns Hopkins Univ, Dept Biomed Engn, Inst Computat Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Liu, G (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Syst Biol Lab, Baltimore, MD 21205 USA.	gangliu2001@gmail.com	Liu, Gang/A-1359-2014; Mac Gabhann, Feilim/A-3436-2010; Popel, Aleksander S/A-6724-2009; Liu, Gang/F-7414-2011	Mac Gabhann, Feilim/0000-0003-3481-7740; Popel, Aleksander/0000-0002-6706-9235; Liu, Gang/0000-0002-8758-1797	National Institutes of Health (NIH) [R01 HL18292, HL101200, R00 HL093219]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL093219, R01HL018292, R01HL101200] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (NIH) grants R01 HL18292 and HL101200 (ASP) and R00 HL093219 (FMG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SK, 1997, EXP PHYSIOL, V82, P231, DOI 10.1113/expphysiol.1997.sp004012; Altman PL., 1971, RESP CIRCULATION; AUKLAND K, 1981, PHYSIOL REV, V61, P556, DOI 10.1152/physrev.1981.61.3.556; Beard DA, 2003, AM J PHYSIOL-HEART C, V285, pH1826, DOI 10.1152/ajpheart.00380.2003; Blomstrand E, 1997, J PHYSIOL-LONDON, V501, P455, DOI 10.1111/j.1469-7793.1997.455bn.x; CHRISTOF.C, 1969, J APPL PHYSIOL, V26, P56, DOI 10.1152/jappl.1969.26.1.56; CLARK A, 1985, BIOPHYS J, V47, P171, DOI 10.1016/S0006-3495(85)83890-X; Deveci D, 2001, AM J PHYSIOL-HEART C, V281, pH241, DOI 10.1152/ajpheart.2001.281.1.H241; EGGINTON S, 1990, J ANAT, V168, P73; Egginton S, 2011, BIOCHEM SOC T, V39, P1633, DOI 10.1042/BST20110715; Egginton S, 2009, PFLUG ARCH EUR J PHY, V457, P963, DOI 10.1007/s00424-008-0563-9; Ellis CG, 2002, AM J PHYSIOL-HEART C, V282, pH156, DOI 10.1152/ajpheart.2002.282.1.H156; ELLSWORTH ML, 1988, MICROVASC RES, V35, P341, DOI 10.1016/0026-2862(88)90089-1; ELLSWORTH ML, 1984, AM J PHYSIOL, V246, pH161, DOI 10.1152/ajpheart.1984.246.2.H161; FEDERSPIEL WJ, 1986, MICROVASC RES, V32, P164, DOI 10.1016/0026-2862(86)90052-X; Flessner Michael F., 1997, American Journal of Physiology, V273, pH2783; Goldman D, 2004, AM J PHYSIOL-HEART C, V287, pH2535, DOI 10.1152/ajpheart.00889.2003; Goldman D, 2000, J THEOR BIOL, V206, P181, DOI 10.1006/jtbi.2000.2113; Goldman D, 2008, MICROCIRCULATION, V15, P795, DOI 10.1080/10739680801938289; Grinberg O, 2005, ADV EXP MED BIOL, V566, P127; GROEBE K, 1990, AM J PHYSIOL, V259, pH84, DOI 10.1152/ajpheart.1990.259.1.H84; HONIG CR, 1984, ADV EXP MED BIOL, V169, P23; Hoofd L, 2009, ADV EXP MED BIOL, V645, P55, DOI 10.1007/978-0-387-85998-9_9; HUDLICKA O, 1992, PHYSIOL REV, V72, P369, DOI 10.1152/physrev.1992.72.2.369; Ji JW, 2007, AM J PHYSIOL-HEART C, V293, pH3740, DOI 10.1152/ajpheart.00009.2007; Ji JW, 2006, J THEOR BIOL, V241, P94, DOI 10.1016/j.jtbi.2005.11.019; JURGENS KD, 1994, P NATL ACAD SCI USA, V91, P3829, DOI 10.1073/pnas.91.9.3829; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Krogh A, 1919, J PHYSIOL-LONDON, V52, P457, DOI 10.1113/jphysiol.1919.sp001844; LARGE J, 1985, J PHYSIOL-LONDON, V362, P13, DOI 10.1113/jphysiol.1985.sp015659; Liu G, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-6; Mac Gabhann F, 2007, ANN BIOMED ENG, V35, P982, DOI 10.1007/s10439-007-9303-0; Mac Gabhann F, 2007, J APPL PHYSIOL, V102, P722, DOI 10.1152/japplphysiol.00800.2006; Mac Gabhann F, 2006, PLOS COMPUT BIOL, V2, P1107, DOI 10.1371/journal.pcbi.0020127; Mac Gabhann F, 2010, WIRES SYST BIOL MED, V2, P694, DOI 10.1002/wsbm.92; MAHLER M, 1985, J GEN PHYSIOL, V86, P105, DOI 10.1085/jgp.86.1.105; MAXWELL LC, 1980, J APPL PHYSIOL, V49, P627, DOI 10.1152/jappl.1980.49.4.627; McGuire BJ, 2001, J APPL PHYSIOL, V91, P2255, DOI 10.1152/jappl.2001.91.5.2255; MENG H, 1993, J APPL PHYSIOL, V74, P2194, DOI 10.1152/jappl.1993.74.5.2194; Milkiewicz M, 2001, MICROCIRCULATION, V8, P229, DOI 10.1038/sj.mn.7800074; Moschandreou TE, 2011, MATH BIOSCI, V232, P1, DOI 10.1016/j.mbs.2011.03.010; Pittman R.N., 2011, REGULATION TISSUE OX; POPEL AS, 1979, AM J PHYSIOL, V237, pH681, DOI 10.1152/ajpheart.1979.237.6.H681; POPEL AS, 1989, CRIT REV BIOMED ENG, V17, P257; PRIES AR, 1990, CIRC RES, V67, P826, DOI 10.1161/01.RES.67.4.826; Pries AR, 2009, CARDIOVASC RES, V81, P328, DOI 10.1093/cvr/cvn318; REED RK, 1981, ACTA PHYSIOL SCAND, V112, P141, DOI 10.1111/j.1748-1716.1981.tb06797.x; Roy TK, 1996, AM J PHYSIOL-HEART C, V271, pH721, DOI 10.1152/ajpheart.1996.271.2.H721; Schiaffino S, 2010, ACTA PHYSIOL, V199, P451, DOI 10.1111/j.1748-1716.2010.02130.x; Secomb TW, 2004, ANN BIOMED ENG, V32, P1519, DOI 10.1114/B:ABME.0000049036.08817.44; Soukup T, 2002, ACTA HISTOCHEM, V104, P399, DOI 10.1078/0065-1281-00660; STELTZER H, 1994, ANAESTHESIA, V49, P229; Talmadge Robert J., 1993, Current Opinion in Rheumatology, V5, P695; Tyml K, 1999, J APPL PHYSIOL, V87, P1496, DOI 10.1152/jappl.1999.87.4.1496; Wagner PD, 2001, ADV EXP MED BIOL, V502, P21; Wang D, 1997, BIOPHYS J, V73, P2764, DOI 10.1016/S0006-3495(97)78305-X; Welter M, 2009, J THEOR BIOL, V259, P405, DOI 10.1016/j.jtbi.2009.04.005; Wittenberg JB, 2003, J EXP BIOL, V206, P2011, DOI 10.1242/jeb.00243; Wust RCI, 2009, ADV EXP MED BIOL, V645, P75, DOI 10.1007/978-0-387-85998-9_12; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348	60	35	36	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44375	10.1371/journal.pone.0044375	http://dx.doi.org/10.1371/journal.pone.0044375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028531	Green Submitted, Green Published, gold			2022-12-27	WOS:000311313900023
J	Wang, DY; Hadj-Henni, L; Thierry, S; Arne, P; Chermette, R; Botterel, F; Hadrich, I; Makni, F; Ayadi, A; Ranque, S; Huang, WY; Guillot, J				Wang, Dong Ying; Hadj-Henni, Leila; Thierry, Simon; Arne, Pascal; Chermette, Rene; Botterel, Francoise; Hadrich, Ines; Makni, Fattouma; Ayadi, Ali; Ranque, Stephane; Huang, Wei Yi; Guillot, Jacques			Simple and Highly Discriminatory VNTR-Based Multiplex PCR for Tracing Sources of Aspergillus flavus Isolates	PLOS ONE			English	Article							TANDEM REPEAT ANALYSIS; INVASIVE ASPERGILLOSIS; FUNGAL KERATITIS; INFECTIONS; FUMIGATUS; DNA; STRAINS; BIRDS; UNIT	Aspergillus flavus is second only to A. fumigatus in causing invasive aspergillosis and it is the major agent responsible for fungal sinusitis, keratitis and endophthalmitis in many countries in the Middle East, Africa and Southeast Asia. Despite the growing challenge due to A. flavus, data on the molecular epidemiology of this fungus remain scarce. The objective of the present study was to develop a new typing method based on the detection of VNTR (Variable number tandem repeat) markers. Eight VNTR markers located on 6 different chromosomes (1, 2, 3, 5, 7 and 8) of A. flavus were selected, combined by pairs for multiplex amplifications and tested on 30 unrelated isolates and six reference strains. The Simpson index for individual markers ranged from 0.398 to 0.818. A combined loci index calculated with all the markers yielded an index of 0.998. The MLVA (Multiple Locus VNTR Analysis) technique proved to be specific and reproducible. In a second time, a total of 55 isolates from Chinese avian farms and from a Tunisian hospital have been evaluated. One major cluster of genotypes could be defined by using the graphing algorithm termed Minimum Spanning Tree. This cluster comprised most of the isolates collected in an avian farm in southern China. The MLVA technique should be considered as an excellent and cost-effective typing method that could be used in many laboratories without the need for sophisticated equipment.	[Arne, Pascal; Chermette, Rene; Guillot, Jacques] ENVA, Lab Sante Anim, UMR BIPAR, Maisons Alfort, France; [Wang, Dong Ying; Huang, Wei Yi] Guangxi Univ, Coll Anim Sci & Technol, Dept Parasitol, Nanning 530004, Peoples R China; [Wang, Dong Ying; Hadj-Henni, Leila; Thierry, Simon] ANSES, Lab Sante Anim, UMR BIPAR, Maisons Alfort, France; [Botterel, Francoise] UPE, Lab Sante Anim, UMR BIPAR, Creteil, France; [Hadrich, Ines; Makni, Fattouma; Ayadi, Ali] Fac Med Sfax, Lab Biol Mol Parasitaire & Fong, Sfax, Tunisia; [Ranque, Stephane] Aix Marseille Univ, UMR MD3, Marseille, France; [Ranque, Stephane] APHM, Lab Parasitol Mycol, Marseille, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Sante Animale de Maisons-Alfort; Ecole Nationale Veterinaire d'Alfort (ENVA); Guangxi University; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Sante Animale de Maisons-Alfort; Ecole Nationale Veterinaire d'Alfort (ENVA); Universite de Sfax; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Guillot, J (corresponding author), ENVA, Lab Sante Anim, UMR BIPAR, Maisons Alfort, France.	jguillot@vet-alfort.fr	Guillot, Jacques/J-9428-2016; Ranque, Stéphane/K-2317-2015	Guillot, Jacques/0000-0003-3577-6979; Ranque, Stéphane/0000-0003-3293-5276; Arne, Pascal/0000-0001-9727-7716	French Ambassy in the People's Republic of China	French Ambassy in the People's Republic of China	DYW is a PhD student who received a grant from the French Ambassy in the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arne P, 2011, INT J MICROBIOL; Bagyalakshmi R, 2007, J MICROBIOL METH, V68, P1, DOI 10.1016/j.mimet.2006.05.021; Balajee SA, 2006, EUKARYOT CELL, V5, P1705, DOI 10.1128/EC.00162-06; Balajee SA, 2009, J CLIN MICROBIOL, V47, P3138, DOI 10.1128/JCM.01070-09; Balajee SA, 2005, EUKARYOT CELL, V4, P625, DOI 10.1128/EC.4.3.625-632.2005; Beernaert LA, 2010, AVIAN PATHOL, V39, P325, DOI 10.1080/03079457.2010.506210; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Grissa I, 2008, BIOCHIMIE, V90, P660, DOI 10.1016/j.biochi.2007.07.014; Grubisha LC, 2010, MOL ECOL, V19, P269, DOI 10.1111/j.1365-294X.2009.04467.x; Hadrich I, 2010, J CLIN MICROBIOL, V48, P2396, DOI 10.1128/JCM.01269-09; Hadrich I, 2011, MYCOPATHOLOGIA, V172, P83, DOI 10.1007/s11046-011-9406-x; Hedayati MT, 2007, MICROBIOL-SGM, V153, P1677, DOI 10.1099/mic.0.2007/007641-0; Heinemann S, 2004, J HOSP INFECT, V57, P149, DOI 10.1016/j.jhin.2004.02.007; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; James MJ, 2000, J CLIN MICROBIOL, V38, P3612, DOI 10.1128/JCM.38.10.3612-3618.2000; KHAIRALLAH SH, 1992, DOC OPHTHALMOL, V79, P269, DOI 10.1007/BF00158257; Krishnan S, 2009, MYCOSES, V52, P206, DOI 10.1111/j.1439-0507.2008.01642.x; Lortholary O, 2011, CLIN MICROBIOL INFEC, V17, P1882, DOI 10.1111/j.1469-0691.2011.03548.x; Midorikawa GEO, 2008, LETT APPL MICROBIOL, V47, P12, DOI 10.1111/j.1472-765X.2008.02377.x; Montiel D, 2003, MYCOL RES, V107, P1427, DOI 10.1017/S0953756203008797; MOODY SF, 1990, APPL ENVIRON MICROB, V56, P2441, DOI 10.1128/AEM.56.8.2441-2452.1990; Pasqualotto AC, 2009, MED MYCOL, V47, pS261, DOI 10.1080/13693780802247702; Robens J, 2003, J TOXICOL-TOXIN REV, V22, P139, DOI 10.1081/TXR-120024089; Rudramurthy SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016086; Schouls LM, 2004, J BACTERIOL, V186, P5496, DOI 10.1128/JB.186.16.5496-5505.2004; Taj-Aldeen SJ, 2003, EUR ARCH OTO-RHINO-L, V260, P331, DOI 10.1007/s00405-002-0547-x; Tell LA, 2005, MED MYCOL, V43, pS71, DOI 10.1080/13693780400020089; Thierry S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-315; Top J, 2004, J CLIN MICROBIOL, V42, P4503, DOI 10.1128/JCM.42.10.4503-4511.2004; Vergnaud G, 2000, GENOME RES, V10, P899, DOI 10.1101/gr.10.7.899; Wang YW, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-278; Wong TY, 1997, INT OPHTHALMOL, V21, P127, DOI 10.1023/A:1026462631716	33	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e44204	10.1371/journal.pone.0044204	http://dx.doi.org/10.1371/journal.pone.0044204			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028503	Green Published, gold, Green Submitted			2022-12-27	WOS:000309742800009
J	Zhan, TZ; Poppelreuther, M; Ehehalt, R; Fullekrug, J				Zhan, Tianzuo; Poppelreuther, Margarete; Ehehalt, Robert; Fuellekrug, Joachim			Overexpressed FATP1, ACSVL4/FATP4 and ACSL1 Increase the Cellular Fatty Acid Uptake of 3T3-L1 Adipocytes but Are Localized on Intracellular Membranes	PLOS ONE			English	Article							ACYL-COA SYNTHETASE; TRANSPORT PROTEINS; EPITHELIAL-CELLS; LIPID-METABOLISM; ADIPOSE-TISSUE; INSULIN; BINDING; EXPRESSION; FAT/CD36; ENZYMES	Long chain acyl-CoA synthetases are essential enzymes of lipid metabolism, and have also been implicated in the cellular uptake of fatty acids. It is controversial if some or all of these enzymes have an additional function as fatty acid transporters at the plasma membrane. The most abundant acyl-CoA synthetases in adipocytes are FATP1, ACSVL4/FATP4 and ACSL1. Previous studies have suggested that they increase fatty acid uptake by direct transport across the plasma membrane. Here, we used a gain-of-function approach and established FATP1, ACSVL4/FATP4 and ACSL1 stably expressing 3T3-L1 adipocytes by retroviral transduction. All overexpressing cell lines showed increased acyl-CoA synthetase activity and fatty acid uptake. FATP1 and ACSVL4/FATP4 localized to the endoplasmic reticulum by confocal microscopy and subcellular fractionation whereas ACSL1 was found on mitochondria. Insulin increased fatty acid uptake but without changing the localization of FATP1 or ACSVL4/FATP4. We conclude that overexpressed acyl-CoA synthetases are able to facilitate fatty acid uptake in 3T3-L1 adipocytes. The intracellular localization of FATP1, ACSVL4/FATP4 and ACSL1 indicates that this is an indirect effect. We suggest that metabolic trapping is the mechanism behind the influence of acyl-CoA synthetases on cellular fatty acid uptake.	[Zhan, Tianzuo; Poppelreuther, Margarete; Ehehalt, Robert; Fuellekrug, Joachim] Heidelberg Univ, Mol Cell Biol Lab, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Zhan, TZ (corresponding author), Heidelberg Univ, Mol Cell Biol Lab, Heidelberg, Germany.	Joachim.Fuellekrug@med.uni-heidelberg.de	Füllekrug, Joachim/A-6581-2008	Zhan, Tianzuo/0000-0002-9346-3180; Ehehalt, Robert/0000-0003-4252-5801	German research foundation DFG [FU 340/5-1, EH 196/5-1]	German research foundation DFG(German Research Foundation (DFG))	This work was supported by the German research foundation DFG (FU 340/5-1 to J.F. and EH 196/5-1 to R.E.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Berggreen C, 2009, AM J PHYSIOL-ENDOC M, V296, pE635, DOI 10.1152/ajpendo.90596.2008; Black PN, 2003, MICROBIOL MOL BIOL R, V67, P454, DOI 10.1128/MMBR.67.3.454-472.2003; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Bonen A, 2007, PHYSIOLOGY, V22, P15, DOI 10.1152/physiologyonline.2007.22.1.15; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Chabowski A, 2005, FEBS LETT, V579, P2428, DOI 10.1016/j.febslet.2004.11.118; Coleman RA, 2000, ANNU REV NUTR, V20, P77, DOI 10.1146/annurev.nutr.20.1.77; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Digel M, 2011, AM J PHYSIOL-ENDOC M, V301, pE785, DOI 10.1152/ajpendo.00079.2011; Digel M, 2009, MOL CELL BIOCHEM, V326, P23, DOI 10.1007/s11010-008-0003-3; DiRusso CC, 2005, J BIOL CHEM, V280, P16829, DOI 10.1074/jbc.M409598200; Doege H, 2006, PHYSIOLOGY, V21, P259, DOI 10.1152/physiol.00014.2006; Ducluzeau PH, 2011, J PHYSIOL BIOCHEM, V67, P285, DOI 10.1007/s13105-011-0074-6; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; Frohnert BI, 2000, PROG LIPID RES, V39, P83, DOI 10.1016/S0163-7827(99)00018-1; Garcia-Martinez C, 2005, AM J PHYSIOL-CELL PH, V288, pC1264, DOI 10.1152/ajpcell.00271.2004; Gargiulo CE, 1999, J LIPID RES, V40, P881; Gimeno RE, 2007, CURR OPIN LIPIDOL, V18, P271, DOI 10.1097/MOL.0b013e3281338558; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Hall AM, 2005, J BIOL CHEM, V280, P11948, DOI 10.1074/jbc.M412629200; Igal RA, 2001, J BIOL CHEM, V276, P42205, DOI 10.1074/jbc.M103386200; Jia ZZ, 2007, J BIOL CHEM, V282, P20573, DOI 10.1074/jbc.M700568200; Joost HG, 2000, METH MOL B, V155, P77; Kampf JP, 2007, PHYSIOLOGY, V22, P7, DOI 10.1152/physiol.00011.2006; Kim JH, 2001, J BIOL CHEM, V276, P24667, DOI 10.1074/jbc.M010793200; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Lawen A, 2005, INT J BIOCHEM CELL B, V37, P277, DOI 10.1016/j.biocel.2004.05.013; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Lee K, 2011, J BIOL CHEM, V286, P25655, DOI 10.1074/jbc.M111.228692; Lewin TM, 2001, J BIOL CHEM, V276, P24674, DOI 10.1074/jbc.M102036200; Liu Q, 2010, FASEB J; Lobo S, 2007, J LIPID RES, V48, P609, DOI 10.1194/jlr.M600441-JLR200; Luiken JJFP, 2002, AM J PHYSIOL-ENDOC M, V282, pE491, DOI 10.1152/ajpendo.00419.2001; Marszalek JR, 2004, J BIOL CHEM, V279, P23882, DOI 10.1074/jbc.M313460200; Mashek DG, 2007, FUTURE LIPIDOL, V2, P465, DOI 10.2217/17460875.2.4.465; Mashek DG, 2006, J LIPID RES, V47, P2004, DOI 10.1194/jlr.M600150-JLR200; Mashek DG, 2006, CURR OPIN LIPIDOL, V17, P274, DOI 10.1097/01.mol.0000226119.20307.2b; Milger K, 2006, J CELL SCI, V119, P4678, DOI 10.1242/jcs.03280; Murphy EJ, 1996, BBA-LIPID LIPID MET, V1301, P191, DOI 10.1016/0005-2760(96)00024-0; Nickerson JG, 2009, J BIOL CHEM, V284, P16522, DOI 10.1074/jbc.M109.004788; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Oikawa E, 1998, J BIOCHEM, V124, P679, DOI 10.1093/oxfordjournals.jbchem.a022165; Ruan H, 2001, DIABETES, V50, P233, DOI 10.2337/diabetes.50.2.233; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Schuck S, 2004, P NATL ACAD SCI USA, V101, P4912, DOI 10.1073/pnas.0401285101; Sebastian D, 2009, J LIPID RES; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; Stahl A, 2002, DEV CELL, V2, P477, DOI 10.1016/S1534-5807(02)00143-0; Stahl A, 2004, PFLUG ARCH EUR J PHY, V447, P722, DOI 10.1007/s00424-003-1106-z; Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9; Stahl A, 2001, TRENDS ENDOCRIN MET, V12, P266, DOI 10.1016/S1043-2760(01)00427-1; Trigatti BL, 1999, BIOCHEM BIOPH RES CO, V255, P34, DOI 10.1006/bbrc.1998.0123; van Oort MM, 2007, BIOCH BIOPHYS ACTA; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P3380, DOI 10.2741/3460; WADA I, 1991, J BIOL CHEM, V266, P19599; Wang YL, 2004, OBES RES, V12, P1781, DOI 10.1038/oby.2004.221; Watkins PA, 2007, J LIPID RES, V48, P2736, DOI 10.1194/jlr.M700378-JLR200; Wiczer BM, 2009, J LIPID RES; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Yin W, 2003, J BIOL CHEM, V278, P43074, DOI 10.1074/jbc.M308484200; Zhan TZ, 2011, J CELL BIOCHEM, V112, P849, DOI 10.1002/jcb.22984; Zunino R, 2007, J CELL SCI, V120, P1178, DOI 10.1242/jcs.03418	64	52	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45087	10.1371/journal.pone.0045087	http://dx.doi.org/10.1371/journal.pone.0045087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024797	Green Published, Green Submitted, gold			2022-12-27	WOS:000308860100055
J	Guan, DW; van der Sanden, S; Zeng, HR; Li, W; Zheng, HY; Ma, C; Su, J; Liu, Z; Guo, X; Zhang, X; Liu, L; Koopmans, M; Ke, CW				Guan, Dawei; van der Sanden, Sabine; Zeng, Hanri; Li, Wei; Zheng, Huanying; Ma, Cong; Su, Juan; Liu, Zheng; Guo, Xue; Zhang, Xin; Liu, Leng; Koopmans, Marion; Ke, Changwen			Population Dynamics and Genetic Diversity of C4 Strains of Human Enterovirus 71 in Mainland China, 1998-2010	PLOS ONE			English	Article							POLIOMYELITIS-LIKE DISEASE; MOUTH-DISEASE; MOLECULAR EPIDEMIOLOGY; EVOLUTIONARY GENETICS; NEUROLOGICAL DISEASE; HAND; FOOT; OUTBREAK; VP1; INFECTION	Background: Since 1997, several countries within the Asian Pacific region have been affected by one or more massive outbreaks of Hand Foot and Mouth Disease (HFMD). Virus typing experiments revealed that these outbreaks were caused by strains of human enterovirus 71 (EV71) belonging to several different, recently emerged subgenogroups. In mainland China, a different situation was observed. The first outbreak, localized in Shangdong Province, was reported in 2007, and was followed by a wide-spread outbreak in mainland China in 2008. Since then, numbers of reported HFMD cases have been persistently high. Methodology/Principal Findings: To gain insight in the epidemiological behavior of EV71 in China, we studied genetic diversity and EV71 population dynamics to address whether the increase in number of reported EV71 infections reflects a real increase in viral spread or is just the result of increased awareness and surveillance. We used systematically collected VP1 gene sequences of 257 EV71 strains collected in Guangdong province from 2008 to 2010 as part of HFMD surveillance activities, and supplemented them with 305 GenBank EV71 reference stains collected in China from 1998 to 2010. All isolates from Guangdong Province belonged to subgenogroup C4. Viral population dynamics indicated that the increased reporting of HFMD in China since 2007 reflects a real increase in viral spread and continued replacement of viral lineages through time. Amino acid sequence comparisons revealed substitution of amino acid in residues 22, 145 and 289 through time regularly with the VP1 gene of EV71 strains isolated in mainland China from 1998 to 2010. Conclusions: EV71 strains isolated in mainland China mainly belonged to subgenogroup C4. There was exponential growth of the EV71 virus population in 2007 and 2008. There was amino acid substitution through time regularly with the VP1 gene which possibly increased viral spread and/or ability of the virus to circulate persistently among the Chinese population.	[Guan, Dawei; Zeng, Hanri; Li, Wei; Zheng, Huanying; Ma, Cong; Su, Juan; Liu, Zheng; Guo, Xue; Zhang, Xin; Liu, Leng; Ke, Changwen] Ctr Dis Control & Prevent Guangdong Prov, Key Lab Pathogen Detect Emergency Response Guangd, Guangzhou, Guangdong, Peoples R China; [van der Sanden, Sabine; Koopmans, Marion] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment	Guan, DW (corresponding author), Ctr Dis Control & Prevent Guangdong Prov, Key Lab Pathogen Detect Emergency Response Guangd, Guangzhou, Guangdong, Peoples R China.	kecw1965@yahoo.com.cn	liu, Zheng/H-4193-2013	liu, Zheng/0000-0002-9351-200X; Koopmans, Marion/0000-0002-5204-2312	Technology Research Center for Pathogen Detection of Emerging Infectious Disease of Guangdong Province, China [(2008)1216 -2]	Technology Research Center for Pathogen Detection of Emerging Infectious Disease of Guangdong Province, China	This work was supported by Technology Research Center for Pathogen Detection of Emerging Infectious Disease of Guangdong Province, China (Grant no. (2008)1216 -2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER JP, 1994, J INFECT DIS, V169, P905, DOI 10.1093/infdis/169.4.905; Bible JM, 2008, J CLIN MICROBIOL, V46, P3192, DOI 10.1128/JCM.00628-08; Bible JM, 2007, REV MED VIROL, V17, P371, DOI 10.1002/rmv.538; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Cardosa MJ, 2003, EMERG INFECT DIS, V9, P461; Chu PY, 2001, ARCH VIROL, V146, P589, DOI 10.1007/s007050170164; CHUMAKOV M, 1979, ARCH VIROL, V60, P329, DOI 10.1007/BF01317504; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; GILBERT GL, 1988, PEDIATR INFECT DIS J, V7, P484, DOI 10.1097/00006454-198807000-00007; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Iwai M, 2009, JPN J INFECT DIS, V62, P254; Kehle J, 2003, J NEUROVIROL, V9, P126, DOI 10.1080/13550280390173364; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; McMinn P, 2001, J VIROL, V75, P7732, DOI 10.1128/JVI.75.16.7732-7738.2001; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Mizuta K, 2005, J CLIN MICROBIOL, V43, P6171, DOI 10.1128/JCM.43.12.6171-6175.2005; Ortner B, 2009, J MED VIROL, V81, P317, DOI 10.1002/jmv.21374; Perez-Velez CM, 2007, CLIN INFECT DIS, V45, P950, DOI 10.1086/521895; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Shih SR, 2000, VIRUS RES, V68, P127, DOI 10.1016/S0168-1702(00)00162-3; SHINDAROV LM, 1979, J HYG EPID MICROB IM, V23, P284; Sun LM, 2011, JPN J INFECT DIS, V64, P13; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tee KK, 2010, J VIROL, V84, P3339, DOI 10.1128/JVI.01019-09; van der Sanden S, 2010, J GEN VIROL, V91, P1949, DOI 10.1099/vir.0.019695-0; van der Sanden S, 2009, J CLIN MICROBIOL, V47, P2826, DOI 10.1128/JCM.00507-09; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang JR, 2002, J CLIN MICROBIOL, V40, P10, DOI 10.1128/JCM.40.1.10-15.2002; Wang SM, 2009, EXPERT REV ANTI-INFE, V7, P735, DOI 10.1586/ERI.09.45; YANG CF, 1992, VIRUS RES, V24, P277, DOI 10.1016/0168-1702(92)90124-R; Zhang Y, 2011, PLOS ONE, V6, P262; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002	37	26	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44386	10.1371/journal.pone.0044386	http://dx.doi.org/10.1371/journal.pone.0044386			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984501	Green Submitted, Green Published, gold			2022-12-27	WOS:000308738500053
J	Hale, ML; Burg, TM; Steeves, TE				Hale, Marie L.; Burg, Theresa M.; Steeves, Tammy E.			Sampling for Microsatellite-Based Population Genetic Studies: 25 to 30 Individuals per Population Is Enough to Accurately Estimate Allele Frequencies	PLOS ONE			English	Article							COMPUTER-PROGRAM; MARKERS; DIVERSITY; ALBATROSSES; RICHNESS; DISTANCE; NUMBER; SIZES; LOCI; DNA	One of the most common questions asked before starting a new population genetic study using microsatellite allele frequencies is "how many individuals do I need to sample from each population?" This question has previously been answered by addressing how many individuals are needed to detect all of the alleles present in a population (i.e. rarefaction based analyses). However, we argue that obtaining accurate allele frequencies and accurate estimates of diversity are much more important than detecting all of the alleles, given that very rare alleles (i.e. new mutations) are not very informative for assessing genetic diversity within a population or genetic structure among populations. Here we present a comparison of allele frequencies, expected heterozygosities and genetic distances between real and simulated populations by randomly subsampling 5-100 individuals from four empirical microsatellite genotype datasets (Formica lugubris, Sciurus vulgaris, Thalassarche melanophris, and Himantopus novaezelandia) to create 100 replicate datasets at each sample size. Despite differences in taxon (two birds, one mammal, one insect), population size, number of loci and polymorphism across loci, the degree of differences between simulated and empirical dataset allele frequencies, expected heterozygosities and pairwise FST values were almost identical among the four datasets at each sample size. Variability in allele frequency and expected heterozygosity among replicates decreased with increasing sample size, but these decreases were minimal above sample sizes of 25 to 30. Therefore, there appears to be little benefit in sampling more than 25 to 30 individuals per population for population genetic studies based on microsatellite allele frequencies.	[Hale, Marie L.; Steeves, Tammy E.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Burg, Theresa M.] Univ Lethbridge, Dept Biol, Lethbridge, AB T1K 3M4, Canada	University of Canterbury; University of Lethbridge	Hale, ML (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand.	marie.hale@canterbury.ac.nz			University of Newcastle (UK)	University of Newcastle (UK)	The unpublished ant and dataset was collected by MLH and Dr. Kirsten Wolff, funded by the University of Newcastle (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashalkhanov S, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-84; BAVERSTOCK PR, 1996, MOL SYSTEMATICS; Burg TM, 1999, MOL ECOL, V8, P338; Burg TM, 2001, MOL ECOL, V10, P2647, DOI 10.1046/j.0962-1083.2001.01392.x; Chapuisat M, 1996, MOL ECOL, V5, P599, DOI 10.1111/j.1365-294X.1996.tb00354.x; Gyllenstrand N, 2002, MOL ECOL NOTES, V2, P67, DOI 10.1046/j.1471-8286.2002.00152.x; Hale ML, 2001, SCIENCE, V293, P2246, DOI 10.1126/science.1062574; Hale ML, 2001, MOL ECOL NOTES, V1, P47, DOI 10.1046/j.1471-8278 .2000.00020.x; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kalinowski ST, 2005, HEREDITY, V94, P33, DOI 10.1038/sj.hdy.6800548; Landguth EL, 2012, MOL ECOL RESOUR, V12, P276, DOI 10.1111/j.1755-0998.2011.03077.x; Miyamoto N, 2008, ANN FOREST SCI, V65, DOI 10.1051/forest:2008014; NEI M, 1978, GENETICS, V89, P583; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pruett CL, 2008, J AVIAN BIOL, V39, P252, DOI 10.1111/j.2008.0908-8857.04094.x; Ruzzante DE, 1998, CAN J FISH AQUAT SCI, V55, P1, DOI 10.1139/cjfas-55-1-1; Ryman N, 2006, MOL ECOL NOTES, V6, P600, DOI 10.1111/j.1471-8286.2006.01378.x; Steeves TE, 2008, MOL ECOL RESOUR, V8, P1105, DOI 10.1111/j.1755-0998.2008.02170.x; Steeves TE, 2010, MOL ECOL, V19, P5090, DOI 10.1111/j.1365-294X.2010.04895.x; Yan Lu-Na, 2004, Acta Zoologica Sinica, V50, P279	21	298	301	3	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45170	10.1371/journal.pone.0045170	http://dx.doi.org/10.1371/journal.pone.0045170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984627	Green Submitted, gold, Green Published			2022-12-27	WOS:000308738500125
J	Sellmyer, MA; Chen, LC; Egeler, EL; Rakhit, R; Wandless, TJ				Sellmyer, Mark A.; Chen, Ling-chun; Egeler, Emily L.; Rakhit, Rishi; Wandless, Thomas J.			Intracellular Context Affects Levels of a Chemically Dependent Destabilizing Domain	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; UBIQUITIN-PROTEASOME SYSTEM; ENDOPLASMIC-RETICULUM; IN-VIVO; PLASMODIUM-FALCIPARUM; MITOCHONDRIAL IMPORT; FLUORESCENT PROTEIN; GAUSSIA LUCIFERASE; MESSENGER-RNA; ER STRESS	The ability to regulate protein levels in live cells is crucial to understanding protein function. In the interest of advancing the tool set for protein perturbation, we developed a protein destabilizing domain (DD) that can confer its instability to a fused protein of interest. This destabilization and consequent degradation can be rescued in a reversible and dose-dependent manner with the addition of a small molecule that is specific for the DD, Shield-1. Proteins encounter different local protein quality control (QC) machinery when targeted to cellular compartments such as the mitochondrial matrix or endoplasmic reticulum (ER). These varied environments could have profound effects on the levels and regulation of the cytoplasmically derived DD. Here we show that DD fusions in the cytoplasm or nucleus can be efficiently degraded in mammalian cells; however, targeting fusions to the mitochondrial matrix or ER lumen leads to accumulation even in the absence of Shield-1. Additionally, we characterize the behavior of the DD with perturbants that modulate protein production, degradation, and local protein QC machinery. Chemical induction of the unfolded protein response in the ER results in decreased levels of an ER-targeted DD indicating the sensitivity of the DD to the degradation environment. These data reinforce that DD is an effective tool for protein perturbation, show that the local QC machinery affects levels of the DD, and suggest that the DD may be a useful probe for monitoring protein quality control machinery.	[Sellmyer, Mark A.; Chen, Ling-chun; Egeler, Emily L.; Rakhit, Rishi; Wandless, Thomas J.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University	Sellmyer, MA (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	wandless@stanford.edu		Sellmyer, Mark/0000-0002-1407-1905	National Institute of General Medical Sciences of the National Institutes of Health [GM073046]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073046] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institute of General Medical Sciences of the National Institutes of Health (GM073046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Armstrong CM, 2007, NAT METHODS, V4, P1007, DOI 10.1038/nmeth1132; Baker BM, 2011, TRENDS BIOCHEM SCI, V36, P254, DOI 10.1016/j.tibs.2011.01.004; Balch W, 2008, SCIENCE; Banaszynski LA, 2008, NAT MED, V14, P1123, DOI 10.1038/nm.1754; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; da Silva LM, 2009, P NATL ACAD SCI USA, V106, P7583, DOI 10.1073/pnas.0901698106; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Egeler EL, 2011, J BIOL CHEM, V286, P31328, DOI 10.1074/jbc.M111.264101; Glass M, 2009, NAT METHODS, V6, P577, DOI 10.1038/nmeth.1346; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Herm-Gotz A, 2007, NAT METHODS, V4, P1003, DOI 10.1038/nmeth1134; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kaser M, 2000, SEMIN CELL DEV BIOL, V11, P181, DOI 10.1006/scdb.2000.0166; Kim HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020252; Leong HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030177; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Ni L, 1999, J BIOL CHEM, V274, P12685, DOI 10.1074/jbc.274.18.12685; Pruett-Miller SM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000376; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Rivera VM, 2000, SCIENCE, V287, P826, DOI 10.1126/science.287.5454.826; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schreiber SL, 2003, CHEM ENG NEWS, V81, P51, DOI 10.1021/cen-v081n009.p051; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Wilcox AJ, 2005, P NATL ACAD SCI USA, V102, P15435, DOI 10.1073/pnas.0507324102; Wiseman RL, 2007, CELL, V131, P809, DOI 10.1016/j.cell.2007.10.025; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145	35	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43297	10.1371/journal.pone.0043297	http://dx.doi.org/10.1371/journal.pone.0043297			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984418	Green Published, gold, Green Submitted			2022-12-27	WOS:000308738500009
J	Tattersall, MC; Gangnon, RE; Karmali, KN; Keevil, JG				Tattersall, Matthew C.; Gangnon, Ronald E.; Karmali, Kunal N.; Keevil, Jon G.			Women Up, Men Down: The Clinical Impact of Replacing the Framingham Risk Score with the Reynolds Risk Score in the United States Population	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; GLOBAL CARDIOVASCULAR RISK; C-REACTIVE PROTEIN; DENSITY-LIPOPROTEIN CHOLESTEROL; US ADULTS; PRIMARY PREVENTION; NATIONAL-HEALTH; LIFETIME RISK; 10-YEAR RISK; PREDICTION	Background: The Reynolds Risk Score (RRS) is one alternative to the Framingham Risk Score (FRS) for cardiovascular risk assessment. The Adult Treatment Panel III (ATP III) integrated the FRS a decade ago, but with the anticipated release of ATP IV, it remains uncertain how and which risk models will be integrated into the recommendations. We sought to define the effects in the United States population of a transition from the FRS to the RRS for cardiovascular risk assessment. Methods: Using the National Health and Nutrition Examination Surveys, we assessed FRS and RRS in 2,502 subjects representing approximately 53.6 Million (M) men (ages 50-79) and women (ages 45-79), without cardiovascular disease or diabetes. We calculated the proportion reclassified by RRS and the subset whose LDL-C goal achievement changed. Results: Compared to FRS, the RRS assigns a higher risk category to 13.9% of women and 9.1% of men while assigning a lower risk to 35.7% of men and 2% of women. Overall, 4.7% of women and 1.1% of men fail to meet newly intensified LDLC goals using the RRS. Conversely, 10.5% of men and 0.6% of women now meet LDL-C goal using RRS when they had not by FRS. Conclusion: In the U. S. population the RRS assigns a new risk category for one in six women and four of nine men. In general, women increase while men decrease risk. In conclusion, adopting the RRS for the 53.6 million eligible U. S. adults would result in intensification of clinical management in 1.6 M additional women and 2.10 M fewer men.	[Tattersall, Matthew C.; Karmali, Kunal N.; Keevil, Jon G.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Div Cardiovasc Med, Madison, WI 53706 USA; [Gangnon, Ronald E.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Tattersall, MC (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Div Cardiovasc Med, Madison, WI 53706 USA.	jgk@medicine.wisc.edu		Gangnon, Ronald/0000-0003-2587-6714	National Institutes of Health under Ruth L. Kirschstein National Research Service Award from the National Heart Lung and Blood Institute [T32 HL 07936]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007936] Funding Source: NIH RePORTER	National Institutes of Health under Ruth L. Kirschstein National Research Service Award from the National Heart Lung and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This investigation was supported by the National Institutes of Health, under Ruth L. Kirschstein National Research Service Award T32 HL 07936 from the National Heart Lung and Blood Institute to the UW-Madison Cardiovascular Research Center, Madison WI, USA. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amarenco P, 2004, STROKE, V35, P2902, DOI 10.1161/01.STR.0000147965.52712.fa; Amarenco P, 2009, LANCET NEUROL, V8, P453, DOI 10.1016/S1474-4422(09)70058-4; [Anonymous], 2005, NAT HLTH NUTR EX SUR; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cook NR, 2012, CIRCULATION, V125, P1748, DOI 10.1161/CIRCULATIONAHA.111.075929; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Ford ES, 2004, J AM COLL CARDIOL, V43, P1791, DOI 10.1016/j.jacc.2003.11.061; Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9; Greenland P, 2001, CIRCULATION, V104, P1863, DOI 10.1161/hc4201.097189; Greenland P, 2010, CIRCULATION, V122, pE584, DOI 10.1161/CIR.0b013e3182051b4c; Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Imperatore G, 2004, AM J EPIDEMIOL, V160, P531, DOI 10.1093/aje/kwh232; Kuczmarski RJ., 2002, VITAL HLTH STAT, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Lloyd-Jones DM, 2004, AM J CARDIOL, V94, P20, DOI 10.1016/j.amjcard.2004.03.023; Lloyd-Jones DM, 2006, CIRCULATION, V113, P791, DOI 10.1161/CIRCULATIONAHA.105.548206; Michos ED, 2009, J AM COLL CARDIOL, V53, P931, DOI 10.1016/j.jacc.2008.12.010; Pasternak Richard C., 2003, Journal of the American College of Cardiology, V41, P1863, DOI 10.1016/S0735-1097(03)00358-9; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Redberg RF, 2009, J AM COLL CARDIOL, V54, P1364, DOI 10.1016/j.jacc.2009.08.005; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Sheridan SL, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-60; Sundquist J, 2001, J AM GERIATR SOC, V49, P109, DOI 10.1046/j.1532-5415.2001.49030.x; Voight BF, 2012, LANCET; Wensley F, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d548; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167	33	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44347	10.1371/journal.pone.0044347	http://dx.doi.org/10.1371/journal.pone.0044347			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984495	Green Published, gold, Green Submitted			2022-12-27	WOS:000308738500049
J	Zhao, J; Li, H; Ding, C; Chen, AT				Zhao, Jing; Li, Hong; Ding, Cody; Chen, Antao			Distractor Detection and Suppression Have a Beneficial Effect on Attentional Blink	PLOS ONE			English	Article							SERIAL VISUAL PRESENTATION; INDIVIDUAL-DIFFERENCES; TEMPORAL ATTENTION; MODEL; TASK; INFORMATION; MEMORY	Background: Attentional blink (AB) is a phenomenon that describes the difficulty individuals have in reporting the second of two masked targets if the second target (T2) arrives 200-500 ms after the first target (T1). Recent studies explain the AB from cognitive resources limitation to distractors interference. For example, the temporary loss of control (TLC) hypothesis suggests that the AB is conduced by distractors disrupting the input filter for target processing. The inhibition models suggest that the T1+1 distractor triggers a suppression mechanism which could be beneficial for T1 processing but would suppress T2 at short T1-T2 lags. These models consider that the AB is caused by the appearance of distractors. However, in the present study, two methods were taken to help individuals to detect the distractors more effectively. An attenuated AB deficit was found when the distractors could be excluded or suppressed in time. We consider that under an appropriate condition the distractors detection and suppression have a beneficial effect on attentional blink. Methodology/Principal Findings: Two methods were employed to help individuals to detect the distractors more effectively: enlarging the low-level-physical characteristic difference between targets and distractors (Experiment 1) and restricting the sets of distractors (Experiment 2). Attenuated AB deficits were found as using the above manipulations. Conclusions/Significance: The present study found when the distractors are detected or identified quickly, they could be effectively suppressed, in order to reduce the interference from the targets and result in a smaller AB deficit. We suggest that the suppression mechanism for distractors have a beneficial effect on AB.	[Zhao, Jing; Chen, Antao] Southwest Univ, Sch Psychol, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China; [Li, Hong] Liaoning Normal Univ, Res Ctr Psychol Dev & Educ, Dalian, Liaoning, Peoples R China; [Ding, Cody] Univ Missouri, Coll Educ, St Louis, MO 63121 USA	Southwest University - China; Liaoning Normal University; University of Missouri System; University of Missouri Saint Louis	Zhao, J (corresponding author), Southwest Univ, Sch Psychol, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China.	xscat@swu.edu.cn			National Natural Science Foundation of China [31170980]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [201107]; New Century Excellent Talents in University [NCET-11-0698]; Fundamental Research Funds for the Central Universities [SWU1009001]; Key Discipline Fund of National 211 Project [NSKD11006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Key Discipline Fund of National 211 Project	This work was supported by the National Natural Science Foundation of China (31170980), the Foundation for the Author of National Excellent Doctoral Dissertation of PR China (201107), the New Century Excellent Talents in University (NCET-11-0698), the Fundamental Research Funds for the Central Universities (SWU1009001), and the Key Discipline Fund of National 211 Project (NSKD11006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowman H, 2007, PSYCHOL REV, V114, P38, DOI 10.1037/0033-295X.114.1.38; BROADBENT DE, 1987, PERCEPT PSYCHOPHYS, V42, P105, DOI 10.3758/BF03210498; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Dehaene S, 2003, P NATL ACAD SCI USA, V100, P8520, DOI 10.1073/pnas.1332574100; Di Lollo V, 2005, PSYCHOL RES-PSYCH FO, V69, P191, DOI 10.1007/s00426-004-0173-x; Fragopanagos N, 2005, COGNITIVE BRAIN RES, V24, P568, DOI 10.1016/j.cogbrainres.2005.03.010; LANDAUER TK, 1968, J VERB LEARN VERB BE, V7, P291, DOI 10.1016/S0022-5371(68)80003-9; Martens S., 2010, PLOS ONE, V5; Martens S, 2006, J COGNITIVE NEUROSCI, V18, P1423, DOI 10.1162/jocn.2006.18.9.1423; Martens S, 2009, EXP PSYCHOL, V56, P18, DOI 10.1027/1618-3169.56.1.18; Olivers CNL, 2008, PSYCHOL REV, V115, P836, DOI 10.1037/a0013395; Olivers CNL, 2007, PSYCHOL RES-PSYCH FO, V71, P126, DOI 10.1007/s00426-005-0029-z; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P364, DOI 10.1037/0096-1523.32.2.364; Potter MC, 1998, J EXP PSYCHOL LEARN, V24, P979, DOI 10.1037/0278-7393.24.4.979; RAYMOND JE, 1995, J EXP PSYCHOL HUMAN, V21, P653, DOI 10.1037/0096-1523.21.3.653; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Shapiro K, 1994, TEMPORAL ALLOCATION; Shih SI, 2008, COGNITIVE PSYCHOL, V56, P210, DOI 10.1016/j.cogpsych.2007.06.001	18	2	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44786	10.1371/journal.pone.0044786	http://dx.doi.org/10.1371/journal.pone.0044786			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005GJ	22984558	Green Published, gold			2022-12-27	WOS:000308738500084
J	Zhao, Y; Zhu, HP; Zou, MH				Zhao, Yu; Zhu, Huaiping; Zou, Ming-Hui			Non-Covalent Interaction between Polyubiquitin and GTP Cyclohydrolase 1 Dictates Its Degradation	PLOS ONE			English	Article							UBIQUITIN-BINDING DOMAINS; NITRIC-OXIDE SYNTHASE; DOPA-RESPONSIVE DYSTONIA; UBA DOMAIN; IN-VIVO; ENDOTHELIAL FUNCTION; TYROSINE NITRATION; 26S PROTEASOME; HIV-1 VPR; TETRAHYDROBIOPTERIN	GTP cyclohydrolase 1 (GTPCH1) is the rate-limiting enzyme in the de novo synthesis of tetrahydrobiopterin (BH4). GTPCH1 protein degradation has been reported in animal models of several diseases, including diabetes mellitus and hypertension. However, the molecular mechanisms by which GTPCH1 is degraded remain uncharacterized. Here we report a novel non-covalent interaction between polyubiquitin and GTPCH1 in vitro and in vivo. The non-covalent binding of GTPCH1 to polyubiquitin via an ubiquitin-binding domain (UBD) results in ubiquitination and degradation. Ectopic expression of ubiquitin in cultured cells accelerated GTPCH1 degradation. In cultured cells and in vitro assays, Lys48-linked ubiquitin chains, but not Lys63-linked chains, interacted with GTPCH1 and targeted it for degradation. Consistently, proteasome inhibition attenuated GTPCH1 degradation. Finally, direct mutagenesis of an isoleucine (Ile131) in the hydrophobic patch of the GTPCH1 UBD affected its ubiquitin binding and the enzyme stability. Taken together, we conclude that GTPCH1 non-covalently interacts with polyubiquitin via an ubiquitin-binding domain. The polyubiquitin binding directs GTPCH1 ubiquitination and proteasome degradation.	[Zhao, Yu; Zhu, Huaiping; Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Sect Mol Med, Oklahoma City, OK USA; [Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Zhao, Y (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Sect Mol Med, Oklahoma City, OK USA.	ming-hui-zou@ouhsc.edu			NIH [HL074399, HL079584, HL080499, HL089920, HL096032, HL105157, HL110448]; American Diabetes Association; Warren Chair in Diabetes Research from the University of Oklahoma Health Sciences Center; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074399, R01HL110488, R01HL105157, R01HL079584, R01HL089920, R01HL080499, R43HL110448, R01HL096032] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Warren Chair in Diabetes Research from the University of Oklahoma Health Sciences Center; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by NIH grants (HL074399, HL079584, HL080499, HL089920, HL096032, HL105157, and HL110448), by a research award from the American Diabetes Association, and by the Warren Chair in Diabetes Research from the University of Oklahoma Health Sciences Center (to Dr. Zou). Dr. Zou is a recipient of the National Established Investigator Award of the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alp NJ, 2004, ARTERIOSCL THROM VAS, V24, P413, DOI 10.1161/01.ATV.0000110785.96039.f6; Alp NJ, 2003, J CLIN INVEST, V112, P725, DOI 10.1172/JCI200317786; Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; Clot F, 2009, BRAIN, V132, P1753, DOI 10.1093/brain/awp084; Crinelli R, 2008, MOL CELL BIOCHEM, V318, P129, DOI 10.1007/s11010-008-9864-8; Dieckmann T, 1998, NAT STRUCT BIOL, V5, P1042, DOI 10.1038/4220; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Dunbar AY, 2006, DRUG METAB DISPOS, V34, P1448, DOI 10.1124/dmd.106.009951; Foxton RH, 2007, NEUROCHEM RES, V32, P751, DOI 10.1007/s11064-006-9201-0; Garavaglia B, 2004, J INHERIT METAB DIS, V27, P455, DOI 10.1023/B:BOLI.0000037349.08483.96; Gorren ACF, 2002, CURR DRUG METAB, V3, P133, DOI 10.2174/1389200024605154; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Higashi Y, 2002, AM J HYPERTENS, V15, P326, DOI 10.1016/S0895-7061(01)02317-2; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Ikeda F, 2010, CELL, V143, P677, DOI 10.1016/j.cell.2010.10.026; KWON NS, 1989, J BIOL CHEM, V264, P20496; Longo N, 2009, J INHERIT METAB DIS, V32, P333, DOI 10.1007/s10545-009-1067-2; LOVENBERG W, 1967, SCIENCE, V155, P217, DOI 10.1126/science.155.3759.217; Mizuno E, 2003, MOL BIOL CELL, V14, P3675, DOI 10.1091/mbc.E02-12-0823; Muller U, 2002, J NEURAL TRANSM, V109, P321, DOI 10.1007/s007020200026; Nie H, 2006, DIABETES, V55, P3133, DOI 10.2337/db06-0505; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Pickart CM, 2001, MOL CELL, V8, P499, DOI 10.1016/S1097-2765(01)00347-1; Raasi S, 2004, J MOL BIOL, V341, P1367, DOI 10.1016/j.jmb.2004.06.057; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Raasi S, 2003, J BIOL CHEM, V278, P8951, DOI 10.1074/jbc.M212841200; Schwartz AL, 1999, ANNU REV MED, V50, P57; Stroes E, 1997, J CLIN INVEST, V99, P41, DOI 10.1172/JCI119131; TAYEH MA, 1989, J BIOL CHEM, V264, P19654; Thony B, 2006, HUM MUTAT, V27, P870, DOI 10.1002/humu.20366; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; Wang SX, 2009, DIABETES, V58, P1893, DOI 10.2337/db09-0267; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Withers-Ward ES, 2000, BIOCHEMISTRY-US, V39, P14103, DOI 10.1021/bi0017071; Xu J, 2007, CIRCULATION, V116, P944, DOI 10.1161/CIRCULATIONAHA.106.684795; Xu J, 2009, HYPERTENSION, V54, P625, DOI 10.1161/HYPERTENSIONAHA.109.133736	39	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43306	10.1371/journal.pone.0043306	http://dx.doi.org/10.1371/journal.pone.0043306			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984419	Green Published, gold, Green Submitted			2022-12-27	WOS:000308738500010
J	Choudhury, SR; Roy, S; Nag, A; Singh, SK; Sengupta, DN				Choudhury, Swarup Roy; Roy, Sujit; Nag, Anish; Singh, Sanjay Kumar; Sengupta, Dibyendu N.			Characterization of an AGAMOUS-like MADS Box Protein, a Probable Constituent of Flowering and Fruit Ripening Regulatory System in Banana	PLOS ONE			English	Article							PHOSPHATE SYNTHASE GENE; DNA-BINDING-PROTEIN; TRANSCRIPTION FACTORS; OVULE DEVELOPMENT; IN-VITRO; ARABIDOPSIS; TOMATO; DOMAIN; EXPRESSION; ETHYLENE	The MADS-box family of genes has been shown to play a significant role in the development of reproductive organs, including dry and fleshy fruits. In this study, the molecular properties of an AGAMOUS like MADS box transcription factor in banana cultivar Giant governor (Musa sp, AAA group, subgroup Cavendish) has been elucidated. We have detected a CArG-box sequence binding AGAMOUS MADS-box protein in banana flower and fruit nuclear extracts in DNA-protein interaction assays. The protein fraction in the DNA-protein complex was analyzed by mass spectrometry and using this information we have obtained the full length cDNA of the corresponding protein. The deduced protein sequence showed similar to 95% amino acid sequence homology with MA-MADS5, a MADS-box protein described previously from banana. We have characterized the domains of the identified AGAMOUS MADS-box protein involved in DNA binding and homodimer formation in vitro using full-length and truncated versions of affinity purified recombinant proteins. Furthermore, in order to gain insight about how DNA bending is achieved by this MADS-box factor, we performed circular permutation and phasing analysis using the wild type recombinant protein. The AGAMOUS MADS-box protein identified in this study has been found to predominantly accumulate in the climacteric fruit pulp and also in female flower ovary. In vivo and in vitro assays have revealed specific binding of the identified AGAMOUS MADS-box protein to CArG-box sequence in the promoters of major ripening genes in banana fruit. Overall, the expression patterns of this MADS-box protein in banana female flower ovary and during various phases of fruit ripening along with the interaction of the protein to the CArG-box sequence in the promoters of major ripening genes lead to interesting assumption about the possible involvement of this AGAMOUS MADS-box factor in banana fruit ripening and floral reproductive organ development.	[Choudhury, Swarup Roy; Nag, Anish; Singh, Sanjay Kumar; Sengupta, Dibyendu N.] Bose Inst, Div Plant Biol, Kolkata, W Bengal, India; [Roy, Sujit] Bose Inst, Dept Chem, Kolkata, W Bengal, India	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute	Choudhury, SR (corresponding author), Donald Danforth Plant Sci Ctr, St Louis, MO USA.	src.bose@gmail.com	Nag, Anish/ABH-8581-2020; Pandey, Sona/M-2847-2013	Nag, Anish/0000-0001-9435-3795; Pandey, Sona/0000-0002-5570-3120	CSIR project [38(1181)/08/EMR-II]; CSIR; Govt. of India	CSIR project(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); Govt. of India	The work is financially supported by research grant from CSIR project [38(1181)/08/EMR-II], CSIR, Govt. of India to DNS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bhattacharyya J, 1998, BIOCHEM MOL BIOL INT, V46, P249; Boss PK, 2001, PLANT MOL BIOL, V45, P541, DOI 10.1023/A:1010634132156; Bowler C, 2004, PLANT J, V39, P776, DOI 10.1111/j.1365-313X.2004.02169.x; BRADLEY D, 1993, CELL, V72, P85, DOI 10.1016/0092-8674(93)90052-R; Causier B, 2005, CURR BIOL, V15, P1508, DOI 10.1016/j.cub.2005.07.063; Chattopadhyay S, 1998, PLANT CELL, V10, P673, DOI 10.1105/tpc.10.5.673; Cho SC, 1999, PLANT MOL BIOL, V40, P419, DOI 10.1023/A:1006273127067; Choudhury SR, 2008, PLANT CELL REP, V27, P1235, DOI 10.1007/s00299-008-0547-4; Choudhury SR, 2009, POSTHARVEST BIOL TEC, V54, P15, DOI 10.1016/j.postharvbio.2009.05.003; Choudhury SR, 2008, PLANTA, V229, P207, DOI 10.1007/s00425-008-0821-2; Choudhury SR, 2008, J PLANT PHYSIOL, V165, P1865, DOI 10.1016/j.jplph.2008.04.012; Davies B, 1999, EMBO J, V18, P4023, DOI 10.1093/emboj/18.14.4023; de Folter S, 2006, TRENDS PLANT SCI, V11, P224, DOI 10.1016/j.tplants.2006.03.008; Dominique SR, 2004, J PROTEOME RES, V3, P662, DOI 10.1021/pr049966q; DRAK J, 1991, P NATL ACAD SCI USA, V88, P3074, DOI 10.1073/pnas.88.8.3074; Elitzur T, 2010, J EXP BOT, V61, P1523, DOI 10.1093/jxb/erq017; Flanagan CA, 1996, PLANT J, V10, P343, DOI 10.1046/j.1365-313X.1996.10020343.x; Fujisawa M, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-26; Garcia-Maroto F, 2003, BIOL PLANTARUM, V46, P321, DOI 10.1023/A:1024353514081; Harlow E., 1988, ANTIBODIES LAB MANUA; Hileman LC, 2006, MOL BIOL EVOL, V23, P2245, DOI 10.1093/molbev/msl095; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; Huang H, 1996, PLANT CELL, V8, P81, DOI 10.1105/tpc.8.1.81; HUANG H, 1995, PLANT MOL BIOL, V28, P549, DOI 10.1007/BF00020401; HUANG H, 1993, NUCLEIC ACIDS RES, V21, P4769, DOI 10.1093/nar/21.20.4769; INABA A, 1986, J JPN SOC HORTIC SCI, V55, P348, DOI 10.2503/jjshs.55.348; Itkin M, 2009, PLANT J, V60, P1081, DOI 10.1111/j.1365-313X.2009.04064.x; Ito T, 2007, PLANT CELL, V19, P3516, DOI 10.1105/tpc.107.055467; Ito Y, 2008, PLANT J, V55, P212, DOI 10.1111/j.1365-313X.2008.03491.x; KERPPOLA TK, 1993, MOL CELL BIOL, V13, P5479, DOI 10.1128/MCB.13.9.5479; Kramer EM, 2004, GENETICS, V166, P1011, DOI 10.1534/genetics.166.2.1011; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Liljegren SJ, 2000, NATURE, V404, P766, DOI 10.1038/35008089; Liu JH, 2009, PLANT CELL REP, V28, P103, DOI 10.1007/s00299-008-0613-y; Lockhart SR, 1998, J BACTERIOL, V180, P6607, DOI 10.1128/JB.180.24.6607-6616.1998; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Martel C, 2011, PLANT PHYSIOL, V157, P1568, DOI 10.1104/pp.111.181107; Messenguy F, 2003, GENE, V316, P1, DOI 10.1016/S0378-1119(03)00747-9; Paciorek T, 2006, J CELL SCI, V119, P1199, DOI 10.1242/jcs.02910; Pan IL, 2010, J EXP BOT, V61, P1795, DOI 10.1093/jxb/erq046; PELLEGRINI L, 1995, NATURE, V376, P490, DOI 10.1038/376490a0; Peumans WJ, 2000, PLANTA, V211, P546, DOI 10.1007/s004250000307; Pinyopich A, 2003, NATURE, V424, P85, DOI 10.1038/nature01741; PNUELI L, 1994, PLANT CELL, V6, P163, DOI 10.1105/tpc.6.2.163; Riechmann JL, 1996, P NATL ACAD SCI USA, V93, P4793, DOI 10.1073/pnas.93.10.4793; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santelli E, 2000, J MOL BIOL, V297, P437, DOI 10.1006/jmbi.2000.3568; Seymour GB, 2011, J EXP BOT, V62, P1179, DOI 10.1093/jxb/erq360; SHARROCKS AD, 1995, NUCLEIC ACIDS RES, V23, P2442, DOI 10.1093/nar/23.13.2442; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SHIRAISHI H, 1993, PLANT J, V4, P385, DOI 10.1046/j.1365-313X.1993.04020385.x; Tadiello A, 2009, J EXP BOT, V60, P651, DOI 10.1093/jxb/ern313; Tang WN, 2003, J BIOL CHEM, V278, P28154, DOI 10.1074/jbc.M212976200; Theissen G, 2000, PLANT MOL BIOL, V42, P115, DOI 10.1023/A:1006332105728; Theissen G, 2001, NATURE, V409, P469, DOI 10.1038/35054172; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trivedi PK, 2004, PLANT SCI, V167, P1351, DOI 10.1016/j.plantsci.2004.07.005; Victoria BM, 2003, PLANT MOL BIOL, V52, P801, DOI 10.1023/A:1025001402838; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; Wang Xin-Li, 2001, Chinese Journal of Biotechnology, V17, P428; Wang Xin-Li, 2001, Chinese Journal of Biotechnology, V17, P293; West AG, 1998, NUCLEIC ACIDS RES, V26, P5277, DOI 10.1093/nar/26.23.5277; West AG, 1997, MOL CELL BIOL, V17, P2876, DOI 10.1128/MCB.17.5.2876; Xu Bi-Yu, 2006, Sheng Wu Gong Cheng Xue Bao, V22, P945; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0; Yao JL, 1999, J AM SOC HORTIC SCI, V124, P8, DOI 10.21273/JASHS.124.1.8	69	30	32	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44361	10.1371/journal.pone.0044361	http://dx.doi.org/10.1371/journal.pone.0044361			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984496	gold, Green Published			2022-12-27	WOS:000308638700055
J	Gould, RA; Sinha, R; Aziz, H; Rouf, R; Dietz, HC; Judge, DP; Butcher, J				Gould, Russell A.; Sinha, Ravi; Aziz, Hamza; Rouf, Rosanne; Dietz, Harry C., III; Judge, Daniel P.; Butcher, Jonathan			Multi-Scale Biomechanical Remodeling in Aging and Genetic Mutant Murine Mitral Valve Leaflets: Insights into Marfan Syndrome	PLOS ONE			English	Article							INTERSTITIAL-CELLS; ANTERIOR LEAFLET; AORTIC-ANEURYSM; MOUSE MODEL; TISSUE; FIBRILLIN-1; PRESSURE; PARALLEL; PROLAPSE; MICROFIBRILS	Mitral valve degeneration is a key component of the pathophysiology of Marfan syndrome. The biomechanical consequences of aging and genetic mutation in mitral valves are poorly understood because of limited tools to study this in mouse models. Our aim was to determine the global biomechanical and local cell-matrix deformation relationships in the aging and Marfan related Fbn1 mutated murine mitral valve. To conduct this investigation, a novel stretching apparatus and gripping method was implemented to directly quantify both global tissue biomechanics and local cellular deformation and matrix fiber realignment in murine mitral valves. Excised mitral valve leaflets from wild-type and Fbn1 mutant mice from 2 weeks to 10 months in age were tested in circumferential orientation under continuous laser optical imaging. Mouse mitral valves stiffen with age, correlating with increases in collagen fraction and matrix fiber alignment. Fbn1 mutation resulted in significantly more compliant valves (modulus 1.34 +/- 0.12 vs. 2.51 +/- 0.31 MPa, respectively, P<.01) at 4 months, corresponding with an increase in proportion of GAGs and decrease in elastin fraction. Local cellular deformation and fiber alignment change linearly with global tissue stretch, and these slopes become more extreme with aging. In comparison, Fbn1 mutated valves have decoupled cellular deformation and fiber alignment with tissue stretch. Taken together, quantitative understanding of multi-scale murine planar tissue biomechanics is essential for establishing consequences of aging and genetic mutations. Decoupling of local cell-matrix deformation kinematics with global tissue stretch may be an important mechanism of normal and pathological biomechanical remodeling in valves.	[Gould, Russell A.; Sinha, Ravi; Butcher, Jonathan] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA; [Aziz, Hamza; Rouf, Rosanne; Dietz, Harry C., III; Judge, Daniel P.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Dietz, Harry C., III] Howard Hughes Med Inst, Bethesda, MD 20817 USA	Cornell University; Johns Hopkins University; Howard Hughes Medical Institute	Gould, RA (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA.	jtb47@cornell.edu	Butcher, Jonathan/AAE-8239-2020; Butcher, Jonathan T/D-2280-2012	Butcher, Jonathan/0000-0002-9309-6296; Butcher, Jonathan T/0000-0002-9309-6296; Sinha, Ravi/0000-0003-4185-5198; Judge, Daniel/0000-0002-3407-0248	National Science Foundation; National Institutes of Health [HL110328]; American Heart Association; Leducq Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041135] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Leducq Foundation(Leducq Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by grants from the National Science Foundation (CAREER award, JTB), National Institutes of Health (HL110328, JTB), American Heart Association (JTB), and the Leducq Foundation (JTB, RR and DJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberts JJJ, 2010, NETH HEART J, V18, P85, DOI 10.1007/BF03091743; Barber JE, 2001, J THORAC CARDIOV SUR, V122, P955, DOI 10.1067/mtc.2001.117621; BARLOW JB, 1966, AM HEART J, V71, P166, DOI 10.1016/0002-8703(66)90179-7; Bax DV, 2003, J BIOL CHEM, V278, P34605, DOI 10.1074/jbc.M303159200; Bhudia SK, 2006, ANN THORAC SURG, V81, P843, DOI 10.1016/j.athoracsur.2005.08.055; Bowles RD, 2010, TISSUE ENG PT A, V16, P1339, DOI [10.1089/ten.tea.2009.0442, 10.1089/ten.TEA.2009.0442]; Butcher JT, 2007, CIRC RES, V100, P1503, DOI 10.1161/CIRCRESAHA.107.148684; Cao L, 2006, J BIOMECH ENG-T ASME, V128, P766, DOI 10.1115/1.2246237; Dal-Bianco JP, 2009, CIRCULATION, V120, P334, DOI 10.1161/CIRCULATIONAHA.108.846782; Dietz HC, 2005, AM J MED GENET C, V139C, P4, DOI 10.1002/ajmg.c.30068; Durbin AD, 2002, CARDIOVASC PATHOL, V11, P69, DOI 10.1016/S1054-8807(01)00109-0; Freed LA, 1999, NEW ENGL J MED, V341, P1, DOI 10.1056/NEJM199907013410101; FUNG YCB, 1967, AM J PHYSIOL, V213, P1532, DOI 10.1152/ajplegacy.1967.213.6.1532; Gleason RL, 2004, J BIOMECH ENG-T ASME, V126, P787, DOI 10.1115/1.1824130; Grande-Allen KJ, 2003, J AM COLL CARDIOL, V42, P271, DOI 10.1016/S0735-1097(03)00626-0; Grashow JS, 2006, ANN BIOMED ENG, V34, P315, DOI [10.1007/s10439-005-9027-y, 10.1007/s10439-005-9027-v]; Habashi JP, 2011, SCIENCE, V332, P361, DOI 10.1126/science.1192152; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Helmke BP, 2000, CIRC RES, V86, P745, DOI 10.1161/01.RES.86.7.745; Hinton RB, 2008, AM J PHYSIOL-HEART C, V294, pH2480, DOI 10.1152/ajpheart.91431.2007; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Ikhumetse JD, 2006, J HEART VALVE DIS, V15, P295; Judge DP, 2008, ANNU REV MED, V59, P43, DOI 10.1146/annurev.med.59.103106.103801; Judge DP, 2011, J CARDIOVASC TRANSL, V4, P741, DOI 10.1007/s12265-011-9314-y; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; Krishnamurthy VK, 2011, J BIOMECH, V44, P77, DOI 10.1016/j.jbiomech.2010.08.026; Ku CH, 2006, CARDIOVASC RES, V71, P548, DOI 10.1016/j.cardiores.2006.03.022; KUNZELMAN KS, 1992, J CARDIAC SURG, V7, P71, DOI 10.1111/j.1540-8191.1992.tb00777.x; Lee SSJ, 2004, STRUCTURE, V12, P717, DOI 10.1016/j.str.2004.02.023; Loeys BL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000488; Mendelson K, 2006, ANN BIOMED ENG, V34, P1799, DOI 10.1007/s10439-006-9163-z; Montgomery RA, 1998, AM J HUM GENET, V63, P1703, DOI 10.1086/302144; Mulholland DL, 1997, CARDIOVASC PATHOL, V6, P167; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Pyeritz RE, 2000, ANNU REV MED, V51, P481, DOI 10.1146/annurev.med.51.1.481; Rabkin E, 2001, CIRCULATION, V104, P2525, DOI 10.1161/hc4601.099489; Sacks MS, 2006, ANN THORAC SURG, V82, P1369, DOI 10.1016/j.athoracsur.2006.03.117; SAHASAKUL Y, 1988, AM J CARDIOL, V62, P424, DOI 10.1016/0002-9149(88)90971-X; Sakamoto H, 1996, J BIOL CHEM, V271, P4916; Sasoglu FM, 2007, J MICROMECH MICROENG, V17, P623, DOI 10.1088/0960-1317/17/3/027; Shawn L, 2010, RADIOFREQUENCY ABLAT, V1, P194; Sherratt MJ, 2003, J MOL BIOL, V332, P183, DOI 10.1016/S0022-2836(03)00829-5; TAMURA K, 1995, AM HEART J, V129, P1149, DOI 10.1016/0002-8703(95)90397-6; Tiemann K, 2003, AM J PHYSIOL-HEART C, V284, pH464, DOI 10.1152/ajpheart.00540.2002; Weyman AE, 2004, J CLIN INVEST, V114, P1543, DOI 10.1172/JCI200423701; Yang B, 1999, AM J PHYSIOL-HEART C, V277, pH1906, DOI 10.1152/ajpheart.1999.277.5.H1906; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041	47	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44639	10.1371/journal.pone.0044639	http://dx.doi.org/10.1371/journal.pone.0044639			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984535	gold, Green Submitted, Green Published			2022-12-27	WOS:000308638700073
J	Laszkiewicz, A; Sniezewski, L; Kasztura, M; Bzdzion, L; Cebrat, M; Kisielow, P				Laszkiewicz, Agnieszka; Sniezewski, Lukasz; Kasztura, Monika; Bzdzion, Lukasz; Cebrat, Malgorzata; Kisielow, Pawel			Bidirectional Activity of the NWC Promoter Is Responsible for RAG-2 Transcription in Non-Lymphoid Cells	PLOS ONE			English	Article							RECOMBINATION ACTIVATING GENE; CONSERVED GENE; EXPRESSION; LOCUS; DNA; ELEMENTS; MICE; IDENTIFICATION	The recombination-activating genes (RAG-1 and RAG-2) encode a V(D)J recombinase responsible for rearrangements of antigen-receptor genes during T and B cell development, and RAG expression is known to correlate strictly with the process of rearrangement. In contrast to RAG-1, the expression of RAG-2 was not previously detected during any other stage of lymphopoiesis or in any other normal tissue. Here we report that the CpG island-associated promoter of the NWC gene (the third evolutionarily conserved gene in the RAG locus), which is located in the second intron of RAG-2, has bidirectional activity and is responsible for the detectable transcription of RAG-2 in some non-lymphoid tissues. We also identify evolutionarily conserved promoter fragments responsible for this bidirectional activity, and show that it is activated by transcription factor ZFP143. The possible implications of our findings are briefly discussed.	[Laszkiewicz, Agnieszka; Sniezewski, Lukasz; Kasztura, Monika; Bzdzion, Lukasz; Cebrat, Malgorzata; Kisielow, Pawel] Polish Acad Sci, Inst Immunol & Expt Therapy, Dept Tumor Immunol, Lab Mol & Cellular Immunol, PL-53114 Wroclaw, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences	Laszkiewicz, A (corresponding author), Polish Acad Sci, Inst Immunol & Expt Therapy, Dept Tumor Immunol, Lab Mol & Cellular Immunol, PL-53114 Wroclaw, Poland.	cebrat@iitd.pan.wroc.pl		Kasztura, Monika/0000-0001-7304-3798; Laszkiewicz, Agnieszka/0000-0002-0317-4255; Cebrat, Malgorzata/0000-0003-4544-3289	Polish Ministry of Science and Higher Education [N N401 049138]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by the Polish Ministry of Science and Higher Education (grant N N401 049138). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anno YN, 2011, NUCLEIC ACIDS RES, V39, P3116, DOI 10.1093/nar/gkq1301; Barreto V, 2001, EUR J IMMUNOL, V31, P3763, DOI 10.1002/1521-4141(200112)31:12<3763::AID-IMMU3763>3.0.CO;2-Y; Cebrat M, 2005, EUR J IMMUNOL, V35, P2230, DOI 10.1002/eji.200526225; Cebrat M, 2008, MOL IMMUNOL, V45, P2297, DOI 10.1016/j.molimm.2007.11.009; Chen ZS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020475; CHUN JJM, 1991, CELL, V64, P189, DOI 10.1016/0092-8674(91)90220-S; Fugmann SD, 2006, P NATL ACAD SCI USA, V103, P3728, DOI 10.1073/pnas.0509720103; Fugmann SD, 2010, SEMIN IMMUNOL, V22, P10, DOI 10.1016/j.smim.2009.11.004; Hsu LY, 2003, IMMUNITY, V19, P105, DOI 10.1016/S1074-7613(03)00181-X; Kalitsis P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-498; Kasztura M, 2009, ACTA BIOCHIM POL, V56, P177; Kisielow P, 2008, INT J IMMUNOGENET, V35, P395, DOI 10.1111/j.1744-313X.2008.00791.x; Kuwata N, 1999, J IMMUNOL, V163, P6355; Laszkiewicz A, 2011, IMMUNOGENETICS, V63, P183, DOI 10.1007/s00251-011-0511-2; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Monroe RJ, 1999, IMMUNITY, V11, P201, DOI 10.1016/S1074-7613(00)80095-3; Myslinski E, 1998, J BIOL CHEM, V273, P21998, DOI 10.1074/jbc.273.34.21998; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Rose AB, 2008, CURR TOP MICROBIOL, V326, P277; Schatz DG, 2004, SEMIN IMMUNOL, V16, P245, DOI 10.1016/j.smim.2004.08.004; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; Schaub M, 2000, NUCLEIC ACIDS RES, V28, P2114, DOI 10.1093/nar/28.10.2114; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Valencia P, 2008, P NATL ACAD SCI USA, V105, P3386, DOI 10.1073/pnas.0800250105; Wei XC, 2002, J IMMUNOL, V169, P873, DOI 10.4049/jimmunol.169.2.873; WILSON A, 1994, J EXP MED, V179, P1355, DOI 10.1084/jem.179.4.1355; Yang MQ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S3; Yannoutsos N, 2004, NAT IMMUNOL, V5, P443, DOI 10.1038/ni1053; Yu W, 1999, SCIENCE, V285, P1080, DOI 10.1126/science.285.5430.1080	31	12	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44807	10.1371/journal.pone.0044807	http://dx.doi.org/10.1371/journal.pone.0044807			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984564	Green Published, Green Submitted, gold			2022-12-27	WOS:000308638700085
J	Li, X; Chen, L; Hong, MY; Zhang, Y; Zu, F; Wen, J; Yi, B; Ma, CZ; Shen, JX; Tu, JX; Fu, TD				Li, Xia; Chen, Li; Hong, Meiyan; Zhang, Yan; Zu, Feng; Wen, Jing; Yi, Bin; Ma, Chaozhi; Shen, Jinxiong; Tu, Jinxing; Fu, Tingdong			A Large Insertion in bHLH Transcription Factor BrTT8 Resulting in Yellow Seed Coat in Brassica rapa	PLOS ONE			English	Article							PROANTHOCYANIDIN SYNTHESIS; ANTHOCYANIN PATHWAY; DOMAIN PROTEIN; GENE ENCODES; COLOR GENE; NAPUS L.; ARABIDOPSIS; IDENTIFICATION; INHERITANCE; EXPRESSION	Yellow seed is a desirable quality trait of the Brassica oilseed species. Previously, several seed coat color genes have been mapped in the Brassica species, but the molecular mechanism is still unknown. In the present investigation, map-based cloning method was used to identify a seed coat color gene, located on A9 in B. rapa. Blast analysis with the Arabidopsis genome showed that there were 22 Arabidopsis genes in this region including at4g09820 to at4g10620. Functional complementation test exhibited a phenotype reversion in the Arabidopsis thaliana tt8-1 mutant and yellow-seeded plant. These results suggested that the candidate gene was a homolog of TRANSPARENT TESTA8 (TT8) locus. BrTT8 regulated the accumulation of proanthocyanidins (PAs) in the seed coat. Sequence analysis of two alleles revealed a large insertion of a new class of transposable elements, Helitron in yellow sarson. In addition, no mRNA expression of BrTT8 was detected in the yellow-seeded line. It indicated that the natural transposon might have caused the loss in function of BrTT8. BrTT8 encodes a basic/helix-loop-helix (bHLH) protein that shares a high degree of similarity with other bHLH proteins in the Brassica. Further expression analysis also revealed that BrTT8 was involved in controlling the late biosynthetic genes (LBGs) of the flavonoid pathway. Our present findings provided with further studies could assist in understanding the molecular mechanism involved in seed coat color formation in Brassica species, which is an important oil yielding quality trait.	[Li, Xia; Hong, Meiyan; Wen, Jing; Yi, Bin; Ma, Chaozhi; Shen, Jinxiong; Tu, Jinxing; Fu, Tingdong] Huazhong Agr Univ, Natl Ctr Rapeseed Improvement Wuhan, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Chen, Li] Guizhou Acad Agr Sci, Guizhou Rapeseed Inst, Guiyang, Peoples R China; [Zhang, Yan] Guangdong Acad Agr Sci, Vegetable Res Inst, Guangzhou, Guangdong, Peoples R China; [Zu, Feng] Yunnan Acad Agr Sci, Ind Crop Res Inst, Kunming, Peoples R China	Huazhong Agricultural University; Guizhou Academy of Agricultural Sciences; Guangdong Academy of Agricultural Sciences; Yunnan Academy of Agricultural Sciences	Li, X (corresponding author), Huazhong Agr Univ, Natl Ctr Rapeseed Improvement Wuhan, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	tujx@mail.hzau.edu.cn	Shen, Jinxiong/AAT-3318-2021; Shen, Jinxiong/Z-3988-2019; wen, jing/HDM-2205-2022		National Key Basic Research Special Foundation of China "973" Project [2011CB109302]; National Natural Science Foundation of China [30971803]	National Key Basic Research Special Foundation of China "973" Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the National Key Basic Research Special Foundation of China "973" Project (No. 2011CB109302) and the National Natural Science Foundation of China "30971803." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASTRUP S, 1984, CARLSBERG RES COMMUN, V49, P105, DOI 10.1007/BF02913969; Abrahams S, 2003, PLANT J, V35, P624, DOI 10.1046/j.1365-313X.2003.01834.x; Auger B, 2009, PLANTA, V230, P1167, DOI 10.1007/s00425-009-1017-0; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Baudry A, 2006, PLANT J, V46, P768, DOI 10.1111/j.1365-313X.2006.02733.x; Bennetzen JL, 2005, CURR OPIN GENET DEV, V15, P621, DOI 10.1016/j.gde.2005.09.010; Broun P, 2005, CURR OPIN PLANT BIOL, V8, P272, DOI 10.1016/j.pbi.2005.03.006; Carey CC, 2004, PLANT CELL, V16, P450, DOI 10.1105/tpc.018796; CHANDLER VL, 1989, PLANT CELL, V1, P1175, DOI 10.1105/tpc.1.12.1175; CHEN BY, 1988, PLANT BREEDING, V101, P52, DOI 10.1111/j.1439-0523.1988.tb00266.x; Chen BY, 1997, HEREDITAS, V126, P133, DOI 10.1111/j.1601-5223.1997.00133.x; Choi JD, 2007, PLANT J, V49, P924, DOI 10.1111/j.1365-313X.2006.03007.x; Ding Y, 2006, THESIS HUAZHONG AGR, P21; Dun XL, 2011, PLANT J, V68, P532, DOI 10.1111/j.1365-313X.2011.04708.x; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; Furukawa T, 2007, PLANT J, V49, P91, DOI 10.1111/j.1365-313X.2006.02958.x; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; Kitamura S, 2004, PLANT J, V37, P104, DOI 10.1046/j.1365-313X.2003.01943.x; Kurauchi T, 2011, J PLANT PHYSIOL, V168, P1264, DOI 10.1016/j.jplph.2011.01.003; Lal SK, 2003, PLANT CELL, V15, P381, DOI 10.1105/tpc.008375; Lei SL, 2007, THEOR APPL GENET, V115, P643, DOI 10.1007/s00122-007-0594-1; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Liu Ren-Hu, 2003, Yichuan, V25, P317; Liu ZW, 2005, THEOR APPL GENET, V110, P303, DOI 10.1007/s00122-004-1835-1; Meng JL, 1998, EUPHYTICA, V103, P329, DOI 10.1023/A:1018646223643; Morgante M, 2005, NAT GENET, V37, P997, DOI 10.1038/ng1615; Nesi N, 2000, PLANT CELL, V12, P1863, DOI 10.1105/tpc.12.10.1863; Nesi N, 2002, PLANT CELL, V14, P2463, DOI 10.1105/tpc.004127; Nesi N, 2009, PLANT CELL REP, V28, P601, DOI 10.1007/s00299-008-0667-x; Ohno S, 2011, J EXP BOT, V62, P5105, DOI 10.1093/jxb/err216; Pelletier MK, 1997, PLANT PHYSIOL, V113, P1437, DOI 10.1104/pp.113.4.1437; Pires N, 2010, MOL BIOL EVOL, V27, P862, DOI 10.1093/molbev/msp288; Pourcel L, 2005, PLANT CELL, V17, P2966, DOI 10.1105/tpc.105.035154; Rahman MH, 2001, PLANT BREEDING, V120, P463, DOI 10.1046/j.1439-0523.2001.00640.x; Rahman MH, 2001, PLANT BREEDING, V120, P197, DOI 10.1046/j.1439-0523.2001.00607.x; Rahman M, 2007, THEOR APPL GENET, V115, P1101, DOI 10.1007/s00122-007-0636-8; SCHWETKA A, 1982, THEOR APPL GENET, V62, P161, DOI 10.1007/BF00293352; SHIRZADEGAN M, 1985, FETT WISS TECHNOL, V87, P235, DOI 10.1002/lipi.19850870605; Sweeney MT, 2006, PLANT CELL, V18, P283, DOI 10.1105/tpc.105.038430; Tang ZL, 1997, PLANT BREEDING, V116, P471, DOI 10.1111/j.1439-0523.1997.tb01033.x; Wei YL, 2007, MOL BIOL REP, V34, P105, DOI 10.1007/s11033-006-9024-8; Yang LX, 2009, P NATL ACAD SCI USA, V106, P19922, DOI 10.1073/pnas.0908008106; Yang LX, 2009, P NATL ACAD SCI USA, V106, P12832, DOI 10.1073/pnas.0905563106; Yi B, 2010, PLANT J, V63, P925, DOI 10.1111/j.1365-313X.2010.04289.x; Zaman M. W., 1989, Sveriges Utsadesforenings Tidskrift, V99, P205; Zhang F, 2003, DEVELOPMENT, V130, P4859, DOI 10.1242/dev.00681; Zhang JF, 2009, PLANT MOL BIOL, V69, P553, DOI 10.1007/s11103-008-9437-y	48	65	76	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44145	10.1371/journal.pone.0044145	http://dx.doi.org/10.1371/journal.pone.0044145			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984469	Green Published, Green Submitted, gold			2022-12-27	WOS:000308638700046
J	Roy, S; Watkins, N; Heck, D				Roy, Snigdha; Watkins, Nick; Heck, Detlef			Comprehensive Analysis of Ultrasonic Vocalizations in a Mouse Model of Fragile X Syndrome Reveals Limited, Call Type Specific Deficits	PLOS ONE			English	Article							UNUSUAL REPERTOIRE; MATERNAL-BEHAVIOR; YOUNG MALES; RAT PUPS; AUTISM; MICE; LANGUAGE; TF/J; COMMUNICATION; DISORDERS	Fragile X syndrome (FXS) is a well-recognized form of inherited mental retardation, caused by a mutation in the fragile X mental retardation 1 (Fmr1) gene. The gene is located on the long arm of the X chromosome and encodes fragile X mental retardation protein (FMRP). Absence of FMRP in fragile X patients as well as in Fmr1 knockout (KO) mice results, among other changes, in abnormal dendritic spine formation and altered synaptic plasticity in the neocortex and hippocampus. Clinical features of FXS include cognitive impairment, anxiety, abnormal social interaction, mental retardation, motor coordination and speech articulation deficits. Mouse pups generate ultrasonic vocalizations (USVs) when isolated from their mothers. Whether those social ultrasonic vocalizations are deficient in mouse models of FXS is unknown. Here we compared isolation-induced USVs generated by pups of Fmr1-KO mice with those of their wild type (WT) littermates. Though the total number of calls was not significantly different between genotypes, a detailed analysis of 10 different categories of calls revealed that loss of Fmr1 expression in mice causes limited and call-type specific deficits in ultrasonic vocalization: the carrier frequency of flat calls was higher, the percentage of downward calls was lower and that the frequency range of complex calls was wider in Fmr1-KO mice compared to their WT littermates.	[Roy, Snigdha; Heck, Detlef] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Watkins, Nick] Christian Bros Univ, Dept Biol, Memphis, TN USA	University of Tennessee System; University of Tennessee Health Science Center	Roy, S (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA.	sroy3@uthsc.edu	Heck, Detlef/GPS-4854-2022	Heck, Detlef/0000-0003-2438-4064	National Institutes of Health [R01NS063009, R01NS060887]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063009, R01NS060887] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health to D. H. H. (R01NS063009 and R01NS060887). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbeduto L, 2007, MENT RETARD DEV D R, V13, P36, DOI 10.1002/mrdd.20142; Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Barnes EF, 2006, J SPEECH LANG HEAR R, V49, P903, DOI 10.1044/1092-4388(2006/065); BROUETTELAHLOU I, 1992, BEHAV BRAIN RES, V50, P147, DOI 10.1016/S0166-4328(05)80296-7; Brudzynski SM, 1999, DEV PSYCHOBIOL, V34, P195, DOI 10.1002/(SICI)1098-2302(199904)34:3<195::AID-DEV4>3.0.CO;2-S; BRUNELLI SA, 1994, J COMP PSYCHOL, V108, P298, DOI 10.1037/0735-7036.108.3.298; Bryant JL, 2010, EUR J NEUROSCI, V32, P41, DOI 10.1111/j.1460-9568.2010.07244.x; Crawford DC, 2001, GENET MED, V3, P359, DOI 10.1097/00125817-200109000-00006; EHRET G, 1986, ANIM BEHAV, V34, P821, DOI 10.1016/S0003-3472(86)80067-7; EHRET G, 1992, ANIM BEHAV, V43, P409, DOI 10.1016/S0003-3472(05)80101-0; Ellegood J, 2010, NEUROIMAGE, V53, P1023, DOI 10.1016/j.neuroimage.2010.03.038; Farrell WJ, 2002, J COMP PSYCHOL, V116, P297, DOI 10.1037//0735-7036.116.3.297; Fujita E, 2008, P NATL ACAD SCI USA, V105, P3117, DOI 10.1073/pnas.0712298105; Gordon N, 1996, EUR J DISORDER COMM, V31, P359; Hagerman R, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-12; Hahn ME, 2005, BEHAV GENET, V35, P31, DOI 10.1007/s10519-004-0854-7; Harris SW, 2008, AM J MENT RETARD, V113, P427, DOI 10.1352/2008.113:427-438; Heck DH, 2008, HUM MOL GENET, V17, P2181, DOI 10.1093/hmg/ddn117; LOESCH DZ, 1988, J MED GENET, V25, P407, DOI 10.1136/jmg.25.6.407; MADISON LS, 1986, J MENT DEFIC RES, V30, P129; Mostofsky SH, 1998, NEUROLOGY, V50, P121, DOI 10.1212/WNL.50.1.121; NEWELL K, 1983, FRAGILE X SYNDROME D, P175; PAUL R, 1987, J AUTISM DEV DISORD, V17, P457, DOI 10.1007/BF01486963; Persico AM, 2006, TRENDS NEUROSCI, V29, P349, DOI 10.1016/j.tins.2006.05.010; REISS AL, 1991, ANN NEUROL, V29, P26, DOI 10.1002/ana.410290107; Rogers SJ, 2001, J DEV BEHAV PEDIATR, V22, P409, DOI 10.1097/00004703-200112000-00008; Roy S, 2011, BEHAV NEUROSCI, V125, P962, DOI 10.1037/a0025920; Scattoni ML, 2011, GENES BRAIN BEHAV, V10, P44, DOI 10.1111/j.1601-183X.2010.00623.x; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Shair HN, 2007, BEHAV BRAIN RES, V182, P180, DOI 10.1016/j.bbr.2007.02.016; SHAMBES GM, 1978, BRAIN BEHAV EVOLUT, V15, P94, DOI 10.1159/000123774; SMITH JC, 1976, J COMP PHYSIOL PSYCH, V90, P1105, DOI 10.1037/h0077287; WELSH JP, 1995, NATURE, V374, P453, DOI 10.1038/374453a0; Wohr M, 2011, GENES BRAIN BEHAV, V10, P35, DOI 10.1111/j.1601-183X.2010.00582.x; Wohr M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020631; Yang M, 2007, FRONT BEHAV NEUROSCI, V1, DOI [10.3389/neuro.08/001.2007, 10.3389/neuro.08.001.2007]; Young DM, 2010, P NATL ACAD SCI USA, V107, P11074, DOI 10.1073/pnas.1005620107; Zajac DJ, 2006, J SPEECH LANG HEAR R, V49, P1147, DOI 10.1044/1092-4388(2006/082); ZESKIND PS, 1988, CHILD DEV, V59, P193; Zingerevich C, 2009, J INTELL DISABIL RES, V53, P11, DOI 10.1111/j.1365-2788.2008.01107.x	41	54	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44816	10.1371/journal.pone.0044816	http://dx.doi.org/10.1371/journal.pone.0044816			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984567	Green Published, Green Submitted, gold			2022-12-27	WOS:000308638700087
J	Scherer, RW; Sieving, PC; Ervin, AM; Dickersin, K				Scherer, Roberta W.; Sieving, Pamela C.; Ervin, Ann-Margret; Dickersin, Kay			Can We Depend on Investigators to Identify and Register Randomized Controlled Trials?	PLOS ONE			English	Article							REGISTRATION; PUBLICATION; STATEMENT	Purpose: To reduce publication bias, systematic reviewers are advised to search conference abstracts to identify randomized controlled trials (RCTs) conducted in humans and not published in full. We assessed the information provided by authors to aid identification of RCTs for reviews. Methods: We handsearched the Association for Research in Vision and Ophthalmology (ARVO) meeting abstracts for 2004 to 2009 to identify reports of RCTs. We compared our classification with that of authors (requested by ARVO 2004-2006), and authors' report of trial registration (required by ARVO 2007-2009). Results: Authors identified their study as a clinical trial for 169/191 (88%; 95% CI, 84-93) RCTs we identified for 2004, 174/212 (82%; 95% CI, 77-87) for 2005 and 162/215 (75%; 95% CI, 70-81) for 2006. Authors provided registration information for 107/172 (62%; 95% CI, 55-69) RCTs for 2007, 103/153 (67%; 95% CI, 60-75) for 2008, and 126/171 (74%; 95% CI, 67-80) for 2009. Most RCT authors providing a trial register name specified ClinicalTrials.gov (276/312; 88%; 95% CI, 85-92) and provided a valid ClinicalTrials.gov registration number (261/276; 95%; 95% CI, 92-97). Based on information provided by authors, trial registration information would be accessible for 48% (83/172) (95% CI, 41-56) of all ARVO abstracts describing RCTs in 2007, 63% (96/153) (95% CI, 55-70) in 2008, and 70% in 2009 (118/171) (95% CI, 62-76). Conclusions: Authors of abstracts describing RCTs frequently did not classify them as clinical trials nor comply with reporting trial registration information, as required by the conference organizers. Systematic reviewers cannot rely on authors to identify relevant unpublished trials or report trial registration, if present.	[Scherer, Roberta W.; Ervin, Ann-Margret; Dickersin, Kay] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Sieving, Pamela C.] Natl Inst Hlth Lib, NIH, Bethesda, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA	Scherer, RW (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.	rscherer@jhsph.edu		Sieving, Pamela/0000-0003-3794-5000	National Eye Institute, National Institutes of Health [U01EY020522-02]; NATIONAL EYE INSTITUTE [U01EY020522] Funding Source: NIH RePORTER	National Eye Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding for this project was provided by the National Eye Institute, National Institutes of Health (U01EY020522-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi K, 2004, BRIT MED J, V329, P637, DOI 10.1136/bmj.329.7467.637; Ad Hoc Working Party of the International Collaborative Group on Clinical Trial Registries, 1993, CLIN TRIALS METAANAL, V28, P255; [Anonymous], TRAIN MAN HANDS; Association for Research in Vision and Ophthalmology Statement on Registering Clinical Trials, ASS RES VIS OPHTH ST; CHALMERS TC, 1977, NEW ENGL J MED, V296, P107; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Dickersin K, 2003, JAMA-J AM MED ASSOC, V290, P516, DOI 10.1001/jama.290.4.516; Gulmezoglu AM, 2005, LANCET, V365, P1829, DOI 10.1016/S0140-6736(05)66589-0; [Institute of Medicine of the National Academies Committee on Reviewing Evidence to Identify Highly Effective Clinical Services Board on Health Care Services], 2008, KNOW WHAT WORKS HLTH; Krleza-Jeric K, 2005, BMJ-BRIT MED J, V330, P956, DOI 10.1136/bmj.330.7497.956; Liu Xuemei, 2009, J Evid Based Med, V2, P8, DOI 10.1111/j.1756-5391.2009.01007.x; McGee RG, 2011, TRANSPLANTATION, V92, P1094, DOI 10.1097/TP.0b013e318232baf2; Moja Lorenzo P, 2009, Trials, V10, P56, DOI 10.1186/1745-6215-10-56; Reveiz L, 2010, J CLIN EPIDEMIOL, V63, P1216, DOI 10.1016/j.jclinepi.2010.01.013; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Scherer R.W., 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.MR000005.PUB2; SCHERER RW, 1994, JAMA-J AM MED ASSOC, V272, P158, DOI 10.1001/jama.272.2.158; Sieving P, 2004, 12 COCHR C OTT 2 6 O; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; Viergever RF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014701; Wu TX, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-46	21	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44183	10.1371/journal.pone.0044183	http://dx.doi.org/10.1371/journal.pone.0044183			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984474	gold, Green Submitted, Green Published			2022-12-27	WOS:000308638700048
J	Dong, WY; Zhang, XY; Wang, HM; Dai, XQ; Sun, XM; Qiu, WW; Yang, FT				Dong, Wenyi; Zhang, Xinyu; Wang, Huimin; Dai, Xiaoqin; Sun, Xiaomin; Qiu, Weiwen; Yang, Fengting			Effect of Different Fertilizer Application on the Soil Fertility of Paddy Soils in Red Soil Region of Southern China	PLOS ONE			English	Article							LONG-TERM FERTILIZATION; ORGANIC-MATTER; PHOSPHORUS FRACTIONS; YIELD DECLINES; CROP YIELD; RICE; CARBON; WHEAT; MANURE; DYNAMICS	Appropriate fertilizer application is an important management practice to improve soil fertility and quality in the red soil regions of China. In the present study, we examined the effects of five fertilization treatments [these were: no fertilizer (CK), rice straw return (SR), chemical fertilizer (NPK), organic manure (OM) and green manure (GM)] on soil pH, soil organic carbon (SOC), total nitrogen (TN), C/N ratio and available nutrients (AN, AP and AK) contents in the plowed layer (0-20 cm) of paddy soil from 1998 to 2009 in Jiangxi Province, southern China. Results showed that the soil pH was the lowest with an average of 5.33 units in CK and was significantly higher in NPK (5.89 units) and OM (5.63 units) treatments (P<0.05). The application of fertilizers have remarkably improved SOC and TN values compared with the CK, Specifically, the OM treatment resulted in the highest SOC and TN concentrations (72.5% and 51.2% higher than CK) and NPK treatment increased the SOC and TN contents by 22.0% and 17.8% compared with CK. The average amounts of C/N ratio ranged from 9.66 to 10.98 in different treatments, and reached the highest in OM treatment (P<0.05). During the experimental period, the average AN and AP contents were highest in OM treatment (about 1.6 and 29.6 times of that in the CK, respectively) and second highest in NPK treatment (about 1.2 and 20.3 times of that in the CK). Unlike AN and AP, the highest value of AK content was observed in NPK treatments with 38.10 mg.kg(-1). Thus, these indicated that organic manure should be recommended to improve soil fertility in this region and K fertilizer should be simultaneously applied considering the soil K contents. Considering the long-term fertilizer efficiency, our results also suggest that annual straw returning application could improve soil fertility in this trial region.	[Dong, Wenyi; Zhang, Xinyu; Wang, Huimin; Dai, Xiaoqin; Sun, Xiaomin; Yang, Fengting] Chinese Acad Sci, Key Lab Ecosyst Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Qiu, Weiwen] New Zealand Inst Plant & Food Res Ltd, Christchurch, New Zealand	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; New Zealand Institute for Plant & Food Research Ltd	Zhang, XY (corresponding author), Chinese Acad Sci, Key Lab Ecosyst Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.	zhangxy@igsnrr.ac.cn	wang, huimin/HDM-8421-2022; Zhang, Kevin/F-5215-2010	qiu, weiwen/0000-0003-4924-7365	Chinese Academy of Sciences [KZCX2-EW-310]; National Natural Science Foundation of China [41171153, 41001179]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Knowledge Innovation Program of the Chinese Academy of Sciences (KZCX2-EW-310) and National Natural Science Foundation of China (No. 41171153, 41001179). The authors declare that no additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao S.D., 2015, SOIL AGR CHEM ANAL, V3; Bhamidimarri SMR, 1996, WATER SCI TECHNOL, V33, P89, DOI 10.1016/0273-1223(96)00265-X; Bhandari A. L., 1992, Journal of the Indian Society of Soil Science, V40, P742; Bi LD, 2009, AGR ECOSYST ENVIRON, V129, P534, DOI 10.1016/j.agee.2008.11.007; Blair N, 2006, SOIL TILL RES, V91, P30, DOI 10.1016/j.still.2005.11.002; Cao CY, 2011, ECOL ENG, V37, P1467, DOI 10.1016/j.ecoleng.2011.03.012; [陈安磊 Chen Anlei], 2010, [生态学报, Acta Ecologica Sinica], V30, P5059; [陈惟财 CHEN Wei-cai], 2009, [土壤通报, Journal of Soil Science], V40, P523; Chen XW, 2003, FOREST ECOL MANAG, V186, P197, DOI 10.1016/S0378-1127(03)00258-5; Darilek JL, 2009, AGR ECOSYST ENVIRON, V129, P286, DOI 10.1016/j.agee.2008.10.002; Daugelene N, 2008, EURASIAN SOIL SCI+, V41, P638, DOI 10.1134/S1064229308060094; Dawe D, 2000, FIELD CROP RES, V66, P175, DOI 10.1016/S0378-4290(00)00075-7; Galantini J, 2006, SOIL TILL RES, V87, P72, DOI 10.1016/j.still.2005.02.032; Gu YF, 2009, EUR J SOIL BIOL, V45, P239, DOI 10.1016/j.ejsobi.2009.02.005; Huang QR, 2009, PEDOSPHERE, V19, P727, DOI 10.1016/S1002-0160(09)60168-5; Huang S, 2010, AGR ECOSYST ENVIRON, V138, P44, DOI 10.1016/j.agee.2010.03.015; Hyvonen R, 2008, BIOGEOCHEMISTRY, V89, P121, DOI 10.1007/s10533-007-9121-3; Imbeah M, 1998, BIORESOURCE TECHNOL, V63, P197, DOI 10.1016/S0960-8524(97)00165-X; Kapkiyai JJ, 1999, SOIL BIOL BIOCHEM, V31, P1773, DOI 10.1016/S0038-0717(99)00088-7; Khalil MI, 2005, SOIL BIOL BIOCHEM, V37, P1507, DOI 10.1016/j.soilbio.2005.01.014; Kumar A, 2001, J AGRON CROP SCI, V186, P47, DOI 10.1046/j.1439-037x.2001.00452.x; Ladha JK, 2003, FIELD CROP RES, V81, P159, DOI 10.1016/S0378-4290(02)00219-8; Lee SB, 2009, SOIL TILL RES, V104, P227, DOI 10.1016/j.still.2009.02.007; Li BY, 2010, PEDOSPHERE, V20, P725, DOI 10.1016/S1002-0160(10)60063-X; Li CK, 1983, RED SOILS CHINA; Li J, 2006, ACTA ECOLOGICA SINIC, V26, P2449; Li ZhongPei, 2006, Agricultural Sciences in China, V5, P522, DOI 10.1016/S1671-2927(06)60087-4; Liu KH, 2010, PEDOSPHERE, V20, P399, DOI 10.1016/S1002-0160(10)60029-X; Liu M, 2011, AGR SCI CHINA, V10, P259, DOI 10.1016/S1671-2927(11)60003-5; Lukin L. Yu., 1994, Agrokhimiya, P38; Ma Li, 2009, Acta Pedologica Sinica, V46, P1050; Manna MC, 2007, SOIL TILL RES, V94, P397, DOI 10.1016/j.still.2006.08.013; MITCHELL CC, 1991, AGRON J, V83, P24, DOI 10.2134/agronj1991.00021962008300010010x; Motavalli PP, 2002, BIOL FERT SOILS, V36, P35, DOI 10.1007/s00374-002-0500-6; Nardi S, 2004, EUR J AGRON, V21, P357, DOI 10.1016/j.eja.2003.10.006; Nie J, 2007, PEDOSPHERE, V17, P295, DOI 10.1016/S1002-0160(07)60036-8; Qu J. F., 2009, CHINESE J TROPICAL A, V29, P75; Shen J, 2004, FIELD CROP RES, V86, P225, DOI 10.1016/j.fcr.2003.08.013; Shen JP, 2010, APPL SOIL ECOL, V46, P119, DOI 10.1016/j.apsoil.2010.06.015; SIKKA R, 1995, BIORESOURCE TECHNOL, V51, P199, DOI 10.1016/0960-8524(94)00119-L; Su YZ, 2006, NUTR CYCL AGROECOSYS, V75, P285, DOI 10.1007/s10705-006-9034-x; Sun W, 2011, AGR FOREST METEOROL, V151, P1193, DOI 10.1016/j.agrformet.2011.04.009; Tejada M, 2008, BIORESOURCE TECHNOL, V99, P4949, DOI 10.1016/j.biortech.2007.09.026; Tong CL, 2009, SOIL TILL RES, V106, P8, DOI 10.1016/j.still.2009.09.003; Vogeler I, 2009, SOIL TILL RES, V103, P137, DOI 10.1016/j.still.2008.10.004; [王伯仁 Wang Boren], 2010, [水土保持学报, Journal of Soil and Water Conservation], V24, P85; Wang YC, 2010, NUTR CYCL AGROECOSYS, V86, P105, DOI 10.1007/s10705-009-9276-5; Whitbread A, 2003, AGR ECOSYST ENVIRON, V100, P251, DOI 10.1016/S0167-8809(03)00189-0; [吴晓晨 Wu xiaochen], 2008, [生态环境, Ecology and Environment], V17, P2019; Wu ZH, 2003, ENVIRON POLLUT, V121, P469, DOI 10.1016/S0269-7491(02)00272-5; Yang JY, 2006, ENVIRON POLLUT, V143, P9, DOI 10.1016/j.envpol.2005.11.010; Yang ShengMao, 2006, Agricultural Sciences in China, V5, P57, DOI 10.1016/S1671-2927(06)60020-5; [袁颖红 YUAN Yinghong], 2008, [土壤, Soils], V40, P237; Zhang HM, 2009, PEDOSPHERE, V19, P199, DOI 10.1016/S1002-0160(09)60109-0; Zhang MK, 2005, SOIL TILL RES, V80, P13, DOI 10.1016/j.still.2004.02.019; Zhang MK, 2004, GEODERMA, V118, P167, DOI 10.1016/S0016-7061(03)00191-5; Zhao J., 2011, ACTA ECOL SIN, V31, P212, DOI [10.1016/j.chnaes.2011.04.001, DOI 10.1016/J.CHNAES.2011.04.001]	57	126	141	12	165	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e44504	10.1371/journal.pone.0044504	http://dx.doi.org/10.1371/journal.pone.0044504			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028550	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900012
J	Hammond, GC; Croudace, TJ; Radhakrishnan, M; Lafortune, L; Watson, A; McMillan-Shields, F; Jones, PB				Hammond, Geoffrey C.; Croudace, Tim J.; Radhakrishnan, Muralikrishnan; Lafortune, Louise; Watson, Alison; McMillan-Shields, Fiona; Jones, Peter B.			Comparative Effectiveness of Cognitive Therapies Delivered Face-to-Face or over the Telephone: An Observational Study Using Propensity Methods	PLOS ONE			English	Article							PSYCHODYNAMIC THERAPIES; PSYCHOTHERAPY; DEPRESSION; DISORDER	Objectives: To compare the clinical and cost-effectiveness of face-to-face (FTF) with over-the-telephone (OTT) delivery of low intensity cognitive behavioural therapy. Design: Observational study following SROBE guidelines. Selection effects were controlled using propensity scores. Non-inferiority comparisons assessed effectiveness. Setting: IAPT (improving access to psychological therapies) services in the East of England. Participants: 39,227 adults referred to IAPT services. Propensity score strata included 4,106 individuals; 147 pairs participated in 1: 1 matching. Intervention: Two or more sessions of computerised cognitive behavioural therapy (CBT). Main outcome measures: Patient-reported outcomes: Patient Health Questionnaire (PHQ-9) for depression; Generalised Anxiety Disorder questionnaire (GAD-7); Work and Social Adjustment Scale (WSAS). Differences between groups were summarised as standardised effect sizes (ES), adjusted mean differences and minimally important difference for PHQ-9. Cost per session for OTT was compared with FTF. Results: Analysis of covariance controlling for number of assessments, provider site, and baseline PHQ-9, GAD-7 and WSAS indicated statistically significantly greater reductions in scores for OTT treatment with moderate (PHQ-9: ES: 0.14; GAD-7: ES: 0.10) or small (WSAS: ES: 0.03) effect sizes. Non-inferiority in favour of OTT treatment for symptom severity persisted as small to moderate effects for all but individuals with the highest symptom severity. In the most stringent comparison, the one-to-one propensity matching, adjusted mean differences in treatment outcomes indicated non-inferiority between OTT versus FTF treatments for PHQ-9 and GAD-7, whereas the evidence was moderate for WSAS. The per-session cost for OTT was 36.2% lower than FTF. Conclusions: The clinical effectiveness of low intensity CBT-based interventions delivered OTT was not inferior to those delivered FTF except for people with more severe illness where FTF was superior. This provides evidence for better targeting of therapy, efficiencies for patients, cost savings for services and greater access to psychological therapies for people with common mental disorders.	[Jones, Peter B.] Univ Cambridge, Dept Psychiat, Cambridge, England; [Hammond, Geoffrey C.; Jones, Peter B.] Cambridgeshire & Peterborough Natl Hlth Serv Fdn, Cambridge, England; [Hammond, Geoffrey C.; Radhakrishnan, Muralikrishnan; Lafortune, Louise; Watson, Alison] Natl Inst Hlth Res Collaborat Leadership Appl Hlt, Cambridge, England; [Croudace, Tim J.] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Croudace, Tim J.] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [Radhakrishnan, Muralikrishnan; Lafortune, Louise] Cambridge Inst Publ Hlth, Cambridge, England; [Watson, Alison; McMillan-Shields, Fiona] Natl Hlth Serv Midlands & E, Cambridge, England	University of Cambridge; University of York - UK; University of Hull; University of York - UK; University of Cambridge	Jones, PB (corresponding author), Univ Cambridge, Dept Psychiat, Cambridge, England.	pbj21@cam.ac.uk	Croudace, Tim/ABC-9681-2021; Lafortune, Louise/AAJ-9257-2020	Lafortune, Louise/0000-0002-9018-1217; Croudace, Tim/0000-0001-8346-7463; Jones, Peter Brian/0000-0002-0387-880X	National Health Service (NHS) East of England; National Institute of Health Research (NIHR) Collaboration for Leadership in Applied Health Research & Care (CLAHRC) for Cambridgeshire Peterborough; Department of Health/NIHR Career Scientist Award in Public Health; National Institute for Health Research [NF-SI-0509-10215, RP-PG-0606-1335] Funding Source: researchfish	National Health Service (NHS) East of England; National Institute of Health Research (NIHR) Collaboration for Leadership in Applied Health Research & Care (CLAHRC) for Cambridgeshire Peterborough(National Institute for Health Research (NIHR)); Department of Health/NIHR Career Scientist Award in Public Health; National Institute for Health Research(National Institute for Health Research (NIHR))	GCH was funded by National Health Service (NHS) East of England (https://www.eoe.nhs.uk/) and the National Institute of Health Research (NIHR) Collaboration for Leadership in Applied Health Research & Care (CLAHRC) for Cambridgeshire & Peterborough (http://www.clahrc-cp.nihr.ac.uk) that also provided salary support to LL and MR. The CLAHRC hosted the study and is, itself, hosted by the Cambridgeshire & Peterborough NHS Foundation Trust. All authors and their employers are partners in the CLAHRC. TJC was supported in part by a Department of Health/NIHR Career Scientist Award in Public Health. The views expressed in this manuscript are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], REP PREP DEP HLTH 20; Bee PE, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-60; Drummond MF, 2015, METHODS EC EVALUATIO; Golub RM, 2012, JAMA-J AM MED ASSOC, V307, P1643, DOI 10.1001/jama.2012.490; Layard R, 2006, BRIT MED J, V332, P1030, DOI 10.1136/bmj.332.7548.1030; Layard R, 2007, COST BENEFIT ANAL PS; London School of Economics and Political Science Centre for Economic Performance Mental Health Policy Group, 2006, DEPR REP NEW DEAL DE; Lovell K, 2006, BMJ-BRIT MED J, V333, P883, DOI 10.1136/bmj.38940.355602.80; Lowe B, 2004, J AFFECT DISORDERS, V81, P61, DOI 10.1016/S0165-0327(03)00198-8; McMillan D, 2010, J AFFECT DISORDERS, V127, P122, DOI 10.1016/j.jad.2010.04.030; Mohr DC, 2008, CLIN PSYCHOL-SCI PR, V15, P243, DOI 10.1111/j.1468-2850.2008.00134.x; Mohr DC, 2006, ANN BEHAV MED, V32, P254, DOI 10.1207/s15324796abm3203_12; Mundt JC, 2002, BRIT J PSYCHIAT, V180, P461, DOI 10.1192/bjp.180.5.461; National Collaborating Centre for Mental Health, 2021, IMPR ACC PSYCH THER; Nolan G, 2009, DEV LOCAL TARIFF IAP; Richards DA, 2009, BRIT J CLIN PSYCHOL, V48, P377, DOI 10.1348/014466509X405178; ROBINSON LA, 1990, PSYCHOL BULL, V108, P30, DOI 10.1037/0033-2909.108.1.30; SCOGIN F, 1990, PROF PSYCHOL-RES PR, V21, P42, DOI 10.1037/0735-7028.21.1.42; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stiles WB, 2006, PSYCHOL MED, V36, P555, DOI 10.1017/S0033291706007136; Stiles WB, 2008, PSYCHOL MED, V38, P677, DOI 10.1017/S0033291707001511; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X	22	49	50	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e42916	10.1371/journal.pone.0042916	http://dx.doi.org/10.1371/journal.pone.0042916			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022PZ	23028436	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900001
J	Oh, Y; Fleming, L; Statham, B; Hamblin, P; Barnett, P; Paton, DJ; Park, JH; Joo, YS; Parida, S				Oh, Yooni; Fleming, Lucy; Statham, Bob; Hamblin, Pip; Barnett, Paul; Paton, David J.; Park, Jong-Hyeon; Joo, Yi Seok; Parida, Satya			Interferon-gamma Induced by In Vitro Re-Stimulation of CD4+T-Cells Correlates with In Vivo FMD Vaccine Induced Protection of Cattle against Disease and Persistent Infection	PLOS ONE			English	Article							DELTA-T-CELLS; MOUTH-DISEASE; IMMUNE-RESPONSES; VIRUS FMDV; HETEROTYPIC RECOGNITION; NONSTRUCTURAL PROTEINS; CELLULAR-RESPONSES; THERMAL-STABILITY; WHOLE-BLOOD; CD4	The immune defense against FMDV has been correlated to the antibody mediated component. However, there are occasions when some animals with high virus neutralising (VN) antibody are not protected following challenge and some with low neutralising antibody which do not succumb to disease. The importance of cell mediated immunity in clinical protection is less clear and so we investigated the source and production of interferon-gamma (IFN-gamma) in re-stimulated whole blood of FMDV immunized cattle and its correlation to vaccine induced protection and FMDV persistence. We were able to show a positive correlation between IFN-gamma response and vaccine induced protection as well as reduction of long term persistence of FMD virus. When combining this IFN-gamma response in re-stimulated blood with virus neutralizing antibody titer in serum on the day of challenge, a better correlation of vaccine-induced protection with IFN-gamma and VN antibody was predicted. Our investigations also showed that CD4+ T-cells are the major proliferating phenotype and IFN-gamma producing cells.	[Park, Jong-Hyeon; Joo, Yi Seok] Natl Vet Res & Quarantine Serv, Anyang, South Korea	Animal & Plant Quarantine Agency		satya.parida@iah.ac.uk	Parida, Satya/E-5463-2015	Parida, Satya/0000-0001-8253-9461	NVRQS, Korea [1355]; Defra, United Kingdom [SE1125]; European Commission [226556]; BBSRC/UK aid (CIDLID) [BB/H009175/1]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001192, BBS/E/I/00001416, BB/H009175/1] Funding Source: researchfish; BBSRC [BB/H009175/1, BBS/E/I/00001416] Funding Source: UKRI	NVRQS, Korea; Defra, United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA)); European Commission(European CommissionEuropean Commission Joint Research Centre); BBSRC/UK aid (CIDLID); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported financially by NVRQS, Korea (project 1355), Defra, United Kingdom (project SE1125), the European Commission (FMD_DISCONVAC project of the EU 7th Framework Programme, grant 226556) and BBSRC/UK aid (CIDLID grant BB/H009175/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON EC, 1982, J COMP PATHOL, V92, P495, DOI 10.1016/0021-9975(82)90002-0; [Anonymous], 2006, EUROPEAN PHARMACOPOE, V63; [Anonymous], 2008, MANUAL STANDARDS DIA; Antas PRZ, 2004, BRAZ J MED BIOL RES, V37, P1119, DOI 10.1590/S0100-879X2004000800003; Bautista EM, 2003, VET IMMUNOL IMMUNOP, V92, P61, DOI 10.1016/S0165-2427(03)00004-7; BECKER Y, 1994, VIRUS GENES, V8, P199, DOI 10.1007/BF01703078; BENSAID A, 1991, VET IMMUNOL IMMUNOP, V27, P51, DOI 10.1016/0165-2427(91)90078-Q; Biron CA, 2001, CURR OPIN IMMUNOL, V13, P458, DOI 10.1016/S0952-7915(00)00241-7; Black GF, 2002, LANCET, V359, P1393, DOI 10.1016/S0140-6736(02)08353-8; Blanco E, 2001, J VIROL, V75, P3164, DOI 10.1128/JVI.75.7.3164-3174.2001; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; BORCA MV, 1986, IMMUNOLOGY, V59, P261; BROWN F, 1992, VACCINE, V10, P1022, DOI 10.1016/0264-410X(92)90111-V; Childerstone AJ, 1999, J GEN VIROL, V80, P663, DOI 10.1099/0022-1317-80-3-663; COLLEN T, 1990, J GEN VIROL, V71, P309, DOI 10.1099/0022-1317-71-2-309; Collen T, 1998, VIRUS RES, V56, P125, DOI 10.1016/S0168-1702(98)00035-5; Collen T., 1994, Cell-mediated immunity in ruminants., P173; Collen T, 1991, T CELL RESPONSES CAT; Cox SJ, 2010, VACCINE, V28, P2318, DOI 10.1016/j.vaccine.2009.12.065; DAVIS WC, 1993, VET IMMUNOL IMMUNOP, V39, P85, DOI 10.1016/0165-2427(93)90167-3; DAVIS WC, 1991, VET IMMUNOL IMMUNOP, V27, P43, DOI 10.1016/0165-2427(91)90077-P; DOEL TR, 1981, ARCH VIROL, V70, P21, DOI 10.1007/BF01320790; Doel TR, 2003, VIRUS RES, V91, P81, DOI 10.1016/S0168-1702(02)00261-7; Foster M, 1998, VET QUART, V20, pS28; Fowler V, 2012, ANTIVIR RES, V94, P25, DOI 10.1016/j.antiviral.2012.02.002; Gerner W, 2007, VET RES, V38, P565, DOI 10.1051/vetres:2007016; Goris N, 2007, VACCINE, V25, P3373, DOI 10.1016/j.vaccine.2006.12.049; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Guzman E, 2008, J GEN VIROL, V89, P667, DOI 10.1099/vir.0.83417-0; Hanekom WA, 2004, J IMMUNOL METHODS, V291, P185, DOI 10.1016/j.jim.2004.06.010; Hegde NR, 2009, VACCINE, V27, P2199, DOI 10.1016/j.vaccine.2009.01.032; Hodgkin PD, 1996, J EXP MED, V184, P277, DOI 10.1084/jem.184.1.277; HOLM S, 1979, SCAND J STAT, V6, P65; HOWARD CJ, 1989, EUR J IMMUNOL, V19, P757, DOI 10.1002/eji.1830190428; Ilott MC, 1997, EPIDEMIOL INFECT, V118, P181, DOI 10.1017/S0950268896007376; Juleff N, 2009, J VIROL, V83, P3626, DOI 10.1128/JVI.02613-08; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MACHUGH ND, 1991, VET IMMUNOL IMMUNOP, V27, P65, DOI 10.1016/0165-2427(91)90081-M; Mateo R, 2008, J VIROL, V82, P12232, DOI 10.1128/JVI.01553-08; MCCULLOUGH KC, 1992, VET MICROBIOL, V30, P99, DOI 10.1016/0378-1135(92)90106-4; McCullough KC, 2004, FOOT AND MOUTH DISEASE: CURRENT PERSPECTIVES, P173; NOSE A, 1986, J CELL BIOL, V103, P2649, DOI 10.1083/jcb.103.6.2649; Oh Y, 2006, SESS RES GROUP STAND; Parida S, 2006, VACCINE, V24, P964, DOI 10.1016/j.vaccine.2005.08.108; Parida S, 2007, J VET DIAGN INVEST, V19, P539, DOI 10.1177/104063870701900513; Parida S, 2009, EXPERT REV VACCINES, V8, P347, DOI 10.1586/14760584.8.3.347; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Reeve R, 2011, VACCINE, V29, P5467, DOI 10.1016/j.vaccine.2011.05.056; Reid E, 2011, J VIROL, V85, P4297, DOI 10.1128/JVI.02495-10; Reid SM, 2003, J VIROL METHODS, V107, P129, DOI 10.1016/S0166-0934(02)00210-0; SAIZ JC, 1992, J GEN VIROL, V73, P2601, DOI 10.1099/0022-1317-73-10-2601; SALT JS, 1993, BRIT VET J, V149, P207, DOI 10.1016/S0007-1935(05)80168-X; Sammin DJ, 2007, VET REC, V160, P647, DOI 10.1136/vr.160.19.647; Sanz-Parra A, 1999, VIROLOGY, V259, P129, DOI 10.1006/viro.1999.9717; Sobrino F, 2001, VET RES, V32, P1, DOI 10.1051/vetres:2001106; SOPP P, 1991, VET IMMUNOL IMMUNOP, V27, P163, DOI 10.1016/0165-2427(91)90095-T; Summerfield A, 2009, VET IMMUNOL IMMUNOP, V128, P205, DOI 10.1016/j.vetimm.2008.10.296; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Takamatsu HH, 2006, VET IMMUNOL IMMUNOP, V112, P49, DOI 10.1016/j.vetimm.2006.03.011; Takamatsu HH, 2002, VET IMMUNOL IMMUNOP, V87, P223, DOI 10.1016/S0165-2427(02)00083-1; Tassignon J, 2005, J IMMUNOL METHODS, V305, P188, DOI 10.1016/j.jim.2005.07.014; VANLIEROP MJC, 1995, J VIROL, V69, P4511, DOI 10.1128/JVI.69.7.4511-4514.1995; Vesosky B, 2004, INFECT IMMUN, V72, P4612, DOI 10.1128/IAI.72.8.4612-4618.2004; Wood PR, 2001, TUBERCULOSIS, V81, P147, DOI 10.1054/tube.2000.0272; Zhang ZD, 2002, ARCH VIROL, V147, P2157, DOI 10.1007/s00705-002-0867-6	65	33	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e44365	10.1371/journal.pone.0044365	http://dx.doi.org/10.1371/journal.pone.0044365			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028529	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900010
J	Oladele, EA; Ormond, L; Adeyemi, O; Patrick, D; Okoh, F; Oresanya, OB; Valadez, JJ				Oladele, Edward Adekola; Ormond, Louise; Adeyemi, Olusegun; Patrick, David; Okoh, Festus; Oresanya, Olusola Bukola; Valadez, Joseph J.			Tracking the Quality of Care for Sick Children Using Lot Quality Assurance Sampling: Targeting Improvements of Health Services in Jigawa, Nigeria	PLOS ONE			English	Article							MALARIA CASE-MANAGEMENT; UNCOMPLICATED MALARIA; PREDICTORS; FACILITIES; WORKERS	Background: In Nigeria, 30% of child deaths are due to malaria. The National Malaria Control Program of Nigeria (NMCP) during 2009 initiated a program to improve the quality of paediatric malaria services delivered in health facilities (HF). This study reports a rapid approach used to assess the existing quality of services in Jigawa state at decentralised levels of the health system. Methods: NMCP selected Lot Quality Assurance Sampling (LQAS) to identify the variation in HF service quality among Senatorial Districts (SD). LQAS was selected because it was affordable and could be used by local health workers (HW) in a population-based survey. NMCP applied a 2-stage LQAS using a structured Rapid Health Facility Assessment (R-HFA) tool to identify high and low performing SD for specified indicators. Findings: LQAS identified variations in HF performance (n = 21) and enabled resources to be targeted to address priorities. All SD exhibited deficient essential services, supplies and equipment. Only 9.7% of HF had Artemisinin-based Combination Therapies and other first-line treatments for childhood illnesses. No SD and few HF exhibited adequate HW performance for the assessment, treatment or counselling of sick children. Using the IMCI algorithm, 17.5% of HW assessed the child's vaccination status, 46.8% assessed nutritional status, and 65.1% assessed children for dehydration. Only 5.1% of HW treatments were appropriate for the assessment. Exit interviews revealed that 5.1% of caregivers knew their children's illness, and only 19.9% could accurately describe how to administer the prescribed drug. Conclusion: This R-HFA, using LQAS principles, is a rapid, simple tool for assessing malaria services and can be used at scale. It identified technical deficiencies that could be corrected by improved continuing medical education, targeted supervision, and recurrent R-HFA assessments of the quality of services.	[Oladele, Edward Adekola; Ormond, Louise; Adeyemi, Olusegun; Patrick, David; Valadez, Joseph J.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Oladele, Edward Adekola] Lautech Univ, Teaching Hosp, Osogbo, Osun State, Nigeria; [Okoh, Festus; Oresanya, Olusola Bukola] Fed Minist Hlth, Natl Malaria Control Program, Abuja, Nigeria	Liverpool School of Tropical Medicine; University of Liverpool	Valadez, JJ (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.	jvaladez@liverpool.ac.uk	Oresanya, Olusola/AAV-5050-2020	Oresanya, Olusola/0000-0002-8261-705X; Oladele, Edward Adekola/0000-0003-4999-1397; Valadez, Joseph/0000-0002-6575-6592	National Malaria Control Programme of Nigeria; ExxonMobil Foundation; Liverpool School of Tropical Medicine International Health Group; Kenneth Newell Memorial Award	National Malaria Control Programme of Nigeria; ExxonMobil Foundation(Exxon Mobil Corporation); Liverpool School of Tropical Medicine International Health Group; Kenneth Newell Memorial Award	This work was supported by the National Malaria Control Programme of Nigeria and a grant from the ExxonMobil Foundation to the World Bank to support the Malaria Control Booster Project for Africa. It was also supported by funding through the Liverpool School of Tropical Medicine International Health Group, and a Kenneth Newell Memorial Award which financed the data entry cleaning and analysis. Neither funder had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partly financed by a grant from the ExxonMobil Foundation to the World Bank to support the Malaria Control Booster Project for Africa, which does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Berenson MLD, 2007, CONFIDENCE INTERVAL; Biai S, 2007, BRIT MED J, V335, P862, DOI 10.1136/bmj.39345.467813.80; Biedron C, 2010, INT J EPIDEMIOL, V39, P72, DOI 10.1093/ije/dyp363; Breman JG., 2007, AM J TROP MED HYGIEN, V77, P6; Chan M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000223; CORE Group Measure Evaluation USAID Save the Children World Bank, 2006, RAP HLTH FAC ASS 2 1; Dodge H. F., 1944, SAMPLING INSPECTION; Federal Ministry of Health, 2005, NAT ANT TREATM GUID; Gwer S, 2007, AM J TROP MED HYG, V77, P6, DOI 10.4269/ajtmh.2007.77.6; Hedt B, 2008, LARGE COUNTRY LOT QU, P60; Lanata CF, 2002, MEJOR ANDA CALIDAD A; Lemeshow S, 1989, SURV METHODOL, V15, P71; National Malaria Control Program, 2009, DET IMPL PLAN HLTH F; Osterholt DM, 2006, TROP MED INT HEALTH, V11, P1147, DOI 10.1111/j.1365-3156.2006.01666.x; Pariyo GW, 2005, HEALTH POLICY PLANN, V20, pI58, DOI 10.1093/heapol/czi051; Robertson SE, 2006, SOC SCI MED, V63, P1648, DOI 10.1016/j.socscimed.2006.04.011; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Rowe AK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-275; Shewhart W, 1931, EC CONTR QUAL MAN PR; Spencer L, 2003, QUALITATIVE RES PRAC, P212; Tukey J, 1950, ACCEPTANCE SAMPLING; Valadez JJ, 1997, STUD FAMILY PLANN, V28, P143, DOI 10.2307/2138116; Valadez JJ, 2005, SOC SCI MED, V61, P1356, DOI 10.1016/j.socscimed.2005.02.002; Valadez JJ, 1996, INT J EPIDEMIOL, V25, P381, DOI 10.1093/ije/25.2.381; Valadez JJ, 2002, COMMUNITY BASED HLTH, P26; Valadez JJ, 1991, ASSESSING CHILD SURV; Wasunna B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-29; Weitzman EA, 1999, HEALTH SERV RES, V34, P1241; World Health Organization, 1994, 9 WHO PROGR CONTR DI; Zurovac D, 2006, TROP MED INT HEALTH, V11, P432, DOI 10.1111/j.1365-3156.2006.01587.x; Zurovac D, 2005, BRIT MED J, V331, P734, DOI 10.1136/bmj.331.7519.734; Zurovac D, 2004, INT J EPIDEMIOL, V33, P1080, DOI 10.1093/ije/dyh253	32	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e44319	10.1371/journal.pone.0044319	http://dx.doi.org/10.1371/journal.pone.0044319			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016KQ	23028519	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000309517500005
J	Plaza, SM; Scheffer, LK; Saunders, M				Plaza, Stephen M.; Scheffer, Louis K.; Saunders, Mathew			Minimizing Manual Image Segmentation Turn-Around Time for Neuronal Reconstruction by Embracing Uncertainty	PLOS ONE			English	Article								The ability to automatically segment an image into distinct regions is a critical aspect in many visual processing applications. Because inaccuracies often exist in automatic segmentation, manual segmentation is necessary in some application domains to correct mistakes, such as required in the reconstruction of neuronal processes from microscopic images. The goal of the automated segmentation tool is traditionally to produce the highest-quality segmentation, where quality is measured by the similarity to actual ground truth, so as to minimize the volume of manual correction necessary. Manual correction is generally orders-of-magnitude more time consuming than automated segmentation, often making handling large images intractable. Therefore, we propose a more relevant goal: minimizing the turn-around time of automated/manual segmentation while attaining a level of similarity with ground truth. It is not always necessary to inspect every aspect of an image to generate a useful segmentation. As such, we propose a strategy to guide manual segmentation to the most uncertain parts of segmentation. Our contributions include 1) a probabilistic measure that evaluates segmentation without ground truth and 2) a methodology that leverages these probabilistic measures to significantly reduce manual correction while maintaining segmentation quality.			Saunders, M (corresponding author), Janelia Farm Res Campus, Ashburn, VA USA.	plaza.stephen@gmail.com						Andres B, 2008, LECT NOTES COMPUT SC, V5096, P142, DOI 10.1007/978-3-540-69321-5_15; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Helmstaedter M, 2011, NAT NEUROSCI, V14, P1081, DOI 10.1038/nn.2868; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Jain V, 2011, LEARNING AGGLOMERATE; Jain V, 2010, PROC CVPR IEEE, P2488, DOI 10.1109/CVPR.2010.5539950; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Sommer C, 2011, I S BIOMED IMAGING, P230, DOI 10.1109/ISBI.2011.5872394; Unnikrishnan R, 2005, WACV 2005: SEVENTH IEEE WORKSHOP ON APPLICATIONS OF COMPUTER VISION, PROCEEDINGS, P394; Unnikrishnan R, 2007, IEEE T PATTERN ANAL, V29, P929, DOI 10.1109/TPAMI.2007.1046	11	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44448	10.1371/journal.pone.0044448	http://dx.doi.org/10.1371/journal.pone.0044448			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028540	Green Published, Green Submitted, gold			2022-12-27	WOS:000309392800009
J	Bottacini, F; Milani, C; Turroni, F; Sanchez, B; Foroni, E; Duranti, S; Serafini, F; Viappiani, A; Strati, F; Ferrarini, A; Delledonne, M; Henrissat, B; Coutinho, P; Fitzgerald, GF; Margolles, A; van Sinderen, D; Ventura, M				Bottacini, Francesca; Milani, Christian; Turroni, Francesca; Sanchez, Borja; Foroni, Elena; Duranti, Sabrina; Serafini, Fausta; Viappiani, Alice; Strati, Francesco; Ferrarini, Alberto; Delledonne, Massimo; Henrissat, Bernard; Coutinho, Pedro; Fitzgerald, Gerald F.; Margolles, Abelardo; van Sinderen, Douwe; Ventura, Marco			Bifidobacterium asteroides PRL2011 Genome Analysis Reveals Clues for Colonization of the Insect Gut	PLOS ONE			English	Article							ESCHERICHIA-COLI; LACTOCOCCUS-LACTIS; SP-NOV; TRANSCRIPTIONAL REGULATION; DNA MICROARRAYS; GENE-EXPRESSION; OXYGEN; SEQUENCE; ATPASE; RESPIRATION	Bifidobacteria are known as anaerobic/microaerophilic and fermentative microorganisms, which commonly inhabit the gastrointestinal tract of various animals and insects. Analysis of the 2,167,301 bp genome of Bifidobacterium asteroides PRL2011, a strain isolated from the hindgut of Apis mellifera var. ligustica, commonly known as the honey bee, revealed its predicted capability for respiratory metabolism. Conservation of the latter gene clusters in various B. asteroides strains enforces the notion that respiration is a common metabolic feature of this ancient bifidobacterial species, which has been lost in currently known mammal-derived Bifidobacterium species. In fact, phylogenomic based analyses suggested an ancient origin of B. asteroides and indicates it as an ancestor of the genus Bifidobacterium. Furthermore, the B. asteroides PRL2011 genome encodes various enzymes for coping with toxic products that arise as a result of oxygen-mediated respiration.	[Bottacini, Francesca; Turroni, Francesca; Fitzgerald, Gerald F.; van Sinderen, Douwe] Natl Univ Ireland, Alimentary Pharmabiot Ctr, Cork, Ireland; [Bottacini, Francesca; Turroni, Francesca; Fitzgerald, Gerald F.; van Sinderen, Douwe] Natl Univ Ireland, Dept Microbiol, Biosci Inst, Cork, Ireland; [Milani, Christian; Foroni, Elena; Duranti, Sabrina; Serafini, Fausta; Viappiani, Alice; Strati, Francesco; Ventura, Marco] Univ Parma, Lab Probiogen, Dept Genet Biol Microorganisms Anthropol & Evolut, I-43100 Parma, Italy; [Sanchez, Borja; Margolles, Abelardo] CSIC, IPLA, Dept Microbiol & Bioquim Prod Lacteos, Villaviciosa, Asturias, Spain; [Ferrarini, Alberto; Delledonne, Massimo] Univ Verona, Dept Biotechnol, Funct Genom Ctr, I-37100 Verona, Italy; [Henrissat, Bernard; Coutinho, Pedro] Univ Aix Marseille, Marseille, France	University College Cork; University College Cork; University of Parma; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Lacteos de Asturias (IPLA); University of Verona; UDICE-French Research Universities; Aix-Marseille Universite	van Sinderen, D (corresponding author), Natl Univ Ireland, Alimentary Pharmabiot Ctr, Cork, Ireland.	d.vansinderen@ucc.ie; marco.ventura@unipr.it	Turroni, Francesca/K-9660-2016; Bottacini, Francesca/AAO-2431-2021; Delledonne, Massimo/O-8685-2017; Margolles, Abelardo/H-3871-2012; Milani, Christian/ABA-8160-2020; Duranti, Sabrina/AAI-7916-2020; Henrissat, Bernard/J-2475-2012; Van Sinderen, Douwe/A-6778-2015; Strati, Francesco/K-7789-2016; ventura, marco/M-8230-2015; Sanchez, Borja/B-7770-2009	Turroni, Francesca/0000-0001-5363-0231; Bottacini, Francesca/0000-0002-0142-2956; Margolles, Abelardo/0000-0003-2278-1816; Duranti, Sabrina/0000-0002-7724-5669; Henrissat, Bernard/0000-0002-3434-8588; Van Sinderen, Douwe/0000-0003-1823-7957; Strati, Francesco/0000-0001-7217-3355; Sanchez, Borja/0000-0003-1408-8018; Ferrarini, Alberto/0000-0002-8452-3380; Milani, Christian/0000-0002-5062-3164; Ventura, Marco/0000-0002-4875-4560; Delledonne, Massimo/0000-0002-7100-4581	Cariparma Bank Foundation; Federation European Microbiology society (FEMS); Irish Research Council for Science, Engineering & Technology (IRCSET); Science Foundation Ireland (SFI), through the Irish Government's National Development Plan [07/CE/B1368, 08/SRC/B1393]	Cariparma Bank Foundation; Federation European Microbiology society (FEMS); Irish Research Council for Science, Engineering & Technology (IRCSET)(Irish Research Council for Science, Engineering and Technology); Science Foundation Ireland (SFI), through the Irish Government's National Development Plan(Science Foundation Ireland)	This work was financially supported by the Cariparma Bank Foundation to MV. This work was also financially supported by a Federation European Microbiology society (FEMS) Advanced Fellowship 2011 and an Irish Research Council for Science, Engineering & Technology (IRCSET) Embark postdoctoral fellowship to FT. DV is a member of The Alimentary Pharmabiotic Centre and the Alimentary Glycoscience Research Cluster, both funded by Science Foundation Ireland (SFI), through the Irish Government's National Development Plan (grant nos. 07/CE/B1368 and 08/SRC/B1393, respectively). The funders had no role in this study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Barrangou R, 2009, J BACTERIOL, V191, P4144, DOI 10.1128/JB.00155-09; Baughn AD, 2004, NATURE, V427, P441, DOI 10.1038/nature02285; Bilban M, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-19; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bott M, 2003, J BIOTECHNOL, V104, P129, DOI 10.1016/S0168-1656(03)00144-5; Breckau D, 2003, J BIOL CHEM, V278, P46625, DOI 10.1074/jbc.M308553200; Brokl M, 2010, J AGR FOOD CHEM, V58, P11561, DOI 10.1021/jf102646n; Busch W, 2002, CRIT REV BIOCHEM MOL, V37, P287, DOI 10.1080/10409230290771528; COTTER PA, 1990, J BACTERIOL, V172, P6333, DOI [DOI 10.1128/jb.172.11.6333-6338.1990, 10.1128/jb.172.11.6333-6338.1990]; Coutinho Pedro M., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P307; Creevey CJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002269; DEVRIES W, 1969, ARCH MIKROBIOL, V65, P275; Duwat P, 2001, J BACTERIOL, V183, P4509, DOI 10.1128/JB.183.15.4509-4516.2001; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fanning S, 2012, P NATL ACAD SCI USA, V109, P2108, DOI 10.1073/pnas.1115621109; Gao F, 2006, NUCLEIC ACIDS RES, V34, pW686, DOI 10.1093/nar/gkl040; Govantes F, 2000, MOL MICROBIOL, V37, P1456, DOI 10.1046/j.1365-2958.2000.02100.x; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; GUNSALUS RP, 1982, P NATL ACAD SCI-BIOL, V79, P320, DOI 10.1073/pnas.79.2.320; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; INGLEDEW WJ, 1984, MICROBIOL REV, V48, P222, DOI 10.1128/MMBR.48.3.222-271.1984; Jeyaprakash A, 2003, J INVERTEBR PATHOL, V84, P96, DOI 10.1016/j.jip.2003.08.007; Jones SA, 2007, INFECT IMMUN, V75, P4891, DOI 10.1128/IAI.00484-07; KAKINUMA Y, 1994, J BIOCHEM-TOKYO, V116, P1302, DOI 10.1093/oxfordjournals.jbchem.a124679; Kasimoglu E, 1996, J BACTERIOL, V178, P5563, DOI 10.1128/jb.178.19.5563-5567.1996; Kawasaki S, 2006, APPL ENVIRON MICROB, V72, P6854, DOI 10.1128/AEM.01216-06; Killer J, 2011, INT J SYST EVOL MICR, V61, P1315, DOI 10.1099/ijs.0.022525-0; Killer J, 2010, ANAEROBE, V16, P165, DOI 10.1016/j.anaerobe.2009.07.007; Kim JF, 2009, J BACTERIOL, V191, P678, DOI 10.1128/JB.01515-08; Lee JH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-247; Lemme A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-58; Lim D, 2001, NAT STRUCT BIOL, V8, P848, DOI 10.1038/nsb1001-848; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Macfarlane S, 2011, ADV APPL MICROBIOL, V75, P111, DOI 10.1016/B978-0-12-387046-9.00005-0; Marco ML, 2006, CURR OPIN BIOTECH, V17, P204, DOI 10.1016/j.copbio.2006.02.005; Matsumoto M, 2004, INT J FOOD MICROBIOL, V93, P109, DOI 10.1016/j.ijfoodmicro.2003.10.009; MCGAVIN GC, 1994, NATURE, V370, P261; Meile L, 1997, SYST APPL MICROBIOL, V20, P57, DOI 10.1016/S0723-2020(97)80048-3; Mills DA, 2005, FEMS MICROBIOL REV, V29, P465, DOI 10.1016/j.femsre.2005.04.011; Motherway MO, 2011, P NATL ACAD SCI USA, V108, P11217, DOI 10.1073/pnas.1105380108; Mozzetti V, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-60; Mrazek J, 2008, FOLIA MICROBIOL, V53, P229, DOI 10.1007/s12223-008-0032-z; Ouwehand AC, 2002, ANTON LEEUW INT J G, V82, P279, DOI 10.1023/A:1020620607611; Paoli M, 2001, PROG BIOPHYS MOL BIO, V76, P103, DOI 10.1016/S0079-6107(01)00007-4; Pedersen MB, 2008, J BACTERIOL, V190, P4903, DOI 10.1128/JB.00447-08; Pokusaeva K, 2011, GENES NUTR, V6, P285, DOI 10.1007/s12263-010-0206-6; Rouillard JM, 2003, NUCLEIC ACIDS RES, V31, P3057, DOI 10.1093/nar/gkg426; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Sambrook J., 2001, MOL CLONING LAB MANU; Sanchez B, 2006, ENVIRON MICROBIOL, V8, P1825, DOI 10.1111/j.1462-2920.2006.01067.x; Saxelin M, 2005, CURR OPIN BIOTECH, V16, P204, DOI 10.1016/j.copbio.2005.02.003; Scardovi V, 1969, Zentralbl Bakteriol Parasitenkd Infektionskr Hyg, V123, P64; Schell MA, 2002, P NATL ACAD SCI USA, V99, P14422, DOI 10.1073/pnas.212527599; SCHRYVERS A, 1978, J BIOL CHEM, V253, P783; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Shi LB, 2005, P NATL ACAD SCI USA, V102, P15629, DOI 10.1073/pnas.0507850102; SHIMAMURA S, 1992, J DAIRY SCI, V75, P3296, DOI 10.3168/jds.S0022-0302(92)78105-3; Simpson PJ, 2005, J APPL MICROBIOL, V99, P493, DOI 10.1111/j.1365-2672.2005.02648.x; Simpson PJ, 2004, INT J SYST EVOL MICR, V54, P401, DOI 10.1099/ijs.0.02667-0; Stevens TJ, 2008, PROTEINS, V70, P378, DOI 10.1002/prot.21521; Turroni F, 2011, INT J FOOD MICROBIOL, V149, P37, DOI 10.1016/j.ijfoodmicro.2010.12.010; Turroni F, 2010, P NATL ACAD SCI USA, V107, P19514, DOI 10.1073/pnas.1011100107; Turroni F, 2009, APPL ENVIRON MICROB, V75, P1534, DOI 10.1128/AEM.02216-08; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; van den Broek LAM, 2008, MOL NUTR FOOD RES, V52, P146, DOI 10.1002/mnfr.200700121; Ventura M, 2004, APPL ENVIRON MICROB, V70, P6197, DOI 10.1128/AEM.70.10.6197-6209.2004; Ventura M, 2001, FEMS MICROBIOL ECOL, V36, P113, DOI 10.1111/j.1574-6941.2001.tb00831.x; Ventura M, 2012, TRENDS MICR IN PRESS; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Ventura M, 2006, INT J SYST EVOL MICR, V56, P2783, DOI 10.1099/ijs.0.64233-0; Ventura M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000785; Volfovsky N., 2001, GENOME BIOL, V2, DOI [DOI 10.1186/GB-2001-2-8-RESEARCH0027, 10.1186/gb-2001-2-8-research0027]; Winstedt L, 1998, J BACTERIOL, V180, P6571, DOI 10.1128/JB.180.24.6571-6580.1998; Yeoman CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012411; Yokota A, 2000, J BACTERIOL, V182, P5196, DOI 10.1128/JB.182.18.5196-5201.2000	80	100	112	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e44229	10.1371/journal.pone.0044229	http://dx.doi.org/10.1371/journal.pone.0044229			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028506	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388900007
J	Chuang, CM; Chang, CH; Wang, HE; Chen, KC; Peng, CC; Hsieh, CL; Peng, RY				Chuang, Chao-Ming; Chang, Chi-Huang; Wang, Hui-Er; Chen, Kuan-Chou; Peng, Chiung-Chi; Hsieh, Chiu-Lan; Peng, Robert Y.			Valproic Acid Downregulates RBP4 and Elicits Hypervitaminosis A-Teratogenesis-A Kinetic Analysis on Retinol/Retinoic Acid Homeostatic System	PLOS ONE			English	Article							RETINOL-BINDING-PROTEIN; HISTONE-DEACETYLASE INHIBITORS; EXPRESSION; MECHANISM; ANTICONVULSANT; DEHYDROGENASE; METABOLITES; RECEPTORS; CARNITINE; OXIDATION	Background: Valproic acid (VPA) is an antiepileptic and anti-migraine prophylactic drug. VPA exhibits two severe side effects, namely acute liver toxicity and teratogenicity. These side effects are usually seen at the genetic and somatic levels. The cited action mechanisms involve inhibition of histone deacetylase, hypofolatenemia, hyperhomocysteinemia, and reactive oxidative stress. The proteomic information associated with VPA teratogenicity is still unavailable. We hypothesized that proteomic analysis might help us identify functional proteins that could be relevantly affected by VPA, and this phenomenon could be very sensitive in early embryonic stage, resulting in VPA teratogenicity. Methodology/Principal Findings: Proteomic analysis on the chicken embryos at Hamburger and Hamilton (HH) stage 28 showed that there were significant downregulations of ovotransferrins, carbonic anhydrase-2, retinol binding protein-4 (RBP4), NADH cytochrome b5 reductase 2 (CYB5R2), apolipoprotein A1, and protein SET, together with upregulation of 60S ribosomal protein L22. Among these, RBP4 was the most significantly downregulated (-32%). Kinetic analysis suggested that this situation could trigger hypervitaminosis A (+39.3%), a condition that has been well known to induce teratogenesis.. Conclusions/Significance: This is the first report showing that VPA dowregulates RBP4. Our finding not only has led to a possible mechanism of VPA teratogenesis, but also has initiated new preventive strategies for avoiding VPA teratogeneis.	[Chen, Kuan-Chou] Taipei Med Univ, Dept Urol, Sch Med, Coll Med, Taipei, Taiwan; [Chuang, Chao-Ming] Hungkuang Univ, Dept Nursing, Taichung, Shalu County, Taiwan; [Chang, Chi-Huang; Peng, Robert Y.] Hungkuang Univ, Biotechnol Res Inst, Taichung, Shalu County, Taiwan; [Wang, Hui-Er] Hungkuang Univ, Dept Food & Appl Technol, Taichung, Shalu County, Taiwan; [Chen, Kuan-Chou] Taipei Med Univ, Dept Urol, Shuang Ho Hosp, Taipei, Taiwan; [Peng, Chiung-Chi] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Hsieh, Chiu-Lan] Changhua Univ Educ, Grad Inst Biotechnol, Changhua, Taiwan	Taipei Medical University; Hungkuang University; Hungkuang University; Hungkuang University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; National Changhua University of Education	Chen, KC (corresponding author), Taipei Med Univ, Dept Urol, Sch Med, Coll Med, Taipei, Taiwan.	kc.chen416@msa.hinet.net; misspeng@ms2.hinet.net; clhsieh@ncue.edu.tw			National Science Council [NSC 99-2313-B-018-002-MY3, 99-2320-B-038-011-MY3, 101-2320-B-039-040-]	National Science Council(Ministry of Science and Technology, Taiwan)	The authors are grateful for financial support from the National Science Council (NSC 99-2313-B-018-002-MY3, 99-2320-B-038-011-MY3 and 101-2320-B-039-040-). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors are also grateful for the Mass Spectrometric Analyses performed at the Proteomics Core Laboratory, Office of Research and Development of China Medical University, Taichung, Taiwan.	Bennett GD, 1997, EPILEPSIA, V38, P415, DOI 10.1111/j.1528-1157.1997.tb01730.x; Berni R, 1994, J BIOL CHEM, V69, P29613; Chen H, 2000, DRUG METAB DISPOS, V28, P315; COHLAN SQ, 1953, SCIENCE, V117, P535, DOI 10.1126/science.117.3046.535; DENCKER L, 1990, DEVELOPMENT, V110, P343; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; Durackova Z, 2010, PHYSIOL RES, V59, P459, DOI 10.33549/physiolres.931844; Eikel D, 2006, CHEM RES TOXICOL, V19, P272, DOI 10.1021/tx0502241; Fernandez I, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-7; FEX G, 1979, EUR J BIOCHEM, V99, P353, DOI 10.1111/j.1432-1033.1979.tb13263.x; Gallego O, 2006, BIOCHEM J, V399, P101, DOI 10.1042/BJ20051988; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; Gropper SS, 2009, ADV NUTR HUMAN METAB, P373; Hsieh CL, 2012, TOXICOLOGY, V291, P32, DOI 10.1016/j.tox.2011.10.015; Huang PH, 2011, MOL PHARMACOL, V79, P197, DOI 10.1124/mol.110.067702; Ishikura H, 1996, J ANAL TOXICOL, V20, P55, DOI 10.1093/jat/20.1.55; JACONI S, 1995, J LIPID RES, V36, P1247; JENKINSON PC, 1986, TERATOGEN CARCIN MUT, V6, P547, DOI 10.1002/tcm.1770060608; Johannessen CU, 2000, NEUROCHEM INT, V37, P103, DOI 10.1016/S0197-0186(00)00013-9; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; KAKKAD BP, 1988, J BIOL CHEM, V263, P12916; Kim YK, 2008, J BIOL CHEM, V283, P5611, DOI 10.1074/jbc.M708885200; Koch S, 1996, ACTA PAEDIATR, V85, P739, DOI 10.1111/j.1651-2227.1996.tb14137.x; Kostetskii I, 1999, DEV BIOL, V206, P206, DOI 10.1006/dbio.1998.9139; Kwon HJ, 2002, INT J CANCER, V97, P290, DOI 10.1002/ijc.1602; LAMMER EJ, 1985, NEW ENGL J MED, V313, P837, DOI 10.1056/NEJM198510033131401; Lheureux PER, 2005, CRIT CARE, V9, P431, DOI 10.1186/cc3742; Lind T, 2011, BONE, V48, P496, DOI 10.1016/j.bone.2010.10.169; LOSCHER W, 1983, J PHARMACOL EXP THER, V226, P845; LUDER AS, 1990, J CLIN INVEST, V86, P1574, DOI 10.1172/JCI114877; Maden M, 1997, DEVELOPMENT, V124, P2799; MADEN M, 1991, DIFFERENTIATION, V47, P49, DOI 10.1111/j.1432-0436.1991.tb00220.x; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Menegola Elena, 2006, Birth Defects Research, V78, P345, DOI 10.1002/bdrc.20082; MOONEY MP, 1981, NEUROBEH TOXICOL TER, V3, P1; NOUROOZZADEH J, 1994, ANAL BIOCHEM, V220, P403, DOI 10.1006/abio.1994.1357; OMTZIGT JGC, 1992, NEUROLOGY, V42, P119; Ornoy A, 2009, REPROD TOXICOL, V28, P1, DOI 10.1016/j.reprotox.2009.02.014; Peter H, 2006, BIOCH PATHOBIOCHEMIE, P123; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Quadro L, 2004, J LIPID RES, V45, P1975, DOI 10.1194/jlr.M400137-JLR200; Rosenberg G, 2007, CELL MOL LIFE SCI, V64, P2090, DOI 10.1007/s00018-007-7079-x; Ross SA, 2000, PHYSIOL REV, V80, P1021, DOI 10.1152/physrev.2000.80.3.1021; Roy M, 2008, J CELL BIOCHEM, V105, P467, DOI 10.1002/jcb.21847; RUBERTE E, 1991, DEVELOPMENT, V111, P45; RUBERTE E, 1993, DEVELOPMENT, V118, P267; Sha K, 2010, BIRTH DEFECTS RES B, V89, P124, DOI 10.1002/bdrb.20236; SUNDARESAN PR, 1977, J NUTR, V107, P70, DOI 10.1093/jn/107.1.70; Tabatabaei AR, 1999, CHEM RES TOXICOL, V12, P323, DOI 10.1021/tx9801864; Takebayashi K, 2011, BIOCHEM BIOPH RES CO, V408, P58, DOI 10.1016/j.bbrc.2011.03.116; van Gelder MMHJ, 2010, HUM REPROD UPDATE, V16, P378, DOI 10.1093/humupd/dmp052; VANDERLAAN JW, 1979, J NEUROCHEM, V32, P1769, DOI 10.1111/j.1471-4159.1979.tb02290.x; Whitsel AI, 2002, TERATOLOGY, V66, P153, DOI 10.1002/tera.10093; Wysocka-Kapcinska M, 2010, PROTEIN EXPRES PURIF, V71, P28, DOI 10.1016/j.pep.2010.01.015	54	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e43692	10.1371/journal.pone.0043692	http://dx.doi.org/10.1371/journal.pone.0043692			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028466	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388400012
J	Arnold, M; Durairaj, V; Mundt, E; Schulze, K; Breunig, KD; Behrens, SE				Arnold, Marina; Durairaj, Vijay; Mundt, Egbert; Schulze, Katja; Breunig, Karin D.; Behrens, Sven-Erik			Protective Vaccination against Infectious Bursal Disease Virus with Whole Recombinant Kluyveromyces lactis Yeast Expressing the Viral VP2 Subunit	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; IMMUNE-RESPONSES; GLUCOSE REPRESSION; HETEROLOGOUS PROTEINS; ANTIGENIC PROPERTIES; VIRULENT CHALLENGE; STRUCTURAL PROTEIN; CONFERS PROTECTION; INDUCE PROTECTION; CAPSID PROTEIN	Here we report on vaccination approaches against infectious bursal disease (IBD) of poultry that were performed with complete yeast of the species Kluyveromyces lactis (K. lactis). Employing a genetic system that enables the rapid production of stably transfected recombinant K. lactis, we generated yeast strains that expressed defined quantities of the virus capsid forming protein VP2 of infectious bursal disease virus (IBDV). Both, subcutaneous as well as oral vaccination regiments with the heat-inactivated but otherwise untreated yeast induced IBDV-neutralizing antibodies in mice and chickens. A full protection against a subsequent IBDV infection was achieved by subcutaneous inoculation of only milligram amounts of yeast per chicken. Oral vaccination also generated protection: while mortality was observed in control animals after virus challenge, none of the vaccinees died and ca. one-tenth were protected as indicated by the absence of lesions in the bursa of Fabricius. Recombinant K. lactis was thus indicated as a potent tool for the induction of a protective immune response by different applications. Subcutaneously applied K. lactis that expresses the IBDV VP2 was shown to function as an efficacious anti-IBD subunit vaccine.	[Arnold, Marina; Behrens, Sven-Erik] Univ Halle Wittenberg, Fac Life Sci NFI, Inst Biochem & Biotechnol, Halle, Germany; [Arnold, Marina; Schulze, Katja; Breunig, Karin D.] Univ Halle Wittenberg, Fac Life Sci NFI, Inst Biol, Halle, Germany; [Durairaj, Vijay; Mundt, Egbert] Univ Georgia, Coll Vet Med, Poultry Diagnost & Res Ctr, Athens, GA USA; [Mundt, Egbert] IDT Biol GmbH, Dessau Rosslau, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; University System of Georgia; University of Georgia; IDT Biologika	Arnold, M (corresponding author), Univ Halle Wittenberg, Fac Life Sci NFI, Inst Biochem & Biotechnol, Halle, Germany.	sven.behrens@biochemtech.uni-halle.de			ForMaT initiative of the Bundesministerium fur Bildung und Forschung (BMBF; project VAKZiNOVA) [03FO1232]	ForMaT initiative of the Bundesministerium fur Bildung und Forschung (BMBF; project VAKZiNOVA)(Federal Ministry of Education & Research (BMBF))	This study was supported by the ForMaT initiative of the Bundesministerium fur Bildung und Forschung (BMBF; project VAKZiNOVA, 03FO1232), Germany. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardiani A, 2010, FEMS YEAST RES, V10, P1060, DOI 10.1111/j.1567-1364.2010.00665.x; AZAD AA, 1991, VACCINE, V9, P715, DOI 10.1016/0264-410X(91)90286-F; Backhaus K, 2011, EUR J CELL BIOL, V90, P745, DOI 10.1016/j.ejcb.2011.04.005; BATHURST IC, 1994, AM J TROP MED HYG, V50, P20, DOI 10.4269/ajtmh.1994.50.20; BECHT H, 1988, J GEN VIROL, V69, P631, DOI 10.1099/0022-1317-69-3-631; Beier R, 1998, AM J PHYSIOL-GASTR L, V275, pG130, DOI 10.1152/ajpgi.1998.275.1.G130; Blanquet S, 2004, J BIOTECHNOL, V110, P37, DOI 10.1016/j.jbiotec.2004.01.012; BOX P, 1989, WORLD POULTRY, V53, P17; Breunig KD, 2000, ENZYME MICROB TECH, V26, P771, DOI 10.1016/S0141-0229(00)00170-8; Bublot M, 2007, J COMP PATHOL, V137, pS81, DOI 10.1016/j.jcpa.2007.04.017; Burns KE, 2003, AVIAN DIS, V47, P54, DOI 10.1637/0005-2086(2003)047[0054:EOTEOH]2.0.CO;2; CHETTLE N, 1989, VET REC, V125, P271, DOI 10.1136/vr.125.10.271; Coulibaly F, 2005, CELL, V120, P761, DOI 10.1016/j.cell.2005.01.009; Cox E, 2006, VET RES, V37, P511, DOI 10.1051/vetres:2006014; Cox JC, 1997, VACCINE, V15, P248, DOI 10.1016/S0264-410X(96)00183-1; DARTEIL R, 1995, VIROLOGY, V211, P481, DOI 10.1006/viro.1995.1430; Dey S, 2009, J VIROL METHODS, V157, P84, DOI 10.1016/j.jviromet.2008.11.020; Donnini C, 2004, APPL ENVIRON MICROB, V70, P2632, DOI 10.1128/AEM.70.5.2632-2638.2004; DROUAL R, 1990, AVIAN DIS, V34, P473, DOI 10.2307/1591439; ENGLERBLUM G, 1993, ANAL BIOCHEM, V210, P235, DOI 10.1006/abio.1993.1189; FAHEY KJ, 1991, AVIAN DIS, V35, P365, DOI 10.2307/1591191; FAHEY KJ, 1989, J GEN VIROL, V70, P1473, DOI 10.1099/0022-1317-70-6-1473; Francois A, 2004, VACCINE, V22, P2351, DOI 10.1016/j.vaccine.2003.10.039; Fuller TE, 2000, MICROB PATHOGENESIS, V29, P39, DOI 10.1006/mpat.2000.0364; Gellissen G, 1997, GENE, V190, P87, DOI 10.1016/S0378-1119(97)00020-6; Granzow H, 1997, J VIROL, V71, P8879, DOI 10.1128/JVI.71.11.8879-8885.1997; HEINE HG, 1993, ARCH VIROL, V131, P277, DOI 10.1007/BF01378632; Hensel A, 1996, J BIOTECHNOL, V44, P171, DOI 10.1016/0168-1656(95)00150-6; HIRAI K, 1979, INFECT IMMUN, V25, P964, DOI 10.1128/IAI.25.3.964-970.1979; Hoshi S, 1999, COMP IMMUNOL MICROB, V22, P63, DOI 10.1016/S0147-9571(98)00017-4; Icard AH, 2008, AVIAN DIS, V52, P590, DOI 10.1637/8302-040408-Reg.1; JAGADISH MN, 1991, GENE, V108, P275, DOI 10.1016/0378-1119(91)90445-H; KIBENGE FSB, 1988, J GEN VIROL, V69, P1757, DOI 10.1099/0022-1317-69-8-1757; Krijger JJ, 2012, MICROB CELL IN PRESS; KUGER P, 1990, NUCLEIC ACIDS RES, V18, P745, DOI 10.1093/nar/18.4.745; Kumar K, 2000, TROP ANIM HEALTH PRO, V32, P357, DOI 10.1023/A:1005225501513; Lai SY, 2004, PROCESS BIOCHEM, V39, P571, DOI 10.1016/S0032-9592(03)00124-9; Li L, 2006, VACCINE, V24, P5919, DOI 10.1016/j.vaccine.2006.04.057; Lu YN, 2004, CANCER RES, V64, P5084, DOI 10.1158/0008-5472.CAN-04-1487; LUCIO B, 1979, AVIAN DIS, V23, P1037, DOI 10.2307/1589620; Muller H, 2012, AVIAN PATHOL, V41, P133, DOI 10.1080/03079457.2012.661403; MULDER W, 1995, CURR GENET, V28, P267, DOI 10.1007/BF00309786; MULLER H, 1986, ARCH VIROL, V87, P191, DOI 10.1007/BF01315299; OKOYE JOA, 1983, TROP ANIM HEALTH PRO, V15, P221, DOI 10.1007/BF02242062; Perozo F, 2008, AVIAN DIS, V52, P315, DOI 10.1637/8122-100207-ResNote.1; Petkov DI, 2009, AVIAN DIS, V53, P347, DOI 10.1637/8456-082208-Reg.1; Pitcovski J, 2003, VACCINE, V21, P4736, DOI 10.1016/S0264-410X(03)00525-5; Pitcovski J, 1996, AVIAN DIS, V40, P753, DOI 10.2307/1592294; Prideaux CT, 1999, INFECT IMMUN, V67, P1962; Raab David, 2010, Syst Synth Biol, V4, P215, DOI 10.1007/s11693-010-9062-3; Rautenschlein S, 2002, VET IMMUNOL IMMUNOP, V89, P159, DOI 10.1016/S0165-2427(02)00202-7; Rodriguez-Lecompte JC, 2005, COMP IMMUNOL MICROB, V28, P321, DOI 10.1016/j.cimid.2005.08.004; Rong J, 2007, VACCINE, V25, P7900, DOI 10.1016/j.vaccine.2007.09.006; ROSALES AG, 1989, AVIAN DIS, V33, P729, DOI 10.2307/1591152; Rosenberger JK, 1986, 123 M AM VET MED ASS; Saugar I, 2005, STRUCTURE, V13, P1007, DOI 10.1016/j.str.2005.04.012; Schreuder MP, 1996, VACCINE, V14, P383, DOI 10.1016/0264-410X(95)00206-G; Schroder A, 2000, J GEN VIROL, V81, P533, DOI 10.1099/0022-1317-81-2-533; Shaw I, 2000, VACCINE, V18, P3230, DOI 10.1016/S0264-410X(00)00133-X; Sheppard M, 1998, ARCH VIROL, V143, P915, DOI 10.1007/s007050050342; Sherman F., 1986, METHODS YEAST GENETI; Shin SJ, 2005, FEMS IMMUNOL MED MIC, V43, P155, DOI 10.1016/j.femsim.2004.07.004; SNYDER DB, 1992, ARCH VIROL, V127, P89, DOI 10.1007/BF01309577; SNYDER DB, 1988, AVIAN DIS, V32, P527, DOI 10.2307/1590923; Stubbs AC, 2001, NAT MED, V7, P625, DOI 10.1038/87974; Tsukamoto K, 1999, VIROLOGY, V257, P352, DOI 10.1006/viro.1999.9641; TSUKAMOTO K, 1995, AVIAN DIS, V39, P218, DOI 10.2307/1591863; Tsukamoto K, 2002, J VIROL, V76, P5637, DOI 10.1128/JVI.76.11.5637-5645.2002; Uccelletti D, 2004, J BIOTECHNOL, V109, P93, DOI 10.1016/j.jbiotec.2003.10.037; VAKHARIA VN, 1994, VACCINE, V12, P452, DOI 10.1016/0264-410X(94)90124-4; van Ooyen AJJ, 2006, FEMS YEAST RES, V6, P381, DOI 10.1111/j.1567-1364.2006.00049.x; Villegas P, 2008, AVIAN DIS, V52, P670, DOI 10.1637/8289-032008-ResNote.1; WOOD GW, 1983, RES VET SCI, V35, P114, DOI 10.1016/S0034-5288(18)32213-6; Wu H, 2004, AVIAN DIS, V48, P663, DOI 10.1637/7074; Wu JX, 2007, PLANT BIOTECHNOL J, V5, P570, DOI 10.1111/j.1467-7652.2007.00270.x; WYETH PJ, 1982, VET REC, V110, P359, DOI 10.1136/vr.110.15.359; Xu XG, 2011, AVIAN DIS, V55, P223, DOI 10.1637/9597-111210-Reg.1; ZENKE FT, 1993, MOL CELL BIOL, V13, P7566, DOI 10.1128/MCB.13.12.7566; Zhou XM, 2010, VACCINE, V28, P3990, DOI 10.1016/j.vaccine.2010.03.021	79	41	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e42870	10.1371/journal.pone.0042870	http://dx.doi.org/10.1371/journal.pone.0042870			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024743	gold, Green Published, Green Submitted			2022-12-27	WOS:000308860100001
J	Park, SB; Seo, MS; Kim, HS; Kang, KS				Park, Sang-Bum; Seo, Min-Soo; Kim, Hyung-Sik; Kang, Kyung-Sun			Isolation and Characterization of Canine Amniotic Membrane-Derived Multipotent Stem Cells	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; MESENCHYMAL STROMAL CELLS; STEM/PROGENITOR CELLS; DIFFERENTIATION; TRANSPLANTATION; EXPRESSION; THERAPY; FLUID	Recent studies have shown that amniotic membrane tissue is a rich source of stem cells in humans. In clinical applications, the amniotic membrane tissue had therapeutic effects on wound healing and corneal surface reconstruction. Here, we successfully isolated and identified multipotent stem cells (MSCs) from canine amniotic membrane tissue. We cultured the canine amniotic membrane-derived multipotent stem cells (cAM-MSCs) in low glucose DMEM medium. cAM-MSCs have a fibroblast-like shape and adhere to tissue culture plastic. We characterized the immunophenotype of cAM-MSCs by flow cytometry and measured cell proliferation by the cumulative population doubling level (CPDL). We performed differentiation studies for the detection of trilineage multipotent ability, under the appropriate culture conditions. Taken together, our results show that cAM-MSCs could be a rich source of stem cells in dogs. Furthermore, cAM-MSCs may be useful as a cell therapy application for veterinary regenerative medicine.	[Park, Sang-Bum; Seo, Min-Soo; Kim, Hyung-Sik; Kang, Kyung-Sun] Seoul Natl Univ, Coll Vet Med, Adult Stem Cell Res Ctr, Seoul, South Korea; [Park, Sang-Bum; Seo, Min-Soo; Kim, Hyung-Sik; Kang, Kyung-Sun] Seoul Natl Univ, Coll Vet Med, Dept Vet Publ Hlth, Lab Stem Cell & Tumor Biol, Seoul, South Korea; [Park, Sang-Bum; Seo, Min-Soo; Kim, Hyung-Sik; Kang, Kyung-Sun] Seoul Natl Univ, Coll Vet Med, BK Program Vet Sci 21, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Park, SB (corresponding author), Seoul Natl Univ, Coll Vet Med, Adult Stem Cell Res Ctr, Seoul, South Korea.	kangpub@snu.ac.kr	Kang, Kyung-Sun/G-6205-2013		National Research Foundation of Korea (NRF) grant; Korean government (MEST) [2010-0020265]	National Research Foundation of Korea (NRF) grant(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST, 2010-0020265). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Byeon YE, 2010, CYTOTHERAPY, V12, P626, DOI 10.3109/14653249.2010.481665; Csaki C, 2007, HISTOCHEM CELL BIOL, V128, P507, DOI 10.1007/s00418-007-0337-z; Diaz-Prado S, 2010, TISSUE ENG C; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x; Gargett CE, 2006, AUST NZ J OBSTET GYN, V46, P250, DOI 10.1111/j.1479-828X.2006.00582.x; Jurga M, 2006, J NEUROSCI RES, V83, P627, DOI 10.1002/jnr.20766; Kamishina H, 2006, AM J VET RES, V67, P1921, DOI 10.2460/ajvr.67.11.1921; Kita K, 2010, STEM CELLS DEV, V19, P491, DOI 10.1089/scd.2009.0192; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Masson NM, 2006, AM J PHYSIOL-GASTR L, V291, pG45, DOI 10.1152/ajpgi.00465.2005; Mead Laura E, 2008, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02c01s6; Mihu CM, 2009, ROM J MORPHOL EMBRYO, V50, P73; Miki Toshio, 2010, Curr Protoc Stem Cell Biol, VChapter 1, DOI [10.1002/9780470151808.sc01e03s3, 10.1002/9780470151808.sc01e03s12]; Nakamura Y, 2006, BRIT J DERMATOL, V154, P1062, DOI 10.1111/j.1365-2133.2006.07209.x; Oh HJ, 2011, THERIOGENOLOGY, V75, P1221, DOI 10.1016/j.theriogenology.2010.11.035; Park SB, 2009, GROWTH FACTORS, V27, P425, DOI 10.3109/08977190903289875; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Perin L, 2007, CELL PROLIFERAT, V40, P936, DOI 10.1111/j.1365-2184.2007.00478.x; Rada T, 2011, STEM CELL REV REP, V7, P64, DOI 10.1007/s12015-010-9147-0; Ryu HH, 2009, J VET SCI, V10, P273, DOI 10.4142/jvs.2009.10.4.273; Seo MS, 2009, J VET SCI, V10, P181, DOI 10.4142/jvs.2009.10.3.181; Troyer DL, 2008, STEM CELLS, V26, P591, DOI 10.1634/stemcells.2007-0439; Uranio MF, 2011, MOL REPROD DEV, V78, P361, DOI 10.1002/mrd.21311; Vieira NM, 2010, CELL TRANSPLANT, V19, P279, DOI 10.3727/096368909X481764; Wang JF, 2004, HAEMATOLOGICA, V89, P837; Yu SJ, 2009, CELL TRANSPLANT, V18, P111, DOI 10.3727/096368909788341243	27	60	62	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44693	10.1371/journal.pone.0044693	http://dx.doi.org/10.1371/journal.pone.0044693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024756	Green Published, Green Submitted, gold			2022-12-27	WOS:000308860100014
J	de Oliveira, LAS; Imbiriba, LA; Russo, MM; Nogueira-Campos, AA; Rodrigues, ED; Pereira, MG; Volchan, E; Vargas, CD				Santos de Oliveira, Laura Alice; Imbiriba, Luis Aureliano; Russo, Maite Mello; Nogueira-Campos, Anaelli A.; Rodrigues, Erika de C.; Pereira, Mirtes G.; Volchan, Eliane; Vargas, Claudia Domingues			Preparing to Grasp Emotionally Laden Stimuli	PLOS ONE			English	Article							SUPPLEMENTARY MOTOR AREA; TRANSCRANIAL MAGNETIC STIMULATION; MOVEMENT-RELATED POTENTIALS; POSTERIOR PARIETAL CORTEX; VOLUNTARY MOVEMENT; READINESS; EXCITABILITY; MODULATION; ACTIVATION; OBJECTS	Background: Contemporary theories of motor control propose that motor planning involves the prediction of the consequences of actions. These predictions include the associated costs as well as the rewarding nature of movements' outcomes. Within the estimation of these costs and rewards would lie the valence, that is, the pleasantness or unpleasantness of a given stimulus with which one is about to interact. The aim of this study was to test if motor preparation encompasses valence. Methodology/Principal Findings: The readiness potential, an electrophysiological marker of motor preparation, was recorded before the grasping of pleasant, neutral and unpleasant stimuli. Items used were balanced in weight and placed inside transparent cylinders to prompt a similar grip among trials. Compared with neutral stimuli, the grasping of pleasant stimuli was preceded by a readiness potential of lower amplitude, whereas that of unpleasant stimuli was associated with a readiness potential of higher amplitude. Conclusions/Significance: We show for the first time that the sensorimotor cortex activity preceding the grasping of a stimulus is affected by its valence. Smaller readiness potential amplitudes found for pleasant stimuli could imply in the recruitment of pre-set motor repertoires, whereas higher amplitudes found for unpleasant stimuli would emerge from a discrepancy between the required action and their aversiveness. Our results indicate that the prediction of action outcomes encompasses an estimate of the valence of a stimulus with which one is about to interact.	[Santos de Oliveira, Laura Alice; Russo, Maite Mello; Nogueira-Campos, Anaelli A.; Volchan, Eliane; Vargas, Claudia Domingues] Univ Fed Rio de Janeiro, Programa Neurobiol Inst Biofis Carlos Chgas Filho, Lab Neurobiol 2, Rio De Janeiro, Brazil; [Santos de Oliveira, Laura Alice; Rodrigues, Erika de C.] Ctr Univ Augusto Motta UNISUAM, Programa Posgraduacao Ciencias Reabilitacao, Rio De Janeiro, Brazil; [Imbiriba, Luis Aureliano] Univ Fed Rio de Janeiro, Escola Educ Fis & Desportos, Rio De Janeiro, Brazil; [Pereira, Mirtes G.] Univ Fed Fluminense, Inst Biomed, Niteroi, RJ, Brazil	Universidade Federal do Rio de Janeiro; Centro Universitario Augusto Motta (UNISUAM); Universidade Federal do Rio de Janeiro; Universidade Federal Fluminense	de Oliveira, LAS (corresponding author), Univ Fed Rio de Janeiro, Programa Neurobiol Inst Biofis Carlos Chgas Filho, Lab Neurobiol 2, Rio De Janeiro, Brazil.	cdvargas@biof.ufrj.br	Volchan, Eliane/C-5792-2013; de Oliveira, Laura A S/T-2180-2017; de Carvalho Rodrigues, Erika/AAE-9445-2020; Pereira, Mirtes Garcia/J-6222-2016; Rodrigues, Erika/R-6007-2017; Vargas, Claudia D./A-1523-2016	de Oliveira, Laura A S/0000-0002-5554-457X; de Carvalho Rodrigues, Erika/0000-0001-5464-2963; Pereira, Mirtes Garcia/0000-0003-4682-223X; Rodrigues, Erika/0000-0001-5464-2963; Vargas, Claudia D./0000-0001-6202-3580	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/Comite Frances de Avaliacao da Cooperacao Universitaria e Cientifica com o Brasil (CAPES/COFECUB); Rede Instituto Brasileiro de Neurociencia (IBN Net)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/Comite Frances de Avaliacao da Cooperacao Universitaria e Cientifica com o Brasil (CAPES/COFECUB); Rede Instituto Brasileiro de Neurociencia (IBN Net)	Funding was provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/Comite Frances de Avaliacao da Cooperacao Universitaria e Cientifica com o Brasil (CAPES/COFECUB) and Rede Instituto Brasileiro de Neurociencia (IBN Net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; BAUER H, 1981, PSYCHOPHYSIOLOGY, V18, P466, DOI 10.1111/j.1469-8986.1981.tb02482.x; Baumgartner T, 2007, NEUROREPORT, V18, P261, DOI 10.1097/WNR.0b013e328012272e; Bradley MM, 2001, EMOTION, V1, P300, DOI 10.1037//1528-3542.1.3.300; Butler T, 2007, NEUROSCIENCE, V150, P1, DOI 10.1016/j.neuroscience.2007.09.048; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Coelho CM, 2010, NEUROSCI LETT, V481, P135, DOI 10.1016/j.neulet.2010.03.027; Colebatch JG, 2007, MOVEMENT DISORD, V22, P601, DOI 10.1002/mds.21323; Cooke DF, 2004, J NEUROPHYSIOL, V91, P1648, DOI 10.1152/jn.00955.2003; Cooke DF, 2003, J NEUROPHYSIOL, V90, P3317, DOI 10.1152/jn.00513.2003; Coombes SA, 2012, CEREB CORTEX, V22, P616, DOI 10.1093/cercor/bhr141; Coombes SA, 2009, COGN AFFECT BEHAV NE, V9, P380, DOI 10.3758/CABN.9.4.380; Cunnington R, 2005, HUM MOVEMENT SCI, V24, P644, DOI 10.1016/j.humov.2005.10.001; Cunnington R, 2003, NEUROIMAGE, V20, P404, DOI 10.1016/S1053-8119(03)00291-X; Darwin C., 1872, P374; DEAN P, 1989, TRENDS NEUROSCI, V12, P137, DOI 10.1016/0166-2236(89)90052-0; DEECKE L, 1990, REV NEUROL, V146, P612; DEECKE L, 1987, CIBA F SYMP, V132, P231; Dirnberger G, 2011, INT J PSYCHOPHYSIOL, V81, P127, DOI 10.1016/j.ijpsycho.2011.04.008; Elliot JA, 2008, APPROACH AVOIDANCE M, P3; Grafton ST, 1997, NEUROIMAGE, V6, P231, DOI 10.1006/nimg.1997.0293; Graziano M, 2006, ANNU REV NEUROSCI, V29, P105, DOI 10.1146/annurev.neuro.29.051605.112924; Graziano MSA, 2006, NEUROPSYCHOLOGIA, V44, P845, DOI 10.1016/j.neuropsychologia.2005.09.009; Grecucci A, 2009, ARCH ITAL BIOL, V147, P37, DOI 10.4449/aib.v147i1/2.755; Hajcak G, 2007, PSYCHOPHYSIOLOGY, V44, P91, DOI 10.1111/j.1469-8986.2006.00487.x; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; IKEDA A, 1992, BRAIN, V115, P1017, DOI 10.1093/brain/115.4.1017; Jahanshahi M, 2003, MOVEMENT DISORD, V18, P1470, DOI 10.1002/mds.10595; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; KAWATO M, 1987, BIOL CYBERN, V57, P169, DOI 10.1007/BF00364149; KELLER I, 1990, ELECTROEN CLIN NEURO, V76, P351, DOI 10.1016/0013-4694(90)90036-J; Kilner JM, 2004, NAT NEUROSCI, V7, P1299, DOI 10.1038/nn1355; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Kristeva-Feige R, 1997, BRAIN RES PROTOC, V1, P13, DOI 10.1016/S1385-299X(97)80327-3; Lang P.J., 2008, A8 U FLOR; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; Lloyd D, 2006, J NEUROPHYSIOL, V95, P205, DOI 10.1152/jn.00614.2005; Lloyd DM, 2009, NEUROSCI BIOBEHAV R, V33, P297, DOI 10.1016/j.neubiorev.2008.09.007; Makris S, 2011, BRAIN COGNITION, V77, P257, DOI 10.1016/j.bandc.2011.08.002; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; McCallum WC, 1993, HUMAN SLOW POTENTIAL, P1; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Morecraft RJ, 1997, NEUROREPORT, V8, P3933; Morrison I, 2007, CEREB CORTEX, V17, P2214, DOI 10.1093/cercor/bhl129; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveri M, 2003, EXP BRAIN RES, V149, P214, DOI 10.1007/s00221-002-1346-8; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Pereira MG, 2006, EMOTION, V6, P622, DOI 10.1037/1528-3542.6.4.622; Pereira MG, 2010, COGN AFFECT BEHAV NE, V10, P94, DOI 10.3758/CABN.10.1.94; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; Proverbio AM, 2011, NEUROPSYCHOLOGIA, V49, P2711, DOI 10.1016/j.neuropsychologia.2011.05.019; Reynolds SM, 2008, NAT NEUROSCI, V11, P423, DOI 10.1038/nn2061; Sabatinelli D, 2004, NEUROREPORT, V15, P1109, DOI 10.1097/00001756-200405190-00005; Schutter DJLG, 2008, PSYCHOPHYSIOLOGY, V45, P345, DOI 10.1111/j.1469-8986.2007.00635.x; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; Shibasaki H, 2006, CLIN NEUROPHYSIOL, V117, P2341, DOI 10.1016/j.clinph.2006.04.025; Stepniewska I, 2005, P NATL ACAD SCI USA, V102, P4878, DOI 10.1073/pnas.0501048102; Takikawa Y, 2002, EXP BRAIN RES, V142, P284, DOI 10.1007/s00221-001-0928-1; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; van Loon AM, 2010, COGN AFFECT BEHAV NE, V10, P174, DOI 10.3758/CABN.10.2.174; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Xu-Wilson M, 2009, EXP BRAIN RES, V196, P475, DOI 10.1007/s00221-009-1879-1; Yazawa S, 2000, EXP BRAIN RES, V131, P165, DOI 10.1007/s002219900311	65	16	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45235	10.1371/journal.pone.0045235	http://dx.doi.org/10.1371/journal.pone.0045235			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024811	Green Published, Green Submitted, gold			2022-12-27	WOS:000308860100069
J	Spangler, JB; Ficklin, SP; Luo, F; Freeling, M; Feltus, FA				Spangler, Jacob B.; Ficklin, Stephen P.; Luo, Feng; Freeling, Michael; Feltus, F. Alex			Conserved Non-Coding Regulatory Signatures in Arabidopsis Co-Expressed Gene Modules	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; GENOME DUPLICATIONS; NETWORKS; EXPRESSION; STORAGE; THALIANA; ELEMENTS; BIOLOGY; ORGANIZATION; INFORMATION	Complex traits and other polygenic processes require coordinated gene expression. Co-expression networks model mRNA co-expression: the product of gene regulatory networks. To identify regulatory mechanisms underlying coordinated gene expression in a tissue-enriched context, ten Arabidopsis thaliana co-expression networks were constructed after manually sorting 4,566 RNA profiling datasets into aerial, flower, leaf, root, rosette, seedling, seed, shoot, whole plant, and global (all samples combined) groups. Collectively, the ten networks contained 30% of the measurable genes of Arabidopsis and were circumscribed into 5,491 modules. Modules were scrutinized for cis regulatory mechanisms putatively encoded in conserved non-coding sequences (CNSs) previously identified as remnants of a whole genome duplication event. We determined the non-random association of 1,361 unique CNSs to 1,904 co-expression network gene modules. Furthermore, the CNS elements were placed in the context of known gene regulatory networks (GRNs) by connecting 250 CNS motifs with known GRN cis elements. Our results provide support for a regulatory role of some CNS elements and suggest the functional consequences of CNS activation of co-expression in specific gene sets dispersed throughout the genome.	[Spangler, Jacob B.; Feltus, F. Alex] Clemson Univ, Dept Biochem & Genet, Clemson, SC 29634 USA; [Luo, Feng] Clemson Univ, Sch Comp, Clemson, SC USA; [Freeling, Michael] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	Clemson University; Clemson University; University of California System; University of California Berkeley	Spangler, JB (corresponding author), Clemson Univ, Dept Biochem & Genet, Clemson, SC 29634 USA.	ffeltus@clemson.edu	Ficklin, Stephen/L-4324-2019	Ficklin, Stephen/0000-0001-9138-6292; Feltus, Frank/0000-0002-2123-6114	National Science Foundation [MCB-0820345]; Division Of Computer and Network Systems [1228312] Funding Source: National Science Foundation; Div Of Molecular and Cellular Bioscience [0820821] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grant MCB-0820345 from the National Science Foundation to FAF (http://www.nsf.gov/awardsearch/showAward.do?AwardNumber = 0820345). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2001, PHYSICA A, V299, P559, DOI 10.1016/S0378-4371(01)00369-7; Barker MS, 2009, GENOME BIOL EVOL, V1, P391, DOI 10.1093/gbe/evp040; Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Childs KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022196; Dongen S, 2000, CLUSTER ALGORITHM GR; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Ficklin SP, 2010, PLANT PHYSL; Ficklin SP, 2011, PLANT PHYSIOL, V156, P1244, DOI 10.1104/pp.111.173047; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Freeling M, 2009, CURR OPIN PLANT BIOL, V12, P126, DOI 10.1016/j.pbi.2009.01.005; Gruis D, 2002, PLANT CELL, V14, P2863, DOI 10.1105/tpc.005009; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hughes MA, 1996, J EXP BOT, V47, P291, DOI 10.1093/jxb/47.3.291; Jeziorska DM, 2009, SEMIN CELL DEV BIOL, V20, P856, DOI 10.1016/j.semcdb.2009.07.007; Kalinka Alex T, 2011, Bioinformatics, V27, P2011, DOI 10.1093/bioinformatics/btr311; Kim HU, 2002, J BIOL CHEM, V277, P22677, DOI 10.1074/jbc.M109298200; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Leskovec J, 2010, J MACH LEARN RES, V11, P985; Luo F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-299; Ma SS, 2007, GENOME RES, V17, P1614, DOI 10.1101/gr.6911207; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Mao LY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-346; Mejia-Guerra MK, 2012, BBA-GENE REGUL MECH, V1819, P454, DOI 10.1016/j.bbagrm.2012.02.016; Moreno-Risueno MA, 2010, CURR OPIN PLANT BIOL, V13, P126, DOI 10.1016/j.pbi.2009.11.005; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; Palaniswamy SK, 2006, PLANT PHYSIOL, V140, P818, DOI 10.1104/pp.105.072280; PANG PP, 1988, PLANT MOL BIOL, V11, P805, DOI 10.1007/BF00019521; Peng FY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-286; Ruuska SA, 2002, PLANT CELL, V14, P1191, DOI 10.1105/tpc.000877; Spangler JB, 2012, NEW PHYTOL, V193, P241, DOI 10.1111/j.1469-8137.2011.03916.x; Thomas BC, 2007, P NATL ACAD SCI USA, V104, P3348, DOI 10.1073/pnas.0611574104; Vogel C., 2010, MOL SYST BIOL, P6; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Woodhouse MR, 2011, PLANT CELL, V23, P4241, DOI 10.1105/tpc.111.093567; Yilmaz A, 2011, NUCLEIC ACIDS RES, V39, pD1118, DOI 10.1093/nar/gkq1120; Zheng XQ, 2011, J PLANT PHYSIOL, V168, P611, DOI 10.1016/j.jplph.2010.09.010	44	7	8	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45041	10.1371/journal.pone.0045041	http://dx.doi.org/10.1371/journal.pone.0045041			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024789	Green Published, gold, Green Submitted			2022-12-27	WOS:000308860100047
J	Delwig, A; Logan, AM; Copenhagen, DR; Ahn, AH				Delwig, Anton; Logan, Anne M.; Copenhagen, David R.; Ahn, Andrew H.			Light Evokes Melanopsin-Dependent Vocalization and Neural Activation Associated with Aversive Experience in Neonatal Mice	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; RETINAL GANGLION-CELLS; PAIN PERCEPTION; PATHWAYS; OPSIN; STIMULATION; AMYGDALA; MOUSE; RAT; SENSITIZATION	Melanopsin-expressing intrinsically photosensitive retinal ganglion cells (ipRGCs) are the only functional photoreceptive cells in the eye of newborn mice. Through postnatal day 9, in the absence of functional rods and cones, these ipRGCs mediate a robust avoidance behavior to a light source, termed negative phototaxis. To determine whether this behavior is associated with an aversive experience in neonatal mice, we characterized light-induced vocalizations and patterns of neuronal activation in regions of the brain involved in the processing of aversive and painful stimuli. Light evoked distinct melanopsin-dependent ultrasonic vocalizations identical to those emitted under stressful conditions, such as isolation from the litter. In contrast, light did not evoke the broad-spectrum calls elicited by acute mechanical pain. Using markers of neuronal activation, we found that light induced the immediate-early gene product Fos in the posterior thalamus, a brain region associated with the enhancement of responses to mechanical stimulation of the dura by light, and thought to be the basis for migrainous photophobia. Additionally, light induced the phosphorylation of extracellular-related kinase (pERK) in neurons of the central amygdala, an intracellular signal associated with the processing of the aversive aspects of pain. However, light did not activate Fos expression in the spinal trigeminal nucleus caudalis, the primary receptive field for painful stimulation to the head. We conclude that these light-evoked vocalizations and the distinct pattern of brain activation in neonatal mice are consistent with a melanopsin-dependent neural pathway involved in processing light as an aversive but not acutely painful stimulus.	[Delwig, Anton; Copenhagen, David R.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Logan, Anne M.; Ahn, Andrew H.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Copenhagen, David R.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Ahn, Andrew H.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Delwig, A (corresponding author), Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA.	cope@phy.ucsf.edu; ahn@neurology.ufl.edu		Ahn, Andrew H/0000-0003-1780-9300	National Institutes of Health [NS066091, EY01869]; March of Dimes; Research to Prevent Blindness (Department of Ophthalmology); Knights Templar Eye Foundation; ARRA [NS047113]; National Eye Institute (Core grant) [EY 002162]; NATIONAL EYE INSTITUTE [P30EY002162, R01EY001869, R37EY001869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS047113, K02NS066091] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Research to Prevent Blindness (Department of Ophthalmology)(Research to Prevent Blindness (RPB)); Knights Templar Eye Foundation; ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute (Core grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funding from the National Institutes of Health NS066091 (AHA), EY01869 (DRC), March of Dimes (DRC) and Research to Prevent Blindness (Department of Ophthalmology and DRC), Knights Templar Eye Foundation (AD), a supplement funded by the ARRA NS047113 (AHA) and National Eye Institute (Core grant EY 002162). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard JF, 1996, PROG BRAIN RES, V107, P243; Blackshaw S, 1999, J NEUROSCI, V19, P3681; Brown TM, 2011, J PHYSIOL-LONDON, V589, P1173, DOI 10.1113/jphysiol.2010.199877; Brown TM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000558; Carrasquillo Y, 2007, J NEUROSCI, V27, P1543, DOI 10.1523/JNEUROSCI.3536-06.2007; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; Crozier WJ, 1927, J GEN PHYSIOL, V10, P407, DOI 10.1085/jgp.10.3.407; de Prado BM, 2009, J PAIN, V10, P992, DOI 10.1016/j.jpain.2009.03.018; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; Dobolyi A, 2005, J COMP NEUROL, V489, P92, DOI 10.1002/cne.20618; Dolgonos S, 2011, INVEST OPHTH VIS SCI, V52, P7852, DOI 10.1167/iovs.11-7604; DRUMMOND PD, 1993, CEPHALALGIA, V13, P321, DOI 10.1046/j.1468-2982.1993.1305321.x; Haack B., 1983, AUDITORY PSYCHOBIOLO, P57; Hamilton R, 2005, EARLY HUM DEV, V81, P461, DOI 10.1016/j.earlhumdev.2004.10.019; Han JS, 2005, J NEUROSCI, V25, P10717, DOI 10.1523/JNEUROSCI.4112-05.2005; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Hofer Myron A, 2002, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0814s17; Ito M, 1999, ANAT EMBRYOL, V200, P403, DOI 10.1007/s004290050289; Johnson J, 2010, P NATL ACAD SCI USA, V107, P17374, DOI 10.1073/pnas.1008533107; Kowacs PA, 2001, CEPHALALGIA, V21, P184, DOI 10.1046/j.1468-2982.2001.00178.x; Lasky RE, 2009, PEDIATRICS, V123, P540, DOI 10.1542/peds.2007-3418; Lemasson M, 2005, BEHAV PROCESS, V68, P13, DOI 10.1016/j.beproc.2004.09.001; Lupi D, 2008, NAT NEUROSCI, V11, P1068, DOI 10.1038/nn.2179; Morag I, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006982.pub2; Noseda R, 2010, NAT NEUROSCI; Okamoto K, 2009, NEUROSCIENCE, V160, P858, DOI 10.1016/j.neuroscience.2009.03.003; Okamoto K, 2010, PAIN, V149, P235, DOI 10.1016/j.pain.2010.02.004; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Qiu J, 2006, NATURE, V444, P143, DOI 10.1038/444143a; Recober A, 2010, NEUROPHARMACOLOGY, V58, P156, DOI 10.1016/j.neuropharm.2009.07.009; Recober A, 2009, J NEUROSCI, V29, P8798, DOI 10.1523/JNEUROSCI.1727-09.2009; ROUTTENBERG A, 1978, DEV PSYCHOBIOL, V11, P469, DOI 10.1002/dev.420110510; Shogan M G, 1993, Neonatal Netw, V12, P7; Tarttelin EE, 2003, FEBS LETT, V554, P410, DOI 10.1016/S0014-5793(03)01212-2; Tarttelin EE, 2003, EXP EYE RES, V76, P393, DOI 10.1016/S0014-4835(02)00300-7; THORINGTON L, 1985, ANN NY ACAD SCI, V453, P28, DOI 10.1111/j.1749-6632.1985.tb11796.x; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; YASUI Y, 1991, J COMP NEUROL, V308, P293, DOI 10.1002/cne.903080212	40	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e43787	10.1371/journal.pone.0043787	http://dx.doi.org/10.1371/journal.pone.0043787			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028470	Green Submitted, Green Published, gold			2022-12-27	WOS:000308788700012
J	Mahe, S; Duhamel, M; Le Calvez, T; Guillot, L; Sarbu, L; Bretaudeau, A; Collin, O; Dufresne, A; Kiers, ET; Vandenkoornhuyse, P				Mahe, Stephane; Duhamel, Marie; Le Calvez, Thomas; Guillot, Laetitia; Sarbu, Ludmila; Bretaudeau, Anthony; Collin, Olivier; Dufresne, Alexis; Kiers, E. Toby; Vandenkoornhuyse, Philippe			PHYMYCO-DB: A Curated Database for Analyses of Fungal Diversity and Evolution	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; MOLECULAR-IDENTIFICATION; PHYLOGENY; SEQUENCES; TREE; CLASSIFICATION; RELIABILITY; PROGRESS; ANIMALS; ORIGINS	Background: In environmental sequencing studies, fungi can be identified based on nucleic acid sequences, using either highly variable sequences as species barcodes or conserved sequences containing a high-quality phylogenetic signal. For the latter, identification relies on phylogenetic analyses and the adoption of the phylogenetic species concept. Such analysis requires that the reference sequences are well identified and deposited in public-access databases. However, many entries in the public sequence databases are problematic in terms of quality and reliability and these data require screening to ensure correct phylogenetic interpretation. Methods and Principal Findings: To facilitate phylogenetic inferences and phylogenetic assignment, we introduce a fungal sequence database. The database PHYMYCO-DB comprises fungal sequences from GenBank that have been filtered to satisfy stringent sequence quality criteria. For the first release, two widely used molecular taxonomic markers were chosen: the nuclear SSU rRNA and EF1-alpha gene sequences. Following the automatic extraction and filtration, a manual curation is performed to remove problematic sequences while preserving relevant sequences useful for phylogenetic studies. As a result of curation, similar to 20% of the automatically filtered sequences have been removed from the database. To demonstrate how PHYMYCO-DB can be employed, we test a set of environmental Chytridiomycota sequences obtained from deep sea samples. Conclusion: PHYMYCO-DB offers the tools necessary to: (i) extract high quality fungal sequences for each of the 5 fungal phyla, at all taxonomic levels, (ii) extract already performed alignments, to act as 'reference alignments', (iii) launch alignments of personal sequences along with stored data. A total of 9120 SSU rRNA and 672 EF1-alpha high-quality fungal sequences are now available. The PHYMYCO-DB is accessible through the URL http://phymycodb.genouest.org/.	[Mahe, Stephane; Duhamel, Marie; Le Calvez, Thomas; Dufresne, Alexis; Vandenkoornhuyse, Philippe] Univ Rennes 1, CNRS, UMR ECOBIO 6553, Rennes, France; [Mahe, Stephane; Duhamel, Marie; Le Calvez, Thomas; Guillot, Laetitia; Sarbu, Ludmila; Bretaudeau, Anthony; Collin, Olivier; Dufresne, Alexis; Vandenkoornhuyse, Philippe] Univ Europeenne Bretagne, Rennes, France; [Duhamel, Marie; Kiers, E. Toby] Vrije Univ Amsterdam, Dept Ecol Sci, Amsterdam, Netherlands; [Guillot, Laetitia; Sarbu, Ludmila; Bretaudeau, Anthony; Collin, Olivier] Univ Rennes 1, CNRS, UMR IRISA 6074, Rennes, France; [Le Calvez, Thomas] AQUASIM, Nantes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Rennes; Universite de Bretagne Occidentale; Vrije Universiteit Amsterdam; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Mahe, S (corresponding author), Univ Rennes 1, CNRS, UMR ECOBIO 6553, Campus Beaulieu, Rennes, France.	philippe.vandenkoornhuyse@univ-rennes1.fr	Toby, Kiers/H-4819-2017	Toby, Kiers/0000-0002-0597-1653; Collin, Olivier/0000-0002-8959-8402; Guillot, Laetitia/0000-0002-9990-0126; Dufresne, Alexis/0000-0001-8231-9098	Total Corporate Foundation for biodiversity and the sea; French National Agency for Research [ANR-10-STRA-002]; French ministry of research; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) "vidi'' and "meervoud'' grant	Total Corporate Foundation for biodiversity and the sea; French National Agency for Research(French National Research Agency (ANR)); French ministry of research(Ministry of Research, FranceEuropean Commission); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) "vidi'' and "meervoud'' grant(Netherlands Organization for Scientific Research (NWO))	This work was supported by a grant from the "Total Corporate Foundation for biodiversity and the sea'' and a grant from the French National Agency for Research within the Systerra call (ANR-10-STRA-002). MD has a Ph.D. grant from the French ministry of research. ETK is supported by an Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) "vidi'' and "meervoud'' grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, EVOL BIOINFORM, V6, P189, DOI 10.4137/EBO.S6271; Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Anderson IC, 2007, J MICROBIOL METH, V68, P248, DOI 10.1016/j.mimet.2006.08.005; Avise J, 2004, MOL MARKERS NATURAL; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Baldauf SL, 1999, AM NAT, V154, pS178, DOI 10.1086/303292; BALDAUF SL, 1993, P NATL ACAD SCI USA, V90, P11558, DOI 10.1073/pnas.90.24.11558; Bar-Hen A, 2008, MOL BIOL EVOL, V25, P869, DOI 10.1093/molbev/msn030; Bass D, 2007, P ROY SOC B-BIOL SCI, V274, P3069, DOI 10.1098/rspb.2007.1067; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bhattacharya D, 2002, J MOL EVOL, V55, P74, DOI 10.1007/s00239-001-2305-x; Bidartondo MI, 2008, SCIENCE, V319, P1616, DOI 10.1126/science.319.5870.1616a; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Boon E, 2010, J EVOLUTION BIOL, V23, P1519, DOI 10.1111/j.1420-9101.2010.02019.x; Bridge PD, 2004, NEW PHYTOL, V161, P15; Bridge PD, 2003, NEW PHYTOL, V160, P43, DOI 10.1046/j.1469-8137.2003.00861.x; Choi IG, 2007, P NATL ACAD SCI USA, V104, P4489, DOI 10.1073/pnas.0611557104; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; D'Auria G, 2006, BIOINFORMATICS, V22, P527, DOI 10.1093/bioinformatics/btk033; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Felsenstein J., 2004, INFERRING PHYLOGENIE; Hawksworth DL, 2009, NATURE, V458, P29, DOI 10.1038/458029c; Hawksworth DL, 1997, PHYTOPATHOLOGY, V87, P888, DOI 10.1094/PHYTO.1997.87.9.888; Hawksworth DL, 2004, NEW PHYTOL, V161, P13; Helgason T, 2003, FEMS MICROBIOL LETT, V229, P127, DOI 10.1016/S0378-1097(03)00802-4; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Holst-Jensen A, 2004, NEW PHYTOL, V161, P11, DOI 10.1111/j.1469-8137.2004.00961.x; Jones MDM, 2011, NATURE, V474, P200, DOI 10.1038/nature09984; Kaminuma E, 2011, NUCLEIC ACIDS RES, V39, pD22, DOI 10.1093/nar/gkq1041; Koljalg U, 2005, NEW PHYTOL, V166, P1063, DOI 10.1111/j.1469-8137.2005.01376.x; Kulikova T, 2007, NUCLEIC ACIDS RES, V35, pD16, DOI 10.1093/nar/gkl913; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le Calvez T, 2009, APPL ENVIRON MICROB, V75, P6415, DOI 10.1128/AEM.00653-09; Lim YW, 2008, ANTON LEEUW INT J G, V93, P99, DOI 10.1007/s10482-007-9184-0; Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446; Moon CD, 2002, MYCOLOGIA, V94, P694, DOI 10.2307/3761720; Nilsson RH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000059; Opik M, 2010, NEW PHYTOL, V188, P223, DOI 10.1111/j.1469-8137.2010.03334.x; Pace NR, 2009, MICROBIOL MOL BIOL R, V73, P565, DOI 10.1128/MMBR.00033-09; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Powell JR, 2011, MOL ECOL, V20, P655, DOI 10.1111/j.1365-294X.2010.04964.x; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; SANDERS IR, 1995, NEW PHYTOL, V130, P419, DOI 10.1111/j.1469-8137.1995.tb01836.x; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Simmons DR, 2009, MYCOL RES, V113, P450, DOI 10.1016/j.mycres.2008.11.019; Tanabe Y, 2004, MOL PHYLOGENET EVOL, V30, P438, DOI 10.1016/S1055-7903(03)00185-4; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Vandenkoornhuyse P, 2002, MOL ECOL, V11, P1555, DOI 10.1046/j.1365-294X.2002.01538.x; Vandenkoornhuyse P, 1998, MYCOLOGIA, V90, P791, DOI 10.2307/3761320; Vandenkoornhuyse P, 2002, SCIENCE, V295, P2051, DOI 10.1126/science.295.5562.2051; Vilgalys R, 2003, NEW PHYTOL, V160, P4, DOI 10.1046/j.1469-8137.2003.00894.x; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Woese CR, 2000, P NATL ACAD SCI USA, V97, P8392, DOI 10.1073/pnas.97.15.8392; Xu Pengfei, 2007, Journal of Genetics and Genomics, V34, P180, DOI 10.1016/S1673-8527(07)60019-8	55	22	23	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e43117	10.1371/journal.pone.0043117	http://dx.doi.org/10.1371/journal.pone.0043117			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028445	Green Published, gold			2022-12-27	WOS:000308788700009
J	Dollezal, LV; Beutelmann, R; Klump, GM				Dollezal, Lena-Vanessa; Beutelmann, Rainer; Klump, Georg M.			Stream Segregation in the Perception of Sinusoidally Amplitude-Modulated Tones	PLOS ONE			English	Article							SONGBIRD FOREBRAIN; AUDITORY-CORTEX; MODEL STRUCTURE; TIME INTERVALS; SPECTRAL CUES; FREQUENCY; SEQUENCES; CARRIERS; MASKING; NOISE	Amplitude modulation can serve as a cue for segregating streams of sounds from different sources. Here we evaluate stream segregation in humans using ABA-sequences of sinusoidally amplitude modulated (SAM) tones. A and B represent SAM tones with the same carrier frequency (1000, 4000 Hz) and modulation depth (30, 100%). The modulation frequency of the A signals (f(modA)) was 30, 100 or 300 Hz, respectively. The modulation frequency of the B signals was up to four octaves higher (Delta f(mod)). Three different ABA-tone patterns varying in tone duration and stimulus onset asynchrony were presented to evaluate the effect of forward suppression. Subjects indicated their 1- or 2-stream percept on a touch screen at the end of each ABA-sequence (presentation time 5 or 15 s). Tone pattern, f(modA), Delta f(mod), carrier frequency, modulation depth and presentation time significantly affected the percentage of a 2-stream percept. The human psychophysical results are compared to responses of avian forebrain neurons evoked by different ABA-SAM tone conditions [1] that were broadly overlapping those of the present study. The neurons also showed significant effects of tone pattern and Delta f(mod) that were comparable to effects observed in the present psychophysical study. Depending on the carrier frequency, modulation frequency, modulation depth and the width of the auditory filters, SAM tones may provide mainly temporal cues (sidebands fall within the range of the filter), spectral cues (sidebands fall outside the range of the filter) or possibly both. A computational model based on excitation pattern differences was used to predict the 50% threshold of 2-stream responses. In conditions for which the model predicts a considerably larger 50% threshold of 2-stream responses (i.e., larger Delta f(mod) at threshold) than was observed, it is unlikely that spectral cues can provide an explanation of stream segregation by SAM.	[Dollezal, Lena-Vanessa; Beutelmann, Rainer; Klump, Georg M.] Carl von Ossietzky Univ Oldenburg, Dept Biol & Environm Sci, Anim Physiol & Behav Grp, D-2900 Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg	Dollezal, LV (corresponding author), Carl von Ossietzky Univ Oldenburg, Dept Biol & Environm Sci, Anim Physiol & Behav Grp, D-2900 Oldenburg, Germany.	lena.vanessa.dollezal@uni-oldenburg.de		Beutelmann, Rainer/0000-0001-9708-4113	Deutsche Forschungsgemeinschaft [SFB TRR 31, GRK 591]; Georg Christoph Lichtenberg stipend of the country of Lower Saxony	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Georg Christoph Lichtenberg stipend of the country of Lower Saxony	This research was supported by the Deutsche Forschungsgemeinschaft (SFB TRR 31, GRK 591) and by a Georg Christoph Lichtenberg stipend of the country of Lower Saxony to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSTIS S, 1985, J EXP PSYCHOL HUMAN, V11, P257, DOI 10.1037/0096-1523.11.3.257; Beauvois MW, 1996, J ACOUST SOC AM, V99, P2270, DOI 10.1121/1.415414; Beauvois MW, 1998, PERCEPT PSYCHOPHYS, V60, P852, DOI 10.3758/BF03206068; Bee MA, 2005, BRAIN BEHAV EVOLUT, V66, P197, DOI 10.1159/000087854; Bee MA, 2004, J NEUROPHYSIOL, V92, P1088, DOI 10.1152/jn.00884.2003; Bee MA, 2010, J COMP PHYSIOL A, V196, P543, DOI 10.1007/s00359-010-0542-4; Breebaart J, 2001, J ACOUST SOC AM, V110, P1074, DOI 10.1121/1.1383297; Bregman A.S., 1990, AUDITORY SCENE ANAL; BREGMAN AS, 1978, J EXP PSYCHOL HUMAN, V4, P380, DOI 10.1037/0096-1523.4.3.380; Bregman AS, 2000, PERCEPT PSYCHOPHYS, V62, P626, DOI 10.3758/BF03212114; Cusack R, 1999, PERCEPTION, V28, P1281, DOI 10.1068/p2804; Dau T, 1996, J ACOUST SOC AM, V99, P3615, DOI 10.1121/1.414959; Dau T, 1997, J ACOUST SOC AM, V102, P2892, DOI 10.1121/1.420344; Fishman YI, 2004, J ACOUST SOC AM, V116, P1656, DOI 10.1121/1.1778903; Fishman YI, 2001, HEARING RES, V151, P167, DOI 10.1016/S0378-5955(00)00224-0; GLASBERG BR, 1990, HEARING RES, V47, P103, DOI 10.1016/0378-5955(90)90170-T; Grimault N, 2002, J ACOUST SOC AM, V111, P1340, DOI 10.1121/1.1452740; Gutschalk A, 2007, J NEUROSCI, V27, P13074, DOI 10.1523/JNEUROSCI.2299-07.2007; HARTMANN WM, 1991, MUSIC PERCEPT, V9, P155; HAUSER R, 1991, J ACOUST SOC AM, V89, P280, DOI 10.1121/1.400511; Hohmann V, 2002, ACTA ACUST UNITED AC, V88, P433; Itatani N, 2011, J NEUROPHYSIOL, V105, P188, DOI 10.1152/jn.00496.2010; Itatani N, 2009, J NEUROPHYSIOL, V101, P3212, DOI 10.1152/jn.91333.2008; Klump Georg, 2000, P193, DOI 10.1002/9783527609734.ch7; Kohlrausch A, 2000, J ACOUST SOC AM, V108, P723, DOI 10.1121/1.429605; Micheyl C, 2005, NEURON, V48, P139, DOI 10.1016/j.neuron.2005.08.039; Micheyl C, 2007, HEARING RES, V229, P116, DOI 10.1016/j.heares.2007.01.007; Moore BCJ, 2002, ACTA ACUST UNITED AC, V88, P320; MOORE BCJ, 1983, J ACOUST SOC AM, V73, P1249, DOI 10.1121/1.389273; MOORE BCJ, 1983, J ACOUST SOC AM, V74, P750, DOI 10.1121/1.389861; Moore BCJ, 2001, J ACOUST SOC AM, V110, P1067, DOI 10.1121/1.1385177; Roberts B, 2002, J ACOUST SOC AM, V112, P2074, DOI 10.1121/1.1508784; Strickland EA, 1997, J ACOUST SOC AM, V102, P1799, DOI 10.1121/1.419617; van Noorden L.P.A.S., 1975, TEMPORAL COHERENCE P; Vliegen J, 1999, J ACOUST SOC AM, V105, P339, DOI 10.1121/1.424503; Wiegrebe L, 1999, J ACOUST SOC AM, V106, P2709, DOI 10.1121/1.428099; Wilson EC, 2007, J NEUROPHYSIOL, V97, P2230, DOI 10.1152/jn.00788.2006; Wojtczak M, 2005, J ACOUST SOC AM, V118, P3198, DOI 10.1121/1.2042970; Wojtczak M, 2011, JARO-J ASSOC RES OTO, V12, P361, DOI 10.1007/s10162-010-0251-2	39	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43615	10.1371/journal.pone.0043615	http://dx.doi.org/10.1371/journal.pone.0043615			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984436	Green Published, gold, Green Submitted			2022-12-27	WOS:000308738500019
J	Gutierrez, PS; Monteoliva, D; Diambra, L				Gutierrez, Pablo S.; Monteoliva, Diana; Diambra, Luis			Cooperative Binding of Transcription Factors Promotes Bimodal Gene Expression Response	PLOS ONE			English	Article							ESCHERICHIA-COLI; DNA RECOGNITION; NOISE; CELL; STOCHASTICITY; MECHANISM; NETWORKS; BINARY; DIFFERENTIATION; CONSEQUENCES	In the present work we extend and analyze the scope of our recently proposed stochastic model for transcriptional regulation, which considers an arbitrarily complex cis-regulatory system using only elementary reactions. Previously, we determined the role of cooperativity on the intrinsic fluctuations of gene expression for activating transcriptional switches, by means of master equation formalism and computer simulation. This model allowed us to distinguish between two cooperative binding mechanisms and, even though the mean expression levels were not affected differently by the acting mechanism, we showed that the associated fluctuations were different. In the present generalized model we include other regulatory functions in addition to those associated to an activator switch. Namely, we introduce repressive regulatory functions and two theoretical mechanisms that account for the biphasic response that some cis-regulatory systems show to the transcription factor concentration. We have also extended our previous master equation formalism in order to include protein production by stochastic translation of mRNA. Furthermore, we examine the graded/binary scenarios in the context of the interaction energy between transcription factors. In this sense, this is the first report to show that the cooperative binding of transcription factors to DNA promotes the "all-or-none" phenomenon observed in eukaryotic systems. In addition, we confirm that gene expression fluctuation levels associated with one of two cooperative binding mechanism never exceed the fluctuation levels of the other.	[Gutierrez, Pablo S.; Diambra, Luis] Univ Nacl La Plata, Ctr Reg Estudios Genm, Buenos Aires, DF, Argentina; [Monteoliva, Diana] Univ Nacl La Plata, Inst Fis, Buenos Aires, DF, Argentina	National University of La Plata; National University of La Plata	Gutierrez, PS (corresponding author), Univ Nacl La Plata, Ctr Reg Estudios Genm, Buenos Aires, DF, Argentina.	ldiambra@gmail.com	L, Diambra/F-6319-2015	L, Diambra/0000-0001-8052-4880				Abeliovich H, 2005, BIOPHYS J, V89, P76, DOI 10.1529/biophysj.105.060194; Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; ACKERS GK, 1982, P NATL ACAD SCI-BIOL, V79, P1129, DOI 10.1073/pnas.79.4.1129; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Biggar SR, 2001, EMBO J, V20, P3167, DOI 10.1093/emboj/20.12.3167; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Buetti-Dinh A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.61; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; Dellarole M, 2010, BIOCHEMISTRY-US, V49, P10277, DOI 10.1021/bi1014908; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Ferreiro DU, 2008, P NATL ACAD SCI USA, V105, P10797, DOI 10.1073/pnas.0802383105; FIERING S, 1990, GENE DEV, V4, P1823, DOI 10.1101/gad.4.10.1823; Fiering S, 2000, BIOESSAYS, V22, P381, DOI 10.1002/(SICI)1521-1878(200004)22:4<381::AID-BIES8>3.0.CO;2-E; Freedman JA, 2009, ONCOGENE, V28, P2873, DOI 10.1038/onc.2009.153; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gaston K, 2003, CELL MOL LIFE SCI, V60, P721, DOI 10.1007/s00018-003-2260-3; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gutierrez PS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011914; Hill T. L., 1985, COOPERATIVITY THEORY; Hofer Thomas, 2005, Genome Inform, V16, P73; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hume DA, 2000, BLOOD, V96, P2323, DOI 10.1182/blood.V96.7.2323.h8002323_2323_2328; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; LI LH, 1994, EMBO J, V13, P4070, DOI 10.1002/j.1460-2075.1994.tb06724.x; Mugler A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.041921; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; NEGULESCU PA, 1994, P NATL ACAD SCI USA, V91, P2873, DOI 10.1073/pnas.91.7.2873; Ochab-Marcinek A, 2010, P NATL ACAD SCI USA, V107, P22096, DOI 10.1073/pnas.1008965107; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; PECCOUD J, 1995, THEOR POPUL BIOL, V48, P222, DOI 10.1006/tpbi.1995.1027; Pirone JR, 2004, J THEOR BIOL, V226, P111, DOI 10.1016/j.jtbi.2003.08.008; PTASHNE M, 2002, GENES SIGNALS; PTASHNE M, 2004, GENETIC SWITCH; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rossi FMV, 2000, MOL CELL, V6, P723, DOI 10.1016/S1097-2765(00)00070-8; Sanchez A, 2008, P NATL ACAD SCI USA, V105, P5081, DOI 10.1073/pnas.0707904105; Sanchez A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001100; Sasai M, 2003, P NATL ACAD SCI USA, V100, P2374, DOI 10.1073/pnas.2627987100; SAUER F, 1993, NATURE, V364, P454, DOI 10.1038/364454a0; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Shu CC, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002140; Sikorski TW, 2009, CURR OPIN CELL BIOL, V21, P344, DOI 10.1016/j.ceb.2009.03.006; Simpson ML, 2003, P NATL ACAD SCI USA, V100, P4551, DOI 10.1073/pnas.0736140100; Soto-Nieves N, 2009, J EXP MED, V206, P867, DOI 10.1084/jem.20082731; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Walczak AM, 2009, P NATL ACAD SCI USA, V106, P6529, DOI 10.1073/pnas.0811999106; WALTERS MC, 1995, P NATL ACAD SCI USA, V92, P7125, DOI 10.1073/pnas.92.15.7125; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; Wilhelm T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-90; Wong JV, 2011, MOL CELL, V41, P275, DOI 10.1016/j.molcel.2011.01.014; Zlokarnik G, 1998, SCIENCE, V279, P84, DOI 10.1126/science.279.5347.84	58	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44812	10.1371/journal.pone.0044812	http://dx.doi.org/10.1371/journal.pone.0044812			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984566	Green Submitted, gold, Green Published			2022-12-27	WOS:000308738500088
J	Koval, AP; Gogolevskaya, IK; Tatosyan, KA; Kramerov, DA				Koval, Anastasia P.; Gogolevskaya, Irina K.; Tatosyan, Karina A.; Kramerov, Dmitri A.			Complementarity of End Regions Increases the Lifetime of Small RNAs in Mammalian Cells	PLOS ONE			English	Article							AU-RICH ELEMENTS; NEURAL BC1 RNA; POLYMERASE-III; 5'-FLANKING SEQUENCES; EVOLUTIONARY HISTORY; NUCLEOTIDE-SEQUENCES; GENE-TRANSCRIPTION; NONCODING RNAS; MESSENGER-RNAS; NEURONAL BC1	Two RNAs (4.5SH and 4.5SI) with unknown functions share a number of features: short length (about 100 nt), transcription by RNA polymerase III, predominately nuclear localization, the presence in various tissues, and relatively narrow taxonomic distribution (4 and 3 rodent families, respectively). It was reported that 4.5SH RNA turns over rapidly, whereas 4.5SI RNA is stable in the cell, but their lifetimes remained unknown. We showed that 4.5SH is indeed short-lived (t(1/2)similar to 18 min) and 4.5SI is long-lived (t(1/2)similar to 22 h) in Krebs ascites carcinoma cells. The RNA structures specifying rapid or slow decay of different small cellular RNAs remain unstudied. We searched for RNA structural features that determine the short lifetime of 4.5SH in comparison with the long lifetime of 4.5SI RNA. The sequences of genes of 4.5SH and 4.5SI RNAs were altered and human cells (HeLa) were transfected with these genes. The decay rate of the original and altered RNAs was measured. The complementarity of 16-nt end regions of 4.5SI RNA proved to contribute to its stability in cells, whereas the lack of such complementarity in 4.5SH RNA caused its rapid decay. Possible mechanisms of the phenomenon are discussed.	[Koval, Anastasia P.; Gogolevskaya, Irina K.; Tatosyan, Karina A.; Kramerov, Dmitri A.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS	Koval, AP (corresponding author), Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia.	kramerov@eimb.ru	Koval, Anastasia/AAB-5984-2020; Kramerov, Dmitri A/B-2108-2018	Kramerov, Dmitri A/0000-0002-9877-7103; Koval, Anastasia/0000-0002-6228-4622; Tatosyan, Karina/0000-0001-8171-6294	Russian Academy of Sciences; Russian Foundation for Basic Research [11-04-00439]	Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	The study was supported by the program "Molecular and Cell Biology" of the Russian Academy of Sciences and Russian Foundation for Basic Research (www.rfbr.ru; grant 11-04-00439). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bail S, 2010, RNA, V16, P1032, DOI 10.1261/rna.1851510; Borodulina OR, 2008, RNA, V14, P1865, DOI 10.1261/rna.1006608; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chernyakov I, 2008, GENE DEV, V22, P1369, DOI 10.1101/gad.1654308; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; DECHIARA TM, 1987, P NATL ACAD SCI USA, V84, P2624, DOI 10.1073/pnas.84.9.2624; Diribarne G, 2009, RNA BIOL, V6, P122, DOI 10.4161/rna.6.2.8115; Fierro-Monti I, 2000, TRENDS BIOCHEM SCI, V25, P241, DOI 10.1016/S0968-0004(00)01580-2; Franks TM, 2007, GENE DEV, V21, P719, DOI 10.1101/gad.1494707; Gogolevskaya IK, 2005, MOL BIOL EVOL, V22, P1546, DOI 10.1093/molbev/msi140; Gogolevskaya IK, 2002, J MOL EVOL, V54, P354, DOI 10.1007/s00239-001-0050-9; Gogolevskaya IK, 2010, GENE, V460, P30, DOI 10.1016/j.gene.2010.04.002; Gogolevskaya IK, 2010, GENE, V451, P32, DOI 10.1016/j.gene.2009.11.007; HARADA F, 1979, NUCLEIC ACIDS RES, V7, P909, DOI 10.1093/nar/7.4.909; HARADA F, 1980, NUCLEIC ACIDS RES, V8, P1273, DOI 10.1093/nar/8.6.1273; Jones CI, 2012, WILEY INTERDISCIP RE; KIM JM, 1994, P NATL ACAD SCI USA, V91, P3607, DOI 10.1073/pnas.91.9.3607; Koval AP, 2009, GENE, V446, P75, DOI 10.1016/j.gene.2009.07.005; Kramerov DA, 2011, WIRES RNA, V2, P772, DOI 10.1002/wrna.91; Krude T, 2010, SUBCELL BIOCHEM, V50, P105, DOI 10.1007/978-90-481-3471-7_6; LABUDA D, 1994, J MOL EVOL, V39, P506; LEE SY, 1990, BIOTECHNIQUES, V9, P676; Lin D, 2008, MOL CELL BIOL, V28, P3008, DOI 10.1128/MCB.01800-07; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Makarova Iu A, 2007, Mol Biol (Mosk), V41, P246; MARTIGNETTI JA, 1993, P NATL ACAD SCI USA, V90, P11563, DOI 10.1073/pnas.90.24.11563; MARTIGNETTI JA, 1993, P NATL ACAD SCI USA, V90, P9698, DOI 10.1073/pnas.90.20.9698; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Muddashetty RS, 2002, J MOL BIOL, V321, P433, DOI 10.1016/S0022-2836(02)00655-1; Mukherjee D, 2002, EMBO J, V21, P165, DOI 10.1093/emboj/21.1.165; Parrott AM, 2007, NUCLEIC ACIDS RES, V35, P6249, DOI 10.1093/nar/gkm668; Parrott AM, 2011, NUCLEIC ACIDS RES, V39, P1485, DOI 10.1093/nar/gkq856; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; QUENTIN Y, 1994, GENETICA, V93, P203, DOI 10.1007/BF01435252; Ro-Choi T.S., 1974, CELL NUCLEUS, P151; ROCHOI TS, 1972, J BIOL CHEM, V247, P3205; Rozhdestvensky TS, 2001, RNA, V7, P722, DOI 10.1017/S1355838201002485; Saunders LR, 2003, FASEB J, V17, P961, DOI 10.1096/fj.02-0958rev; SCHOENIGER LO, 1986, MOL CELL BIOL, V6, P1508, DOI 10.1128/MCB.6.5.1508; Serdobova IM, 1998, J MOL EVOL, V46, P202, DOI 10.1007/PL00006295; WEINBERG RA, 1968, J MOL BIOL, V38, P289, DOI 10.1016/0022-2836(68)90387-2; Wilusz JE, 2011, SCIENCE, V334, P817, DOI 10.1126/science.1213671; YUSHOK W. D., 1956, JOUR FRANKLIN INST, V262, P507, DOI 10.1016/0016-0032(56)90688-3; ZIEVE G, 1976, CELL, V8, P19, DOI 10.1016/0092-8674(76)90181-1; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	46	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44157	10.1371/journal.pone.0044157	http://dx.doi.org/10.1371/journal.pone.0044157			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984470	gold, Green Published, Green Submitted			2022-12-27	WOS:000308738500033
J	van Wietmarschen, HA; Dai, WD; van der Kooij, AJ; Reijmers, TH; Schroen, Y; Wang, M; Xu, ZL; Wang, XC; Kong, HW; Xu, GW; Hankemeier, T; Meulman, JJ; van der Greef, J				van Wietmarschen, Herman A.; Dai, Weidong; van der Kooij, Anita J.; Reijmers, Theo H.; Schroen, Yan; Wang, Mei; Xu, Zhiliang; Wang, Xinchang; Kong, Hongwei; Xu, Guowang; Hankemeier, Thomas; Meulman, Jacqueline J.; van der Greef, Jan			Characterization of Rheumatoid Arthritis Subtypes Using Symptom Profiles, Clinical Chemistry and Metabolomics Measurements	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; PRINCIPAL-COMPONENTS-ANALYSIS; MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; DISEASE-ACTIVITY; ACYLCARNITINES; SYSTEMS; CLASSIFICATION; METABONOMICS; STRATEGY	Objective: The aim is to characterize subgroups or phenotypes of rheumatoid arthritis (RA) patients using a systems biology approach. The discovery of subtypes of rheumatoid arthritis patients is an essential research area for the improvement of response to therapy and the development of personalized medicine strategies. Methods: In this study, 39 RA patients are phenotyped using clinical chemistry measurements, urine and plasma metabolomics analysis and symptom profiles. In addition, a Chinese medicine expert classified each RA patient as a Cold or Heat type according to Chinese medicine theory. Multivariate data analysis techniques are employed to detect and validate biochemical and symptom relationships with the classification. Results: The questionnaire items 'Red joints', 'Swollen joints', 'Warm joints' suggest differences in the level of inflammation between the groups although c-reactive protein (CRP) and rheumatoid factor (RHF) levels were equal. Multivariate analysis of the urine metabolomics data revealed that the levels of 11 acylcarnitines were lower in the Cold RA than in the Heat RA patients, suggesting differences in muscle breakdown. Additionally, higher dehydroepiandrosterone sulfate (DHEAS) levels in Heat patients compared to Cold patients were found suggesting that the Cold RA group has a more suppressed hypothalamic-pituitary-adrenal (HPA) axis function. Conclusion: Significant and relevant biochemical differences are found between Cold and Heat RA patients. Differences in immune function, HPA axis involvement and muscle breakdown point towards opportunities to tailor disease management strategies to each of the subgroups RA patient.	[van Wietmarschen, Herman A.; Reijmers, Theo H.; Hankemeier, Thomas; van der Greef, Jan] Leiden Univ, LACDR, Div Analyt Biosci, Leiden, Netherlands; [van Wietmarschen, Herman A.; Schroen, Yan; Wang, Mei; van der Greef, Jan] Sino Dutch Ctr Prevent & Personalized Med, Zeist, Netherlands; [Dai, Weidong; Kong, Hongwei; Xu, Guowang] Chinese Acad Sci, Dalian Inst Chem Phys, CAS Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China; [van der Kooij, Anita J.; Meulman, Jacqueline J.] Leiden Univ, Inst Math, NL-2300 RA Leiden, Netherlands; [Reijmers, Theo H.; Hankemeier, Thomas] Leiden Univ, Netherlands Metabol Ctr, Leiden, Netherlands; [Schroen, Yan] Oxrider, Educ & Res, Nieuwegein, Netherlands; [Wang, Mei; van der Greef, Jan] SU BioMed, Utrechtseweg, Zeist, Netherlands; [Xu, Zhiliang] Coll Life Sci Co Ltd, Hangzhou, Zhejiang, Peoples R China; [Wang, Xinchang] Zhejiang Xinhua Hosp, Dept Rheumatol & Immunol, Hangzhou, Zhejiang, Peoples R China; [van der Greef, Jan] TNO Pharma, TNO Netherlands Org Appl Sci Res, Zeist, Netherlands	Leiden University; Leiden University - Excl LUMC; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Zhejiang Chinese Medical University; Netherlands Organization Applied Science Research	van Wietmarschen, HA (corresponding author), Leiden Univ, LACDR, Div Analyt Biosci, Leiden, Netherlands.	h.vanwietmarschen@lacdr.leidenuniv.nl; xugw@dicp.ac.cn	Dai, Weidong/C-7636-2013; , 戴伟东/AAU-6590-2020; Hankemeier, Thomas/V-5407-2019; Xu, Guowang/L-6910-2014; , 戴伟东/GQP-9052-2022	, 戴伟东/0000-0002-9593-138X; Hankemeier, Thomas/0000-0001-7871-2073; Xu, Guowang/0000-0003-4298-3554; , 戴伟东/0000-0002-9593-138X	State Ministry of Science & Technology of China [2009DFA41250]; key foundation from National Natural Science Foundation of China [20835006]; National Natural Science Foundation of China [21021004]; Osteo- and Rheumatoid Arthritis Foundation	State Ministry of Science & Technology of China(Ministry of Science and Technology, China); key foundation from National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Osteo- and Rheumatoid Arthritis Foundation	This study has been supported by the International cooperation project (No. 2009DFA41250) from the State Ministry of Science & Technology of China and the key foundation (No. 20835006), the creative research group project (No. 21021004) from National Natural Science Foundation of China and the Osteo- and Rheumatoid Arthritis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2005, NAT CLIN PRACT RHEUM, V1, P62, DOI 10.1038/ncprheum0050; Anderson JJ, 2000, ARTHRITIS RHEUM, V43, P22, DOI 10.1002/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; Callard R, 1999, IMMUNITY, V11, P507, DOI 10.1016/S1074-7613(00)80125-9; Conaghan PG, 2011, CLIN RHEUMATOL, V30, pS41, DOI 10.1007/s10067-010-1639-4; Cutolo M, 2000, ANN NY ACAD SCI, V917, P835; Dai WD, 2011, J PHARMACEUT BIOMED, V56, P86, DOI 10.1016/j.jpba.2011.04.020; Dessein Patrick H, 2007, BMC Cardiovasc Disord, V7, P31, DOI 10.1186/1471-2261-7-31; George-Gay Beverly, 2003, J Perianesth Nurs, V18, P96, DOI 10.1053/jpan.2003.50013; Gika HG, 2007, J PROTEOME RES, V6, P3291, DOI 10.1021/pr070183p; Glocker MO, 2006, MED RES REV, V26, P63, DOI 10.1002/med.20045; Gu Y, 2012, MOL BIOSYST, V8, P1535, DOI 10.1039/c2mb25022e; Guebre-Egziabher F, 2008, EUR J CLIN NUTR, V62, P1287, DOI 10.1038/sj.ejcn.1602857; He YT, 2007, JCR-J CLIN RHEUMATOL, V13, P317, DOI 10.1097/RHU.0b013e31815d019b; Hendriks MMWB, 2007, PROTEOMICS, V7, P3672, DOI 10.1002/pmic.200700046; Higgins JP, 2002, YALE J BIOL MED, V75, P247; Isaacs JD, 2011, ANN RHEUM DIS, V70, P4, DOI 10.1136/ard.2010.135376; Jiang Miao, 2011, Front Med, V5, P219, DOI 10.1007/s11684-011-0133-y; Jiang WY, 2005, TRENDS PHARMACOL SCI, V26, P558, DOI 10.1016/j.tips.2005.09.006; Jones MG, 2005, CLIN CHIM ACTA, V360, P173, DOI 10.1016/j.cccn.2005.04.029; Kang GL, 2008, EVID-BASED COMPL ALT, V5, P273, DOI 10.1093/ecam/nem026; Kazory A, 2010, AM J CARDIOL, V106, P694, DOI 10.1016/j.amjcard.2010.04.024; Khan NA, 2012, ARTHRIT CARE RES, V64, P206, DOI 10.1002/acr.20685; KIND T, 2010, BIOANAL REV, V12, P23, DOI DOI 10.1007/S12566-010-0015-9; Kraan TCTMV, 2007, ANN RHEUM DIS, V66, P1008, DOI 10.1136/ard.2006.063412; Krahenbuhl S, 1999, CLIN CHIM ACTA, V279, P35, DOI 10.1016/S0009-8981(98)00161-2; Li S, 2007, IET SYST BIOL, V1, P51, DOI 10.1049/iet-syb:20060032; Linting M, 2007, PSYCHOL METHODS, V12, P336, DOI 10.1037/1082-989X.12.3.336; Linting M, 2012, J PERS ASSESS, V94, P12, DOI 10.1080/00223891.2011.627965; Lu C, 2010, RHEUMATOL INT, V32, P61; Lu C, 2009, J ALTERN COMPLEM MED, V15, P1021, DOI 10.1089/acm.2009.0065; Maillefert JF, 2010, JOINT BONE SPINE, V77, P558, DOI 10.1016/j.jbspin.2010.02.018; McClellan JE, 2002, ANAL CHEM, V74, P5799, DOI 10.1021/ac026073d; Meulman JJ, 2009, SPSS CATEGORIES 17 0; Ni M., 1995, YELLOW EMPERORS CLAS; NISHISATO S, 1984, PSYCHOMETRIKA, V49, P25, DOI 10.1007/BF02294203; Paglia G, 2008, RAPID COMMUN MASS SP, V22, P3809, DOI 10.1002/rcm.3799; Patterson AD, 2009, J PROTEOME RES, V8, P4293, DOI 10.1021/pr9004103; Reuter SE, 2011, J INTERN MED, V270, P76, DOI 10.1111/j.1365-2796.2010.02341.x; RITCHIE DM, 1968, Q J MED, V37, P393; Robinson V, 2002, COCHRANE DATABASE SY; Ryu H, 2010, J ALTERN COMPLEM MED, V16, P663, DOI 10.1089/acm.2009.0331; SEWELL AC, 1995, EUR J PEDIATR, V154, P871, DOI 10.1007/BF01957495; van Baarsen LGM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2912; van der Greef J, 2005, NAT REV DRUG DISCOV, V4, P961, DOI 10.1038/nrd1904; van der Helm-van Mil AHM, 2005, ARTHRITIS RES THER, V7, pR949, DOI 10.1186/ar1767; Van der Kooij A. J., 2004, SAGE HDB QUANTITATIV, P49; van Wietmarschen H, 2009, JCR-J CLIN RHEUMATOL, V15, P330, DOI 10.1097/RHU.0b013e3181ba3926; van Wietmarschen HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024846; Vandeginste BGM, 1998, HDB CHEMOMETRICS Q B, P374; VANDERHEIJDE DMFM, 1990, ANN RHEUM DIS, V49, P916, DOI 10.1136/ard.49.11.916; Verhagen AP, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000518, DOI 10.1002/14651858.CD000518]; WOLFE F, 1991, J RHEUMATOL, V18, P973	55	57	57	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44331	10.1371/journal.pone.0044331	http://dx.doi.org/10.1371/journal.pone.0044331			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984493	Green Published, gold			2022-12-27	WOS:000308738500047
J	Vatolin, S; Khan, SN; Reu, FJ				Vatolin, Sergei; Khan, Shahper N.; Reu, Frederic J.			Direct Chromatin PCR (DC-PCR): Hypotonic Conditions Allow Differentiation of Chromatin States during Thermal Cycling	PLOS ONE			English	Article							GENES; CANCER	Current methods to study chromatin configuration are not well suited for high throughput drug screening since they require large cell numbers and multiple experimental steps that include centrifugation for isolation of nuclei or DNA. Here we show that site specific chromatin analysis can be achieved in one step by simply performing direct chromatin PCR (DC-PCR) on cells. The basic underlying observation was that standard hypotonic PCR buffers prevent global cellular chromatin solubilization during thermal cycling while more loosely organized chromatin can be amplified. Despite repeated heating to >90 degrees C, 41 of 61 tested 5' sequences of silenced genes (CDKN2A, PU.1, IRF4, FOSB, CD34) were not amplifiable while 47 could be amplified from expressing cells. Two gene regions (IRF4, FOSB) even required pre-heating of cells in isotonic media to allow this differentiation; otherwise none of 19 assayed sequences yielded PCR products. Cells with baseline expression or epigenetic reactivation gave similar DC-PCR results. Silencing during differentiation of CD34 positive cord blood cells closed respective chromatin while treatment of myeloma cells with an IRF4 transcriptional inhibitor opened a site to DC-PCR that was occupied by RNA polymerase II and NF kappa B as determined by ChIP. Translation into real-time PCR can not be achieved with commercial real-time PCR buffers which potently open chromatin, but even with simple ethidium bromide addition to standard PCR mastermix we were able to identify hits in small molecules screens that suppressed IRF4 expression or reactivated CDKN2A in myeloma cells using densitometry or visual inspection of PCR plates under UV light. While need in drug development inspired this work, application to genome-wide analysis appears feasible using phi29 for selective amplification of open cellular chromatin followed by library construction from supernatants since such supernatants yielded similar results as gene specific DC-PCR.	[Vatolin, Sergei; Khan, Shahper N.; Reu, Frederic J.] Cleveland Clin Fdn, Dept Translat Hematol & Oncol Res, Taussig Canc Inst, Cleveland, OH 44195 USA; [Reu, Frederic J.] Cleveland Clin Fdn, Dept Hematol Oncol & Blood Disorders, Taussig Canc Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Vatolin, S (corresponding author), Cleveland Clin Fdn, Dept Translat Hematol & Oncol Res, Taussig Canc Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	reuf@ccf.org		Reu, Frederic/0000-0003-1160-8030; Vatolin, Sergei/0000-0002-7752-3921; Khan, Shahper N./0000-0002-3931-6702	Scott Hamilton CARES grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER	Scott Hamilton CARES grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The work was supported by a Scott Hamilton CARES grant to F.J. Reu. The authors thank Nancy N. Vacc and Robert J. Tomsich for generous financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERKOWITZ EM, 1975, P NATL ACAD SCI USA, V72, P3328, DOI 10.1073/pnas.72.9.3328; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Dulac C, 2010, NATURE, V465, P728, DOI 10.1038/nature09231; FRENSTER JH, 1965, NATURE, V206, P680, DOI 10.1038/206680a0; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Juengel A, 2010, CURR OPIN RHEUMATOL, V22, P284, DOI 10.1097/BOR.0b013e3283389641; Liu JH, 2006, EMBO J, V25, P2119, DOI 10.1038/sj.emboj.7601101; Maunakea AK, 2010, CIRC RES, V107, P327, DOI 10.1161/CIRCRESAHA.110.222463; Nagy PL, 2003, P NATL ACAD SCI USA, V100, P6364, DOI 10.1073/pnas.1131966100; O'Neill LP, 2003, METHODS, V31, P76, DOI 10.1016/S1046-2023(03)00090-2; SAELAND S, 1988, BLOOD, V72, P1580; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shaffer AL, 2009, CLIN CANCER RES, V15, P2954, DOI 10.1158/1078-0432.CCR-08-1845; Shandrick S, 2002, ELECTROPHORESIS, V23, P591, DOI 10.1002/1522-2683(200202)23:4<591::AID-ELPS591>3.0.CO;2-W; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; WU C, 1979, CELL, V16, P807, DOI 10.1016/0092-8674(79)90096-5; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0	17	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44690	10.1371/journal.pone.0044690	http://dx.doi.org/10.1371/journal.pone.0044690			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984542	Green Submitted, Green Published, gold			2022-12-27	WOS:000308738500074
J	de Souza, CF; Xander, P; Monteiro, AC; Silva, AGD; da Silva, DCP; Mai, S; Bernardo, V; Lopes, JD; Jasiulionis, MG				de Souza, Camila Ferreira; Xander, Patricia; Monteiro, Ana Carolina; dos Santos Silva, Amanda Goncalves; Pereira da Silva, Debora Castanheira; Mai, Sabine; Bernardo, Viviane; Lopes, Jose Daniel; Jasiulionis, Miriam Galvonas			Mining Gene Expression Signature for the Detection of Pre-Malignant Melanocytes and Early Melanomas with Risk for Metastasis	PLOS ONE			English	Article							DNA METHYLATION; EPIGENETIC REGULATION; TRANSCRIPTION FACTOR; MINIMUM INFORMATION; MICROARRAY DATA; TUMOR-CELLS; STEM-CELLS; CHROMATIN; GROWTH; MOUSE	Background: Metastatic melanoma is a highly aggressive skin cancer and currently resistant to systemic therapy. Melanomas may involve genetic, epigenetic and metabolic abnormalities. Evidence is emerging that epigenetic changes might play a significant role in tumor cell plasticity and metastatic phenotype of melanoma cells. Principal findings: In this study, we developed a systematic approach to identify genes implicated in melanoma progression. To do this, we used the Affymetrix GeneChip Arrays to screen 34,000 mouse transcripts in melan-a melanocytes, 4C pre-malignant melanocytes, 4C11- non-metastatic and 4C11+ metastatic melanoma cell lines. The genome-wide association studies revealed pathways commonly over-represented in the transition from immortalized to pre-malignant stage, and under-represented in the transition from non-metastatic to metastatic stage. Additionally, the treatment of cells with 10 mM 5-aza-29-deoxycytidine (5AzaCdR) for 48 hours allowed us to identify genes differentially re-expressed at specific stages of melan-a malignant transformation. Treatment of human primary melanocytes with the demethylating agent 5AzaCdR in combination to the histone deacetylase inhibitor Trichostatin A (TSA) revealed changes on melanocyte morphology and gene expression which could be an indicator of epigenetic flexibility in normal melanocytes. Moreover, changes on gene expression recognized by affecting the melanocyte biology (NDRG2 and VDR), phenotype of metastatic melanoma cells (HSPB1 and SERPINE1) and response to cancer therapy (CTCF, NSD1 and SRC) were found when Mel-2 and/or Mel-3-derived patient metastases were exposed to 5AzaCdR plus TSA treatment. Hierarchical clustering and network analyses in a panel of five patient-derived metastatic melanoma cells showed gene interactions that have never been described in melanomas. Significance: Despite the heterogeneity observed in melanomas, this study demonstrates the utility of our murine melanoma progression model to identify molecular markers commonly perturbed in metastasis. Additionally, the novel gene expression signature identified here may be useful in the future into a model more closely related to translational research.	[de Souza, Camila Ferreira; Monteiro, Ana Carolina; Jasiulionis, Miriam Galvonas] Univ Fed Sao Paulo, Dept Farmacol, Sao Paulo, Brazil; [Xander, Patricia] Univ Fed Sao Paulo, Dept Ciencias Biol, Sao Paulo, Brazil; [dos Santos Silva, Amanda Goncalves] Hosp AC Camargo Fund Antonio Prudente, CIPE, Sao Paulo, Brazil; [Pereira da Silva, Debora Castanheira] Hosp AC Camargo Fund Antonio Prudente, Dept Oncol Cutanea, Sao Paulo, Brazil; [Mai, Sabine] Univ Manitoba, Manitoba Inst Cell Biol, Canc Care Manitoba, Winnipeg, MB, Canada; [Bernardo, Viviane] Univ Fed Sao Paulo, Dept Informat Saude, Sao Paulo, Brazil; [Lopes, Jose Daniel] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); A.C.Camargo Cancer Center; A.C.Camargo Cancer Center; University of Manitoba; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	de Souza, CF (corresponding author), Univ Fed Sao Paulo, Dept Farmacol, Sao Paulo, Brazil.	mjasiulionis@gmail.com	Jasiulionis, Miriam/G-2207-2012; Xander, Patricia/E-4682-2012; Mai, Sabine/E-5667-2017; Silva, Amanda/G-4992-2010	Jasiulionis, Miriam/0000-0002-4135-0440; Xander, Patricia/0000-0002-6329-6449; Mai, Sabine/0000-0002-5797-2201; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [09/51462-9, 06/61293-1, 2006/61293-1, 11/12306-1]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [09/51462-9 to C. F. S. & 06/61293-1 and 2006/61293-1 AND 11/12306-1 to M.G.J.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrian S, 2003, CELL STRESS CHAPERON, V8, P249, DOI 10.1379/1466-1268(2003)008<0249:OOHIAH>2.0.CO;2; Aldrian S, 2002, CELL STRESS CHAPERON, V7, P177, DOI 10.1379/1466-1268(2002)007<0177:OOHATM>2.0.CO;2; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brozyna AA, 2011, HUM PATHOL, V42, P618, DOI 10.1016/j.humpath.2010.09.014; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cheli Y, 2011, ONCOGENE, V30, P2307, DOI 10.1038/onc.2010.598; Costa FF, 2009, EPIGENOMICS-UK, V1, P387, DOI 10.2217/EPI.09.25; Do JT, 2008, STEM CELLS, V26, P2821, DOI 10.1634/stemcells.2008-0482; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Escamilla-Del-Arenal M, 2011, HUM GENET, V130, P307, DOI 10.1007/s00439-011-1029-2; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Gallagher WM, 2005, CARCINOGENESIS, V26, P1856, DOI 10.1093/carcin/bgi152; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ithychanda SS, 2009, J BIOL CHEM, V284, P4713, DOI 10.1074/jbc.M807719200; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kim A, 2008, PIGM CELL MELANOMA R, V21, P653, DOI 10.1111/j.1755-148X.2008.00503.x; Kim A, 2009, CARCINOGENESIS, V30, P927, DOI 10.1093/carcin/bgp072; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Lassmann S, 2007, J MOL MED-JMM, V85, P289, DOI 10.1007/s00109-006-0126-5; LYON MF, 1962, AM J HUM GENET, V14, P135; Meeran SM, 2010, PLOS ONE, V5; Mendes-Pereira AM, 2012, P NATL ACAD SCI USA, V109, P2730, DOI 10.1073/pnas.1018872108; Molognoni F, 2011, EPIGENETICS-US, V6, P451, DOI 10.4161/epi.6.4.14917; Montecino M, 2007, ARCH BIOCHEM BIOPHYS, V460, P293, DOI 10.1016/j.abb.2006.12.015; Moriyama M, 2006, J CELL BIOL, V173, P333, DOI 10.1083/jcb.200509084; Mossman D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023127; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Nishimura EK, 2010, CELL STEM CELL, V6, P130, DOI 10.1016/j.stem.2009.12.010; Oba-Shinjo SM, 2006, NEOPLASIA, V8, P231, DOI 10.1593/neo.05781; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Parker KA, 2010, J CLIN PATHOL, V63, P1012, DOI 10.1136/jcp.2010.080119; Ricca TI, 2009, TRANSL ONCOL, V2, P329, DOI 10.1593/tlo.09220; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Roschke AV, 2005, P NATL ACAD SCI USA, V102, P2964, DOI 10.1073/pnas.0405578102; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Seftor EA, 2006, J CELL MOL MED, V10, P174, DOI 10.1111/j.1582-4934.2006.tb00299.x; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Silva AGS, 2010, NEOPLASIA, V12, P11, DOI 10.1593/neo.91004; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2009, EXP DERMATOL, V18, P760, DOI 10.1111/j.1600-0625.2009.00892.x; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Soto-Reyes E, 2010, ONCOGENE, V29, P2217, DOI 10.1038/onc.2009.509; Souza CF, 2012, DERMATOL RES PRACT; Steele N, 2009, BRIT J CANCER, V100, P758, DOI 10.1038/sj.bjc.6604932; Szyf M, 2009, ANNU REV PHARMACOL, V49, P243, DOI 10.1146/annurev-pharmtox-061008-103102; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Utikal J, 2009, J CELL SCI, V122, P3502, DOI 10.1242/jcs.054783; Vergani E, 2011, NEOPLASIA, V13, P1132, DOI 10.1593/neo.111102; Vidwans SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018257; Zhao JP, 2009, J BIOL CHEM, V284, P34308, DOI 10.1074/jbc.M109.045021	61	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44800	10.1371/journal.pone.0044800	http://dx.doi.org/10.1371/journal.pone.0044800			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984562	Green Submitted, Green Published, gold			2022-12-27	WOS:000308638700084
J	Doan, LT; Javier, AL; Furr, NM; Nguyen, KL; Cho, KW; Monuki, ES				Doan, Linda T.; Javier, Anna L.; Furr, Nicole M.; Nguyen, Kevin L.; Cho, Ken W.; Monuki, Edwin S.			A Bmp Reporter with Ultrasensitive Characteristics Reveals That High Bmp Signaling Is Not Required for Cortical Hem Fate	PLOS ONE			English	Article							NEURAL STEM-CELLS; CAJAL-RETZIUS CELLS; ROOF PLATE; HIPPOCAMPAL NEUROGENESIS; ADULT HIPPOCAMPUS; CEREBRAL-CORTEX; IN-VIVO; TRANSCRIPTIONAL ACTIVITY; GRADIENT MORPHOGEN; RESPONSE ELEMENTS	Insights into Bone morphogenetic protein (Bmp) functions during forebrain development have been limited by a lack of Bmp signaling readouts. Here we used a novel Bmp signaling reporter ("BRE-gal" mice) to study Bmp signaling in the dorsal telencephalon. At early stages, BRE-gal expression was restricted to the dorsal telencephalic midline. At later stages, strong BRE-gal expression occurred in neurons of the marginal zone and dentate gyrus. Comparisons to nuclear phospho-Smad1/5/8 (pSmad) and Msx1 indicated that BRE-gal expression occurred exclusively in neural cells with high-level Bmp signaling. BRE-gal responsiveness to Bmps was confirmed in reporter-negative cortical cells cultured with Bmp4, and both in vivo and in vitro, BRE-gal expression was switch-like, or ultrasensitive. In the early dorsal telencephalon, BRE-gal expression negatively correlated with the cortical selector gene Lhx2, indicating a BRE-gal expression border that coincides with the cortex-hem boundary. However, in Lhx2 null chimeras, neither BRE-gal nor nuclear pSmad increases were observed in ectopic hem cells. These findings establish BRE-gal as an ultrasensitive reporter of Bmp signaling in the dorsal telencephalon, imply that hem fate can be specified at different Bmp signaling intensities, and suggest that Lhx2 primarily regulates the responses to rather than the intensity of - Bmp signaling in dorsal telencephalic cells.	[Doan, Linda T.; Javier, Anna L.; Furr, Nicole M.; Nguyen, Kevin L.; Cho, Ken W.; Monuki, Edwin S.] Univ Calif Irvine, Sch Biol Sci, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Doan, Linda T.; Monuki, Edwin S.] Univ Calif Irvine, Sch Med, Dept Pathol & Lab Med, Irvine, CA 92717 USA; [Doan, Linda T.; Monuki, Edwin S.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Doan, LT (corresponding author), Univ Calif Irvine, Sch Biol Sci, Dept Dev & Cell Biol, Irvine, CA 92717 USA.	emonuki@uci.edu		Doan, Linda/0000-0003-0274-2529; Monuki, Edwin/0000-0001-5130-781X	University of California Irvine Medical Scientist Training Program program; National Institutes of Health [R01 NS064587]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056219] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064587] Funding Source: NIH RePORTER	University of California Irvine Medical Scientist Training Program program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the University of California Irvine Medical Scientist Training Program program (LTD) and National Institutes of Health grant R01 NS064587 (ESM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Alam D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023139; Alexander C, 2011, DEVELOPMENT, V138, P5135, DOI 10.1242/dev.067801; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; Badea TC, 2003, J NEUROSCI, V23, P2314; Bielle F, 2005, NAT NEUROSCI, V8, P1002, DOI 10.1038/nn1511; Blank U, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-86; Bonaguidi MA, 2008, J NEUROSCI, V28, P9194, DOI 10.1523/JNEUROSCI.3314-07.2008; Bulchand S, 2001, MECH DEVELOP, V100, P165, DOI 10.1016/S0925-4773(00)00515-3; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; Cheng X, 2006, J NEUROSCI, V26, P7640, DOI 10.1523/JNEUROSCI.0714-06.2006; Chizhikov VV, 2010, P NATL ACAD SCI USA, V107, P10725, DOI 10.1073/pnas.0910786107; Chizhikov VV, 2005, DEV BIOL, V277, P287, DOI 10.1016/j.ydbio.2004.10.011; Chowdhury TG, 2010, FRONT NEUROANAT, V4, DOI 10.3389/neuro.05.010.2010; Cornell RA, 2000, CURR OPIN NEUROBIOL, V10, P63, DOI 10.1016/S0959-4388(99)00049-5; Currle DS, 2005, DEVELOPMENT, V132, P3549, DOI 10.1242/dev.01915; DelRio JA, 1996, J NEUROSCI, V16, P6896; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Fernandes M, 2007, DEVELOPMENT, V134, P3789, DOI 10.1242/dev.004325; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Gobeske KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007506; Hebert JM, 2003, GENESIS, V35, P214, DOI 10.1002/gene.10183; Houzelstein D, 1997, MECH DEVELOP, V65, P123, DOI 10.1016/S0925-4773(97)00065-8; Hu JS, 2008, P NATL ACAD SCI USA, V105, P3398, DOI 10.1073/pnas.0709100105; JIANG J, 1993, CELL, V72, P741, DOI 10.1016/0092-8674(93)90402-C; Kalinovsky A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001013; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; Liu AM, 2005, NAT REV NEUROSCI, V6, P945, DOI 10.1038/nrn1805; Mangale VS, 2008, SCIENCE, V319, P304, DOI 10.1126/science.1151695; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Monteiro RM, 2004, J CELL SCI, V117, P4653, DOI 10.1242/jcs.01337; Monteiro RM, 2008, GENESIS, V46, P335, DOI 10.1002/dvg.20402; Monuki ES, 2001, NEURON, V32, P591, DOI 10.1016/S0896-6273(01)00504-9; Porter FD, 1997, DEVELOPMENT, V124, P2935; Ragsdale CW, 2001, CURR OPIN NEUROBIOL, V11, P50, DOI 10.1016/S0959-4388(00)00173-2; Ramos C, 2005, TRENDS GENET, V21, P624, DOI 10.1016/j.tig.2005.09.001; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; STRYER L, 1995, BIOCHEMISTRY-US, pR34; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Takiguchi-Hayashi K, 2004, J NEUROSCI, V24, P2286, DOI 10.1523/JNEUROSCI.4671-03.2004; Tang J, 2009, BIOCHEM BIOPH RES CO, V385, P341, DOI 10.1016/j.bbrc.2009.05.067; Tsai MJ, 2007, J NEUROSCI RES, V85, P2950, DOI 10.1002/jnr.21395; Venza I, 2011, HUM MOL GENET, V20, P1016, DOI 10.1093/hmg/ddq547; von Bubnoff A, 2005, DEV BIOL, V281, P210, DOI 10.1016/j.ydbio.2005.02.014; Yao LC, 2006, DEVELOPMENT, V133, P4025, DOI 10.1242/dev.02561	49	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44009	10.1371/journal.pone.0044009	http://dx.doi.org/10.1371/journal.pone.0044009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984456	Green Published, gold			2022-12-27	WOS:000308638700037
J	Patrelli, TS; Gizzo, S; Sianesi, N; Levati, L; Pezzuto, A; Ferrari, B; Modena, AB				Patrelli, Tito Silvio; Gizzo, Salvatore; Sianesi, Nicoletta; Levati, Luca; Pezzuto, Antonio; Ferrari, Bruno; Modena, Alberto Bacchi			Anti-Mullerian Hormone Serum Values and Ovarian Reserve: Can It Predict a Decrease in Fertility after Ovarian Stimulation by ART Cycles?	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; ASSISTED REPRODUCTIVE TECHNOLOGY; SPONTANEOUS MENSTRUAL-CYCLE; ANTRAL FOLLICLE COUNT; INHIBIN-B; ANTIMULLERIAN-HORMONE; GRANULOSA-CELLS; ESTROUS-CYCLE; RAT OVARY; EXPRESSION	Background: A variety of indicators of potentially successful ovarian stimulation cycles are available, including biomarkers such as anti-Mullerian hormone. The aim of our study was to confirm the usefulness of serum anti-Mullerian hormone assay in predicting ovarian response and reproductive outcome in women eligible for ART cycles. Materials: Forty-six women undergoing ART cycles at the Centre for Reproductive Medicine in Parma were recruited from March-to-June 2010. Inclusion criteria: age <42 years; body-mass-index =20-25; regular menstrual cycles; basal serum FSH concentration <12 IU/L and basal serum estradiol concentration <70 pg/mL. The couples included in our study reported a variety of primary infertility causes. All women underwent FSH stimulation and pituitary suppression (GnRH-agonist/GnRH-antagonist protocols). Women were considered poor-responders if thay had <= 3 oocytes; normal-responders 4-9 oocytes and high-responders >= 10 oocytes. Serum samples for the AMH assays were obtained on the first and last days of stimulation. A P value <= 0.05 was considered statistically significant. Result: FSH levels increased significantly when AMH levels decreased. The total dose of r-FSH administered to induce ovulation was not correlated to AMH. The number of follicles on the hCG, serum estradiol levels on the hCG-day, and the number of retrieved oocytes were significantly correlated to AMH. The number of fertilized oocytes was significantly correlated to the AMH levels. No significant correlation was found between obtained embryos or transferred embryos and AMH. Basal serum AMH levels were significantly higher than those measured on the hCG-day, which appeared significantly reduced. There was a significant correlation between AMH in normal responders and AMH in both high and poor responders. Conclusions: Our data confirm the clinical usefulness of AMH in ART-cycles to customize treatment protocols and suggest the necessity of verifying an eventual permanent decrease in AMH levels after IVF.	[Patrelli, Tito Silvio; Gizzo, Salvatore; Sianesi, Nicoletta; Levati, Luca; Pezzuto, Antonio; Ferrari, Bruno; Modena, Alberto Bacchi] Univ Parma, Dept Gynecol Obstet & Neonatol, I-43100 Parma, Italy	University of Parma	Patrelli, TS (corresponding author), Univ Parma, Dept Gynecol Obstet & Neonatol, I-43100 Parma, Italy.	titosilvio.patrelli@gmail.com						ABMA JC, 1997, VITAL HLTH STAT, V0019; BAARENDS WM, 1995, ENDOCRINOLOGY, V136, P4951, DOI 10.1210/en.136.11.4951; Bancsi LFJMM, 2002, FERTIL STERIL, V77, P328, DOI 10.1016/S0015-0282(01)02983-1; Bancsi LFJMM, 2000, FERTIL STERIL, V73, P552, DOI 10.1016/S0015-0282(99)00552-X; Broekmans FJ, 2006, HUM REPROD UPDATE, V12, P685, DOI 10.1093/humupd/dml034; Chang MY, 1998, FERTIL STERIL, V69, P505, DOI 10.1016/S0015-0282(97)00557-8; de Vet A, 2002, FERTIL STERIL, V77, P357, DOI 10.1016/S0015-0282(01)02993-4; Durlinger ALL, 2002, ENDOCRINOLOGY, V143, P1076, DOI 10.1210/en.143.3.1076; Durlinger ALL, 2002, REPRODUCTION, V124, P601, DOI 10.1530/reprod/124.5.601; Eldar-Geva T, 2005, HUM REPROD, V20, P3178, DOI 10.1093/humrep/dei203; Fanchin R, 2005, HUM REPROD, V20, P747, DOI 10.1093/humrep/deh669; Fanchin R, 2003, HUM REPROD, V18, P323, DOI 10.1093/humrep/deg042; Ficicioglu C, 2006, FERTIL STERIL, V85, P592, DOI 10.1016/j.fertnstert.2005.09.019; Guibourdenche J, 2003, MOL CELL ENDOCRINOL, V211, P55, DOI 10.1016/j.mce.2003.09.011; Hazout A, 2004, FERTIL STERIL, V82, P1323, DOI 10.1016/j.fertnstert.2004.03.061; Hehenkamp WJK, 2006, J CLIN ENDOCR METAB, V91, P4057, DOI 10.1210/jc.2006-0331; HIROBE S, 1994, BIOL REPROD, V50, P1238, DOI 10.1095/biolreprod50.6.1238; Klein NA, 1996, J CLIN ENDOCR METAB, V81, P1038, DOI 10.1210/jc.81.3.1038; Kwee J, 2008, FERTIL STERIL, V90, P737, DOI 10.1016/j.fertnstert.2007.07.1293; La Marca A, 2005, J SOC GYNECOL INVEST, V12, P545, DOI 10.1016/j.jsgi.2005.06.001; La Marca A, 2007, HUM REPROD, V22, P766, DOI 10.1093/humrep/del421; La Marca A, 2006, HUM REPROD, V21, P3103, DOI 10.1093/humrep/del291; La Marca A, 2006, CLIN ENDOCRINOL, V64, P603, DOI 10.1111/j.1365-2265.2006.02533.x; La Marca A, 2004, HUM REPROD, V19, P2738, DOI 10.1093/humrep/deh508; Long WQ, 2000, J CLIN ENDOCR METAB, V85, P540, DOI 10.1210/jc.85.2.540; Loverro G, 2003, Reprod Biomed Online, V7, P200; Lukas-Croisier C, 2003, MOL ENDOCRINOL, V17, P550, DOI 10.1210/me.2002-0186; MUNSTERBERG A, 1991, DEVELOPMENT, V113, P613; Muttukrishna S, 2005, BJOG-INT J OBSTET GY, V112, P1384, DOI 10.1111/j.1471-0528.2005.00670.x; Muttukrishna S, 2004, BJOG-INT J OBSTET GY, V111, P1248, DOI 10.1111/j.1471-0528.2004.00452.x; Rajpert-De Meyts E, 1999, J CLIN ENDOCR METAB, V84, P3836, DOI 10.1210/jc.84.10.3836; Rey R, 2000, HUM PATHOL, V31, P1202, DOI 10.1053/hupa.2000.18498; Rey RA, 1996, AM J OBSTET GYNECOL, V174, P958, DOI 10.1016/S0002-9378(96)70333-2; Sowers MR, 2008, J CLIN ENDOCR METAB, V93, P3478, DOI 10.1210/jc.2008-0567; TAKAHASHI M, 1986, BIOL REPROD, V35, P447, DOI 10.1095/biolreprod35.2.447; Templeton A, 1996, LANCET, V348, P1402, DOI 10.1016/S0140-6736(96)05291-9; Tremellen KP, 2005, AUST NZ J OBSTET GYN, V45, P20, DOI 10.1111/j.1479-828X.2005.00332.x; UENO S, 1989, ENDOCRINOLOGY, V125, P1060, DOI 10.1210/endo-125-2-1060; van Rooij IAJ, 2002, HUM REPROD, V17, P3065, DOI 10.1093/humrep/17.12.3065; van Rooij IAJ, 2005, FERTIL STERIL, V83, P979, DOI 10.1016/j.fertnstert.2004.11.029; van Rooij Ilse A J, 2004, Menopause, V11, P601, DOI 10.1097/01.GME.0000123642.76105.6E; vanKooij RJ, 1996, FERTIL STERIL, V66, P769, DOI 10.1016/S0015-0282(16)58634-8; Ventura S J, 2001, Natl Vital Stat Rep, V49, P1; Weenen C, 2004, MOL HUM REPROD, V10, P77, DOI 10.1093/molehr/gah015; Weinstein M, 1993, BIOMEDICAL DEMOGRAPH, P209; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_	46	32	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44571	10.1371/journal.pone.0044571	http://dx.doi.org/10.1371/journal.pone.0044571			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984527	Green Published, gold, Green Submitted			2022-12-27	WOS:000308638700070
J	Sivitz, AB; Hermand, V; Curie, C; Vert, G				Sivitz, Alicia B.; Hermand, Victor; Curie, Catherine; Vert, Gregory			Arabidopsis bHLH100 and bHLH101 Control Iron Homeostasis via a FIT-Independent Pathway	PLOS ONE			English	Article							DEFICIENCY RESPONSES; THALIANA; ROOTS; GENES; TRANSFORMATION; STRESS	Iron deficiency induces a complex set of responses in plants, including developmental and physiological changes, to increase iron uptake from soil. In Arabidopsis, many transporters involved in the absorption and distribution of iron have been identified over the past decade. However, little is known about the signaling pathways and networks driving the various responses to low iron. Only the basic helix-loop-helix (bHLH) transcription factor FIT has been shown to control the expression of the root iron uptake machinery genes FRO2 and IRT1. Here, we characterize the biological role of two other iron-regulated transcription factors, bHLH100 and bHLH101, in iron homeostasis. First direct transcriptional targets of FIT were determined in vivo. We show that bHLH100 and bHLH101 do not regulate FIT target genes, suggesting that they play a non-redundant role with the two closely related bHLH factors bHLH038 and bHLH039 that have been suggested to act in concert with FIT. bHLH100 and bHLH101 play a crucial role in iron-deficiency responses, as attested by their severe growth defects and iron homeostasis related phenotypes on low-iron media. To gain further insight into the biological role of bHLH100 and bHLH101, we performed microarray analysis using the corresponding double mutant and showed that bHLH100 and bHLH101 likely regulate genes involved in the distribution of iron within the plant. Altogether, this work establishes bHLH100 and bHLH101 as key regulators of iron-deficiency responses independent of the master regulator FIT and sheds light on new regulatory networks important for proper growth and development under low iron conditions.	[Sivitz, Alicia B.; Hermand, Victor; Curie, Catherine; Vert, Gregory] Ctr Natl Rech Sci, Inst Biol Integrat Plantes, Unite Mixte Rech 5004, Montpellier, France; [Sivitz, Alicia B.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Vert, Gregory] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA	Institut Agro; Montpellier SupAgro; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Dartmouth College; Salk Institute	Sivitz, AB (corresponding author), Ctr Natl Rech Sci, Inst Biol Integrat Plantes, Unite Mixte Rech 5004, Montpellier, France.	Gregory.Vert@supagro.inra.fr	Hermand, Victor/AAD-4414-2022	Vert, Greg/0000-0002-0844-9991	European Molecular Biology Organization [ALTF 160-2009]; Human Frontier Science Program Organization [CDA0005/2007]; Agence Nationale de la Recherche [ANR-08-JCJC-0058]	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program Organization(Human Frontier Science Program); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by a European Molecular Biology Organization long-term fellowship to ABS (ALTF 160-2009) and grants to GV from the Human Frontier Science Program Organization (CDA0005/2007) and the Agence Nationale de la Recherche (ANR-08-JCJC-0058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Colangelo EP, 2004, PLANT CELL, V16, P3400, DOI 10.1105/tpc.104.024315; Dereeper A, 2008, NUCL ACIDS RES; Dinneny JR, 2008, SCIENCE, V320, P942, DOI 10.1126/science.1153795; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Jakoby M, 2004, FEBS LETT, V577, P528, DOI 10.1016/j.febslet.2004.10.062; Katari MS, 2010, PLANT PHYSIOL, V152, P500, DOI 10.1104/pp.109.147025; Klatte M, 2009, PLANT PHYSIOL, V150, P257, DOI 10.1104/pp.109.136374; LOBREAUX S, 1991, BIOCHEM J, V274, P601, DOI 10.1042/bj2740601; Long TA, 2010, PLANT CELL, V22, P2219, DOI 10.1105/tpc.110.074096; Meiser J, 2011, PLANT PHYSIOL, V157, P2154, DOI 10.1104/pp.111.183285; Murgia I, 2011, J PLANT PHYSIOL, V168, P894, DOI 10.1016/j.jplph.2010.11.020; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Ritchie RJ, 2006, PHOTOSYNTH RES, V89, P27, DOI 10.1007/s11120-006-9065-9; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; Santi S, 2009, NEW PHYTOL, V183, P1072, DOI 10.1111/j.1469-8137.2009.02908.x; Sivitz A, 2011, PLANT J, V66, P1044, DOI 10.1111/j.1365-313X.2011.04565.x; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Wang HY, 2007, PLANTA, V226, P897, DOI 10.1007/s00425-007-0535-x; Yuan YX, 2008, CELL RES, V18, P385, DOI 10.1038/cr.2008.26; Yuan YX, 2005, CELL RES, V15, P613, DOI 10.1038/sj.cr.7290331	22	136	145	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44843	10.1371/journal.pone.0044843	http://dx.doi.org/10.1371/journal.pone.0044843			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984573	Green Submitted, gold, Green Published			2022-12-27	WOS:000308638700091
J	Suganuma, N; Ito, S; Aso, H; Kondo, M; Sato, M; Sokabe, M; Hasegawa, Y				Suganuma, Nobukazu; Ito, Satoru; Aso, Hiromichi; Kondo, Masashi; Sato, Mitsuo; Sokabe, Masahiro; Hasegawa, Yoshinori			STIM1 Regulates Platelet-Derived Growth Factor-Induced Migration and Ca2+ Influx in Human Airway Smooth Muscle Cells	PLOS ONE			English	Article							OPERATED CALCIUM INFLUX; CHANNEL; ENTRY; ACTIVATION; RECEPTOR; ORAI1; PROLIFERATION; CONTRACTION; CHEMOTAXIS; INHIBITOR	It is suggested that migration of airway smooth muscle (ASM) cells plays an important role in the pathogenesis of airway remodeling in asthma. Increases in intracellular Ca2+ concentrations ([Ca2+](i)) regulate most ASM cell functions related to asthma, such as contraction and proliferation. Recently, STIM1 was identified as a sarcoplasmic reticulum (SR) Ca2+ sensor that activates Orai1, the Ca2+ channel responsible for store-operated Ca2+ entry (SOCE). We investigated the role of STIM1 in [Ca2+](i) and cell migration induced by platelet-derived growth factor (PDGF)-BB in human ASM cells. Cell migration was assessed by a chemotaxis chamber assay. Human ASM cells express STIM1, STIM2, and Orai1 mRNAs. SOCE activated by thapsigargin, an inhibitor of SR Ca2+-ATPase, was significantly blocked by STIM1 siRNA and Orai1 siRNA but not by STIM2 siRNA. PDGF-BB induced a transient increase in [Ca2+](i) followed by sustained [Ca2+](i) elevation. Sustained increases in [Ca2+](i) due to PDGF-BB were significantly inhibited by a Ca2+ chelating agent EGTA or by siRNA for STIM1 or Orai1. The numbers of migrating cells were significantly increased by PDGF-BB treatment for 6 h. Knockdown of STIM1 and Orai1 by siRNA transfection inhibited PDGF-induced cell migration. Similarly, EGTA significantly inhibited PDGF-induced cell migration. In contrast, transfection with siRNA for STIM2 did not inhibit the sustained elevation of [Ca2+](i) or cell migration induced by PDGF-BB. These results demonstrate that STIM1 and Orai1 are essential for PDGF-induced cell migration and Ca2+ influx in human ASM cells. STIM1 could be an important molecule responsible for airway remodeling.	[Suganuma, Nobukazu; Ito, Satoru; Aso, Hiromichi; Kondo, Masashi; Sato, Mitsuo; Hasegawa, Yoshinori] Nagoya Univ, Grad Sch Med, Dept Resp Med, Nagoya, Aichi 4648601, Japan; [Sokabe, Masahiro] Nagoya Univ, Grad Sch Med, Dept Physiol, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University	Suganuma, N (corresponding author), Nagoya Univ, Grad Sch Med, Dept Resp Med, Nagoya, Aichi 4648601, Japan.	itori@med.nagoya-u.ac.jp	Sato, MITSUO/I-7280-2014; Ito, Satoru/AAT-5219-2020; Hasegawa, Yoshinori/I-1277-2012; Kondo, Masashi/I-7378-2014; Sokabe, Masahiro/I-1565-2012	Sato, MITSUO/0000-0001-5458-9576; Ito, Satoru/0000-0001-7885-4653; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [22890837]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid (#22890837) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to S. Ito). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aso H, 2012, AM J PHYSIOL-LUNG C, V302, pL266, DOI 10.1152/ajplung.00248.2011; Aubart FC, 2009, MOL THER, V17, P455, DOI 10.1038/mt.2008.291; Ay B, 2004, AM J PHYSIOL-LUNG C, V286, pL909, DOI 10.1152/ajplung.00317.2003; Baba Y, 2008, NAT IMMUNOL, V9, P81, DOI 10.1038/ni1546; Bisaillon JM, 2010, AM J PHYSIOL-CELL PH, V298, pC993, DOI 10.1152/ajpcell.00325.2009; Bonner JC, 1996, AM J PHYSIOL-LUNG C, V271, pL880, DOI 10.1152/ajplung.1996.271.6.L880; BRUNDAGE RA, 1991, SCIENCE, V254, P703, DOI 10.1126/science.1948048; Carlin SM, 2003, AM J PHYSIOL-LUNG C, V284, pL1020, DOI 10.1152/ajplung.00092.2002; Chen YF, 2011, P NATL ACAD SCI USA, V108, P15225, DOI 10.1073/pnas.1103315108; Darbellay B, 2010, J BIOL CHEM, V285, P22437, DOI 10.1074/jbc.M110.118984; Deng XX, 2009, J BIOL CHEM, V284, P22501, DOI 10.1074/jbc.R109.018655; Feng MY, 2010, CELL, V143, P84, DOI 10.1016/j.cell.2010.08.040; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2010, PFLUG ARCH EUR J PHY, V460, P417, DOI 10.1007/s00424-009-0777-5; Gerthoffer William T, 2008, Proc Am Thorac Soc, V5, P97, DOI 10.1513/pats.200704-051VS; Goncharova EA, 2006, NAT PROTOC, V1, P2933, DOI 10.1038/nprot.2006.434; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Helli PB, 2008, EUR RESPIR J, V32, P1529, DOI 10.1183/09031936.00054608; Ito S, 2004, EUR J PHARMACOL, V486, P325, DOI 10.1016/j.ejphar.2004.01.013; Ito S, 2002, AM J RESP CELL MOL, V26, P491, DOI 10.1165/ajrcmb.26.4.4701; Ito S, 2008, AM J RESP CELL MOL, V38, P407, DOI 10.1165/rcmb.2007-0259OC; Ito S, 2010, AM J RESP CELL MOL, V43, P26, DOI 10.1165/rcmb.2009-0073OC; Iwata S, 2009, EUR J PHARMACOL, V605, P15, DOI 10.1016/j.ejphar.2008.12.045; James AL, 2002, AM J RESP CRIT CARE, V166, P1590, DOI 10.1164/rccm.2108069; Joubert P, 2005, J ALLERGY CLIN IMMUN, V116, P713, DOI 10.1016/j.jaci.2005.05.042; Krymskaya VP, 2004, FASEB J, V18, P428, DOI 10.1096/fj.04-2869fje; Lazaar AL, 2005, J ALLERGY CLIN IMMUN, V116, P488, DOI 10.1016/j.jaci.2005.06.030; Li J, 2011, BRIT J PHARMACOL, V164, P382, DOI 10.1111/j.1476-5381.2011.01368.x; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Liu B, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-168; Madison JM, 2003, AM J RESP CELL MOL, V29, P8, DOI 10.1165/rcmb.F272; Morioka M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026384; Parameswaran K, 2002, AM J RESP CRIT CARE, V166, P738, DOI 10.1164/rccm.200204-291OC; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Peel SE, 2008, AM J RESP CELL MOL, V38, P744, DOI 10.1165/rcmb.2007-0395OC; Peel SE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-119; Perez-Zoghbi JF, 2009, PULM PHARMACOL THER, V22, P388, DOI 10.1016/j.pupt.2008.09.006; Pfitzer G, 2001, J APPL PHYSIOL, V91, P497, DOI 10.1152/jappl.2001.91.1.497; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Sathish V, 2012, EUR RESPIR J, V40, P470, DOI 10.1183/09031936.00090511; Sweeney M, 2002, J APPL PHYSIOL, V92, P1594, DOI 10.1152/japplphysiol.00722.2001; Takeda N, 2006, AM J RESP CELL MOL, V35, P722, DOI 10.1165/rcmb.2006-0034OC; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; Xiao BL, 2011, NAT CHEM BIOL, V7, P351, DOI [10.1038/NCHEMBIO.558, 10.1038/nchembio.558]; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Zou JJ, 2011, J APPL PHYSIOL, V110, P1256, DOI 10.1152/japplphysiol.01124.2010; Zuyderduyn S, 2008, EUR RESPIR J, V32, P265, DOI 10.1183/09031936.00051407	51	38	39	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e45056	10.1371/journal.pone.0045056	http://dx.doi.org/10.1371/journal.pone.0045056			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984609	gold, Green Published, Green Submitted			2022-12-27	WOS:000308638700107
J	Brosseau, L; Drame, PM; Besnard, P; Toto, JC; Foumane, V; Le Mire, J; Mouchet, F; Remoue, F; Allan, R; Fortes, F; Carnevale, P; Manguin, S				Brosseau, Laura; Drame, Papa Makhtar; Besnard, Patrick; Toto, Jean-Claude; Foumane, Vincent; Le Mire, Jacques; Mouchet, Francois; Remoue, Franck; Allan, Richard; Fortes, Filomeno; Carnevale, Pierre; Manguin, Sylvie			Human Antibody Response to Anopheles Saliva for Comparing the Efficacy of Three Malaria Vector Control Methods in Balombo, Angola	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; IMMUNO-EPIDEMIOLOGIC TOOL; EVALUATING HUMAN EXPOSURE; FIELD-EVALUATION; GLAND PROTEINS; INDOOR USE; GAMBIAE; PEPTIDE; BITES; ZEROFLY(R)	Human antibody (Ab) response to Anopheles whole saliva, used as biomarker of Anopheles exposure, was investigated over a period of two years (2008-2009), in children between 2 to 9 years old, before and after the introduction of three different malaria vector control methods; deltamethrin treated long lasting impregnated nets (LLIN) and insecticide treated plastic sheeting (ITPS) - Zero Fly (R)) (ITPS-ZF), deltamethrin impregnated Durable (Wall) Lining (ITPS-DL - Zerovector (R)) alone, and indoor residual spraying (IRS) with lambdacyhalothrin alone. These different vector control methods resulted in considerable decreases in all three entomological (82.4%), parasitological (54.8%) and immunological criteria analyzed. The highest reductions in the number of Anopheles collected and number of positive blood smears, respectively 82.1% and 58.3%, were found in Capango and Canjala where LLIN and ITPS-ZF were implemented. The immunological data based on the level of anti-saliva IgG Ab in children of all villages dropped significantly from 2008 to 2009, except in Chissequele. These results indicated that these three vector control methods significantly reduced malaria infections amongst the children studied and IRS significantly reduced the human-Anopheles contact. The number of Anopheles, positive blood smears, and the levels of anti-saliva IgG Ab were most reduced when LLIN and ITPS-ZF were used in combination, compared to the use of one vector control method alone, either ITPS-DL or IRS. Therefore, as a combination of two vector control methods is significantly more effective than one control method only, this control strategy should be further developed at a more global scale.	[Brosseau, Laura; Manguin, Sylvie] Inst Rech Dev, UMR MD3, Montpellier, France; [Drame, Papa Makhtar; Mouchet, Francois; Remoue, Franck] Inst Rech Dev, UMR MIVEGEC, Montpellier, France; [Besnard, Patrick; Le Mire, Jacques] Med Serv Sonamet, Lobito, Angola; [Toto, Jean-Claude; Foumane, Vincent] Org Coordinat Lutte Endemioes Afrique Cent, Lab Rech Paludisme, Yaounde, Cameroon; [Allan, Richard] Mentor Initiat, Crawley, England; [Fortes, Filomeno] Natl Malaria Control Programme, Luanda, Angola	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Manguin, S (corresponding author), Inst Rech Dev, UMR MD3, Montpellier, France.	sylvie.manguin@ird.fr	Manguin, Sylvie/GOE-5338-2022; Mouchet, Francois/I-2349-2012; Manguin, Sylvie/G-1787-2015	Manguin, Sylvie/0000-0002-5925-7164; Manguin, Sylvie/0000-0002-5925-7164; BROSSEAU, Laura/0000-0002-4911-2287; Fortes, Fabiane/0000-0001-6217-3474	Diabetes Australia Research Trust Southern Australia (DART S.A.); Fondation Infectiopole Sud	Diabetes Australia Research Trust Southern Australia (DART S.A.); Fondation Infectiopole Sud	This study received funding support from Diabetes Australia Research Trust Southern Australia (DART S.A.) and Drame PM was supported by a post-doctoral fellowship from "Fondation Infectiopole Sud". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEIER JC, 1987, AM J TROP MED HYG, V36, P459, DOI 10.4269/ajtmh.1987.36.459; Calvo E, 2007, INSECT BIOCHEM MOLEC, V37, P164, DOI 10.1016/j.ibmb.2006.11.005; Chandre F, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-65; Cornelie S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-75; Curtis CF, 1999, T ROY SOC TROP MED H, V93, P460, DOI 10.1016/S0035-9203(99)90337-1; Curtis CF, 2000, B WORLD HEALTH ORGAN, V78, P1389; Diabate A, 2006, TROP MED INT HEALTH, V11, P597, DOI 10.1111/j.1365-3156.2006.01605.x; Djenontin A, 2010, AM J TROP MED HYG, V83, P266, DOI 10.4269/ajtmh.2010.10-0012; Djenontin A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-233; Drame PM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-72; Drame PM, 2010, AM J TROP MED HYG, V83, P115, DOI 10.4269/ajtmh.2010.09-0684; Drame PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015596; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; Graham K, 2002, MED VET ENTOMOL, V16, P404, DOI 10.1046/j.1365-2915.2002.00395.x; Mittal PK, 2011, J VECTOR DIS, V48, P138; Okumu FO, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-208; Orlandi-Pradines E, 2007, MICROBES INFECT, V9, P1454, DOI 10.1016/j.micinf.2007.07.012; PENNEYS NS, 1988, J AM ACAD DERMATOL, V18, P87, DOI 10.1016/S0190-9622(88)70013-4; Poinsignon A, 2010, TROP MED INT HEALTH, V15, P1198, DOI 10.1111/j.1365-3156.2010.02611.x; Poinsignon A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-198; Remoue F, 2006, T ROY SOC TROP MED H, V100, P363, DOI 10.1016/j.trstmh.2005.06.032; RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143; Sharma SK, 2009, INDIAN J MED RES, V130, P458; Waitayakul A, 2006, ACTA TROP, V98, P66, DOI 10.1016/j.actatropica.2006.02.004; WHO, 2010, WORLD MALARIA REPORT 2010, P1	25	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e44189	10.1371/journal.pone.0044189	http://dx.doi.org/10.1371/journal.pone.0044189			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028499	Green Published, Green Submitted, gold			2022-12-27	WOS:000309554700008
J	Hammarlund, E; Amanna, IJ; Dubois, ME; Barron, A; Engelmann, F; Messaoudi, I; Slifka, MK				Hammarlund, Erika; Amanna, Ian J.; Dubois, Melissa E.; Barron, Alex; Engelmann, Flora; Messaoudi, Ilhem; Slifka, Mark K.			A Flow Cytometry-Based Assay for Quantifying Non-Plaque Forming Strains of Yellow Fever Virus	PLOS ONE			English	Article							WEST-NILE-VIRUS; LIMITING DILUTION ANALYSIS; INFECTION; DENGUE; ACTIVATION; CELLS; NEUTRALIZATION; QUANTITATION; FREQUENCIES; VACCINES	Primary clinical isolates of yellow fever virus can be difficult to quantitate by standard in vitro methods because they may not form discernable plaques or induce a measurable cytopathic effect (CPE) on cell monolayers. In our hands, the Dakar strain of yellow fever virus (YFV-Dakar) could not be measured by plaque assay (PA), focus-forming assay (FFA), or by measurement of CPE. For these reasons, we developed a YFV-specific monoclonal antibody (3A8.B6) and used it to optimize a highly sensitive flow cytometry-based tissue culture limiting dilution assay (TC-LDA) to measure levels of infectious virus. The TC-LDA was performed by incubating serial dilutions of virus in replicate wells of C6/36 cells and stained intracellularly for virus with MAb 3A8.B6. Using this approach, we could reproducibly quantitate YFV-Dakar in tissue culture supernatants as well as from the serum of viremic rhesus macaques experimentally infected with YFV-Dakar. Moreover, the TC-LDA approach was >10-fold more sensitive than standard plaque assay for quantitating typical plaque-forming strains of YFV including YFV-17D and YFV-FNV (French neurotropic vaccine). Together, these results indicate that the TC-LDA technique is effective for quantitating both plaque-forming and non-plaque-forming strains of yellow fever virus, and this methodology may be readily adapted for the study and quantitation of other non-plaque-forming viruses.	[Hammarlund, Erika; Barron, Alex; Engelmann, Flora; Messaoudi, Ilhem; Slifka, Mark K.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Amanna, Ian J.; Dubois, Melissa E.; Slifka, Mark K.] Najit Technol Inc, Beaverton, OR USA; [Barron, Alex; Engelmann, Flora; Messaoudi, Ilhem] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University	Hammarlund, E (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA.	slifkam@ohsu.edu		Barron, Alexander/0000-0001-5962-553X; Amanna, Ian/0000-0001-7545-4013	National Institutes of Health [UO1 AI082196, U54 AI081680, R44 AI079898]; Oregon National Primate Research Center [8P51 OD011092-53]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI079898, U54AI081680, U01AI082196] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon National Primate Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grants, UO1 AI082196 (to MKS), U54 AI081680 (to Jay A. Nelson, subproject to MKS), R44 AI079898 (to IJA and MKS) and Oregon National Primate Research Center grant, 8P51 OD011092-53 (to MKS and IM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanna IJ, 2006, J IMMUNOL METHODS, V317, P175, DOI 10.1016/j.jim.2006.09.005; Amanna IJ, 2012, NAT MED, V18, P974, DOI 10.1038/nm.2763; Bae HG, 2003, J VIROL METHODS, V110, P185, DOI 10.1016/S0166-0934(03)00129-0; ELDADAH ZA, 1991, J MED VIROL, V33, P260, DOI 10.1002/jmv.1890330410; Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013; Kraus AA, 2007, J CLIN MICROBIOL, V45, P3777, DOI 10.1128/JCM.00827-07; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022553; Liu JE, 2008, J VIROL METHODS, V154, P20, DOI 10.1016/j.jviromet.2008.09.019; Mantel N, 2008, J VIROL METHODS, V151, P40, DOI 10.1016/j.jviromet.2008.03.026; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; MILLER RG, 1977, IMMUNOL REV, V35, P38, DOI 10.1111/j.1600-065X.1977.tb00234.x; Monath TP, 2010, VACCINE, V28, P3827, DOI 10.1016/j.vaccine.2010.03.023; Monath TP CM, 2008, VACCINES; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; PATTERSON KD, 1992, SOC SCI MED, V34, P855, DOI 10.1016/0277-9536(92)90255-O; Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030; Reinhardt B, 1998, J MED VIROL, V56, P159, DOI 10.1002/(SICI)1096-9071(199810)56:2&lt;159::AID-JMV10&gt;3.0.CO;2-B; Slifka MK, 1996, J IMMUNOL METHODS, V199, P37, DOI 10.1016/S0022-1759(96)00146-9; Staples JE, 2008, JAMA-J AM MED ASSOC, V300, P960, DOI 10.1001/jama.300.8.960; TASWELL C, 1981, J IMMUNOL, V126, P1614; TASWELL C, 1979, THYMUS, V1, P119; TESH RB, 1979, AM J TROP MED HYG, V28, P1053, DOI 10.4269/ajtmh.1979.28.1053; Tesh RB, 2001, J INFECT DIS, V183, P1431, DOI 10.1086/320199; Tomori O, 2004, CRIT REV CL LAB SCI, V41, P391, DOI 10.1080/10408360490497474	25	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e41707	10.1371/journal.pone.0041707	http://dx.doi.org/10.1371/journal.pone.0041707			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028428	gold, Green Submitted, Green Published			2022-12-27	WOS:000309388400004
J	Schaal, SM; Sen Garg, M; Ghosh, M; Lovera, L; Lopez, M; Patel, M; Louro, J; Patel, S; Tuesta, L; Chan, WM; Pearse, DD				Schaal, Sandra Marie; Sen Garg, Maneesh; Ghosh, Mousumi; Lovera, Lilie; Lopez, Michael; Patel, Monal; Louro, Jack; Patel, Samik; Tuesta, Luis; Chan, Wai-Man; Pearse, Damien Daniel			The Therapeutic Profile of Rolipram, PDE Target and Mechanism of Action as a Neuroprotectant following Spinal Cord Injury	PLOS ONE			English	Article							CAMP-SPECIFIC PHOSPHODIESTERASE; OLFACTORY ENSHEATHING GLIA; AMP-SPECIFIC PHOSPHODIESTERASE; IMPROVES FUNCTIONAL RECOVERY; INHIBITOR ROLIPRAM; SCHWANN-CELLS; DIFFERENTIAL EXPRESSION; AXONAL REGENERATION; CYTOKINE PRODUCTION; SIGNALING PATHWAY	The extent of damage following spinal cord injury (SCI) can be reduced by various neuroprotective regimens that include maintaining levels of cyclic adenosine monophosphate (cyclic AMP), via administration of the phosphodiesterase 4 (PDE4) inhibitor Rolipram. The current study sought to determine the optimal neuroprotective dose, route and therapeutic window for Rolipram following contusive SCI in rat as well as its prominent PDE target and putative mechanism of protection. Rolipram or vehicle control (10% ethanol) was given subcutaneously (s.c.) daily for 2 wk post-injury (PI) after which the preservation of oligodendrocytes, neurons and central myelinated axons was stereologically assessed. Doses of 0.1 mg/kg to 1.0 mg/kg (given at 1 h PI) increased neuronal survival; 0.5 mg to 1.0 mg/kg protected oligodendrocytes and 1.0 mg/kg produced optimal preservation of central myelinated axons. Ethanol also demonstrated significant neuronal and oligo-protection; though the preservation provided was significantly less than Rolipram. Subsequent use of this optimal Rolipram dose, 1.0 mg/kg, via different routes (i.v., s.c. or oral, 1 h PI), demonstrated that i.v. administration produced the most significant and consistent cyto- and axo-protection, although all routes were effective. Examination of the therapeutic window for i. v. Rolipram (1.0 mg/kg), when initiated between 1 and 48 h after SCI, revealed maximal neuroprotection at 2 h post-SCI, although the protective efficacy of Rolipram could still be observed when administration was delayed for up to 48 h PI. Importantly, use of the optimal Rolipram regimen significantly improved locomotor function after SCI as measured by the BBB score. Lastly we show SCI-induced changes in PDE4A, B and D expression and phosphorylation as well as cytokine expression and immune cell infiltration. We demonstrate that Rolipram abrogates SCI-induced PDE4B1 and PDE4A5 production, PDE4A5 phosphorylation, MCP-1 expression and immune cell infiltration, while preventing post-injury reductions in IL-10. This work supports the use of Rolipram as an acute neuroprotectant following SCI and defines an optimal administration protocol and target for its therapeutic application.	[Schaal, Sandra Marie; Sen Garg, Maneesh; Ghosh, Mousumi; Lovera, Lilie; Lopez, Michael; Patel, Monal; Louro, Jack; Patel, Samik; Tuesta, Luis; Chan, Wai-Man; Pearse, Damien Daniel] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Schaal, Sandra Marie; Pearse, Damien Daniel] Univ Miami, Neurosci Program, Miami, FL USA; [Pearse, Damien Daniel] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Pearse, Damien Daniel] Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami	Pearse, DD (corresponding author), Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA.	DPearse@med.miami.edu	Pearse, Damien D/D-3176-2011	Pearse, Damien D/0000-0003-1783-221X	United States National Institutes of Health (NIH) NINDS [RO1NSO56281]; Carnival Cruise Lines; Hearst Foundation; Bryon Riesch Paralysis Foundation; Craig H. Neilsen Foundation; Daniel Heumann Foundation; Miami Project to Cure Paralysis; Buoniconti Fund; State of Florida; Lois Pope LIFE Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056281] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH) NINDS; Carnival Cruise Lines; Hearst Foundation; Bryon Riesch Paralysis Foundation; Craig H. Neilsen Foundation; Daniel Heumann Foundation; Miami Project to Cure Paralysis; Buoniconti Fund; State of Florida; Lois Pope LIFE Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by: United States National Institutes of Health (NIH) NINDS Grant Number RO1NSO56281 (D. D. P.), Carnival Cruise Lines (commercial, funding provided as a donation with no commercial interest), The Hearst Foundation, The Bryon Riesch Paralysis Foundation, The Craig H. Neilsen Foundation, The Daniel Heumann Foundation, The Miami Project to Cure Paralysis, The Buoniconti Fund, The State of Florida, and a Lois Pope LIFE Fellowship (S. M. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Altura BM, 1996, NEUROSCI LETT, V220, P207, DOI 10.1016/S0304-3940(96)13268-7; Aronowski J, 2003, STROKE, V34, P1246, DOI 10.1161/01.STR.0000068170.80517.B3; Aspiotis R, 2010, BIOORG MED CHEM LETT, V20, P5502, DOI 10.1016/j.bmcl.2010.07.076; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Barakat DJ, 2005, CELL TRANSPLANT, V14, P225, DOI 10.3727/000000005783983106; Barber R, 2004, AM J PHYSIOL-LUNG C, V287, pL332, DOI 10.1152/ajplung.00384.2003; BARNETTE MS, 1995, J PHARMACOL EXP THER, V273, P1396; BARNETTE MS, 1995, J PHARMACOL EXP THER, V273, P674; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beard MB, 2002, CELL SIGNAL, V14, P453, DOI 10.1016/S0898-6568(01)00264-9; Beattie MS, 2004, TRENDS MOL MED, V10, P580, DOI 10.1016/j.molmed.2004.10.006; Beaumont E, 2009, NEUROSCIENCE, V163, P985, DOI 10.1016/j.neuroscience.2009.07.039; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; Belmadani A, 2003, J NEUROVIROL, V9, P45, DOI 10.1080/13550280390173409; Belmadani A, 2004, NEUROREPORT, V15, P2093, DOI 10.1097/00001756-200409150-00019; Berrocal YA, 2007, NEUROSCI LETT, V413, P58, DOI 10.1016/j.neulet.2006.11.030; Bethea JR, 1999, J NEUROTRAUM, V16, P851, DOI 10.1089/neu.1999.16.851; Bethea JR, 2002, CURR OPIN NEUROL, V15, P355, DOI 10.1097/00019052-200206000-00021; Bhat RV, 1996, GLIA, V17, P169; Bielekova B, 2009, MULT SCLER J, V15, P1206, DOI 10.1177/1352458509345903; Block F, 2004, BRAIN RES, V998, P29, DOI 10.1016/j.brainres.2003.10.058; Block F, 2001, NEUROSCI LETT, V298, P103, DOI 10.1016/S0304-3940(00)01729-8; Block F, 2001, NEUROREPORT, V12, P1507, DOI 10.1097/00001756-200105250-00041; Block F, 1997, NEUROREPORT, V8, P3829, DOI 10.1097/00001756-199712010-00033; Bradbury EJ, 1998, EUR J NEUROSCI, V10, P3058, DOI 10.1046/j.1460-9568.1998.00307.x; Bretzner F, 2010, J NEUROSCI RES, V88, P2833, DOI 10.1002/jnr.22440; Burnouf C, 2002, CURR PHARM DESIGN, V8, P1255, DOI 10.2174/1381612023394665; Casha S, 2012, BRAIN, V135, P1224, DOI 10.1093/brain/aws072; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; D'Sa C, 2002, J NEUROCHEM, V81, P745, DOI 10.1046/j.1471-4159.2002.00878.x; Dai HN, 2009, J NEUROTRAUM, V26, P1719, DOI [10.1089/neu.2008.0592, 10.1089/neu.2008-0592]; DAMOISEAUX JGMC, 1994, IMMUNOLOGY, V83, P140; Dastidar SG, 2007, CURR OPIN INVEST DR, V8, P364; Davis KM, 2001, J BIOMED SCI, V8, P7, DOI 10.1159/000054008; DeMarch Z, 2007, NEUROBIOL DIS, V25, P266, DOI 10.1016/j.nbd.2006.09.006; Downing TL, 2012, J CONTROL RELEASE, V161, P910, DOI 10.1016/j.jconrel.2012.05.034; Duplantier AJ, 1996, J MED CHEM, V39, P120, DOI 10.1021/jm9505066; Farooqui SM, 2000, BRAIN RES, V867, P52, DOI 10.1016/S0006-8993(00)02224-1; Faroqui SM, 2001, BIOL REPROD, V64, P1583, DOI 10.1095/biolreprod64.6.1583; Francis SH, 1999, CRIT REV CL LAB SCI, V36, P275, DOI 10.1080/10408369991239213; Francischi JN, 2000, EUR J PHARMACOL, V399, P243, DOI 10.1016/S0014-2999(00)00330-7; GEISLER FH, 1991, NEW ENGL J MED, V324, P1829, DOI 10.1056/NEJM199106273242601; GENAIN CP, 1995, P NATL ACAD SCI USA, V92, P3601, DOI 10.1073/pnas.92.8.3601; Ghosh M, 2012, GLIA, V60, P1839, DOI 10.1002/glia.22401; Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831; Gorio A, 2002, P NATL ACAD SCI USA, V99, P9450, DOI 10.1073/pnas.142287899; GRIFFITHS IR, 1983, J NEUROL SCI, V58, P335, DOI 10.1016/0022-510X(83)90093-X; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; Guizar-Sahagun G, 2009, SPINAL CORD, V47, P156, DOI 10.1038/sc.2008.85; HALL ED, 1992, J NEUROTRAUM, V9, pS165; HARRIS AL, 1989, J PHARMACOL EXP THER, V251, P199; Hatinen S, 2008, RESTOR NEUROL NEUROS, V26, P493; HEASLIP RJ, 1995, EUR J PHARMACOL, V286, P281, DOI 10.1016/0014-2999(95)00457-2; HORROBIN DF, 1977, PROSTAG OTH LIPID M, V14, P667, DOI 10.1016/0090-6980(77)90194-0; Houslay MD, 1998, ADV PHARMACOL, V44, P225, DOI 10.1016/S1054-3589(08)60128-3; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Houslay MD, 2001, PROG NUCLEIC ACID RE, V69, P249, DOI 10.1016/S0079-6603(01)69049-4; Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002; Huston E, 2000, J BIOL CHEM, V275, P28063; Iannotti CA, 2011, EXP NEUROL, V230, P3, DOI 10.1016/j.expneurol.2010.03.010; Iona S, 1998, MOL PHARMACOL, V53, P23, DOI 10.1124/mol.53.1.23; Jin SLC, 2002, P NATL ACAD SCI USA, V99, P7628, DOI 10.1073/pnas.122041599; Kajana S, 2008, EXP NEUROL, V210, P671, DOI 10.1016/j.expneurol.2007.12.021; Kajana S, 2009, J SPINAL CORD MED, V32, P175, DOI 10.1080/10790268.2009.11760769; Keane RW, 2006, J NEUROTRAUM, V23, P335, DOI 10.1089/neu.2006.23.335; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; Kontogeorgakos VA, 2009, ARCH ORTHOP TRAUM SU, V129, P189, DOI 10.1007/s00402-008-0594-x; Koopmans GC, 2009, EXP NEUROL, V216, P490, DOI 10.1016/j.expneurol.2009.01.005; Laliberte F, 2002, FEBS LETT, V512, P205, DOI 10.1016/S0014-5793(02)02259-7; Larson JL, 1996, PHARMACOL TOXICOL, V78, P44, DOI 10.1111/j.1600-0773.1996.tb00178.x; Lee SM, 2011, J NEUROTRAUM, V28, P1893, DOI 10.1089/neu.2011.1860; Lee SI, 2010, J NEUROSCI RES, V88, P2409, DOI 10.1002/jnr.22411; Lee YL, 2000, NEUROCHEM INT, V36, P417, DOI 10.1016/S0197-0186(99)00133-3; Leskovar A, 2000, J EXP BIOL, V203, P1783; Liu XZ, 1997, J NEUROSCI, V17, P5395; Lo TP, 2009, J COMP NEUROL, V514, P433, DOI 10.1002/cne.22014; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; MacKenzie SJ, 2000, BIOCHEM J, V347, P571, DOI 10.1042/0264-6021:3470571; MacKenzie SJ, 1998, P NATL ACAD SCI USA, V95, P3549, DOI 10.1073/pnas.95.7.3549; Mann C, 2008, EXP NEUROL, V211, P34, DOI 10.1016/j.expneurol.2007.12.013; McTigue DM, 1998, J NEUROSCI RES, V53, P368, DOI 10.1002/(SICI)1097-4547(19980801)53:3<368::AID-JNR11>3.0.CO;2-1; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Mu XJ, 2000, J NEUROTRAUM, V17, P773, DOI 10.1089/neu.2000.17.773; Murdoch H, 2007, J NEUROSCI, V27, P9513, DOI 10.1523/JNEUROSCI.1493-07.2007; Navarro J, 1998, J VIROL, V72, P4712, DOI 10.1128/JVI.72.6.4712-4720.1998; Nikulina E, 2004, P NATL ACAD SCI USA, V101, P8786, DOI 10.1073/pnas.0402595101; Noble LJ, 2002, J NEUROSCI, V22, P7526; Pearse DD, 2007, GLIA, V55, P976, DOI 10.1002/glia.20490; Pearse DD, 2005, J NEUROTRAUM, V22, P680, DOI 10.1089/neu.2005.22.680; Pearse DD, 2004, J NEUROTRAUM, V21, P1223, DOI 10.1089/0897715041953876; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Pearse DD, 2001, NEUROSCIENCE, V107, P143, DOI 10.1016/S0306-4522(01)00320-7; Pearse DD, 2003, J NEUROPATH EXP NEUR, V62, P1096, DOI 10.1093/jnen/62.11.1096; Pinzon A, 2008, EXP NEUROL, V213, P129, DOI 10.1016/j.expneurol.2008.05.018; Pinzon A, 2008, BRAIN RES, V1243, P146, DOI 10.1016/j.brainres.2008.09.047; Piriyawat P, 2003, STROKE, V34, P1242, DOI 10.1161/01.STR.0000067706.23777.04; PRASAD KN, 1971, NATURE-NEW BIOL, V233, P141, DOI 10.1038/newbio233141a0; Rabchevsky AG, 2011, PHARMACOL THERAPEUT, V132, P15, DOI 10.1016/j.pharmthera.2011.05.001; Rodger J, 2005, MOL CELL NEUROSCI, V30, P452, DOI 10.1016/j.mcn.2005.08.009; Saldou N, 1998, CELL SIGNAL, V10, P427, DOI 10.1016/S0898-6568(97)00169-1; Schaal SM, 2007, CELL TRANSPLANT, V16, P207, DOI 10.3727/000000007783464768; Schwartz G, 2001, J NEUROSURG, V94, P245, DOI 10.3171/spi.2001.94.2.0245; Shepherd MC, 2004, BRIT J PHARMACOL, V142, P339, DOI 10.1038/sj.bjp.0705770; Sipski ML, 2006, NAT CLIN PRACT NEURO, V2, P402, DOI 10.1038/ncpneuro0221; Sivaswamy S, 2010, EUR J NEUROSCI, V32, P1800, DOI 10.1111/j.1460-9568.2010.07451.x; Sommer N, 1997, J NEUROIMMUNOL, V79, P54, DOI 10.1016/S0165-5728(97)00111-2; Souness JE, 1997, CELL SIGNAL, V9, P227, DOI 10.1016/S0898-6568(96)00173-8; Strong R, 2000, NEUROPHARMACOLOGY, V39, P515, DOI 10.1016/S0028-3908(99)00156-2; SUTHERLAND E W, 1960, Acta Endocrinol Suppl (Copenh), V34(Suppl 50), P171; Takami T, 2002, J NEUROSCI, V22, P6670; Tator C H, 1999, Neurosurg Focus, V6, pe8; Teng YD, 2004, P NATL ACAD SCI USA, V101, P3071, DOI 10.1073/pnas.0306239101; Thrivikraman KV, 2002, BRAIN RES PROTOC, V10, P84, DOI 10.1016/S1385-299X(02)00185-X; TORPHY TJ, 1991, THORAX, V46, P512, DOI 10.1136/thx.46.7.512; Troadec JD, 2002, MOL PHARMACOL, V62, P1043, DOI 10.1124/mol.62.5.1043; VERGHESE MW, 1995, MOL PHARMACOL, V47, P1164; WACHTEL H, 1983, J PHARM PHARMACOL, V35, P440, DOI 10.1111/j.2042-7158.1983.tb04318.x; Walsh KA, 2010, ORTHOPEDICS, V33, P249, DOI 10.3928/01477447-20100225-15; Wang F, 2012, STROKE, V43, P205, DOI 10.1161/STROKEAHA.111.629576; Wang XX, 2006, ANN NEUROL, V60, P540, DOI 10.1002/ana.20953; WEST NR, 1989, J NEUROPATH EXP NEUR, V48, P94, DOI 10.1097/00005072-198901000-00008; Whitaker CM, 2008, NEUROSCI LETT, V438, P200, DOI 10.1016/j.neulet.2008.03.087; XU XM, 1995, J COMP NEUROL, V351, P145, DOI 10.1002/cne.903510113; Yang L, 2008, EXP NEUROL, V211, P311, DOI 10.1016/j.expneurol.2007.02.010; Ye Y, 1997, J NEUROCHEM, V69, P2397; Yu F, 2008, J NEUROTRAUM, V25, P184, DOI 10.1089/neu.2007.0438; Zhang HT, 2006, PSYCHOPHARMACOLOGY, V186, P209, DOI 10.1007/s00213-006-0369-4	130	46	48	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e43634	10.1371/journal.pone.0043634	http://dx.doi.org/10.1371/journal.pone.0043634			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028463	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388400011
J	Zhu, WB; Wu, CC; Deng, WY; Pei, RJ; Wang, Y; Cao, L; Qin, B; Lu, MJ; Chen, XW				Zhu, Wenbo; Wu, Chunchen; Deng, Wanyu; Pei, Rongjun; Wang, Yun; Cao, Liang; Qin, Bo; Lu, Mengji; Chen, Xinwen			Inhibition of the HCV Core Protein on the Immune Response to HBV Surface Antigen and on HBV Gene Expression and Replication In Vivo	PLOS ONE			English	Article							HEPATITIS-C VIRUS; AMINO-ACID SUBSTITUTIONS; T-CELL FUNCTION; B-VIRUS; DENDRITIC CELLS; STRUCTURAL PROTEINS; VIRAL INTERFERENCE; HUH-7 CELLS; BALB/C MICE; MOUSE MODEL	The hepatitis C virus (HCV) core protein is a multifunctional protein that can interfere with the induction of an immune response. It has been reported that the HCV core protein inhibits HBV replication in vitro. In this study, we test the effect of the HCV core gene on the priming of the immune response to hepatitis B surface antigen (HBsAg) and on the replication of HBV in vivo. Our results showed that the full-length HCV core gene inhibits the induction of an immune response to the heterogeneous antigen, HBsAg, at the site of inoculation when HCV core (pC191) and HBsAg (pHBsAg) expression plasmids are co-administered as DNA vaccines into BALB/c mice. The observed interference effect of the HCV core occurs in the priming stage and is limited to the DNA form of the HBsAg antigen, but not to the protein form. The HCV core reduces the protective effect of the HBsAg when the HBsAg and the HCV core are co-administered as vaccines in an HBV hydrodynamic mouse model because the HCV core induces immune tolerance to the heterogeneous HBsAg DNA antigen. These results suggest that HCV core may play an important role in viral persistence by the attenuation of host immune responses to different antigens. We further tested whether the HCV core interfered with the priming of the immune response in hepatocytes via the hydrodynamic co-injection of an HBV replication-competent plasmid and an HCV core plasmid. The HCV core inhibited HBV replication and antigen expression in both BALB/c (H-2d) and C57BL/6 (H-2b) mice, the mouse models of acute and chronic hepatitis B virus infections. Thus, the HCV core inhibits the induction of a specific immune response to an HBsAg DNA vaccine. However, HCV C also interferes with HBV gene expression and replication in vivo, as observed in patients with coinfection.	[Zhu, Wenbo; Wu, Chunchen; Deng, Wanyu; Pei, Rongjun; Wang, Yun; Cao, Liang; Qin, Bo; Lu, Mengji; Chen, Xinwen] Chinese Acad Sci, State Key Lab Virol, Wuhan Inst Virol, Wuhan, Peoples R China; [Lu, Mengji] Univ Hosp Essen, Inst Virol, Essen, Germany	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; University of Duisburg Essen	Zhu, WB (corresponding author), Chinese Acad Sci, State Key Lab Virol, Wuhan Inst Virol, Wuhan, Peoples R China.	chenxw@wh.iov.cn	Cao, Liang/E-4055-2017; Lu, Mengji/ABF-9410-2020	Cao, Liang/0000-0001-5974-9815; 	National Basic Research Priorities Program of China [2007CB512901, 2011CB106303]; Deutsche Forschungsgemeinschaft [GRK 1045/2, TRR60]	National Basic Research Priorities Program of China(National Basic Research Program of China); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the National Basic Research Priorities Program of China (2007CB512901 and 2011CB106303) (http://www.973.gov.cn/AreaAppl.aspx) and the grants of Deutsche Forschungsgemeinschaft (GRK 1045/2 and TRR60) (http://www.dfg.de/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTI A, 1995, J HEPATOL, V22, P38; Alberti A, 2005, ALIMENT PHARM THER, V22, P74, DOI 10.1111/j.1365-2036.2005.02602.x; Alekseeva Ekaterina, 2009, Genet Vaccines Ther, V7, P7, DOI 10.1186/1479-0556-7-7; Ando Y, 1997, CLIN DIAGN LAB IMMUN, V4, P104, DOI 10.1128/CDLI.4.1.104-106.1997; Bain C, 2001, GASTROENTEROLOGY, V120, P512, DOI 10.1053/gast.2001.21212; Bellecave P, 2009, HEPATOLOGY, V50, P46, DOI 10.1002/hep.22951; BRADLEY DW, 1983, J MED VIROL, V11, P207, DOI 10.1002/jmv.1890110304; Chen SY, 2003, J BIOL CHEM, V278, P591, DOI 10.1074/jbc.M204241200; Chu CJ, 2008, J GASTROEN HEPATOL, V23, P512, DOI 10.1111/j.1440-1746.2008.05384.x; Dolganiuc A, 2003, J IMMUNOL, V170, P5615, DOI 10.4049/jimmunol.170.11.5615; Dubuisson J, 2007, WORLD J GASTROENTERO, V13, P2406, DOI 10.3748/wjg.v13.i17.2406; Duenas-Carrera S, 2000, VACCINE, V19, P992, DOI 10.1016/S0264-410X(00)00209-7; Dustin LB, 2007, ANNU REV IMMUNOL, V25, P71, DOI 10.1146/annurev.immunol.25.022106.141602; Eyre NS, 2009, J HEPATOL, V51, P446, DOI 10.1016/j.jhep.2009.04.025; Gordon EJ, 2000, J INFECT DIS, V181, P42, DOI 10.1086/315162; Hahn CS, 2000, VIROLOGY, V276, P127, DOI 10.1006/viro.2000.0541; Herzer K, 2003, J VIROL, V77, P8299, DOI 10.1128/JVI.77.15.8299-8309.2003; Hiraga N, 2009, J HEPATOL, V51, P1046, DOI 10.1016/j.jhep.2009.09.002; Hu GJ, 1999, VACCINE, V17, P3160, DOI 10.1016/S0264-410X(99)00130-9; Huang LR, 2006, P NATL ACAD SCI USA, V103, P17862, DOI 10.1073/pnas.0608578103; Inchauspe G, 1997, VACCINE, V15, P853, DOI 10.1016/S0264-410X(96)00275-7; Isaguliants MG, 2004, VACCINE, V22, P1656, DOI 10.1016/j.vaccine.2003.09.047; Jamma Shailaja, 2010, Curr Hepat Rep, V9, P260, DOI 10.1007/s11901-010-0060-4; Jardi R, 2001, HEPATOLOGY, V34, P404, DOI 10.1053/jhep.2001.26511; Kim HS, 2002, ARCH PHARM RES, V25, P364, DOI 10.1007/BF02976640; Kittlesen DJ, 2000, J CLIN INVEST, V106, P1239, DOI 10.1172/JCI10323; LAGGING LM, 1995, J VIROL, V69, P5859, DOI 10.1128/JVI.69.9.5859-5863.1995; Lee CH, 2001, VIROLOGY, V279, P271, DOI 10.1006/viro.2000.0694; Lei Yan-Chang, 2006, Zhonghua Gan Zang Bing Za Zhi, V14, P738; Liao G, 2008, HEPATOLOGY, V47, P25, DOI 10.1002/hep.21992; LIAW YF, 1994, GASTROENTEROLOGY, V106, P1048, DOI 10.1016/0016-5085(94)90766-8; LIAW YF, 1991, INFECTION, V19, P250, DOI 10.1007/BF01644957; LIAW YF, 1995, HEPATOLOGY, V22, P1101, DOI 10.1016/0270-9139(95)90615-0; Lin WY, 2006, J VIROL, V80, P9226, DOI 10.1128/JVI.00459-06; Mann EA, 2006, VIRUS RES, V121, P51, DOI 10.1016/j.virusres.2006.04.001; MIMMS LT, 1993, BRIT MED J, V307, P1095, DOI 10.1136/bmj.307.6912.1095; Ohkawa K, 2004, J BIOL CHEM, V279, P11719, DOI 10.1074/jbc.M308560200; Poynard T, 2003, LANCET, V362, P2095, DOI 10.1016/S0140-6736(03)15109-4; Rehermann B, 2007, SEMIN LIVER DIS, V27, P152, DOI 10.1055/s-2007-979468; SANTOLINI E, 1994, J VIROL, V68, P3631, DOI 10.1128/JVI.68.6.3631-3641.1994; Sarobe P, 2003, J VIROL, V77, P10862, DOI 10.1128/JVI.77.20.10862-10871.2003; Sarobe P, 2002, J VIROL, V76, P5062, DOI 10.1128/JVI.76.10.5062-5070.2002; Satoi J, 2001, J VIROL, V75, P12121, DOI 10.1128/JVI.75.24.12121-12127.2001; SHIH CM, 1993, J VIROL, V67, P5823, DOI 10.1128/JVI.67.10.5823-5832.1993; Soguero C, 2002, J VIROL, V76, P9345, DOI 10.1128/JVI.76.18.9345-9354.2002; Szabo G, 2008, J HEPATOL, V48, P8, DOI 10.1016/j.jhep.2007.10.005; Szabo G, 2007, HEPATOLOGY, V46, P1279, DOI 10.1002/hep.21938; Wu CC, 2012, J VIROL, V86, P4658, DOI 10.1128/JVI.06353-11; Wu CC, 2010, J GEN VIROL, V91, P483, DOI 10.1099/vir.0.012740-0; Yang PL, 2002, P NATL ACAD SCI USA, V99, P13825, DOI 10.1073/pnas.202398599; Yao ZQ, 2005, J VIROL, V79, P15417, DOI 10.1128/JVI.79.24.15417-15429.2005; Zhu WB, 2010, CLIN VACCINE IMMUNOL, V17, P1139, DOI 10.1128/CVI.00490-09; Zimmermann M, 2008, J HEPATOL, V48, P51, DOI 10.1016/j.jhep.2007.08.008	53	14	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45146	10.1371/journal.pone.0045146	http://dx.doi.org/10.1371/journal.pone.0045146			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024803	Green Submitted, gold, Green Published			2022-12-27	WOS:000308860100061
J	Blatti, JL; Beld, J; Behnke, CA; Mendez, M; Mayfield, SP; Burkart, MD				Blatti, Jillian L.; Beld, Joris; Behnke, Craig A.; Mendez, Michael; Mayfield, Stephen P.; Burkart, Michael D.			Manipulating Fatty Acid Biosynthesis in Microalgae for Biofuel through Protein-Protein Interactions	PLOS ONE			English	Article							ACYL CARRIER PROTEIN; AUTOMATED DOCKING; ACP THIOESTERASE; CHLAMYDOMONAS; EXPRESSION; CHAIN; TRIACYLGLYCEROLS; IDENTIFICATION; PURIFICATION; SPECIFICITY	Microalgae are a promising feedstock for renewable fuels, and algal metabolic engineering can lead to crop improvement, thus accelerating the development of commercially viable biodiesel production from algae biomass. We demonstrate that protein-protein interactions between the fatty acid acyl carrier protein (ACP) and thioesterase (TE) govern fatty acid hydrolysis within the algal chloroplast. Using green microalga Chlamydomonas reinhardtii (Cr) as a model, a structural simulation of docking CrACP to CrTE identifies a protein-protein recognition surface between the two domains. A virtual screen reveals plant TEs with similar in silico binding to CrACP. Employing an activity-based crosslinking probe designed to selectively trap transient protein-protein interactions between the TE and ACP, we demonstrate in vitro that CrTE must functionally interact with CrACP to release fatty acids, while TEs of vascular plants show no mechanistic crosslinking to CrACP. This is recapitulated in vivo, where overproduction of the endogenous CrTE increased levels of short-chain fatty acids and engineering plant TEs into the C. reinhardtii chloroplast did not alter the fatty acid profile. These findings highlight the critical role of protein-protein interactions in manipulating fatty acid biosynthesis for algae biofuel engineering as illuminated by activity-based probes.	[Blatti, Jillian L.; Beld, Joris; Burkart, Michael D.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Behnke, Craig A.; Mendez, Michael] Sapphire Energy Inc, San Diego, CA USA; [Mayfield, Stephen P.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Blatti, JL (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	mburkart@ucsd.edu		Behnke, Craig/0000-0001-6949-7957	United States Department of Energy (DOE) [DE-EE0003373]; United States National Science Foundation (NSF) [0742551]; Rubicon Postdoctoral Fellowship; California Energy Commission CILMSF [500-10-039.]	United States Department of Energy (DOE)(United States Department of Energy (DOE)); United States National Science Foundation (NSF)(National Science Foundation (NSF)); Rubicon Postdoctoral Fellowship; California Energy Commission CILMSF	Funding was provided by the United States Department of Energy (DOE) DE-EE0003373; United States National Science Foundation (NSF) 0742551; Rubicon Postdoctoral Fellowship; and California Energy Commission CILMSF 500-10-039. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PYMOL V1 4; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BOYNTON JE, 1988, SCIENCE, V240, P1534, DOI 10.1126/science.2897716; Cantu DC, 2010, PROTEIN SCI, V19, P1281, DOI 10.1002/pro.417; Chan DI, 2010, BIOCHEM J, V430, P1, DOI 10.1042/BJ20100462; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Dani KGS, 2011, PLANT BIOLOGY, V13, P453, DOI 10.1111/j.1438-8677.2010.00410.x; DAVIES HM, 1993, PHYTOCHEMISTRY, V33, P1353, DOI 10.1016/0031-9422(93)85089-A; DORMANN P, 1995, ARCH BIOCHEM BIOPHYS, V316, P612, DOI 10.1006/abbi.1995.1081; Durrett TP, 2008, PLANT J, V54, P593, DOI 10.1111/j.1365-313X.2008.03442.x; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Facciotti MT, 1998, FETT-LIPID, V100, P167; Fujita Y, 2007, MOL MICROBIOL, V66, P829, DOI 10.1111/j.1365-2958.2007.05947.x; Gong Y, 2011, J BASIC MICROB, V51, P1; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; James GO, 2011, BIORESOURCE TECHNOL, V102, P3343, DOI 10.1016/j.biortech.2010.11.051; JONES A, 1995, PLANT CELL, V7, P359, DOI 10.1105/tpc.7.3.359; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kan YA, 2010, J PHYCOL, V46, P1356, DOI 10.1111/j.1529-8817.2010.00904.x; La Clair JJ, 2004, CHEM BIOL, V11, P195, DOI 10.1016/j.chembiol.2004.02.010; Liu XY, 2011, P NATL ACAD SCI USA, V108, P6899, DOI 10.1073/pnas.1103014108; Mata TM, 2010, RENEW SUST ENERG REV, V14, P217, DOI 10.1016/j.rser.2009.07.020; Mayer KM, 2005, J BIOL CHEM, V280, P3621, DOI 10.1074/jbc.M411351200; Mayfield SP, 2003, P NATL ACAD SCI USA, V100, P438, DOI 10.1073/pnas.0237108100; Meier JL, 2008, MOL BIOSYST, V4, P663, DOI 10.1039/b801397g; Meier JL, 2009, CHEM SOC REV, V38, P2012, DOI 10.1039/b805115c; Mendez M., 2010, PRODUCTION FATTY ACI; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Miernyk JA, 2008, PLANT J, V53, P597, DOI 10.1111/j.1365-313X.2007.03316.x; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Murugan E, 2010, PROTEIN EXPRES PURIF, V71, P132, DOI 10.1016/j.pep.2010.01.007; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Radakovits R, 2011, METAB ENG, V13, P89, DOI 10.1016/j.ymben.2010.10.003; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ryall K, 2003, GENE, V313, P139, DOI 10.1016/S0378-1119(03)00671-1; Salas JJ, 2002, ARCH BIOCHEM BIOPHYS, V403, P25, DOI 10.1016/S0003-9861(02)00017-6; Schaeffer ML, 2001, BBA-MOL CELL BIOL L, V1532, P67, DOI 10.1016/S1388-1981(01)00116-0; Scott SA, 2010, CURR OPIN BIOTECH, V21, P277, DOI 10.1016/j.copbio.2010.03.005; Specht E, 2010, BIOTECHNOL LETT, V32, P1373, DOI 10.1007/s10529-010-0326-5; Thelen JJ, 2002, METAB ENG, V4, P12, DOI 10.1006/mben.2001.0204; VOELKER TA, 1992, SCIENCE, V257, P72, DOI 10.1126/science.1621095; Walker TL, 2005, J PHYCOL, V41, P1077, DOI 10.1111/j.1529-8817.2005.00133.x; Weissman KJ, 2008, CHEMBIOCHEM, V9, P826, DOI 10.1002/cbic.200700751; Weissman KJ, 2006, CHEM BIOL, V13, P625, DOI 10.1016/j.chembiol.2006.04.010; Worthington AS, 2008, CHEMBIOCHEM, V9, P2096, DOI 10.1002/cbic.200800198; Worthington AS, 2006, ACS CHEM BIOL, V1, P687, DOI 10.1021/cb6003965; Worthington AS, 2010, ORG BIOMOL CHEM, V8, P1769, DOI 10.1039/b925966j; Worthington AS, 2006, ORG BIOMOL CHEM, V4, P44, DOI 10.1039/b512735a; Yu WL, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-91; Zhang YM, 2001, J BIOL CHEM, V276, P8231, DOI 10.1074/jbc.M008042200; Zornetzer GA, 2010, BIOCHEMISTRY-US, V49, P470, DOI 10.1021/bi9014659	57	82	101	2	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e42949	10.1371/journal.pone.0042949	http://dx.doi.org/10.1371/journal.pone.0042949			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028438	Green Published, gold, Green Submitted			2022-12-27	WOS:000308788700006
J	Bhat, R; Crowe, EP; Bitto, A; Moh, M; Katsetos, CD; Garcia, FU; Johnson, FB; Trojanowski, JQ; Sell, C; Torres, C				Bhat, Rekha; Crowe, Elizabeth P.; Bitto, Alessandro; Moh, Michelle; Katsetos, Christos D.; Garcia, Fernando U.; Johnson, Frederick Bradley; Trojanowski, John Q.; Sell, Christian; Torres, Claudio			Astrocyte Senescence as a Component of Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID-BETA-PROTEIN; CELLULAR SENESCENCE; IN-VITRO; NATURAL OLIGOMERS; DNA-DAMAGE; CELLS; BIOMARKER; COLLAGENASE; P16(INK4A); ACTIVATION	Aging is the main risk factor for Alzheimer's disease (AD); however, the aspects of the aging process that predispose the brain to the development of AD are largely unknown. Astrocytes perform a myriad of functions in the central nervous system to maintain homeostasis and support neuronal function. In vitro, human astrocytes are highly sensitive to oxidative stress and trigger a senescence program when faced with multiple types of stress. In order to determine whether senescent astrocytes appear in vivo, brain tissue from aged individuals and patients with AD was examined for the presence of senescent astrocytes using p16(INK4a) and matrix metalloproteinase-1 (MMP-1) expression as markers of senescence. Compared with fetal tissue samples (n=4), a significant increase in p16(INK4a)-positive astrocytes was observed in subjects aged 35 to 50 years (n=6; P=0.02) and 78 to 90 years (n=11; P, 10(-6)). In addition, the frontal cortex of AD patients (n=15) harbored a significantly greater burden of p16(INK4a)-positive astrocytes compared with non-AD adult control subjects of similar ages (n=25; P=0.02) and fetal controls (n=4; P, 10(-7)). Consistent with the senescent nature of the p16(INK4a)-positive astrocytes, increased metalloproteinase MMP-1 correlated with p16(INK4a). In vitro, beta-amyloid 1-42 (A beta(1-42)) triggered senescence, driving the expression of p16(INK4a) and senescence-associated beta-galactosidase. In addition, we found that senescent astrocytes produce a number of inflammatory cytokines including interleukin-6 (IL-6), which seems to be regulated by p38MAPK. We propose that an accumulation of p16(INK4a)-positive senescent astrocytes may link increased age and increased risk for sporadic AD.	[Bhat, Rekha; Crowe, Elizabeth P.; Bitto, Alessandro; Moh, Michelle; Katsetos, Christos D.; Garcia, Fernando U.; Sell, Christian; Torres, Claudio] Drexel Univ, Coll Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Johnson, Frederick Bradley; Trojanowski, John Q.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Drexel University; University of Pennsylvania	Bhat, R (corresponding author), Drexel Univ, Coll Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	claudio.torres@drexelmed.edu		Crowe, Elizabeth/0000-0003-1910-2800	National Institutes of Health/National Institute on Aging [AG022443, AG022443-S1]; Resident Research Fellowship; Drexel University College of Medicine; Medical Student Summer Research Fellowship; Aging Initiative Fellowship, Drexel University College of Medicine; Department of Pathology, Drexel University College of Medicine; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022443] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Resident Research Fellowship; Drexel University College of Medicine; Medical Student Summer Research Fellowship; Aging Initiative Fellowship, Drexel University College of Medicine; Department of Pathology, Drexel University College of Medicine; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was supported by National Institutes of Health/National Institute on Aging grants AG022443 (CS) and AG022443-S1 (CT); the Resident Research Fellowship, Drexel University College of Medicine, awarded to RB; the Medical Student Summer Research Fellowship, Drexel University College of Medicine, awarded to MM; and the Aging Initiative Fellowship, Drexel University College of Medicine, awarded to AB. EPC was supported by funds from the Department of Pathology, Drexel University College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2004, J NEUROSCI, V24, P565, DOI 10.1523/JNEUROSCI.4042-03.2004; AHRONHEIM JC, 1983, JAMA-J AM MED ASSOC, V250, P1182, DOI 10.1001/jama.250.9.1182; Allaman I, 2010, J NEUROSCI, V30, P3326, DOI 10.1523/JNEUROSCI.5098-09.2010; Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; Bachstetter AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-79; Baker DJ, 2011, NATURE; Bitto A, 2010, EXP CELL RES, V316, P2961, DOI 10.1016/j.yexcr.2010.06.021; Campisi J, 2011, SEMIN CANCER BIOL, V21, P354, DOI 10.1016/j.semcancer.2011.09.001; Chimenti C, 2003, CIRC RES, V93, P604, DOI 10.1161/01.RES.0000093985.76901.AF; Chkhotua AB, 2003, AM J KIDNEY DIS, V41, P1303, DOI 10.1016/S0272-6386(03)00363-9; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Coppe JP, 2011, J BIOL CHEM, V286, P36396, DOI 10.1074/jbc.M111.257071; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Donnini S, 2010, FASEB J, V24, P2385, DOI 10.1096/fj.09-146456; Fa M, 2010, J VIS EXP; Freir DB, 2011, NEUROBIOL AGING, V32, P2211, DOI 10.1016/j.neurobiolaging.2010.01.001; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Golde TE, 2009, ALZHEIMERS RES THER, V1, DOI 10.1186/alzrt5; Halassa MM, 2009, NEUROPHARMACOLOGY, V57, P343, DOI 10.1016/j.neuropharm.2009.06.031; Hamby ME, 2010, NEUROTHERAPEUTICS, V7, P494, DOI 10.1016/j.nurt.2010.07.003; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Hou LL, 2011, IN VITRO CELL DEV-AN, V47, P573, DOI 10.1007/s11626-011-9439-y; Hu JG, 1998, BRAIN RES, V785, P195, DOI 10.1016/S0006-8993(97)01318-8; Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x; Jeyapalan JC, 2008, MECH AGEING DEV, V129, P467, DOI 10.1016/j.mad.2008.04.001; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; KOO EH, 1994, J BIOL CHEM, V269, P17386; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; LI YT, 1994, NEUROBIOL AGING, V15, P1, DOI 10.1016/0197-4580(94)90139-2; Livney MG, 2011, AM J GERIAT PSYCHIAT, V19, P430, DOI 10.1097/JGP.0b013e3181f7d881; Maggio M, 2006, J GERONTOL A-BIOL, V61, P575, DOI 10.1093/gerona/61.6.575; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Munoz L, 2010, NEUROPHARMACOLOGY, V58, P561, DOI 10.1016/j.neuropharm.2009.11.010; Myung NH, 2008, AGE, V30, P209, DOI 10.1007/s11357-008-9050-7; Pertusa M, 2007, J NEUROCHEM, V101, P794, DOI 10.1111/j.1471-4159.2006.04369.x; Poling A, 2008, BEHAV BRAIN RES, V193, P230, DOI 10.1016/j.bbr.2008.06.001; PUCK TT, 1958, J EXP MED, V108, P945, DOI 10.1084/jem.108.6.945; Ressler S, 2006, AGING CELL, V5, P379, DOI 10.1111/j.1474-9726.2006.00231.x; Rhein V, 2009, CELL MOL NEUROBIOL, V29, P1063, DOI 10.1007/s10571-009-9398-y; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Salminen A, 2011, EUR J NEUROSCI, V34, P3, DOI 10.1111/j.1460-9568.2011.07738.x; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Thies W, 2011, ALZHEIMERS DEMENT, V7, P175, DOI [10.1016/j.jalz.2011.02.004, 10.1016/j.jalz.2011.02.002]; Tresini M, 1998, CANCER RES, V58, P1; Tsuji T, 2006, AM J RESP CRIT CARE, V174, P886, DOI 10.1164/rccm.200509-1374OC; Verkhratsky A, 2012, ASN NEURO, V4, DOI 10.1042/AN20120010; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Wang HY, 2002, NEUROBIOL AGING, V23, P213, DOI 10.1016/S0197-4580(01)00279-2; WEST MD, 1989, EXP CELL RES, V184, P138, DOI 10.1016/0014-4827(89)90372-8; Zeng GY, 1996, EXP CELL RES, V222, P150, DOI 10.1006/excr.1996.0019	62	307	321	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45069	10.1371/journal.pone.0045069	http://dx.doi.org/10.1371/journal.pone.0045069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984612	Green Published, Green Submitted, gold			2022-12-27	WOS:000308738500113
J	Ouyang, F; Men, XY; Yang, B; Su, JW; Zhang, YS; Zhao, ZH; Ge, F				Ouyang, Fang; Men, Xingyuan; Yang, Bing; Su, Jianwei; Zhang, Yongsheng; Zhao, Zihua; Ge, Feng			Maize Benefits the Predatory Beetle, Propylea japonica (Thunberg), to Provide Potential to Enhance Biological Control for Aphids in Cotton	PLOS ONE			English	Article							TRANSGENIC BT COTTON; STABLE-ISOTOPE RATIOS; NONTRANSGENIC COTTON; NATURAL ENEMIES; CARBON; BIODIVERSITY; MANAGEMENT; DELTA-C-13; SURVIVAL; PESTS	Background: Biological control provided by natural enemies play an important role in integrated pest management. Generalist insect predators provide an important biological service in the regulation of agricultural insect pests. Our goal is to understand the explicit process of oviposition preference, habitat selection and feeding behavior of predators in farmland ecosystem consisting of multiple crops, which is central to devising and delivering an integrated pest management program. Methodology: The hypotheses was that maize can serve as habitat for natural enemies and benefits predators to provide potential to enhance biological control for pest insects in cotton. This explicit process of a predatory beetle, Propylea japonica, in agricultural ecosystem composed of cotton and maize were examined by field investigation and stable carbon isotope analysis during 2008-2010. Principal Finding: Field investigation showed that P. japonica adults will search host plants for high prey abundance before laying eggs, indicating indirectly that P. japonica adults prefer to inhabit maize plants and travel to cotton plants to actively prey on aphids. The delta C-13 values of adult P. japonica in a dietary shift experiment found that individual beetles were shifting from a C-3- to a C-4-based diet of aphids reared on maize or cotton, respectively, and began to reflect the isotope ratio of their new C-4 resources within one week. Approximately 80-100% of the diet of P. japonica adults in maize originated from a C-3-based resource in June, July and August, while approximately 80% of the diet originated from a C-4-based resource in September. Conclusion/Significance: Results suggest that maize can serve as a habitat or refuge source for the predator beetle, P. Japonica, and benefits predators to provide potential to enhance biological control for insect pests in cotton.	[Ouyang, Fang; Yang, Bing; Su, Jianwei; Zhao, Zihua; Ge, Feng] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Men, Xingyuan] Shandong Acad Agr Sci, Inst Plant Protect, Jinan, Peoples R China; [Zhang, Yongsheng] Hunan Agr Univ, Coll Biosafety Sci & Technol, Changsha, Hunan, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Shandong Academy of Agricultural Sciences; Hunan Agricultural University	Ouyang, F (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	gef@ioz.ac.cn	Ouyang, Fang/AAQ-3601-2021	Ouyang, Fang/0000-0002-4291-8149	National Nature Science Fund of China [31030012, 30921063]; National Key Technology RD Program [2012BAD19B05]	National Nature Science Fund of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program)	This project was supported by National Nature Science Fund of China (No. 31030012, 30921063) and National Key Technology R&D Program (2012BAD19B05). The funders had not role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; China NoBoSo, 2009, CHIN STAT YB; Crist TO, 2006, OECOLOGIA, V147, P510, DOI 10.1007/s00442-005-0275-1; Gao F, 2010, ENTOMOL EXP APPL, V136, P72, DOI 10.1111/j.1570-7458.2010.01005.x; Ge Feng, 1995, Acta Entomologica Sinica, V38, P436; Gould F, 2002, P NATL ACAD SCI USA, V99, P16581, DOI 10.1073/pnas.242382499; Gratton C, 2006, OECOLOGIA, V147, P615, DOI 10.1007/s00442-005-0322-y; Horner TA, 2003, J ECON ENTOMOL, V96, P914, DOI 10.1603/0022-0493-96.3.914; Huang JK, 2002, SCIENCE, V295, P674, DOI 10.1126/science.1067226; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Liu J, 2004, ANN ENTOMOL SOC AM, V97, P235, DOI 10.1603/0013-8746(2004)097[0235:PDOAGH]2.0.CO;2; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; LU YH, 2010, LOGIC CIRCUITS CARBO, V328, P1151, DOI DOI 10.1126/SCIENCE.1187881; Markow TA, 2000, FUNCT ECOL, V14, P261, DOI 10.1046/j.1365-2435.2000.00408.x; Men X, 2005, CROP PROT, V24, P319, DOI 10.1016/j.cropro.2004.08.006; Men XY, 2003, ENVIRON ENTOMOL, V32, P270, DOI 10.1603/0046-225X-32.2.270; Oelbermann K, 2002, OECOLOGIA, V130, P337, DOI 10.1007/s004420100813; Ostrom PH, 1997, OECOLOGIA, V109, P108, DOI 10.1007/s004420050064; Ouyang F, 2011, J INSECT PHYSIOL, V57, P153, DOI 10.1016/j.jinsphys.2010.10.007; PETELLE M, 1979, OECOLOGIA, V38, P159, DOI 10.1007/BF00346561; Prasifka JR, 2004, ECOL ENTOMOL, V29, P226, DOI 10.1111/j.0307-6946.2004.00585.x; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; Schallhart N, 2009, AGR FOREST ENTOMOL, V11, P333, DOI 10.1111/j.1461-9563.2009.00428.x; TEERI JA, 1979, OECOLOGIA, V39, P197, DOI 10.1007/BF00348068; TURNER MG, 1989, ANNU REV ECOL SYST, V20, P171, DOI 10.1146/annurev.es.20.110189.001131; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; With KA, 2002, ECOL APPL, V12, P52, DOI 10.1890/1051-0761(2002)012[0052:TEOLSO]2.0.CO;2; Wu J.G., 2000, CHINESE J ECOL, V19, P42, DOI [10.13292/j.1000-4890.2000.0008, DOI 10.13292/J.1000-4890.2000.0008]; Wu KM, 2005, ANNU REV ENTOMOL, V50, P31, DOI 10.1146/annurev.ento.50.071803.130349; WU KM, 2008, LOGIC CIRCUITS CARBO, V321, P1676, DOI DOI 10.1126/SCIENCE.1160550	31	29	37	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44379	10.1371/journal.pone.0044379	http://dx.doi.org/10.1371/journal.pone.0044379			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984499	gold, Green Published, Green Submitted			2022-12-27	WOS:000308738500052
J	Plassart, P; Terrat, S; Thomson, B; Griffiths, R; Dequiedt, S; Lelievre, M; Regnier, T; Nowak, V; Bailey, M; Lemanceau, P; Bispo, A; Chabbi, A; Maron, PA; Mougel, C; Ranjard, L				Plassart, Pierre; Terrat, Sebastien; Thomson, Bruce; Griffiths, Robert; Dequiedt, Samuel; Lelievre, Melanie; Regnier, Tiffanie; Nowak, Virginie; Bailey, Mark; Lemanceau, Philippe; Bispo, Antonio; Chabbi, Abad; Maron, Pierre-Alain; Mougel, Christophe; Ranjard, Lionel			Evaluation of the ISO Standard 11063 DNA Extraction Procedure for Assessing Soil Microbial Abundance and Community Structure	PLOS ONE			English	Article							DIVERSITY; BACTERIAL; PURIFICATION; FUNGAL; GENES; BIOGEOGRAPHY; PH; REPRODUCIBILITY; HABITATS; PROFILES	Soil DNA extraction has become a critical step in describing microbial biodiversity. Historically, ascertaining overarching microbial ecological theories has been hindered as independent studies have used numerous custom and commercial DNA extraction procedures. For that reason, a standardized soil DNA extraction method (ISO-11063) was previously published. However, although this ISO method is suited for molecular tools such as quantitative PCR and community fingerprinting techniques, it has only been optimized for examining soil bacteria. Therefore, the aim of this study was to assess an appropriate soil DNA extraction procedure for examining bacterial, archaeal and fungal diversity in soils of contrasting land-use and physico-chemical properties. Three different procedures were tested: the ISO-11063 standard; a custom procedure (GnS-GII); and a modified ISO procedure (ISOm) which includes a different mechanical lysis step (a FastPrep (R)-24 lysis step instead of the recommended bead-beating). The efficacy of each method was first assessed by estimating microbial biomass through total DNA quantification. Then, the abundances and community structure of bacteria, archaea and fungi were determined using real-time PCR and terminal restriction fragment length polymorphism approaches. Results showed that DNA yield was improved with the GnS-GII and ISOm procedures, and fungal community patterns were found to be strongly dependent on the extraction method. The main methodological factor responsible for differences between extraction procedure efficiencies was found to be the soil homogenization step. For integrative studies which aim to examine bacteria, archaea and fungi simultaneously, the ISOm procedure results in higher DNA recovery and better represents microbial communities.	[Plassart, Pierre; Nowak, Virginie; Lemanceau, Philippe; Maron, Pierre-Alain; Mougel, Christophe; Ranjard, Lionel] INRA, Agroecol UMR1347, F-21034 Dijon, France; [Plassart, Pierre; Terrat, Sebastien; Dequiedt, Samuel; Lelievre, Melanie; Regnier, Tiffanie; Nowak, Virginie; Maron, Pierre-Alain; Mougel, Christophe; Ranjard, Lionel] INRA, Agroecol UMR1347, Plateforme GenoSol, F-21034 Dijon, France; [Thomson, Bruce; Griffiths, Robert; Bailey, Mark] Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Bispo, Antonio] ADEME, Serv Agr & Foret, Angers, France; [Chabbi, Abad] INRA, UEFE, Lusignan, France	INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; UK Centre for Ecology & Hydrology (UKCEH); INRAE	Plassart, P (corresponding author), INRA, Agroecol UMR1347, F-21034 Dijon, France.	ranjard@dijon.inra.fr	Mougel, Christophe/D-5118-2017; Griffiths, Robert/D-5237-2011; Thomson, Bruce/E-6974-2012; BISPO, Antonio/AAQ-5782-2021; Terrat, Sebastien/T-3790-2017	Mougel, Christophe/0000-0001-8675-3115; Griffiths, Robert/0000-0002-3341-4547; BISPO, Antonio/0000-0002-6985-8385; Terrat, Sebastien/0000-0001-5209-6196	the European Commission within EcoFINDERS project [FP7-264465]; ADEME (French Environment and Energy Management Agency); Regional Council of Burgundy (PARI project); Natural Environment Research Council [CEH010021] Funding Source: researchfish	the European Commission within EcoFINDERS project; ADEME (French Environment and Energy Management Agency); Regional Council of Burgundy (PARI project)(Region Bourgogne-Franche-Comte); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the European Commission within EcoFINDERS project (FP7-264465) and by ADEME (French Environment and Energy Management Agency), and the Regional Council of Burgundy (PARI project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atlas RM, 1993, MICROBIAL ECOLOGY FU, V3rd, pxii; Baker KL, 2009, SOIL BIOL BIOCHEM, V41, P2292, DOI 10.1016/j.soilbio.2009.08.010; Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; Bridge P, 2001, PLANT SOIL, V232, P147, DOI 10.1023/A:1010346305799; Burggraf S, 1997, INT J SYST BACTERIOL, V47, P657, DOI 10.1099/00207713-47-3-657; Carrigg C, 2007, APPL MICROBIOL BIOT, V77, P955, DOI 10.1007/s00253-007-1219-y; Curtis TP, 2005, SCIENCE, V309, P1331, DOI 10.1126/science.1118176; Delmont TO, 2011, J MICROBIOL METH, V86, P397, DOI 10.1016/j.mimet.2011.06.013; Delmont TO, 2011, APPL ENVIRON MICROB, V77, P1315, DOI 10.1128/AEM.01526-10; Dequiedt S, 2011, GLOBAL ECOL BIOGEOGR, V20, P641, DOI 10.1111/j.1466-8238.2010.00628.x; Dequiedt S, 2009, ENV MICROBIOL REP, V1, P251, DOI 10.1111/j.1758-2229.2009.00040.x; Dunbar J, 2001, APPL ENVIRON MICROB, V67, P190, DOI 10.1128/AEM.67.1.190-197.2001; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Fortin N, 2004, J MICROBIOL METH, V56, P181, DOI 10.1016/j.mimet.2003.10.006; Garrity GM, 2005, BERGEYS MANUAL SYS A, V2, P159, DOI DOI 10.1007/0-387-28021-9_21; Griffiths RI, 2011, ENVIRON MICROBIOL, V13, P1642, DOI 10.1111/j.1462-2920.2011.02480.x; Gubry-Rangin C, 2011, P NATL ACAD SCI USA, V108, P21206, DOI 10.1073/pnas.1109000108; Guo F, 2013, APPL MICROBIOL BIOT, V97, P4607, DOI 10.1007/s00253-012-4244-4; Herrera A, 2007, J MICROBIOL METH, V70, P1, DOI 10.1016/j.mimet.2007.04.005; Jenkins SN, 2009, ANTON LEEUW INT J G, V95, P319, DOI 10.1007/s10482-009-9317-8; Kuske CR, 1998, APPL ENVIRON MICROB, V64, P2463; Lakay FM, 2007, J APPL MICROBIOL, V102, P265, DOI 10.1111/j.1365-2672.2006.03052.x; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Lopez-Gutierrez JC, 2004, J MICROBIOL METH, V57, P399, DOI 10.1016/j.mimet.2004.02.009; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; Maron PA, 2011, CR BIOL, V334, P403, DOI 10.1016/j.crvi.2010.12.003; Marstorp H, 2000, SOIL BIOL BIOCHEM, V32, P879, DOI 10.1016/S0038-0717(99)00210-2; Martin-Laurent F, 2001, APPL ENVIRON MICROB, V67, P2354, DOI 10.1128/AEM.67.5.2354-2359.2001; Mueller GM, 2007, BIODIVERS CONSERV, V16, P1, DOI 10.1007/s10531-006-9117-7; Ochsenreiter T, 2003, ENVIRON MICROBIOL, V5, P787, DOI 10.1046/j.1462-2920.2003.00476.x; Pan Y, 2010, APPL ENVIRON MICROB, V76, P7451, DOI 10.1128/AEM.01595-10; Petric I, 2011, J MICROBIOL METH, V84, P454, DOI 10.1016/j.mimet.2011.01.016; Philippot L., 2010, Journal of Soils and Sediments, V10, P1344, DOI 10.1007/s11368-010-0265-8; PORTEOUS LA, 1994, CURR MICROBIOL, V29, P301, DOI 10.1007/BF01577445; Prevost-Boure NC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024166; Purohit MK, 2009, LETT APPL MICROBIOL, V49, P338, DOI 10.1111/j.1472-765X.2009.02663.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rajendhran J, 2008, BIOTECHNOL ADV, V26, P576, DOI 10.1016/j.biotechadv.2008.08.002; Ranjard L, 2003, ENVIRON MICROBIOL, V5, P1111, DOI 10.1046/j.1462-2920.2003.00521.x; Ranjard L, 2009, ENV MICROBIOL REP, V1, P97, DOI 10.1111/j.1758-2229.2009.00023.x; Ranjard L, 2010, AGRON SUSTAIN DEV, V30, P359, DOI 10.1051/agro/2009033; Robe P, 2003, EUR J SOIL BIOL, V39, P183, DOI 10.1016/S1164-5563(03)00033-5; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Roose-Amsaleg CL, 2001, APPL SOIL ECOL, V18, P47, DOI 10.1016/S0929-1393(01)00149-4; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Rousk J, 2009, MICROB ECOL, V58, P75, DOI 10.1007/s00248-008-9444-1; Rousk J, 2009, APPL ENVIRON MICROB, V75, P1589, DOI 10.1128/AEM.02775-08; Rutgers M, 2009, EUR J SOIL SCI, V60, P820, DOI 10.1111/j.1365-2389.2009.01163.x; Sagova-Mareckova M, 2008, APPL ENVIRON MICROB, V74, P2902, DOI 10.1128/AEM.02161-07; Schloss PD, 2003, CURR OPIN BIOTECH, V14, P303, DOI 10.1016/S0958-1669(03)00067-3; Schneegurt Mark A., 2003, Current Issues in Molecular Biology, V5, P1; SMALLA K, 1993, J APPL BACTERIOL, V74, P78, DOI 10.1111/j.1365-2672.1993.tb02999.x; Stach JEM, 2001, FEMS MICROBIOL ECOL, V36, P139, DOI 10.1111/j.1574-6941.2001.tb00834.x; Stahl D.A., 1991, NUCL ACID TECHNIQUES, P205; Terrat S, 2012, MICROB BIOTECHNOL, V5, P135, DOI 10.1111/j.1751-7915.2011.00307.x; Thomson BC, 2010, MICROB ECOL, V59, P335, DOI 10.1007/s00248-009-9575-z; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Yarwood SA, 2010, MICROB ECOL, V60, P606, DOI 10.1007/s00248-010-9675-9; Yergeau E, 2007, ENVIRON MICROBIOL, V9, P2670, DOI 10.1111/j.1462-2920.2007.01379.x; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	65	86	87	1	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44279	10.1371/journal.pone.0044279	http://dx.doi.org/10.1371/journal.pone.0044279			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984486	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000308638700052
J	Simoes, JM; Teles, MC; Oliveira, RF; Van der Linden, A; Verhoye, M				Simoes, Jose M.; Teles, Magda C.; Oliveira, Rui F.; Van der Linden, Annemie; Verhoye, Marleen			A Three-Dimensional Stereotaxic MRI Brain Atlas of the Cichlid Fish Oreochromis mossambicus	PLOS ONE			English	Article							SOCIAL-BEHAVIOR; MOUSE-BRAIN; EVOLUTION; ORGANIZATION; POPULATION; DATABASES; FIGHTS	The African cichlid Oreochromis mossambicus (Mozambique tilapia) has been used as a model system in a wide range of behavioural and neurobiological studies. The increasing number of genetic tools available for this species, together with the emerging interest in its use for neurobiological studies, increased the need for an accurate hodological mapping of the tilapia brain to supplement the available histological data. The goal of our study was to elaborate a three-dimensional, high-resolution digital atlas using magnetic resonance imaging, supported by Nissl staining. Resulting images were viewed and analysed in all orientations (transverse, sagittal, and horizontal) and manually labelled to reveal structures in the olfactory bulb, telencephalon, diencephalon, optic tectum, and cerebellum. This high resolution tilapia brain atlas is expected to become a very useful tool for neuroscientists using this fish model and will certainly expand their use in future studies regarding the central nervous system.	[Simoes, Jose M.; Teles, Magda C.; Oliveira, Rui F.] Inst Super Psicol Aplicada, Unidade Invest Ecoetol, Lisbon, Portugal; [Simoes, Jose M.; Teles, Magda C.; Oliveira, Rui F.] Gulbenkian Inst Sci, Champalimaud Neurosci Programme, Oeiras, Portugal; [Van der Linden, Annemie; Verhoye, Marleen] Univ Antwerp, Bioimaging Lab, B-2020 Antwerp, Belgium	Instituto Superior Psicologia Aplicada (ISPA); Fundacao Champalimaud; University of Antwerp	Simoes, JM (corresponding author), Inst Super Psicol Aplicada, Unidade Invest Ecoetol, Lisbon, Portugal.	jsimoes@ispa.pt	Oliveira, Rui/A-3581-2013; Simões, José Miguel/M-5330-2014; Van der Linden, Annemie/L-7855-2017	Oliveira, Rui/0000-0003-1528-618X; Simões, José Miguel/0000-0001-9808-8378; Van der Linden, Annemie/0000-0003-2941-6520; Verhoye, Marleen/0000-0002-6267-0611; Teles, Magda C/0000-0002-3051-8332	FCT (Fundacao para Ciencia e Tecnologia, Portugal) [PTDC/PSI/71811/2006]; Plurianual Programme RD unit [MAR-LVT-Lisboa-331]; FCT [SFRH/BD/40976/2007, SFRH/BD/44848/2008]	FCT (Fundacao para Ciencia e Tecnologia, Portugal)(Portuguese Foundation for Science and Technology); Plurianual Programme RD unit; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was funded by FCT (Fundacao para Ciencia e Tecnologia, Portugal) with the grant PTDC/PSI/71811/2006 and the Plurianual Programme R&D unit MAR-LVT-Lisboa-331). During this study JMS and MCT were supported by FCT Ph.D. fellowships (SFRH/BD/40976/2007 and SFRH/BD/44848/2008, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes RA, 2009, P NATL ACAD SCI USA, V106, P15985, DOI 10.1073/pnas.0900817106; Baerends G.P., 1950, BEHAVIOUR          S, V1, P1; Bauerle A, 1993, OREOCHROMIS MOSSAMBI, V34, P375; Burmeister SS, 2009, BRAIN BEHAV EVOLUT, V74, P110, DOI 10.1159/000235613; Burmeister SS, 2005, PLOS BIOL, V3, P1996, DOI 10.1371/journal.pbio.0030363; Cannestra AF, 1997, BRAIN RES BULL, V43, P141, DOI 10.1016/S0361-9230(96)00429-7; Dhenain M, 2001, DEV BIOL, V232, P458, DOI 10.1006/dbio.2001.0189; Ebbesson SO., 1980, COMP NEUROLOGY TELEN, P41, DOI 10.1007/978-1-4613-2988-6_3; FERNALD RD, 1985, J COMP NEUROL, V238, P202, DOI 10.1002/cne.902380207; Fryer G, 1972, CICHLID FISHES GREAT; GHOSH P, 1994, NEUROIMAGE, V1, P345, DOI 10.1006/nimg.1994.1019; Gonzalez-Voyer A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014355; Gonzalez-Voyer A, 2009, P ROY SOC B-BIOL SCI, V276, P161, DOI 10.1098/rspb.2008.0979; Grosenick L, 2007, NATURE, V445, P429, DOI 10.1038/nature05511; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Kovacevic N, 2005, CEREB CORTEX, V15, P639, DOI 10.1093/cercor/bhh165; McLaren DG, 2009, NEUROIMAGE, V45, P52, DOI 10.1016/j.neuroimage.2008.10.058; Meek J., 1998, CENTRAL NERVOUS SYST, P758; MEYER A, 1993, TRENDS ECOL EVOL, V8, P279, DOI 10.1016/0169-5347(93)90255-N; Natt O, 2002, J NEUROSCI METH, V120, P203, DOI 10.1016/S0165-0270(02)00211-X; Newman JD, 2009, BRAIN RES REV, V62, P1, DOI 10.1016/j.brainresrev.2009.09.001; Nieuwenhuys R., 1990, Cerebral Cortex, V8A, P31; Northcutt RG, 2006, J COMP NEUROL, V494, P903, DOI 10.1002/cne.20853; Northcutt RG, 1983, FISH NEUROBIOLOGY, P117; Oliveira RF, 2005, NATURE, V437, P207, DOI 10.1038/437207a; Oliveira RF, 2001, NATURE, V409, P475, DOI 10.1038/35054128; Oliveira RF, 2009, INTEGR COMP BIOL, V49, P423, DOI 10.1093/icb/icp055; Pepels PPLM, 2002, PEPTIDES, V23, P1053, DOI 10.1016/S0196-9781(02)00037-2; Poirier C, 2008, NEUROIMAGE, V41, P1, DOI 10.1016/j.neuroimage.2008.01.069; Pollen AA, 2007, BRAIN BEHAV EVOLUT, V70, P21, DOI 10.1159/000101067; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Roland P E, 1994, Hum Brain Mapp, V1, P173, DOI 10.1002/hbm.460010303; Sakharkar AJ, 2005, J COMP NEUROL, V489, P148, DOI 10.1002/cne.20614; Salzburger W, 2004, NATURWISSENSCHAFTEN, V91, P277, DOI 10.1007/s00114-004-0528-6; Schmahmann JD, 1999, NEUROIMAGE, V10, P233, DOI 10.1006/nimg.1999.0459; Schwarz AJ, 2006, NEUROIMAGE, V32, P538, DOI 10.1016/j.neuroimage.2006.04.214; Sefc KM, 2011, INT J EVOLUTIONARY B, V2011; Smith PF, 2003, MOL ECOL, V12, P2497, DOI 10.1046/j.1365-294X.2003.01905.x; Toga AW, 2002, NAT REV NEUROSCI, V3, P302, DOI 10.1038/nrn782; Ullmann JFP, 2010, NEUROIMAGE, V51, P76, DOI 10.1016/j.neuroimage.2010.01.086; Van Essen DC, 2002, CURR OPIN NEUROBIOL, V12, P574, DOI 10.1016/S0959-4388(02)00361-6; Vellema M, 2011, NEUROIMAGE, V57, P352, DOI 10.1016/j.neuroimage.2011.04.033; Wong M, 2011, BIOL REV, V86, P511, DOI 10.1111/j.1469-185X.2010.00158.x; Wullimann MF, 1996, NEUROANATOMY ZEBRAFI, DOI 10.1007/978-3-0348-8979-7_6	44	24	25	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44086	10.1371/journal.pone.0044086	http://dx.doi.org/10.1371/journal.pone.0044086			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984463	gold, Green Published			2022-12-27	WOS:000308638700043
J	Zhao, QF; Qian, Y; Li, RM; Tan, BH; Han, HH; Liu, MY; Qian, M; Du, B				Zhao, Qufei; Qian, Yu; Li, Ruimei; Tan, Binghe; Han, Honghui; Liu, Mingyao; Qian, Min; Du, Bing			Norcantharidin Facilitates LPS-Mediated Immune Responses by Up-Regulation of AKT/NF-kappa B Signaling in Macrophages	PLOS ONE			English	Article							INNATE IMMUNITY; BACTERIAL-INFECTION; RELA/P65 SUBUNIT; BINDING PROTEIN; ACTIVATION; RECEPTOR; PHOSPHORYLATION; RECOGNITION; KINASE; ALPHA	Norcantharidin (NCTD), a demethylated analog of cantharidin, is a common used clinical drug to inhibit proliferation and metastasis of cancer cells. But the role of NCTD in modulating immune responses remains unknown. Here, we investigated the function and mechanism of NCTD in regulation of TLR4 associated immune response in macrophages. We evaluated the influence of NCTD on host defense against invaded pathogens by acute peritonitis mouse model, ELISA, Q-PCR, nitrite quantification, phagocytosis assay and gelatin zymography assay. Our data showed that the survival and the serum concentrations of IL-6 and TNF-alpha were all enhanced by NCTD significantly in peritonitis mouse model. Accordingly, LPS-induced cytokine, nitric oxide and MMP-9 production as well as the phagocytosis of bacteria were all up-regulated by NCTD in a dose dependent manner in both RAW264.7 cells and bone marrow-derived macrophages (BMMs). Then we further analyzed TLR4 associated signaling pathway by Western blot, Immunofluorescence and EMSA in the presence or absence of LPS. The phosphorylation of AKT and p65 at serine 536 but not serine 468 was enhanced obviously by NCTD in a dose dependent manner, whereas the degradation of I kappa B alpha was little effected. Consequently, the nuclear translocation and DNA binding ability of NF-kappa B was also increased by NCTD obviously in RAW264.7 cells. Our results demonstrated that NCTD could facilitate LPS-mediated immune response through promoting the phosphorylation of AKT/p65 and transcriptional activity of NF-kappa B, thus reprofiling the traditional anti-tumor drug NCTD as a novel immune regulator in promoting host defense against bacterial infection.	[Zhao, Qufei] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200062, Peoples R China; E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China	East China Normal University; East China Normal University	Zhao, QF (corresponding author), E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200062, Peoples R China.	mqian@bio.ecnu.edu.cn; bdu.ecnu@gmail.com		Du, Bing/0000-0002-5402-6527; Liu, Mingyao/0000-0001-7339-5048	National Basic Research Program of China [2012CB910400]; National Natural Science Foundation of China [31000398, 81172816]; Science and Technology Commission of Shanghai Municipality [09JC1405200, 11DZ2260300]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by National Basic Research Program of China [2012CB910400]; National Natural Science Foundation of China [31000398 and 81172816]; and The Science and Technology Commission of Shanghai Municipality [09JC1405200 and 11DZ2260300]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; CARREL JE, 1974, SCIENCE, V183, P755, DOI 10.1126/science.183.4126.755; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; Chang C, 2011, MOL BIOL REP, V38, P163, DOI 10.1007/s11033-010-0090-6; Chen YJ, 2009, CHEM-BIOL INTERACT, V181, P440, DOI 10.1016/j.cbi.2009.07.004; Chen YJ, 2009, LIFE SCI, V85, P642, DOI 10.1016/j.lfs.2009.09.003; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Douillette A, 2006, J BIOL CHEM, V281, P13275, DOI 10.1074/jbc.M512815200; Doyle SE, 2004, J EXP MED, V199, P81, DOI 10.1084/jem.20031237; Esteve PO, 2002, J BIOL CHEM, V277, P35150, DOI 10.1074/jbc.M108600200; Fraser IP, 1998, SEMIN IMMUNOL, V10, P363, DOI 10.1006/smim.1998.0141; Hajjar AM, 2001, J IMMUNOL, V166, P15, DOI 10.4049/jimmunol.166.1.15; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Huang Y, 2009, CYTOTECHNOLOGY, V59, P201, DOI [10.1007/s10616-009-9210-3, 10.1007/s10616-009-9221-0]; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Kim JH, 2006, MOL PHARMACOL, V69, P1783, DOI 10.1124/mol.105.021048; Kok SH, 2005, CANCER LETT, V217, P43, DOI 10.1016/j.canlet.2004.07.045; Lambert LA, 2007, ANN SURG ONCOL, V14, P3037, DOI 10.1245/s10434-007-9548-8; Liu L, 2004, BIOCHEM J, V380, P31, DOI 10.1042/BJ20031300; Luan JL, 2010, CYTOTECHNOLOGY, V62, P349, DOI 10.1007/s10616-009-9250-8; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Odeh M, 2004, LIVER INT, V24, P110, DOI 10.1111/j.1478-3231.2004.0894.x; OKAHARA H, 1994, CANCER RES, V54, P3233; Pearson AM, 1996, CURR OPIN IMMUNOL, V8, P20, DOI 10.1016/S0952-7915(96)80100-2; Picozzi VJ, 2001, ONCOLOGY-NY, V15, P1296; Rosenberger CM, 2003, NAT REV MOL CELL BIO, V4, P385, DOI 10.1038/nrm1104; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Sizemore N, 1999, MOL CELL BIOL, V19, P4798; STEINKAMP JA, 1982, SCIENCE, V215, P64, DOI 10.1126/science.7053559; Tobinick EL, 2009, DRUG NEWS PERSPECT, V22, P119, DOI 10.1358/dnp.2009.22.2.1303818; Ulevitch RJ, 2000, IMMUNOL RES, V21, P49, DOI 10.1385/IR:21:2-3:49; Willenborg DO, 1999, J NEUROIMMUNOL, V100, P21, DOI 10.1016/S0165-5728(99)00212-X; Worthington HV, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001972.pub4; Xu P, 2001, BIOL REPROD, V65, P240, DOI 10.1095/biolreprod65.1.240; Zhang Z, 2011, J IMMUNOL, V186, P5376, DOI 10.4049/jimmunol.1002946; Zhao M, 2001, P NATL ACAD SCI USA, V98, P9814, DOI 10.1073/pnas.161275798	43	23	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44956	10.1371/journal.pone.0044956	http://dx.doi.org/10.1371/journal.pone.0044956			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984593	Green Published, Green Submitted, gold			2022-12-27	WOS:000308638700102
J	Guney, E; Oliva, B				Guney, Emre; Oliva, Baldo			Exploiting Protein-Protein Interaction Networks for Genome-Wide Disease-Gene Prioritization	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; TOPOLOGICAL FEATURES; CANDIDATE GENES; COMPLEX TRAITS; ASSOCIATION; DISORDERS; IDENTIFICATION; INFLAMMATION; PREDICTION; PHENOTYPE	Complex genetic disorders often involve products of multiple genes acting cooperatively. Hence, the pathophenotype is the outcome of the perturbations in the underlying pathways, where gene products cooperate through various mechanisms such as protein-protein interactions. Pinpointing the decisive elements of such disease pathways is still challenging. Over the last years, computational approaches exploiting interaction network topology have been successfully applied to prioritize individual genes involved in diseases. Although linkage intervals provide a list of disease-gene candidates, recent genome-wide studies demonstrate that genes not associated with any known linkage interval may also contribute to the disease phenotype. Network based prioritization methods help highlighting such associations. Still, there is a need for robust methods that capture the interplay among disease-associated genes mediated by the topology of the network. Here, we propose a genome-wide network-based prioritization framework named GUILD. This framework implements four network-based disease-gene prioritization algorithms. We analyze the performance of these algorithms in dozens of disease phenotypes. The algorithms in GUILD are compared to state-of-the-art network topology based algorithms for prioritization of genes. As a proof of principle, we investigate top-ranking genes in Alzheimer's disease (AD), diabetes and AIDS using disease-gene associations from various sources. We show that GUILD is able to significantly highlight disease-gene associations that are not used a priori. Our findings suggest that GUILD helps to identify genes implicated in the pathology of human disorders independent of the loci associated with the disorders.	[Guney, Emre; Oliva, Baldo] Univ Pompeu Fabra, Struct Bioinformat Grp GRIB, Barcelona, Catalonia, Spain	Pompeu Fabra University	Oliva, B (corresponding author), Univ Pompeu Fabra, Struct Bioinformat Grp GRIB, Barcelona Res Pk Biomed PRBB, Barcelona, Catalonia, Spain.	baldo.oliva@upf.edu	Oliva, Baldomero/A-2690-2009; Gasull, Martina/J-4076-2019; Guney, Emre/B-2568-2017	Oliva, Baldomero/0000-0003-0702-0250; Guney, Emre/0000-0002-3466-6535	Departament d'Educacio i Universitats de la Generalitat de Catalunya i del Fons Social Europeu (Department of Education and Universities of the Generalitat of Catalonia and the European Social Fons); Spanish Ministry of Science and Innovation (MICINN); FEDER (Fonds Europeen de Developpement Regional) [BIO2008-0205, BIO2011-22568, PSE-0100000-2007, PSE-0100000-2009]; EU [EUI2009-04018]	Departament d'Educacio i Universitats de la Generalitat de Catalunya i del Fons Social Europeu (Department of Education and Universities of the Generalitat of Catalonia and the European Social Fons); Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER (Fonds Europeen de Developpement Regional)(European Commission); EU(European Commission)	Departament d'Educacio i Universitats de la Generalitat de Catalunya i del Fons Social Europeu (Department of Education and Universities of the Generalitat of Catalonia and the European Social Fons). Spanish Ministry of Science and Innovation (MICINN), FEDER (Fonds Europeen de Developpement Regional) BIO2008-0205, BIO2011-22568, PSE-0100000-2007, and PSE-0100000-2009; and by EU grant EraSysbio+ (SHIPREC) Euroinvestigacion (EUI2009-04018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Akula N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024220; Ala U, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000043; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Aragues R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-172; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Broeckel U, 2004, J PHYSIOL-LONDON, V554, P40, DOI 10.1113/jphysiol.2003.051128; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Chen J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-392; Chen J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-73; Davis AP, 2011, NUCLEIC ACIDS RES, V39, pD1067, DOI 10.1093/nar/gkq813; Dezso Z, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-36; Erten S, 2011, BIODATA MIN, V4, DOI 10.1186/1756-0381-4-19; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Garcia-Garcia J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-56; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; He G, 2010, NATURE, V467, P95, DOI 10.1038/nature09325; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hofmann-Apitius M, 2008, PHILOS T R SOC A, V366, P3091, DOI 10.1098/rsta.2008.0099; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Jonsson PF, 2006, BIOINFORMATICS, V22, P2291, DOI 10.1093/bioinformatics/btl390; Kann MG, 2007, BRIEF BIOINFORM, V8, P333, DOI 10.1093/bib/bbm031; Kim M, 2009, HUM MOL GENET, V18, P3987, DOI 10.1093/hmg/ddp323; Kitsios GD, 2009, ANN HUM GENET, V73, P514, DOI 10.1111/j.1469-1809.2009.00533.x; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Krauthammer M, 2004, P NATL ACAD SCI USA, V101, P15148, DOI 10.1073/pnas.0404315101; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lee I, 2011, GENOME RES; Li YJ, 2010, BIOINFORMATICS, V26, P1219, DOI 10.1093/bioinformatics/btq108; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; Nabieva E, 2005, BIOINFORMATICS, V21, pI302, DOI 10.1093/bioinformatics/bti1054; Navlakha S, 2010, BIOINFORMATICS, V26, P1057, DOI 10.1093/bioinformatics/btq076; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Perez-Iratxeta C, 2002, NAT GENET, V31, P316, DOI 10.1038/ng895; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Said MR, 2004, P NATL ACAD SCI USA, V101, P18006, DOI 10.1073/pnas.0405996101; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wachi S, 2005, BIOINFORMATICS, V21, P4205, DOI 10.1093/bioinformatics/bti688; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; White S., 2003, P 9 ACM SIGKDD INT C, P266, DOI [DOI 10.1145/956750.956782, 10.1145/956750.956782]; Woo HN, 2009, BIOCHEM BIOPH RES CO, V390, P1093, DOI 10.1016/j.bbrc.2009.10.093; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Xu JZ, 2006, BIOINFORMATICS, V22, P2800, DOI 10.1093/bioinformatics/btl467; Yang SY, 2007, MOL GENET METAB, V92, P36, DOI 10.1016/j.ymgme.2007.06.001	55	72	74	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e43557	10.1371/journal.pone.0043557	http://dx.doi.org/10.1371/journal.pone.0043557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028459	gold, Green Published, Green Submitted			2022-12-27	WOS:000309392800002
J	Lhomme, P; Ayasse, M; Valterova, I; Lecocq, T; Rasmont, P				Lhomme, Patrick; Ayasse, Manfred; Valterova, Irena; Lecocq, Thomas; Rasmont, Pierre			Born in an Alien Nest : How Do Social Parasite Male Offspring Escape from Host Aggression?	PLOS ONE			English	Article							CHEMICAL RECOGNITION SYSTEM; DUFOURS GLAND SECRETION; SLAVE-MAKING ANT; POLISTES-ATRIMANDIBULARIS; INTERSPECIFIC RECOGNITION; POLYERGUS-BREVICEPS; POSTPHARYNGEAL GLAND; SPECIES HYMENOPTERA; OVARIAN DEVELOPMENT; PSITHYRUS-VESTALIS	Social parasites exploit the colony resources of social insects. Some of them exploit the host colony as a food resource or as a shelter whereas other species also exploit the brood care behavior of their social host. Some of these species have even lost the worker caste and rely completely on the host's worker force to rear their offspring. To avoid host defenses and bypass their recognition code, these social parasites have developed several sophisticated chemical infiltration strategies. These infiltration strategies have been highly studied in several hymenopterans. Once a social parasite has successfully entered a host nest and integrated its social system, its emerging offspring still face the same challenge of avoiding host recognition. However, the strategy used by the offspring to survive within the host nest without being killed is still poorly documented. In cuckoo bumblebees, the parasite males completely lack the morphological and chemical adaptations to social parasitism that the females possess. Moreover, young parasite males exhibit an early production of species-specific cephalic secretions, used as sexual pheromones. Host workers might thus be able to recognize them. Here we used a bumblebee host-social parasite system to test the hypothesis that social parasite male offspring exhibit a chemical defense strategy to escape from host aggression during their intranidal life. Using behavioral assays, we showed that extracts from the heads of young cuckoo bumblebee males contain a repellent odor that prevents parasite males from being attacked by host workers. We also show that social parasitism reduces host worker aggressiveness and helps parasite offspring acceptance.	[Lhomme, Patrick; Lecocq, Thomas; Rasmont, Pierre] Univ Mons, Zool Lab, B-7000 Mons, Belgium; [Ayasse, Manfred] Univ Ulm, Inst Expt Ecol, Dept Chem Ecol, Ulm, Germany; [Valterova, Irena] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic	University of Mons; Ulm University; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	Lhomme, P (corresponding author), Univ Mons, Zool Lab, B-7000 Mons, Belgium.	patrick.lhomme@umons.ac.be; irena@uochb.cas.cz	Lhomme, Patrick/AFN-5332-2022; Lhomme, Patrick/M-6395-2014	Lhomme, Patrick/0000-0001-6735-9104; Lhomme, Patrick/0000-0001-6735-9104; Valterova, Irena/0000-0001-5723-6143; Lecocq, Thomas/0000-0002-4947-0332	Fonds pour la Recherche dans l'Industrie et l'Agriculture; Fonds National pour la Recherche Scientifique; Academy of Sciences of the Czech Republic [Z40550506]	Fonds pour la Recherche dans l'Industrie et l'Agriculture(Fonds de la Recherche Scientifique - FNRS); Fonds National pour la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	This work was supported by the Fonds pour la Recherche dans l'Industrie et l'Agriculture, the Fonds National pour la Recherche Scientifique and the Academy of Sciences of the Czech Republic (research project Z40550506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGREN L, 1979, ZOON, V7, P1; Akino T, 1999, P ROY SOC B-BIOL SCI, V266, P1419, DOI 10.1098/rspb.1999.0796; Akino Toshiharu, 2000, Entomological Science, V3, P1; [Anonymous], 1971, INSECT SOC; AYASSE M, 1995, APIDOLOGIE, V26, P163, DOI 10.1051/apido:19950301; Bagneres AG, 1996, SCIENCE, V272, P889, DOI 10.1126/science.272.5263.889; Bauer S, 2009, BEHAV ECOL SOCIOBIOL, V64, P45, DOI 10.1007/s00265-009-0817-3; Beekman M, 2008, ANNU REV ENTOMOL, V53, P19, DOI 10.1146/annurev.ento.53.103106.093515; BENTON T, 2006, BUMBLEBEES; Bergman P, 1997, THESIS GOTEBORG U; BERGSTROM G, 1981, Entomologica Scandinavica Supplement, P173; Bloch G, 1996, PHYSIOL ENTOMOL, V21, P257, DOI 10.1111/j.1365-3032.1996.tb00863.x; CARLIN NF, 1986, BEHAV ECOL SOCIOBIOL, V19, P123, DOI 10.1007/BF00299947; CARLIN NF, 1988, INSECT SOC, V35, P191, DOI 10.1007/BF02223932; Cervo R, 2008, BEHAV ECOL SOCIOBIOL, V62, P1319, DOI 10.1007/s00265-008-0560-1; CERVO R, 1994, ETHOL ECOL EVOL, P61; Cervo R, 2006, ANN ZOOL FENN, V43, P531; Chapman NC, 2009, BEHAV ECOL, V20, P817, DOI 10.1093/beheco/arp065; Chernenko A, 2011, ETHOLOGY, V117, P1081, DOI 10.1111/j.1439-0310.2011.01972.x; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Coppee A, 2011, CHEMOECOLOGY, V21, P75, DOI 10.1007/s00049-011-0070-x; D'Ettorre P, 2002, P ROY SOC B-BIOL SCI, V269, P1911, DOI 10.1098/rspb.2002.2110; D'Ettorre P, 2000, CHEMOECOLOGY, V10, P135, DOI 10.1007/PL00001815; D'Ettorre P., 1998, INS SOC LIFE, V2, P71; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; De Meulemeester T, 2011, INSECT SOC, V58, P227, DOI 10.1007/s00040-011-0146-1; DESCOINS C, 1984, NOVA ACTA REG SOC, V3, P149; DETTNER K, 1994, ANNU REV ENTOMOL, V39, P129, DOI 10.1146/annurev.en.39.010194.001021; Dronnet S, 2005, APIDOLOGIE, V36, P59, DOI 10.1051/apido:2004070; DUCHATEAU MJ, 1989, J ETHOL, V7, P141, DOI 10.1007/BF02350036; DUCHATEAU MJ, 1989, ENTOMOL EXP APPL, V51, P199, DOI 10.1007/BF00347883; Errard C, 2003, INSECT SOC, V50, P268, DOI 10.1007/s00040-003-0677-1; Errard C, 1997, INSECT SOC, V44, P189, DOI 10.1007/s000400050040; ERRARD C, 1994, J INSECT BEHAV, V7, P83, DOI 10.1007/BF01989829; FISHER RM, 1992, CAN ENTOMOL, V124, P69, DOI 10.4039/Ent12469-1; FISHER RM, 1987, ANIM BEHAV, V35, P1026, DOI 10.1016/S0003-3472(87)80159-8; Grangier J, 2007, BEHAV PROCESS, V74, P93, DOI 10.1016/j.beproc.2006.10.009; Hartel S, 2006, APIDOLOGIE, V37, P462, DOI 10.1051/apido:2006012; HEFETZ A, 1984, EXPERIENTIA, V40, P539, DOI 10.1007/BF01982317; HEFETZ A, 1992, NATURWISSENSCHAFTEN, V79, P417, DOI 10.1007/BF01138575; Hernandez JV, 2006, ANIM BEHAV, V71, P945, DOI 10.1016/j.anbehav.2005.09.004; Hovorka O, 1998, J CHEM ECOL, V24, P183, DOI 10.1023/A:1022353315874; HOWARD RW, 1982, J CHEM ECOL, V8, P1227, DOI 10.1007/BF00990755; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Johnson CA, 2005, BEHAV ECOL SOCIOBIOL, V57, P245, DOI 10.1007/s00265-004-0851-0; Johnson CA, 2001, J CHEM ECOL, V27, P1787, DOI 10.1023/A:1010456608626; Katzav-Gozansky T, 2004, NATURWISSENSCHAFTEN, V91, P186, DOI 10.1007/s00114-004-0513-0; Katzav-Gozansky T, 2008, J INSECT PHYSIOL, V54, P378, DOI 10.1016/j.jinsphys.2007.10.008; Kreuter K, 2012, BEHAV ECOL SOCIOBIOL, V66, P475, DOI 10.1007/s00265-011-1294-z; KULLENBERG B, 1973, ZOON Supplement, P23; Lahav S, 1998, BEHAV ECOL SOCIOBIOL, V43, P203, DOI 10.1007/s002650050482; Lambardi D, 2007, BEHAV ECOL SOCIOBIOL, V61, P843, DOI 10.1007/s00265-006-0313-y; Lecocq T, 2011, SYST ENTOMOL, V36, P453, DOI 10.1111/j.1365-3113.2011.00576.x; Lenoir A, 2001, INSECT SOC, V48, P101, DOI 10.1007/PL00001751; Lenoir A, 2001, ANNU REV ENTOMOL, V46, P573, DOI 10.1146/annurev.ento.46.1.573; Liu ZB, 2000, J ETHOL, V18, P69, DOI 10.1007/s101640070002; Liu Zhibin, 2003, Entomological Science, V6, P125, DOI 10.1046/j.1343-8786.2003.00014.x; Lorenzi MC, 2007, BIOL J LINN SOC, V91, P505, DOI 10.1111/j.1095-8312.2007.00815.x; LORENZI MC, 1992, B ZOOL, V59, P267, DOI 10.1080/11250009209386681; Lorenzi MC, 2003, INSECT SOC, V50, P82, DOI 10.1007/s000400300013; Lorenzi MC, 2002, PARASITOLOGY, V125, P507, DOI 10.1017/S003118200200238X; Lorenzi MC, 1999, J INSECT BEHAV, V12, P147, DOI 10.1023/A:1020906631121; Martin SJ, 2008, J INSECT PHYSIOL, V54, P700, DOI 10.1016/j.jinsphys.2008.01.010; Martin SJ, 2007, P ROY SOC B-BIOL SCI, V274, P2717, DOI 10.1098/rspb.2007.0795; Martin SJ, 2010, J CHEM ECOL, V36, P855, DOI 10.1007/s10886-010-9805-3; Mori A, 2000, INSECT SOC, V47, P7, DOI 10.1007/s000400050002; Nash D. R., 2008, SOCIOBIOLOGY COMMUNI, P55, DOI DOI 10.1093/ACPROF:OSO/9780199216840.003.0004; OBIN MS, 1989, ANIM BEHAV, V38, P430, DOI 10.1016/S0003-3472(89)80036-3; ONDRICEKFALLSCHEER RL, 1992, SOCIOBIOLOGY, V20, P245; Orivel J, 1997, BEHAV ECOL SOCIOBIOL, V40, P87, DOI 10.1007/s002650050319; Ruano F, 2005, J INSECT PHYSIOL, V51, P1158, DOI 10.1016/j.jinsphys.2005.06.005; SOROKER V, 1994, NATURWISSENSCHAFTEN, V81, P510; Sramkova A, 2009, CHEMOECOLOGY, V19, P55, DOI 10.1007/s00049-009-0009-7; Stearns S.C., 1992, pi; STUART RJ, 1987, BEHAV ECOL SOCIOBIOL, V21, P229, DOI 10.1007/BF00292504; Stuart RJ, 2000, BEHAV ECOL, V11, P676, DOI 10.1093/beheco/11.6.676; Summers K, 1997, BEHAV ECOL, V8, P260, DOI 10.1093/beheco/8.3.260; TENGO J, 1977, SCIENCE, V196, P1117, DOI 10.1126/science.196.4294.1117; Tengo J, 1976, J CHEM ECOL, V2, P57, DOI 10.1007/BF00988024; TOPOFF H, 1988, ETHOLOGY, V78, P209; Tsuneoka Y, 2009, APPL ENTOMOL ZOOL, V44, P133, DOI 10.1303/aez.2009.133; Turillazzi S, 2000, NATURWISSENSCHAFTEN, V87, P172, DOI 10.1007/s001140050697; Urbanova K, 2004, BIOCHEM SYST ECOL, V32, P1025, DOI 10.1016/j.bse.2004.02.010; Valterova I, 1996, COLLECT CZECH CHEM C, V61, P1501, DOI 10.1135/cccc19961501; van Zweden JS, 2009, J INSECT PHYSIOL, V55, P158, DOI 10.1016/j.jinsphys.2008.11.001; Vander Meer Robert K., 1998, P79; VANHONK CGJ, 1981, BEHAV ECOL SOCIOBIOL, V9, P9, DOI 10.1007/BF00299847; Vergara CH, 2003, APIDOLOGIE, V34, P563, DOI 10.1051/apido:2003056; VIENNE C, 1995, INSECT SOC, V42, P267, DOI 10.1007/BF01240421; Visicchio R, 2000, ETHOL ECOL EVOL, V12, P67, DOI 10.1080/03949370.2000.9728323; Wisenden BD, 1999, REV FISH BIOL FISHER, V9, P45, DOI 10.1023/A:1008865801329; Zimma BO, 2003, J COMP PHYSIOL A, V189, P769, DOI 10.1007/s00359-003-0451-x	92	24	24	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e43053	10.1371/journal.pone.0043053	http://dx.doi.org/10.1371/journal.pone.0043053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028441	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388900001
J	Cheng, JF; Joyce, A; Yates, K; Aouizerat, B; Sanyal, AJ				Cheng, Jianfeng; Joyce, Andrew; Yates, Katherine; Aouizerat, Bradley; Sanyal, Arun J.			Metabolomic Profiling to Identify Predictors of Response to Vitamin E for Non-Alcoholic Steatohepatitis (NASH)	PLOS ONE			English	Article							SAMPLING VARIABILITY; ANTIOXIDANT ENZYMES; GLUTATHIONE; SENSITIZES	Vitamin E was recently shown to improve hepatic histology in a randomized controlled trial of pioglitazone or vitamin E for nonalcoholic steatohepatitis (PIVENS). The current study utilized samples collected in the PIVENS trial to identify: (1) baseline metabolomic profiles that could identify who would respond to vitamin E treatment and (2) end of treatment metabolomic profiles reflective of histologic improvement. A comprehensive analysis of metabolomics profiles (n = 547) quantified by mass spectrometry was performed in vitamin E responders (n = 16), vitamin E non-responders (n = 15), and placebo responders (n = 15). At baseline, phenyl-propionic acid (Odds ratio: 29.4, p < 0.01), indole-propionic acid levels (Odds ratio: 16.2, p < 0.01) were directly associated with a subsequent histologic response to vitamin E treatment whereas gamma-carboxyethylhydroxychroman (CEHC) levels were inversely related to histologic response. Adjusting for baseline values by analysis of covariance, the end of treatment levels of gamma-glutamyl leucine (Fold change: 0.82, p < 0.02) and gamma-glutamyl valine (Fold change: 0.8, p < 0.03) were significantly lower in vitamin E responders compared to non-responders. The levels of gamma-glutamyl transpeptidase were not significantly different across the two groups. Subjects receiving placebo who demonstrated a histologic improvement also demonstrated lower levels of gamma-glutamylated amino acids (leucine, valine and isoleucine) compared to vitamin E non-responders. These data provide exploratory proof that there are measurable differences in the metabolic profile of subjects who are likely (vs unlikely) to respond to vitamin E treatment for NASH and in those experiencing histologic improvement (vs no improvement) on treatment and support further studies to validate these biomarkers.	[Cheng, Jianfeng; Sanyal, Arun J.] Virginia Commonwealth Univ, Sch Med, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, Richmond, VA 23284 USA; [Joyce, Andrew] Venebio Grp LLC, Richmond, VA USA; [Yates, Katherine] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Aouizerat, Bradley] Univ Calif San Francisco, Dept Physiol Nursing, San Francisco, CA USA	Virginia Commonwealth University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California San Francisco	Sanyal, AJ (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, Richmond, VA 23284 USA.	asanyal@mcvh-vcu.edu			ARRA (American Recovery and Reinvestment Act) from the National Institutes of Health [3UO1 DK 061731-08S1]; NASH [R01 - NIDDK - 1R01DK08140];  [2T32 DK 007150-35]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK061731, U01DK061730, T32DK007150] Funding Source: NIH RePORTER	ARRA (American Recovery and Reinvestment Act) from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NASH; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an ARRA (American Recovery and Reinvestment Act) supplement to a contract (3UO1 DK 061731-08S1) from the National Institutes of Health, NASH R01 - NIDDK - 1R01DK08140 and a training grant (2T32 DK 007150-35) awarded to Dr. Arun Sanyal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, J HEPATOL, V42, P132, DOI 10.1016/j.jhep.2004.09.012; Arun J, 2010, NEW ENGL J MED, V362, P18; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Attwood G, 2006, J APPL MICROBIOL, V100, P1261, DOI 10.1111/j.1365-2672.2006.02896.x; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Colell A, 1998, GASTROENTEROLOGY, V115, P1541, DOI 10.1016/S0016-5085(98)70034-4; [Committee DDIC USDoHaH], 2004, ACT PLAN LIV DIS; Djavaheri-Mergny M, 2002, MOL CELL BIOCHEM, V232, P103, DOI 10.1023/A:1014834315936; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Garcia-Ruiz C, 2006, J GASTROEN HEPATOL, V21, pS3, DOI 10.1111/j.1440-1746.2006.04570.x; Hardeland R, 1999, ADV EXP MED BIOL, V467, P389; Li N, 1998, J CELL PHYSIOL, V177, P148, DOI 10.1002/(SICI)1097-4652(199810)177:1<148::AID-JCP16>3.0.CO;2-9; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Mari M, 2004, J CLIN INVEST, V113, P895, DOI 10.1172/JCI200419852; Mari M, 2007, LIVER INT, V27, P440, DOI 10.1111/j.1478-3231.2007.01475.x; Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006; Martin HL, 2009, FASEB J, V23, P3263, DOI 10.1096/fj.08-125443; Miele Luca, 2006, Recenti Prog Med, V97, P1; Mitsuyoshi Hironori, 2006, Nihon Rinsho, V64, P1077; Nobili V, 2005, CLIN CHIM ACTA, V355, P105, DOI 10.1016/j.cccn.2004.12.022; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Sachdeva R, 2005, CHEM RES TOXICOL, V18, P1018, DOI 10.1021/tx0496441; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Sanyal AJ, 2004, CLIN GASTROENTEROL H, V2, P1107, DOI 10.1016/S1542-3565(04)00457-4; Youssef Wael, 2002, Semin Gastrointest Dis, V13, P17	26	37	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44106	10.1371/journal.pone.0044106	http://dx.doi.org/10.1371/journal.pone.0044106			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028489	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400018
J	Priyadarshini, S; Aich, P				Priyadarshini, Sushri; Aich, Palok			Effects of Psychological Stress on Innate Immunity and Metabolism in Humans: A Systematic Analysis	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; MENDELIAN-INHERITANCE; INFLAMMATORY CYTOKINE; INTERACTION NETWORKS; DISEASE; BIOMART; GLUCOCORTICOIDS; IDENTIFICATION; ASSOCIATIONS; MODULATION	Stress is perhaps easiest to conceptualize as a process which allows an organism to accommodate for the demands of its environment such that it can adapt to the prevailing set of conditions. Psychological stress is an important component with the potential to affect physiology adversely as has become evident from various studies in the area. Although these studies have established numerous effects of psychological stress on physiology, a global strategy for the correlation of these effects has yet to begin. Our comparative and systematic analysis of the published literature has unraveled certain interesting molecular mechanisms as clues to account for some of the observed effects of psychological stress on human physiology. In this study, we attempt to understand initial phase of the physiological response to psychological stress by analyzing interactions between innate immunity and metabolism at systems level by analyzing the data available in the literature. In light of our gene association-networks and enrichment analysis we have identified candidate genes and molecular systems which might have some associative role in affecting psychological stress response system or even producing some of the observed terminal effects (such as the associated physiological disorders). In addition to the already accepted role of psychological stress as a perturbation that can disrupt physiological homeostasis, we speculate that it is potentially capable of causing deviation of certain biological processes from their basal level activity after which they can return back to their basal tones once the effects of stress diminish. Based on the derived inferences of our comparative analysis, we have proposed a probabilistic mechanism for how psychological stress could affect physiology such that these adaptive deviations are sometimes not able to bounce back to their original basal tones, and thus increase physiological susceptibility to metabolic and immune imbalance.	[Priyadarshini, Sushri; Aich, Palok] NISER, Sch Biol Sci, Bhubaneswar, Odisha, India	National Institute of Science Education & Research (NISER)	Aich, P (corresponding author), NISER, Sch Biol Sci, Inst Phys Campus,Sachivalaya Marg, Bhubaneswar, Odisha, India.	palok.aich@niser.ac.in	Aich, Palok/A-3605-2010	Aich, Palok/0000-0003-4927-7812	NISER	NISER	Authors would like to thank NISER for supporting the work.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Aich P, 2009, OMICS, V13, P199, DOI 10.1089/omi.2009.0012; Alper S, 2008, P NATL ACAD SCI USA, V105, P7016, DOI 10.1073/pnas.0802405105; Antonov AV, 2010, NUCLEIC ACIDS RES, V38, pW78, DOI 10.1093/nar/gkq482; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bah J, 2010, METABOLISM, V59, P1156, DOI 10.1016/j.metabol.2009.11.007; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Beurel E, 2010, TRENDS IMMUNOL, V31, P24, DOI 10.1016/j.it.2009.09.007; BLALOCK JE, 1989, PHYSIOL REV, V69, P1, DOI 10.1152/physrev.1989.69.1.1; Bose M, 2009, CURR OPIN ENDOCRINOL, V16, P340, DOI 10.1097/MED.0b013e32832fa137; Brydon L, 2009, BRAIN BEHAV IMMUN, V23, P217, DOI 10.1016/j.bbi.2008.09.007; Buske-Kirschbaum A, 2002, J CLIN ENDOCR METAB, V87, P4245, DOI 10.1210/jc.2001-010872; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; COHEN S, 1991, NEW ENGL J MED, V325, P606, DOI 10.1056/NEJM199108293250903; Coulet Adrien, 2011, J Biomed Semantics, V2 Suppl 2, pS10, DOI 10.1186/2041-1480-2-S2-S10; Cousijn H, 2010, P NATL ACAD SCI USA, V107, P9867, DOI 10.1073/pnas.1003514107; Deveaux V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005844; Dhabhar FS, 2002, BRAIN BEHAV IMMUN, V16, P785, DOI 10.1016/S0889-1591(02)00036-3; Dinu I R, 2009, Rom J Intern Med, V47, P9; DOHMS JE, 1991, VET IMMUNOL IMMUNOP, V30, P89, DOI 10.1016/0165-2427(91)90011-Z; Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24; Drago A, 2010, EUR J CLIN PHARMACOL, V66, P5, DOI 10.1007/s00228-009-0724-6; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Elftman MD, 2010, J IMMUNOL, V184, P1867, DOI 10.4049/jimmunol.0902469; EXTON J H, 1987, Diabetes Metabolism Reviews, V3, P163; FUCHS E, 1995, PSYCHONEUROENDOCRINO, V20, P33, DOI 10.1016/0306-4530(94)E0006-U; Gleimer M, 2003, IMMUNITY, V19, P469, DOI 10.1016/S1074-7613(03)00272-3; Godbout JP, 2006, J NEUROIMMUNE PHARM, V1, P421, DOI 10.1007/s11481-006-9036-0; Graugnard DE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-142; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hirasawa H, 2009, WORLD J GASTROENTERO, V15, P4132, DOI 10.3748/wjg.15.4132; Horvath TL, 2006, INT J OBESITY, V30, pS30, DOI 10.1038/sj.ijo.0803275; Hwang TH, 2011, BIOINFORMATICS, V27, P2692, DOI 10.1093/bioinformatics/btr463; Idova G, 1997, INT J IMMUNOPHARMACO, V19, P535, DOI 10.1016/S0192-0561(97)00077-5; Imrich R, 2004, ANN NY ACAD SCI, V1018, P266, DOI 10.1196/annals.1296.031; Joergensen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020795; Jones P, 2008, NUCLEIC ACIDS RES, V36, pD878, DOI 10.1093/nar/gkm1021; Juster RP, 2011, DEV PSYCHOPATHOL, V23, P725, DOI 10.1017/S0954579411000289; Kao CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018696; Kenagy GJ, 2000, GEN COMP ENDOCR, V117, P189, DOI 10.1006/gcen.1999.7397; KRAHN DD, 1986, BRAIN RES BULL, V17, P285, DOI 10.1016/0361-9230(86)90233-9; Kvetnansky R, 2009, PHYSIOL REV, V89, P535, DOI 10.1152/physrev.00042.2006; Kyrou I, 2009, CURR OPIN PHARMACOL, V9, P787, DOI 10.1016/j.coph.2009.08.007; Maes M, 2001, CLIN SCI, V101, P193, DOI 10.1042/CS20010157; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Neuschwander-Tetri BA, 2007, HEPATOLOGY, V46, P12, DOI 10.1002/hep.21821; Ozgur A, 2008, BIOINFORMATICS, V24, pI277, DOI 10.1093/bioinformatics/btn182; Otero M, 2006, RHEUMATOLOGY, V45, P944, DOI 10.1093/rheumatology/kel157; Oury F, 2011, TRENDS ENDOCRINOL ME; Pankevich DE, 2009, PHYSIOL BEHAV, V98, P94, DOI 10.1016/j.physbeh.2009.04.015; Raison CL, 2003, AM J PSYCHIAT, V160, P1554, DOI 10.1176/appi.ajp.160.9.1554; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sharma S, 2011, PEDIAT ALLERGY IMMUN; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Stan D, 2011, CELL TISSUE RES, V343, P379, DOI 10.1007/s00441-010-1092-3; Sternberg EM, 2001, J ENDOCRINOL, V169, P429, DOI 10.1677/joe.0.1690429; Szczepanska-Sadowska E, 2010, J PHYSIOL PHARMACOL, V61, P509; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tsolakidou A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-546; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Visser U, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-257; Wang XJ, 2011, BRIEF FUNCT GENOMICS, V10, P280, DOI 10.1093/bfgp/elr024; Wang Zhou, 2003, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V19, P95; Wolf JM, 2009, BRAIN BEHAV IMMUN, V23, P742, DOI 10.1016/j.bbi.2008.09.009; Wolowczuk I, 2008, CLIN DEV IMMUNOL, P1, DOI 10.1155/2008/639803; Yang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021502; Yu WK, 2003, WORLD J GASTROENTERO, V9, P1824, DOI 10.3748/wjg.v9.i8.1824; Zhu MJ, 2007, INT J BIOL SCI, V3, P420	69	41	42	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e43232	10.1371/journal.pone.0043232	http://dx.doi.org/10.1371/journal.pone.0043232			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028447	gold, Green Submitted, Green Published			2022-12-27	WOS:000309388400007
J	Rougerie, R; Naumann, S; Nassig, WA				Rougerie, Rodolphe; Naumann, Stefan; Naessig, Wolfgang A.			Morphology and Molecules Reveal Unexpected Cryptic Diversity in the Enigmatic Genus Sinobirma Bryk, 1944 (Lepidoptera: Saturniidae)	PLOS ONE			English	Article								The wild silkmoth genus Sinobirma Bryk, 1944 is a poorly known monotypic taxon from the eastern end of the Himalaya Range. It was convincingly proposed to be closely related to some members of an exclusively Afro-tropical group of Saturniidae, but its biogeographical and evolutionary history remains enigmatic. After examining recently collected material from Tibet, northern India, and northeastern Myanmar, we realized that this unique species, S. malaisei Bryk, 1944 only known so far from a few specimens and from a very restricted area near the border between north-eastern Myanmar and the Yunnan province of China, may in fact belong to a group of closely related cryptic species. In this work, we combined morphological comparative study, DNA barcoding, and the sequences of a nuclear marker (D2 expansion segment of the 28S rRNA gene) to unequivocally delimit three distinct species in the genus Sinobirma, of which two are described as new to science: S. myanmarensis sp. n. and S. bouyeri sp. n. An informative DNA barcode sequence was obtained from the female holotype of S. malaisei-collected in 1934-ensuring the proper assignation of this name to the newly collected and studied specimens. Our findings represent another example of the potential of coupling traditional taxonomy and DNA barcoding for revealing and solving difficult cases of cryptic diversity. This approach is now being generalized to the world fauna of Saturniidae, with the participation of most of the taxonomists studying these moths.	[Rougerie, Rodolphe] Univ Rouen, Lab Ecol, Mont St Aignan, France; [Naessig, Wolfgang A.] Forschungsinst Senckenberg, Frankfurt, Germany	Universite de Rouen Normandie; Senckenberg Gesellschaft fur Naturforschung (SGN)	Rougerie, R (corresponding author), Univ Rouen, Lab Ecol, Mont St Aignan, France.	rrougeri@gmail.com	Rougerie, Rodolphe/D-2930-2009	Rougerie, Rodolphe/0000-0003-0937-2815	Upper-Normandy region through the University of Rouen, France; government of Canada through Genome Canada; Ontario Genomics Institute; Natural Sciences and Engineering Research Council of Canada (NSERC)	Upper-Normandy region through the University of Rouen, France(Region Normandie); government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	RR was supported by a postdoctoral fellowship by the Upper-Normandy region through the University of Rouen, France. Laboratory analyses on sequences generated between 2007 and 2010 were funded by the government of Canada through Genome Canada and the Ontario Genomics Institute in support of the International Barcode of Life project, by the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouyer Thierry, 2004, Nachrichten des Entomologischen Vereins Apollo, V25, P27; Bryk Felix, 1944, ARKIV ZOOL [STOCKHOLM], V35A, P1; Decaens T, 2008, ZOOTAXA, P34, DOI 10.11646/zootaxa.1944.1.2; Fletcher DS, 1982, THE GENERIC NAMES OF, V4; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hausmann A, 2009, ZOOTAXA, P1; Hausmann A, 2009, SPIXIANA, V32, P161; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lees DC, 2010, ZOOL SCR, V39, P642, DOI 10.1111/j.1463-6409.2010.00447.x; Nassig WA, 1994, NACHR ENT VER APOLLO, V15, P369; Nassig Wolfgang A., 2010, Journal of Research on the Lepidoptera, V43, P37; Naumann S, 2004, MEMOIR, V1, P235; Naumann Stefan, 2010, Nachrichten des Entomologischen Vereins Apollo, V31, P31; Naumann Stefan, 2008, Nachrichten des Entomologischen Vereins Apollo, V29, P149; Oberprieler R.G., 1997, Metamorphosis Occasional Supplement, V3, P142; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rougerie R, 2003, NOTA LEPID, V25, P227; Saux C, 2004, MOL PHYLOGENET EVOL, V33, P457, DOI 10.1016/j.ympev.2004.06.017; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vaglia T, 2008, ZOOTAXA, P18, DOI 10.11646/zootaxa.1923.1.2; Vinciguerra Roberto, 2005, Beitraege zur Kenntnis der Wilden Seidenspinner, V3, P46; ZHU H.-F, 1996, FAUNA SINICA INSECTA, V5	23	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e43920	10.1371/journal.pone.0043920	http://dx.doi.org/10.1371/journal.pone.0043920			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028478	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388400014
J	Vasilyan, D; Bohme, M				Vasilyan, Davit; Boehme, Madelaine			Pronounced Peramorphosis in Lissamphibians-Aviturus exsecratus (Urodela, Cryptobranchidae) from the Paleocene-Eocene Thermal Maximum of Mongolia	PLOS ONE			English	Article							EVOLUTION	Background: The oldest and largest member of giant salamanders (Cryptobranchidae) Aviturus exsecratus appears in the latest Paleocene (near the Paleocene-Eocene Thermal Maximum) of Mongolia. Based on femoral and vertebral morphology and metrics, a terrestrial adaptation has been supposed for this species. Methodology/Principal Findings: A detailed morphological reinvestigation of published as well as unpublished material reveals that this salamander shows a vomerine dentition that is posteriorly shifted and arranged in a zigzag pattern, a strongly developed olfactory region within the cranial cavity, and the highest bone ossification and relatively longest femur among all fossil and recent cryptobranchids. Conclusions/Significance: The presence of these characteristics indicates a peramorphic developmental pattern for Aviturus exsecratus. Our results from Av. exsecratus indicate for the first time pronounced peramorphosis within a crown-group lissamphibian. Av. exsecratus represents a new developmental trajectory within both fossil and recent lissamphibian clades characterized by extended ontogeny and large body size, resembling the pattern known from late Paleozoic eryopines. Moreover, Av. exsecratus is not only a cryptobranchid with distinctive peramorphic characters, but also the first giant salamander with partially terrestrial (amphibious) lifestyle. The morphology of the vomers and dentaries suggests the ability of both underwater and terrestrial feeding.	[Vasilyan, Davit; Boehme, Madelaine] Univ Tubingen, Dept Geosci, Tubingen, Germany; [Boehme, Madelaine] Senckenberg Ctr Human Evolut & Palaeoecol HEP, Tubingen, Germany	Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN)	Vasilyan, D (corresponding author), Univ Tubingen, Dept Geosci, Tubingen, Germany.	davit.vasilyan@ifg.uni-tuebingen.de	Vasilyan, Davit/H-9603-2019	Vasilyan, Davit/0000-0001-8712-0678	Deutsche Forschungsgemeinschaft [BO1550/14-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was financed by Deutsche Forschungsgemeinschaft, grant nr. BO1550/14-1 to MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Badamgarev D, 1985, PALEONTOLOGY STRATIG; Bohme M, 2012, PALAEOGEOGR PALAEOCL, V342, P64, DOI 10.1016/j.palaeo.2012.04.032; Chkhikvadze V.M., 1982, VERTEBR HUNGARICA, V21, P63; CUNDALL D, 1987, EXPERIENTIA, V43, P1229, DOI 10.1007/BF01945537; Duellman WE, 1994, BIOL AMPHIBIA; ELWOOD JRL, 1994, J MORPHOL, V220, P47, DOI 10.1002/jmor.1052200106; Estes R., 1981, GYMNOPHIONA CAUDATA; Gingerich P.D., 2003, CAUSES CONSEQUENCES, V369, P463; Gubin Yu.M., 1991, Paleontologicheskii Zhurnal, V1991, P96; Luterbacher H. P., 2004, GEOLOGIC TIME SCALE, P384, DOI DOI 10.1017/CBO9780511536045.021; Meng J, 1998, NATURE, V394, P364, DOI 10.1038/28603; Osawa G., 1902, MITT MED FAC U TOKIO, V5, P1; Pawley K, 2006, J PALEONTOL, V80, P561, DOI 10.1666/0022-3360(2006)80[561:TASOEM]2.0.CO;2; Rose CS, 1996, J ZOOL, V239, P253, DOI 10.1111/j.1469-7998.1996.tb05451.x; Schoch RR, 2009, ANNU REV EARTH PL SC, V37, P135, DOI 10.1146/annurev.earth.031208.100113; Secord R, 2006, AM J SCI, V306, P211, DOI 10.2475/ajs.306.4.211; Sever D. M., 2003, REPROD BIOL PHYLOGEN; Shishkin MA, 1975, FOSSIL FAUNA FLORA M, P230; Ting Suyin, 2003, Geological Society of America Special Paper, V369, P521; Tolstikova NV, 1976, PALEONTOLOGY BIOSTRA, P145; Vasilyan D, 2012, J VERTEBRAT IN PRESS; Westphal F., 1958, PALAEONTOGR ABT A, V110, P20; Witzmann Florian, 2009, Palaeodiversity, P233; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zhang P, 2006, P NATL ACAD SCI USA, V103, P7360, DOI 10.1073/pnas.0602325103; Zug G. R., 2001, HERPETOLOGY, P57	26	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e40665	10.1371/journal.pone.0040665	http://dx.doi.org/10.1371/journal.pone.0040665			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028420	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400001
J	Oehme, AK; Rashed, AN; Hefele, B; Wong, ICK; Rascher, W; Neubert, A				Oehme, Ann-Kathrin; Rashed, Asia N.; Hefele, Barbara; Wong, Ian C. K.; Rascher, Wolfgang; Neubert, Antje			Adverse Drug Reactions in Hospitalised Children in Germany Are Decreasing: Results of a Nine Year Cohort-Based Comparison	PLOS ONE			English	Article							CYSTIC-FIBROSIS; RISK-FACTORS; INTENSIFIED SURVEILLANCE; PEDIATRIC-PATIENTS; PAYMENT SYSTEM; METAANALYSIS; QUALITY; CARE; IMPLEMENTATION; MULTICENTER	Background: In recent years, efforts have been made to improve paediatric drug therapy. The aim of this research was to investigate any changes regarding the frequency and nature of adverse drug reactions (ADRs) in hospitalized children in one paediatric general medical ward over a 9-year period. Methodology: Two prospective observational cohort studies were conducted at a large University hospital in Germany in 1999 and 2008, respectively. Children aged 0-18 years admitted to the study ward during the study periods were included. ADRs were identified using intensive chart review. Uni- and multivariable regression has been used for data analysis. Results: A total of 520 patients (574 admissions) were included [1999: n = 144 (167); 2008: n = 376 (407)]. Patients received a total of 2053 drugs [median 3, interquartile range (IQR) 2-5]. 19% of patients did not receive any medication. Median length of stay was 4 days (IQR 3-7; range 1-190 days) with a significantly longer length of stay in 1999. The overall ADR incidence was 13.1% (95% CI, 9.8-16.3) varying significantly between the two study cohorts [1999: 21.9%, 95% CI, 14.7-29.0; 2008: 9.2%, 95% CI, 5.9-12.5 (p < 0.001)]. Antibacterials and corticosteroids for systemic use caused most of the ADRs in both cohorts (1999; 2008). Exposure to systemic antibacterials decreased from 62.9% to 43.5% whereas exposure to analgesics and anti-inflammatory drugs increased from 17.4% to 45.2%, respectively. The use of high risk drugs decreased from 75% to 62.2%. In 1999, 45.7% and in 2008 96.2% of ADRs were identified by treating clinicians (p < 0.001). Conclusions: Between 1999 and 2008, the incidence of ADRs decreased significantly. Improved treatment strategies and an increased awareness of ADRs by physicians are most likely to be the cause for this positive development. Nevertheless further research on ADRs particularly in primary care and the establishment of prospective pharmacovigilance systems are still needed.	[Rashed, Asia N.; Wong, Ian C. K.; Neubert, Antje] UCL Sch Pharm, Ctr Paediat Pharm Res, London, England; [Oehme, Ann-Kathrin; Rascher, Wolfgang] Univ Erlangen Nurnberg, Dept Paediat & Adolescents Med, D-91054 Erlangen, Germany; [Hefele, Barbara] Univ Erlangen Nurnberg, Dept Children & Adolescents Med, D-91054 Erlangen, Germany; [Neubert, Antje] Univ Erlangen Nurnberg, Dept Paediat & Adolescents Med, Paediat Clin Study Ctr, D-91054 Erlangen, Germany	University of London; University College London; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Neubert, A (corresponding author), UCL Sch Pharm, Ctr Paediat Pharm Res, London, England.	antje.neubert@uk-erlangen.de		Rashed, Asia/0000-0003-1313-0915; Wong, Ian Chi Kei/0000-0001-8242-0014	ELAN funds of the Medical Faculty of the Friedrich Alexander University, Erlangen-Nuremberg	ELAN funds of the Medical Faculty of the Friedrich Alexander University, Erlangen-Nuremberg	This study was financially supported by the ELAN funds of the Medical Faculty of the Friedrich Alexander University, Erlangen-Nuremberg (www.http://www.elan.med.uni-erlangen.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard L, 2010, BRIT J CLIN PHARMACO, V70, P481, DOI 10.1111/j.1365-2125.2010.03682.x; Buckley MS, 2007, PEDIATR CRIT CARE ME, V8, P145, DOI 10.1097/01.PCC.0000257038.39434.04; Carrasco-Garrido P, 2009, BRIT J CLIN PHARMACO, V68, P455, DOI 10.1111/j.1365-2125.2009.03449.x; Ceci Adriana, 2009, Paediatr Drugs, V11, P18; Choonara, 2002, PAEDIAT PERINATOL DR, V5, P12, DOI [10.1185/146300902322125109, DOI 10.1185/146300902322125109]; Clavenna A, 2009, ARCH DIS CHILD, V94, P724, DOI 10.1136/adc.2008.154377; Dormann H, 2000, DRUG SAFETY, V22, P161, DOI 10.2165/00002018-200022020-00007; Gonzalez-Martin G, 1998, INT J CLIN PHARM TH, V36, P530; Haffner S, 2005, DRUG SAFETY, V28, P453, DOI 10.2165/00002018-200528050-00008; Hay AD, 2009, HEALTH TECHNOL ASSES, V13, pIX, DOI 10.3310/hta13270; Impicciatore P, 2001, BRIT J CLIN PHARMACO, V52, P77, DOI 10.1046/j.0306-5251.2001.01407.x; Knopf H, 2010, BRIT J CLIN PHARMACO, V70, P409, DOI 10.1111/j.1365-2125.2010.03713.x; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Martinez-Mir I, 1999, BRIT J CLIN PHARMACO, V47, P681, DOI 10.1046/j.1365-2125.1999.00943.x; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Neubert A, 2006, EUR J CLIN PHARMACOL, V62, P959, DOI 10.1007/s00228-006-0197-9; Neubert A, 2010, PHARMACOL RES, V62, P243, DOI 10.1016/j.phrs.2010.04.006; Perrott DA, 2004, ARCH PEDIAT ADOL MED, V158, P521, DOI 10.1001/archpedi.158.6.521; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Rashed AN, 2012, DRUG SAFETY, V35, P481, DOI 10.2165/11597920-000000000-00000; Rashed AN, 2012, EUR J CLIN PHARMACOL, V68, P801, DOI 10.1007/s00228-011-1183-4; Reinhold T, 2009, GESUNDHEITSWESEN, V71, P306, DOI 10.1055/s-0028-1119399; ROGERS WH, 1990, JAMA-J AM MED ASSOC, V264, P1989, DOI 10.1001/jama.264.15.1989; Schonhofer P, 2003, LANCET, V361, P968, DOI 10.1016/S0140-6736(03)12751-1; Schumock G T, 1992, Hosp Pharm, V27, P538; Smyth RMD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0024061; Stern M, 2008, EUR RESPIR J, V31, P29, DOI 10.1183/09031936.00056507; Sturkenboom MCJM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2245; Thuermann PA, 2002, DRUG SAFETY, V25, P713, DOI 10.2165/00002018-200225100-00004; Turner S, 1999, ACTA PAEDIATR, V88, P965, DOI 10.1080/08035259950168469; van den Bemt PMLA, 2000, PHARM WORLD SCI, V22, P62, DOI 10.1023/A:1008721321016; van der Hooft CS, 2008, PHARMACOEPIDEM DR S, V17, P365, DOI 10.1002/pds.1565; van Westreenen Mireille, 2010, Paediatr Drugs, V12, P343, DOI 10.2165/11316240-000000000-00000; Weiss J, 2002, PEDIATRICS, V110, P254, DOI 10.1542/peds.110.2.254; WHO, 2005, WHO ADV REACT TERM T; WHO, 2011, INT CLASS DIS VERS 1; WHO, 1972, 498 WHO, VWHO Meeting; Wiedemann B, 2001, EUR RESPIR J, V17, P1187, DOI 10.1183/09031936.01.00053901; Wilke MH, 2001, UNFALLCHIRURG, V104, P372, DOI 10.1007/s001130050745; Zopf Y, 2008, DRUG SAFETY, V31, P789, DOI 10.2165/00002018-200831090-00007	40	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44349	10.1371/journal.pone.0044349	http://dx.doi.org/10.1371/journal.pone.0044349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028526	Green Published, gold			2022-12-27	WOS:000311313900021
J	Li, XH; Feng, YY; Deng, HX; Zhang, WZ; Kuang, D; Deng, QF; Dai, XY; Lin, DF; Huang, SL; Xin, LL; He, YF; Huang, K; He, MA; Guo, H; Zhang, XM; Wu, TC				Li, Xiaohai; Feng, Yingying; Deng, Huaxin; Zhang, Wangzhen; Kuang, Dan; Deng, Qifei; Dai, Xiayun; Lin, Dafeng; Huang, Suli; Xin, Lili; He, Yunfeng; Huang, Kun; He, Meian; Guo, Huan; Zhang, Xiaomin; Wu, Tangchun			The Dose-Response Decrease in Heart Rate Variability: Any Association with the Metabolites of Polycyclic Aromatic Hydrocarbons in Coke Oven Workers?	PLOS ONE			English	Article							PARTICULATE AIR-POLLUTION; EXPOSURE; RISK; POPULATION; MORTALITY; DISEASE; EVENTS; BRAIN; PAHS	Background: Air pollution has been associated with an increased risk of cardiopulmonary mortality and decreased heart rate variability (HRV). However, it is unclear whether coke oven emissions (COEs) and polycyclic aromatic hydrocarbons (PAHs) are associated with HRV. Objectives: Our goal in the present study was to investigate the association of exposure to COEs and the urinary metabolite profiles of PAHs with HRV of coke oven workers. Methods: We measured benzene soluble matter, carbon monoxide, sulfur dioxide, particulate matters, and PAHs at different workplaces of a coke oven plant. We determined 10 urinary PAH metabolites and HRV indices of 1333 workers using gas chromatography-mass spectrometry and a 3-channel digital Holter monitor, respectively. Results: Our results showed that there was a significant COEs-related dose-dependent decrease in HRV, and an inverse relationship between the quartiles of urinary 2-hydroxynaphthalene and five HRV indices (p(trend)<0.01 for all). After adjustment for potential confounders, elevation per interquartile range (IQR) (1.81 mu g/mmol creatinine) of urinary 2-hydroxynaphthalene was associated with a 5.46% (95% CI, 2.50-8.32) decrease in standard deviation of NN intervals (SDNN). As workers worked more years, SDNN gradually declined in the same quartiles of 2-hydroxynaphthalene levels (p(trend) = 1.40x10(-4)), especially in workers with the highest levels of 2-hydroxynaphthalene. Conclusions: Occupational exposure to COEs is associated with a dose-response decrease in HRV. In particular, increased exposure to 2-hydroxynaphthalene is associated with significantly decreased HRV. Increase of working years and exposure levels has resulted in a gradual decline of HRV.	[Li, Xiaohai; Feng, Yingying; Deng, Huaxin; Kuang, Dan; Deng, Qifei; Dai, Xiayun; Lin, Dafeng; Huang, Suli; Xin, Lili; He, Yunfeng; Huang, Kun; He, Meian; Guo, Huan; Zhang, Xiaomin; Wu, Tangchun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Occupat & Environm Hlth, Wuhan 430074, Peoples R China; [Li, Xiaohai; Feng, Yingying; Deng, Huaxin; Kuang, Dan; Deng, Qifei; Dai, Xiayun; Lin, Dafeng; Huang, Suli; Xin, Lili; He, Yunfeng; Huang, Kun; He, Meian; Guo, Huan; Zhang, Xiaomin; Wu, Tangchun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Minist Educ,Key Lab Environm & Hlth, Wuhan 430074, Peoples R China; [Zhang, Wangzhen] Wuhan Iron & Steel Grp Corp, Inst Ind Hlth, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; China Baowu Steel Group	Li, XH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Occupat & Environm Hlth, Wuhan 430074, Peoples R China.	wut@mails.tjmu.edu.cn	Zhang, Xiaomin/F-3206-2018; Xin, lili/HHS-3172-2022; Lin, Dafeng/J-1015-2014; Zhang, Xiaomin/GVT-8927-2022		National Key Basic Research and Development Program (973 project) [2011CB503806]; Natural National Scientific Foundation of China [30972453]	National Key Basic Research and Development Program (973 project)(National Basic Research Program of China); Natural National Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by the National Key Basic Research and Development Program (973 project) (2011CB503806) and Natural National Scientific Foundation of China (30972453). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Toxic Substances and Disease Registry, 1995, TOX PROF POL AR HYDR; Agency for Toxic Substances and Disease Registry, 2005, TOX PROF NAPHTH 1 ME; Baccarelli A, 2008, CIRCULATION, V117, P1802, DOI 10.1161/CIRCULATIONAHA.107.726067; Billman GE, 2009, AM J PHYSIOL-HEART C, V297, pH1171, DOI 10.1152/ajpheart.00534.2009; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Burstyn I, 2005, EPIDEMIOLOGY, V16, P744, DOI 10.1097/01.ede.0000181310.65043.2f; Camm AJ, 1996, CIRCULATION, V93, P1043; Campo L, 2008, J CHROMATOGR B, V875, P531, DOI 10.1016/j.jchromb.2008.10.017; Cavallari JM, 2007, ENVIRON HEALTH PERSP, V115, P1046, DOI 10.1289/ehp.10019; Chahine T, 2007, ENVIRON HEALTH PERSP, V115, P1617, DOI 10.1289/ehp.10318; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Gesto M, 2006, COMP BIOCHEM PHYS C, V144, P173, DOI 10.1016/j.cbpc.2006.08.002; GONZALEZ FJ, 1994, DRUG METAB REV, V26, P165, DOI 10.3109/03602539409029789; Grova N, 2011, CHEM RES TOXICOL, V24, P1653, DOI 10.1021/tx2003596; Huikuri HV, 2001, AUTON NEUROSCI-BASIC, V90, P95, DOI 10.1016/S1566-0702(01)00273-9; Ito K, 2011, ENVIRON HEALTH PERSP, V119, P467, DOI 10.1289/ehp.1002667; Jacob P, 2011, J CHROMATOGR B, V879, P267, DOI 10.1016/j.jchromb.2010.12.012; Lee MS, 2011, OCCUP ENVIRON MED, V68, P474, DOI 10.1136/oem.2010.055681; Magari SR, 2001, CIRCULATION, V104, P986, DOI 10.1161/hc3401.095038; Mastrangelo G, 1996, ENVIRON HEALTH PERSP, V104, P1166, DOI 10.2307/3432909; [National Institute of Occupational Safety and Health NIOSH Manual of Analytical Methods], 1998, NIOSH MAN AN METH; National Toxicology Program, 2011, Rep Carcinog, V12, P120; Nolan J, 1998, CIRCULATION, V98, P1510, DOI 10.1161/01.CIR.98.15.1510; Park SK, 2010, ENVIRON HEALTH PERSP, V118, P1406, DOI 10.1289/ehp.0901778; Pope CA, 2006, CIRCULATION, V114, P2443, DOI 10.1161/CIRCULATIONAHA.106.636977; Pope CA, 2009, CIRCULATION, V120, P941, DOI 10.1161/CIRCULATIONAHA.109.857888; Roggi C, 1997, SCI TOTAL ENVIRON, V199, P247, DOI 10.1016/S0048-9697(97)05458-2; Routledge HC, 2006, HEART, V92, P220, DOI 10.1136/hrt.2004.051672; Schroeder EB, 2003, HYPERTENSION, V42, P1106, DOI 10.1161/01.HYP.0000100444.71069.73; Tsuji H, 1996, CIRCULATION, V94, P2850, DOI 10.1161/01.CIR.94.11.2850; van Boven AJ, 1998, AM HEART J, V135, P571, DOI 10.1016/S0002-8703(98)70269-8; Weichenthal S, 2011, ENVIRON HEALTH PERSP, V119, P1373, DOI 10.1289/ehp.1003321; Wellenius GA, 2011, INHAL TOXICOL, V23, P84, DOI 10.3109/08958378.2010.554461; Wheeler A, 2006, ENVIRON HEALTH PERSP, V114, P560, DOI 10.1289/ehp.8337; Wu SW, 2010, ENVIRON HEALTH PERSP, V118, P87, DOI 10.1289/ehp.0900818; Xu XH, 2010, SCI TOTAL ENVIRON, V408, P4943, DOI 10.1016/j.scitotenv.2010.07.034; Yang XB, 2007, ENVIRON HEALTH PERSP, V115, P1573, DOI 10.1289/ehp.10104; Zanobetti A, 2010, ENVIRON HEALTH PERSP, V118, P324, DOI 10.1289/ehp.0901003	38	46	51	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44562	10.1371/journal.pone.0044562	http://dx.doi.org/10.1371/journal.pone.0044562			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024753	Green Published, Green Submitted, gold			2022-12-27	WOS:000308860100011
J	White, HE; Dent, CL; Hall, VJ; Crolla, JA; Chitty, LS				White, Helen E.; Dent, Carolyn L.; Hall, Victoria J.; Crolla, John A.; Chitty, Lyn S.			Evaluation of a Novel Assay for Detection of the Fetal Marker RASSF1A: Facilitating Improved Diagnostic Reliability of Noninvasive Prenatal Diagnosis	PLOS ONE			English	Article							MATERNAL PLASMA; DNA; BLOOD; SERUM	Background: Analysis of cell free fetal (cff) DNA in maternal plasma is used routinely for non invasive prenatal diagnosis (NIPD) of fetal sex determination, fetal rhesus D status and some single gene disorders. True positive results rely on detection of the fetal target being analysed. No amplification of the target may be interpreted either as a true negative result or a false negative result due to the absence or very low levels of cffDNA. The hypermethylated RASSF1A promoter has been reported as a universal fetal marker to confirm the presence of cffDNA. Using methylation-sensitive restriction enzymes hypomethylated maternal sequences are digested leaving hypermethylated fetal sequences detectable. Complete digestion of maternal sequences is required to eliminate false positive results. Methods: cfDNA was extracted from maternal plasma (n = 90) and digested with methylation-sensitive and insensitive restriction enzymes. Analysis of RASSF1A, SRY and DYS14 was performed by real-time PCR. Results: Hypermethylated RASSF1A was amplified for 79 samples (88%) indicating the presence of cffDNA. SRY real time PCR results and fetal sex at delivery were 100% accurate. Eleven samples (12%) had no detectable hypermethylated RASSF1A and 10 of these (91%) had gestational ages less than 7 weeks 2 days. Six of these samples were male at delivery, five had inconclusive results for SRY analysis and one sample had no amplifiable SRY. Conclusion: Use of this assay for the detection of hypermethylated RASSF1A as a universal fetal marker has the potential to improve the diagnostic reliability of NIPD for fetal sex determination and single gene disorders.	[White, Helen E.; Dent, Carolyn L.; Hall, Victoria J.] Salisbury Dist Hosp, Natl Genet Reference Lab Wessex, Salisbury, Wilts, England; [White, Helen E.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Crolla, John A.] Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury, Wilts, England; [Chitty, Lyn S.] UCL, London Inst Child Hlth, Clin & Mol Genet Unit, London, England; [Chitty, Lyn S.] Univ Coll London Hosp NHS Fdn Trust, Fetal Med Unit, London, England	Salisbury District Hospital; University of Southampton; Salisbury District Hospital; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	White, HE (corresponding author), Salisbury Dist Hosp, Natl Genet Reference Lab Wessex, Salisbury, Wilts, England.	hew@soton.ac.uk		chitty, lyn/0000-0002-4857-7138	National Institutes for Health Research (NIHR) under the Programme Grants for Applied Research programme (the "RAPID'' project) [RP-PG-0707-10107]; NIHR Biomedical Research Centre at University College London Hospitals; Great Ormond Street Hospital Children's Charity; National Institute for Health Research [RP-PG-0707-10107] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1253] Funding Source: researchfish	National Institutes for Health Research (NIHR) under the Programme Grants for Applied Research programme (the "RAPID'' project); NIHR Biomedical Research Centre at University College London Hospitals; Great Ormond Street Hospital Children's Charity; National Institute for Health Research(National Institute for Health Research (NIHR)); Great Ormond Street Hospital Childrens Charity	This article presents independent research commissioned by the National Institutes for Health Research (NIHR) under the Programme Grants for Applied Research programme (the "RAPID'' project, RP-PG-0707-10107). LSC receives some funding from the NIHR Biomedical Research Centre at University College London Hospitals and the Great Ormond Street Hospital Children's Charity. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberry M, 2007, PRENATAL DIAG, V27, P415, DOI 10.1002/pd.1700; Chan KCA, 2006, CLIN CHEM, V52, P2211, DOI 10.1373/clinchem.2006.074997; Chitty LS, 2011, ULTRASOUND OBST GYN, V37, P283, DOI 10.1002/uog.8893; Chitty LS, 2008, PRENATAL DIAG, V28, P83, DOI 10.1002/pd.1929; Chiu RWK, 2002, LANCET, V360, P998, DOI 10.1016/S0140-6736(02)11086-5; Daniels G, 2009, PRENATAL DIAG, V29, P101, DOI 10.1002/pd.2172; Dhallan R, 2007, LANCET, V369, P474, DOI 10.1016/S0140-6736(07)60115-9; Forest MG, 1998, TRENDS ENDOCRIN MET, V9, P284, DOI 10.1016/S1043-2760(98)00067-8; Hill M, 2011, CLIN GENET, V80, P68, DOI 10.1111/j.1399-0004.2010.01533.x; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Mattocks CJ, 2010, EUR J HUM GENET, V18, P1276, DOI 10.1038/ejhg.2010.101; Mujezinovic F, 2007, OBSTET GYNECOL, V110, P687, DOI 10.1097/01.AOG.0000278820.54029.e3; Page-Christiaens GCML, 2006, ANN NY ACAD SCI, V1075, P123, DOI 10.1196/annals.1368.016; Pertl B, 2000, HUM GENET, V106, P45, DOI 10.1007/s004390051008; Raymond FL, 2010, PRENATAL DIAG, V30, P674, DOI 10.1002/pd.2575; Scheffer PG, 2010, OBSTET GYNECOL, V115, P117, DOI 10.1097/AOG.0b013e3181c3c938; Tong YK, 2010, CLIN CHEM, V56, P90, DOI 10.1373/clinchem.2009.134114; Zimmermann B, 2005, CLIN CHEM, V51, P1598, DOI 10.1373/clinchem.2005.051235	21	38	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45073	10.1371/journal.pone.0045073	http://dx.doi.org/10.1371/journal.pone.0045073			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024794	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000308860100052
J	Thomassen, BJW; Pilot, P; Scholtes, VAB; Grohs, JG; Holen, K; Bisbe, E; Poolman, RW				Thomassen, Bregje J. W.; Pilot, Peter; Scholtes, Vanessa A. B.; Grohs, Josef G.; Holen, Ketil; Bisbe, Elvira; Poolman, Rudolf W.			Limit Allogeneic Blood Use with Routine Re-use of Patient's Own Blood: A Prospective, Randomized, Controlled Trial in Total Hip Surgery	PLOS ONE			English	Article							COMPLEMENT SPLIT PRODUCTS; FILTERED SHED BLOOD; POSTOPERATIVE INFECTION; AUTOLOGOUS TRANSFUSION; REPLACEMENT SURGERY; ORTHOPEDIC-SURGERY; EFFICACY; ARTHROPLASTY; METAANALYSIS; CYTOKINES	Background: There are risks related to blood incompatibility and blood-borne diseases when using allogeneic blood transfusion. Several alternatives exist today, one of which, used for autologous blood salvage perioperatively, is the Sangvia Blood Management System. This study was designed to investigate the efficacy of the system and to add data to previously reported safety results. Methodology/Principal Findings: Two hundred sixteen patients undergoing primary or revision total hip arthroplasty (THA) were enrolled in this randomized, controlled, assessor-blinded multicenter study. Randomization was either autologous blood transfusion (Sangvia group) or no use of autologous blood (Control group), both in combination with a transfusion protocol for allogeneic transfusion. Patients were followed during hospital stay and at two months after discharge. The primary outcome was allogeneic blood transfusion frequency. Data on blood loss, postoperative hemoglobin/hematocrit, safety and quality of life were also collected. The effectiveness analysis including all patients showed an allogeneic blood transfusion rate of 14% in both groups. The efficacy analysis included 197 patients and showed a transfusion rate of 9% in the Sangvia group as compared to 13% in the Control group (95%CI -0.05-0.12, p = 0.5016). A mean of 522 mL autologous blood was returned in the Sangvia group and lower calculated blood loss was seen. 1095 mL vs 1285 mL in the Control group (95%CI 31-346, p = 0.0175). No differences in postoperative hemoglobin was detected but a lower hematocrit reduction after surgery was seen among patients receiving autologous blood. No relevant differences were found for safety parameters or quality of life. Conclusions/Significance: General low use of allogeneic blood in THA is seen in the current study of the Sangvia system used together with a transfusion protocol. The trial setting is under-powered due to premature termination and therefore not able to verify efficacy for the system itself but contributes with descriptive data on safety.	[Thomassen, Bregje J. W.] Med Ctr Haaglanden, Dept Orthopaed Surg, The Hague, Netherlands; [Pilot, Peter] Reinier de Graaf Hosp, Dept Orthopaed Surg, Delft, Netherlands; [Scholtes, Vanessa A. B.; Poolman, Rudolf W.] Onze Lieve Vrouw Hosp, Dept Orthopaed Surg, Amsterdam, Netherlands; [Grohs, Josef G.] Med Univ Vienna, Dept Orthopaed Surg, Vienna, Austria; [Holen, Ketil] St Olavs Hosp, Dept Orthopaed Surg, Trondheim, Norway; [Bisbe, Elvira] Hosp Univ Mar Esperanca, Dept Anesthesiol, Barcelona, Spain	Haaglanden Medical Center; Reinier de Graaf Hospital; Onze Lieve Vrouwe Gasthuis Hospital; Medical University of Vienna; Norwegian University of Science & Technology (NTNU)	Thomassen, BJW (corresponding author), Med Ctr Haaglanden, Dept Orthopaed Surg, The Hague, Netherlands.	bregje_thomassen@hotmail.com	Grohs, Josef Georg/AAT-7134-2020; Poolman, Rudolf/AAM-7815-2020	Grohs, Josef Georg/0000-0001-6109-8417; Poolman, Rudolf/0000-0003-3178-2247; BISBE VIVES, Elvira/0000-0001-6723-7350	Astra Tech AB, Molndal, Sweden	Astra Tech AB, Molndal, Sweden	This study was funded by Astra Tech AB, Molndal, Sweden. Representatives from the company were involved in the study design, data analysis and preparation of the manuscript. The funder has supported in the planning, conduct and reporting of the study. They have contributed with writing the study protocol and manuscript, organized study meetings, monitored the data and data analysis.	Andersson I, 2001, CAN J ANAESTH, V48, P251, DOI 10.1007/BF03019754; Boutron I, 2004, J CLIN EPIDEMIOL, V57, P543, DOI 10.1016/j.jclinepi.2003.12.010; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Carless PA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001888.pub3; Dodd RY, 2005, DEV BIOLOGICALS, V120, P3; Duffy G, 1996, TRANSFUSION MED, V6, P325, DOI 10.1111/j.1365-3148.1996.tb00091.x; Garvin KL, 2005, CLIN ORTHOP RELAT R, P205, DOI 10.1097/01.blo.0000192033.50316.bf; Glance LG, 2011, ANESTHESIOLOGY, V114, P283, DOI 10.1097/ALN.0b013e3182054d06; Grosvenor D, 2000, J BONE JOINT SURG AM, V82A, P951, DOI 10.2106/00004623-200007000-00006; Grzelak I, 1998, TRANSFUSION, V38, P1104, DOI 10.1046/j.1537-2995.1998.38111299056323.x; Hurle R, 2004, UROL INT, V72, P135, DOI 10.1159/000075967; Innerhofer P, 2005, TRANSFUSION, V45, P103, DOI 10.1111/j.1537-2995.2005.04149.x; Kvarnstrom A, 2008, VOX SANG, V95, P33, DOI 10.1111/j.1423-0410.2008.01059.x; LACHIN JM, 1981, CONTROL CLIN TRIALS, V2, P93, DOI 10.1016/0197-2456(81)90001-5; del Trujillo MM, 2008, ARCH ORTHOP TRAUM SU, V128, P1031, DOI 10.1007/s00402-007-0440-6; Moonen AFCM, 2007, TRANSFUSION, V47, P379, DOI 10.1111/j.1537-2995.2007.01127.x; Munoz M, 2006, ACTA ANAESTH SCAND, V50, P443, DOI 10.1111/j.1399-6576.2006.00977.x; Munoz M, 2005, ARCH ORTHOP TRAUM SU, V125, P385, DOI 10.1007/s00402-005-0817-3; Munoz M, 2009, VOX SANG, V96, P1, DOI 10.1111/j.1423-0410.2008.01108.x; Poolman RW, 2007, J BONE JOINT SURG AM, V89A, P550, DOI 10.2106/JBJS.F.00683; Salido JA, 2002, J BONE JOINT SURG AM, V84A, P216, DOI 10.2106/00004623-200202000-00008; Shander A, 2010, TRANSFUSION, V50, P753, DOI 10.1111/j.1537-2995.2009.02518.x; Sharma R, 2011, J ARTHROPLASTY, V26, P909, DOI 10.1016/j.arth.2010.08.014; Spahn DR, 2008, ANESTHESIOLOGY, V109, P951, DOI 10.1097/ALN.0b013e31818e3d75; Stachura A, 2011, VOX SANG, V100, P239, DOI 10.1111/j.1423-0410.2010.01377.x; Strumper D, 2004, TRANSFUSION, V44, P1567, DOI 10.1111/j.1537-2995.2004.03233.x; Sukeik M, 2011, J BONE JOINT SURG BR, V93B, P39, DOI 10.1302/0301-620X.93B1.24984; TARTTER PI, 1995, IMMUNOL INVEST, V24, P277, DOI 10.3109/08820139509062778; Thoms RJ, 2009, J AM ACAD ORTHOP SUR, V17, P727; Weber EWG, 2005, EUR J ANAESTH, V22, P249, DOI 10.1017/S0265021505000426; Weber EWG, 2005, ANESTH ANALG, V100, P1416, DOI 10.1213/01.ANE.0000150610.44631.9D; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; WYLIE BR, 1993, ANAESTH INTENS CARE, V21, P24, DOI 10.1177/0310057X9302100109	33	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44503	10.1371/journal.pone.0044503	http://dx.doi.org/10.1371/journal.pone.0044503			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028549	Green Published, gold, Green Submitted			2022-12-27	WOS:000308788700022
J	Wu, XG; Yung, LM; Cheng, WH; Yu, PB; Babitt, JL; Lin, HY; Xia, Y				Wu, Xinggang; Yung, Lai-Ming; Cheng, Wai-Hang; Yu, Paul B.; Babitt, Jodie L.; Lin, Herbert Y.; Xia, Yin			Hepcidin Regulation by BMP Signaling in Macrophages Is Lipopolysaccharide Dependent	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-6; MESSENGER-RNA EXPRESSION; IRON-METABOLISM; INHIBITION; INTERLEUKIN-6; TRANSCRIPTION; INFLAMMATION; OVERLOAD; PROMOTER; ELEMENTS	Hepcidin is an antimicrobial peptide, which also negatively regulates iron in circulation by controlling iron absorption from dietary sources and iron release from macrophages. Hepcidin is synthesized mainly in the liver, where hepcidin is regulated by iron loading, inflammation and hypoxia. Recently, we have demonstrated that bone morphogenetic protein (BMP)hemojuvelin (HJV)-SMAD signaling is central for hepcidin regulation in hepatocytes. Hepcidin is also expressed by macrophages. Studies have shown that hepcidin expression by macrophages increases following bacterial infection, and that hepcidin decreases iron release from macrophages in an autocrine and/or paracrine manner. Although previous studies have shown that lipopolysaccharide (LPS) can induce hepcidin expression in macrophages, whether hepcidin is also regulated by BMPs in macrophages is still unknown. Therefore, we examined the effects of BMP signaling on hepcidin expression in RAW 264.7 and J774 macrophage cell lines, and in primary peritoneal macrophages. We found that BMP4 or BMP6 alone did not have any effect on hepcidin expression in macrophages although they stimulated Smad1/5/8 phosphorylation and Id1 expression. In the presence of LPS, however, BMP4 and BMP6 were able to stimulate hepcidin expression in macrophages, and this stimulation was abolished by the NF-kappa B inhibitor Ro1069920. These results suggest that hepcidin expression is regulated differently in macrophages than in hepatocytes, and that BMPs regulate hepcidin expression in macrophages in a LPS-NF-kappa B dependent manner.	[Wu, Xinggang; Cheng, Wai-Hang; Xia, Yin] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Xia, Yin] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China; [Xia, Yin] Chinese Univ Hong Kong, Jinan Univ, Minist Educ, Key Lab Regenerat Med, Guangzhou, Guangdong, Peoples R China; [Yung, Lai-Ming; Yu, Paul B.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Babitt, Jodie L.; Lin, Herbert Y.] Harvard Univ, Massachusetts Gen Hosp, Program Anemia Signaling Res,Program Membrane Bio, Div Nephrol,Ctr Syst Biol,Dept Med,Med Sch, Boston, MA USA	Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen; Chinese University of Hong Kong; Jinan University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Wu, XG (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.	Xia.Yin@cuhk.edu.hk	Yu, Paul B./J-7540-2019; Xia, Yin/M-5440-2018	Yu, Paul B./0000-0003-2145-4944; Xia, Yin/0000-0003-0315-7532; Cheng, Wai Hang/0000-0002-3408-9184	Chinese University of Hong Kong; Hong Kong Research Grant Council (RGC) [2140759]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087727, R01DK071837] Funding Source: NIH RePORTER	Chinese University of Hong Kong(Chinese University of Hong Kong); Hong Kong Research Grant Council (RGC)(Hong Kong Research Grants Council); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	YX is supported in part by the startup funding offered by the Chinese University of Hong Kong and Hong Kong Research Grant Council (RGC) 2140759. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Bleuming S, 2006, J PATHOL, V209, P190, DOI 10.1002/path.1976; Derwall M, 2012, ARTERIOSCL THROM VAS, V32, P613, DOI 10.1161/ATVBAHA.111.242594; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Fukuda T, 2009, J BIOL CHEM, V284, P7149, DOI 10.1074/jbc.M801681200; Ganz T, 2009, CURR OPIN IMMUNOL, V21, P63, DOI 10.1016/j.coi.2009.01.011; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; Kwon SJ, 2009, IMMUNOLOGY, V128, pe758, DOI 10.1111/j.1365-2567.2009.03079.x; Lee GT, 2010, J BIOL CHEM, V285, P39401, DOI 10.1074/jbc.M110.103705; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; Lee P, 2004, P NATL ACAD SCI USA, V101, P9263, DOI 10.1073/pnas.0403108101; Liu XB, 2005, BLOOD CELL MOL DIS, V35, P47, DOI 10.1016/j.bcmd.2005.04.006; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nguyen NB, 2006, AM J PHYSIOL-LUNG C, V291, pL417, DOI 10.1152/ajplung.00484.2005; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Peyssonnaux C, 2006, BLOOD, V107, P3727, DOI 10.1182/blood-2005-06-2259; Pinto JP, 2010, IMMUNOLOGY, V130, P217, DOI 10.1111/j.1365-2567.2009.03226.x; Qin HW, 2009, J IMMUNOL, V183, P97, DOI 10.4049/jimmunol.0801986; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Song SNJ, 2010, BLOOD, V116, P3627, DOI 10.1182/blood-2010-03-271791; Sow FB, 2007, J LEUKOCYTE BIOL, V82, P934, DOI 10.1189/jlb.0407216; Sow FB, 2009, J LEUKOCYTE BIOL, V86, P1247, DOI 10.1189/jlb.1208719; Steinbicker AU, 2011, BLOOD, V118, P4224, DOI 10.1182/blood-2011-03-339952; Swinney DC, 2002, J BIOL CHEM, V277, P23573, DOI 10.1074/jbc.M200842200; Theurl I, 2008, BLOOD, V111, P2392, DOI 10.1182/blood-2007-05-090019; Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103; Truksa J, 2009, BLOOD, V113, P688, DOI 10.1182/blood-2008-05-160184; Wang LJ, 2009, J CLIN INVEST, V119, P3322, DOI 10.1172/JCI39939; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Wu SJ, 2012, INNATE IMMUN-LONDON, V18, P318, DOI 10.1177/1753425911405087; Xia Y, 2008, BLOOD, V111, P5195, DOI 10.1182/blood-2007-09-111567; Xia Y, 2011, J IMMUNOL, V186, P1369, DOI 10.4049/jimmunol.1002047; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888	38	28	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44622	10.1371/journal.pone.0044622	http://dx.doi.org/10.1371/journal.pone.0044622			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028567	Green Published, gold, Green Submitted			2022-12-27	WOS:000308788700026
J	Duenez-Guzman, EA; Sadedin, S				Duenez-Guzman, Edgar A.; Sadedin, Suzanne			Evolving Righteousness in a Corrupt World	PLOS ONE			English	Article							SOCIAL-STATUS; PUNISHMENT; EVOLUTION; ALTRUISM; EMOTION; COOPERATION; EXPRESSION; QUEEN; POWER	Punishment offers a powerful mechanism for the maintenance of cooperation in human and animal societies, but the maintenance of costly punishment itself remains problematic. Game theory has shown that corruption, where punishers can defect without being punished themselves, may sustain cooperation. However, in many human societies and some insect ones, high levels of cooperation coexist with low levels of corruption, and such societies show greater wellbeing than societies with high corruption. Here we show that small payments from cooperators to punishers can destabilize corrupt societies and lead to the spread of punishment without corruption (righteousness). Righteousness can prevail even in the face of persistent power inequalities. The resultant righteous societies are highly stable and have higher wellbeing than corrupt ones. This result may help to explain the persistence of costly punishing behavior, and indicates that corruption is a sub-optimal tool for maintaining cooperation in human societies.	[Duenez-Guzman, Edgar A.; Sadedin, Suzanne] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Duenez-Guzman, Edgar A.] Katholieke Univ Leuven, Lab Socioecol & Social Evolut, Louvain, Belgium	Harvard University; KU Leuven	Duenez-Guzman, EA (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	duenez@bio.kuleuven.be			Howard Hughes Medical Institute Collaborative Innovation Award	Howard Hughes Medical Institute Collaborative Innovation Award(Howard Hughes Medical Institute)	This work was supported by a Howard Hughes Medical Institute Collaborative Innovation Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidt TS, 2009, OXFORD REV ECON POL, V25, P271, DOI 10.1093/oxrep/grp012; Alonso-Terme R., 1998, ECON GOV, V3, P23, DOI [DOI 10.1007/S101010100039, 10.1007/s101010100039]; Ambraseys N, 2011, NATURE, V469, P153, DOI 10.1038/469153a; AXELROD R, 1986, AM POLIT SCI REV, V80, P1095, DOI 10.2307/1960858; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Bjornskov C, 2003, KYKLOS, V56, P3, DOI 10.1111/1467-6435.00207; Borgers T, 1997, J ECON THEORY, V77, P1, DOI 10.1006/jeth.1997.2319; Borgers T, 1996, ECON J, V106, P1374, DOI 10.2307/2235529; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Brescoll VL, 2008, PSYCHOL SCI, V19, P268, DOI 10.1111/j.1467-9280.2008.02079.x; CARPENTER B, 1978, PERS SOC PSYCHOL B, V4, P68, DOI 10.1177/014616727800400114; Cillessen AHN, 2004, CHILD DEV, V75, P147, DOI 10.1111/j.1467-8624.2004.00660.x; Diener E., 2003, WELL BEING FDN HEDON; Eldakar OT, 2008, P NATL ACAD SCI USA, V105, P6982, DOI 10.1073/pnas.0712173105; Eldakar OT, 2007, J THEOR BIOL, V249, P198, DOI 10.1016/j.jtbi.2007.07.024; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fu F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016104; Gardner A, 2004, AM NAT, V164, P753, DOI 10.1086/425623; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; Hamlin JK, 2011, P NATL ACAD SCI USA, V108, P19931, DOI 10.1073/pnas.1110306108; HARVEY MD, 1978, PERS SOC PSYCHOL B, V4, P579, DOI 10.1177/014616727800400417; Hauert C, 2010, J THEOR BIOL, V267, P22, DOI 10.1016/j.jtbi.2010.08.009; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Holmberg S, 2011, HEALTH ECON POLICY L, V6, P529, DOI 10.1017/S174413311000023X; Jensen K, 2007, P NATL ACAD SCI USA, V104, P13046, DOI 10.1073/pnas.0705555104; Kawabata S, 2005, INSECT SOC, V52, P89, DOI 10.1007/s00040-004-0778-5; KESSLER RC, 1979, J HEALTH SOC BEHAV, V20, P259, DOI 10.2307/2136450; Kummerli R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024350; Lammers J, 2010, PSYCHOL SCI, V21, P737, DOI 10.1177/0956797610368810; Marmot M., 2004, STATUS SYNDROME SOCI; Mathew S, 2011, P NATL ACAD SCI USA, V108, P11375, DOI 10.1073/pnas.1105604108; MAURO P, 1995, Q J ECON, V110, P681, DOI 10.2307/2946696; Monnin T, 2001, BEHAV ECOL SOCIOBIOL, V50, P97, DOI 10.1007/s002650100351; Nakamaru M, 2006, J THEOR BIOL, V240, P475, DOI 10.1016/j.jtbi.2005.10.011; NARAYAN D, 2001, CURRENT SOCIOLOGY, V0049; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; Ohtsuki H, 2009, NATURE, V457, P79, DOI 10.1038/nature07601; Portes A, 1998, ANN REV SOCIOLOGY, P24; Rand DG, 2010, J THEOR BIOL, V265, P624, DOI 10.1016/j.jtbi.2010.06.010; Ratnieks FLW, 2009, PHILOS T R SOC B, V364, P3169, DOI 10.1098/rstb.2009.0129; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Saigo T, 2004, P ROY SOC B-BIOL SCI, V271, pS509, DOI 10.1098/rsbl.2004.0238; STEIL J, 1978, PERS SOC PSYCHOL B, V4, P393, DOI 10.1177/014616727800400307; Stroeymeyt N, 2007, BEHAV ECOL SOCIOBIOL, V61, P1449, DOI 10.1007/s00265-007-0377-3; Tanzi V, 1998, STAFF PAPERS INT MON; Tavits M, 2008, COMP POLIT STUD, V41, P1607, DOI 10.1177/0010414007308537; Tiedens LZ, 2001, J PERS SOC PSYCHOL, V80, P86, DOI 10.1037//0022-3514.80.1.86; Ubeda F, 2011, EVOLUTION, V65, P1127, DOI 10.1111/j.1558-5646.2010.01194.x; von Rueden C, 2011, P ROY SOC B-BIOL SCI, V278, P2223, DOI 10.1098/rspb.2010.2145; Wei SJ, 1997, NATL BUREAU EC RES W, P6255; Weibull J W, 1997, EVOLUTIONARY GAME TH; Weibull JW, 1995, EVOLUTIONARY GAME TH, V31, DOI DOI 10.1016/S0898-1221(96)90123-6; Wenseleers T, 2005, BEHAV ECOL SOCIOBIOL, V58, P80, DOI 10.1007/s00265-004-0892-4; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; Wright EO, 1980, CLASS STRUCTURE INCO; Xiao E, 2005, P NATL ACAD SCI USA, V102, P7398, DOI 10.1073/pnas.0502399102	57	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44432	10.1371/journal.pone.0044432	http://dx.doi.org/10.1371/journal.pone.0044432			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005GJ	22984510	Green Published, gold, Green Submitted			2022-12-27	WOS:000308738500057
J	Grellety, E; Shepherd, S; Roederer, T; Manzo, ML; Doyon, S; Ategbo, EA; Grais, RF				Grellety, Emmanuel; Shepherd, Susan; Roederer, Thomas; Manzo, Mahamane L.; Doyon, Stephane; Ategbo, Eric-Alain; Grais, Rebecca F.			Effect of Mass Supplementation with Ready-to-Use Supplementary Food during an Anticipated Nutritional Emergency	PLOS ONE			English	Article							USE THERAPEUTIC FOOD; MALNOURISHED MALAWIAN CHILDREN; PROPENSITY SCORE; DEVELOPING-COUNTRIES; MALNUTRITION; MORTALITY; GROWTH; INTERVENTIONS; TRIAL	Background: Previous studies have shown the benefits of ready-to-use supplementary food (RUSF) distribution in reducing the incidence and prevalence of severe acute malnutrition. Methods and Findings: To compare the incidence of wasting, stunting and mortality between children aged 6 to 23 mo participating and not participating in distributions of RUSF, we implemented two exhaustive prospective cohorts including all children 60 cm to 80 cm, resident in villages of two districts of Maradi region in Niger (n = 2238). Villages (20) were selected to be representative of the population. All registered children were eligible for the monthly distributions between July and October 2010. Age, sex, height, weight, and Mid-Upper Arm Circumference (MUAC) were measured at baseline and two weeks after each distribution; the amount and type of distribution and the amount shared and remaining were also assessed. We compared the incidence of wasting, stunting, and mortality among children participating in the distribution (intervention) of RUSF versus children not participating in the distribution (comparison). The absolute rate of wasting was 4.71 events per child-year (503 events/106.59 child-year) in the intervention group and 4.98 events per child-year (322 events/64.54 child-year) in the comparison group. The intervention group had a small but higher weight-for-length Z-score gain (-0.2z vs. -0.3z) and less loss of MUAC than the comparison group (-2.8 vs. -4.0 mm). There was no difference in length gain (2.7 vs. 2.8 cm). Mortality was lower for children whose households received the intervention than those who did not (adjusted HR 0.55, 95% CI: 0.32-0.98). Conclusions: Short-term distribution with RUSF for children 6 to 23 months improve the nutritional status of children at risk for malnutrition. Fewer children who participated in the RUSF distribution died than those who did not.	[Grellety, Emmanuel; Roederer, Thomas; Grais, Rebecca F.] Epicentre, Paris, France; [Shepherd, Susan; Doyon, Stephane] Med Sans Frontieres, Paris, France; [Manzo, Mahamane L.] Minist Hlth, Reg Dept, Maradi, Niger; [Ategbo, Eric-Alain] United Nations Int Children Emergency Fund, Niamey, Niger	Doctors Without Borders	Grellety, E (corresponding author), Epicentre, Paris, France.	Emmanuel.GRELLETY@epicentre.msf.org	Roederer, Thomas/AAW-4175-2021	Roederer, Thomas/0000-0003-1733-8721; Grellety Bosviel, Emmanuel/0000-0001-9736-414X	Medecins Sans Frontieres (MSF); United Nations International Children Emergency Fund (UNICEF)	Medecins Sans Frontieres (MSF); United Nations International Children Emergency Fund (UNICEF)	This study was supported by Medecins Sans Frontieres (MSF) and the United Nations International Children Emergency Fund (UNICEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen R., 2008, SAGE U PAPER SERIES; [Anonymous], 2010, ANNUAIRE STAT SANITA; Briend A, 1999, LANCET, V353, P1767, DOI 10.1016/S0140-6736(99)01078-8; Ciliberto MA, 2005, AM J CLIN NUTR, V81, P864, DOI 10.1093/ajcn/81.4.864; Cohuet S, 2010, APPETITE IN PRESS; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; de Pee S, 2009, FOOD NUTR BULL, V30, P3; Defourny I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005455; Dewey KG, 2008, MATERN CHILD NUTR, V4, P24, DOI 10.1111/j.1740-8709.2007.00124.x; Direction des Enquetes et Recensements de l'Institut National de la Statistique (INS), 2010, RAPP ENQ NAT NUTR JU; GOLDEN MHN, 1993, LANCET, V342, P360, DOI 10.1016/0140-6736(93)91491-4; GOLDEN MHN, 1991, ACTA PAEDIATR SCAND, P95; Golden MH, 2009, FOOD NUTR BULL, V30, pS267, DOI 10.1177/15648265090303S302; Hall A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026854; HEIKENS GT, 1989, EUR J CLIN NUTR, V43, P145; Imbens GW, 2000, BIOMETRIKA, V87, P706, DOI 10.1093/biomet/87.3.706; Isanaka S, 2009, JAMA-J AM MED ASSOC, V301, P277, DOI 10.1001/jama.2008.1018; Little RJ, 2009, BIOMETRICS, V65, P640, DOI 10.1111/j.1541-0420.2008.01066.x; Maleta T, 2004, J PEDIATR GASTR NUTR, V38, P152; Patel MP, 2005, J HEALTH POPUL NUTR, V23, P351; PELLETIER DL, 1993, AM J PUBLIC HEALTH, V83, P1130, DOI 10.2105/AJPH.83.8.1130; PELLETIER DL, 1995, B WORLD HEALTH ORGAN, V73, P443; Rivera JA, 2004, JAMA-J AM MED ASSOC, V291, P2563, DOI 10.1001/jama.291.21.2563; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sandige H, 2004, J PEDIATR GASTR NUTR, V39, P141, DOI 10.1097/00005176-200408000-00003; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519	26	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44549	10.1371/journal.pone.0044549	http://dx.doi.org/10.1371/journal.pone.0044549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984524	gold, Green Published			2022-12-27	WOS:000308738500064
J	Gruter, C; Schurch, R; Czaczkes, TJ; Taylor, K; Durance, T; Jones, SM; Ratnieks, FLW				Grueter, Christoph; Schuerch, Roger; Czaczkes, Tomer J.; Taylor, Keeley; Durance, Thomas; Jones, Sam M.; Ratnieks, Francis L. W.			Negative Feedback Enables Fast and Flexible Collective Decision-Making in Ants	PLOS ONE			English	Article							FOOD RECRUITMENT; PHEROMONES; MUTUALISMS; LANDMARKS; FORAGERS; PATTERNS; GEOMETRY; HONEYDEW; PROTOCOL; BEHAVIOR	Positive feedback plays a major role in the emergence of many collective animal behaviours. In many ants pheromone trails recruit and direct nestmate foragers to food sources. The strong positive feedback caused by trail pheromones allows fast collective responses but can compromise flexibility. Previous laboratory experiments have shown that when the environment changes, colonies are often unable to reallocate their foragers to a more rewarding food source. Here we show both experimentally, using colonies of Lasius niger, and with an agent-based simulation model, that negative feedback caused by crowding at feeding sites allows ant colonies to maintain foraging flexibility even with strong recruitment to food sources. In a constant environment, negative feedback prevents the frequently found bias towards one feeder (symmetry breaking) and leads to equal distribution of foragers. In a changing environment, negative feedback allows a colony to quickly reallocate the majority of its foragers to a superior food patch that becomes available when foraging at an inferior patch is already well underway. The model confirms these experimental findings and shows that the ability of colonies to switch to a superior food source does not require the decay of trail pheromones. Our results help to resolve inconsistencies between collective foraging patterns seen in laboratory studies and observations in the wild, and show that the simultaneous action of negative and positive feedback is important for efficient foraging in mass-recruiting insect colonies.	[Grueter, Christoph; Czaczkes, Tomer J.; Taylor, Keeley; Durance, Thomas; Jones, Sam M.; Ratnieks, Francis L. W.] Univ Sussex, Lab Apiculture & Social Insects, Sch Life Sci, Falmer, England; [Schuerch, Roger] Univ Sussex, Social Evolut Res Grp, Sch Life Sci, Falmer, England	University of Sussex; University of Sussex	Gruter, C (corresponding author), Univ Sussex, Lab Apiculture & Social Insects, Sch Life Sci, Falmer, England.	cg213@sussex.ac.uk	Schurch, Roger/J-8744-2019	Schurch, Roger/0000-0001-9075-8912; Czaczkes, Tomer/0000-0002-1350-4975; Gruter, Christoph/0000-0001-5553-5465	Swiss National Science Foundation [PA00P3_129134, PBBEP3_133529]; Biotechnology and Biological Sciences Research Council	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Christoph Gruter was supported by a postdoctoral fellowship from the Swiss National Science Foundation (grant-no. PA00P3_129134) (www.snf.ch). Tomer J.Czaczkes was supported by a PhD studentship from the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/). Roger Schurch was also supported by a fellowship from the Swiss National Science Foundation (grant-no. PBBEP3_133529). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ame JM, 2006, P NATL ACAD SCI USA, V103, P5835, DOI 10.1073/pnas.0507877103; BECKERS R, 1992, INSECT SOC, V39, P59, DOI 10.1007/BF01240531; BECKERS R, 1993, J INSECT BEHAV, V6, P751, DOI 10.1007/BF01201674; BECKERS R, 1990, INSECT SOC, V37, P258, DOI 10.1007/BF02224053; Bonabeau E, 1997, TRENDS ECOL EVOL, V12, P188, DOI 10.1016/S0169-5347(97)01048-3; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; Collett M, 2009, CURR BIOL, V19, pR1103, DOI 10.1016/j.cub.2009.10.004; Collett TS, 2003, CURR OPIN NEUROBIOL, V13, P718, DOI 10.1016/j.conb.2003.10.004; Couzin ID, 2009, TRENDS COGN SCI, V13, P36, DOI 10.1016/j.tics.2008.10.002; Czaczkes TJ, 2011, BIOL LETTERS, V7, P521, DOI 10.1098/rsbl.2011.0067; DENEUBOURG JL, 1983, J THEOR BIOL, V105, P259, DOI 10.1016/S0022-5193(83)80007-1; Detrain C, 2008, ADV INSECT PHYSIOL, V35, P123, DOI 10.1016/S0065-2806(08)00002-7; DREISIG H, 1988, ECOL ENTOMOL, V13, P143, DOI 10.1111/j.1365-2311.1988.tb00342.x; Dussutour A, 2004, NATURE, V428, P70, DOI 10.1038/nature02345; Dussutour A, 2009, P ROY SOC B-BIOL SCI, V276, P4353, DOI 10.1098/rspb.2009.1235; Dussutour A, 2009, J EXP BIOL, V212, P2337, DOI 10.1242/jeb.029827; Evison SEF, 2008, BEHAV ECOL SOCIOBIOL, V63, P261, DOI 10.1007/s00265-008-0657-6; Gerbier G, 2008, ANIM COGN, V11, P637, DOI 10.1007/s10071-008-0153-4; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Gruter C, 2011, BEHAV ECOL SOCIOBIOL, V65, P141, DOI 10.1007/s00265-010-1020-2; Halloy J, 2007, SCIENCE, V318, P1155, DOI 10.1126/science.1144259; Helantera H, 2011, SOCIOBIOLOGY, V57, P445; Jackson DE, 2004, NATURE, V432, P907, DOI 10.1038/nature03105; Jeanson R, 2004, ANIM BEHAV, V67, P531, DOI 10.1016/j.anbehav.2003.06.013; Jeanson Raphael, 2009, P460; Lukeman R, 2010, P NATL ACAD SCI USA, V107, P12576, DOI 10.1073/pnas.1001763107; Mailleux AC, 2005, J INSECT PHYSIOL, V51, P297, DOI 10.1016/j.jinsphys.2004.12.001; Mailleux AC, 2003, P ROY SOC B-BIOL SCI, V270, P1609, DOI 10.1098/rspb.2003.2398; Nieh JC, 2010, CURR BIOL, V20, P310, DOI 10.1016/j.cub.2009.12.060; O'Toole DV, 1999, J THEOR BIOL, V198, P305, DOI 10.1006/jtbi.1999.0917; Oliver TH, 2008, J EVOLUTION BIOL, V21, P1597, DOI 10.1111/j.1420-9101.2008.01600.x; R Core Team, 2020, R LANG ENV STAT COMP; Robinson EJH, 2005, NATURE, V438, P442, DOI 10.1038/438442a; Robinson EJH, 2008, J THEOR BIOL, V255, P250, DOI 10.1016/j.jtbi.2008.08.015; Schmidt VM, 2006, ANIM BEHAV, V72, P1309, DOI 10.1016/j.anbehav.2006.03.023; Seeley T., 1995, WISDOM HIVE SOCIAL P; Seeley T.D., 2010, HONEYBEE DEMOCRACY; Seeley TD, 2012, SCIENCE, V335, P108, DOI 10.1126/science.1210361; Sokal RR, 1995, BIOMETRY; Steck K, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-5; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; Sumpter DJT, 2003, ANIM BEHAV, V66, P273, DOI 10.1006/anbe.2003.2224; Traniello James F.A., 1995, P241; VERHAEGHE JC, 1983, INSECT SOC, V30, P347, DOI 10.1007/BF02223992; Volkl W, 1999, OECOLOGIA, V118, P483, DOI 10.1007/s004420050751; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Wilensky U., 1999, NETLOGO; WILSON EDWARD O., 1962, ANIMAL BEHAVIOR, V10, P134, DOI 10.1016/0003-3472(62)90141-0; Zhang HP, 2010, P NATL ACAD SCI USA, V107, P13626, DOI 10.1073/pnas.1001651107; Zuur Alain F., 2009, P1	53	34	34	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44501	10.1371/journal.pone.0044501	http://dx.doi.org/10.1371/journal.pone.0044501			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984518	Green Published, gold, Green Submitted			2022-12-27	WOS:000308738500061
J	Weghofer, A; Tea, MK; Barad, DH; Kim, A; Singer, CF; Wagner, K; Gleicher, N				Weghofer, Andrea; Tea, Muy-Kheng; Barad, David H.; Kim, Ann; Singer, Christian F.; Wagner, Klaus; Gleicher, Norbert			BRCA1/2 Mutations Appear Embryo-Lethal Unless Rescued by Low (CGG n < 26) FMR1 Sub-Genotypes: Explanation for the "BRCA Paradox"?	PLOS ONE			English	Article							BREAST-CANCER; GENE; PREVALENCE; REPEAT; RISK; CARRIERS; WOMEN; WHITE; P53	BRCA1/2 mutations and recently described constitutional FMR1 genotypes have, independently, been associated with prematurely diminished ovarian reserve. Whether they interrelate in distribution, and whether observed effects of BRCA1/2 and FMR1 on ovaries are independent of each other, is unknown. In a prospective comparative cohort study, we, therefore, investigated the distribution of constitutional FMR1 genotypes, normal (norm), heterozygous (het) and homozygous (hom), and of their respective sub-genotypes (high/low), in 99 BRCA1/2 mutation-positive women and 410 female controls to determine whether distribution patterns differed between study and control patients. In contrast to controls, BRCA1/2 carriers demonstrated almost complete absence of all constitutional FMR1 genotypes except for sub-genotypes with low (CGG (n<26)) alleles. Cross tabulation between BRCA1/2-positive patients and controls confirmed significant group membership, related to FMR1 distribution (P < 0.0001). These results offer as most likely explanation the conclusion that BRCA1/2 mutations are embryo-lethal, unless rescued by low (CGG (n<26)) FMR1 sub-genotypes, present in approximately one quarter of all women. Women with low FMR1 sub-genotypes, therefore, should reflect increased BRCA1/2-associated cancer risks, while the remaining approximately 75 percent should face almost no such risks. If confirmed, this observation offers opportunities for more efficient and less costly BRCA1/2 cancer screening. The study also suggests that previously reported risk towards prematurely diminished ovarian reserve in association with BRCA mutations is FMR1-mediated, and offers a possible explanation for the so-called "BRCA paradox" by raising the possibility that the widely perceived BRCA1/2-associated tumor risk is actually FMR1-mediated.	[Weghofer, Andrea; Barad, David H.; Kim, Ann; Gleicher, Norbert] Ctr Human Reprod, New York, NY USA; [Weghofer, Andrea] Med Univ Vienna, Dept Gynecol Endocrinol & Reprod Med, Vienna, Austria; [Tea, Muy-Kheng; Singer, Christian F.] Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria; [Barad, David H.; Gleicher, Norbert] Fdn Reprod Med, New York, NY USA; [Wagner, Klaus] Med Univ Graz, Dept Human Genet, Graz, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Graz	Weghofer, A (corresponding author), Ctr Human Reprod, New York, NY USA.	ngleicher@thechr.com	Barad, David/AAF-4332-2021		Foundation for Reproductive Medicine, New York, N.Y., USA; Center for Human Reproduction (CHR) - New York; Merck-Serono; Schering Plough; Ferring Pharmaceuticals; Bard Medical	Foundation for Reproductive Medicine, New York, N.Y., USA; Center for Human Reproduction (CHR) - New York; Merck-Serono(Merck & Company); Schering Plough(Merck & CompanySchering Plough Corporation); Ferring Pharmaceuticals(Ferring Pharmaceuticals); Bard Medical	This study was supported by funds from the not-for-profit Foundation for Reproductive Medicine, New York, N.Y., 10021, USA and intramural funds from the Center for Human Reproduction (CHR) - New York, a for-profit fertility and research center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; N.G., A. W. and D. H. B. have in the past received research support, speakers' honoraria and travel funds from EDM Serono (now Merck-Serono), Organon Pharmaceutical (now Schering Plough), Ferring Pharmaceuticals and Bard Medical, none, however, related to the subject of this paper. N.G. and D. H. B. are listed as co-inventors on pending U. S. patent applications, claiming diagnostic benefits from determining of ovarian FMR1 genotypes and sub-genotypes in association with female infertility. The patent claims are (1) Diagnostic relevance of CGG repeat numbers on the FMR1 gene in predicting functional ovarian reserve over time (i.e., ovarian aging patterns); (2) Newly described, so-called "ovarian" genotypes and sub-genotypes, based on a normal range of 26-34 CGG repeats as "normal" range; (3) Diagnostic relevance of these newly described genotypes and sub-genotypes in defining specific ovarian aging patterns and relevance to defining autoimmune risk. N.G. is the owner of The CHR, and A. K. and D. H. B. are employed there. A. W. is an associate visiting scientist at The CHR. The CHR was a funder of this study and where this research was conducted. The medical corporation, however, exerted no influence on this study. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ademuyiwa FO, 2011, CANCER RES, V71, P640, DOI 10.1158/0008-5472.CAN-10-3021; Altekruse S. F., 1975, SEER CANC STAT REV 1; Antoniou AC, 2001, GENET EPIDEMIOL, V21, P1, DOI 10.1002/gepi.1014; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Campeau PM, 2008, HUM GENET, V124, P31, DOI 10.1007/s00439-008-0529-1; Cao L, 2003, GENE DEV, V17, P201, DOI 10.1101/gad.1050003; Chen LS, 2003, HUM MOL GENET, V12, P3067, DOI 10.1093/hmg/ddg331; Crook T, 1997, LANCET, V350, P638, DOI 10.1016/S0140-6736(05)63327-2; Davis-Dao C, 2012, J CLIN ENDOCR METAB, V97, pE393, DOI 10.1210/jc.2011-2439; Evers B, 2006, ONCOGENE, V25, P5885, DOI 10.1038/sj.onc.1209871; GLEICHER N, 1980, MT SINAI J MED, V47, P511; Gleicher N, 1981, Prog Clin Biol Res, V70, P339; Gleicher N, 2007, J AUTOIMMUN, V28, P1, DOI 10.1016/j.jaut.2006.12.004; Gleicher N, 2012, J AUTOIMMUN, V38, pJ74, DOI 10.1016/j.jaut.2011.05.016; Gleicher N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018781; Gleicher N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015303; Gleicher N, 2010, REPROD BIOMED ONLINE, V20, P768, DOI 10.1016/j.rbmo.2010.02.020; Gleicher N, 2010, REPROD BIOMED ONLINE, V20, P485, DOI 10.1016/j.rbmo.2009.12.017; Hakem R, 1997, NAT GENET, V16, P298, DOI 10.1038/ng0797-298; Ikegami H, 2007, DIABETES RES CLIN PR, V77, pS116, DOI 10.1016/j.diabres.2007.01.044; John EM, 2007, JAMA-J AM MED ASSOC, V298, P2869, DOI 10.1001/jama.298.24.2869; Kadouri L, 2007, J MED GENET, V44, P467, DOI 10.1136/jmg.2006.048173; Krausz C, 2012, J CLIN ENDOCR METAB, V97, P764, DOI 10.1210/jc.2012-1130; Ludwig T, 1997, GENE DEV, V11, P1226, DOI 10.1101/gad.11.10.1226; Malone KE, 2006, CANCER RES, V66, P8297, DOI 10.1158/0008-5472.CAN-06-0503; Oktay K, 2010, J CLIN ONCOL, V28, P240, DOI 10.1200/JCO.2009.24.2057; Petek E, 1999, AM J MED GENET, V84, P229, DOI 10.1002/(SICI)1096-8628(19990528)84:3<229::AID-AJMG13>3.3.CO;2-K; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Terplan M, 2011, GYNECOL ONCOL; Thompson D, 2002, JNCI-J NATL CANCER I, V94, P1358, DOI 10.1093/jnci/94.18.1358; Vogel KJ, 2007, J CLIN ONCOL, V25, P4635, DOI 10.1200/JCO.2006.10.4703; Wagner T, 1999, GENOMICS, V62, P369, DOI 10.1006/geno.1999.6026; Willemsen R, 2011, CLIN GENET, V80, P214, DOI 10.1111/j.1399-0004.2011.01723.x; Wittenberger MD, 2007, FERTIL STERIL, V87, P456, DOI 10.1016/j.fertnstert.2006.09.004; Xu CF, 1997, GENE CHROMOSOME CANC, V18, P102, DOI 10.1002/(SICI)1098-2264(199702)18:2<102::AID-GCC4>3.3.CO;2-A	35	18	19	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44753	10.1371/journal.pone.0044753	http://dx.doi.org/10.1371/journal.pone.0044753			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984553	gold, Green Submitted, Green Published			2022-12-27	WOS:000308738500080
J	White, O; Lefevre, P; Wing, AM; Bracewell, RM; Thonnard, JL				White, Olivier; Lefevre, Philippe; Wing, Alan M.; Bracewell, R. Martyn; Thonnard, Jean-Louis			Active Collisions in Altered Gravity Reveal Eye-Hand Coordination Strategies	PLOS ONE			English	Article							GRIP FORCE ADJUSTMENTS; OBJECT MANIPULATION; VISUAL INFORMATION; LOAD PERTURBATIONS; POINTING MOVEMENT; HEAD MOVEMENTS; ARM MOVEMENTS; TARGET; TASK; DIRECTION	Most object manipulation tasks involve a series of actions demarcated by mechanical contact events, and gaze is usually directed to the locations of these events as the task unfolds. Typically, gaze foveates the target 200 ms in advance of the contact. This strategy improves manual accuracy through visual feedback and the use of gaze-related signals to guide the hand/ object. Many studies have investigated eye-hand coordination in experimental and natural tasks; most of them highlighted a strong link between eye movements and hand or object kinematics. In this experiment, we analyzed gaze strategies in a collision task but in a very challenging dynamical context. Participants performed collisions while they were exposed to alternating episodes of microgravity, hypergravity and normal gravity. First, by isolating the effects of inertia in microgravity, we found that peak hand acceleration marked the transition between two modes of grip force control. Participants exerted grip forces that paralleled load force profiles, and then increased grip up to a maximum shifted after the collision. Second, we found that the oculomotor strategy adapted visual feedback of the controlled object around the collision, as demonstrated by longer durations of fixation after collision in new gravitational environments. Finally, despite large variability of arm dynamics in altered gravity, we found that saccades were remarkably time-locked to the peak hand acceleration in all conditions. In conclusion, altered gravity allowed light to be shed on predictive mechanisms used by the central nervous system to coordinate gaze, hand and grip motor actions during a mixed task that involved transport of an object and high impact loads.	[White, Olivier] Univ Bourgogne, Unite Format & Rech Sci & Tech Act Phys & Sport, Dijon, France; [White, Olivier] INSERM, Cognit Act & Sensorimotor Plast U1093, Dijon, France; [Lefevre, Philippe] Catholic Univ Louvain, Inst Informat & Commun Technol Elect & Appl Math, B-3000 Louvain, Belgium; [Lefevre, Philippe; Thonnard, Jean-Louis] Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium; [Wing, Alan M.; Bracewell, R. Martyn] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England; [Bracewell, R. Martyn] Bangor Univ, Wolfson Ctr Clin & Cognit Neurosci, Bangor, Gwynedd, Wales	Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite Catholique Louvain; Universite Catholique Louvain; University of Birmingham; Bangor University	White, O (corresponding author), Univ Bourgogne, Unite Format & Rech Sci & Tech Act Phys & Sport, Dijon, France.	olivier.white@u-bourgogne.fr	White, Olivier/AAJ-6914-2020	White, Olivier/0000-0002-9119-1329; Wing, Alan/0000-0002-2623-3801	Prodex (PROgramme for the Development of Scientific EXperiments by the European Space Agency); OSTC (Office for Scientific, Technical and Cultural Affairs); ESA/ESTEC (European Space Agency/European Space Research and Technology Centre) from the UK Medical Research Council [14725/00/NL/JS]; European Union Information Society Technologies; INSERM; Universite de Bourgogne	Prodex (PROgramme for the Development of Scientific EXperiments by the European Space Agency); OSTC (Office for Scientific, Technical and Cultural Affairs); ESA/ESTEC (European Space Agency/European Space Research and Technology Centre) from the UK Medical Research Council; European Union Information Society Technologies; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite de Bourgogne	This research was supported by grants from Prodex (PROgramme for the Development of Scientific EXperiments by the European Space Agency), OSTC (Office for Scientific, Technical and Cultural Affairs) and ESA/ESTEC (European Space Agency/European Space Research and Technology Centre) Contract 14725/00/NL/JS to JLT, from the UK Medical Research Council to AMW, and European Union Information Society Technologies to AMW and RMB and by INSERM and Universite de Bourgogne to OWH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS RA, 1990, J EXP PSYCHOL HUMAN, V16, P248, DOI 10.1037/0096-1523.16.2.248; Augurelle AS, 2003, EXP BRAIN RES, V148, P533, DOI 10.1007/s00221-002-1322-3; Binsted G, 1999, EXP BRAIN RES, V127, P193, DOI 10.1007/s002210050789; Binsted G, 2001, HUM MOVEMENT SCI, V20, P563, DOI 10.1016/S0167-9457(01)00068-9; BOOTSMA RJ, 1993, J EXP PSYCHOL HUMAN, V19, P1041, DOI 10.1037/0096-1523.19.5.1041; Bowman M, 2009, EXP BRAIN RES, V195, P273, DOI 10.1007/s00221-009-1781-x; CARNAHAN H, 1991, J MOTOR BEHAV, V23, P109, DOI 10.1080/00222895.1991.9942028; Clarke AH, 2002, BEHAV RES METH INS C, V34, P549, DOI 10.3758/BF03195484; Crevecoeur F, 2009, NEUROSCIENCE, V161, P589, DOI 10.1016/j.neuroscience.2009.03.025; de Brouwer S, 2002, J NEUROPHYSIOL, V87, P1646, DOI 10.1152/jn.00432.2001; Delevoye-Turrell YN, 2003, Q J EXP PSYCHOL-A, V56, P1113, DOI 10.1080/02724980245000025; Flanagan JR, 2006, CURR OPIN NEUROBIOL, V16, P650, DOI 10.1016/j.conb.2006.10.005; Foerster RM, 2011, J VISION, V11, DOI 10.1167/11.7.9; Gentili R, 2007, NEUROSCIENCE, V145, P20, DOI 10.1016/j.neuroscience.2006.11.035; GOODALE MA, 1986, NATURE, V320, P748, DOI 10.1038/320748a0; HagerRoss C, 1996, EXP BRAIN RES, V110, P142; Helsen WF, 2000, J MOTOR BEHAV, V32, P241, DOI 10.1080/00222890009601375; Hermsdorfer J, 2000, EXP BRAIN RES, V132, P52, DOI 10.1007/s002219900325; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; LAND MF, 1992, NATURE, V359, P318, DOI 10.1038/359318a0; McIntyre J, 2001, ACTA ASTRONAUT, V49, P111, DOI 10.1016/S0094-5765(01)00087-X; Mrotek LA, 2004, EXP BRAIN RES, V155, P413, DOI 10.1007/s00221-003-1748-2; Nanayakkara T, 2003, J NEUROPHYSIOL, V90, P4016, DOI 10.1152/jn.00430.2003; Neggers SFW, 2000, J NEUROPHYSIOL, V83, P639, DOI 10.1152/jn.2000.83.2.639; Neggers SFW, 2001, J NEUROPHYSIOL, V86, P961, DOI 10.1152/jn.2001.86.2.961; Nowak DA, 2002, SOMATOSENS MOT RES, V19, P49, DOI 10.1080/08990220120113048; Nowak DA, 2001, MOTOR CONTROL, V5, P231, DOI 10.1123/mcj.5.3.231; Nowak DA, 2006, EXP BRAIN RES, V173, P650, DOI 10.1007/s00221-006-0409-7; Papaxanthis C, 1998, EXP BRAIN RES, V120, P496, DOI 10.1007/s002210050423; Pelz J, 2001, EXP BRAIN RES, V139, P266, DOI 10.1007/s002210100745; Rodrigues ST, 2002, J SPORT SCI, V20, P187, DOI 10.1080/026404102317284754; Ronsse R, 2007, J NEUROSCI METH, V159, P158, DOI 10.1016/j.jneumeth.2006.06.016; Saunders JA, 2003, EXP BRAIN RES, V152, P341, DOI 10.1007/s00221-003-1525-2; Senot P, 2005, J NEUROPHYSIOL, V94, P4471, DOI 10.1152/jn.00527.2005; Serrien DJ, 1999, EXP BRAIN RES, V124, P100, DOI 10.1007/s002210050604; Starkes J, 2002, J SPORT SCI, V20, P217, DOI 10.1080/026404102317284772; Turrell YN, 1999, EXP BRAIN RES, V128, P86, DOI 10.1007/s002210050822; Vercher JL, 1996, J NEUROPHYSIOL, V76, P1133, DOI 10.1152/jn.1996.76.2.1133; WERKHOVEN P, 1992, VISION RES, V32, P2313, DOI 10.1016/0042-6989(92)90095-Z; White O, 2005, EXP BRAIN RES, V163, P324, DOI 10.1007/s00221-004-2175-8; White O, 2011, NEUROSCIENCE, V189, P269, DOI 10.1016/j.neuroscience.2011.04.055; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8; Zago M, 2005, J NEUROPHYSIOL, V93, P1055, DOI 10.1152/jn.00833.2004	44	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44291	10.1371/journal.pone.0044291	http://dx.doi.org/10.1371/journal.pone.0044291			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984488	Green Submitted, Green Published, gold			2022-12-27	WOS:000308738500044
J	Ali, Z; Mishra, A; Kumar, R; Alam, P; Pandey, P; Ram, R; Thinlas, T; Mohammad, G; Pasha, MAQ				Ali, Zahara; Mishra, Aastha; Kumar, Rahul; Alam, Perwez; Pandey, Priyanka; Ram, Rekhbala; Thinlas, Tashi; Mohammad, Ghulam; Pasha, M. A. Qadar			Interactions among Vascular-Tone Modulators Contribute to High Altitude Pulmonary Edema and Augmented Vasoreactivity in Highlanders	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; NITRIC-OXIDE; OXIDATIVE STRESS; ASYMMETRIC DIMETHYLARGININE; L-ARGININE; ARTERIAL-HYPERTENSION; CONVERTING ENZYME; HYPOBARIC HYPOXIA; NATURAL-SELECTION; ADAPTATION	Background: The interactions among various biomarkers remained unexplored under the stressful environment of high-altitude. Present study evaluated interactions among biomarkers to study susceptibility for high altitude pulmonary edema (HAPE) in HAPE-patients (HAPE-p) and adaptation in highland natives (HLs); both in comparison to HAPE-free sojourners (HAPE-f). Methodology/Principal Findings: All the subjects were recruited at 3500 m. We measured clinical parameters, biochemical levels in plasma and gene expression using RNA from blood; analyzed various correlations between and among the clinical parameters, especially arterial oxygen saturation (SaO(2)) and mean arterial pressure (MAP) and biochemical parameters like, asymmetric dimethylarginine (ADMA), serotonin (5-HT), 8-iso-prostaglandin F2 alpha (8-isoPGF2 alpha), endothelin-1 (ET-1), plasma renin activity (PRA), plasma aldosterone concentration (PAC), superoxide dismutase (SOD) and nitric oxide (NO) in HAPE-p, HAPE-f and HLs. ADMA, 5-HT, 8-isoPGF2 alpha, ET-1 levels, and PAC were significantly higher (p<0.0001, each), whereas SOD activity and NO level were significantly lower in HAPE-p than HAPE-f (p <= 0.001). Furthermore, ADMA, 5-HT, 8-isoPGF2 alpha, NO levels and PAC were significantly higher (p<0.0001), whereas ET-1 level significantly (p, 0.0001) and SOD activity non-significantly (p. 0.05) lower in HLs than HAPE-f. The expression of respective genes differed in the three groups. In the correlations, SaO(2) inversely correlated with ADMA, 5-HT and 8-isoPGF2 alpha and positively with SOD in HAPE-p (p <= 0.009). MAP correlated positively with 5-HT and 8-isoPGF2 alpha in HAPE-p and HLs (p <= 0.004). A strong positive correlation was observed between ADMA and 5-HT, 5-HT and 8-isoPGF2 alpha (p <= 0.001), whereas inverse correlation of SOD with ET-1 in HAPE-p and HLs (p <= 0.004), with 5-HT and 8-isoPGF2 alpha in HAPE-p (p = 0.01) and with 5-HT in HLs (p = 0.05). Conclusions/Significance: The interactions among these markers confer enhanced vascular activity in HLs and HAPE in sojourners.	[Ali, Zahara; Mishra, Aastha; Kumar, Rahul; Alam, Perwez; Pandey, Priyanka; Ram, Rekhbala; Pasha, M. A. Qadar] Inst Genom & Integrat Biol, Delhi, India; [Ali, Zahara; Mishra, Aastha; Alam, Perwez; Pandey, Priyanka; Pasha, M. A. Qadar] Univ Pune, Dept Biotechnol, Pune, Maharashtra, India; [Thinlas, Tashi; Mohammad, Ghulam] SNM Hosp, Dept Med, Ladakh, Jammu & Kashmir, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Savitribai Phule Pune University	Ali, Z (corresponding author), Inst Genom & Integrat Biol, Delhi, India.	qpasha@igib.res.in		Alam, Perwez/0000-0002-7229-8008; Kumar, Rahul/0000-0002-2709-5981; Alam, Perwez/0000-0003-0668-2236	Council of Scientific and Industrial Research, India under the Supra-Institutional Project [SIP0006]	Council of Scientific and Industrial Research, India under the Supra-Institutional Project	The Council of Scientific and Industrial Research, India, financially supported under the Supra-Institutional Project-SIP0006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2010, P NATL ACAD SCI USA, V107, P18961, DOI 10.1073/pnas.1006108107; Ahsan A, 2004, THORAX, V59, P1000, DOI 10.1136/thx.2004.029124; Arrigoni FI, 2003, CIRCULATION, V107, P1195, DOI 10.1161/01.CIR.0000051466.00227.13; Basnyat B, 2003, LANCET, V361, P1967, DOI 10.1016/S0140-6736(03)13591-X; Beall CM, 2001, NATURE, V414, P411, DOI 10.1038/35106641; Beall CA, 2007, RESP PHYSIOL NEUROBI, V158, P161, DOI 10.1016/j.resp.2007.05.013; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Berger MM, 2009, HIGH ALT MED BIOL, V10, P17, DOI 10.1089/ham.2008.1053; Busch T, 2001, AM J RESP CRIT CARE, V163, P368, DOI 10.1164/ajrccm.163.2.2001134; Charu R, 2006, THORAX, V61, P1011, DOI 10.1136/thx.2006.066019; Cooke JP, 1997, CIRCULATION, V96, P379; Dosek A, 2007, RESP PHYSIOL NEUROBI, V158, P128, DOI 10.1016/j.resp.2007.03.013; Droma Y, 1996, EUR RESPIR J, V9, P1947, DOI 10.1183/09031936.96.09091947; Eddahibi S, 1999, CIRC RES, V84, P329, DOI 10.1161/01.RES.84.3.329; Gorenflo M, 2001, J CARDIOVASC PHARM, V37, P489, DOI 10.1097/00005344-200104000-00016; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; HERVE P, 1995, AM J MED, V99, P249, DOI 10.1016/S0002-9343(99)80156-9; Jefferson JA, 2004, HIGH ALT MED BIOL, V5, P61, DOI 10.1089/152702904322963690; Kielstein JT, 2005, ARTERIOSCL THROM VAS, V25, P1414, DOI 10.1161/01.ATV.0000168414.06853.f0; Konigshoff M, 2010, THORAX, V65, P949, DOI 10.1136/thx.2009.134353; Lee SL, 1998, FREE RADICAL BIO MED, V24, P855, DOI 10.1016/S0891-5849(97)00359-6; Lemarie CA, 2008, J MOL MED, V86, P673, DOI 10.1007/s00109-008-0323-5; Leon-Velarde F, 2010, PROG CARDIOVASC DIS, V52, P540, DOI 10.1016/j.pcad.2010.02.012; Linz W, 1999, CARDIOVASC RES, V43, P549, DOI 10.1016/S0008-6363(99)00091-7; MACGREGOR GA, 1981, NATURE, V291, P329, DOI 10.1038/291329a0; MacLean MR, 2007, INT J CLIN PRACT, V61, P27, DOI 10.1111/j.1742-1241.2007.01497.x; Marcos E, 2004, CIRC RES, V94, P1263, DOI 10.1161/01.RES.0000126847.27660.69; MILLEDGE JS, 1982, J APPL PHYSIOL, V52, P320, DOI 10.1152/jappl.1982.52.2.320; Mishra A, 2012, CLIN SCI, V122, P299, DOI 10.1042/CS20110205; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; Montuschi P, 2004, FASEB J, V18, P1791, DOI 10.1096/fj.04-2330rev; Moore LG, 1998, YEARB PHYS ANTHROPOL, V41, P25; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; Morrow JD, 2002, AM J RESP CRIT CARE, V166, pS25, DOI 10.1164/rccm.2206011; Nakanishi I, 1995, J PHYSIOL-LONDON, V489, P869, DOI 10.1113/jphysiol.1995.sp021099; Pasha MAQ, 2003, CURR SCI INDIA, V85, P502; Pasha MAQ, 2001, ANN HUM GENET, V65, P531, DOI 10.1017/S0003480001008879; Rajput C, 2006, BIOCHEM BIOPH RES CO, V341, P1218, DOI 10.1016/j.bbrc.2006.01.086; ROCK PB, 1993, J APPL PHYSIOL, V75, P1208, DOI 10.1152/jappl.1993.75.3.1208; Sartori C, 1999, CIRCULATION, V99, P2665, DOI 10.1161/01.CIR.99.20.2665; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Skoro-Sajer N, 2007, AM J RESP CRIT CARE, V176, P1154, DOI 10.1164/rccm.200702-278OC; Struthers AD, 2004, CARDIOVASC RES, V61, P663, DOI 10.1016/j.cardiores.2003.11.037; Suda O, 2004, ARTERIOSCL THROM VAS, V24, P1682, DOI 10.1161/01.ATV.0000136656.26019.6e; Vallance P, 2004, ARTERIOSCL THROM VAS, V24, P1023, DOI 10.1161/01.ATV.0000128897.54893.26; Zakrzewicz Dariusz, 2009, BMC Pulm Med, V9, P5, DOI 10.1186/1471-2466-9-5	46	35	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44049	10.1371/journal.pone.0044049	http://dx.doi.org/10.1371/journal.pone.0044049			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984459	Green Submitted, Green Published, gold			2022-12-27	WOS:000308638700040
J	Yu, J; Walter, K; Omura, N; Hong, SM; Young, A; Li, A; Vincent, A; Goggins, M				Yu, Jun; Walter, Kimberly; Omura, Noriyuki; Hong, Seung-Mo; Young, Angela; Li, Ang; Vincent, Audrey; Goggins, Michael			Unlike Pancreatic Cancer Cells Pancreatic Cancer Associated Fibroblasts Display Minimal Gene Induction after 5-Aza-2 '-Deoxycytidine	PLOS ONE			English	Article							TUMOR-STROMAL INTERACTIONS; DUCTAL ADENOCARCINOMA; ABERRANT METHYLATION; DNA METHYLATION; BREAST-CANCER; PROMOTER METHYLATION; BLADDER-CANCER; MULTIPLE GENES; CARCINOMA; EXPRESSION	Purpose: Cancer associated stromal fibroblasts (CAFs) undergo transcriptional and phenotypic changes that contribute to tumor progression, but the mechanisms responsible for these changes are not well understood. Aberrant DNA methylation is an important cause of transcriptional alterations in cancer cells but it is not known how important DNA methylation alterations are to CAF behavior. Experimental Design: We used Affymetrix exon arrays to compare genes induced by the DNA methylation inhibitor 5-aza-dC in cultured pancreatic cancer associated fibroblasts, pancreatic control fibroblasts and pancreatic cancer cell lines. Results: We found that pancreatic CAFs and control pancreatic fibroblasts were less responsive to 5-aza-dC-mediated gene reactivation than pancreatic cancer cells (mean+/2SD of genes induced >= 5-fold was 9 +/- 10 genes in 10 pancreatic CAF cultures, 17 +/- 14 genes in 3 control pancreatic fibroblast cultures, and 134 +/- 85 genes in 4 pancreatic cancer cell lines). We examined differentially expressed genes between CAFs and control fibroblasts for candidate methylated genes and identified the disintegrin and metalloprotease, ADAM12 as hypomethylated and overexpressed in pancreatic CAF lines and overexpressed in fibroblasts adjacent to primary pancreatic adenocarcinomas. Conclusions: Compared to pancreatic cancer cells, few genes are reactivated by DNMT1 inhibition in pancreatic CAFs suggesting these cells do not harbor many functionally important alterations in DNA methylation. CAFs may also not be very responsive to therapeutic targeting with DNA methylation inhibitors.	[Yu, Jun; Walter, Kimberly; Omura, Noriyuki; Hong, Seung-Mo; Young, Angela; Li, Ang; Vincent, Audrey; Goggins, Michael] Johns Hopkins Med Inst, Dept Pathol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD USA; [Goggins, Michael] Johns Hopkins Med Inst, Dept Med, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD USA; [Goggins, Michael] Johns Hopkins Med Inst, Dept Oncol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Yu, J (corresponding author), Johns Hopkins Med Inst, Dept Pathol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD USA.	mgoggins@jhmi.edu	Vincent, Audrey/I-2934-2016	Vincent, Audrey/0000-0003-0058-2058; Hong, Seung-Mo/0000-0002-8888-6007	National Cancer Institute [CA62924, RC2148346]; Michael Rolfe Foundation; NATIONAL CANCER INSTITUTE [P50CA062924] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Michael Rolfe Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute grants (CA62924 and RC2148346), and the Michael Rolfe Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Bender CM, 1998, CANCER RES, V58, P95; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Boyd ZS, 2009, J MOL DIAGN, V11, P290, DOI 10.2353/jmoldx.2009.080124; Campbell I, 2009, CANCER RES, V69, P6765, DOI 10.1158/0008-5472.CAN-08-4253; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Cohen SJ, 2008, PANCREAS, V37, P154, DOI 10.1097/MPA.0b013e31816618ce; Dahl JA, 2007, STEM CELLS, V25, P1037, DOI 10.1634/stemcells.2006-0430; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; Direkze NC, 2004, CANCER RES, V64, P8492, DOI 10.1158/0008-5472.CAN-04-1708; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Eyden B, 2008, J CELL MOL MED, V12, P22, DOI 10.1111/j.1582-4934.2007.00213.x; Ferguson AT, 2000, P NATL ACAD SCI USA, V97, P6049, DOI 10.1073/pnas.100566997; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; Frohlich C, 2006, CLIN CANCER RES, V12, P7359, DOI 10.1158/1078-0432.CCR-06-1066; Fujita H, 2010, PANCREAS; Fukushima N, 2002, AM J PATHOL, V160, P1573, DOI 10.1016/S0002-9440(10)61104-2; Hanson JA, 2006, JNCI-J NATL CANCER I, V98, P255, DOI 10.1093/jnci/djj051; Hu M, 2005, NAT GENET, V37, P899, DOI 10.1038/ng1596; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Iacobuzio-Donahue CA, 2002, CANCER RES, V62, P5351; Iba K, 1999, AM J PATHOL, V154, P1489, DOI 10.1016/S0002-9440(10)65403-X; Infante JR, 2007, J CLIN ONCOL, V25, P319, DOI 10.1200/JCO.2006.07.8824; Issa JPJ, 2001, CANCER RES, V61, P3573; Jiang L, 2008, CANCER RES, V68, P9900, DOI 10.1158/0008-5472.CAN-08-1319; Jin BL, 2009, CANCER RES, V69, P7412, DOI 10.1158/0008-5472.CAN-09-0116; Jones PA, 2009, NAT REV GENET, V10, P805, DOI 10.1038/nrg2651; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kanda M, 2009, INT J ONCOL, V35, P477, DOI 10.3892/ijo_00000359; Kelloff Gary J., 2007, Cancer Biomarkers, V3, P1; Kim ST, 2007, P NATL ACAD SCI USA, V104, P17052, DOI 10.1073/pnas.0708293104; Kveiborg M, 2008, INT J BIOCHEM CELL B, V40, P1685, DOI 10.1016/j.biocel.2008.01.025; Lau JCY, 2004, NUCLEIC ACIDS RES, V32, P3376, DOI 10.1093/nar/gkh671; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lee KM, 2003, BIOCHEM BIOPH RES CO, V301, P1038, DOI 10.1016/S0006-291X(03)00086-X; Liang G, 2002, CANCER RES, V62, P961; Maegawa S, 2010, GENOME RES, V20, P332, DOI 10.1101/gr.096826.109; Mann J, 2010, GASTROENTEROLOGY, V138, P705, DOI 10.1053/j.gastro.2009.10.002; Matsubayashi H, 2005, CLIN CANCER RES, V11, P573; Menigatti M, 2009, ONCOGENE, V28, P899, DOI 10.1038/onc.2008.444; Mishra PJ, 2008, CANCER RES, V68, P4331, DOI 10.1158/0008-5472.CAN-08-0943; Ohuchida K, 2004, CANCER RES, V64, P3215, DOI 10.1158/0008-5472.CAN-03-2464; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Omura N, 2009, INT J CLIN EXP PATHO, V2, P310; Omura Noriyuki, 2008, Proceedings of the American Association for Cancer Research Annual Meeting, V49, P7; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pietras K, 2008, PLOS MED, V5, P123, DOI 10.1371/journal.pmed.0050019; Qiu W, 2008, NAT GENET, V40, P650, DOI 10.1038/ng.117; Sato N, 2003, CANCER RES, V63, P4158; Sato N, 2006, GASTROENTEROLOGY, V130, P548, DOI 10.1053/j.gastro.2005.11.008; Sato N, 2005, CLIN CANCER RES, V11, P4681, DOI 10.1158/1078-0432.CCR-04-2471; Sato N, 2005, ONCOGENE, V24, P850, DOI 10.1038/sj.onc.1208050; Sato N, 2004, AM J PATHOL, V164, P903, DOI 10.1016/S0002-9440(10)63178-1; Sato N, 2003, CANCER RES, V63, P3735; Sato N, 2003, ONCOGENE, V22, P5021, DOI 10.1038/sj.onc.1206807; Sun WY, 2010, CLIN CANCER RES, V16, P857, DOI 10.1158/1078-0432.CCR-09-2604; Tian H, 2009, P NATL ACAD SCI USA, V106, P4254, DOI 10.1073/pnas.0813203106; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Vincent A, 2011, CLIN CANCER RES, V17, P4341, DOI 10.1158/1078-0432.CCR-10-3431; Walter K, 2008, CANCER BIOL THER, V7, P882, DOI 10.4161/cbt.7.6.5869; Walter K, 2010, CLIN CANCER RES, V16, P1781, DOI 10.1158/1078-0432.CCR-09-1913; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Yu J, 2012, CLIN CANCER RES, V18, P981, DOI 10.1158/1078-0432.CCR-11-2347; Yu J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-169; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205	72	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43456	10.1371/journal.pone.0043456	http://dx.doi.org/10.1371/journal.pone.0043456			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984426	Green Published, gold, Green Submitted			2022-12-27	WOS:000308638700020
J	Broderick, S; Wang, XX; Simms, N; Page-McCaw, A				Broderick, Sarah; Wang, Xiaoxi; Simms, Nicholas; Page-McCaw, Andrea			Drosophila Ninjurin A Induces Nonapoptotic Cell Death	PLOS ONE			English	Article							IMMUNE-RESPONSE; ADHESION MOLECULE; TRANSMEMBRANE PROTEIN; BACTERIAL-INFECTION; INNATE IMMUNITY; HOST-DEFENSE; ACTIVATION; GENE; MELANOGASTER; EXPRESSION	Ninjurins are conserved transmembrane proteins that are upregulated across species in response to injury and stress. Their biological functions are not understood, in part because there have been few in vivo studies of their function. We analyzed the expression and function of one of three Drosophila Ninjurins, NijA. We found that NijA protein is redistributed to the cell surface in larval immune tissues after septic injury and is upregulated by the Toll pathway. We generated a null mutant of NijA, which displayed no detectable phenotype. In ectopic expression studies, NijA induced cell death, as evidenced by cell loss and acridine orange staining. These dying cells did not display hallmarks of apoptotic cells including TUNEL staining and inhibition by p35, indicating that NijA induced nonapoptotic cell death. In cell culture, NijA also induced cell death, which appeared to be cell autonomous. These in vivo studies identify a new role for the Ninjurin family in inducing nonapoptotic cell death.	[Page-McCaw, Andrea] Vanderbilt Univ Sch Med, Dept Canc Biol, Nashville, TN 37203 USA; [Broderick, Sarah; Wang, Xiaoxi; Page-McCaw, Andrea] Vanderbilt Univ Sch Med, Dept Cell & Dev Biol, Nashville, TN USA; [Broderick, Sarah; Wang, Xiaoxi; Page-McCaw, Andrea] Vanderbilt Univ Sch Med, Program Dev Biol, Nashville, TN USA; [Simms, Nicholas] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Rensselaer Polytechnic Institute	Page-McCaw, A (corresponding author), Vanderbilt Univ Sch Med, Dept Canc Biol, Nashville, TN 37203 USA.	andrea.page-mccaw@vanderbilt.edu	Wang, Xiaoxi/C-7178-2015	Wang, Xiaoxi/0000-0002-2232-8504	Basil O'Connor Starter Scholar Research Award [5-FY07-99]; National Institutes of Health [R01 GM073883]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073883] Funding Source: NIH RePORTER	Basil O'Connor Starter Scholar Research Award(March of Dimes); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Basil O'Connor Starter Scholar Research Award no. 5-FY07-99 and by National Institutes of Health R01 GM073883, both to APM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BJ, 2009, BIOCHEM BIOPH RES CO, V387, P321, DOI 10.1016/j.bbrc.2009.07.019; ANDERSON KV, 1979, DEV BIOL, V70, P217, DOI 10.1016/0012-1606(79)90018-6; Araki T, 1997, J BIOL CHEM, V272, P21373, DOI 10.1074/jbc.272.34.21373; Araki T, 1996, NEURON, V17, P353, DOI 10.1016/S0896-6273(00)80166-X; Araki T, 2000, J NEUROSCI, V20, P187, DOI 10.1523/JNEUROSCI.20-01-00187.2000; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bass BP, 2009, CELL DEATH DIFFER, V16, P1362, DOI 10.1038/cdd.2009.79; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Bratton DL, 2011, TRENDS IMMUNOL, V32, P350, DOI 10.1016/j.it.2011.04.009; Brennan CA, 2007, CURR BIOL, V17, P67, DOI 10.1016/j.cub.2006.11.026; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Charroux B, 2009, P NATL ACAD SCI USA, V106, P9797, DOI 10.1073/pnas.0903971106; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Denton D, 2012, CELL DEATH DIFFER, V19, P87, DOI 10.1038/cdd.2011.146; Di Giovanni S, 2005, J BIOL CHEM, V280, P2084, DOI 10.1074/jbc.M411975200; EDGAR BA, 1986, CELL, V44, P871, DOI 10.1016/0092-8674(86)90009-7; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; Glasheen BM, 2009, P NATL ACAD SCI USA, V106, P2659, DOI 10.1073/pnas.0804171106; Goto A, 2003, DEV BIOL, V264, P582, DOI 10.1016/j.ydbio.2003.06.001; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Han JH, 2011, NAT IMMUNOL, V12, P1143, DOI 10.1038/ni.2159; Hu XD, 2004, P NATL ACAD SCI USA, V101, P9369, DOI 10.1073/pnas.0307062101; Kanda H, 2011, P NATL ACAD SCI USA, V108, P18977, DOI 10.1073/pnas.1103242108; Kim JW, 2001, MOL CELLS, V11, P151; Koike M, 2008, J DERMATOL, V35, P6, DOI 10.1111/j.1346-8138.2007.00403.x; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kubo T, 2002, J NEUROCHEM, V82, P1129, DOI 10.1046/j.1471-4159.2002.01060.x; Kurucz E, 2003, P NATL ACAD SCI USA, V100, P2622, DOI 10.1073/pnas.0436940100; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lee HJ, 2009, CELL DEATH DIFFER, V16, P1395, DOI 10.1038/cdd.2009.78; LEMAITRE B, 1995, EMBO J, V14, P536, DOI 10.1002/j.1460-2075.1995.tb07029.x; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leulier F, 2006, MOL CELL BIOL, V26, P7821, DOI 10.1128/MCB.00548-06; McCall K, 2010, CURR OPIN CELL BIOL, V22, P882, DOI 10.1016/j.ceb.2010.09.002; MCGUIRE SE, 2004, SCI STKE, pPL6; Miyairi I, 2007, J IMMUNOL, V179, P1814, DOI 10.4049/jimmunol.179.3.1814; Nakamoto M, 2012, IMMUNITY, V36, P658, DOI 10.1016/j.immuni.2012.03.003; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Primrose DA, 2007, J CELL SCI, V120, P1189, DOI 10.1242/jcs.03417; Ryoo HD, 2010, CURR OPIN CELL BIOL, V22, P889, DOI 10.1016/j.ceb.2010.08.022; Salmen S, 2007, CLIN EXP IMMUNOL, V150, P539, DOI 10.1111/j.1365-2249.2007.03524.x; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; Sorrentino RP, 2004, GENETICS, V166, P1343, DOI 10.1534/genetics.166.3.1343; Tauszig S, 2000, P NATL ACAD SCI USA, V97, P10520, DOI 10.1073/pnas.180130797; Taylor K, 2007, FLY, V1, P197, DOI 10.4161/fly.5082; Toyama T, 2004, J HEPATOL, V41, P637, DOI 10.1016/j.jhep.2004.06.027; WERTMAN KF, 1992, GENETICS, V132, P337; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; Wright CW, 2005, VIROLOGY, V335, P61, DOI 10.1016/j.virol.2005.02.007; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zettervall CJ, 2004, P NATL ACAD SCI USA, V101, P14192, DOI 10.1073/pnas.0403789101; Zhang S, 2006, GENE DEV, V20, P1899, DOI 10.1101/gad.1426906	57	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e44567	10.1371/journal.pone.0044567	http://dx.doi.org/10.1371/journal.pone.0044567			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028562	Green Submitted, Green Published, gold			2022-12-27	WOS:000309973900013
J	Shill, J; Mavoa, H; Crammond, B; Loff, B; Peeters, A; Lawrence, M; Allender, S; Sacks, G; Swinburn, BA				Shill, Jane; Mavoa, Helen; Crammond, Brad; Loff, Bebe; Peeters, Anna; Lawrence, Mark; Allender, Steven; Sacks, Gary; Swinburn, Boyd A.			Regulation to Create Environments Conducive to Physical Activity: Understanding the Barriers and Facilitators at the Australian State Government Level	PLOS ONE			English	Article								Introduction: Policy and regulatory interventions aimed at creating environments more conducive to physical activity (PA) are an important component of strategies to improve population levels of PA. However, many potentially effective policies are not being broadly implemented. This study sought to identify potential policy/regulatory interventions targeting PA environments, and barriers/facilitators to their implementation at the Australian state/territory government level. Methods: In-depth interviews were conducted with senior representatives from state/territory governments, statutory authorities and non-government organisations (n = 40) to examine participants': 1) suggestions for regulatory interventions to create environments more conducive to PA; 2) support for preselected regulatory interventions derived from a literature review. Thematic and constant comparative analyses were conducted. Results: Policy interventions most commonly suggested by participants fell into two areas: 1) urban planning and provision of infrastructure to promote active travel; 2) discouraging the use of private motorised vehicles. Of the eleven preselected interventions presented to participants, interventions relating to walkability/cycling and PA facilities received greatest support. Interventions involving subsidisation (of public transport, PA-equipment) and the provision of more public transport infrastructure received least support. These were perceived as not economically viable or unlikely to increase PA levels. Dominant barriers were: the powerful 'road lobby', weaknesses in the planning system and the cost of potential interventions. Facilitators were: the provision of evidence, collaboration across sectors, and synergies with climate change/environment agendas. Conclusion: This study points to how difficult it will be to achieve policy change when there is a powerful 'road lobby' and government investment prioritises road infrastructure over PA-promoting infrastructure. It highlights the pivotal role of the planning and transport sectors in implementing PA-promoting policy, however suggests the need for clearer guidelines and responsibilities for state and local government levels in these areas. Health outcomes need to be given more direct consideration and greater priority within non-health sectors.	[Shill, Jane; Mavoa, Helen; Lawrence, Mark; Allender, Steven; Sacks, Gary; Swinburn, Boyd A.] Deakin Univ, World Hlth Org Collaborating Ctr Obes Prevent, Melbourne, Vic, Australia; [Allender, Steven] Univ Oxford, Dept Publ Hlth, Oxford, England; [Crammond, Brad; Loff, Bebe; Peeters, Anna] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia	Deakin University; World Health Organization; University of Oxford; Monash University	Mavoa, H (corresponding author), Deakin Univ, World Hlth Org Collaborating Ctr Obes Prevent, Melbourne, Vic, Australia.	helen.mavoa@deakin.edu.au	Sacks, Gary/I-5731-2014; Peeters, Anna/M-8284-2019; PEETERS, ANNA/B-3663-2013; Allender, Steven/G-9881-2011	Sacks, Gary/0000-0001-9736-1539; Peeters, Anna/0000-0003-4340-9132; PEETERS, ANNA/0000-0003-4340-9132; Lawrence, Mark/0000-0001-6899-3983; Allender, Steven/0000-0002-4842-3294	National Health and Medical Research Council Strategic Award [410507]	National Health and Medical Research Council Strategic Award	This study was funded by a National Health and Medical Research Council Strategic Award grant (ID 410507) http://www.nhmrc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allender S, 2011, HEALTH PROMOT INT, DOI [10.1093/heapro/dar1018, DOI 10.1093/HEAPRO/DAR1018]; Allender Steven, 2009, Aust New Zealand Health Policy, V6, P20, DOI 10.1186/1743-8462-6-20; ANAO and Department of the Prime Minister and Cabinet, 2006, IMPL PROGR POL IN MA, P13; Australian Bureau of Statistics, 2004, 4835 0 55 001 PHYS A; Australian Local Government Association, 2011, ED BUDG 2011 12 AN F; Bauman A.E., 2007, ENV CORRELATES PHYS; Boeije H, 2002, QUAL QUANT, V36, P391, DOI 10.1023/A:1020909529486; Buse K., 2005, MAKING HLTH POLICY; Davison KK, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-19; De Leeuw E., 1993, HEALTH PROMOT INT, V8, P49, DOI [DOI 10.1093/HEAPRO/8.1.49, 10.1093/heapro/8.1.49]; *DEP INFR, 2002, MELB 2030 PLANN SUST; Department of Infrastructure and Transport, 2011, NAT BUILD PROGR; Department of Innovation Industry Science and Research, 2011, 114 DEP INN IND SCI; Douglas MJ, 2011, J PUBLIC HEALTH-UK, V33, P160, DOI 10.1093/pubmed/fdr032; Government of South Australia, 2010, S AUSTR APPR HLTH AL; Grant JL, 2010, CAN J PUBLIC HEALTH, V101, P237, DOI 10.1007/BF03404381; Haines A, 2009, LANCET, V374, P2035, DOI 10.1016/S0140-6736(09)61667-6; Hillsdon M., 2005, EFFECTIVENESS PUBLIC; Kickbusch I, 2010, IMPLEMENTING HLTH AL; Landry R, 2001, RES POLICY, V30, P333, DOI 10.1016/S0048-7333(00)00081-0; Lawrence M, 2007, PUBLIC HLTH NUTR PRI, P450; Lawrence M, 2010, PREVENTING CHILDHOOD; Lewis J. M., 2005, HLTH POLICY POLITICS; Litman T., 2011, EVALUATING NONMOTORI; Milio N, 1987, Health Promot, V2, P263, DOI 10.1093/heapro/2.3.263; Millstone E, 2007, OBES REV, V8, P29, DOI 10.1111/j.1467-789X.2007.00356.x; Morabia Alfredo, 2009, Prev Med, V49, P275, DOI 10.1016/j.ypmed.2009.09.016; National Preventative Health Taskforce, 2010, TAK PREV ACT RESP AU; National Prevention Council, 2011, NAT PREV STRAT; Organization WH, 2009, GLOB HLTH RISKS MORT; Parliament of Australia, 2010, MULT SYST GOV AUSTR; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Port Phillip City Council, 2011, PORT PHILL PLANN SCH; Russell J, 2008, J HEALTH SERV RES PO, V13, P40, DOI 10.1258/jhsrp.2007.006029; Sabatier P. A., 1993, POLICY CHANGE LEARNI; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Shill J, 2012, OBES REV, V13, P162, DOI 10.1111/j.1467-789X.2011.00937.x; STOKOLS D, 1992, AM PSYCHOL, V47, P6, DOI 10.1037/0003-066X.47.1.6; van Sluijs EMF, 2007, BMJ-BRIT MED J, V335, P703, DOI 10.1136/bmj.39320.843947.BE; VCEC, 2006, MAK RIGHT CHOIC OPT; Victorian Government, 2008, VICT TRANSP PLAN; WEISS CH, 1979, PUBLIC ADMIN REV, V39, P426, DOI 10.2307/3109916; WHO, PREV INS PHYS ACT; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1; Yancey AK, 2009, PREV MED, V49, P277, DOI 10.1016/j.ypmed.2009.08.012	45	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e42831	10.1371/journal.pone.0042831	http://dx.doi.org/10.1371/journal.pone.0042831			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016KQ	23028434	Green Published, gold			2022-12-27	WOS:000309517500003
J	Dharmaratne, N; Glendining, KA; Young, TR; Tran, H; Sawatari, A; Leamey, CA				Dharmaratne, Nuwan; Glendining, Kelly A.; Young, Timothy R.; Tran, Heidi; Sawatari, Atomu; Leamey, Catherine A.			Ten-m3 Is Required for the Development of Topography in the Ipsilateral Retinocollicular Pathway	PLOS ONE			English	Article							UNCROSSED RETINAL PROJECTIONS; LATERAL GENICULATE-NUCLEUS; EPHRIN-AS; INTRACELLULAR DOMAIN; BRANCH EXTENSION; EXPRESSION; EYE; RETINOGENICULATE; PROTEINS; RECEPTOR	The alignment of ipsilaterally and contralaterally projecting retinal axons that view the same part of visual space is fundamental to binocular vision. While much progress has been made regarding the mechanisms which regulate contralateral topography, very little is known of the mechanisms which regulate the mapping of ipsilateral axons such that they align with their contralateral counterparts. Results: Using the advantageous model provided by the mouse retinocollicular pathway, we have performed anterograde tracing experiments which demonstrate that ipsilateral retinal axons begin to form terminal zones (TZs) in the superior colliculus (SC), within the first few postnatal days. These appear mature by postnatal day 11. Importantly, TZs formed by ipsilaterally-projecting retinal axons are spatially offset from those of contralaterally-projecting axons arising from the same retinotopic location from the outset. This pattern is consistent with that required for adult visuotopy. We further demonstrate that a member of the Ten-m/Odz/Teneurin family of homophilic transmembrane glycoproteins, Ten-m3, is an essential regulator of ipsilateral retinocollicular topography. Ten-m3 mRNA is expressed in a high-medial to low-lateral gradient in the developing SC. This corresponds topographically with its high-ventral to low-dorsal retinal gradient. In Ten-m3 knockout mice, contralateral ventrotemporal axons appropriately target rostromedial SC, whereas ipsilateral axons exhibit dramatic targeting errors along both the mediolateral and rostrocaudal axes of the SC, with a caudal shift of the primary TZ, as well as the formation of secondary, caudolaterally displaced TZs. In addition to these dramatic ipsilateral-specific mapping errors, both contralateral and ipsilateral retinocollicular TZs exhibit more subtle changes in morphology. Conclusions: We conclude that important aspects of adult visuotopy are established via the differential sensitivity of ipsilateral and contralateral axons to intrinsic guidance cues. Further, we show that Ten-m3 plays a critical role in this process and is particularly important for the mapping of the ipsilateral retinocollicular pathway.	[Leamey, Catherine A.] Univ Sydney, Sch Med Sci, Discipline Physiol, Sydney, NSW 2006, Australia; Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Leamey, CA (corresponding author), Univ Sydney, Sch Med Sci, Discipline Physiol, Sydney, NSW 2006, Australia.	cathy@physiol.usyd.edu.au		Young, Timothy Raymond/0000-0002-6568-4592; Leamey, Catherine/0000-0002-3390-4933	National Health and Medical Research Council (NHMRC) [632685]; University of Sydney	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney(University of Sydney)	This work was funded by National Health and Medical Research Council (NHMRC) project grant 632685 and University of Sydney research and development grants to CAL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagutti C, 2003, J CELL SCI, V116, P2957, DOI 10.1242/jcs.00603; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Cang JH, 2008, J NEUROSCI, V28, P11015, DOI 10.1523/JNEUROSCI.2478-08.2008; Culican SM, 2009, MOL CELL NEUROSCI, V41, P304, DOI 10.1016/j.mcn.2009.04.001; Dhande OS, 2011, J NEUROSCI, V31, P3384, DOI 10.1523/JNEUROSCI.4899-10.2011; DRAGER UC, 1975, J NEUROPHYSIOL, V38, P690, DOI 10.1152/jn.1975.38.3.690; DRAGER UC, 1980, J COMP NEUROL, V191, P383, DOI 10.1002/cne.901910306; Feldheim DA, 2004, J NEUROSCI, V24, P2542, DOI 10.1523/JNEUROSCI.0239-03.2004; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Feng K, 2002, J BIOL CHEM, V277, P26128, DOI 10.1074/jbc.M203722200; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Garcia-Frigola C, 2008, DEVELOPMENT, V135, P1833, DOI 10.1242/dev.020693; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Haustead DJ, 2008, J NEUROSCI, V28, P7376, DOI 10.1523/JNEUROSCI.1135-08.2008; Herrera E, 2003, CELL, V114, P545, DOI 10.1016/S0092-8674(03)00684-6; Hindges R, 2002, NEURON, V35, P475, DOI 10.1016/S0896-6273(02)00799-7; Hong WZ, 2012, NATURE, V484, P201, DOI 10.1038/nature10926; Kenzelmann D, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-30; LAVAIL JH, 1978, J COMP NEUROL, V182, P399, DOI 10.1002/cne.901820304; Leamey CA, 2007, PLOS BIOL, V5, P2077, DOI 10.1371/journal.pbio.0050241; Leamey CA, 2008, CEREB CORTEX, V18, P53, DOI 10.1093/cercor/bhm031; Leamey CA, 2009, CURR OPIN NEUROBIOL, V19, P181, DOI 10.1016/j.conb.2009.05.006; Lee R, 2008, J NEUROSCI, V28, P5910, DOI 10.1523/JNEUROSCI.0632-08.2008; Li H, 2006, MOL CELL NEUROSCI, V33, P136, DOI 10.1016/j.mcn.2006.06.012; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; McLaughlin T, 2003, DEVELOPMENT, V130, P2407, DOI 10.1242/dev.00467; Merlin S, 2012, CEREB CORTEX; Mosca TJ, 2012, NATURE, V484, P237, DOI 10.1038/nature10923; Nicol X, 2007, NAT NEUROSCI, V10, P340, DOI 10.1038/nn1842; Nunes SM, 2005, EXP CELL RES, V305, P122, DOI 10.1016/j.yexcr.2004.12.020; Oohashi T, 1999, J CELL BIOL, V145, P563, DOI 10.1083/jcb.145.3.563; Pequignot MO, 2003, DEV DYNAM, V228, P231, DOI 10.1002/dvdy.10376; Petros TJ, 2009, J NEUROSCI, V29, P3463, DOI 10.1523/JNEUROSCI.5655-08.2009; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; Pfeiffenberger C, 2006, J NEUROSCI, V26, P12873, DOI 10.1523/JNEUROSCI.3595-06.2006; Plas DT, 2008, J NEUROSCI, V28, P7057, DOI 10.1523/JNEUROSCI.3598-06.2008; Rashid T, 2005, NEURON, V47, P57, DOI 10.1016/j.neuron.2005.05.030; REESE BE, 1986, J COMP NEUROL, V250, P8, DOI 10.1002/cne.902500103; Rubin BP, 2002, DEVELOPMENT, V129, P4697; Schmitt AM, 2006, NATURE, V439, P31, DOI 10.1038/nature04334; SIMON DK, 1992, J NEUROSCI, V12, P1212; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Thakar S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1445; Triplett JW, 2009, CELL, V139, P175, DOI 10.1016/j.cell.2009.08.028; Tucker RP, 2012, MOL BIOL EVOL, V29, P1019, DOI 10.1093/molbev/msr271; Upton AL, 2002, NEUROSCIENCE, V111, P597, DOI 10.1016/S0306-4522(01)00602-9; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; Winters JJ, 2011, J NEUROSCI, V31, P17736, DOI 10.1523/JNEUROSCI.1482-11.2011; Wu HH, 2000, DEV BRAIN RES, V120, P105, DOI 10.1016/S0165-3806(99)00145-5; Wu HH, 2000, J COMP NEUROL, V426, P651, DOI 10.1002/1096-9861(20001030)426:4<651::AID-CNE11>3.0.CO;2-X; Young TR, 2009, INT J BIOCHEM CELL B, V41, P990, DOI 10.1016/j.biocel.2008.06.014; Zhang JY, 2012, NAT NEUROSCI, V15, P298, DOI 10.1038/nn.3007; Zheng LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022956; Zhou XH, 2003, GENE EXPR PATTERNS, V3, P397, DOI 10.1016/S1567-133X(03)00087-5	55	37	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e43083	10.1371/journal.pone.0043083	http://dx.doi.org/10.1371/journal.pone.0043083			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028443	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388400005
J	Philipp, EER; Wessels, W; Gruber, H; Strahl, J; Wagner, AE; Ernst, IMA; Rimbach, G; Kraemer, L; Schreiber, S; Abele, D; Rosenstiel, P				Philipp, Eva E. R.; Wessels, Wiebke; Gruber, Heike; Strahl, Julia; Wagner, Anika E.; Ernst, Insa M. A.; Rimbach, Gerald; Kraemer, Lars; Schreiber, Stefan; Abele, Doris; Rosenstiel, Philip			Gene Expression and Physiological Changes of Different Populations of the Long-Lived Bivalve Arctica islandica under Low Oxygen Conditions	PLOS ONE			English	Article							HYPOXIA TOLERANCE; PROLONGED ANOXIA; BALTIC SEA; KIEL BAY; LIFE; TEMPERATURE; DEPRESSION; ADAPTATION; STRESS; PHOSPHOFRUCTOKINASE	The bivalve Arctica islandica is extremely long lived (>400 years) and can tolerate long periods of hypoxia and anoxia. European populations differ in maximum life spans (MLSP) from 40 years in the Baltic to >400 years around Iceland. Characteristic behavior of A. islandica involves phases of metabolic rate depression (MRD) during which the animals burry into the sediment for several days. During these phases the shell water oxygen concentrations reaches hypoxic to anoxic levels, which possibly support the long life span of some populations. We investigated gene regulation in A. islandica from a long-lived (MLSP 150 years) German Bight population and the short-lived Baltic Sea population, experimentally exposed to different oxygen levels. A new A. islandica transcriptome enabled the identification of genes important during hypoxia/anoxia events and, more generally, gene mining for putative stress response and (anti-) aging genes. Expression changes of a) antioxidant defense: Catalase, Glutathione peroxidase, manganese and copper-zinc Superoxide dismutase; b) oxygen sensing and general stress response: Hypoxia inducible factor alpha, Prolyl hydroxylase and Heat-shock protein 70; and c) anaerobic capacity: Malate dehydrogenase and Octopine dehydrogenase, related transcripts were investigated. Exposed to low oxygen, German Bight individuals suppressed transcription of all investigated genes, whereas Baltic Sea bivalves enhanced gene transcription under anoxic incubation (0 kPa) and, further, decreased these transcription levels again during 6 h of re-oxygenation. Hypoxic and anoxic exposure and subsequent re-oxygenation in Baltic Sea animals did not lead to increased protein oxidation or induction of apoptosis, emphasizing considerable hypoxia/re-oxygenation tolerance in this species. The data suggest that the energy saving effect of MRD may not be an attribute of Baltic Sea A. islandica chronically exposed to high environmental variability (oxygenation, temperature, salinity). Contrary, higher physiological flexibility and stress hardening may predispose these animals to perform a pronounced stress response at the expense of life span.	[Philipp, Eva E. R.; Wessels, Wiebke; Gruber, Heike; Kraemer, Lars; Schreiber, Stefan; Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Strahl, Julia; Abele, Doris] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany; [Wagner, Anika E.; Ernst, Insa M. A.; Rimbach, Gerald] Univ Kiel, Inst Human Nutr & Foodsci, Kiel, Germany	University of Kiel; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Kiel	Philipp, EER (corresponding author), Univ Kiel, Inst Clin Mol Biol, Kiel, Germany.	e.philipp@ikmb.uni-kiel.de; p.rosenstiel@mucosa.de	Rimbach, Gerald/A-7178-2011; Wagner, Anika/AAE-3579-2019; Rosenstiel, Philip/A-5137-2009; Kraemer, Lars/B-9289-2017	Rimbach, Gerald/0000-0001-7888-4684; Wagner, Anika/0000-0003-3047-7128; Rosenstiel, Philip/0000-0002-9692-8828; Kraemer, Lars/0000-0002-0586-8357; Abele, Doris/0000-0002-5766-5017	Medical Faculty Kiel; DFG clusters of Excellence "The Future Ocean" and "Inflammation at Interfaces"; German Research Foundation (DFG) priority programme "Host-parasite co-evolution", Genomics Analysis platform [1399]	Medical Faculty Kiel; DFG clusters of Excellence "The Future Ocean" and "Inflammation at Interfaces"; German Research Foundation (DFG) priority programme "Host-parasite co-evolution", Genomics Analysis platform(German Research Foundation (DFG))	This research was supported by the Medical Faculty Kiel, the DFG clusters of Excellence "The Future Ocean" and "Inflammation at Interfaces", and the German Research Foundation (DFG) priority programme 1399 "Host-parasite co-evolution", Genomics Analysis platform. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele D, 2002, NATURE, V420, P27, DOI 10.1038/420027a; Abele D, 2011, TEMPERATURE ADAPTATI, P67; Abele D, 2008, FREE RADICAL RES, V42, P474, DOI 10.1080/10715760802108849; Abele D, 2007, FRONT BIOSCI-LANDMRK, V12, P933, DOI 10.2741/2115; Abele D, 2010, CAN J FISH AQUAT SCI, V67, P977, DOI 10.1139/F10-035; Altieri AH, 2006, MAR ECOL PROG SER, V325, P295, DOI 10.3354/meps325295; [Anonymous], 2008, AQUACULTURE, DOI DOI 10.1016/j.aquaculture.2008.03.041; Basova L, 2012, AQUAT BIOL, V14, P141, DOI 10.3354/ab00387; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Buttemer WA, 2010, FUNCTIONAL ECOLOGY, V9999; David E, 2005, FEBS J, V272, P5635, DOI 10.1111/j.1742-4658.2005.04960.x; FELBECK H, 1980, COMP BIOCHEM PHYS B, V66, P205, DOI 10.1016/0305-0491(80)90054-1; Gorr TA, 2010, PHYSIOL BIOCHEM ZOOL, V83, P733, DOI 10.1086/648581; Gracey AY, 2008, CURR BIOL, V18, P1501, DOI 10.1016/j.cub.2008.08.049; Greenway SC, 1999, J EXP MAR BIOL ECOL, V242, P259, DOI 10.1016/S0022-0981(99)00103-3; Greenway SC, 2000, J COMP PHYSIOL B, V170, P285, DOI 10.1007/s003600000098; Hermes-Lima M, 1998, COMP BIOCHEM PHYS B, V120, P437, DOI 10.1016/S0305-0491(98)10053-6; Hermes-Lima M, 2002, COMP BIOCHEM PHYS C, V133, P537, DOI 10.1016/S1532-0456(02)00080-7; Hicks DW, 2005, J MOLLUS STUD, V71, P401, DOI 10.1093/mollus/eyi042; Hiebenthal C, 2012, AQUAT BIOL, V14, P289, DOI 10.3354/ab00405; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Ivanina AV, 2010, AQUAT TOXICOL, V99, P330, DOI 10.1016/j.aquatox.2010.05.013; JOHANSSON LH, 1988, ANAL BIOCHEM, V174, P331, DOI 10.1016/0003-2697(88)90554-4; Kawabe S, 2012, MAR BIOTECHNOL, V14, P106, DOI 10.1007/s10126-011-9394-3; Krivoruchko A, 2010, OXID MED CELL LONGEV, V3, P186, DOI 10.4161/oxim.3.3.12356; Larade K, 2002, CELL MOL RESPONSES S; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Levraut J, 2003, AM J PHYSIOL-HEART C, V284, pH549, DOI 10.1152/ajpheart.00708.2002; Mangel M, 2008, FUNCT ECOL, V22, P422, DOI 10.1111/j.1365-2435.2008.01410.x; Morley SA, 2007, OECOLOGIA, V153, P29, DOI 10.1007/s00442-007-0720-4; OESCHGER R, 1990, MAR ECOL PROG SER, V59, P133, DOI 10.3354/meps059133; Philipp EER, 2012, BIOINFORMATICS; Philipp EER, 2010, GERONTOLOGY, V56, P55, DOI 10.1159/000221004; Piontkivska H, 2010, COMP BIOCH PHYSL D; PORTNER HO, 1984, MAR BIOL, V79, P237, DOI 10.1007/BF00393255; Ramnanan CJ, 2009, MOL CELL BIOCHEM, V323, P9, DOI 10.1007/s11010-008-9959-2; Rattan SIS, 2008, AGEING RES REV, V7, P63, DOI 10.1016/j.arr.2007.03.002; REGNOUF F, 1970, COMP BIOCHEM PHYSIOL, V32, P411, DOI 10.1016/0010-406X(70)90458-5; Rimoldi S, 2012, MOL BIOL REP, V39, P4009, DOI 10.1007/s11033-011-1181-8; Rissanen E, 2006, J EXP BIOL, V209, P994, DOI 10.1242/jeb.02103; Rozen S, 2000, Methods Mol Biol, V132, P365; Rumohr H, 2001, DIFFERENT FACES ANOX, P273; Rytkonen KT, 2011, MOL BIOL EVOL, V28, P1913, DOI 10.1093/molbev/msr012; Schone BR, 2005, PALAEOGEOGR PALAEOCL, V228, P130, DOI 10.1016/j.palaeo.2005.03.049; Shams I, 2004, P NATL ACAD SCI USA, V101, P9698, DOI 10.1073/pnas.0403540101; Soitamo AJ, 2001, J BIOL CHEM, V276, P19699, DOI 10.1074/jbc.M009057200; Sonanez-Organis JG, 2009, COMP BIOCHEM PHYS C, V150, P395, DOI 10.1016/j.cbpc.2009.06.005; Storey KR, 2010, TOP CURR GENET, V21, P227, DOI 10.1007/978-3-642-12422-8_13; Strahl J, 2007, AQUAT BIOL, V1, P77, DOI 10.3354/ab00008; Strahl J, 2011, J EXP BIOL, V214, P4223, DOI 10.1242/jeb.055178; Strahl J, 2011, COMP BIOCHEM PHYS A, V158, P513, DOI 10.1016/j.cbpa.2010.12.015; Strahl J, 2010, MAR BIOL, V157, P1283, DOI 10.1007/s00227-010-1408-6; TAYLOR AC, 1976, J MAR BIOL ASSOC UK, V56, P95, DOI 10.1017/S0025315400020464; THEEDE H, 1969, MAR BIOL, V2, P325, DOI 10.1007/BF00355712; Tschischka K, 2000, J EXP BIOL, V203, P3355; Turbill C, 2011, P ROY SOC B-BIOL SCI, V278, P3355, DOI 10.1098/rspb.2011.0190; Van Breukelen F, 2000, J EXP BIOL, V203, P1123; VANDEPUTTE C, 1994, CELL BIOL TOXICOL, V10, P415, DOI 10.1007/BF00755791; Vogt M, 2001, J APPL PHYSIOL, V91, P173, DOI 10.1152/jappl.2001.91.1.173; Wanamaker AD, 2008, RADIOCARBON, V50, P399, DOI 10.1017/S0033822200053510; WEIGELT M, 1986, MEERESFORSCHUNG, V31, P124; WEIGELT M, 1990, MEERESFORSCHUNG, V33, P1; WITBAARD R, 1994, NETH J SEA RES, V33, P91, DOI 10.1016/0077-7579(94)90054-X; ZAMMIT VA, 1976, BIOCHEM J, V160, P447, DOI 10.1042/bj1600447; Ziuganov V V, 2004, Adv Gerontol, V14, P21	65	38	38	6	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44621	10.1371/journal.pone.0044621	http://dx.doi.org/10.1371/journal.pone.0044621			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028566	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388400029
J	Varlet, M; Marin, L; Issartel, J; Schmidt, RC; Bardy, BG				Varlet, Manuel; Marin, Ludovic; Issartel, Johann; Schmidt, R. C.; Bardy, Benoit G.			Continuity of Visual and Auditory Rhythms Influences Sensorimotor Coordination	PLOS ONE			English	Article							MOTOR TRACKING; SYNCHRONIZATION; MOVEMENT; DYNAMICS; INFORMATION; TRANSITIONS; SEQUENCES; RESPONSES; VELOCITY; FEEDBACK	People often coordinate their movement with visual and auditory environmental rhythms. Previous research showed better performances when coordinating with auditory compared to visual stimuli, and with bimodal compared to unimodal stimuli. However, these results have been demonstrated with discrete rhythms and it is possible that such effects depend on the continuity of the stimulus rhythms (i.e., whether they are discrete or continuous). The aim of the current study was to investigate the influence of the continuity of visual and auditory rhythms on sensorimotor coordination. We examined the dynamics of synchronized oscillations of a wrist pendulum with auditory and visual rhythms at different frequencies, which were either unimodal or bimodal and discrete or continuous. Specifically, the stimuli used were a light flash, a fading light, a short tone and a frequency-modulated tone. The results demonstrate that the continuity of the stimulus rhythms strongly influences visual and auditory motor coordination. Participants' movement led continuous stimuli and followed discrete stimuli. Asymmetries between the half-cycles of the movement in term of duration and nonlinearity of the trajectory occurred with slower discrete rhythms. Furthermore, the results show that the differences of performance between visual and auditory modalities depend on the continuity of the stimulus rhythms as indicated by movements closer to the instructed coordination for the auditory modality when coordinating with discrete stimuli. The results also indicate that visual and auditory rhythms are integrated together in order to better coordinate irrespective of their continuity, as indicated by less variable coordination closer to the instructed pattern. Generally, the findings have important implications for understanding how we coordinate our movements with visual and auditory environmental rhythms in everyday life.	[Varlet, Manuel; Marin, Ludovic; Bardy, Benoit G.] Univ Montpellier I, EuroMov, Montpellier, France; [Issartel, Johann] Dublin City Univ, Dublin 9, Ireland; [Schmidt, R. C.] Coll Holy Cross, Dept Psychol, Worcester, MA 01610 USA	Universite de Montpellier; Dublin City University; College of the Holy Cross	Varlet, M (corresponding author), Univ Montpellier I, EuroMov, Montpellier, France.	manuel.varlet@gmail.com	Bardy, Benoît/AAU-3078-2021	Bardy, Benoit/0000-0001-9272-1734; Varlet, Manuel/0000-0001-5772-2061; Marin, Ludovic/0000-0002-9040-8012	SKILLS, an Integrated Project (FP6-IST) of the Commission of the European Community [035005]; Agence Nationale de la Recherche [ANR-09-BLAN-0405-01]	SKILLS, an Integrated Project (FP6-IST) of the Commission of the European Community; Agence Nationale de la Recherche(French National Research Agency (ANR))	This research was supported by SKILLS, an Integrated Project (FP6-IST contract #035005) of the Commission of the European Community and by an Agence Nationale de la Recherche grant (Project SCAD # ANR-09-BLAN-0405-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assisi CG, 2005, BIOL CYBERN, V93, P6, DOI 10.1007/s00422-005-0558-y; Balasubramaniam R, 2004, EXP BRAIN RES, V159, P129, DOI 10.1007/s00221-004-2066-z; Bald L, 1942, J APPL PSYCHOL, V26, P382, DOI 10.1037/h0059216; Batschelet E, 1981, CIRCULAR STAT BIOL; BEEK PJ, 1988, HUM MOVEMENT SCI, V7, P301, DOI 10.1016/0167-9457(88)90015-2; Buekers MJ, 2000, NEUROSCI LETT, V290, P181, DOI 10.1016/S0304-3940(00)01350-1; Bushara KO, 2001, J NEUROSCI, V21, P300, DOI 10.1523/JNEUROSCI.21-01-00300.2001; BYBLOW WD, 1995, J MOTOR BEHAV, V27, P123, DOI 10.1080/00222895.1995.9941705; Chen YQ, 2002, HUM MOVEMENT SCI, V21, P515, DOI 10.1016/S0167-9457(02)00138-0; de Rugy A, 2008, EXP BRAIN RES, V184, P269, DOI 10.1007/s00221-007-1180-0; Elliott MT, 2010, EUR J NEUROSCI, V31, P1828, DOI 10.1111/j.1460-9568.2010.07205.x; Fendrich R, 2001, PERCEPT PSYCHOPHYS, V63, P719, DOI 10.3758/BF03194432; Fink PW, 2000, EXP BRAIN RES, V134, P9, DOI 10.1007/s002210000439; Hove MJ, 2010, J EXP PSYCHOL HUMAN, V36, P1525, DOI 10.1037/a0019059; Huys R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000061; Kelso J, 1984, AM J PHYSIOL-REG I, V15, pR1000, DOI DOI 10.1152/ajpregu.1984.246.6.R1000; Kelso JAS, 2001, P ROY SOC B-BIOL SCI, V268, P1207; Kilner J, 2007, SOC NEUROSCI-UK, V2, P158, DOI 10.1080/17470910701428190; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; KOLERS PA, 1985, J EXP PSYCHOL HUMAN, V11, P150, DOI 10.1037/0096-1523.11.2.150; Lagarde J, 2006, EXP BRAIN RES, V173, P673, DOI 10.1007/s00221-006-0410-1; McAnally KI, 2002, ACTA PSYCHOL, V109, P331, DOI 10.1016/S0001-6918(01)00065-8; Mottet D, 1999, BIOL CYBERN, V80, P235, DOI 10.1007/s004220050521; MYERS AK, 1981, PERCEPT PSYCHOPHYS, V30, P33, DOI 10.3758/BF03206134; Peper CLE, 1998, BIOL CYBERN, V79, P291, DOI 10.1007/s004220050479; RADEAU M, 1987, PSYCHOL RES-PSYCH FO, V49, P17, DOI 10.1007/BF00309198; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2004, PSYCHOL RES-PSYCH FO, V68, P252, DOI 10.1007/s00426-003-0143-8; Repp BH, 2003, J MOTOR BEHAV, V35, P355, DOI 10.1080/00222890309603156; Repp BH, 2002, J EXP PSYCHOL HUMAN, V28, P1085, DOI 10.1037//0096-1523.28.5.1085; Repp BH, 2007, MUSIC PERCEPT, V24, P367, DOI 10.1525/MP.2007.24.4.367; Robertson SD, 1999, J EXP PSYCHOL HUMAN, V25, P1316, DOI 10.1037/0096-1523.25.5.1316; Roerdink M, 2005, HUM MOVEMENT SCI, V24, P379, DOI 10.1016/j.humov.2005.06.007; Roerdink M, 2008, EXP BRAIN RES, V184, P143, DOI 10.1007/s00221-007-1085-y; Schmidt RC, 2007, J EXP PSYCHOL HUMAN, V33, P860, DOI 10.1037/0096-1523.33.4.860; Spencer RMC, 2005, BRAIN COGNITION, V58, P84, DOI 10.1016/j.bandc.2004.09.010; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Stephen DG, 2008, PHYSICA A, V387, P5271, DOI 10.1016/j.physa.2008.05.015; Torre K, 2008, ACTA PSYCHOL, V129, P284, DOI 10.1016/j.actpsy.2008.08.003; Torre K, 2010, MOTOR CONTROL, V14, P323, DOI 10.1123/mcj.14.3.323; Torre K, 2009, EXP BRAIN RES, V199, P157, DOI 10.1007/s00221-009-1991-2; Varlet M, HUM MOV SCI IN PRESS; WARREN DH, 1981, PERCEPT PSYCHOPHYS, V30, P557, DOI 10.3758/BF03202010; WIMMERS RH, 1992, HUM MOVEMENT SCI, V11, P217, DOI 10.1016/0167-9457(92)90062-G; Wing AM, 2010, EXP BRAIN RES, V200, P277, DOI 10.1007/s00221-009-2134-5; WING AM, 1973, PERCEPT PSYCHOPHYS, V13, P455, DOI 10.3758/BF03205802; WING AM, 1973, PERCEPT PSYCHOPHYS, V14, P5, DOI 10.3758/BF03198607; Zelaznik HN, 2002, J EXP PSYCHOL HUMAN, V28, P575, DOI 10.1037//0096-1523.28.3.575	48	53	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44082	10.1371/journal.pone.0044082	http://dx.doi.org/10.1371/journal.pone.0044082			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014PP	23028488	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388400017
J	Yamauchi, M; Yamaguchi, R; Nakata, A; Kohno, T; Nagasaki, M; Shimamura, T; Imoto, S; Saito, A; Ueno, K; Hatanaka, Y; Yoshida, R; Higuchi, T; Nomura, M; Beer, DG; Yokota, J; Miyano, S; Gotoh, N				Yamauchi, Mai; Yamaguchi, Rui; Nakata, Asuka; Kohno, Takashi; Nagasaki, Masao; Shimamura, Teppei; Imoto, Seiya; Saito, Ayumu; Ueno, Kazuko; Hatanaka, Yousuke; Yoshida, Ryo; Higuchi, Tomoyuki; Nomura, Masaharu; Beer, David G.; Yokota, Jun; Miyano, Satoru; Gotoh, Noriko			Epidermal Growth Factor Receptor Tyrosine Kinase Defines Critical Prognostic Genes of Stage I Lung Adenocarcinoma	PLOS ONE			English	Article							SIGNATURES; INHIBITORS	Purpose: To identify stage I lung adenocarcinoma patients with a poor prognosis who will benefit from adjuvant therapy. Patients and Methods: Whole gene expression profiles were obtained at 19 time points over a 48-hour time course from human primary lung epithelial cells that were stimulated with epidermal growth factor (EGF) in the presence or absence of a clinically used EGF receptor tyrosine kinase (RTK)-specific inhibitor, gefitinib. The data were subjected to a mathematical simulation using the State Space Model (SSM). "Gefitinib-sensitive" genes, the expressional dynamics of which were altered by addition of gefitinib, were identified. A risk scoring model was constructed to classify high- or low-risk patients based on expression signatures of 139 gefitinib-sensitive genes in lung cancer using a training data set of 253 lung adenocarcinomas of North American cohort. The predictive ability of the risk scoring model was examined in independent cohorts of surgical specimens of lung cancer. Results: The risk scoring model enabled the identification of high-risk stage IA and IB cases in another North American cohort for overall survival (OS) with a hazard ratio (HR) of 7.16 (P = 0.029) and 3.26 (P = 0.0072), respectively. It also enabled the identification of high-risk stage I cases without bronchioalveolar carcinoma (BAC) histology in a Japanese cohort for OS and recurrence-free survival (RFS) with HRs of 8.79 (P = 0.001) and 3.72 (P = 0.0049), respectively. Conclusion: The set of 139 gefitinib-sensitive genes includes many genes known to be involved in biological aspects of cancer phenotypes, but not known to be involved in EGF signaling. The present result strongly re-emphasizes that EGF signaling status in cancer cells underlies an aggressive phenotype of cancer cells, which is useful for the selection of early-stage lung adenocarcinoma patients with a poor prognosis.	[Yamauchi, Mai; Nakata, Asuka; Gotoh, Noriko] Univ Tokyo, Inst Med Sci, Div Syst Biomed Technol, Minato Ku, Tokyo, Japan; [Yamaguchi, Rui; Nagasaki, Masao; Shimamura, Teppei; Imoto, Seiya; Saito, Ayumu; Ueno, Kazuko; Hatanaka, Yousuke; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Minato Ku, Tokyo, Japan; [Kohno, Takashi] Natl Canc Ctr, Res Inst, Div Genome Biol, Chuo Ku, Tokyo 104, Japan; [Yoshida, Ryo; Higuchi, Tomoyuki] Inst Stat Math, Tachikawa, Tokyo, Japan; [Nomura, Masaharu] Tokyo Med Univ, Dept Thorac Surg, Shinjuku Ku, Tokyo, Japan; [Beer, David G.] Univ Michigan, Dept Surg, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Yokota, Jun] Natl Canc Ctr, Res Inst, Div Multistep Carcinogenesis, Chuo Ku, Tokyo 104, Japan	University of Tokyo; University of Tokyo; National Cancer Center - Japan; Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan; Tokyo Medical University; University of Michigan System; University of Michigan; National Cancer Center - Japan	Gotoh, N (corresponding author), Univ Tokyo, Inst Med Sci, Div Syst Biomed Technol, Minato Ku, Tokyo, Japan.	ngotoh@ims.u-tokyo.ac.jp	GOTOH, Noriko/D-8430-2015	Miyano, Satoru/0000-0002-1753-6616; Nagasaki, Masao/0000-0002-4292-8785; Gotoh, Noriko/0000-0003-3733-260X; Shimamura, Teppei/0000-0003-2994-872X	Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science & Technology (MEXT) of Japan [22130009]; Research and Development of the Next-Generation Integrated Simulation of Living Matter, a part of the Development and Use of the Next-Generation Supercomputer Project of MEXT of Japan; National Cancer Center Research and Development Fund	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science & Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research and Development of the Next-Generation Integrated Simulation of Living Matter, a part of the Development and Use of the Next-Generation Supercomputer Project of MEXT of Japan; National Cancer Center Research and Development Fund(National Cancer Center - Japan)	This work was supported by a grant for the 3rd-term Comprehensive 10-year Strategy for Cancer Control from the Ministry of Health, Labor and Welfare of Japan (http://www.mhlw.go.jp/english/) to JY, TK, and NG, by Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science & Technology (MEXT) of Japan (http://www.mext.go.jp/english/) to NG (22130009), by Research and Development of the Next-Generation Integrated Simulation of Living Matter, a part of the Development and Use of the Next-Generation Supercomputer Project of MEXT of Japan (http://www.mext.go.jp/english/) to SM, and by the National Cancer Center Research and Development Fund to TK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Asamura H, 2008, J THORAC ONCOL, V3, P46, DOI 10.1097/JTO.0b013e31815e8577; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bose D, 2010, LANCET ONCOL, V11, P373, DOI 10.1016/S1470-2045(09)70341-9; Chansky K, 2009, J THORAC ONCOL, V4, P792, DOI 10.1097/JTO.0b013e3181a7716e; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kadara H, 2011, CLIN CANCER RES, V17, P1490, DOI 10.1158/1078-0432.CCR-10-2703; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li HZ, 2004, BIOINFORMATICS, V20, P208, DOI 10.1093/bioinformatics/bth900; Liang Yulan, 2006, Functional & Integrative Genomics, V6, P1, DOI 10.1007/s10142-005-0006-z; Okayama H, 2012, CANCER RES IN PRESS; Roepman P, 2009, CLIN CANCER RES, V15, P284, DOI 10.1158/1078-0432.CCR-08-1258; Shawver LK, 2002, CANCER CELL, V1, P117, DOI 10.1016/S1535-6108(02)00039-9; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Sotiriou C, 2007, NAT REV CANCER, V7, P545, DOI 10.1038/nrc2173; Subramanian J, 2010, JNCI-J NATL CANCER I, V102, P464, DOI 10.1093/jnci/djq025; Tomida S, 2009, J CLIN ONCOL, V27, P2793, DOI 10.1200/JCO.2008.19.7053; Wan YW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012222; Witsch E, 2010, PHYSIOLOGY, V25, P85, DOI 10.1152/physiol.00045.2009; Yamaguchi R, 2008, GENOME INFORM SER, V21, P101; Yamauchi M, 2009, BIOMARK MED, V3, P139, DOI 10.2217/BMM.09.9; Zhu CQ, 2010, J CLIN ONCOL, V28, P4417, DOI 10.1200/JCO.2009.26.4325	23	104	105	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e43923	10.1371/journal.pone.0043923	http://dx.doi.org/10.1371/journal.pone.0043923			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028479	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400015
J	De Ingeniis, J; Ratnikov, B; Richardson, AD; Scott, DA; Aza-Blanc, P; De, SK; Kazanov, M; Pellecchia, M; Ronai, Z; Osterman, AL; Smith, JW				De Ingeniis, Jessica; Ratnikov, Boris; Richardson, Adam D.; Scott, David A.; Aza-Blanc, Pedro; De, Surya K.; Kazanov, Marat; Pellecchia, Maurizio; Ronai, Ze'ev; Osterman, Andrei L.; Smith, Jeffrey W.			Functional Specialization in Proline Biosynthesis of Melanoma	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; BREAST-CANCER; OXIDASE; APOPTOSIS; METABOLISM; PYRROLINE-5-CARBOXYLATE; OVEREXPRESSION; STIMULATION; EXPRESSION; GENERATION	Proline metabolism is linked to hyperprolinemia, schizophrenia, cutis laxa, and cancer. In the latter case, tumor cells tend to rely on proline biosynthesis rather than salvage. Proline is synthesized from either glutamate or ornithine; both are converted to pyrroline-5-carboxylate (P5C), and then to proline via pyrroline-5-carboxylate reductases (PYCRs). Here, the role of three isozymic versions of PYCR was addressed in human melanoma cells by tracking the fate of C-13-labeled precursors. Based on these studies we conclude that PYCR1 and PYCR2, which are localized in the mitochondria, are primarily involved in conversion of glutamate to proline. PYCRL, localized in the cytosol, is exclusively linked to the conversion of ornithine to proline. This analysis provides the first clarification of the role of PYCRs to proline biosynthesis.	[De Ingeniis, Jessica; Ratnikov, Boris; Richardson, Adam D.; Scott, David A.; Aza-Blanc, Pedro; De, Surya K.; Kazanov, Marat; Pellecchia, Maurizio; Ronai, Ze'ev; Osterman, Andrei L.; Smith, Jeffrey W.] Sanford Burnham Med Res Inst, La Jolla, CA USA	Sanford Burnham Prebys Medical Discovery Institute	De Ingeniis, J (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA USA.	jsmith@sanfordburnham.org	Richardson, Adam D/N-7845-2014; Pellecchia, Maurizio/Y-7072-2018; Kazanov, Marat D/D-6381-2013	Richardson, Adam D/0000-0003-3646-2584; Kazanov, Marat D/0000-0002-2314-5507; RONAI, ZEEV/0000-0002-3859-0400; De, SURYA/0000-0001-5014-0798; Scott, David/0000-0002-8668-2449	National Institutes of Health [PO1CA128814]; NATIONAL CANCER INSTITUTE [P01CA128814] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health PO1CA128814 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOER P, 1991, BIOCHEM MED METAB B, V46, P28, DOI 10.1016/0885-4505(91)90047-O; Bunk B, 2006, BIOINFORMATICS, V22, P2962, DOI 10.1093/bioinformatics/btl526; Donald SP, 2001, CANCER RES, V61, P1810; Ernst T, 2002, AM J PATHOL, V160, P2169, DOI 10.1016/S0002-9440(10)61165-0; Gerratana B, 2003, BIOCHEMISTRY-US, V42, P7836, DOI 10.1021/bi034361d; Hu CAA, 2007, MOL CELL BIOCHEM, V295, P85, DOI 10.1007/s11010-006-9276-6; Knowles LM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-168; Krasilnikov M, 2003, ONCOGENE, V22, P4092, DOI 10.1038/sj.onc.1206598; Kretz R, 2011, J INHERIT METAB DIS, V34, P731, DOI 10.1007/s10545-011-9319-3; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Liu W, 2012, P NATL ACAD SCI USA, V109, P8983, DOI 10.1073/pnas.1203244109; Liu Y, 2006, ONCOGENE, V25, P5640, DOI 10.1038/sj.onc.1209564; Liu YM, 2009, CANCER RES, V69, P6414, DOI 10.1158/0008-5472.CAN-09-1223; Maxwell SA, 2003, J BIOL CHEM, V278, P9784, DOI 10.1074/jbc.M210012200; Meng ZH, 2006, J MOL BIOL, V359, P1364, DOI 10.1016/j.jmb.2006.04.053; MIXSON AJ, 1988, J BIOL CHEM, V263, P10720; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Nanchen Annik, 2007, V358, P177, DOI 10.1007/978-1-59745-244-1_11; Nocek B, 2005, J MOL BIOL, V354, P91, DOI 10.1016/j.jmb.2005.08.036; Portnoy VA, 2010, APPL ENVIRON MICROB, V76, P6529, DOI 10.1128/AEM.01178-10; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Reversade B, 2009, NAT GENET, V41, P1016, DOI 10.1038/ng.413; Richardson AD, 2008, BREAST CANCER RES TR, V110, P297, DOI 10.1007/s10549-007-9732-3; Sander V, 2007, EMBO J, V26, P2955, DOI 10.1038/sj.emboj.7601705; Satyamoorthy K, 2003, CANCER RES, V63, P756; Scott DA, 2011, J BIOL CHEM; Shah M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001258; Smalley KSM, 2008, CANCER RES, V68, P5743, DOI 10.1158/0008-5472.CAN-08-0235; Tian J, 2010, AM J HUM GENET, V87, P768, DOI 10.1016/j.ajhg.2010.11.005; van Winden WA, 2002, BIOTECHNOL BIOENG, V80, P477, DOI 10.1002/bit.10393; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; WILLIAMS I, 1975, ANAL BIOCHEM, V64, P85, DOI 10.1016/0003-2697(75)90408-X	32	87	88	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45190	10.1371/journal.pone.0045190	http://dx.doi.org/10.1371/journal.pone.0045190			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024808	Green Published, gold, Green Submitted			2022-12-27	WOS:000308860100066
J	Fuentes, EN; Ruiz, P; Valdes, JA; Molina, A				Fuentes, Eduardo N.; Ruiz, Pamela; Antonio Valdes, Juan; Molina, Alfredo			Catabolic Signaling Pathways, Atrogenes, and Ubiquitinated Proteins Are Regulated by the Nutritional Status in the Muscle of the Fine Flounder	PLOS ONE			English	Article							GROWTH-FACTOR-I; SKELETAL-MUSCLE; GENE-EXPRESSION; LIGASE ATROGIN1/MAFBX; PROTEASOME PATHWAY; ATROPHY; PROTEOLYSIS; ATROGIN-1; INSULIN; TARGET	A description of the intracellular mechanisms that modulate skeletal muscle atrophy in early vertebrates is still lacking. In this context, we used the fine flounder, a unique and intriguing fish model, which exhibits remarkably slow growth due to low production of muscle-derived IGF-I, a key growth factor that has been widely acknowledged to prevent and revert muscle atrophy. Key components of the atrophy system were examined in this species using a detailed time-course of sampling points, including two contrasting nutritional periods. Under basal conditions high amounts of the atrogenes MuRF-1 and Atrogin-1 were observed. During fasting, the activation of the P38/MAPK and Akt/FoxO signaling pathways decreased; whereas, the activation of the I kappa B alpha/NF kappa B pathway increased. These changes in signal transduction activation were concomitant with a strong increase in MuRF-1, Atrogin-1, and protein ubiquitination. During short-term refeeding, the P38/MAPK and Akt/FoxO signaling pathways were strongly activated, whereas the activation of the I kappa B alpha/NF kappa B pathway decreased significantly. The expression of both atrogenes, as well as the ubiquitination of proteins, dropped significantly during the first hour of refeeding, indicating a strong anti-atrophic condition during the onset of refeeding. During long-term refeeding, Akt remained activated at higher than basal levels until the end of refeeding, and Atrogin-1 expression remained significantly lower during this period. This study shows that the components of the atrophy system in skeletal muscle appeared early in the evolution of vertebrates and some mechanisms have been conserved, whereas others have not. These results represent an important achievement for the area of fish muscle physiology, showing an integrative view of the atrophy system in a non-mammalian species and contributing to novel insights on the molecular basis of muscle growth regulation in earlier vertebrates.	[Fuentes, Eduardo N.; Ruiz, Pamela; Antonio Valdes, Juan; Molina, Alfredo] Univ Andres Bello, Fac Biol, Dept Ciencias Biol, Lab Biotecnol Mol, Santiago, Chile	Universidad Andres Bello	Fuentes, EN (corresponding author), Univ Andres Bello, Fac Biol, Dept Ciencias Biol, Lab Biotecnol Mol, Santiago, Chile.	amolina@unab.cl	Molina, Alfredo/K-5531-2015; Fuentes, Eduardo/G-1290-2014	Fuentes, Eduardo/0000-0001-7400-8548; Ruiz, Pamela/0000-0003-0093-4439	Universidad Andres Research Bello Fund [DI-14-11/I]; Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1090416]	Universidad Andres Research Bello Fund; Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by: Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) Grant 1090416 (to AM) and Universidad Andres Research Bello Fund DI-14-11/I (to ENF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attaix D, 2001, CURR OPIN CLIN NUTR, V4, P45, DOI 10.1097/00075197-200101000-00009; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bower NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011100; Bower NI, 2010, BIOCHEM BIOPH RES CO, V396, P265, DOI 10.1016/j.bbrc.2010.04.076; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Cleveland BM, 2010, COMP BIOCHEM PHYS B, V157, P248, DOI 10.1016/j.cbpb.2010.06.010; Cleveland BM, 2010, AM J PHYSIOL-REG I, V298, pR341, DOI 10.1152/ajpregu.00516.2009; Fuentes EN, 2012, GEN COMP ENDOCR, V177, P120, DOI 10.1016/j.ygcen.2012.02.019; Fuentes EN, 2012, ENDOCRINOLOGY, V153, P283, DOI 10.1210/en.2011-1313; FUENTES EN, 2011, AM J PHYSIOL-REG I, V300, P1532, DOI DOI 10.1152/AJPREGU.00535.2010; FURUNO K, 1990, J BIOL CHEM, V265, P8550; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Glass DJ, 2003, TRENDS MOL MED, V9, P344, DOI 10.1016/S1471-4914(03)00138-2; Jagoe RT, 2002, FASEB J, V16, P1697, DOI 10.1096/fj.02-0312com; Jagoe RT, 2001, CURR OPIN CLIN NUTR, V4, P183, DOI 10.1097/00075197-200105000-00003; Johnston IA, 1999, AQUACULTURE, V177, P99, DOI 10.1016/S0044-8486(99)00072-1; JOHNSTON IA, 1982, COMP BIOCHEM PHYS B, V73, P105, DOI 10.1016/0305-0491(82)90204-8; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52; Lagirand-Cantaloube J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004973; Latres E, 2005, J BIOL CHEM, V280, P2737, DOI 10.1074/jbc.M407517200; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Li YP, 2005, FASEB J, V19, P362, DOI 10.1096/fj.04-2364com; Lin YC, 2011, FISH PHYSIOL BIOCHEM, V37, P977, DOI 10.1007/s10695-011-9502-3; Moylan JS, 2008, AM J PHYSIOL-CELL PH, V295, pC986, DOI 10.1152/ajpcell.00041.2008; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Ren HX, 2010, P NATL ACAD SCI USA, V107, P5857, DOI 10.1073/pnas.0909570107; Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE591, DOI 10.1152/ajpendo.00073.2004; Safian D, 2012, J ENDOCRINOL, V214, P95, DOI 10.1530/JOE-12-0057; Salem M, 2006, PHYSIOL GENOMICS, V28, P33, DOI 10.1152/physiolgenomics.00114.2006; Salem M, 2010, J PROTEOMICS, V73, P778, DOI 10.1016/j.jprot.2009.10.014; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Seiliez I, 2008, J NUTR, V138, P487, DOI 10.1093/jn/138.3.487; STICKLAND NC, 1983, J ANAT, V137, P323; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Tacchi L, 2010, COMP BIOCHEM PHYS B, V157, P364, DOI 10.1016/j.cbpb.2010.08.004; Tawa NE, 1997, J CLIN INVEST, V100, P197, DOI 10.1172/JCI119513; Trendelenburg AU, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-3; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WEATHERLEY AH, 1988, J FISH BIOL, V33, P851, DOI 10.1111/j.1095-8649.1988.tb05532.x; Witt SH, 2005, J MOL BIOL, V350, P713, DOI 10.1016/j.jmb.2005.05.021; Zhang GH, 2011, EMBO J, V30, P4323, DOI 10.1038/emboj.2011.292	48	34	36	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44256	10.1371/journal.pone.0044256	http://dx.doi.org/10.1371/journal.pone.0044256			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024748	Green Published, gold, Green Submitted			2022-12-27	WOS:000308860100006
J	Payne, CJ; Jessop, TS; Guay, PJ; Johnstone, M; Feore, M; Mulder, RA				Payne, Catherine J.; Jessop, Tim S.; Guay, Patrick-Jean; Johnstone, Michele; Feore, Megan; Mulder, Raoul A.			Population, Behavioural and Physiological Responses of an Urban Population of Black Swans to an Intense Annual Noise Event	PLOS ONE			English	Article							HUMAN DISTURBANCE; STRESS-RESPONSE; LIFE-HISTORY; ENERGY-EXPENDITURE; FLIGHT DISTANCE; PENGUINS; EXPOSURE; ECOLOGY; BIRDS; WILD	Wild animals in urban environments are exposed to a broad range of human activities that have the potential to disturb their life history and behaviour. Wildlife responses to disturbance can range from emigration to modified behaviour, or elevated stress, but these responses are rarely evaluated in concert. We simultaneously examined population, behavioural and hormonal responses of an urban population of black swans Cygnus atratus before, during and after an annual disturbance event involving large crowds and intense noise, the Australian Formula One Grand Prix. Black swan population numbers were lowest one week before the event and rose gradually over the course of the study, peaking after the event, suggesting that the disturbance does not trigger mass emigration. We also found no difference in the proportion of time spent on key behaviours such as locomotion, foraging, resting or self-maintenance over the course of the study. However, basal and capture stress-induced corticosterone levels showed significant variation, consistent with a modest physiological response. Basal plasma corticosterone levels were highest before the event and decreased over the course of the study. Capture-induced stress levels peaked during the Grand Prix and then also declined over the remainder of the study. Our results suggest that even intensely noisy and apparently disruptive events may have relatively low measurable short-term impact on population numbers, behaviour or physiology in urban populations with apparently high tolerance to anthropogenic disturbance. Nevertheless, the potential long-term impact of such disturbance on reproductive success, individual fitness and population health will need to be carefully evaluated.	[Payne, Catherine J.; Jessop, Tim S.; Johnstone, Michele; Feore, Megan; Mulder, Raoul A.] Univ Melbourne, Dept Zool, Melbourne, Vic 3010, Australia; [Guay, Patrick-Jean] Victoria Univ, Inst Sustainabil & Innovat, Melbourne, Vic 8001, Australia	University of Melbourne; Victoria University	Payne, CJ (corresponding author), Univ Melbourne, Dept Zool, Melbourne, Vic 3010, Australia.	r.mulder@unimelb.edu.au	Jessop, Tim/Q-2473-2019; Jessop, Tim/I-6647-2012	Jessop, Tim S./0000-0002-7712-4373	Department of Zoology of the University of Melbourne; Victoria University fellowship	Department of Zoology of the University of Melbourne; Victoria University fellowship	Funding was provided by the Department of Zoology of the University of Melbourne and a Victoria University fellowship to P.J.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Andersen R, 1996, BIOL CONSERV, V77, P169, DOI 10.1016/0006-3207(96)00004-3; Barja I, 2007, J STEROID BIOCHEM, V104, P136, DOI 10.1016/j.jsbmb.2007.03.008; BATTEN L A, 1977, Biological Conservation, V11, P49, DOI 10.1016/0006-3207(77)90027-1; Bechet A, 2004, J APPL ECOL, V41, P689, DOI 10.1111/j.0021-8901.2004.00928.x; Blas J, 2007, P NATL ACAD SCI USA, V104, P8880, DOI 10.1073/pnas.0700232104; Blumstein DT, 2006, ANIM BEHAV, V71, P389, DOI 10.1016/j.anbehav.2005.05.010; Blumstein DT, 2005, J APPL ECOL, V42, P943, DOI 10.1111/j.1365-2664.2005.01071.x; Chamberlain DE, 2009, IBIS, V151, P1, DOI 10.1111/j.1474-919X.2008.00899.x; Conomy JT, 1998, J WILDLIFE MANAGE, V62, P1135, DOI 10.2307/3802568; Crino OL, 2011, GEN COMP ENDOCR, V173, P323, DOI 10.1016/j.ygcen.2011.06.001; Delaney DK, 1999, J WILDLIFE MANAGE, V63, P60, DOI 10.2307/3802487; Ditchkoff Stephen S., 2006, Urban Ecosystems, V9, P5, DOI 10.1007/s11252-006-3262-3; Donaldson Michael R., 2007, Urban Ecosystems, V10, P139, DOI 10.1007/s11252-006-0015-2; Ellenberg U, 2007, GEN COMP ENDOCR, V152, P54, DOI 10.1016/j.ygcen.2007.02.022; Evans J, 2010, ETHOLOGY, V116, P588, DOI 10.1111/j.1439-0310.2010.01771.x; Fernandez-Juricic E, 2000, BIRD STUDY, V47, P13, DOI 10.1080/00063650009461156; Finney SK, 2005, BIOL CONSERV, V121, P53, DOI 10.1016/j.biocon.2004.04.009; Forman RTT, 2002, ENVIRON MANAGE, V29, P782, DOI 10.1007/s00267-001-0065-4; Francis CD, 2009, CURR BIOL, V19, P1415, DOI 10.1016/j.cub.2009.06.052; French SS, 2008, J COMP PHYSIOL B, V178, P997, DOI 10.1007/s00360-008-0290-8; Frid A, 2002, CONSERV ECOL, V6; Gill JA, 1996, J APPL ECOL, V33, P786, DOI 10.2307/2404948; Gill JA, 2001, BIOL CONSERV, V97, P265, DOI 10.1016/S0006-3207(00)00002-1; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Guay PJ, 2009, EMU, V109, P248, DOI 10.1071/MU09020; HENSON P, 1991, WILDLIFE SOC B, V19, P248; Hill D, 1997, J APPL ECOL, V34, P275, DOI 10.2307/2404876; HOCKIN D, 1992, J ENVIRON MANAGE, V36, P253, DOI 10.1016/S0301-4797(08)80002-3; Kitchen Kim, 2010, Australian Field Ornithology, V27, P1; Landys MM, 2006, GEN COMP ENDOCR, V148, P132, DOI 10.1016/j.ygcen.2006.02.013; Lowry H, 2011, ETHOLOGY, V117, P490, DOI 10.1111/j.1439-0310.2011.01902.x; Manor R, 2005, J WILDLIFE MANAGE, V69, P1683, DOI 10.2193/0022-541X(2005)69[1683:EOHDOU]2.0.CO;2; Martin JGA, 2008, BEHAV PROCESS, V77, P66, DOI 10.1016/j.beproc.2007.06.004; McClung MR, 2004, BIOL CONSERV, V119, P279, DOI 10.1016/j.biocon.2003.11.012; Moller AP, 2008, BEHAV ECOL SOCIOBIOL, V63, P63, DOI 10.1007/s00265-008-0636-y; Monaghan P, 2011, P ROYAL SOC B; MONIE L, 2011, THESIS VICTORIA U ST; Mulder RA, 2010, WILDLIFE RES, V37, P440, DOI 10.1071/WR10007; Mullner A, 2004, BIOL CONSERV, V118, P549, DOI 10.1016/j.biocon.2003.10.003; Nisbet ICT, 2000, WATERBIRDS, V23, P312; Partecke J, 2006, ECOLOGY, V87, P1945, DOI 10.1890/0012-9658(2006)87[1945:SATCUA]2.0.CO;2; Paton DC, 2000, DISTURBANCE DISTANCE; Regel J, 1997, POLAR BIOL, V18, P246, DOI 10.1007/s003000050185; Rich EL, 2005, AM J PHYSIOL-REG I, V288, pR1628, DOI 10.1152/ajpregu.00484.2004; Riddington R, 1996, BIRD STUDY, V43, P269, DOI 10.1080/00063659609461019; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Romero LM, 2002, BIOL CONSERV, V108, P371, DOI 10.1016/S0006-3207(02)00128-3; Spellerberg IF, 1998, GLOBAL ECOL BIOGEOGR, V7, P317, DOI 10.1046/j.1466-822x.1998.00308.x; URQUHART J, 1984, ANNU REV PHARMACOL, V24, P199; Van Meter PE, 2009, HORM BEHAV, V55, P329, DOI 10.1016/j.yhbeh.2008.11.001; Walker BG, 2006, CONSERV BIOL, V20, P146, DOI 10.1111/j.1523-1739.2005.00271.x; Webb NV, 2005, CONDOR, V107, P178, DOI 10.1650/7607; Weimerskirch H, 2002, J EXP BIOL, V205, P475; Wingfield JC, 1998, AM ZOOL, V38, P191, DOI 10.1093/icb/38.1.191; WINGFIELD JC, 1995, AM ZOOL, V35, P285; Wright AJ, 2007, INT J COMP PSYCHOL, V20	57	18	18	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45014	10.1371/journal.pone.0045014	http://dx.doi.org/10.1371/journal.pone.0045014			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	007AD	23024783	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000308860100041
J	van Sighem, A; Vidondo, B; Glass, TR; Bucher, HC; Vernazza, P; Gebhardt, M; de Wolf, F; Derendinger, S; Jeannin, A; Bezemer, D; Fraser, C; Low, N				van Sighem, Ard; Vidondo, Beatriz; Glass, Tracy R.; Bucher, Heiner C.; Vernazza, Pietro; Gebhardt, Martin; de Wolf, Frank; Derendinger, Steven; Jeannin, Andre; Bezemer, Daniela; Fraser, Christophe; Low, Nicola		Swiss HIV Cohort Study	Resurgence of HIV Infection among Men Who Have Sex with Men in Switzerland: Mathematical Modelling Study	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; TRANSMISSION; EPIDEMIC; PREVENTION; HIV/AIDS; BEHAVIOR	Background: New HIV infections in men who have sex with men (MSM) have increased in Switzerland since 2000 despite combination antiretroviral therapy (cART). The objectives of this mathematical modelling study were: to describe the dynamics of the HIV epidemic in MSM in Switzerland using national data; to explore the effects of hypothetical prevention scenarios; and to conduct a multivariate sensitivity analysis. Methodology/Principal Findings: The model describes HIV transmission, progression and the effects of cART using differential equations. The model was fitted to Swiss HIV and AIDS surveillance data and twelve unknown parameters were estimated. Predicted numbers of diagnosed HIV infections and AIDS cases fitted the observed data well. By the end of 2010, an estimated 13.5% (95% CI 12.5, 14.6%) of all HIV-infected MSM were undiagnosed and accounted for 81.8% (95% CI 81.1, 82.4%) of new HIV infections. The transmission rate was at its lowest from 1995-1999, with a nadir of 46 incident HIV infections in 1999, but increased from 2000. The estimated number of new infections continued to increase to more than 250 in 2010, although the reproduction number was still below the epidemic threshold. Prevention scenarios included temporary reductions in risk behaviour, annual test and treat, and reduction in risk behaviour to levels observed earlier in the epidemic. These led to predicted reductions in new infections from 2 to 26% by 2020. Parameters related to disease progression and relative infectiousness at different HIV stages had the greatest influence on estimates of the net transmission rate. Conclusions/Significance: The model outputs suggest that the increase in HIV transmission amongst MSM in Switzerland is the result of continuing risky sexual behaviour, particularly by those unaware of their infection status. Long term reductions in the incidence of HIV infection in MSM in Switzerland will require increased and sustained uptake of effective interventions.	[van Sighem, Ard; de Wolf, Frank; Bezemer, Daniela] Stichting HIV Monitoring, Amsterdam, Netherlands; [Vidondo, Beatriz; Gebhardt, Martin; Derendinger, Steven] Swiss Fed Off Publ Hlth, Div Communicable Dis, Bern, Switzerland; [Vidondo, Beatriz; Low, Nicola] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Glass, Tracy R.; Bucher, Heiner C.] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland; [Glass, Tracy R.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Vernazza, Pietro] Cantonal Hosp St Gallen, Div Infect Dis, St Gallen, Switzerland; [de Wolf, Frank] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, London, England; [Jeannin, Andre] Univ Lausanne, Inst Social & Prevent Med, Lausanne, Switzerland; [Fraser, Christophe] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC, Ctr Outbreak Anal & Modelling, London, England	University of Bern; University of Basel; University of Basel; Swiss Tropical & Public Health Institute; Kantonsspital St. Gallen; Imperial College London; University of Lausanne; Imperial College London	van Sighem, A (corresponding author), Stichting HIV Monitoring, Amsterdam, Netherlands.	low@ispm.unibe.ch	Fraser, Christophe/A-8109-2008; Pantaleo, Giuseppe/K-6163-2016; Glass, Tracy R/D-5046-2017; Low, Nicola/H-4718-2019	Fraser, Christophe/0000-0003-2399-9657; Glass, Tracy R/0000-0001-7075-9803; Low, Nicola/0000-0003-4817-8986; Vidondo, Beatriz/0000-0001-9693-2301	Swiss School of Public Health; Swiss Federal Office of Public Health; Dutch Ministry of Health; UK Medical Research Council; Royal Society; MRC [G0600719, G0800596] Funding Source: UKRI; Medical Research Council [G0600719, G0600719B, G0800596] Funding Source: researchfish	Swiss School of Public Health; Swiss Federal Office of Public Health; Dutch Ministry of Health; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study received support from the Swiss School of Public Health plus (www.ssphplus.ch) and the Swiss Federal Office of Public Health (http://www.bag.admin.ch/aktuell/); Stichting HIV Monitoring (HIV Monitoring Foundation) is financed by the Dutch Ministry of Health (www.rijksoverheid.nl); Christophe Fraser receives funding from the UK Medical Research Council (www.mrc.ac.uk) and the Royal Society (www.royalsociety.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Baggaley RF, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-9; Balthasar H, 2007, INT J PUBLIC HEALTH, V52, P27, DOI 10.1007/s00038-006-5086-6; Balthasar H, 2010, JAIDS-J ACQ IMM DEF, V54, P542, DOI 10.1097/QAI.0b013e3181e19a6b; Bezemer D, 2008, AIDS, V22, P1071, DOI 10.1097/QAD.0b013e3282fd167c; Bezemer D, 2010, EPIDEMICS-NETH, V2, P66, DOI 10.1016/j.epidem.2010.04.001; Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; Cairns G, 2011, HIV PREVALENCE IS CA; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Daneel S, 2008, SWISS MED WKLY, V138, P453, DOI 2008/31/smw-12007; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Glass TR, 2004, AIDS, V18, P1707, DOI 10.1097/01.aids.0000131396.21963.81; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hasse B, 2010, CLIN INFECT DIS, V51, P1314, DOI 10.1086/656809; Heijman T, 2011, AIDS S4, DOI [10.1097/QAD.0b013e32834f9d7c, DOI 10.1097/QAD.0B013E32834F9D7C]; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Imhof C, 2010, BAG B, V40, P863; Kouyos RD, 2010, J INFECT DIS, V201, P1488, DOI 10.1086/651951; Lambert PC, 2007, BIOSTATISTICS, V8, P576, DOI 10.1093/biostatistics/kxl030; Lociciro S, 2010, COMPORTEMENTS FACE V; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Mayer KH, 2011, CLIN INFECT DIS, V52, P1371, DOI 10.1093/cid/cir206; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Ostrow DE, 2002, AIDS, V16, P775, DOI 10.1097/00002030-200203290-00013; Sanchez MA, 1997, AM J EPIDEMIOL, V145, P1127; Staub R, 2009, MED REV, V10, P12; Stolte IG, 2004, AIDS, V18, P303, DOI 10.1097/00002030-200401230-00021; Sullivan PS, 2009, ANN EPIDEMIOL, V19, P423, DOI 10.1016/j.annepidem.2009.03.004; Swiss Federal Office for Public Health, 2011, BAG B, V12, P253; Swiss Federal Office of Public Health, 2011, HIV AIDS SCHWEIZ 201; Van de Ven P, 2000, AIDS, V14, P2951, DOI 10.1097/00002030-200012220-00023; van Sighem A, 2011, MONITORING REPORT 20; Ward H, 2007, CLIN INFECT DIS, V44, P26, DOI 10.1086/509922; Wood Evan, 2009, BMJ, V338, pb1649, DOI 10.1136/bmj.b1649	36	57	58	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44819	10.1371/journal.pone.0044819	http://dx.doi.org/10.1371/journal.pone.0044819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024766	Green Published, gold, Green Accepted			2022-12-27	WOS:000308860100024
J	Roberts, SK; McAinsh, M; Widdicks, L				Roberts, Stephen K.; McAinsh, Martin; Widdicks, Lisa			Cch1p Mediates Ca2+ Influx to Protect Saccharomyces cerevisiae against Eugenol Toxicity	PLOS ONE			English	Article							ANTIFUNGAL ACTIVITY; CANDIDA-ALBICANS; CALCIUM; YEAST; AMIODARONE; CHANNEL; STRESS; FLUCONAZOLE; HOMOLOG; RELEASE	Eugenol has antifungal activity and is recognised as having therapeutic potential. However, little is known of the cellular basis of its antifungal activity and a better understanding of eugenol tolerance should lead to better exploitation of eugenol in antifungal therapies. The model yeast, Saccharomyces cerevisiae, expressing apoaequorin was used to show that eugenol induces cytosolic Ca2+ elevations. We investigated the eugenol Ca2+ signature in further detail and show that exponentially growing cells exhibit Ca2+ elevation resulting exclusively from the influx of Ca2+ across the plasma membrane whereas in stationary growth phase cells Ca2+ influx from intracellular and extracellular sources contribute to the eugenol-induced Ca2+ elevation. Ca2+ channel deletion yeast mutants were used to identify the pathways mediating Ca2+ influx; intracellular Ca2+ release was mediated by the vacuolar Ca2+ channel, Yvc1p, whereas the Ca2+ influx across the plasma membrane could be resolved into Cch1p-dependent and Cch1p-independent pathways. We show that the growth of yeast devoid the plasma membrane Ca2+ channel, Cch1p, was hypersensitive to eugenol and that this correlated with reduced Ca2+ elevations. Taken together, these results indicate that a cch1p-mediated Ca2+ influx is part of an intracellular signal which protects against eugenol toxicity. This study provides fresh insight into the mechanisms employed by fungi to tolerate eugenol toxicity which should lead to better exploitation of eugenol in antifungal therapies.	[Roberts, Stephen K.; Widdicks, Lisa] Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster, England; [McAinsh, Martin] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England	Lancaster University; Lancaster University	Roberts, SK (corresponding author), Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster, England.	s.k.roberts@lancaster.ac.uk		roberts, stephen/0000-0003-1740-5330; McAinsh, Martin Robert/0000-0003-4294-6470	Natural Environment Research Council [ceh010010] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Ahmad A, 2010, J MED MICROBIOL, V59, P1178, DOI 10.1099/jmm.0.020693-0; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Batiza AF, 1996, J BIOL CHEM, V271, P23357, DOI 10.1074/jbc.271.38.23357; Bonilla M, 2002, EMBO J, V21, P2343, DOI 10.1093/emboj/21.10.2343; Brand A, 2007, CURR BIOL, V17, P347, DOI 10.1016/j.cub.2006.12.043; Courchesne WE, 2003, MOL MICROBIOL, V47, P223, DOI 10.1046/j.1365-2958.2003.03291.x; Denis V, 2002, J CELL BIOL, V156, P29, DOI 10.1083/jcb.200111004; Edlind T, 2002, MOL MICROBIOL, V46, P257, DOI 10.1046/j.1365-2958.2002.03165.x; Fischer M, 1997, FEBS LETT, V419, P259, DOI 10.1016/S0014-5793(97)01466-X; Gietz D, 1998, METHOD MICROBIOL, V26, P53; Hong MP, 2010, J BIOL CHEM, V285, P10951, DOI 10.1074/jbc.M109.056218; IIDA H, 1994, MOL CELL BIOL, V14, P8259, DOI 10.1128/MCB.14.12.8259; Kaur R, 2004, ANTIMICROB AGENTS CH, V48, P1600, DOI 10.1128/AAC.48.5.1600-1613.2004; Liu M, 2006, EUKARYOT CELL, V5, P1788, DOI 10.1128/EC.00158-06; Locke EG, 2000, MOL CELL BIOL, V20, P6686, DOI 10.1128/MCB.20.18.6686-6694.2000; Loukin S, 2008, FASEB J, V22, P2405, DOI 10.1096/fj.07-101410; Loukin SH, 2007, FASEB J, V21, P1813, DOI 10.1096/fj.06-7898com; Loukin SH, 2009, FEBS LETT, V583, P754, DOI 10.1016/j.febslet.2009.01.027; Maresova L, 2009, J BIOL CHEM, V284, P2795, DOI 10.1074/jbc.M806693200; Martin DC, 2011, J BIOL CHEM, V286, P10744, DOI 10.1074/jbc.M110.177451; Monk BC, 2008, SCIENCE, V321, P367, DOI 10.1126/science.1159746; Muend S, 2008, FEMS YEAST RES, V8, P425, DOI 10.1111/j.1567-1364.2008.00354.x; Palmer CP, 2001, P NATL ACAD SCI USA, V98, P7801, DOI 10.1073/pnas.141036198; Peiter E, 2005, FEBS LETT, V579, P5697, DOI 10.1016/j.febslet.2005.09.058; Pinontoan R, 2002, BIOSCI BIOTECH BIOCH, V66, P1069, DOI 10.1271/bbb.66.1069; Popa CV, 2010, FEBS J, V277, P4027, DOI 10.1111/j.1742-4658.2010.07794.x; Rao A, 2010, ANTIMICROB AGENTS CH, V54, P5062, DOI 10.1128/AAC.01050-10; Reedy J. L., 2010, Fungal Genetics and Biology, V47, P107, DOI 10.1016/j.fgb.2009.09.002; Sen Gupta S, 2003, J BIOL CHEM, V278, P28831, DOI 10.1074/jbc.M303300200; Yoo CB, 2005, CANCER LETT, V225, P41, DOI 10.1016/j.canlet.2004.11.018; Zore GB, 2011, PHYTOMEDICINE, V18, P1181, DOI 10.1016/j.phymed.2011.03.008	31	23	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e43989	10.1371/journal.pone.0043989	http://dx.doi.org/10.1371/journal.pone.0043989			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028482	gold, Green Published, Green Accepted			2022-12-27	WOS:000308788700013
J	Gonon, F; Konsman, JP; Cohen, D; Boraud, T				Gonon, Francois; Konsman, Jan-Pieter; Cohen, David; Boraud, Thomas			Why Most Biomedical Findings Echoed by Newspapers Turn Out to be False: The Case of Attention Deficit Hyperactivity Disorder	PLOS ONE			English	Article							DOPAMINE-D4 RECEPTOR GENE; CEREBRAL GLUCOSE-METABOLISM; SUBSTANCE USE DISORDERS; DEFICIT/HYPERACTIVITY DISORDER; FOLLOW-UP; DRD4 GENE; MULTIMODAL TREATMENT; TRANSPORTER DENSITY; NATIONAL TRENDS; THYROID-HORMONE	Context: Because positive biomedical observations are more often published than those reporting no effect, initial observations are often refuted or attenuated by subsequent studies. Objective: To determine whether newspapers preferentially report on initial findings and whether they also report on subsequent studies. Methods: We focused on attention deficit hyperactivity disorder (ADHD). Using Factiva and PubMed databases, we identified 47 scientific publications on ADHD published in the 1990s and soon echoed by 347 newspapers articles. We selected the ten most echoed publications and collected all their relevant subsequent studies until 2011. We checked whether findings reported in each "top 10" publication were consistent with previous and subsequent observations. We also compared the newspaper coverage of the "top 10" publications to that of their related scientific studies. Results: Seven of the "top 10" publications were initial studies and the conclusions in six of them were either refuted or strongly attenuated subsequently. The seventh was not confirmed or refuted, but its main conclusion appears unlikely. Among the three "top 10" that were not initial studies, two were confirmed subsequently and the third was attenuated. The newspaper coverage of the "top 10" publications (223 articles) was much larger than that of the 67 related studies (57 articles). Moreover, only one of the latter newspaper articles reported that the corresponding "top 10" finding had been attenuated. The average impact factor of the scientific journals publishing studies echoed by newspapers (17.1 n = 56) was higher (p < 0.0001) than that corresponding to related publications that were not echoed (6.4 n = 56). Conclusion: Because newspapers preferentially echo initial ADHD findings appearing in prominent journals, they report on uncertain findings that are often refuted or attenuated by subsequent studies. If this media reporting bias generalizes to health sciences, it represents a major cause of distortion in health science communication.	[Gonon, Francois; Boraud, Thomas] Univ Bordeaux, Inst Neurodegenerat Dis, Bordeaux, France; [Gonon, Francois; Boraud, Thomas] CNRS, UMR 5293, Bordeaux, France; [Konsman, Jan-Pieter] Univ Bordeaux, Ctr Resonance Magnet Syst Biol, Bordeaux, France; [Konsman, Jan-Pieter] CNRS, UMR 5536, Bordeaux, France; [Cohen, David] Florida Int Univ, Sch Social Work, Miami, FL 33199 USA	UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; State University System of Florida; Florida International University	Gonon, F (corresponding author), Univ Bordeaux, Inst Neurodegenerat Dis, Bordeaux, France.	francois.gonon@u-bordeaux2.fr		Konsman, Jan Pieter/0000-0001-7247-0472	Centre National de la Recherche Scientifique [CNRS UMR 5293, UPR 3255]; University of Bordeaux; Region Aquitaine; Institut des Sciences de la Communication du CNRS (ISCC); Agence Nationale de la Recherche (ANR VSN-RAP)	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University of Bordeaux; Region Aquitaine(Region Nouvelle-Aquitaine); Institut des Sciences de la Communication du CNRS (ISCC); Agence Nationale de la Recherche (ANR VSN-RAP)(French National Research Agency (ANR))	This work was supported by the Centre National de la Recherche Scientifique (CNRS UMR 5293 and UPR 3255), the University of Bordeaux and by grants from the Region Aquitaine, from the Institut des Sciences de la Communication du CNRS (ISCC) and from the Agence Nationale de la Recherche (ANR VSN-RAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACHOROWSKI JA, 1990, PEDIATRICS, V86, P244; Barkley RA, 2003, PEDIATRICS, V111, P97, DOI 10.1542/peds.111.1.97; Biederman J, 1999, PEDIATRICS, V104, part. no., DOI 10.1542/peds.104.2.e20; Biederman J, 2008, AM J PSYCHIAT, V165, P597, DOI 10.1176/appi.ajp.2007.07091486; Bubela T, 2009, NAT BIOTECHNOL, V27, P514, DOI 10.1038/nbt0609-514; Bubela TM, 2004, CAN MED ASSOC J, V170, P1399, DOI 10.1503/cmaj.1030762; Carrasco X, 2006, AM J MED GENET B, V141B, P51, DOI 10.1002/ajmg.b.30259; Cheon KA, 2003, EUR J NUCL MED MOL I, V30, P306, DOI 10.1007/s00259-002-1047-3; Comings DE, 1999, AM J MED GENET, V88, P358, DOI 10.1002/(SICI)1096-8628(19990820)88:4<358::AID-AJMG13>3.0.CO;2-G; Contopoulos-Ioannidis DG, 2008, SCIENCE, V321, P1298, DOI 10.1126/science.1160622; Curran S, 2001, AM J MED GENET, V105, P387, DOI 10.1002/ajmg.1366; Dopfner M, 2004, EUR CHILD ADOLES PSY, V13, P117, DOI 10.1007/s00787-004-1011-9; Dougherty DD, 1999, LANCET, V354, P2132, DOI 10.1016/S0140-6736(99)04030-1; Dresel S, 2000, EUR J NUCL MED, V27, P1518, DOI 10.1007/s002590000330; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; El-Faddagh M, 2004, J NEURAL TRANSM, V111, P883, DOI 10.1007/s00702-003-0054-2; Ernst M, 1997, J AM ACAD CHILD PSY, V36, P1399, DOI 10.1097/00004583-199710000-00022; ERNST M, 1994, J AM ACAD CHILD PSY, V33, P858, DOI 10.1097/00004583-199407000-00012; Ernst M, 1998, J NEUROPSYCH CLIN N, V10, P168, DOI 10.1176/jnp.10.2.168; Faraone SV, 2007, PSYCHOL MED, V37, P1743, DOI 10.1017/S0033291707000335; Faraone Stephen V, 2003, World Psychiatry, V2, P104; Faraone SV, 2010, J CLIN PSYCHIAT, V71, P754, DOI 10.4088/JCP.08m04902pur; Faraone Stephen V, 2009, P T, V34, P678; Ficks CA, 2009, CURR PSYCHIAT REP, V11, P387, DOI 10.1007/s11920-009-0058-1; Findling RL, 1996, J CHILD ADOL PSYCHOP, V6, P165, DOI 10.1089/cap.1996.6.165; Frank Y, 2004, PEDIATR NEUROL, V31, P345, DOI 10.1016/j.pediatrneurol.2004.06.010; Fusar-Poli P, 2012, AM J PSYCHIAT; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Gonon F, 2011, AM J MED GENET B, V156B, P989, DOI 10.1002/ajmg.b.31236; Gornick MC, 2007, AM J MED GENET B, V144B, P379, DOI 10.1002/ajmg.b.30460; Hauser P, 1997, PSYCHONEUROENDOCRINO, V22, P107, DOI 10.1016/S0306-4530(96)00043-1; HAUSER P, 1993, NEW ENGL J MED, V328, P997, DOI 10.1056/NEJM199304083281403; Hawi Z, 2000, AM J MED GENET, V96, P268, DOI 10.1002/1096-8628(20000612)96:3<268::AID-AJMG6>3.0.CO;2-#; Hesse S, 2009, PSYCHIAT RES-NEUROIM, V171, P120, DOI 10.1016/j.pscychresns.2008.01.002; Holmes J, 2000, MOL PSYCHIATR, V5, P523, DOI 10.1038/sj.mp.4000751; Holtzman NA, 2005, COMMUNITY GENET, V8, P133, DOI 10.1159/000086756; Iaboli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009829; Ioannidis JPA, 2011, JAMA-J AM MED ASSOC, V305, P2200, DOI 10.1001/jama.2011.713; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jensen PS, 2007, J AM ACAD CHILD PSY, V46, P989, DOI 10.1097/chi.0b013e3180686d48; Jensen PS, 2004, PEDIATRICS, V113, P762; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1073; Johansson S, 2008, AM J MED GENET B, V147B, P1470, DOI 10.1002/ajmg.b.30662; Jucaite A, 2005, BIOL PSYCHIAT, V57, P229, DOI 10.1016/j.biopsych.2004.11.009; Katusic SK, 2005, J CHILD ADOL PSYCHOP, V15, P764, DOI 10.1089/cap.2005.15.764; la Fougere C, 2006, NUCL MED COMMUN, V27, P733, DOI 10.1097/01.mnm.0000230077.48480.68; LaHoste GJ, 1996, MOL PSYCHIATR, V1, P121; Lambert NM, 1998, J LEARN DISABIL-US, V31, P533, DOI 10.1177/002221949803100603; Larisch R, 2006, NUCL MED COMMUN, V27, P267, DOI 10.1097/00006231-200603000-00010; LeFever GB, 1999, AM J PUBLIC HEALTH, V89, P1359, DOI 10.2105/AJPH.89.9.1359; Martinez-Levy G, 2009, NEUROSCI LETT, V451, P257, DOI 10.1016/j.neulet.2009.01.004; Mayes R, 2008, HARVARD REV PSYCHIAT, V16, P151, DOI 10.1080/10673220802167782; Mill J, 2001, MOL PSYCHIATR, V6, P440, DOI 10.1038/sj.mp.4000881; Mill J, 2008, J CHILD PSYCHOL PSYC, V49, P1020, DOI 10.1111/j.1469-7610.2008.01909.x; Molina BSG, 2007, J AM ACAD CHILD PSY, V46, P1028, DOI 10.1097/chi.0b013e3180686d96; Molina BSG, 2009, J AM ACAD CHILD PSY, V48, P484, DOI 10.1097/CHI.0b013e31819c23d0; Muglia P, 2000, AM J MED GENET, V96, P273, DOI 10.1002/1096-8628(20000612)96:3<273::AID-AJMG7>3.0.CO;2-Z; Olfson M, 2003, AM J PSYCHIAT, V160, P1071, DOI 10.1176/appi.ajp.160.6.1071; Olfson M, 2002, J AM ACAD CHILD PSY, V41, P514, DOI 10.1097/00004583-200205000-00008; Pelham WE, 2008, J CLIN CHILD ADOLESC, V37, P184, DOI 10.1080/15374410701818681; PHILLIPS DP, 1991, NEW ENGL J MED, V325, P1180, DOI 10.1056/NEJM199110173251620; Popper CW, 1997, J CLIN PSYCHIAT, V58, P14; Robison LM, 1999, CLIN PEDIATR, V38, P209, DOI 10.1177/000992289903800402; Roman T, 2001, AM J MED GENET, V105, P471, DOI 10.1002/ajmg.1408; Rowe DC, 1998, MOL PSYCHIATR, V3, P419, DOI 10.1038/sj.mp.4000432; Safer DJ, 1996, PEDIATRICS, V98, P1084; SARAVIS S, 1990, PEDIATRICS, V86, P75; Schwartz LM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8164; Schwitzer G, 2008, PLOS MED, V5, P700, DOI 10.1371/journal.pmed.0050095; Smith KM, 2003, AM J MED GENET B, V119B, P77, DOI 10.1002/ajmg.b.20005; Smith TF, 2010, AM J MED GENET B, V153B, P1189, DOI 10.1002/ajmg.b.31090; Sonuga-Barke EJS, 2010, J CHILD PSYCHOL PSYC, V51, P113, DOI 10.1111/j.1469-7610.2009.02213.x; SPENCER T, 1995, J CHILD PSYCHOL PSYC, V36, P879, DOI 10.1111/j.1469-7610.1995.tb01335.x; Spencer TJ, 2007, BIOL PSYCHIAT, V62, P1059, DOI 10.1016/j.biopsych.2006.12.008; Spencer TJ, 2005, BIOL PSYCHIAT, V57, P1293, DOI 10.1016/j.biopsych.2005.03.036; Swanson J, 2008, J ATTEN DISORD, V12, P4, DOI 10.1177/1087054708319345; SWANSON JM, 1995, NEW ENGL J MED, V333, P944, DOI 10.1056/NEJM199510053331419; Taylor E, 2006, CLIN HDB CHILD ADOLE, P489; Vaidya CJ, 1998, P NATL ACAD SCI USA, V95, P14494, DOI 10.1073/pnas.95.24.14494; Valentine J, 1997, J PAEDIATR CHILD H, V33, P117, DOI 10.1111/j.1440-1754.1997.tb01012.x; Van der Oord S, 2008, CLIN PSYCHOL REV, V28, P783, DOI 10.1016/j.cpr.2007.10.007; van Dyck CH, 2002, AM J PSYCHIAT, V159, P309, DOI 10.1176/appi.ajp.159.2.309; Volkow ND, 2007, NEUROIMAGE, V34, P1182, DOI 10.1016/j.neuroimage.2006.10.014; Volkow ND, 2009, JAMA-J AM MED ASSOC, V302, P1084, DOI 10.1001/jama.2009.1308; Weiss M, 2006, J CLIN PSYCHIAT, V67, P611, DOI 10.4088/JCP.v67n0412; WEISS RE, 1994, J CLIN ENDOCR METAB, V78, P1525, DOI 10.1210/jc.78.6.1525; WEISS RE, 1993, J PEDIATR-US, V123, P539, DOI 10.1016/S0022-3476(05)80947-3; Weiss RE, 1997, THYROID, V7, P389, DOI 10.1089/thy.1997.7.389; WENDER EH, 1991, PEDIATRICS, V88, P960; Wilens TE, 2003, PEDIATRICS, V111, P179, DOI 10.1542/peds.111.1.179; Wilens TE, 2008, ARCH PEDIAT ADOL MED, V162, P916, DOI 10.1001/archpedi.162.10.916; Woloshin S, 2009, ANN INTERN MED, V150, P613, DOI 10.7326/0003-4819-150-9-200905050-00007; WOLRAICH ML, 1995, JAMA-J AM MED ASSOC, V274, P1617, DOI 10.1001/jama.274.20.1617; WOLRAICH ML, 1994, NEW ENGL J MED, V330, P301, DOI 10.1056/NEJM199402033300501; ZAMETKIN AJ, 1993, ARCH GEN PSYCHIAT, V50, P333; ZAMETKIN AJ, 1990, NEW ENGL J MED, V323, P1361, DOI 10.1056/NEJM199011153232001; Zito JM, 1999, ARCH PEDIAT ADOL MED, V153, P1257, DOI 10.1001/archpedi.153.12.1257	99	45	46	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44275	10.1371/journal.pone.0044275	http://dx.doi.org/10.1371/journal.pone.0044275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005GJ	22984483	Green Submitted, Green Published, gold			2022-12-27	WOS:000308738500042
J	Huber, O; Brunner, A; Maier, P; Kaufmann, R; Couraud, PO; Cremer, C; Fricker, G				Huber, Olga; Brunner, Alexander; Maier, Patrick; Kaufmann, Rainer; Couraud, Pierre-Olivier; Cremer, Christoph; Fricker, Gert			Localization Microscopy (SPDM) Reveals Clustered Formations of P-Glycoprotein in a Human Blood-Brain Barrier Model	PLOS ONE			English	Article							OPTICAL RECONSTRUCTION MICROSCOPY; ENDOTHELIAL-CELL LINE; MULTIDRUG TRANSPORTER; FLUORESCENT PROTEIN; SIN VECTOR; RESOLUTION; MEMBRANE; LIMIT	P-glycoprotein (Pgp; also known as MDR1, ABCB1) is the most important and best studied efflux transporter at the blood-brain barrier (BBB); however, the organization of Pgp is unknown. The aim of this study was to employ the recently developed super-resolution fluorescence microscopy method spectral precision distance microscopy/spectral position determination microscopy (SPDM) to investigate the spatial distribution of Pgp in the luminal plasma membrane of brain capillary endothelial cells. Potential disturbing effects of cell membrane curvatures on the distribution analysis are addressed with computer simulations. Immortalized human cerebral microvascular endothelial cells (hCMEC/D3) served as a model of human BBB. hCMEC/D3 cells were transduced with a Pgp-green fluorescent protein (GFP) fusion protein incorporated in a lentivirus-derived vector. The expression and localization of the Pgp-GFP fusion protein was visualized by SPDM. The limited resolution of SPDM in the z-direction leads to a projection during the imaging process affecting the appeared spatial distribution of fluorescence molecules in the super-resolution images. Therefore, simulations of molecule distributions on differently curved cell membranes were performed and their projected spatial distribution was investigated. Function of the fusion protein was confirmed by FACS analysis after incubation of cells with the fluorescent probe eFluxx-ID Gold in absence and presence of verapamil. More than 112,000 single Pgp-GFP molecules (corresponding to approximately 5,600 Pgp-GFP molecules per cell) were detected by SPDM with an averaged spatial resolution of approximately 40 nm in hCMEC/D3 cells. We found that Pgp-GFP is distributed in clustered formations in hCMEC/D3 cells while the influence of present random cell membrane curvatures can be excluded based on the simulation results. Individual formations are distributed randomly over the cell membrane.	[Huber, Olga; Cremer, Christoph; Fricker, Gert] Univ Heidelberg, Inst Pharm & Mol Biotechnol, Heidelberg, Germany; [Brunner, Alexander; Kaufmann, Rainer; Cremer, Christoph] Univ Heidelberg, Kirchhoff Inst Phys, Heidelberg, Germany; [Brunner, Alexander] German Canc Res Ctr, Dept Med Phys Radiol, Heidelberg, Germany; [Maier, Patrick] Univ Heidelberg, Mannheim Med Ctr, Dept Radiat Oncol, D-6800 Mannheim, Germany; [Kaufmann, Rainer] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Couraud, Pierre-Olivier] Univ Paris 05, Dept Cell Biol, Paris, France; [Cremer, Christoph] Inst Mol Biol, Mainz, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Oxford; UDICE-French Research Universities; Universite Paris Cite; Institute of Molecular Biology (IMB)	Huber, O (corresponding author), Univ Heidelberg, Inst Pharm & Mol Biotechnol, Heidelberg, Germany.	gert.fricker@uni-hd.de	Kaufmann, Rainer/U-6406-2019; Fricker, Gert/N-4157-2018; Kaufmann, Rainer/N-8911-2014	Kaufmann, Rainer/0000-0002-4165-0195; Fricker, Gert/0000-0003-3894-961X; Kaufmann, Rainer/0000-0002-4165-0195	University of Heidelberg	University of Heidelberg	This work has been supported by a Frontier Project grant (University of Heidelberg) to Gert Fricker and Christoph Cremer (http://www.uni-heidelberg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Annibale P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022678; Baddeley D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020645; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bornfleth H, 1998, J MICROSC-OXFORD, V189, P118, DOI 10.1046/j.1365-2818.1998.00276.x; Cremer C, 1999, 40 PRINCIPLES SPECTR; Doyle LA, 2003, ONCOGENE, V22, P7340, DOI 10.1038/sj.onc.1206938; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Kaufmann R, 2011, J MICROSC-OXFORD, V242, P46, DOI 10.1111/j.1365-2818.2010.03436.x; Kaufmann R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031128; Lebedeva IV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022429; Lemmer P, 2008, APPL PHYS B-LASERS O, V93, P1, DOI 10.1007/s00340-008-3152-x; Loscher Wolfgang, 2005, NeuroRx, V2, P86, DOI 10.1602/neurorx.2.1.86; Maier P, 2008, RADIAT RES, V169, P301, DOI 10.1667/RR1067.1; Maier P, 2010, RADIAT RES, V173, P612, DOI 10.1667/RR1952.1; Matsuda A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012768; Miller DS, 2008, PHARMACOL REV, V60, P196, DOI 10.1124/pr.107.07109; Miller DS, 2010, TRENDS PHARMACOL SCI, V31, P246, DOI 10.1016/j.tips.2010.03.003; Miller DS, 2000, MOL PHARMACOL, V58, P1357, DOI 10.1124/mol.58.6.1357; Orlowski S, 2006, CELL MOL LIFE SCI, V63, P1038, DOI 10.1007/s00018-005-5554-9; Peterman EJG, 1999, J PHYS CHEM A, V103, P10553, DOI 10.1021/jp991968o; Reymann J, 2008, CHROMOSOME RES, V16, P367, DOI 10.1007/s10577-008-1238-2; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sai Y, 1999, J CELL SCI, V112, P4535; Sharom FJ, 1997, J MEMBRANE BIOL, V160, P161, DOI 10.1007/s002329900305; Slimane TA, 2003, MOL BIOL CELL, V14, P611, DOI 10.1091/mbc.E02-08-0528; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Zastre JA, 2009, J NEUROSCI RES, V87, P1023, DOI 10.1002/jnr.21898	30	22	22	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44776	10.1371/journal.pone.0044776	http://dx.doi.org/10.1371/journal.pone.0044776			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984556	gold, Green Published, Green Submitted			2022-12-27	WOS:000308738500083
J	Lu, YT; Wang, LY; He, MY; Huang, WH; Li, H; Wang, YK; Kong, JM; Qi, ST; Ouyang, J; Qiu, XZ				Lu, Yuntao; Wang, Leyu; He, Minyi; Huang, Wenhua; Li, Hong; Wang, Yongkui; Kong, Jiming; Qi, Songtao; Ouyang, Jun; Qiu, Xiaozhong			Nix Protein Positively Regulates NF-kappa B Activation in Gliomas	PLOS ONE			English	Article							CELL-DEATH; SIGNALING PATHWAY; BNIP3; EXPRESSION; CANCER; APOPTOSIS; AUTOPHAGY; HYPOXIA; GENE; CHEMORESISTANCE	Previous reports indicate that the NIX/BNIP3L gene acts as a pro-apoptotic factor by interacting with BCL2 and BCL-XL, playing an important role in hypoxia-dependent cell death and acting as a tumor suppressor. However, many studies also showed that NIX is linked to a protective role and cell survival in cancer cells. Nuclear factor-kappa B (NF-kappa B) can attenuate apoptosis in human cancers in response to chemotherapeutic agents and ionizing radiation. We observed an absence of i-kappa B alpha (NF-kappa B activation inhibitor) expression, but a greater expression of Nix and p-NF-kappa B proteins in the Nix-wt U251 cells, which was not observed in the Nix-kn cells under hypoxic conditions. Using electrophoretic mobility shift assay (EMSA) and luciferase detection, the activation of NF-kappa B was detected only in the Nix-wt U251 cells with hypoxia. These data imply that Nix protein might play a role in the positive regulation of the NF-kappa B pathway. Moreover, 46 cases of glioma also showed high levels of Nix protein expression, which was always accompanied by high p-NF-kappa B expression. Patients with Nix (+) showed less tissue apoptosis behavior in glioblastoma (GBM), unlike that observed in the Nix-negative patients (-). The same apoptotic tendency was also identified in anaplastic astrocytoma (AA) groups, but not in astrocytoma (AS). On analyzing the Kaplan-Meier curve, better tumor-free survival was observed only in cases of astrocytoma, and not in AA and GBM. Thus, our study indicates that Nix protein might have multiple functions in regulating glioma behaviors. In the low-grade gliomas (astrocytoma) with low expression of NF-kappa B, the cell death-inducing function that occurs through a Bax mechanism might predominate and act as a tumor suppressor. While in the malignant gliomas (AA and GBM), with higher expression of the NIX gene and with activity of the NF-kappa B pathway, the oncogene function of Nix was predominant.	[Lu, Yuntao; Wang, Leyu; He, Minyi; Huang, Wenhua; Wang, Yongkui; Ouyang, Jun; Qiu, Xiaozhong] So Med Univ, Dept Anat, Key Lab Construct & Detect Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Lu, Yuntao; Li, Hong; Qi, Songtao] So Med Univ, Dept Neurosurg, Affiliated Nangfang Hosp, Guangzhou, Guangdong, Peoples R China; [He, Minyi] So Med Univ, Dept Organ Transplantat, Zhujiang Hosp, Guangzhou, Guangdong, Peoples R China; [Kong, Jiming] Univ Manitoba, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; University of Manitoba	Lu, YT (corresponding author), So Med Univ, Dept Anat, Key Lab Construct & Detect Guangdong Prov, Guangzhou, Guangdong, Peoples R China.	qqiuxzh@yahoo.com.cn	huang, wenhua/AAO-5990-2020; qiu, xiaozhong/B-8466-2014	huang, wenhua/0000-0003-2382-9180; Lu, Yuntao/0000-0003-4125-304X; Kong, Jiming/0000-0002-2859-9831	National Natural Science Foundation of China [81101921]; Science Technology Program of Guangzhou Municipality [11C32120736]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Technology Program of Guangzhou Municipality	This work was financially supported by National Natural Science Foundation of China (81101921), and Science Technology Program of Guangzhou Municipality (11C32120736). The funding is supported by the government. The government had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All study related design, data collection and analysis, decision to publish or preparation of the manuscript are finished by the authors.	Angileri FF, 2008, CANCER-AM CANCER SOC, V112, P2258, DOI 10.1002/cncr.23407; Arlt A, 2002, INT J CLIN PHARM TH, V40, P336; Bacon AL, 2007, ONCOGENE, V26, P132, DOI 10.1038/sj.onc.1209761; Bacon AL, 2004, ANN MED, V36, P530, DOI 10.1080/07853890410018231; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Coupienne I, 2010, BIOCH PHARM; Diwan A, 2007, P NATL ACAD SCI USA, V104, P6794, DOI 10.1073/pnas.0610666104; Erkan M, 2005, ONCOGENE, V24, P4421, DOI 10.1038/sj.onc.1208642; Esencay M, 2010, J NEURO-ONCOL, V99, P33, DOI 10.1007/s11060-010-0111-2; Fei PW, 2004, CANCER CELL, V6, P597, DOI 10.1016/j.ccr.2004.10.012; Galvez AS, 2006, J BIOL CHEM, V281, P1442, DOI 10.1074/jbc.M509056200; Hayashi S, 2001, NEUROL MED-CHIR, V41, P187, DOI 10.2176/nmc.41.187; Korkolopoulou P, 2008, HUM PATHOL, V39, P1143, DOI 10.1016/j.humpath.2008.01.020; Koul D, 2006, BIOCHEM BIOPH RES CO, V350, P463, DOI 10.1016/j.bbrc.2006.09.077; Lefranc F, 2005, J CLIN ONCOL, V23, P2411, DOI 10.1200/JCO.2005.03.089; Mazure NM, 2010, CURR OPIN CELL BIOL, V22, P177, DOI 10.1016/j.ceb.2009.11.015; Murai M, 2005, CLIN CANCER RES, V11, P1021; Nihei N, 1996, GENE CHROMOSOME CANC, V17, P260, DOI 10.1002/(SICI)1098-2264(199612)17:4<260::AID-GCC8>3.0.CO;2-1; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Ren YF, 2019, ANTIOXID REDOX SIGN, V31, P771, DOI 10.1089/ars.2019.7731; Sarkar FH, 2008, INT REV IMMUNOL, V27, P293, DOI 10.1080/08830180802276179; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Shen HM, 2009, APOPTOSIS, V14, P348, DOI 10.1007/s10495-009-0315-0; Sowter HM, 2001, CANCER RES, V61, P6669; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sun SY, 2004, JNCI-J NATL CANCER I, V96, P662, DOI 10.1093/jnci/djh123; Tracy K, 2007, AUTOPHAGY, V3, P616, DOI 10.4161/auto.4892; Wong MLH, 2007, J CLIN NEUROSCI, V14, P301, DOI 10.1016/j.jocn.2006.11.005; Xue J, 2010, GASTROENTEROLOGY, V138, P606, DOI 10.1053/j.gastro.2009.09.049; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Ziegler DS, 2008, J CLIN ONCOL, V26, P493, DOI 10.1200/JCO.2007.13.9717	33	8	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44559	10.1371/journal.pone.0044559	http://dx.doi.org/10.1371/journal.pone.0044559			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984526	gold, Green Submitted, Green Published			2022-12-27	WOS:000308738500065
J	Marcellin, D; Abramowski, D; Young, D; Richter, J; Weiss, A; Marcel, A; Maassen, J; Kauffmann, M; Bibel, M; Shimshek, DR; Faull, RLM; Bates, GP; Kuhn, RR; Van der Putten, PH; Schmid, P; Lotz, GP				Marcellin, David; Abramowski, Dorothee; Young, Douglas; Richter, Jens; Weiss, Andreas; Marcel, Audrey; Maassen, Julia; Kauffmann, Muriel; Bibel, Miriam; Shimshek, Derya R.; Faull, Richard L. M.; Bates, Gillian P.; Kuhn, Rainer R.; Van der Putten, P. Herman; Schmid, Peter; Lotz, Gregor P.			Fragments of HdhQ150 Mutant Huntingtin Form a Soluble Oligomer Pool That Declines with Aggregate Deposition upon Aging	PLOS ONE			English	Article							IN MOUSE MODEL; INTRANUCLEAR INCLUSIONS; NEURONAL DYSFUNCTION; POLYGLUTAMINE TRACT; TRANSGENIC MICE; DISEASE; PROTEIN; CELLS; EXON-1; PHENOTYPES	Cleavage of the full-length mutant huntingtin (mhtt) protein into smaller, soluble aggregation-prone mhtt fragments appears to be a key process in the neuropathophysiology of Huntington's Disease (HD). Recent quantification studies using TR-FRET-based immunoassays showed decreasing levels of soluble mhtt correlating with an increased load of aggregated mhtt in the aging HdhQ150 mouse brain. To better characterize the nature of these changes at the level of native mhtt species, we developed a detection method that combines size exclusion chromatography (SEC) and time-resolved fluorescence resonance energy transfer (TR-FRET) that allowed us to resolve and define the formation, aggregation and temporal dynamics of native soluble mhtt species and insoluble aggregates in the brain of the HdhQ150 knock-in mouse. We found that mhtt fragments and not full-length mhtt form oligomers in the brains of one month-old mice long before disease phenotypes and mhtt aggregate histopathology occur. As the HdhQ150 mice age, brain levels of soluble full-length mhtt protein remain similar. In contrast, the soluble oligomeric pool of mhtt fragments slightly increases during the first two months before it declines between 3 and 8 months of age. This decline inversely correlates with the formation of insoluble mhtt aggregates. We also found that the pool-size of soluble mhtt oligomers is similar in age-matched heterozygous and homozygous HdhQ150 mouse brains whereas insoluble aggregate formation is greatly accelerated in the homozygous mutant brain. The capacity of the soluble mhtt oligomer pool therefore seems exhausted already in the heterozygous state and likely kept constant by changes in flux and, as a consequence, increased rate of insoluble aggregate formation. We demonstrate that our novel findings in mice translate to human HD brain but not HD patient fibroblasts.	[Marcellin, David; Abramowski, Dorothee; Young, Douglas; Richter, Jens; Weiss, Andreas; Marcel, Audrey; Maassen, Julia; Kauffmann, Muriel; Bibel, Miriam; Shimshek, Derya R.; Kuhn, Rainer R.; Van der Putten, P. Herman; Schmid, Peter; Lotz, Gregor P.] Novartis Pharma AG, Novartis Inst BioMed Res, Basel, Switzerland; [Faull, Richard L. M.] Univ Auckland, Ctr Brain Res, Auckland 1, New Zealand; [Bates, Gillian P.] Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England	Novartis; University of Auckland; University of London; King's College London	Marcellin, D (corresponding author), Novartis Pharma AG, Novartis Inst BioMed Res, Basel, Switzerland.	gregor.lotz@novartis.com	; Bates, Gillian/E-1146-2012	Faull, Richard/0000-0003-3385-9498; Bates, Gillian/0000-0002-4041-6305; Lotz, Gregor/0000-0002-0231-5503; Shimshek, Derya/0000-0001-8602-7850	CHDI foundation	CHDI foundation	We thank the CHDI foundation for support and Taconic Artemis for providing the Rosa26 ES cell lines.	Baldo B, 2012, CHEM BIOL, V19, P264, DOI 10.1016/j.chembiol.2011.12.020; Baldo B, 2012, J BIOL CHEM, V287, P1406, DOI 10.1074/jbc.M111.294801; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Benn CL, 2005, HUM MOL GENET, V14, P3065, DOI 10.1093/hmg/ddi340; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bennett MJ, 2002, P NATL ACAD SCI USA, V99, P11634, DOI 10.1073/pnas.182393899; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Burke KA, 2011, METHODS, V53, P275, DOI 10.1016/j.ymeth.2010.12.028; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; GRAVELAND GA, 1985, SCIENCE, V227, P770, DOI 10.1126/science.3155875; Hands SL, 2010, ACTA NEUROPATHOL, V120, P419, DOI 10.1007/s00401-010-0703-0; Herrera F, 2011, PLOS CURR, V11, P3; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8; Labbadia J, 2011, J CLIN INVEST, V121, P3306, DOI 10.1172/JCI57413; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Lotz GP, 2010, J BIOL CHEM, V285, P38183, DOI 10.1074/jbc.M110.160218; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Mitsui K, 2006, METHOD ENZYMOL, V412, P63, DOI 10.1016/S0076-6879(06)12005-4; MYERS RH, 1988, NEUROLOGY, V38, P341, DOI 10.1212/WNL.38.3.341; Olshina MA, 2010, J BIOL CHEM, V285, P21807, DOI 10.1074/jbc.M109.084434; Paganetti P, 2009, CHEMBIOCHEM, V10, P1678, DOI 10.1002/cbic.200900131; Pouladi MA, 2009, BRAIN, V132, P919, DOI 10.1093/brain/awp006; Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Sathasivam K, 1999, HUM MOL GENET, V8, P813, DOI 10.1093/hmg/8.5.813; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Squitieri F, 2003, BRAIN, V126, P946, DOI 10.1093/brain/awg077; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Weiss A, 2011, ANAL BIOCHEM, V410, P304, DOI 10.1016/j.ab.2010.11.044; Weiss A, 2009, ANAL BIOCHEM, V395, P8, DOI 10.1016/j.ab.2009.08.001; Weiss A, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-11; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	43	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44457	10.1371/journal.pone.0044457	http://dx.doi.org/10.1371/journal.pone.0044457			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984513	Green Published, gold, Green Submitted			2022-12-27	WOS:000308738500060
J	Huan, ML; Zhang, B; Teng, ZH; Cui, H; Wang, JP; Liu, XY; Xia, H; Zhou, SY; Mei, QB				Huan, Menglei; Zhang, Bangle; Teng, Zenghui; Cui, Han; Wang, Jieping; Liu, Xinyou; Xia, Hui; Zhou, Siyuan; Mei, Qibing			In Vitro and In Vivo Antitumor Activity of a Novel pH-Activated Polymeric Drug Delivery System for Doxorubicin	PLOS ONE			English	Article							CELL LUNG-CANCER; MICELLES; PACLITAXEL; COPOLYMER; THERAPY; RELEASE; TARGET; GROWTH; MODEL	Background: Conventional chemotherapy agent such as doxorubicin (DOX) is of limited clinical use because of its inherently low selectivity, which can lead to systemic toxicity in normal healthy tissue. Methods: A pH stimuli-sensitive conjugate based on polyethylene glycol (PEG) with covalently attachment doxorubicin via hydrazone bond (PEG-hyd-DOX) was prepared for tumor targeting delivery system. While PEG-DOX conjugates via amid bond (PEG-ami-DOX) was synthesized as control. Results: The synthetic conjugates were confirmed by proton nuclear magnetic resonance (NMR) spectroscopy, the release profile of DOX from PEG-hyd-DOX was acid-liable for the hydrazone linkage between DOX and PEG, led to different intracellular uptake route; intracellular accumulation of PEG-hyd-DOX was higher than PEG-ami-DOX due to its pH-triggered profile, and thereby more cytotoxicity against MCF-7, MDA-MB-231 (breast cancer models) and HepG2 (hepatocellular carcinoma model) cell lines. Following the in vitro results, we xenografted MDA-MB-231 cell onto SCID mice, PEG-hyd-DOX showed stronger antitumor efficacy than free DOX and was tumor-targeting. Conclusions: Results from these in vivo experiments were consistent with our in vitro results; suggested this pH-triggered PEG-hyd-DOX conjugate could target DOX to tumor tissues and release free drugs by acidic tumor environment, which would be potent in antitumor drug delivery.	[Mei, Qibing] Fourth Mil Med Univ, Sch Pharm, State Adm Tradit Chinese Med, Key Lab Gastrointestinal Pharmacol Chinese Mat Me, Xian 710032, Peoples R China; [Huan, Menglei; Zhang, Bangle; Teng, Zenghui; Cui, Han; Zhou, Siyuan] Fourth Mil Med Univ, Sch Pharm, Dept Pharmaceut, Xian 710032, Peoples R China; [Wang, Jieping; Liu, Xinyou] Fourth Mil Med Univ, Tangdu Hosp, Dept Pharm, Xian 710032, Peoples R China; [Xia, Hui] Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Thorac Cardio Surg, Beijing, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Chinese People's Liberation Army General Hospital	Mei, QB (corresponding author), Fourth Mil Med Univ, Sch Pharm, State Adm Tradit Chinese Med, Key Lab Gastrointestinal Pharmacol Chinese Mat Me, Xian 710032, Peoples R China.	meiqibing@hotmail.com		Zhang, Bang-Le/0000-0001-9008-5391	Natural Science Foundation of Shaanxi Province [2010JM4043]	Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province)	This work was supported by the Natural Science Foundation of Shaanxi Province (2010JM4043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco E, 2007, J CONTROL RELEASE, V122, P365, DOI 10.1016/j.jconrel.2007.04.014; Chen CH, 2008, BIOSCI BIOTECH BIOCH, V72, P1586, DOI 10.1271/bbb.80096; Chen W, 2010, J CONTROL RELEASE, V142, P40, DOI 10.1016/j.jconrel.2009.09.023; Cheng C, 2008, BIOCONJUGATE CHEM, V19, P1194, DOI 10.1021/bc8000062; Cuong N.V., 2011, CANCERS, V3, P61, DOI DOI 10.3390/CANCERS3010061; Denmeade SR, 1998, CANCER RES, V58, P2537; Fox ME, 2009, MOL PHARMACEUT, V6, P1562, DOI 10.1021/mp9001206; Gettinger S, 2008, SEMIN RESP CRIT CARE, V29, P291, DOI 10.1055/s-2008-1076749; Hu FQ, 2009, BIOMATERIALS, V30, P6955, DOI 10.1016/j.biomaterials.2009.09.008; Huan ML, 2009, BIOORG MED CHEM LETT, V19, P2579, DOI 10.1016/j.bmcl.2009.03.016; Kakinoki A, 2008, BIOL PHARM BULL, V31, P103, DOI 10.1248/bpb.31.103; Kim TH, 2010, BIOMATERIALS, V31, P7386, DOI 10.1016/j.biomaterials.2010.06.004; Ko J, 2007, J CONTROL RELEASE, V123, P109, DOI 10.1016/j.jconrel.2007.07.012; Kotsakis A, 2010, EXPERT OPIN PHARMACO, V11, P2363, DOI 10.1517/14656566.2010.498581; Kukowska-Latallo JF, 2005, CANCER RES, V65, P5317, DOI 10.1158/0008-5472.CAN-04-3921; Lacroix L, 2008, EXPERT REV MOL DIAGN, V8, P167, DOI 10.1586/14737159.8.2.167; Lee ALZ, 2009, BIOMATERIALS, V30, P919, DOI 10.1016/j.biomaterials.2008.10.062; Leroux JC, 2001, J CONTROL RELEASE, V72, P71, DOI 10.1016/S0168-3659(01)00263-2; Liao D, 2011, NANOMED-NANOTECHNOL, V7, P665, DOI 10.1016/j.nano.2011.03.001; Lin JP, 2009, BIOMATERIALS, V30, P108, DOI 10.1016/j.biomaterials.2008.09.010; Murakami T, 2008, NANOMEDICINE-UK, V3, P453, DOI 10.2217/17435889.3.4.453; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Ryu BY, 2008, J BIOMAT SCI-POLYM E, V19, P311, DOI 10.1163/156856208783720994; Sethuraman VA, 2006, BIOMACROMOLECULES, V7, P64, DOI 10.1021/bm0503571; Xiong XB, 2010, BIOMATERIALS, V31, P757, DOI 10.1016/j.biomaterials.2009.09.080; Zhu SJ, 2010, BIOMATERIALS, V31, P1360, DOI 10.1016/j.biomaterials.2009.10.044	26	24	25	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e44116	10.1371/journal.pone.0044116	http://dx.doi.org/10.1371/journal.pone.0044116			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028490	Green Published, Green Submitted, gold			2022-12-27	WOS:000309554700005
J	Chen, MJ; Xu, B; Ji, WL; Qiao, SL; Hu, N; Hu, YH; Wu, W; Qiu, LL; Zhang, RY; Wang, YB; Wang, SL; Zhou, ZM; Xia, YK; Wang, XR				Chen, Minjian; Xu, Bin; Ji, Wenliang; Qiao, Shanlei; Hu, Nan; Hu, Yanhui; Wu, Wei; Qiu, Lianglin; Zhang, Ruyang; Wang, Yubang; Wang, Shoulin; Zhou, Zuomin; Xia, Yankai; Wang, Xinru			Bisphenol A Alters n-6 Fatty Acid Composition and Decreases Antioxidant Enzyme Levels in Rat Testes: A LC-QTOF-Based Metabolomics Study	PLOS ONE			English	Article							MICROSOMAL LIPID-PEROXIDATION; TANDEM MASS-SPECTROMETRY; SPERM DNA-DAMAGE; OXIDATIVE STRESS; ENVIRONMENTAL CONTAMINANTS; IN-VIVO; EXPOSURE; STEROIDOGENESIS; INFERTILITY; URINARY	Background: Male reproductive toxicity induced by exposure to bisphenol A (BPA) has been widely reported. The testes have proven to be a major target organ of BPA toxicity, so studying testicular metabolite variation holds promise for the discovery of mechanisms linked to the toxic effects of BPA on reproduction. Methodology/Principal Findings: Male Sprague-Dawley rats were orally administered doses of BPA at the levels of 0, 50 mg/kg/d for 8 weeks. We used an unbiased liquid chromatography-quadrupole time-of-flight (LC-QTOF)-based metabolomics approach to discover, identify, and analyze the variation of testicular metabolites. Two n-6 fatty acids, linoleic acid (LA) and arachidonic acid (AA) were identified as potential testicular biomarkers. Decreased levels of LA and increased levels of AA as well as AA/LA ratio were observed in the testes of the exposed group. According to these suggestions, testicular antioxidant enzyme levels were detected. Testicular superoxide dismutase (SOD) declined significantly in the exposed group compared with that in the non-exposed group, and the glutathione peroxidase (GSH-Px) as well as catalase (CAT) also showed a decreasing trend in BPA treated group. Conclusions/Significance: BPA caused testicular n-6 fatty acid composition variation and decreased antioxidant enzyme levels. This study emphasizes that metabolomics brings the promise of biomarkers identification for the discovery of mechanisms underlying reproductive toxicity.	[Chen, Minjian; Xu, Bin; Qiao, Shanlei; Hu, Yanhui; Wu, Wei; Qiu, Lianglin; Wang, Shoulin; Zhou, Zuomin; Xia, Yankai; Wang, Xinru] Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Peoples R China; [Chen, Minjian; Xu, Bin; Qiao, Shanlei; Hu, Yanhui; Wu, Wei; Qiu, Lianglin; Wang, Shoulin; Xia, Yankai; Wang, Xinru] Nanjing Med Univ, Sch Publ Hlth, Minist Educ, Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China; [Ji, Wenliang] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Hu, Nan] Bruker Daltonics Inc, Shanghai Off, Shanghai, Peoples R China; [Zhang, Ruyang] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Peoples R China; [Wang, Yubang] Nanjing Med Univ, Sch Publ Hlth, Safety Assessment & Res Ctr Drug Pesticide & Vet, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Jiangsu Provincial Center for Disease Control & Prevention; Nanjing Medical University; Nanjing Medical University	Chen, MJ (corresponding author), Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Peoples R China.	yankaixia@njmu.edu.cn; xrwang@njmu.edu.cn	Wu, Wei/C-4409-2012; Wang, Xin/AAN-8435-2021	Wu, Wei/0000-0002-0267-1284; Wang, Xin/0000-0002-4457-7376	National 973 Program [2009CB941703]; Key Project of National Natural Science Foundation of China [30930079]; National Natural Science Foundation of China [81072328]; The Key Project of MOE [211063]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National 973 Program(National Basic Research Program of China); Key Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); The Key Project of MOE; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by grants from the National 973 Program, 2009CB941703; Key Project of National Natural Science Foundation of China No. 30930079; National Natural Science Foundation of China, No. 81072328; The Key Project of MOE, No. 211063; and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 2008, ADV EXP MED BIOL, V636, P154, DOI 10.1007/978-0-387-09597-4_9; Aitken RJ, 2006, J CLIN ENDOCR METAB, V91, P4154, DOI 10.1210/jc.2006-1309; Aly HAA, 2009, FOOD CHEM TOXICOL, V47, P1733, DOI 10.1016/j.fct.2009.03.019; Appasamy M, 2007, REPROD BIOMED ONLINE, V14, P159, DOI 10.1016/S1472-6483(10)60783-3; Boudonck KJ, 2009, TOXICOL PATHOL, V37, P280, DOI 10.1177/0192623309332992; BRUNA E, 1989, LIPIDS, V24, P970, DOI 10.1007/BF02544543; Burczynski JM, 2001, FREE RADICAL BIO MED, V30, P1029, DOI 10.1016/S0891-5849(01)00497-X; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; D'Cruz SC, 2012, REPROD SCI, V19, P163, DOI 10.1177/1933719111415547; D'Cruz SC, 2012, FOOD CHEM TOXICOL, V50, P1124, DOI 10.1016/j.fct.2011.11.041; Dandekar S P, 2002, J Postgrad Med, V48, P186; DAVIS JT, 1966, BIOCHEM J, V98, P342, DOI 10.1042/bj0980342; de Catalfo GEH, 2005, CELL BIOCHEM FUNCT, V23, P175, DOI [10.1027/cbf.1135, 10.1002/cbf.1135]; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Hales DB, 2005, ANN NY ACAD SCI, V1061, P120, DOI 10.1196/annals.1336.014; Izumi Y, 2011, SYST BIOL REPROD MED, V57, P228, DOI 10.3109/19396368.2011.574248; JORDAN RA, 1982, BIOCHEM PHARMACOL, V31, P1393, DOI 10.1016/0006-2952(82)90034-X; LAWTON LJ, 1991, BIOL TRACE ELEM RES, V28, P83, DOI 10.1007/BF02863075; Li DK, 2011, FERTIL STERIL, V95, P625, DOI 10.1016/j.fertnstert.2010.09.026; Li YJ, 2009, TOXICOL SCI, V108, P427, DOI 10.1093/toxsci/kfp024; LOKESH BR, 1981, J LIPID RES, V22, P905; Mathur PP, 2011, ASIAN J ANDROL, V13, P585, DOI 10.1038/aja.2011.40; McBurney RN, 2009, TOXICOL PATHOL, V37, P52, DOI 10.1177/0192623308329287; Meeker JD, 2010, REPROD TOXICOL, V30, P532, DOI 10.1016/j.reprotox.2010.07.005; Naughton CK, 2001, HUM REPROD UPDATE, V7, P473, DOI 10.1093/humupd/7.5.473; Oresic M, 2008, TRENDS BIOTECHNOL, V26, P647, DOI 10.1016/j.tibtech.2008.09.001; Parman T, 2011, TOXICOL SCI, V124, P487, DOI 10.1093/toxsci/kfr238; Pottenger LH, 2000, TOXICOL SCI, V54, P3, DOI 10.1093/toxsci/54.1.3; Richter CA, 2007, REPROD TOXICOL, V24, P199, DOI 10.1016/j.reprotox.2007.06.004; Saradha B, 2006, ENVIRON TOXICOL PHAR, V21, P34, DOI 10.1016/j.etap.2005.06.004; Sieber M, 2009, TOXICOL SCI, V109, P336, DOI 10.1093/toxsci/kfp070; Sikka SC, 2001, CURR MED CHEM, V8, P851, DOI 10.2174/0929867013373039; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; United States Environmental Protection Agency, 2010, BISPH A ACT PLAN CAS; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Vessby B, 2002, ANN NY ACAD SCI, V967, P183; Volkel W, 2005, DRUG METAB DISPOS, V33, P1748, DOI 10.1124/dmd.105.005454; Wang XJ, 2000, J BIOL CHEM, V275, P20204, DOI 10.1074/jbc.M003113200; Ye XY, 2005, ANAL BIOANAL CHEM, V383, P638, DOI 10.1007/s00216-005-0019-4	40	23	24	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44754	10.1371/journal.pone.0044754	http://dx.doi.org/10.1371/journal.pone.0044754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024759	gold, Green Submitted, Green Published			2022-12-27	WOS:000308860100017
J	Mori, MA; Sales, VM; Motta, FL; Fonseca, RG; Alenina, N; Guadagnini, D; Schadock, I; Silva, ED; Torres, HAM; dos Santos, EL; Castro, CH; D'Almeida, V; Andreotti, S; Campana, AB; Sertie, RAL; Saad, MJA; Lima, FB; Bader, M; Pesquero, JB				Mori, Marcelo A.; Sales, Vicencia Micheline; Motta, Fabiana Louise; Fonseca, Raphael Gomes; Alenina, Natalia; Guadagnini, Dioze; Schadock, Ines; Silva, Elton Dias; Torres, Hugo A. M.; dos Santos, Edson Lucas; Castro, Charlles Heldan; D'Almeida, Vania; Andreotti, Sandra; Campana, Amanda Baron; Sertie, Rogerio A. L.; Saad, Mario J. A.; Lima, Fabio Bessa; Bader, Michael; Pesquero, Joao Bosco			Kinin B1 Receptor in Adipocytes Regulates Glucose Tolerance and Predisposition to Obesity	PLOS ONE			English	Article							SYSTEMIC INSULIN-RESISTANCE; ADIPOSE-TISSUE; GLUT4 TRANSLOCATION; B-2 RECEPTOR; BRADYKININ; MUSCLE; ADIPONECTIN; METABOLISM; INHIBITION; EXPRESSION	Background: Kinins participate in the pathophysiology of obesity and type 2 diabetes by mechanisms which are not fully understood. Kinin B-1 receptor knockout mice (B-1(-/-)) are leaner and exhibit improved insulin sensitivity. Methodology/Principal Findings: Here we show that kinin B-1 receptors in adipocytes play a role in controlling whole body insulin action and glucose homeostasis. Adipocytes isolated from mouse white adipose tissue (WAT) constitutively express kinin B-1 receptors. In these cells, treatment with the B-1 receptor agonist des-Arg(9)-bradykinin improved insulin signaling, GLUT4 translocation, and glucose uptake. Adipocytes from B-1(-/-) mice showed reduced GLUT4 expression and impaired glucose uptake at both basal and insulin-stimulated states. To investigate the consequences of these phenomena to whole body metabolism, we generated mice where the expression of the kinin B-1 receptor was limited to cells of the adipose tissue (aP2-B-1/B-1(-/-)). Similarly to B-1(-/-) mice, aP2-B-1/B-1(-/-) mice were leaner than wild type controls. However, exclusive expression of the kinin B1 receptor in adipose tissue completely rescued the improved systemic insulin sensitivity phenotype of B-1(-/-) mice. Adipose tissue gene expression analysis also revealed that genes involved in insulin signaling were significantly affected by the presence of the kinin B-1 receptor in adipose tissue. In agreement, GLUT4 expression and glucose uptake were increased in fat tissue of aP2-B-1/B-1(-/-) when compared to B-1(-/-) mice. When subjected to high fat diet, aP2-B-1/B-1(-/-) mice gained more weight than B-1(-/-) littermates, becoming as obese as the wild types. Conclusions/Significance: Thus, kinin B-1 receptor participates in the modulation of insulin action in adipocytes, contributing to systemic insulin sensitivity and predisposition to obesity.	[Mori, Marcelo A.; Sales, Vicencia Micheline; Motta, Fabiana Louise; Fonseca, Raphael Gomes; Silva, Elton Dias; Torres, Hugo A. M.; dos Santos, Edson Lucas; Pesquero, Joao Bosco] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil; [Alenina, Natalia; Schadock, Ines; Saad, Mario J. A.; Bader, Michael] Max Delbruck Ctr Mol Med MDC, Berlin, Germany; [Guadagnini, Dioze] Univ Estadual Campinas, Dept Internal Med, Campinas, SP, Brazil; [Castro, Charlles Heldan] Univ Fed Sao Paulo, Dept Med, Sao Paulo, Brazil; [D'Almeida, Vania] Univ Fed Sao Paulo, Dept Biosci, Sao Paulo, Brazil; [Andreotti, Sandra; Campana, Amanda Baron; Sertie, Rogerio A. L.; Lima, Fabio Bessa] Univ Sao Paulo, Dept Physiol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Universidade Estadual de Campinas; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Mori, MA (corresponding author), Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil.	jbpesquero@unifesp.br	D'Almeida, Vania/AAB-7115-2020; Lima, Fabio Bessa/H-2677-2014; Lima, Fabio/L-5634-2019; Castro, Charlles HM/C-1594-2012; Sertié, Rogerio/H-2701-2014; dos Santos, Edson Lucas/AAU-5857-2020; Santos, Edson/C-6820-2014; D'Almeida, Vânia/AAV-3955-2020; Bader, Michael/K-2124-2013; Saad, Mario/ABD-8262-2020; Mori, Marcelo A/R-2881-2018	Lima, Fabio Bessa/0000-0003-0573-9544; Castro, Charlles HM/0000-0001-9144-996X; dos Santos, Edson Lucas/0000-0002-6557-7914; Santos, Edson/0000-0002-6557-7914; D'Almeida, Vânia/0000-0003-0947-5312; Mori, Marcelo A/0000-0001-7112-5263; Motta, Fabiana/0000-0003-2230-995X; Schadock, Ines/0000-0002-6717-6276; Bader, Michael/0000-0003-4780-4164	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes); Deutsche Forschungsgemeinschaft [BA1374/16-1]; German Ministry of Education and Science [BRA09/014]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Ministry of Education and Science	This work was supported by grants of the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes), Deutsche Forschungsgemeinschaft (BA1374/16-1) and the German Ministry of Education and Science (BRA09/014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo RC, 2006, BIOL CHEM, V387, P431, DOI 10.1515/BC.2006.057; Arner P, 2003, TRENDS ENDOCRIN MET, V14, P137, DOI 10.1016/S1043-2760(03)00024-9; Beard KM, 2006, DIABETES, V55, P2678, DOI 10.2337/db05-1538; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Bogan JS, 2001, MOL CELL BIOL, V21, P4785, DOI 10.1128/MCB.21.14.4785-4806.2001; Calixto JB, 2004, BRIT J PHARMACOL, V143, P803, DOI 10.1038/sj.bjp.0706012; Alonso-Vale MIC, 2008, J PINEAL RES, V45, P422, DOI 10.1111/j.1600-079X.2008.00610.x; Cassis LA, 2008, CURR HYPERTENS REP, V10, P93, DOI 10.1007/s11906-008-0019-9; DEBLASI A, 1989, TRENDS PHARMACOL SCI, V10, P227, DOI 10.1016/0165-6147(89)90266-6; Dias JP, 2012, DIABETES OBES METAB, V14, P244, DOI 10.1111/j.1463-1326.2011.01521.x; DIETZE G, 1977, KLIN WOCHENSCHR, V55, P357, DOI 10.1007/BF01488118; Dietze GJ, 1996, DIABETES, V45, pS110, DOI 10.2337/diab.45.1.S110; Duka A, 2008, HYPERTENSION, V51, P1352, DOI 10.1161/HYPERTENSIONAHA.107.108506; Duka I, 2001, HYPERTENSION, V38, P1355, DOI 10.1161/hy1201.096574; Isami S, 1996, DIABETOLOGIA, V39, P412, DOI 10.1007/s001250050460; Kishi K, 1998, DIABETES, V47, P550, DOI 10.2337/diabetes.47.4.550; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; LIMA FB, 1994, DIABETES, V43, P53, DOI 10.2337/diabetes.43.1.53; MCCONNELL HM, 1992, SCIENCE, V257, P1906, DOI 10.1126/science.1329199; Merino VF, 2009, J MOL MED, V87, P953, DOI 10.1007/s00109-009-0501-0; Miyata T, 1998, EUR J ENDOCRINOL, V138, P344, DOI 10.1530/eje.0.1380344; Mori MA, 2008, DIABETES, V57, P1491, DOI 10.2337/db07-1508; Mori MA, 2010, DIABETES, V59, P2960, DOI 10.2337/db10-0367; Pesquero JB, 2000, P NATL ACAD SCI USA, V97, P8140, DOI 10.1073/pnas.120035997; Prada PO, 2007, DIABETOLOGIA, V50, P1949, DOI 10.1007/s00125-007-0723-z; RODBELL M, 1964, J BIOL CHEM, V239, P375; ROSS SR, 1990, P NATL ACAD SCI USA, V87, P9590, DOI 10.1073/pnas.87.24.9590; Shi H, 2006, DIABETES, V55, P699, DOI 10.2337/diabetes.55.03.06.db05-0841; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Trayhurn P, 2001, P NUTR SOC, V60, P329, DOI 10.1079/PNS200194; Waki H, 2007, ANNU REV PATHOL-MECH, V2, P31, DOI 10.1146/annurev.pathol.2.010506.091859; Xu HY, 2002, ENDOCRINOLOGY, V143, P1502, DOI 10.1210/en.143.4.1502; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yang WS, 2001, J CLIN ENDOCR METAB, V86, P3815, DOI 10.1210/jc.86.8.3815; Zuccollo A, 1999, IMMUNOPHARMACOLOGY, V45, P69, DOI 10.1016/S0162-3109(99)00149-6	37	25	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44782	10.1371/journal.pone.0044782	http://dx.doi.org/10.1371/journal.pone.0044782			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024762	Green Published, Green Accepted, gold			2022-12-27	WOS:000308860100020
J	Palazzo, C; Ravaud, JF; Trinquart, L; Dalichampt, M; Ravaud, P; Poiraudeau, S				Palazzo, Clemence; Ravaud, Jean-Francois; Trinquart, Ludovic; Dalichampt, Marie; Ravaud, Philippe; Poiraudeau, Serge			Respective Contribution of Chronic Conditions to Disability in France: Results from the National Disability-Health Survey	PLOS ONE			English	Article							ATTRIBUTABLE FRACTIONS; SELF-REPORT; PEOPLE; RISK; AGREEMENT; DISEASE; IMPACT	Background: Representative national data on disability are becoming increasingly important in helping policymakers decide on public health strategies. We assessed the respective contribution of chronic health conditions to disability for three age groups (18-40, 40-65, and >65 years old) using data from the 2008-2009 Disability-Health Survey in France. Methods: Data on 12 chronic conditions and on disability for 24,682 adults living in households were extracted from the Disability-Health Survey results. A weighting factor was applied to obtain representative estimates for the French population. Disability was defined as at least one restriction in activities of daily living (ADL), severe disability as the inability to perform at least one ADL alone, and self-reported disability as a general feeling of being disabled. To account for comorbidities, we assessed the contribution of each chronic disorder to disability by using the average attributable fraction (AAF). Findings: We estimated that 38.8 million people in France (81.7% [95% CI 80.9; 82.6]) had a chronic condition: 14.3% (14.0; 14.6) considered themselves disabled, 4.6% (4.4;4.9) were restricted in ADL and 1.7% (1.5;1.8) were severely disabled. Musculoskeletal and sensorial impairments contributed the most to self-reported disability (AAF 15.4% and 12.3%). Neurological and musculoskeletal diseases had the largest impact on disability (AAF 17.4% and 16.4%, respectively). Neurological disorders contributed the most to severe disability (AAF 31.0%). Psychiatric diseases contributed the most to disability categories for patients 18-40 years old (AAFs 23.8%-40.3%). Cardiovascular conditions were also among the top four contributors to disability categories (AAFs 8.5%-11.1%). Conclusions: Neurological, musculoskeletal, and cardiovascular chronic disorders mainly contribute to disability in France. Psychiatric impairments have a heavy burden for people 18-40 years old. These findings should help policymakers define priorities for health-service delivery in France and perhaps other developed countries.	[Palazzo, Clemence; Trinquart, Ludovic; Dalichampt, Marie; Ravaud, Philippe] INSERM, U738, Paris, France; [Palazzo, Clemence; Trinquart, Ludovic; Dalichampt, Marie; Ravaud, Philippe] Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, F-75181 Paris, France; [Palazzo, Clemence; Ravaud, Philippe; Poiraudeau, Serge] Univ Paris 05, PRES, Paris, France; [Palazzo, Clemence; Poiraudeau, Serge] Hop Cochin, AP HP, Serv Reeduc & Readaptat Appareil Locomoteur & Pat, F-75674 Paris, France; [Ravaud, Jean-Francois; Poiraudeau, Serge] INSERM, Inst Federatif Rech Handicap, Paris, France; [Ravaud, Jean-Francois] INSERM, U988, Villejuif, France; [Ravaud, Jean-Francois] CNRS, UMR 8211, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); UDICE-French Research Universities; Universite Paris Cite	Palazzo, C (corresponding author), INSERM, U738, Paris, France.	clemence.palazzo@cch.aphp.fr	RAVAUD, Jean-François/F-7190-2013; POIRAUDEAU, SERGE/P-5301-2016; ravaud, philippe/C-1694-2009; Trinquart, Ludovic/H-4961-2019	RAVAUD, Jean-François/0000-0003-3959-4195; Trinquart, Ludovic/0000-0002-3028-4900; Poiraudeau, Serge/0000-0002-1988-9124; Ravaud, Philippe/0000-0001-8264-9206	French National Institute of Statistics and Economic Studies (INSEE); French Head Office of Research, Studies, Evaluation and Statistics (DREES) of the Social Affairs Ministry [PA 11/R 10100LL]; Pfizer France	French National Institute of Statistics and Economic Studies (INSEE); French Head Office of Research, Studies, Evaluation and Statistics (DREES) of the Social Affairs Ministry; Pfizer France(Pfizer)	This work was supported by the French National Institute of Statistics and Economic Studies (INSEE) and the French Head Office of Research, Studies, Evaluation and Statistics (DREES) of the Social Affairs Ministry (contract PA 11/R 10100LL). The French National Institute of Statistics and Economic Studies (INSEE) and the French Head Office of Research, Studies, Evaluation and Statistics (DREES) of the Social Affairs Ministry had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received a grant from Pfizer France, which had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aijanseppa S, 2005, J EPIDEMIOL COMMUN H, V59, P413, DOI 10.1136/jech.2004.026302; Allonier C, 2007, B INFORM EC SANTE, P123; [Anonymous], 2011, LANCET, V377, P1977, DOI 10.1016/S0140-6736(11)60844-1; [Anonymous], 2007, TRENDS SEVERE DISABI; Australian Institute of Health and Welfare, 2004, DIS ITS REL HLTH CON; Baumeister H, 2010, J CLIN EPIDEMIOL, V63, P558, DOI 10.1016/j.jclinepi.2009.08.009; EIDE GE, 1995, J CLIN EPIDEMIOL, V48, P645, DOI 10.1016/0895-4356(94)00161-I; FLEISS JL, 1979, AM J EPIDEMIOL, V110, P103, DOI 10.1093/oxfordjournals.aje.a112794; Goillot C, 2003, ENQUETES HANDICAPS I; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Gregory PC, 2011, J GERONTOL A; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kieling C, 2011, LANCET, V378, P1515, DOI 10.1016/S0140-6736(11)60827-1; Knight M, 2001, J PUBLIC HEALTH MED, V23, P179, DOI 10.1093/pubmed/23.3.179; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; Lund R, 2010, AGE AGEING, V39, P319, DOI 10.1093/ageing/afq020; Moe JO, 2011, EUR J AGEING, V8, P49, DOI 10.1007/s10433-011-0179-3; Nerich V, 2006, INFLAMM BOWEL DIS, V12, P218, DOI 10.1097/01.MIB.0000206540.38834.8c; Noel Delphine, 2012, Rev Prat, V62, P38; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Participation and Activity Limitation Survey 2006, 2006, PART ACT LIM SURV 20; Peng XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012129; Perruccio AV, 2007, J EPIDEMIOL COMMUN H, V61, P1056, DOI 10.1136/jech.2006.047308; Ravaud JF, 2002, POPULATION, V57, P541, DOI 10.2307/1535058; Ruckinger S, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-7; SAS Institute, 2008, INTR SURV SAMPL AN P; Sousa RM, 2009, LANCET, V374, P1821, DOI 10.1016/S0140-6736(09)61829-8; WHO, 2007, INT CLASS DIS ICD; WHO, 2001, WHO INT CLASS FUNCT; World Health Organisation, 2004, WHO REG EST 2004; Wray LA, 2001, GERONTOLOGIST, V41, P499, DOI 10.1093/geront/41.4.499	31	35	37	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44994	10.1371/journal.pone.0044994	http://dx.doi.org/10.1371/journal.pone.0044994			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	007AD	23024781	gold, Green Submitted, Green Published			2022-12-27	WOS:000308860100039
J	Willcock, S; Phillips, OL; Platts, PJ; Balmford, A; Burgess, ND; Lovett, JC; Ahrends, A; Bayliss, J; Doggart, N; Doody, K; Fanning, E; Green, J; Hall, J; Howell, KL; Marchant, R; Marshall, AR; Mbilinyi, B; Munishi, PKT; Owen, N; Swetnam, RD; Topp-Jorgensen, EJ; Lewis, SL				Willcock, Simon; Phillips, Oliver L.; Platts, Philip J.; Balmford, Andrew; Burgess, Neil D.; Lovett, Jon C.; Ahrends, Antje; Bayliss, Julian; Doggart, Nike; Doody, Kathryn; Fanning, Eibleis; Green, Jonathan; Hall, Jaclyn; Howell, Kim L.; Marchant, Rob; Marshall, Andrew R.; Mbilinyi, Boniface; Munishi, Pantaleon K. T.; Owen, Nisha; Swetnam, Ruth D.; Topp-Jorgensen, Elmer J.; Lewis, Simon L.			Towards Regional, Error-Bounded Landscape Carbon Storage Estimates for Data-Deficient Areas of the World	PLOS ONE			English	Article							EASTERN ARC MOUNTAINS; LAND-USE CHANGE; MIOMBO WOODLANDS; BIOMASS DYNAMICS; FOREST STRUCTURE; NUTRIENT STOCKS; EMISSIONS; SOIL; DEFORESTATION; PLANTATIONS	Monitoring landscape carbon storage is critical for supporting and validating climate change mitigation policies. These may be aimed at reducing deforestation and degradation, or increasing terrestrial carbon storage at local, regional and global levels. However, due to data-deficiencies, default global carbon storage values for given land cover types such as 'lowland tropical forest' are often used, termed 'Tier 1 type' analyses by the Intergovernmental Panel on Climate Change (IPCC). Such estimates may be erroneous when used at regional scales. Furthermore uncertainty assessments are rarely provided leading to estimates of land cover change carbon fluxes of unknown precision which may undermine efforts to properly evaluate land cover policies aimed at altering land cover dynamics. Here, we present a repeatable method to estimate carbon storage values and associated 95% confidence intervals (CI) for all five IPCC carbon pools (aboveground live carbon, litter, coarse woody debris, belowground live carbon and soil carbon) for data-deficient regions, using a combination of existing inventory data and systematic literature searches, weighted to ensure the final values are regionally specific. The method meets the IPCC 'Tier 2' reporting standard. We use this method to estimate carbon storage over an area of 33.9 million hectares of eastern Tanzania, reporting values for 30 land cover types. We estimate that this area stored 6.33 (5.92-6.74) Pg C in the year 2000. Carbon storage estimates for the same study area extracted from five published Africa-wide or global studies show a mean carbon storage value of similar to 50% of that reported using our regional values, with four of the five studies reporting lower carbon storage values. This suggests that carbon storage may have been underestimated for this region of Africa. Our study demonstrates the importance of obtaining regionally appropriate carbon storage estimates, and shows how such values can be produced for a relatively low investment.	[Willcock, Simon; Phillips, Oliver L.; Owen, Nisha; Lewis, Simon L.] Univ Leeds, Leeds, W Yorkshire, England; [Platts, Philip J.; Balmford, Andrew; Bayliss, Julian; Green, Jonathan; Swetnam, Ruth D.] Univ Cambridge, Cambridge, England; [Platts, Philip J.; Marchant, Rob; Marshall, Andrew R.] Univ York, York YO10 5DD, N Yorkshire, England; [Burgess, Neil D.] WWF US, Washington, DC USA; [Burgess, Neil D.; Topp-Jorgensen, Elmer J.] Univ Copenhagen, Copenhagen, Denmark; [Lovett, Jon C.] Univ Twente, NL-7500 AE Enschede, Netherlands; [Ahrends, Antje] Royal Bot Gardens, Edinburgh, Midlothian, Scotland; [Doggart, Nike] Tanzanian Forest Conservat Grp, Dar Es Salaam, Tanzania; [Doody, Kathryn] Frankfurt Zool Soc, Frankfurt, Germany; [Fanning, Eibleis; Owen, Nisha] Soc Environm Explorat, London, England; [Hall, Jaclyn] Univ Louvain, Louvain, Belgium; [Howell, Kim L.] Univ Dar Es Salaam, Dar Es Salaam, Tanzania; [Marshall, Andrew R.] Flamingo Land Ltd, Malton, England; [Mbilinyi, Boniface; Munishi, Pantaleon K. T.] Sokoine Univ Agr, Morogoro, Tanzania; [Lewis, Simon L.] UCL, London, England	University of Leeds; University of Cambridge; University of York - UK; World Wildlife Fund; University of Copenhagen; University of Twente; Royal Botanic Gardens, Kew; University of Dar es Salaam; Sokoine University of Agriculture; University of London; University College London	Willcock, S (corresponding author), Univ Leeds, Leeds, W Yorkshire, England.	gysw@leeds.ac.uk	Green, Jonathan M H/D-7081-2017; Lewis, Simon/I-9025-2012; Swetnam, Ruth D/I-2848-2017; Phillips, Oliver/A-1523-2011; Topp-Jørgensen, Elmer/N-6198-2019; Platts, Philip J./C-2002-2009; Topp-Jørgensen, Elmer/I-7488-2013	Swetnam, Ruth D/0000-0002-5199-9622; Phillips, Oliver/0000-0002-8993-6168; Topp-Jørgensen, Elmer/0000-0002-5050-9273; Platts, Philip J./0000-0002-0153-0121; Green, Jonathan/0000-0002-5003-0203; Hall, Jaclyn/0000-0002-5289-5585; Balmford, Andrew/0000-0002-0144-3589; Marchant, Robert/0000-0001-5013-4056; Willcock, Simon/0000-0001-9534-9114; Lewis, Simon/0000-0002-8066-6851; Bayliss, Julian/0000-0002-1480-294X	Leverhulme Trust; Royal Society University Research Fellowship; Stokenchurch Charity; Udzungwa Forest Project; WWF Tanzania Programme Office, through the Critical Ecosystem Partnership Fund	Leverhulme Trust(Leverhulme Trust); Royal Society University Research Fellowship(Royal Society of London); Stokenchurch Charity; Udzungwa Forest Project; WWF Tanzania Programme Office, through the Critical Ecosystem Partnership Fund	This study is part of the Valuing the Arc research programme (http://valuingthearc.org/) funded by the Leverhulme Trust (http://www.leverhulme.ac.uk/). Simon L. Lewis was funded by a Royal Society University Research Fellowship; Simon Willcock additionally by the Stokenchurch Charity; Andrew R. Marshall received additional funding from the Udzungwa Forest Project and WWF Tanzania Programme Office, through the Critical Ecosystem Partnership Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002142; Ahrends A, 2010, P NATL ACAD SCI USA, V107, P14556, DOI 10.1073/pnas.0914471107; Baccini A, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/4/045011; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; Baker TR, 2004, GLOBAL CHANGE BIOL, V10, P545, DOI 10.1111/j.1365-2486.2004.00751.x; Batjes N. H., 2004, SOTER BASED SOIL PAR; Burgess ND, 2007, BIOL CONSERV, V134, P209, DOI 10.1016/j.biocon.2006.08.015; Burgess ND, 2010, ORYX, V44, P339, DOI 10.1017/S0030605310000554; Cadavid LF, 1998, FIELD CROP RES, V57, P45, DOI 10.1016/S0378-4290(97)00114-7; Chamshama SAO, 1980, THINNING PINUS PATUL; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Clark DB, 2000, FOREST ECOL MANAG, V137, P185, DOI 10.1016/S0378-1127(99)00327-8; de Boer WF, 2000, AQUAT BOT, V66, P225, DOI 10.1016/S0304-3770(99)00072-8; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; DESHMUKH I, 1986, J APPL ECOL, V23, P115, DOI 10.2307/2403085; Doherty RM, 2010, GLOBAL CHANGE BIOL, V16, P617, DOI 10.1111/j.1365-2486.2009.01997.x; Economic Research Bureau, 2006, STUD EST MECH PAYM W; Eggleston S., 2006, 2006 IPCC GUIDELINES, V5; Ek TM, 1994, THESIS AGR U NORWAY; FORCONSULT, 2005, FOR COND ASS E ARC M; Garcia-Oliva F, 2004, CLIMATIC CHANGE, V65, P347, DOI 10.1023/B:CLIM.0000038211.84327.d9; Gibbs HK, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045023; *GLC, 2003, GLOB LAND COV 2000 D; Glenday J, 2008, ENVIRON MONIT ASSESS, V142, P85, DOI 10.1007/s10661-007-9910-0; Glenday J, 2006, FOREST ECOL MANAG, V235, P72, DOI 10.1016/j.foreco.2006.08.014; Gullison RE, 2007, SCIENCE, V316, P985, DOI 10.1126/science.1136163; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Harris NL, 2012, SCIENCE, V336, P1573, DOI 10.1126/science.1217962; Hartemink AE, 2004, AGROFOREST SYST, V63, P33, DOI 10.1023/B:AGFO.0000049431.12758.01; Hartemink AE, 1997, LAND DEGRAD DEV, V8, P305, DOI 10.1002/(SICI)1099-145X(199712)8:4<305::AID-LDR261>3.0.CO;2-0; Houghton RA, 2001, GLOBAL CHANGE BIOL, V7, P731, DOI 10.1046/j.1365-2486.2001.00426.x; [HTSL Forest Resources Management Project], 1997, NAT REC LEV LAND US; Hurtt GC, 2006, GLOBAL CHANGE BIOL, V12, P1208, DOI 10.1111/j.1365-2486.2006.01150.x; IPCC, 2006, GUID NAT GREENH GAS; ISRIC, 2010, SOTER WISE BASED SOI; Jones MB, 1997, J TROP ECOL, V13, P347, DOI 10.1017/S0266467400010555; Kairo JG, 2008, FOREST ECOL MANAG, V255, P2670, DOI 10.1016/j.foreco.2008.01.031; Kamau DM, 2008, PLANT SOIL, V307, P29, DOI 10.1007/s11104-008-9576-6; Kaonga ML, 2005, THESIS U CAMBRIDGE; Kraenzel M, 2002, FOREST ECOL MANAG, V5863, P1; Lal R, 2005, FOREST ECOL MANAG, V220, P242, DOI 10.1016/j.foreco.2005.08.015; Lal R, 2001, ADV SOIL SCI ASSESSM; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Lioubimtseva E, 1998, GLOBAL PLANET CHANGE, V17, P95, DOI 10.1016/S0921-8181(98)00015-0; LOVETT J C, 1990, Mitteilungen aus dem Institut fuer Allgemeine Botanik Hamburg, V23, P287; Manlay RJ, 2002, AGR ECOSYST ENVIRON, V88, P215, DOI 10.1016/S0167-8809(01)00218-3; Marshall N. T, 1998, SEARCHING CURE CONSE, P112; Martin AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023533; Michelsen A, 2004, SOIL BIOL BIOCHEM, V36, P1707, DOI 10.1016/j.soilbio.2004.04.028; Mills A. J., 2005, South African Journal of Plant and Soil, V22, P183; Mitchard ETA, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/049001; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Mshandete AM, 2008, ELECTRON J BIOTECHN, V11, DOI 10.2225/vol10-issue4-fulltext-7; Munishi PKT, 2004, J TROP FOR SCI, V16, P78; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; [NBS National Bureau of Statistics Ministry of Planning Economy and Empowerment], 2006, TANZ CENS 2002 AN RE, VX, P193; Nunifu TK, 1997, THESIS LAKEHEAD U TH; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Penman J., 2003, Definitions and methodological options to inventory emissions from direct human-induced degradation of forests and devegetation of other vegetation types; Pfliegner K, 2005, ARC J, V19, P11; Phillips OL, 2008, PHILOS T R SOC B, V363, P1819, DOI 10.1098/rstb.2007.0033; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Platts PJ, 2011, ENVIRON CONSERV, V38, P312, DOI 10.1017/S0376892911000191; Platts PJ, ECOGRAPHY IN PRESS; Prentice Iain Colin, 2001, CARBON CYCLE ATMOSPH; Ramankutty N, 2007, GLOBAL CHANGE BIOL, V13, P51, DOI 10.1111/j.1365-2486.2006.01272.x; Rossi J, 2009, CATENA, V77, P19, DOI 10.1016/j.catena.2008.12.003; Ruesch A. S., 2008, NEW IPCC TIERL GLOBA; RUTHERFORD MC, 1993, ECOL MODEL, V67, P129, DOI 10.1016/0304-3800(93)90002-A; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Saunders M. J., 2007, Wetlands Ecology and Management, V15, P489, DOI 10.1007/s11273-007-9051-9; Schlesinger WH., 1998, BIOGEOCHEMISTRY ANAL, V73, P353, DOI 10.1016/0016-7037(92)90106-s; Scholes RJ, 1993, AFRICAN SAVANNAS SYN; SCHROEDER P, 1994, AGROFOREST SYST, V27, P89, DOI 10.1007/BF00704837; SCHROTH G, 1995, AGROFOREST SYST, V31, P181, DOI 10.1007/BF00711725; Shirima DD, 2011, AFR J ECOL, V49, P332, DOI 10.1111/j.1365-2028.2011.01269.x; Sierra CA, 2007, FOREST ECOL MANAG, V243, P299, DOI 10.1016/j.foreco.2007.03.026; Slim FJ, 1996, MAR FRESHWATER RES, V47, P999, DOI 10.1071/MF9960999; Smidansky ED, 2003, PLANTA, V216, P656, DOI 10.1007/s00425-002-0897-z; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; STEINKE TD, 1995, HYDROBIOLOGIA, V295, P159, DOI 10.1007/BF00029123; STOORVOGEL JJ, 1993, FERT RES, V35, P227, DOI 10.1007/BF00750641; STROMGAARD P, 1985, FOREST ECOL MANAG, V12, P163, DOI 10.1016/0378-1127(85)90089-1; Swetnam RD, 2011, J ENVIRON MANAGE, V92, P563, DOI 10.1016/j.jenvman.2010.09.007; Topp-Jorgensen E, 2005, BIODIVERS CONSERV, V14, P2653, DOI 10.1007/s10531-005-8399-5; Tothill JC, 1985, 2 INT SAV S CSIRO BR; TWILLEY RR, 1992, WATER AIR SOIL POLL, V64, P265, DOI 10.1007/BF00477106; Unruh J. D., 1993, Climate Research, V3, P39, DOI 10.3354/cr003039; Vagen TG, 2005, LAND DEGRAD DEV, V16, P53, DOI 10.1002/ldr.644; van der Werf GR, 2009, NAT GEOSCI, V2, P737, DOI 10.1038/ngeo671; Wagner F., 2003, IPCC GOOD PRACTICE G; Wauters JB, 2008, FOREST ECOL MANAG, V255, P2347, DOI 10.1016/j.foreco.2007.12.038; WOOMER PL, 1993, WATER AIR SOIL POLL, V70, P403, DOI 10.1007/BF01105011; Zahabu E, 2006, HANDEI VILLAGE FORES; Zahabu E, 2006, KITULANGALO FOREST A; Zanne A.E., 2009, GLOBAL WOOD DENSITY, DOI [DOI 10.5061/DRYAD.234, 10.5061/dryad.234]; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	97	21	22	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44795	10.1371/journal.pone.0044795	http://dx.doi.org/10.1371/journal.pone.0044795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024764	Green Published, Green Accepted, gold			2022-12-27	WOS:000308860100022
J	Brummel-Ziedins, KE; Orfeo, T; Callas, PW; Gissel, M; Mann, KG; Bovill, EG				Brummel-Ziedins, Kathleen E.; Orfeo, Thomas; Callas, Peter W.; Gissel, Matthew; Mann, Kenneth G.; Bovill, Edwin G.			The Prothrombotic Phenotypes in Familial Protein C Deficiency Are Differentiated by Computational Modeling of Thrombin Generation	PLOS ONE			English	Article							RECURRENT VENOUS THROMBOEMBOLISM; DEEP-VEIN THROMBOSIS; BLOOD-COAGULATION; ANTICOAGULANT PATHWAY; PULMONARY-EMBOLISM; ANTITHROMBIN-III; LINKAGE ANALYSIS; PLASMA FACTOR; RISK; THROMBOPHILIA	The underlying cause of thrombosis in a large protein C (PC) deficient Vermont kindred appears to be multicausal and not explained by PC deficiency alone. We evaluated the contribution of coagulation factors to thrombin generation in this population utilizing a mathematical model that incorporates a mechanistic description of the PC pathway. Thrombin generation profiles for each individual were generated with and without the contribution of the PC pathway. Parameters that describe thrombin generation: maximum level (MaxL) and rate (MaxR), their respective times (TMaxL, TMaxR), area under the curve (AUC) and clotting time (CT) were examined in individuals +/- PC mutation, +/- prothrombin G20210A polymorphism and +/- thrombosis history (DVT or PE). This family (n = 364) is shifted towards greater thrombin generation relative to the mean physiologic control. When this family was analyzed with the PC pathway, our results showed that: carriers of the PC mutation (n = 81) had higher MaxL and MaxR and greater AUC (all p<0.001) than non-carriers (n = 283); and individuals with a DVT and/or PE history (n = 13) had higher MaxL (p = 0.005) and greater AUC (p<0.001) than individuals without a thrombosis history (n = 351). These differences were further stratified by gender, with women in all categories generating more thrombin than males. These results show that all individuals within this family with or without PC deficiency have an increased baseline procoagulant potential reflective of increased thrombin generation. In addition, variations within the plasma composition of each individual can further segregate out increased procoagulant phenotypes, with gender-associated plasma compositional differences playing a large role.	[Brummel-Ziedins, Kathleen E.; Orfeo, Thomas; Gissel, Matthew; Mann, Kenneth G.] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA; [Bovill, Edwin G.] Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA; [Callas, Peter W.] Univ Vermont, Dept Math & Stat, Burlington, VT 05405 USA	University of Vermont; University of Vermont; University of Vermont	Brummel-Ziedins, KE (corresponding author), Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA.	Kathleen.brummel@uvm.edu			National Institutes of Health [HL46703]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Program Project grant HL46703 (Project 5) from the National Institutes of Health (KBZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAART CF, 1995, BRIT MED J, V311, P910; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Berntorp E, 2008, SEMIN THROMB HEMOST, V34, P670, DOI 10.1055/s-0028-1104546; BOVILL EG, 1989, BLOOD, V73, P712; Bovill EG, 1999, THROMB HAEMOSTASIS, V82, P662; Bovill EG, 2000, THROMB HAEMOSTASIS, V83, P366; Bravo MC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-45; Brummel KE, 2002, BLOOD, V100, P148, DOI 10.1182/blood.V100.1.148; Brummel-Ziedins K, 2008, J THROMB HAEMOST, V6, P104; Brummel-Ziedins K, 2005, J THROMB HAEMOST, V3, P1472, DOI 10.1111/j.1538-7836.2005.01249.x; Brummel-Ziedins KE, 2005, J THROMB HAEMOST, V3, P2497, DOI 10.1111/j.1538-7836.2005.01584.x; Butenas S, 2004, J BIOL CHEM, V279, P22875, DOI 10.1074/jbc.M400531200; Chatterjee MS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000950; Christiansen SC, 2010, J THROMB HAEMOST, V8, P2159, DOI 10.1111/j.1538-7836.2010.03994.x; Cote HCF, 1997, J BIOL CHEM, V272, P6194, DOI 10.1074/jbc.272.10.6194; DAHLBACK B, 1993, P NATL ACAD SCI USA, V90, P1004, DOI 10.1073/pnas.90.3.1004; Dahlback B, 2005, ARTERIOSCL THROM VAS, V25, P1311, DOI 10.1161/01.ATV.0000168421.13467.82; Danforth CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030385; Danforth CM, 2009, MATH MED BIOL, V26, P323, DOI 10.1093/imammb/dqp011; DOYLE MF, 1990, J BIOL CHEM, V265, P10693; EGEBERG O, 1965, THROMB DIATH HAEMOST, V13, P516, DOI 10.1055/s-0038-1656297; ESMON CT, 1992, ARTERIOSCLER THROMB, V12, P135, DOI 10.1161/01.ATV.12.2.135; ESMON CT, 1989, J BIOL CHEM, V264, P4743; Evans A, 2003, TWIN RES, V6, P432, DOI 10.1375/136905203770326439; Gissel M, 2010, THROMB RES, V126, P262, DOI 10.1016/j.thromres.2010.07.002; Hasstedt SJ, 2007, THROMB HAEMOSTASIS, V98, P587, DOI 10.1160/TH07-02-0134; Hasstedt SJ, 2009, BLOOD, V114, P3084, DOI 10.1182/blood-2009-05-219485; Hasstedt SJ, 2004, J THROMB HAEMOST, V2, P868, DOI 10.1111/j.1538-7836.2004.00663.x; Hasstedt SJ, 1998, AM J HUM GENET, V63, P569, DOI 10.1086/301947; Heit JA, 1999, ARCH INTERN MED, V159, P445, DOI 10.1001/archinte.159.5.445; Hockin MF, 2002, J BIOL CHEM, V277, P18322, DOI 10.1074/jbc.M201173200; Kyrle PA, 2004, NEW ENGL J MED, V350, P2558, DOI 10.1056/NEJMoa032959; LEIPOLD RJ, 1995, J BIOL CHEM, V270, P25383, DOI 10.1074/jbc.270.43.25383; LU D, 1994, J BIOL CHEM, V269, P29032; Luan D, 2007, PLOS COMPUT BIOL, V3, P1347, DOI 10.1371/journal.pcbi.0030142; Mann KG, 2011, CIRCULATION, V124, P225, DOI 10.1161/CIRCULATIONAHA.110.952648; Mann KG, 2003, CHEST, V124, p4S, DOI 10.1378/chest.124.3_suppl.4S; Mcrae S, 2006, LANCET, V368, P371, DOI 10.1016/S0140-6736(06)69110-1; Middeldorp S, 1998, CARDIOVASCULAR THROM, P59; MILETICH J, 1987, NEW ENGL J MED, V317, P991, DOI 10.1056/NEJM198710153171604; Mitrophanov AY, 2012, TRANSFUSION, V52, P2475, DOI 10.1111/j.1537-2995.2012.03610.x; Mitrophanov AY, 2011, THROMB RES, V128, P381, DOI 10.1016/j.thromres.2011.05.013; Nagashima H, 2002, J BIOL CHEM, V277, P50439, DOI 10.1074/jbc.M208222200; Orfeo T, 2004, J BIOL CHEM, V279, P19580, DOI 10.1074/jbc.M400727200; Orfeo T, 2010, J THROMB HAEMOST, V8, P1745, DOI 10.1111/j.1538-7836.2010.03917.x; Orfeo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027852; Pabinger I, 1996, ARTERIOSCL THROM VAS, V16, P742, DOI 10.1161/01.ATV.16.6.742; Panteleev MA, 2006, BIOPHYS J, V90, P1489, DOI 10.1529/biophysj.105.069062; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Rosendaal FR, 1999, THROMB HAEMOSTASIS, V82, P610; Scott BT, 2002, BLOOD COAGUL FIBRIN, V13, P519, DOI 10.1097/00001721-200209000-00007; Scott BT, 2001, THROMB HAEMOSTASIS, V85, P82, DOI 10.1055/s-0037-1612908; Segal JB, 2009, JAMA-J AM MED ASSOC, V301, P2472, DOI 10.1001/jama.2009.853; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; SVENSSON PJ, 1994, NEW ENGL J MED, V330, P517, DOI 10.1056/NEJM199402243300801; TAIT RC, 1995, THROMB HAEMOSTASIS, V73, P87; Thompson AR, 1994, HEMOSTASIS THROMBOSI, P55; TOMCZAK JA, 1994, THROMB RES, V74, P243, DOI 10.1016/0049-3848(94)90112-0; TRAUSCHTVANHORN JJ, 1992, AM J OBSTET GYNECOL, V167, P968, DOI 10.1016/S0002-9378(12)80021-4; Tripodi A, 2011, NEW ENGL J MED, V365, P147, DOI 10.1056/NEJMra1011170; vandenBelt AGM, 1996, CLIN APPL THROMB-HEM, V2, P227, DOI 10.1177/107602969600200402; Vossen CY, 2005, J THROMB HAEMOST, V3, P459, DOI 10.1111/j.1538-7836.2005.01197.x; Vossen CY, 2004, J THROMB HAEMOST, V2, P242, DOI 10.1111/j.1538-7933.2003.00592.x; Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001; Wolberg AS, 2007, THROMB RES, V119, P663, DOI 10.1016/j.thromres.2006.07.003; Wong JH, 2008, J CLIN INVEST, V118, P2969, DOI 10.1172/JCI34957	66	23	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44378	10.1371/journal.pone.0044378	http://dx.doi.org/10.1371/journal.pone.0044378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984498	gold, Green Published, Green Submitted			2022-12-27	WOS:000308738500051
J	Hatori, A; Yui, JJ; Yamasaki, T; Xie, L; Kumata, K; Fujinaga, M; Yoshida, Y; Ogawa, M; Nengaki, N; Kawamura, K; Fukumura, T; Zhang, MR				Hatori, Akiko; Yui, Joji; Yamasaki, Tomoteru; Xie, Lin; Kumata, Katsushi; Fujinaga, Masayuki; Yoshida, Yuichiro; Ogawa, Masanao; Nengaki, Nobuki; Kawamura, Kazunori; Fukumura, Toshimitsu; Zhang, Ming-Rong			PET Imaging of Lung Inflammation with [F-18]FEDAC, a Radioligand for Translocator Protein (18 kDa)	PLOS ONE			English	Article							PERIPHERAL BENZODIAZEPINE-RECEPTOR; POSITRON-EMISSION-TOMOGRAPHY; LYMPHOID-TISSUE; LIPOPOLYSACCHARIDE; INJURY; MACROPHAGES; RESPONSES; KINETICS; OUTCOMES; BRAIN	Purpose: The translocator protein (18 kDa) (TSPO) is highly expressed on the bronchial and bronchiole epithelium, submucosal glands in intrapulmonary bronchi, pneumocytes and alveolar macrophages in human lung. This study aimed to perform positron emission tomography (PET) imaging of lung inflammation with [F-18]FEDAC, a specific TSPO radioligand, and to determine cellular sources enriching TSPO expression in the lung. Methods: An acute lung injury model was prepared by intratracheal administration of lipopolysaccharide (LPS) to rat. Uptake of radioactivity in the rat lungs was measured with small-animal PET after injection of [F-18] FEDAC. Presence of TSPO was examined in the lung tissue using Western blot and immunohistochemical assays. Results: The uptake of [F-18] FEDAC increased in the lung with the progress of inflammation by treatment with LPS. Pretreatment with a TSPO-selective ligand PK11195 showed a significant decrease in the lung uptake of [F-18] FEDAC due to competitive binding to TSPO. TSPO expression was elevated in the inflamed lung section and its level responded to the [F-18] FEDAC uptake and severity of inflammation. Increase of TSPO expression was mainly found in the neutrophils and macrophages of inflamed lungs. Conclusion: From this study we conclude that PET with [F-18] FEDAC may be a useful tool for imaging TSPO expression and evaluating progress of lung inflammation. Study on human lung using [F-18] FEDAC-PET is promising.	[Hatori, Akiko; Yui, Joji; Yamasaki, Tomoteru; Xie, Lin; Kumata, Katsushi; Fujinaga, Masayuki; Yoshida, Yuichiro; Ogawa, Masanao; Nengaki, Nobuki; Kawamura, Kazunori; Fukumura, Toshimitsu; Zhang, Ming-Rong] Natl Inst Radiol Sci, Mol Imaging Ctr, Dept Mol Probes, Chiba 260, Japan	National Institutes for Quantum Science & Technology	Hatori, A (corresponding author), Natl Inst Radiol Sci, Mol Imaging Ctr, Dept Mol Probes, Chiba 260, Japan.	zhang@nirs.go.jp	Fukumura, Toshimitsu/E-2847-2012	, Lin/0000-0002-6472-322X				Banfi A, 2009, EXP LUNG RES, V35, P186, DOI 10.1080/01902140802495862; Bribes E, 2004, J HISTOCHEM CYTOCHEM, V52, P19, DOI 10.1177/002215540405200103; CAMSONNE R, 1984, J LABELLED COMPD RAD, V21, P985, DOI 10.1002/jlcr.2580211012; CANAT X, 1993, LIFE SCI, V52, P107, DOI 10.1016/0024-3205(93)90293-C; Chen DL, 2009, AM J RESP CRIT CARE, V180, P533, DOI 10.1164/rccm.200904-0501OC; Chen DL, 2004, AM J PHYSIOL-LUNG C, V286, pL834, DOI 10.1152/ajplung.00339.2003; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Cheung AM, 2006, AM J RESP CRIT CARE, V174, P538, DOI 10.1164/rccm.200505-693OC; Hardwick Matthew J, 2005, Mol Imaging, V4, P432; HARMSEN AG, 1988, INFECT IMMUN, V56, P1858, DOI 10.1128/IAI.56.8.1858-1863.1988; Harris RS, 2011, J NUCL MED, V52, P1713, DOI 10.2967/jnumed.110.086355; Hicks RJ, 2009, J NUCL MED, V50, p31S, DOI 10.2967/jnumed.108.057216; Huang KL, 2008, AM J CHINESE MED, V36, P301, DOI 10.1142/S0192415X08005783; Husain A.N, 2010, ROBBINS COTRAN PATHO, P677; Itoh T, 2007, AM J PHYSIOL-LUNG C, V293, pL446, DOI 10.1152/ajplung.00412.2005; IWATA M, 1991, INFECT IMMUN, V59, P1514, DOI 10.1128/IAI.59.4.1514-1520.1991; Jansson AH, 2004, LUNG, V182, P163, DOI 10.1007/s00408-004-1803-1; Ji B, 2008, J NEUROSCI, V28, P12255, DOI 10.1523/JNEUROSCI.2312-08.2008; JONES HA, 1994, AM J RESP CRIT CARE, V149, P1635, DOI 10.1164/ajrccm.149.6.7516252; Jones HA, 1997, EUR RESPIR J, V10, P795; Jones HA, 2003, EUR RESPIR J, V21, P567, DOI 10.1183/09031936.03.00048502; Jones HA, 2002, TOXICOL APPL PHARM, V183, P46, DOI 10.1006/taap.2002.9462; Jones Hazel A, 2005, Toxicol Appl Pharmacol, V207, P230, DOI 10.1016/j.taap.2005.02.027; Kumar V, 2010, ROBBINS COTRAN PATHO, P43; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; MAK JCW, 1990, J PHARMACOL EXP THER, V252, P880; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; RUFF MR, 1985, SCIENCE, V229, P1281, DOI 10.1126/science.2994216; Schuster DP, 2004, AM J RESP CELL MOL, V30, P129, DOI 10.1165/rcmb.2003-0213TR; Wang HF, 2009, BIOCHEM BIOPH RES CO, V389, P80, DOI 10.1016/j.bbrc.2009.08.102; Yanamoto K, 2010, NUCL MED BIOL, V37, P853, DOI 10.1016/j.nucmedbio.2010.04.183; Yanamoto K, 2009, BIOORG MED CHEM LETT, V19, P1707, DOI 10.1016/j.bmcl.2009.01.093; Yui J, 2010, J NUCL MED, V51, P1301, DOI 10.2967/jnumed.109.072223	35	55	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45065	10.1371/journal.pone.0045065	http://dx.doi.org/10.1371/journal.pone.0045065			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984611	Green Published, gold			2022-12-27	WOS:000308738500112
J	Kaschner, K; Quick, NJ; Jewell, R; Williams, R; Harris, CM				Kaschner, Kristin; Quick, Nicola J.; Jewell, Rebecca; Williams, Rob; Harris, Catriona M.			Global Coverage of Cetacean Line-Transect Surveys: Status Quo, Data Gaps and Future Challenges	PLOS ONE			English	Article							EASTERN TROPICAL PACIFIC; POPULATION-DENSITY; HARBOR PORPOISE; WHALE ABUNDANCE; MARINE MAMMALS; DOLPHINS; TRENDS; WATERS; RECAPTURE; DIVERSITY	Knowledge of abundance, trends and distribution of cetacean populations is needed to inform marine conservation efforts, ecosystem models and spatial planning. We compiled a geo-spatial database of published data on cetacean abundance from dedicated visual line-transect surveys and encoded >1100 abundance estimates for 47 species from 430 surveys conducted worldwide from 1975-2005. Our subsequent analyses revealed large spatial, temporal and taxonomic variability and gaps in survey coverage. With the exception of Antarctic waters, survey coverage was biased toward the northern hemisphere, especially US and northern European waters. Overall, <25% of the world's ocean surface was surveyed and only 6% had been covered frequently enough (>= 5 times) to allow trend estimation. Almost half the global survey effort, defined as total area (km(2)) covered by all survey study areas across time, was concentrated in the Eastern Tropical Pacific (ETP). Neither the number of surveys conducted nor the survey effort had increased in recent years. Across species, an average of 10% of a species' predicted range had been covered by at least one survey, but there was considerable variation among species. With the exception of three delphinid species, <1% of all species' ranges had been covered frequently enough for trend analysis. Sperm whales emerged from our analyses as a relatively data-rich species. This is a notoriously difficult species to survey visually, and we use this as an example to illustrate the challenges of using available data from line-transect surveys for the detection of trends or for spatial planning. We propose field and analytical methods to fill in data gaps to improve cetacean conservation efforts.	[Kaschner, Kristin] Univ Freiburg, Inst Biol Zool 1, Evolutionary Biol & Ecol Lab, Freiburg, Germany; [Quick, Nicola J.; Jewell, Rebecca] SMRU Ltd, New Technol Ctr, St Andrews, Fife, Scotland; [Williams, Rob; Harris, Catriona M.] Univ St Andrews, Sea Mammal Res Unit, Scottish Oceans Inst, St Andrews, Fife, Scotland; [Quick, Nicola J.; Jewell, Rebecca; Harris, Catriona M.] Univ St Andrews, Ctr Res Ecol & Environm Modelling, St Andrews, Fife, Scotland	University of Freiburg; University of St Andrews; University of St Andrews	Kaschner, K (corresponding author), Univ Freiburg, Inst Biol Zool 1, Evolutionary Biol & Ecol Lab, Albertstr 21A, Freiburg, Germany.	Kristin.kaschner@biologie.uni-freiburg.de	Kaschner, Kristin/GQQ-6475-2022; Williams, Rob/C-5882-2011	Williams, Rob/0000-0001-7496-453X; Quick, Nicola/0000-0003-3840-6711; Kaschner, Kristin/0000-0002-4061-626X; Harris, Catriona/0000-0001-9198-2414	Pew Charitable Trusts of Philadelphia through the Sea Around Us Project; United Kingdom Hydrographic Office; E&P Sound and Marine Life Programme [JIP22 06-10]; German Research Foundation (DFG); Albert-Ludwigs-University of Freiburg	Pew Charitable Trusts of Philadelphia through the Sea Around Us Project; United Kingdom Hydrographic Office; E&P Sound and Marine Life Programme; German Research Foundation (DFG)(German Research Foundation (DFG)); Albert-Ludwigs-University of Freiburg	Financial support for data collection was provided by Pew Charitable Trusts of Philadelphia through the Sea Around Us Project, the United Kingdom Hydrographic Office, and the E&P Sound and Marine Life Programme under contract reference JIP22 06-10. The article processing charge was funded by the German Research Foundation (DFG) and the Albert-Ludwigs-University of Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angliss RP, 2005, NOAATMNMFSAFSC161 US; [Anonymous], 2008, SCANS 2 SMALL CETACE; Ardron J. A., 2010, MARXAN GOOD PRACTICE; Balmford A, 2004, P NATL ACAD SCI USA, V101, P9694, DOI 10.1073/pnas.0403239101; Barlow J, 2006, MAR MAMMAL SCI, V22, P446, DOI 10.1111/j.1748-7692.2006.00032.x; Barlow J, 2005, MAR MAMMAL SCI, V21, P429, DOI 10.1111/j.1748-7692.2005.tb01242.x; Barlow J, 2003, LJ0313 SWFSC NMFS NO; Barlow J, 2007, FISH B-NOAA, V105, P509; Barlow Jay, 2005, Journal of Cetacean Research and Management, V7, P239; Blaylock RA, 1995, NMFSSEFSC363 US DEP; Branch T. A., 2001, Journal of Cetacean Research and Management, V3, P143; Branch T. A., 2001, Journal of Cetacean Research and Management, V3, P251; Buckland S.T., 1993, Reports of the International Whaling Commission Special Issue, V14, P33; Buckland S. T., 2002, Journal of Cetacean Research and Management, V4, P41; Buckland S.T., 2001, pi; Buckland S.T., 1993, International North Pacific Fisheries Commission Bulletin, V53, P387; Buckland ST, 2005, PHILOS T R SOC B, V360, P243, DOI 10.1098/rstb.2004.1589; Butterworth DS, 1995, SC46SH24; Butterworth DS, 1989, SC41O20; Calambokidis J, 2004, MAR MAMMAL SCI, V20, P63, DOI 10.1111/j.1748-7692.2004.tb01141.x; Carretta JV, 2005, NOAATMNMFSSWFSC388 U; Danil K, 2006, MAR ECOL PROG SER, V318, P277, DOI 10.3354/meps318277; Davis RW, 2000, MMS2000003USGSBRDCR1, VII; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Evans PGH, 2004, MAMMAL REV, V34, P131, DOI 10.1046/j.0305-1838.2003.00027.x; Ferguson MC, 2005, CETACEAN POPULATION; George JCC, 2004, MAR MAMMAL SCI, V20, P755, DOI 10.1111/j.1748-7692.2004.tb01191.x; Gerrodette T, 2005, MAR ECOL PROG SER, V291, P1, DOI 10.3354/meps291001; Gerrodette T, 2002, LJ0206 SWFSC NMFS NO; Gerrodette T, 2002, LJ0220 SWFSC NMFS NO; Gerrodette T, 2005, LJ0505 SWFSC NMFS NO; Gilles A, 2009, MAR ECOL PROG SER, V383, P295, DOI 10.3354/meps08020; Grand J, 2007, ECOL LETT, V10, P364, DOI 10.1111/j.1461-0248.2007.01025.x; Gunnlaugsson T., 1993, REPORT INT WHALING C, V43, P315; Gunnlaugsson T, 1990, REPORTS INT WHALING, V40, P481; Hammond P.S., 2009, CETACEAN OFFSHORE DI; Hammond PS, 2002, J APPL ECOL, V39, P361, DOI 10.1046/j.1365-2664.2002.00713.x; Hansen LJ, 1995, ESTIMATES CETACCAN A; Hedley Sharon L., 1999, Journal of Cetacean Research and Management, V1, P255; Jewell R, 2012, MAR ECOL PROG SER, V453, P227, DOI 10.3354/meps09636; KASAMATSU F, 1995, ANTARCT SCI, V7, P365, DOI 10.1017/S0954102095000514; Kaschner K, 2006, MAR ECOL PROG SER, V316, P285, DOI 10.3354/meps316285; Kaschner K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019653; Kot CY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012990; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marques TA, 2009, J ACOUST SOC AM, V125, P1982, DOI 10.1121/1.3089590; Matkin CO, 2008, MAR ECOL PROG SER, V356, P269, DOI 10.3354/meps07273; MOBLEY JR, 2000, LJ0014C SW FISH SCI; Mollett A, 2009, ENV RISK MANAGEMENT; Moore JE, 2011, J APPL ECOL, V48, P1195, DOI 10.1111/j.1365-2664.2011.02018.x; Pressey RL, 1996, NAT CONSERV SER, V4, P23; Redfern JV, 2008, MAR ECOL PROG SER, V363, P1, DOI 10.3354/meps07495; Reeves RR, 2005, GLOBAL PRIORTTIES RE; Rosales-Nanduca H, 2011, MAR ECOL PROG SER, V431, P281, DOI 10.3354/meps09120; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Siebert U, 2006, J SEA RES, V56, P65, DOI 10.1016/j.seares.2006.01.003; Sigurjonsson J., 1989, International Whaling Commission Report of the Commission, V39, P395; Smith TD, 1999, MAR MAMMAL SCI, V15, P1, DOI 10.1111/j.1748-7692.1999.tb00779.x; Taylor BL, 2007, MAR MAMMAL SCI, V23, P157, DOI 10.1111/j.1748-7692.2006.00092.x; Thomas Len, 2007, Journal of Cetacean Research and Management, V9, P1; Underwood JG, 2010, CONSERV BIOL, V24, P162, DOI 10.1111/j.1523-1739.2009.01303.x; Wade P.R., 1993, REPORTS INT WHALING, V43, P477; Wade PR, 2007, MAR ECOL PROG SER, V343, P1, DOI 10.3354/meps07069; WADE PR, 1995, FISH B-NOAA, V93, P345; Wade PR, 1998, MAR MAMMAL SCI, V14, P1, DOI 10.1111/j.1748-7692.1998.tb00688.x; Waring GT, 2005, NMFSNE194 US DEP COM; Whitehead H, 2002, MAR ECOL PROG SER, V242, P295, DOI 10.3354/meps242295; Williams R, 2011, MAR POLLUT BULL, V62, P1303, DOI 10.1016/j.marpolbul.2011.02.029; Williams R, 2011, CONSERV BIOL, V25, P526, DOI 10.1111/j.1523-1739.2011.01656.x; Williams R, 2009, BIOL CONSERV, V142, P1542, DOI 10.1016/j.biocon.2008.12.028	70	82	86	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44075	10.1371/journal.pone.0044075	http://dx.doi.org/10.1371/journal.pone.0044075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984461	Green Published, gold			2022-12-27	WOS:000308738500028
J	Wu, H; Zhang, HJ; Zhang, XM; Xu, HF; Wang, M; Huang, JD; Zheng, BJ				Wu, Hao; Zhang, Hao-Jie; Zhang, Xiao-min; Xu, Hui-fang; Wang, Ming; Huang, Jian-dong; Zheng, Bo-Jian			Identification of Drug Resistant Mutations in HIV-1 CRF07_BC Variants Selected by Nevirapine In Vitro	PLOS ONE			English	Article							TRANSCRIPTASE INHIBITOR RESISTANCE; HUMAN IMMUNODEFICIENCY VIRUS-1; REVERSE-TRANSCRIPTASE; NONNUCLEOSIDE INHIBITORS; GENOTYPIC ANALYSIS; GENETIC DIVERSITY; PROTEASE; SUBTYPE; SUSCEPTIBILITIES; STRAINS	Since the antiretroviral therapy (ART) was introduced to patients infected by human immunodeficiency virus (HIV), the HIV related mortality and morbidity have been significantly reduced. The major obstacle for long-term successful anti-HIV treatment is the emergence of drug resistant mutants. Current data of drug resistance was mainly obtained on HIV-1 subtype B but rarely on non-B virus, even more rare with newly emerged circulating recombinant forms (CRFs). The lack of such data limits the rational management of ART for the increasing number of patients infected by non-subtype B virus. In this study, a HIV-1 CRF07_BC strain CNGZD was isolated from a HIV patient and its genome was sequenced and deposited in GenBank (JQ423923). Potential drug resistant mutants of this CRF07_BC virus strain were selected in PBMCs cultures in the presence of Nevirapine (NVP), which is the most frequently used antiretroviral drug in China. Four combination profiles of mutations were identified in the NVP-selected mutants, which were initiated with A98G, V108I, Y181C and I135T/I382L and followed by more than two other mutations at the end of the selections, respectively. A total of seven previously reported mutations (A98G, V106M, V108I, I135T, Y181C, V189I, K238N) and seven novel mutations (P4H, T48I, I178M, V314A, I382L/V, T386A) in the reverse transcriptase gene were found in these NVP-selected mutants. Phenotypic analysis in the NVP-selected mutants showed that all the mutations, except P4H, contribute to NVP resistance. Among them, V106M and Y181C reduce NVP susceptibility for more than 20-fold, while the other mutations cause less than 20 folds drug resistance. Although the information obtained in this in vitro selection study may not fully cover resistant mutations which will actually occur in patients, it has still provided useful information for rational management of ART in patients infected with HIV CRF_BC subtype.	[Wu, Hao; Zhang, Hao-Jie; Zhang, Xiao-min; Zheng, Bo-Jian] Univ Hong Kong, Dept Microbiol, Guangzhou, Guangdong, Peoples R China; [Huang, Jian-dong] Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Wu, H (corresponding author), Univ Hong Kong, Dept Microbiol, Guangzhou, Guangdong, Peoples R China.	bzheng@hkucc.hku.hk	/C-4277-2009	/0000-0001-7531-2816	AIDS Trust Fund, Hong Kong SAR Government	AIDS Trust Fund, Hong Kong SAR Government	This work was financially supported by by AIDS Trust Fund, Hong Kong SAR Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azijn H, 2010, ANTIMICROB AGENTS CH, V54, P718, DOI 10.1128/AAC.00986-09; BYRNES VW, 1994, ANTIMICROB AGENTS CH, V38, P1404, DOI 10.1128/AAC.38.6.1404; Casado JL, 2000, AIDS, V14, pF1, DOI 10.1097/00002030-200001280-00001; Ceccherini-Silberstein F, 2007, J VIROL, V81, P11507, DOI 10.1128/JVI.00303-07; Chen JHK, 2007, J CLIN VIROL, V39, P125, DOI 10.1016/j.jcv.2007.03.008; Conway B, 2001, AIDS, V15, P1269, DOI 10.1097/00002030-200107060-00008; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Grossman Z, 2004, AIDS, V18, P909, DOI 10.1097/00002030-200404090-00008; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Iglesias-Ussel MD, 2002, J GEN VIROL, V83, P93, DOI 10.1099/0022-1317-83-1-93; JR Ye, 2011, AIDS RES HUM RETROVI; Kieffer TL, 2004, J INFECT DIS, V189, P1452, DOI 10.1086/382488; Kleim JP, 1996, P NATL ACAD SCI USA, V93, P34, DOI 10.1073/pnas.93.1.34; Li TS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003918; Liao LJ, 2007, AIDS RES HUM RETROV, V23, P1062, DOI 10.1089/aid.2007.0050; Loemba H, 2002, ANTIMICROB AGENTS CH, V46, P2087, DOI 10.1128/AAC.46.7.2087-2094.2002; Martinez-Cajas JL, 2008, AIDS REV, V10, P212; MELLORS JW, 1992, MOL PHARMACOL, V41, P446; Michael N, 1999, HIV PROTOCOLS; Reuman EC, 2010, J ANTIMICROB CHEMOTH, V65, P1477, DOI 10.1093/jac/dkq140; Rhee SY, 2006, AIDS, V20, P643, DOI 10.1097/01.aids.0000216363.36786.2b; RICHMAN D, 1991, P NATL ACAD SCI USA, V88, P11241, DOI 10.1073/pnas.88.24.11241; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; Services DoHaH, 2011, GUID US ANT AG HIV 1, P174; Shafer RW, 2008, AIDS REV, V10, P67; Staden R, 2000, Methods Mol Biol, V132, P115; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Tombuyzer L, 2009, ANTIVIR THER, V14, P103; van't Wout AB, 2008, NAT PROTOC, V3, P363, DOI 10.1038/nprot.2008.3; Vergne L, 2000, J CLIN MICROBIOL, V38, P3919, DOI 10.1128/JCM.38.11.3919-3925.2000; Vergne L, 2006, J CLIN VIROL, V36, P43, DOI 10.1016/j.jcv.2006.01.012; Yu G, 2009, AIDS RES HUM RETROV, V25, P869, DOI 10.1089/aid.2008.0312; Zhang HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006108; Zhang QW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031233	36	5	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44333	10.1371/journal.pone.0044333	http://dx.doi.org/10.1371/journal.pone.0044333			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984494	Green Published, gold			2022-12-27	WOS:000308738500048
J	Ceci, ML; Pedraza, M; de Carlos, JA				Ceci, Maria Laura; Pedraza, Maria; de Carlos, Juan A.			The Embryonic Septum and Ventral Pallium, New Sources of Olfactory Cortex Cells	PLOS ONE			English	Article							CAJAL-RETZIUS CELLS; CORTICAL GABAERGIC INTERNEURONS; MAMMALIAN TELENCEPHALON; PREOPTIC AREA; MIGRATION; EXPRESSION; ORIGINS; ROLES; MOUSE	The mammalian olfactory cortex is a complex structure located along the rostro-caudal extension of the ventrolateral prosencephalon, which is divided into several anatomically and functionally distinct areas: the anterior olfactory nucleus, piriform cortex, olfactory tubercle, amygdaloid olfactory nuclei, and the more caudal entorhinal cortex. Multiple forebrain progenitor domains contribute to the cellular diversity of the olfactory cortex, which is invaded simultaneously by cells originating in distinct germinal areas in the dorsal and ventral forebrain. Using a combination of dye labeling techniques, we identified two novel areas that contribute cells to the developing olfactory cortices, the septum and the ventral pallium, from which cells migrate along a radial and then a tangential path. We characterized these cell populations by comparing their expression of calretinin, calbindin, reelin and Tbr1 with that of other olfactory cell populations.	[Ceci, Maria Laura] Univ Chile, Santiago, Chile; [Pedraza, Maria; de Carlos, Juan A.] Inst Cajal Consejo Super Invest Cient, Dept Mol Cellular & Dev Neurobiol, Madrid, Spain	Universidad de Chile; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Ceci, ML (corresponding author), Univ Chile, Santiago, Chile.	decarlos@cajal.csic.es	De Carlos, Juan A./Q-8999-2018	De Carlos, Juan A./0000-0001-9096-5372; Pedraza, Maria/0000-0002-1973-3269	Spanish Ministerio de Ciencia e Innovacion [BFU2010-21377]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by grant BFU2010-21377 from the Spanish Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bielle F, 2005, NAT NEUROSCI, V8, P1002, DOI 10.1038/nn1511; Carney RSE, 2006, J NEUROSCI, V26, P11562, DOI 10.1523/JNEUROSCI.3092-06.2006; De Carlos JA, 2009, DEV DEGENERATION REG, P19; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; Moreno FG, 2008, CEREB CORTEX, V18, P1239, DOI 10.1093/cercor/bhm154; Garcia-Moreno F, 2010, NAT NEUROSCI, V13, P680, DOI 10.1038/nn.2556; Garcia-Moreno F, 2007, J COMP NEUROL, V500, P419, DOI 10.1002/cne.21128; Gelman D, 2011, J NEUROSCI, V31, P16570, DOI 10.1523/JNEUROSCI.4068-11.2011; Gelman DM, 2009, J NEUROSCI, V29, P9380, DOI 10.1523/JNEUROSCI.0604-09.2009; Hevner RF, 2003, DEV BRAIN RES, V141, P39, DOI 10.1016/S0165-3806(02)00641-7; Ceci ML, 2010, CEREB CORTEX, V20, P2348, DOI 10.1093/cercor/bhp305; Meyer G, 2004, J NEUROSCI, V24, P9878, DOI 10.1523/JNEUROSCI.3060-04.2004; Meyer G, 2002, CEREB CORTEX, V12, P1225, DOI 10.1093/cercor/12.12.1225; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Ramony Cajal S., 1890, GACETA MED CATALANA, V13, P737; Retzius G., 1893, BIOL UNTERSUCH, V5, P1; Rubin AN, 2010, J NEUROSCI, V30, P12050, DOI 10.1523/JNEUROSCI.6178-09.2010; Stoykova A, 2000, J NEUROSCI, V20, P8042; Takiguchi-Hayashi K, 2004, J NEUROSCI, V24, P2286, DOI 10.1523/JNEUROSCI.4671-03.2004; Teissier A, 2010, J NEUROSCI, V30, P10563, DOI 10.1523/JNEUROSCI.0776-10.2010; Yun K, 2001, DEVELOPMENT, V128, P193; Zimmer C, 2010, DEVELOPMENT, V137, P293, DOI 10.1242/dev.041178	23	25	25	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44716	10.1371/journal.pone.0044716	http://dx.doi.org/10.1371/journal.pone.0044716			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984546	Green Submitted, gold, Green Published			2022-12-27	WOS:000308638700078
J	Sasahara, K; Cody, ML; Cohen, D; Taylor, CE				Sasahara, Kazutoshi; Cody, Martin L.; Cohen, David; Taylor, Charles E.			Structural Design Principles of Complex Bird Songs: A Network-Based Approach	PLOS ONE			English	Article							REPERTOIRE SIZE; SMALL-WORLD; EVOLUTION; SYNTAX; RULES	Bird songs are acoustic communication signals primarily used in male-male aggression and in male-female attraction. These are often monotonous patterns composed of a few phrases, yet some birds have extremely complex songs with a large phrase repertoire, organized in non-random fashion with discernible patterns. Since structure is typically associated with function, the structures of complex bird songs provide important clues to the evolution of animal communication systems. Here we propose an efficient network-based approach to explore structural design principles of complex bird songs, in which the song networks-transition relationships among different phrases and the related structural measures-are employed. We demonstrate how this approach works with an example using California Thrasher songs, which are sequences of highly varied phrases delivered in succession over several minutes. These songs display two distinct features: a large phrase repertoire with a 'small-world' architecture, in which subsets of phrases are highly grouped and linked with a short average path length; and a balanced transition diversity amongst phrases, in which deterministic and non-deterministic transition patterns are moderately mixed. We explore the robustness of this approach with variations in sample size and the amount of noise. Our approach enables a more quantitative study of global and local structural properties of complex bird songs than has been possible to date.	[Sasahara, Kazutoshi] Nagoya Univ, Grad Sch Informat Sci, Nagoya, Aichi 4648601, Japan; [Cody, Martin L.; Taylor, Charles E.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Cohen, David] Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90024 USA; [Cohen, David] Carnegie Mellon Univ, Dept Elect & Comp Engn, Moffett Field, CA USA	Nagoya University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Carnegie Mellon University	Sasahara, K (corresponding author), Nagoya Univ, Grad Sch Informat Sci, Nagoya, Aichi 4648601, Japan.	sasahara@is.nagoya-u.ac.jp		Sasahara, Kazutoshi/0000-0003-2572-0648; Cody, Martin/0000-0003-2028-8390	National Science Foundation [1125423]; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan [24700291]	National Science Foundation(National Science Foundation (NSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by National Science Foundation Award No. 1125423. KS was supported by the Japan Society for the Promotion of Science Fellowship and a Grant-in Aid (No. 24700291) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER MC, 1986, AM NAT, V128, P491, DOI 10.1086/284582; Bollobas B., 2001, RANDOM GRAPHS; Byers BE, 2009, ANIM BEHAV, V77, P13, DOI 10.1016/j.anbehav.2008.10.003; Cancho RFI, 2001, P ROY SOC B-BIOL SCI, V268, P2261, DOI 10.1098/rspb.2001.1800; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; CATCHPOLE CK, 1980, BEHAVIOUR, V74, P149, DOI 10.1163/156853980X00366; CHATFIELD C, 1970, J THEOR BIOL, V29, P427, DOI 10.1016/0022-5193(70)90107-4; Cody ML, 1998, BIRDS N AM ONLINE; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; DOBSON CW, 1979, BEHAVIOUR, V68, P86, DOI 10.1163/156853979X00250; Feher O, 2009, NATURE, V459, P564, DOI 10.1038/nature07994; Garamszegi LZ, 2005, BEHAV ECOL SOCIOBIOL, V57, P305, DOI 10.1007/s00265-004-0866-6; HIEBERT SM, 1989, ANIM BEHAV, V37, P266, DOI 10.1016/0003-3472(89)90115-2; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jin DZ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001108; Kakishita Y, 2009, DATA MIN KNOWL DISC, V18, P446, DOI 10.1007/s10618-008-0122-1; Kipper S, 2010, ADV STUD BEHAV, V41, P77, DOI 10.1016/S0065-3454(10)41003-7; Kroodsma Donald, 2005, SINGING LIFE BIRDS; LEMON RE, 1993, ETHOLOGY, V93, P198; Lusseau D, 2003, P ROY SOC B-BIOL SCI, V270, pS186, DOI 10.1098/rsbl.2003.0057; MARLER P., 1962, CONDOR, V64, P368, DOI 10.2307/1365545; Marler P, 2004, NATURES MUSIC SCI BI, P39; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Okanoya K, 2004, ADV STUD BEHAV, V34, P297, DOI 10.1016/S0065-3454(04)34008-8; Sasahara K, 2007, ARTIF LIFE, V13, P259, DOI 10.1162/artl.2007.13.3.259; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; SEARCY WA, 1984, BEHAV ECOL SOCIOBIOL, V14, P281, DOI 10.1007/BF00299499; Todt D, 1998, BIOL CYBERN, V79, P487, DOI 10.1007/s004220050498; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wey T, 2008, ANIM BEHAV, V75, P333, DOI 10.1016/j.anbehav.2007.06.020; Zann RA., 1996, ZEBRA FINCH SYNTHESI	34	50	51	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e44436	10.1371/journal.pone.0044436	http://dx.doi.org/10.1371/journal.pone.0044436			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028539	Green Submitted, Green Published, gold			2022-12-27	WOS:000309554700012
J	van Zoggel, H; Carpentier, G; Dos Santos, C; Hamma-Kourbali, Y; Courty, J; Amiche, M; Delbe, J				van Zoggel, Hanneke; Carpentier, Gilles; Dos Santos, Celia; Hamma-Kourbali, Yamina; Courty, Jose; Amiche, Mohamed; Delbe, Jean			Antitumor and Angiostatic Activities of the Antimicrobial Peptide Dermaseptin B2	PLOS ONE			English	Article							AFFIN REGULATORY PEPTIDE; CARCINOMA-CELL LINES; PHOSPHOLIPID-MEMBRANES; FROG-SKIN; BOVINE LACTOFERRICIN; CYTOLYTIC ACTIVITY; CATIONIC PEPTIDES; ENDOTHELIAL-CELLS; MOLECULAR-CLONING; CANCER-CELLS	Recently, we have found that the skin secretions of the Amazonian tree frog Phyllomedusa bicolor contains molecules with antitumor and angiostatic activities and identified one of them as the antimicrobial peptide dermaseptin (Drs) B2. In the present study we further explored the in vitro and in vivo antitumor activity of this molecule and investigated its mechanism of action. We showed that Drs B2 inhibits the proliferation and colony formation of various human tumor cell types, and the proliferation and capillary formation of endothelial cells in vitro. Furthermore, Drs B2 inhibited tumor growth of the human prostate adenocarcinoma cell line PC3 in a xenograft model in vivo. Research on the mechanism of action of Drs B2 on tumor PC3 cells demonstrated a rapid increasing amount of cytosolic lactate dehydrogenase, no activation of caspase-3, and no changes in mitochondrial membrane potential. Confocal microscopy analysis revealed that Drs B2 can interact with the tumor cell surface, aggregate and penetrate the cells. These data together indicate that Drs B2 does not act by apoptosis but possibly by necrosis. In conclusion, Drs B2 could be considered as an interesting and promising pharmacological and therapeutic leader molecule for the treatment of cancer.	[van Zoggel, Hanneke; Carpentier, Gilles; Dos Santos, Celia; Hamma-Kourbali, Yamina; Courty, Jose; Amiche, Mohamed; Delbe, Jean] Univ Paris Est Creteil, Lab Rech Croissance Cellulaire Reparat & Regenera, Creteil, France	Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Delbe, J (corresponding author), Univ Paris Est Creteil, Lab Rech Croissance Cellulaire Reparat & Regenera, Creteil, France.	delbe@univ-paris12.fr	Hamma-Kourbali, Yamina/R-3692-2018; Courty, Jose/Q-3702-2018; Delbe, Jean/R-3680-2018; AMICHE, Mohamed/R-3684-2018	Hamma-Kourbali, Yamina/0000-0002-2754-8928; Dos Santos, Celia/0000-0002-0431-1004; Carpentier, Gilles/0000-0002-3730-7263	French Agence Nationale de la Recherche [ANR-06-RIB 016-02]; French Association pour la Recherche sur le Cancer; ANR [ANR-06-RIB 016-02]; French Institut national du cancer from the Centre National de la Recherche Scientifique [INCA-PL06-093]	French Agence Nationale de la Recherche(French National Research Agency (ANR)); French Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); ANR(French National Research Agency (ANR)); French Institut national du cancer from the Centre National de la Recherche Scientifique	Hanneke van Zoggel was funded by a grant from the French Agence Nationale de la Recherche (ANR-06-RIB 016-02) and by the French Association pour la Recherche sur le Cancer. This work was partly supported by a grant from ANR (ANR-06-RIB 016-02) and a grant from the French Institut national du cancer (INCA-PL06-093) from the Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour A, 2008, BIOCHIMIE, V90, P1791, DOI 10.1016/j.biochi.2008.04.010; AMICHE M, 1994, J BIOL CHEM, V269, P17847; AMICHE M, 1993, BIOCHEM BIOPH RES CO, V191, P983, DOI 10.1006/bbrc.1993.1314; Amiche M, 2011, CURR PHARM BIOTECHNO, V12, P1184, DOI 10.2174/138920111796117319; BAKER MA, 1993, CANCER RES, V53, P3052; Banki K, 1999, J IMMUNOL, V162, P1466; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carpentier G, 2010, IMAGE J; Carpentier G, 2009, IMAGE J; Charpentier S, 1998, J BIOL CHEM, V273, P14690, DOI 10.1074/jbc.273.24.14690; Chen HM, 1997, BBA-GEN SUBJECTS, V1336, P171, DOI 10.1016/S0304-4165(97)00024-X; Conlon JM, 2007, TOXICON, V50, P498, DOI 10.1016/j.toxicon.2007.04.017; CRUCIANI RA, 1991, P NATL ACAD SCI USA, V88, P3792, DOI 10.1073/pnas.88.9.3792; DALY JW, 1992, P NATL ACAD SCI USA, V89, P10960, DOI 10.1073/pnas.89.22.10960; DAUCHEL MC, 1989, J CELL BIOCHEM, V39, P411, DOI 10.1002/jcb.240390407; Eliassen LT, 2006, INT J CANCER, V119, P493, DOI 10.1002/ijc.21886; Eliassen LT, 2002, ANTICANCER RES, V22, P2703; Galanth C, 2009, BIOCHEMISTRY-US, V48, P313, DOI 10.1021/bi802025a; Ganz T, 1998, CURR OPIN IMMUNOL, V10, P41, DOI 10.1016/S0952-7915(98)80029-0; Gatti L, 2005, METH MOLEC MED, V111, P127; GILLIES RJ, 1986, ANAL BIOCHEM, V159, P109, DOI 10.1016/0003-2697(86)90314-3; GOSPODAROWICZ D, 1983, J CELL BIOL, V97, P1677, DOI 10.1083/jcb.97.6.1677; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Griffa A., 2010, GIT IMAGING MICROSCO, V1, P43; HABERMANN E, 1965, BIOCHEM Z, V343, P192; Hamma-Kourbali Y, 2008, J CELL PHYSIOL, V214, P250, DOI 10.1002/jcp.21191; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Huet E, 2011, AM J PATHOL, V179, P1278, DOI 10.1016/j.ajpath.2011.05.036; Jenssen H, 2005, J PEPT RES, V66, P48, DOI 10.1111/j.1747-0285.2006.00332.x; Jester JV, 1999, INVEST OPHTH VIS SCI, V40, P1959; Jin S, 2007, J CELL SCI, V120, P379, DOI 10.1242/jcs.03349; Johansson J, 1998, J BIOL CHEM, V273, P3718, DOI 10.1074/jbc.273.6.3718; Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838; Kaufmann SH, 2000, BIOESSAYS, V22, P1007, DOI 10.1002/1521-1878(200011)22:11<1007::AID-BIES7>3.3.CO;2-W; La Rocca P, 1999, BIOPHYS CHEM, V76, P145, DOI 10.1016/S0301-4622(98)00232-4; LAAROUBI K, 1994, GROWTH FACTORS, V10, P89, DOI 10.3109/08977199409010982; Liao PC, 2005, LIFE SCI, V76, P1623, DOI 10.1016/j.lfs.2004.09.021; LICHTENSTEIN A, 1986, BLOOD, V68, P1407; Littmann E, 1997, IEEE T NEURAL NETWOR, V8, P175, DOI 10.1109/72.554203; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Mader JS, 2005, MOL CANCER THER, V4, P612, DOI 10.1158/1535-7163.MCT-04-0077; Mai JC, 2001, CANCER RES, V61, P7709; Mailloux A, 2001, EUR J CELL BIOL, V80, P442, DOI 10.1078/0171-9335-00171; MARTIN E, 1995, J LEUKOCYTE BIOL, V58, P128, DOI 10.1002/jlb.58.2.128; Mayer B, 2003, NEWS PHYSIOL SCI, V18, P89, DOI 10.1152/nips.01433.2002; MOR A, 1994, BIOCHEMISTRY-US, V33, P6642, DOI 10.1021/bi00187a034; MOR A, 1994, J BIOL CHEM, V269, P1934; NICOLAS P, 1995, ANNU REV MICROBIOL, V49, P277, DOI 10.1146/annurev.mi.49.100195.001425; Nicolas P, 2006, HANDBOOK OF BIOLOGICALLY ACTIVE PEPTIDES, P295, DOI 10.1016/B978-012369442-3/50048-9; Nicolas P, 2009, BBA-BIOMEMBRANES, V1788, P1537, DOI 10.1016/j.bbamem.2008.09.006; Nishimura M, 2004, J DERMATOL SCI, V36, P87, DOI 10.1016/j.jdermsci.2004.07.001; Papo N, 2005, CELL MOL LIFE SCI, V62, P784, DOI 10.1007/s00018-005-4560-2; Papo N, 2003, PEPTIDES, V24, P1693, DOI 10.1016/j.peptides.2003.09.013; Papo N, 2003, BIOCHEMISTRY-US, V42, P9346, DOI 10.1021/bi027212o; Papo N, 2003, J BIOL CHEM, V278, P21018, DOI 10.1074/jbc.M211204200; POUNY Y, 1992, BIOCHEMISTRY-US, V31, P12416, DOI 10.1021/bi00164a017; Rasband W.S., 1997, IMAGE J; Ridler T, 1978, IEEE T SYSTEMS MAN C; Savoia D, 2008, BIOORGAN MED CHEM, V16, P8205, DOI 10.1016/j.bmc.2008.07.032; Shin SY, 2000, BIOCHEM BIOPH RES CO, V275, P904, DOI 10.1006/bbrc.2000.3269; Simmaco M, 1998, BIOPOLYMERS, V47, P435, DOI 10.1002/(SICI)1097-0282(1998)47:6<435::AID-BIP3>3.3.CO;2-#; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; STRAHILEVITZ J, 1994, BIOCHEMISTRY-US, V33, P10951, DOI 10.1021/bi00202a014; Vacherot F, 1999, PROSTATE, V38, P126, DOI 10.1002/(SICI)1097-0045(19990201)38:2<126::AID-PROS6>3.0.CO;2-C; van Zoggel H, 2012, AMINO ACIDS, V42, P385, DOI 10.1007/s00726-010-0815-9; Vonesch C, 2008, IEEE T IMAGE PROCESS, V17, P539, DOI 10.1109/TIP.2008.917103; Walter J, 2001, IMAGE J; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yeung TK, 1999, BIOCHEM BIOPH RES CO, V263, P398, DOI 10.1006/bbrc.1999.1375; Yoo YC, 1997, JPN J CANCER RES, V88, P184, DOI 10.1111/j.1349-7006.1997.tb00364.x; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	76	46	47	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e44351	10.1371/journal.pone.0044351	http://dx.doi.org/10.1371/journal.pone.0044351			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028527	Green Published, gold			2022-12-27	WOS:000309388900009
J	Morillo, E; Sanchez-Trujillo, MA; Moyano, JR; Villaverde, J; Gomez-Pantoja, ME; Perez-Martinez, JI				Morillo, Esmeralda; Antonia Sanchez-Trujillo, Maria; Ramon Moyano, Jose; Villaverde, Jaime; Eulalia Gomez-Pantoja, Maria; Ignacio Perez-Martinez, Jose			Enhanced Solubilisation of Six PAHs by Three Synthetic Cyclodextrins for Remediation Applications: Molecular Modelling of the Inclusion Complexes	PLOS ONE			English	Article							HYDROXYPROPYL-BETA-CYCLODEXTRIN; FORMATION-CONSTANTS; CONTAMINATED SOILS; AROMATIC-HYDROCARBONS; HERBICIDE NORFLURAZON; GAMMA-CYCLODEXTRIN; ORGANIC-COMPOUNDS; MM2 CALCULATIONS; CHEMISTRY; THERMODYNAMICS	Solubilisation of six polycyclic aromatic hydrocarbons (PAHs) (acenaphthene, anthracene, fluoranthene, fluorene, phenanthrene and pyrene) by three synthetic cyclodextrins (CDs) (2-hydroxypropyl-beta-CD, hydroxypropyl-gamma-CD and ramdomly methylated-beta-CD) was investigated in order to select the CD which presents the greatest increase in solubility and better complexation parameters for its use in contaminated scenarios. The presence of the three cyclodextrins greatly enhanced the apparent water solubility of all the PAHs through the formation of inclusion complexes of 1: 1 stoichiometry. Anthracene, fluoranthene, fluorene and phenanthrene clearly presented a higher solubility when beta-CD derivatives were used, and especially the complexes with the ramdomly methylated-beta-CD were favoured. On the contrary, pyrene presented its best solubility results when using 2-hydroxypropyl-gamma-CD, but for acenaphthene the use of any of the three CDs gave the same results. Complementary to experimental phase-solubility studies, a more in-depth estimation of the inclusion process for the different complexes was carried out using molecular modelling in order to find a correlation between the degree of solubilisation and the fit of PAH molecules within the cavity of the different CDs and to know the predominant driving forces of the complexation.	[Morillo, Esmeralda; Antonia Sanchez-Trujillo, Maria; Villaverde, Jaime; Eulalia Gomez-Pantoja, Maria] Sci Res Council IRNAS CSIC, Inst Nat Resources & Agrobiol Seville, Agrochem & Soil Conservaton Dept, Seville, Spain; [Ramon Moyano, Jose; Ignacio Perez-Martinez, Jose] Univ Seville, Fac Pharm, Dept Pharm & Pharmaceut Technol, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS); University of Sevilla	Morillo, E (corresponding author), Sci Res Council IRNAS CSIC, Inst Nat Resources & Agrobiol Seville, Agrochem & Soil Conservaton Dept, Seville, Spain.	morillo@irnase.csic.es	Villaverde, Jaime/J-3835-2015; Pérez-Martínez, José Ignacio/AAT-6984-2020; Villaverde, Jaime/AAG-1424-2021; Morillo, Esmeralda/E-2180-2017; Moyano Mendez, Jose Ramon/L-8949-2018	Villaverde, Jaime/0000-0002-8694-7929; Villaverde, Jaime/0000-0002-8694-7929; Morillo, Esmeralda/0000-0002-4485-2315; Perez Martinez, Jose Ignacio/0000-0001-5955-716X; Moyano Mendez, Jose Ramon/0000-0003-0200-3806; Gomez-Pantoja Cabezas, Maria Eulalia/0000-0001-5802-2083	Spanish Ministry of Science and Innovation [CTM2006-04626, CTM2009-07335]; Fondo Europeo de Desarrollo Regional, FEDER; CSIC [JAEPre 0800763]; Fondo Social Europeo (FSE)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondo Europeo de Desarrollo Regional, FEDER(European CommissionSpanish Government); CSIC; Fondo Social Europeo (FSE)(European Social Fund (ESF)European Commission)	Support from projects CTM2006-04626 and CTM2009-07335, Spanish Ministry of Science and Innovation (co-funded by Fondo Europeo de Desarrollo Regional, FEDER), are greatly appreciated. M. A. Sanchez-Trujillo acknowledges a research contract from CSIC (JAEPre 0800763) cofinanced by Fondo Social Europeo (FSE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan IJ, 2007, ENVIRON SCI TECHNOL, V41, P5498, DOI 10.1021/es0704939; [Anonymous], 2009, HYPERCH 8 0 8 WIND; Aree T, 1999, CARBOHYD RES, V315, P199, DOI 10.1016/S0008-6215(99)00033-6; Badr T, 2004, J HAZARD MATER, V112, P215, DOI 10.1016/j.jhazmat.2004.04.017; Balogh K, 2007, J INCL PHENOM MACRO, V57, P457, DOI 10.1007/s10847-006-9234-7; Barbiric DJ, 2000, J MOL STRUC-THEOCHEM, V532, P171, DOI 10.1016/S0166-1280(00)00516-9; Bardi L, 2007, J INCL PHENOM MACRO, V57, P439, DOI 10.1007/s10847-006-9231-x; BLYSHAK LA, 1989, ANAL CHEM, V61, P955, DOI 10.1021/ac00184a008; Breivik K, 2004, ENVIRON POLLUT, V128, P3, DOI 10.1016/j.envpol.2003.08.031; Castagne D, 2010, J PHARM PHARM SCI, V13, P362, DOI 10.18433/J3BS34; Del Valle EMM, 2004, PROCESS BIOCHEM, V39, P1033, DOI 10.1016/S0032-9592(03)00258-9; DELAPENA AM, 1991, J PHYS CHEM-US, V95, P3330; Do Thi T, 2010, J PHARM SCI-US, V99, P3863, DOI 10.1002/jps.22227; Dodziuk H., 2006, CYCLODEXTRINS THEIR, P333; FATHALLAH M, 1994, J ORG CHEM, V59, P1288, DOI 10.1021/jo00085a015; Fenyvesi E, 1996, J INCLUS PHENOM MOL, V25, P229, DOI 10.1007/BF01041575; Fifere A, 2011, CELL CHEM TECHNOL, V45, P149; Gruiz K, 2010, CONSTRUCTION FOR A SUSTAINABLE ENVIRONMENT, P207; Higuchi T., 1965, ADV ANAL CHEM INSTRU, V4, P117; Immel S, 1996, STARCH-STARKE, V48, P225, DOI 10.1002/star.19960480606; JAIME C, 1990, J ORG CHEM, V55, P4772, DOI 10.1021/jo00302a058; Ko SO, 1999, ENVIRON SCI TECHNOL, V33, P2765, DOI 10.1021/es9813360; Leila N, 2011, J MOL LIQ, V160, P8, DOI 10.1016/j.molliq.2011.02.016; Lipkowitz KB, 1998, CHEM REV, V98, P1829, DOI 10.1021/cr9700179; Liu L, 2002, J INCL PHENOM MACRO, V42, P1, DOI 10.1023/A:1014520830813; Liu L, 2004, J INCL PHENOM MACRO, V50, P95, DOI 10.1007/s10847-003-8847-3; Loftsson T, 2004, J PHARM SCI-US, V93, P1091, DOI 10.1002/jps.20047; Loftsson T, 2007, INT J PHARMACEUT, V329, P1, DOI 10.1016/j.ijpharm.2006.10.044; Molnar M, 2002, J INCL PHENOM MACRO, V44, P447, DOI 10.1023/A:1023032305920; Morillo E, 2007, J ENVIRON MONITOR, V9, P1001, DOI 10.1039/b705955h; Morillo E, 2008, WATER AIR SOIL POLL, V187, P41, DOI 10.1007/s11270-007-9495-9; Morillo E, 2006, CYCLODEXTRINS THEIR, P459; Ockenden WA, 2003, ENVIRON POLLUT, V121, P75, DOI 10.1016/S0269-7491(02)00204-X; OHASHI M, 1990, J AM CHEM SOC, V112, P5824, DOI 10.1021/ja00171a023; Pinzaru I. A., 2011, Journal of Agroalimentary Processes and Technologies, V17, P123; Ravelet C, 2002, J LIQ CHROMATOGR R T, V25, P421, DOI 10.1081/JLC-120003363; Rekharsky MV, 1998, CHEM REV, V98, P1875, DOI 10.1021/cr970015o; Ross PD, 1996, BIOPHYS J, V71, P2144, DOI 10.1016/S0006-3495(96)79415-8; SANEMASA I, 1989, B CHEM SOC JPN, V62, P3098, DOI 10.1246/bcsj.62.3098; Stroud JL, 2009, ENVIRON POLLUT, V157, P2678, DOI 10.1016/j.envpol.2009.05.009; Szejtli J, 1998, CHEM REV, V98, P1743, DOI 10.1021/cr970022c; Uekama K, 2006, CYCLODEXTRINS THEIR, P381, DOI DOI 10.1002/3527608982.CH14; UNECE, 1998, PROT PERS ORG POLL 1; Villaverde J, 2005, J AGR FOOD CHEM, V53, P5366, DOI 10.1021/jf0502449; Villaverde J, 2006, J AGR FOOD CHEM, V54, P4766, DOI 10.1021/jf060548a; Wan JZ, 2009, J HAZARD MATER, V166, P221, DOI 10.1016/j.jhazmat.2008.11.021; WANG XJ, 1993, ENVIRON SCI TECHNOL, V27, P2821, DOI 10.1021/es00049a023; Wenz G, 2006, CHEM REV, V106, P782, DOI 10.1021/cr970027+; Ying GG, 2006, ENVIRON INT, V32, P417, DOI 10.1016/j.envint.2005.07.004; Yong CW, 2008, PHARM RES, V25, P1092, DOI 10.1007/s11095-007-9506-y; Zhou HW, 2009, J COMPUT AID MOL DES, V23, P153, DOI 10.1007/s10822-008-9247-y	51	44	44	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44137	10.1371/journal.pone.0044137	http://dx.doi.org/10.1371/journal.pone.0044137			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028493	Green Published, gold			2022-12-27	WOS:000309388400020
J	Turck, N; Robin, X; Walter, N; Fouda, C; Hainard, A; Sztajzel, R; Wagner, G; Hochstrasser, DF; Montaner, J; Burkhard, PR; Sanchez, JC				Turck, Natacha; Robin, Xavier; Walter, Nadia; Fouda, Catherine; Hainard, Alexandre; Sztajzel, Roman; Wagner, Ghislaine; Hochstrasser, Denis F.; Montaner, Joan; Burkhard, Pierre R.; Sanchez, Jean-Charles			Blood Glutathione S-Transferase-pi as a Time Indicator of Stroke Onset	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; ATTENUATED INVERSION-RECOVERY; POSTMORTEM CEREBROSPINAL-FLUID; RAT CEREBRAL-CORTEX; HEMORRHAGIC TRANSFORMATION; THROMBOLYTIC THERAPY; EARLY-DIAGNOSIS; SYMPTOM ONSET; GST-PI; SERUM	Background: Ability to accurately determine time of stroke onset remains challenging. We hypothesized that an early biomarker characterized by a rapid increase in blood after stroke onset may help defining better the time window during which an acute stroke patient may be candidate for intravenous thrombolysis or other intravascular procedures. Methods: The blood level of 29 proteins was measured by immunoassays on a prospective cohort of stroke patients (N = 103) and controls (N = 132). Mann-Whitney U tests, ROC curves and diagnostic odds ratios were applied to evaluate their clinical performances. Results: Among the 29 molecules tested, GST-pi concentration was the most significantly elevated marker in the blood of stroke patients (p<0.001). More importantly, GST-pi displayed the best area under the curve (AUC, 0.79) and the best diagnostic odds ratios (10.0) for discriminating early (N = 22, <3 h of stroke onset) vs. late stroke patients (N = 81, >3 h after onset). According to goal-oriented distinct cut-offs (sensitivity(Se)-oriented: 17.7 or specificity(Sp)-oriented: 65.2 ug/L), the GST-pi test obtained 91%Se/50%Sp and 50%Se/91%Sp, respectively. Moreover, GST-pi showed also the highest AUC (0.83) and performances for detecting patients treated with tPA (N = 12) compared to ineligible patients (N = 103). Conclusions: This study demonstrates that GST-pi can accurately predict the time of stroke onset in over 50% of early stroke patients. The GST-pi test could therefore complement current guidelines for tPA administration and potentially increase the number of patients accessing thrombolysis.	[Turck, Natacha; Robin, Xavier; Walter, Nadia; Fouda, Catherine; Hainard, Alexandre; Hochstrasser, Denis F.; Sanchez, Jean-Charles] Fac Med, Dept Human Prot Sci, Biomed Prote Res Grp, Geneva, Switzerland; [Robin, Xavier] Ctr Med Univ Geneva, Swiss Inst Bioinformat, Geneva, Switzerland; [Sztajzel, Roman; Wagner, Ghislaine; Burkhard, Pierre R.] Univ Geneva, Univ Hosp Geneva, Dept Neurol, Geneva, Switzerland; [Montaner, Joan] Autonomous Univ Barcelona UAB, Vall dHebron Hosp, VHIR, Neurovasc Res Lab, Catalonia, Spain; [Montaner, Joan] Autonomous Univ Barcelona UAB, Vall dHebron Hosp, Stroke Unit, Catalonia, Spain; [Sztajzel, Roman; Wagner, Ghislaine; Burkhard, Pierre R.] Univ Geneva, Fac Med, Geneva, Switzerland	University of Geneva; Swiss Institute of Bioinformatics; University of Geneva; University of Geneva; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; University of Geneva	Turck, N (corresponding author), Fac Med, Dept Human Prot Sci, Biomed Prote Res Grp, Geneva, Switzerland.	natacha.turck@unige.ch	Robin, Xavier/A-1680-2009; Montaner, Joan/D-3063-2015	Robin, Xavier/0000-0002-6813-3200; Montaner, Joan/0000-0003-4845-2279	Proteome Sciences plc; Fondo de Investigaciones Sanitarias [FIS PI08/361, PI11/0176]	Proteome Sciences plc; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	Neurovascular Research Laboratory takes part in the Spanish stroke research network (RENEVAS, RD06/0026/0010) and the European Stroke Network (EUSTROKE 7FP Health F2-08-202213). This Swiss study was funded by Proteome Sciences plc. UNIGE has granted to Proteome Sciences the exclusive (worldwide) license to a patent protecting GSTP and NDKA as brain damage markers. The Spanish project was funded in part by a grant from the Fondo de Investigaciones Sanitarias (FIS PI08/361 and PI11/0176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers GW, 2008, CHEST, V133, p630S, DOI 10.1378/chest.08-0720; Allard L, 2005, CLIN CHEM, V51, P2043, DOI 10.1373/clinchem.2005.053942; Allard L, 2007, BIOMARK INSIGHTS, V2, P155; Aoki J, 2010, J NEUROL SCI, V293, P39, DOI 10.1016/j.jns.2010.03.011; AWASTHI YC, 1994, INT J BIOCHEM, V26, P295, DOI 10.1016/0020-711X(94)90050-7; Bauer B, 2008, J CEREBR BLOOD F MET, V28, P1222, DOI 10.1038/jcbfm.2008.16; Brouns R, CLIN CHEM, V56, P451; Burgess JA, 2006, J PROTEOME RES, V5, P1674, DOI 10.1021/pr060160v; CUNNINGHAM RT, 1991, EUR J CLIN INVEST, V21, P497, DOI 10.1111/j.1365-2362.1991.tb01401.x; Dayon L, 2008, ANAL CHEM, V80, P2921, DOI 10.1021/ac702422x; Ebinger M, 2010, STROKE, V41, P250, DOI 10.1161/STROKEAHA.109.568410; Fink JN, 2002, STROKE, V33, P988, DOI 10.1161/01.STR.0000014585.17714.67; Foerch C, 2007, STROKE, V38, P2491, DOI 10.1161/STROKEAHA.106.480111; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Grotta JC, 2001, ARCH NEUROL-CHICAGO, V58, P2009, DOI 10.1001/archneur.58.12.2009; Hainard A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000459; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; Khaja AM, 2007, LANCET, V369, P319, DOI 10.1016/S0140-6736(07)60154-8; Kleindorfer D, 2008, STROKE, V39, P924, DOI 10.1161/STROKEAHA.107.490375; Lescuyer P, 2004, PROTEOMICS, V4, P2234, DOI 10.1002/pmic.200300822; Martinez-Lara E, 2003, NEUROBIOL AGING, V24, P501, DOI 10.1016/S0197-4580(02)00139-2; Mendioroz M, 2011, J NEUROL, V258, P486, DOI 10.1007/s00415-010-5785-z; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Montaner J, 2003, CIRCULATION, V107, P598, DOI 10.1161/01.CIR.0000046451.38849.90; Montaner J, 2001, STROKE, V32, P2762, DOI 10.1161/hs1201.99512; Nadeau JO, 2005, CAN J NEUROL SCI, V32, P433, DOI 10.1017/S0317167100004418; Perkins CJ, 2001, STROKE, V32, P2774, DOI 10.1161/hs1201.099634; Petkova M, 2010, RADIOLOGY, V257, P782, DOI 10.1148/radiol.10100461; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Schumacher HC, 2007, ANN EMERG MED, V50, P99, DOI 10.1016/j.annemergmed.2007.01.021; SHEN HX, 1995, BIOCHEM PHARMACOL, V50, P1233, DOI 10.1016/0006-2952(95)00263-Y; Sienkiewicz-Jarosz H, 2009, NEUROL NEUROCHIR POL, V43, P126; Smeyne M, 2007, P NATL ACAD SCI USA, V104, P1977, DOI 10.1073/pnas.0610978104; Tamura Y, 2007, NEUROSCIENCE, V148, P535, DOI 10.1016/j.neuroscience.2007.06.026; Thomalla G, 2011, LANCET NEUROL, V10, P978, DOI 10.1016/S1474-4422(11)70192-2; Thomalla G, 2009, ANN NEUROL, V65, P724, DOI 10.1002/ana.21651; Tuck MK, 2009, J PROTEOME RES, V8, P113, DOI 10.1021/pr800545q; Turck N, 2010, INTENS CARE MED, V36, P107, DOI 10.1007/s00134-009-1641-y; Zimmermann-Ivol CG, 2004, MOL CELL PROTEOMICS, V3, P66, DOI 10.1074/mcp.M300066-MCP200	39	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e43830	10.1371/journal.pone.0043830	http://dx.doi.org/10.1371/journal.pone.0043830			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028472	Green Published, gold, Green Submitted			2022-12-27	WOS:000309742800007
J	Gilbert, JR; Shapiro, LR; Barnes, GR				Gilbert, Jessica R.; Shapiro, Laura R.; Barnes, Gareth R.			Peak-Clustering Method for MEG Group Analysis to Minimise Artefacts Due to Smoothness	PLOS ONE			English	Article							CATEGORY-SPECIFICITY; PERMUTATION METHODS; BEAMFORMER IMAGES; RANDOM-FIELD; OBJECTS; CORTEX; BRAIN	Magnetoencephalography (MEG), a non-invasive technique for characterizing brain electrical activity, is gaining popularity as a tool for assessing group-level differences between experimental conditions. One method for assessing task-condition effects involves beamforming, where a weighted sum of field measurements is used to tune activity on a voxel-by-voxel basis. However, this method has been shown to produce inhomogeneous smoothness differences as a function of signal-tonoise across a volumetric image, which can then produce false positives at the group level. Here we describe a novel method for group-level analysis with MEG beamformer images that utilizes the peak locations within each participant's volumetric image to assess group-level effects. We compared our peak-clustering algorithm with SnPM using simulated data. We found that our method was immune to artefactual group effects that can arise as a result of inhomogeneous smoothness differences across a volumetric image. We also used our peak-clustering algorithm on experimental data and found that regions were identified that corresponded with task-related regions identified in the literature. These findings suggest that our technique is a robust method for group-level analysis with MEG beamformer images.	[Gilbert, Jessica R.; Shapiro, Laura R.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Barnes, Gareth R.] UCL, Wellcome Trust Ctr Neuroimaging, London, England	Aston University; University of London; University College London	Gilbert, JR (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	gilberjr@aston.ac.uk; l.r.shapiro@aston.ac.uk	Barnes, Gareth/ABB-7650-2020; Gilbert, Jessica/I-7074-2019	Barnes, Gareth/0000-0002-5396-7712; Gilbert, Jessica/0000-0002-4194-6172; Shapiro, Laura/0000-0002-3276-457X	Wellcome Trust [091593] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Barnes GR, 2004, HUM BRAIN MAPP, V23, P120, DOI 10.1002/hbm.20047; Barnes GR, 2003, HUM BRAIN MAPP, V18, P1, DOI 10.1002/hbm.10072; Gerlach C, 2006, NEUROPSYCHOLOGIA, V44, P1247, DOI 10.1016/j.neuropsychologia.2005.09.010; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Litvak V, 2007, EUR J NEUROSCI, V25, P2862, DOI 10.1111/j.1460-9568.2007.05531.x; Mattout Jeremie, 2007, Comput Intell Neurosci, P67613, DOI 10.1155/2007/67613; Moss HE, 2005, CEREB CORTEX, V15, P616, DOI 10.1093/cercor/bhh163; Pantazis D, 2005, NEUROIMAGE, V25, P383, DOI 10.1016/j.neuroimage.2004.09.040; Price CJ, 2003, COGN NEUROPSYCHOL, V20, P561, DOI 10.1080/02643290244000284; Sekihara K, 2004, IEEE T BIO-MED ENG, V51, P1726, DOI 10.1109/TBME.2004.827926; Simmons WK, 2003, COGN NEUROPSYCHOL, V20, P451, DOI 10.1080/02643290342000032; Tyler LK, 2004, J COGNITIVE NEUROSCI, V16, P351, DOI 10.1162/089892904322926692; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Vrba J, 2001, METHODS, V25, P249, DOI 10.1006/meth.2001.1238; Woolrich M, 2011, NEUROIMAGE, V57, P1466, DOI 10.1016/j.neuroimage.2011.04.041; Worsley KJ, 1999, HUM BRAIN MAPP, V8, P98, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<98::AID-HBM5>3.3.CO;2-6	17	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45084	10.1371/journal.pone.0045084	http://dx.doi.org/10.1371/journal.pone.0045084			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024795	Green Published, gold, Green Accepted			2022-12-27	WOS:000308860100053
J	Kumar, V; Lo, PHY; Sawai, H; Kato, N; Takahashi, A; Deng, ZZ; Urabe, Y; Mbarek, H; Tokunaga, K; Tanaka, Y; Sugiyama, M; Mizokami, M; Muroyama, R; Tateishi, R; Omata, M; Koike, K; Tanikawa, C; Kamatani, N; Kubo, M; Nakamura, Y; Matsuda, K				Kumar, Vinod; Lo, Paulisally Hau Yi; Sawai, Hiromi; Kato, Naoya; Takahashi, Atsushi; Deng, Zhenzhong; Urabe, Yuji; Mbarek, Hamdi; Tokunaga, Katsushi; Tanaka, Yasuhito; Sugiyama, Masaya; Mizokami, Masashi; Muroyama, Ryosuke; Tateishi, Ryosuke; Omata, Masao; Koike, Kazuhiko; Tanikawa, Chizu; Kamatani, Naoyuki; Kubo, Michiaki; Nakamura, Yusuke; Matsuda, Koichi			Soluble MICA and a MICA Variation as Possible Prognostic Biomarkers for HBV-Induced Hepatocellular Carcinoma	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; GENOME-WIDE ASSOCIATION; SQUAMOUS-CELL CARCINOMA; T-CELLS; SUSCEPTIBILITY LOCUS; JAPANESE POPULATION; NKG2D LIGANDS; EXPRESSION; GENE; ALLELE	MHC class I polypeptide-related chain A (MICA) molecule is induced in response to viral infection and various types of stress. We recently reported that a single nucleotide polymorphism (SNP) rs2596542 located in the MICA promoter region was significantly associated with the risk for hepatitis C virus (HCV)-induced hepatocellular carcinoma (HCC) and also with serum levels of soluble MICA (sMICA). In this study, we focused on the possible involvement of MICA in liver carcinogenesis related to hepatitis B virus (HBV) infection and examined correlation between the MICA polymorphism and the serum sMICA levels in HBV-induced HCC patients. The genetic association analysis revealed a nominal association with an SNP rs2596542; a G allele was considered to increase the risk of HBV-induced HCC (P = 0.029 with odds ratio of 1.19). We also found a significant elevation of sMICA in HBV-induced HCC cases. Moreover, a G allele of SNP rs2596542 was significantly associated with increased sMICA levels (P = 0.009). Interestingly, HCC patients with the high serum level of sMICA (>5 pg/ml) exhibited poorer prognosis than those with the low serum level of sMICA (<= 5 pg/ml) (P = 0.008). Thus, our results highlight the importance of MICA genetic variations and the significance of sMICA as a predictive biomarker for HBV-induced HCC.	[Kumar, Vinod; Lo, Paulisally Hau Yi; Deng, Zhenzhong; Urabe, Yuji; Mbarek, Hamdi; Tanikawa, Chizu; Nakamura, Yusuke; Matsuda, Koichi] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan; [Sawai, Hiromi; Tokunaga, Katsushi] Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo, Japan; [Kato, Naoya; Muroyama, Ryosuke] Univ Tokyo, Inst Med Sci, Unit Dis Control Genome Med, Tokyo, Japan; [Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Dept Clin Mol Informat Med, Nagoya, Aichi, Japan; [Sugiyama, Masaya; Mizokami, Masashi] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Chiba, Japan; [Tateishi, Ryosuke; Omata, Masao; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Nagoya City University; National Center for Global Health & Medicine - Japan; University of Tokyo	Kumar, V (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan.	koichima@ims.u-tokyo.ac.jp	Kumar, Vinod/ABC-4866-2020; Kubo, Michiaki/N-7947-2015; Tateishi, Ryosuke/G-7758-2014; Matsuda, Koichi/D-4597-2011	Kumar, Vinod/0000-0002-2775-6049; Tateishi, Ryosuke/0000-0003-3021-2517; Mbarek, Hamdi/0000-0002-1108-0371; Matsuda, Koichi/0000-0001-7292-2686; Tanaka, Yasuhito/0000-0002-2473-6966	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government; Grants-in-Aid for Scientific Research [23710316] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was conducted as a part of the BioBank Japan Project that was supported by the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004; Chen CJ, 2002, HEPATOLOGY, V36, P1046, DOI 10.1053/jhep.2002.37084; Cui R, 2011, GUT, V60, P799, DOI 10.1136/gut.2010.215947; Cui R, 2009, GASTROENTEROLOGY, V137, P1768, DOI 10.1053/j.gastro.2009.07.070; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Guerrero RB, 2005, J HEPATOL, V42, P760, DOI 10.1016/j.jhep.2005.02.005; Hata J, 2007, HUM MOL GENET, V16, P630, DOI 10.1093/hmg/ddm005; Holdenrieder S, 2006, INT J CANCER, V118, P684, DOI 10.1002/ijc.21382; Jinushi M, 2005, J HEPATOL, V43, P1013, DOI 10.1016/j.jhep.2005.05.026; Jinushi M, 2003, INT J CANCER, V104, P354, DOI 10.1002/ijc.10966; Jinushi M, 2006, P NATL ACAD SCI USA, V103, P9190, DOI 10.1073/pnas.0603503103; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kew MC, 2010, PATHOL BIOL, V58, P273, DOI 10.1016/j.patbio.2010.01.005; Kumar V, 2011, J HUM GENET, V56, P436, DOI 10.1038/jhg.2011.35; Kumar V, 2011, NAT GENET, V43, P455, DOI 10.1038/ng.809; Lara-Pezzi E, 2002, J CLIN INVEST, V110, P1831, DOI 10.1172/JCI200215887; Li K, 2009, CANCER IMMUNOL IMMUN, V58, P641, DOI 10.1007/s00262-008-0585-3; Lu M, 2009, IMMUNOLOGY, V128, pe230, DOI 10.1111/j.1365-2567.2008.02953.x; Mbarek H, 2011, HUM MOL GENET, V20, P3884, DOI 10.1093/hmg/ddr301; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Nuckel H, 2010, LEUKEMIA, V24, P1152, DOI 10.1038/leu.2010.74; Ota M, 1997, TISSUE ANTIGENS, V49, P448, DOI 10.1111/j.1399-0039.1997.tb02778.x; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Sherman M, 2010, SEMIN LIVER DIS, V30, P3, DOI 10.1055/s-0030-1247128; Tamaki S, 2008, HUM IMMUNOL, V69, P88, DOI 10.1016/j.humimm.2008.01.010; Tamaki S, 2007, J ORAL PATHOL MED, V36, P351, DOI 10.1111/j.1600-0714.2007.00539.x; Tamaki S, 2009, CLIN IMMUNOL, V130, P331, DOI 10.1016/j.clim.2008.09.004; Tanikawa C, 2012, NAT GENET, V44, P430, DOI 10.1038/ng.1109; Urabe Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002541; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638	36	64	66	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44743	10.1371/journal.pone.0044743	http://dx.doi.org/10.1371/journal.pone.0044743			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024757	gold, Green Published, Green Submitted			2022-12-27	WOS:000308860100015
J	Tsang, LM; Achituv, Y; Chu, KH; Chan, BKK				Tsang, Ling Ming; Achituv, Yair; Chu, Ka Hou; Chan, Benny Kwok Kan			Zoogeography of Intertidal Communities in the West Indian Ocean as Determined by Ocean Circulation Systems: Patterns from the Tetraclita Barnacles	PLOS ONE			English	Article							GENETIC-STRUCTURE; COMPARATIVE PHYLOGEOGRAPHY; CHTHAMALUS-MALAYENSIS; POPULATION-STRUCTURE; LARVAL DEVELOPMENT; SOUTH-AFRICA; RED-SEA; CIRRIPEDIA; DISPERSAL; CRUSTACEA	The Indian Ocean is the least known ocean in the world with the biogeography of marine species in the West Indian Ocean (WIO) understudied. The hydrography of WIO is characterized by four distinct oceanographic systems and there were few glacial refugia formations in the WIO during the Pleistocene. We used the widely distributed intertidal barnacle Tetraclita to test the hypothesis that the distribution and connectivity of intertidal animals in the WIO are determined by the major oceanographic regime but less influenced by historical events such as Pleistocene glaciations. Tetraclita were studied from 32 locations in the WIO. The diversity and distribution of Tetraclita species in the Indian Ocean were examined based on morphological examination and sequence divergence of two mitochondrial genes (12S rDNA and COI) and one nuclear gene (histone 3, H3). Divergence in DNA sequences revealed the presence of seven evolutionarily significant units (ESUs) of Tetraclita in WIO, with most of them recognized as valid species. The distribution of these ESUs is closely tied to the major oceanographic circulation systems. T. rufotincta is distributed in the Monsoonal Gyre. T. ehsani is present in the Gulf of Oman and NW India. Tetraclita sp. nov. is associated with the Hydrochemical Front at 10 degrees S latitude. T. reni is confined to southern Madagascan and Mauritian waters, influenced by the West Wind Drift. The endemic T. achituvi is restricted to the Red Sea. Tetraclita serrata consists of two ESUs (based on mtDNA analysis) along the east to west coast of South Africa. The two ESUs could not be distinguished from morphological analysis and nuclear H3 sequences. Our results support that intertidal species in the West Indian Ocean are associated with each of the major oceanographic circulation systems which determine gene flow. Geographical distribution is, however, less influenced by the geological history of the region.	[Tsang, Ling Ming; Chu, Ka Hou] Chinese Univ Hong Kong, Sch Life Sci, Simon FS Li Marine Sci Lab, Shatin, Hong Kong, Peoples R China; [Achituv, Yair] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Chan, Benny Kwok Kan] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan	Chinese University of Hong Kong; Bar Ilan University; Academia Sinica - Taiwan	Tsang, LM (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Simon FS Li Marine Sci Lab, Shatin, Hong Kong, Peoples R China.	chankk@gate.sinica.edu.tw	Tsang, Ling Ming/Q-7628-2018; Chu, Ka Hou/B-8010-2011	Tsang, Ling Ming/0000-0002-5029-5690; Chu, Ka Hou/0000-0001-8107-5415; Chan, Benny/0000-0001-9479-024X	Career Development Award in Academia Sinica, Taiwan [AS-98-CDA-L15]; The Research Committee; The Chinese University of Hong Kong; Research Grants Council; Hong Kong Special Administrative Region [CUHK463509]; Israel Science Foundation (ISF) [574/10]	Career Development Award in Academia Sinica, Taiwan; The Research Committee; The Chinese University of Hong Kong(Chinese University of Hong Kong); Research Grants Council(Hong Kong Research Grants Council); Hong Kong Special Administrative Region; Israel Science Foundation (ISF)(Israel Science Foundation)	This work was supported by grants from the Career Development Award in Academia Sinica, Taiwan (AS-98-CDA-L15) to BKKC, The Research Committee, The Chinese University of Hong Kong, and Research Grants Council, Hong Kong Special Administrative Region, (Project no. CUHK463509) to KHC and Israel Science Foundation (ISF) grant 574/10 to YA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHITUV Y, 1978, J EXP MAR BIOL ECOL, V31, P315, DOI 10.1016/0022-0981(78)90066-7; ACHITUV Y, 1987, J EXP MAR BIOL ECOL, V108, P181, DOI 10.1016/S0022-0981(87)80022-9; ACHITUV Y, 1972, Journal of Experimental Marine Biology and Ecology, V8, P73, DOI 10.1016/0022-0981(72)90057-3; Acker J. G., 2007, EOS T AGU, V88, P14, DOI [DOI 10.1029/2007EO020003, 10.1029/2007EO020003]; Antonov J. I., 2010, WORLD OCEAN ATLAS 20, V2; Antony Fernando S., 2006, MONOGRAPH INDIAN BAR; Appelbaum L, 2002, MOL ECOL, V11, P1731, DOI 10.1046/j.1365-294X.2002.01560.x; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Barber PH, 2006, EVOLUTION, V60, P1825; Barnard MA, 1924, ANN S AFR MUS, V20, P89; BARNES M, 1981, J EXP MAR BIOL ECOL, V54, P149, DOI 10.1016/0022-0981(81)90141-6; Benzie JAH, 2002, MOL ECOL, V11, P2553, DOI 10.1046/j.1365-294X.2002.01638.x; Briggs J.C., 1974, CIMAC C SHANGH CHIN, DOI 10.2307/1442613; Briggs JC, 2003, J BIOGEOGR, V30, P381, DOI 10.1046/j.1365-2699.2003.00809.x; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; Burrows MT, 1999, J MAR BIOL ASSOC UK, V79, P93, DOI 10.1017/S0025315498000101; Bustamante RH, 1996, J BIOGEOGR, V23, P339, DOI 10.1046/j.1365-2699.1996.00026.x; Chan BKK, 2007, ZOOL SCR, V36, P79, DOI 10.1111/j.1463-6409.2007.00260.x; Chan BKK, 2008, MAR ECOL PROG SER, V362, P201, DOI 10.3354/meps07446; Chan BKK, 2009, ZOOTAXA, P57, DOI 10.11646/zootaxa.2019.1.4; Chan BKK, 2003, J CRUSTACEAN BIOL, V23, P522, DOI 10.1651/C-2350; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Courtillot V, 1999, EARTH PLANET SC LETT, V166, P177, DOI 10.1016/S0012-821X(98)00282-9; Daniel A, 1974, P S MAR INTERTIDAL B, V38, P179; Darwin C., 1854, MONOGRAPH SUBCLASS C; De Grave S, 2001, J BIOGEOGR, V28, P1239, DOI 10.1046/j.1365-2699.2001.00633.x; Dietrich G., 1973, BIOL INDIAN OCEAN, P1; DiMarco SF, 2002, DEEP-SEA RES PT II, V49, P1481, DOI 10.1016/S0967-0645(01)00159-X; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evans BS, 2004, MAR ECOL PROG SER, V270, P163, DOI 10.3354/meps270163; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FISHELSON L, 1971, MAR BIOL, V10, P113, DOI 10.1007/BF00354828; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Froukh T, 2007, MOL ECOL, V16, P1359, DOI 10.1111/j.1365-294X.2007.03236.x; Gaither MR, 2010, J BIOGEOGR, V37, P133, DOI 10.1111/j.1365-2699.2009.02188.x; He LJ, 2011, MAR ECOL-EVOL PERSP, V32, P52, DOI 10.1111/j.1439-0485.2010.00406.x; JAYARAMAN R., 1957, PROC INDIAN ACAD SCI SECT B, V45, P151; Johnson D. H., 1973, BIOL INDIAN OCEAN; Keith SA, 2011, DIVERS DISTRIB, V17, P275, DOI 10.1111/j.1472-4642.2010.00734.x; Kemp JM, 1998, J BIOGEOGR, V25, P919, DOI 10.1046/j.1365-2699.1998.00249.x; Kensley B, 1981, SMITHSONIAN CONTRIBU, V338, P1, DOI DOI 10.5479/SI.00810282.338; LAWSON TJ, 1977, MAR BIOL, V43, P71, DOI 10.1007/BF00392573; Lourie SA, 2005, MOL ECOL, V14, P1073, DOI 10.1111/j.1365-294X.2005.02464.x; Lourie SA, 2004, CONSERV BIOL, V18, P1004, DOI 10.1111/j.1523-1739.2004.00137.x; Lutjeharms JRE, 2000, CONT SHELF RES, V20, P1907, DOI 10.1016/S0278-4343(00)00053-4; Lutjeharms JRE, 2006, AGULHAS CURRENT; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Marko PB, 2004, MOL ECOL, V13, P597, DOI 10.1046/j.1365-294X.2004.02096.x; MCCLANAHAN TR, 1988, MAR ECOL PROG SER, V44, P191, DOI 10.3354/meps044191; Newman W.A., 1976, Memoirs of the San Diego Society of Natural History, VNo. 9, P1; Nylander JAA., 2004, BIOINFORMATICS; OMAR GI, 1995, SCIENCE, V270, P1341, DOI 10.1126/science.270.5240.1341; Pannacciulli FG, 1997, MAR BIOL, V128, P73, DOI 10.1007/s002270050070; Pilsbry HA, 1916, US NATL MUSEUM B, V93, P241; Ragionieri L, 2010, ESTUAR COAST SHELF S, V86, P179, DOI 10.1016/j.ecss.2009.11.002; Reid DG, 2006, J BIOGEOGR, V33, P990, DOI 10.1111/j.1365-2699.2006.01469.x; REN X, 1989, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V11, P431; ROBERTS CM, 1992, J BIOGEOGR, V19, P239, DOI 10.2307/2845449; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ross Arnold, 1999, Pakistan Journal of Marine Sciences, V8, P41; Samyn Y, 2005, J BIOGEOGR, V32, P1523, DOI 10.1111/j.1365-2699.2005.01295.x; Schils T, 2003, J BIOGEOGR, V30, P1339, DOI 10.1046/j.1365-2699.2003.00933.x; Shahdadi A, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.136.1772; SHANNON LV, 1985, OCEANOGR MAR BIOL, V23, P105; Shemesh E, 2009, ZOOL SCR, V38, P365, DOI 10.1111/j.1463-6409.2008.00384.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sink KJ, 2005, AFR J MAR SCI, V27, P81, DOI 10.2989/18142320509504070; Sirocko F, 2003, NATURE, V423, P813, DOI 10.1038/423813a; Southward AJ, 2003, J MAR BIOL ASSOC UK, V83, P797, DOI 10.1017/S0025315403007835h; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teske PR, 2007, MAR BIOL, V152, P697, DOI 10.1007/s00227-007-0724-y; Tsang LM, 2008, MAR ECOL PROG SER, V364, P107, DOI 10.3354/meps07476; Tsang LM, 2009, MOL ECOL, V18, P1463, DOI 10.1111/j.1365-294X.2009.04090.x; Tsang LM, 2011, CRUTACEAN ISSUE 19 P; Utinomi H., 1969, Videnskabelige Meddelelser Dansk naturh Foren, V132, P79; Utinomi H., 1968, VIDENSK MEDDEL NATUR, V131, P161; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Wafar M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014613; Wagh A. B., 1969, Current Science, V38, P344; Wagh AB, 1971, J BOMBAY NATURAL HIS, V71, P322; Williams S, 2011, EVOLUTION, V65, P1752, DOI 10.1111/j.1558-5646.2011.01255.x; WYRTKI K, 1971, P531; Wyrtki K, 1973, BIOL INDIAN OCEAN, P1; Yan Y, 2004, J CRUSTACEAN BIOL, V24, P519, DOI 10.1651/C-2491; Yan Y, 2001, J MAR BIOL ASSOC UK, V81, P623, DOI 10.1017/S0025315401004283; Zardi GI, 2007, MAR ECOL PROG SER, V337, P135, DOI 10.3354/meps337135	89	43	44	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45120	10.1371/journal.pone.0045120	http://dx.doi.org/10.1371/journal.pone.0045120			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024801	Green Submitted, Green Published, gold			2022-12-27	WOS:000308860100059
J	Zhang, YP; Li, J; Tardif, T; Burmeister, M; Villafuerte, SM; McBride-Chang, C; Li, H; Shi, BJ; Liang, WL; Zhang, ZX; Shu, H				Zhang, Yuping; Li, Jun; Tardif, Twila; Burmeister, Margit; Villafuerte, Sandra M.; McBride-Chang, Catherine; Li, Hong; Shi, Bingjie; Liang, Weilan; Zhang, Zhixiang; Shu, Hua			Association of the DYX1C1 Dyslexia Susceptibility Gene with Orthography in the Chinese Population	PLOS ONE			English	Article							DEVELOPMENTAL DYSLEXIA; CANDIDATE GENE; SUPPORT; ADOLESCENTS; CHILDREN; VARIANT; SKILLS; EKN1; TWIN	Several independent studies have supported the association of DYX1C1 with dyslexia, but its role in general reading development remains unclear. Here, we investigated the contribution of this gene to reading, with a focus on orthographic skills, in a sample of 284 unrelated Chinese children aged 5 to 11 years who were participating in the Chinese Longitudinal Study of Reading Development. We tested this association using a quantitative approach for Chinese character reading, Chinese character dictation, orthographic judgment, and visual skills. Significant or marginally significant associations were observed at the marker rs11629841 with children's orthographic judgments at ages 7 and 8 years (all P values<0.020). Significant associations with Chinese character dictation (all P values<0.013) were also observed for this single-nucleotide polymorphism (SNP) at ages 9, 10, and 11 years. Further analyses revealed that the association with orthographic skills was specific to the processing of specific components of characters (P values<0.046). No association was found at either SNP of rs3743205 or rs57809907. Our findings suggest that DYX1C1 influences reading development in the general Chinese population and supports a universal effect of this gene.	[Zhang, Yuping; Li, Jun; Shi, Bingjie; Shu, Hua] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Tardif, Twila] Univ Michigan, Dept Psychol, Ann Arbor, MI USA; [Burmeister, Margit; Villafuerte, Sandra M.] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Burmeister, Margit; Villafuerte, Sandra M.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Burmeister, Margit] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [McBride-Chang, Catherine] Chinese Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China; [Li, Hong] Beijing Normal Univ, Dept Psychol, Beijing 100875, Peoples R China; [Liang, Weilan; Zhang, Zhixiang] Peking Univ, Hosp 1, Beijing 100871, Peoples R China	Beijing Normal University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Chinese University of Hong Kong; Beijing Normal University; Peking University	Zhang, YP (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	shuh@bnu.edu.cn	Burmeister, Margit/A-3157-2013	Burmeister, Margit/0000-0002-1914-2434; Tardif, Twila Z/0000-0001-8739-9090	Natural Science Foundation of China [30870758]; Fundamental Research Funds for the Central University; U.S. Natural Sciences Foundation [BCS-0350272]; Research Grants Council of the Hong Kong Special Administrative Region [448907]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central University; U.S. Natural Sciences Foundation; Research Grants Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council)	This research was supported by a grant from the Natural Science Foundation of China (30870758), by the Fundamental Research Funds for the Central University, and by BCS-0350272 from the U.S. Natural Sciences Foundation. Funding was also provided by the Research Grants Council of the Hong Kong Special Administrative Region (project reference #448907). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bates TC, 2010, MOL PSYCHIATR, V15, P1190, DOI 10.1038/mp.2009.120; Bellini G, 2005, J MOL NEUROSCI, V27, P311, DOI 10.1385/JMN:27:3:311; Brkanac Z, 2007, AM J MED GENET B, V144B, P556, DOI 10.1002/ajmg.b.30471; Chow BWY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016640; Cope NA, 2005, MOL PSYCHIATR, V10, P237, DOI 10.1038/sj.mp.4001596; Dahdouh F, 2009, PSYCHIAT GENET, V19, P59, DOI 10.1097/YPG.0b013e32832080e1; Fisher SE, 2002, NAT REV NEUROSCI, V3, P767, DOI 10.1038/nrn936; Gardner MF, 1996, TESTS VISUAL PERCEPT; Gayan J, 2001, DEV NEUROPSYCHOL, V20, P483, DOI 10.1207/S15326942DN2002_3; Han ZX, 2007, COGN NEUROPSYCHOL, V24, P431, DOI 10.1080/02643290701381853; Ho CSH, 2004, COGNITION, V91, P43, DOI 10.1016/S0010-0277(03)00163-X; Hultquist AM, 1997, ANN DYSLEXIA, V47, P89, DOI 10.1007/s11881-997-0022-x; Kere J, 2011, WIRES COGN SCI, V2, P441, DOI 10.1002/wcs.138; Lei L, 2011, J CHILD PSYCHOL PSYC, V52, P212, DOI 10.1111/j.1469-7610.2010.02311.x; LI H, 2006, PSYCHOL DEV ED, V18, P35; Li H, 2012, J RES READ, V35, P287, DOI 10.1111/j.1467-9817.2010.01460.x; Lim CKP, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-16; Lin D, 2010, PSYCHOL SCI, V21, P1117, DOI 10.1177/0956797610375447; Liu C, 2008, NEUROIMAGE, V40, P1350, DOI 10.1016/j.neuroimage.2007.10.014; Marino C, 2007, GENES BRAIN BEHAV, V6, P640, DOI 10.1111/j.1601-183X.2006.00291.x; Marino C, 2005, EUR J HUM GENET, V13, P491, DOI 10.1038/sj.ejhg.5201356; McBride-Chang C, 2002, CHILD DEV, V73, P1392, DOI 10.1111/1467-8624.00479; McBride-Chang Catherine., 2005, READ WRIT, V18, P99, DOI [10.1007/s11145-004-7343-5, DOI 10.1007/S11145-004-7343-5]; Meng HY, 2005, HUM GENET, V118, P87, DOI 10.1007/s00439-005-0017-9; Olson Richard K, 2002, Dyslexia, V8, P143, DOI 10.1002/dys.228; Ouellette G, 2008, CHILD DEV, V79, P899, DOI 10.1111/j.1467-8624.2008.01166.x; Pak A.K.H., 2005, READ WRIT, V18, P437, DOI [10.1007/s11145-005-6575-3, DOI 10.1007/S11145-005-6575-3]; Paracchini S, 2011, GENES BRAIN BEHAV, V10, P158, DOI 10.1111/j.1601-183X.2010.00651.x; Poelmans G, 2011, MOL PSYCHIATR, V16, P365, DOI 10.1038/mp.2010.105; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raven JC., 1996, STANDARD PROGR MATRI; Saviour Pushpa, 2008, Indian J Hum Genet, V14, P99, DOI 10.4103/0971-6866.45002; Scerri TS, 2004, J MED GENET, V41, P853, DOI 10.1136/jmg.2004.018341; Shaywitz SE, 1998, NEW ENGL J MED, V338, P307, DOI 10.1056/NEJM199801293380507; SHAYWITZ SE, 1990, JAMA-J AM MED ASSOC, V264, P998, DOI 10.1001/jama.264.8.998; Shu H, 2006, J EDUC PSYCHOL, V98, P122, DOI 10.1037/0022-0663.98.1.122; Shu H, 1999, READING CHINESE SCRIPT, P1; Shu H, 2003, CHILD DEV, V74, P27, DOI 10.1111/1467-8624.00519; STEVENSON HW, 1982, CHILD DEV, V53, P1164, DOI 10.2307/1129005; STEVENSON J, 1987, J CHILD PSYCHOL PSYC, V28, P229, DOI 10.1111/j.1469-7610.1987.tb00207.x; Taipale M, 2003, P NATL ACAD SCI USA, V100, P11553, DOI 10.1073/pnas.1833911100; Tan LH, 2001, NEUROIMAGE, V13, P836, DOI 10.1006/nimg.2001.0749; Tardif T., 2008, CHINESE COMMUNICATIV; Wigg KG, 2004, MOL PSYCHIATR, V9, P1111, DOI 10.1038/sj.mp.4001543; Woodcock R.W., 1989, WOODCOCK JOHNSON TES; Yang JF, 2009, J MEM LANG, V61, P238, DOI 10.1016/j.jml.2009.05.001	47	53	55	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e42969	10.1371/journal.pone.0042969	http://dx.doi.org/10.1371/journal.pone.0042969			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028439	Green Published, Green Submitted, gold			2022-12-27	WOS:000308788700007
J	Baek, KH; Lee, H; Yang, S; Lim, SB; Lee, W; Lee, JE; Lim, JJ; Jun, K; Lee, DR; Chung, Y				Baek, Kwang-Hyun; Lee, Heyjin; Yang, Sunmee; Lim, Soo-Bin; Lee, Wonwoo; Lee, Jeoung Eun; Lim, Jung-Jin; Jun, Kisun; Lee, Dong-Ryul; Chung, Young			Embryonic Demise Caused by Targeted Disruption of a Cysteine Protease Dub-2	PLOS ONE			English	Article							DEUBIQUITINATING ENZYMES; PREIMPLANTATION LETHALITY; PROTEOLYTIC PATHWAY; UBIQUITIN PATHWAY; CANCER-THERAPY; SYSTEM; PROLIFERATION; DEGRADATION; ACTIVATION; APOPTOSIS	Background: A plethora of biological metabolisms are regulated by the mechanisms of ubiquitination, wherein this process is balanced with the action of deubiquitination system. Dub-2 is an IL-2-inducible, immediate-early gene that encodes a deubiquitinating enzyme with growth regulatory activity. DUB-2 presumably removes ubiquitin from ubiquitin-conjugated target proteins regulating ubiquitin-mediated proteolysis, but its specific target proteins are unknown yet. Methodology/Principal Findings: To elucidate the functional role of Dub-2, we generated genetically modified mice by introducing neo cassette into the second exon of Dub-2 and then homologous recombination was done to completely abrogate the activity of DUB-2 proteins. We generated Dub-2+/- heterozygous mice showing a normal phenotype and are fertile, whereas new born mouse of Dub-2-/- homozygous alleles could not survive. In addition, Dub-2-/- embryo could not be seen between E6.5 and E12.5 stages. Furthermore, the number of embryos showing normal embryonic development for further stages is decreased in heterozygotes. Even embryonic stem cells from inner cell mass of Dub-2-/- embryos could not be established. Conclusions: Our study suggests that the targeted disruption of Dub-2 may cause embryonic lethality during early gestation, possibly due to the failure of cell proliferation during hatching process.	[Baek, Kwang-Hyun; Lee, Heyjin; Yang, Sunmee; Lim, Soo-Bin; Lee, Wonwoo; Lee, Jeoung Eun; Lim, Jung-Jin; Jun, Kisun; Lee, Dong-Ryul; Chung, Young] CHA Univ, CHA Gen Hosp, CHA Stem Cell Inst, Dept Biomed Sci, Gyeonggi Do, South Korea	Pochon Cha University	Baek, KH (corresponding author), CHA Univ, CHA Gen Hosp, CHA Stem Cell Inst, Dept Biomed Sci, Gyeonggi Do, South Korea.	baek@cha.ac.kr		Baek, Kwang-Hyun/0000-0001-7662-7190	Basic Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0015312]	Basic Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0015312). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroggio XI, 2004, PLOS BIOL, V2, P113, DOI 10.1371/journal.pbio.0020002; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Ande SR, 2009, EUR J PHARMACOL, V625, P199, DOI 10.1016/j.ejphar.2009.08.042; Ardley HC, 2004, NEURODEGENER DIS, V1, P71, DOI 10.1159/000080048; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Ayton P, 2001, GENESIS, V30, P201, DOI 10.1002/gene.1066; Baek KH, 2006, CURR PROTEIN PEPT SC, V7, P171, DOI 10.2174/138920306776359740; Baek KH, 2004, J BIOL CHEM, V279, P2368, DOI 10.1074/jbc.M304774200; Balakirev MY, 2003, EMBO REP, V4, P517, DOI 10.1038/sj.embor.embor824; Burrows JF, 2009, J BIOL CHEM, V284, P9587, DOI 10.1074/jbc.M807216200; Burrows JF, 2004, J BIOL CHEM, V279, P13993, DOI 10.1074/jbc.M311291200; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Ciechanover A, 2000, J CELL BIOCHEM, P40; D'Andrea A, 1998, CRIT REV BIOCHEM MOL, V33, P337, DOI 10.1080/10409239891204251; de la Coste A, 2006, IMMUNOL LETT, V102, P1, DOI 10.1016/j.imlet.2005.06.014; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; HANDYSIDE AH, 1984, J EXP ZOOL, V231, P429, DOI 10.1002/jez.1402310317; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Hussain S, 2009, CELL CYCLE, V8, P1688, DOI 10.4161/cc.8.11.8739; Kawaguchi M, 2007, GENE, V392, P77, DOI 10.1016/j.gene.2006.11.012; Kawamura K, 2003, DEV BIOL, V256, P331, DOI 10.1016/S0012-1606(02)00135-5; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kon N, 2010, ONCOGENE, V29, P1270, DOI 10.1038/onc.2009.427; Layfield R, 2001, NEUROPATH APPL NEURO, V27, P171, DOI 10.1046/j.1365-2990.2001.00335.x; Levy R, 2001, INT REV CYTOL, V210, P1; Lindsay LL, 2001, DEV GROWTH DIFFER, V43, P305; Mao Y, 2005, P NATL ACAD SCI USA, V102, P12700, DOI 10.1073/pnas.0506344102; Mbikay M, 2007, DEV BIOL, V306, P584, DOI 10.1016/j.ydbio.2007.03.523; Migone TS, 2001, BLOOD, V98, P1935, DOI 10.1182/blood.V98.6.1935; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Ramakrishna S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037772; Ramakrishna S, 2011, J BIOL CHEM, V286, P10505, DOI 10.1074/jbc.M110.162321; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Schwartz AL, 1999, ANNU REV MED, V50, P57; Sharma N, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-61; Sorokin AV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1411, DOI 10.1134/S000629790913001X; Tripathi R, 2009, J REPROD IMMUNOL, V83, P31, DOI 10.1016/j.jri.2009.05.009; Wright A, 2007, DEV CELL, V13, P705, DOI 10.1016/j.devcel.2007.09.007; Zhu Y, 1996, P NATL ACAD SCI USA, V93, P3275, DOI 10.1073/pnas.93.8.3275; Zhu Y, 1996, MOL CELL BIOL, V16, P4808; Zhu YA, 1997, J BIOL CHEM, V272, P51	41	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44223	10.1371/journal.pone.0044223	http://dx.doi.org/10.1371/journal.pone.0044223			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984479	Green Published, Green Submitted, gold			2022-12-27	WOS:000308738500039
J	Buckley, RC; Castley, JG; Pegas, FD; Mossaz, AC; Steven, R				Buckley, Ralf C.; Castley, J. Guy; Pegas, Fernanda de Vasconcellos; Mossaz, Alexa C.; Steven, Rochelle			A Population Accounting Approach to Assess Tourism Contributions to Conservation of IUCN-Redlisted Mammal Species	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; GLOBAL BIODIVERSITY; TRADE-OFFS; AREA	Over 1,000 mammal species are red-listed by IUCN, as Critically Endangered, Endangered or Vulnerable. Conservation of many threatened mammal species, even inside protected areas, depends on costly active day-to-day defence against poaching, bushmeat hunting, invasive species and habitat encroachment. Many parks agencies worldwide now rely heavily on tourism for routine operational funding: >50% in some cases. This puts rare mammals at a new risk, from downturns in tourism driven by external socioeconomic factors. Using the survival of individual animals as a metric or currency of successful conservation, we calculate here what proportions of remaining populations of IUCN-redlisted mammal species are currently supported by funds from tourism. This proportion is >= 5% for over half of the species where relevant data exist, >= 15% for one fifth, and up to 66% in a few cases. Many of these species, especially the most endangered, survive only in one single remaining subpopulation. These proportions are not correlated either with global population sizes or recognition as wildlife tourism icons. Most of the more heavily tourism-dependent species, however, are medium sized (>7.5 kg) or larger. Historically, biological concern over the growth of tourism in protected areas has centered on direct disturbance to wildlife. These results show that conservation of threatened mammal species has become reliant on revenue from tourism to a previously unsuspected degree. On the one hand, this provides new opportunities for conservation funding; but on the other, dependence on such an uncertain source of funding is a new, large and growing threat to red-listed species.	[Buckley, Ralf C.; Castley, J. Guy; Pegas, Fernanda de Vasconcellos; Mossaz, Alexa C.; Steven, Rochelle] Griffith Univ, Int Ctr Ecotourism Res, Gold Coast, Qld, Australia	Griffith University	Buckley, RC (corresponding author), Griffith Univ, Int Ctr Ecotourism Res, Gold Coast, Qld, Australia.	r.buckley@griffith.edu.au	Steven, Rochelle/AAD-5898-2020; Castley, James Guy/A-7056-2010; Buckley, Ralf/G-7032-2014	Castley, James Guy/0000-0002-8418-5828; Buckley, Ralf/0000-0003-0442-5818; Steven, Rochelle/0000-0002-3474-6818				Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Barrett MA, 2009, NATURE, V461, P470, DOI 10.1038/461470a; Bourton J, 2009, BBC NEWS; Bovarnick A, 2010, FINANCIAL SUSTAINABI; Bruner AG, 2004, BIOSCIENCE, V54, P1119, DOI 10.1641/0006-3568(2004)054[1119:FCASOM]2.0.CO;2; Buckley R, 2010, NATURE, V467, P1047, DOI 10.1038/4671047d; Buckley R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000143; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Clements GR, 2011, FRONT ECOL ENVIRON, V9, P521, DOI 10.1890/100177; Conde DA, 2011, SCIENCE, V331, P1390, DOI 10.1126/science.1200674; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Doak DF, 2010, NATURE, V467, P959, DOI 10.1038/nature09439; Dudley JP, 2002, CONSERV BIOL, V16, P319, DOI 10.1046/j.1523-1739.2002.00306.x; Ferreira S., 2004, GeoJournal, V60, P301, DOI 10.1023/B:GEJO.0000034736.23918.05; Flather CH, 2011, TRENDS ECOL EVOL, V26, P307, DOI 10.1016/j.tree.2011.03.001; Fletcher J, 2008, INT J TOUR RES, V10, P537, DOI 10.1002/jtr.699; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; Gordon A, 2011, BIOL CONSERV, V144, P558, DOI 10.1016/j.biocon.2010.10.011; Hayward MW, 2011, BIODIVERS CONSERV, V20, P2563, DOI 10.1007/s10531-011-0091-3; He FL, 2011, NATURE, V473, P368, DOI 10.1038/nature09985; Hodgson JA, 2011, J APPL ECOL, V48, P148, DOI 10.1111/j.1365-2664.2010.01919.x; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Jenkins RKB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027570; Karanth KU, 2011, SCIENCE, V332, P791, DOI 10.1126/science.332.6031.791-a; Mansourian S., 2008, PUBLIC FUNDS PROTECT; McDonald RI, 2011, BIOL CONSERV, V144, P383, DOI 10.1016/j.biocon.2010.09.016; McShane TO, 2011, BIOL CONSERV, V144, P966, DOI 10.1016/j.biocon.2010.04.038; Mooney H, 2009, SCIENCE, V325, P1474, DOI 10.1126/science.1180935; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Perrings C, 2011, SCIENCE, V331, P1139, DOI 10.1126/science.1202400; Persha L, 2011, SCIENCE, V331, P1606, DOI 10.1126/science.1199343; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Willis KJ, 2009, SCIENCE, V326, P806, DOI 10.1126/science.1178838	39	60	60	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44134	10.1371/journal.pone.0044134	http://dx.doi.org/10.1371/journal.pone.0044134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984467	Green Published, gold, Green Submitted			2022-12-27	WOS:000308738500032
J	DePape, AMR; Hall, GBC; Tillmann, B; Trainor, LJ				DePape, Anne-Marie R.; Hall, Geoffrey B. C.; Tillmann, Barbara; Trainor, Laurel J.			Auditory Processing in High-Functioning Adolescents with Autism Spectrum Disorder	PLOS ONE			English	Article							ABSOLUTE PITCH; SPEECH-PERCEPTION; MUSIC ACQUISITION; EARLY RECOGNITION; ASPERGER-SYNDROME; CHILDREN; INFANTS; LANGUAGE; DISCRIMINATION; INTEGRATION	Autism Spectrum Disorder (ASD) is a pervasive developmental disorder including abnormalities in perceptual processing. We measure perception in a battery of tests across speech (filtering, phoneme categorization, multisensory integration) and music (pitch memory, meter categorization, harmonic priming). We found that compared to controls, the ASD group showed poorer filtering, less audio-visual integration, less specialization for native phonemic and metrical categories, and a higher instance of absolute pitch. No group differences were found in harmonic priming. Our results are discussed in a developmental framework where culture-specific knowledge acquired early compared to late in development is most impaired, perhaps because of early-accelerated brain growth in ASD. These results suggest that early auditory remediation is needed for good communication and social functioning.	[DePape, Anne-Marie R.; Hall, Geoffrey B. C.; Trainor, Laurel J.] McMaster Univ, Hamilton, ON, Canada; [Trainor, Laurel J.] Baycrest Hosp, Rotman Res Inst, Toronto, ON, Canada; [Tillmann, Barbara] Univ Lyon 1, INSERM U1028, CNRS UMR 5292, Lyon Neurosci Res Ctr,Auditory Cognit & Psychoaco, F-69365 Lyon, Rhone Alpes, France	McMaster University; University of Toronto; University Toronto Affiliates; Baycrest; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet	DePape, AMR (corresponding author), McMaster Univ, Hamilton, ON, Canada.	ljt@mcmaster.ca		Trainor, Laurel/0000-0003-3397-2079; /0000-0002-3398-6692	Natural Sciences and Engineering Research Council of Canada; Social Sciences and Humanities Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This research was supported by a grant from the Natural Sciences and Engineering Research Council of Canada to LJT and a graduate fellowship from the Social Sciences and Humanities Research Council of Canada to ARD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara JI, 2004, J CHILD PSYCHOL PSYC, V45, P1107, DOI 10.1111/j.1469-7610.2004.t01-1-00303.x; Allen R, 2010, MUSIC PERCEPT, V27, P251, DOI 10.1525/MP.2010.27.4.251; Allen R, 2009, AUTISM, V13, P21, DOI 10.1177/1362361307098511; Ashburner J, 2008, AM J OCCUP THER, V62, P564, DOI 10.5014/ajot.62.5.564; BACHEM A, 1955, J ACOUST SOC AM, V27, P1180, DOI 10.1121/1.1908155; Baharloo S, 1998, AM J HUM GENET, V62, P224, DOI 10.1086/301704; Baker AEZ, 2008, J AUTISM DEV DISORD, V38, P867, DOI 10.1007/s10803-007-0459-0; Baranek GT, 2007, AM J MENT RETARD, V112, P233, DOI 10.1352/0895-8017(2007)112[233:HSPIYC]2.0.CO;2; Baranek GT, 1999, J AUTISM DEV DISORD, V29, P213, DOI 10.1023/A:1023080005650; Barnea-Goraly N, 2004, BIOL PSYCHIAT, V55, P323, DOI 10.1016/j.biopsych.2003.10.022; BaronCohen S, 1997, J COGNITIVE NEUROSCI, V9, P548, DOI 10.1162/jocn.1997.9.4.548; Best CT, 2001, J ACOUST SOC AM, V109, P775, DOI 10.1121/1.1332378; Bigand E, 1999, J EXP PSYCHOL HUMAN, V25, P184, DOI 10.1037/0096-1523.25.1.184; Bigand E, 2003, J EXP PSYCHOL HUMAN, V29, P159, DOI 10.1037/0096-1523.29.1.159; Bird G, 2006, NEUROIMAGE, V31, P1614, DOI 10.1016/j.neuroimage.2006.02.037; Boddaert N, 2004, AM J PSYCHIAT, V161, P2117, DOI 10.1176/appi.ajp.161.11.2117; Brenton JN, 2008, PEDIATR NEUROL, V39, P137, DOI 10.1016/j.pediatrneurol.2008.05.004; Brown WA, 2003, J AUTISM DEV DISORD, V33, P163, DOI 10.1023/A:1022987309913; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Casanova MF, 2004, EUR ARCH PSY CLIN N, V254, P148, DOI 10.1007/s00406-004-0457-6; Casanova MF, 2002, NEUROLOGY, V58, P428, DOI 10.1212/WNL.58.3.428; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Clayton M., 2000, TIME INDIAN MUSIC; Constantino JN, 2007, J AUTISM DEV DISORD, V37, P1256, DOI 10.1007/s10803-006-0269-9; Cook EH, 2009, AUTISM RES, V2, P178, DOI 10.1002/aur.82; Corrigall KA, 2010, MUSIC PERCEPT, V28, P195, DOI 10.1525/mp.2010.28.2.195; Costa-Giomi E, 2003, ANN NY ACAD SCI, V999, P477, DOI 10.1196/annals.1284.058; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; Courchesne E, 2004, MENT RETARD DEV D R, V10, P106, DOI 10.1002/mrdd.20020; Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Dawson G, 2005, DEV NEUROPSYCHOL, V27, P403, DOI 10.1207/s15326942dn2703_6; Dawson G, 2004, DEV PSYCHOL, V40, P271, DOI 10.1037/0012-1649.40.2.271; Dawson G, 1998, J AUTISM DEV DISORD, V28, P479, DOI 10.1023/A:1026043926488; Dawson G., 1989, AUTISM NATURE DIAGNO, P49; de Gelder B., 1991, EUROPEAN J COGNITIVE, V3, P69, DOI [10.1080/09541449108406220, DOI 10.1080/09541449108406220]; DEMANY L, 1982, INFANT BEHAV DEV, V5, P261, DOI 10.1016/S0163-6383(82)80036-2; Dunn L.M., 1981, PEABODY PICTURE VOCA; Fassbender C., 1993, AUDITORY GROUPING SE; Finnigan E, 2010, AUTISM, V14, P321, DOI 10.1177/1362361309357747; Folland NA, 2012, J ACOUST SOC AM, V131, P993, DOI 10.1121/1.3651254; Frith U., 1989, AUTISM EXPLAINING EN, V6th; Gerry DW, 2010, DEVELOPMENTAL SCI, V13, P545, DOI 10.1111/j.1467-7687.2009.00912.x; Gomes E, 2004, ARQ NEURO-PSIQUIAT, V62, P797, DOI 10.1590/S0004-282X2004000500011; Gopnik A., 1999, SCI CRIB MINDS BRAIN; Griffiths TD, 2007, NEURON, V56, P580, DOI 10.1016/j.neuron.2007.11.004; Groen WB, 2009, J AUTISM DEV DISORD, V39, P742, DOI 10.1007/s10803-008-0682-3; Han LA, 1998, SCAND AUDIOL, V27, P105, DOI 10.1080/010503998420342; Hannon EE, 2005, P NATL ACAD SCI USA, V102, P12639, DOI 10.1073/pnas.0504254102; Hannon EE, 2005, PSYCHOL SCI, V16, P48, DOI 10.1111/j.0956-7976.2005.00779.x; Hannon EE, 2007, TRENDS COGN SCI, V11, P466, DOI 10.1016/j.tics.2007.08.008; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; Heaton P, 1999, NEUROCASE, V5, P503, DOI 10.1080/13554799908402745; Heaton P, 2008, COGN NEUROPSYCHOL, V25, P771, DOI 10.1080/02643290802336277; Heaton P, 2007, J AUTISM DEV DISORD, V37, P1355, DOI 10.1007/s10803-006-0283-y; Heaton P, 2009, PHILOS T R SOC B, V364, P1443, DOI 10.1098/rstb.2008.0327; Herbert MR, 2002, ANN NEUROL, V52, P588, DOI 10.1002/ana.10349; Iarocci G, 2006, J AUTISM DEV DISORD, V36, P77, DOI 10.1007/s10803-005-0044-3; Iarocci G, 2010, AUTISM, V14, P305, DOI 10.1177/1362361309353615; Jarvinen-Pasley A, 2007, DEVELOPMENTAL SCI, V10, P786, DOI 10.1111/j.1467-7687.2007.00637.x; Just MA, 2004, BRAIN, V127, P1811, DOI 10.1093/brain/awh199; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Kawabe T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009503; Kern JK, 2006, AUTISM, V10, P480, DOI 10.1177/1362361306066564; Kirschner S, 2010, EVOL HUM BEHAV, V31, P354, DOI 10.1016/j.evolhumbehav.2010.04.004; Kirschner S, 2009, J EXP CHILD PSYCHOL, V102, P299, DOI 10.1016/j.jecp.2008.07.005; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9096, DOI 10.1073/pnas.1532872100; Lane AE, 2010, J AUTISM DEV DISORD, V40, P112, DOI 10.1007/s10803-009-0840-2; Lepisto T, 2009, BIOL PSYCHOL, V82, P301, DOI 10.1016/j.biopsycho.2009.09.004; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Loui P, 2011, J COGNITIVE NEUROSCI, V23, P1015, DOI 10.1162/jocn.2010.21500; McAdams S, 1997, J ACOUST SOC AM, V102, P2945, DOI 10.1121/1.420349; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; McIntosh D. N., 1999, SENSORY PROFILE USER, P59; Mottron L, 1999, NEUROCASE, V5, P485, DOI 10.1093/neucas/5.6.485; Neurobehavioral Systems, 2007, PRES 11 0; OSTERLING J, 1994, J AUTISM DEV DISORD, V24, P247, DOI 10.1007/BF02172225; Osterling JA, 2002, DEV PSYCHOPATHOL, V14, P239, DOI 10.1017/S0954579402002031; Overy K, 2009, MUSIC PERCEPT, V26, P489, DOI 10.1525/MP.2009.26.5.489; Patel AD, 2009, CURR BIOL, V19, P827, DOI 10.1016/j.cub.2009.03.038; Peppe S, 2007, J SPEECH LANG HEAR R, V50, P1015, DOI 10.1044/1092-4388(2007/071); Pfordresher PQ, 2009, MUSIC PERCEPT, V25, P95; Pierce K, 2011, ARCH GEN PSYCHIAT, V68, P101, DOI 10.1001/archgenpsychiatry.2010.113; Plaisted K, 1999, J CHILD PSYCHOL PSYC, V40, P733, DOI 10.1111/1469-7610.00489; Plantinga J, 2008, MUSIC PERCEPT, V26, P121, DOI 10.1525/MP.2008.26.2.121; Poulin-Charronnat B, 2005, COGNITION, V94, pB67, DOI 10.1016/j.cognition.2004.05.003; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; RIMLAND B, 1995, J AUTISM DEV DISORD, V25, P61, DOI 10.1007/BF02178168; Rimland B, 1984, MENTAL RETARDATION D, P55; Rogers SJ, 2003, J AUTISM DEV DISORD, V33, P631, DOI 10.1023/B:JADD.0000006000.38991.a7; Roid G, 2005, LEITER INT PERFORMAN; Rosenblum LD, 1997, PERCEPT PSYCHOPHYS, V59, P347, DOI 10.3758/BF03211902; Rosenhall U, 1999, J AUTISM DEV DISORD, V29, P349, DOI 10.1023/A:1023022709710; Ross DA, 2004, J ACOUST SOC AM, V116, P1793, DOI 10.1121/1.1758973; Russo N, 2009, DEVELOPMENTAL SCI, V12, P557, DOI 10.1111/j.1467-7687.2008.00790.x; Russo N, 2009, J AUTISM DEV DISORD, V39, P1185, DOI 10.1007/s10803-009-0737-0; Rutherford MD, 2005, NEUROCASE, V11, P129, DOI 10.1080/13554790590925529; Schachner A, 2009, CURR BIOL, V19, P831, DOI 10.1016/j.cub.2009.03.061; Schellenberg EG, 2005, DEVELOPMENTAL SCI, V8, P551, DOI 10.1111/j.1467-7687.2005.00447.x; Schoen SA, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.029.2009; Schultz RT, 2000, ARCH GEN PSYCHIAT, V57, P331, DOI 10.1001/archpsyc.57.4.331; SHAH A, 1983, J CHILD PSYCHOL PSYC, V24, P613, DOI 10.1111/j.1469-7610.1983.tb00137.x; Shukla DK, 2011, J CHILD PSYCHOL PSYC, V52, P286, DOI 10.1111/j.1469-7610.2010.02342.x; Simpson K, 2010, J DEV PHYS DISABIL, V22, P165, DOI 10.1007/s10882-009-9173-5; Smith EG, 2007, J CHILD PSYCHOL PSYC, V48, P813, DOI 10.1111/j.1469-7610.2007.01766.x; Smith NA, 2011, INFANCY, V16, P655, DOI 10.1111/j.1532-7078.2011.00067.x; Sussman E, 2007, HEARING RES, V225, P117, DOI 10.1016/j.heares.2006.12.013; Teder-Salejarvi WA, 2005, COGNITIVE BRAIN RES, V23, P221, DOI 10.1016/j.cogbrainres.2004.10.021; Tillmann B, 2006, EUR J COGN PSYCHOL, V18, P343, DOI 10.1080/09541440500269548; Tillmann B, 2007, COGNITIVE NEUROPSYCH, V24, P1; Trainor LJ, 2010, SPRINGER HANDB AUDIT, V36, P89, DOI 10.1007/978-1-4419-6114-3_4; TRAINOR LJ, 1992, J EXP PSYCHOL HUMAN, V18, P394, DOI 10.1037/0096-1523.18.2.394; TRAINOR LJ, 1994, PERCEPT PSYCHOPHYS, V56, P125, DOI 10.3758/BF03213891; Trehub SE, 2009, CORTEX, V45, P110, DOI 10.1016/j.cortex.2008.05.012; Trehub SE, 2001, ANN NY ACAD SCI, V930, P1; TREHUB SE, 1984, CHILD DEV, V55, P821, DOI 10.2307/1130133; Tucker-Davis Technologies, 2007, PROGR ATT; Wan CY, 2010, FUTUR NEUROL, V5, P797, DOI 10.2217/FNL.10.55; Wan CY, 2010, BRAIN RES BULL, V82, P161, DOI 10.1016/j.brainresbull.2010.04.010; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Wechsler D, 1997, DIGIT SPAN SUBTEST W; WERKER JF, 1988, DEV PSYCHOL, V24, P672, DOI 10.1037/0012-1649.24.5.672; Werker JF, 2005, DEV PSYCHOBIOL, V46, P233, DOI 10.1002/dev.20060; Werner E, 2000, J AUTISM DEV DISORD, V30, P157, DOI 10.1023/A:1005463707029; Willeford J., 1977, CENTRAL AUDITORY DYS, P43; Williams JHG, 2004, RES DEV DISABIL, V25, P559, DOI 10.1016/j.ridd.2004.01.008; Winkler I, 2003, P NATL ACAD SCI USA, V100, P11812, DOI 10.1073/pnas.2031891100; YOUNG RL, 1995, J AUTISM DEV DISORD, V25, P231, DOI 10.1007/BF02179286; Zwaigenbaum L, 2009, PEDIATRICS, V123, P1383, DOI 10.1542/peds.2008-1606	130	61	62	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44084	10.1371/journal.pone.0044084	http://dx.doi.org/10.1371/journal.pone.0044084			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005GJ	22984462	Green Published, Green Submitted, gold			2022-12-27	WOS:000308738500029
J	Forbes, EK; de Cassan, SC; Llewellyn, D; Biswas, S; Goodman, AL; Cottingham, MG; Long, CA; Pleass, RJ; Hill, AVS; Hill, F; Draper, SJ				Forbes, Emily K.; de Cassan, Simone C.; Llewellyn, David; Biswas, Sumi; Goodman, Anna L.; Cottingham, Matthew G.; Long, Carole A.; Pleass, Richard J.; Hill, Adrian V. S.; Hill, Fergal; Draper, Simon J.			T Cell Responses Induced by Adenoviral Vectored Vaccines Can Be Adjuvanted by Fusion of Antigen to the Oligomerization Domain of C4b-Binding Protein	PLOS ONE			English	Article							PRIME-BOOST IMMUNIZATION; AMYLOID-P COMPONENT; IN-VITRO; MEDIATED PROTECTION; PLASMODIUM-BERGHEI; FC-RECEPTORS; MALARIA; IMMUNOGENICITY; ANTIBODY; C4BP	Viral vectored vaccines have been shown to induce both T cell and antibody responses in animals and humans. However, the induction of even higher level T cell responses may be crucial in achieving vaccine efficacy against difficult disease targets, especially in humans. Here we investigate the oligomerization domain of the alpha-chain of C4b-binding protein (C4 bp) as a candidate T cell "molecular adjuvant" when fused to malaria antigens expressed by human adenovirus serotype 5 (AdHu5) vectored vaccines in BALB/c mice. We demonstrate that i) C-terminal fusion of an oligomerization domain can enhance the quantity of antigen-specific CD4(+) and CD8(+) T cell responses induced in mice after only a single immunization of recombinant AdHu5, and that the T cells maintain similar functional cytokine profiles; ii) an adjuvant effect is observed for AdHu5 vectors expressing either the 42 kDa C-terminal domain of Plasmodium yoelii merozoite surface protein 1 (PyMSP1(42)) or the 83 kDa ectodomain of P. falciparum strain 3D7 apical membrane antigen 1 (PfAMA1), but not a candidate 128kDa P. falciparum MSP1 biallelic fusion antigen; iii) following two homologous immunizations of AdHu5 vaccines, antigen-specific T cell responses are further enhanced, however, in both BALB/c mice and New Zealand White rabbits no enhancement of functional antibody responses is observed; and iv) that the T cell adjuvant activity of C4 bp is not dependent on a functional Fc-receptor gamma-chain in the host, but is associated with the oligomerization of small (<80 kDa) antigens expressed by recombinant AdHu5. The oligomerization domain of C4 bp can thus adjuvant T cell responses induced by AdHu5 vectors against selected antigens and its clinical utility as well as mechanism of action warrant further investigation.	[Forbes, Emily K.; de Cassan, Simone C.; Llewellyn, David; Biswas, Sumi; Goodman, Anna L.; Cottingham, Matthew G.; Hill, Adrian V. S.; Draper, Simon J.] Univ Oxford, Jenner Inst, Oxford, England; [Long, Carole A.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Pleass, Richard J.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Hill, Fergal] Imaxio SA, Lyon, France	University of Oxford; Jenner Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Liverpool School of Tropical Medicine; University of Liverpool	Forbes, EK (corresponding author), Univ Oxford, Jenner Inst, Oxford, England.	ekforbes@hotmail.com	Draper, Simon J/F-1758-2011; Hill, Fergal/AAI-1329-2021; Pleass, Richard/N-7831-2019; Pleass, Richard J/L-4148-2015	Draper, Simon J/0000-0002-9415-1357; Pleass, Richard/0000-0001-7438-8296; Pleass, Richard J/0000-0001-7438-8296; Cottingham, Matthew/0000-0003-0766-6465; Goodman, Anna/0000-0003-0643-9017	Wellcome Trust; EMVDA (European Malaria Vaccine Development Association, a European Commission); European Community [242095]; Division of Intramural Research, National Institutes of Allergy and Infectious Diseases, National Institutes of Health; PATH Malaria Vaccine Initiative; MRC [G0700735, G0300145, G1000527, G0600424] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001020] Funding Source: NIH RePORTER; Medical Research Council [G0300145, G1000527, G0700735, G0600424] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10233] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); EMVDA (European Malaria Vaccine Development Association, a European Commission); European Community(European Commission); Division of Intramural Research, National Institutes of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PATH Malaria Vaccine Initiative; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by the Wellcome Trust and the EMVDA (European Malaria Vaccine Development Association, a European Commission FP6-funded consortium). The research leading to these results has also received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement No 242095. In addition, this work was supported in part by the Division of Intramural Research, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, and also by the PATH Malaria Vaccine Initiative who support the GIA Reference Center. AVSH and SJD are Jenner Investigators. AVSH is a Wellcome Trust Principal Research Fellow. SJD is a MRC Career Development Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, except that the design of the rabbit study and the GIA analysis was performed following discussion with PATH MVI.	Ali MH, 2005, BIOORGAN MED CHEM, V13, P5013, DOI 10.1016/j.bmc.2005.05.037; Barnes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003155; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Biswas S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020977; Blom AM, 2004, MOL IMMUNOL, V40, P1333, DOI 10.1016/j.molimm.2003.12.002; Brodeur SR, 2003, IMMUNITY, V18, P837, DOI 10.1016/S1074-7613(03)00149-3; Capone S, 2010, VACCINE, V29, P256, DOI 10.1016/j.vaccine.2010.10.041; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; Christiansen D, 2000, J VIROL, V74, P4672, DOI 10.1128/JVI.74.10.4672-4678.2000; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; de Cassan SC, 2011, J IMMUNOL, V187, P2602, DOI 10.4049/jimmunol.1101004; Dicks MDJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040385; Douglas AD, 2010, VACCINE, V28, P7167, DOI 10.1016/j.vaccine.2010.08.068; Draper SJ, 2008, NAT MED, V14, P819, DOI 10.1038/nm.1850; Draper SJ, 2010, J IMMUNOL, V185, P7583, DOI 10.4049/jimmunol.1001760; Draper SJ, 2010, NAT REV MICROBIOL, V8, P62, DOI 10.1038/nrmicro2240; Dutta S, 2003, P NATL ACAD SCI USA, V100, P12295, DOI 10.1073/pnas.2032858100; Forbes EK, 2011, J IMMUNOL, V187, P3738, DOI 10.4049/jimmunol.1003783; Goodman AL, 2010, INFECT IMMUN, V78, P4601, DOI 10.1128/IAI.00315-10; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Kask L, 2002, BIOCHEMISTRY-US, V41, P9349, DOI 10.1021/bi025980+; Libyh MT, 1997, BLOOD, V90, P3978, DOI 10.1182/blood.V90.10.3978; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Lu JH, 2008, NATURE, V456, P989, DOI 10.1038/nature07468; Miura K, 2009, CLIN VACCINE IMMUNOL, V16, P963, DOI 10.1128/CVI.00042-09; Moore AC, 2005, J IMMUNOL, V175, P7264, DOI 10.4049/jimmunol.175.11.7264; O'Hara GA, 2012, J INFECT DIS, V205, P772, DOI 10.1093/infdis/jir850; Ogun SA, 2008, INFECT IMMUN, V76, P3817, DOI 10.1128/IAI.01369-07; Ophorst OJAE, 2007, VACCINE, V25, P6501, DOI 10.1016/j.vaccine.2007.06.019; Oudin S, 2000, J IMMUNOL, V164, P1505, DOI 10.4049/jimmunol.164.3.1505; Pleass RJ, 2009, PARASITE IMMUNOL, V31, P529, DOI 10.1111/j.1365-3024.2009.01101.x; Reyes-Sandoval A, 2010, INFECT IMMUN, V78, P145, DOI 10.1128/IAI.00740-09; Roederer M, 2011, CYTOMETRY A; Rotman HL, 1998, J IMMUNOL, V161, P1908; SCHWALBE RA, 1990, J BIOL CHEM, V265, P21749; Sheehy SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031208; Sheehy SH, 2011, MOL THER, V19, P2269, DOI 10.1038/mt.2011.176; Sjoberg AP, 2006, J IMMUNOL, V176, P7612, DOI 10.4049/jimmunol.176.12.7612; Sorensen IJ, 1996, SCAND J IMMUNOL, V44, P401, DOI 10.1046/j.1365-3083.1996.d01-326.x; Spencer AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033555; Sridhar S, 2008, J VIROL, V82, P3822, DOI 10.1128/JVI.02568-07; Wille-Reece U, 2006, J EXP MED, V203, P1249, DOI 10.1084/jem.20052433; Yewdell JW, 1999, ADV IMMUNOL, V73, P1, DOI 10.1016/S0065-2776(08)60785-3; Yoneto T, 2001, J IMMUNOL, V166, P6236, DOI 10.4049/jimmunol.166.10.6236	45	22	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44943	10.1371/journal.pone.0044943	http://dx.doi.org/10.1371/journal.pone.0044943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984589	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000308738500096
J	Souquiere, S; Makuwa, M; Salle, B; Kazanji, M				Souquiere, Sandrine; Makuwa, Maria; Salle, Bettina; Kazanji, Mirdad			New Strain of Simian Immunodeficiency Virus Identified in Wild-Born Chimpanzees from Central Africa	PLOS ONE			English	Article							PAN-TROGLODYTES-TROGLODYTES; HIV-1 NEF; INFECTED CHIMPANZEES; CAPTURED CHIMPANZEE; TYPE-1 INFECTION; SOOTY MANGABEYS; DOWN-REGULATION; GENE FLOW; LENTIVIRUS; SIVCPZ	Studies of primate lentiviruses continue to provide information about the evolution of simian immunodeficiency viruses (SIVs) and the origin and emergence of HIV since chimpanzees in west-central Africa (Pan troglodytes troglodytes) were recognized as the reservoir of SIVcpzPtt viruses, which have been related phylogenetically to HIV-1. Using in-house peptide ELISAs to study SIV prevalence, we tested 104 wild-born captive chimpanzees from Gabon and Congo. We identified two new cases of SIVcpz infection in Gabon and characterized a new SIVcpz strain, SIVcpzPtt-Gab4. The complete sequence (9093 bp) was obtained by a PCR-based 'genome walking' approach to generate 17 overlapping fragments. Phylogenetic analyses of separated genes (gag, pol-vif and env-nef) showed that SIVcpzPtt-Gab4 is closely related to SIVcpzPtt-Gab1 and SIVcpzPtt-Gab2. No significant variation in viral load was observed during 3 years of follow-up, but a significantly lower CD4+ T cells count was found in infected than in uninfected chimpanzees (p < 0.05). No clinical symptoms of SIV infection were observed in the SIV-positive chimpanzees. Further field studies with non-invasive methods are needed to determine the prevalence, geographic distribution, species association, and natural history of SIVcpz strains in the chimpanzee habitat in Gabon.	[Souquiere, Sandrine; Makuwa, Maria; Kazanji, Mirdad] Ctr Int Rech Med Franceville, Unite Retrovirol, Franceville, Gabon; [Salle, Bettina] Ctr Int Rech Med Franceville, Ctr Primatol, Franceville, Gabon; [Kazanji, Mirdad] Reseau Int Inst Pasteur, Inst Pasteur Bangui, Bangui, Cent Afr Republ		Souquiere, S (corresponding author), Ctr Int Rech Med Franceville, Unite Retrovirol, BP 769, Franceville, Gabon.	mirdad.kazanji@pasteur.fr			Gabonese Government; Total-Gabon; French Foreign Ministry	Gabonese Government; Total-Gabon; French Foreign Ministry	The CIRMF is funded by the Gabonese Government, Total-Gabon and the French Foreign Ministry. The funders had no role in study design, data collection or analysis, the decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Apetrei C, 2004, FRONT BIOSCI-LANDMRK, V9, P225, DOI 10.2741/1154; Bailes E, 2003, SCIENCE, V300, P1713, DOI 10.1126/science.1080657; Bibollet-Ruche F, 2004, AIDS RES HUM RETROV, V20, P1377, DOI 10.1089/aid.2004.20.1377; Bibollet-Ruche F, 2012, J CLIN INVEST, V122, P1644, DOI 10.1172/JCI61429; Chahroudi A, 2011, J VIROL, V85, P5757, DOI 10.1128/JVI.02690-10; Chan ML, 2010, P ROY SOC B-BIOL SCI, V277, P3773, DOI 10.1098/rspb.2010.0972; Corbet S, 2000, J VIROL, V74, P529, DOI 10.1128/JVI.74.1.529-534.2000; Courgnaud V, 2001, J VIROL, V75, P857, DOI 10.1128/JVI.75.2.857-866.2001; Dimmic MW, 2002, J MOL EVOL, V55, P65, DOI 10.1007/s00239-001-2304-y; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Dube M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000856; Etienne L, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-4; FRANSEN K, 1994, MOL CELL PROBE, V8, P317, DOI 10.1006/mcpr.1994.1043; Gagneux P, 2001, PHILOS T R SOC B, V356, P889, DOI 10.1098/rstb.2001.0865; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Goldstein S, 2000, J VIROL, V74, P11744, DOI 10.1128/JVI.74.24.11744-11753.2000; Greenberg M, 1998, CURR BIOL, V8, P1239, DOI 10.1016/S0960-9822(07)00518-0; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Heeney JL, 2006, J VIROL, V80, P7208, DOI 10.1128/JVI.00382-06; HUET T, 1990, NATURE, V345, P356, DOI 10.1038/345356a0; JANSSENS W, 1994, AIDS RES HUM RETROV, V10, P1191, DOI 10.1089/aid.1994.10.1191; Jeang K T, 1994, Curr Top Microbiol Immunol, V188, P123; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KEELE BF, 2006, SCIENCE; Keele BF, 2009, NATURE, V460, P515, DOI 10.1038/nature08200; Kirchhoff F, 2004, J VIROL, V78, P6864, DOI 10.1128/JVI.78.13.6864-6874.2004; Klatt NR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007153; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Liu WM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000097; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; Mouinga-Ondeme A, 2012, J VIROL, V86, P1255, DOI 10.1128/JVI.06016-11; Muller-Trutwin MC, 2000, J MED PRIMATOL, V29, P166, DOI 10.1034/j.1600-0684.2000.290310.x; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Neel C, 2010, J VIROL, V84, P1464, DOI 10.1128/JVI.02129-09; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Nerrienet E, 2005, J VIROL, V79, P1312, DOI 10.1128/JVI.79.2.1312-1319.2005; Oates JF, 2009, PRIMATES, V50, P78, DOI 10.1007/s10329-008-0116-z; Ondoa P, 2001, J MED PRIMATOL, V30, P243, DOI 10.1034/j.1600-0684.2001.d01-56.x; PEETERS M, 1989, AIDS, V3, P625, DOI 10.1097/00002030-198910000-00001; PEETERS M, 1992, AIDS, V6, P447, DOI 10.1097/00002030-199205000-00002; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rouet F, 2005, J CLIN MICROBIOL, V43, P2709, DOI 10.1128/JCM.43.6.2709-2717.2005; Rudicell RS, 2011, J VIROL, V85, P9918, DOI 10.1128/JVI.05475-11; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Salemi M, 2003, J VIROL, V77, P7202, DOI 10.1128/JVI.77.13.7202-7213.2003; Santiago ML, 2003, J VIROL, V77, P7545, DOI 10.1128/JVI.77.13.7545-7562.2003; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Schmokel J, 2011, J VIROL, V85, P742, DOI 10.1128/JVI.02087-10; Sharp PM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006841; Sharp PM, 2005, J VIROL, V79, P3891, DOI 10.1128/JVI.79.7.3891-3902.2005; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon F, 2001, AIDS RES HUM RETROV, V17, P937, DOI 10.1089/088922201750290050; Simon F, 1998, NAT MED, V4, P1032, DOI 10.1038/2017; Souquiere S, 2001, J VIROL, V75, P7086, DOI 10.1128/JVI.75.15.7086-7096.2001; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Taaffe J, 2010, J VIROL, V84, P5476, DOI 10.1128/JVI.00039-10; Takehisa J, 2009, J VIROL, V83, P1635, DOI 10.1128/JVI.02311-08; Terio KA, 2011, J ZOO WILDLIFE MED, V42, P597, DOI 10.1638/2010-0237.1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Heuverswyn F, 2007, VIROLOGY, V368, P155, DOI 10.1016/j.virol.2007.06.018; Van Heuverswyn F, 2006, NATURE, V444, P164, DOI 10.1038/444164a; VandeWoude S, 2006, CLIN MICROBIOL REV, V19, P728, DOI 10.1128/CMR.00009-06; Wain LV, 2007, MOL BIOL EVOL, V24, P1853, DOI 10.1093/molbev/msm110; Yang CF, 1999, J CLIN MICROBIOL, V37, P2581, DOI 10.1128/JCM.37.8.2581-2586.1999; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008	67	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44298	10.1371/journal.pone.0044298	http://dx.doi.org/10.1371/journal.pone.0044298			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984489	Green Published, Green Submitted, gold			2022-12-27	WOS:000308738500045
J	Sulzner, K; Johnson, CK; Bonde, RK; Gomez, NA; Powell, J; Nielsen, K; Luttrell, MP; Osterhaus, ADME; Aguirre, AA				Sulzner, Kathryn; Johnson, Christine Kreuder; Bonde, Robert K.; Gomez, Nicole Auil; Powell, James; Nielsen, Klaus; Luttrell, M. Page; Osterhaus, A. D. M. E.; Aguirre, A. Alonso			Health Assessment and Seroepidemiologic Survey of Potential Pathogens in Wild Antillean Manatees (Trichechus manatus manatus)	PLOS ONE			English	Article							TOXOPLASMA-GONDII INFECTION; DUGONGS DUGONG-DUGON; FLORIDA MANATEE; MARINE MAMMALS; SERUM CHEMISTRY; CALIFORNIA; LEPTOSPIROSIS; ANTIBODIES; LATIROSTRIS; DISEASE	The Antillean manatee (Trichechus manatus manatus), a subspecies of the West Indian manatee, inhabits fresh, brackish, and warm coastal waters distributed along the eastern border of Central America, the northern coast of South America, and throughout the Wider Caribbean Region. Threatened primarily by human encroachment, poaching, and habitat degradation, Antillean manatees are listed as endangered by the International Union for the Conservation of Nature. The impact of disease on population viability remains unknown in spite of concerns surrounding the species' ability to rebound from a population crash should an epizootic occur. To gain insight on the baseline health of this subspecies, a total of 191 blood samples were collected opportunistically from wild Antillean manatees in Belize between 1997 and 2009. Hematologic and biochemical reference intervals were established, and antibody prevalence to eight pathogens with zoonotic potential was determined. Age was found to be a significant factor of variation in mean blood values, whereas sex, capture site, and season contributed less to overall differences in parameter values. Negative antibody titers were reported for all pathogens surveyed except for Leptospira bratislava, L. canicola, and L. icterohemorrhagiae, Toxoplasma gondii, and morbillivirus. As part of comprehensive health assessment in manatees from Belize, this study will serve as a benchmark aiding in early disease detection and in the discernment of important epidemiologic patterns in the manatees of this region. Additionally, it will provide some of the initial tools to explore the broader application of manatees as sentinel species of nearshore ecosystem health.	[Sulzner, Kathryn; Johnson, Christine Kreuder] Univ Calif Davis, Wildlife Hlth Ctr, Sch Vet Med, Davis, CA 95616 USA; [Bonde, Robert K.] US Geol Survey, Sirenia Project, Gainesville, FL USA; [Gomez, Nicole Auil; Powell, James] Sea Shore Alliance, St Petersburg, FL USA; [Nielsen, Klaus] Canadian Food Inspect Agcy, Nepean, ON, Canada; [Luttrell, M. Page] Univ Georgia, Coll Vet Med, SE Cooperat Wildlife Dis Study, Dept Populat Hlth, Athens, GA USA; [Osterhaus, A. D. M. E.] Erasmus MC, Rotterdam, Netherlands; [Aguirre, A. Alonso] Smithsonian Mason Sch Conservat, Front Royal, VA USA; [Aguirre, A. Alonso] George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA	University of California System; University of California Davis; United States Department of the Interior; United States Geological Survey; Canadian Food Inspection Agency; University System of Georgia; University of Georgia; Erasmus University Rotterdam; Erasmus MC; Smithsonian Institution; George Mason University	Sulzner, K (corresponding author), Univ Calif Davis, Wildlife Hlth Ctr, Sch Vet Med, Davis, CA 95616 USA.	aaguirr3@gmu.edu		Bonde, Robert/0000-0001-9179-4376	University of California, Davis, CA; Wildlife Health Center's Wildlife Fellowship Fund; Preventive Veterinary Department, University of California, Davis, CA	University of California, Davis, CA(University of California System); Wildlife Health Center's Wildlife Fellowship Fund; Preventive Veterinary Department, University of California, Davis, CA	Financial support for many of the serological assays performed in this study was provided in part by the University of California, Davis, CA, Wildlife Health Center's Wildlife Fellowship Fund and by a grant from the Preventive Veterinary Department, University of California, Davis, CA. Additional laboratory tests and services were offered in-kind by Dr. Pat Conrad, Department of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis, CA; Dr. William Reisen, Center for Vectorborne Disease Research, University of California, Davis, CA; Dr. Dave Stallknecht and Page Luttrell, Department of Population Health, College of Veterinary Medicine, University of Georgia, Athens, GA; Dr. Klaus Nielsen, Canadian Food Inspection Agency, Nepean, Ontario, Canada; and Dr. A. D. M. E Osterhaus, Department of Virology, Erasmus Medical Centre, Rotterdam, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AA, 2008, MECH AGEING DEV, V129, P656, DOI 10.1016/j.mad.2008.09.004; Aguirre AA, 2002, CONSERVATION MEDICINE, P79; Aguirre AA, 2003, VERH BER ERKRG ZOOTI, V41, P1; Alves-Stanley CD, 2010, MAR ECOL PROG SER, V402, P255, DOI 10.3354/meps08450; Arnold J, 1999, 13 BIENN C BIOL MAR, P66; Auil N, 1998, BELIZE MANATEE RECOV, P1; Auil NE, 2004, THESIS TEXAS A M U C; Bacchus Marie-Lys C., 2009, Aquatic Mammals, V35, P62, DOI 10.1578/AM.35.1.2009.62; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Bonde R.K., 2004, ECOHEALTH, V1, P255, DOI [10.1007/s10393-004-0095-5.2, DOI 10.1007/S10393-004-0095-5.2]; Bonde RK, 2001, 14 BIENN C BIOL MAR, P29; Bossart G.D., 2007, MICROBE, V2, P544, DOI 10.1128/microbe.2.544.1; Bossart GD, 2001, CRC HANDBOOK OF MARINE MAMMAL MEDICINE, SECOND EDITION, P383, DOI 10.1201/9781420041637.sec4; Bossart GD, 1999, J AM VET MED ASSOC, V214, P1178; Bossart GD, 2002, EXP MOL PATHOL, V72, P37, DOI 10.1006/exmp.2001.2407; Bossart GD, 1998, TOXICOL PATHOL, V26, P276, DOI 10.1177/019262339802600214; Bradley JE, 2006, IMMUNOLOGY, P277; BUERGELT CD, 1983, J AM VET MED ASSOC, V183, P1294; Cameron CE, 2008, J CLIN MICROBIOL, V46, P1728, DOI 10.1128/JCM.02022-07; Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002; Colegrove KM, 2005, J WILDLIFE DIS, V41, P426, DOI 10.7589/0090-3558-41.2.426; Conrad PA, 2005, INT J PARASITOL, V35, P1155, DOI 10.1016/j.ijpara.2005.07.002; CONVERSE LJ, 1994, J ZOO WILDLIFE MED, V25, P423; Dabritz HA, 2008, J PARASITOL, V94, P675, DOI 10.1645/GE-1342.1; Deutsch CJ, 2008, IUCN 2010; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; DIXON WJ, 1953, BIOMETRICS, V9, P74, DOI 10.2307/3001634; Dona MG, 2011, J WILDLIFE DIS, V47, P673, DOI 10.7589/0090-3558-47.3.673; Dubey JP, 2008, VET PARASITOL, V153, P147, DOI 10.1016/j.vetpar.2008.01.030; Dubey JP, 2004, VET PARASITOL, V126, P57, DOI 10.1016/j.vetpar.2004.09.005; Dubey JP, 2003, VET PARASITOL, V116, P275, DOI 10.1016/S0304-4017(03)00263-2; Dubey JP, 1998, INT J PARASITOL, V28, P1019, DOI 10.1016/S0020-7519(98)00023-X; DUIGNAN PJ, 1995, MAR MAMMAL SCI, V11, P441, DOI 10.1111/j.1748-7692.1995.tb00668.x; Godinez CR, 1999, J WILDLIFE DIS, V35, P108, DOI 10.7589/0090-3558-35.1.108; Gomez Nicole Auil, 2011, University of British Columbia Fisheries Centre Research Reports, V19, P19; Gulland FMD, 1996, J WILDLIFE DIS, V32, P572, DOI 10.7589/0090-3558-32.4.572; Halvorsen Katherine M., 2008, Aquatic Mammals, V34, P412, DOI 10.1578/AM.34.4.2008.412; Harr K, 2006, J ZOO WILDLIFE MED, V37, P151, DOI 10.1638/05-023.1; Harr KE, 2008, J ZOO WILDLIFE MED, V39, P180, DOI 10.1638/2007-0134R.1; Harr KE, 2011, J WILDLIFE DIS, V47, P1026, DOI 10.7589/0090-3558-47.4.1026; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Harvey JW, 2007, J ZOO WILDLIFE MED, V38, P269, DOI 10.1638/1042-7260(2007)038[0269:CBIHMT]2.0.CO;2; Harvey JW, 2009, VET CLIN PATH, V38, P183, DOI 10.1111/j.1939-165X.2009.00113.x; Hunter ME, 2010, ANIM CONSERV, V13, P592, DOI 10.1111/j.1469-1795.2010.00383.x; INSKEEP W, 1990, J WILDLIFE DIS, V26, P377, DOI 10.7589/0090-3558-26.3.377; JAIN N.C., 1993, ESSENTIALS VET HEMAT, P19; JARQUE CM, 1987, INT STAT REV, V55, P163, DOI 10.2307/1403192; Johnson CK, 2009, P NATL ACAD SCI USA, V106, P2242, DOI 10.1073/pnas.0806449106; Keller M, 2005, THESIS U FLORIDA GAI; KJERFVE B, 1989, MAR GEOL, V88, P187, DOI 10.1016/0025-3227(89)90097-2; Lanyon JM, 2010, AQUAT MAMM, V36, P46, DOI 10.1578/AM.36.1.2010.46; Lanyon Janet M., 2009, Aquatic Mammals, V35, P187, DOI 10.1578/AM.35.2.2009.187; Lassen ED, 2006, VET HEMATOLOGY CLIN, P355; Leendertz FH, 2006, BIOL CONSERV, V131, P325, DOI 10.1016/j.biocon.2006.05.002; Lloyd-Smith JO, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-125; Lounsbury VJ, 2005, MARINE MAMMALS ASHOR, P129; Marmontel M, 1997, CONSERV BIOL, V11, P467, DOI 10.1046/j.1523-1739.1997.96019.x; Mathews PD, 2012, J ZOO WILDLIFE MED, V43, P85, DOI 10.1638/2011-0178.1; Mayo Clinic Staff, 2009, FDN MED ED RES 1998; MEDWAY W, 1982, J WILDLIFE DIS, V18, P229, DOI 10.7589/0090-3558-18.2.229; MIGAKI G, 1990, VET PATHOL, V27, P463, DOI 10.1177/030098589902700615; MIGAKI G, 1977, AM J VET RES, V38, P135; Mignucci-Giannoni AA, 2002, ENVIRON MANAGE, V25; Mikaelian I, 2000, J COMP PATHOL, V122, P73, DOI 10.1053/jcpa.1999.0341; Miller MA, 2002, J PARASITOL, V88, P594, DOI 10.1645/0022-3395(2002)088[0594:EOAIFA]2.0.CO;2; Moore SE, 2008, J MAMMAL, V89, P534, DOI 10.1644/07-MAMM-S-312R1.1; Nielsen O, 2001, J WILDLIFE DIS, V37, P89, DOI 10.7589/0090-3558-37.1.89; Ortiz RM, 1999, J EXP BIOL, V202, P33; Osterhaus A, 1997, NATURE, V388, P838, DOI 10.1038/42163; OSTERHAUS ADME, 1990, VET MICROBIOL, V23, P343, DOI 10.1016/0378-1135(90)90165-R; Reep R.L., 2006, FLORIDA MANATEE BIOL; Reynolds JE, 1991, MANATEES DUGONGS, p[29, 51]; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rodas-Trejo J, 2008, TROP CONSERV SCI, V1, P321, DOI 10.1177/194008290800100403; Self-Sullivan C, 2008, THESIS TEXAS A M U C; SHAPIRO SS, 1968, J AM STAT ASSOC, V63, P1343, DOI 10.2307/2285889; Silva FMO, 2007, J VET MED A, V54, P119, DOI 10.1111/j.1439-0442.2007.00891.x; Smith KF, 2009, ANIM CONSERV, V12, P1, DOI 10.1111/j.1469-1795.2008.00228.x; Sukthana Yaowalark, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P314; Taylor J. A., 2000, SCHALMS VET HEMATOLO, P391; Uranga RM, 2010, CURR GERONTOL GERIAT, V2010, P1; Van Dolah FM, 2000, ENVIRON HEALTH PERSP, V108, P133, DOI 10.1289/ehp.00108s1133; Vidya TNC, 2002, J BIOSCIENCES, V27, P521, DOI 10.1007/BF02705050; VISSER IKG, 1993, VET RES, V24, P169; Walsh Michael T., 1999, P507; Wilson M. L., 2001, Ecosystem change and public health: a global perspective, P283; Wong AW, 2012, AQUAT MAMM, V38, P1, DOI 10.1578/AM.38.1.2012.1; Woodruff RA, 2005, J WILDLIFE DIS, V41, P437, DOI 10.7589/0090-3558-41.2.437	88	22	22	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44517	10.1371/journal.pone.0044517	http://dx.doi.org/10.1371/journal.pone.0044517			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984521	Green Published, gold			2022-12-27	WOS:000308738500062
J	Zhao, J; Chen, J				Zhao, Jin; Chen, Jin			Interspecific Variation in Compensatory Regrowth to Herbivory Associated with Soil Nutrients in Three Ficus (Moraceae) Saplings	PLOS ONE			English	Article							MANDUCA-SEXTA LEPIDOPTERA; HOST NICOTIANA-ATTENUATA; PLANT MESSENGER-RNAS; MOLECULAR-INTERACTIONS; ARTHROPOD HERBIVORY; BIOMASS ALLOCATION; RESOURCE AVAILABILITY; EUCALYPTUS-GLOBULUS; SUCCESSIONAL STATUS; TROPICAL FOREST	Plant compensatory regrowth is an induced process that enhances plant tolerance to herbivory. Plant behavior against herbivores differs between species and depends on resource availability, thus making general predictions related to plant compensatory regrowth difficult. To understand how soil nutrients determine the degree of compensatory regrowth for different plant species, we selected saplings of three Ficus species and treated with herbivore insects and artificial injury in both glasshouse conditions and in the field at two soil nutrient levels. Compensatory regrowth was calculated by biomass, relative growth rate and photosynthetic characteristics. A similar pattern was found in both the glasshouse and in the field for species F. hispida, where overcompensatory regrowth was triggered only under fertile conditions, and full compensatory regrowth occurred under infertile conditions. For F. auriculata, overcompensatory regrowth was stimulated only under infertile conditions and full compensatory regrowth occurred under fertile conditions. Ficus racemosa displayed full compensatory regrowth in both soil nutrient levels, but without overcompensatory regrowth following any of the treatments. The three Ficus species differed in biomass allocation following herbivore damage and artificial injury. The root/shoot ratio of F. hispida decreased largely following herbivore damage and artificial injury, while the root/shoot ratio for F. auriculata increased against damage treatments. The increase of shoot and root size for F. hispida and F. auriculata, respectively, appeared to be caused by a significant increase in photosynthesis. The results indicated that shifts in biomass allocation and increased photosynthesis are two of the mechanisms underlying compensatory regrowth. Contrasting patterns among the three Ficus species suggest that further theoretical and empirical work is necessary to better understand the complexity of the plant responses to herbivore damage.	[Zhao, Jin; Chen, Jin] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Mengla, Yunnan, Peoples R China; [Zhao, Jin] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhao, J (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Mengla, Yunnan, Peoples R China.	cj@xtbg.org.cn			National Natural Science Foundation of China (NSFC) [30570361]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (NSFC, 30570361) (http://www.nsfc.gov.cn/nsfc/cen/00/download.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldea M, 2006, OECOLOGIA, V149, P221, DOI 10.1007/s00442-006-0444-x; Anttonen S, 2002, CAN J FOREST RES, V32, P498, DOI [10.1139/x01-217, 10.1139/X01-217]; Barton KE, 2008, OIKOS, V117, P917, DOI 10.1111/j.0030-1299.2008.16324.x; BASSMAN JH, 1982, FOREST SCI, V28, P599; BELSKY AJ, 1993, EVOL ECOL, V7, P109, DOI 10.1007/BF01237737; Boege K, 2005, TRENDS ECOL EVOL, V20, P441, DOI 10.1016/j.tree.2005.05.001; CHAPIN FS, 1989, OECOLOGIA, V79, P551, DOI 10.1007/BF00378674; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; COLEY PD, 1988, OECOLOGIA, V74, P531, DOI 10.1007/BF00380050; COLEY PD, 1983, ECOL MONOGR, V53, P209, DOI 10.2307/1942495; COWAN IR, 1982, ENCY PLANT PHYSL, P589; CRAWLEY MJ, 1997, PLANT ECOL, P736; Dumas J. B. A, 1831, ANN CHIM PHYS, V2, P198; Dungan RJ, 2007, J ECOL, V95, P603, DOI 10.1111/j.1365-2745.2007.01243.x; EDWARDSJONES G, 1993, OIKOS, V66, P463, DOI 10.2307/3544941; Eichhorn MP, 2010, ECOLOGY, V91, P1092, DOI 10.1890/09-0300.1; Evans G.C., 1972, QUANTITATIVE ANAL PL, P734; Eyles A, 2009, TREE PHYSIOL, V29, P753, DOI 10.1093/treephys/tpp014; Fay PA, 1996, ECOLOGY, V77, P521, DOI 10.2307/2265627; Ferraro DO, 2002, OIKOS, V98, P125, DOI 10.1034/j.1600-0706.2002.980113.x; Fornoni J, 2011, FUNCT ECOL, V25, P399, DOI 10.1111/j.1365-2435.2010.01805.x; Garrido E, 2012, NEW PHYTOL, V193, P445, DOI 10.1111/j.1469-8137.2011.03923.x; GLEESON SK, 1994, FUNCT ECOL, V8, P543, DOI 10.2307/2390080; Glynn C, 2003, OIKOS, V101, P385, DOI 10.1034/j.1600-0706.2003.12089.x; GREEN TR, 1972, SCIENCE, V175, P776, DOI 10.1126/science.175.4023.776; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Halitschke R, 2003, PLANT PHYSIOL, V131, P1894, DOI 10.1104/pp.102.018184; Haukioja E, 2000, EVOL ECOL, V14, P551, DOI 10.1023/A:1011091606022; Hawkes CV, 2001, ECOLOGY, V82, P2045, DOI 10.1890/0012-9658(2001)082[2045:TIOHOP]2.0.CO;2; Hermans C, 2006, TRENDS PLANT SCI, V11, P610, DOI 10.1016/j.tplants.2006.10.007; Hermsmeier D, 2001, PLANT PHYSIOL, V125, P683, DOI 10.1104/pp.125.2.683; HILBERT DW, 1981, OECOLOGIA, V51, P14, DOI 10.1007/BF00344645; Hoffmann WA, 2003, J ECOL, V91, P475, DOI 10.1046/j.1365-2745.2003.00777.x; Hui X, 2004, ANN BOT-LONDON, V94, P377, DOI 10.1093/aob/mch153; KOZLOWSKI TT, 1992, BOT REV, V58, P107, DOI 10.1007/BF02858600; Lehtila K, 2000, OIKOS, V90, P160, DOI 10.1034/j.1600-0706.2000.900116.x; Leps J, 2001, J ECOL, V89, P186, DOI 10.1046/j.1365-2745.2001.00540.x; Mabry CM, 1997, OECOLOGIA, V111, P225, DOI 10.1007/s004420050229; MASCHINSKI J, 1989, AM NAT, V134, P1, DOI 10.1086/284962; McCloud ES, 1997, PLANTA, V203, P430, DOI 10.1007/s004250050210; MCNAUGHTON SJ, 1983, OIKOS, V40, P329, DOI 10.2307/3544305; MEYER GA, 1993, ECOLOGY, V74, P1117, DOI 10.2307/1940481; MUTIKAINEN P, 1995, OECOLOGIA, V104, P487, DOI 10.1007/BF00341346; Nabity PD, 2009, ANN BOT-LONDON, V103, P655, DOI 10.1093/aob/mcn127; Ozaki K, 2004, ECOL RES, V19, P225, DOI 10.1111/j.1440-1703.2003.00627.x; Pilson D, 2000, EVOL ECOL, V14, P457, DOI 10.1023/A:1010953714344; Pinkard EA, 2007, TREE PHYSIOL, V27, P1053, DOI 10.1093/treephys/27.7.1053; Rand TA, 2004, ECOLOGY, V85, P2046, DOI 10.1890/03-3087; Reymond P, 2004, PLANT CELL, V16, P3132, DOI 10.1105/tpc.104.026120; Roda A, 2004, MOL ECOL, V13, P2421, DOI 10.1111/j.1365-294X.2004.02260.x; ROSENTHAL JP, 1994, TRENDS ECOL EVOL, V9, P145, DOI 10.1016/0169-5347(94)90180-5; Schittko U, 2001, PLANT PHYSIOL, V125, P701, DOI 10.1104/pp.125.2.701; Sixto H, 2005, FORESTRY, V78, P93, DOI 10.1093/forestry/cpi009; Snyder KA, 2007, FOREST ECOL MANAG, V246, P222, DOI 10.1016/j.foreco.2007.04.032; Stowe KA, 2000, ANNU REV ECOL SYST, V31, P565, DOI 10.1146/annurev.ecolsys.31.1.565; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Thomson VP, 2003, OECOLOGIA, V134, P167, DOI 10.1007/s00442-002-1102-6; Tiffin P, 2000, EVOL ECOL, V14, P523, DOI 10.1023/A:1010881317261; TRUMBLE JT, 1993, ANNU REV ENTOMOL, V38, P93, DOI 10.1146/annurev.en.38.010193.000521; Valladares F, 2006, PLANT BIOLOGY, V8, P688, DOI 10.1055/s-2006-924107; VANDERMEIJDEN E, 1988, OIKOS, V51, P355, DOI 10.2307/3565318; Wise MJ, 2007, AM NAT, V169, P443, DOI 10.1086/512044; Wise MJ, 2005, OIKOS, V109, P417, DOI 10.1111/j.0030-1299.2005.13878.x; Xia Shang-Wen, 2007, Acta Botanica Yunnanica, V29, P694; Zangerl AR, 2002, P NATL ACAD SCI USA, V99, P1088, DOI 10.1073/pnas.022647099; Zeiger E, 1987, STOMATAL FUNCTION	66	16	17	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45092	10.1371/journal.pone.0045092	http://dx.doi.org/10.1371/journal.pone.0045092			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984616	Green Submitted, gold, Green Published			2022-12-27	WOS:000308738500116
J	Derrett, S; Samaranayaka, A; Wilson, S; Langley, J; Ameratunga, S; Cameron, ID; Lilley, R; Wyeth, E; Davie, G				Derrett, Sarah; Samaranayaka, Ari; Wilson, Suzanne; Langley, John; Ameratunga, Shanthi; Cameron, Ian D.; Lilley, Rebbecca; Wyeth, Emma; Davie, Gabrielle			Prevalence and Predictors of Sub-Acute Phase Disability after Injury among Hospitalised and Non-Hospitalised Groups: A Longitudinal Cohort Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEALTH-STATUS; FUNCTIONAL CONSEQUENCES; GENERAL HEALTH; MAJOR TRAUMA; WORK STATUS; DETERMINANTS; POPULATION; OUTCOMES; RECOVERY	Introduction: To reduce the burden on injury survivors and their supporters, factors associated with poor outcomes need to be identified so that timely post-injury interventions can be implemented. To date, few studies have investigated outcomes for both those who were hospitalised and those who were not. Aim: To describe the prevalence and to identify pre-injury and injury-related predictors of disability among hospitalised and non-hospitalised people, three months after injury. Methods: Participants in the Prospective Outcomes of Injury Study were aged 18-64 years and on an injury entitlement claims register with New Zealand's no-fault injury compensation insurer, following referral by healthcare professionals. A wide range of pre-injury demographic, health and injury-related characteristics were collected at interview. Participants were categorised as 'hospitalised' if they were placed on New Zealand's National Minimum Data Set within seven days of the injury event. Injury severity scores (NISS) and 12 injury categories were derived from ICD-10 codes. WHODAS assessed disability. Multivariable analyses examined relationships between explanatory variables and disability. Results: Of 2856 participants, 2752 (96%) had WHODAS scores available for multivariable analysis; 673 were hospitalised; 2079 were not. Disability was highly prevalent among hospitalised (53.6%) and non-hospitalised (39.4%) participants, three-months after injury. In both groups, pre-injury disability, obesity and higher injury severity were associated with increased odds of post-injury disability. A range of other factors were associated with disability in only one group: e. g. female, >= 2 chronic conditions and leg fracture among hospitalised; aged 35-54 years, trouble accessing healthcare, spine or lower extremity sprains/dislocations and assault among non-hospitalised. Significance: Disability was highly prevalent among both groups yet, with a few exceptions, factors associated with disability were not common to both groups. Where possible, including a range of injured people in studies, hospitalised and not, will increase understanding of the burden of disability in the sub-acute phase.	[Derrett, Sarah; Samaranayaka, Ari; Wilson, Suzanne; Langley, John; Lilley, Rebbecca; Davie, Gabrielle] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Injury Prevent Res Unit, Dunedin, New Zealand; [Ameratunga, Shanthi] Univ Auckland, Fac Med & Hlth Sci, Sch Populat Hlth, Auckland 1, New Zealand; [Cameron, Ian D.] Univ Sydney, Sydney Med Sch, Rehabil Studies Unit, Sydney, NSW 2006, Australia; [Wyeth, Emma] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Te Roopu Rangahau Hauora Maori Ngai Tahu Ngai Ta, Dunedin, New Zealand	University of Otago; University of Auckland; University of Sydney; University of Otago	Derrett, S (corresponding author), Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Injury Prevent Res Unit, Dunedin, New Zealand.	sarah.derrett@otago.ac.nz	Wyeth, Emma/GLU-8874-2022	Ameratunga, Shanthi/0000-0001-8042-2251; Derrett, Sarah/0000-0003-2867-0498; Wyeth, Emma/0000-0002-6869-5190; Davie, Gabrielle/0000-0001-5466-5364	Health Research Council of New Zealand; Accident Compensation Corporation, New Zealand; Health Research Council of New Zealand Eru Pomare Research Fellowship; ACC Early Research Career Post-Doctoral Fellowship; Australian National Health and Medical Research Council Practitioner Fellowship	Health Research Council of New Zealand(Health Research Council of New Zealand); Accident Compensation Corporation, New Zealand; Health Research Council of New Zealand Eru Pomare Research Fellowship; ACC Early Research Career Post-Doctoral Fellowship; Australian National Health and Medical Research Council Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This study is funded by the Health Research Council of New Zealand (2007-2013), and was co-funded by the Accident Compensation Corporation, New Zealand (2007-2010). The views and conclusions expressed herein are the authors' and may not reflect those of the funders. EW was supported by a Health Research Council of New Zealand Eru Pomare Research Fellowship, RL by an ACC Early Research Career Post-Doctoral Fellowship and IDC by an Australian National Health and Medical Research Council Practitioner Fellowship. The Accident Compensation Corporation sent out invitations to eligible potential participants on the research team's behalf, and also provided, following participants' consent, information from the electronic record about participants' injuries. The funders had no role in study design, analysis, decision to publish, or preparation of the manuscript.	Accident Compensation Corporation, 2010, ANN REP 2010 ACC COM; Accident Compensation Corporation, 2009, ANN REP 2009 ACC COM; Ameratunga SN, 2006, ANN EMERG MED, V48, P729, DOI 10.1016/j.annemergmed.2006.07.001; American Psychiatric Association Committee of Nomenclature and Statistics, 1980, DIAGN STAT MAN MENT; Andrews G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008343; [Anonymous], 2009, STAT REL 11 STAT SOF; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Black JA, 2011, J TRAUMA, V71, P1003, DOI 10.1097/TA.0b013e3182238833; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Cripps RA, 2008, INJURY CHRONIC HLTH; Derrett S, 2009, INJURY PREV, V15, DOI [10.1136/ip.2009.022558a, 10.1136/ip.2009.022558]; Derrett S, 2011, INJURY PREV, V17, P415, DOI 10.1136/injuryprev-2011-040044; Edmondson D, 2008, PSYCHO-ONCOL, V17, P161, DOI 10.1002/pon.1197; European Center for Injury Prevention, 2011, ICD MAP; Federici S, 2010, DISABIL REHABIL, V32, P687, DOI 10.3109/09638280903290012; Fingerhut LA, 2006, INJURY PREV, V12, P24, DOI 10.1136/ip.2005.009076; Fitchett G, 1999, REHABIL PSYCHOL, V44, P333, DOI 10.1037//0090-5550.44.4.333; Gennarelli TA, 2008, ABBREVIATED INJURY S; Gofin R, 1997, Inj Prev, V3, P120, DOI 10.1136/ip.3.2.120; Holbrook TL, 1999, J TRAUMA, V46, P765, DOI 10.1097/00005373-199905000-00003; Holbrook TL, 2004, J TRAUMA, V56, P284, DOI 10.1097/01.TA.0000109758.75406.F8; Holtslag HR, 2007, J TRAUMA, V62, P919, DOI 10.1097/01.ta.0000224124.47646.62; Krahn GL, 2009, DISABIL HEALTH J, V2, P49, DOI 10.1016/j.dhjo.2008.12.003; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Langley J, 2012, INJURY PREV, V18, P73, DOI 10.1136/injuryprev-2011-040278; Langley J, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-68; Lilley R, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000400; Lyons RA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001140; MacKenzie EJ, 2000, EPIDEMIOL REV, V22, P112, DOI 10.1093/oxfordjournals.epirev.a018006; MacKenzie EJ, 1998, AM J PUBLIC HEALTH, V88, P1630, DOI 10.2105/AJPH.88.11.1630; Malm Sigrun, 2008, Ann Adv Automot Med, V52, P93; Meerding WJ, 2006, EUR J PUBLIC HEALTH, V16, P271, DOI 10.1093/eurpub/ckl006; Meerding WJ, 2004, J TRAUMA, V56, P150, DOI 10.1097/01.TA.0000062969.65847.8B; Michaels AJ, 2000, J TRAUMA, V48, P841, DOI 10.1097/00005373-200005000-00007; Ministry of Health, 2008, PORTR HLTH KEY RES 2; Ministry of Health, 2011, NAT COLL GLOSS APP B; Ministry of Social Development, 2000, DIR MEAS LIV STAND N; O'Donnell ML, 2005, J TRAUMA, V59, P1328, DOI 10.1097/01.ta.0000197621.94561.4e; Overgaard M, 2011, J TRAUMA, V71, P435, DOI 10.1097/TA.0b013e31820e7ec3; Pape HC, 2010, J TRAUMA, V69, P1243, DOI 10.1097/TA.0b013e3181ce1fa1; Pargament KI, 2001, J SCI STUD RELIG, V40, P497, DOI 10.1111/0021-8294.00073; Peterman AH, 2002, ANN BEHAV MED, V24, P49, DOI 10.1207/S15324796ABM2401_06; Polinder S, 2007, J TRAUMA, V62, P133, DOI 10.1097/TA.0b013e31802b71c9; Polinder S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-783; Portney KE, 1997, AM BEHAV SCI, V40, P632, DOI 10.1177/0002764297040005009; Pukk Karin, 2003, Qual Manag Health Care, V12, P225; Robinson D, 1997, J AM MED INFORM ASSN, V4, P465, DOI 10.1136/jamia.1997.0040465; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Smith DL, 2008, DISABIL HEALTH J, V1, P79, DOI 10.1016/j.dhjo.2008.01.001; Soberg HL, 2007, J TRAUMA, V62, P461, DOI 10.1097/01.ta.0000222916.30253.ea; Sport and Recreation New Zealand, 2004, NZ PHYS ACT QUEST; Statistics New Zealand, 2006, 2006 CENS QUEST; Statistics New Zealand, 2006, 2006 CENS POP DWELL; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; Ustun B., 2010, MEASURING HLTH DISAB; Vles WJ, 2005, J TRAUMA, V58, P126, DOI 10.1097/01.TA.0000112342.40296.1F; Ware J.E., 2000, SF 36 HLTH SURVEY MA; Watson WL, 2007, INJURY PREV, V13, P45, DOI 10.1136/ip.2005.010157; WHO, 2011, WORLD REPORT ON DISABILITY, P1; World Health Organisation (WHO), 2001, INT CLASS FUNCT DIS; World Health Organization, 2008, The global burden of disease: 2004 update; World Health Organization, 2011, BMI CLASS	64	54	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44909	10.1371/journal.pone.0044909	http://dx.doi.org/10.1371/journal.pone.0044909			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	003VE	22984584	gold, Green Published			2022-12-27	WOS:000308638700099
J	Kumar, A; Mocklinghoff, S; Yumoto, F; Jaroszewski, L; Farr, CL; Grzechnik, A; Nguyen, P; Weichenberger, CX; Chiu, HJ; Klock, HE; Elsliger, MA; Deacon, AM; Godzik, A; Lesley, SA; Conklin, BR; Fletterick, RJ; Wilson, IA				Kumar, Abhinav; Moecklinghoff, Sabine; Yumoto, Fumiaki; Jaroszewski, Lukasz; Farr, Carol L.; Grzechnik, Anna; Phuong Nguyen; Weichenberger, Christian X.; Chiu, Hsiu-Ju; Klock, Heath E.; Elsliger, Marc-Andre; Deacon, Ashley M.; Godzik, Adam; Lesley, Scott A.; Conklin, Bruce R.; Fletterick, Robert J.; Wilson, Ian A.			Structure of a Novel Winged-Helix Like Domain from Human NFRKB Protein	PLOS ONE			English	Article							CHROMATIN REMODELING COMPLEX; INO80; TRANSCRIPTION; PREDICTION; REVEALS; DIFFRACTION; GENOMICS; SYSTEM	The human nuclear factor related to kappa-B-binding protein (NFRKB) is a 1299-residue protein that is a component of the metazoan INO80 complex involved in chromatin remodeling, transcription regulation, DNA replication and DNA repair. Although full length NFRKB is predicted to be around 65% disordered, comparative sequence analysis identified several potentially structured sections in the N-terminal region of the protein. These regions were targeted for crystallographic studies, and the structure of one of these regions spanning residues 370-495 was determined using the JCSG high-throughput structure determination pipeline. The structure reveals a novel, mostly helical domain reminiscent of the winged-helix fold typically involved in DNA binding. However, further analysis shows that this domain does not bind DNA, suggesting it may belong to a small group of winged-helix domains involved in protein-protein interactions.	[Kumar, Abhinav; Jaroszewski, Lukasz; Farr, Carol L.; Grzechnik, Anna; Weichenberger, Christian X.; Chiu, Hsiu-Ju; Klock, Heath E.; Elsliger, Marc-Andre; Deacon, Ashley M.; Godzik, Adam; Lesley, Scott A.; Wilson, Ian A.] Joint Ctr Struct Genom, La Jolla, CA USA; [Kumar, Abhinav; Chiu, Hsiu-Ju; Deacon, Ashley M.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA USA; [Moecklinghoff, Sabine; Yumoto, Fumiaki; Phuong Nguyen; Fletterick, Robert J.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Farr, Carol L.; Grzechnik, Anna; Elsliger, Marc-Andre; Lesley, Scott A.; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Klock, Heath E.; Lesley, Scott A.] Novartis Res Fdn, Genom Inst, Prot Sci Dept, San Diego, CA USA; [Jaroszewski, Lukasz; Weichenberger, Christian X.; Godzik, Adam] Sanford Burnham Med Res Inst, Program Bioinformat & Syst Biol, La Jolla, CA USA; [Godzik, Adam] Univ Calif San Diego, Ctr Res Biol Syst, La Jolla, CA 92093 USA; [Yumoto, Fumiaki; Conklin, Bruce R.] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Conklin, Bruce R.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Conklin, Bruce R.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of California System; University of California San Francisco; Scripps Research Institute; Novartis; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kumar, A (corresponding author), Joint Ctr Struct Genom, La Jolla, CA USA.	Flett@msg.UCSF.edu; wilson@scripps.edu	Conklin, Bruce/E-4738-2019; Godzik, Adam/A-7279-2009; Godzik, Adam/AAW-1467-2020	Godzik, Adam/0000-0002-2425-852X; Godzik, Adam/0000-0002-2425-852X; Weichenberger, Christian X./0000-0002-2176-0274; Elsliger, Marc Andre/0000-0002-1989-7626; Conklin, Bruce/0000-0003-1463-6061	National Institutes of Health, National Institute of General Medical Sciences, Protein Structure Initiative [U01 GM094614, U54 GM094586]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; National Center for Research Resources [P41RR001209]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, U54GM094586, U01GM094614] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of General Medical Sciences, Protein Structure Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health, National Institute of General Medical Sciences, Protein Structure Initiative grants U01 GM094614 to Robert Fletterick and U54 GM094586 to the Joint Center for Structural Genomics (JCSG). The Stanford Synchrotron Radiation Lightsource (SSRL) Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393) and the National Center for Research Resources (P41RR001209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bao YH, 2007, MUTAT RES-FUND MOL M, V618, P18, DOI 10.1016/j.mrfmmm.2006.10.006; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Chen L, 2011, J BIOL CHEM, V286, P11283, DOI 10.1074/jbc.M111.222505; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Cohen AE, 2002, J APPL CRYSTALLOGR, V35, P720, DOI 10.1107/S0021889802016709; Conaway RC, 2009, TRENDS BIOCHEM SCI, V34, P71, DOI 10.1016/j.tibs.2008.10.010; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Silva RS, 2005, J BIOL CHEM, V280, P13779, DOI 10.1074/jbc.M413781200; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Ebbert R, 1999, MOL MICROBIOL, V32, P741, DOI 10.1046/j.1365-2958.1999.01390.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Jin JY, 2005, J BIOL CHEM, V280, P41207, DOI 10.1074/jbc.M509128200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lesley SA, 2002, P NATL ACAD SCI USA, V99, P11664, DOI 10.1073/pnas.142413399; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Rychlewski L, 2000, PROTEIN SCI, V9, P232, DOI 10.1110/ps.9.2.232; Safo MK, 2006, ACTA CRYSTALLOGR F, V62, P320, DOI 10.1107/S1744309106009742; Santarsiero BD, 2002, J APPL CRYSTALLOGR, V35, P278, DOI 10.1107/S0021889802001474; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Schwartz T, 2001, NAT STRUCT BIOL, V8, P761, DOI 10.1038/nsb0901-761; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Slabinski L, 2007, BIOINFORMATICS, V23, P3403, DOI 10.1093/bioinformatics/btm477; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P1174, DOI 10.1107/S0907444903009922; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Yang YD, 2011, BIOINFORMATICS, V27, P2076, DOI 10.1093/bioinformatics/btr350; Yao T, 2008, MOL CELL, V31, P909, DOI 10.1016/j.molcel.2008.08.027; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	43	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43761	10.1371/journal.pone.0043761	http://dx.doi.org/10.1371/journal.pone.0043761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984442	Green Published, Green Submitted, gold			2022-12-27	WOS:000308638700029
J	Okoro, EU; Zhao, YF; Guo, ZM; Zhou, LC; Lin, XH; Yang, H				Okoro, Emmanuel Ugochukwu; Zhao, Yanfeng; Guo, ZhongMao; Zhou, Lichun; Lin, Xinghua; Yang, Hong			Apolipoprotein E4 Is Deficient in Inducing Macrophage ABCA1 Expression and Stimulating the Sp1 Signaling Pathway	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; MONOCYTE-DERIVED MACROPHAGES; TRANSPORTER A1 EXPRESSION; HUMAN-E APOPROTEIN; CHOLESTEROL EFFLUX; LDL-RECEPTOR; TANGIER-DISEASE; LIPID EFFLUX; E GENOTYPES; BINDING	ATP binding cassette A1 (ABCA1) is a membrane protein that promotes cellular cholesterol efflux. Using RAW 264.7 macrophages, we studied the relative effects of apolipoprotein (apo) E3 and apoE4 on ABCA1 and on the signaling pathway that regulates its expression. Both lipid-associated and lipid-free apoE4 forms induced similar to 30% lower levels of ABCA1 protein and mRNA than apoE3 forms. Phosphorylated levels of phosphoinositol 3-kinase (PI3K), protein kinase C zeta (PKC zeta) and specificity protein 1 (Sp1) were also lower when treated with apoE4 compared to apoE3. The reduced ability of apoE4 to induce ABCA1 expression, PKC zeta and Sp1 phosphorylation were confirmed in human THP-1 monocytes/macrophages. Sequential phosphorylation of PI3K, PKC zeta and Sp1 has been suggested as a mechanism for upregulation of ABCA1 expression. Both apoE3 and apoE4 reduced total cholesterol and cholesterol esters in lipid-laden RAW 264.7 cells, and induced apoAI-mediated cholesterol efflux. However, the cholesterol esters and cholesterol efflux in apoE4-treated cells were similar to 50% and similar to 24% lower, respectively, compared to apoE3-treated cells. Accumulation of cholesterol esters in macrophages is a mechanism for foam cell formation. Thus the reduced ability of apoE4 to activate the PI3K-PKC zeta-Sp1 signaling pathway and induce ABCA1 expression likely impairs cholesterol ester removal, and increases foam cell formation.	[Okoro, Emmanuel Ugochukwu; Zhao, Yanfeng; Guo, ZhongMao; Zhou, Lichun; Lin, Xinghua; Yang, Hong] Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA	Meharry Medical College	Okoro, EU (corresponding author), Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA.	hyang@mmc.edu			United States National Institutes of Health [F32HL105044, R01ES014471, R01HL089382, SC1HL101431]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089382, SC1HL101431, F32HL105044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014472] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by United States National Institutes of Health grants: F32HL105044 (EO), R01ES014471, R01HL089382 (ZMG) and SC1HL101431 (HY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASU SK, 1981, P NATL ACAD SCI-BIOL, V78, P7545, DOI 10.1073/pnas.78.12.7545; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Blacklow SC, 2007, CURR OPIN STRUC BIOL, V17, P419, DOI 10.1016/j.sbi.2007.08.017; BLUE ML, 1983, P NATL ACAD SCI-BIOL, V80, P283, DOI 10.1073/pnas.80.1.283; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Chen W, 2001, J BIOL CHEM, V276, P43564, DOI 10.1074/jbc.M107938200; Chen XP, 2011, J BIOL CHEM, V286, P8917, DOI 10.1074/jbc.M110.214429; Chen XP, 2012, J BIOL CHEM, V287, P3751, DOI 10.1074/jbc.M111.310888; CLAVEY V, 1995, ARTERIOSCL THROM VAS, V15, P963, DOI 10.1161/01.ATV.15.7.963; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; FOLCH J, 1957, J BIOL CHEM, V226, P497; FUNKE H, 1984, ARTERIOSCLEROSIS, V4, P452, DOI 10.1161/01.ATV.4.5.452; GHISELLI G, 1982, J CLIN INVEST, V70, P474, DOI 10.1172/JCI110638; Gong JS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-9; GREEN PHR, 1979, J CLIN INVEST, V64, P233, DOI 10.1172/JCI109444; Gregg RE, 1986, J CLIN INVEST, V78, P3; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Heeren J, 1999, J CELL SCI, V112, P349; Heeren J, 2006, ARTERIOSCL THROM VAS, V26, P442, DOI 10.1161/01.ATV.0000201282.64751.47; Heeren J, 2004, J BIOL CHEM, V279, P55483, DOI 10.1074/jbc.M409324200; Heeren J, 2003, J BIOL CHEM, V278, P14370, DOI 10.1074/jbc.M209006200; Heeren J, 2001, J BIOL CHEM, V276, P42333, DOI 10.1074/jbc.M107461200; Huang ZH, 2006, ARTERIOSCL THROM VAS, V26, P157, DOI 10.1161/01.ATV.0000193627.12516.1d; KRUTH HS, 1994, J BIOL CHEM, V269, P24511; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; LILLYSTAUDERMAN M, 1993, J LIPID RES, V34, P190; Linton MF, 1998, J CLIN INVEST, V101, P1726, DOI 10.1172/JCI2181; MAHLEY RW, 1984, J LIPID RES, V25, P1277; Mamotte CDS, 1999, AM J PHYSIOL-ENDOC M, V276, pE553, DOI 10.1152/ajpendo.1999.276.3.E553; MAZZONE T, 1987, J BIOL CHEM, V262, P11657; Minagawa Hirohisa, 2009, J Neurosci Res, V87, P2498, DOI 10.1002/jnr.22073; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Oram JF, 2000, BBA-MOL CELL BIOL L, V1529, P321, DOI 10.1016/S1388-1981(00)00157-8; Rellin L, 2008, BBA-MOL CELL BIOL L, V1781, P232, DOI 10.1016/j.bbalip.2008.02.001; RUBINSZTEIN DC, 1990, J CLIN INVEST, V86, P1306, DOI 10.1172/JCI114839; Selva DM, 2004, J LIPID RES, V45, P1040, DOI 10.1194/jlr.M400007-JLR200; SHELBURNE FA, 1974, J BIOL CHEM, V249, P1428; SHORE VG, 1973, BIOCHEMISTRY-US, V12, P502, DOI 10.1021/bi00727a022; Song YQ, 2004, ANN INTERN MED, V141, P137, DOI 10.7326/0003-4819-141-2-200407200-00013; TAKAHASHI S, 1992, P NATL ACAD SCI USA, V89, P9252, DOI 10.1073/pnas.89.19.9252; TSUCHIYA S, 1982, CANCER RES, V42, P1530; UTERMANN G, 1975, FEBS LETT, V56, P352, DOI 10.1016/0014-5793(75)81125-2; Van Eck M, 2002, P NATL ACAD SCI USA, V99, P6298, DOI 10.1073/pnas.092327399; Vedhachalam C, 2007, BIOCHEMISTRY-US, V46, P2583, DOI 10.1021/bi602407r; WEISGRABER KH, 1977, ATHEROSCLEROSIS, V28, P121, DOI 10.1016/0021-9150(77)90150-2; WEISGRABER KH, 1984, J CLIN INVEST, V73, P1024, DOI 10.1172/JCI111287; WEISGRABER KH, 1982, J BIOL CHEM, V257, P2518; WEISGRABER KH, 1981, J BIOL CHEM, V256, P9077; Weisgraber KH, 1981, J BIOL CHEM, V257, P4171; Willis F, 2003, J NATL MED ASSOC, V95, P71; WILLNOW TE, 1994, SCIENCE, V264, P1471, DOI 10.1126/science.7515194; WILSON PWF, 1994, JAMA-J AM MED ASSOC, V272, P1666, DOI 10.1001/jama.272.21.1666; Wu DF, 2005, J LIPID RES, V46, P1380, DOI 10.1194/jlr.M400430-JLR200; Yamamoto T, 2008, ANAL BIOCHEM, V372, P222, DOI 10.1016/j.ab.2007.09.005; Yamamoto T, 2007, BIOCHEM BIOPH RES CO, V354, P820, DOI 10.1016/j.bbrc.2007.01.066; Yamamura T, 1999, J LIPID RES, V40, P253; Yancey PG, 2007, ARTERIOSCL THROM VAS, V27, P1123, DOI 10.1161/ATVBAHA.107.139592; ZANNIS VI, 1982, J LIPID RES, V23, P911; Zhang WY, 1996, J BIOL CHEM, V271, P28641, DOI 10.1074/jbc.271.45.28641; ZHAO Y, 2011, PLOS ONE, V6	60	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44430	10.1371/journal.pone.0044430	http://dx.doi.org/10.1371/journal.pone.0044430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984509	Green Published, Green Submitted, gold			2022-12-27	WOS:000308638700061
J	Ye, MM; Yang, YL; Zhang, Y; Zhang, TQ; Shao, WY				Ye, Miaomiao; Yang, Yulong; Zhang, Yan; Zhang, Tuqiao; Shao, Weiyun			Hydrothermal Synthesis of Hydrangea-Like F-Doped Titania Microspheres for the Photocatalytic Degradation of Carbamazepine under UV and Visible Light Irradiation	JOURNAL OF NANOMATERIALS			English	Article							TIO2 POWDERS; SURFACE FLUORINATION; FABRICATION; OXIDATION; WATER	Hydrangea-like F-doped TiO2 microspheres have been synthesized on a large scale by a simple hydrothermal process using potassium titanium oxalate as the titanium source, ammonium fluoride and hydrogen peroxide as the etchant. The photocatalytic activities were evaluated using carbamazepine as the target organic molecule under UV and visible light irradiation. Structural characterization indicates that the hydrangea-like TiO2 microspheres, with an average diameter of 2.80 mu m, are composed of numerous anatase TiO2 petals. Moreover, it is found that both the NH4F and H2O2 dosages have important effects on the formation of the hydrangea-like structures. In addition, photocatalytic experiments show that the hydrangea-like TiO2 microspheres calcined at 500 degrees C exhibit high photocatalytic efficiency under both UV and visible light irradiation. The enhanced photocatalytic activity can be attributed to the successful fluorine doping, good crystallinity, and the unique nanostructures.	[Ye, Miaomiao; Yang, Yulong; Zhang, Yan; Zhang, Tuqiao; Shao, Weiyun] Zhejiang Univ, Inst Municipal Engn, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Shao, WY (corresponding author), Zhejiang Univ, Inst Municipal Engn, Hangzhou 310058, Zhejiang, Peoples R China.	shaowy@zju.edu.cn	Fei, Zhangjun/H-5152-2012; Ye, Miaomiao/A-9123-2016; Ye, Miaomiao/G-8865-2015	Ye, Miaomiao/0000-0002-5546-1133; 	National Natural Science Foundation of China [51108406]; Fundamental Research Funds for the Central Universities [2011FZA4022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was financially supported by the National Natural Science Foundation of China (Grant no. 51108406) and the Fundamental Research Funds for the Central Universities (2011FZA4022), to the authors we are grateful.	Chen YJ, 2008, APPL CATAL B-ENVIRON, V80, P147, DOI 10.1016/j.apcatb.2007.11.010; Guo YP, 2011, J NANOMATER, V2011, DOI 10.1155/2011/296953; Huo YN, 2009, APPL CATAL B-ENVIRON, V89, P543, DOI 10.1016/j.apcatb.2009.01.019; Li XZ, 2003, ENVIRON SCI TECHNOL, V37, P3989, DOI 10.1021/es0262941; Liu SW, 2011, CHEM MATER, V23, P4085, DOI 10.1021/cm200597m; Liu SW, 2010, J AM CHEM SOC, V132, P11914, DOI 10.1021/ja105283s; Liu ZY, 2007, CHEM-EUR J, V13, P1851, DOI 10.1002/chem.200601092; Livraghi S, 2006, J AM CHEM SOC, V128, P15666, DOI 10.1021/ja064164c; Markowska-Szczupak A, 2011, CATAL TODAY, V169, P249, DOI 10.1016/j.cattod.2010.11.055; Pan JH, 2008, J AM CHEM SOC, V130, P11256, DOI 10.1021/ja803582m; Park H, 2004, J PHYS CHEM B, V108, P4086, DOI 10.1021/jp036735i; Ryu J, 2004, ENVIRON SCI TECHNOL, V38, P2928, DOI 10.1021/es034725p; Sakthivel S, 2004, J PHYS CHEM B, V108, P19384, DOI 10.1021/jp046857q; SERPONE N, 1995, J PHYS CHEM-US, V99, P16646, DOI 10.1021/j100045a026; SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603; Xiang QJ, 2011, CHEM COMMUN, V47, P4532, DOI 10.1039/c1cc10501a; Xie Y, 2007, J MOL CATAL A-CHEM, V277, P119, DOI 10.1016/j.molcata.2007.07.031; Yang GD, 2010, APPL CATAL B-ENVIRON, V96, P458, DOI 10.1016/j.apcatb.2010.03.004; Yang HM, 2009, J MATER CHEM, V19, P6907, DOI 10.1039/b911709a; Ye MM, 2011, MATER LETT, V65, P2384, DOI 10.1016/j.matlet.2011.04.073; Ye MM, 2010, J HAZARD MATER, V184, P612, DOI 10.1016/j.jhazmat.2010.08.080; Ye MM, 2010, CHEM-EUR J, V16, P6243, DOI 10.1002/chem.200903516; Ye MM, 2009, J HAZARD MATER, V167, P1021, DOI 10.1016/j.jhazmat.2009.01.091; Yu JC, 2002, CHEM MATER, V14, P3808, DOI 10.1021/cm020027c; Yu JG, 2006, J MOL CATAL A-CHEM, V246, P176, DOI 10.1016/j.molcata.2005.10.034; Yu JG, 2007, J PHYS CHEM C, V111, P10582, DOI 10.1021/jp0707889; Yu JG, 2006, ADV FUNCT MATER, V16, P2035, DOI 10.1002/adfm.200600552; Yu JG, 2009, J PHYS CHEM C, V113, P6743, DOI 10.1021/jp900136q	28	644	663	22	198	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1687-4110	1687-4129		J NANOMATER	J. Nanomater.		2012	2012								583417	10.1155/2012/583417	http://dx.doi.org/10.1155/2012/583417			8	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Materials Science	908GX	22984514	Green Submitted, gold			2022-12-27	WOS:000301480000001
J	Sernova, NV; Gelfand, MS				Sernova, Natalia V.; Gelfand, Mikhail S.			Comparative Genomics of CytR, an Unusual Member of the LacI Family of Transcription Factors	PLOS ONE			English	Article							CAMP RECEPTOR PROTEIN; DIFFERENT OPERATORS SUGGESTS; COLI CYTIDINE REPRESSOR; CRP ACTIVATOR PROTEIN; ESCHERICHIA-COLI; DEOP2 PROMOTER; SALMONELLA-TYPHIMURIUM; NUCLEOTIDE-SEQUENCE; MAXIMUM-LIKELIHOOD; BINDING-SITES	CytR is a transcription regulator from the LacI family, present in some gamma-proteobacteria including Escherichia coli and known not only for its cellular role, control of transport and utilization of nucleosides, but for a number of unusual structural properties. The present study addressed three related problems: structure of CytR-binding sites and motifs, their evolutionary conservation, and identification of new members of the CytR regulon. While the majority of CytR-binding sites are imperfect inverted repeats situated between binding sites for another transcription factor, CRP, other architectures were observed, in particular, direct repeats. While the similarity between sites for different genes in one genome is rather low, and hence the consensus motif is weak, there is high conservation of orthologous sites in different genomes (mainly in the Enterobacteriales) arguing for the presence of specific CytR-DNA contacts. On larger evolutionary distances candidate CytR sites may migrate but the approximate distance between flanking CRP sites tends to be conserved, which demonstrates that the overall structure of the CRP-CytR-DNA complex is gene-specific. The analysis yielded candidate CytR-binding sites for orthologs of known regulon members in less studied genomes of the Enterobacteriales and Vibrionales and identified a new candidate member of the CytR regulon, encoding a transporter named NupT (YcdZ).	[Sernova, Natalia V.; Gelfand, Mikhail S.] Russian Acad Sci, AA Kharkevich Inst Informat Transmiss Problems, Moscow, Russia; [Gelfand, Mikhail S.] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow 117234, Russia	Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Lomonosov Moscow State University	Gelfand, MS (corresponding author), Russian Acad Sci, AA Kharkevich Inst Informat Transmiss Problems, Moscow, Russia.	gelfand@iitp.ru	Gelfand, Mikhail S/F-3425-2012	Gelfand, Mikhail/0000-0003-4181-0846	Ministry of Education and Science of Russia [07.514.11.4007]; Russian Foundation of Basic Research [10-04-00431]; Russian Academy of Sciences via the Program in Molecular and Cellular Biology	Ministry of Education and Science of Russia(Ministry of Education and Science, Russian Federation); Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences via the Program in Molecular and Cellular Biology(Russian Academy of Sciences)	This study was partially supported by the Ministry of Education and Science of Russia via contract 07.514.11.4007, the Russian Foundation of Basic Research via grant 10-04-00431, and the Russian Academy of Sciences via the Program in Molecular and Cellular Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIBA H, 1981, BIOCHEMISTRY-US, V20, P4774, DOI 10.1021/bi00519a038; ANDERSON WB, 1971, J BIOL CHEM, V246, P5929; Barbier CS, 1997, J BIOL CHEM, V272, P16962, DOI 10.1074/jbc.272.27.16962; BARBIER CS, 1993, J BACTERIOL, V175, P4625, DOI 10.1128/JB.175.15.4625-4630.1993; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Brikun I, 1996, J BACTERIOL, V178, P1614, DOI 10.1128/jb.178.6.1614-1622.1996; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CRAIG JE, 1994, MOL MICROBIOL, V11, P1159, DOI 10.1111/j.1365-2958.1994.tb00392.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gelfand MS, 2000, NUCLEIC ACIDS RES, V28, P695, DOI 10.1093/nar/28.3.695; GERLACH P, 1991, J BACTERIOL, V173, P5419, DOI 10.1128/jb.173.17.5419-5430.1991; GERLACH P, 1990, MOL MICROBIOL, V4, P479, DOI 10.1111/j.1365-2958.1990.tb00614.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HAMMERJESPERSEN K, 1975, MOL GEN GENET, V137, P327, DOI 10.1007/BF00703258; Hampshire AJ, 2007, METHODS, V42, P128, DOI 10.1016/j.ymeth.2007.01.002; HOLST B, 1992, EMBO J, V11, P3635, DOI 10.1002/j.1460-2075.1992.tb05448.x; Holt AK, 2010, BIOCHEMISTRY-US, V49, P432, DOI 10.1021/bi901583n; Jorgensen CI, 1998, MOL MICROBIOL, V27, P41, DOI 10.1046/j.1365-2958.1998.00655.x; Kallipolitis BH, 1997, CELL, V89, P1101, DOI 10.1016/S0092-8674(00)80297-4; Kallipolitis BH, 2004, J MOL BIOL, V342, P1, DOI 10.1016/j.jmb.2004.05.067; Kallipolitis BH, 1998, MOL MICROBIOL, V29, P1091, DOI 10.1046/j.1365-2958.1998.00999.x; Lai JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035018; Meibom KL, 2000, J BIOL CHEM, V275, P11951, DOI 10.1074/jbc.275.16.11951; Mironov A. A., 2000, Molekulyarnaya Biologiya (Moscow), V34, P253; MOLLEGAARD NE, 1993, J BIOL CHEM, V268, P17471; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; NORREGAARDMADSEN M, 1994, MOL MICROBIOL, V14, P989, DOI 10.1111/j.1365-2958.1994.tb01333.x; Patching SG, 2005, ORG BIOMOL CHEM, V3, P462, DOI 10.1039/b414739a; PEDERSEN H, 1991, J BIOL CHEM, V266, P17804; PEDERSEN H, 1995, MOL MICROBIOL, V17, P843, DOI 10.1111/j.1365-2958.1995.mmi_17050843.x; Pedersen H, 1997, EMBO J, V16, P2108, DOI 10.1093/emboj/16.8.2108; Perini LT, 1996, J BIOL CHEM, V271, P33242, DOI 10.1074/jbc.271.52.33242; Price MN, 2007, PLOS COMPUT BIOL, V3, P1739, DOI 10.1371/journal.pcbi.0030175; RASMUSSEN PB, 1993, NUCLEIC ACIDS RES, V21, P879, DOI 10.1093/nar/21.4.879; Rasmussen PB, 1996, P NATL ACAD SCI USA, V93, P10151, DOI 10.1073/pnas.93.19.10151; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; SEEGER C, 1995, J BACTERIOL, V177, P5506, DOI 10.1128/jb.177.19.5506-5516.1995; SINGER JT, 1985, J BACTERIOL, V163, P1095, DOI 10.1128/JB.163.3.1095-1100.1985; SOGAARDANDERSEN L, 1993, CELL, V75, P557, DOI 10.1016/0092-8674(93)90389-8; SOGAARDANDERSEN L, 1991, P NATL ACAD SCI USA, V88, P4921, DOI 10.1073/pnas.88.11.4921; SOGAARDANDERSEN L, 1991, MOL MICROBIOL, V5, P969, DOI 10.1111/j.1365-2958.1991.tb00772.x; SOGAARDANDERSEN L, 1990, MOL MICROBIOL, V4, P1595, DOI 10.1111/j.1365-2958.1990.tb02071.x; SOGAARDANDERSEN L, 1990, J BACTERIOL, V172, P5706, DOI 10.1128/jb.172.10.5706-5713.1990; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomsen LE, 1999, J MOL BIOL, V288, P165, DOI 10.1006/jmbi.1999.2668; Tretyachenko-Ladokhina V, 2002, J MOL BIOL, V316, P531, DOI 10.1006/jmbi.2001.5302; Tretyachenko-Ladokhina V, 2006, J MOL BIOL, V362, P271, DOI 10.1016/j.jmb.2006.06.085; ValentinHansen P, 1996, MOL MICROBIOL, V20, P461, DOI 10.1046/j.1365-2958.1996.5341056.x; VALENTINHANSEN P, 1986, NUCLEIC ACIDS RES, V14, P2215, DOI 10.1093/nar/14.5.2215; WEICKERT MJ, 1992, J BIOL CHEM, V267, P15869; ZHANG YB, 1992, J BACTERIOL, V174, P5758, DOI 10.1128/JB.174.17.5758-5759.1992; Zheng DL, 2004, NUCLEIC ACIDS RES, V32, P5874, DOI 10.1093/nar/gkh908; Zolotukhina M, 2003, RES MICROBIOL, V154, P510, DOI 10.1016/S0923-2508(03)00125-6	55	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e44194	10.1371/journal.pone.0044194	http://dx.doi.org/10.1371/journal.pone.0044194			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028500	Green Submitted, Green Published, gold			2022-12-27	WOS:000309554700009
J	Osi, A; Prondvai, E; Butler, R; Weishampel, DB				Osi, Attila; Prondvai, Edina; Butler, Richard; Weishampel, David B.			Phylogeny, Histology and Inferred Body Size Evolution in a New Rhabdodontid Dinosaur from the Late Cretaceous of Hungary	PLOS ONE			English	Article							ORNITHOPOD DINOSAURIA; BONE MICROSTRUCTURE; ORNITHISCHIA; OSTEOLOGY; REMAINS; ISLAND; RULE	Background: Rhabdodontid ornithopod dinosaurs are characteristic elements of Late Cretaceous European vertebrate faunas and were previously collected from lower Campanian to Maastrichtian continental deposits. Phylogenetic analyses have placed rhabdodontids among basal ornithopods as the sister taxon to the clade consisting of Tenontosaurus, Dryosaurus, Camptosaurus, and Iguanodon. Recent studies considered Zalmoxes, the best known representative of the clade, to be significantly smaller than closely related ornithopods such as Tenontosaurus, Camptosaurus, or Rhabdodon, and concluded that it was probably an island dwarf that inhabited the Maastrichtian Hat, eg Island. Methodology/Principal Findings: Rhabdodontid remains from the Santonian of western Hungary provide evidence for a new, small-bodied form, which we assign to Mochlodon vorosi n. sp. The new species is most similar to the early Campanian M. suessi from Austria, and the close affinities of the two species is further supported by the results of a global phylogenetic analysis of ornithischian dinosaurs. Bone histological studies of representatives of all rhabdodontids indicate a similar adult body length of 1.6-1.8 m in the Hungarian and Austrian species, 2.4-2.5 m in the subadults of both Zalmoxes robustus and Z. shqiperorum and a much larger, 5-6 m adult body length in Rhabdodon. Phylogenetic mapping of femoral lengths onto the results of the phylogenetic analysis suggests a femoral length of around 340 mm as the ancestral state for Rhabdodontidae, close to the adult femoral lengths known for Zalmoxes (320-333 mm). Conclusions/Significance: Our analysis of body size evolution does not support the hypothesis of autapomorhic nanism for Zalmoxes. However, Rhabdodon is reconstructed as having undergone autapomorphic giantism and the reconstructed small femoral length (245 mm) of Mochlodon is consistent with a reduction in size relative to the ancestral rhabdodontid condition. Our results imply a pre-Santonian divergence between western and eastern rhabdodontid lineages within the western Tethyan archipelago.	[Osi, Attila; Prondvai, Edina] Eotvos Lorand Univ, Hungarian Acad Sci, Lendulet Dinosaur Res Grp, Budapest, Hungary; [Butler, Richard] Univ Munich, GeoBio Ctr, Munich, Germany; [Weishampel, David B.] Johns Hopkins Univ, Ctr Funct Anat & Evolut, Baltimore, MD USA	Eotvos Lorand University; Hungarian Academy of Sciences; University of Munich; Johns Hopkins University	Osi, A (corresponding author), Eotvos Lorand Univ, Hungarian Acad Sci, Lendulet Dinosaur Res Grp, Budapest, Hungary.	hungaros@gmail.com	Butler, Richard J./A-5239-2011; Ősi, Attila/K-2414-2018; Prondvai, Edina/I-3178-2019	Butler, Richard J./0000-0003-2136-7541; Ősi, Attila/0000-0003-2967-997X; Prondvai, Edina/0000-0002-1284-8311	MTA-ELTE Lendulet Dinosaur Research Group [95102]; Hungarian Scientific Research Fund [OTKA T-38045, PD 73021, NF 84193]; National Geographic Society [7228-02, 7508-03]; Bolyai Fellowship; Hungarian Natural History Museum; Eotvos Lorand University; Jurassic Foundation; Hantken Foundation; Hungarian Oil and Gas Company (MOL); Alexander von Humboldt Postdoctoral Research Fellowship; German Research Foundation Emmy Noether Programme [BU 2587/3-1]	MTA-ELTE Lendulet Dinosaur Research Group; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Geographic Society(National Geographic Society); Bolyai Fellowship(Hungarian Academy of Sciences); Hungarian Natural History Museum; Eotvos Lorand University; Jurassic Foundation; Hantken Foundation; Hungarian Oil and Gas Company (MOL); Alexander von Humboldt Postdoctoral Research Fellowship(Alexander von Humboldt Foundation); German Research Foundation Emmy Noether Programme(German Research Foundation (DFG))	Field and laboratory work was supported by the MTA-ELTE Lendulet Dinosaur Research Group (Grant no. 95102), Hungarian Scientific Research Fund (OTKA T-38045, PD 73021, NF 84193), National Geographic Society (Grant No. 7228-02, 7508-03), Bolyai Fellowship (O. A.), Hungarian Natural History Museum, Eotvos Lorand University, Jurassic Foundation, Hantken Foundation, and the Hungarian Oil and Gas Company (MOL). RJB was supported during the completion of this research by an Alexander von Humboldt Postdoctoral Research Fellowship and the German Research Foundation Emmy Noether Programme (BU 2587/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain R, 2003, CR PALEVOL, V2, P27, DOI 10.1016/S1631-0683(03)00002-2; Barrett PM, 2011, SPEC PAP PALAEONTOL, P131, DOI 10.1111/j.1475-4983.2011.01076.x; Benton MJ, 2010, PALAEOGEOGR PALAEOCL, V293, P438, DOI 10.1016/j.palaeo.2010.01.026; Brinkmann W, 1988, DOCUMENTA NATURAE, V45, P1; BUFFETAUT E, 1991, CR ACAD SCI II, V312, P943; Buffetaut E., 1996, NEUES JB GEOLOGIE PA, V1, P1; Buffetaut Eric, 1993, Modern Geology, V18, P161; Bunzel E., 1871, ABHANDLUNGEN KAISERL, V5, P1; Butler RJ, 2011, PALAEONTOLOGY, V54, P667, DOI 10.1111/j.1475-4983.2011.01046.x; Carpenter K, 2008, ANN CARNEGIE MUS, V76, P227, DOI 10.2992/0097-4463(2008)76[227:ANSOCO]2.0.CO;2; Carrano Matthew T., 2006, P225; CASE TJ, 1993, OECOLOGIA, V94, P102, DOI 10.1007/BF00317309; Cerda IA, 2012, J VERTEBR PALEONTOL, V32, P355, DOI 10.1080/02724634.2012.646804; Chanthasit P., 2010, THESIS U CLAUDE BERN; Codrea V, 2010, PALAEOGEOGR PALAEOCL, V293, P391, DOI 10.1016/j.palaeo.2009.10.027; Company J., 2004, THESIS U VALENCIA VA; Cubo J, 2005, SYST BIOL, V54, P562, DOI 10.1080/10635150591003461; DiCroce Tony, 2001, P183; Fejfar O, 2005, ACTA PALAEONTOL POL, V50, P295; GALTON P M, 1980, Palaeontology (Oxford), V23, P411; Galton P.M., 1983, Geologica et Palaeontologica, V17, P207; Galton Peter M., 2009, Revue de Paleobiologie, V28, P211; Galton PM., 1974, B BRIT MUS NAT HIS A, V25, P1; Garcia G, 1999, CR ACAD SCI II A, V328, P415, DOI 10.1016/S1251-8050(99)80108-6; Godefroit P, 2009, GEODIVERSITAS, V31, P525, DOI 10.5252/g2009n3a3; Goloboff PA, 2008, CLADISTICS, V24, P758, DOI 10.1111/j.1096-0031.2008.00209.x; Gould GC, 2004, B AM MUS NAT HIST, P219; Han F-L, 2012, J VERT PALE IN PRESS; Holliday CM, 2007, J MORPHOL, V268, P457, DOI 10.1002/jmor.10524; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Horner JR, 2009, J VERTEBR PALEONTOL, V29, P734, DOI 10.1671/039.029.0312; Hubner TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029958; Irmis Randall B., 2007, Historical Biology, V19, P3, DOI 10.1080/08912960600719988; Jianu C.-M., 1994, SARGETIA, V16, P29; Knauer J, 1992, ANN REPORT HUNGARIAN, V1990, P463; Lapparent A. F.de., 1947, Memoires de la Societe Geologique de France Paleontologie, V56, P1; Makovicky PJ, 2011, J VERTEBR PALEONTOL, V31, P626, DOI 10.1080/02724634.2011.557114; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Matheron P, 1869, MEMOIRES ACAD IMPERI, V1868, P345; Matheron P, 1892, C R ASS FRANC AVANC, V20, P382; Mcdonald AT, 2010, ZOOTAXA, P1; McDonald AT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036745; Millien V, 2006, PLOS BIOL, V4, P1863, DOI 10.1371/journal.pbio.0040321; Neraudeau D, 2003, C R PALEVOL, V2, P221, DOI 10.1016/S1631-0683(03)00032-0; NEWTON ET, 1892, GEOLOGICAL MAGAZINE, V9, P49; Nopcsa F., 1902, Denkschriften der Akademie Wien, Vlxxii, P149; Nopcsa F., 1904, Denkschriften der Akademie Wien, Vlxxiv, P229; Nopcsa F., 1923, Quarterly Journal of the Geological Society of London, V79, P100; Nopcsa F., 1914, VERHANDLUNGEN ZOOLOG, V54, P12; Nopcsa F., 1925, PALAEONT HUNG, V1, P273; Nopcsa F., 1915, MITTEILUNGEN JAHRBUC, V23, P3; Novas FE, 2004, AMEGHINIANA, V41, P75; Osi A, 2004, GEOBIOS-LYON, V37, P749, DOI 10.1016/j.geobios.2003.06.005; Osi A, 2009, CRETACEOUS SEDIMENTS, P51; Osi A, 2012, BERNISSART IN PRESS; Palombo MR, 2011, TERRA DELGLI ELEFANT, P479; Pereda Suberbiola Xabier, 1999, Estudios del Museo de Ciencias Naturales de Alava, V14, P257; Pincemaille M, 1997, ORNITHOPODE CRETACE; Pincemaille-Quillevere M, 2006, B SOC GEOL FR, V177, P97, DOI 10.2113/gssgfbull.177.2.97; Pincemaille-Quillevere Marie, 2002, Oryctos, V4, P39; Prondvai E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031392; Ruiz-Omenaca Jose Ignacio, 2007, P3; Sachs S, 2006, GEOBIOS-LYON, V39, P415, DOI 10.1016/j.geobios.2005.01.003; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Sander PM, 2005, SCIENCE, V310, P1800, DOI 10.1126/science.1120125; Scheetz R.D., 1999, THESIS MONTANA STATE; Seeley H.G., 1881, Q J GEOLOGICAL SOC, V37, P620, DOI [DOI 10.1144/GSL.JGS.1881.037.01-04.49, 10.1144/GSL.JGS.1881.037.01-04.49]; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno P. C, 2005, STEM ARCHOSAURIA VER; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Steel R, 1969, HDB PALAOHERPETOLOGI, V15, P1; Stein K., 2009, METHODS FOSSIL PREPA, P69; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Tuba Gy, 2006, FOLDTANI KOZLONY, V136, P1; Weishampel David B., 2003, Journal of Systematic Palaeontology, V1, P65, DOI 10.1017/S1477201903001032; Weishampel DB, 2010, PALAEOGEOGR PALAEOCL, V293, P419, DOI 10.1016/j.palaeo.2010.03.024; Weishampel DB, 2011, TRANSYLVANIAN DINOSAURS, P1; Wells N.A., 1989, Paleontological Society Special Publication, P120; Winkler DA, 1997, J VERTEBR PALEONTOL, V17, P330, DOI 10.1080/02724634.1997.10010978	79	58	62	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44318	10.1371/journal.pone.0044318	http://dx.doi.org/10.1371/journal.pone.0044318			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028518	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000309392800005
J	Jian, WS; Hsu, MH; Sukati, H; Syed-Abdul, S; Scholl, J; Dube, N; Hsu, CK; Wu, TJ; Lin, V; Chi, T; Chang, P; Li, YC				Jian, Wen-Shan; Hsu, Min-Huei; Sukati, Hosea; Syed-Abdul, Shabbir; Scholl, Jeremiah; Dube, Nduduzo; Hsu, Chun-Kung; Wu, Tai-jung; Lin, Vera; Chi, Tex; Chang, Peter; Li, Yu-Chuan			LabPush: A Pilot Study of Providing Remote Clinics with Laboratory Results via Short Message Service (SMS) in Swaziland, Africa	PLOS ONE			English	Article							INFORMATION-SYSTEMS; DESIGN	Background: Turnaround time (TAT) is an important indicator of laboratory performance. It is often difficult to achieve fast TAT for blood tests conducted at clinics in developing countries. This is because clinics where the patient is treated are often far away from the laboratory, and transporting blood samples and test results between the two locations creates significant delay. Recent efforts have sought to mitigate this problem by using Short Message Service (SMS) to reduce TAT. Studies reporting the impact of this technique have not been published in scientific literature however. In this paper we present a study of LabPush, a system developed to test whether SMS delivery of HIV related laboratory results to clinics could shorten TAT time significantly. Method: LapPush was implemented in six clinics of the Kingdom of Swaziland. SMS results were sent out from the laboratory as a supplement to normal transport of paper results. Each clinic was equipped with a mobile phone to receive SMS results. The laboratory that processes the blood tests was equipped with a system for digital input of results, and transmission of results via SMS to the clinics. Results: Laboratory results were received for 1041 different clinical cases. The total number of SMS records received (1032) was higher than that of paper records (965), indicating a higher loss rate for paper records. A statistical comparison of TAT for SMS and paper reports indicates a statistically significant improvement for SMS. Results were more positive for more rural clinics, and an urban clinic with high workload. Conclusion: SMS can be used to reduce TAT for blood tests taken at clinics in developing countries. Benefits are likely to be greater at clinics that are further away from laboratories, due to the difficulties this imposes on transport of paper records.	[Chang, Peter] Taipei Med Univ & Hosp, Taipei, Taiwan; [Jian, Wen-Shan] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Hsu, Min-Huei; Syed-Abdul, Shabbir; Hsu, Chun-Kung; Wu, Tai-jung; Chi, Tex; Li, Yu-Chuan] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Biomed Informat, Taipei, Taiwan; [Sukati, Hosea] Natl Blood Programme, Manzini, Swaziland; [Sukati, Hosea] Natl Clin Labs, Manzini, Swaziland; [Syed-Abdul, Shabbir] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Scholl, Jeremiah] Karolinska Inst, Hlth Informat Ctr, Stockholm, Sweden; [Dube, Nduduzo] AIDS Healtcare Fdn, Manzini, Swaziland; [Lin, Vera] Taipei Med Univ, Int Off, Taipei, Taiwan; [Hsu, Min-Huei] Taipei Hosp, Dept Hlth, Taipei, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; National Yang Ming Chiao Tung University; Karolinska Institutet; Taipei Medical University	Chang, P (corresponding author), Taipei Med Univ & Hosp, Taipei, Taiwan.	peterchang@tmu.edu.tw; jaak88@gmail.com	Syed Abdul, Shabbir/AAI-2322-2020; li, JACK/HHC-6755-2022; Chi, Tex/I-9129-2012	Syed Abdul, Shabbir/0000-0002-0412-767X; Jian, Wen-Shan/0000-0002-1739-4398; Li, Yu-Chuan (Jack)/0000-0001-6497-4232; Chi, Tex/0000-0002-4476-2600	National Science Council (NSC), Taiwan [NSC100-2622-E-038-001-CC2(1/2), NSC99-2511-S-038-005-MY3, NSC 100-2320-B-038 -034, NSC 100-2325-B-038 -006]; Department of Health, Executive Yuan, Taiwan [DOH101-TD -C-111-008]; Taipei Medical University [A0051-4100]	National Science Council (NSC), Taiwan(Ministry of Science and Technology, Taiwan); Department of Health, Executive Yuan, Taiwan; Taipei Medical University	This research is sponsored in part by National Science Council (NSC), Taiwan, under grants NSC100-2622-E-038-001-CC2(1/2), NSC99-2511-S-038-005-MY3, NSC 100-2320-B-038 -034 and NSC 100-2325-B-038 -006; by Department of Health, Executive Yuan, Taiwan under grant DOH101-TD -C-111-008; and by Taipei Medical University under grant A0051-4100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], SWAZ COUNTR COOP STR; Audit Commission, 1993, CRIT PATH AN PATH SE, P9; Berg M, 2001, INT J MED INFORM, V64, P143, DOI 10.1016/S1386-5056(01)00200-3; Buys P, 2009, WORLD DEV, V37, P1494, DOI 10.1016/j.worlddev.2009.01.011; Chetty M, 2004, P S AFR TEL NETW APP, P239; Deglise C, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1823; Essajee S, 2011, FAST TRACKING INFANT; Fall K, 2003, ACM SIGCOMM COMP COM, V33, P27; HANDORF CR, 1995, ARCH PATHOL LAB MED, V119, P867; Hasvold PE, 2011, INT J MED INFORM, V80, P631, DOI 10.1016/j.ijmedinf.2011.06.007; Hasvold PE, 2011, INT J MED INFORM, V80, DOI 10.1016/j.ijmedinf.2011.01.006; Hawkins Robert C, 2007, Clin Biochem Rev, V28, P179; Howanitz JH, 2001, AM J CLIN PATHOL, V116, P311, DOI 10.1309/H0DY-6VTW-NB36-U3L6; Lindgren A., 2008, P 2008 ACM WORKSH WI, P1, DOI DOI 10.1145/1410064.1410066; Neuberger J, 1996, CLIN CHIM ACTA, V248, P11, DOI 10.1016/0009-8981(95)06262-9; Nkengasong NJ, 2010, CHALLENGES DEV LAB C; Scholl J, 2011, J BIOMED INFORM, V44, P958, DOI 10.1016/j.jbi.2011.07.008; Sjoberg C, 1998, J AM MED INFORM ASSN, V5, P177, DOI 10.1136/jamia.1998.0050177; Sorensen T, 2008, J TELEMED TELECARE, V14, P37, DOI 10.1258/jtt.2007.070502; Syed-Abdul S, 2012, COMPUT METH PROG BIO, V107, P557, DOI 10.1016/j.cmpb.2011.11.004; Uba SA, 2011, SMS PRINT PIL PROGR; Wakabi W, 2010, LANCET, V376, P943, DOI 10.1016/S0140-6736(10)61435-3; Zurovac D, 2011, LANCET, V378, P795, DOI 10.1016/S0140-6736(11)60783-6	23	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44462	10.1371/journal.pone.0044462	http://dx.doi.org/10.1371/journal.pone.0044462			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028543	Green Submitted, gold, Green Published			2022-12-27	WOS:000309388400026
J	Coppe, A; Bortoluzzi, S; Murari, G; Marino, IAM; Zane, L; Papetti, C				Coppe, Alessandro; Bortoluzzi, Stefania; Murari, Giulia; Marino, Ilaria Anna Maria; Zane, Lorenzo; Papetti, Chiara			Sequencing and Characterization of Striped Venus Transcriptome Expand Resources for Clam Fishery Genetics	PLOS ONE			English	Article							CHAMELEA-GALLINA; ADRIATIC SEA; SSR-MARKERS; ANNOTATION; ASSEMBLER; SOFTWARE; GENOMICS; MOLLUSK	Background: The striped venus Chamelea gallina clam fishery is among the oldest and the largest in the Mediterranean Sea, particularly in the inshore waters of northern Adriatic Sea. The high fishing pressure has lead to a strong stock abundance decline, enhanced by several irregular mortality events. The nearly complete lack of molecular characterization limits the available genetic resources for C. gallina. We achieved the first transcriptome of this species with the aim of identifying an informative set of expressed genes, potential markers to assess genetic structure of natural populations and molecular resources for pathogenic contamination detection. Methodology/Principal Findings: The 454-pyrosequencing of a normalized cDNA library of a pool C. gallina adult individuals yielded 298,494 raw reads. Different steps of reads assembly and filtering produced 36,422 contigs of high quality, one half of which (18,196) were annotated by similarity. A total of 111 microsatellites and 20,377 putative SNPs were identified. A panel of 13 polymorphic transcript-linked microsatellites was developed and their variability assessed in 12 individuals. Remarkably, a scan to search for contamination sequences of infectious origin indicated the presence of several Vibrionales species reported to be among the most frequent clam pathogen's species. Results reported in this study were included in a dedicated database available at http://compgen.bio.unipd.it/chameleabase. Conclusions/Significance: This study represents the first attempt to sequence and de novo annotate the transcriptome of the clam C. gallina. The availability of this transcriptome opens new perspectives in the study of biochemical and physiological role of gene products and their responses to large and small-scale environmental stress in C. gallina, with high throughput experiments such as custom microarray or targeted re-sequencing. Molecular markers, such as the already optimized EST-linked microsatellites and the discovered SNPs will be useful to estimate effects of demographic processes and to detect minute levels of population structuring.	[Coppe, Alessandro; Bortoluzzi, Stefania; Murari, Giulia; Marino, Ilaria Anna Maria; Zane, Lorenzo; Papetti, Chiara] Univ Padua, Dept Biol, Padua, Italy	University of Padua	Zane, L (corresponding author), Univ Padua, Dept Biol, Via G Colombo, Padua, Italy.	lorenzo.zane@unipd.it	Zane, Lorenzo/G-6249-2010; Bortoluzzi, Stefania/G-8211-2011	Zane, Lorenzo/0000-0002-6963-2132; Bortoluzzi, Stefania/0000-0001-8240-3070; Papetti, Chiara/0000-0002-4567-459X	Veneto Region (Italy) [4069]; University of Padova [GRIC11Z79P, GRIC110B82, CPDA110183]	Veneto Region (Italy); University of Padova	This work was part of the project CLODIA funded by the Veneto Region (Italy) Law 15/2007 (DGR n. 4069) to Mariella Rasotto and LZ. AC, CP and IAMM are post-doctorate fellows supported by University of Padova salary grants GRIC11Z79P, GRIC110B82 and by University of Padova research grant CPDA110183, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amos W, 2007, MOL ECOL NOTES, V7, P10, DOI 10.1111/j.1471-8286.2006.01560.x; BACKELJAU T, 1994, J MAR BIOL ASSOC UK, V74, P211, DOI 10.1017/S0025315400035773; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Chodroff RA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r72; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Clark MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-362; Colakoglu FA, 2011, BIOL TRACE ELEM RES, V143, P983, DOI 10.1007/s12011-010-8943-3; Coombs JA, 2008, MOL ECOL RESOUR, V8, P578, DOI 10.1111/j.1471-8286.2007.02036.x; Coppe A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-635; Dame R.F., 2011, ECOLOGY MARINE BIVAL; EGGLETON JD, 2007, STRUCTURE DYNAMICS N, P91; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Feldmeyer B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-317; Feng ZP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-451; Fleury E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-341; Franchini Paolo, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-59; Froglia C., 1989, MARINE INVERTEBRATE; Garrison, 2010, FREEBAYES; Giangaspero A, 2005, PREV VET MED, V69, P203, DOI 10.1016/j.prevetmed.2005.02.006; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Gosling E, 2003, BIVALVE MOLLUSCS BIO; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Henry JQ, 2010, INTEGR COMP BIOL, V50, P707, DOI 10.1093/icb/icq076; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Hu ZL, 2008, ONLINE J BIOINFORMAT, V9, P108, DOI DOI 10.1186/1471-2105-13-134; Huvet A, 2012, MAR BIOTECHNOL, V14, P402, DOI 10.1007/s10126-011-9421-4; Kalendar R., 2009, GENES GENOMES GENOMI, V3, P1; Kocot KM, 2011, NATURE, V477, P452, DOI 10.1038/nature10382; Milan M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-234; Moran VA, 2012, NUCL ACIDS RES; Moreira R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035009; Morello EB, 2005, FISH RES, V76, P430, DOI 10.1016/j.fishres.2005.07.002; Roldan EM, 2011, J FOOD SAFETY, V31, P257, DOI 10.1111/j.1745-4565.2010.00294.x; Moschino V, 2006, COMP BIOCHEM PHYS A, V145, P433, DOI 10.1016/j.cbpa.2006.07.021; Munoz P, 2006, FISH SHELLFISH IMMUN, V20, P12, DOI 10.1016/j.fsi.2005.02.002; Nielsen EE, 2009, MOL ECOL, V18, P3128, DOI 10.1111/j.1365-294X.2009.04272.x; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; PATWARY MU, 1994, J SHELLFISH RES, V13, P547; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Romanelli M, 2009, ACTA ADRIAT, V50, P171; Tanguy A, 2008, GENE, V408, P27, DOI 10.1016/j.gene.2007.10.021; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Torresi M, 2011, VET ITAL, V47, P371; Traversa D, 2004, APPL ENVIRON MICROB, V70, P4367, DOI 10.1128/AEM.70.7.4367-4370.2004; Trevisan R, 2012, AQUAT TOXICOL, V108, P85, DOI 10.1016/j.aquatox.2011.09.023; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang HX, 2011, GENES GENET SYST, V86, P197, DOI 10.1266/ggs.86.197; Wenne R, 2007, AQUAT LIVING RESOUR, V20, P241, DOI 10.1051/alr:2007037; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031	52	21	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44185	10.1371/journal.pone.0044185	http://dx.doi.org/10.1371/journal.pone.0044185			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028497	gold, Green Submitted, Green Published			2022-12-27	WOS:000311313900014
J	Rui, R; Lou, J; Zou, L; Zhong, R; Wang, J; Xia, D; Wang, Q; Li, H; Wu, J; Lu, XZ; Li, CQ; Liu, L; Xia, JH; Xu, H				Rui, Rui; Lou, Jiao; Zou, Li; Zhong, Rong; Wang, Ji; Xia, Ding; Wang, Qi; Li, Heng; Wu, Jing; Lu, Xuzai; Li, Chuanqi; Liu, Li; Xia, Jiahong; Xu, Hua			Excess Body Mass Index and Risk of Liver Cancer: A Nonlinear Dose-Response Meta-Analysis of Prospective Studies	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; DIABETES-MELLITUS; SEX-HORMONES; KOREAN MEN; OBESITY; CIRRHOSIS; COHORT; OVERWEIGHT; NUTRITION; MORTALITY	Background: Excess body weight measured as body mass index (BMI) has a positive association with risk of common cancers. However, previous meta-analyses related to BMI and liver cancer had inconsistent results. The purpose of the current study is to establish a nonlinear dose-response relationship between BMI and incidence risk of liver cancer. Methods: A systematic literature search for relevant articles published from 1966 to November 2011 was conducted in PUBMED and EMBASE digital databases. Additional articles were manually searched by using the reference lists of identified papers. Restricted cubic splines and generalized least-squares regression methods were used to model a potential curvilinear relationship and to make a dose-response meta-analysis. Stratified analysis, sensitivity analysis and assessment of bias were performed in our meta-analysis. Results: 8 articles including 1,779,471 cohort individuals were brought into meta-analysis. A non-linear dose-response association between BMI and risk of liver cancer was visually significant (P for nonlinearity<0.001), besides, the point value of BMI also enhanced the results quantitatively, where relative risks were 1.02 (95% CI = 1.02-1.03), 1.35 (95% CI = 1.24-1.47) and 2.22-fold (95% CI = 1.74-2.83) when BMI was at the point of 25, 30 and 35 kg/m(2) compared with reference (the median value of the lowest category), respectively. The ethnicity of the population was found as the main source of heterogeneity. In subsequent stratified analysis, no evidence of heterogeneity was showed in Asian and White populations (P for heterogeneity>0.1), and all value of BMI still presented significantly increased risk of cancer. Conclusions: The findings from meta-analysis provided that excess BMI had significant increased association with risk of liver cancer, although the biological mechanisms underlying the obesity-cancer link still need to be clarified.	[Rui, Rui; Xia, Ding; Wang, Qi; Li, Heng; Xu, Hua] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Urol, Wuhan 430074, Peoples R China; [Rui, Rui; Lou, Jiao; Zou, Li; Zhong, Rong; Wu, Jing; Lu, Xuzai] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Rui, Rui; Lou, Jiao; Zou, Li; Zhong, Rong; Wu, Jing; Lu, Xuzai] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE Key Lab Environm & Hlth, Wuhan 430074, Peoples R China; [Wang, Ji] Univ Calif San Francisco, Dept Urol, San Francisco, CA USA; [Wang, Ji] Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Li, Chuanqi] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Med & Hlth Management, Wuhan 430074, Peoples R China; [Liu, Li] Guangdong Pharmaceut Univ, Guangdong Key Lab Mol Epidemiol, Guangzhou, Guangdong, Peoples R China; [Liu, Li] Guangdong Pharmaceut Univ, Dept Epidemiol & Biostat, Guangzhou, Guangdong, Peoples R China; [Xia, Jiahong] Huazhong Univ Sci & Technol, Dept Cardiovasc Surg, Union Hosp, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Huazhong University of Science & Technology; Guangdong Pharmaceutical University; Guangdong Pharmaceutical University; Huazhong University of Science & Technology	Xu, H (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Urol, Wuhan 430074, Peoples R China.	xuhuawhu@163.com			fundamental research funds for Huazhong University of Science and Technology (HUST) [2011TS019]	fundamental research funds for Huazhong University of Science and Technology (HUST)	This work was supported by fundamental research funds for Huazhong University of Science and Technology (HUST: NO. 2011TS019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aune D, 2012, ANN ONCOL, V23, P843, DOI 10.1093/annonc/mdr398; Aune D., 2011, ANN ONCOL; Batty GD, 2005, INT J OBESITY, V29, P1267, DOI 10.1038/sj.ijo.0803020; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chen CL, 2008, GASTROENTEROLOGY, V135, P111, DOI 10.1053/j.gastro.2008.03.073; Chen Y, 2012, EUR J CANC; Chuang SC, 2009, CANCER LETT, V286, P9, DOI 10.1016/j.canlet.2008.10.040; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Gao C, 2009, HEPATOB PANCREAT DIS, V8, P465; Garcia-Compean D, 2009, WORLD J GASTROENTERO, V15, P280, DOI 10.3748/wjg.15.280; Giovannucci E, 2003, HORM METAB RES, V35, P694, DOI 10.1055/s-2004-814147; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; Hart CL, 2010, INT J OBESITY, V34, P1051, DOI 10.1038/ijo.2010.20; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ioannou GN, 2007, CLIN GASTROENTEROL H, V5, P938, DOI 10.1016/j.cgh.2007.02.039; Jee SH, 2008, INT J CANCER, V123, P1892, DOI 10.1002/ijc.23719; Jenks S, 2010, J NATL CANCER I, V102, P519, DOI 10.1093/jnci/djq147; Joshi S, 2008, PUBLIC HEALTH, V122, P1144, DOI 10.1016/j.puhe.2008.04.003; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kuriyama S, 2005, INT J CANCER, V113, P148, DOI 10.1002/ijc.20529; Larsson SC, 2007, BRIT J CANCER, V97, P1005, DOI 10.1038/sj.bjc.6603932; Larsson SC, 2011, AM J EPIDEMIOL, V174, P993, DOI 10.1093/aje/kwr226; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; McGlynn KA, 2005, BEST PRACT RES CL GA, V19, P3, DOI 10.1016/j.bpg.2004.10.004; MOLLER H, 1994, EUR J CANCER, V30A, P344, DOI 10.1016/0959-8049(94)90254-2; N'Kontchou G, 2006, CLIN GASTROENTEROL H, V4, P1062, DOI 10.1016/j.cgh.2006.05.013; Nair S, 2002, HEPATOLOGY, V36, P150, DOI 10.1053/jhep.2002.33713; Oh SW, 2005, J CLIN ONCOL, V23, P4742, DOI 10.1200/JCO.2005.11.726; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Orsini N, 2011, STATA J, V11, P1; Parr CL, 2010, LANCET ONCOL, V11, P741, DOI 10.1016/S1470-2045(10)70141-8; Pischon T, 2006, J NATL CANCER I, V98, P920, DOI 10.1093/jnci/djj246; Polesel J, 2009, ANN ONCOL, V20, P353, DOI 10.1093/annonc/mdn565; Rapp K, 2005, BRIT J CANCER, V93, P1062, DOI 10.1038/sj.bjc.6602819; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Samanic C, 2004, CANCER CAUSE CONTROL, V15, P35, DOI 10.1023/B:CACO.0000016573.79453.ba; Samanic C, 2006, CANCER CAUSE CONTROL, V17, P901, DOI 10.1007/s10552-006-0023-9; Takamatsu S, 2008, HEPATO-GASTROENTEROL, V55, P609; Tobias A., 1999, STATA TECHNICAL B, V8, P15; Toffanin S, 2010, CANCER CELL, V17, P115, DOI 10.1016/j.ccr.2010.01.018; Wang CS, 2009, CANCER EPIDEM BIOMAR, V18, P2054, DOI 10.1158/1055-9965.EPI-08-1131; Wiseman M, 2008, P NUTR SOC, V67, P253, DOI 10.1017/S002966510800712X; Wolk A, 2001, CANCER CAUSE CONTROL, V12, P13, DOI 10.1023/A:1008995217664; Yan SQ, 2001, CANCER RES, V61, P5016; Yeh SH, 2010, ONCOLOGY-BASEL, V78, P172, DOI 10.1159/000315247; Yu MW, 2008, J CLIN ONCOL, V26, P5576, DOI 10.1200/JCO.2008.16.1075	51	27	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44522	10.1371/journal.pone.0044522	http://dx.doi.org/10.1371/journal.pone.0044522			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028553	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900029
J	Steffener, J; Habeck, CG; Stern, Y				Steffener, Jason; Habeck, Christian G.; Stern, Yaakov			Age-Related Changes in Task Related Functional Network Connectivity	PLOS ONE			English	Article							EVENT-RELATED FMRI; INDEPENDENT COMPONENT ANALYSIS; VERBAL WORKING-MEMORY; DEFAULT MODE; TIME-SERIES; HUMAN BRAIN; BLOOD-FLOW; MRI DATA; ACTIVATION; MAINTENANCE	Aging has a multi-faceted impact on brain structure, brain function and cognitive task performance, but the interaction of these different age-related changes is largely unexplored. We hypothesize that age-related structural changes alter the functional connectivity within the brain, resulting in altered task performance during cognitive challenges. In this neuroimaging study, we used independent components analysis to identify spatial patterns of coordinated functional activity involved in the performance of a verbal delayed item recognition task from 75 healthy young and 37 healthy old adults. Strength of functional connectivity between spatial components was assessed for age group differences and related to speeded task performance. We then assessed whether age-related differences in global brain volume were associated with age-related differences in functional network connectivity. Both age groups used a series of spatial components during the verbal working memory task and the strength and distribution of functional network connectivity between these components differed across the age groups. Poorer task performance, i.e. slower speed with increasing memory load, in the old adults was associated with decreases in functional network connectivity between components comprised of the supplementary motor area and the middle cingulate and between the precuneus and the middle/superior frontal cortex. Advancing age also led to decreased brain volume; however, there was no evidence to support the hypothesis that age-related alterations in functional network connectivity were the result of global brain volume changes. These results suggest that age-related differences in the coordination of neural activity between brain regions partially underlie differences in cognitive performance.	[Steffener, Jason] Columbia Univ Coll Phys & Surg, Dept Neurol, Cognit Neurosci Div, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA	Columbia University; Columbia University	Steffener, J (corresponding author), Columbia Univ Coll Phys & Surg, Dept Neurol, Cognit Neurosci Div, New York, NY 10032 USA.	js2746@columbia.edu		Stern, Yaakov/0000-0001-7542-3241	National Institute of Aging grant [5R01AG026158-5, 1K01AG035061]; NATIONAL INSTITUTE ON AGING [R01AG026158, K01AG035061] Funding Source: NIH RePORTER	National Institute of Aging grant; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institute of Aging grant 5R01AG026158-5 (to Y.S.) and National Institute of Aging grant 1K01AG035061 (to J.S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EA, 2011, NEURO IMAGE IN PRESS; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Altamura M, 2007, PSYCHIAT RES-NEUROIM, V154, P103, DOI 10.1016/j.pscychresns.2006.08.002; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Barch DM, 1997, NEUROPSYCHOLOGIA, V35, P1373, DOI 10.1016/S0028-3932(97)00072-9; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Blumen HM, 2011, BEHAV BRAIN RES, V224, P397, DOI 10.1016/j.bbr.2011.06.004; Bonchev Danail, 2005, P191; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Calhoun VD, 2001, NEUROIMAGE, V14, P1080, DOI 10.1006/nimg.2001.0921; Calhoun VD, 2001, HUM BRAIN MAPP, V13, P43, DOI 10.1002/hbm.1024; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Chang C, 2010, FILM COMMENT, V46, P81; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Fotenos AF, 2005, NEUROLOGY, V64, P1032, DOI 10.1212/01.WNL.0000154530.72969.11; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Grady CL, 1998, NEUROIMAGE, V8, P409, DOI 10.1006/nimg.1998.0376; Grinband J, 2008, NEUROIMAGE, V43, P509, DOI 10.1016/j.neuroimage.2008.07.065; Habeck C, 2005, NEURAL COMPUT, V17, P1602, DOI 10.1162/0899766053723023; Habeck C, 2005, COGNITIVE BRAIN RES, V23, P207, DOI 10.1016/j.cogbrainres.2004.10.010; Habeck C, 2004, COGNITIVE BRAIN RES, V18, P306, DOI 10.1016/j.cogbrainres.2003.10.019; Harrison BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022964; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Honey GD, 2000, NEUROIMAGE, V12, P495, DOI 10.1006/nimg.2000.0624; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Kang J, 2011, NEUROIMAGE, V56, P1222, DOI 10.1016/j.neuroimage.2011.03.033; Kirschen MP, 2005, NEUROIMAGE, V24, P462, DOI 10.1016/j.neuroimage.2004.08.036; Koshino H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022909; Luber B, 2007, BRAIN RES, V1128, P120, DOI 10.1016/j.brainres.2006.10.011; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; MacWhinney B, 1997, SPATIAL VISION, V11, P99, DOI 10.1163/156856897X00113; Mayer JS, 2010, HUM BRAIN MAPP, V31, P126, DOI 10.1002/hbm.20850; Meda SA, 2012, BIOL PSYCHIAT, V71, P881, DOI 10.1016/j.biopsych.2012.01.025; Metzak P, 2011, HUM BRAIN MAPP, V32, P856, DOI 10.1002/hbm.21072; Muller NG, 2006, NEUROSCIENCE, V139, P51, DOI 10.1016/j.neuroscience.2005.09.018; NELSON HE, 1978, CORTEX, V14, P234, DOI 10.1016/S0010-9452(78)80049-5; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reuter-Lorenz PA, 2000, J COGNITIVE NEUROSCI, V12, P174, DOI 10.1162/089892900561814; Rypma B, 1999, NEUROIMAGE, V9, P216, DOI 10.1006/nimg.1998.0404; Sambataro F, 2010, NEUROBIOL AGING, V31, P839, DOI 10.1016/j.neurobiolaging.2008.05.022; Schmithorst VJ, 2004, J MAGN RESON IMAGING, V19, P365, DOI 10.1002/jmri.20009; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Sorg C, 2009, CURR ALZHEIMER RES, V6, P541, DOI 10.2174/156720509790147106; Steffener J, 2011, BIOCH BIOPH IN PRESS; Steffener J, 2011, BRAIN IMAGING BEHAV, V5, P212, DOI 10.1007/s11682-011-9125-4; Steffener J, 2009, BRAIN IMAGING BEHAV, V3, P142, DOI 10.1007/s11682-008-9056-x; Stern Y, 2011, BRAIN RES IN PRESS; Stern Y, 1987, MODIFIED MINIMENTAL; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Tucker AM, 2011, BEHAV BRAIN RES, V218, P73, DOI 10.1016/j.bbr.2010.11.012; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Worsley KJ, 1997, NEUROIMAGE, V6, P305, DOI 10.1006/nimg.1997.0294; Wu T, 2007, NEUROSCI LETT, V422, P164, DOI 10.1016/j.neulet.2007.06.011; Yordanova J, 2004, BRAIN, V127, P351, DOI 10.1093/brain/awh042; Ystad M, 2011, NEUROIMAGE, V55, P24, DOI 10.1016/j.neuroimage.2010.11.016; Ystad M, 2010, NEUROIMAGE, V52, P379, DOI 10.1016/j.neuroimage.2010.03.062; Yu Q, 2011, FRONTIERS SYSTEMS NE, V5; Yu QB, 2011, FRONT SYST NEUROSCI, V5, DOI [10.3389/fnsys.2011.00007, 10.3389/fnsys.2011.00103]; Zarahn E, 2005, CEREB CORTEX, V15, P303, DOI 10.1093/cercor/bhh132; Zarahn E, 2007, NEUROBIOL AGING, V28, P784, DOI 10.1016/j.neurobiolaging.2006.03.002	73	34	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44421	10.1371/journal.pone.0044421	http://dx.doi.org/10.1371/journal.pone.0044421			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028536	Green Submitted, Green Published, gold			2022-12-27	WOS:000311313900025
J	Gong, XC; Liu, ZS; Guo, P; Chi, CQ; Chen, J; Wang, XB; Tang, YQ; Wu, XL; Liu, CZ				Gong, Xiao-Cui; Liu, Ze-Shen; Guo, Peng; Chi, Chang-Qiao; Chen, Jian; Wang, Xing-Biao; Tang, Yue-Qin; Wu, Xiao-Lei; Liu, Chun-Zhong			Bacteria in Crude Oil Survived Autoclaving and Stimulated Differentially by Exogenous Bacteria	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; DIESEL FUEL; PETROLEUM; MICROORGANISMS; STRESS; BIODEGRADATION; BIOSTIMULATION; HYDROCARBONS; DEGRADATION; SIMILARITY	Autoclaving of crude oil is often used to evaluate the hydrocarbon-degrading abilities of bacteria. This may be potentially useful for bioaugmentation and microbial enhanced oil recovery (MEOR). However, it is not entirely clear if "endogenous" bacteria (e.g., spores) in/on crude oil survive the autoclaving process, or influence subsequent evaluation of the hydrocarbon-degradation abilities of the "exogenous" bacterial strains. To test this, we inoculated autoclaved crude oil medium with six exogenous bacterial strains (three Dietzia strains, two Acinetobacter strains, and one Pseudomonas strain). The survival of the spore-forming Bacillus and Paenibacillus and the non-spore-forming mesophilic Pseudomonas, Dietzia, Alcaligenes, and Microbacterium was detected using a 16S rRNA gene clone library and terminal restriction fragment length polymorphism (T-RFLP) analysis. However, neither bacteria nor bacterial activity was detected in three controls consisting of non-inoculated autoclaved crude oil medium. These results suggest that detection of endogenous bacteria was stimulated by the six inoculated strains. In addition, inoculation with Acinetobacter spp. stimulated detection of Bacillus, while inoculation with Dietzia spp. and Pseudomonas sp. stimulated the detection of more Pseudomonas. In contrast, similar exogenous bacteria stimulated similar endogenous bacteria at the genus level. Based on these results, special emphasis should be applied to evaluate the influence of bacteria capable of surviving autoclaving on the hydrocarbon-degrading abilities of exogenous bacteria, in particular, with regard to bioaugmentation and MEOR. Bioaugmentation and MEOR technologies could then be developed to more accurately direct the growth of specific endogenous bacteria that may then improve the efficiency of treatment or recovery of crude oil.	[Gong, Xiao-Cui; Liu, Ze-Shen; Guo, Peng; Chi, Chang-Qiao; Chen, Jian; Wang, Xing-Biao; Tang, Yue-Qin; Wu, Xiao-Lei; Liu, Chun-Zhong] Peking Univ, Coll Engn, Dept Energy & Resources Engn, Beijing 100871, Peoples R China	Peking University	Wu, XL (corresponding author), Peking Univ, Coll Engn, Dept Energy & Resources Engn, Beijing 100871, Peoples R China.	xiaolei_wu@pku.edu.cn	guo, peng/AAG-4052-2019; Guo, Peng/GWC-0572-2022; Wu, Xiao-Lei/G-6882-2011	Wu, Xiao-Lei/0000-0002-9897-6903	National Natural Science Foundation of China [31070107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China, with the grant numbers of 31070107. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERTON G, 1969, APPL MICROBIOL, V17, P745, DOI 10.1128/AEM.17.5.745-749.1969; ALHADHRAMI MN, 1995, MAR POLLUT BULL, V30, P403, DOI 10.1016/0025-326X(94)00235-2; BEAMAN TC, 1982, J BACTERIOL, V150, P870, DOI 10.1128/JB.150.2.870-877.1982; BENEDICT RG, 1958, APPL MICROBIOL, V6, P401, DOI 10.1128/AEM.6.6.401-407.1958; Berry BJ, 2010, APPL ENVIRON MICROB, V76, P2377, DOI 10.1128/AEM.02147-09; Bonch-Osmolovskaya EA, 2003, APPL ENVIRON MICROB, V69, P6143, DOI 10.1128/AEM.69.10.6143-6151.2003; Chaillan F, 2004, RES MICROBIOL, V155, P587, DOI 10.1016/j.resmic.2004.04.006; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Colores GM, 2000, APPL ENVIRON MICROB, V66, P2959, DOI 10.1128/AEM.66.7.2959-2964.2000; CROWE JH, 1987, BIOCHEM J, V242, P1, DOI 10.1042/bj2420001; Eguchi M, 1996, APPL ENVIRON MICROB, V62, P1287, DOI 10.1128/AEM.62.4.1287-1294.1996; GILBERT GL, 1964, APPL MICROBIOL, V12, P496, DOI 10.1128/AEM.12.6.496-503.1964; Head IM, 2006, NAT REV MICROBIOL, V4, P173, DOI 10.1038/nrmicro1348; Iwabuchi N, 2000, APPL ENVIRON MICROB, V68, P2337; Kanaly RA, 2002, APPL ENVIRON MICROB, V68, P5826, DOI 10.1128/AEM.68.12.5826-5833.2002; KILLHAM K, 1984, APPL ENVIRON MICROB, V47, P301, DOI 10.1128/AEM.47.2.301-306.1984; Lazar I, 2007, PETROL SCI TECHNOL, V25, P1353, DOI 10.1080/10916460701287714; LECHEVALLIER MW, 1988, APPL ENVIRON MICROB, V54, P649, DOI 10.1128/AEM.54.3.649-654.1988; Li H, 2010, MICROB ECOL, V60, P771, DOI 10.1007/s00248-010-9733-3; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MEASURES JC, 1975, NATURE, V257, P398, DOI 10.1038/257398a0; Meredith W, 2000, ORG GEOCHEM, V31, P1059, DOI 10.1016/S0146-6380(00)00136-4; Nie Y, 2011, APPL ENVIRON MICROB, V77, P7279, DOI 10.1128/AEM.00203-11; Olivier SA, 2011, APPL ENVIRON MICROB, V77, P2317, DOI 10.1128/AEM.01957-10; Orphan VJ, 2000, APPL ENVIRON MICROB, V66, P700, DOI 10.1128/AEM.66.2.700-711.2000; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; ROBERSON EB, 1992, APPL ENVIRON MICROB, V58, P1284, DOI 10.1128/AEM.58.4.1284-1291.1992; RUTALA WA, 1982, APPL ENVIRON MICROB, V43, P1311, DOI 10.1128/AEM.43.6.1311-1316.1982; Sagripanti JL, 1999, APPL ENVIRON MICROB, V65, P4255; SCHLEY DG, 1960, APPL MICROBIOL, V8, P15, DOI 10.1128/AEM.8.1.15-19.1960; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seklemova E, 2001, BIODEGRADATION, V12, P311, DOI 10.1023/A:1014356223118; Singleton DR, 2001, APPL ENVIRON MICROB, V67, P4374, DOI 10.1128/AEM.67.9.4374-4376.2001; Tang YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033535; Tang YQ, 2011, APPL MICROBIOL BIOT, V91, P1447, DOI 10.1007/s00253-011-3479-9; Thomassin-Lacroix EJM, 2002, APPL MICROBIOL BIOT, V59, P551, DOI 10.1007/s00253-002-1038-0; Townsend GT, 2003, ENVIRON SCI TECHNOL, V37, P5213, DOI 10.1021/es0264495; Van Hamme JD, 2003, MICROBIOL MOL BIOL R, V67, P503, DOI 10.1128/MMBR.67.4.503-549.2003; van Hamme JD, 2001, APPL ENVIRON MICROB, V67, P4974; Wang XB, 2011, BIORESOURCE TECHNOL, V102, P7755, DOI 10.1016/j.biortech.2011.06.009; Wu XL, 2001, ENVIRON MICROBIOL, V3, P355, DOI 10.1046/j.1462-2920.2001.00199.x; Yamane K, 2011, FEMS MICROBIOL ECOL, V76, P220, DOI 10.1111/j.1574-6941.2011.01044.x; Yamane K, 2008, BIOSCI BIOTECH BIOCH, V72, P2831, DOI 10.1271/bbb.80227; Yoshida N, 2005, J BIOSCI BIOENG, V99, P143, DOI 10.1263/jbb.99.143; Yu SL, 2011, J ENVIRON SCI, V23, P1; Yu SL, 2010, J BIOSCI BIOENG, V110, P500, DOI 10.1016/j.jbiosc.2010.05.005; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418	47	22	27	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e40842	10.1371/journal.pone.0040842	http://dx.doi.org/10.1371/journal.pone.0040842			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028421	Green Published, Green Submitted, gold			2022-12-27	WOS:000309742800001
J	Suzuki, K; Adachi, Y; Numata, T; Nakada, S; Yanagita, M; Nakagata, N; Evans, SM; Graf, D; Economides, A; Haraguchi, R; Moon, AM; Yamada, G				Suzuki, Kentaro; Adachi, Yasuha; Numata, Tomokazu; Nakada, Shoko; Yanagita, Motoko; Nakagata, Naomi; Evans, Sylvia M.; Graf, Daniel; Economides, Aris; Haraguchi, Ryuma; Moon, Anne M.; Yamada, Gen			Reduced BMP Signaling Results in Hindlimb Fusion with Lethal Pelvic/Urogenital Organ Aplasia: A New Mouse Model of Sirenomelia	PLOS ONE			English	Article							EXTERNAL GENITALIA; LIMB DEVELOPMENT; MUTANT MICE; ECTODERMAL RIDGE; CRE-RECOMBINASE; EXPRESSION; MESODERM; BUD; MECHANISMS; OUTGROWTH	Sirenomelia, also known as mermaid syndrome, is a developmental malformation of the caudal body characterized by leg fusion and associated anomalies of pelvic/urogenital organs including bladder, kidney, rectum and external genitalia. Most affected infants are stillborn, and the few born alive rarely survive beyond the neonatal period. Despite the many clinical studies of sirenomelia in humans, little is known about the pathogenic developmental mechanisms that cause the complex array of phenotypes observed. Here, we provide new evidences that reduced BMP (Bone Morphogenetic Protein) signaling disrupts caudal body formation in mice and phenocopies sirenomelia. Bmp4 is strongly expressed in the developing caudal body structures including the peri-cloacal region and hindlimb field. In order to address the function of Bmp4 in caudal body formation, we utilized a conditional Bmp4 mouse allele (Bmp4(flox/flox)) and the Isl1 (Islet1)-Cre mouse line. Isl1-Cre is expressed in the peri-cloacal region and the developing hindimb field. Isl1Cre; Bmp4(flox/flox) conditional mutant mice displayed sirenomelia phenotypes including hindlimb fusion and pelvic/urogenital organ dysgenesis. Genetic lineage analyses indicate that Isl1-expressing cells contribute to both the aPCM (anterior Peri-Cloacal Mesenchyme) and the hindlimb bud. We show Bmp4 is essential for the aPCM formation independently with Shh signaling. Furthermore, we show Bmp4 is a major BMP ligand for caudal body formation as shown by compound genetic analyses of Bmp4 and Bmp7. Taken together, this study reveals coordinated development of caudal body structures including pelvic/urogenital organs and hindlimb orchestrated by BMP signaling in Isl1-expressing cells. Our study offers new insights into the pathogenesis of sirenomelia.	[Suzuki, Kentaro; Adachi, Yasuha; Numata, Tomokazu; Nakada, Shoko; Yamada, Gen] WMU, Inst Adv Med, Dept Dev Genet, Wakayama, Japan; [Suzuki, Kentaro; Adachi, Yasuha; Numata, Tomokazu; Nakada, Shoko; Yamada, Gen] Kumamoto Univ, IMEG, Dept Organ Format, Kumamoto, Japan; [Yanagita, Motoko] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Nakagata, Naomi] Kumamoto Univ, Div Reprod Engn, Ctr Anim Resources & Dev, Kumamoto, Japan; [Evans, Sylvia M.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Evans, Sylvia M.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Graf, Daniel] Univ Zurich, Fac Med, Inst Oral Biol, Zurich, Switzerland; [Economides, Aris] Regeneron Pharmaceut, Genome Engn Technol, Tarrytown, NY USA; [Haraguchi, Ryuma] Ehime Univ, Grad Sch Med, Dept Mol Pathol, Matsuyama, Ehime 790, Japan; [Moon, Anne M.] Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA	Kumamoto University; Kyoto University; Kumamoto University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Geneva; University of Zurich; Regeneron; Ehime University	Yamada, G (corresponding author), WMU, Inst Adv Med, Dept Dev Genet, Wakayama, Japan.	genyama77@yahoo.co.jp	Evans, Sylvia/G-1980-2015; Graf, Daniel/H-1214-2011; Yanagita, Motoko/AAJ-7731-2021	Graf, Daniel/0000-0003-1163-8117; Economides, Aris/0000-0002-6508-8942; Yanagita, Motoko/0000-0002-0339-9008; Nakagata, Naomi/0000-0002-5737-9993; moon, anne/0000-0002-9090-1093	Scientific Research on Innovative Areas Molecular Mechanisms for Establishment of Sex Differences [22132006]; Ministry of Education, Culture, Sports, Science, and Technology, Japan; National Institutes of Health Grant [R01-ES016597-01A1];  [24590235]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016597] Funding Source: NIH RePORTER	Scientific Research on Innovative Areas Molecular Mechanisms for Establishment of Sex Differences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Scientific Research on Innovative Areas Molecular Mechanisms for Establishment of Sex Differences (22132006); the global Center-of-Excellence (COE) Cell Fate Regulation Research and Education Unit from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grant-in-Aid for Young Scientists (B); Grant-in-Aid for Scientific Research (C) (24590235) and National Institutes of Health Grant R01-ES016597-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Barbara PD, 2002, DEVELOPMENT, V129, P551; BARR M, 1988, TERATOLOGY, V38, P487, DOI 10.1002/tera.1420380513; Bastida MF, 2009, DEVELOPMENT, V136, P3779, DOI 10.1242/dev.036418; Benazet JD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001339; Benazet JD, 2009, SCIENCE, V323, P1050, DOI 10.1126/science.1168755; Bonilla-Claudio M, 2012, DEVELOPMENT, V139, P709, DOI 10.1242/dev.073197; Browne Marybeth, 2004, J Perinatol, V24, P329, DOI 10.1038/sj.jp.7211085; Chang WI, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000050; Chen H, 1998, NAT GENET, V19, P51, DOI 10.1038/ng0598-51; CHEVALLIER A, 1977, J EMBRYOL EXP MORPH, V41, P245; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Garrido-Allepuz C, 2011, DIS MODEL MECH, V4, P289, DOI 10.1242/dmm.007732; Goncalves A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019370; Harada M, 2009, NAT GENET, V41, P289, DOI 10.1038/ng.316; Haraguchi R, 2001, DEVELOPMENT, V128, P4241; Haraguchi R, 2012, PLOS ONE IN PRESS; Haraguchi R, 2007, DEVELOPMENT, V134, P525, DOI 10.1242/dev.02736; KALLEN B, 1974, TERATOLOGY, V9, P99, DOI 10.1002/tera.1420090113; KALLEN B, 1992, J MED GENET, V29, P30, DOI 10.1136/jmg.29.1.30; Kawakami Y, 2011, DEVELOPMENT, V138, P4465, DOI 10.1242/dev.065359; Kimmel SG, 2000, J PEDIATR SURG, V35, P227, DOI 10.1016/S0022-3468(00)90014-9; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Loomis CA, 1996, NATURE, V382, P360, DOI 10.1038/382360a0; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Macatee TL, 2003, DEVELOPMENT, V130, P6361, DOI 10.1242/dev.00850; MILDENBERGER H, 1988, J PEDIATR SURG, V23, P166, DOI 10.1016/S0022-3468(88)80150-7; Moon AM, 2000, NAT GENET, V26, P455, DOI 10.1038/82601; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Naiche LA, 2007, DEVELOPMENT, V134, P93, DOI 10.1242/dev.02712; Naiche LA, 2011, DEV DYNAM, V240, P2290, DOI 10.1002/dvdy.22731; Ohta S, 2007, DEVELOPMENT, V134, P4315, DOI 10.1242/dev.008151; Omori A, 2011, CONGENIT ANOM, V51, P102, DOI 10.1111/j.1741-4520.2011.00318.x; Opitz JM, 2002, AM J MED GENET, V115, P269, DOI 10.1002/ajmg.10983; ORAHILLY R, 1989, TERATOLOGY, V40, P409, DOI 10.1002/tera.1420400502; Ouimette JF, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1036; Park EJ, 2008, DEV DYNAM, V237, P447, DOI 10.1002/dvdy.21415; Penington EC, 2003, J PEDIATR SURG, V38, P1287, DOI 10.1016/S0022-3468(03)00384-1; Selever J, 2004, DEV BIOL, V276, P268, DOI 10.1016/j.ydbio.2004.08.024; Solloway MJ, 1999, DEVELOPMENT, V126, P1753; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; STEVENSON RE, 1986, PEDIATRICS, V78, P451; Stocker J T, 1987, Perspect Pediatr Pathol, V10, P7; Suzuki K, 2008, EUR J HUM GENET, V16, P36, DOI 10.1038/sj.ejhg.5201925; Taori KB., 2002, INDIAN J RADIOL IMAG, V12, P399; Wang J, 2011, BIRTH DEFECTS RES A, V91, P441, DOI 10.1002/bdra.20785; Warburton David, 2004, Paediatr Respir Rev, V5 Suppl A, pS283, DOI 10.1016/S1526-0542(04)90052-8; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Yamada G, 2006, DEV DYNAM, V235, P1738, DOI 10.1002/dvdy.20807; Yamada G, 2003, DIFFERENTIATION, V71, P445, DOI 10.1046/j.1432-0436.2003.7108001.x; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yang L, 2006, DEVELOPMENT, V133, P1575, DOI 10.1242/dev.02322; Yuan SP, 2000, ANAT REC, V260, P204, DOI 10.1002/1097-0185(20001001)260:2<204::AID-AR90>3.0.CO;2-5; Zakany J, 2004, SCIENCE, V304, P1669, DOI 10.1126/science.1096049; Zakany J, 2007, DEV BIOL, V306, P883, DOI 10.1016/j.ydbio.2007.03.517; Zakin L, 2005, DEVELOPMENT, V132, P2489, DOI 10.1242/dev.01822; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008; Zouvelou V, 2009, INT J DEV BIOL, V53, P597, DOI 10.1387/ijdb.082648vz	62	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e43453	10.1371/journal.pone.0043453	http://dx.doi.org/10.1371/journal.pone.0043453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028455	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000309742800005
J	Fine-Coulson, K; Reaves, BJ; Karls, RK; Quinn, FD				Fine-Coulson, Kari; Reaves, Barbara J.; Karls, Russell K.; Quinn, Frederick D.			The Role of Lipid Raft Aggregation in the Infection of Type II Pneumocytes by Mycobacterium tuberculosis	PLOS ONE			English	Article							LUNG EPITHELIAL-CELLS; IN-VITRO; MEMBRANE; CHOLESTEROL; CAVEOLAE; INVASION; ENTRY; ENDOCYTOSIS; ASSOCIATION; EXPRESSION	Dynamic, cholesterol-dense regions of the plasma membrane, known as lipid rafts (LR), have been observed to develop during and may be directly involved in infection of host cells by various pathogens. This study focuses on LR aggregation induced in alveolar epithelial cells during infection with Mycobacterium tuberculosis (Mtb) bacilli. We report dose- and time-dependent increases in LR aggregation after infection with three different strains at multiplicities of infection of 1, 10 and 100 from 2-24 hr post infection (hpi). Specific strain-dependent variations were noted among H37Rv, HN878 and CDC1551 with H37Rv producing the most significant increase from 15 aggregates per cell (APC) to 27 APC at MOI 100 during the 24 hour infection period. Treatment of epithelial cells with Culture Filtrate Protein, Total Lipids and gamma-irradiated whole cells from each strain failed to induce the level of LR aggregation observed during infection with any of the live strains. However, filtered supernatants from infected epithelial cells did produce comparable LR aggregation, suggesting a secreted mycobacterial product produced during infection of host cells is responsible for LR aggregation. Disruption of lipid raft formation prior to infection indicates that Mtb bacilli utilize LR aggregates for internalization and survival in epithelial cells. Treatment of host cells with the LR-disruption agent Filipin III produced a nearly 22% reduction in viable bacteria for strains H37Rv and HN878, and a 7% reduction for strain CDC1551 after 6 hpi. This study provides evidence for significant mycobacterial-induced changes in the plasma membrane of alveolar epithelial cells and that Mtb strains vary in their ability to facilitate aggregation and utilization of LR.	[Fine-Coulson, Kari; Reaves, Barbara J.; Karls, Russell K.; Quinn, Frederick D.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Fine-Coulson, K (corresponding author), Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA.	fquinn@uga.edu		Karls, Russell/0000-0002-6474-6106	American Lung Association; University of Georgia Faculty of Infectious Diseases	American Lung Association; University of Georgia Faculty of Infectious Diseases	This work was supported in part by research grants from the American Lung Association (R.K.) and the University of Georgia Faculty of Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M. D., 2004, J BIOPHOTONICS INT, V11, P36; Amer AO, 2005, AUTOPHAGY, V1, P53, DOI 10.4161/auto.1.1.1589; Auriac A, 2010, HAEMATOL-HEMATOL J, V95, P1269, DOI 10.3324/haematol.2009.019992; Barczak AK, 2005, J INFECT DIS, V192, P600, DOI 10.1086/432006; Barman S, 2004, J VIROL, V78, P5258, DOI 10.1128/JVI.78.10.5258-5269.2004; Bermudez LE, 1996, INFECT IMMUN, V64, P1400, DOI 10.1128/IAI.64.4.1400-1406.1996; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Constant P, 2002, J BIOL CHEM, V277, P38148, DOI 10.1074/jbc.M206538200; Dao DN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000081; de Chastellier C, 2006, CELL MICROBIOL, V8, P242, DOI 10.1111/j.1462-5822.2005.00617.x; Dobos KM, 2000, INFECT IMMUN, V68, P6300, DOI 10.1128/IAI.68.11.6300-6310.2000; Drake DR, 2001, J IMMUNOL, V166, P7009, DOI 10.4049/jimmunol.166.12.7009; Drennan MB, 2004, AM J PATHOL, V164, P49, DOI 10.1016/S0002-9440(10)63095-7; Duncan MJ, 2004, J BIOL CHEM, V279, P18944, DOI 10.1074/jbc.M400769200; Fine KL, 2012, CELL MICROBIOL, DOI [10.1111/j.1462-5822.2012.01804, DOI 10.1111/J.1462-5822.2012.01804]; French CT, 2009, CELL MICROBIOL, V11, P1735, DOI 10.1111/j.1462-5822.2009.01361.x; Gajate C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005044; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Gekara NO, 2005, CELL MICROBIOL, V7, P1345, DOI 10.1111/j.1462-5822.2005.00561.x; Goluszko P, 2005, INFECT IMMUN, V73, P7791, DOI 10.1128/IAI.73.12.7791-7796.2005; Hansen CG, 2010, TRENDS CELL BIOL, V20, P177, DOI 10.1016/j.tcb.2010.01.005; Hauck FR, 2009, AM FAM PHYSICIAN, V79, P879; Hayakawa E, 2007, BIOPHYS J, V93, P4018, DOI 10.1529/biophysj.107.104075; Henning LN, 2008, J IMMUNOL, V180, P7847, DOI 10.4049/jimmunol.180.12.7847; Hurley JH, 2010, CELL, V143, P875, DOI 10.1016/j.cell.2010.11.030; Janes PW, 2000, SEMIN IMMUNOL, V12, P23, DOI 10.1006/smim.2000.0204; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kalia A, 1999, ANAL BIOCHEM, V275, P1, DOI 10.1006/abio.1999.4259; Kowalski MP, 2004, J IMMUNOL, V172, P418, DOI 10.4049/jimmunol.172.1.418; Kremer L, 2002, MICROBIOL-SGM, V148, P3145, DOI 10.1099/00221287-148-10-3145; Kumari M, 2011, INFECT IMMUN, V79, P3159, DOI 10.1128/IAI.05406-11; Lafont F, 2005, CELL MICROBIOL, V7, P613, DOI 10.1111/j.1462-5822.2005.00515.x; Le Lay S, 2009, J LIPID RES, V50, P1609, DOI 10.1194/jlr.M800601-JLR200; Lencer WI, 1999, BBA-MOL CELL RES, V1450, P177, DOI 10.1016/S0167-4889(99)00070-1; Lim JS, 2010, AGING CELL, V9, P243, DOI 10.1111/j.1474-9726.2010.00554.x; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Manca C, 1999, J IMMUNOL, V162, P6740; Mehta PK, 1996, INFECT IMMUN, V64, P2673, DOI 10.1128/IAI.64.7.2673-2679.1996; Mitchell JS, 2009, IMMUNOL CELL BIOL, V87, P324, DOI 10.1038/icb.2008.103; Munoz S, 2009, SCAND J IMMUNOL, V70, P256, DOI 10.1111/j.1365-3083.2009.02295.x; Nichols B, 2003, J CELL SCI, V116, P4707, DOI 10.1242/jcs.00840; Ordway D, 2007, J IMMUNOL, V179, P522, DOI 10.4049/jimmunol.179.1.522; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Patel HH, 2009, ANTIOXID REDOX SIGN, V11, P1357, DOI [10.1089/ars.2008.2365, 10.1089/ARS.2008.2365]; Pike LJ, 2009, J LIPID RES, V50, pS323, DOI 10.1194/jlr.R800040-JLR200; Popik W, 2002, J VIROL, V76, P4709, DOI 10.1128/JVI.76.10.4709-4722.2002; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Querbes W, 2006, J VIROL, V80, P9402, DOI 10.1128/JVI.01086-06; Radeva G, 2005, FEBS J, V272, P4924, DOI 10.1111/j.1742-4658.2005.04905.x; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Regueiro V, 2009, INFECT IMMUN, V77, P714, DOI 10.1128/IAI.00852-08; Rocha-Ramirez LM, 2008, TUBERCULOSIS, V88, P212, DOI 10.1016/j.tube.2007.10.003; Rogee S, 2007, MOL THER, V15, P1963, DOI 10.1038/sj.mt.6300283; Ros-Baro A, 2001, P NATL ACAD SCI USA, V98, P12050, DOI 10.1073/pnas.211341698; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Roy S, 2004, IMMUNOLOGY, V112, P471, DOI 10.1046/j.1365-2567.2004.01905.x; Sato K, 2002, J INFECT DIS, V185, P1139, DOI 10.1086/340040; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Shin DM, 2008, CELL MICROBIOL, V10, P1893, DOI 10.1111/j.1462-5822.2008.01179.x; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Sinsimer D, 2008, INFECT IMMUN, V76, P3027, DOI 10.1128/IAI.01663-07; Tahir SA, 2008, CANCER RES, V68, P731, DOI 10.1158/0008-5472.CAN-07-2668; Togayachi A, 2010, P NATL ACAD SCI USA, V107, P11900, DOI 10.1073/pnas.0914298107; Triantafilou M, 2004, J CELL SCI, V117, P4007, DOI 10.1242/jcs.01270; Tsenova L, 2005, J INFECT DIS, V192, P98, DOI 10.1086/430614; Welin A, 2008, INFECT IMMUN, V76, P2882, DOI 10.1128/IAI.01549-07; Wickremasinghe MI, 1999, J IMMUNOL, V163, P3936; Xu ZX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008532; Young RM, 2003, J BIOL CHEM, V278, P20746, DOI 10.1074/jbc.M211402200; Yu CJ, 2005, J LIPID RES, V46, P1678, DOI 10.1194/jlr.M500060-JLR200; Zaas DW, 2009, J BIOL CHEM, V284, P9955, DOI 10.1074/jbc.M808629200; Zaas DW, 2005, BBA-MOL CELL RES, V1746, P305, DOI 10.1016/j.bbamcr.2005.10.003; Zaas DW, 2005, J BIOL CHEM, V280, P4864, DOI 10.1074/jbc.M411702200; Zheng YZ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007146	76	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45028	10.1371/journal.pone.0045028	http://dx.doi.org/10.1371/journal.pone.0045028			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024786	Green Submitted, Green Published, gold			2022-12-27	WOS:000308860100044
J	Gautam, A; Dixit, S; Embers, M; Gautam, R; Philipp, MT; Singh, SR; Morici, L; Dennis, VA				Gautam, Aarti; Dixit, Saurabh; Embers, Monica; Gautam, Rajeev; Philipp, Mario T.; Singh, Shree R.; Morici, Lisa; Dennis, Vida A.			Different Patterns of Expression and of IL-10 Modulation of Inflammatory Mediators from Macrophages of Lyme Disease-Resistant and -Susceptible Mice	PLOS ONE			English	Article							BORRELIA-BURGDORFERI LIPOPROTEINS; COLLAGEN-INDUCED ARTHRITIS; HUMAN MONOCYTIC CELLS; IFN-GAMMA; INTERLEUKIN-10 PRODUCTION; TREPONEMA-PALLIDUM; MESSENGER-RNA; HOST-DEFENSE; PROINFLAMMATORY CYTOKINES; BACTERIAL LIPOPROTEINS	C57BL/6J (C57) mice develop mild arthritis (Lyme disease-resistant) whereas C3H/HeN (C3H) mice develop severe arthritis (Lyme disease-susceptible) after infection with the spirochete Borrelia burgdorferi. We hypothesized that susceptibility and resistance to Lyme disease, as modeled in mice, is associated with early induction and regulation of inflammatory mediators by innate immune cells after their exposure to live B. burgdorferi spirochetes. Here, we employed multiplex ELISA and qRT-PCR to investigate quantitative differences in the levels of cytokines and chemokines produced by bone marrow-derived macrophages from C57 and C3H mice after these cells were exposed ex vivo to live spirochetes or spirochetal lipoprotein. Upon stimulation, the production of both cytokines and chemokines was up-regulated in macrophages from both mouse strains. Interestingly, however, our results uncovered two distinct patterns of spirochete- and lipoprotein-inducible inflammatory mediators displayed by mouse macrophages, such that the magnitude of the chemokine up-regulation was larger in C57 cells than it was in C3H cells, for most chemokines. Conversely, cytokine up-regulation was more intense in C3H cells. Gene transcript analyses showed that the displayed patterns of inflammatory mediators were associated with a TLR2/TLR1 transcript imbalance: C3H macrophages expressed higher TLR2 transcript levels as compared to those expressed by C57 macrophages. Exogenous IL-10 dampened production of inflammatory mediators, especially those elicited by lipoprotein stimulation. Neutralization of endogenously produced IL-10 increased production of inflammatory mediators, notably by macrophages of C57 mice, which also displayed more IL-10 than C3H macrophages. The distinct patterns of proinflammatory mediator production, along with TLR2/TLR1 expression, and regulation in macrophages from Lyme disease-resistant and -susceptible mice suggests itself as a blueprint to further investigate differential pathogenesis of Lyme disease.	[Gautam, Aarti; Dixit, Saurabh; Embers, Monica; Philipp, Mario T.; Dennis, Vida A.] Tulane Univ, Hlth Sci Ctr, Div Bacteriol & Parasitol, Tulane Natl Primate Res Ctr, Covington, LA USA; [Gautam, Rajeev] Tulane Univ, Hlth Sci Ctr, Div Microbiol, Tulane Natl Primate Res Ctr, Covington, LA USA; [Dixit, Saurabh; Singh, Shree R.; Dennis, Vida A.] Alabama State Univ, Ctr Nanobiotechnol Res, Montgomery, AL 36101 USA; [Morici, Lisa] Tulane Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, New Orleans, LA 70118 USA	Tulane University; Tulane University; Tulane University	Gautam, A (corresponding author), USA, Integrat Syst Biol Program, Ctr Environm Hlth Res, Ft Detrick, MD USA.	vdennis@alasu.edu	; dixit, saurabh/E-3296-2013	Singh, Shree R./0000-0002-3571-2222; dixit, saurabh/0000-0002-9140-9543; Embers, Monica/0000-0003-4051-7592	National Institute of Allergy and Infectious Diseases [R21AI073356]; National Center for Research Resources, National Institutes of Health [RR00164]; National Science Foundation-Centers of Research Excellence in Science and Technology [HRD- 0734232]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073356] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Science Foundation-Centers of Research Excellence in Science and Technology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The project described was supported by Grant Number R21AI073356 from the National Institute of Allergy and Infectious Diseases; Grant Number RR00164 from the National Center for Research Resources, National Institutes of Health and Grant Number HRD- 0734232 from National Science Foundation-Centers of Research Excellence in Science and Technology. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Anguita J, 1996, J CLIN INVEST, V97, P1028, DOI 10.1172/JCI118494; Anguita J, 1998, J INFECT DIS, V178, P1512, DOI 10.1086/314448; BARTHOLD SW, 1991, AM J PATHOL, V139, P263; BARTHOLD SW, 1993, AM J PATHOL, V143, P959; Behera AK, 2008, CELL MICROBIOL, V10, P320, DOI 10.1111/j.1462-5822.2007.01043.x; Behera AK, 2006, J IMMUNOL, V177, P657, DOI 10.4049/jimmunol.177.1.657; Bockenstedt LK, 2001, INFECT IMMUN, V69, P5264, DOI 10.1128/IAI.69.9.5264-5269.2001; Bolz DD, 2004, J IMMUNOL, V173, P2003, DOI 10.4049/jimmunol.173.3.2003; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Brown CR, 2008, INFECT IMMUN, V76, P5500, DOI 10.1128/IAI.00808-08; Brown CR, 1999, INFECT IMMUN, V67, P3329, DOI 10.1128/IAI.67.7.3329-3333.1999; Brown CR, 2004, INFECT IMMUN, V72, P4956, DOI 10.1128/IAI.72.9.4956-4965.2004; Brown CR, 2003, J IMMUNOL, V171, P893, DOI 10.4049/jimmunol.171.2.893; Brown JP, 1999, INFECT IMMUN, V67, P5142, DOI 10.1128/IAI.67.10.5142-5150.1999; Burns MJ, 1998, INFECT IMMUN, V66, P4875, DOI 10.1128/IAI.66.10.4875-4883.1998; Cervantes JL, 2011, P NATL ACAD SCI USA, V108, P3683, DOI 10.1073/pnas.1013776108; COBURN J, 1993, P NATL ACAD SCI USA, V90, P7059, DOI 10.1073/pnas.90.15.7059; Coburn J, 2003, P NATL ACAD SCI USA, V100, P7301, DOI 10.1073/pnas.1131117100; Coburn J, 1998, INFECT IMMUN, V66, P1946, DOI 10.1128/IAI.66.5.1946-1952.1998; COBURN J, 1994, INFECT IMMUN, V62, P5559, DOI 10.1128/IAI.62.12.5559-5567.1994; Crandall H, 2006, J IMMUNOL, V177, P7930, DOI 10.4049/jimmunol.177.11.7930; Cruz AR, 2008, INFECT IMMUN, V76, P56, DOI 10.1128/IAI.01039-07; Dame TM, 2007, J IMMUNOL, V178, P1172, DOI 10.4049/jimmunol.178.2.1172; Dennis VA, 2006, INFECT IMMUN, V74, P5780, DOI 10.1128/IAI.00678-06; Dennis VA, 2009, INFECT IMMUN, V77, P1238, DOI 10.1128/IAI.01078-08; Diterich I, 2001, INFECT IMMUN, V69, P687, DOI 10.1128/IAI.69.2.687-694.2001; Ganapamo F, 2003, EUR J IMMUNOL, V33, P1934, DOI 10.1002/eji.200323655; Ganapamo F, 2000, INFECT IMMUN, V68, P7162, DOI 10.1128/IAI.68.12.7162-7165.2000; Gautam A, 2011, INFECT IMMUN, V79, P4876, DOI 10.1128/IAI.05451-11; Gergel EI, 2001, INFECT IMMUN, V69, P2190, DOI 10.1128/IAI.69.4.2190-2197.2001; Giambartolomei GH, 1998, INFECT IMMUN, V66, P2691, DOI 10.1128/IAI.66.6.2691-2697.1998; Giambartolomei GH, 2002, INFECT IMMUN, V70, P1881, DOI 10.1128/IAI.70.4.1881-1888.2002; Glickstein L, 2001, INFECT IMMUN, V69, P3737, DOI 10.1128/IAI.69.6.3737-3743.2001; Harjacek M, 2000, J RHEUMATOL, V27, P497; Haupl T, 1997, FEMS IMMUNOL MED MIC, V19, P15; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; Johansson ACM, 2001, J IMMUNOL, V167, P3505, DOI 10.4049/jimmunol.167.6.3505; Jones KL, 2008, CLIN INFECT DIS, V46, P85, DOI 10.1086/524022; Joosten LAB, 1997, ARTHRITIS RHEUM, V40, P249, DOI 10.1002/art.1780400209; KASAMA T, 1994, J IMMUNOL, V152, P3559; KeaneMyers A, 1996, J IMMUNOL, V156, P2488; Lazarus JJ, 2008, INFECT IMMUN, V76, P1153, DOI 10.1128/IAI.01404-07; Lazarus JJ, 2006, J IMMUNOL, V177, P7076, DOI 10.4049/jimmunol.177.10.7076; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Lisinski TJ, 2002, J LEUKOCYTE BIOL, V72, P503; Liu NY, 2004, INFECT IMMUN, V72, P3195, DOI 10.1128/IAI.72.6.3195-3203.2004; Londono D, 2011, J IMMUNOL, V186, P7176, DOI 10.4049/jimmunol.1100060; Ma Y, 1998, INFECT IMMUN, V66, P161, DOI 10.1128/IAI.66.1.161-168.1998; Marre ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012871; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Miller JC, 2008, EXP MOL PATHOL, V85, P20, DOI 10.1016/j.yexmp.2008.03.004; Miller JC, 2010, INFECT IMMUN, V78, P3144, DOI 10.1128/IAI.01070-09; Miller JC, 2008, J IMMUNOL, V181, P8492, DOI 10.4049/jimmunol.181.12.8492; Montgomery RR, 2001, J INFECT DIS, V183, P1631, DOI 10.1086/320703; Mullegger RR, 2000, J INVEST DERMATOL, V115, P1115, DOI 10.1046/j.1523-1747.2000.00198.x; Murthy PK, 2000, INFECT IMMUN, V68, P6663, DOI 10.1128/IAI.68.12.6663-6669.2000; NORGARD MV, 1995, INFECT IMMUN, V63, P1507, DOI 10.1128/IAI.63.4.1507-1515.1995; Norgard MV, 1996, INFECT IMMUN, V64, P3845, DOI 10.1128/IAI.64.9.3845-3852.1996; Olson CM, 2009, J IMMUNOL, V182, P3728, DOI 10.4049/jimmunol.0804111; Oosting M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025998; Oosting M, 2010, J INFECT DIS, V201, P1849, DOI 10.1086/652871; Petzke MM, 2009, J IMMUNOL, V183, P5279, DOI 10.4049/jimmunol.0901390; Pohl-Koppe A, 1998, J IMMUNOL, V160, P1804; Sabino GJ, 2011, AM J PATHOL, V179, P1917, DOI 10.1016/j.ajpath.2011.06.029; Sahay B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000687; Salazar JC, 2005, CLIN DIAGN LAB IMMUN, V12, P949, DOI 10.1128/CDLI.12.8.949-958.2005; Salazar JC, 2003, J IMMUNOL, V171, P2660, DOI 10.4049/jimmunol.171.5.2660; Salazar JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000444; Sellati TJ, 1999, J IMMUNOL, V163, P2049; Shin JJ, 2007, ARTHRITIS RHEUM-US, V56, P1325, DOI 10.1002/art.22441; Shin JHJ, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3128; Singh SK, 2005, CLIN EXP RHEUMATOL, V23, P311; Sjowall J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018220; Sonderegger FL, 2012, J IMMUNOL, V188, P1381, DOI 10.4049/jimmunol.1102359; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Strle K, 2012, ARTHRITIS RHEUM-US, V64, P1497, DOI 10.1002/art.34383; Strle K, 2009, J INFECT DIS, V200, P1936, DOI 10.1086/648091; Wang GQ, 2008, J IMMUNOL, V180, P8306, DOI 10.4049/jimmunol.180.12.8306; Wang XH, 2008, FEMS IMMUNOL MED MIC, V52, P124, DOI 10.1111/j.1574-695X.2007.00356.x; Wooten RM, 2002, J IMMUNOL, V168, P348, DOI 10.4049/jimmunol.168.1.348; Wooten RM, 2001, CURR OPIN MICROBIOL, V4, P274, DOI 10.1016/S1369-5274(00)00202-2; Yakimchuk K, 2011, EUR J IMMUNOL, V41, P694, DOI 10.1002/eji.201040808	85	20	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e43860	10.1371/journal.pone.0043860	http://dx.doi.org/10.1371/journal.pone.0043860			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024745	gold, Green Published, Green Submitted			2022-12-27	WOS:000308860100003
J	Ohkawa, N; Saitoh, Y; Tokunaga, E; Nihonmatsu, I; Ozawa, F; Murayama, A; Shibata, F; Kitamura, T; Inokuchi, K				Ohkawa, Noriaki; Saitoh, Yoshito; Tokunaga, Eri; Nihonmatsu, Itsuko; Ozawa, Fumiko; Murayama, Akiko; Shibata, Fumi; Kitamura, Toshio; Inokuchi, Kaoru			Spine Formation Pattern of Adult-Born Neurons Is Differentially Modulated by the Induction Timing and Location of Hippocampal Plasticity	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ENHANCED SYNAPTIC PLASTICITY; GENERATED GRANULE CELLS; DENDRITIC SPINES; DENTATE GYRUS; SPATIAL MEMORY; FUNCTIONAL-INTEGRATION; NEUROGENESIS; BRAIN; ACTIN	In the adult hippocampus dentate gyrus (DG), newly born neurons are functionally integrated into existing circuits and play important roles in hippocampus-dependent memory. However, it remains unclear how neural plasticity regulates the integration pattern of new neurons into preexisting circuits. Because dendritic spines are major postsynaptic sites for excitatory inputs, spines of new neurons were visualized by retrovirus-mediated labeling to evaluate integration. Long-term potentiation (LTP) was induced at 12, 16, or 21 days postinfection (dpi), at which time new neurons have no, few, or many spines, respectively. The spine expression patterns were investigated at one or two weeks after LTP induction. Induction at 12 dpi increased later spinogenesis, although the new neurons at 12 dpi didn't respond to the stimulus for LTP induction. Induction at 21 dpi transiently mediated spine enlargement. Surprisingly, LTP induction at 16 dpi reduced the spine density of new neurons. All LTP-mediated changes specifically appeared within the LTP-induced layer. Therefore, neural plasticity differentially regulates the integration of new neurons into the activated circuit, dependent on their developmental stage. Consequently, new neurons at different developmental stages may play distinct roles in processing the acquired information by modulating the connectivity of activated circuits via their integration.	[Ohkawa, Noriaki; Saitoh, Yoshito; Inokuchi, Kaoru] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Biochem, Sugitani, Toyama, Japan; [Ohkawa, Noriaki; Saitoh, Yoshito; Tokunaga, Eri; Ozawa, Fumiko; Murayama, Akiko; Inokuchi, Kaoru] CREST, JST, Kawaguchi, Saitama, Japan; [Ohkawa, Noriaki; Saitoh, Yoshito; Tokunaga, Eri; Nihonmatsu, Itsuko; Ozawa, Fumiko; Murayama, Akiko; Inokuchi, Kaoru] MITILS, Mitsubishi Kagaku Inst Life Sci, Machida, Tokyo, Japan; [Shibata, Fumi; Kitamura, Toshio] Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Minato Ku, Tokyo, Japan	University of Toyama; Japan Science & Technology Agency (JST); Mitsubishi Kagaku Institute of Life Sciences (MITILS); University of Tokyo	Ohkawa, N (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Biochem, Sugitani, Toyama, Japan.	inokuchi@med.u-toyama.ac.jp	Inokuchi, Kaoru/AAI-9693-2020; Kitamura, Toshio/AAA-2071-2021	Inokuchi, Kaoru/0000-0002-5393-3133; Ohkawa, Noriaki/0000-0002-6754-9933	Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government; Mitsubishi Foundation; Uehara Memorial Foundation; Sasakawa Scientific Research Grant from the Japan Science Society; Grants-in-Aid for Scientific Research [24650164] Funding Source: KAKEN	Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Sasakawa Scientific Research Grant from the Japan Science Society; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (JST) to KI, a Grant-in-Aid for Scientific Research to KI, a Grant-in-Aid for Young Scientists B to NO from the Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government, the Mitsubishi Foundation, the Uehara Memorial Foundation to KI, and the Sasakawa Scientific Research Grant from the Japan Science Society to NO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM WC, 1994, P NATL ACAD SCI USA, V91, P10049, DOI 10.1073/pnas.91.21.10049; Abraham WC, 2002, J NEUROSCI, V22, P9626; Ambrogini P, 2010, HIPPOCAMPUS, V20, P799, DOI 10.1002/hipo.20679; Biou V, 2008, EUR J NEUROSCI, V27, P2847, DOI 10.1111/j.1460-9568.2008.06269.x; Bruel-Jungerman E, 2006, J NEUROSCI, V26, P5888, DOI 10.1523/JNEUROSCI.0782-06.2006; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Dobrossy MD, 2003, MOL PSYCHIATR, V8, P974, DOI 10.1038/sj.mp.4001419; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Jakubs K, 2008, J NEUROSCI, V28, P12477, DOI 10.1523/JNEUROSCI.3240-08.2008; Johnson OL, 2006, BRAIN RES, V1113, P1, DOI 10.1016/j.brainres.2006.06.116; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 1998, CURR BIOL, V8, P939, DOI 10.1016/S0960-9822(07)00377-6; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kitamura T, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-13; Kitamura T, 2009, CELL, V139, P814, DOI 10.1016/j.cell.2009.10.020; Kohler SJ, 2011, P NATL ACAD SCI USA, V108, P10326, DOI 10.1073/pnas.1017099108; Kondo S, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-27; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Li GN, 2010, CURR OPIN NEUROBIOL, V20, P126, DOI 10.1016/j.conb.2009.12.008; Matsuo R, 2000, J NEUROCHEM, V74, P2239, DOI 10.1046/j.1471-4159.2000.0742239.x; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; Medvedev NI, 2010, NEUROSCIENCE, V165, P1170, DOI 10.1016/j.neuroscience.2009.11.047; Meighan SE, 2006, J NEUROCHEM, V96, P1227, DOI 10.1111/j.1471-4159.2005.03565.x; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; MORRIS RGM, 1989, J NEUROSCI, V9, P3040; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Okada D, 2009, SCIENCE, V324, P904, DOI 10.1126/science.1171498; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; Popov VI, 2004, NEUROSCIENCE, V128, P251, DOI 10.1016/j.neuroscience.2004.06.029; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Schuster T, 1998, J NEUROBIOL, V37, P359, DOI 10.1002/(SICI)1097-4695(19981115)37:3<359::AID-NEU2>3.0.CO;2-4; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Snyder JS, 2009, J NEUROSCI, V29, P14484, DOI 10.1523/JNEUROSCI.1768-09.2009; STEWARD O, 1976, J COMP NEUROL, V167, P285, DOI 10.1002/cne.901670303; Sun BG, 2009, CELL STEM CELL, V5, P624, DOI 10.1016/j.stem.2009.10.003; Tamamaki N, 1999, J COMP NEUROL, V411, P257; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; Tronel S, 2010, P NATL ACAD SCI USA, V107, P7963, DOI 10.1073/pnas.0914613107; Trouche S, 2009, P NATL ACAD SCI USA, V106, P5919, DOI 10.1073/pnas.0811054106; Villarreal DM, 2002, NAT NEUROSCI, V5, P48, DOI 10.1038/nn776; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	61	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45270	10.1371/journal.pone.0045270	http://dx.doi.org/10.1371/journal.pone.0045270			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024813	gold, Green Published			2022-12-27	WOS:000308860100071
J	Perrone, G; Gaeta, LM; Zagami, M; Nasorri, F; Coppola, R; Borzomati, D; Bartolozzi, F; Altomare, V; Trodella, L; Tonini, G; Santini, D; Cavani, A; Muda, AO				Perrone, Giuseppe; Gaeta, Laura Maria; Zagami, Mariagiovanna; Nasorri, Francesca; Coppola, Roberto; Borzomati, Domenico; Bartolozzi, Francesco; Altomare, Vittorio; Trodella, Lucio; Tonini, Giuseppe; Santini, Daniele; Cavani, Andrea; Muda, Andrea Onetti			In Situ Identification of CD44+/CD242-Cancer Cells in Primary Human Breast Carcinomas	PLOS ONE			English	Article							CANCER-INITIATING CELLS; METASTASIS; CD44(+)/CD24(-); EXPRESSION; TUMORS; CD24; CHEMOTHERAPY; SURVIVE; MARKER; CD44	Breast cancer cells with the CD44+/CD24- phenotype have been reported to be tumourigenic due to their enhanced capacity for cancer development and their self-renewal potential. The identification of human tumourigenic breast cancer cells in surgical samples has recently received increased attention due to the implications for prognosis and treatment, although limitations exist in the interpretation of these studies. To better identify the CD44+/CD24- cells in routine surgical specimens, 56 primary breast carcinoma cases were analysed by immunofluorescence and confocal microscopy, and the results were compared using flow cytometry analysis to correlate the amount and distribution of the CD44+/CD24- population with clinicopathological features. Using these methods, we showed that the breast carcinoma cells displayed four distinct sub-populations based on the expression pattern of CD44 and CD24. The CD44+/CD24- cells were found in 91% of breast tumours and constituted an average of 6.12% (range, 0.11%-21.23%) of the tumour. A strong correlation was found between the percentage of CD44+/CD24- cells in primary tumours and distant metastasis development (p = 0.0001); in addition, there was an inverse significant association with ER and PGR status (p = 0.002 and p = 0.001, respectively). No relationship was evident with tumour size (T) and regional lymph node (N) status, differentiation grade, proliferative index or HER2 status. In a multivariate analysis, the percentage of CD44+/CD24- cancer cells was an independent factor related to metastasis development (p = 0.004). Our results indicate that confocal analysis of fluorescence-labelled breast cancer samples obtained at surgery is a reliable method to identify the CD44+/CD24- tumourigenic cell population, allowing for the stratification of breast cancer patients into two groups with substantially different relapse rates on the basis of CD44+/CD24- cell percentage.	[Perrone, Giuseppe; Gaeta, Laura Maria; Zagami, Mariagiovanna; Muda, Andrea Onetti] Campus Biomed Univ Rome, Dept Pathol, Rome, Italy; [Nasorri, Francesca; Cavani, Andrea] IDI IRCCS, Expt Immunol Lab, Rome, Italy; [Coppola, Roberto; Borzomati, Domenico] Campus Biomed Univ Rome, Dept Surg, Rome, Italy; [Bartolozzi, Francesco] Campus Biomed Univ Rome, Dept Epidemiol, Rome, Italy; [Altomare, Vittorio] Campus Biomed Univ Rome, Senol Unit, Rome, Italy; [Trodella, Lucio] Campus Biomed Univ Rome, Radiotherapy Unit, Rome, Italy; [Tonini, Giuseppe; Santini, Daniele] Campus Biomed Univ Rome, Oncol Unit, Rome, Italy; [Zagami, Mariagiovanna] Osped S Maria Misericordia, Dept Pathol, Udine, Italy	University Campus Bio-Medico - Rome Italy; IRCCS Istituto Dermopatico dell'Immacolata (IDI); University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy; Hospital Santa Maria della Misericordia	Perrone, G (corresponding author), Campus Biomed Univ Rome, Dept Pathol, Rome, Italy.	a.onetti@unicampus.it	perrone, giuseppe/ABF-5105-2020; Onetti Muda, Andrea/G-5384-2012; Coppola, Roberto/M-9998-2016; Muda, Andrea Onetti/AAA-5105-2020; Perrone, Giuseppe/E-7062-2011	Onetti Muda, Andrea/0000-0002-0274-6178; Coppola, Roberto/0000-0001-5798-0714; Perrone, Giuseppe/0000-0002-9538-5729; Altomare, Vittorio/0000-0002-9839-4129; Santini, Daniele/0000-0002-9118-3337; borzomati, domenico/0000-0001-8110-4917; Tonini, Giuseppe/0000-0003-4442-8677	Campus Bio-Medico University of Rome; "Consorzio Interuniversitario Trapianti d'organo'', Rome, Italy	Campus Bio-Medico University of Rome; "Consorzio Interuniversitario Trapianti d'organo'', Rome, Italy	This work was supported by grants from Campus Bio-Medico University of Rome (grant "Progetto d'Ateneo 2008'') and from "Consorzio Interuniversitario Trapianti d'organo'', Rome, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham BK, 2005, CLIN CANCER RES, V11, P1154; Ahmed MA, 2011, BREAST CANC IN PRESS; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Dey D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005329; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fillmore C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1673; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Gaviraghi M, 2011, BIOSCIENCE REP, V31, P45, DOI 10.1042/BSR20100018; Hebbard L, 2000, J CELL SCI, V113, P2619; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Hyun CL, 2008, J CLIN PATHOL, V61, P317, DOI 10.1136/jcp.2007.050336; Jijiwa M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024217; Kristiansen G, 2003, CLIN CANCER RES, V9, P4906; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Mylona E, 2008, HUM PATHOL, V39, P1096, DOI 10.1016/j.humpath.2007.12.003; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Pandit TS, 2009, INT J ONCOL, V35, P297, DOI 10.3892/ijo_00000340; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; ROBINS P, 1995, HUM PATHOL, V28, P873; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; Snyder EL, 2009, LAB INVEST, V89, P857, DOI 10.1038/labinvest.2009.54; Sobin L, 2009, TNM CLASSIFICATION M; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Yang YM, 2008, CANCER INVEST, V26, P725, DOI 10.1080/07357900801941845	29	33	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e43110	10.1371/journal.pone.0043110	http://dx.doi.org/10.1371/journal.pone.0043110			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028444	Green Published, Green Submitted, gold			2022-12-27	WOS:000308788700008
J	Balasubramanian, S; Quinones, L; Kasiganesan, H; Zhang, YH; Pleasant, DL; Sundararaj, KP; Zile, MR; Bradshaw, AD; Kuppuswamy, D				Balasubramanian, Sundaravadivel; Quinones, Lakeya; Kasiganesan, Harinath; Zhang, Yuhua; Pleasant, Dorea L.; Sundararaj, Kamala P.; Zile, Michael R.; Bradshaw, Amy D.; Kuppuswamy, Dhandapani			beta 3 Integrin in Cardiac Fibroblast Is Critical for Extracellular Matrix Accumulation during Pressure Overload Hypertrophy in Mouse	PLOS ONE			English	Article							FOCAL ADHESION KINASE; BETA(3) INTEGRIN; TYROSINE KINASE; ALPHA(V)BETA(3) INTEGRIN; CELL-ADHESION; ACTIVATION; GROWTH; SRC; SURVIVAL; COMPLEX	The adhesion receptor beta 3 integrin regulates diverse cellular functions in various tissues. As beta 3 integrin has been implicated in extracellular matrix (ECM) remodeling, we sought to explore the role of beta 3 integrin in cardiac fibrosis by using wild type (WT) and b3 integrin null (beta 3-/-) mice for in vivo pressure overload (PO) and in vitro primary cardiac fibroblast phenotypic studies. Compared to WT mice, beta 3-/- mice upon pressure overload hypertrophy for 4 wk by transverse aortic constriction (TAC) showed a substantially reduced accumulation of interstitial fibronectin and collagen. Moreover, pressure overloaded LV from beta 3-/- mice exhibited reduced levels of both fibroblast proliferation and fibroblast-specific protein-1 (FSP1) expression in early time points of PO. To test if the observed impairment of ECM accumulation in beta 3-/- mice was due to compromised cardiac fibroblast function, we analyzed primary cardiac fibroblasts from WT and beta 3-/- mice for adhesion to ECM proteins, cell spreading, proliferation, and migration in response to platelet derived growth factor-BB (PDGF, a growth factor known to promote fibrosis) stimulation. Our results showed that beta 3-/- cardiac fibroblasts exhibited a significant reduction in cell-matrix adhesion, cell spreading, proliferation and migration. In addition, the activation of PDGF receptor associated tyrosine kinase and non-receptor tyrosine kinase Pyk2, upon PDGF stimulation were impaired in beta 3-/- cells. Adenoviral expression of a dominant negative form of Pyk2 (Y402F) resulted in reduced accumulation of fibronectin. These results indicate that beta 3 integrin-mediated Pyk2 signaling in cardiac fibroblasts plays a critical role in PO-induced cardiac fibrosis.	[Balasubramanian, Sundaravadivel; Quinones, Lakeya; Kasiganesan, Harinath; Zhang, Yuhua; Pleasant, Dorea L.; Sundararaj, Kamala P.; Zile, Michael R.; Bradshaw, Amy D.; Kuppuswamy, Dhandapani] Med Univ S Carolina, Gazes Cardiac Res Inst, Dept Med, Div Cardiol, Charleston, SC 29425 USA; [Zile, Michael R.; Bradshaw, Amy D.] Ralph H Johnson Dept Vet Affairs Med Ctr, Charleston, SC USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Balasubramanian, S (corresponding author), Med Univ S Carolina, Gazes Cardiac Res Inst, Dept Med, Div Cardiol, Charleston, SC 29425 USA.	kuppusd@musc.edu		Jenkins, Dorea/0000-0001-9510-8601; Zile, Michael/0000-0001-7076-221X	National Institutes of Health [R01 RHL092124A]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM072643] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by National Institutes of Health R01 RHL092124A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002; Arslan F, 2011, CIRC RES, V108, P582, DOI 10.1161/CIRCRESAHA.110.224428; Balasubramanian S, 2003, J BIOL CHEM, V278, P42214, DOI 10.1074/jbc.M303428200; Borges E, 2000, J BIOL CHEM, V275, P39867, DOI 10.1074/jbc.M007040200; Bowers SLK, 2010, J MOL CELL CARDIOL, V48, P474, DOI 10.1016/j.yjmcc.2009.08.024; Bradshaw AD, 1999, MOL BIOL CELL, V10, P1569, DOI 10.1091/mbc.10.5.1569; Bradshaw AD, 2009, CIRCULATION, V119, P269, DOI 10.1161/CIRCULATIONAHA.108.773424; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Montero JC, 2011, CLIN CANCER RES, V17, P5546, DOI 10.1158/1078-0432.CCR-10-2616; Clemente CFMZ, 2007, CIRC RES, V101, P1339, DOI 10.1161/CIRCRESAHA.107.160978; Dalla Costa AP, 2010, CARDIOVASC RES, V86, P421, DOI 10.1093/cvr/cvp416; Danen EHJ, 2005, J CELL BIOL, V169, P515, DOI 10.1083/jcb.200412081; Destaing O, 2008, MOL BIOL CELL, V19, P394, DOI 10.1091/mbc.E07-03-0227; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; Gopal U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017649; Gough W, 2011, J BIOMOL SCREEN, V16, P155, DOI 10.1177/1087057110393340; Hauselmann SP, 2011, FREE RADICAL BIO MED, V51, P609, DOI 10.1016/j.freeradbiomed.2011.05.007; Harris BS, 2011, AM J PHYSIOL-HEART C, V301, pH841, DOI 10.1152/ajpheart.01247.2010; Harston RK, 2011, J SIGNAL TRANSDUCT, V2011; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Hsueh WA, 1998, HYPERTENSION, V31, P176, DOI 10.1161/01.HYP.31.1.176; Huntley BK, 2010, J CELL PHYSIOL, V225, P251, DOI 10.1002/jcp.22253; Ishigaki T, 2011, J CELL PHYSIOL, V226, P2617, DOI 10.1002/jcp.22614; Johnston RK, 2009, FASEB J, V23, P2759, DOI 10.1096/fj.08-127480; Kuppuswamy D, 2002, CIRC RES, V90, P1240, DOI 10.1161/01.RES.0000025080.78636.23; Lipinski CA, 2010, EXPERT OPIN THER TAR, V14, P95, DOI 10.1517/14728220903473194; Majhen D, 2011, LIFE SCI, V89, P241, DOI 10.1016/j.lfs.2011.06.009; Manso AM, 2009, J INVEST MED, V57, P856, DOI 10.2310/JIM.0b013e3181c5e61f; Manso AM, 2009, AM J PHYSIOL-HEART C, V296, pH627, DOI 10.1152/ajpheart.00444.2008; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Morgan EA, 2010, FASEB J, V24, P1117, DOI 10.1096/fj.09-138420; Mulgrew K, 2006, MOL CANCER THER, V5, P3122, DOI 10.1158/1535-7163.MCT-06-0356; Murasawa S, 2000, J BIOL CHEM, V275, P26856; Nyberg P, 2008, FRONT BIOSCI, V13, P6537, DOI 10.2741/3173; Ren J, 2007, J MOL CELL CARDIOL, V42, P367, DOI 10.1016/j.yjmcc.2006.11.002; Roe MT, 2008, CIRCULATION, V117, P886, DOI 10.1161/CIRCULATIONAHA.107.759167; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Schneider M, 2007, CARDIOVASC RES, V75, P40, DOI 10.1016/j.cardiores.2007.03.027; Shai SY, 2002, CIRC RES, V90, P458, DOI 10.1161/hh0402.105790; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Stewart JA, 2010, CELL TISSUE RES, V340, P117, DOI 10.1007/s00441-010-0943-2; Suryakumar G, 2010, J CARDIOVASC PHARM, V55, P567, DOI 10.1097/FJC.0b013e3181d9f5d4; Taddei ML, 2011, J PATHOLOGY; WEBER KT, 1992, J AM COLL CARDIOL, V20, P3, DOI 10.1016/0735-1097(92)90130-F; Willey CD, 2003, J MOL CELL CARDIOL, V35, P671, DOI 10.1016/S0022-2828(03)00112-3; Willey CD, 2008, INT J BIOL SCI, V4, P184; Zachary I, 2001, CARDIOVASC RES, V49, P568, DOI 10.1016/S0008-6363(00)00268-6; Zile MR, 2012, AM J PHYSIOL-HEART C, V302, pH1429, DOI 10.1152/ajpheart.00580.2011	49	38	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45076	10.1371/journal.pone.0045076	http://dx.doi.org/10.1371/journal.pone.0045076			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984613	Green Published, gold, Green Submitted			2022-12-27	WOS:000308738500114
J	Bano-Polo, M; Baeza-Delgado, C; Orzaez, M; Marti-Renom, MA; Abad, C; Mingarro, I				Bano-Polo, Manuel; Baeza-Delgado, Carlos; Orzaez, Mar; Marti-Renom, Marc A.; Abad, Concepcion; Mingarro, Ismael			Polar/Ionizable Residues in Transmembrane Segments: Effects on Helix-Helix Packing	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; GLYCOPHORIN-A DIMERIZATION; ALPHA-HELICES; BIOLOGICAL MEMBRANE; PROTEIN INTEGRATION; POLAR RESIDUES; ER MEMBRANE; WEB SERVER; ASSOCIATION; SEQUENCE	The vast majority of membrane proteins are anchored to biological membranes through hydrophobic alpha-helices. Sequence analysis of high-resolution membrane protein structures show that ionizable amino acid residues are present in transmembrane (TM) helices, often with a functional and/or structural role. Here, using as scaffold the hydrophobic TM domain of the model membrane protein glycophorin A (GpA), we address the consequences of replacing specific residues by ionizable amino acids on TM helix insertion and packing, both in detergent micelles and in biological membranes. Our findings demonstrate that ionizable residues are stably inserted in hydrophobic environments, and tolerated in the dimerization process when oriented toward the lipid face, emphasizing the complexity of protein-lipid interactions in biological membranes.	[Bano-Polo, Manuel; Baeza-Delgado, Carlos; Abad, Concepcion; Mingarro, Ismael] Univ Valencia, Dept Bioquim & Biol Mol, E-46100 Burjassot, Spain; [Orzaez, Mar] Ctr Invest Principe Felipe, Valencia, Spain; [Marti-Renom, Marc A.] Ctr Nacl Anal Genom, Struct Genom Team, Genome Biol Grp, Barcelona, Spain; [Marti-Renom, Marc A.] Ctr Genom Regulat, Struct Genom Grp, Barcelona, Spain	University of Valencia; Prince Felipe Research Center; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Bano-Polo, M (corresponding author), Univ Valencia, Dept Bioquim & Biol Mol, E-46100 Burjassot, Spain.	Ismael.Mingarro@uv.es	Mingarro, Ismael/B-4745-2014; Orzaez, Mar/B-4992-2014; Baeza-Delgado, Carlos/O-8473-2019; Polo, Manuel Bano/P-5346-2016; Baeza-Delgado, Carlos/U-1452-2018; Marti-Renom, Marc A./Y-8803-2019; Marti-Renom, Marc/A-1836-2010	Mingarro, Ismael/0000-0002-1910-1229; Orzaez, Mar/0000-0003-3231-5835; Polo, Manuel Bano/0000-0002-4840-4480; Baeza-Delgado, Carlos/0000-0001-8551-9124; Marti-Renom, Marc A./0000-0002-0151-4279; Marti-Renom, Marc/0000-0002-0151-4279	Spanish Ministry of Science and Innovation (MICINN) [BFU2009-08401, BFU2010-19310]; European Union; Generalitat Valenciana [PROMETEO/2010/005]; MICINN	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission)	This work was supported by grants BFU2009-08401 (to IM) and BFU2010-19310 (to MAM-R) from the Spanish Ministry of Science and Innovation (MICINN, ERDF supported by the European Union), as well as by PROMETEO/2010/005 (to IM) from the Generalitat Valenciana. MB-P and CB-D were recipients of FPU and FPI predoctoral fellowships from the MICINN, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeza-Delgado C, 2013, EUR BIOPHYS J BIOPHY, V42, P199, DOI 10.1007/s00249-012-0813-9; Caputo GA, 2004, BIOCHEMISTRY-US, V43, P8794, DOI 10.1021/bi049696p; Chin CN, 2000, J MOL BIOL, V303, P1, DOI 10.1006/jmbi.2000.4122; Cymer F, 2012, BBA-BIOMEMBRANES, V1818, P963, DOI 10.1016/j.bbamem.2011.07.035; DeGrado WF, 2003, PROTEIN SCI, V12, P647, DOI 10.1110/ps.0236503; Duong MT, 2007, J MOL BIOL, V371, P422, DOI 10.1016/j.jmb.2007.05.026; Gafvelin G, 1997, J BIOL CHEM, V272, P6119, DOI 10.1074/jbc.272.10.6119; Garcia-Saez AJ, 2004, BIOCHEMISTRY-US, V43, P10930, DOI 10.1021/bi036044c; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; Hermansson M, 2003, J MOL BIOL, V334, P803, DOI 10.1016/j.jmb.2003.10.019; Herrmann JR, 2010, J MOL BIOL, V396, P452, DOI 10.1016/j.jmb.2009.11.054; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Illergard K, 2011, PROTEINS, V79, P79, DOI 10.1002/prot.22859; Jayasinghe S, 2001, PROTEIN SCI, V10, P455, DOI 10.1110/ps.43501; JOHANSSON M, 1993, MOL GEN GENET, V239, P251, DOI 10.1007/BF00281625; Johnson RM, 2006, BIOCHEMISTRY-US, V45, P8507, DOI 10.1021/bi060063f; KOLMAR H, 1995, EMBO J, V14, P3895, DOI 10.1002/j.1460-2075.1995.tb00061.x; Langosch D, 1996, J MOL BIOL, V263, P525, DOI 10.1006/jmbi.1996.0595; LEMMON MA, 1992, J BIOL CHEM, V267, P7683; LEMMON MA, 1992, BIOCHEMISTRY-US, V31, P12719, DOI 10.1021/bi00166a002; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; MacKenzie KR, 2006, CHEM REV, V106, P1931, DOI 10.1021/cr0404388; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Martinez-Gil L, 2008, BIOPHYS J, V95, pL36, DOI 10.1529/biophysj.108.138602; Martinez-Gil L, 2011, FEBS J, V278, P3846, DOI 10.1111/j.1742-4658.2011.08185.x; Mingarro I, 1996, PROTEIN SCI, V5, P1339, DOI 10.1002/pro.5560050712; Monne M, 1998, J MOL BIOL, V284, P1177, DOI 10.1006/jmbi.1998.2218; Orzaez M, 2005, FEBS LETT, V579, P1633, DOI 10.1016/j.febslet.2005.01.078; Orzaez M, 2004, J MOL BIOL, V335, P631, DOI 10.1016/j.jmb.2003.10.062; Orzaez M, 2000, PROTEIN SCI, V9, P1246, DOI 10.1110/ps.9.6.1246; POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Smith SO, 2001, BIOCHEMISTRY-US, V40, P6553, DOI 10.1021/bi010357v; Sulistijo ES, 2003, J BIOL CHEM, V278, P51950, DOI 10.1074/jbc.M308429200; Tulumello DV, 2009, BIOCHEMISTRY-US, V48, P12096, DOI 10.1021/bi9013819; Vilar M, 2002, J BIOL CHEM, V277, P23447, DOI 10.1074/jbc.M202935200; Vilar M, 2009, NEURON, V62, P72, DOI 10.1016/j.neuron.2009.02.020; Wong WC, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-57; Zhang JM, 2009, BIOPHYS J, V96, P4418, DOI 10.1016/j.bpj.2009.03.008; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698	44	23	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44263	10.1371/journal.pone.0044263	http://dx.doi.org/10.1371/journal.pone.0044263			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984481	Green Published, gold			2022-12-27	WOS:000308738500040
J	Hector, A; von Felten, S; Hautier, Y; Weilenmann, M; Bruelheide, H				Hector, Andy; von Felten, Stefanie; Hautier, Yann; Weilenmann, Maja; Bruelheide, Helge			Effects of Dominance and Diversity on Productivity along Ellenberg's Experimental Water Table Gradients	PLOS ONE			English	Article							ECOSYSTEM FUNCTION; PLANT; COMPLEMENTARITY; BIODIVERSITY; SELECTION	Heinz Ellenberg's historically important work on changes in the abundances of a community of grass species growing along experimental gradients of water table depth has played an important role in helping to identify the hydrological niches of plant species in wet meadows. We present a previously unpublished complete version of Ellenberg's dataset from the 1950s together with the results of a series of modern statistical analyses testing for hypothesized overyielding of aboveground net primary production as a consequence of resource-based niche differentiation. Interactions of species with water table depth and soil type in the results of our analyses are qualitatively consistent with earlier interpretations of evidence for differences in the fundamental and realized niches of species. Arrhenatherum elatius tended to dominate communities and this effect was generally positively related to increasing water table depth. There was little overyielding of aboveground net primary production during the two repeats of the experiment conducted in successive single growing seasons. Examination of how the effects of biodiversity on ecosystem processes vary across environmental gradients is an underutilized approach - particularly where the gradient is thought to be an axis of niche differentiation as is the case with water availability. Furthermore, advances in ecology and statistics during the 60 years since Ellenberg's classic experiment was performed suggest that it may be worth repeating over a longer duration and with modern experimental design and methodologies.	[Hector, Andy; von Felten, Stefanie; Hautier, Yann; Weilenmann, Maja] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Hector, Andy] Microsoft Res, Cambridge, England; [Bruelheide, Helge] Univ Halle Wittenberg, Inst Biol Geobot & Bot Garden, Halle, Saale, Germany	University of Zurich; Microsoft; Martin Luther University Halle Wittenberg	Hector, A (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	andrew.hector@uzh.ch	Hector, Andrew/H-4199-2011; von Felten, Stefanie/L-3514-2019; Hautier, Yann/D-5426-2015; Hautier, Yann/I-2526-2019; von Felten, Stefanie/D-2701-2009; Bruelheide, Helge/G-3907-2013	Hector, Andrew/0000-0002-1309-7716; von Felten, Stefanie/0000-0002-5264-6394; Hautier, Yann/0000-0003-4347-7741; Hautier, Yann/0000-0003-4347-7741; Bruelheide, Helge/0000-0003-3135-0356				Auckland P, 1978, 78 CSIRO DIV LAND US, V78, P1; Austin MP, 2006, ECOL MODEL, V199, P197, DOI 10.1016/j.ecolmodel.2006.05.023; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Carroll IT, 2011, ECOLOGY, V92, P1157; Ellenberg H., 1953, BER DT BOT GES, V65, P351, DOI 10.1111/j.1438-8677.1953.tb00671.x; Ellenberg H, 1954, PLANT ECOL, V5, P199, DOI [10.1007/BF00299574, DOI 10.1007/BF00299574]; Fox JW, 2005, ECOL LETT, V8, P846, DOI 10.1111/j.1461-0248.2005.00795.x; Fox JW, 2008, ECOLOGY, P1139; Harper J. L, 1977, POPULATION BIOL PLAN; Hector Andy, 2009, P94; Hutchinson GE, 1957, QUANTITATIVE BIOL, V22, P515; LIETH H., 1958, Zeitschrift fur Acker- und Pflanzenbau, V106, P205; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2011, ECOLOGY, V92, P1157; Moore JL, 2001, OIKOS, V94, P303, DOI 10.1034/j.1600-0706.2001.940211.x; Mueller-Dombios D, 1974, AIMS METHODS VEGETAT, P150; Pinheiro J, 2001, MIXED EFFECTS MODELS; R Development Core Team, 2010, LANG ENV STAT COMP; Silvertown J, 1999, NATURE, V400, P61, DOI 10.1038/21877; Trenbath B. R., 1974, Advances in Agronomy, V26, P177, DOI 10.1016/S0065-2113(08)60871-8; Vandermeer J.H., 1989, ECOLOGY INTERCROPPIN, DOI [10.1017/CBO9780511623523, DOI 10.1017/CBO9780511623523]; [No title captured]; [No title captured]	23	9	10	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43358	10.1371/journal.pone.0043358	http://dx.doi.org/10.1371/journal.pone.0043358			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984421	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000308738500011
J	Khalaf, H; Bengtsson, T				Khalaf, Hazem; Bengtsson, Torbjorn			Altered T-Cell Responses by the Periodontal Pathogen Porphyromonas gingivalis	PLOS ONE			English	Article							NF-KAPPA-B; PROTEINASE-ACTIVATED RECEPTOR-2; ENDOTHELIAL-CELLS; VIRULENCE FACTORS; EPITHELIAL-CELLS; GINGIPAINS; ATHEROSCLEROSIS; INVASION; AP-1; TRANSCRIPTION	Several studies support an association between the chronic inflammatory diseases periodontitis and atherosclerosis with a crucial role for the periodontal pathogen Porphyromonas gingivalis. However, the interplay between this pathogen and the adaptive immune system, including T-cells, is sparsely investigated. Here we used Jurkat T-cells to determine the effects of P. gingivalis on T-cell-mediated adaptive immune responses. We show that viable P. gingivalis targets IL-2 expression at the protein level. Initial cellular events, including ROS production and [Ca2+](i), were elevated in response to P. gingivalis, but AP-1 and NF-kappa B activity dropped below basal levels and T-cells were unable to sustain stable IL-2 accumulation. IL-2 was partially restored by Leupeptin, but not by Cathepsin B Inhibitor, indicating an involvement of Rgp proteinases in the suppression of IL-2 accumulation. This was further confirmed by purified Rgp that caused a dose-dependent decrease in IL-2 levels. These results provide new insights of how this periodontal pathogen evades the host adaptive immune system by inhibiting IL-2 accumulation and thus attenuating T-cell proliferation and cellular communication.	[Khalaf, Hazem; Bengtsson, Torbjorn] Univ Orebro, Sch Hlth & Med Sci, Div Clin Med, Orebro, Sweden	Orebro University	Khalaf, H (corresponding author), Univ Orebro, Sch Hlth & Med Sci, Div Clin Med, Orebro, Sweden.	hazem.khalaf@oru.se		Khalaf, Hazem/0000-0002-3373-7864	Swedish Research Council; Swedish Heart-Lung Foundation; Swedish Fund for Research without Animal Experiments; Swedish Heart and Lung Association; Foundation of Olle Engkvist	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Fund for Research without Animal Experiments; Swedish Heart and Lung Association(Swedish Heart-Lung Foundation); Foundation of Olle Engkvist	This work was supported by grants from the Swedish Research Council, the Swedish Heart-Lung Foundation, the Swedish Fund for Research without Animal Experiments, the Swedish Heart and Lung Association and the Foundation of Olle Engkvist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Andrukhov O, 2011, J PERIODONTOL, V82, P885, DOI 10.1902/jop.2010.100425; Aoki Y, 2010, BIOCHEM BIOPH RES CO, V398, P86, DOI 10.1016/j.bbrc.2010.06.040; Belibasakis GN, 2011, INFLAMMATION, V34, P133, DOI 10.1007/s10753-010-9216-1; Calkins CC, 1998, J BIOL CHEM, V273, P6611, DOI 10.1074/jbc.273.12.6611; Cui J, 2002, J BIOL CHEM, V277, P47175, DOI 10.1074/jbc.M205870200; Darveau RP, 1998, INFECT IMMUN, V66, P1660, DOI 10.1128/IAI.66.4.1660-1665.1998; Deshpande RG, 1998, INFECT IMMUN, V66, P5337, DOI 10.1128/IAI.66.11.5337-5343.1998; Gemmell E, 2007, PERIODONTOL 2000, V43, P14, DOI 10.1111/j.1600-0757.2006.00173.x; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guo YH, 2010, PERIODONTOL 2000, V54, P15, DOI 10.1111/j.1600-0757.2010.00377.x; Hansson GK, 2009, ARTERIOSCL THROM VAS, V29, P1714, DOI 10.1161/ATVBAHA.108.179713; Holt SC, 1999, PERIODONTOL 2000, V20, P168, DOI 10.1111/j.1600-0757.1999.tb00162.x; Jagels MA, 1996, INFECT IMMUN, V64, P1984, DOI 10.1128/IAI.64.6.1984-1991.1996; JAIN J, 1992, J EXP MED, V175, P853, DOI 10.1084/jem.175.3.853; Kadowaki T, 2000, J BIOCHEM, V128, P153, DOI 10.1093/oxfordjournals.jbchem.a022735; Khalaf H, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-26; Kitamura Y, 2002, J PERIODONTAL RES, V37, P464, DOI 10.1034/j.1600-0765.2002.01364.x; Kobayashi-Sakamoto M, 2003, CURR MICROBIOL, V46, P109, DOI 10.1007/s00284-002-3782-x; Kuramitsu HK, 1998, ORAL MICROBIOL IMMUN, V13, P263, DOI 10.1111/j.1399-302X.1998.tb00706.x; LAMONT RJ, 1995, INFECT IMMUN, V63, P3878, DOI 10.1128/IAI.63.10.3878-3885.1995; Lourbakos A, 1998, FEBS LETT, V435, P45, DOI 10.1016/S0014-5793(98)01036-9; Macian F, 2004, CURR OPIN IMMUNOL, V16, P209, DOI 10.1016/j.coi.2004.01.013; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Mallat Z, 1999, CIRC RES, V85, pE17, DOI 10.1161/01.RES.85.8.e17; Nilsson J, 2009, TRENDS CARDIOVAS MED, V19, P272, DOI 10.1016/j.tcm.2010.02.010; Oda T, 2003, ORAL MICROBIOL IMMUN, V18, P30, DOI 10.1034/j.1399-302X.2003.180105.x; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Pae HO, 2004, J IMMUNOL, V172, P4744, DOI 10.4049/jimmunol.172.8.4744; Patrussi L, 2008, IMMUNOL LETT, V115, P75, DOI 10.1016/j.imlet.2007.10.012; Pores-Fernando AT, 2009, IMMUNOL REV, V231, P160, DOI 10.1111/j.1600-065X.2009.00809.x; Quintana A, 2009, CELL CALCIUM, V45, P109, DOI 10.1016/j.ceca.2008.07.003; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sareila O, 2011, ANTIOXID REDOX SIGN, V15, P2197, DOI 10.1089/ars.2010.3635; Sasaki N, 2009, CIRCULATION, V120, P1996, DOI 10.1161/CIRCULATIONAHA.109.863431; Shpacovitch VM, 2002, J INVEST DERMATOL, V118, P380, DOI 10.1046/j.0022-202x.2001.01658.x; Stathopoulou PG, 2009, ORAL MICROBIOL IMMUN, V24, P11, DOI 10.1111/j.1399-302X.2008.00467.x; Sugawara S, 2000, J IMMUNOL, V165, P411, DOI 10.4049/jimmunol.165.1.411; Tam V, 2009, INFECT IMMUN, V77, P1451, DOI 10.1128/IAI.01377-08; Tonetti MS, 2009, J CLIN PERIODONTOL, V36, P15, DOI 10.1111/j.1600-051X.2009.01417.x; Weinberg A, 1997, INFECT IMMUN, V65, P313, DOI 10.1128/IAI.65.1.313-316.1997; Yun LWP, 2007, CLIN EXP IMMUNOL, V150, P217, DOI 10.1111/j.1365-2249.2007.03488.x; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018	43	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45192	10.1371/journal.pone.0045192	http://dx.doi.org/10.1371/journal.pone.0045192			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984628	Green Published, gold, Green Submitted			2022-12-27	WOS:000308738500126
J	Marshall, JAR; Bogacz, R; Gilchrist, ID				Marshall, James A. R.; Bogacz, Rafal; Gilchrist, Iain D.			Consistent Implementation of Decisions in the Brain	PLOS ONE			English	Article							SPEED-ACCURACY TRADEOFF; PERCEPTUAL DECISION; NEURAL BASIS; AREA LIP; CHOICE; MODELS; TIME; MICROSTIMULATION; PERFORMANCE; TASK	Despite the complexity and variability of decision processes, motor responses are generally stereotypical and independent of decision difficulty. How is this consistency achieved? Through an engineering analogy we consider how and why a system should be designed to realise not only flexible decision-making, but also consistent decision implementation. We specifically consider neurobiologically-plausible accumulator models of decision-making, in which decisions are made when a decision threshold is reached. To trade-off between the speed and accuracy of the decision in these models, one can either adjust the thresholds themselves or, equivalently, fix the thresholds and adjust baseline activation. Here we review how this equivalence can be implemented in such models. We then argue that manipulating baseline activation is preferable as it realises consistent decision implementation by ensuring consistency of motor inputs, summarise empirical evidence in support of this hypothesis, and suggest that it could be a general principle of decision making and implementation. Our goal is therefore to review how neurobiologically-plausible models of decision-making can manipulate speed-accuracy trade-offs using different mechanisms, to consider which of these mechanisms has more desirable decision-implementation properties, and then review the relevant neuroscientific data on which mechanism brains actually use.	[Marshall, James A. R.] Univ Sheffield, Dept Comp Sci, Kroto Res Inst, Sheffield S10 2TN, S Yorkshire, England; [Bogacz, Rafal] Univ Bristol, Dept Comp Sci, Bristol, Avon, England; [Gilchrist, Iain D.] Univ Bristol, Sch Expt Psychol, Bristol, Avon, England	University of Sheffield; University of Bristol; University of Bristol	Marshall, JAR (corresponding author), Univ Sheffield, Dept Comp Sci, Kroto Res Inst, Sheffield S10 2TN, S Yorkshire, England.	James.Marshall@sheffield.ac.uk	Gilchrist, Iain/E-8627-2010	Gilchrist, Iain D./0000-0003-2070-6679; Marshall, James/0000-0002-1506-167X	Biotechnology and Biological Sciences Research Council (BBSRC) Career Development Fellowship; Engineering and Physical Sciences Research Council (EPSRC) [EP/I032622/1]; BBSRC [BB/G02166X/2, BB/G02166X/1] Funding Source: UKRI; EPSRC [EP/I032622/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G02166X/1, BB/G02166X/2] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/I032622/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) Career Development Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	IG is supported by a Biotechnology and Biological Sciences Research Council (BBSRC) Career Development Fellowship. RB and IG are supported by Engineering and Physical Sciences Research Council (EPSRC) grant EP/I032622/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHILL A T, 1975, Mathematical Biosciences, V24, P191, DOI 10.1016/0025-5564(75)90075-9; Bogacz R, 2007, NEURAL COMPUT, V19, P442, DOI 10.1162/neco.2007.19.2.442; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Bogacz R, 2010, TRENDS NEUROSCI, V33, P10, DOI 10.1016/j.tins.2009.09.002; Brown P., 2001, STOCH DYNAM, V1, P159, DOI 10.1142/S0219493701000102; Brown S, 2005, PSYCHOL REV, V112, P117, DOI 10.1037/0033-295X.112.1.117; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Ditterich J, 2003, NAT NEUROSCI, V6, P891, DOI 10.1038/nn1094; Ditterich J, 2006, NEURAL NETWORKS, V19, P981, DOI 10.1016/j.neunet.2006.05.042; Forstmann BU, 2008, P NATL ACAD SCI USA, V105, P17538, DOI 10.1073/pnas.0805903105; Fortsmann BU, 2010, P NATL ACAD SCI USA, V107, P15916; Frank MJ, 2007, PHILOS T R SOC B, V362, P1641, DOI 10.1098/rstb.2007.2058; Furman M, 2008, NEURON, V60, P1153, DOI 10.1016/j.neuron.2008.12.003; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; GRICE GR, 1968, PSYCHOL REV, V75, P359, DOI 10.1037/h0026287; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Ivanoff J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002635; Ludwig CJH, 2009, COGNITIVE PSYCHOL, V59, P180, DOI 10.1016/j.cogpsych.2009.04.002; Ludwig CJH, 2005, J NEUROSCI, V25, P9907, DOI 10.1523/JNEUROSCI.2197-05.2005; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; McNamara JM, 2009, TRENDS ECOL EVOL, V24, P670, DOI 10.1016/j.tree.2009.05.011; PARKER GA, 1990, NATURE, V348, P27, DOI 10.1038/348027a0; Purcell BA, 2010, PSYCHOL REV, V117, P1113, DOI 10.1037/a0020311; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Roxin A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000046; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; van Veen V, 2008, J COGNITIVE NEUROSCI, V20, P1952, DOI 10.1162/jocn.2008.20146; VICKERS D, 1970, Ergonomics, V13, P37, DOI 10.1080/00140137008931117; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852	33	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43443	10.1371/journal.pone.0043443	http://dx.doi.org/10.1371/journal.pone.0043443			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005GJ	22984425	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000308738500014
J	Moreira, MT; Oskrochi, R; Foxcroft, DR				Moreira, Maria T.; Oskrochi, Reza; Foxcroft, David R.			Personalised Normative Feedback for Preventing Alcohol Misuse in University Students: Solomon Three-Group Randomised Controlled Trial	PLOS ONE			English	Article							BRIEF INTERVENTION; HAZARDOUS DRINKING; SOCIAL NORMS; DRUG-USE; COLLEGE-STUDENTS; MEDICAL-STUDENTS; HEAVY DRINKING; BINGE-DRINKING; MISPERCEPTIONS; PREVALENCE	Background: Young people tend to over-estimate peer group drinking levels. Personalised normative feedback (PNF) aims to correct this misperception by providing information about personal drinking levels and patterns compared with norms in similar aged peer groups. PNF is intended to raise motivation for behaviour change and has been highlighted for alcohol misuse prevention by the British Government Behavioural Insight Team. The objective of the trial was to assess the effectiveness of PNF with college students for the prevention of alcohol misuse. Methodology: Solomon three-group randomised controlled trial. 1751 students, from 22 British Universities, allocated to a PNF group, a normal control group, or a delayed measurement control group to allow assessment of any measurement effects. PNF was provided by email. Participants completed online questionnaires at baseline, 6- and 12-months (only 12-months for the delayed measurement controls). Drinking behaviour measures were (i) alcohol disorders; (ii) frequency; (iii) typical quantity, (iv) weekly consumption; (v) alcohol-related problems; (vi) perceived drinking norms; and (vii) positive alcohol expectancies. Analyses focused on high-risk drinkers, as well as all students, because of research evidence for the prevention paradox in student drinkers. Principal Findings: Follow-up rates were low, with only 50% and 40% responding at 6- and 12-months, respectively, though comparable to similar European studies. We found no evidence for any systematic attrition bias. Overall, statistical analyses with the high risk sub-sample, and for all students, showed no significant effects of the intervention, at either time-point, in a completed case analysis and a multiple imputation analysis. Conclusions: We found no evidence for the effectiveness of PNF for the prevention of alcohol misuse and alcohol-related problems in a UK student population.	[Moreira, Maria T.] Inst Super Saude Alto Ave, Braga, Portugal; [Oskrochi, Reza] Oxford Brookes Univ, Med Stat Programme, Oxford OX3 0BP, England; [Foxcroft, David R.] Oxford Brookes Univ, Dept Psychol Social Work & Publ Hlth, Oxford OX3 0BP, England	Oxford Brookes University; Oxford Brookes University	Moreira, MT (corresponding author), Inst Super Saude Alto Ave, Braga, Portugal.	david.foxcroft@brookes.ac.uk	Moreira, Teresa/ABB-7040-2021; Oskrochi, Gholamreza/R-4435-2019	Moreira, Teresa/0000-0002-2554-697X; Foxcroft, David/0000-0001-9752-7527; Oskrochi, Gholamreza/0000-0001-6077-9771	Portuguese Foundation for Science and Technology; Alcohol Research UK; European Foundation for Alcohol Research; alcohol industry for prevention projects; Drinkaware Trust	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Alcohol Research UK; European Foundation for Alcohol Research; alcohol industry for prevention projects; Drinkaware Trust	MTM was supported by a fellowship from the Portuguese Foundation for Science and Technology. Other parts of this study were supported by Alcohol Research UK and the European Foundation for Alcohol Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; MTM and RO declare no competing interests. DRF declares that his Department has received funding from the alcohol industry for prevention projects, and that he is a Trustee of the alcohol-industry funded Drinkaware Trust. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials	AGOSTINELLI G, 1995, J DRUG EDUC, V25, P31, DOI 10.2190/XD56-D6WR-7195-EAL3; Anderson P., 2006, ALCOHOL EUROPE; Babor TF., 2001, AUDIT ALCOHOL USE DI; BAER JS, 1991, J STUD ALCOHOL, V52, P580, DOI 10.15288/jsa.1991.52.580; Bewick BM, 2008, ADDICT BEHAV, V33, P1192, DOI 10.1016/j.addbeh.2008.05.002; Bewick BM, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1461; Borsari B, 2003, J STUD ALCOHOL, V64, P331, DOI 10.15288/jsa.2003.64.331; Cabinet Office Behavioural Insights Team, 2011, BEH INS TEAM ANN UPD; Campbell D. T., 1963, EXPT QUASIEXPERIMENT, P171; Centre for Addiction and Mental Health, 2008, EV YOUR DRINK; Danielsson AK, 2012, ADDICTION, V107, P71, DOI 10.1111/j.1360-0443.2011.03537.x; Dimeff L.A., 1999, BRIEF ALCOHOL SCREEN; Ekman DS, 2011, ADDICT BEHAV, V36, P654, DOI 10.1016/j.addbeh.2011.01.015; Foxcroft DR, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009307; Foxcroft DR, 2009, ADDICTION, V104, P1132, DOI 10.1111/j.1360-0443.2009.02574.x; Ham LS, 2003, CLIN PSYCHOL REV, V23, P719, DOI 10.1016/S0272-7358(03)00071-0; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jessor R., 1977, PROBLEM BEHAV PSYCHO; Johnson KO, 2006, ALCOHOL ALCOHOLISM, V41, P174, DOI 10.1093/alcalc/agh243; Kypri K, 2004, ADDICTION, V99, P1410, DOI 10.1111/j.1360-0443.2004.00847.x; Kypri K, 2005, ADDICTION, V100, P713, DOI 10.1111/j.1360-0443.2005.01116.x; Kypri K, 2002, ALCOHOL ALCOHOLISM, V37, P457, DOI 10.1093/alcalc/37.5.457; Kypri K, 2009, ARCH INTERN MED, V169, P1508, DOI 10.1001/archinternmed.2009.249; Larimer ME, 2004, ALCOHOL RES HEALTH, V28, P94; Lewis MA, 2004, PSYCHOL ADDICT BEHAV, V18, P334, DOI 10.1037/0893-164X.18.4.334; Lovecchio CP, 2010, J HEALTH COMMUN, V15, P805, DOI 10.1080/10810730.2010.514032; Marteau TM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d228; McCambridge J, 2011, SOC STUD ADD MAN M Y; McCambridge J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023748; McShane KE, 2003, ADDICT BEHAV, V28, P1523, DOI 10.1016/S0306-4603(03)00074-1; Moreira MT, 2009, SNF UK TRIAL MAT; Moreira T, 2009, COCHRANE DATABASE SY, P3; NHS Information Centre Lifestyles Statistics, 2009, STAT ALC ENGL 2009; Perkins HW, 1999, J AM COLL HEALTH, V47, P253, DOI 10.1080/07448489909595656; Perkins HW, 2002, J STUD ALCOHOL, P164, DOI 10.15288/jsas.2002.s14.164; Pickard M, 2000, MED EDUC, V34, P148, DOI 10.1046/j.1365-2923.2000.00491.x; Fernandez-Hermida JR, 2012, ADDICTION, V107, P1570, DOI 10.1111/j.1360-0443.2012.03867.x; ROSE G, 1981, BMJ-BRIT MED J, V282, P1847, DOI 10.1136/bmj.282.6279.1847; Saunders JB, 2004, ALCOHOL CLIN EXP RES, V28, P322, DOI 10.1097/01.ALC.0000113418.12889.08; Schulenberg JE, 2002, J STUD ALCOHOL, P54, DOI 10.15288/jsas.2002.s14.54; Sobell LC, 1996, ADDICT BEHAV, V21, P817, DOI 10.1016/0306-4603(96)00039-1; Strahan RF, 2007, PSYCHOL REP, V100, P483, DOI 10.2466/PR0.100.2.483-488; Underwood B, 2000, BRIT DENT J, V189, P314, DOI 10.1038/sj.bdj.4800756a; Walters ST, 2005, ADDICT BEHAV, V30, P1168, DOI 10.1016/j.addbeh.2004.12.005; Webb E, 1998, MED EDUC, V32, P325, DOI 10.1046/j.1365-2923.1998.00204.x; Webb J, 1992, J EARLY ADOLESC, V12, P441, DOI DOI 10.1177/0272431692012004006; WECHSLER H, 1994, JAMA-J AM MED ASSOC, V272, P1672, DOI 10.1001/jama.272.21.1672; Weitzman ER, 2004, J DRUG EDUC, V34, P247, DOI 10.2190/W6L6-G171-M4FT-TWAP; White HR, 2006, INT J DRUG POLICY, V17, P310, DOI 10.1016/j.drugpo.2006.02.006; White IR, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d40	50	35	37	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44120	10.1371/journal.pone.0044120	http://dx.doi.org/10.1371/journal.pone.0044120			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005GJ	22984466	Green Published, gold			2022-12-27	WOS:000308738500031
J	Begcy, K; Mariano, ED; Gentile, A; Lembke, CG; Zingaretti, SM; Souza, GM; Menossi, M				Begcy, Kevin; Mariano, Eduardo D.; Gentile, Agustina; Lembke, Carolina G.; Zingaretti, Sonia Marli; Souza, Glaucia M.; Menossi, Marcelo			A Novel Stress-Induced Sugarcane Gene Confers Tolerance to Drought, Salt and Oxidative Stress in Transgenic Tobacco Plants	PLOS ONE			English	Article							CARBON-ISOTOPE DISCRIMINATION; WATER-USE EFFICIENCY; ARABIDOPSIS-THALIANA; SIGNAL-TRANSDUCTION; LOW-TEMPERATURE; GAS-EXCHANGE; EXPRESSION; RESPONSES; SALINITY; OVEREXPRESSION	Background: Drought is a major abiotic stress that affects crop productivity worldwide. Sugarcane can withstand periods of water scarcity during the final stage of culm maturation, during which sucrose accumulation occurs. Meanwhile, prolonged periods of drought can cause severe plant losses. Methodology/Principal Findings: In a previous study, we evaluated the transcriptome of drought-stressed plants to better understand sugarcane responses to drought. Among the up-regulated genes was Scdr1 (sugarcane drought-responsive 1). The aim of the research reported here was to characterize this gene. Scdr1 encodes a putative protein containing 248 amino acids with a large number of proline (19%) and cysteine (13%) residues. Phylogenetic analysis showed that ScDR1is in a clade with homologs from other monocotyledonous plants, separate from those of dicotyledonous plants. The expression of Scdr1 in different varieties of sugarcane plants has not shown a clear association with drought tolerance. Conclusions/Significance: The overexpression of Scdr1 in transgenic tobacco plants increased their tolerance to drought, salinity and oxidative stress, as demonstrated by increased photosynthesis, water content, biomass, germination rate, chlorophyll content and reduced accumulation of ROS. Physiological parameters, such as transpiration rate (E), net photosynthesis (A), stomatal conductance (gs) and internal leaf CO2 concentration, were less affected by abiotic stresses in transgenic Scdr1 plants compared with wild-type plants. Overall, our results indicated that Scdr1 conferred tolerance to multiple abiotic stresses, highlighting the potential of this gene for biotechnological applications.	[Begcy, Kevin; Mariano, Eduardo D.; Gentile, Agustina; Menossi, Marcelo] Univ Estadual Campinas, Inst Biol, Dept Genet Evolucao & Bioagentes, Lab Genoma Func, Campinas, SP, Brazil; [Lembke, Carolina G.; Souza, Glaucia M.] Univ Sao Paulo, Inst Quim, Dept Bioquim, Lab Transducao Sinal, BR-01498 Sao Paulo, Brazil; [Zingaretti, Sonia Marli] Univ Ribeirao Preto, Unidade Biotecnol, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade de Ribeirao Preto	Begcy, K (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Genet Evolucao & Bioagentes, Lab Genoma Func, Campinas, SP, Brazil.	menossi@unicamp.br	Menossi, Marcelo/A-4364-2012; Begcy, Kevin/AAK-6264-2020; zingaretti, sonia m/C-1123-2013; Lembke, Carolina G/O-3845-2014; Mariano, Eduardo D/B-8382-2012; Menossi, Marcelo/C-6305-2014; Gentile, Agustina/G-7174-2012; Lembke, Carolina/AFO-3103-2022; zingaretti, sonia marli/AAE-4433-2022; Souza, Glaucia/E-6780-2012	Menossi, Marcelo/0000-0002-9211-3787; Begcy, Kevin/0000-0002-5046-8029; zingaretti, sonia m/0000-0001-6755-4153; Mariano, Eduardo D/0000-0002-6465-6397; Menossi, Marcelo/0000-0002-9211-3787; Lembke, Carolina/0000-0002-0653-2353; zingaretti, sonia marli/0000-0001-6755-4153; Souza, Glaucia/0000-0001-6903-9913	National Council for Scientific and Technological Development (CNPq); Fundacao de Amparo a Pesquisa de Sao Paulo (FAPESP) [2008/5798-6, 2008/57908-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [574002/2008-1, 552802/2007-7]; Financiadora de Estudos e Projetos (FINEP) [815/07]	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep))	KB received a fellowship from National Council for Scientific and Technological Development (CNPq). This research was developed as part of a research network involving grants 2008/5798-6 and 2008/57908-6 from Fundacao de Amparo a Pesquisa de Sao Paulo (FAPESP), 574002/2008-1 and 552802/2007-7 from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and 815/07 from Financiadora de Estudos e Projetos (FINEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affenzeller MJ, 2009, J EXP BOT, V60, P939, DOI 10.1093/jxb/ern348; Ahmad S, 1999, INT J AGRIC BIOL, V2, P1; Alscher RG, 1997, PHYSIOL PLANTARUM, V100, P224, DOI 10.1034/j.1399-3054.1997.1000203.x; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Atkin OK, 2009, ANN BOT-LONDON, V103, P581, DOI 10.1093/aob/mcn094; Begcy K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023776; BLISS RD, 1986, PLANT CELL ENVIRON, V9, P721, DOI 10.1111/j.1365-3040.1986.tb02104.x; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; BRADFORD KJ, 1990, PLANT PHYSIOL, V94, P840, DOI 10.1104/pp.94.2.840; Brandalise M, 2003, J BIOENERG BIOMEMBR, V35, P203, DOI 10.1023/A:1024603530043; Bray EA, 2004, J EXP BOT, V55, P2331, DOI 10.1093/jxb/erh270; Bray EA, 1997, TRENDS PLANT SCI, V2, P48, DOI 10.1016/S1360-1385(97)82562-9; BRUGNOLI E, 1991, PLANT PHYSIOL, V95, P628, DOI 10.1104/pp.95.2.628; Chandra A, 2008, ACTA PHYSIOL PLANT, V30, P63, DOI 10.1007/s11738-007-0091-9; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Chaves M, 2010, FUNCT PLANT BIOL, V37, pIII, DOI 10.1071/FPv37n2_FO; Cumbie WP, 2011, HEREDITY, V107, P105, DOI 10.1038/hdy.2010.168; Ebdon JS, 2004, CROP SCI, V44, P1754, DOI 10.2135/cropsci2004.1754; Farquhar GD, 2003, PLANT CELL ENVIRON, V26, P801; Flexas J, 2006, PHYSIOL PLANTARUM, V127, P343, DOI 10.1111/j.1399-3054.2006.00621.x; Foolad MR, 1998, PLANT BREEDING, V117, P171, DOI 10.1111/j.1439-0523.1998.tb01473.x; Fravolinil A, 2002, J EXP BOT, V53, P2261, DOI 10.1093/jxb/erf084; Gao JP, 2007, J INTEGR PLANT BIOL, V49, P742, DOI 10.1111/j.1744-7909.2007.00495.x; Gay C, 1999, ANAL BIOCHEM, V273, P149, DOI 10.1006/abio.1999.4208; Ghannoum O, 2002, FUNCT PLANT BIOL, V29, P1337, DOI 10.1071/FP02056; Giraud E, 2008, PLANT PHYSIOL, V147, P595, DOI 10.1104/pp.107.115121; Guo QF, 2008, J PLANT PHYSIOL, V165, P1745, DOI 10.1016/j.jplph.2007.10.002; HAIGH AM, 1987, AUST J PLANT PHYSIOL, V14, P485, DOI 10.1071/PP9870485; Hoagland D.R., 1950, WATER CULTURE METHOD, V347, P1, DOI DOI 10.1007/S12374-010-9112-0; Jia JP, 2006, PLANT J, V48, P710, DOI 10.1111/j.1365-313X.2006.02905.x; JONES RA, 1986, EUPHYTICA, V35, P575, DOI 10.1007/BF00021866; Koussevitzky S, 2008, J BIOL CHEM, V283, P34197, DOI 10.1074/jbc.M806337200; Lakshmanan P, 2005, IN VITRO CELL DEV-PL, V41, P345, DOI 10.1079/IVP2005643; Lawlor DW, 2002, PLANT CELL ENVIRON, V25, P275, DOI 10.1046/j.0016-8025.2001.00814.x; LIPTAY A, 1983, PLANT PHYSIOL, V73, P935, DOI 10.1104/pp.73.4.935; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MAYBANK J, 1995, ATMOS OCEAN, V33, P195, DOI 10.1080/07055900.1995.9649532; MEINZER FC, 1994, PLANT PHYSIOL, V104, P521, DOI 10.1104/pp.104.2.521; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mito T, 2010, PLANT BIOTECHNOL J; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; Monti A, 2006, J EXP BOT, V57, P1253, DOI 10.1093/jxb/erj091; Morran S, 2011, PLANT BIOTECHNOL J, V9, P230, DOI 10.1111/j.1467-7652.2010.00547.x; Pastore D, 2007, J EXP BOT, V58, P195, DOI 10.1093/jxb/erl273; Pinheiro C, 2011, J EXP BOT, V62, P869, DOI 10.1093/jxb/erq340; Poss JA, 2000, TREE PHYSIOL, V20, P1121; Priyanka B, 2010, PLANT BIOTECHNOL J, V8, P76, DOI 10.1111/j.1467-7652.2009.00467.x; Quan RD, 2010, PLANT BIOTECHNOL J, V8, P476, DOI 10.1111/j.1467-7652.2009.00492.x; Rocha FR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-71; Rodrigues FA, 2011, BIOL PLANTARUM, V55, P43, DOI 10.1007/s10535-011-0006-x; Sekhar K, 2010, PLANT CELL ENVIRON, V33, P1324, DOI 10.1111/j.1365-3040.2010.02151.x; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Shinozaki K, 1997, PLANT PHYSIOL, V115, P327, DOI 10.1104/pp.115.2.327; Solari LI, 2006, TREE PHYSIOL, V26, P1333, DOI 10.1093/treephys/26.10.1333; TOPFER R, 1987, NUCLEIC ACIDS RES, V15, P5890, DOI 10.1093/nar/15.14.5890; Trujillo LE, 2008, PLANT CELL PHYSIOL, V49, P512, DOI 10.1093/pcp/pcn025; Umezawa T, 2006, CURR OPIN BIOTECH, V17, P113, DOI 10.1016/j.copbio.2006.02.002; UNGAR IA, 1978, BOT REV, V44, P233, DOI 10.1007/BF02919080; Waclawovsky AJ, 2010, PLANT BIOTECHNOL J, V8, P263, DOI 10.1111/j.1467-7652.2009.00491.x; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Williams DG, 2001, NEW PHYTOL, V150, P285, DOI 10.1046/j.1469-8137.2001.00093.x; Yang H, 2011, J EXP BOT, V62, P4143, DOI 10.1093/jxb/err102; Zhang XX, 2008, PLANT MOL BIOL, V68, P131, DOI 10.1007/s11103-008-9357-x; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	64	34	36	4	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44697	10.1371/journal.pone.0044697	http://dx.doi.org/10.1371/journal.pone.0044697			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984543	Green Submitted, gold, Green Published			2022-12-27	WOS:000308638700077
J	Elshorbagy, AK; Valdivia-Garcia, M; Refsum, H; Butte, N				Elshorbagy, Amany K.; Valdivia-Garcia, Maria; Refsum, Helga; Butte, Nancy			The Association of Cysteine with Obesity, Inflammatory Cytokines and Insulin Resistance in Hispanic Children and Adolescents	PLOS ONE			English	Article							HOMOCYSTEINE S-METHYLTRANSFERASE; BODY-COMPOSITION; ENERGY-EXPENDITURE; OXIDATIVE STRESS; ADIPOSE-TISSUE; HORDALAND HOMOCYSTEINE; METHIONINE RESTRICTION; LIPID-METABOLISM; DEFICIENT MICE; RISK	Context: Plasma total cysteine (tCys) independently relates to fat mass in adults. Dietary cyst(e)ine promotes adiposity and decreases glucose tolerance in some rodent models, but alleviates insulin resistance in others. Objective: To investigate whether the association of tCys with body fat extends to children at particular risk of obesity, and whether tCys is associated with insulin resistance and obesity-associated inflammation. Methods: We explored the cross-sectional relations of fasting plasma tCys and related metabolites with body composition measured by dual-energy X-ray absorptiometry in 984 Hispanic children and adolescents aged 4-19 years from the Viva La Familia Study. Linear and logistic regression and dose-response curves were used to evaluate relations of tCys with obesity, insulin resistance and inflammatory markers including interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), monocyte chemoattractant protein-1 (MCP-1) and C-reactive protein (CRP). Results: tCys, methionine and total homocysteine (tHcy) increased with age. Upper tCys quartile was independently associated with a 5-fold increased risk of obesity (95% CI 3.5-8.0, P<0.001), and 2-fold risk of insulin resistance (95% CI: 1.6-5.0, P<0.001; adjusted for body fat%). Within the overweight/obese subgroup, but not in normal-weight children, tCys accounted for 9% of the variability in body fat% (partial r = 0.30, P<0.001; adjusted for age and gender). tCys correlated positively with serum non-esterified fatty acids and leptin, partly independent of body fat, but was not associated with serum IL-6, TNF-alpha or MCP-1. A positive correlation with CRP disappeared after adjustment for BMI. Conclusion: tCys is independently associated with obesity and insulin resistance in Hispanic children and adolescents, highlighting a previously underappreciated link between the sulfur amino acid metabolic pathway and obesity and cardiometabolic risk.	[Elshorbagy, Amany K.; Valdivia-Garcia, Maria; Refsum, Helga] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Elshorbagy, Amany K.] Univ Alexandria, Fac Med, Dept Physiol, Alexandria, Egypt; [Refsum, Helga] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway; [Butte, Nancy] Baylor Coll Med, Dept Pediat, USDA ARS, Childrens Nutr Res Ctr, Houston, TX 77030 USA	University of Oxford; Egyptian Knowledge Bank (EKB); Alexandria University; University of Oslo; Baylor College of Medicine; United States Department of Agriculture (USDA)	Elshorbagy, AK (corresponding author), Univ Oxford, Dept Pharmacol, S Parks Rd, Oxford OX1 3QT, England.	amany.elshorbagy@pharm.ox.ac.uk	Elshorbagy, Amany/A-4117-2015; Refsum, Helga/A-4073-2010	Elshorbagy, Amany/0000-0002-8624-860X	National Institutes of Health (NIH) [DK59264, DK080457]; USDA/ARS [6250-51000-053]; Research Council of Norway; Johan Throne Holst Foundation for Nutrition Research; Charles Wolfson Charitable Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059264, R01DK080457] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA/ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Research Council of Norway(Research Council of Norway); Johan Throne Holst Foundation for Nutrition Research; Charles Wolfson Charitable Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (NIH) [DK59264, DK080457], and the USDA/ARS [Cooperative Agreement 6250-51000-053]. This study has also received support from The Research Council of Norway, The Johan Throne Holst Foundation for Nutrition Research and the Charles Wolfson Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniades C, 2009, CIRCULATION, V119, P2507, DOI 10.1161/CIRCULATIONAHA.108.808675; Battezzati A, 2007, NUTR METAB CARDIOVAS, V17, P525, DOI 10.1016/j.numecd.2006.03.006; Blouet C, 2007, FREE RADICAL BIO MED, V42, P1089, DOI 10.1016/j.freeradbiomed.2007.01.006; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Butte NF, 2006, AM J CLIN NUTR, V84, P646, DOI 10.1093/ajcn/84.3.646; Cai GW, 2008, CYTOKINE, V44, P242, DOI 10.1016/j.cyto.2008.08.006; Di Renzo L, 2010, OBESITY, V18, P2125, DOI 10.1038/oby.2010.50; El-Khairy L, 2003, CLIN CHEM, V49, P113, DOI 10.1373/49.1.113; Elshorbagy AK, 2011, NUTR METAB IN PRESS, DOI [10.1016/j.numecd.20111001.1008, DOI 10.1016/J.NUMECD.2011.1001.1008]; Elshorbagy AK, 2008, AM J CLIN NUTR, V88, P738, DOI 10.1093/ajcn/88.3.738; Elshorbagy AK, 2012, J NUTR BIOCHEM, V23, P332, DOI 10.1016/j.jnutbio.2010.12.009; Elshorbagy AK, 2012, CURR OPIN CLIN NUTR, V15, P49, DOI 10.1097/MCO.0b013e32834d199f; Elshorbagy AK, 2011, J LIPID RES, V52, P104, DOI 10.1194/jlr.M010215; Elshorbagy AK, 2009, OBESITY, V17, P1435, DOI 10.1038/oby.2008.671; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Gupta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027598; Hammarqvist F, 2010, AMINO ACIDS, V39, P359, DOI 10.1007/s00726-009-0446-1; Haque JA, 2010, LAB INVEST, V90, P1704, DOI 10.1038/labinvest.2010.112; Jernas M, 2006, FASEB J, V20, P1540, DOI 10.1096/fj.05-5678fje; Johnson RK, 1996, J AM DIET ASSOC, V96, P1140, DOI 10.1016/S0002-8223(96)00293-3; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Karelis AD, 2008, LANCET, V372, P1281, DOI 10.1016/S0140-6736(08)61531-7; Kendig EL, 2011, TOXICOL APPL PHARM, V257, P338, DOI 10.1016/j.taap.2011.09.017; Kerr MA, 2009, PEDIATRICS, V123, P627, DOI 10.1542/peds.2008-1049; Keskin M, 2005, PEDIATRICS, V115, pE500, DOI 10.1542/peds.2004-1921; KNITTLE JL, 1979, J CLIN INVEST, V63, P239, DOI 10.1172/JCI109295; Lieberman MW, 1996, P NATL ACAD SCI USA, V93, P7923, DOI 10.1073/pnas.93.15.7923; Liu J, 2011, J CLIN ENDOCR METAB, V96, P438, DOI 10.1210/jc.2010-1174; Maffeis C, 2008, J PEDIATR-US, V152, P207, DOI 10.1016/j.jpeds.2007.09.021; Malloy VL, 2006, AGING CELL, V5, P305, DOI 10.1111/j.1474-9726.2006.00220.x; Mani S, 2011, FREE RADICAL BIO MED, V50, P1280, DOI 10.1016/j.freeradbiomed.2011.01.038; Matsubara Y, 2009, ANN NUTR METAB, V54, P258, DOI 10.1159/000229506; Molgaard C, 1998, APPL RADIAT ISOTOPES, V49, P577, DOI 10.1016/S0969-8043(97)00076-6; Ogden Cynthia L, 2010, Natl Health Stat Report, P1; OLEFSKY JM, 1979, HORM METAB RES, V11, P209, DOI 10.1055/s-0028-1092709; Puyau MR, 2004, MED SCI SPORT EXER, V36, P1625, DOI 10.1249/01.MSS.0000139898.30804.60; Sampath H, 2011, ANN NY ACAD SCI, V1243, P47, DOI 10.1111/j.1749-6632.2011.06303.x; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; Team RDC, 2004, R LANG ENV STAT; Teng YW, 2012, J BIOL CHEM, V287, P16187, DOI 10.1074/jbc.M111.303255; Teng YW, 2011, J BIOL CHEM, V286, P36258, DOI 10.1074/jbc.M111.265348; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Ueki I, 2011, AM J PHYSIOL-ENDOC M, V301, pE668, DOI 10.1152/ajpendo.00151.2011; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307	46	49	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44166	10.1371/journal.pone.0044166	http://dx.doi.org/10.1371/journal.pone.0044166			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984471	Green Published, Green Submitted, gold			2022-12-27	WOS:000308638700047
J	Iida, J; Dorchak, J; Lehman, JR; Clancy, R; Luo, CQ; Chen, YQ; Somiari, S; Ellsworth, RE; Hu, H; Mural, RJ; Shriver, CD				Iida, Joji; Dorchak, Jesse; Lehman, John R.; Clancy, Rebecca; Luo, Chunqing; Chen, Yaqin; Somiari, Stella; Ellsworth, Rachel E.; Hu, Hai; Mural, Richard J.; Shriver, Craig D.			FH535 Inhibited Migration and Growth of Breast Cancer Cells	PLOS ONE			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; HUMAN-MELANOMA INVASION; METAPLASTIC CARCINOMAS; WNT PATHWAY; STEM-CELLS; INTEGRIN; COLLAGEN; TARGET; MOTILITY; ADHESION	There is substantial evidence indicating that the WNT signaling pathway is activated in various cancer cell types including breast cancer. Previous studies reported that FH535, a small molecule inhibitor of the WNT signaling pathway, decreased growth of cancer cells but not normal fibroblasts, suggesting this pathway plays a role in tumor progression and metastasis. In this study, we tested FH535 as a potential inhibitor for malignant phenotypes of breast cancer cells including migration, invasion, and growth. FH535 significantly inhibited growth, migration, and invasion of triple negative (TN) breast cancer cell lines (MDA-MB231 and HCC38) in vitro. We demonstrate that FH535 was a potent growth inhibitor for TN breast cancer cell lines (HCC38 and MDA-MB-231) but not for other, non-TN breast cancer cell lines (MCF-7, T47D or SK-Br3) when cultured in three dimensional (3D) type I collagen gels. Western blotting analyses suggest that treatment of MDA-MB-231 cells with FH535 markedly inhibited the expression of NEDD9 but not activations of FAK, Src, or downstream targets such as p38 and Erk1/2. We demonstrated that NEDD9 was specifically associated with CSPG4 but not with b1 integrin or CD44 in MDA-MB-231 cells. Analyses of gene expression profiles in breast cancer tissues suggest that CSPG4 expression is higher in Basal-type breast cancers, many of which are TN, than any other subtypes. These results suggest not only a mechanism for migration and invasion involving the canonical WNT-signaling pathways but also novel strategies for treating patients who develop TN breast cancer.	[Iida, Joji; Dorchak, Jesse; Lehman, John R.; Clancy, Rebecca] Windber Res Inst, Dept Cell Biol, Windber, PA USA; [Luo, Chunqing; Chen, Yaqin; Hu, Hai] Windber Res Inst, Dept Biomed Informat, Windber, PA USA; [Somiari, Stella] Windber Res Inst, Dept Tissue Bank, Windber, PA USA; [Ellsworth, Rachel E.] Windber Res Inst, Dept Genet, Windber, PA USA; [Shriver, Craig D.] Walter Reed Natl Mil Med Ctr, Dept Surg, Bethesda, MD USA	Windber Research Institute; Windber Research Institute; Windber Research Institute; Windber Research Institute; Walter Reed National Military Medical Center	Iida, J (corresponding author), Windber Res Inst, Dept Cell Biol, Windber, PA USA.	g.iida@wriwindber.org		Hu, Hai/0000-0001-5345-8371	United States Department of Defense (Military Molecular Medicine Initiative) [MDA W81XWHH-05-2-0075, Protocol 01-20006]	United States Department of Defense (Military Molecular Medicine Initiative)(United States Department of Defense)	This research was supported by a grant from the United States Department of Defense (Military Molecular Medicine Initiative MDA W81XWHH-05-2-0075, Protocol 01-20006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013; Bissell MJ, 1999, AM J PATHOL, V155, P675, DOI 10.1016/S0002-9440(10)65164-4; Bravo-Cordero JJ, 2007, EMBO J, V26, P1499, DOI 10.1038/sj.emboj.7601606; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Campoli M, 2010, ADV CANCER RES, V109, P73, DOI 10.1016/B978-0-12-380890-5.00003-X; CARTER WG, 1990, J CELL BIOL, V110, P1387, DOI 10.1083/jcb.110.4.1387; Chang JX, 2012, MED ONCOL; Cooney CA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2895; Eck SM, 2009, BREAST CANCER RES TR, V116, P79, DOI 10.1007/s10549-008-0085-3; Eisenmann KM, 1999, NAT CELL BIOL, V1, P507, DOI 10.1038/70302; Geyer FC, 2011, MODERN PATHOL, V24, P209, DOI 10.1038/modpathol.2010.205; Handeli S, 2008, MOL CANCER THER, V7, P521, DOI 10.1158/1535-7163.MCT-07-2063; Hayes MJ, 2008, CLIN CANCER RES, V14, P4038, DOI 10.1158/1078-0432.CCR-07-4379; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; IIDA J, 1995, CANCER RES, V55, P2177; Iida J, 1998, J BIOL CHEM, V273, P5955, DOI 10.1074/jbc.273.10.5955; Iida J, 2004, J INVEST DERMATOL, V122, P167, DOI 10.1046/j.0022-202X.2003.22114.x; Iida J, 1996, SEMIN CANCER BIOL, V7, P155, DOI 10.1006/scbi.1996.0021; Iida J, 2001, J BIOL CHEM, V276, P18786, DOI 10.1074/jbc.M010053200; Iida J, 2007, BIOCHEM J, V403, P553, DOI 10.1042/BJ20061176; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Izumchenko E, 2009, CANCER RES, V69, P7198, DOI 10.1158/0008-5472.CAN-09-0795; KEELY PJ, 1995, J CELL SCI, V108, P595; Kenny PA, 2007, FRONT BIOSCI-LANDMRK, V12, P3468, DOI 10.2741/2327; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; King TD, 2011, J CELL BIOCH; Klemm F, 2011, CARCINOGENESIS, V32, P434, DOI 10.1093/carcin/bgq269; Knutson JR, 1996, MOL BIOL CELL, V7, P383, DOI 10.1091/mbc.7.3.383; Kong CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022666; Lacroix-Triki M, 2010, MODERN PATHOL, V23, P1438, DOI 10.1038/modpathol.2010.141; LANGUINO LR, 1989, J CELL BIOL, V109, P2455, DOI 10.1083/jcb.109.5.2455; Legg J, 2003, DEVELOPMENT, V130, P6049, DOI 10.1242/dev.00837; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li Y, 2011, ONCOGENE, V30, P2633, DOI 10.1038/onc.2010.632; Lim SK, 2011, FASEB J, V25, P3004, DOI 10.1096/fj.10-169136; Liu CC, 2010, P NATL ACAD SCI USA, V107, P5136, DOI 10.1073/pnas.0911220107; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Matsuda Y, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2317; Paquette B, 2011, BRIT J CANCER, V105, P534, DOI 10.1038/bjc.2011.260; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Poincloux R, 2011, P NATL ACAD SCI USA, V108, P1943, DOI 10.1073/pnas.1010396108; Price MA, 2011, PIGM CELL MELANOMA R, V24, P1148, DOI 10.1111/j.1755-148X.2011.00929.x; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Provenzano PP, 2009, TRENDS CELL BIOL, V19, P638, DOI 10.1016/j.tcb.2009.08.009; Singh MK, 2007, CELL BIOCHEM BIOPHYS, V48, P54, DOI 10.1007/s12013-007-0036-3; Svendsen A, 2011, ACTA NEUROPATHOL, V122, P495, DOI 10.1007/s00401-011-0867-2; Vaid M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023000; Wang X, 2010, CURR MOL MED, V10, P419, DOI 10.2174/156652410791316977; Wang XH, 2010, JNCI-J NATL CANCER I, V102, P1496, DOI 10.1093/jnci/djq343; Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010; Yang JB, 2004, J CELL BIOL, V165, P881, DOI 10.1083/jcb.200403174; Yang JB, 2009, CANCER RES, V69, P7538, DOI 10.1158/0008-5472.CAN-08-4626	54	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44418	10.1371/journal.pone.0044418	http://dx.doi.org/10.1371/journal.pone.0044418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984505	gold, Green Published, Green Submitted			2022-12-27	WOS:000308638700059
J	Zhu, Y; Du, P; Nakhleh, L				Zhu, Yun; Du, Peng; Nakhleh, Luay			Gene Duplicability-Connectivity-Complexity across Organisms and a Neutral Evolutionary Explanation	PLOS ONE			English	Article							DUPLICATE GENES; NETWORKS; ROBUSTNESS; PRESERVATION; REDUNDANCY; MODEL	Gene duplication has long been acknowledged by biologists as a major evolutionary force shaping genomic architectures and characteristics across the Tree of Life. Major research has been conducting on elucidating the fate of duplicated genes in a variety of organisms, as well as factors that affect a gene's duplicability-that is, the tendency of certain genes to retain more duplicates than others. In particular, two studies have looked at the correlation between gene duplicability and its degree in a protein-protein interaction network in yeast, mouse, and human, and another has looked at the correlation between gene duplicability and its complexity (length, number of domains, etc.) in yeast. In this paper, we extend these studies to six species, and two trends emerge. There is an increase in the duplicability-connectivity correlation that agrees with the increase in the genome size as well as the phylogenetic relationship of the species. Further, the duplicability-complexity correlation seems to be constant across the species. We argue that the observed correlations can be explained by neutral evolutionary forces acting on the genomic regions containing the genes. For the duplicability-connectivity correlation, we show through simulations that an increasing trend can be obtained by adjusting parameters to approximate genomic characteristics of the respective species. Our results call for more research into factors, adaptive and non-adaptive alike, that determine a gene's duplicability.	[Zhu, Yun; Nakhleh, Luay] Rice Univ, Dept Comp Sci, Houston, TX 77251 USA; [Du, Peng] Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido, Japan	Rice University; Hokkaido University	Zhu, Y (corresponding author), Rice Univ, Dept Comp Sci, Houston, TX 77251 USA.	yun.zhu@rice.edu; nakhleh@rice.edu			National Science Foundation grant [CCF-0622037]; Alfred P. Sloan Research Fellowship	National Science Foundation grant(National Science Foundation (NSF)); Alfred P. Sloan Research Fellowship(Alfred P. Sloan Foundation)	This work was supported in part by National Science Foundation grant CCF-0622037 and an Alfred P. Sloan Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg J, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-51; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; Bhan A, 2002, BIOINFORMATICS, V18, P1486, DOI 10.1093/bioinformatics/18.11.1486; Birney E, 2006, NUCLEIC ACIDS RES, V34, pD556, DOI 10.1093/nar/gkj133; Chia N, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.021906; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; D'Antonio M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002029; Dittmar K, 2010, EVOLUTION AFTER GENE DUPLICATION, P1, DOI 10.1002/9780470619902; Force A, 1999, GENETICS, V151, P1531; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Hahn MW, 2007, PLOS GENET, V3, P2135, DOI 10.1371/journal.pgen.0030197; Hanada K, 2011, MOL BIOL EVOL, V28, P377, DOI 10.1093/molbev/msq204; He XL, 2005, CURR BIOL, V15, P1016, DOI 10.1016/j.cub.2005.04.035; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Kitami T, 2002, NAT GENET, V32, P191, DOI 10.1038/ng945; Li W. H, 1997, MOL EVOLUTION; Liang H, 2007, TRENDS GENET, V23, P375, DOI 10.1016/j.tig.2007.04.005; Liao BY, 2007, TRENDS GENET, V23, P378, DOI 10.1016/j.tig.2007.05.006; Light S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-159; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2001, GENETICS, V159, P1789; Lynch M, 2007, NAT REV GENET, V8, P803, DOI 10.1038/nrg2192; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Mahadevan R, 2008, BIOPHYS J, V94, P1216, DOI 10.1529/biophysj.107.118414; Mithani A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000868; Navlakha S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001119; Ohno S., 1970, EVOLUTION GENE DUPLI; Ohta T, 2000, GENE, V259, P45, DOI 10.1016/S0378-1119(00)00428-5; OHTA T, 1987, GENETICS, V115, P207; Ohta T, 1992, MOL PHYLOGENET EVOL, V1, P305, DOI 10.1016/1055-7903(92)90006-3; Paps J, 2009, MOL BIOL EVOL, V26, P2397, DOI 10.1093/molbev/msp150; Prachumwat A, 2006, MOL BIOL EVOL, V23, P30, DOI 10.1093/molbev/msi249; Ratmann O, 2007, PLOS COMPUT BIOL, V3, P2266, DOI 10.1371/journal.pcbi.0030230; Roth C, 2007, J EXP ZOOL PART B, V308B, P58, DOI 10.1002/jez.b.21124; STRING-database, 2012, GEN DUPL CONN COMPL, V9; Treangen TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001284; VanderSluis B, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.82; Wagner A, 2005, BIOESSAYS, V27, P176, DOI 10.1002/bies.20170; Wagner A, 2008, BIOESSAYS, V30, P367, DOI 10.1002/bies.20728; WALSH JB, 1995, GENETICS, V139, P421; Wang Z, 2009, GENOME BIOL EVOL, V1, P23, DOI 10.1093/gbe/evp002; Wiuf C, 2006, P NATL ACAD SCI USA, V103, P7566, DOI 10.1073/pnas.0600061103; WYSOCKI LJ, 1989, ANNU REV BIOCHEM, V58, P509; Yamada T, 2009, NAT REV MOL CELL BIO, V10, P791, DOI 10.1038/nrm2787; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhang Z, 2005, MOL BIOL EVOL, V22, P501, DOI 10.1093/molbev/msi034	46	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44491	10.1371/journal.pone.0044491	http://dx.doi.org/10.1371/journal.pone.0044491			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984517	gold, Green Published, Green Submitted			2022-12-27	WOS:000308638700065
J	Sinha, A; Rae, R; Iatsenko, I; Sommer, RJ				Sinha, Amit; Rae, Robbie; Iatsenko, Igor; Sommer, Ralf J.			System Wide Analysis of the Evolution of Innate Immunity in the Nematode Model Species Caenorhabditis elegans and Pristionchus pacificus	PLOS ONE			English	Article							PATHOGEN SERRATIA-MARCESCENS; GENE-EXPRESSION; C. ELEGANS; MICROARRAY DATA; LIFE-SPAN; TRANSLATIONAL INHIBITION; TRANSCRIPTION FACTOR; VIRULENCE FACTORS; INFECTION; DIVERSITY	The evolution of genetic mechanisms used to combat bacterial infections is critical for the survival of animals and plants, yet how these genes evolved to produce a robust defense system is poorly understood. Studies of the nematode Caenorhabditis elegans have uncovered a plethora of genetic regulators and effectors responsible for surviving pathogens. However, comparative studies utilizing other free-living nematodes and therefore providing an insight into the evolution of innate immunity have been lacking. Here, we take a systems biology approach and use whole genome microarrays to profile the transcriptional response of C. elegans and the necromenic nematode Pristionchus pacificus after exposure to the four different pathogens Serratia marcescens, Xenorhabdus nematophila, Staphylococcus aureus and Bacillus thuringiensis DB27. C. elegans is susceptible to all four pathogens whilst P. pacificus is only susceptible to S. marcescens and X. nematophila. We show an unexpected level of specificity in host responses to distinct pathogens within and across species, revealing an enormous complexity of effectors of innate immunity. Functional domains enriched in the transcriptomes on different pathogens are similar within a nematode species but different across them, suggesting differences in pathogen sensing and response networks. We find translation inhibition to be a potentially conserved response to gram-negative pathogens in both the nematodes. Further computational analysis indicates that both nematodes when fed on pathogens up-regulate genes known to be involved in other stress responses like heat shock, oxidative and osmotic stress, and genes regulated by DAF-16/FOXO and TGF-beta pathways. This study presents a platform for comparative systems analysis of two nematode model species, and a catalog of genes involved in the evolution of nematode immunity and identifies both pathogen specific and pan-pathogen responses. We discuss the potential effects of ecology on evolution of downstream effectors and upstream regulators on evolution of nematode innate immunity.	[Sinha, Amit; Rae, Robbie; Iatsenko, Igor; Sommer, Ralf J.] Max Planck Inst Dev Biol, Dept Evolutionary Biol, Tubingen, Germany	Max Planck Society	Sommer, RJ (corresponding author), Max Planck Inst Dev Biol, Dept Evolutionary Biol, Tubingen, Germany.	ralf.sommer@tuebingen.mpg.de	Iatsenko, Igor/AAI-6699-2021; Sinha, Amit/B-6312-2013; Sinha, Amit/H-5116-2019	Iatsenko, Igor/0000-0002-9249-8998; Sinha, Amit/0000-0003-1849-710X; Sinha, Amit/0000-0003-1849-710X	Max-Planck Society	Max-Planck Society(Max Planck Society)	This work was funded by the Max-Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 2001, P NATL ACAD SCI USA, V98, P2735, DOI 10.1073/pnas.041613098; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Alper S, 2008, P NATL ACAD SCI USA, V105, P7016, DOI 10.1073/pnas.0802405105; Anagnostou SH, 2008, BIOCHEM J, V416, P211, DOI 10.1042/BJ20081426; Baugh LR, 2009, SCIENCE, V324, P92, DOI 10.1126/science.1169628; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Bolz DD, 2010, J BIOL CHEM, V285, P10832, DOI 10.1074/jbc.M109.091629; Borchert N, 2010, GENOME RES, V20, P837, DOI 10.1101/gr.103119.109; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Coolon JD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000503; DALLEY BK, 1992, DEV BIOL, V151, P80, DOI 10.1016/0012-1606(92)90215-3; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Dieterich C, 2008, NAT GENET, V40, P1193, DOI 10.1038/ng.227; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; Dunbar TL, 2012, CELL HOST MICROBE, V11, P375, DOI 10.1016/j.chom.2012.02.008; Eddy Sean R, 2009, Genome Inform, V23, P205; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Engelmann I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019055; Estes KA, 2010, P NATL ACAD SCI USA, V107, P2153, DOI 10.1073/pnas.0914643107; Ewbank Jonathan J, 2006, WormBook, P1; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; Felix MA, 2010, CURR BIOL, V20, pR965, DOI 10.1016/j.cub.2010.09.050; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Forst Steven, 2002, P57, DOI 10.1079/9780851995670.0057; Frank S. A., 2002, IMMUNOLOGY EVOLUTION, P33; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Griffitts JS, 2001, SCIENCE, V293, P860, DOI 10.1126/science.1062441; Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Herrmann M, 2007, ZOOL SCI, V24, P883, DOI 10.2108/zsj.24.883; Herrmann M, 2006, ZOOLOGY, V109, P96, DOI 10.1016/j.zool.2006.03.001; Herrmann M, 2010, BIOL J LINN SOC, V100, P170, DOI 10.1111/j.1095-8312.2010.01410.x; Hong RL, 2008, P NATL ACAD SCI USA, V105, P7779, DOI 10.1073/pnas.0708406105; Hong RL, 2006, BIOESSAYS, V28, P651, DOI 10.1002/bies.20404; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Irazoqui JE, 2008, P NATL ACAD SCI USA, V105, P17469, DOI 10.1073/pnas.0809527105; Irazoqui JE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000982; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Kao CY, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001314; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kim KW, 2010, P NATL ACAD SCI USA, V107, P17445, DOI 10.1073/pnas.1012611107; Kurz CL, 2003, EMBO J, V22, P1451, DOI 10.1093/emboj/cdg159; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; McEwan DL, 2012, CELL HOST MICROBE, V11, P364, DOI 10.1016/j.chom.2012.02.007; Melo JA, 2012, CELL, V149, P452, DOI 10.1016/j.cell.2012.02.050; Morgan K, 2012, MOL ECOL, V21, P250, DOI 10.1111/j.1365-294X.2011.05382.x; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nandakumar M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000273; Nicholas HR, 2004, CURR BIOL, V14, P1256, DOI 10.1016/j.cub.2004.07.022; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pires da Silva Andre, 2005, WormBook, P1; Pires-DaSilva A, 2004, GENE DEV, V18, P1198, DOI 10.1101/gad.293504; Powell JR, 2009, P NATL ACAD SCI USA, V106, P2782, DOI 10.1073/pnas.0813048106; Pujol N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000105; Pukkila-Worley R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002074; Rae R, 2008, J EXP BIOL, V211, P1927, DOI 10.1242/jeb.014944; Rae R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002864; Rae R, 2010, ENVIRON MICROBIOL, V12, P3007, DOI 10.1111/j.1462-2920.2010.02278.x; Reichert K, 2005, CHEMOSPHERE, V61, P229, DOI 10.1016/j.chemosphere.2005.01.077; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Roberts AF, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-61; Rohlfing AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009010; Rudel D, 2005, DEV BIOL, V277, P200, DOI 10.1016/j.ydbio.2004.09.021; Schlager B, 2009, GENESIS, V47, P300, DOI 10.1002/dvg.20499; Schulenburg H, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-49; Schulenburg H, 2004, IMMUNOL REV, V198, P36, DOI 10.1111/j.0105-2896.2004.0125.x; Schulenburg H, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-114; Schulenburg H, 2008, IMMUNOBIOLOGY, V213, P237, DOI 10.1016/j.imbio.2007.12.004; Schulenburg H, 2007, MOL IMMUNOL, V44, P3338, DOI 10.1016/j.molimm.2007.02.019; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Sinha A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-254; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sommer RJ, 1996, FUND APPL NEMATOL, V19, P511; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Thomas S, 2010, NUCLEIC ACIDS RES, V38, pD774, DOI 10.1093/nar/gkp1021; Thompson JD., 1994, COEVOLUTIONARY PROCE; Tian H, 2008, CURR BIOL, V18, P142, DOI 10.1016/j.cub.2007.12.048; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; van de Peppel J, 2003, EMBO REP, V4, P387, DOI 10.1038/sj.embor.embor798; Wang XY, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001110; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Wei JZ, 2003, P NATL ACAD SCI USA, V100, P2760, DOI 10.1073/pnas.0538072100; Wong D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r194; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569	93	32	32	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e44255	10.1371/journal.pone.0044255	http://dx.doi.org/10.1371/journal.pone.0044255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028509	Green Submitted, Green Published, gold			2022-12-27	WOS:000309973900006
J	Rabinowitz, PM; Galusha, D; Vegso, S; Michalove, J; Rinne, S; Scotch, M; Kane, M				Rabinowitz, Peter M.; Galusha, Deron; Vegso, Sally; Michalove, Jennifer; Rinne, Seppo; Scotch, Matthew; Kane, Michael			Comparison of Human and Animal Surveillance Data for H5N1 Influenza A in Egypt 2006-2011	PLOS ONE			English	Article							AVIAN INFLUENZA; VIRUS; TEMPERATURE	Background: The majority of emerging infectious diseases are zoonotic (transmissible between animals and humans) in origin, and therefore integrated surveillance of disease events in humans and animals has been recommended to support effective global response to disease emergence. While in the past decade there has been extensive global surveillance for highly pathogenic avian influenza (HPAI) infection in both animals and humans, there have been few attempts to compare these data streams and evaluate the utility of such integration. Methodology: We compared reports of bird outbreaks of HPAI H5N1 in Egypt for 2006-2011 compiled by the World Organisation for Animal Health (OIE) and the UN Food and Agriculture Organization (FAO) EMPRESi reporting system with confirmed human H5N1 cases reported to the World Health Organization (WHO) for Egypt during the same time period. Principal Findings: Both human cases and bird outbreaks showed a cyclic pattern for the country as a whole, and there was a statistically significant temporal correlation between the data streams. At the governorate level, the first outbreak in birds in a season usually but not always preceded the first human case, and the time lag between events varied widely, suggesting regional differences in zoonotic risk and/or surveillance effectiveness. In a multivariate risk model, lower temperature, lower urbanization, higher poultry density, and the recent occurrence of a bird outbreak were associated with increased risk of a human case of HPAI in the same governorate, although the positive predictive value of a bird outbreak was low. Conclusions: Integrating data streams of surveillance for human and animal cases of zoonotic disease holds promise for better prediction of disease risk and identification of environmental and regional factors that can affect risk. Such efforts can also point out gaps in human and animal surveillance systems and generate hypotheses regarding disease transmission.	[Rabinowitz, Peter M.; Galusha, Deron; Vegso, Sally] Yale Univ, Yale Occupat & Environm Med Program, New Haven, CT 06520 USA; [Michalove, Jennifer] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Kane, Michael] Yale Univ, Yale Ctr Analyt Sci, New Haven, CT USA; [Scotch, Matthew] Arizona State Univ, Dept Biomed Informat, Phoenix, AZ USA; [Rinne, Seppo] Yale Univ, Dept Internal Med, New Haven, CT USA	Yale University; Yale University; Yale University; Arizona State University; Arizona State University-Downtown Phoenix; Yale University	Rabinowitz, PM (corresponding author), Yale Univ, Yale Occupat & Environm Med Program, New Haven, CT 06520 USA.	peter.rabinowitz@yale.edu		Radin, Jennifer/0000-0003-3843-0842; Rinne, Seppo/0000-0002-8662-1224; Trufan, Sally/0000-0003-3342-0629; Scotch, Matthew/0000-0001-5100-9724				Aly MM, 2008, AVIAN DIS, V52, P269, DOI 10.1637/8166-103007-Reg.1; [Anonymous], 2009, SUSTAINING GLOBAL SU; Cattoli G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004842; Chumpolbanchorn Kamlang, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P102; Dejpichai R, 2009, EMERG INFECT DIS, V15, P756, DOI 10.3201/eid1505.080316; Food and Agriculture Organization (FAO), FAO AFR; Food and Agriculture Organization (FAO) FAO GeoNetwork, 2005, GLOB POULTR DENS; Guan Y, 2009, REV SCI TECH OIE, V28, P39, DOI 10.20506/rst.28.1.1868; Handoussa Heba, EGYPT HUMAN DEV REPO; Kayali G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017730; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Paek MR, 2010, POULTRY SCI, V89, P1647, DOI 10.3382/ps.2010-00800; Park AW, 2007, LANCET INFECT DIS, V7, P543, DOI 10.1016/S1473-3099(07)70186-X; Rabinowitz PM, 2008, ECOHEALTH, V5, P224, DOI 10.1007/s10393-008-0170-4; Saad MD, 2007, EMERG INFECT DIS, V13, P1120, DOI 10.3201/eid1307.061222; Shahid MA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-38; WHO, AV INFL; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997	19	20	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e43851	10.1371/journal.pone.0043851	http://dx.doi.org/10.1371/journal.pone.0043851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23028474	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517500004
J	Noris, B; Nadel, J; Barker, M; Hadjikhani, N; Billard, A				Noris, Basilio; Nadel, Jacqueline; Barker, Mandy; Hadjikhani, Nouchine; Billard, Aude			Investigating Gaze of Children with ASD in Naturalistic Settings	PLOS ONE			English	Article							IMPAIRED RECOGNITION; SOCIAL CONTINGENCY; BIOLOGICAL MOTION; YOUNG-CHILDREN; EYE CONTACT; AUTISM; ATTENTION; SPECTRUM; STIMULI; INFORMATION	Background: Visual behavior is known to be atypical in Autism Spectrum Disorders (ASD). Monitor-based eye-tracking studies have measured several of these atypicalities in individuals with Autism. While atypical behaviors are known to be accentuated during natural interactions, few studies have been made on gaze behavior in natural interactions. In this study we focused on i) whether the findings done in laboratory settings are also visible in a naturalistic interaction; ii) whether new atypical elements appear when studying visual behavior across the whole field of view. Methodology/Principal Findings: Ten children with ASD and ten typically developing children participated in a dyadic interaction with an experimenter administering items from the Early Social Communication Scale (ESCS). The children wore a novel head-mounted eye-tracker, measuring gaze direction and presence of faces across the child's field of view. The analysis of gaze episodes to faces revealed that children with ASD looked significantly less and for shorter lapses of time at the experimenter. The analysis of gaze patterns across the child's field of view revealed that children with ASD looked downwards and made more extensive use of their lateral field of view when exploring the environment. Conclusions/Significance: The data gathered in naturalistic settings confirm findings previously obtained only in monitor-based studies. Moreover, the study allowed to observe a generalized strategy of lateral gaze in children with ASD when they were looking at the objects in their environment.	[Noris, Basilio; Billard, Aude] Ecole Polytech Fed Lausanne, Learning Algorithms & Syst Lab, Lausanne, Switzerland; [Nadel, Jacqueline] Hop La Pitie Salpetriere, Emot Ctr, Paris, France; [Barker, Mandy] Univ Lausanne, Univ Hosp Canton Vaud, Dept Child & Adolescent Psychiat, Lausanne, Switzerland; [Hadjikhani, Nouchine] Ecole Polytech Fed Lausanne, Brain & Mind Inst, Lausanne, Switzerland; [Hadjikhani, Nouchine] Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, HST, Boston, MA 02114 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Harvard University; Massachusetts General Hospital	Noris, B (corresponding author), Ecole Polytech Fed Lausanne, Learning Algorithms & Syst Lab, Lausanne, Switzerland.	basilio.noris@epfl.ch	Hadjikhani, Nouchine/C-2018-2008	Hadjikhani, Nouchine/0000-0003-4075-3106	National Centre for Competence in Research of the Swiss National Science Foundation	National Centre for Competence in Research of the Swiss National Science Foundation(Swiss National Science Foundation (SNSF))	This work was funded by the IM2 program of the National Centre for Competence in Research of the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APA, 2000, DIAGN STAT MAN MENT; Ashwin C, 2006, SOC NEUROSCI-UK, V1, P349, DOI 10.1080/17470910601040772; BARONCOHEN S, 1995, BRIT J DEV PSYCHOL, V13, P379, DOI 10.1111/j.2044-835X.1995.tb00687.x; Billard A, 2007, ASSIST TECHNOL, V19, P37, DOI 10.1080/10400435.2007.10131864; Bird G, 2006, NEUROIMAGE, V31, P1614, DOI 10.1016/j.neuroimage.2006.02.037; Blake R, 2003, PSYCHOL SCI, V14, P151, DOI 10.1111/1467-9280.01434; Bogdashina, 2003, SENSORY PERCEPTUAL I; Chawarska K, 2009, J AUTISM DEV DISORD, V39, P1663, DOI 10.1007/s10803-009-0803-7; Dakin S, 2005, NEURON, V48, P497, DOI 10.1016/j.neuron.2005.10.018; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Elison JT, 2008, IMFAR LOND; Fletcher-Watson S, 2008, J AUTISM DEV DISORD, V38, P1785, DOI 10.1007/s10803-008-0548-8; Gaily E, 2009, EPILEPSIA, V50, P206, DOI 10.1111/j.1528-1167.2008.01961.x; Golarai G, 2006, CLIN NEUROSCI RES, V6, P145, DOI 10.1016/j.cnr.2006.08.001; Grandin Temple, 1995, THINKING PICTURES EX; Grynszpan O, 2009, P IEEE C VI IN PRESS; HENDRICKSON A, 1992, BEHAV BRAIN RES, V49, P21, DOI 10.1016/S0166-4328(05)80191-3; HUTT C, 1966, BEHAV SCI, V11, P346, DOI 10.1002/bs.3830110504; Jemel B, 2006, J AUTISM DEV DISORD, V36, P91, DOI 10.1007/s10803-005-0050-5; Jones F, 2008, ARCH GEN PSYCHIAT, V65; Joseph RM, 2003, J CHILD PSYCHOL PSYC, V44, P529, DOI 10.1111/1469-7610.00142; Kennedy DP, 2009, NAT NEUROSCI, V12, P1226, DOI 10.1038/nn.2381; Klin A, 2002, AM J PSYCHIAT, V159, P895, DOI 10.1176/appi.ajp.159.6.895; Klin A, 2008, DEVELOPMENTAL SCI, V11, P40, DOI 10.1111/j.1467-7687.2007.00608.x; Landry R, 2004, J CHILD PSYCHOL PSYC, V45, P1115, DOI 10.1111/j.1469-7610.2004.00304.x; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Merin N, 2007, J AUTISM DEV DISORD, V37, P108, DOI 10.1007/s10803-006-0342-4; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; Mottron L, 2007, DEV PSYCHOPATHOL, V19, P23, DOI 10.1017/S0954579407070022; Mundy P, 1997, J AUTISM DEV DISORD, V27, P653, DOI 10.1023/A:1025802832021; Mundy P., 2003, MANUAL ABRIDGED EARL; Nadel J., 1999, IMITATION INFANCY; Nadel J, 1999, DEVELOPMENTAL SCI, V2, P164, DOI 10.1111/1467-7687.00065; Noris B., 2010, J COMPUTER VISION IM, V2010; Noris B, 2007, ADV INTEL SOFT COMPU, V45, P663; Pedersen J, 1997, EUR CHILD ADOLES PSY, V6, P96; Pelphrey KA, 2002, J AUTISM DEV DISORD, V32, P249, DOI 10.1023/A:1016374617369; Riby DM, 2009, J AUTISM DEV DISORD, V39, P421, DOI 10.1007/s10803-008-0641-z; RICHER JM, 1976, ACTA PSYCHIAT SCAND, V53, P193, DOI 10.1111/j.1600-0447.1976.tb00074.x; RITVO ER, 1986, J AM ACAD CHILD PSY, V25, P137, DOI 10.1016/S0002-7138(09)60611-7; Robins B., 2005, Universal Access in the Information Society, V4, P105, DOI 10.1007/s10209-005-0116-3; Roos EM, 2008, AUTISM, V12, P275, DOI 10.1177/1362361307089521; Scassellati B, 2007, SPRINGER TRAC ADV RO, V28, P552; Seibert J. M., 1982, INFANT MENT HEALTH J, V3, P244, DOI [10.1002/1097-0355(198224)3:43.0.CO;2-R, DOI 10.1002/1097-0355(198224)3:43.0.CO;2-R, DOI 10.1002/1097-0355(198224)3:4<244::AID-IMHJ2280030406>3.0.CO;2-R]; Senju A, 2009, NEUROSCI BIOBEHAV R, V33, P1204, DOI 10.1016/j.neubiorev.2009.06.001; Senju A, 2009, TRENDS COGN SCI, V13, P127, DOI 10.1016/j.tics.2008.11.009; Shic F., 2007, DEV LEARN 2007 ICDL, P70; Shic F, 2008, P EYE TRACK RES APPL; Sigman M, 2004, MENT RETARD DEV D R, V10, P221, DOI 10.1002/mrdd.20046; Simmons DR, 2009, VISION RES, V49, P2705, DOI 10.1016/j.visres.2009.08.005; Soussignan R, 2006, INFANCY, V10, P123, DOI 10.1207/s15327078in1002_2; Sparrow S. S., 2016, VINELAND ADAPTIVE BE, V3rd; Speer LL, 2007, AUTISM, V11, P265, DOI 10.1177/1362361307076925; Spezio ML, 2007, J AUTISM DEV DISORD, V37, P929, DOI 10.1007/s10803-006-0232-9; Spezio ML, 2007, J NEUROSCI, V27, P3994, DOI 10.1523/JNEUROSCI.3789-06.2007; Swettenham J, 1998, J CHILD PSYCHOL PSYC, V39, P747, DOI 10.1111/1469-7610.00373; Trepagnier C, 2002, CYBERPSYCHOL BEHAV, V5, P213, DOI 10.1089/109493102760147204; Yoshida H, 2008, INFANCY, V13, P229, DOI 10.1080/15250000802004437; Young GS, 2009, DEV SCI; Zwaigenbaum L, 2005, INT J DEV NEUROSCI, V23, P143, DOI 10.1016/j.ijdevneu.2004.05.001	60	69	70	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e44144	10.1371/journal.pone.0044144	http://dx.doi.org/10.1371/journal.pone.0044144			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016YB	23028494	gold, Green Published, Green Submitted			2022-12-27	WOS:000309554700007
J	Theorell, T; Nyberg, A; Leineweber, C; Hanson, LLM; Oxenstierna, G; Westerlund, H				Theorell, Tores; Nyberg, Anna; Leineweber, Constanze; Hanson, Linda L. Magnusson; Oxenstierna, Gabriel; Westerlund, Hugo			Non-Listening and Self Centered Leadership - Relationships to Socioeconomic Conditions and Employee Mental Health	PLOS ONE			English	Article							MANAGERIAL LEADERSHIP; SWEDISH MEN; DEPRESSION; POPULATION; PREVALENCE; SYMPTOMS; STRESS; STRAIN; RISK	Background: The way in which leadership is experienced in different socioeconomic strata is of interest per se, as well as how it relates to employee mental health. Methods: Three waves of SLOSH (Swedish Longitudinal Occupational Survey of Health, a questionnaire survey on a sample of the Swedish working population) were used, 2006, 2008 and 2010 (n = 5141). The leadership variables were: "Non-listening leadership" (one question: "Does your manager listen to you?" - four response categories), "Self centered leadership" (sum of three five-graded questions - "non-participating", "asocial" and "loner"). The socioeconomic factors were education and income. Emotional exhaustion and depressive symptoms were used as indicators of mental health. Results: Non-listening leadership was associated with low income and low education whereas self-centered leadership showed a weaker relationship with education and no association at all with income. Both leadership variables were significantly associated with emotional exhaustion and depressive symptoms. "Self centered" as well as "non-listening" leadership in 2006 significantly predicted employee depressive symptoms in 2008 after adjustment for demographic variables. These predictions became non-significant when adjustment was made for job conditions (demands and decision latitude) in the "non-listening" leadership analyses, whereas predictions of depressive symptoms remained significant after these adjustments in the "self-centered leadership" analyses. Conclusions: Our results show that the leadership variables are associated with socioeconomic status and employee mental health. "Non-listening" scores were more sensitive to societal change and more strongly related to socioeconomic factors and job conditions than "self-centered" scores.	[Theorell, Tores; Nyberg, Anna; Leineweber, Constanze; Hanson, Linda L. Magnusson; Oxenstierna, Gabriel; Westerlund, Hugo] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden	Stockholm University	Theorell, T (corresponding author), Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden.	tores.theorell@stressforskning.su.se	Nyberg, Anna/AAA-1817-2020; Westerlund, Hugo/A-3049-2012; Hanson, Linda L Magnusson/D-2435-2017; Leineweber, Constanze/Z-1330-2019; Leineweber, Constanze/G-7052-2012	Westerlund, Hugo/0000-0002-8806-5698; Hanson, Linda L Magnusson/0000-0002-2908-1903; Leineweber, Constanze/0000-0001-8433-2405; Theorell, Tores/0000-0003-1956-7931	Swedish Research Council - The Swedish Longitudinal Occupational Survey of Health - Wave III [825-2009-6192/SLOSH]; Swedish Council for Working Life and Social Research [2005-0734]	Swedish Research Council - The Swedish Longitudinal Occupational Survey of Health - Wave III; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This study was supported by the Swedish Research Council, project number 825-2009-6192/SLOSH - The Swedish Longitudinal Occupational Survey of Health - Wave III (www.vr.se) and the Swedish Council for Working Life and Social Research, project number 2005-0734, nationally representative longitudinal work environment survey (www.fas.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen I, 2009, J EPIDEMIOL COMMUN H, V63, P575, DOI 10.1136/jech.2008.082719; Brooker AS, 2001, J COMMUNITY APPL SOC, V11, P97, DOI 10.1002/casp.620; Grandey AA, 2005, AC MAN C HAW; Grav S, 2012, J CLIN NURS, V21, P111, DOI 10.1111/j.1365-2702.2011.03868.x; Hanson LLM, 2008, SCAND J PUBLIC HEALT, V36, P737, DOI 10.1177/1403494808090164; Hanson LLM, 2009, INT ARCH OCC ENV HEA, V82, P951, DOI 10.1007/s00420-009-0406-9; Hasson D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-130; Hetland H, 2007, EUR J WORK ORGAN PSY, V16, P58, DOI 10.1080/13594320601084558; Holmberg I., 2006, SCAND J MANAG, V22, P307, DOI DOI 10.1016/J.SCAMAN.2006.10.002; Karasek R., 1990, HLTH WORK STRESS PRO; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Kinsten A, 2007, SWEDISH LONGITUDINAL; Kosidou K, 2011, J AFFECT DISORDERS, V134, P160, DOI 10.1016/j.jad.2011.05.024; Leiter M P, 1999, J Health Hum Serv Adm, V21, P472; Lohela M, 2009, J OCCUP ENVIRON MED, V51, P195, DOI 10.1097/JOM.0b013e318192bd2c; Lowe KB, 1996, LEADERSHIP QUART, V7, P385, DOI 10.1016/S1048-9843(96)90027-2; Marmot M., 2004, STATUS SYNDROME OUR; Miech RA, 2000, J HEALTH SOC BEHAV, V41, P162, DOI 10.2307/2676303; Molarius A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-302; Nielsen K, 2008, WORK STRESS, V22, P16, DOI 10.1080/02678370801979430; Nyberg A, 2009, OCCUP ENVIRON MED, V66, P51, DOI 10.1136/oem.2008.039362; Nyberg A, 2008, SCAND J PUBLIC HEALT, V36, P803, DOI 10.1177/1403494808093329; Nyberg A, 2011, WORK, V39, P267, DOI 10.3233/WOR-2011-1175; Sogaard HJ, 2009, SCAND J PUBLIC HEALT, V37, P855, DOI 10.1177/1403494809344653; THEORELL T, 1988, SCAND J WORK ENV HEA, V14, P189, DOI 10.5271/sjweh.1932; Yan XY, 2011, J INT MED RES, V39, P1142, DOI 10.1177/147323001103900402	26	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e44119	10.1371/journal.pone.0044119	http://dx.doi.org/10.1371/journal.pone.0044119			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016YB	23028491	Green Published, gold, Green Submitted			2022-12-27	WOS:000309554700006
J	Fu, JJ; Bazazi, AR; Altice, FL; Mohamed, MN; Kamarulzaman, A				Fu, Jeannia J.; Bazazi, Alexander R.; Altice, Frederick L.; Mohamed, Mahmood N.; Kamarulzaman, Adeeba			Absence of Antiretroviral Therapy and Other Risk Factors for Morbidity and Mortality in Malaysian Compulsory Drug Detention and Rehabilitation Centers	PLOS ONE			English	Article							CHI MINH CITY; HIV PREVENTION; HUMAN-RIGHTS; INJECT DRUGS; USERS; PEOPLE; CARE; CHALLENGES; PROVINCE; VIETNAM	Background: Throughout Asia, people who use drugs are confined in facilities referred to as compulsory drug detention and rehabilitation centers. The limited transparency and accessibility of these centers has posed a significant challenge to evaluating detainees and detention conditions directly. Despite HIV being highly prevalent in this type of confined setting, direct evaluation of detainees with HIV and their access to medical care has yet to be reported in the literature. Methods: We evaluated the health status of 100 adult male detainees with HIV and their access to medical care in the two largest Malaysian compulsory drug detention and rehabilitation centers holding HIV-infected individuals. Results: Approximately 80% of all detainees with HIV were surveyed in each detention center. Most participants reported multiple untreated medical conditions. None reported being able to access antiretroviral therapy during detention and only 9% reported receiving any HIV-related clinical assessment or care. Nearly a quarter screened positive for symptoms indicative of active tuberculosis, yet none reported having been evaluated for tuberculosis. Although 95% of participants met criteria for opioid dependence prior to detention, none reported being able to access opioid substitution therapy during detention, with 86% reporting current cravings for opioids and 87% anticipating relapsing to drug use after release. Fourteen percent of participants reported suicidal ideation over the previous two weeks. Conclusion: We identified a lack of access to antiretroviral therapy in two of the six compulsory drug detention and rehabilitation centers in Malaysia designated to hold HIV-infected individuals and found significant, unmet health needs among detainees with HIV. Individuals confined under such conditions are placed at considerably high risk for morbidity and mortality. Our findings underscore the urgent need for evidence-based drug policies that respect the rights of people who use drugs and seek to improve, rather than undermine, their health.	[Fu, Jeannia J.; Bazazi, Alexander R.; Altice, Frederick L.; Kamarulzaman, Adeeba] Yale Univ, Sch Med, Dept Internal Med, Sect Infect Dis,AIDS Program, New Haven, CT 06510 USA; [Bazazi, Alexander R.; Altice, Frederick L.] Yale Univ, Sch Publ Hlth, Div Epidemiol Microbial Dis, New Haven, CT USA; [Fu, Jeannia J.; Bazazi, Alexander R.; Altice, Frederick L.; Kamarulzaman, Adeeba] Univ Malaya, Med Ctr, Ctr Excellence Res AIDS CERiA, Kuala Lumpur, Malaysia; [Mohamed, Mahmood N.] Univ Utara Malaysia, Sintok, Kedah, Malaysia	Yale University; Yale University; Universiti Malaya; Universiti Utara Malaysia	Altice, FL (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Infect Dis,AIDS Program, New Haven, CT 06510 USA.	frederick.altice@yale.edu	KAMARULZAMAN, ADEEBA/B-5216-2010	Bazazi, Alexander/0000-0002-4284-5082	University of Malaysia Research University grant; NIH [MSTP TG T32GM07205]; Ministry of Higher Education, Malaysia: High Impact Research [E-000001-20001]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA017072, R01DA025943] Funding Source: NIH RePORTER	University of Malaysia Research University grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Higher Education, Malaysia: High Impact Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for the study was provided by the University of Malaysia Research University grant 2007. ARB is supported by NIH MSTP TG T32GM07205. This work was supported in part by grants from the Ministry of Higher Education, Malaysia: High Impact Research E-000001-20001 to AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amon JJ, 2011, JAIDS-J ACQ IMM DEF, V57, pE29, DOI 10.1097/QAI.0b013e318215de81; Black DW, 2004, J AM ACAD PSYCHIATRY, V32, P158; Bohn M, 1991, PROBL DRUG DEP 1991; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Choi P, 2010, INT J STD AIDS, V21, P416, DOI 10.1258/ijsa.2009.009180; Cohen JE, 2008, PLOS MED, V5, P1682, DOI 10.1371/journal.pmed.0050234; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Fozi K, 2006, Med J Malaysia, V61, P519; Hariz NH, 2010, NEW STRAITS TIMES; Hien NT, 2000, AIDS CARE, V12, P483, DOI 10.1080/09540120050123882; Human Rights Watch, 2010, SKIN CABL ILL ARR AR; Human Rights Watch, 2010, DARKN KNOWS NO LIM I; Human Rights Watch, 2008, UNBR CYCL DRUG DEP T; Isa A R, 1993, Med J Malaysia, V48, P124; Jurgens R, 2010, LANCET, V376, P475, DOI 10.1016/S0140-6736(10)60830-6; Kamarulzaman A, 2009, JAIDS-J ACQ IMM DEF, V52, pS17, DOI 10.1097/QAI.0b013e3181bbc9af; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Ministry of Health of Malaysia (MOH), 2008, SUMM HIV AIDS CAS RE; Pearshouse Richard, 2009, HIV AIDS Policy Law Rev, V14, P11; Reid G, 2007, INT J DRUG POLICY, V18, P136, DOI 10.1016/j.drugpo.2006.12.015; Saucier Roxanne, 2010, INT J PRISONER HLTH, V6, P81, DOI DOI 10.1080/17449200802692086; SU J, 2004, CHINESE J DURG DEPEN, V13, P221; Thomson N., 2010, DETENTION TREATMENT; Tran SD, 1998, J ACQ IMMUN DEF SYND, V17, P283, DOI 10.1097/00042560-199803010-00015; United Nations Office on Drugs and Crime (UNODC) Economic and Social Commission for Asia and the Pacific (ESCAP) Joint United Nations Programme on HIV/AIDS (UNAIDS), 2010, REP REG CONS COMP CT; WARE JE, 1995, INT J TECHNOL ASSESS, V11, P525, DOI 10.1017/S0266462300008710; Wolfe D, 2010, JAIDS-J ACQ IMM DEF, V55, pS56, DOI 10.1097/QAI.0b013e3181f9c0de; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; World Health Organization, 2009, ASS COMP TREATM PEOP; Zhu WX, 2009, DRUG ALCOHOL REV, V28, P641, DOI 10.1111/j.1465-3362.2009.00068.x	31	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44249	10.1371/journal.pone.0044249	http://dx.doi.org/10.1371/journal.pone.0044249			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	040HS	23028508	Green Accepted, Green Published, gold			2022-12-27	WOS:000311313900015
J	Jahn, T; Zuther, M; Friedrichs, B; Heuser, C; Guhlke, S; Abken, H; Hombach, AA				Jahn, Tobias; Zuther, Martin; Friedrichs, Bjoern; Heuser, Claudia; Guhlke, Stefan; Abken, Hinrich; Hombach, Andreas A.			An IL12-IL2-Antibody Fusion Protein Targeting Hodgkin's Lymphoma Cells Potentiates Activation of NK and T cells for an Anti-Tumor Attack	PLOS ONE			English	Article							REED-STERNBERG CELLS; ANTI-CD16/CD30 BISPECIFIC ANTIBODY; TUMOR-CELLS; IMMUNE-SYSTEM; DISEASE; EXPRESSION; CYTOKINES; LYSIS; FRAGMENTS; SUBSETS	Successful immunotherapy of Hodgkin's disease is so far hampered by the striking unresponsiveness of lymphoma infiltrating immune cells. To mobilize both adoptive and innate immune cells for an anti-tumor attack we fused the pro-inflammatory cytokines IL2 and IL12 to an anti-CD30 scFv antibody in a dual cytokine fusion protein to accumulate both cytokines at the malignant CD30(+) Hodgkin/Reed-Sternberg cells in the lymphoma lesion. The tumor-targeted IL12-IL2 fusion protein was superior in activating resting T cells to amplify and secrete pro-inflammatory cytokines compared to targeted IL2 or IL12 alone. NK cells were also activated by the dual cytokine protein to secrete IFN-gamma and to lyse target cells. The tumor-targeted IL12-IL2, when applied by i.v. injection to immune-competent mice with established antigen-positive tumors, accumulated at the tumor site and induced tumor regression. Data demonstrate that simultaneous targeting of two cytokines in a spatial and temporal simultaneous fashion to pre-defined tissues is feasible by a dual-cytokine antibody fusion protein. In the case of IL12 and IL2, this produced superior anti-tumor efficacy implying the strategy to muster a broader immune cell response in the combat against cancer.	[Hombach, Andreas A.] Univ Cologne, Dept Internal Med 1, D-50931 Cologne, Germany; Univ Cologne, CMMC, D-50931 Cologne, Germany	University of Cologne; University of Cologne	Hombach, AA (corresponding author), Univ Cologne, Dept Internal Med 1, D-50931 Cologne, Germany.	andreas.hombach@uk-koeln.de		Hombach, Andreas/0000-0001-9328-8442	"Deutsche Krebshilfe'', Bonn; Medical Faculty University of Cologne	"Deutsche Krebshilfe'', Bonn(Deutsche Krebshilfe); Medical Faculty University of Cologne	The study was funded through the "Deutsche Krebshilfe'', Bonn, and the "Koln Fortune'' program of the Medical Faculty University of Cologne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohlen H, 2000, ANN HEMATOL, V79, P110, DOI 10.1007/s002770050564; Cozen W, 2008, BLOOD, V111, P3377, DOI 10.1182/blood-2007-08-106872; ENGERT A, 1990, CANCER RES, V50, P2929; Evens AM, 2008, NAT CLIN PRACT ONCOL, V5, P543, DOI 10.1038/ncponc1186; Hartmann F, 1997, BLOOD, V89, P2042, DOI 10.1182/blood.V89.6.2042; Hartmann F, 2001, CLIN CANCER RES, V7, P1873; Heuser C, 2004, INT J CANCER, V110, P386, DOI 10.1002/ijc.20098; Heuser C, 2003, INT J CANCER, V106, P545, DOI 10.1002/ijc.11279; Hisada M, 2004, CANCER RES, V64, P1152, DOI 10.1158/0008-5472.CAN-03-2084; HOMBACH A, 1993, INT J CANCER, V55, P830, DOI 10.1002/ijc.2910550523; Hombach A, 2005, INT J CANCER, V115, P241, DOI 10.1002/ijc.20829; Hombach A, 1998, SCAND J IMMUNOL, V48, P497; Hombach A, 1998, J IMMUNOL METHODS, V218, P53, DOI 10.1016/S0022-1759(98)00115-X; JOST LM, 1992, J IMMUNOL METHODS, V147, P153, DOI 10.1016/S0022-1759(12)80003-2; KAPP U, 1994, ANN ONCOL, V5, pS121, DOI 10.1093/annonc/5.suppl_1.S121; Kemp RA, 2001, J IMMUNOL, V167, P6497, DOI 10.4049/jimmunol.167.11.6497; Kennedy-Nasser AA, 2011, PEDIATR HEMAT ONCOL, V28, P176, DOI 10.3109/08880018.2011.557261; Kuppers R, 2002, ANN ONCOL, V13, P11, DOI 10.1093/annonc/13.S1.11; Maggio E, 2002, ANN ONCOL, V13, P52, DOI 10.1093/annonc/13.S1.52; NEWCOM SR, 1992, BLOOD, V79, P191; Overwijk WW, 2006, J IMMUNOL, V176, P5213, DOI 10.4049/jimmunol.176.9.5213; POHL C, 1993, INT J CANCER, V54, P418, DOI 10.1002/ijc.2910540312; Poppema S, 2000, SEMIN CANCER BIOL, V10, P345, DOI 10.1006/scbi.2000.0327; Qin ZH, 2003, CANCER RES, V63, P4095; Ranft K, 2009, CANCER LETT, V282, P187, DOI 10.1016/j.canlet.2009.03.011; RENNER C, 1995, EUR J IMMUNOL, V25, P2027, DOI 10.1002/eji.1830250734; ROBBINS PF, 1991, CANCER RES, V51, P3657; Rooney CM, 2002, ANN HEMATOL, V81, pS39; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schliemann C, 2009, BLOOD, V113, P2275, DOI 10.1182/blood-2008-05-160747; Schreck S, 2009, HEMATOL ONCOL, V27, P31, DOI 10.1002/hon.878; Shusterman S, 2010, J CLIN ONCOL, V28, P4969, DOI 10.1200/JCO.2009.27.8861; Skinnider BF, 2002, BLOOD, V99, P618, DOI 10.1182/blood.V99.2.618; Skinnider BF, 2002, BLOOD, V99, P4283, DOI 10.1182/blood-2002-01-0099; SLIVNICK DJ, 1990, SEMIN ONCOL, V17, P673; Stein Harald, 2009, Curr Hematol Malig Rep, V4, P125, DOI 10.1007/s11899-009-0018-1; Toennies HM, 2004, J LEUKOCYTE BIOL, V75, P350, DOI 10.1189/jlb.0803401; van den Berg A, 1999, AM J PATHOL, V154, P1685, DOI 10.1016/S0002-9440(10)65424-7; Wang BL, 2001, ONCOGENE, V20, P6930, DOI 10.1038/sj.onc.1204871; Wu CY, 1997, J IMMUNOL, V159, P1658	40	27	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44482	10.1371/journal.pone.0044482	http://dx.doi.org/10.1371/journal.pone.0044482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028547	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900028
J	Patel, NR; Bole, M; Chen, C; Hardin, CC; Kho, AT; Mih, J; Deng, LH; Butler, J; Tschumperlin, D; Fredberg, JJ; Krishnan, R; Koziel, H				Patel, Naimish R.; Bole, Medhavi; Chen, Cheng; Hardin, Charles C.; Kho, Alvin T.; Mih, Justin; Deng, Linhong; Butler, James; Tschumperlin, Daniel; Fredberg, Jeffrey J.; Krishnan, Ramaswamy; Koziel, Henry			Cell Elasticity Determines Macrophage Function	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; LUNG-MECHANICS; ACTIVATION; FILOPODIA; STIFFNESS; TUBERCULOSIS; PERSPECTIVE; PNEUMONIA; SUBSTRATE; ADHESIVE	Macrophages serve to maintain organ homeostasis in response to challenges from injury, inflammation, malignancy, particulate exposure, or infection. Until now, receptor ligation has been understood as being the central mechanism that regulates macrophage function. Using macrophages of different origins and species, we report that macrophage elasticity is a major determinant of innate macrophage function. Macrophage elasticity is modulated not only by classical biologic activators such as LPS and IFN-gamma, but to an equal extent by substrate rigidity and substrate stretch. Macrophage elasticity is dependent upon actin polymerization and small rhoGTPase activation, but functional effects of elasticity are not predicted by examination of gene expression profiles alone. Taken together, these data demonstrate an unanticipated role for cell elasticity as a common pathway by which mechanical and biologic factors determine macrophage function.	[Patel, Naimish R.; Bole, Medhavi; Koziel, Henry] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Pulm Crit Care & Sleep Med,Dept Med, Boston, MA 02215 USA; [Chen, Cheng; Deng, Linhong] Chongqing Univ, Bioengn Coll, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing 630044, Peoples R China; [Chen, Cheng; Hardin, Charles C.; Mih, Justin; Butler, James; Tschumperlin, Daniel; Fredberg, Jeffrey J.; Krishnan, Ramaswamy] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Program Mol & Integrat Physiol Sci, Boston, MA 02115 USA; [Kho, Alvin T.] Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Cambridge, MA USA; [Kho, Alvin T.] Childrens Hosp, Informat Program, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Chongqing University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University; Boston Children's Hospital	Patel, NR (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Pulm Crit Care & Sleep Med,Dept Med, Boston, MA 02215 USA.	npatel@bidmc.harvard.edu	Deng, Linhong/O-3218-2019; Deng, Linhong/C-1485-2009; Fredberg, Jeffrey/M-9877-2019	Deng, Linhong/0000-0003-1970-8239; Chen, Cheng/0000-0002-7323-1104	National Heart, Lung, and Blood Institute; National Institute of Allergy and Infectious Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102373, K25HL091124, K25HL111212] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by the National Heart, Lung, and Blood Institute and the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G, 2004, J APPL PHYSIOL, V96, P293, DOI 10.1152/japplphysiol.00270.2003; Arredouani M, 2004, J EXP MED, V200, P267, DOI 10.1084/jem.20040731; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; ERZURUM SC, 1992, J IMMUNOL, V149, P154; Fereol S, 2006, CELL MOTIL CYTOSKEL, V63, P321, DOI 10.1002/cm.20130; FERTSCH D, 1984, J IMMUNOL, V132, P2436; Flannagan RS, 2010, J CELL BIOL, V191, P1205, DOI 10.1083/jcb.201007056; Gang Z, 2009, MICROSC RES TECHNIQ, V72, P672, DOI 10.1002/jemt.20716; Gaspari R, 2009, J ULTRAS MED, V28, P855, DOI 10.7863/jum.2009.28.7.855; Haslett C, 1999, AM J RESP CRIT CARE, V160, pS5, DOI 10.1164/ajrccm.160.supplement_1.4; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; INGENITO EP, 1994, J APPL PHYSIOL, V77, P2689, DOI 10.1152/jappl.1994.77.6.2689; Jones J, 2005, CLIN CANCER RES, V11, P5730, DOI 10.1158/1078-0432.CCR-04-2225; Kang I, 2010, AM J RESP CELL MOL, V43, P591, DOI 10.1165/rcmb.2006-0381OC; Kho AT, 2004, GENE DEV, V18, P629, DOI 10.1101/gad.1182504; Kong L, 2009, CELL HOST MICROBE, V6, P150, DOI 10.1016/j.chom.2009.06.008; Kress H, 2007, P NATL ACAD SCI USA, V104, P11633, DOI 10.1073/pnas.0702449104; Krishnan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005486; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082; Maki-Petaja KM, 2006, CIRCULATION, V114, P1185, DOI 10.1161/CIRCULATIONAHA.105.601641; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Medvedev AE, 2006, J ENDOTOXIN RES, V12, P133, DOI 10.1179/096805106X102255; MINK SN, 1981, J APPL PHYSIOL, V50, P283, DOI 10.1152/jappl.1981.50.2.283; Mizgerd JP, 2006, PLOS MED, V3, P155, DOI 10.1371/journal.pmed.0030076; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Patel NR, 2007, J IMMUNOL, V179, P6973, DOI 10.4049/jimmunol.179.10.6973; Pena OM, 2011, J IMMUNOL; Peterson JR, 2004, NAT STRUCT MOL BIOL, V11, P747, DOI 10.1038/nsmb796; Pittet LA, 2011, AM J RESP CELL MOL B; Rook GAW, 2007, CURR MOL MED, V7, P327; Seo YS, 2010, SCAND J GASTROENTERO, V45, P449, DOI 10.3109/00365520903536515; SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302; Thrasher AJ, 2010, NAT REV IMMUNOL, V10, P182, DOI 10.1038/nri2724; Trepat X, 2007, NATURE, V447, P592, DOI 10.1038/nature05824; Tschumperlin DJ, 2010, J BIOMECH, V43, P99, DOI 10.1016/j.jbiomech.2009.09.015; Vonna L, 2007, EUR BIOPHYS J BIOPHY, V36, P145, DOI 10.1007/s00249-006-0118-y; WHEELER AP, 1990, J APPL PHYSIOL, V68, P2542, DOI 10.1152/jappl.1990.68.6.2542; Yan ZQ, 2007, IMMUNOL REV, V219, P187, DOI 10.1111/j.1600-065X.2007.00554.x; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29	44	173	174	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e41024	10.1371/journal.pone.0041024	http://dx.doi.org/10.1371/journal.pone.0041024			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028423	gold, Green Published, Green Submitted			2022-12-27	WOS:000311313900001
J	Steinmann, C; Ibsen, MW; Hansen, AS; Jensen, JH				Steinmann, Casper; Ibsen, Mikael W.; Hansen, Anne S.; Jensen, Jan H.			FragIt: A Tool to Prepare Input Files for Fragment Based Quantum Chemical Calculations	PLOS ONE			English	Article							MOLECULAR-ORBITAL METHOD; ACCURATE CALCULATIONS; PDB2PQR	Near linear scaling fragment based quantum chemical calculations are becoming increasingly popular for treating large systems with high accuracy and is an active field of research. However, it remains difficult to set up these calculations without expert knowledge. To facilitate the use of such methods, software tools need to be available to support these methods and help to set up reasonable input files which will lower the barrier of entry for usage by non-experts. Previous tools relies on specific annotations in structure files for automatic and successful fragmentation such as residues in PDB files. We present a general fragmentation methodology and accompanying tools called FragIt to help setup these calculations. FragIt uses the SMARTS language to locate chemically appropriate fragments in large structures and is applicable to fragmentation of any molecular system given suitable SMARTS patterns. We present SMARTS patterns of fragmentation for proteins, DNA and polysaccharides, specifically for D-galactopyranose for use in cyclodextrins. FragIt is used to prepare input files for the Fragment Molecular Orbital method in the GAMESS program package, but can be extended to other computational methods easily.	[Steinmann, Casper; Ibsen, Mikael W.; Hansen, Anne S.; Jensen, Jan H.] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark	University of Copenhagen	Steinmann, C (corresponding author), Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark.	steinmann@chem.ku.dk	Jensen, Jan Halborg/G-4338-2010; Hansen, Anne Schou/I-9181-2016; Svendsen, Casper/T-6775-2018	Jensen, Jan Halborg/0000-0002-1465-1010; Hansen, Anne Schou/0000-0002-6285-586X; Svendsen, Casper/0000-0002-5638-1346	IRENE	IRENE	Funded by IRENE: http://www.irene-fp7.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chiba M, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2772850; Dapprich S, 1999, J MOL STRUC-THEOCHEM, V461, P1, DOI 10.1016/S0166-1280(98)00475-8; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Fedorov DG, 2009, FRAGMENT MOLECULAR ORBITAL METHOD: PRACTICAL APPLICATIONS TO LARGE MOLECULAR SYSTEMS, P1, DOI 10.1201/9781420078497; Fedorov DG, 2004, J CHEM PHYS, V121, P2483, DOI 10.1063/1.1769362; Fedorov DG, 2004, J CHEM PHYS, V120, P6832, DOI 10.1063/1.1687334; Fedorov DG, 2004, J COMPUT CHEM, V25, P872, DOI 10.1002/jcc.20018; Fedorov DG, 2005, J PHYS CHEM A, V109, P2638, DOI 10.1021/jp047186z; Fedorov DG, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2007588; Fedorov DG, 2008, J PHYS CHEM A, V112, P11808, DOI 10.1021/jp805435n; Fedorov DG, 2007, J PHYS CHEM A, V111, P6904, DOI 10.1021/jp0716740; Fedorov DG, 2007, J COMPUT CHEM, V28, P1476, DOI 10.1002/jcc.20645; Fedorov DG, 2006, CHEM PHYS LETT, V433, P182, DOI 10.1016/j.cplett.2006.10.052; Fedorov DG, 2011, J PHYS CHEM LETT, V2, P282, DOI 10.1021/jz1016894; Fedorov DG, 2009, CHEM PHYS LETT, V477, P169, DOI 10.1016/j.cplett.2009.06.072; Fletcher G, 2012, J CHEM THEORY COMPUT; Gao JL, 1997, J COMPUT CHEM, V18, P1061, DOI 10.1002/(SICI)1096-987X(199706)18:8<1061::AID-JCC10>3.0.CO;2-G; Gordon MS, 2012, CHEM REV, V112, P632, DOI 10.1021/cr200093j; James CA, 2006, DAYLIGHT THEORY MANU; Lewell XQ, 1998, J CHEM INF COMP SCI, V38, P511, DOI 10.1021/ci970429i; Mayhall NJ, 2011, J CHEM THEORY COMPUT, V7, P1336, DOI 10.1021/ct200033b; Nakano T, 2000, CHEM PHYS LETT, V318, P614, DOI 10.1016/S0009-2614(00)00070-1; Nakano T, 2002, CHEM PHYS LETT, V351, P475, DOI 10.1016/S0009-2614(01)01416-6; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Steinmann C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041117; Steinmann C, 2010, J PHYS CHEM A, V114, P8705, DOI 10.1021/jp101498m; Suarez E, 2009, J CHEM THEORY COMPUT, V5, P1667, DOI 10.1021/ct8005002; Suenaga M., 2005, J COMPUT CHEM-JPN, V4, P25, DOI [10.2477/jccj.4.25, DOI 10.2477/JCCJ.4.25]; Suenaga M, 2008, J COMPUT CHEM-JPN, V7, P33, DOI 10.2477/jccj.H1920; Svensson M, 1996, J PHYS CHEM-US, V100, P19357, DOI 10.1021/jp962071j; Xie WS, 2007, J CHEM THEORY COMPUT, V3, P1890, DOI 10.1021/ct700167b	34	32	32	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44480	10.1371/journal.pone.0044480	http://dx.doi.org/10.1371/journal.pone.0044480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028546	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900027
J	Buck, NE; Dashnow, H; Pitt, JJ; Wood, LR; Peters, HL				Buck, Nicole E.; Dashnow, Harriet; Pitt, James J.; Wood, Leonie R.; Peters, Heidi L.			Development of Transgenic Mice Containing an Introduced Stop Codon on the Human Methylmalonyl-CoA Mutase Locus	PLOS ONE			English	Article							NONSENSE MUTATION; MOUSE MODEL; IDENTIFICATION; ACIDEMIA; ACIDURIA; GENE	The mutation R403stop was found in an individual with mut(0) methylmalonic aciduria (MMA) which resulted from a single base change of C -> T in exon 6 of the methylmalonyl-CoA mutase gene (producing a TGA stop codon). In order to accurately model the human MMA disorder we introduced this mutation onto the human methylmalonyl-CoA mutase locus of a bacterial artificial chromosome. A mouse model was developed using this construct. The transgene was found to be intact in the mouse model, with 7 copies integrated at a single site in chromosome 3. The phenotype of the hemizygous mouse was unchanged until crossed against a methylmalonyl-CoA mutase knockout mouse. Pups with no endogenous mouse methylmalonyl-CoA mutase and one copy of the transgene became ill and died within 24 hours. This severe phenotype could be partially rescued by the addition of a transgene carrying two copies of the normal human methylmalonyl-CoA mutase locus. The "humanized'' mice were smaller than control litter mates and had high levels of methylmalonic acid in their blood and tissues. This new transgenic MMA stop codon model mimics (at both the phenotypic and genotypic levels) the key features of the human MMA disorder. It will allow the trialing of pharmacological and, cell and gene therapies for the treatment of MMA and other human metabolic disorders caused by stop codon mutations.	[Buck, Nicole E.; Dashnow, Harriet; Pitt, James J.; Wood, Leonie R.; Peters, Heidi L.] Univ Melbourne, Dept Paediat, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Pitt, James J.] Murdoch Childrens Res Inst, VCGS Pathol, Parkville, Vic, Australia	Murdoch Children's Research Institute; University of Melbourne; Murdoch Children's Research Institute	Buck, NE (corresponding author), Univ Melbourne, Dept Paediat, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.	heidi.peters@mcri.edu.au	Dashnow, Harriet/AAG-8213-2019; peters, heidi/GWD-0358-2022	Dashnow, Harriet/0000-0001-8433-6270; Peters, Heidi/0000-0001-7189-5874	Murdoch Childrens Research Institute; Victorian Government's Operational Infrastructure Support Program; National Health and Medical Research Council clinical Career Development Award	Murdoch Childrens Research Institute; Victorian Government's Operational Infrastructure Support Program; National Health and Medical Research Council clinical Career Development Award(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Murdoch Childrens Research Institute and the Victorian Government's Operational Infrastructure Support Program. HP was the recipient of a National Health and Medical Research Council clinical Career Development Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaviva C, 2005, HUM MUTAT, V25, P167, DOI 10.1002/humu.20128; Barton-Davis ER, 1999, J CLIN INVEST, V104, P375, DOI 10.1172/JCI7866; Chase TH, 2010, BLOOD, V115, P1267, DOI 10.1182/blood-2009-05-219808; Du M, 2002, J MOL MED, V80, P595, DOI 10.1007/s00109-002-0363-1; Fowler B, 2008, J INHERIT METAB DIS, V31, P350, DOI 10.1007/s10545-008-0839-4; Lempp TJ, 2007, MOL GENET METAB, V90, P284, DOI 10.1016/j.ymgme.2006.10.002; LINDBLAD B, 1968, ACTA PAEDIATR SCAND, V57, P417, DOI 10.1111/j.1651-2227.1968.tb07314.x; MATSUI SM, 1983, NEW ENGL J MED, V308, P857, DOI 10.1056/NEJM198304143081501; Osborn O, 2010, CELL MOL NEUROBIOL, V30, P23, DOI 10.1007/s10571-009-9427-x; Peters H, 2003, J BIOL CHEM, V278, P52909, DOI 10.1074/jbc.M310533200; Peters HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040609; Peters Heidi L, 2002, Hum Mutat, V20, P406, DOI 10.1002/humu.9074; Rashed MS, 1997, CLIN CHEM, V43, P1129; Sangkuhl K, 2004, HUM MOL GENET, V13, P893, DOI 10.1093/hmg/ddh105; Worgan LC, 2006, HUM MUTAT, V27, P31, DOI 10.1002/humu.20258; Yang CM, 2007, P NATL ACAD SCI USA, V104, P15394, DOI 10.1073/pnas.0610878104	16	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44974	10.1371/journal.pone.0044974	http://dx.doi.org/10.1371/journal.pone.0044974			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024777	Green Published, gold, Green Submitted			2022-12-27	WOS:000308860100035
J	Duan, JL; Cai, WM				Duan, Jianli; Cai, Weiming			OsLEA3-2, an Abiotic Stress Induced Gene of Rice Plays a Key Role in Salt and Drought Tolerance	PLOS ONE			English	Article							EMBRYOGENESIS ABUNDANT PROTEINS; LEA PROTEINS; ARABIDOPSIS-THALIANA; ABSCISIC-ACID; WATER-STRESS; SACCHAROMYCES-CEREVISIAE; SEQUENCE-ANALYSIS; FREEZING TOLERANCE; PLANT DESICCATION; EXPRESSION	Late embryogenesis abundant (LEA) proteins are involved in tolerance to drought, cold and high salinity in many different organisms. In this report, a LEA protein producing full-length gene OsLEA3-2 was identified in rice (Oryza sativa) using the Rapid Amplification of cDNA Ends (RACE) method. OsLEA3-2 was found to be only expressed in the embryo and can be induced by abiotic stresses. The coding protein localizes to the nucleus and overexpression of OsLEA3-2 in yeast improved growth performance compared with control under salt- and osmotic-stress conditions. OsLEA3-2 was also inserted into pHB vector and overexpressed in Arabidopsis and rice. The transgenic Arabidopsis seedlings showed better growth on MS media supplemented with 150 mM mannitol or 100 mM NaCl as compared with wild type plants. The transgenic rice also showed significantly stronger growth performance than control under salinity or osmotic stress conditions and were able to recover after 20 days of drought stress. In vitro analysis showed that OsLEA3-2 was able to protect LDH from aggregation on freezing and inactivation on desiccation. These results indicated that OsLEA3-2 plays an important role in tolerance to abiotic stresses.	[Duan, Jianli; Cai, Weiming] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai, Peoples R China; [Duan, Jianli] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Duan, JL (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai, Peoples R China.	wmcai@sibs.ac.cn	Duan, Jianli/GOP-3297-2022	Duan, Jianli/0000-0001-7347-4774	National Basic Research Program of China [2011CB710902]; National Scientific Program [2012AA101103-03]; National Natural Science Foundation of China [90917009, 31070237]; Knowledge Innovation Program of the Chinese Academy of Sciences [KJCX2-YW-L08]; China Manned Space Flight Technology Project; National Transgenic Program [2009ZX08004-008B]	National Basic Research Program of China(National Basic Research Program of China); National Scientific Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); China Manned Space Flight Technology Project; National Transgenic Program	This work was supported by the National Basic Research Program of China (grant 2011CB710902), the National Scientific Program (grant 2012AA101103-03), the National Natural Science Foundation of China (grant 90917009, 31070237), the Knowledge Innovation Program of the Chinese Academy of Sciences (grant KJCX2-YW-L08), the China Manned Space Flight Technology Project and the National Transgenic Program (grant 2009ZX08004-008B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YQ, 2012, MOL BIOL REP, V39, P2883, DOI 10.1007/s11033-011-1048-z; BAKER J, 1988, PLANT MOL BIOL, V11, P277, DOI 10.1007/BF00027385; BARTELS D, 1988, PLANTA, V175, P485, DOI 10.1007/BF00393069; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Bies-Etheve N, 2008, PLANT MOL BIOL, V67, P107, DOI 10.1007/s11103-008-9304-x; BOSTOCK RM, 1992, PLANT PHYSIOL, V98, P1356, DOI 10.1104/pp.98.4.1356; BRAY EA, 1993, PLANT PHYSIOL, V103, P1035, DOI 10.1104/pp.103.4.1035; Browne J, 2002, NATURE, V416, P38, DOI 10.1038/416038a; Close TJ, 1997, PHYSIOL PLANTARUM, V100, P291, DOI 10.1034/j.1399-3054.1997.1000210.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; CURRY J, 1991, PLANT MOL BIOL, V16, P1073, DOI 10.1007/BF00016078; DURE L, 1993, PLANT J, V3, P363, DOI 10.1046/j.1365-313X.1993.t01-18-00999.x; GODOY JA, 1990, PLANT MOL BIOL, V15, P695, DOI 10.1007/BF00016120; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Hara M, 2001, J PLANT PHYSIOL, V158, P1333, DOI 10.1078/0176-1617-00600; Hellwege EM, 1996, PLANTA, V198, P423, DOI 10.1007/BF00620059; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; HONG BM, 1988, PLANT MOL BIOL, V11, P495, DOI 10.1007/BF00039030; Honjoh K, 2000, BIOSCI BIOTECH BIOCH, V64, P1656, DOI 10.1271/bbb.64.1656; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Imai R, 1996, GENE, V170, P243, DOI 10.1016/0378-1119(95)00868-3; Lal S, 2008, TRANSGENIC RES, V17, P651, DOI 10.1007/s11248-007-9145-4; Liu Y, 2010, CURR MICROBIOL, V60, P373, DOI 10.1007/s00284-009-9552-2; Mao J, 2005, P NATL ACAD SCI USA, V102, P12270, DOI 10.1073/pnas.0501011102; Moons A, 1997, GENE, V191, P197, DOI 10.1016/S0378-1119(97)00059-0; ROBERTS JK, 1993, PLANT CELL, V5, P769, DOI 10.1105/tpc.5.7.769; Sanchez-Ballesta MT, 2004, J AGR FOOD CHEM, V52, P1950, DOI 10.1021/jf035216+; TAKAHASHI R, 1994, PLANT MOL BIOL, V26, P339, DOI 10.1007/BF00039544; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Wang Bing-Feng, 2008, Journal of Forestry Research (Harbin), V19, P58, DOI 10.1007/s11676-008-0010-y; WHITE CN, 1995, PLANT PHYSIOL, V108, P1337, DOI 10.1104/pp.108.3.1337; WILHELM KS, 1993, PLANT MOL BIOL, V23, P1073, DOI 10.1007/BF00021822; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xu DP, 1996, PLANT PHYSIOL, V110, P249, DOI 10.1104/pp.110.1.249; Zhang L, 2000, J BIOCHEM, V127, P611, DOI 10.1093/oxfordjournals.jbchem.a022648	35	121	143	4	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45117	10.1371/journal.pone.0045117	http://dx.doi.org/10.1371/journal.pone.0045117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024799	gold, Green Published, Green Submitted			2022-12-27	WOS:000308860100057
J	Sakaguchi, A; Joyce, E; Aoki, T; Schedl, P; Steward, R				Sakaguchi, Ayako; Joyce, Eric; Aoki, Tsutomu; Schedl, Paul; Steward, Ruth			The Histone H4 Lysine 20 Monomethyl Mark, Set by PR-Set7 and Stabilized by L(3)mbt, Is Necessary for Proper Interphase Chromatin Organization	PLOS ONE			English	Article							DNA-DAMAGE CHECKPOINT; DROSOPHILA-MELANOGASTER; CHROMOSOME STRUCTURE; RNA INTERFERENCE; CELL-LINES; METHYLATION; EXPRESSION; GENES; COMPLEX; TRIMETHYLATION	Drosophila PR-Set7 or SET8 is a histone methyltransferase that specifically monomethylates histone H4 lysine 20 (H4K20). L(3)MBT has been identified as a reader of methylated H4K20. It contains several conserved domains including three MBT repeats binding mono- and dimethylated H4K20 peptides. We find that the depletion of PR-Set7 blocks de novo H4K20me1 resulting in the immediate activation of the DNA damage checkpoint, an increase in the size of interphase nuclei, and drastic reduction of cell viability. L(3)mbt on the other hand stabilizes the monomethyl mark, as L(3)mbt-depleted S2 cells show a reduction of more than 60% of bulk monomethylated H4K20 (H4K20me1) while viability is barely affected. Ploidy and basic chromatin structure show only small changes in PR-Set7-depleted cells, but higher order interphase chromatin organization is significantly affected presumably resulting in the activation of the DNA damage checkpoint. In the absence of any other known functions of PR-Set7, the setting of the de novo monomethyl mark appears essential for cell viability in the presence or absence of the DNA damage checkpoint, but once newly assembled chromatin is established the monomethyl mark, protected by L(3)mbt, is dispensable.	[Sakaguchi, Ayako; Steward, Ruth] Rutgers State Univ, Waksman Inst, Canc Inst New Jersey, Piscataway, NJ 08854 USA; [Steward, Ruth] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA; [Aoki, Tsutomu; Schedl, Paul] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Joyce, Eric] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Princeton University; Harvard University; Harvard Medical School	Sakaguchi, A (corresponding author), Rutgers State Univ, Waksman Inst, Canc Inst New Jersey, Piscataway, NJ 08854 USA.	steward@waksman.rutgers.edu			National Institutes of Health [PHSHD 18055]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by the National Institutes of Health (PHSHD 18055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman JR, 2012, G3-GENES GENOM GENET, V2, P731, DOI 10.1534/g3.112.002840; Bonasio R, 2010, SEMIN CELL DEV BIOL, V21, P221, DOI 10.1016/j.semcdb.2009.09.010; Bonilla CY, 2008, MOL CELL, V30, P267, DOI 10.1016/j.molcel.2008.03.023; Brustel J, 2011, TRENDS CELL BIOL; CARTWRIGHT IL, 1984, EMBO J, V3, P3101, DOI 10.1002/j.1460-2075.1984.tb02265.x; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; Dej KJ, 1999, DEVELOPMENT, V126, P293; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; GATEFF E, 1993, MECH DEVELOP, V41, P15, DOI 10.1016/0925-4773(93)90052-Y; Georlette D, 2007, GENE DEV, V21, P2880, DOI 10.1101/gad.1600107; Hamada FN, 2005, GENE DEV, V19, P2289, DOI 10.1101/gad.1343705; HAN M, 1988, CELL, V55, P1137, DOI 10.1016/0092-8674(88)90258-9; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Kalakonda N, 2008, ONCOGENE, V27, P4293, DOI 10.1038/onc.2008.67; Karachentsev D, 2005, GENE DEV, V19, P431, DOI 10.1101/gad.1263005; Karachentsev D, 2007, DEV BIOL, V304, P46, DOI 10.1016/j.ydbio.2006.12.019; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; LOUIS C, 1980, CELL, V22, P387, DOI 10.1016/0092-8674(80)90349-9; Lu JR, 2007, P NATL ACAD SCI USA, V104, P9381, DOI 10.1073/pnas.0610279104; Luger K, 1998, CURR OPIN GENET DEV, V8, P140, DOI 10.1016/S0959-437X(98)80134-2; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Pei HD, 2011, NATURE, V470, P124, DOI 10.1038/nature09658; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Rice JC, 2002, GENE DEV, V16, P2225, DOI 10.1101/gad.1014902; Rice JC, 2001, NATURE, V414, P258, DOI 10.1038/35104721; Richter C, 2011, NAT CELL BIOL, V13, P1029, DOI 10.1038/ncb2306; Sakaguchi A, 2008, GENETICS, V179, P317, DOI 10.1534/genetics.108.087650; Sakaguchi A, 2007, J CELL BIOL, V176, P155, DOI 10.1083/jcb.200607178; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Silahtaroglu AN, 2003, MOL CELL PROBE, V17, P165, DOI 10.1016/S0890-8508(03)00048-3; Song YH, 2005, MOL CELLS, V19, P167; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tardat M, 2007, J CELL BIOL, V179, P1413, DOI 10.1083/jcb.200706179; Tardat M, 2010, NAT CELL BIOL, V12, P1086, DOI 10.1038/ncb2113; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; UDVARDY A, 1984, J MOL BIOL, V172, P385, DOI 10.1016/S0022-2836(84)80013-3; Williams BR, 2007, GENETICS, V177, P31, DOI 10.1534/genetics.107.076356; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Yohn CB, 2003, GENETICS, V165, P1889; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhang Y, 2010, PLOS BIOL, V8, DOI [10.1371/journal.pbio.1000430, 10.1371/journal.pbio.1000494]	48	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45321	10.1371/journal.pone.0045321	http://dx.doi.org/10.1371/journal.pone.0045321			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024815	Green Published, Green Submitted, gold			2022-12-27	WOS:000308860100073
J	Song, H; Meng, Q; Liu, XQ				Song, Huiling; Meng, Qing; Liu, Xiang-Qin			Protein Trans-Splicing of an Atypical Split Intein Showing Structural Flexibility and Cross-Reactivity	PLOS ONE			English	Article							SWISS-MODEL REPOSITORY; CRYSTAL-STRUCTURE; HIGHLY EFFICIENT; MINI-INTEIN; DNAE GENE; IN-VITRO; LIGATION; SEMISYNTHESIS; CYCLIZATION; MODULATION	Inteins catalyze a protein splicing reaction to excise the intein from a precursor protein and join the flanking sequences (exteins) with a peptide bond. In a split intein, the intein fragments (I-N and I-C) can reassemble non-covalently to catalyze a trans-splicing reaction that joins the exteins from separate polypeptides. An atypical split intein having a very small I-N and a large I-C is particularly useful for joining synthetic peptides with recombinant proteins, which can be a generally useful method of introducing site-specific chemical labeling or modifications into proteins. However, a large I-C derived from an Ssp DnaX intein was found recently to undergo spontaneous C-cleavage, which raised questions regarding its structure-function and ability to trans-splice. Here, we show that this I-C could undergo trans-splicing in the presence of I-N, and the trans-splicing activity completely suppressed the C-cleavage activity. We also found that this I-C could trans-splice with small I-N sequences derived from two other inteins, showing a cross-reactivity of this atypical split intein. Furthermore, we found that this I-C could trans-splice even when the I-N sequence was embedded in a nearly complete intein sequence, suggesting that the small I-N could project out of the central pocket of the intein to become accessible to the I-C. Overall, these findings uncovered a new atypical split intein that can be valuable for peptide-protein trans-splicing, and they also revealed an interesting structural flexibility and cross-reactivity at the active site of this intein.	[Song, Huiling; Meng, Qing] Donghua Univ, Inst Biol Sci & Biotechnol, Shanghai, Peoples R China; [Song, Huiling; Liu, Xiang-Qin] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada	Donghua University; Dalhousie University	Song, H (corresponding author), Donghua Univ, Inst Biol Sci & Biotechnol, Shanghai, Peoples R China.	mengqing@dhu.edu.cn; paul.liu@dal.ca			National Sciences and Engineering Research Council of Canada; Chinese National High Technology Research and Development Program 863 [2006AA03Z451]; Chinese National Natural Science Foundation of China [30800186, 31070698]; Shanghai key projects of basic research [10JC1400300]	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Chinese National High Technology Research and Development Program 863(National High Technology Research and Development Program of China); Chinese National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai key projects of basic research	This work was supported by a grant to XQL from the National Sciences and Engineering Research Council of Canada and by research grants to QM from the Chinese National High Technology Research and Development Program 863 (NO 2006AA03Z451), the Chinese National Natural Science Foundation of China (NO 30800186 and 31070698), and the Shanghai key projects of basic research (NO 10JC1400300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amitai G, 2009, P NATL ACAD SCI USA, V106, P11005, DOI 10.1073/pnas.0904366106; Ando T, 2007, CHEM COMMUN, P4995, DOI 10.1039/b712843f; Appleby-Tagoe JH, 2011, J BIOL CHEM, V286, P34440, DOI 10.1074/jbc.M111.277350; Ding Y, 2003, J BIOL CHEM, V278, P39133, DOI 10.1074/jbc.M306197200; Evans TC, 2000, J BIOL CHEM, V275, P9091, DOI 10.1074/jbc.275.13.9091; Evans TC, 1998, PROTEIN SCI, V7, P2256, DOI 10.1002/pro.5560071103; Gilmore JM, 2006, ANGEW CHEM INT EDIT, V45, P5307, DOI 10.1002/anie.200600368; Gorbalenya AE, 1998, NUCLEIC ACIDS RES, V26, P1741, DOI 10.1093/nar/26.7.1741; Hall TMT, 1997, CELL, V91, P85, DOI 10.1016/S0092-8674(01)80011-8; Ichiyanagi K, 2000, J MOL BIOL, V300, P889, DOI 10.1006/jmbi.2000.3873; Iwai H, 2006, FEBS LETT, V580, P1853, DOI 10.1016/j.febslet.2006.02.045; Kalia J, 2006, CHEMBIOCHEM, V7, P1375, DOI 10.1002/cbic.200600150; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Klabunde T, 1998, NAT STRUCT BIOL, V5, P31, DOI 10.1038/nsb0198-31; Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008; Li J, 2008, HUM GENE THER, V19, P958, DOI 10.1089/hum.2008.009; Lin CW, 2006, J AM CHEM SOC, V128, P4542, DOI 10.1021/ja0604111; Liu XQ, 1997, FEBS LETT, V408, P311, DOI 10.1016/S0014-5793(97)00393-1; Liu XQ, 1997, P NATL ACAD SCI USA, V94, P7851, DOI 10.1073/pnas.94.15.7851; Ludwig C, 2006, ANGEW CHEM INT EDIT, V45, P5218, DOI 10.1002/anie.200600570; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Noren CJ, 2000, ANGEW CHEM INT EDIT, V39, P450; Paulus H, 2001, BIOORG CHEM, V29, P119, DOI 10.1006/bioo.2001.1203; Perler FB, 2005, IUBMB LIFE, V57, P469, DOI 10.1080/15216540500163343; PERLER FB, 1994, NUCLEIC ACIDS RES, V22, P1125, DOI 10.1093/nar/22.7.1125; Qi XM, 2011, FEBS LETT, V585, P2513, DOI 10.1016/j.febslet.2011.06.035; Sun WC, 2004, J BIOL CHEM, V279, P35281, DOI 10.1074/jbc.M405491200; Tan LP, 2005, PROTEIN PEPTIDE LETT, V12, P769, DOI 10.2174/0929866054864193; Toshio Yamazaki TO, 1998, J AM CHEM SOC, V120, P2; Volkmann G, 2009, PROTEIN SCI, V18, P2393, DOI 10.1002/pro.249; Wu H, 1998, P NATL ACAD SCI USA, V95, P9226, DOI 10.1073/pnas.95.16.9226; Wu W, 2002, NUCLEIC ACIDS RES, V30, P4864, DOI 10.1093/nar/gkf621; Xie JM, 2006, NAT REV MOL CELL BIO, V7, P775, DOI 10.1038/nrm2005; Xu MQ, 1996, EMBO J, V15, P5146, DOI 10.1002/j.1460-2075.1996.tb00898.x	34	6	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45355	10.1371/journal.pone.0045355	http://dx.doi.org/10.1371/journal.pone.0045355			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024818	gold, Green Published, Green Submitted			2022-12-27	WOS:000308860100076
J	Zhang, HW; Abiraj, K; Thorek, DLJ; Waser, B; Smith-Jones, PM; Honer, M; Reubi, JC; Maecke, HR				Zhang, Hanwen; Abiraj, Keelara; Thorek, Daniel L. J.; Waser, Beatrice; Smith-Jones, Peter M.; Honer, Michael; Reubi, Jean Claude; Maecke, Helmut R.			Evolution of Bombesin Conjugates for Targeted PET Imaging of Tumors	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; HUMAN CANCER XENOGRAFTS; IN-VIVO EVALUATION; PROSTATE-CANCER; PEPTIDE RECEPTORS; HIGH-AFFINITY; MOUSE MODEL; EXPRESSION; ANTAGONIST; ANALOG	Bombesin receptors are under intense investigation as molecular targets since they are overexpressed in several prevalent solid tumors. We rationally designed and synthesized a series of modified bombesin (BN) peptide analogs to study the influence of charge and spacers at the N-terminus, as well as amino acid substitutions, on both receptor binding affinity and pharmacokinetics. This enabled development of a novel Cu-64/67-labeled BN peptide for PET imaging and targeted radiotherapy of BN receptor-positive tumors. Our results show that N-terminally positively charged peptide ligands had significantly higher affinity to human gastrin releasing peptide receptor (GRPr) than negatively charged or uncharged ligands (IC50: 3.2 +/- 0.5 vs 26.3 +/- 3.5 vs 41.5 +/- 2.5 nM). The replacement of Nle(14) by Met, and deletion of D-Tyr(6), further resulted in 8-fold higher affinity. Contrary to significant changes to human GRPr binding, modifications at the N-terminal and at the 6th, 11th, and 14th position of BN induced only slight influences on affinity to mouse GRPr. [Cu-II]-CPTA-[beta Ala(11)] BN(7-14) ([Cu-II]-BZH7) showed the highest internalization rate into PC-3 cells with relatively slow efflux because of its subnanomolar affinity to GRPr. Interestingly, [Cu-64/67]-BZH7 also displayed similar affinities to the other 2 human BN receptor subtypes. In vivo studies showed that [Cu-64/67]-BZH7 had a high accumulation in PC-3 xenografts and allowed for clear-cut visualization of the tumor in PET imaging. In addition, a CPTA-glycine derivative, forming a hippurane-type spacer, enhanced kidney clearance of the radiotracer. These data indicate that the species variation of BN receptor plays an important role in screening radiolabeled BN. As well, the positive charge from the metallated complex at the N-terminal significantly increases affinity to human GRPr. Application of these observations enabled the novel ligand [Cu-64/67]-BZH7 to clearly visualize PC-3 tumors in vivo. This study provides a strong starting point for optimizing radiopeptides for targeting carcinomas that express any of the BN receptor subtypes.	[Zhang, Hanwen; Maecke, Helmut R.] Univ Basel Hosp, Dept Radiol, Div Radiol Chem, CH-4031 Basel, Switzerland; [Zhang, Hanwen; Thorek, Daniel L. J.; Smith-Jones, Peter M.] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA; [Abiraj, Keelara; Honer, Michael] F Hoffmann La Roche & Co Ltd, Pharma Res & Early Dev pRED, Translat Res Sci, CH-4002 Basel, Switzerland; [Waser, Beatrice; Reubi, Jean Claude] Univ Bern, Inst Pathol, Div Cell Biol & Expt Canc Res, Bern, Switzerland; [Maecke, Helmut R.] Univ Hosp Freiburg, Dept Nucl Med, Freiburg, Germany	University of Basel; Memorial Sloan Kettering Cancer Center; Roche Holding; University of Bern; University of Freiburg	Zhang, HW (corresponding author), Univ Basel Hosp, Dept Radiol, Div Radiol Chem, CH-4031 Basel, Switzerland.	zhangh1@mskcc.org		Zhang, Hanwen/0000-0001-7710-5116	Swiss National Science Foundation [3100A0-100390]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors thank the Swiss National Science Foundation (Grant No. 3100A0-100390), for financial support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Elgaliel WR, 2008, BIOCONJUGATE CHEM, V19, P2040, DOI 10.1021/bc800290c; Abiraj K, 2011, J NUCL MED, V52, P1970, DOI 10.2967/jnumed.111.094375; ANDERSON CJ, 1995, J NUCL MED, V36, P2315; Baum RP, 2007, EUR J NUCL MED MOL I, V34, pS193; Cescato R, 2008, J NUCL MED, V49, P318, DOI 10.2967/jnumed.107.045054; Chen XY, 2004, J NUCL MED, V45, P1390; CUTTITTA F, 1985, NATURE, V316, P823, DOI 10.1038/316823a0; de Jong M, 2010, J NUCL MED, V51, P501, DOI 10.2967/jnumed.109.065706; De Silva RA, 2011, J NUCL MED, V52, P986, DOI 10.2967/jnumed.110.085613; de Wiele CV, 2008, J NUCL MED, V49, P260, DOI 10.2967/jnumed.107.047167; Dimitrakopoulou-Strauss A, 2007, J NUCL MED, V48, P1245, DOI 10.2967/jnumed.106.038091; Fani M, 2008, CONTRAST MEDIA MOL I, V3, P53, DOI 10.1002/cmmi.232; Fani M, 2011, J NUCL MED, V52, P1110, DOI 10.2967/jnumed.111.087999; Garrison JC, 2008, BIOCONJUGATE CHEM, V19, P1803, DOI 10.1021/bc8001375; Garrison JC, 2007, J NUCL MED, V48, P1327, DOI 10.2967/jnumed.107.039487; HALMOS G, 1995, CANCER RES, V55, P280; Hoffman TJ, 2009, NUCL MED BIOL, V36, P579, DOI 10.1016/j.nucmedbio.2009.03.007; Lantry LE, 2006, J NUCL MED, V47, P1144; Lears KA, 2011, J NUCL MED, V52, P470, DOI 10.2967/jnumed.110.082826; Lin JT, 1995, EUR J PHARMACOL, V294, P55, DOI 10.1016/0014-2999(95)00510-2; Maina T, 2005, J NUCL MED, V46; Mansi R, 2011, EUR J NUCL MED MOL I, V38, P97, DOI 10.1007/s00259-010-1596-9; Mansi R, 2009, CLIN CANCER RES, V15, P5240, DOI 10.1158/1078-0432.CCR-08-3145; Mantey SA, 1997, J BIOL CHEM, V272, P26062, DOI 10.1074/jbc.272.41.26062; Markwalder R, 1999, CANCER RES, V59, P1152; Nimmagadda S, 2010, CANCER RES, V70, P3935, DOI 10.1158/0008-5472.CAN-09-4396; Nock B, 2003, EUR J NUCL MED MOL I, V30, P247, DOI 10.1007/s00259-002-1040-x; Nock BA, 2005, J MED CHEM, V48, P100, DOI 10.1021/jm049437y; Pradhan TK, 1998, EUR J PHARMACOL, V343, P275, DOI 10.1016/S0014-2999(97)01527-6; Prasanphanich AF, 2007, P NATL ACAD SCI USA, V104, P12462, DOI 10.1073/pnas.0705347104; Preston SR, 1996, CRIT REV ONCOL HEMAT, V23, P225, DOI 10.1016/1040-8428(96)00204-1; Reubi JC, 2004, EUR J NUCL MED MOL I, V31, P803, DOI 10.1007/s00259-004-1476-2; Reubi JC, 2002, CLIN CANCER RES, V8, P1139; Rogers BE, 2003, BIOCONJUGATE CHEM, V14, P756, DOI 10.1021/bc034018l; Schroeder RPJ, 2009, METHODS, V48, P200, DOI 10.1016/j.ymeth.2009.04.002; Schuhmacher J, 2005, J NUCL MED, V46, P691; SCHWARZBACH R, 1995, APPL RADIAT ISOTOPES, V46, P329, DOI 10.1016/0969-8043(95)00010-B; SHIPP MA, 1991, P NATL ACAD SCI USA, V88, P10662, DOI 10.1073/pnas.88.23.10662; Shokeen M, 2009, ACCOUNTS CHEM RES, V42, P832, DOI 10.1021/ar800255q; SMITHJONES PM, 1991, BIOCONJUGATE CHEM, V2, P415, DOI 10.1021/bc00012a006; STUDER M, 1990, HELV CHIM ACTA, V73, P149, DOI 10.1002/hlca.19900730116; Sun BD, 2000, PROSTATE, V42, P295; Van de Wiele C, 2000, EUR J NUCL MED, V27, P1694, DOI 10.1007/s002590000355; Zhang HW, 2007, EUR J NUCL MED MOL I, V34, P1198, DOI 10.1007/s00259-006-0347-4; Zhang HW, 2004, CANCER RES, V64, P6707, DOI 10.1158/0008-5472.CAN-03-3845; Zhang XZ, 2006, J NUCL MED, V47, P492	46	34	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44046	10.1371/journal.pone.0044046	http://dx.doi.org/10.1371/journal.pone.0044046			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024746	Green Published, Green Submitted, gold			2022-12-27	WOS:000308860100004
J	Linderman, JA; Chambers, MC; Gupta, AS; Schneider, DS				Linderman, Jessica A.; Chambers, Moria C.; Gupta, Avni S.; Schneider, David S.			Infection-Related Declines in Chill Coma Recovery and Negative Geotaxis in Drosophila melanogaster	PLOS ONE			English	Article							CARBON-DIOXIDE ANESTHESIA; TEMPERATURE STRESS; OXIDATIVE STRESS; IMMUNE-RESPONSE; COLD; RESISTANCE; EXPRESSION; LONGEVITY; GENES; AGE	Studies of infection in Drosophila melanogaster provide insight into both mechanisms of host resistance and tolerance of pathogens. However, research into the pathways involved in these processes has been limited by the relatively few metrics that can be used to measure sickness and health throughout the course of infection. Here we report measurements of infection-related declines in flies' performance on two different behavioral assays. D. melanogaster are slower to recover from a chill-induced coma during infection with either Listeria monocytogenes or Streptococcus pneumoniae. L. monocytogenes infection also impacts flies' performance during a negative geotaxis assay, revealing a decline in their rate of climbing as part of their innate escape response after startle. In addition to providing new measures for assessing health, these assays also suggest pathological consequences of and metabolic shifts that may occur over the course of an infection.	[Linderman, Jessica A.; Chambers, Moria C.; Gupta, Avni S.; Schneider, David S.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University	Linderman, JA (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	dschneider@stanford.edu		Chambers, Moria/0000-0002-2577-549X	Ellison Medical Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094944] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the Ellison Medical Foundation (http://www.ellisonfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARKING R, 1990, DEV GENET, V11, P141, DOI 10.1002/dvg.1020110204; Ayres JS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000150; Boyer L, 2012, ADV EXP MED BIOL, V710, P29, DOI 10.1007/978-1-4419-5638-5_4; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Burger JMS, 2006, EXP GERONTOL, V41, P1108, DOI 10.1016/j.exger.2006.08.008; Chambers MC, 2012, CURR OPIN IMMUNOL, V24, P10, DOI 10.1016/j.coi.2011.11.003; CHEN CP, 1994, J INSECT PHYSIOL, V40, P661, DOI 10.1016/0022-1910(94)90093-0; Colinet H, 2010, J EXP BIOL, V213, P4146, DOI 10.1242/jeb.051003; Colinet H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010925; de Carvalho JF, 2009, ISR MED ASSOC J, V11, P629; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Dionne MS, 2006, CURR BIOL, V16, P1977, DOI 10.1016/j.cub.2006.08.052; DRIVER CJI, 1980, EXP GERONTOL, V15, P167, DOI 10.1016/0531-5565(80)90061-3; French SS, 2011, INTEGR COMP BIOL, V51, P505, DOI 10.1093/icb/icr019; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; Goto SG, 2010, BIOCHEM BIOPH RES CO, V391, P1251, DOI 10.1016/j.bbrc.2009.12.053; Hamilos G, 2012, INT J MICROBIOLOGY, V2012, P1; Hosamani R, 2010, NEUROCHEM RES, V35, P1402, DOI 10.1007/s11064-010-0198-z; Hosamani R, 2009, NEUROTOXICOLOGY, V30, P977, DOI 10.1016/j.neuro.2009.08.012; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; Le Bourg E, 2010, BIOGERONTOLOGY; Le Bourg E, 2007, BIOGERONTOLOGY, V8, P431, DOI 10.1007/s10522-007-9086-6; Le Bourg E, 2010, BIOGERONTOLOGY, V11, P245, DOI 10.1007/s10522-009-9250-2; Le Bourg E, 2009, BIOGERONTOLOGY, V10, P613, DOI 10.1007/s10522-008-9206-y; LEBOURG E, 1984, GERONTOLOGY, V30, P79, DOI 10.1159/000212612; Liehl P, 2006, PLOS PATHOG, V2, P551, DOI 10.1371/journal.ppat.0020056; Linder JE, 2009, FLY, V3, P143, DOI 10.4161/fly.8051; Llorens JV, 2007, FASEB J, V21, P333, DOI 10.1096/fj.05-5709com; MacAlpine JLP, 2011, J INSECT PHYSIOL, V57, P35, DOI 10.1016/j.jinsphys.2010.09.003; Macdonald SS, 2004, J INSECT PHYSIOL, V50, P695, DOI 10.1016/j.jinsphys.2004.05.004; MacMillan HA, 2011, J INSECT PHYSIOL, V57, P12, DOI 10.1016/j.jinsphys.2010.10.004; Mansueto P, 2012, CLIN DEV IMMUNOL, P1; McKean KA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-76; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Nelson RJ, 1996, Q REV BIOL, V71, P511, DOI 10.1086/419555; Nilson TL, 2006, J INSECT PHYSIOL, V52, P1027, DOI 10.1016/j.jinsphys.2006.07.001; Ots I, 2001, P ROY SOC B-BIOL SCI, V268, P1175, DOI 10.1098/rspb.2001.1636; PERRON JM, 1972, J INSECT PHYSIOL, V18, P1869, DOI 10.1016/0022-1910(72)90157-6; Protzer U, 2012, LIVING LIVER HEPATIC, P1; Qin W, 2005, INSECT MOL BIOL, V14, P607, DOI 10.1111/j.1365-2583.2005.00589.x; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; SCHWAN WR, 1994, P NATL ACAD SCI USA, V91, P6428, DOI 10.1073/pnas.91.14.6428; Shirasu-Hiza MM, 2007, CURR BIOL, V17, pR353, DOI 10.1016/j.cub.2007.03.049; Udaka H, 2010, J INSECT PHYSIOL, V56, P1889, DOI 10.1016/j.jinsphys.2010.08.008; Vijendravarma RK, 2009, EVOLUTION, V63, P104, DOI 10.1111/j.1558-5646.2008.00516.x; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; Xu J, 2012, INSECT MOL BIOL, V21, P269, DOI 10.1111/j.1365-2583.2012.01133.x; Zhang J, 2011, J EXP BIOL, V214, P4021, DOI 10.1242/jeb.059535	48	33	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e41907	10.1371/journal.pone.0041907	http://dx.doi.org/10.1371/journal.pone.0041907			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028430	gold, Green Published			2022-12-27	WOS:000308788700004
J	Megremis, S; Demetriou, P; Makrinioti, H; Manoussaki, AE; Papadopoulos, NG				Megremis, Spyridon; Demetriou, Philippos; Makrinioti, Heidi; Manoussaki, Alkistis E.; Papadopoulos, Nikolaos G.			The Genomic Signature of Human Rhinoviruses A, B and C	PLOS ONE			English	Article							SINGLE-STRANDED RNA; CPG; DINUCLEOTIDE; EVOLUTION; FREQUENCIES; SEQUENCE; VIRUSES; IDENTIFICATION; ACTIVATION; CLEAVAGE	Human rhinoviruses are single stranded positive sense RNA viruses that are presented in more than 50% of acute upper respiratory tract infections. Despite extensive studies on the genetic diversity of the virus, little is known about the forces driving it. In order to explain this diversity, many research groups have focused on protein sequence requirements for viable, functional and transmissible virus but have missed out an important aspect of viral evolution such as the genomic ontology of the virus. This study presents for the first time the genomic signature of 111 fully sequenced HRV strains from all three groups HRV-A, HRV-B and HRV-C. We observed an HRV genome tendency to eliminate CpG and UpA dinucleotides, coupling with over-representation of UpG and CpA. We propose a specific mechanism which describes how rapid changes in the HRV genomic sequence can take place under the strict control of conservation of the polypeptide backbone. Moreover, the distribution of the observed under- and over-represented dinucleotides along the HRV genome is presented. Distance matrice tables based on CpG and UpA odds ratios were constructed and viewed as heatmaps and distance trees. None of the suppressions can be attributed to codon usage or in RNA secondary structure requirements. Since viral recognition is dependent on RNA motifs rich in CpG and UpA, it is possible that the overall described genome evolution mechanism acts in order to protect the virus from host recognition.	[Megremis, Spyridon; Demetriou, Philippos; Makrinioti, Heidi; Manoussaki, Alkistis E.; Papadopoulos, Nikolaos G.] Univ Athens, Dept Allergy, Pediat Clin 2, Athens, Greece	National & Kapodistrian University of Athens	Megremis, S (corresponding author), Univ Athens, Dept Allergy, Pediat Clin 2, Athens, Greece.	spyridonmegremis@gmail.com	Papadopoulos, Nikolaos/ABE-1774-2021; N.G., Papadopoulos/L-8670-2013	Papadopoulos, Nikolaos/0000-0002-4448-3468; N.G., Papadopoulos/0000-0002-4448-3468; Megremis, Spyridon/0000-0002-4082-5387; Papadopoulos, Nikolaos/0000-0002-2508-3872	European Commission's Seventh Framework programme [260895]	European Commission's Seventh Framework programme(European Commission)	This work was supported by the European Commission's Seventh Framework programme under grant agreement No 260895 (PREDICTA) KMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BR, 2011, NUCLEIC ACIDS RES, V39, P9329, DOI 10.1093/nar/gkr586; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; BEUTLER E, 1989, P NATL ACAD SCI USA, V86, P192, DOI 10.1073/pnas.86.1.192; BURGE C, 1992, P NATL ACAD SCI USA, V89, P1358, DOI 10.1073/pnas.89.4.1358; Burns CC, 2009, J VIROL, V83, P9957, DOI 10.1128/JVI.00508-09; DAMBE, SOFTW PACK DAT AN MO; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Domingo E, 1995, MOL EVOLUTION VIRUSE, P181; Domingo Esteban, 1994, P161; Dominguez SR, 2008, J CLIN VIROL, V43, P219, DOI 10.1016/j.jcv.2008.06.007; Dorn A, 2008, CURR OPIN MOL THER, V10, P10; Forsbach A, 2008, J IMMUNOL, V180, P3729, DOI 10.4049/jimmunol.180.6.3729; Friedel M, 2009, BIOINFORMATICS, V25, P2603, DOI 10.1093/bioinformatics/btp436; Greenbaum BD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000079; GROMEIER M, 1999, ORIGIN EVOLUTION VIR, P287; HOLLAND J, 1982, SCIENCE, V215, P1577, DOI 10.1126/science.7041255; Jimenez-Baranda S, 2011, J VIROL, V85, P3893, DOI 10.1128/JVI.01908-10; Jossinet F, 2005, BIOINFORMATICS, V21, P3320, DOI 10.1093/bioinformatics/bti504; Kandimalla ER, 2003, BIOCHEM SOC T, V31, P654, DOI 10.1042/bst0310654; KARLIN S, 1994, J VIROL, V68, P2889, DOI 10.1128/JVI.68.5.2889-2897.1994; Lai MMC, 1995, MOL BASIS VIRUS EVOL, P119; Lau SKP, 2007, J CLIN MICROBIOL, V45, P3655, DOI 10.1128/JCM.01254-07; Lobo FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006282; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; McErlean P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001847; Melchjorsen J, 2005, J VIROL, V79, P12944, DOI 10.1128/JVI.79.20.12944-12951.2005; Palmenberg AC, 2010, J ALLERGY CLIN IMMUN, V125, P1190, DOI 10.1016/j.jaci.2010.04.010; Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557; Puigbo P, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-38; Rima BK, 1997, J GEN VIROL, V78, P2859, DOI 10.1099/0022-1317-78-11-2859; Rima BK, 1997, J GEN VIROL, V78, P97, DOI 10.1099/0022-1317-78-1-97; Scherbik SV, 2006, J VIROL, V80, P2987, DOI 10.1128/JVI.80.6.2987-2999.2006; Simmonds P, 2001, J GEN VIROL, V82, P693, DOI 10.1099/0022-1317-82-4-693; Sugiyama T, 2005, J IMMUNOL, V174, P2273, DOI 10.4049/jimmunol.174.4.2273; Washenberger CL, 2007, VIRUS RES, V130, P85, DOI 10.1016/j.virusres.2007.05.020; WESSELINGH SL, 1994, J IMMUNOL, V152, P1289	36	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44557	10.1371/journal.pone.0044557	http://dx.doi.org/10.1371/journal.pone.0044557			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028561	Green Published, Green Submitted, gold			2022-12-27	WOS:000308788700024
J	Cui, LN; Zhou, XM; Li, JG; Wang, LY; Wang, JB; Li, Q; Chu, JD; Zheng, LH; Wu, Q; Han, ZY; Shi, YQ; Han, Y; Fan, DM				Cui, Lina; Zhou, Xinmin; Li, Jinge; Wang, Liuyi; Wang, Jingbo; Li, Qiang; Chu, Jindong; Zheng, Linhua; Wu, Qiong; Han, Zheyi; Shi, Yongquan; Han, Ying; Fan, Daiming			Dynamic microRNA Profiles of Hepatic Differentiated Human Umbilical Cord Lining-Derived Mesenchymal Stem Cells	PLOS ONE			English	Article							HEPATOCYTE-LIKE CELLS; LIVER-REGENERATION; STROMAL CELLS; PROLIFERATION; PLURIPOTENCY; MOUSE	Despite the extensive hepatic differentiation potential of human umbilical cord lining-derived mesenchymal stem cells (hUC-MSC), little is known about the molecular mechanisms of hUC-MSC differentiation. At the post-transcriptional level, microRNAs are key players in the control of cell fate determination during differentiation. In this study, we aimed to identify microRNAs involved in the hepatic differentiation of hUC-MSCs. After successfully isolating hUC-MSCs, we induced hepatocyte formation in vitro with growth factors. After 26 days of induction, hUC-MSCs could express hepatocyte-specific genes, synthesize urea and glycogen and uptake low-density lipoprotein. Cellular total RNA from hUC-MSCs and hepatic differentiated hUC-MSCs was collected at 7 time points, including 2 days, 6 days, 10 days, 14 days, 22 days and 26 days, for microRNA microarray analysis. Dynamic microRNA profiles were identified that did not overlap or only partially overlapped with microRNAs reported to be involved in human liver development, hepatocyte regeneration or hepatic differentiation of liver-derived progenitor cells. A total of 61 microRNAs among 1205 human and 144 human viral microRNAs displayed consistent changes and were altered at least 2-fold between hUC-MSCs and hepatic differentiated hUC-MSCs. Among these microRNAs, 25 were over-expressed; this over-expression occurred either gradually or increased sharply and was maintained at a high level. A total of 36 microRNAs were under-expressed, with an expression pattern similar to that of the over-expressed microRNAs. The expression of the altered expressed microRNAs was also confirmed by quantitative reverse-transcription polymerase chain reaction. We also found that microRNAs involved in hepatic differentiation were not enriched in hepatocyte or hepatocellular carcinoma cells and can potentially target liver-enriched transcription factors and genes. The elucidation of the microRNA profile during the hepatic differentiation of hUC-MSCs provides the basis for clarifying the role of microRNAs in hUC-MSC hepatic differentiation and specific microRNA selection for the conversion of hUC-MSCs to hepatocytes.	[Cui, Lina; Zhou, Xinmin; Li, Jinge; Wang, Jingbo; Li, Qiang; Chu, Jindong; Zheng, Linhua; Wu, Qiong; Han, Zheyi; Shi, Yongquan; Han, Ying; Fan, Daiming] Fourth Mil Med Univ, State Key Lab Canc Biol, Xijing Hosp Digest Dis, Xian 710032, Shaanxi Provinc, Peoples R China; [Wang, Liuyi] Yanan Univ, Dept Gastroenterol, Affiliated Hosp, Yanan, Shaanxi Provinc, Peoples R China	Air Force Military Medical University; Yanan University	Cui, LN (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, Xijing Hosp Digest Dis, Xian 710032, Shaanxi Provinc, Peoples R China.	hanying@fmmu.edu.cn	wang, jing/GRS-7509-2022; Shi, Yongquan/AAE-3954-2020; 金华, 郑/GWM-7529-2022		National Natural Science Foundation of China [81070326]; "863" Program of China [2011AA020111]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "863" Program of China(National High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China (No. 81070326) and "863" Program of China (2011AA020111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Brett JO, 2011, AGING-US, V3, P108, DOI 10.18632/aging.100285; Campard D, 2008, GASTROENTEROLOGY, V134, P833, DOI 10.1053/j.gastro.2007.12.024; Castro RE, 2010, AM J PHYSIOL-GASTR L, V299, pG887, DOI 10.1152/ajpgi.00216.2010; Chen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020238; Chen YX, 2010, LIVER TRANSPLANT, V16, P1086, DOI 10.1002/lt.22111; DEUSE T, 2010, CELL TRANSPLANT; Jung KH, 2011, INT J ONCOL; Kim YJ, 2009, J BONE MINER RES, V24, P816, DOI 10.1359/JBMR.081230; Kita K, 2010, STEM CELLS DEV, V19, P491, DOI 10.1089/scd.2009.0192; Li CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031292; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Peng L, 2011, HEPATOLOGY; Song GS, 2010, HEPATOLOGY, V51, P1735, DOI 10.1002/hep.23547; Tsai PC, 2009, LIVER TRANSPLANT, V15, P484, DOI 10.1002/lt.21715; Tzur G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007511; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xie CQ, 2011, STEM CELLS DEV, V20, P205, DOI 10.1089/scd.2010.0283; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zhang YN, 2009, CYTOTHERAPY, V11, P548, DOI 10.1080/14653240903051533; Zhao QJ, 2009, CYTOTHERAPY, V11, P414, DOI 10.1080/14653240902849754	21	36	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44737	10.1371/journal.pone.0044737	http://dx.doi.org/10.1371/journal.pone.0044737			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984549	Green Submitted, gold, Green Published			2022-12-27	WOS:000308738500078
J	Kemirembe, K; Liebmann, K; Bootes, A; Smith, WA; Suzuki, Y				Kemirembe, Karen; Liebmann, Kate; Bootes, Abigail; Smith, Wendy A.; Suzuki, Yuichiro			Amino Acids and TOR Signaling Promote Prothoracic Gland Growth and the Initiation of Larval Molts in the Tobacco Hornworm Manduca sexta	PLOS ONE			English	Article							JUVENILE-HORMONE; CRITICAL WEIGHT; BODY-SIZE; PUBERTY; SILKWORM; ECDYSONE; ECDYSTEROIDOGENESIS; METAMORPHOSIS; STIMULATION; NUTRITION	Molting in arthropods is orchestrated by a series of endocrine changes that occur towards the end of an instar. However, little is understood about the mechanisms that trigger these endocrine changes. Here, nutritional inputs were manipulated to investigate the minimal nutritional inputs required for a Manduca sexta larva to initiate a molt. Amino acids were found to be necessary for a larva to molt, indicating the involvement of an amino acid sensitive pathway. Feeding rapamycin, an inhibitor of the target of rapamycin (TOR) signaling, delayed the onset of a molt and resulted in abnormally larger larvae. Rapamycin also suppressed the growth of the prothoracic glands relative to the whole body growth, and this was accompanied by suppression of ecdysone production and secretion. Higher doses of rapamycin also slowed the growth rate, indicating that TOR signaling also plays a role in systemic growth. TOR signaling therefore couples the nutritional status of the larva to the endocrine system to regulate the timing of a molt.	[Kemirembe, Karen; Liebmann, Kate; Suzuki, Yuichiro] Wellesley Coll, Dept Biol Sci, Wellesley, MA 02181 USA; [Bootes, Abigail; Smith, Wendy A.] Northeastern Univ, Dept Biol, Boston, MA 02115 USA	Wellesley College; Northeastern University	Kemirembe, K (corresponding author), Wellesley Coll, Dept Biol Sci, Wellesley, MA 02181 USA.	ysuzuki@wellesley.edu		Suzuki, Yuichiro/0000-0002-0957-3564	Sherman Fairchild Summer Research Award; Mentoring in the Sciences AT&T Research Grant; Susan Todd Horton Class of 1910 Trust (Bartels) fund; Wellesley College; Brachman-Hoffman foundation; National Science Foundation [IOS-1027453]; Direct For Biological Sciences [1027453] Funding Source: National Science Foundation	Sherman Fairchild Summer Research Award; Mentoring in the Sciences AT&T Research Grant; Susan Todd Horton Class of 1910 Trust (Bartels) fund; Wellesley College; Brachman-Hoffman foundation; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The study was supported by Sherman Fairchild Summer Research Award to K. K. and K. L. L.; the Mentoring in the Sciences AT&T Research Grant to K. K.; the Susan Todd Horton Class of 1910 Trust (Bartels) fund to K. L. L.; grants from Wellesley College, the Brachman-Hoffman foundation and the National Science Foundation IOS-1027453 to Y.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002498; AGUI N, 1979, P NATL ACAD SCI USA, V76, P5694, DOI 10.1073/pnas.76.11.5694; Arsham AM, 2003, J BIOL CHEM, V278, P29655, DOI 10.1074/jbc.M212770200; Bateman JM, 2004, CELL, V119, P87, DOI 10.1016/j.cell.2004.08.028; Caldwell PE, 2005, CURR BIOL, V15, P1785, DOI 10.1016/j.cub.2005.09.011; Callier V, 2011, P NATL ACAD SCI USA, V108, P14664, DOI 10.1073/pnas.1106556108; CARROW GM, 1981, P NATL ACAD SCI-BIOL, V78, P5866, DOI 10.1073/pnas.78.9.5866; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Davidowitz G, 2003, EVOL DEV, V5, P188, DOI 10.1046/j.1525-142X.2003.03026.x; Ebling FJP, 2005, REPRODUCTION, V129, P675, DOI 10.1530/rep.1.00367; Gajdos ZKZ, 2010, MOL CELL ENDOCRINOL, V324, P21, DOI 10.1016/j.mce.2010.01.038; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; GRUETZMACHER MC, 1984, J INSECT PHYSIOL, V30, P771, DOI 10.1016/0022-1910(84)90013-1; Gu SH, 2012, INSECT BIOCHEM MOLEC, V42, P296, DOI 10.1016/j.ibmb.2011.12.010; Gu SH, 2011, INSECT BIOCHEM MOLEC, V41, P197, DOI 10.1016/j.ibmb.2010.12.004; Gu SH, 2009, INSECT BIOCHEM MOLEC, V39, P171, DOI 10.1016/j.ibmb.2008.10.012; Heming BS., 2003, INSECT DEV EVOLUTION; Kaplowitz PB, 2008, PEDIATRICS, V121, pS208, DOI 10.1542/peds.2007-1813F; KIRKWOOD RN, 1987, P NUTR SOC, V46, P177, DOI 10.1079/PNS19870026; Layalle S, 2008, DEV CELL, V15, P568, DOI 10.1016/j.devcel.2008.08.003; Masumura M, 2000, GEN COMP ENDOCR, V118, P393, DOI 10.1006/gcen.1999.7438; Mirth C, 2005, CURR BIOL, V15, P1796, DOI 10.1016/j.cub.2005.09.017; Mirth CK, 2007, BIOESSAYS, V29, P344, DOI 10.1002/bies.20552; Nijhout H.F., 1998, INSECT HORMONES, P280; NIJHOUT HF, 1979, J INSECT PHYSIOL, V25, P277, DOI 10.1016/0022-1910(79)90055-6; NIJHOUT HF, 1981, AM ZOOL, V21, P631; NIJHOUT HF, 1974, J EXP BIOL, V61, P493; Parker NF, 2011, DEV BIOL, V357, P318, DOI 10.1016/j.ydbio.2011.07.002; Plant TM, 2002, J ADOLESCENT HEALTH, V31, P185, DOI 10.1016/S1054-139X(02)00484-6; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Riddiford LM, 2008, J INSECT PHYSIOL, V54, P895, DOI 10.1016/j.jinsphys.2008.01.014; Roa J, 2009, ENDOCRINOLOGY, V150, P5016, DOI 10.1210/en.2009-0096; Roa JA, 2010, TRENDS ENDOCRIN MET, V21, P519, DOI 10.1016/j.tem.2010.05.003; SAKURAI S, 1989, ARCH INSECT BIOCHEM, V10, P179, DOI 10.1002/arch.940100303; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Shahab M, 2005, P NATL ACAD SCI USA, V102, P2129, DOI 10.1073/pnas.0409822102; Sharpe RM, 2002, NAT CELL BIOL, V4, pS33, DOI 10.1038/ncb-nm-fertilityS33; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; Smith W., 2011, INSECT ENDOCRINOLOGY, P1; SONG QS, 1994, DEV GENET, V15, P332, DOI 10.1002/dvg.1020150404; Teles MG, 2011, MOL CELL ENDOCRINOL, V346, P84, DOI 10.1016/j.mce.2011.05.019; TRUMAN JW, 1981, AM ZOOL, V21, P655; Walsh AL, 2011, J INSECT PHYSIOL, V57, P809, DOI 10.1016/j.jinsphys.2011.03.009; WARREN JT, 1984, EXPERIENTIA, V40, P393, DOI 10.1007/BF01952570; WARREN JT, 1988, P NATL ACAD SCI USA, V85, P958, DOI 10.1073/pnas.85.3.958; WATSON RD, 1985, J INSECT PHYSIOL, V31, P487, DOI 10.1016/0022-1910(85)90097-6; Wigglesworth VB, 1934, Q J MICROSC SCI, V77, P191; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501	49	30	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44429	10.1371/journal.pone.0044429	http://dx.doi.org/10.1371/journal.pone.0044429			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984508	Green Submitted, Green Published, gold			2022-12-27	WOS:000308738500056
J	Lemasson, A; Remeuf, K; Rossard, A; Zimmermann, E				Lemasson, Alban; Remeuf, Kevin; Rossard, Arnaud; Zimmermann, Elke			Cross-Taxa Similarities in Affect-Induced Changes of Vocal Behavior and Voice in Arboreal Monkeys	PLOS ONE			English	Article							CERCOPITHECUS-CAMPBELLI-CAMPBELLI; SHREWS TUPAIA-BELANGERI; RUMBLE VOCALIZATIONS; LOXODONTA-AFRICANA; DISTURBANCE CALLS; SOCIAL-ISOLATION; CAPTIVE GROUP; ALARM CALLS; EXPRESSION; EMOTION	Measuring the affective state of an individual across species with comparable non-invasive methods is a current challenge in animal communication research. This study aims to explore to which extent affect intensity is conveyed in the vocal behaviours of three nonhuman primate species (Campbell's monkeys, De Brazza's monkeys, red-capped mangabeys), which vary in body size, ecological niche and social system. Similarly in the three species, we experimentally induced a change in captive social groups' affect by locking all group members together in their outside enclosure. The two experimental conditions which varied in affect intensity consisted in imposing a pre-reunion 90 mn-separation by splitting up the respective group into two subgroups (High affect condition) or not (Low affect condition). We measured call rates as well as voice features at the time of reunion in both conditions. The three studied species reacted in a very similar way. Across species, call rates changed significantly between the behaviourally defined states. Furthermore, contact call duration and, to some extent, voice pitch increased. Our results suggest, for the first time in arboreal Old World monkeys, that affect intensity is conveyed reliably in vocal behaviour and specific acoustic characteristics of voice, irrespective of body size and ecological niche differences between species. Cross-taxa similarities in acoustic cues of affect intensity point to phylogenetic constraints and inheritance from a common ancestor, whereas variations in vocal behaviour and affect intensity-related acoustic cues between species may be an adaptation to specific social requirements and depend on social systems. Our findings as well as a comparison with published works on acoustic communication in other vertebrate groups support the hypothesis that affect intensity in human voice originates from precursors already found deep inside the vertebrate phylogeny.	[Lemasson, Alban; Remeuf, Kevin; Rossard, Arnaud] Univ Rennes 1, CNRS, UMR 6552, Stn Biol Paimpont, Paimpont, France; [Lemasson, Alban] Inst Univ France, Paris, France; [Zimmermann, Elke] Univ Vet Med Hannover, Inst Zool, Hannover, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Institut Universitaire de France; University of Veterinary Medicine Hannover, Foundation	Lemasson, A (corresponding author), Univ Rennes 1, CNRS, UMR 6552, Stn Biol Paimpont, Paimpont, France.	alban.lemasson@univ-rennes1.fr			Agence Nationale de la Recherche; Institut Universitaire de France	Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut Universitaire de France	This research was funded by the 'Agence Nationale de la Recherche' and the 'Institut Universitaire de France'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenmuller E, 2013, EVOLUTION E IN PRESS; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Aureli F, 2007, BIOL LETTERS, V3, P147, DOI 10.1098/rsbl.2007.0041; Bachorowski JA, 1999, CURR DIR PSYCHOL SCI, V8, P53, DOI 10.1111/1467-8721.00013; Banse R, 1996, J PERS SOC PSYCHOL, V70, P614, DOI 10.1037/0022-3514.70.3.614; Bastian A, 2008, J ACOUST SOC AM, V124, P598, DOI 10.1121/1.2924123; BEIER EG, 1972, J CONSULT CLIN PSYCH, V39, P166, DOI 10.1037/h0033170; BOLINGER JJ, 1978, IEEE T POWER AP SYST, V97, P1245, DOI 10.1109/TPAS.1978.354607; Bortz J, 1993, STAT SOZIALWISSENSCH; Bouchet H, 2012, AM J PRIMATOL, V74, P12, DOI 10.1002/ajp.21002; Bouchet H, 2010, AM J PRIMATOL, V72, P360, DOI 10.1002/ajp.20791; Colonnello V, 2010, DEV PSYCHOBIOL, V52, P1, DOI 10.1002/dev.20406; Coude G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026822; De Marco A, 2011, AM J PHYS ANTHROPOL, V146, P457, DOI 10.1002/ajpa.21606; DuBois AL, 2009, BIOL LETTERS, V5, P163, DOI 10.1098/rsbl.2008.0626; EAST ML, 1993, BEHAV ECOL SOCIOBIOL, V33, P355; Esch HC, 2009, J MAMMAL, V90, P638, DOI 10.1644/08-MAMM-A-069R.1; EWBANK R, 1971, ANIM PROD, V13, P685, DOI 10.1017/S0003356100000179; Fichtel C, 2001, BEHAVIOUR, V138, P97, DOI 10.1163/15685390151067094; FISCHER J, 1995, ETHOLOGY, V101, P51, DOI 10.1111/j.1439-0310.1995.tb00345.x; Fitch WT, 2000, PHONETICA, V57, P205; Fritz T, 2009, CURR BIOL, V19, P573, DOI 10.1016/j.cub.2009.02.058; Galat G., 1985, TERRE ET LA VIE, V40, P3; Gautier-Hion, 1999, HIST NATURELLE PRIMA; Glenn ME, 1998, AM J PHYS ANTHROPOL, V105, P481, DOI 10.1002/(SICI)1096-8644(199804)105:4<481::AID-AJPA6>3.3.CO;2-L; Goodall J, 1986, CHIMPANZEES GOMBE, DOI DOI 10.1002/AJPA.1330730313; Gouzoules H, 2000, ANIM BEHAV, V59, P501, DOI 10.1006/anbe.1999.1318; Haccou P, 1994, STAT ANAL BEHAV DATA; Harnmerschmidt K, 2007, J VOICE, V21, P531, DOI 10.1016/j.jvoice.2006.03.002; Hatfield E., 1994, REV PERSONALITY SOCI; Johnstone T, 2000, PSYCHOPHYSIOLOGY, V37, pS52; Jurgens U, 2002, NEUROSCI BIOBEHAV R, V26, P235, DOI 10.1016/S0149-7634(01)00068-9; Juslin PN, 2001, EMOTION, V1, P381, DOI 10.1037//1528-3542.1.4.381; Juslin PN, 2003, ANN NY ACAD SCI, V1000, P279, DOI 10.1196/annals.1280.025; Laukka P, 2004, THESIS U UPPSALA; Leavesley AJ, 2005, ANIM BEHAV, V70, P365, DOI 10.1016/j.anbehav.2004.10.017; Leighty KA, 2008, ANIM BEHAV, V76, P1601, DOI 10.1016/j.anbehav.2008.06.022; Lemasson A, 2005, APPL ANIM BEHAV SCI, V91, P289, DOI 10.1016/j.applanim.2004.10.011; Lemasson A, 2011, J ACOUST SOC AM, V129, P3341, DOI 10.1121/1.3569704; Lemasson A, 2006, AM J PRIMATOL, V68, P1161, DOI 10.1002/ajp.20315; Lemasson A, 2011, ADV INTERACT STUD, V1, P39; Lemasson A, 2010, NATURWISSENSCHAFTEN, V97, P1023, DOI 10.1007/s00114-010-0715-6; Manser MB, 2001, P ROY SOC B-BIOL SCI, V268, P2315, DOI 10.1098/rspb.2001.1773; Manteuffel G, 2004, APPL ANIM BEHAV SCI, V88, P163, DOI 10.1016/j.applanim.2004.02.012; Marx G, 2001, APPL ANIM BEHAV SCI, V75, P61, DOI 10.1016/S0168-1591(01)00180-0; McNaughton N, 2004, NEUROSCI BIOBEHAV R, V28, P285, DOI 10.1016/j.neubiorev.2004.03.005; Moss C, 1988, ELEPHANT MEMORIES 13; Muller MN, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P112, DOI 10.1017/CBO9780511606397.012; Okamoto K, 2001, PRIMATES, V42, P161, DOI 10.1007/BF02558143; Ouattara K, 2009, P NATL ACAD SCI USA, V106, P22026, DOI 10.1073/pnas.0908118106; Perez EC, 2012, HORM BEHAV, V61, P573, DOI 10.1016/j.yhbeh.2012.02.004; Rendall D, 2003, J ACOUST SOC AM, V113, P3390, DOI 10.1121/1.1568942; Richard J-P, 1991, BIOACOUSTICS, V3, P45, DOI DOI 10.1080/09524622.1991.9753156; Rowell TE, 1988, PRIMATE RAD EVOLUTIO, P439; Sauter DA, 2010, P NATL ACAD SCI USA, V107, P2408, DOI 10.1073/pnas.0908239106; Schehka S, 2007, J COMP PHYSIOL A, V193, P845, DOI 10.1007/s00359-007-0236-8; Schehka S, 2009, BEHAV BRAIN RES, V203, P223, DOI 10.1016/j.bbr.2009.05.007; SCHERER KR, 1986, PSYCHOL BULL, V99, P143, DOI 10.1037/0033-2909.99.2.143; Scherer KR, 2003, SPEECH COMMUN, V40, P227, DOI 10.1016/S0167-6393(02)00084-5; Scherer KR, 2001, J CROSS CULT PSYCHOL, V32, P76, DOI 10.1177/0022022101032001009; Soltis J, 2009, J COMP PSYCHOL, V123, P222, DOI 10.1037/a0015223; Stoeger AS, 2011, J ACOUST SOC AM, V130, P1700, DOI 10.1121/1.3605538; Suzuki TN, 2012, ANIM BEHAV, V84, P53, DOI 10.1016/j.anbehav.2012.03.030; Watwood SL, 2003, THESIS MIT; Weib BM, 2007, J ACOUST SOC AM, V122, P3710, DOI 10.1121/1.2799907; Wilson DR, 2012, ANIM BEHAV, V83, P535, DOI 10.1016/j.anbehav.2011.11.033; Zimmermann E, 2013, EVOLUTION E IN PRESS; Zimmermann E, 2010, HBK BEHAV NEUROSCI, V19, P215, DOI 10.1016/B978-0-12-374593-4.00022-X	68	20	20	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45106	10.1371/journal.pone.0045106	http://dx.doi.org/10.1371/journal.pone.0045106			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984618	gold, Green Submitted, Green Published			2022-12-27	WOS:000308738500117
J	Lian, H; Ma, YW; Feng, J; Dong, W; Yang, Q; Lu, D; Zhang, LF				Lian, Hong; Ma, Yuanwu; Feng, Juan; Dong, Wei; Yang, Qing; Lu, Dan; Zhang, Lianfeng			Heparin-Binding EGF-Like Growth Factor Induces Heart Interstitial Fibrosis via an Akt/mTor/p70s6k Pathway	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; FACTOR RECEPTOR; IN-VITRO; HB-EGF; KERATINOCYTE MIGRATION; DILATED CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; TRANSGENIC MICE; LIVER FIBROSIS; MESSENGER-RNA	Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is essential for maintaining normal function of the adult heart and is known to play an important role in myocardial remodeling. In the present study, we observed that heart-specific HB-EGF transgenic (TG) mice had systolic dysfunction with decreased fractional shortening (FS%), increased end-systolic diameter (LVIDs) at 5 months of age, increased heart fibrosis, and increased mRNA expression of Col1 alpha 1 and Col3 alpha 1 at 1, 3, 5 and 7 months of age compared to nontransgenic (NTG) littermates. However, the left ventricular anterior wall thickness at end-systole (LVAWs) of the TG mice was not different than the NTG mice. Phosphorylation levels of Akt, mTor and p70s6k were increased due to HB-EGF expression in TG mice compared with the NTG mice at 3 and 7 months of age. Additionally, activated Akt, mTor and p70s6k were co-localized with vimentin to cardiac fibroblasts isolated from TG mice. Furthermore, HB-EGF significantly increased phosphorylation levels of Akt, mTor and p70s6k and increased expression of type I collagen in cultured primary cardiac fibroblasts. Rapamycin (Rapa) and CRM197, inhibitors of mTor and HB-EGF respectively, could inhibit the expression of type I collagen in the cultured primary cardiac fibroblasts and Rapa suppressed interstitial fibrosis of the heart tissues in vivo. In addition, a BrdU assay showed that HB-EGF increased proliferation of cardiac fibroblasts by 30% compared with cells without HB-EGF treatment. HB-EGF-induced proliferation was completely diminished in the presence of Rapa. These results suggest that HB-EGF induced heart fibrosis and proliferation of cardiac fibroblasts occurs through activation of the Akt/mTor/p70s6k pathway.	[Lian, Hong; Ma, Yuanwu; Feng, Juan; Dong, Wei; Yang, Qing; Lu, Dan; Zhang, Lianfeng] Chinese Acad Med Sci, Inst Lab Anim Sci, Minist Hlth, Key Lab Human Dis Comparat Med, Beijing 100730, Peoples R China; [Lian, Hong; Ma, Yuanwu; Feng, Juan; Dong, Wei; Yang, Qing; Lu, Dan; Zhang, Lianfeng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, Lianfeng] Chinese Acad Med Sci, Inst Lab Anim Sci, State Adm Tradit Chinese Med, Key Lab Human Dis Anim Model, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS	Lian, H (corresponding author), Chinese Acad Med Sci, Inst Lab Anim Sci, Minist Hlth, Key Lab Human Dis Comparat Med, Beijing 100730, Peoples R China.	Zhanglf@cnilas.org		LU, Dan/0000-0002-5204-2574; Ma, Yuanwu/0000-0002-1882-1777	Ministry of Health Foundation [200802036]	Ministry of Health Foundation	The present work was supported by the Ministry of Health Foundation (200802036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM JA, 1993, BIOCHEM BIOPH RES CO, V190, P125, DOI 10.1006/bbrc.1993.1020; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Biecker E, 2005, J PHARMACOL EXP THER, V313, P952, DOI 10.1124/jpet.104.079616; Blaine SA, 2009, AM J PHYSIOL-GASTR L, V297, pG434, DOI 10.1152/ajpgi.00152.2009; Bridle KR, 2006, J LAB CLIN MED, V147, P234, DOI 10.1016/j.lab.2005.12.009; Bridle KR, 2009, LIVER TRANSPLANT, V15, P1315, DOI 10.1002/lt.21804; Caiazza F, 2010, MOL ENDOCRINOL, V24, P953, DOI 10.1210/me.2009-0293; DAS SK, 1994, DEVELOPMENT, V120, P1071; Fu SL, 1999, P NATL ACAD SCI USA, V96, P5716, DOI 10.1073/pnas.96.10.5716; Fujino T, 1998, CARDIOVASC RES, V38, P365, DOI 10.1016/S0008-6363(98)00010-8; Gabele E, 2005, J BIOL CHEM, V280, P13374, DOI 10.1074/jbc.M409444200; GORDON JW, 1981, SCIENCE, V214, P1244, DOI 10.1126/science.6272397; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; HIGASHIYAMA S, 1993, J CELL BIOL, V122, P933, DOI 10.1083/jcb.122.4.933; HIGASHIYAMA S, 1992, J BIOL CHEM, V267, P6205; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; Iwamoto R, 2000, CYTOKINE GROWTH F R, V11, P335, DOI 10.1016/S1359-6101(00)00013-7; Iwamoto R, 2003, P NATL ACAD SCI USA, V100, P3221, DOI 10.1073/pnas.0537588100; Jin KL, 2005, J NEUROSCI RES, V81, P497, DOI 10.1002/jnr.20510; Juan F, 2008, INT J CARDIOL, V128, P83, DOI 10.1016/j.ijcard.2008.03.006; Kirkland G, 1998, J AM SOC NEPHROL, V9, P1464; Kiso S, 2003, GASTROENTEROLOGY, V124, P701, DOI 10.1053/gast.2003.50097; Lemjabbar H, 2002, NAT MED, V8, P41, DOI 10.1038/nm0102-41; MARIKOVSKY M, 1993, P NATL ACAD SCI USA, V90, P3889, DOI 10.1073/pnas.90.9.3889; Means AL, 2003, GASTROENTEROLOGY, V124, P1020, DOI 10.1053/gast.2003.50150; Mine N, 2005, DEVELOPMENT, V132, P4317, DOI 10.1242/dev.02030; MIYAGAWA J, 1995, J CLIN INVEST, V95, P404, DOI 10.1172/JCI117669; Mulder GM, 2011, NEPHROL DIAL TRANSPL; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Neef M, 2006, J HEPATOL, V45, P786, DOI 10.1016/j.jhep.2006.07.030; Pauschinger M, 1999, CIRCULATION, V99, P2750, DOI 10.1161/01.CIR.99.21.2750; Raab G, 1997, BBA-REV CANCER, V1333, pF179, DOI 10.1016/S0304-419X(97)00024-3; Reynolds CM, 2002, HYPERTENSION, V39, P525, DOI 10.1161/hy0202.103076; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Shegogue D, 2004, J BIOL CHEM, V279, P23166, DOI 10.1074/jbc.M401238200; Shillingford Jonathan M, 2010, J AM SOC NEPHROL, V21, P489; Shirakata Y, 2005, J CELL SCI, V118, P2363, DOI 10.1242/jcs.02346; Su EJ, 2003, AM J PHYSIOL-HEART C, V284, pH1429, DOI 10.1152/ajpheart.00885.2002; Takemura T, 2001, J AM SOC NEPHROL, V12, P964, DOI 10.1681/ASN.V125964; Tanaka N, 2002, BIOCHEM BIOPH RES CO, V297, P375, DOI 10.1016/S0006-291X(02)02197-6; Taniyama Y, 2002, HYPERTENSION, V40, P47, DOI 10.1161/01.HYP.0000020755.56955.BF; Tokumaru S, 2000, J CELL BIOL, V151, P209, DOI 10.1083/jcb.151.2.209; Ushikoshi H, 2005, LAB INVEST, V85, P862, DOI 10.1038/labinvest.3700282; VAUGHAN TJ, 1992, BIOCHEM J, V287, P681, DOI 10.1042/bj2870681; Wang SN, 2010, AM J PHYSIOL-RENAL, V298, pF142, DOI 10.1152/ajprenal.00320.2009; Wei S, 1999, J CARD FAIL, V5, P117, DOI 10.1016/S1071-9164(99)90034-9; Xiang XX, 2011, ACTA BIOCH BIOPH SIN, V43, P501, DOI 10.1093/abbs/gmr041; Xie H, 2007, P NATL ACAD SCI USA, V104, P18315, DOI 10.1073/pnas.0707909104; Zhao HP, 2010, J PHARMACOL SCI, V112, P214, DOI 10.1254/jphs.09314FP; Zhu JL, 1999, GASTROENTEROLOGY, V117, P1198, DOI 10.1016/S0016-5085(99)70406-3	50	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44946	10.1371/journal.pone.0044946	http://dx.doi.org/10.1371/journal.pone.0044946			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984591	Green Published, Green Submitted, gold			2022-12-27	WOS:000308738500098
J	Rieucau, G; Blanchard, P; Martin, JGA; Favreau, FR; Goldizen, AW; Pays, O				Rieucau, Guillaume; Blanchard, Pierrick; Martin, Julien G. A.; Favreau, Francois-Rene; Goldizen, Anne W.; Pays, Olivier			Investigating Differences in Vigilance Tactic Use within and between the Sexes in Eastern Grey Kangaroos	PLOS ONE			English	Article							GROUP-SIZE; PREDATION RISK; GRAY KANGAROO; BEHAVIOR; COMPETITION; SEGREGATION; DILUTION; JUNCOS; COSTS; MODEL	Aggregation is thought to enhance an animal's security through effective predator detection and the dilution of risk. A decline in individual vigilance as group size increases is commonly reported in the literature and called the group size effect. However, to date, most of the research has only been directed toward examining whether this effect occurs at the population level. Few studies have explored the specific contributions of predator detection and risk dilution and the basis of individual differences in the use of vigilance tactics. We tested whether male and female (non-reproductive or with young) eastern grey kangaroos (Macropus giganteus) adopted different vigilance tactics when in mixed-sex groups and varied in their reliance on predator detection and/or risk dilution as group size changed. This species exhibits pronounced sexual dimorphism with females being much smaller than males, making them differentially vulnerable toward predators. We combined field observations with vigilance models describing the effects of detection and dilution on scanning rates as group size increased. We found that females with and without juveniles relied on predator detection and risk dilution, but the latter adjusted their vigilance to the proportion of females with juveniles within their group. Two models appeared to equally support the data for males suggesting that males, similarly to females, relied on predator detection and risk dilution but may also have adjusted their vigilance according to the proportion of mothers within their group. Differential vulnerability may cause sex differences in vigilance tactic use in this species. The presence of males within a group that do not, or only partially, contribute to predator detection and are less at risk may cause additional security costs to females. Our results call for reexamination of the classical view of the safety advantages of grouping to provide a more detailed functional interpretation of gregariousness.	[Rieucau, Guillaume] Inst Marine Res, N-5024 Bergen, Norway; [Rieucau, Guillaume; Blanchard, Pierrick] Univ Toulouse, CNRS, ENFA, Lab Evolut & Divers Biol,UMR 5174, Toulouse, France; [Martin, Julien G. A.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Favreau, Francois-Rene] Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, UMR5558, F-69622 Villeurbanne, France; [Favreau, Francois-Rene; Goldizen, Anne W.] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia; [Favreau, Francois-Rene; Pays, Olivier] Univ Angers, Grp Ecol & Conservat, Angers, France	Institute of Marine Research - Norway; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); University of California System; University of California Los Angeles; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; University of Queensland; Universite d'Angers	Rieucau, G (corresponding author), Inst Marine Res, POB 1870, N-5024 Bergen, Norway.	guillaume.rieucau@imr.no	Martin, Julien GA/H-5843-2019; Goldizen, Anne/G-7366-2012	Martin, Julien GA/0000-0001-7726-6809; Goldizen, Anne/0000-0003-0101-4108; Rieucau, Guillaume/0000-0002-8968-4992; Rieucau, Guillaume/0000-0002-7995-1065	Fyssen Foundation; Institute of Marine Research, Bergen, Norway; Fonds de recherche du Quebec Nature et technologies (FQRNT); National Science Foundation; University of Queensland	Fyssen Foundation; Institute of Marine Research, Bergen, Norway; Fonds de recherche du Quebec Nature et technologies (FQRNT); National Science Foundation(National Science Foundation (NSF)); University of Queensland(University of Queensland)	GR was financially supported by a Fyssen Foundation postdoctoral fellowship and by a postdoctoral fellowship from the Institute of Marine Research, Bergen, Norway. GR and PB are at the Laboratoire Evolution et Diversite Biologique (EDB) part of the "Laboratoire d'Excellence" (LABEX) entitled TULIP (ANR-10-LABX-41). JM was funded by an Fonds de recherche du Quebec Nature et technologies (FQRNT) fellowship and an National Science Foundation - Long-Term Research in Environmental Biology (NSF-LTREB) grant. AWG and F-RF were supported by research funds from the University of Queensland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauchamp G, 2008, BEHAV ECOL, V19, P1361, DOI 10.1093/beheco/arn096; Blanchard P, 2008, BEHAV ECOL SOCIOBIOL, V62, P1863, DOI 10.1007/s00265-008-0615-3; Blumstein DT, 2010, J EVOLUTION BIOL, V23, P879, DOI 10.1111/j.1420-9101.2010.01967.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Caro Tim, 2005, pXIII; Carter AJ, 2009, BEHAV ECOL SOCIOBIOL, V64, P237, DOI 10.1007/s00265-009-0840-4; Carter AJ, 2009, ANIM BEHAV, V77, P839, DOI 10.1016/j.anbehav.2008.12.007; Childress MJ, 2003, ANIM BEHAV, V66, P389, DOI 10.1006/anbe.2003.2217; COLAGROSS AML, 1993, AUST J ZOOL, V41, P325, DOI 10.1071/ZO9930325; Cripps JK, 2011, BIOL LETTERS, V7, P859, DOI 10.1098/rsbl.2011.0526; DEHN MM, 1990, BEHAV ECOL SOCIOBIOL, V26, P337; DUNCAN P, 1990, OECOLOGIA, V84, P411, DOI 10.1007/BF00329768; Fairbanks B, 2007, ANIM BEHAV, V73, P115, DOI 10.1016/j.anbehav.2006.07.002; Favreau FR, 2010, P ROY SOC B-BIOL SCI, V277, P2089, DOI 10.1098/rspb.2009.2337; Fernandez-Juricic E, 2004, BEHAV ECOL SOCIOBIOL, V55, P502, DOI 10.1007/s00265-003-0698-9; FITZGIBBON CD, 1990, ANIM BEHAV, V40, P837, DOI 10.1016/S0003-3472(05)80984-4; Fortin D, 2004, OIKOS, V107, P172, DOI 10.1111/j.0030-1299.2004.12976.x; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Jarman P.J., 1986, P399; JARMAN PJ, 1989, KANGAROOS, WALLABIES AND RAT-KANGAROOS, VOLS 1 AND 2, P433; JARMAN PJ, 1987, ANIM BEHAV, V35, P1044, DOI 10.1016/S0003-3472(87)80161-6; Krebs JR, 1993, INTRO BEHAV ECOLOGY; Lima SL, 1999, BEHAV ECOL SOCIOBIOL, V46, P110, DOI 10.1007/s002650050599; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; LIMA SL, 1995, ANIM BEHAV, V49, P11, DOI 10.1016/0003-3472(95)80149-9; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lopez P, 2005, ANIM BEHAV, V69, P1, DOI 10.1016/j.anbehav.2004.05.010; Lung MA, 2007, BEHAV ECOL, V18, P12, DOI [10.1093/beheco/ar1066, 10.1093/beheco/arl066]; Michelena P, 2004, ANIM BEHAV, V68, P1371, DOI 10.1016/j.anbehav.2004.04.008; Michelena P, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016014, 10.1371/journal.pone.0018631]; Pays O, 2008, BEHAV ECOL SOCIOBIOL, V62, P757, DOI 10.1007/s00265-007-0501-4; Pays O, 2007, P ROY SOC B-BIOL SCI, V274, P1287, DOI 10.1098/rspb.2006.0204; Pays O, 2009, BEHAV ECOL, V20, P469, DOI 10.1093/beheco/arp019; PULLIAM HR, 1973, J THEOR BIOL, V38, P419, DOI 10.1016/0022-5193(73)90184-7; PULLIAM HR, 1982, J THEOR BIOL, V95, P89, DOI 10.1016/0022-5193(82)90289-2; Quinn JL, 2005, BEHAVIOUR, V142, P1377, DOI 10.1163/156853905774539391; Rieucau G, 2008, OIKOS, V117, P501, DOI 10.1111/j.0030-1299.2008.16274.x; Rieucau G, 2010, BEHAV ECOL, V21, P684, DOI 10.1093/beheco/arq039; Ruckstuhl KE, 2002, BIOL REV, V77, P77, DOI 10.1017/S1464793101005814; SHORT J, 1985, J APPL ECOL, V22, P435, DOI 10.2307/2403176	40	18	18	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44801	10.1371/journal.pone.0044801	http://dx.doi.org/10.1371/journal.pone.0044801			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984563	Green Published, gold			2022-12-27	WOS:000308738500087
J	Han, FC; Yu, HP; Li, P; Zhang, JP; Tian, C; Li, HB; Zheng, QY				Han, Fengchan; Yu, Heping; Li, Ping; Zhang, Jiangping; Tian, Cong; Li, Hongbo; Zheng, Qing Yin			Mutation in Phex Gene Predisposes BALB/c-PhexHyp-Duk/Y Mice to Otitis Media	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; FIBROBLAST GROWTH FACTOR-23; MIDDLE-EAR; MOUSE MODEL; EFFUSION; PROLIFERATION; CYTOKINES; ETIOLOGY	Genetic susceptibility underlying otitis media (OM) remains to be understood. We show in this study that mutation in Phex gene predisposes the BALB/c-Phex(Hyp-Duk)/Y (abbreviated Hyp-Duk/Y) mice to OM, which occurs at post-natal day 21 (P21) with an average penetrance of 73%. The OM was identified by effusion in the middle ear cavity and/or thickening of middle ear mucosae, and was characterised by increase in goblet cells, deformity of epithelial cilia and higher expression of proliferating cell nuclear antigen (PCNA) in cells of the middle ear mucosae. Moreover, the transcription levels of Tlr2, Tlr4, Nfkb1, Ccl4, Il1b and Tnf alpha in the ears of the Hyp-Duk/Y mice at P35 were significantly upregulated, compared to those of the controls. Higher expression levels of TLR2, TLR4, NF-kappa B and TNF-alpha in the middle ears were demonstrated by immunohistochemistry (IHC). However, the OM in the mice was not prevented by azithromycin administration from gestational day 18 to P35. Further study showed that, in contrast to the low mRNA levels of Phex gene in the ears of the Hyp-Duk/Y mice, the mRNA level of Fgf23 was significantly elevated at P9, P14, P21 and P35. Meanwhile, mRNA levels of EP2 (PGE2 receptor), which expressed in the middle ear epithelia as demonstrated by IHC, were already increased at P14 even before the occurrence of OM, indicating that PGE2, an inflammatory mediator, is involved in the OM development in the mutants. Taking together, Phex mutation primarily up-regulates gene expression levels in FGF23 mediated pathways in the middle ears, resulting in cell proliferation and defence impairment at the mucosae and subsequently bacterial infection. The Hyp-Duk/Y mouse is a new genetic mouse model of OM.	[Han, Fengchan; Li, Ping; Li, Hongbo; Zheng, Qing Yin] Binzhou Med Univ, Transformat Otol & Neurosci Ctr, Yantai, Shandong, Peoples R China; [Han, Fengchan; Yu, Heping; Zhang, Jiangping; Tian, Cong; Zheng, Qing Yin] Case Western Reserve Univ, Dept Otolaryngol Head & Neck Surg, Cleveland, OH 44106 USA; [Zheng, Qing Yin] Jackson Lab, Bar Harbor, ME 04609 USA	Binzhou Medical University; Case Western Reserve University; Jackson Laboratory	Zheng, QY (corresponding author), Binzhou Med Univ, Transformat Otol & Neurosci Ctr, Yantai, Shandong, Peoples R China.	qing.Zheng@case.edu	Tian, Cong/D-4921-2011; Tian, Cong/E-6300-2012	Tian, Cong/0000-0002-5645-6600	National Institutes of Health [R21DC005846, R01DC007392]; Foundation of Taishan Scholar [tshw20110575, ZR2012HZ004]; Binzhou Medical University [BY2012KYQD01]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007392, R21DC005846, R01DC009246] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation of Taishan Scholar; Binzhou Medical University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This project was supported by National Institutes of Health grants (R21DC005846 and R01DC007392), Foundation of Taishan Scholar (tshw20110575 and ZR2012HZ004) and Research Initiation Grant of Binzhou Medical University (BY2012KYQD01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowe AE, 2001, BIOCHEM BIOPH RES CO, V284, P977, DOI 10.1006/bbrc.2001.5084; BUNSE T, 1987, ARCH OTO-RHINO-LARYN, V244, P123, DOI 10.1007/BF00458562; BUNSE T, 1987, ARCH OTO-RHINO-LARYN, V243, P387, DOI 10.1007/BF00464648; Darrow David H, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P416, DOI 10.1097/00020840-200312000-00002; Depreux FFS, 2008, J CLIN INVEST, V118, P651, DOI 10.1172/JCI32899; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Enomoto F, 1995, Nihon Jibiinkoka Gakkai Kaiho, V98, P959; Erben RG, 2005, J BONE MINER RES, V20, P1149, DOI 10.1359/JBMR.050212; Fukumoto S, 2002, CURR OPIN NEPHROL HY, V11, P385, DOI 10.1097/00041552-200207000-00003; Furukawa M, 2007, INFECT IMMUN, V75, P2562, DOI 10.1128/IAI.01656-06; Han FC, 2009, INT J EXP PATHOL, V90, P480, DOI 10.1111/j.1365-2613.2009.00677.x; Han FC, 2009, INFECT IMMUN, V77, P3100, DOI 10.1128/IAI.00204-09; Hardisty RE, 2003, JARO-J ASSOC RES OTO, V4, P130, DOI 10.1007/s10162-002-3015-9; HERMAN P, 1994, AM J OTOLARYNG, V15, P258, DOI 10.1016/0196-0709(94)90092-2; Igaki JM, 1923, ENDOCR J, V58, P647; Imanishi Yasuo, 2002, Clin Calcium, V12, P634; JUNG TTK, 1988, LARYNGOSCOPE, V98, P980; Kubba H, 2000, CLIN OTOLARYNGOL, V25, P181, DOI 10.1046/j.1365-2273.2000.00350.x; LIM DJ, 1971, ANN OTO RHINOL LARYN, V80, P838, DOI 10.1177/000348947108000611; LIM DJ, 1971, LARYNGOSCOPE, V81, P1772, DOI 10.1288/00005537-197111000-00003; Liu SG, 2009, MOL ENDOCRINOL, V23, P1505, DOI 10.1210/me.2009-0085; Lorenz-Depiereux B, 2004, MAMM GENOME, V15, P151, DOI 10.1007/s00335-003-2310-z; Martin A, 1923, FASEB J, V25, P2551; Medici D, 2008, J CELL BIOL, V182, P459, DOI 10.1083/jcb.200803024; Megerian CA, 2008, HEARING RES, V237, P90, DOI 10.1016/j.heares.2008.01.002; Piette A, 2009, VET MICROBIOL, V134, P45, DOI 10.1016/j.vetmic.2008.09.009; Razzaque MS, 2009, AM J PHYSIOL-RENAL, V296, pF470, DOI 10.1152/ajprenal.90538.2008; Rovers MM, 2004, LANCET, V363, P465, DOI 10.1016/S0140-6736(04)15495-0; Samuel EA, 2008, CYTOKINE, V41, P38, DOI 10.1016/j.cyto.2007.10.009; Schachern PA, 2009, ARCH OTOLARYNGOL, V135, P657, DOI 10.1001/archoto.2009.72; Shalhoub V, CALCIF TISSUE INT, V89, P140; Skovbjerg S, CLIN MICROBIOL INFEC, V16, P1382; Smirnova MG, 2004, MEDIAT INFLAMM, V13, P75, DOI 10.1080/09629350410001688477; Syal A, 2006, AM J PHYSIOL-RENAL, V290, pF450, DOI 10.1152/ajprenal.00234.2005; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; TOS M, 1975, LARYNGOSCOPE, V85, P377, DOI 10.1288/00005537-197502000-00015; Tournis S. T., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P150; Yamashita T, 2002, J BIOL CHEM, V277, P28265, DOI 10.1074/jbc.M202527200	38	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e43010	10.1371/journal.pone.0043010	http://dx.doi.org/10.1371/journal.pone.0043010			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028440	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900002
J	Rao, MV; Yuan, AD; Campbell, J; Kumar, A; Nixon, RA				Rao, Mala V.; Yuan, Aidong; Campbell, Jabbar; Kumar, Asok; Nixon, Ralph A.			The C-Terminal Domains of NF-H and NF-M Subunits Maintain Axonal Neurofilament Content by Blocking Turnover of the Stationary Neurofilament Network	PLOS ONE			English	Article							NEURONAL INTERMEDIATE-FILAMENTS; AMYOTROPHIC-LATERAL-SCLEROSIS; MOLECULAR-MASS SUBUNIT; GANGLION-CELL NEURONS; IN-VIVO; TRANSPORT RATE; RADIAL GROWTH; HEAVY SUBUNIT; SCIATIC-NERVE; TAIL DOMAIN	Newly synthesized neurofilaments or protofilaments are incorporated into a highly stable stationary cytoskeleton network as they are transported along axons. Although the heavily phosphorylated carboxyl-terminal tail domains of the heavy and medium neurofilament (NF) subunits have been proposed to contribute to this process and particularly to stability of this structure, their function is still obscure. Here we show in NF-H/M tail deletion [NF-(H/M)(tail Delta)] mice that the deletion of both of these domains selectively lowers NF levels 3-6 fold along optic axons without altering either rates of subunit synthesis or the rate of slow axonal transport of NF. Pulse labeling studies carried out over 90 days revealed a significantly faster rate of disappearance of NF from the stationary NF network of optic axons in NF-(H/M)(tail Delta) mice. Faster NF disappearance was accompanied by elevated levels of NF-L proteolytic fragments in NF-(H/M)(tail Delta) axons. We conclude that NF-H and NF-M C-terminal domains do not normally regulate NF transport rates as previously proposed, but instead increase the proteolytic resistance of NF, thereby stabilizing the stationary neurofilament cytoskeleton along axons.	[Rao, Mala V.; Yuan, Aidong; Campbell, Jabbar; Kumar, Asok; Nixon, Ralph A.] Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY 10962 USA; [Rao, Mala V.; Yuan, Aidong; Nixon, Ralph A.] NYU, Dept Psychiat, Langone Med Ctr, New York, NY 10016 USA; [Nixon, Ralph A.] NYU, Dept Cell Biol, Langone Med Ctr, New York, NY 10016 USA; [Kumar, Asok] NYU, Dept Pathol, Langone Med Ctr, New York, NY 10016 USA	Nathan Kline Institute for Psychiatric Research; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Rao, MV (corresponding author), Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY 10962 USA.	rao@nki.rfmh.org		Rao, Mala/0000-0001-7985-2414	NIH/NIH [AG005604]; NATIONAL INSTITUTE ON AGING [R01AG005604, R37AG005604] Funding Source: NIH RePORTER	NIH/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH/NIH AG005604. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerley S, 2003, J CELL BIOL, V161, P489, DOI 10.1083/jcb.200303138; ARCHER DR, 1994, J NEUROCHEM, V62, P1119; Chen JG, 2000, J CELL SCI, V113, P3861; CHING GY, 1993, J CELL BIOL, V122, P1323, DOI 10.1083/jcb.122.6.1323; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; Ehlers MD, 1998, J NEUROSCI, V18, P720; FRIEDE RL, 1970, ANAT REC, V167, P379, DOI 10.1002/ar.1091670402; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Garcia ML, 2003, J CELL BIOL, V163, P1011, DOI 10.1083/jcb.200308159; GARNER JA, 1988, BRAIN RES, V458, P309, DOI 10.1016/0006-8993(88)90473-8; Gong CX, 2003, NEUROSCI LETT, V340, P107, DOI 10.1016/S0304-3940(03)00096-X; GOTOW T, 1994, J CELL SCI, V107, P1949; Grant P, 2000, J NEUROCYTOL, V29, P843, DOI 10.1023/A:1010999509251; HIROKAWA N, 1988, J NEUROSCI, V8, P2769; HIROKAWA N, 1984, J CELL BIOL, V98, P1523, DOI 10.1083/jcb.98.4.1523; HOFFMAN PN, 1987, P NATL ACAD SCI USA, V84, P3472, DOI 10.1073/pnas.84.10.3472; HSIEH ST, 1994, J NEUROSCI, V14, P6392; JULIEN JP, 1982, J BIOL CHEM, V257, P467; Jung C, 2000, CELL MOTIL CYTOSKEL, V47, P120, DOI 10.1002/1097-0169(200010)47:2<120::AID-CM3>3.0.CO;2-6; Jung C, 2000, BRAIN RES, V856, P12, DOI 10.1016/S0006-8993(99)02314-8; Kim OJ, 2002, J NEUROSCI, V22, P5920; LEE MK, 1993, J CELL BIOL, V122, P1337, DOI 10.1083/jcb.122.6.1337; Leterrier JF, 1996, J BIOL CHEM, V271, P15687, DOI 10.1074/jbc.271.26.15687; LEWIS SE, 1988, J CELL BIOL, V107, P2689, DOI 10.1083/jcb.107.6.2689; Marszalek JR, 1996, J CELL BIOL, V135, P711, DOI 10.1083/jcb.135.3.711; Millecamps S, 2007, J NEUROSCI, V27, P4947, DOI 10.1523/JNEUROSCI.5299-06.2007; NAKAGAWA T, 1995, J CELL BIOL, V129, P411, DOI 10.1083/jcb.129.2.411; NIXON RA, 1980, BRAIN RES, V200, P69, DOI 10.1016/0006-8993(80)91095-1; NIXON RA, 1986, J CELL BIOL, V102, P647, DOI 10.1083/jcb.102.2.647; Nixon RA, 1998, BIOESSAYS, V20, P798, DOI 10.1002/(SICI)1521-1878(199810)20:10<798::AID-BIES5>3.0.CO;2-7; NIXON RA, 1994, J CELL BIOL, V126, P1031, DOI 10.1083/jcb.126.4.1031; OHARA O, 1993, J CELL BIOL, V121, P387, DOI 10.1083/jcb.121.2.387; PANT HC, 1988, BIOCHEM J, V256, P665, DOI 10.1042/bj2560665; Rao MV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017087; Rao MV, 2002, J CELL BIOL, V158, P681, DOI 10.1083/jcb.200202037; Rao MV, 1998, J CELL BIOL, V143, P171, DOI 10.1083/jcb.143.1.171; Rao MV, 2002, J CELL BIOL, V159, P279, DOI 10.1083/JCB.200205062; Rao MV, 2003, J CELL BIOL, V163, P1021, DOI 10.1083/jcb.200308076; Rao MV, 2003, NEUROCHEM RES, V28, P1041, DOI 10.1023/A:1023259207015; SAKAGUCHI T, 1993, NEUROSCI LETT, V153, P65, DOI 10.1016/0304-3940(93)90078-Y; Sanchez I, 2000, J CELL BIOL, V151, P1013, DOI 10.1083/jcb.151.5.1013; Sanchez I, 1996, J NEUROSCI, V16, P5095; SIHAG RK, 1991, J BIOL CHEM, V266, P18861; Stys PK, 2002, NEUROSCI LETT, V328, P150, DOI 10.1016/S0304-3940(02)00469-X; Veeranna, 2010, NEUROBIOL A IN PRESS; Yabe JT, 2001, J NEUROSCI, V21, P2195; Yabe JT, 1999, J CELL SCI, V112, P3799; Yang YM, 1996, CELL, V86, P655, DOI 10.1016/S0092-8674(00)80138-5; Yates DM, 2009, EUR J CELL BIOL, V88, P193, DOI 10.1016/j.ejcb.2008.11.004; Yuan A, 2008, J NEUROSCI, V28, P1682, DOI 10.1523/JNEUROSCI.5242-07.2008; Yuan AD, 2006, J NEUROSCI, V26, P10006, DOI 10.1523/JNEUROSCI.2580-06.2006; Yuan AD, 2009, J NEUROSCI, V29, P11316, DOI 10.1523/JNEUROSCI.1942-09.2009; Zhang B, 1997, J CELL BIOL, V139, P1307, DOI 10.1083/jcb.139.5.1307; Zhu QZ, 1997, EXP NEUROL, V148, P299, DOI 10.1006/exnr.1997.6654	55	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44320	10.1371/journal.pone.0044320	http://dx.doi.org/10.1371/journal.pone.0044320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028520	Green Published, gold			2022-12-27	WOS:000309392800006
J	Arulselvan, P; Wen, CC; Lan, CW; Chen, YH; Wei, WC; Yang, NS				Arulselvan, Palanisamy; Wen, Chih-Chun; Lan, Chun-Wen; Chen, Yung-Hsiang; Wei, Wen-Chi; Yang, Ning-Sun			Dietary Administration of Scallion Extract Effectively Inhibits Colorectal Tumor Growth: Cellular and Molecular Mechanisms in Mice	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1; COLON-CANCER CHEMOPREVENTION; CRYPT FOCI FORMATION; NITRIC-OXIDE; WELSH ONION; ADHESION MOLECULES; DOWN-REGULATION; KAPPA-B; ANGIOGENESIS; EXPRESSION	Colorectal cancer is a common malignancy and a leading cause of cancer death worldwide. Diet is known to play an important role in the etiology of colon cancer and dietary chemoprevention is receiving increasing attention for prevention and/or alternative treatment of colon cancers. Allium fistulosum L., commonly known as scallion, is popularly used as a spice or vegetable worldwide, and as a traditional medicine in Asian cultures for treating a variety of diseases. In this study we evaluated the possible beneficial effects of dietary scallion on chemoprevention of colon cancer using a mouse model of colon carcinoma (CT-26 cells subcutaneously inoculated into BALB/c mice). Tumor lysates were subjected to western blotting for analysis of key inflammatory markers, ELISA for analysis of cytokines, and immunohistochemistry for analysis of inflammatory markers. Metabolite profiles of scallion extracts were analyzed by LC-MS/MS. Scallion extracts, particularly hot-water extract, orally fed to mice at 50 mg (dry weight)/kg body weight resulted in significant suppression of tumor growth and enhanced the survival rate of test mice. At the molecular level, scallion extracts inhibited the key inflammatory markers COX-2 and iNOS, and suppressed the expression of various cellular markers known to be involved in tumor apoptosis (apoptosis index), proliferation (cyclin D1 and c-Myc), angiogenesis (VEGF and HIF-1 alpha), and tumor invasion (MMP-9 and ICAM-1) when compared with vehicle control-treated mice. Our findings may warrant further investigation of the use of common scallion as a chemopreventive dietary agent to lower the risk of colon cancer.	[Arulselvan, Palanisamy; Wen, Chih-Chun; Lan, Chun-Wen; Chen, Yung-Hsiang; Wei, Wen-Chi; Yang, Ning-Sun] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Lan, Chun-Wen] Natl Chung Hsing Univ, Taiwan Int Grad Program, Taipei, Taiwan; [Lan, Chun-Wen] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan; [Lan, Chun-Wen] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Wei, Wen-Chi] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung 80424, Taiwan; [Yang, Ning-Sun] Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Sun Yat Sen University; National Taiwan University	Arulselvan, P (corresponding author), Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan.	nsyang@gate.sinica.edu.tw	Arulselvan, Palanisamy/M-6388-2014	Arulselvan, Palanisamy/0000-0002-1835-9738	National Science Council grant [NSC-99-2321-B-400-006]; Academia Sinica, Taiwan in the form of a Postdoctoral Research Fellowship	National Science Council grant; Academia Sinica, Taiwan in the form of a Postdoctoral Research Fellowship	This study was financially supported by a National Science Council grant (NSC-99-2321-B-400-006) and by Academia Sinica, Taiwan in the form of a Postdoctoral Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Anto RJ, 1996, MUTAT RES-GENET TOX, V370, P127, DOI 10.1016/0165-1218(96)00074-2; Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; Chen JH, 1999, J CARDIOVASC PHARM, V33, P515, DOI 10.1097/00005344-199904000-00001; Chen JH, 2000, J NUTR, V130, P34; Chin YW, 2006, AAPS J, V8, pE239, DOI 10.1007/BF02854894; Chiu SC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-513; Choi YL, 2004, J HISTOCHEM CYTOCHEM, V52, P591, DOI 10.1177/002215540405200504; Dolcetti L, 2008, CANCER LETT, V267, P216, DOI 10.1016/j.canlet.2008.03.012; Dowlati A, 2008, CLIN CANCER RES, V14, P1407, DOI 10.1158/1078-0432.CCR-07-1154; Duvoix A, 2005, CANCER LETT, V223, P181, DOI 10.1016/j.canlet.2004.09.041; Dymicka-Piekarska V, 2009, THROMB RES, V124, P80, DOI 10.1016/j.thromres.2008.11.021; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Gupta SC, 2010, CANCER METAST REV, V29, P405, DOI 10.1007/s10555-010-9235-2; Hagos GK, 2007, MOL CANCER THER, V6, P2230, DOI 10.1158/1535-7163.MCT-07-0069; Hardy G, 2003, CURR OPIN CLIN NUTR, V6, P661, DOI 10.1097/00075197-200311000-00010; Hirota K, 2006, CRIT REV ONCOL HEMAT, V59, P15, DOI 10.1016/j.critrevonc.2005.12.003; Hsu CH, 2007, ADV EXP MED BIOL, V595, P471; Hu CE, 2011, SCAND J GASTROENTERO, V46, P156, DOI 10.3109/00365521.2010.516450; Huerta S, 2008, EXPERT REV MOL DIAGN, V8, P277, DOI 10.1586/14737159.8.3.277; Kohno H, 2006, INT J CANCER, V118, P2936, DOI 10.1002/ijc.21719; La Vecchia C, 2004, PUBLIC HEALTH NUTR, V7, P965, DOI 10.1079/PHN2004562; Lee SJ, 2007, TOXICOL APPL PHARM, V225, P198, DOI 10.1016/j.taap.2007.07.010; Lee SI, 2008, J GASTROEN HEPATOL, V23, P138, DOI 10.1111/j.1440-1746.2007.05181.x; Liang S, 2008, ANN BIOMED ENG, V36, P661, DOI 10.1007/s10439-008-9445-8; Lin YC, 2006, CLIN CANCER RES, V12, P7165, DOI 10.1158/1078-0432.CCR-06-1393; Lopez-Lazaro M, 2006, CANCER EPIDEM BIOMAR, V15, P2332, DOI 10.1158/1055-9965.EPI-06-0369; Mehta RG, 2010, PHARM RES-DORDR, V27, P950, DOI 10.1007/s11095-010-0085-y; Melillo G, 2006, MOL CANCER RES, V4, P601, DOI 10.1158/1541-7786.MCR-06-0235; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; Mousa AS, 2005, NUTR CANCER, V53, P104, DOI 10.1207/s15327914nc5301_12; Naumov GN, 2006, CELL CYCLE, V5, P1779, DOI 10.4161/cc.5.16.3018; Patel BB, 2009, AM J PHYSIOL-GASTR L, V296, pG955, DOI 10.1152/ajpgi.90726.2008; Rao CV, 2004, MUTAT RES-FUND MOL M, V555, P107, DOI 10.1016/j.mrfmmm.2004.05.022; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; SANO H, 1995, CANCER RES, V55, P3785; Schmidt EV, 1999, ONCOGENE, V18, P2988, DOI 10.1038/sj.onc.1202751; Singh RP, 2003, CURR CANCER DRUG TAR, V3, P205, DOI 10.2174/1568009033481985; Singh RP, 2005, ONCOGENE, V24, P1188, DOI 10.1038/sj.onc.1208276; Singh V, 2006, NUTR CANCER, V55, P178, DOI 10.1207/s15327914nc5502_9; Sinnamon MJ, 2008, INT J EXP PATHOL, V89, P466, DOI 10.1111/j.1365-2613.2008.00621.x; Sung YY, 2011, MOL MED REP, V4, P431, DOI 10.3892/mmr.2011.451; Takahashi M, 2000, CARCINOGENESIS, V21, P1319, DOI 10.1093/carcin/21.7.1319; Tsai TH, 2005, J FOOD SCI, V70, pC93, DOI 10.1111/j.1365-2621.2005.tb09028.x; Tu YY, 2011, NAT MED, V17, P1217, DOI 10.1038/nm.2471; Velmurugan B, 2010, MOL CARCINOGEN, V49, P641, DOI 10.1002/mc.20643; Wang BS, 2005, FOOD CHEM, V91, P147, DOI 10.1016/j.foodchem.2004.06.009; Wang SX, 2006, INT J CANCER, V118, P932, DOI 10.1002/ijc.21289; Warren CA, 2009, J NUTR, V139, P101, DOI 10.3945/jn.108.096271; Wiseman M, 2008, P NUTR SOC, V67, P253, DOI 10.1017/S002966510800712X; Yamamoto Y, 2005, BIOSCI BIOTECH BIOCH, V69, P1311, DOI 10.1271/bbb.69.1311	52	20	21	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44658	10.1371/journal.pone.0044658	http://dx.doi.org/10.1371/journal.pone.0044658			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024755	Green Published, gold, Green Submitted			2022-12-27	WOS:000308860100013
J	Li, JX; Mao, GK; Xia, GL				Li, Junxia; Mao, Guankun; Xia, Guoliang			FSH Modulates PKAI and GPR3 Activities in Mouse Oocyte of COC in a Gap Junctional Communication (GJC)-Dependent Manner to Initiate Meiotic Resumption	PLOS ONE			English	Article							PROTEIN-KINASE-A; FOLLICLE-STIMULATING-HORMONE; CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; MEDIATED GENE-EXPRESSION; CUMULUS CELL COMPLEX; ADENOSINE-MONOPHOSPHATE; MAMMALIAN OOCYTES; BINDING PROTEIN; GRANULOSA-CELLS; RODENT OOCYTES	Many studies have shown that cyclic adenosine-5'-monophosphate (cAMP)-dependent protein kinase A (PKA) and G-protein-coupled receptor 3 (GPR3) are crucial for controlling meiotic arrest in oocytes. However, it is unclear how gonadotropins modulate these factors to regulate oocyte maturation, especially by gap junctional communication (GJC). Using an in vitro meiosis-arrested mouse cumulus-oocyte complex (COC) culture model, we showed that there is a close relationship between follicle-stimulating hormone (FSH) and the PKA type I (PKAI) and GPR3. The effect of FSH on oocyte maturation was biphasic, initially inhibitory and then stimulatory. During FSH-induced maturation, rapid cAMP surges were observed in both cumulus cells and oocyte. Most GJC between cumulus cells and oocyte ceased immediately after FSH stimulation and recommenced after the cAMP surge. FSH-induced maturation was blocked by PKAI activator 8-AHA-cAMP. Levels of PKAI regulatory subunits and GPR3 decreased and increased, respectively, after FSH stimulation. In the presence of the GJC inhibitor carbenoxolone (CBX), FSH failed to induce the meiotic resumption and the changes in PKAI, GPR3 and cAMP surge in oocyte were no longer detected. Furthermore, GPR3 was upregulated by high cAMP levels, but not by PKAI activation. When applied after FSH stimulation, the specific phosphodiesterase 3A (PDE3A) inhibitor cilostamide immediately blocked meiotic induction, regardless of when it was administered. PKAI activation inhibited mitogen-activated protein kinase (MAPK) phosphorylation in the oocytes of COCs, which participated in the initiation of FSH-induced meiotic maturation in vitro. Just before FSH-induced meiotic maturation, cAMP, PKAI, and GPR3 returned to basal levels, and PDE3A activity and MAPK phosphorylation increased markedly. These experiments show that FSH induces a transient increase in cAMP levels and regulates GJC to control PKAI and GPR3 activities, thereby creating an inhibitory phase. After PDE3A and MAPK activities increase, meiosis resumes.	[Li, Junxia; Mao, Guankun; Xia, Guoliang] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China	China Agricultural University	Li, JX (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	glxiachina@sohu.com		Xia, Guoliang/0000-0003-3674-0142	National Basic Research Program of China [2012CB944401, 2012CB944701]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Basic Research Program of China (No. 2012CB944401 and No. 2012CB944701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini DF, 2001, REPRODUCTION, V121, P647, DOI 10.1530/rep.0.1210647; Araki K, 1996, BIOL REPROD, V55, P1315, DOI 10.1095/biolreprod55.6.1315; BORNSLAEGER EA, 1986, DEV BIOL, V114, P453, DOI 10.1016/0012-1606(86)90209-5; BROWER PT, 1982, DEV BIOL, V90, P144, DOI 10.1016/0012-1606(82)90219-6; Brown RL, 2002, BIOL REPROD, V67, P981, DOI 10.1095/biolreprod.101.003046; Carabatsos MJ, 2000, DEV BIOL, V226, P167, DOI 10.1006/dbio.2000.9863; Choi T, 1996, P NATL ACAD SCI USA, V93, P4730, DOI 10.1073/pnas.93.10.4730; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; Constantinescu A, 2004, J BIOL CHEM, V279, P43321, DOI 10.1074/jbc.M406994200; Constantinescu A, 2002, J BIOL CHEM, V277, P18810, DOI 10.1074/jbc.M112107200; DEKEL N, 1988, MOL CELL ENDOCRINOL, V56, P115, DOI 10.1016/0303-7207(88)90015-9; Diaz FJ, 2007, J CELL SCI, V120, P1330, DOI 10.1242/jcs.000968; DOWNS SM, 1989, GAMETE RES, V23, P323, DOI 10.1002/mrd.1120230309; DOWNS SM, 1995, DEV BIOL, V167, P502, DOI 10.1006/dbio.1995.1044; DOWNS SM, 1995, DEV BIOL, V172, P72, DOI 10.1006/dbio.1995.0006; DOWNS SM, 1988, J EXP ZOOL, V245, P86, DOI 10.1002/jez.1402450113; Downs SM, 2002, DEV BIOL, V245, P200, DOI 10.1006/dbio.2002.0613; DOWNS SM, 1984, ENDOCRINOLOGY, V114, P418, DOI 10.1210/endo-114-2-418; Downs SM, 2008, MOL REPROD DEV, V75, P105, DOI 10.1002/mrd.20781; Duckworth BC, 2002, P NATL ACAD SCI USA, V99, P16794, DOI 10.1073/pnas.222661299; Duncan FE, 2006, DEV DYNAM, V235, P2961, DOI 10.1002/dvdy.20930; Eppig JJ, 1997, BIOL REPROD, V56, P976, DOI 10.1095/biolreprod56.4.976; Freudzon L, 2005, J CELL BIOL, V171, P255, DOI 10.1083/jcb.200506194; HAGIWARA M, 1993, MOL CELL BIOL, V13, P4852, DOI 10.1128/MCB.13.8.4852; Han SJ, 2006, CELL CYCLE, V5, P227, DOI 10.4161/cc.5.3.2395; Hinckley M, 2005, DEV BIOL, V287, P249, DOI 10.1016/j.ydbio.2005.08.019; Horner K, 2003, DEV BIOL, V258, P385, DOI 10.1016/S0012-1606(03)00134-9; KNUTSEN HK, 1992, BIOCHEM BIOPH RES CO, V184, P454, DOI 10.1016/0006-291X(92)91215-C; Ledent C, 2005, P NATL ACAD SCI USA, V102, P8922, DOI 10.1073/pnas.0503840102; Lincoln AJ, 2002, NAT GENET, V30, P446, DOI 10.1038/ng856; Masciarelli S, 2004, J CLIN INVEST, V114, P196, DOI 10.1172/JCI2004210804; Mehlmann LM, 2002, SCIENCE, V297, P1343, DOI 10.1126/science.1073978; Mehlmann LM, 2004, SCIENCE, V306, P1947, DOI 10.1126/science.1103974; Mehlmann LM, 2005, DEV BIOL, V288, P397, DOI 10.1016/j.ydbio.2005.09.030; Michael LF, 2000, MOL CELL BIOL, V20, P1596, DOI 10.1128/MCB.20.5.1596-1603.2000; Ning G, 2008, MOL ENDOCRINOL, V22, P1682, DOI 10.1210/me.2007-0480; Pirino G, 2009, CELL CYCLE, V8, P665, DOI 10.4161/cc.8.4.7846; Richard FJ, 2001, BIOL REPROD, V65, P1444, DOI 10.1095/biolreprod65.5.1444; SHERIZLY I, 1988, HUM REPROD, V3, P761, DOI 10.1093/oxfordjournals.humrep.a136780; Su YQ, 2003, DEV BIOL, V263, P126, DOI 10.1016/S0012-1606(03)00437-8; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Thomas RE, 2004, BIOL REPROD, V70, P548, DOI 10.1095/biolreprod.103.021204; Thompson W J, 1979, Adv Cyclic Nucleotide Res, V10, P69; Vaccari S, 2008, DEV BIOL, V316, P124, DOI 10.1016/j.ydbio.2008.01.018; Verlhac MH, 2000, CURR BIOL, V10, P1303, DOI 10.1016/S0960-9822(00)00753-3; Vozzi C, 2001, REPRODUCTION, V122, P619, DOI 10.1530/reprod/122.4.619; Vuong BQ, 2009, NAT IMMUNOL, V10, P420, DOI 10.1038/ni.1708; Webb RJ, 2002, DEV BIOL, V246, P441, DOI 10.1006/dbio.2002.0630; Zhang B, 2011, MOL BIOL REP; Zhang MJ, 2011, ENDOCRINOLOGY, V152, P4377, DOI 10.1210/en.2011-1118; Zhang MJ, 2010, SCIENCE, V330, P366, DOI 10.1126/science.1193573; Zhang Y, 2008, DEV DYNAM, V237, P3777, DOI 10.1002/dvdy.21799	52	15	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e37835	10.1371/journal.pone.0037835	http://dx.doi.org/10.1371/journal.pone.0037835			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028418	gold, Green Submitted, Green Published			2022-12-27	WOS:000308788700001
J	Chen, YC; Chien, YW; Chang, PJ; Hsieh, WS; Chen, PC				Chen, Yi-Chun; Chien, Yi-Wen; Chang, Pei-Jen; Hsieh, Wu-Shiun; Chen, Pau-Chung			Probiotic Supplement Use among Young Children in Taiwan: A Prospective Cohort Study	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; NATIONAL-HEALTH; VITAMIN; MARKETPLACE; ADOLESCENTS; PREVENTION; MANAGEMENT; PREBIOTICS; BACTERIA; GUIDANCE	Objectives: The objective of this study is to provide details on probiotic supplement use among young children in Taiwan. Participants and Methods: This study is based on the Taiwan Birth Cohort Study database. We used questionnaires to collect information on probiotic supplement use among young children from birth to 18 months of age, while also considering their demographic characteristics and other covariates. Low-birth-weight infants, preterm infants, those with birth defects, and those with caregivers who returned incomplete questionnaires were excluded. The final valid sample comprised 16,991 cases. Results: Approximately half the children received probiotic supplements before the age of 18 months. Only 6.3% of the children received probiotic supplements during the two periods of birth to 6 months and 7 to 18 months. Firstborn children, native mothers, mothers with higher educational levels, higher family income, and parents who lead healthy lifestyles were positively related to probiotic supplement use among children. Young children who were breastfed, with eczema, or with gastrointestinal tract problems were significantly positively associated with probiotic supplement use. Conclusion: The findings show that probiotic supplement usage among young children is associated with a more socially advantaged circumstance and certain child health factors, such as eczema, diarrhea, and constipation. Parents might use probiotic supplements for prevention or treatment of child diseases. The findings of this research could serve as a baseline for future studies, and provide insight into probiotic supplement use behavior for health professionals caring for infants and young children.	[Chen, Yi-Chun; Chien, Yi-Wen] Taipei Med Univ, Sch Nutr & Hlth Sci, Taipei, Taiwan; [Chang, Pei-Jen] Natl Taipei Univ Nursing & Hlth Sci, Dept Nursing, Taipei, Taiwan; [Hsieh, Wu-Shiun] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Taipei 10764, Taiwan; [Hsieh, Wu-Shiun] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Chen, Pau-Chung] Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei 10764, Taiwan	Taipei Medical University; National Taipei University of Nursing & Health Science (NTUNHS); National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Chen, YC (corresponding author), Taipei Med Univ, Sch Nutr & Hlth Sci, Taipei, Taiwan.	yichun@tmu.edu.tw	Chen, Pau-Chung/H-5686-2011	Chen, Pau-Chung/0000-0002-6242-5974; HSIEH, WU-SHIUN/0000-0002-0609-3311	Bureau of Health Promotion, Department of Health, Taiwan	Bureau of Health Promotion, Department of Health, Taiwan	The study was supported by a grant from the Bureau of Health Promotion, Department of Health, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003048.pub3; Amagase H, 2008, CLIN INFECT DIS, V46, pS73, DOI 10.1086/523338; Asp NG, 2008, J NUTR, V138, p1210S, DOI 10.1093/jn/138.6.1210S; Bar-on ME, 2001, PEDIATRICS, V107, P423, DOI 10.1542/peds.107.2.423; Boyle RJ, 2006, CLIN EXP ALLERGY, V36, P568, DOI 10.1111/j.1365-2222.2006.02472.x; Boyle RJ, 2006, AM J CLIN NUTR, V83, P1256, DOI 10.1093/ajcn/83.6.1256; Braegger C, 2011, J PEDIATR GASTR NUTR, V52, P238, DOI 10.1097/MPG.0b013e3181fb9e80; Briefel R, 2006, J AM DIET ASSOC, V106, pS52, DOI 10.1016/j.jada.2005.09.041; Chmielewska A, 2010, WORLD J GASTROENTERO, V16, P69, DOI 10.3748/wjg.v16.i1.69; Chuang CH, 2012, J PEDIATR GASTR NUTR, V54, P71, DOI 10.1097/MPG.0b013e31822dbafe; Degnan FH, 2008, CLIN INFECT DIS, V46, pS133, DOI 10.1086/523324; FAO/WHO, 2001, REG CLIN ASP DAIR PR; Ghisolfi J, 2002, J PEDIATR GASTR NUTR, V35, P467, DOI 10.1097/00005176-200210000-00001; Gunther S, 2004, J AM DIET ASSOC, V104, P27, DOI 10.1016/j.jada.2003.10.009; Joint FAO/WHO Working Group, 2002, GUID EV PROB FOOD; Jordan AB, 2006, PEDIATRICS, V118, pE1303, DOI 10.1542/peds.2006-0732; Kalliomaki M, 2010, J NUTR, V140, p713S, DOI 10.3945/jn.109.113761; Kim SH, 2002, NUTR RES, V22, P433, DOI 10.1016/S0271-5317(01)00322-0; Lee J, 2008, J ALLERGY CLIN IMMUN, V121, P116, DOI 10.1016/j.jaci.2007.10.043; Lonnerdal B, 2003, AM J CLIN NUTR, V77, p1537S; Lung FW, 2011, RES DEV DISABIL, V32, P2697, DOI 10.1016/j.ridd.2011.06.002; Marteau P, 2002, BRIT J NUTR, V87, pS153, DOI 10.1079/BJN2002531; Martin R, 2005, J HUM LACT, V21, P8, DOI 10.1177/0890334404272393; Martin R, 2003, J PEDIATR-US, V143, P754, DOI 10.1016/j.jpeds.2003.09.028; Michail S, 2006, J PEDIATR GASTR NUTR, V43, P550, DOI 10.1097/01.mpg.0000239990.35517.bf; Osborn DA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006475.pub2; Picciano MF, 2007, ARCH PEDIAT ADOL MED, V161, P978, DOI 10.1001/archpedi.161.10.978; Rabot S, 2010, J NUTR, V140, p677S, DOI 10.3945/jn.109.113738; Radimer K, 2004, AM J EPIDEMIOL, V160, P339, DOI 10.1093/aje/kwh207; Radimer KL, 2005, J AM DIET ASSOC, V105, P703, DOI 10.1016/j.jada.2005.03.037; Saavedra JM, 2004, AM J CLIN NUTR, V79, P261; Saxelin M, 2008, CLIN INFECT DIS, V46, pS76, DOI 10.1086/523337; Shaikh U, 2009, ARCH PEDIAT ADOL MED, V163, P150, DOI 10.1001/archpediatrics.2008.523; Stanton C, 2001, AM J CLIN NUTR, V73, p476S, DOI 10.1093/ajcn/73.2.476s; Thomas DW, 2010, PEDIATRICS, V126, P1217, DOI 10.1542/peds.2010-2548; Wallace B, 2009, NUTR CLIN PRACT, V24, P50, DOI 10.1177/0884533608329298; Yu SM, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.5.e4	37	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43885	10.1371/journal.pone.0043885	http://dx.doi.org/10.1371/journal.pone.0043885			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984450	gold, Green Published, Green Submitted			2022-12-27	WOS:000308738500027
J	Garcia, MB; Espadaler, X; Olesen, JM				Garcia, Maria B.; Espadaler, Xavier; Olesen, Jens M.			Extreme Reproduction and Survival of a True Cliffhanger: The Endangered Plant Borderea chouardii (Dioscoreaceae)	PLOS ONE			English	Article							ANT-POLLINATION; SEEDS	Cliff sides are extreme habitats, often sheltering a rich and unique flora. One example is the dioecious herb Borderea chouardii (Dioscoreaceae), which is a Tertiary, tropical relict, occurring only on two adjacent vertical cliffs in the world. We studied its reproductive biology, which in some aspects is extreme, especially the unusual double mutualistic role of ants as both pollinators and dispersers. We made a 2-year pollination census and four years of seed-dispersal experiments, recording flower visitors and dispersal rates. Fruit and seed set, self-sowing of seeds, seedling recruitment, and fate of seedlings from seeds sowed by different agents were scored over a period of 17 years. The ants Lasius grandis and L. cinereus were the main pollinators, whereas another ant Pheidole pallidula dispersed seeds. Thus ants functioned as double mutualists. Two thirds of all new seedlings came from self-sown seeds, and 1/3 was dispersed by ants, which gathered the seeds with their oil-rich elaiosome. Gravity played a minor role to dispersal. Both ant dispersal and self-sowing resulted in the same survival rate of seedlings. A double mutualism is a risky reproductive strategy, but B. chouardii buffers that by an unusual long-term demographic stability (some individuals exceed 300 years in lifespan) and its presence in a climatically very stable habitat, inaccessible to large herbivores. Such a combination of traits and habitat properties may explain the persistence of this relict species.	[Garcia, Maria B.] Spanish Natl Res Council, Pyrenean Inst Ecol, Zaragoza, Spain; [Espadaler, Xavier] Univ Autonoma Barcelona, Ctr Ecol Res & Forestry Applicat, Bellaterra, Spain; [Olesen, Jens M.] Aarhus Univ, Inst Biosci, Aarhus, Denmark	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE); Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Aarhus University	Garcia, MB (corresponding author), Spanish Natl Res Council, Pyrenean Inst Ecol, Zaragoza, Spain.	mariab@ipe.csic.es	Espadaler, Xavier/F-1898-2011; Garcia, Maria Begoña/B-6630-2015; Olesen, Jens M/A-3011-2009	Espadaler, Xavier/0000-0002-7681-5957; Garcia, Maria Begoña/0000-0003-4231-6006; Olesen, Jens M/0000-0003-1998-1083; Olesen, Jes/0000-0002-6712-2702	Spanish Ministry of Science; CYTED program; Danish National Research Council; Regional Government of Aragon; INAGA	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CYTED program; Danish National Research Council(Danmarks Grundforskningsfond); Regional Government of Aragon(Gobierno de Aragon); INAGA	The staff of Regional Government of Aragon (in particular J. Guiral, J. Inchausti, M. Alcantara, D. Guzman, J. Puente and the INAGA) provided permits and most of the funding for this study over years. The Spanish Ministry of Science, the CYTED program, and the Danish National Research Council also supported the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beattie A. J., 1985, EVOLUTIONARY ECOLOGY; BEATTIE AJ, 1984, AM J BOT, V71, P421, DOI 10.2307/2443499; BHATKAR A, 1970, Florida Entomologist, V53, P229, DOI 10.2307/3493193; BOND WJ, 1989, OECOLOGIA, V81, P412, DOI 10.1007/BF00377092; BURKILL I. H., 1960, JOUR LINNEAN SOC LONDON BOT, V56, P319; CULVER DC, 1980, AM J BOT, V67, P710, DOI 10.2307/2442664; DAVIDSON DW, 1977, ECOLOGY, V58, P711, DOI 10.2307/1936208; DETRAIN C, 1990, INSECT SOC, V37, P315, DOI 10.1007/BF02225995; ERIKSSON O, 1992, OECOLOGIA, V91, P360, DOI 10.1007/BF00317624; Garcia MB, 2003, CONSERV BIOL, V17, P1672, DOI 10.1111/j.1523-1739.2003.00030.x; Garcia MB, 1995, PLANT SYST EVOL, V198, P17, DOI 10.1007/BF00985105; GAUSSEN HENRI, 1952, BULL SOC BOT FRANCE, V99, P23; Gomez C, 1998, J BIOGEOGR, V25, P573, DOI 10.1046/j.1365-2699.1998.2530573.x; Gomez JM, 1996, OECOLOGIA, V105, P236, DOI 10.1007/BF00328552; GOMEZ JM, 1992, OECOLOGIA, V91, P410, DOI 10.1007/BF00317631; Hagerup O. Myre-Best[theta]vning, 1943, BOT TIDSSKR, V46, P116; Hansen DM, 2009, BIOTROPICA, V41, P202, DOI 10.1111/j.1744-7429.2008.00473.x; HICKMAN JC, 1974, SCIENCE, V184, P1290, DOI 10.1126/science.184.4143.1290; Holldobler B, 1984, PSYCHE, V91, P2; Hutcheon JM, 1994, BATS, V12, P10; Larson DW, 2000, J BIOGEOGR, V27, P319, DOI 10.1046/j.1365-2699.2000.00401.x; Larson DW, 2000, CLIFF ECOLOGY PATTEN; Lengyel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005480; Mark S, 1996, OECOLOGIA, V107, P95, DOI 10.1007/BF00582239; Olesen JM, 2012, PERSPECT PLANT ECOL, V14, P169, DOI 10.1016/j.ppees.2012.01.003; Pinheiro J, 2001, MIXED EFFECTS MODELS; Proctor M., 1996, NATURAL HIST POLLINA; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; Segarra JG, 2005, FLORA IBERICA PLANTA, V21; Sernander R., 1906, KGL SVENSK VETENSK, V41, P1; STRONG DR, 1975, SCIENCE, V190, P804, DOI 10.1126/science.190.4216.804; Wojcik DP, 2008, FORMIS; WYATT R, 1981, AM J BOT, V68, P1212, DOI 10.2307/2443043	33	35	36	5	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44657	10.1371/journal.pone.0044657	http://dx.doi.org/10.1371/journal.pone.0044657			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984539	Green Published, gold			2022-12-27	WOS:000308738500072
J	Imoukhuede, PI; Popel, AS				Imoukhuede, Princess I.; Popel, Aleksander S.			Expression of VEGF Receptors on Endothelial Cells in Mouse Skeletal Muscle	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR-1; STOCHASTIC GENE-EXPRESSION; TYROSINE KINASE; SIGNAL-TRANSDUCTION; LIPID RAFTS; STRAIN DIFFERENCES; CEREBRAL-ISCHEMIA; COMPARTMENT MODEL; PROTEIN-KINASE; STEM-CELLS	VEGFR surface localization plays a critical role in converting extracellular VEGF signaling towards angiogenic outcomes, and the quantitative characterization of these parameters is critical for advancing computational models; however the levels of these receptors on blood vessels is currently unknown. Therefore our aim is to quantitatively determine the VEGFR localization on endothelial cells from mouse hindlimb skeletal muscles. We contextualize this VEGFR quantification through comparison to VEGFR-levels on cells in vitro. Using quantitative fluorescence we measure and compare the levels of VEGFR1 and VEGFR2 on endothelial cells isolated from C57BL/6 and BALB/c gastrocnemius and tibialis anterior hindlimb muscles. Fluorescence measurements are calibrated using beads with known numbers of phycoerythrin molecules. The data show a 2-fold higher VEGFR1 surface localization relative to VEGFR2 with 2,000-3,700 VEGFR1/endothelial cell and 1,300-2,000 VEGFR2/endothelial cell. We determine that endothelial cells from the highly glycolytic muscle, tibialis anterior, contain 30% higher number of VEGFR1 surface receptors than gastrocnemius; BALB/c mice display similar to 17% higher number of VEGFR1 than C57BL/6. When we compare these results to mouse fibroblasts in vitro, we observe high levels of VEGFR1 (35,800/cell) and very low levels of VEGFR2 (700/cell), while in human endothelial cells in vitro, we observe that the balance of VEGFRs is inverted, with higher levels VEGFR2 (5,800/cell) and lower levels of VEGFR1 (1,800/cell). Our studies also reveal significant cell-to-cell heterogeneity in receptor expression, and the quantification of these dissimilarities ex vivo for the first time provides insight into the balance of anti-angiogenic or modulatory (VEGFR1) and pro-angiogenic (VEGFR2) signaling.	[Imoukhuede, Princess I.] Univ Illinois, Dept Bioengn, Urbana, IL USA; [Popel, Aleksander S.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA	University of Illinois System; University of Illinois Urbana-Champaign; Johns Hopkins University	Imoukhuede, PI (corresponding author), Univ Illinois, Dept Bioengn, Urbana, IL USA.	pii@illinois.edu	Popel, Aleksander S/A-6724-2009; Imoukhuede, P I/T-7580-2017	Imoukhuede, P I/0000-0002-4257-1085; Popel, Aleksander/0000-0002-6706-9235	National institutes of Health [R01 HL101200, R01 CA138264]; UNCF/Merck; FASEB; NIH [T32 HL007581]; NATIONAL CANCER INSTITUTE [R01CA138264] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007581, R01HL101200] Funding Source: NIH RePORTER	National institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNCF/Merck(Merck & Company); FASEB; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research is supported by National institutes of Health grants R01 HL101200 and R01 CA138264 to A. S. Popel and by a UNCF/Merck Postdoctoral Fellowship, FASEB Postdoctoral Professional Development Award, and T32 HL007581 (The T32 HL007581 is from the NIH) to PII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annex BH, 1998, AM J PHYSIOL-HEART C, V274, pH860, DOI 10.1152/ajpheart.1998.274.3.H860; Aronowski JW, 2003, ILAR J, V44, P105, DOI 10.1093/ilar.44.2.105; BALANDA KP, 1988, AM STAT, V42, P111, DOI 10.2307/2684482; BARONE FC, 1993, J CEREBR BLOOD F MET, V13, P683, DOI 10.1038/jcbfm.1993.87; Bauer AL, 2007, BIOPHYS J, V92, P3105, DOI 10.1529/biophysj.106.101501; Bentley K, 2008, J THEOR BIOL, V250, P25, DOI 10.1016/j.jtbi.2007.09.015; Bentley K, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000549; Bernatchez PN, 2007, J BIOL CHEM, V282, P30745, DOI 10.1074/jbc.M704798200; Berthaut A, 2009, MOL VIS, V15, P1997; Bhattacharya R, 2005, FASEB J, V19, P1692, DOI 10.1096/fj.05-3889fje; Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009; Bishop E T, 1999, Angiogenesis, V3, P335, DOI 10.1023/A:1026546219962; BOBIK A, 1993, PHARMACOL REV, V45, P1; BROCKHOFF G, 1994, CYTOMETRY, V17, P75, DOI 10.1002/cyto.990170110; Bruns AF, 2009, BIOCHEM SOC T, V37, P1193, DOI 10.1042/BST0371193; Cao YH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.259re1; Casalou C, 2011, MOL CANCER RES, V9, P215, DOI 10.1158/1541-7786.MCR-10-0155; Chalothorn D, 2007, PHYSIOL GENOMICS, V30, P179, DOI 10.1152/physiolgenomics.00047.2007; Chen JH, 2001, CELL BIOL INT, V25, P257, DOI 10.1006/cbir.2000.0617; Cherwek DH, 2000, AM J PHYSIOL-HEART C, V279, pH932, DOI 10.1152/ajpheart.2000.279.3.H932; Chu CL, 2004, BIOCHEM J, V379, P331, DOI 10.1042/BJ20031082; CLAUSS M, 1990, J EXP MED, V172, P1535, DOI 10.1084/jem.172.6.1535; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; DAGOSTINO RB, 1990, AM STAT, V44, P316, DOI 10.2307/2684359; Davis GE, 2011, INT REV CEL MOL BIO, V288, P101, DOI 10.1016/B978-0-12-386041-5.00003-0; DeCarlo LT, 1997, PSYCHOL METHODS, V2, P292, DOI 10.1037/1082-989X.2.3.292; DEWEY CF, 1981, J BIOMECH ENG-T ASME, V103, P177, DOI 10.1115/1.3138276; DOKUN AO, 2008, NY TIMES        1026, V117, P1207; Dunk C, 2001, AM J PATHOL, V158, P265, DOI 10.1016/S0002-9440(10)63965-X; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ewan LC, 2006, TRAFFIC, V7, P1270, DOI 10.1111/j.1600-0854.2006.00462.x; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Finley SD, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-193; Fukino K, 2003, BIOCHEM BIOPH RES CO, V310, P143, DOI 10.1016/j.bbrc.2003.08.134; Gampel A, 2006, BLOOD, V108, P2624, DOI 10.1182/blood-2005-12-007484; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gevertz JL, 2006, J THEOR BIOL, V243, P517, DOI 10.1016/j.jtbi.2006.07.002; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; Grayson WL, 2004, BIOTECHNOL PROGR, V20, P905, DOI 10.1021/bp034296z; Helisch A, 2006, ARTERIOSCL THROM VAS, V26, P520, DOI 10.1161/01.ATV.0000202677.55012.a0; Hetheridge C, 2011, BIOCHEM SOC T, V39, P1597, DOI 10.1042/BST20110738; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Hiratsuka S, 2001, CANCER RES, V61, P1207; Huang K, 2001, INT J BIOCHEM CELL B, V33, P315, DOI 10.1016/S1357-2725(01)00019-X; HUDLICKA O, 1985, J EXP BIOL, V115, P215; Hynes RO, 1999, TRENDS BIOCHEM SCI, V24, pM33, DOI 10.1016/S0968-0004(99)01479-6; Imoukhuede PI, 2011, EXP CELL RES, V317, P955, DOI 10.1016/j.yexcr.2010.12.014; Janes KA, 2010, NAT METHODS, V7, P311, DOI [10.1038/nmeth.1442, 10.1038/NMETH.1442]; Jeong JH, 2012, ADV MATER, V24, P58, DOI 10.1002/adma.201103207; Jin X, 2007, J MOL CELL CARDIOL, V43, P292, DOI 10.1016/j.yjmcc.2007.06.002; Jones MC, 2009, TRAFFIC, V10, P754, DOI 10.1111/j.1600-0854.2009.00898.x; Jopling HM, 2011, BIOCHEM BIOPH RES CO, V410, P170, DOI 10.1016/j.bbrc.2011.04.093; Jopling HM, 2009, ARTERIOSCL THROM VAS, V29, P1119, DOI 10.1161/ATVBAHA.109.186239; Kearney JB, 2004, BLOOD, V103, P4527, DOI 10.1182/blood-2003-07-2315; Labrecque L, 2003, MOL BIOL CELL, V14, P334, DOI 10.1091/mbc.E02-07-0379; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Li S, 2002, FASEB J; Liu PS, 1997, P NATL ACAD SCI USA, V94, P13666, DOI 10.1073/pnas.94.25.13666; Lloyd PG, 2003, AM J PHYSIOL-HEART C, V284, pH1668, DOI 10.1152/ajpheart.00743.2002; Mac Gabhann F, 2007, ANN BIOMED ENG, V35, P982, DOI 10.1007/s10439-007-9303-0; Mac Gabhann F, 2007, BIOPHYS CHEM, V128, P125, DOI 10.1016/j.bpc.2007.03.010; Mac Gabhann F, 2010, WIRES SYST BIOL MED, V2, P694, DOI 10.1002/wsbm.92; Mac Gabhann F, 2010, MICROCIRCULATION, V17, P333, DOI 10.1111/j.1549-8719.2010.00034.x; Majid A, 2000, STROKE, V31, P2707, DOI 10.1161/01.STR.31.11.2707; Majka SM, 2003, J CLIN INVEST, V111, P71, DOI 10.1172/JCI200316157; McKinney-Freeman SL, 2002, P NATL ACAD SCI USA, V99, P1341, DOI 10.1073/pnas.032438799; Meyer RD, 2006, J BIOL CHEM, V281, P867, DOI 10.1074/jbc.M506454200; Miljan Erik A, 2002, Sci STKE, V2002, pre15, DOI 10.1126/stke.2002.160.re15; Mitsuda T, 2002, J BIOL CHEM, V277, P11239, DOI 10.1074/jbc.M107756200; Mittar S, 2009, EXP CELL RES, V315, P877, DOI 10.1016/j.yexcr.2008.12.020; Murakami S, 2010, ACTA MED OKAYAMA, V64, P11; Neagoe PE, 2005, J BIOL CHEM, V280, P9904, DOI 10.1074/jbc.M412017200; NICOSIA RF, 1994, AM J PATHOL, V145, P1023; Nielsen JS, 2008, J CELL SCI, V121, P3683, DOI 10.1242/jcs.037507; Nielsen JS, 2009, MICROCIRCULATION, V16, P487, DOI 10.1080/10739680902941737; Niepel M, 2009, CURR OPIN CHEM BIOL, V13, P556, DOI 10.1016/j.cbpa.2009.09.015; Nilsson I, 2010, EMBO J, V29, P1377, DOI 10.1038/emboj.2010.30; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pannu KK, 2001, CYTOMETRY, V45, P250, DOI 10.1002/1097-0320(20011201)45:4<250::AID-CYTO10021>3.0.CO;2-T; Peirce S, 2008, MICROCIRCULATION, V15, P739, DOI 10.1080/10739680802220331; Pilpel Y, 2011, METHODS MOL BIOL, V759, P407, DOI 10.1007/978-1-61779-173-4_23; Prahst C, 2008, J BIOL CHEM, V283, P25110, DOI 10.1074/jbc.C800137200; Quinn PJ, 2010, PROG LIPID RES, V49, P390, DOI 10.1016/j.plipres.2010.05.002; Quitub AA, 2009, IEEE ENG MED BIOL, V28, P14, DOI 10.1109/MEMB.2009.931791; Raghu H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-647; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rose NL, 2003, TRANSPL P, V35, P2455, DOI 10.1016/j.transproceed.2003.08.025; Rush JS, 2012, J BIOL CHEM, V287, P712, DOI 10.1074/jbc.M111.294470; Sawano A, 1996, CELL GROWTH DIFFER, V7, P213; Sawano A, 2001, BLOOD, V97, P785, DOI 10.1182/blood.V97.3.785; Scholz D, 2002, J MOL CELL CARDIOL, V34, P775, DOI 10.1006/jmcc.2002.2013; SEETHARAM L, 1995, ONCOGENE, V10, P135; Semenza GL, 2004, J APPL PHYSIOL, V96, P1173, DOI 10.1152/japplphysiol.00770.2003; Shibuya Masaubmi, 2006, Angiogenesis, V9, P225, DOI 10.1007/s10456-006-9055-8; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Smalley KSM, 2006, IN VITRO CELL DEV-AN, V42, P242; Sonveaux P, 2004, CIRC RES, V95, P154, DOI 10.1161/01.RES.0000136344.27825.72; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stefanini MO, 2010, CANCER RES, V70, P9886, DOI 10.1158/0008-5472.CAN-10-1419; Stefanini MO, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000622; Stefanini MO, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-77; Sugimori H, 2004, BRAIN RES PROTOC, V13, P189, DOI 10.1016/j.brainresprot.2004.06.001; Sundberg C, 2009, AM J PATHOL, V175, P171, DOI 10.2353/ajpath.2009.080769; Takahashi T, 1997, ONCOGENE, V14, P2079, DOI 10.1038/sj.onc.1201047; VAISMAN N, 1990, J BIOL CHEM, V265, P19461; van Beijnum JR, 2008, NAT PROTOC, V3, P1085, DOI 10.1038/nprot.2008.71; VILLASCHI S, 1994, LAB INVEST, V71, P291; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Wang LL, 2006, CYTOM PART B-CLIN CY, V70B, P410, DOI 10.1002/cyto.b.20140; Wu FTH, 2010, AM J PHYSIOL-HEART C, V298, pH2174, DOI 10.1152/ajpheart.00365.2009; Wu FTH, 2009, METHOD ENZYMOL, V467, P461, DOI 10.1016/S0076-6879(09)67018-X; Wu FTH, 2009, PHYSIOL GENOMICS, V38, P29, DOI 10.1152/physiolgenomics.00031.2009; Wu FTH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005108; Zajchowski LD, 2002, EUR J BIOCHEM, V269, P737, DOI 10.1046/j.0014-2956.2001.02715.x; Zhang Z, 2010, CELL DEATH DIFFER, V17, P499, DOI 10.1038/cdd.2009.152	120	40	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44791	10.1371/journal.pone.0044791	http://dx.doi.org/10.1371/journal.pone.0044791			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984559	Green Published, Green Submitted, gold			2022-12-27	WOS:000308738500085
J	Saifudeen, Z; Liu, J; Dipp, S; Yao, X; Li, YW; McLaughlin, N; Aboudehen, K; El-Dahr, SS				Saifudeen, Zubaida; Liu, Jiao; Dipp, Susana; Yao, Xiao; Li, Yuwen; McLaughlin, Nathaniel; Aboudehen, Karam; El-Dahr, Samir S.			A p53-Pax2 Pathway in Kidney Development: Implications for Nephrogenesis	PLOS ONE			English	Article							TUMOR-SUPPRESSOR P53; NEPHRON PROGENITOR POPULATION; DEVELOPING MOUSE KIDNEY; GENE-EXPRESSION; MAMMALIAN KIDNEY; CELL-SURVIVAL; TRANSCRIPTIONAL ACTIVATION; BRANCHING MORPHOGENESIS; INTERMEDIATE MESODERM; EMBRYONIC KIDNEY	Congenital reduction in nephron number (renal hypoplasia) is a predisposing factor for chronic kidney disease and hypertension. Despite identification of specific genes and pathways in nephrogenesis, determinants of final nephron endowment are poorly understood. Here, we report that mice with germ-line p53 deletion (p53(-/-)) manifest renal hypoplasia; the phenotype can be recapitulated by conditional deletion of p53 from renal progenitors in the cap mesenchyme (CMp53-/-). Mice or humans with germ-line heterozygous mutations in Pax2 exhibit renal hypoplasia. Since both transcription factors are developmentally expressed in the metanephros, we tested the hypothesis that p53 and Pax2 cooperate in nephrogenesis. In this study, we provide evidence for the presence of genetic epistasis between p53 and Pax2: a) p53(-/-) and CMp53-/- embryos express lower Pax2 mRNA and protein in nephron progenitors than their wild-type littermates; b) ChIP-Seq identified peaks of p53 occupancy in chromatin regions of the Pax2 promoter and gene in embryonic kidneys; c) p53 binding to Pax2 gene is significantly more enriched in Pax2 -expressing than non-expressing metanephric mesenchyme cells; d) in transient transfection assays, Pax2 promoter activity is stimulated by wild-type p53 and inhibited by a dominant negative mutant p53; e) p53 knockdown in cultured metanephric mesenchyme cells down-regulates endogenous Pax2 expression; f) reduction of p53 gene dosage worsens the renal hypoplasia in Pax2(+/-) mice. Bioinformatics identified a set of developmental renal genes likely to be co-regulated by p53 and Pax2. We propose that the cross-talk between p53 and Pax2 provides a transcriptional platform that promotes nephrogenesis, thus contributing to nephron endowment.	[Saifudeen, Zubaida; Liu, Jiao; Dipp, Susana; Yao, Xiao; Li, Yuwen; McLaughlin, Nathaniel; Aboudehen, Karam; El-Dahr, Samir S.] Tulane Univ, Hlth Sci Ctr, Dept Pediat, Sect Pediat Nephrol, New Orleans, LA 70118 USA; [Saifudeen, Zubaida; Liu, Jiao; El-Dahr, Samir S.] Tulane Univ, Hlth Sci Ctr, Hypertens & Renal Ctr Excellence, New Orleans, LA 70118 USA	Tulane University; Tulane University	Saifudeen, Z (corresponding author), Tulane Univ, Hlth Sci Ctr, Dept Pediat, Sect Pediat Nephrol, New Orleans, LA 70118 USA.	zubisaif@tulane.edu	li, yuwen/HGU-6435-2022; Li, yu/HHZ-5236-2022	aboudehen, karam/0000-0003-4975-464X	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK62550]; National Institutes of Health National Center for Research Resources (NIH-NCRR) Center of Biomedical Research Excellence [P20RR017659]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017659] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health National Center for Research Resources (NIH-NCRR) Center of Biomedical Research Excellence; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant R01DK62550 to SED and by National Institutes of Health National Center for Research Resources (NIH-NCRR) Center of Biomedical Research Excellence grant support P20RR017659 to ZS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboudehen K, 2012, AM J PHYSIOL-RENAL, V302, pF928, DOI 10.1152/ajprenal.00642.2011; Almog N, 1997, BBA-REV CANCER, V1333, pF1, DOI 10.1016/S0304-419X(97)00012-7; Armata HL, 2010, MOL CELL BIOL, V30, P5787, DOI 10.1128/MCB.00347-10; Baatout S, 2002, IN VIVO, V16, P215; Bouchard M, 2000, DEVELOPMENT, V127, P3703; Bouchard M, 2002, GENE DEV, V16, P2958, DOI 10.1101/gad.240102; Bouchard M, 2005, DEVELOPMENT, V132, P2633, DOI 10.1242/dev.01833; Boyle S, 2008, DEV BIOL, V313, P234, DOI 10.1016/j.ydbio.2007.10.014; Boyle SC, 2011, DEVELOPMENT, V138, P4245, DOI 10.1242/dev.070433; Brodbeck S, 2004, PEDIATR NEPHROL, V19, P249, DOI 10.1007/s00467-003-1374-z; Brophy PD, 2001, DEVELOPMENT, V128, P4747; Chen SW, 2011, J BIOL CHEM, V286, P32775, DOI 10.1074/jbc.M111.248278; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; Choi J, 1999, CELL MOL LIFE SCI, V55, P38, DOI 10.1007/s000180050268; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Clark P, 2004, J AM SOC NEPHROL, V15, P299, DOI 10.1097/01.ASN.0000111248.23454.19; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; Dermitzakis ET, 2005, NAT REV GENET, V6, P151, DOI 10.1038/nrg1527; DRESSLER GR, 1992, P NATL ACAD SCI USA, V89, P1179, DOI 10.1073/pnas.89.4.1179; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gong KQ, 2007, MOL CELL BIOL, V27, P7661, DOI 10.1128/MCB.00465-07; Grieshammer U, 2005, DEVELOPMENT, V132, P3847, DOI 10.1242/dev.01944; Hilliard S, 2011, DEV BIOL, V353, P354, DOI 10.1016/j.ydbio.2011.03.017; HOEVER M, 1994, ONCOGENE, V9, P109; HOLLANDER MC, 1993, J BIOL CHEM, V268, P24385; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Ikeda S, 1999, INVEST OPHTH VIS SCI, V40, P1874; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Karner CM, 2011, DEVELOPMENT, V138, P1247, DOI 10.1242/dev.057646; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; LUNA RMD, 1995, NATURE, V378, P203; Mah SP, 2000, DEV BIOL, V223, P38, DOI 10.1006/dbio.2000.9738; Molchadsky A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003707; Morris GF, 1996, P NATL ACAD SCI USA, V93, P895, DOI 10.1073/pnas.93.2.895; Mugford JW, 2009, DEV BIOL, V333, P312, DOI 10.1016/j.ydbio.2009.06.043; Mugford JW, 2008, DEV BIOL, V324, P88, DOI 10.1016/j.ydbio.2008.09.010; Muratovska A, 2003, ONCOGENE, V22, P7989, DOI 10.1038/sj.onc.1206766; Naim E, 2005, KIDNEY INT, V68, P955, DOI 10.1111/j.1523-1755.2005.00489.x; Narlis M, 2007, J AM SOC NEPHROL, V18, P1121, DOI 10.1681/ASN.2006070739; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Park D, 2006, DEVELOPMENT, V133, P4193, DOI 10.1242/dev.02614; Patel SR, 2004, DEV BIOL, V267, P505, DOI 10.1016/j.ydbio.2003.11.002; Perantoni AO, 2005, DEVELOPMENT, V132, P3859, DOI 10.1242/dev.01945; Pfeffer PL, 2002, DEVELOPMENT, V129, P307; Poladia DP, 2006, DEV BIOL, V291, P325, DOI 10.1016/j.ydbio.2005.12.034; Porteous S, 2000, HUM MOL GENET, V9, P1, DOI 10.1093/hmg/9.1.1; Qin QY, 2009, J NEUROSCI, V29, P5183, DOI 10.1523/JNEUROSCI.0420-09.2009; Reidy KJ, 2009, SEMIN NEPHROL, V29, P321, DOI 10.1016/j.semnephrol.2009.03.009; ROTHENPIELER UW, 1993, DEVELOPMENT, V119, P711; ROTTER V, 1993, P NATL ACAD SCI USA, V90, P9075, DOI 10.1073/pnas.90.19.9075; SAH VP, 1995, NAT GENET, V10, P175, DOI 10.1038/ng0695-175; Saifudeen Z, 2005, J BIOL CHEM, V280, P23094, DOI 10.1074/jbc.M414575200; Saifudeen Z, 2005, AM J PHYSIOL-RENAL, V288, pF899, DOI 10.1152/ajprenal.00370.2004; Saifudeen Z, 2002, J CLIN INVEST, V109, P1021, DOI 10.1172/JCI200213972; Saifudeen Z, 2000, J BIOL CHEM, V275, P15557, DOI 10.1074/jbc.M909810199; Saifudeen Z, 2009, J AM SOC NEPHROL, V20, P2328, DOI 10.1681/ASN.2008121224; SANYANUSIN P, 1995, NAT GENET, V9, P358, DOI 10.1038/ng0495-358; Sasai N, 2008, CELL, V133, P878, DOI 10.1016/j.cell.2008.03.035; SCHMID P, 1991, DEVELOPMENT, V113, P857; Schwarz M, 2000, DEVELOPMENT, V127, P4325; Sims-Lucas S, 2011, DEV DYNAM, V240, P240, DOI 10.1002/dvdy.22501; Sorenson CM, 2004, J BIOL CHEM, V279, P11368, DOI 10.1074/jbc.M310079200; Stiewe T, 2007, NAT REV CANCER, V7, P165, DOI 10.1038/nrc2072; STUART ET, 1995, EMBO J, V14, P5638, DOI 10.1002/j.1460-2075.1995.tb00251.x; Takebayashi-Suzuki K, 2003, DEVELOPMENT, V130, P3929, DOI 10.1242/dev.00615; Teodoro JG, 2006, SCIENCE, V313, P968, DOI 10.1126/science.1126391; Thornborrow EC, 1999, J BIOL CHEM, V274, P33747, DOI 10.1074/jbc.274.47.33747; Torban E, 2006, J BIOL CHEM, V281, P12705, DOI 10.1074/jbc.M513181200; Torres M, 1995, DEVELOPMENT, V121, P4057; Torres MA, 1996, DEVELOPMENT, V122, P3381; Valerius M. Todd, 2002, Mechanisms of Development, V112, P219, DOI 10.1016/S0925-4773(02)00008-4; Wallingford JB, 1997, CURR BIOL, V7, P747, DOI 10.1016/S0960-9822(06)00333-2; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; ZAUBERMAN A, 1995, NUCLEIC ACIDS RES, V23, P2584, DOI 10.1093/nar/23.14.2584; Zhang LL, 2000, CANCER RES, V60, P3655; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao TBA, 2010, TRENDS CELL BIOL, V20, P170, DOI 10.1016/j.tcb.2009.12.004; Zhao Z, 2010, GENE DEV, V24, P1389, DOI 10.1101/gad.1940710	81	31	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44869	10.1371/journal.pone.0044869	http://dx.doi.org/10.1371/journal.pone.0044869			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984579	Green Published, Green Submitted, gold			2022-12-27	WOS:000308738500093
J	Zhou, T; Zhang, W; Sweiss, NJ; Chen, ES; Moller, DR; Knox, KS; Ma, SF; Wade, MS; Noth, I; Machado, RF; Garcia, JGN				Zhou, Tong; Zhang, Wei; Sweiss, Nadera J.; Chen, Edward S.; Moller, David R.; Knox, Kenneth S.; Ma, Shwu-Fan; Wade, Michael S.; Noth, Imre; Machado, Roberto F.; Garcia, Joe G. N.			Peripheral Blood Gene Expression as a Novel Genomic Biomarker in Complicated Sarcoidosis	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; IDIOPATHIC PULMONARY-FIBROSIS; C CHEMOKINE RECEPTOR-2; MEDICAL PROGRESS; RISK-FACTOR; ACE GENE; POLYMORPHISMS; ASSOCIATION; CANCER; INJURY	Sarcoidosis, a systemic granulomatous syndrome invariably affecting the lung, typically spontaneously remits but in similar to 20% of cases progresses with severe lung dysfunction or cardiac and neurologic involvement (complicated sarcoidosis). Unfortunately, current biomarkers fail to distinguish patients with remitting (uncomplicated) sarcoidosis from other fibrotic lung disorders, and fail to identify individuals at risk for complicated sarcoidosis. We utilized genome-wide peripheral blood gene expression analysis to identify a 20-gene sarcoidosis biomarker signature distinguishing sarcoidosis (n = 39) from healthy controls (n = 35, 86% classification accuracy) and which served as a molecular signature for complicated sarcoidosis (n = 17). As aberrancies in T cell receptor (TCR) signaling, JAK-STAT (JS) signaling, and cytokine-cytokine receptor (CCR) signaling are implicated in sarcoidosis pathogenesis, a 31-gene signature comprised of T cell signaling pathway genes associated with sarcoidosis (TCR/JS/CCR) was compared to the unbiased 20-gene biomarker signature but proved inferior in prediction accuracy in distinguishing complicated from uncomplicated sarcoidosis. Additional validation strategies included significant association of single nucleotide polymorphisms (SNPs) in signature genes with sarcoidosis susceptibility and severity (unbiased signature genes -CX3CR1, FKBP1A, NOG, RBM12B, SENS3, TSHZ2; T cell/JAK-STAT pathway genes such as AKT3, CBLB, DLG1, IFNG, IL2RA, IL7R, ITK, JUN, MALT1, NFATC2, PLCG1, SPRED1). In summary, this validated peripheral blood molecular gene signature appears to be a valuable biomarker in identifying cases with sarcoidoisis and predicting risk for complicated sarcoidosis.	[Zhou, Tong; Wade, Michael S.; Machado, Roberto F.; Garcia, Joe G. N.] Univ Illinois, Inst Personalized Resp Med, Chicago, IL USA; [Zhou, Tong; Wade, Michael S.; Machado, Roberto F.; Garcia, Joe G. N.] Univ Illinois, Dept Med, Sect Pulm Crit Care Sleep & Allergy, Chicago, IL USA; [Zhang, Wei] Univ Illinois, Inst Human Genet, Chicago, IL USA; [Zhang, Wei] Univ Illinois, Dept Pediat, Chicago, IL USA; [Sweiss, Nadera J.] Univ Illinois, Dept Med, Rheumatol Sect, Chicago, IL USA; [Chen, Edward S.; Moller, David R.] Johns Hopkins Univ, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD USA; [Knox, Kenneth S.] Univ Arizona, Dept Med, Sect Pulm & Crit Care, Tucson, AZ USA; [Ma, Shwu-Fan; Noth, Imre] Univ Chicago, Dept Med, Sect Pulm Crit Care, Chicago, IL 60637 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Johns Hopkins University; University of Arizona; University of Chicago	Zhou, T (corresponding author), Univ Illinois, Inst Personalized Resp Med, Chicago, IL USA.	jggarcia@uic.edu		Machado, Roberto/0000-0002-3722-5954; Sweiss, Nadera/0000-0003-2215-0221	National Institutes of Health [NHLBI HL58094, R01HL112051, HL68019, HL83870, U01 HL105371-01, RC2 HL101740-01, NHLBI K23HL098454]; Johns Hopkins Sarcoidosis gene bank/database; Hospital for the Consumptives of Maryland (Eudowood); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105371, RC2HL101740, R01HL068019, R01HL083870] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins Sarcoidosis gene bank/database; Hospital for the Consumptives of Maryland (Eudowood); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health grants: NHLBI HL58094 (JGNG), R01HL112051 (WZ), HL68019 (DRM), HL83870 (DRM), U01 HL105371-01 (JGNG), RC2 HL101740-01 (JGNG), NHLBI K23HL098454 (RM). This work was also supported by the Johns Hopkins Sarcoidosis gene bank/database and the Hospital for the Consumptives of Maryland (Eudowood). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahoshi M, 2004, HUM GENET, V114, P503, DOI 10.1007/s00439-004-1099-5; Antoniou KM, 2006, CHEST, V130, P982, DOI 10.1378/chest.130.4.982; Arbustini E, 1996, AM J RESP CRIT CARE, V153, P851, DOI 10.1164/ajrccm.153.2.8564143; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BESNER G, 1990, CELL REGUL, V1, P811, DOI 10.1091/mbc.1.11.811; Bombieri C, 2000, EUR J HUM GENET, V8, P717, DOI 10.1038/sj.ejhg.5200524; BREWERTON DA, 1977, CLIN EXP IMMUNOL, V27, P227; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Duan S, 2008, AM J HUM GENET, V82, P1101, DOI 10.1016/j.ajhg.2008.03.006; Furuya K, 1996, THORAX, V51, P777, DOI 10.1136/thx.51.8.777; Grunewald J, 2004, AM J RESP CRIT CARE, V169, P696, DOI 10.1164/rccm.200303-459OC; Grunewald Johan, 2007, Proc Am Thorac Soc, V4, P461, DOI 10.1513/pats.200606-130MS; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; HIGASHIYAMA S, 1993, J CELL BIOL, V122, P933, DOI 10.1083/jcb.122.4.933; HOMMA T, 1995, J CLIN INVEST, V96, P1018, DOI 10.1172/JCI118087; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hunninghake GW, 1999, AM J RESP CRIT CARE, V160, P736; Hutyrova B, 2002, AM J RESP CRIT CARE, V165, P148, DOI 10.1164/ajrccm.165.2.2106004; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Iannuzzi Michael C, 2007, Proc Am Thorac Soc, V4, P108, DOI 10.1513/pats.200607-141JG; ITO N, 1994, BIOCHEM BIOPH RES CO, V198, P25, DOI 10.1006/bbrc.1994.1004; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; KATARIA YP, 1976, ANN NY ACAD SCI, V278, P69, DOI 10.1111/j.1749-6632.1976.tb47017.x; Kelly DM, 2005, AM J RESP CRIT CARE, V172, P1299, DOI 10.1164/rccm.200411-1594OC; KISO S, 1995, HEPATOLOGY, V22, P1584, DOI 10.1016/0270-9139(95)90168-X; Koth LL, 2011, AM J RESP CRIT CARE, V184, P1153, DOI 10.1164/rccm.201106-1143OC; Kruit A, 2006, CHEST, V129, P1584, DOI 10.1378/chest.129.6.1584; Lockstone HE, 2010, AM J RESP CRIT CARE, V181, P1367, DOI 10.1164/rccm.200912-1855OC; Maliarik MJ, 2000, AM J RESP CELL MOL, V22, P672, DOI 10.1165/ajrcmb.22.6.3745; MARIKOVSKY M, 1993, P NATL ACAD SCI USA, V90, P3889, DOI 10.1073/pnas.90.9.3889; McCarthy DW, 1996, J INVEST DERMATOL, V106, P49, DOI 10.1111/1523-1747.ep12327214; McGrath DS, 2001, AM J RESP CRIT CARE, V164, P197, DOI 10.1164/ajrccm.164.2.2011009; Morgenthau AS, 2011, CHEST, V139, P174, DOI 10.1378/chest.10-0188; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Morohashi K, 2003, CHEST, V123, P1520, DOI 10.1378/chest.123.5.1520; Newman LS, 1997, NEW ENGL J MED, V336, P1224, DOI 10.1056/NEJM199704243361706; Nunes H, 2010, SEMIN RESP CRIT CARE, V31, P428, DOI 10.1055/s-0030-1262211; Pabst S, 2006, CLIN EXP IMMUNOL, V143, P420, DOI 10.1111/j.1365-2249.2006.03008.x; R Development Core Team, 2005, R LANG ENV STAT COMP; Rossman MD, 2003, AM J HUM GENET, V73, P720, DOI 10.1086/378097; Schurmann M, 2002, EUR J HUM GENET, V10, P729, DOI 10.1038/sj.ejhg.5200868; Schurmann M, 2001, AM J RESP CRIT CARE, V164, P840, DOI 10.1164/ajrccm.164.5.2007056; Sharma SM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2855; Spagnolo P, 2003, AM J RESP CRIT CARE, V168, P1162, DOI 10.1164/rccm.200303-456OC; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Sweiss NJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009088; Thuerigen O, 2006, J CLIN ONCOL, V24, P1839, DOI 10.1200/JCO.2005.04.7019; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valentonyte R, 2005, AM J RESP CRIT CARE, V171, P1136, DOI 10.1164/rccm.200405-658OC; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; Vapnik V., 1998, STAT LEARNING THEORY; WILSON SE, 1994, EXP EYE RES, V59, P665, DOI 10.1006/exer.1994.1152; Zajicek JP, 1999, QJM-INT J MED, V92, P103, DOI 10.1093/qjmed/92.2.103; Zhang W, 2008, AM J HUM GENET, V82, P631, DOI 10.1016/j.ajhg.2007.12.015; Zhang XG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-197	58	60	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44818	10.1371/journal.pone.0044818	http://dx.doi.org/10.1371/journal.pone.0044818			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984568	Green Published, gold, Green Submitted			2022-12-27	WOS:000308738500089
J	Chatfield, MWH; Moler, P; Richards-Zawacki, CL				Chatfield, Matthew W. H.; Moler, Paul; Richards-Zawacki, Corinne L.			The Amphibian Chytrid Fungus, Batrachochytrium dendrobatidis, in Fully Aquatic Salamanders from Southeastern North America	PLOS ONE			English	Article							FROG RANA-PIPIENS; CRYPTOBRANCHUS-ALLEGANIENSIS; SIREN-INTERMEDIA; POPULATION CHARACTERISTICS; INFECTIOUS-DISEASE; CHYTRIDIOMYCOSIS; HELLBENDER; PATHOGEN; DECLINES; BIODIVERSITY	Little is known about the impact that the pathogenic amphibian chytrid fungus, Batrachochytrium dendrobatidis (Bd), has on fully aquatic salamander species of the eastern United States. As a first step in determining the impacts of Bd on these species, we aimed to determine the prevalence of Bd in wild populations of fully aquatic salamanders in the genera Amphiuma, Necturus, Pseudobranchus, and Siren. We sampled a total of 98 salamanders, representing nine species from sites in Florida, Mississippi, and Louisiana. Overall, infection prevalence was found to be 0.34, with significant differences among genera but no clear geographic pattern. We also found evidence for seasonal variation, but additional sampling throughout the year is needed to clarify this pattern. The high rate of infection discovered in this study is consistent with studies of other amphibians from the southeastern United States. Coupled with previously published data on life histories and population densities, the results presented here suggest that fully aquatic salamanders may be serving as important vectors of Bd and the interaction between these species and Bd warrants additional research.	[Chatfield, Matthew W. H.; Richards-Zawacki, Corinne L.] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA; [Moler, Paul] Florida Fish & Wildlife Conservat Commiss, Wildlife Res Lab, Gainesville, FL USA	Tulane University; Florida Fish & Wildlife Conservation Commission	Chatfield, MWH (corresponding author), Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA.	mattchat@tulane.edu	Richards-Zawacki, Corinne/F-2731-2011	Richards-Zawacki, Corinne/0000-0002-4212-041X	Tulane University	Tulane University	This study was funded by Tulane University through start-up funds given to C.L.R.-Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bodinof CM, 2011, DIS AQUAT ORGAN, V96, P1, DOI 10.3354/dao02380; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Brannelly LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038473; Briggler Jeffrey T., 2008, Herpetological Review, V39, P443; Briggler Jeffrey T., 2007, Herpetological Review, V38, P174; Burgmeier NG, 2011, J WILDLIFE DIS, V47, P836, DOI 10.7589/0090-3558-47.4.836; Daszak P, 2004, HERPETOL J, V14, P201; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; ETHERIDGE K, 1990, HERPETOLOGICA, V46, P407; Fontenot CL, 2011, HERPETOL CONSERV BIO, V6, P395; Foster RL, 2009, J HERPETOL, V43, P579, DOI 10.1670/08-156.1; Frese PW, 2003, SOUTHWEST NAT, V48, P534, DOI 10.1894/0038-4909(2003)048<0534:PCGASA>2.0.CO;2; Gaertner James P., 2009, Herpetological Review, V40, P184; Garland S, 2010, DIS AQUAT ORGAN, V92, P113, DOI 10.3354/dao02053; GEHLBACH F R, 1978, Southwestern Naturalist, V23, P423, DOI 10.2307/3670250; Gehlbach FR, 1973, SIREN INTERMEDIA; Goka K, 2009, MOL ECOL, V18, P4757, DOI 10.1111/j.1365-294X.2009.04384.x; Gonynor Jessica L., 2011, Herpetological Review, V42, P58; Hampton PM, 2009, J HERPETOL, V43, P704, DOI 10.1670/08-168.1; Harris RN, 2006, ECOHEALTH, V3, P53, DOI 10.1007/s10393-005-0009-1; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; HUTCHISON V H, 1976, Herpetologica, V32, P327; Johnson ML, 2003, DIS AQUAT ORGAN, V57, P255, DOI 10.3354/dao057255; Kinney VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016708; La Marca E, 2005, BIOTROPICA, V37, P190, DOI 10.1111/j.1744-7429.2005.00026.x; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Mendelson JR, 2006, SCIENCE, V313, P48, DOI 10.1126/science.1128396; Murray KA, 2009, CONSERV BIOL, V23, P1242, DOI 10.1111/j.1523-1739.2009.01211.x; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Parris MJ, 2006, CAN J ZOOL, V84, P58, DOI 10.1139/Z05-175; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Pullen KD, 2010, DIS AQUAT ORGAN, V91, P9, DOI 10.3354/dao02249; RENO HW, 1972, COPEIA, P625; Rothermel BB, 2008, DIS AQUAT ORGAN, V82, P3, DOI 10.3354/dao01974; Sheafor B, 2008, J WILDLIFE DIS, V44, P226, DOI 10.7589/0090-3558-44.2.226; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Sorensen K, 2004, SOUTHEAST NAT, V3, P249, DOI 10.1656/1528-7092(2004)003[0249:PCOSLA]2.0.CO;2; SPEARE R, 2000, GLOBAL DISTRIBUTION; Talley Brooke L., 2011, Herpetological Review, V42, P216; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1; Woodhams Douglas C., 2008, Herpetological Review, V39, P66	43	19	24	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44821	10.1371/journal.pone.0044821	http://dx.doi.org/10.1371/journal.pone.0044821			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984569	gold, Green Published			2022-12-27	WOS:000308638700088
J	Herter, DA; Wagner, R; Holderried, F; Fenik, Y; Riessen, R; Weyrich, P; Celebi, N				Herter, Dorothea Adelheid; Wagner, Robert; Holderried, Friederike; Fenik, Yelena; Riessen, Reimer; Weyrich, Peter; Celebi, Nora			Effect of Supervised Students' Involvement on Diagnostic Accuracy in Hospitalized Medical Patients - A Prospective Controlled Study	PLOS ONE			English	Article							EXPERT-NOVICE DIFFERENCES; REASONING STRATEGIES; EMERGENCY-DEPARTMENT; EDUCATION; PHYSICIANS; HISTORY; INTERRUPTIONS; MULTITASKING; EXPERIENCE; FEATURES	Background: During internships most medical students engage in history taking and physical examination during evaluation of hospitalized patients. However, the students' ability for pattern recognition is not as developed as in medical experts and complete history taking is often not repeated by an expert, so important clues may be missed. On the other hand, students' history taking is usually more extensive than experts' history taking and medical students discuss their findings with a Supervisor. Thus the effect of student involvement on diagnostic accuracy is unclear. We therefore compared the diagnostic accuracy for patients in the medical emergency department with and without student involvement in the evaluation process. Methodology/Principal Findings: Patients in the medical emergency department were assigned to evaluation by either a supervised medical student or an emergency department physician. We only included patients who were admitted to our hospital and subsequently cared for by another medical team on the ward. We compared the working diagnosis from the emergency department with the discharge diagnosis. A total of 310 patients included in the study were cared for by 41 medical students and 21 emergency department physicians. The working diagnosis was changed in 22% of the patients evaluated by physicians evaluation and in 10% of the patients evaluated by supervised medical students (p=.006). There was no difference in the expenditures for diagnostic procedures, length of stay in the emergency department or patient comorbidity complexity level. Conclusion/Significance: Involvement of closely supervised medical students in the evaluation process of hospitalized medical patients leads to an improved diagnostic accuracy compared to evaluation by an emergency department physician alone.	[Herter, Dorothea Adelheid; Holderried, Friederike; Fenik, Yelena] Univ Tubingen, Sch Med, Off Dean, Tubingen, Germany; [Wagner, Robert; Weyrich, Peter; Celebi, Nora] Univ Tubingen Hosp, Dept Endocrinol Diabetol Nephrol & Angiol, Tubingen, Germany; [Riessen, Reimer] Med Intens Care Unit, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Herter, DA (corresponding author), Univ Tubingen, Sch Med, Off Dean, Tubingen, Germany.	Nora.Celebi@med.uni-tuebingen.de	Wagner, Robert/B-3689-2012; Riessen, Reimer/AFR-0686-2022	Wagner, Robert/0000-0002-6120-0191; Holderried, Friederike/0000-0003-1828-0920				Alboni P, 2001, J AM COLL CARDIOL, V37, P1921, DOI 10.1016/S0735-1097(01)01241-4; Britton P, 2012, BR J RADIOL; Burley Duncan, 2011, Emerg Nurse, V19, P32; Chisholm CD, 2000, ACAD EMERG MED, V7, P1239, DOI 10.1111/j.1553-2712.2000.tb00469.x; Christ M, 2010, DTSCH ARZTEBL INT, V107, P892, DOI 10.3238/arztebl.2010.0892; Coderre S, 2003, MED EDUC, V37, P695, DOI 10.1046/j.1365-2923.2003.01577.x; Coderre S, 2010, ACAD MED, V85, P1125, DOI 10.1097/ACM.0b013e3181e1b229; Dormann H, 2010, DTSCH ARZTEBL INT, V107, P261, DOI 10.3238/arztebl.2010.0261; Eva KW, 2007, MED EDUC, V41, P1152, DOI 10.1111/j.1365-2923.2007.02923.x; Eva KW, 2010, MED EDUC, V44, P775, DOI 10.1111/j.1365-2923.2010.03705.x; Eva KW, 2010, ACAD MED, V85, P1112, DOI 10.1097/ACM.0b013e3181e16103; Eva KW, 2005, MED EDUC, V39, P98, DOI 10.1111/j.1365-2929.2004.01972.x; Eva KW, 2002, TEACH LEARN MED, V14, P257, DOI 10.1207/S15328015TLM1404_10; HAMPTON JR, 1975, BRIT MED J, V2, P486, DOI 10.1136/bmj.2.5969.486; HASSEBROCK F, 1993, AM J PSYCHOL, V106, P155, DOI 10.2307/1423166; Heuer JF, 2011, EUR J EMERG MED; HOBUS PPM, 1987, MED EDUC, V21, P471, DOI 10.1111/j.1365-2923.1987.tb01405.x; Ilgen JS, 2011, ACAD EMERG MED, V18, pS79, DOI 10.1111/j.1553-2712.2011.01182.x; Kassirer JP, 2010, ACAD MED, V85, P1118, DOI 10.1097/ACM.0b013e3181d5dd0d; Kilminster SM, 2000, MED EDUC, V34, P827, DOI 10.1046/j.1365-2923.2000.00758.x; Kilminster S, 2007, MED TEACH, V29, P2, DOI 10.1080/01421590701210907; Kurdak H, 2008, MED TEACH, V30, P768, DOI 10.1080/01421590802232834; Laxmisan A, 2007, INT J MED INFORM, V76, P801, DOI 10.1016/j.ijmedinf.2006.09.019; Leuppi JD, 2005, SWISS MED WKLY, V135, P520; Nendaz MR, 2006, J GEN INTERN MED, V21, P1302, DOI 10.1111/j.1525-1497.2006.00587.x; Nikendei C, 2009, MED TEACH, V31, P591, DOI 10.1080/01421590902833010; Norman G, 2007, MED EDUC, V41, P1140, DOI 10.1111/j.1365-2923.2007.02914.x; POSES RM, 1990, ARCH INTERN MED, V150, P1874, DOI 10.1001/archinte.150.9.1874; Prideaux D, 2009, MED TEACH, V31, P96, DOI 10.1080/01421590802509157; RICH EC, 1987, ARCH INTERN MED, V147, P1957, DOI 10.1001/archinte.147.11.1957; Rosen MP, 2000, ACAD MED, V75, P1199, DOI 10.1097/00001888-200012000-00017; Scheitel SM, 1996, MAYO CLIN PROC, V71, P1131, DOI 10.4065/71.12.1131; Schwarz MR, 2004, MED TEACH, V26, P215, DOI 10.1080/01421590310001642939; Sood R, 2008, MED TEACH, V30, P585, DOI 10.1080/01421590802139823; Summerton N, 2008, BRIT J GEN PRACT, V58, P273, DOI 10.3399/bjgp08X279779; Suzuki Y, 2008, MED TEACH, V30, P846, DOI 10.1080/01421590802298207; Ten Cate O, 2007, MED TEACH, V29, P752, DOI 10.1080/01421590701724741; Weigl M, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-110; Westbrook JI, 2010, QUAL SAF HEALTH CARE, V19, P284, DOI 10.1136/qshc.2009.039255; Weyrich P, 2012, MED KLIN-INTENSIVMED, V107, P67, DOI 10.1007/s00063-011-0075-9	40	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44866	10.1371/journal.pone.0044866	http://dx.doi.org/10.1371/journal.pone.0044866			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984578	gold, Green Submitted, Green Published			2022-12-27	WOS:000308638700094
J	Petroli, CD; Sansaloni, CP; Carling, J; Steane, DA; Vaillancourt, RE; Myburg, AA; da Silva, OB; Pappas, GJ; Kilian, A; Grattapaglia, D				Petroli, Cesar D.; Sansaloni, Carolina P.; Carling, Jason; Steane, Dorothy A.; Vaillancourt, Rene E.; Myburg, Alexander A.; da Silva, Orzenil Bonfim, Jr.; Pappas, Georgios Joannis, Jr.; Kilian, Andrzej; Grattapaglia, Dario			Genomic Characterization of DArT Markers Based on High-Density Linkage Analysis and Physical Mapping to the Eucalyptus Genome	PLOS ONE			English	Article							ARRAYS TECHNOLOGY DART; DIVERSITY ARRAYS; HIGH-THROUGHPUT; PSEUDO-BACKCROSS; GENETIC-MAP; GRANDIS; GLOBULUS; RAPD; RFLP; AFLP	Diversity Arrays Technology (DArT) provides a robust, high throughput, cost-effective method to query thousands of sequence polymorphisms in a single assay. Despite the extensive use of this genotyping platform for numerous plant species, little is known regarding the sequence attributes and genome-wide distribution of DArT markers. We investigated the genomic properties of the 7,680 DArT marker probes of a Eucalyptus array, by sequencing them, constructing a high density linkage map and carrying out detailed physical mapping analyses to the Eucalyptus grandis reference genome. A consensus linkage map with 2,274 DArT markers anchored to 210 microsatellites and a framework map, with improved support for ordering, displayed extensive collinearity with the genome sequence. Only 1.4 Mbp of the 75 Mbp of still unplaced scaffold sequence was captured by 45 linkage mapped but physically unaligned markers to the 11 main Eucalyptus pseudochromosomes, providing compelling evidence for the quality and completeness of the current Eucalyptus genome assembly. A highly significant correspondence was found between the locations of DArT markers and predicted gene models, while most of the 89 DArT probes unaligned to the genome correspond to sequences likely absent in E. grandis, consistent with the pan-genomic feature of this multi-Eucalyptus species DArT array. These comprehensive linkage-to-physical mapping analyses provide novel data regarding the genomic attributes of DArT markers in plant genomes in general and for Eucalyptus in particular. DArT markers preferentially target the gene space and display a largely homogeneous distribution across the genome, thereby providing superb coverage for mapping and genome-wide applications in breeding and diversity studies. Data reported on these ubiquitous properties of DArT markers will be particularly valuable to researchers working on less-studied crop species who already count on DArT genotyping arrays but for which no reference genome is yet available to allow such detailed characterization.	[Petroli, Cesar D.; Sansaloni, Carolina P.; da Silva, Orzenil Bonfim, Jr.; Pappas, Georgios Joannis, Jr.; Grattapaglia, Dario] EMBRAPA Genet Resources & Biotechnol, Plant Genet Lab, Brasilia, DF, Brazil; [Petroli, Cesar D.; Sansaloni, Carolina P.; Grattapaglia, Dario] Univ Brasilia, Dept Cell Biol, Brasilia, DF, Brazil; [Carling, Jason; Kilian, Andrzej] Div Arrays Technology Pty Ltd, Yarralumla, Russia; [Steane, Dorothy A.; Vaillancourt, Rene E.] Univ Tasmania, Sch Plant Sci, Hobart, Tas, Australia; [Steane, Dorothy A.; Vaillancourt, Rene E.] Univ Tasmania, CRC Forestry, Hobart, Tas, Australia; [Steane, Dorothy A.] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn ML12, Maroochydore, Qld, Australia; [Myburg, Alexander A.] Univ Pretoria, Forestry & Agr Biotechnol Inst, Dept Genet, ZA-0002 Pretoria, South Africa; [Grattapaglia, Dario] Univ Catolica Brasilia, Genom Sci Program, Brasilia, DF, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Brasilia; University of Tasmania; University of Tasmania; University of the Sunshine Coast; University of Pretoria; Universidade Catolica de Brasilia	Petroli, CD (corresponding author), EMBRAPA Genet Resources & Biotechnol, Plant Genet Lab, Brasilia, DF, Brazil.	dario.grattapaglia@embrapa.br	Vaillancourt, Rene E/J-7456-2014; Grattapaglia, Dario/B-5864-2014; Silva-Junior, Orzenil/B-3488-2013; Vaillancourt, Rene E/C-6123-2013; Grattapaglia, Dario/AAB-6805-2020; Steane, Dorothy/N-9940-2013; Myburg, Alexander A/C-5426-2008; Pappas, Georgios J/D-5933-2016; Pappas, Georgios J./N-8071-2019	Vaillancourt, Rene E/0000-0002-1159-9149; Grattapaglia, Dario/0000-0002-0050-970X; Silva-Junior, Orzenil/0000-0002-2104-2010; Vaillancourt, Rene E/0000-0002-1159-9149; Grattapaglia, Dario/0000-0002-0050-970X; Myburg, Alexander A/0000-0003-0644-5003; Pappas, Georgios J/0000-0002-1100-976X; Pappas, Georgios J./0000-0002-1100-976X; Kilian, Andrzej/0000-0002-2730-7462; Steane, Dorothy/0000-0002-8061-8454	Brazilian Ministry of Science and Technology (CNPq) [559245/2008-4, 560831/2008-0]; PRONEX FAP-DF Project Grant [193.000.570/2009]; CAPES (Brazilian Ministry of Education); CNPq	Brazilian Ministry of Science and Technology (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PRONEX FAP-DF Project Grant; CAPES (Brazilian Ministry of Education)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The project was supported by the Brazilian Ministry of Science and Technology (CNPq Project Grants 559245/2008-4 and 560831/2008-0) and PRONEX FAP-DF Project Grant "NEXTREE" 193.000.570/2009 to DG. This study was carried out as part of Cesar Petroli's doctoral thesis at the University of Brasilia. CPS and CDP had doctoral fellowships from CAPES (Brazilian Ministry of Education) and DG a productivity research fellowship from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Bartos J, 2011, THEOR APPL GENET, V122, P1133, DOI 10.1007/s00122-010-1518-z; Belaj A, 2012, TREE GENET GENOMES, V8, P365, DOI 10.1007/s11295-011-0447-6; Bolibok-Bragoszewska H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-578; Brondani RPV, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-20; Brondani RPV, 2001, BIOTECHNIQUES, V31, P793; Bundock PC, 2000, SILVAE GENET, V49, P223; BYRNE M, 1995, THEOR APPL GENET, V91, P869, DOI 10.1007/BF00223894; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Cheema J, 2009, BRIEF BIOINFORM, V10, P595, DOI 10.1093/bib/bbp045; Drost DR, 2009, PLANT J, V58, P1054, DOI 10.1111/j.1365-313X.2009.03828.x; Drummond A. J., 2012, GENEIOUS V5 6; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Faria DA, 2010, J HERED, V101, P512, DOI 10.1093/jhered/esq024; Faria DA, 2011, TREE GENET GENOMES, V7, P63, DOI 10.1007/s11295-010-0315-9; Freeman JS, 2006, SILVAE GENET, V55, P202, DOI 10.1515/sg-2006-0028; Ganal MW, 2009, CURR OPIN PLANT BIOL, V12, P211, DOI 10.1016/j.pbi.2008.12.009; GRATTAPAGLIA D, 1994, CAN J FOREST RES, V24, P1074, DOI 10.1139/x94-142; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Grattapaglia D, 2008, NEW PHYTOL, V179, P911, DOI 10.1111/j.1469-8137.2008.02503.x; Grattapaglia Dario, 2004, Genet Mol Res, V3, P369; Grattapaglia D, 2012, TREE GENET GENOMES, V8, P463, DOI 10.1007/s11295-012-0491-x; Grattapaglia D, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-65; Hackett CA, 2003, HEREDITY, V90, P33, DOI 10.1038/sj.hdy.6800173; Hippolyte I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-65; Howard EL, 2011, THEOR APPL GENET, V122, P1265, DOI 10.1007/s00122-011-1529-4; Hudson C, 2011, TREE GENET GENOMES, P1; Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25; James KE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001682; Jones N, 2009, NEW PHYTOL, V183, P935, DOI 10.1111/j.1469-8137.2009.02933.x; KEATS BJB, 1991, GENOMICS, V9, P557, DOI 10.1016/0888-7543(91)90426-F; Kilian A, 2009, CAM INTELLECT PROP, P204, DOI 10.1017/CBO9780511581182.016; Kullan ARK, 2012, TREE GENET GENOMES, V8, P163, DOI 10.1007/s11295-011-0430-2; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Mace ES, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-13; Mantovani P, 2008, MOL BREEDING, V22, P629, DOI 10.1007/s11032-008-9205-3; Marques CM, 1998, THEOR APPL GENET, V96, P727, DOI 10.1007/s001220050795; Milczarski P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028495; Morgante M, 2007, CURR OPIN PLANT BIOL, V10, P149, DOI 10.1016/j.pbi.2007.02.001; Myburg AA, 2004, GENETICS, V166, P1405, DOI 10.1534/genetics.166.3.1405; Myburg AA, 2003, THEOR APPL GENET, V107, P1028, DOI 10.1007/s00122-003-1347-4; Neves LG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-189; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Potts BM., 2004, ENCY FOREST SCI, P1480, DOI [10.1016/B0-12-145160-7/00084-3, DOI 10.1016/B0-12-145160-7/00084-3]; Rafalski A, 2004, TRENDS GENET, V20, P103, DOI 10.1016/j.tig.2003.12.002; Reddy UK, 2011, GENOME, V54, P349, DOI [10.1139/G11-001, 10.1139/g11-001]; Resende MDV, 2012, NEW PHYTOL, V194, P116, DOI 10.1111/j.1469-8137.2011.04038.x; Sansaloni CP, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-16; Sansaloni CP, 2011, BMC P S7, V5, P54, DOI [10.1186/1753-6561-5-S7-P54, DOI 10.1186/1753-6561-5-S7-P54]; Schouten HJ, 2012, MOL BREEDING, V29, P645, DOI 10.1007/s11032-011-9579-5; Steane DA, 2011, MOL PHYLOGENET EVOL, V59, P206, DOI 10.1016/j.ympev.2011.02.003; Supriya A, 2011, THEOR APPL GENET, V123, P239, DOI 10.1007/s00122-011-1580-1; TANKSLEY SD, 1989, BIO-TECHNOL, V7, P257, DOI 10.1038/nbt0389-257; Thamarus KA, 2002, THEOR APPL GENET, V104, P379, DOI 10.1007/s001220100717; Tinker NA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-39; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; Van Schalkwyk A, 2012, THEOR APPL GENET, V124, P947, DOI 10.1007/s00122-011-1759-5; Verhaegen D, 1996, GENOME, V39, P1051, DOI 10.1139/g96-132; Vision TJ, 2000, GENETICS, V155, P407; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; Wenzl P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-206; WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/nar/18.22.6531; Wittenberg AHJ, 2005, MOL GENET GENOMICS, V274, P30, DOI 10.1007/s00438-005-1145-6; Xia L, 2005, THEOR APPL GENET, V110, P1092, DOI 10.1007/s00122-005-1937-4; Yang SY, 2011, J GENET, V90, P103, DOI 10.1007/s12041-011-0050-5	69	53	55	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44684	10.1371/journal.pone.0044684	http://dx.doi.org/10.1371/journal.pone.0044684			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984541	Green Published, Green Submitted, gold			2022-12-27	WOS:000308638700076
J	Hu, YC; Li, YP; Lin, HF; Yang, ZH; Cheng, LX				Hu, Yuncui; Li, Yanpeng; Lin, Hongfei; Yang, Zhihao; Cheng, Liangxi			Integrating Various Resources for Gene Name Normalization	PLOS ONE			English	Article							KNOWLEDGE	The recognition and normalization of gene mentions in biomedical literature are crucial steps in biomedical text mining. We present a system for extracting gene names from biomedical literature and normalizing them to gene identifiers in databases. The system consists of four major components: gene name recognition, entity mapping, disambiguation and filtering. The first component is a gene name recognizer based on dictionary matching and semi-supervised learning, which utilizes the co-occurrence information of a large amount of unlabeled MEDLINE abstracts to enhance feature representation of gene named entities. In the stage of entity mapping, we combine the strategies of exact match and approximate match to establish linkage between gene names in the context and the EntrezGene database. For the gene names that map to more than one database identifiers, we develop a disambiguation method based on semantic similarity derived from the Gene Ontology and MEDLINE abstracts. To remove the noise produced in the previous steps, we design a filtering method based on the confidence scores in the dictionary used for NER. The system is able to adjust the trade-off between precision and recall based on the result of filtering. It achieves an F-measure of 83% (precision: 82.5% recall: 83.5%) on BioCreative II Gene Normalization (GN) dataset, which is comparable to the current state-of-the-art.	[Hu, Yuncui; Li, Yanpeng; Lin, Hongfei; Yang, Zhihao] Dalian Univ Technol, Sch Comp Sci & Technol, Dalian, Liaoning, Peoples R China; [Cheng, Liangxi] Dalian Univ Technol, Dept Biomed Engn, Dalian, Liaoning, Peoples R China	Dalian University of Technology; Dalian University of Technology	Hu, YC (corresponding author), Dalian Univ Technol, Sch Comp Sci & Technol, Dalian, Liaoning, Peoples R China.	huyuncui@mail.dlut.edu.cn			Natural Science Foundation of China [60673039, 61070098]; National High Tech Research and Development Plan of China [2006AA01Z151]; Fundamental Research Funds for the Central Universities [DUT10JS09]; Liaoning Province Doctor Startup Fund [20091015]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Tech Research and Development Plan of China(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Liaoning Province Doctor Startup Fund	This work was supported by grant from the Natural Science Foundation of China (No. 60673039 and 61070098)(http://www.nsfc.gov.cn/Portal0/default124.htm), the National High Tech Research and Development Plan of China (No. 2006AA01Z151)(http://www.most.gov.cn/eng/programmes1/200610/t20061009_36225.htm), the Fundamental Research Funds for the Central Universities (No. DUT10JS09) and Liaoning Province Doctor Startup Fund (No. 20091015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando RK, 2007, P 2 BIOCREATIVE CHAL, V23, P101; Carpenter B, 2004, P 13 ANN TEXT RETR C; Cohen AM, 2005, BRIEF BIOINFORM, V6, P57, DOI 10.1093/bib/6.1.57; Cohen AM, 2007, P 2 BIOCREATIVE CHAL, P169; Fang H. R., 2006, P BIONLP WORKSH LINK, P41; Fluck J., 2007, P 2 BIOCREATIVE CHAL, P149; Fundel K, 2007, P 2 BIOCREATIVE CHAL, P153; Ganchev K., 2007, P 2 BIOCREATIVE CHAL, P119; Gonzalez G, 2007, P 2 BIOCREATIVE CHAL, P227; Grover C., 2007, P 2 BIOCREATIVE CHAL, P273; Hakenberg J, 2011, BIOINFORMATICS; Hakenberg J., 2007, P 2 BIOCREATIVE CHAL, P141; Hakenberg J, 2008, BIOINFORMATICS, V24, pI126, DOI 10.1093/bioinformatics/btn299; Hirschman L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S1; Hirschman L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S11; Huang HS, 2007, P 2 BIOCREATIVE CHAL, P109; Huang ML, 2011, BIOINFORMATICS, V27, P1032, DOI 10.1093/bioinformatics/btr042; Klinger R., 2007, P 2 BIOCREATIVE CHAL, P89; Kuo CJ, 2007, P 2 BIOCREATIVE CHAL; Kuo CJ, 2007, P 2 BIOCREATIVE CHAL, P105; Lau W, 2007, P 2 BIOCR CHALL EV W, P165; Li YP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-223; Luong T, 2007, P 2 BIOCREATIVE CHAL, P145; Morgan AA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S3; Nakov P, 2007, P 2 BIOCR CHALL EV W, P297; Neves ML, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-157; Schuemie M.J., 2007, P 2 BIOCREATIVE CHAL, P131; Settles B, 2005, BIOINFORMATICS, V21, P3191, DOI 10.1093/bioinformatics/bti475; Smith L, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-s2-s2, 10.1186/gb-2008-9-S2-S2]; Sparck-Jones K, 2000, INFORM PROCESS MANAG, V36, P779, DOI 10.1016/S0306-4573(00)00015-7; SPARCKJONES K, 1972, J DOC, V28, P11, DOI 10.1108/eb026526; Wermter J, 2009, BIOINFORMATICS, V25, P815, DOI 10.1093/bioinformatics/btp071; Xu H, 2007, BIOINFORMATICS, V23, P1015, DOI 10.1093/bioinformatics/btm056	33	106	113	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43558	10.1371/journal.pone.0043558	http://dx.doi.org/10.1371/journal.pone.0043558			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22384115	Green Published, gold			2022-12-27	WOS:000308738500017
J	Guo, ZL; Liu, S; Hu, SM; Li, T; Huang, YS; Liu, GX; Zhang, H; Lin, SJ				Guo, Zhiling; Liu, Sheng; Hu, Simin; Li, Tao; Huang, Yousong; Liu, Guangxing; Zhang, Huan; Lin, Senjie			Prevalent Ciliate Symbiosis on Copepods: High Genetic Diversity and Wide Distribution Detected Using Small Subunit Ribosomal RNA Gene	PLOS ONE			English	Article							MITOCHONDRIAL CYTOCHROME-B; PFIESTERIA-PISCICIDA; PROTOZOAN EPIBIONTS; PLANKTONIC COPEPODS; EUPHAUSIACEA; PERITRICHIA; ZOOPLANKTON; CRUSTACEANS; CILIOPHORA; PHYLOGENY	Toward understanding the genetic diversity and distribution of copepod-associated symbiotic ciliates and the evolutionary relationships with their hosts in the marine environment, we developed a small subunit ribosomal RNA gene (18S rDNA)based molecular method and investigated the genetic diversity and genotype distribution of the symbiotic ciliates on copepods. Of the 10 copepod species representing six families collected from six locations of Pacific and Atlantic Oceans, 9 were found to harbor ciliate symbionts. Phylogenetic analysis of the 391 ciliate 18S rDNA sequences obtained revealed seven groups (ribogroups), six (containing 99% of all the sequences) belonging to subclass Apostomatida, the other clustered with peritrich ciliate Vorticella gracilis. Among the Apostomatida groups, Group III were essentially identical to Vampyrophrya pelagica, and the other five groups represented the undocumented ciliates that were close to Vampyrophrya/Gymnodinioides/Hyalophysa. Group VI ciliates were found in all copepod species but one (Calanus sinicus), and were most abundant among all ciliate sequences obtained, indicating that they are the dominant symbiotic ciliates universally associated with copepods. In contrast, some ciliate sequences were found only in some of the copepods examined, suggesting the host selectivity and geographic differentiation of ciliates, which requires further verification by more extensive sampling. Our results reveal the wide occurrence and high genetic diversity of symbiotic ciliates on marine copepods and highlight the need to systematically investigate the host- and geography-based genetic differentiation and ecological roles of these ciliates globally.	[Guo, Zhiling; Liu, Sheng; Hu, Simin; Li, Tao] Chinese Acad Sci, Key Lab Marine Bioresources Sustainable Utilizat, S China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China; [Guo, Zhiling; Zhang, Huan; Lin, Senjie] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Lin, Senjie] Xiamen Univ, Marine Biodivers & Global Change Lab, Xiamen, Fujian, Peoples R China; [Huang, Yousong; Liu, Guangxing; Zhang, Huan] Ocean Univ China, Dept Environm Sci, Qingdao, Shandong, Peoples R China	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; University of Connecticut; Xiamen University; Ocean University of China	Guo, ZL (corresponding author), Chinese Acad Sci, Key Lab Marine Bioresources Sustainable Utilizat, S China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China.	huan.zhang@uconn.edu; senjie.lin@uconn.edu	Guo, chentao/G-7320-2016; zhang, yaqun/J-8478-2014; Guo, Zhiling/AAJ-6843-2020; Lin, Senjie/A-7466-2011; Gong, Qiyong/W-3052-2019; Luo, Cheng/A-4647-2015	Guo, Zhiling/0000-0001-9549-2164; Gong, Qiyong/0000-0002-5912-4871; Luo, Cheng/0000-0003-0524-5886; Yao, Dezhong/0000-0002-8042-879X; Li, Qifu/0000-0003-3904-410X; Lei, Xu/0000-0003-2271-1287	Key Topics in Innovation Engineering [KZCX2-YW-JS206]; National Science Foundation of China-Overseas Collaboration Fund [41129001, 40828006]; National Science Foundation of China [41076085, 41006067, 41076096, U1033003]; National Science Foundation grant [EF-0629624]	Key Topics in Innovation Engineering; National Science Foundation of China-Overseas Collaboration Fund; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation grant(National Science Foundation (NSF))	The study was supported by Key Topics in Innovation Engineering (No. KZCX2-YW-JS206) (http://www.cas.cn/), National Science Foundation of China-Overseas Collaboration Fund (41129001, 40828006) (http://www.nsfc.gov.cn/), the National Science Foundation of China (41076085, 41006067, 41076096, U1033003) (http://www.nsfc.gov.cn/), and National Science Foundation grant EF-0629624. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSON L, 1991, SYST PARASITOL, V18, P147, DOI 10.1007/BF00017668; Bozkurt A, 2009, CRUSTACEANA, V82, P515, DOI 10.1163/156854009X407687; BRADBURY PC, 1973, J PROTOZOOL, V20, P210, DOI 10.1111/j.1550-7408.1973.tb00865.x; Bradbury Phyllis C., 1994, P139; Brate J, 2010, ISME J, V4, P1144, DOI 10.1038/ismej.2010.39; Carman KR, 1997, MICROSC RES TECHNIQ, V37, P116, DOI 10.1002/(SICI)1097-0029(19970415)37:2<116::AID-JEMT2>3.0.CO;2-M; Chatton E., 1935, Archives de Zoologie Experimentale et Generale Paris, V77, P1; Chen Q.C., 1965, CALANOIDAVOL, P20; Cheung MK, 2010, ISME J, V4, P1053, DOI 10.1038/ismej.2010.26; Clamp John C., 2008, Denisia, V23, P395; Doherty M, 2010, APPL ENVIRON MICROB, V76, P3924, DOI 10.1128/AEM.01604-09; Fernandez-Leborans G, 2000, CRUSTACEANA, V73, P643, DOI 10.1163/156854000504705; Fernandez-Leborans G, 2000, CRUSTACEANA, V73, P1205, DOI 10.1163/156854000505209; Fernandez-Leborans G, 2006, J NAT HIST, V40, P1983, DOI 10.1080/00222930601010861; Gerber R. P, 2000, IDENTIFICATION MAN 1; Gerber RP, 2000, IDENTIFICATION MAN 2; Gomez-Gutierrez J, 2010, DIS AQUAT ORGAN, V88, P249, DOI 10.3354/dao02155; GRIMES BH, 1992, J PROTOZOOL, V39, P65, DOI 10.1111/j.1550-7408.1992.tb01285.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HENEBRY MS, 1979, T AM MICROSC SOC, V98, P495, DOI 10.2307/3225899; HOCKIN DC, 1984, CRUSTACEANA, V46, P319, DOI 10.1163/156854084X00261; Ismar SMH, 2008, MAR BIOL, V154, P335, DOI 10.1007/s00227-008-0928-9; Jayasree L, 2001, J NAT HIST, V35, P157, DOI 10.1080/00222930150215297; Landers SC, 2010, EUR J PROTISTOL, V46, P171, DOI 10.1016/j.ejop.2010.03.001; Lin SJ, 2006, J PLANKTON RES, V28, P667, DOI 10.1093/plankt/fbi150; LINDLEY JA, 1978, MAR BIOL, V46, P131, DOI 10.1007/BF00391528; Liu Sheng, 2010, Acta Ecologica Sinica, V30, P22; Lynn D.H, 2008, CIL PROT CHAR CLASS, V3rd ed.; Lynn DH, 2005, J EUKARYOT MICROBIOL, V52, p7S; Morado J. Frank, 1995, Reviews in Fisheries Science, V3, P275; NAGASAWA S, 1988, HYDROBIOLOGIA, V167, P255, DOI 10.1007/BF00026312; Ohtsuka S, 2004, MAR ECOL PROG SER, V282, P129, DOI 10.3354/meps282129; Ohtsuka Susumu, 2011, V15, P1; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; PRESCOTT DM, 1994, MICROBIOL REV, V58, P233, DOI 10.1128/MMBR.58.2.233-267.1994; Qiu DJ, 2010, APPL ENVIRON MICROB, V76, P5639, DOI 10.1128/AEM.03009-09; Regali-Seleghim MH, 2004, J PLANKTON RES, V26, P501, DOI 10.1093/plankt/fbh055; Silva-Briano M, 2011, J LIMNOL, V70, P329, DOI 10.4081/jlimnol.2011.329; Struder-Kypke MC, 2010, SYST BIODIVERS, V8, P131, DOI 10.1080/14772000903507744; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner JT, 2004, ZOOL STUD, V43, P255; Utermohl H, 1958, MITT INT VER LIMNOL, V9, P1; VALBONESI A, 1988, B ZOOL, V55, P179; Visse Marko, 2007, Proceedings of the Estonian Academy of Sciences Biology Ecology, V56, P173; Wahl M, 1997, HYDROBIOLOGIA, V355, P49, DOI 10.1023/A:1003054802699; Walkusz W, 2007, OCEANOLOGIA, V49, P369; WEISSMAN P, 1993, LIMNOL OCEANOGR, V38, P613, DOI 10.4319/lo.1993.38.3.0613; XU ZK, 1991, HYDROBIOLOGIA, V209, P183, DOI 10.1007/BF00015341; Zhang H, 2005, J PHYCOL, V41, P411, DOI 10.1111/j.1529-8817.2005.04168.x; Zhang H, 2002, APPL ENVIRON MICROB, V68, P989, DOI 10.1128/AEM.68.2.989-994.2002	50	105	106	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44847	10.1371/journal.pone.0044847	http://dx.doi.org/10.1371/journal.pone.0044847			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024768	Green Submitted, Green Published, gold			2022-12-27	WOS:000308860100026
J	Luo, C; Qiu, C; Guo, ZW; Fang, JJ; Li, QF; Lei, X; Xia, Y; Lai, YX; Gong, QY; Zhou, D; Yao, DZ				Luo, Cheng; Qiu, Chuan; Guo, Zhiwei; Fang, Jiajia; Li, Qifu; Lei, Xu; Xia, Yang; Lai, Yongxiu; Gong, Qiyong; Zhou, Dong; Yao, Dezhong			Disrupted Functional Brain Connectivity in Partial Epilepsy: A Resting-State fMRI Study	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; INDEPENDENT COMPONENT ANALYSIS; ALZHEIMERS-DISEASE; DEFAULT NETWORK; SPONTANEOUS FLUCTUATIONS; CINGULATE CORTEX; BOLD SIGNAL; MRI; SCHIZOPHRENIA; ATTENTION	Examining the spontaneous activity to understand the neural mechanism of brain disorder is a focus in recent resting-state fMRI. In the current study, to investigate the alteration of brain functional connectivity in partial epilepsy in a systematical way, two levels of analyses (functional connectivity analysis within resting state networks (RSNs) and functional network connectivity (FNC) analysis) were carried out on resting-state fMRI data acquired from the 30 participants including 14 healthy controls(HC) and 16 partial epilepsy patients. According to the etiology, all patients are subdivided into temporal lobe epilepsy group (TLE, included 7 patients) and mixed partial epilepsy group (MPE, 9 patients). Using group independent component analysis, eight RSNs were identified, and selected to evaluate functional connectivity and FNC between groups. Compared with the controls, decreased functional connectivity within all RSNs was found in both TLE and MPE. However, dissociating patterns were observed within the 8 RSNs between two patient groups, i.e, compared with TLE, we found decreased functional connectivity in 5 RSNs increased functional connectivity in 1 RSN, and no difference in the other 2 RSNs in MPE. Furthermore, the hierarchical disconnections of FNC was found in two patient groups, in which the intra-system connections were preserved for all three subsystems while the lost connections were confined to intersystem connections in patients with partial epilepsy. These findings may suggest that decreased resting state functional connectivity and disconnection of FNC are two remarkable characteristics of partial epilepsy. The selective impairment of FNC implicated that it is unsuitable to understand the partial epilepsy only from global or local perspective. We presumed that studying epilepsy in the multi-perspective based on RSNs may be a valuable means to assess the functional changes corresponding to specific RSN and may contribute to the understanding of the neuro-pathophysiological mechanism of epilepsy.	[Luo, Cheng; Qiu, Chuan; Guo, Zhiwei; Lei, Xu; Xia, Yang; Lai, Yongxiu; Yao, Dezhong] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China; [Fang, Jiajia; Li, Qifu; Zhou, Dong] Sichuan Univ, W China Hosp, Dept Neurol, Chengdu 610064, Peoples R China; [Li, Qifu] Hainan Med Coll, Affiliated Hosp, Dept Neurol, Haikou, Peoples R China; [Lei, Xu] Southwest Univ, Sch Psychol, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China; [Gong, Qiyong] Sichuan Univ, W China Hosp, Dept Radiol, HMRRC, Chengdu 610064, Peoples R China	University of Electronic Science & Technology of China; Sichuan University; Hainan Medical University; Southwest University - China; Sichuan University	Yao, DZ (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China.	zhoudong66@yahoo.de; dyao@uestc.edu.cn	Guo, chentao/G-7320-2016; zhang, yaqun/J-8478-2014; Guo, Zhiling/AAJ-6843-2020; Lin, Senjie/A-7466-2011; Gong, Qiyong/W-3052-2019; Luo, Cheng/A-4647-2015	Guo, Zhiling/0000-0001-9549-2164; Gong, Qiyong/0000-0002-5912-4871; Luo, Cheng/0000-0003-0524-5886; Yao, Dezhong/0000-0002-8042-879X; Li, Qifu/0000-0003-3904-410X; Lei, Xu/0000-0003-2271-1287	973 project [2011CB707803]; National Nature Science Foundation of China [30870655, 81071222, 60736029, 81160166, 81100974]; 863 Project [2009AA02Z301]; PCSIRT project; project of Hainan Provincial Department of Health [Qiongwei 2009-52]	973 project(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 Project(National High Technology Research and Development Program of China); PCSIRT project(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); project of Hainan Provincial Department of Health	This project was funded by grants from the 973 project 2011CB707803, the National Nature Science Foundation of China #30870655, #81071222, #60736029, #81160166, #81100974, the 863 Project #2009AA02Z301, the PCSIRT project, the project of Hainan Provincial Department of Health (Qiongwei 2009-52). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai F, 2008, NEUROSCI LETT, V438, P111, DOI 10.1016/j.neulet.2008.04.021; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Benbadis SR, 2001, NEUROL CLIN, V19, P251, DOI 10.1016/S0733-8619(05)70018-9; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Berkovic SF, 2006, TRENDS NEUROSCI, V29, P391, DOI 10.1016/j.tins.2006.05.009; Bettus G, 2008, EPILEPSY RES, V81, P58, DOI 10.1016/j.eplepsyres.2008.04.020; Bettus G, 2009, HUM BRAIN MAPP, V30, P1580, DOI 10.1002/hbm.20625; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bush G, 2010, NEUROPSYCHOPHARMACOL, V35, P278, DOI 10.1038/npp.2009.120; Calhoun VD, 2004, BIOL PSYCHIAT, V55, P842, DOI 10.1016/j.biopsych.2004.01.011; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; D'Argembeau A, 2005, NEUROIMAGE, V25, P616, DOI 10.1016/j.neuroimage.2004.11.048; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Daubechies I, 2009, P NATL ACAD SCI USA, V106, P10415, DOI 10.1073/pnas.0903525106; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Demirci O, 2009, NEUROIMAGE, V46, P419, DOI 10.1016/j.neuroimage.2009.02.014; Fornito A, 2010, CURR OPIN PSYCHIATR, V23, P239, DOI 10.1097/YCO.0b013e328337d78d; Fox MD, 2006, NAT NEUROSCI, V9, P23, DOI 10.1038/nn1616; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Frings L, 2009, J NEUROL, V256, P2021, DOI 10.1007/s00415-009-5233-0; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Gotman J, 2008, EPILEPSIA, V49, P42, DOI 10.1111/j.1528-1167.2008.01509.x; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Harrison BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001794; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Kiviniemi VJ, 2005, MAGN RESON IMAGING, V23, P531, DOI 10.1016/j.mri.2005.02.009; Kwan P, 2004, J NEUROL NEUROSUR PS, V75, P1376, DOI 10.1136/jnnp.2004.045690; Laufs H, 2007, CURR OPIN NEUROL, V20, P417, DOI 10.1097/WCO.0b013e3282202b92; Lei X, 2011, HUM BRAIN MAPP, V32, P1141, DOI 10.1002/hbm.21098; Lei X, 2010, NEUROIMAGE, V52, P1123, DOI 10.1016/j.neuroimage.2010.01.024; Liao W, 2011, HUM BRAIN MAPP, V32, P883, DOI 10.1002/hbm.21076; Liao W, 2010, BIOL CYBERN, V102, P57, DOI 10.1007/s00422-009-0350-5; Lui S, 2008, J MAGN RESON IMAGING, V27, P1214, DOI 10.1002/jmri.21370; Luo C, 2012, HUM BRAIN MAPP, V33, P1279, DOI 10.1002/hbm.21286; Luo C, 2011, HUM BRAIN MAPP, V32, P438, DOI 10.1002/hbm.21034; Luo C, 2010, EPILEPSY RES, V91, P133, DOI 10.1016/j.eplepsyres.2010.07.003; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Masterton RAJ, 2010, NEUROIMAGE, V51, P252, DOI 10.1016/j.neuroimage.2010.01.109; Medvedev A. V., 2001, Australasian Physical and Engineering Sciences in Medicine, V24, P37, DOI 10.1007/BF03178284; Noonan SK, 2009, BRAIN RES, V1262, P48, DOI 10.1016/j.brainres.2008.12.076; Pavlou E, 2011, CHILD NERV SYST, V27, P373, DOI 10.1007/s00381-010-1321-9; Qiao PF, 2011, BRAIN DEV IN PRESS; Rombouts SARB, 2009, HUM BRAIN MAPP, V30, P256, DOI 10.1002/hbm.20505; Sakoglu U, 2010, MAGN RESON MATER PHY, V23, P351, DOI 10.1007/s10334-010-0197-8; Sander JW, 2003, CURR OPIN NEUROL, V16, P165, DOI 10.1097/00019052-200304000-00008; Schevon CA, 2007, NEUROIMAGE, V35, P140, DOI 10.1016/j.neuroimage.2006.11.009; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Tian LX, 2006, NEUROSCI LETT, V400, P39, DOI 10.1016/j.neulet.2006.02.022; Vlooswijk MCG, 2010, LANCET NEUROL, V9, P1018, DOI 10.1016/S1474-4422(10)70180-0; Waites AB, 2006, ANN NEUROL, V59, P335, DOI 10.1002/ana.20733; Wieser HG, 2004, EPILEPSIA, V45, P32; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhang H, 2010, NEUROIMAGE, V51, P1414, DOI 10.1016/j.neuroimage.2010.03.039; Zhang ZQ, 2010, BRAIN RES, V1323, P152, DOI 10.1016/j.brainres.2010.01.042; Zhang ZQ, 2009, J NEUROL, V256, P1705, DOI 10.1007/s00415-009-5187-2; Zhang ZQ, 2009, NEUROSCI LETT, V458, P97, DOI 10.1016/j.neulet.2009.04.040; Zhou Y, 2007, SCHIZOPHR RES, V97, P194, DOI 10.1016/j.schres.2007.05.029; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	71	105	106	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e28196	10.1371/journal.pone.0028196	http://dx.doi.org/10.1371/journal.pone.0028196			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	23024768	Green Submitted, Green Published, gold			2022-12-27	WOS:000312662100002
J	Palavesam, A; Guerrero, FD; Heekin, AM; Wang, J; Dowd, SE; Sun, Y; Foil, LD; de Leon, AAP				Palavesam, Azhahianambi; Guerrero, Felix D.; Heekin, Andrew M.; Wang, Ju; Dowd, Scot E.; Sun, Yan; Foil, Lane D.; de Leon, Adalberto A. Perez			Pyrosequencing-Based Analysis of the Microbiome Associated with the Horn Fly, Haematobia irritans	PLOS ONE			English	Article							BACTERIAL DIVERSITY; STAPHYLOCOCCUS-SAPROPHYTICUS; WOLBACHIA INFECTION; BITING FLIES; L DIPTERA; DNA; EXPRESSION; MUSCIDAE; TRACT; PARATRANSGENESIS	The horn fly, Haematobia irritans, is one of the most economically important pests of cattle. Insecticides have been a major element of horn fly management programs. Growing concerns with insecticide resistance, insecticide residues on farm products, and non-availability of new generation insecticides, are serious issues for the livestock industry. Alternative horn fly control methods offer the promise to decrease the use of insecticides and reduce the amount of insecticide residues on livestock products and give an impetus to the organic livestock farming segment. The horn fly, an obligatory blood feeder, requires the help of microflora to supply additional nutrients and metabolize the blood meal. Recent advancements in DNA sequencing methodologies enable researchers to examine the microflora diversity independent of culture methods. We used the bacterial 16S tag-encoded FLX-titanium amplicon pyrosequencing (bTEFAP) method to carry out the classification analysis of bacterial flora in adult female and male horn flies and horn fly eggs. The bTEFAP method identified 16S rDNA sequences in our samples which allowed the identification of various prokaryotic taxa associated with the life stage examined. This is the first comprehensive report of bacterial flora associated with the horn fly using a culture-independent method. Several rumen, environmental, symbiotic and pathogenic bacteria associated with the horn fly were identified and quantified. This is the first report of the presence of Wolbachia in horn flies of USA origin and is the first report of the presence of Rikenella in an obligatory blood feeding insect.	[Palavesam, Azhahianambi; Guerrero, Felix D.; Heekin, Andrew M.; Wang, Ju; de Leon, Adalberto A. Perez] ARS, USDA, Knipling Bushland US Livestock Insects Res Lab, Kerrville, TX USA; [Palavesam, Azhahianambi] Univ Maryland, Inst Biosci & Biotechnol Res, College Pk, MD 20742 USA; [Dowd, Scot E.] Mol Res LP, Shallowater, TX USA; [Sun, Yan] Res & Testing Lab, Lubbock, TX USA; [Foil, Lane D.] Louisiana State Univ, Dept Entomol, Baton Rouge, LA 70803 USA; [Palavesam, Azhahianambi] Tamil Nadu Vet & Anim Sci Univ, Madras Vet Coll, Dept Vet Parasitol, Madras, Tamil Nadu, India	United States Department of Agriculture (USDA); University System of Maryland; University of Maryland College Park; Louisiana State University System; Louisiana State University; Tamil Nadu Veterinary & Animal Sciences University	Palavesam, A (corresponding author), ARS, USDA, Knipling Bushland US Livestock Insects Res Lab, Kerrville, TX USA.	nambibio@gmail.com	Palavesam, Azhahianambi/H-3307-2019; Dowd, Scot E/M-5386-2017; Palavesam, Azhahianambi/K-7606-2015; Garcia-Vallve, Santiago/A-4226-2008; Pujadas, Gerard/B-1457-2010; Arola, Lluis/C-6074-2011; Muguerza, Begona/C-6704-2015	Palavesam, Azhahianambi/0000-0002-7108-6767; Dowd, Scot E/0000-0002-6296-1427; Palavesam, Azhahianambi/0000-0002-7108-6767; Quinones, Mar/0000-0003-0180-2147; Garcia-Vallve, Santiago/0000-0002-0348-7497; Pujadas, Gerard/0000-0003-2598-8089; Arola, Lluis/0000-0003-2767-1974; Muguerza, Begona/0000-0001-7384-8588	U.S. Department of Agriculture APHIS-IS [34-WT-10-5000-1992-IA]; University of Maryland; U.S. Department of Agriculture-APHIS Cooperative Agreement Fund [58-6205-0-038]; Agricultural Research Service	U.S. Department of Agriculture APHIS-IS; University of Maryland; U.S. Department of Agriculture-APHIS Cooperative Agreement Fund; Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The authors thank the U.S. Department of Agriculture APHIS-IS for support provided to this study through the cooperative agreement 34-WT-10-5000-1992-IA with the University of Maryland and U.S. Department of Agriculture-APHIS Cooperative Agreement Fund 58-6205-0-038 with the Agricultural Research Service. This article reports the results of research only. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation of endorsement by the U.S. Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril C, 2008, VET MICROBIOL, V127, P203, DOI 10.1016/j.vetmic.2007.08.006; Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Ai H, 2008, CARBOHYD POLYM, V72, P419, DOI 10.1016/j.carbpol.2007.09.010; Aksoy S, 2008, ADV EXP MED BIOL, V627, P35, DOI 10.1007/978-0-387-78225-6_3; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Andreotti R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-6; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Bomar L, 2011, MBIO, V2, DOI 10.1128/mBio.00012-11; Brennan LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002083; BRUCE W. G., 1938, JOUR KANSAS ENT SOC, V11, P88; BYFORD RL, 1992, J ANIM SCI, V70, P597, DOI 10.2527/1992.702597x; Callaway TR, 2010, J ANIM SCI, V88, P3977, DOI 10.2527/jas.2010-2900; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CANO RJ, 1994, APPL ENVIRON MICROB, V60, P2164, DOI 10.1128/AEM.60.6.2164-2167.1994; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Cheng Q, 1999, INSECT MOL BIOL, V8, P125, DOI 10.1046/j.1365-2583.1999.810125.x; Chung CY, 2004, EMERG INFECT DIS, V10, P1311; Coutinho-Abreu IV, 2010, PARASITOL INT, V59, P1, DOI 10.1016/j.parint.2009.10.002; Cupp EW, 1998, J MED ENTOMOL, V35, P591, DOI 10.1093/jmedent/35.4.591; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Dugas JE, 2001, ARCH MICROBIOL, V175, P259, DOI 10.1007/s002030000243; Durvasula RV, 1999, MED VET ENTOMOL, V13, P115, DOI 10.1046/j.1365-2915.1999.00175.x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Floate KD, 2006, BIOCONTROL SCI TECHN, V16, P767, DOI 10.1080/09583150600699606; FOIL LD, 1994, REV SCI TECH OIE, V13, P1125, DOI 10.20506/rst.13.4.821; FRANKEL H, 1978, BRIT J HIST SCI, V11, P130, DOI 10.1017/S0007087400016551; Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398; Frydman HM, 2006, NATURE, V441, P509, DOI 10.1038/nature04756; GARGALLO D, 1987, APPL ENVIRON MICROB, V53, P1983, DOI 10.1128/AEM.53.8.1983-1986.1987; GARGALLOVIOLA D, 1989, J CLIN MICROBIOL, V27, P860, DOI 10.1128/JCM.27.5.860-868.1989; Gilbert DG, 1989, IUBIO ARCH MOL GEN B; Gillespie BE, 1999, J DAIRY SCI, V82, P1581, DOI 10.3168/jds.S0022-0302(99)75386-5; Glaser RW, 1923, AM J HYG, V3, P469, DOI 10.1093/oxfordjournals.aje.a118948; Grisi L., 2002, A Hora Veterinaria, V21, P8; Hammer O., 1941, Videnskabelige Meddelelser fra Dansk Naturhistorisk Forening i Kjobenhavn, V105, P141; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; HEDMAN P, 1990, J INFECTION, V21, P11, DOI 10.1016/0163-4453(90)90554-L; Hejazi A, 1997, J MED MICROBIOL, V46, P903, DOI 10.1099/00222615-46-11-903; Hornok S, 2008, VET PARASITOL, V154, P354, DOI 10.1016/j.vetpar.2008.03.019; HOVELIUS B, 1984, REV INFECT DIS, V6, P328; Jaklic D, 2008, J MED MICROBIOL, V57, P617, DOI 10.1099/jmm.0.47515-0; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; JUKES T H, 1969, P21; Kunz S. E., 1991, CRC HDB PEST MANAGEM, P68; Leite RC, 1998, MEM I OSWALDO CRUZ, V93, P761, DOI 10.1590/S0074-02761998000600012; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; LYSYK TJ, 1991, CAN ENTOMOL, V123, P1199, DOI 10.4039/Ent1231199-6; Maillard R, 2007, EMERG INFECT DIS, V13, P1383, DOI 10.3201/eid1309.070236; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Megharaj M, 2003, CURR MICROBIOL, V47, P51, DOI 10.1007/s00284-002-3889-0; Mrazek J, 2008, FOLIA MICROBIOL, V53, P229, DOI 10.1007/s12223-008-0032-z; O'Hara CM, 2000, CLIN MICROBIOL REV, V13, P534, DOI 10.1128/CMR.13.4.534-546.2000; Owens WE, 1998, AM J VET RES, V59, P1122; Oyarzun MP, 2008, MED VET ENTOMOL, V22, P188, DOI 10.1111/j.1365-2915.2008.00733.x; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; Perotti MA, 2001, J MED ENTOMOL, V38, P180, DOI 10.1603/0022-2585-38.2.180; Pitta DW, 2010, MICROB ECOL, V59, P511, DOI 10.1007/s00248-009-9609-6; Riehle MA, 2007, INT J PARASITOL, V37, P595, DOI 10.1016/j.ijpara.2006.12.002; Rodriguez SD, 2009, INFECT GENET EVOL, V9, P1092, DOI 10.1016/j.meegid.2009.09.007; Ruang-areerate T, 2004, CURR MICROBIOL, V49, P10, DOI 10.1007/s00284-003-4245-8; Sinshaw A, 2006, VET PARASITOL, V142, P35, DOI 10.1016/j.vetpar.2006.06.032; Spier SJ, 2004, AM J VET RES, V65, P829, DOI 10.2460/ajvr.2004.65.829; STEINHAUS EA, 1960, BACTERIOL REV, V24, P365, DOI 10.1128/MMBR.24.4.365-373.1960; STIRRAT JH, 1955, J PARASITOL, V41, P398, DOI 10.2307/3274240; Torres L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-105; Velasco R., 2001, INF AGROPECU BIOLECH, V14, P4; Veneti Z, 2004, APPL ENVIRON MICROB, V70, P5366, DOI 10.1128/AEM.70.9.5366-5372.2004; Watrelot-Virieux D, 2006, J VET MED B, V53, P150, DOI 10.1111/j.1439-0450.2006.00923.x; Weiss BL, 2006, APPL ENVIRON MICROB, V72, P7013, DOI 10.1128/AEM.01507-06; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; WILLIAMS JD, 1985, AUST VET J, V62, P367, DOI 10.1111/j.1751-0813.1985.tb14210.x; Worthen PL, 2006, APPL ENVIRON MICROB, V72, P4775, DOI 10.1128/AEM.00356-06; Yanti S. D., 2009, Asian Journal of Food and Agro-Industry, V2, pS241; Zhang B, 2009, VET PARASITOL, V162, P350, DOI 10.1016/j.vetpar.2009.03.012; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	80	98	101	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e44390	10.1371/journal.pone.0044390	http://dx.doi.org/10.1371/journal.pone.0044390			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23185345	Green Published, Green Submitted, gold			2022-12-27	WOS:000309554700011
J	Li, LQ; Zhang, Y; Zou, LY; Li, CQ; Yu, B; Zheng, XQ; Zhou, Y				Li, Liqi; Zhang, Yuan; Zou, Lingyun; Li, Changqing; Yu, Bo; Zheng, Xiaoqi; Zhou, Yue			An Ensemble Classifier for Eukaryotic Protein Subcellular Location Prediction Using Gene Ontology Categories and Amino Acid Hydrophobicity	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; LOCALIZATION PREDICTION; MULTIPLE SITES; WEB SERVER; EUK-MPLOC; PSI-BLAST; SEQUENCE; FEATURES; PLOC; COMPLEXITY	With the rapid increase of protein sequences in the post-genomic age, it is challenging to develop accurate and automated methods for reliably and quickly predicting their subcellular localizations. Till now, many efforts have been tried, but most of which used only a single algorithm. In this paper, we proposed an ensemble classifier of KNN (k-nearest neighbor) and SVM (support vector machine) algorithms to predict the subcellular localization of eukaryotic proteins based on a voting system. The overall prediction accuracies by the one-versus-one strategy are 78.17%, 89.94% and 75.55% for three benchmark datasets of eukaryotic proteins. The improved prediction accuracies reveal that GO annotations and hydrophobicity of amino acids help to predict subcellular locations of eukaryotic proteins.	[Li, Liqi; Zhang, Yuan; Li, Changqing; Zhou, Yue] Third Mil Med Univ, Xinqiao Hosp, Dept Orthoped, Chongqing, Peoples R China; [Zou, Lingyun] Third Mil Med Univ, Coll Basic Med Sci, Dept Microbiol, Chongqing, Peoples R China; [Yu, Bo] Yichun Peoples Hosp, Dept Orthoped, Yichun, Peoples R China; [Zheng, Xiaoqi] Shanghai Normal Univ, Dept Math, Shanghai, Peoples R China; [Zheng, Xiaoqi] Sci Comp Key Lab Shanghai Univ, Shanghai, Peoples R China	Army Medical University; Army Medical University; Shanghai Normal University; Shanghai Key Laboratory of Scalable Computing & System	Li, LQ (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Orthoped, Chongqing, Peoples R China.	xqzheng@shnu.edu.cn; zhouyxq@163.com			National Natural Science Foundation of China [30901512, 31100953]; Shanghai Leading Academic Discipline Project [S30405]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by grants from the National Natural Science Foundation of China (No. 30901512 and No. 31100953) and the Shanghai Leading Academic Discipline Project (No. S30405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari HR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-160; B Panwar, 2011, AMINO ACIDS; Bhasin M, 2004, NUCLEIC ACIDS RES, V32, pW414, DOI 10.1093/nar/gkh350; Bulashevska A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-298; Cai YD, 2005, J THEOR BIOL, V234, P145, DOI 10.1016/j.jtbi.2004.11.017; Cai Yu-Dong, 2000, Molecular Cell Biology Research Communications, V4, P172, DOI 10.1006/mcbr.2001.0269; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, J PROTEOME RES, V6, P1728, DOI 10.1021/pr060635i; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; Cuo Jian, 2006, Journal of Bioinformatics and Computational Biology, V4, P1181; Currie RA, 2005, REPROD TOXICOL, V20, P433, DOI 10.1016/j.reprotox.2005.03.014; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Gu Q, 2010, AMINO ACIDS, V38, P975, DOI 10.1007/s00726-008-0209-4; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016036; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025297; Huang WL, 2009, BIOSYSTEMS, V98, P73, DOI 10.1016/j.biosystems.2009.06.007; Jia PL, 2007, BIOCHEM BIOPH RES CO, V357, P366, DOI 10.1016/j.bbrc.2007.03.139; Khan A, 2011, COMPUT BIOL CHEM, V35, P218, DOI 10.1016/j.compbiolchem.2011.05.003; Khan A, 2010, AMINO ACIDS, V38, P347, DOI 10.1007/s00726-009-0238-7; Kim JK, 2006, PATTERN RECOGN LETT, V27, P996, DOI 10.1016/j.patrec.2005.11.014; Laurila K, 2011, AMINO ACIDS, V40, P975, DOI 10.1007/s00726-010-0724-y; Lei ZD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-491; Liao B, 2011, PROTEIN PEPTIDE LETT, V18, P1086, DOI 10.2174/092986611797200931; Lin TH, 2011, IEEE ACM T COMPUT BI, V8, P441, DOI 10.1109/TCBB.2009.82; Liqi L., 2011, J COMPUT BIOL BIOINF, V3, P15; Marinov M, 2001, HUM HERED, V51, P169, DOI 10.1159/000053338; Mei SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-44; Mount D.W., 2009, COLD SPRING HARB PRO; NAKASHIMA H, 1994, J MOL BIOL, V238, P54, DOI 10.1006/jmbi.1994.1267; Park KJ, 2003, BIOINFORMATICS, V19, P1656, DOI 10.1093/bioinformatics/btg222; Pierleoni A, 2011, BIOINFORMATICS, V27, P1224, DOI 10.1093/bioinformatics/btr108; Qian ZL, 2006, BIOCHEM BIOPH RES CO, V348, P1034, DOI 10.1016/j.bbrc.2006.07.149; Qiu JD, 2010, AMINO ACIDS, V38, P1201, DOI 10.1007/s00726-009-0331-y; Rao HB, 2011, NUCLEIC ACIDS RES, V39, pW385, DOI 10.1093/nar/gkr284; Rashid M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-337; Sahu SS, 2010, COMPUT BIOL CHEM, V34, P320, DOI 10.1016/j.compbiolchem.2010.09.002; Seo MJ, 2005, GYNECOL ONCOL, V96, P621, DOI 10.1016/j.ygyno.2004.11.032; Shen HB, 2007, AMINO ACIDS, V33, P57, DOI 10.1007/s00726-006-0478-8; Shen HB, 2009, ANAL BIOCHEM, V394, P269, DOI 10.1016/j.ab.2009.07.046; Shen YQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-563; Shi RJ, 2011, PROTEIN PEPTIDE LETT, V18, P625, DOI 10.2174/092986611795222768; Shi SP, 2011, BBA-MOL CELL RES, V1813, P424, DOI 10.1016/j.bbamcr.2011.01.011; SMITH TF, 1980, NATURE, V285, P620, DOI 10.1038/285620a0; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024498; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018476; Wang T, 2010, PROTEIN PEPTIDE LETT, V17, P32, DOI 10.2174/092986610789909494; Wang W, 2011, PROTEIN PEPTIDE LETT, V18, P480, DOI 10.2174/092986611794927947; Xie D, 2005, NUCLEIC ACIDS RES, V33, pW105, DOI 10.1093/nar/gki359; Xu QA, 2011, IEEE ACM T COMPUT BI, V8, P748, DOI 10.1109/TCBB.2010.22; Yu NY, 2011, NUCLEIC ACIDS RES, V39, pD241, DOI 10.1093/nar/gkq1093; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Yu X., 2011, AMINO ACIDS; Yuan Z, 1999, FEBS LETT, V451, P23, DOI 10.1016/S0014-5793(99)00506-2; Zhang Y, 2010, ACTA BIOMATER, V6, P776, DOI 10.1016/j.actbio.2009.08.025; Zhang Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1999, DOI 10.1271/bbb.90187; Zheng XQ, 2009, AMINO ACIDS, V37, P427, DOI 10.1007/s00726-008-0172-0; Zhou XB, 2008, AMINO ACIDS, V35, P383, DOI 10.1007/s00726-007-0608-y; Zou Lingyun, 2007, Journal of Genetics and Genomics, V34, P1080, DOI 10.1016/S1673-8527(07)60123-4	62	93	98	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2012	7	1							e31057	10.1371/journal.pone.0031057	http://dx.doi.org/10.1371/journal.pone.0031057			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BU	22984619	gold, Green Submitted, Green Published			2022-12-27	WOS:000301770300007
J	Strode, C; de Melo-Santos, M; Magalhaes, T; Araujo, A; Ayres, C				Strode, Clare; de Melo-Santos, Maria; Magalhaes, Tereza; Araujo, Ana; Ayres, Contancia			Expression Profile of Genes during Resistance Reversal in a Temephos Selected Strain of the Dengue Vector, Aedes aegypti	PLOS ONE			English	Article							INSECTICIDE-RESISTANCE; ANOPHELES-GAMBIAE; DETOXIFICATION GENES; CULEX-QUINQUEFASCIATUS; LARVAL TOLERANCE; FIELD-EVALUATION; MALARIA VECTORS; MOSQUITO; CULICIDAE; DIPTERA	Background: The mosquito Aedes aegypti is one of the most important disease vectors because it transmits two major arboviruses, dengue and yellow fever, which cause significant global morbidity and mortality. Chemical insecticides form the cornerstone of vector control. The organophosphate temephos a larvicide recommended by WHO for controlling Ae. aegypti, however, resistance to this compound has been reported in many countries, including Brazil. Methodology/Principal Findings: The aim of this study was to identify genes implicated in metabolic resistance in an Ae. aegypti temephos resistant strain, named RecR, through microarray analysis. We utilized a custom 'Ae. aegypti detox chip' and validated microarray data through RT-PCR comparing susceptible and resistant individuals. In addition, we analyzed gene expression in 4th instar larvae from a reversed susceptible strain (RecRev), exposed and unexposed to temephos. The results obtained revealed a set of 13 and 6 genes significantly over expressed in resistant adult mosquitoes and larvae, respectively. One of these genes, the cytochrome P450 CYP6N12, was up-regulated in both stages. RT-PCR confirmed the microarray results and, additionally, showed no difference in gene expression between temephos exposed and unexposed RecRev mosquitoes. This suggested that the differences in the transcript profiles among the strains are heritable due to a selection process and are not caused by immediate insecticide exposure. Reversal of temephos resistance was demonstrated and, importantly, there was a positive correlation between a decrease in the resistance ratio and an accompanying decrease in the expression levels of previously over expressed genes. Some of the genes identified here have also been implicated in metabolic resistance in other mosquito species and insecticide resistant populations of Ae. aegypti. Conclusions/Significance: The identification of gene expression signatures associated to insecticide resistance and their suppression could greatly aid the development of improved strategies of vector control.	[Strode, Clare] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England; [de Melo-Santos, Maria; Magalhaes, Tereza; Araujo, Ana; Ayres, Contancia] Ctr Pesquisas Aggeu Magalhaes FIOCRUZ, Dept Entomol, Recife, PE, Brazil	Liverpool School of Tropical Medicine; University of Liverpool; Fundacao Oswaldo Cruz	Strode, C (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England.	c.strode@liv.ac.uk	Magalhaes, Tereza/V-6632-2019; Ball, Becky/E-6573-2011; Magalhaes, Catarina/A-6836-2016	Strode, Clare/0000-0003-2833-8073; Cary, Stephen/0000-0002-2876-2387; Ball, Becky/0000-0001-8592-1316; Magalhaes, Catarina/0000-0001-9576-2398; Ruprecht, Ulrike/0000-0002-0898-7677	National Council for Scientific and Technological Development 384 (CNPq Pronex grant) [550116/2010-9]; Fundacao de Amparo a Ciencia e Tecnologia do 385 Estado de Pernambuco (FACEPE) [APQ 1361-4.00/08]	National Council for Scientific and Technological Development 384 (CNPq Pronex grant); Fundacao de Amparo a Ciencia e Tecnologia do 385 Estado de Pernambuco (FACEPE)	This work was funded by National Council for Scientific and Technological Development 384 (CNPq Pronex grant 550116/2010-9) and Fundacao de Amparo a Ciencia e Tecnologia do 385 Estado de Pernambuco (FACEPE, Grant ID: APQ 1361-4.00/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bingham G, 2011, TROP MED INT HEALTH, V16, P492, DOI 10.1111/j.1365-3156.2010.02717.x; Boyer S, 2006, ENVIRON TOXICOL CHEM, V25, P470, DOI 10.1897/05-267R2.1; Braga IA, 2004, MEM I OSWALDO CRUZ, V99, P199, DOI 10.1590/S0074-02762004000200015; Chung H, 2007, GENETICS, V175, P1071, DOI 10.1534/genetics.106.066597; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Duangkaew P, 2011, ARCH INSECT BIOCHEM, V76, P236, DOI 10.1002/arch.20413; ffrench-Constant RH, 1998, PHILOS T R SOC B, V353, P1685, DOI 10.1098/rstb.1998.0319; Lan Q., 1992, Insect Molecular Biology, V1, P71, DOI 10.1111/j.1365-2583.1993.tb00107.x; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5; Liu N, 1996, BIOCHEM GENET, V34, P133, DOI 10.1007/BF02396246; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumjuan N, 2005, INSECT BIOCHEM MOLEC, V35, P861, DOI 10.1016/j.ibmb.2005.03.008; Lumjuan N, 2011, INSECT BIOCHEM MOLEC, V41, P203, DOI 10.1016/j.ibmb.2010.12.005; Macoris MD, 2003, MEM I OSWALDO CRUZ, V98, P703, DOI 10.1590/S0074-02762003000500020; Magalhaes T, 2008, EXP PARASITOL, V120, P364, DOI 10.1016/j.exppara.2008.09.003; Marcombe S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-494; Marinotti O, 2006, INSECT MOL BIOL, V15, P1, DOI 10.1111/j.1365-2583.2006.00610.x; Marinotti O, 2005, INSECT MOL BIOL, V14, P365, DOI 10.1111/j.1365-2583.2005.00567.x; Melo-Santos MAV, 2010, ACTA TROP, V113, P180, DOI 10.1016/j.actatropica.2009.10.015; Montella IR, 2007, AM J TROP MED HYG, V77, P467, DOI 10.4269/ajtmh.2007.77.467; Muller P, 2008, MOL ECOL, V17, P1145, DOI 10.1111/j.1365-294X.2007.03617.x; Muller P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-36; Ortelli F, 2003, BIOCHEM J, V373, P957, DOI 10.1042/BJ20030169; Peixoto CA, 2008, PARASITOL RES, V103, P717, DOI 10.1007/s00436-008-1020-6; Poupardin R, 2008, INSECT BIOCHEM MOLEC, V38, P540, DOI 10.1016/j.ibmb.2008.01.004; Raghavendra K, 2011, ACTA TROP, V118, P50, DOI 10.1016/j.actatropica.2011.02.001; Raghavendra K, 2011, J VECTOR DIS, V48, P18; Raghavendra K, 2010, INDIAN J MED RES, V132, P260; Raghavendra K, 2010, PARASITOL RES, V107, P1291, DOI 10.1007/s00436-010-2001-0; Riaz MA, 2009, AQUAT TOXICOL, V93, P61, DOI 10.1016/j.aquatox.2009.03.005; Saude Md, 2006, QUANTIFICATION METHO, P1; Sharma SK, 2010, ACTA TROP, V116, P24, DOI 10.1016/j.actatropica.2010.05.002; Stevenson BJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001595; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; de Melo-Santos MAV, 2009, BIOL CONTROL, V49, P186, DOI 10.1016/j.biocontrol.2009.01.011; Vaughan A, 1997, BIOCHEM J, V325, P359, DOI 10.1042/bj3250359; Vontas J, 2005, INSECT MOL BIOL, V14, P509, DOI 10.1111/j.1365-2583.2005.00582.x; Wang JF, 1998, J MED ENTOMOL, V35, P716, DOI 10.1093/jmedent/35.5.716; WHO, 2021, DENGUE DENGUE HAEMOR; Wondji CS, 2009, GENOME RES, V19, P452, DOI 10.1101/gr.087916.108	43	57	60	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e39439	10.1371/journal.pone.0039439	http://dx.doi.org/10.1371/journal.pone.0039439			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	23028563	Green Published, Green Accepted, gold			2022-12-27	WOS:000307212800002
J	Hu, Y; Duan, JH; Zhan, QM; Wang, FD; Lu, X; Yang, XD				Hu, Yan; Duan, Jinhong; Zhan, Qimin; Wang, Fengdan; Lu, Xin; Yang, Xian-Da			Novel MUC1 Aptamer Selectively Delivers Cytotoxic Agent to Cancer Cells In Vitro	PLOS ONE			English	Article							TARGETED DRUG-DELIVERY; EXPRESSION; DESIGN; ACID	Chemotherapy is a primary treatment for cancer, but its efficacy is often limited by the adverse effects of cytotoxic agents. Targeted drug delivery may reduce the non-specific toxicity of chemotherapy by selectively directing anticancer drugs to tumor cells. MUC1 protein is an attractive target for tumor-specific drug delivery owning to its overexpression in most adenocarcinomas. In this study, a novel MUC1 aptamer is exploited as the targeting ligand for carrying doxorubicin (Dox) to cancer cells. We developed an 86-base DNA aptamer (MA3) that bound to a peptide epitope of MUC1 with a K-d of 38.3 nM and minimal cross reactivity to albumin. Using A549 lung cancer and MCF-7 breast cancer cells as MUC1-expressing models, MA3 was found to preferentially bind to MUC1-positive but not MUC1-negative cells. An aptamer-doxorubicin complex (Apt-Dox) was formulated by intercalating doxorubicin into the DNA structure of MA3. Apt-Dox was found capable of carrying doxorubicin into MUC1-positive tumor cells, while significantly reducing the drug intake by MUC1-negative cells. Moreover, Apt-Dox retained the efficacy of doxorubicin against MUC1-positive tumor cells, but lowered the toxicity to MUC1-negative cells (P<0.01). The results suggest that the MUC1 aptamer may have potential utility as a targeting ligand for selective delivery of cytotoxic agent to MUC1-expressing tumors.	[Hu, Yan; Duan, Jinhong; Yang, Xian-Da] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Hu, Yan; Duan, Jinhong; Zhan, Qimin; Wang, Fengdan; Lu, Xin; Yang, Xian-Da] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhan, Qimin] Chinese Acad Med Sci, Canc Inst & Hosp, Beijing 100730, Peoples R China; [Wang, Fengdan; Lu, Xin] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Hu, Y (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China.	ayangmd@gmail.com			Chinese Ministry of Science and Technology [2011CB933504, 2011CB911004, 2011CB911003]; Natural Science Foundation of China [81071870]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funds from the Chinese Ministry of Science and Technology (2011CB933504, 2011CB911004, 2011CB911003) and the Natural Science Foundation of China (81071870).	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Brown KC, 2010, CURR PHARM DESIGN, V16, P1040, DOI 10.2174/138161210790963788; Burchell JM, 2001, J MAMMARY GLAND BIOL, V6, P355, DOI 10.1023/A:1011331809881; Cao Y, 1999, VIRCHOWS ARCH, V434, P503, DOI 10.1007/s004280050375; Croce MV, 2001, BREAST CANCER RES TR, V69, P1, DOI 10.1023/A:1012220902991; Dassie JP, 2009, NAT BIOTECHNOL, V27, P839, DOI 10.1038/nbt.1560; Davis KA, 1996, NUCLEIC ACIDS RES, V24, P702, DOI 10.1093/nar/24.4.702; Dhar S, 2008, P NATL ACAD SCI USA, V105, P17356, DOI 10.1073/pnas.0809154105; Farokhzad OC, 2004, CANCER RES, V64, P7668, DOI 10.1158/0008-5472.CAN-04-2550; Farokhzad OC, 2006, P NATL ACAD SCI USA, V103, P6315, DOI 10.1073/pnas.0601755103; Farokhzad OC, 2006, EXPERT OPIN DRUG DEL, V3, P311, DOI 10.1517/17425247.3.3.311; Ferreira CSM, 2006, TUMOR BIOL, V27, P289, DOI 10.1159/000096085; Ferreira CSM, 2009, NUCLEIC ACIDS RES, V37, P866, DOI 10.1093/nar/gkn967; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; Haj HTB, 2003, CHEM-BIOL INTERACT, V145, P349, DOI 10.1016/S0009-2797(03)00061-9; Huang YF, 2009, CHEMBIOCHEM, V10, P862, DOI 10.1002/cbic.200800805; Lee Y, 2008, BIOCONJUGATE CHEM, V19, P525, DOI 10.1021/bc700382z; Levy-Nissenbaum E, 2008, TRENDS BIOTECHNOL, V26, P442, DOI 10.1016/j.tibtech.2008.04.006; Murray A, 1998, J PEPT RES, V52, P375; Osborne SE, 1997, CURR OPIN CHEM BIOL, V1, P5, DOI 10.1016/S1367-5931(97)80102-0; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Ren LF, 1997, CHEM-BIOL INTERACT, V104, P55, DOI 10.1016/S0009-2797(97)03767-8; SENTER PD, 1995, BIOCONJUGATE CHEM, V6, P389, DOI 10.1021/bc00034a008; Sudimack J, 2000, ADV DRUG DELIVER REV, V41, P147, DOI 10.1016/S0169-409X(99)00062-9; Taylor-Papadimitriou J, 1999, BBA-MOL BASIS DIS, V1455, P301, DOI 10.1016/S0925-4439(99)00055-1; Vasir JK, 2005, TECHNOL CANCER RES T, V4, P363, DOI 10.1177/153303460500400405; Vogel CL, 2009, J CLIN ONCOL, V27; Ye Xin, 2009, Cardiovascular & Hematological Disorders - Drug Targets, V9, P206	28	106	113	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31970	10.1371/journal.pone.0031970	http://dx.doi.org/10.1371/journal.pone.0031970			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384115	Green Published, Green Submitted, gold			2022-12-27	WOS:000302875500060
J	Yang, WH; He, KL; Zhang, J; Guo, SY				Yang, Wenhui; He, Kanglai; Zhang, Jie; Guo, Shuyuan			pH-Controlled Bacillus thuringiensis Cry1Ac Protoxin Loading and Release from Polyelectrolyte Microcapsules	PLOS ONE			English	Article							CALCIUM-CARBONATE PARTICLES; LOW-MOLECULAR-WEIGHT; DELTA-ENDOTOXIN; SPODOPTERA-EXIGUA; INSECTICIDAL ACTIVITY; MULTILAYER FILMS; DOMAIN III; TOXICITY; ENCAPSULATION; FORMULATIONS	Crystal proteins synthesized by Bacillus thuringiensis (Bt) have been used as biopesticides because of their toxicity to the insect larval hosts. To protect the proteins from environmental stress to extend their activity, we have developed a new microcapsule formulation. Poly (acrylic acid) (PAH) and poly (styrene sulfonate) (PSS) were fabricated through layer-by-layer self-assembly based on a CaCO3 core. Cry1Ac protoxins were loaded into microcapsules through layer-by-layer self-assembly at low pH, and the encapsulated product was stored in water at 4 degrees C. Scanning electron microscopy (SEM) was used to observe the morphology of the capsules. To confirm the successful encapsulation, the loading results were observed with a confocal laser scattering microscope (CLSM), using fluorescein-labeled Cry1Ac protoxin (FITC-Cry1Ac). The protoxins were released from the capsule under the alkaline condition corresponding to the midgut of certain insects, a condition which seldom exists elsewhere in the environment. The following bioassay experiment demonstrated that the microcapsules with Cry1Ac protoxins displayed approximately equivalent insecticidal activity to the Asian corn borer compared with free Cry1Ac protoxins, and empty capsules proved to have no effect on insects. Further result also indicated that the formulation could keep stable under the condition of heat and desiccation. These results suggest that this formulation provides a promising methodology that protects protoxins from the environment and releases them specifically in the target insects' midgut, which has shown potential as biopesticide in the field.	[Yang, Wenhui; Guo, Shuyuan] Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China; [He, Kanglai; Zhang, Jie] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Beijing Institute of Technology; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Yang, WH (corresponding author), Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China.	guosy@bit.edu.cn	Yang, Wan/K-7592-2013	Yang, Wan/0000-0002-7555-9728	Major State Basic Research Development Program of China (973 Program) [2009CB118902]; Natural Science Foundation of China [31171911]; National High Technology Research and Development Program of China (863 Program) [2011AA10A203]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the grants from the Major State Basic Research Development Program of China (973 Program; No. 2009CB118902), the Natural Science Foundation of China (No. 31171911), and the National High Technology Research and Development Program of China (863 Program; No. 2011AA10A203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antipov A, 2003, MACROMOL RAPID COMM, V24, P274, DOI 10.1002/marc.200390041; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Chung AJ, 2002, LANGMUIR, V18, P1176, DOI 10.1021/la010873m; Colfen H, 2003, CURR OPIN COLLOID IN, V8, P23, DOI 10.1016/S1359-0294(03)00012-8; Cote JC, 2001, PHYTOPROTECTION, V82, P73, DOI 10.7202/706218ar; de Maagd RA, 2000, APPL ENVIRON MICROB, V66, P1559, DOI 10.1128/AEM.66.4.1559-1563.2000; DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A; deMaagd RA, 1996, APPL ENVIRON MICROB, V62, P1537, DOI 10.1128/AEM.62.5.1537-1543.1996; DIDYMUS JM, 1993, J CHEM SOC FARADAY T, V89, P2891, DOI 10.1039/ft9938902891; Donath E, 2002, CHEM-EUR J, V8, P5481, DOI 10.1002/1521-3765(20021202)8:23<5481::AID-CHEM5481>3.0.CO;2-8; Gao CY, 2002, ANGEW CHEM INT EDIT, V41, P3789, DOI 10.1002/1521-3773(20021018)41:20<3789::AID-ANIE3789>3.0.CO;2-D; Garcia-Gutierrez K, 2011, BIOPROC BIOSYST ENG, V34, P701, DOI 10.1007/s00449-011-0519-x; Huang DF, 2007, J INVERTEBR PATHOL, V95, P175, DOI 10.1016/j.jip.2007.02.016; IGNOFFO CM, 1971, J ECON ENTOMOL, V64, P850, DOI 10.1093/jee/64.4.850; IGNOFFO CM, 1992, FLA ENTOMOL, V75, P516, DOI 10.2307/3496133; Jada A, 2003, COLLOID SURFACE A, V219, P7, DOI 10.1016/S0927-7757(03)00010-4; Jada A, 2000, J MATER SCI LETT, V19, P2077, DOI 10.1023/A:1026737701570; Kato T, 1998, SUPRAMOL SCI, V5, P411, DOI 10.1016/S0968-5677(98)00041-8; Lamprecht A, 2000, EUR J PHARM BIOPHARM, V49, P1, DOI 10.1016/S0939-6411(99)00063-6; Luo K, 1999, APPL ENVIRON MICROB, V65, P457; MACINTOSH SC, 1990, J AGR FOOD CHEM, V38, P1145, DOI 10.1021/jf00094a051; Myasnik M, 2001, CURR MICROBIOL, V43, P140, DOI 10.1007/s002840010276; Oppert B, 1997, J BIOL CHEM, V272, P23473, DOI 10.1074/jbc.272.38.23473; Rajamohan F, 1996, P NATL ACAD SCI USA, V93, P14338, DOI 10.1073/pnas.93.25.14338; Regev A, 1996, APPL ENVIRON MICROB, V62, P3581, DOI 10.1128/AEM.62.10.3581-3586.1996; Sopena F, 2009, CIENC INVESTIG AGRAR, V36, P27; Sukhorukov GB, 2001, MACROMOL RAPID COMM, V22, P44, DOI 10.1002/1521-3927(20010101)22:1<44::AID-MARC44>3.0.CO;2-U; Tamez-Guerra P, 2000, J ECON ENTOMOL, V93, P219, DOI 10.1603/0022-0493-93.2.219; Tiourina OP, 2001, MACROMOL BIOSCI, V1, P209, DOI 10.1002/1616-5195(20010701)1:5<209::AID-MABI209>3.3.CO;2-P; Tong WJ, 2006, J PHYS CHEM B, V110, P12905, DOI 10.1021/jp055258w; Tong WJ, 2005, J PHYS CHEM B, V109, P13159, DOI 10.1021/jp0511092; Wei W, 2008, ADV MATER, V20, P2292, DOI 10.1002/adma.200702663; Xue J, 2008, FEMS MICROBIOL LETT, V280, P95, DOI 10.1111/j.1574-6968.2007.01053.x; Yoo PJ, 2006, NAT MATER, V5, P234, DOI 10.1038/nmat1596; Zhao QH, 2008, NANOMED-NANOTECHNOL, V4, P302, DOI 10.1016/j.nano.2008.06.004	35	152	155	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45233	10.1371/journal.pone.0045233	http://dx.doi.org/10.1371/journal.pone.0045233			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024810	Green Published, Green Submitted, gold			2022-12-27	WOS:000308860100068
J	Li, Y; Farooq, M; Sheng, DL; Chandramouli, C; Lan, T; Mahajan, NK; Kini, RM; Hong, YH; Lisowsky, T; Ge, RW				Li, Yan; Farooq, Muhammad; Sheng, Donglai; Chandramouli, Chanchal; Lan, Tian; Mahajan, Nilesh K.; Kini, R. Manjunatha; Hong, Yunhan; Lisowsky, Thomas; Ge, Ruowen			Augmenter of Liver Regeneration (alr) Promotes Liver Outgrowth during Zebrafish Hepatogenesis	PLOS ONE			English	Article							HEPATIC STIMULATOR SUBSTANCE; DISULFIDE RELAY SYSTEM; MITOCHONDRIAL SULFHYDRYL OXIDASE; INTERMEMBRANE SPACE; RESPIRATORY-CHAIN; PROTEIN IMPORT; CYTOCHROME-C; GENE; HEPATOPOIETIN; YEAST	Augmenter of Liver Regeneration (ALR) is a sulfhydryl oxidase carrying out fundamental functions facilitating protein disulfide bond formation. In mammals, it also functions as a hepatotrophic growth factor that specifically stimulates hepatocyte proliferation and promotes liver regeneration after liver damage or partial hepatectomy. Whether ALR also plays a role during vertebrate hepatogenesis is unknown. In this work, we investigated the function of alr in liver organogenesis in zebrafish model. We showed that alr is expressed in liver throughout hepatogenesis. Knockdown of alr through morpholino antisense oligonucleotide (MO) leads to suppression of liver outgrowth while overexpression of alr promotes liver growth. The small-liver phenotype in alr morphants results from a reduction of hepatocyte proliferation without affecting apoptosis. When expressed in cultured cells, zebrafish Alr exists as dimer and is localized in mitochondria as well as cytosol but not in nucleus or secreted outside of the cell. Similar to mammalian ALR, zebrafish Alr is a flavin-linked sulfhydryl oxidase and mutation of the conserved cysteine in the CxxC motif abolishes its enzymatic activity. Interestingly, overexpression of either wild type Alr or enzyme-inactive Alr(C131S) mutant promoted liver growth and rescued the liver growth defect of alr morphants. Nevertheless, alr(C131S) is less efficacious in both functions. Meantime, high doses of alr MOs lead to widespread developmental defects and early embryonic death in an alr sequence-dependent manner. These results suggest that alr promotes zebrafish liver outgrowth using mechanisms that are dependent as well as independent of its sulfhydryl oxidase activity. This is the first demonstration of a developmental role of alr in vertebrate. It exemplifies that a low-level sulfhydryl oxidase activity of Alr is essential for embryonic development and cellular survival. The dose-dependent and partial suppression of alr expression through MO-mediated knockdown allows the identification of its late developmental role in vertebrate liver organogenesis.	[Li, Yan; Farooq, Muhammad; Sheng, Donglai; Chandramouli, Chanchal; Lan, Tian; Mahajan, Nilesh K.; Kini, R. Manjunatha; Hong, Yunhan; Ge, Ruowen] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Farooq, Muhammad] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia; [Kini, R. Manjunatha] Virginia Commonwealth Univ, Med Coll Virginia, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Lisowsky, Thomas] MultiBIND Biotec GmbH, Cologne, Germany	National University of Singapore; King Saud University; Virginia Commonwealth University	Li, Y (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsgerw@nus.edu.sg	He, Zheng-Guo/P-3647-2014; Ge, Ruowen/D-8352-2012; Kini, Manjunatha/H-8029-2012; Chandramouli, Chanchal/AAF-2848-2020; Hong, Yunhan/D-4197-2009; Farooq, Muhammad/G-9838-2013; Li, Zhi-Yong/G-9701-2011; Li, Zhi-Yong/G-9701-2011	Ge, Ruowen/0000-0002-0750-7336; Farooq, Muhammad/0000-0001-9891-2443; Kini, Manjunatha/0000-0002-6100-3251; Zhang, Yuesheng/0000-0002-0976-2875; Li, Zhi-Yong/0000-0003-3039-8833; Li, Zhi-Yong/0000-0002-6814-9165	Singapore Biomedical Research Council [BMRC/01/1/21/18/068]; Ministry of Education [R-154-000-475-112]; NCI NIH HHS [CA120533, R01 CA124627, R01 CA120533, P30 CA016056] Funding Source: Medline	Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Ministry of Education; NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by the Singapore Biomedical Research Council grant BMRC/01/1/21/18/068 and Ministry of Education grant R-154-000-475-112 to Dr. Ge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2005, J MOL BIOL, V353, P937, DOI 10.1016/j.jmb.2005.08.049; Bihlmaier K, 2007, J CELL BIOL, V179, P389, DOI 10.1083/jcb.200707123; Cao Y, 2009, FREE RADICAL BIO MED, V47, P1057, DOI 10.1016/j.freeradbiomed.2009.07.017; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Chen XX, 2003, J BIOL CHEM, V278, P49022, DOI 10.1074/jbc.M304057200; Chu J, 2009, HEPATOLOGY, V50, P1656, DOI 10.1002/hep.23157; Daithankar VN, 2010, BIOCHEMISTRY-US, V49, P6737, DOI 10.1021/bi100912m; Daithankar VN, 2009, BIOCHEMISTRY-US, V48, P4828, DOI 10.1021/bi900347v; Di Fonzo A, 2009, AM J HUM GENET, V84, P594, DOI 10.1016/j.ajhg.2009.04.004; Farooq M, 2008, DEV BIOL, V317, P336, DOI 10.1016/j.ydbio.2008.02.034; Farrell SR, 2005, BIOCHEMISTRY-US, V44, P1532, DOI 10.1021/bi0479555; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Gandhi CR, 1999, HEPATOLOGY, V29, P1435, DOI 10.1002/hep.510290522; Gandhi CR, 2009, J CELL PHYSL; Gatzidou E, 2006, WORLD J GASTROENTERO, V12, P4951, DOI 10.3748/wjg.v12.i31.4951; GHOSH C, 1994, CELL BIOL TOXICOL, V10, P167, DOI 10.1007/BF00757560; HAGIYA M, 1994, P NATL ACAD SCI USA, V91, P8142, DOI 10.1073/pnas.91.17.8142; HE FH, 1993, HEPATOLOGY, V17, P225, DOI 10.1016/0270-9139(93)90081-W; Hofhaus G, 1999, EUR J CELL BIOL, V78, P349, DOI 10.1016/S0171-9335(99)80069-7; Ilowski M, 2011, BIOCHEM BIOPH RES CO, V404, P148, DOI 10.1016/j.bbrc.2010.11.083; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kondili VG, 2005, DIGEST DIS SCI, V50, P297, DOI 10.1007/s10620-005-1598-9; Korzh S, 2001, MECH DEVELOP, V103, P137, DOI 10.1016/S0925-4773(01)00330-6; LABRECQUE DR, 1975, J PHYSIOL-LONDON, V248, P273, DOI 10.1113/jphysiol.1975.sp010973; Lange H, 2001, EMBO REP, V2, P715, DOI 10.1093/embo-reports/kve161; Lee JE, 2000, FEBS LETT, V477, P62, DOI 10.1016/S0014-5793(00)01767-1; Levitan A, 2004, J BIOL CHEM, V279, P20002, DOI 10.1074/jbc.M312877200; Li Y, 2002, EUR J BIOCHEM, V269, P3888, DOI 10.1046/j.1432-1033.2002.03054.x; Li Y, 2000, J BIOL CHEM, V275, P37443, DOI 10.1074/jbc.M004373200; Liatsos GD, 2003, DIGEST DIS SCI, V48, P1929, DOI 10.1023/A:1026157901805; LISOWSKY T, 1995, GENOMICS, V29, P690, DOI 10.1006/geno.1995.9950; LISOWSKY T, 1992, MOL GEN GENET, V232, P58, DOI 10.1007/BF00299137; Lisowsky T, 2001, DIGEST LIVER DIS, V33, P173, DOI 10.1016/S1590-8658(01)80074-8; Lu CR, 2002, FASEB J, V16, P90, DOI 10.1096/fj.01-0506fje; Lu J, 2002, WORLD J GASTROENTERO, V8, P353; McClure KD, 2008, DEV BIOL, V319, P68, DOI 10.1016/j.ydbio.2008.04.004; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Passeri MJ, 2009, HEPATOLOGY, V49, P443, DOI 10.1002/hep.22667; Sadler KC, 2007, P NATL ACAD SCI USA, V104, P1570, DOI 10.1073/pnas.0610774104; Shin D, 2007, DEVELOPMENT, V134, P2041, DOI 10.1242/dev.000281; Tanigawa K, 2000, J GASTROENTEROL, V35, P112, DOI 10.1007/s005350050023; Thasler WE, 2005, HISTOPATHOLOGY, V47, P57, DOI 10.1111/j.1365-2559.2005.02172.x; Thirunavukkarasu C, 2008, J HEPATOL, V48, P578, DOI 10.1016/j.jhep.2007.12.010; Tokatlidis K, 2005, CELL, V121, P965, DOI 10.1016/j.cell.2005.06.019; Wang CP, 2006, WORLD J GASTROENTERO, V12, P4859; Wang G, 1999, J BIOL CHEM, V274, P11469, DOI 10.1074/jbc.274.17.11469; Wang WZ, 2007, BIOCHEMISTRY-US, V46, P3246, DOI 10.1021/bi602499t; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Wiedenmann J, 2009, IUBMB LIFE, V61, P1029, DOI 10.1002/iub.256; Yabu T, 2001, FISHERIES SCI, V67, P333, DOI 10.1046/j.1444-2906.2001.00233.x; Yang XM, 1997, SCI CHINA SER C, V40, P642, DOI 10.1007/BF02882695	52	150	169	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30835	10.1371/journal.pone.0030835	http://dx.doi.org/10.1371/journal.pone.0030835			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22905149	gold, Green Published			2022-12-27	WOS:000301703800034
J	Li, YY; Zhu, RN; Qian, Y; Deng, J				Li, Yuyun; Zhu, Runan; Qian, Yuan; Deng, Jie			The Characteristics of Blood Glucose and WBC Counts in Peripheral Blood of Cases of Hand Foot and Mouth Disease in China: A Systematic Review	PLOS ONE			English	Review							ENTEROVIRUS 71; OUTBREAK; INFECTIONS; MALAYSIA; TAIWAN; MANIFESTATIONS	Background: Outbreaks of Hand Foot and Mouth Disease (HFMD) have occurred in many parts of the world especially in China. We aimed to summarize the characteristics of the levels of blood glucose and white blood cell (WBC) counts in cases of HFMD in Mainland China and Taiwan, using meta-analysis based on systematic review of published articles. Methods: We systematically reviewed published studies, from the MEDLINE and WANFANG Data, about the levels of blood glucose and WBC counts in cases of HFMD until 15(th) June 2011, and quantitatively summarized the characteristics of them using meta-analysis. Results: In total, 37 studies were included in this review. In Mainland China and Taiwan, generally, the average level of blood glucose, the prevalence of hyperglycemia, WBC counts and the prevalence of leukocytosis increased with the severity of the illness. There was no significant difference in the prevalence of leukocytosis between ANS (autonomic nervous system dysregulation)/PE (pulmonary edema) group and CNS (central nervous system) group, and in the average level of blood glucose between healthy controls and mild cases of HFMD. WBC counts in cases infected by EV71 were less than those in cases infected by CA16. Conclusions: our analyses indicated that blood glucose and WBC counts increased with the severity of HFMD disease, which would help doctors to manage patients efficiently.	[Li, Yuyun; Zhu, Runan; Qian, Yuan; Deng, Jie] Capital Inst Pediat, Virol Lab, Beijing, Peoples R China	Capital Institute of Pediatrics (CIP)	Li, YY (corresponding author), Capital Inst Pediat, Virol Lab, Beijing, Peoples R China.	qybds1129@163.com	He, Zheng-Guo/P-3647-2014; Ge, Ruowen/D-8352-2012; Kini, Manjunatha/H-8029-2012; Chandramouli, Chanchal/AAF-2848-2020; Hong, Yunhan/D-4197-2009; Farooq, Muhammad/G-9838-2013; Li, Zhi-Yong/G-9701-2011; Li, Zhi-Yong/G-9701-2011	Ge, Ruowen/0000-0002-0750-7336; Farooq, Muhammad/0000-0001-9891-2443; Kini, Manjunatha/0000-0002-6100-3251; Zhang, Yuesheng/0000-0002-0976-2875; Li, Zhi-Yong/0000-0003-3039-8833; Li, Zhi-Yong/0000-0002-6814-9165	NCI NIH HHS [CA120533, R01 CA124627, R01 CA120533, P30 CA016056] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abubakar S, 1999, SCAND J INFECT DIS, V31, P331, DOI 10.1080/00365549950163734; AbuBakar S, 2009, EMERG INFECT DIS, V15, P79, DOI 10.3201/eid1501.080264; Ahmad K, 2000, LANCET, V356, P1338, DOI 10.1016/S0140-6736(05)74253-7; ALEXANDER JP, 1994, J INFECT DIS, V169, P905, DOI 10.1093/infdis/169.4.905; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; Chen JH, 2010, ACTA ACAD MEDICINAE, V32, P363; Chen WB, 2000, 5 DIAGNOSTICS; Chu PY, 2001, ARCH VIROL, V146, P589, DOI 10.1007/s007050170164; Cui LD, 2011, CHINA PRAC MED, V6, P50; Dai W, 2011, CHINESE COMMUNITY DO, V13, P88; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ding NZ, 2009, VIRUS RES, V145, P157, DOI 10.1016/j.virusres.2009.06.006; Fan XC, 2009, ANHUI MED J, V30, P253; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hsia SH, 2005, PEDIATR INFECT DIS J, V24, P331, DOI 10.1097/01.inf.0000157219.19674.98; Huang S, 2008, ANHUI MED J, V29, P361; Huang YF, 2003, J INFECTION, V46, P238, DOI 10.1053/jinf.2002.1117; Jiang J, 2010, J QILU NURSING, V16, P119; Kehle J, 2003, J NEUROVIROL, V9, P126, DOI 10.1080/13550280390173364; Li CC, 2002, SCAND J INFECT DIS, V34, P104, DOI 10.1080/00365540110077119; Li JM, 2009, CHIN PEDIAT EMERG ME, V16, P142; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li Q., 2010, ANHUI MED J, V31, P1410; Li SH, 2010, CHIN PECIATR EMERG M, V17, P49; Li SH, 2010, CHIN J CLIN INFECT D, V3, P337; [李玉芬 Li Yufen], 2010, [临床儿科杂志, Journal of Chinical Pediatrics], V28, P1011; Liao Y, 2010, JILIN MED J, P4075; Lin TY, 2003, EMERG INFECT DIS, V9, P291, DOI 10.3201/eid0903.020285; Lin TY, 2003, CLIN INFECT DIS, V36, P269, DOI 10.1086/345905; Lin TY, 2002, ACTA PAEDIATR, V91, P632, DOI 10.1080/080352502760069016; Liu J, 2009, ANHUI MED J, V30, P261; Liu X, 2010, CHIN J MED ULTRASOUN, V7, P1844; Liu Ying-xia, 2008, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V22, P475; Lu CY, 2002, J MED VIROL, V67, P217, DOI 10.1002/jmv.2210; Luo LP, 2010, J N CHINA COAL MED U, V12, P356; Mai LL, 2011, CHINESE J NEW CLIN M, V4, P356; MANTEL N, 1959, J NATL CANCER I, V22, P719; [毛国顺 MAO Guoshun], 2008, [中华传染病杂志, Chinese Journal of Infections Diseases], V26, P387; [毛月燕 MAO Yue-yan], 2009, [中华传染病杂志, Chinese Journal of Infections Diseases], V27, P35; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Qian N, 2010, THESIS QINGDAO U, P17; Shen Q, 2011, J MED RES, V40, P93; Shimizu H, 1999, JPN J INFECT DIS, V52, P12; Tang LP, 2009, CHIN J M ISDIAGN, V9, P6840; Verbruggen SCAT, 2007, CLIN NUTR, V26, P677, DOI 10.1016/j.clnu.2007.08.012; Wang HC, 2010, CHINA CLIN PRAC MED, V4, P155; Wang JR, 2002, J CLIN MICROBIOL, V40, P10, DOI 10.1128/JCM.40.1.10-15.2002; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Wei XL, 2010, SHANDONG MED J, V50, P70; World Health Organization, 2017, GUID DRINK WAT QUAL, VFourth, DOI 10.1016/S1462-0758(00)00006-6; Yan ZW, 2011, CHIN J GEN PRACT, V10, P343; Yang T, 2010, ACTA MEDCINAE SINICA, V23, P68; Yu LX, 2011, CHIN PEDIAT EMERG ME, V18, P57; [岳保珠 Yue Baozhu], 2010, [中国全科医学, Chinese General Practice], V13, P2239; Zhang GH, 2010, CHINA CLIN PRAC MED, V4, P132; Zhang JH, 2010, CHINESE FOREIGN MED, V8, P12; Zhang Shou-Bin, 2008, Zhongguo Dang Dai Er Ke Za Zhi, V10, P38; Zhao H., 2008, J CLIN PEDIAT, V26, P467; Zheng NH, 2011, CHINA MODERN DOCTOR, V49, P126; Zhou AR, 2000, 5 BIOCH; [周大明 Zhou Daming], 2010, [重庆医科大学学报, Acta Universitatis Scientiae Medicinae Chongqing], V35, P1724	63	150	169	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29003	10.1371/journal.pone.0029003	http://dx.doi.org/10.1371/journal.pone.0029003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22905149	Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400018
J	Li, YQ; He, ZG				Li, Yuqing; He, Zheng-Guo			The Mycobacterial LysR-Type Regulator OxyS Responds to Oxidative Stress and Negatively Regulates Expression of the Catalase-Peroxidase Gene	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATOR; PATHOGENIC MYCOBACTERIA; TUBERCULOSIS; KATG; FURA; SENSITIVITY; SMEGMATIS; MACROPHAGES; RESISTANCE; PROTEINS	Protection against oxidative stress is one of the primary defense mechanisms contributing to the survival of Mycobacterium tuberculosis in the host. In this study, we provide evidence that OxyS, a LysR-type transcriptional regulator functions as an oxidative stress response regulator in mycobacteria. Overexpression of OxyS lowers expression of the catalase-peroxidase (KatG) gene in M. smegmatis. OxyS binds directly with the katG promoter region and a conserved, GC-rich T-N-11-A motif for OxyS binding was successfully characterized in the core binding site. Interestingly, the DNA-binding activity of OxyS was inhibited by H2O2, but not by dithiothreitol. Cys25, which is situated at the DNA-binding domain of OxyS, was found to have a regulatory role for the DNA-binding ability of OxyS in response to oxidative stress. In contrast, the other three cysteine residues in OxyS do not appear to have this function. Furthermore, the mycobacterial strain over-expressing OxyS had a higher sensitivity to H2O2. Thus, OxyS responds to oxidative stress through a unique cysteine residue situated in its DNA-binding domain and negatively regulates expression of the katG gene. These findings uncover a specific regulatory mechanism for mycobacterial adaptation to oxidative stress.	[Li, Yuqing; He, Zheng-Guo] Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Ctr Prote Res, Coll Life Sci & Technol, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	He, ZG (corresponding author), Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Ctr Prote Res, Coll Life Sci & Technol, Wuhan, Hubei, Peoples R China.	hezhengguo@mail.hzau.edu.cn	He, Zheng-Guo/P-3647-2014; Ge, Ruowen/D-8352-2012; Kini, Manjunatha/H-8029-2012; Chandramouli, Chanchal/AAF-2848-2020; Hong, Yunhan/D-4197-2009; Farooq, Muhammad/G-9838-2013; Li, Zhi-Yong/G-9701-2011; Li, Zhi-Yong/G-9701-2011	Ge, Ruowen/0000-0002-0750-7336; Farooq, Muhammad/0000-0001-9891-2443; Kini, Manjunatha/0000-0002-6100-3251; Zhang, Yuesheng/0000-0002-0976-2875; Li, Zhi-Yong/0000-0003-3039-8833; Li, Zhi-Yong/0000-0002-6814-9165	National Natural Science Foundation of China [31025002, 30930003]; Fundamental Research Funds for the Central Universities [2011PY140]; Hubei Chutian Scholar Program; NCI NIH HHS [CA120533, R01 CA124627, R01 CA120533, P30 CA016056] Funding Source: Medline	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Hubei Chutian Scholar Program; NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Natural Science Foundation of China (31025002, 30930003), the Fundamental Research Funds for the Central Universities (2011PY140) and Hubei Chutian Scholar Program (to Z-GH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Chen H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001602; CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484; DERETIC V, 1995, MOL MICROBIOL, V17, P889, DOI 10.1111/j.1365-2958.1995.mmi_17050889.x; Dhandayuthapani S, 1996, J BACTERIOL, V178, P3641, DOI 10.1128/jb.178.12.3641-3649.1996; Domenech P, 2001, MICROBES INFECT, V3, P713, DOI 10.1016/S1286-4579(01)01422-8; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Guo MM, 2009, GENOME RES, V19, P1301, DOI 10.1101/gr.086595.108; He ZG, 2003, J BIOL CHEM, V278, P29538, DOI 10.1074/jbc.M304318200; Italiani VCS, 2011, J BACTERIOL, V193, P1734, DOI 10.1128/JB.01339-10; Jittawuttipoka T, 2009, J BACTERIOL, V191, P7372, DOI 10.1128/JB.00788-09; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Lee HI, 2010, J BIOCHEM, V147, P511, DOI 10.1093/jb/mvp197; Li YQ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-242; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Manca C, 1999, INFECT IMMUN, V67, P74, DOI 10.1128/IAI.67.1.74-79.1999; Master S, 2001, J BACTERIOL, V183, P4033, DOI 10.1128/JB.183.13.4033-4039.2001; Milano A, 2001, J BACTERIOL, V183, P6801, DOI 10.1128/JB.183.23.6801-6806.2001; Muraoka S, 2003, J MOL BIOL, V328, P555, DOI 10.1016/S0022-2836(03)00312-7; Nguyen L, 2005, TRENDS CELL BIOL, V15, P269, DOI 10.1016/j.tcb.2005.03.009; Pagan-Ramos E, 1998, J BACTERIOL, V180, P4856; Pym AS, 2001, MOL MICROBIOL, V40, P879, DOI 10.1046/j.1365-2958.2001.02427.x; Sala C, 2003, J BACTERIOL, V185, P5357, DOI 10.1128/JB.185.18.5357-5362.2003; Sala C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-33; SHERMAN DR, 1995, P NATL ACAD SCI USA, V92, P6625, DOI 10.1073/pnas.92.14.6625; Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104; Sreevatsan S, 1996, J CLIN MICROBIOL, V34, P2007, DOI 10.1128/JCM.34.8.2007-2010.1996; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Yu K., 1999, Tubercle and Lung Disease, V79, P191, DOI 10.1054/tuld.1998.0203; Zahrt TC, 2001, MOL MICROBIOL, V39, P1174, DOI 10.1046/j.1365-2958.2001.02321.x; Zhang H, 2008, FEBS J, V275, P753, DOI 10.1111/j.1742-4658.2007.06241.x; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	36	150	169	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30186	10.1371/journal.pone.0030186	http://dx.doi.org/10.1371/journal.pone.0030186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22905149	Green Published, gold, Green Submitted			2022-12-27	WOS:000301454400077
J	Wang, XM; Mao, XO; Xie, L; Sun, F; Greenberg, DA; Jin, KL				Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin			Conditional Depletion of Neurogenesis Inhibits Long-Term Recovery after Experimental Stroke in Mice	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; SUBVENTRICULAR ZONE; FOREBRAIN NEUROGENESIS; BRAIN; CELLS; REPLACEMENT; PRECURSORS; MIGRATION; NEURONS	We reported previously that ablation of doublecortin (DCX)-immunopositive newborn neurons in mice worsens anatomical and functional outcome measured 1 day after experimental stroke, but whether this effect persists is unknown. We generated transgenic mice that express herpes simplex virus thymidine kinase under control of the DCX promoter (DCX-TK transgenic mice). DCX-expressing and recently divided cells in the rostral subventricular zone (SVZ) and hippocampus of DCX-TK transgenic mice, but not wild-type mice, were specifically depleted after ganciclovir (GCV) treatment for 14 days. Focal cerebral ischemia was induced by permanent distal middle cerebral artery occlusion (MCAO) on day 14 of vehicle or GCV treatment, and mice were killed 12 weeks after MCAO. Infarct volume was significantly increased and neurologic deficits were more severe in GCV- compared to vehicle-treated DCX-TK transgenic mice at first 8 weeks, after depletion of DCX- and bromodeoxyuridine-immunoreactive cells in the SVZ and dentate gyrus following focal ischemia. Our results indicate that endogenous neurogenesis in a critical period following experimental stroke influences the course of long-term recovery.	[Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin] Buck Inst Res Aging, Novato, CA USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Dept Pharmacol & Neurosci, Ft Worth, TX USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Inst Aging & Alzheimers Dis Res, Ft Worth, TX USA	Buck Institute for Research on Aging; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center	Wang, XM (corresponding author), Buck Inst Res Aging, Novato, CA USA.	kunlin.jin@unthsc.edu	Pausch, Hubert/U-5934-2019; Sun, Fen/I-8516-2016; Zeng, Maomao/M-1422-2013; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Prokopenko, Mikhail/A-3995-2008; Wang, X. Rosalind/B-7097-2008	Pausch, Hubert/0000-0002-0501-6760; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Tang, Hailiang/0000-0003-1852-3128; SUN, FEN/0000-0003-2094-9494; Wurmser, Christine/0000-0003-0649-6206; Yu, Zhuowei/0000-0002-9152-6491; Wang, Xuelong/0000-0003-4616-1531; Kou, Xiaoxing/0000-0001-9680-0077; Prokopenko, Mikhail/0000-0002-4215-0344; Miller, Jennifer/0000-0003-2110-3693; Wang, X. Rosalind/0000-0001-5454-6197; Fries, Ruedi/0000-0002-4657-1787; Mao, Ying/0000-0001-8055-115X	United States Public Health Service Grant [NS57186, AG21980, NS44921, NS62414]	United States Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service)	This work was supported by United States Public Health Service Grants NS57186 and AG21980 (to KJ) and NS44921 and NS62414 (to DAG). The URL of any funder's website is www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameh EA, 2009, SURG INFECT, V10, P105, DOI 10.1089/sur.2007.082; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Encarnacion A, 2011, J NEUROSCI METH, V196, P247, DOI 10.1016/j.jneumeth.2011.01.010; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gu WG, 2000, J CEREBR BLOOD F MET, V20, P1166, DOI 10.1097/00004647-200008000-00002; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2010, AGING CELL, V9, P1076, DOI 10.1111/j.1474-9726.2010.00638.x; Jin KL, 2010, P NATL ACAD SCI USA, V107, P7993, DOI 10.1073/pnas.1000154107; Jorgensen H S, 1999, Phys Med Rehabil Clin N Am, V10, P887; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Lai B, 2008, NEUROSCI LETT, V442, P305, DOI 10.1016/j.neulet.2008.07.032; Liu JL, 1998, J NEUROSCI, V18, P7768; Mayo NE, 1999, DISABIL REHABIL, V21, P258; MCDERMOTT KW, 1991, J ANAT, V178, P45; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; REARDON JE, 1989, J BIOL CHEM, V264, P19039; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhu CL, 2009, J NEUROCHEM, V111, P1447, DOI 10.1111/j.1471-4159.2009.06413.x	26	658	680	34	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38932	10.1371/journal.pone.0038932	http://dx.doi.org/10.1371/journal.pone.0038932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22808095	Green Submitted, gold, Green Published			2022-12-27	WOS:000305652700041
J	Wang, XJ; Wei, DL; Song, ZG; Jiao, HC; Lin, H				Wang, Xiao Juan; Wei, Dai Lin; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai			Effects of Fatty Acid Treatments on the Dexamethasone-Induced Intramuscular Lipid Accumulation in Chickens	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE CELLS; INDUCED INSULIN-RESISTANCE; MAMMALIAN TARGET; GENE-EXPRESSION; DOWN-REGULATION; PPAR-ALPHA; RAT; RECEPTOR; LIVER	Background: Glucocorticoid has an important effect on lipid metabolism in muscles, and the type of fatty acid likely affects mitochondrial utilization. Therefore, we hypothesize that the different fatty acid types treatment may affect the glucocorticoid induction of intramuscular lipid accumulation. Methodology/Principal Findings: The effect of dexamethasone (DEX) on fatty acid metabolism and storage in skeletal muscle of broiler chickens (Gallus gallus domesticus) was investigated with and without fatty acid treatments. Male Arbor Acres chickens (31 d old) were treated with either palmitic acid (PA) or oleic acid (OA) for 7 days, followed by DEX administration for 3 days (35-37 d old). The DEX-induced lipid uptake and oxidation imbalance, which was estimated by increased fatty acid transport protein 1 (FATP1) expression and decreased carnitine palmitoyl transferase 1 activity, contributed to skeletal muscle lipid accumulation. More sensitive than glycolytic muscle, the oxidative muscle in DEX-treated chickens showed a decrease in the AMP to ATP ratio, a decrease in AMP-activated protein kinase (AMPK) alpha phosphorylation and its activity, as well as an increase in the phosphorylation of mammalian target of rapamycin (mTOR) and ribosomal p70S6 kinase, without Akt activation. DEX-stimulated lipid deposition was augmented by PA, but alleviated by OA, in response to pathways that were regulated differently, including AMPK, mTOR and FATP1. Conclusions: DEX-induced intramuscular lipid accumulation was aggravated by SFA but alleviated by unsaturated fatty acid. The suppressed AMPK and augmented mTOR signaling pathways were involved in glucocortcoid-mediated enhanced intramuscular fat accumulation.	[Wang, Xiao Juan; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai] Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China; [Wei, Dai Lin] Taian Cent Hosp, Dept Endocrine, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Wang, XJ (corresponding author), Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China.	hailin@sdau.edu.cn	Pausch, Hubert/U-5934-2019; Sun, Fen/I-8516-2016; Zeng, Maomao/M-1422-2013; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Prokopenko, Mikhail/A-3995-2008; Wang, X. Rosalind/B-7097-2008	Pausch, Hubert/0000-0002-0501-6760; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Tang, Hailiang/0000-0003-1852-3128; SUN, FEN/0000-0003-2094-9494; Wurmser, Christine/0000-0003-0649-6206; Yu, Zhuowei/0000-0002-9152-6491; Wang, Xuelong/0000-0003-4616-1531; Kou, Xiaoxing/0000-0001-9680-0077; Prokopenko, Mikhail/0000-0002-4215-0344; Miller, Jennifer/0000-0003-2110-3693; Wang, X. Rosalind/0000-0001-5454-6197; Fries, Ruedi/0000-0002-4657-1787; Mao, Ying/0000-0001-8055-115X	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China [2004CB117507]; National Natural Science Foundation of China [30771573]; Research Fund for the Doctoral Program of Higher Education of China	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from the Shandong Science Fund for Distinguished Youth Scholars, the National Basic Research Program of China (2004CB117507), the National Natural Science Foundation of China (No.30771573), and Research Fund for the Doctoral Program of Higher Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the sponsoring agencies.	Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Berthiaume M, 2007, AM J PHYSIOL-ENDOC M, V293, pE1045, DOI 10.1152/ajpendo.00276.2007; BIEBER LL, 1972, ANAL BIOCHEM, V50, P509, DOI 10.1016/0003-2697(72)90061-9; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Bowes SB, 1996, J ENDOCRINOL, V148, P501, DOI 10.1677/joe.0.1480501; Braun EJ, 2008, COMP BIOCHEM PHYS B, V151, P1, DOI 10.1016/j.cbpb.2008.05.007; Cai YL, 2009, COMP BIOCHEM PHYS C, V150, P164, DOI 10.1016/j.cbpc.2009.04.005; Caton PW, 2011, BIOCHEM J, V437, P521, DOI 10.1042/BJ20110702; Christ-Crain M, 2008, FASEB J, V22, P1672, DOI 10.1096/fj.07-094144; Chuang JC, 2010, J LIPID RES, V51, P1344, DOI 10.1194/jlr.M002196; Clark H, 2004, EUR J BIOCHEM, V271, P2215, DOI 10.1111/j.1432-1033.2004.04151.x; Close B, 1997, LAB ANIM-UK, V31, P1, DOI 10.1258/002367797780600297; Coll T, 2006, DIABETES, V55, P2779, DOI 10.2337/db05-1494; Cota D, 2009, OBESITY, V17, P1641, DOI 10.1038/oby.2009.84; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; de Oliveira C, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-11; Duchene S, 2008, DOMEST ANIM ENDOCRIN, V34, P1, DOI 10.1016/j.domaniend.2006.09.002; Dupont J, 1999, J ENDOCRINOL, V162, P67, DOI 10.1677/joe.0.1620067; Dupont JL, 2004, DOMEST ANIM ENDOCRIN, V26, P127, DOI 10.1016/j.domaniend.2003.09.004; Dupont J, 2008, J ENDOCRINOL, V197, P531, DOI 10.1677/JOE-08-0055; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Foucaud L, 1998, BBA-LIPID LIPID MET, V1391, P204, DOI 10.1016/S0005-2760(97)00213-0; Gao D, 2009, BRIT J NUTR, V102, P1557, DOI 10.1017/S0007114509990948; Gaster M, 2005, DIABETES, V54, P648, DOI 10.2337/diabetes.54.3.648; GRIFFIN HD, 1982, BRIT POULTRY SCI, V23, P307, DOI 10.1080/00071688208447962; Halevy O, 2000, J NUTR, V130, P858, DOI 10.1093/jn/130.4.858; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hayat MA, 1973, PRINCIPLES TECHNIQUE, V3, P237; Hickson-Bick DLM, 2000, J MOL CELL CARDIOL, V32, P511, DOI 10.1006/jmcc.1999.1098; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hu ZY, 2009, J CLIN INVEST, V119, P3059, DOI 10.1172/JCI38770; HUNNICUTT JW, 1994, DIABETES, V43, P540, DOI 10.2337/diabetes.43.4.540; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kamara K, 1998, PHYSIOL BEHAV, V64, P1, DOI 10.1016/S0031-9384(97)00534-9; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Koh EH, 2003, DIABETES, V52, P2331, DOI 10.2337/diabetes.52.9.2331; Korach-Andre M, 2005, AM J PHYSIOL-ENDOC M, V288, pE106, DOI 10.1152/ajpendo.00089.2004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011; Lillie RD, 1976, HISTOPATHOLOGIC TECH, Vfourth, P559; Lin H, 2004, COMP BIOCHEM PHYS B, V139, P737, DOI 10.1016/j.cbpc.2004.09.013; Liu ZQ, 2004, AM J PHYSIOL-ENDOC M, V287, pE275, DOI 10.1152/ajpendo.00457.2003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mordier S, 2007, BIOCHEM BIOPH RES CO, V362, P206, DOI 10.1016/j.bbrc.2007.08.004; Nader N, 2010, MOL ENDOCRINOL, V24, P1748, DOI 10.1210/me.2010-0192; Nakken GN, 2010, J APPL PHYSIOL, V108, P298, DOI 10.1152/japplphysiol.00906.2009; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Prasad SSSV, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-111; Proszkowiec-Weglarz M, 2006, COMP BIOCHEM PHYS B, V143, P92, DOI 10.1016/j.cbpb.2005.10.009; Qi D, 2004, DIABETES, V53, P1790, DOI 10.2337/diabetes.53.7.1790; Qi D, 2006, AM J PHYSIOL-ENDOC M, V291, P420; Rivas DA, 2009, J ENDOCRINOL, V202, P441, DOI 10.1677/JOE-09-0202; Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105; Ruderman NB, 2006, OBESITY, V14, p25S, DOI 10.1038/oby.2006.279; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; RYDER JM, 1985, J AGR FOOD CHEM, V33, P678, DOI 10.1021/jf00064a027; Saha AK, 2003, MOL CELL BIOCHEM, V253, P65, DOI 10.1023/A:1026053302036; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Sekulic A, 2000, CANCER RES, V60, P3504; Shah OJ, 2000, AM J PHYSIOL, V279, P74; SIMON J, 1974, ENDOCRINOLOGY, V95, P1439, DOI 10.1210/endo-95-5-1439; Sipula IJ, 2006, METABOLISM, V55, P1637, DOI 10.1016/j.metabol.2006.08.002; SMOLENSKI RT, 1993, BIOMED CHROMATOGR, V7, P189, DOI 10.1002/bmc.1130070404; Staiger H, 2005, DIABETOLOGIA, V48, P2115, DOI 10.1007/s00125-005-1895-z; Stuart M, 2010, END ABSTR, V21, P180; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wang XJ, 2012, STRESS, V15, P443, DOI 10.3109/10253890.2011.639413; Wang XJ, 2010, COMP BIOCHEM PHYS C, V151, P447, DOI 10.1016/j.cbpc.2010.01.010; Watt MJ, 2006, J PHYSIOL-LONDON, V574, P139, DOI 10.1113/jphysiol.2006.107318; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Zhang JL, 2004, AM J PHYSIOL-ENDOC M, V286, pE168, DOI 10.1152/ajpendo.00232.2003; Zhao JP, 2009, COMP BIOCHEM PHYS C, V149, P448, DOI 10.1016/j.cbpc.2008.10.106	75	658	680	34	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36663	10.1371/journal.pone.0036663	http://dx.doi.org/10.1371/journal.pone.0036663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22808095	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500022
J	Wang, XL; Wurmser, C; Pausch, H; Jung, S; Reinhardt, F; Tetens, J; Thaller, G; Fries, R				Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Reinhardt, Friedrich; Tetens, Jens; Thaller, Georg; Fries, Ruedi			Identification and Dissection of Four Major QTL Affecting Milk Fat Content in the German Holstein-Friesian Population	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; GROWTH-HORMONE RECEPTOR; MISSENSE MUTATION; GENE; DGAT1; AGPAT6; YIELD; TRANSCRIPTION; EXPRESSION; TISSUE	Milk composition traits exhibit a complex genetic architecture with a small number of major quantitative trait loci (QTL) explaining a large fraction of the genetic variation and numerous QTL with minor effects. In order to identify QTL for milk fat percentage (FP) in the German Holstein-Friesian (HF) population, a genome-wide association study (GWAS) was performed. The study population consisted of 2327 progeny-tested bulls. Genotypes were available for 44,280 SNPs. Phenotypes in the form of estimated breeding values (EBVs) for FP were used as highly heritable traits. A variance components-based approach was used to account for population stratification. The GWAS identified four major QTL regions explaining 46.18% of the FP EBV variance. Besides two previously known FP QTL on BTA14 (P = 8.91x10-(198)) and BTA20 (P = 7.03x10(-12)) within DGAT1 and GHR, respectively, we uncovered two additional QTL regions on BTA5 (P = 2.00x10(-13)) and BTA27 (P = 9.83x10(-5)) encompassing EPS8 and GPAT4, respectively. EPS8 and GPAT4 are involved in lipid metabolism in mammals. Re-sequencing of EPS8 and GPAT4 revealed 50 polymorphisms. Genotypes for five of them were inferred for the entire study population. Two polymorphisms affecting potential transcription factor binding sites of EPS8 (P = 1.40x10(-12)) and GPAT4 (P = 5.18x10(-5)), respectively, were highly significantly associated with the FP EBV. Our results provide evidence that alteration of regulatory sites is an important aspect of genetic variation of complex traits in cattle.	[Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Fries, Ruedi] Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany; [Reinhardt, Friedrich] Vereinigte Informat Syst Tierhaltung wV, Verden, Germany; [Tetens, Jens; Thaller, Georg] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany	Technical University of Munich; University of Kiel	Wang, XL (corresponding author), Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany.	xiaolong.wang@tierzucht.tum.de	Pausch, Hubert/U-5934-2019; Sun, Fen/I-8516-2016; Zeng, Maomao/M-1422-2013; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Prokopenko, Mikhail/A-3995-2008; Wang, X. Rosalind/B-7097-2008	Pausch, Hubert/0000-0002-0501-6760; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Tang, Hailiang/0000-0003-1852-3128; SUN, FEN/0000-0003-2094-9494; Wurmser, Christine/0000-0003-0649-6206; Yu, Zhuowei/0000-0002-9152-6491; Wang, Xuelong/0000-0003-4616-1531; Kou, Xiaoxing/0000-0001-9680-0077; Prokopenko, Mikhail/0000-0002-4215-0344; Miller, Jennifer/0000-0003-2110-3693; Wang, X. Rosalind/0000-0001-5454-6197; Fries, Ruedi/0000-0002-4657-1787; Mao, Ying/0000-0001-8055-115X	German Ministry of Education and Research, BMBF [0315134A, 0315134D, 0315131A]; Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)	German Ministry of Education and Research, BMBF(Federal Ministry of Education & Research (BMBF)); Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)(China Scholarship Council)	This study is part of the projects FUGATO-plus GenoTrack and FUGATO-plus MeGA-M and was financially supported by the German Ministry of Education and Research, BMBF (grants 0315134A, 0315134D and 0315131A), the Forderverein Biotechnologieforschung e.V. (FBF), Bonn, and Lohmann Tierzucht GmbH, Cuxhaven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the vit w.V. Verden for providing phenotype data and the China Scholarship Council (CSC) for supporting X. Wang by a grant.	Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Bionaz M, 2008, J NUTR, V138, P1019, DOI 10.1093/jn/138.6.1019; Blott S, 2003, GENETICS, V163, P253; Bouwman AC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-43; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Buttchereit N, 2010, J DAIRY SCI, V93, P1702, DOI 10.3168/jds.2009-2198; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Chatterjee S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005197; Cohen-Zinder M, 2005, GENOME RES, V15, P936, DOI 10.1101/gr.3806705; Ed L, 2009, BIOINFORMATICS, V25, P1836, DOI 10.1093/bioinformatics/btp314; FAZIOLI F, 1993, EMBO J, V12, P3799, DOI 10.1002/j.1460-2075.1993.tb06058.x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gremme G, 2005, INFORM SOFTWARE TECH, V47, P965, DOI 10.1016/j.infsof.2005.09.005; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Guo DL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000446; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Loor JJ, 2005, PHYSIOL GENOMICS, V23, P217, DOI 10.1152/physiolgenomics.00132.2005; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Portales-Casamar E, 2009, JASPAR 2010 GREATLY; Quackenbush J, 2001, NUCLEIC ACIDS RES, V29, P159, DOI 10.1093/nar/29.1.159; Schennink A, 2007, ANIM GENET, V38, P467, DOI 10.1111/j.1365-2052.2007.01635.x; Schennink A, 2009, ANIM GENET, V40, P909, DOI 10.1111/j.1365-2052.2009.01940.x; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Signorelli F, 2009, LIVEST SCI, V125, P74, DOI 10.1016/j.livsci.2009.02.014; Thaller G, 2003, J ANIM SCI, V81, P1911; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Viitala S, 2006, GENETICS, V173, P2151, DOI 10.1534/genetics.105.046730; Winter A, 2002, P NATL ACAD SCI USA, V99, P9300, DOI 10.1073/pnas.142293799; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	35	658	680	34	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40711	10.1371/journal.pone.0040711	http://dx.doi.org/10.1371/journal.pone.0040711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808095	gold, Green Submitted, Green Published			2022-12-27	WOS:000306362400093
